PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Figaji, AA; Fieggen, AG; Sandler, SJI; Argent, AC; Le Roux, PD; Peter, JC				Figaji, A. A.; Fieggen, A. G.; Sandler, S. J. I.; Argent, A. C.; Le Roux, P. D.; Peter, J. C.			Intracranial pressure and cerebral oxygenation changes after decompressive craniectomy in a child with traumatic brain swelling	CHILDS NERVOUS SYSTEM			English	Article						decompressive craniectomy; cerebral tissue oxygenation; raised intracranial pressure; monitoring; traumatic brain injury; children	SEVERE HEAD-INJURY; TISSUE OXYGEN; INSPIRED OXYGEN; BLOOD-FLOW; HYPERTENSION; CRANIOTOMY; MORTALITY; RELEVANCE; LACTATE	Case report The authors present the case of a 5-year-old child with severe traumatic brain injury in whom decompressive hemicraniectomy was performed for progressive increased intracranial pressure (ICP) unresponsive to medical treatment. Data from ICP and cerebral tissue oxygenation monitoring in the contralateral hemisphere were recorded, which demonstrated the immediate and delayed mechanical and physiological changes occurring after bony and dural decompression. Discussion The role of the procedure and that of the monitoring approach are discussed.	Univ Cape Town, Red Cross Childrens Hosp, Div Neurosurg, Inst Child Hlth, ZA-7700 Cape Town, South Africa; Univ Cape Town, Red Cross Childrens Hosp, Div Pediat Crit Care, Inst Child Hlth, ZA-7700 Cape Town, South Africa; Univ Penn, Hosp Univ Penn, Dept Neurosurg, Philadelphia, PA 19107 USA		Figaji, AA (corresponding author), Univ Cape Town, Red Cross Childrens Hosp, Div Neurosurg, Inst Child Hlth, Klipfontein Rd, ZA-7700 Cape Town, South Africa.	afigaji@ich.uct.ac.za	Fieggen, Anthony Graham/AAT-6510-2021; Argent, Andrew/J-1605-2019	Fieggen, Anthony Graham/0000-0001-6541-8377; Argent, Andrew/0000-0001-9333-2036; Figaji, Anthony/0000-0002-3357-6490			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; Cooper P R, 1976, Surg Neurol, V5, P25; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Figaji AA, 2006, SAMJ S AFR MED J, V96, P969; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Johnson DL, 1998, PEDIATR NEUROSURG, V28, P167, DOI 10.1159/000028643; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Marshall RS, 2004, CURR OPIN NEUROL, V17, P705, DOI 10.1097/00019052-200412000-00010; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; Panerai RB, 2004, BRIT J NEUROSURG, V18, P471, DOI 10.1080/02688690400012343; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Reithmeier T, 2005, ACTA NEUROCHIR, V147, P947, DOI 10.1007/s00701-005-0543-1; Stiefel MF, 2004, J NEUROSURG, V101, P241, DOI 10.3171/jns.2004.101.2.0241; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Valadka AB, 2002, ACT NEUR S, V81, P299	21	13	13	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	NOV	2007	23	11					1331	1335		10.1007/s00381-007-0388-4			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	212TJ	WOS:000249619400018	17632729				2022-02-06	
J	Vicente, E; Tramontina, F; Leite, MC; Nardin, P; Silva, M; Karkow, AR; Adolf, R; Lucion, AB; Netto, CA; Gottfried, C; Goncalves, CA				Vicente, Evelin; Tramontina, Francine; Leite, Marina C.; Nardin, Patricia; Silva, Mariane; Karkow, Ana R.; Adolf, Rafael; Lucion, Aldo B.; Netto, Carlos A.; Gottfried, Carmem; Goncalves, Carlos A.			S100b levels in the cerebrospinal fluid of rats are sex and anaesthetic dependent	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						anaesthesia; astrocyte; S100B; sex-dependent glial differentiation; thiopental	TRAUMATIC BRAIN-INJURY; PROTEIN CONCENTRATIONS; CULTURED ASTROCYTES; NEONATAL-RAT; AGE; SERUM; GLUTAMATE; BLOOD; STRESS; NEURODEGENERATION	1. In the present study, we investigated the effect of anaesthetics (thiopental, ketamine and halothane) on CSF concentrations of S100B, as well as a possible sex dependence, because several studies have suggested astrocytes as putative targets for oestrogen. 2. S100B is a calcium-binding protein that acts as a neurotrophic cytokine and is expressed in the central nervous system, predominantly by astrocytes. At nanomolar concentrations, S100B stimulates neurite outgrowth and glial glutamate uptake, as well as protecting neurons against glutamate excitoxicity. 3. Peripheral S100B concentrations, particularly in the serum and cerebrospinal fluid (CSF), have been used as a parameter of glial activation or death in several physiological and pathological conditions. 4. Higher levels of CSF S100B were found when rats were anaesthetized with thiopental; these levels, independently of anaesthetic, were sex dependent. Conversely, no effect of anaesthetic or sex was observed on serum concentrations of S100B. 5. The increase in CSF concentrations of S100B induced by thiopental was confirmed in non-anaesthetized neonatal rats and cortical astrocyte cultures. 6. Assuming CSF S100B as a marker of development, glial activation or even brain damage, investigations regarding the sex dependence of its concentration may be useful in gaining an understanding of sex variations in the behaviour and the pathological course of, as well as susceptibility to, many brain disorders. The findings of the present study reinforce the sex effect on synaptic plasticity and suggest a sex dependence of neural communication mediated by extracellular S100B without restricting the influence of astrocytes on the developmental phase.	Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Post Grad Programmes Neurosci, Porto Alegre, RS, Brazil; Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Post Grad Programmes Biochem, Porto Alegre, RS, Brazil; Univ Fed Rio Grande do Sul, Inst Basic Hlth Sci, Post Grad Programmes Physiol, Porto Alegre, RS, Brazil		Goncalves, CA (corresponding author), Univ Fed Rio Grande do Sul, ICBS, Dept Bioquim, Ramiro Barcelos,2600-Anxo, Porto Alegre, RS, Brazil.	casg@ufrgs.br	Lucion, Aldo/L-1518-2014; Gottfried, Carmem/AAG-2355-2019; Goncalves, Carlos AS/K-1851-2014	Gottfried, Carmem/0000-0001-8838-1300; /0000-0002-1907-6051; Netto, Carlos Alexandre/0000-0002-0596-5667; Nardin, Patricia/0000-0003-0719-9369			Ahlemeyer B, 2000, BRAIN RES, V858, P121, DOI 10.1016/S0006-8993(99)02438-5; Bruschettini M, 2005, DEV BRAIN RES, V159, P113, DOI 10.1016/j.devbrainres.2005.07.003; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; ESOUZA MT, 2000, PHYSIOL BEHAV, V71, P29; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Gazzolo D, 2000, CLIN CHEM, V46, P998; Gerlai R, 1996, NEUROBIOL LEARN MEM, V66, P143, DOI 10.1006/nlme.1996.0055; Gottfried C, 2003, NEUROSCIENCE, V121, P553, DOI 10.1016/S0306-4522(03)00557-8; Hachem S, 2005, GLIA, V51, P81, DOI 10.1002/glia.20184; Himmelseher S, 2005, ANESTH ANALG, V101, P524, DOI 10.1213/01.ANE.0000160585.43587.5B; Kleindienst A, 2005, J NEUROSURG, V102, P1115, DOI 10.3171/jns.2005.102.6.1115; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Leite MC, 2006, BRAIN RES BULL, V70, P179, DOI 10.1016/j.brainresbull.2006.05.003; Margis R, 2004, BRAIN RES, V1028, P213, DOI 10.1016/j.brainres.2004.09.013; Mong JA, 2006, NEUROSCIENCE, V138, P967, DOI 10.1016/j.neuroscience.2005.10.017; Morale MC, 2006, NEUROSCIENCE, V138, P869, DOI 10.1016/j.neuroscience.2005.07.060; Netto CBO, 2006, ARCH MED RES, V37, P683, DOI 10.1016/j.arcmed.2005.11.005; Nygaard O, 1997, CLIN CHEM, V43, P541; ODowd BS, 1997, NEUROBIOL LEARN MEM, V67, P197, DOI 10.1006/nlme.1997.3766; Portela LVC, 2002, CLIN CHEM, V48, P950; Qu H, 1999, BIOCHEM PHARMACOL, V58, P1075, DOI 10.1016/S0006-2952(99)00175-6; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; SAIJA A, 1989, NEUROPHARMACOLOGY, V28, P997, DOI 10.1016/0028-3908(89)90202-5; Scaccianoce S, 2004, BRAIN RES, V1004, P208, DOI 10.1016/j.brainres.2004.01.028; Schousboe A, 2003, NEUROCHEM RES, V28, P347, DOI 10.1023/A:1022397704922; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Tort ABL, 2003, CLIN BIOCHEM, V36, P629, DOI 10.1016/S0009-9120(03)00107-3; Tramontina F, 2006, CELL MOL NEUROBIOL, V26, P81, DOI 10.1007/s10571-006-9099-8; Tramontina F, 2000, BRAIN RES PROTOC, V6, P86, DOI 10.1016/S1385-299X(00)00041-6; Tramontina F, 2006, NEUROCHEM RES, V31, P815, DOI 10.1007/s11064-006-9085-z; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Van den Hove DLA, 2006, NEUROREPORT, V17, P1077, DOI 10.1097/01.wnr.0000223391.74575.c9; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; Vicente E, 2004, NEUROTOXICOLOGY, V25, P771, DOI 10.1016/j.neuro.2004.03.001; Wiesmann M, 1998, CLIN CHEM, V44, P1056; Willoughby KA, 2004, J NEUROCHEM, V91, P1284, DOI 10.1111/j.1471-4159.2004.02812.x	38	13	13	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1440-1681			CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	NOV	2007	34	11					1126	1130		10.1111/j.1440-1681.2007.04687.x			5	Pharmacology & Pharmacy; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Physiology	210VK	WOS:000249483500007	17880365				2022-02-06	
J	Lew, HL; Thomander, D; Gray, M; Poole, JH				Lew, Henry L.; Thomander, Darryl; Gray, Max; Poole, John H.			The effects of increasing stimulus complexity in event-related Potentials and reaction time testing: Clinical applications in evaluating patients with traumatic brain injury	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article						event related potential; P300; reaction time; traumatic brain injury; posttraurnatic amnesia	MILD HEAD-INJURY; BIOLOGICAL DETERMINANTS; P300; RECOVERY; ERP; PERFORMANCE; MODERATE; LATENCY; TASK	This study compared the effectiveness of P300 event related potentials (ERPs) and reaction time (RT) in discriminating patients with traumatic brain injury (TBI) from healthy control subjects. In particular, we examined how the use of more complex, ecologically relevant stimuli may affect the clinical utility of these tasks. We also evaluated how length of posttraumatic amnesia (PTA) and loss of consciousness (LOC) related to P300 and RT measures in our patient sample. There were 22 subjects (I I patients with TBI and I I age-matched healthy control subjects). Four stimulus detection procedures were used: two using simple, conventional stimuli (auditory tone discrimination, AT; visual color discrimination, VC), and two using complex, ecologically relevant stimuli in the auditory and visual modalities (auditory word category discrimination, AWC; visual facial affect discrimination, VFA). Our results showed that RT measures were more effective in identifying TBI patients when complex stimuli were used (AWC and VFA). On the other hand, ERP measures were more effective in identifying TBI patients when simple stimuli were used (AT and VC). We also found a remarkably high correlation between duration of PTA and P300 amplitude.	VAPAHCS, PM&R Serv, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; VA Palo Alto Hlth Care Syst, Def & Vet & Brain Injury Ctr, Palo Alto, CA USA; VA Palo Alto Hlth Care Syst, Dept Psychol, Palo Alto, CA USA		Lew, HL (corresponding author), VAPAHCS, PM&R Serv, MS-B117,3801 Miranda Ave, Palo Alto, CA 94304 USA.	henrylew@stanford.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5K12HD01097] Funding Source: Medline		Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; CARDENAS V, 1996, BRAIN INJURY, V10, P79; CICERONE K, 2006, BRAIN INJURY, V10, P79; Clark C. R., 1992, Brain Injury, V6, P509, DOI 10.3109/02699059209008148; Eger E, 2003, NEUROPSYCHOLOGIA, V41, P808, DOI 10.1016/S0028-3932(02)00287-7; Ekman P., 1976, PICTURES FACIAL AFFE; Fowler B, 1997, BIOL PSYCHOL, V46, P113, DOI 10.1016/S0301-0511(97)05253-8; Hogan AM, 2006, BRAIN, V129, P2177, DOI 10.1093/brain/awl160; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Levinson DM, 1997, ARCH CLIN NEUROPSYCH, V12, P155, DOI 10.1016/S0887-6177(96)00026-1; Lew HL, 2006, J HEAD TRAUMA REHAB, V21, P350, DOI 10.1097/00001199-200607000-00006; Lew HL, 2005, AM J PHYS MED REHAB, V84, P393, DOI 10.1097/01.phm.0000163703.91647.a7; Lew HL, 2005, J REHABIL RES DEV, V42, P29, DOI 10.1682/JRRD.2004.05.0056; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Lew HL, 2003, AM J PHYS MED REHAB, V82, P53, DOI [10.1097/00002060-200301000-00009, 10.1097/01.PHM.0000043771.90606.81]; Lew HL, 2002, AM J PHYS MED REHAB, V81, P524, DOI 10.1097/00002060-200207000-00011; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; NISHIMURA N, 1995, PSYCHIAT CLIN NEUROS, V49, P79, DOI 10.1111/j.1440-1819.1995.tb01863.x; Novitski N, 2004, COGNITIVE BRAIN RES, V20, P26, DOI 10.1016/j.cogbrainres.2003.12.011; Ohnuma A, 1994, Rinsho Shinkeigaku, V34, P5; OLBRICH HM, 1986, SURG NEUROL, V26, P112, DOI 10.1016/0090-3019(86)90362-9; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; POLICH J, 1987, ELECTROEN CLIN NEURO, V68, P311, DOI 10.1016/0168-5597(87)90052-9; Potter DD, 2001, NEUROPSYCHOLOGIA, V39, P1464, DOI 10.1016/S0028-3932(01)00057-4; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Solbakk AK, 2000, J CLIN EXP NEUROPSYC, V22, P743, DOI 10.1076/jcen.22.6.743.953; STARBUCK VN, 1995, NEUROPSY NEUROPSY BE, V8, P189; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; Viggiano MP, 1996, J CLIN EXP NEUROPSYC, V18, P631, DOI 10.1080/01688639608408288; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; WAYMAN JW, 1992, J ACOUST SOC AM, V91, P3527, DOI 10.1121/1.402841	34	13	13	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0736-0258			J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	OCT	2007	24	5					398	404		10.1097/WNP.0b013e318150694b			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	221FS	WOS:000250213400005	17912064				2022-02-06	
J	Oertel, MF; Schwedler, M; Stein, M; Wachter, D; Scharbrodt, W; Schmidinger, A; Boker, DK				Oertel, Matthias F.; Schwedler, Madlen; Stein, Marco; Wachter, Dorothee; Scharbrodt, Wolfram; Schmidinger, Andrea; Boeker, Dieter-Karsten			Cerebral energy failure after subarachnoid hemorrhage: The role of relative hyperglycolysis	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						subarachnoid hemorrhage; hyperglycolysis; glucose metabolism; oxygen metabolism; energy crises; outcome	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; ACUTE STAGE; EMISSION TOMOGRAPHY; CLINICAL-TRIAL; BLOOD-FLOW; METABOLISM; MICRODIALYSIS; DYSFUNCTION; VASOSPASM	After subarachnoid hemorrhage (SAH) cerebral metabolism is significantly impaired. Hyperglycolysis describes the reduction of oxidative metabolism followed by a relative increase of anaerobic glycolysis to maintain energy supply. This phenomenon is known in head injury but has not as yet been shown after SAH. This Study was conducted to test the hypothesis that hyperglycolysis is present ill SAH patients and is associated with vasospasm. A total of 105 measurements were conducted on 21 SAH patients (age 49 +/- 15 years, median World Federation of Neurosurgical Societies Grade 4) over the first 5 days following admission. Arteriovenous differences were calculated for oxygen (avDO(2)) and glucose (avDGlc). Relative hyperglycolysis was defined as metabolic ratio (MR = avDO(2)[mmol/L]/avDGlc[mmol/L]) < 3.44. Juaular-venous saturation for oxygen (SjvO(2)), mean arterial blood pressure (MAP), intracranial pressure (ICP), cerebral perfusion pressure (CPP) were monitored. Relative hyperglycolyis was recorded in 34% of studies after SAH. In hyperglycolytic studies both jugular-venous lactate and SjvO, were significantly elevated (jugular-venous lactate 14.9 +/- 9.9 us. 11.8 +/- 5.5 mg/dL, p = 0.04; SjvO(2): 70.0 +/- 18% us. 81.7 +/- 9%, p = 0.002). Relative hyperglycolysis is associated with outcome after SAH. In patients who died after SAH almost 50% of Studies showed hyperglycolysis, whereas patients who survived without neurological deficit had no hyperglycolytic events. Relative hyperglycolysis is a common event after SAH. It may be associated with relative hyperemia but most importantly with outcome. (c) 2006 Elsevier Ltd. All rights reserved.	Univ Hosp, Dept Neurosurg, D-35385 Giessen, Germany		Oertel, MF (corresponding author), Univ Hosp, Dept Neurosurg, Klinikstrasse 29, D-35385 Giessen, Germany.	matthias.oertel@neuro.med.uni-giessen.de	Mielke, Dorothee/AAU-6776-2021				AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Adembri C, 2006, ANESTHESIOLOGY, V104, P80, DOI 10.1097/00000542-200601000-00014; ATKINS DL, 1998, DEV TRANSMEMBRANE AC; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Cesarini KG, 2002, ACTA NEUROCHIR, V144, P1121, DOI 10.1007/s00701-002-1011-9; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Frykholm P, 2004, ACTA NEUROL SCAND, V109, P25, DOI 10.1034/j.1600-0404.2003.00174.x; GAAB MR, 1990, ACT NEUR S, V51, P320; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Hayashi T, 2000, J NEUROSURG, V93, P1014, DOI 10.3171/jns.2000.93.6.1014; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; HOVDA DA, 1990, ACT NEUR S, V51, P331; JENNETT B, 1975, LANCET, V7905, P480; KASSELL NF, 1985, STROKE, V16, P562, DOI 10.1161/01.STR.16.4.562; KAWAMURA S, 1992, ACTA NEUROCHIR, V114, P12, DOI 10.1007/BF01401107; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; King W A, 1994, Neurosurg Clin N Am, V5, P767; Marmarou A, 1993, Acta Neurochir Suppl (Wien), V57, P160; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Nilsson OG, 1999, NEUROSURGERY, V45, P1176, DOI 10.1097/00006123-199911000-00032; O'Connell MT, 2005, ACTA NEUROCHIR SUPPL, V95, P165; Oertel M, 2002, ACT NEUR S, V81, P69; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Pickard JD, 2005, ACT NEUR S, V95, P459; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Sarrafzadeh A, 2004, J NEUROSURG, V100, P400, DOI 10.3171/jns.2004.100.3.0400; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; SEITZ HD, 1977, ACTA NEUROCHIR, V38, P211, DOI 10.1007/BF01401092; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; WOLF AL, 1993, J NEUROSURG, V78, P54, DOI 10.3171/jns.1993.78.1.0054; Wu GJ, 2005, ANN NY ACAD SCI, V1042, P168, DOI 10.1196/annals.1338.019	32	13	14	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	OCT	2007	14	10					948	954		10.1016/j.jocn.2006.11.002			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	217HE	WOS:000249938200006	17669657				2022-02-06	
J	Dehail, P; Petit, H; Joseph, PA; Vuadens, P; Mazaux, JM				Dehail, Patrick; Petit, Herve; Joseph, Pierre-Alain; Vuadens, Philippe; Mazaux, Jean-Michel			Assessment of postural instability in patients with traumatic brain injury upon enrolment in a vocational adjustment programme	JOURNAL OF REHABILITATION MEDICINE			English	Article						balance impairment; posturography; traumatic brain; injury; return to work	BALANCE DEFICITS; HEAD-INJURY; REHABILITATION; ADMISSION; MODERATE; OUTCOMES; SWAY	Objective: To assess postural instability in patients with traumatic brain injury upon enrolment to vocational adjustment. Design: A cross-sectional study. Patients and methods: Sixty-eight patients at the time of admission to a vocational adjustment programme and 52 healthy age-matched controls were evaluated. Complaints of dizziness, or balance impairment and data from a clinical examination were recorded. Postural characteristics during quiet upright standing were assessed using a static posturographic platform. Results: Twenty-six patients complained of dizziness or instability and 36 had evidence of neurological impairment. Centre of pressure displacement and area were significantly increased in the traumatic brain injury group as a whole, compared with controls, even among 23 patients who had no complaint or clinical abnormality. Conclusion: In spite of a high variability in time since injury, significant posturographic abnormalities were found in patients with traumatic brain injury, including those who had no complaints or evidence of neurological impairment. Posturography may help in understanding how a traumatic brain injury impairs the human balance, and may provide helpful information for patients participating in vocational adjustment programmes, especially when jobs require a long standing posture or balance.	Hop Pellegrin, CHU Bordeaux, Serv Med Phys Readaptat, F-33076 Bordeaux, France; Univ Victor Segalen, Ctr Hosp Univ Bordeaux, EA Handicap Syst Nerveux, Rehabil Unit,UEROS Aquitaine Network, Bordeaux, France; Clin Romande Readaptat, Sion, Switzerland		Dehail, P (corresponding author), Hop Pellegrin, CHU Bordeaux, Serv Med Phys Readaptat, F-33076 Bordeaux, France.	patrick.dehail@chu-bordeaux.fr	Dehail, Patrick/T-5081-2019				Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Black K, 2000, BRAIN INJURY, V14, P141, DOI 10.1080/026990500120808; BROOKS N, 1994, EUROPEAN HEAD INJURY; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Greenwald BD, 2001, J HEAD TRAUMA REHAB, V16, P238, DOI 10.1097/00001199-200106000-00003; Gurr B, 2001, BRAIN INJURY, V15, P387, DOI 10.1080/02699050010005904; Juneja G, 1998, AM J PHYS MED REHAB, V77, P388, DOI 10.1097/00002060-199809000-00005; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; Mrazik M, 2000, BRAIN INJURY, V14, P921, DOI 10.1080/026990500445736; NEWTON RA, 1995, BRAIN INJURY, V9, P445, DOI 10.3109/02699059509008204; Raven J., 1976, MANUAL RAVENS PROGRE; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Wechsler D, 1974, WECHSLER MEMORY SCAL; Wechsler D., 1981, WAIS R MANUAL; WOBER C, 1993, ARCH PHYS MED REHAB, V74, P1151	18	13	13	0	4	TAYLOR & FRANCIS AS	OSLO	PO BOX 12 POSTHUSET, NO-0051 OSLO, NORWAY	1650-1977			J REHABIL MED	J. Rehabil. Med.	SEP	2007	39	7					531	536		10.2340/16501977-0096			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	213IS	WOS:000249660700005	17724552	Green Submitted, gold			2022-02-06	
J	Keiski, MA; Shore, DL; Hamilton, JM				Keiski, Michelle A.; Shore, Douglas L.; Hamilton, Joanna M.			The role of depression in verbal memory following traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article						depression; memory; traumatic brain injury	MAJOR DEPRESSION; LEARNING TEST; HEAD-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT; SUBCORTICAL DYSFUNCTION; CLINICAL DEPRESSION; RECOGNITION MEMORY; PREFRONTAL CORTEX; TEST-PERFORMANCE; EPISODIC MEMORY	The purpose of this study was to characterize the relationship between verbal memory and depression scores on the Personality Assessment Inventory folio wing traumatic brain injury. Depression was associated with diminished delayed recall and recognition on the California Verbal Learning Test-H (CVLT-II), even after controlling for a neuropsychological composite score and/or a measure of motivation (i.e., the TOMM). There was no relationship between depression and recall on Verbal Paired Associates or Logical Memory when controlling for the same covariates. The findings were most consistent with depressed subjects failing to utilize the semantic organization of the CVLT-II list to enhance their learning.	Univ Windsor, Dept Psychol, Windsor, ON N9B 3P4, Canada		Keiski, MA (corresponding author), Univ Windsor, Dept Psychol, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	keiski@uwindsor.ca					ALOIA MS, 1995, BRAIN INJURY, V9, P575, DOI 10.3109/02699059509008216; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; [Anonymous], 1997, WECHSLER MEMORY SCAL; ATTEBERRYBENNETT J, 1986, INT J CLIN NEUROPSYC, V8, P114; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BOONE KB, 1995, NEUROPSYCHOLOGY, V9, P390, DOI 10.1037/0894-4105.9.3.390; BRAND AN, 1992, J AFFECT DISORDERS, V25, P77, DOI 10.1016/0165-0327(92)90095-N; CALEV A, 1985, BRIT J CLIN PSYCHOL, V24, P127, DOI 10.1111/j.2044-8260.1985.tb01323.x; CHANNON S, 1993, J ABNORM PSYCHOL, V102, P323, DOI 10.1037/0021-843X.102.2.323; COHEN RM, 1982, ARCH GEN PSYCHIAT, V39, P593; Coleman EA, 1996, BIOL PSYCHIAT, V39, P346, DOI 10.1016/0006-3223(95)00185-9; COUGHLAN AK, 1984, BRIT J PSYCHIAT, V145, P164, DOI 10.1192/bjp.145.2.164; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Delis D.C., 2000, CVLT 2 CALIFORNIA VE; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; DOLAN RJ, 1994, PSYCHOL MED, V24, P849, DOI 10.1017/S0033291700028944; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; FOSSATI P, 1995, ENCEPHALE, V21, P295; GASS CS, 1986, J CONSULT CLIN PSYCH, V54, P261, DOI 10.1037/0022-006X.54.2.261; GOLINKOFF M, 1989, J AFFECT DISORDERS, V17, P105, DOI 10.1016/0165-0327(89)90032-3; Grant MM, 2001, BIOL PSYCHIAT, V50, P35, DOI 10.1016/S0006-3223(00)01072-6; Heaton RK, 1991, COMPREHENSIVE NORMS; HERTEL PT, 1990, J EXP PSYCHOL GEN, V119, P45, DOI 10.1037/0096-3445.119.1.45; Hertel PT, 2000, PSYCHOL LEARN MOTIV, V39, P47, DOI 10.1016/S0079-7421(00)80030-4; ILSLEY JE, 1995, J AFFECT DISORDERS, V35, P1, DOI 10.1016/0165-0327(95)00032-I; Kramer JH, 2005, NEUROPSYCHOLOGY, V19, P799, DOI 10.1037/0894-4105.19.6.799; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; LARRABEE GJ, 1986, J CLIN EXP NEUROPSYC, V8, P275, DOI 10.1080/01688638608401318; MASSMAN PJ, 1992, J CLIN EXP NEUROPSYC, V14, P687, DOI 10.1080/01688639208402856; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Morey LC, 1991, PERSONALITY ASSESMEN; NEWMAN PJ, 1986, INT J CLIN NEUROPSYC, V8, P109; NEWMAN PJ, 1992, HDB NEUROPSYCHOLOGIC, P263; Nitschke JB, 2004, BIOL PSYCHOL, V67, P125, DOI 10.1016/j.biopsycho.2004.03.004; Novack TA, 2000, BRAIN INJURY, V14, P987; OTTO MW, 1994, ARCH CLIN NEUROPSYCH, V9, P81, DOI 10.1016/0887-6177(94)90016-7; Payne HC, 2000, BRAIN INJURY, V14, P479, DOI 10.1080/026990500120583; PRIGATANO GP, 1987, NEUROBEHAVIORAL RECO, P216; Purcell R, 1997, PSYCHOL MED, V27, P1277, DOI 10.1017/S0033291797005448; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; RICHARDS PM, 1989, J CONSULT CLIN PSYCH, V57, P396, DOI 10.1037/0022-006X.57.3.396; RUTTAN LA, 1998, DISSERTAION ABSTRACT, V59, P2432; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; SWEET JJ, 1992, CLIN PSYCHOL REV, V12, P21, DOI 10.1016/0272-7358(92)90090-U; Tabachnick B., 2001, USING MULIVARIATE ST; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; VEIEL HOF, 1997, J CLIN ECPT NEUROPSY, V19, P487; WEINGARTNER H, 1981, ARCH GEN PSYCHIAT, V38, P42; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Wilde MC, 1995, J CLIN EXP NEUROPSYC, V17, P849, DOI 10.1080/01688639508402434; WOLFE J, 1987, J AFFECT DISORDERS, V13, P83, DOI 10.1016/0165-0327(87)90077-2; Zakzanis KK, 1998, NEUROPSY NEUROPSY BE, V11, P111	59	13	13	1	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	SEP	2007	21	5					744	761		10.1080/13854040600775346			18	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	210KO	WOS:000249455300002	17676541				2022-02-06	
J	Philbin, N; Handrigan, M; Rice, J; McNickle, K; McGwin, G; Williams, R; Warndorf, M; Arnaud, F; Malkevich, N; McCarron, R; Freilich, D				Philbin, Nora; Handrigan, Michael; Rice, Jennifer; McNickle, Kyle; McGwin, Gerald; Williams, Rita; Warndorf, Mathew; Arnaud, Francoise; Malkevich, Nina; McCarron, Richard; Freilich, Daniel			Resuscitation following severe, controlled hemorrhage associated with a 24 h delay to surgical intervention in swine using a hemoglobin based oxygen carrier as an oxygen bridge to definitive care	RESUSCITATION			English	Article						hemorrhage; trauma; hypovolemic shock; resuscitation; HBOC-201; swine	BOVINE POLYMERIZED HEMOGLOBIN; TRAUMATIC BRAIN-INJURY; LIVER-INJURY; VOLUME RESUSCITATION; COMBAT CASUALTIES; HETASTARCH HEX; BLOOD-LOSS; HBOC-201; MODEL; SHOCK	Objectives: To test our hypothesis that the hemoglobin based oxygen carrier HBOC-201 would have similar or superior efficacy to 6% hetastarch (HEX) as a pre-hospital 'bridging' fluid for hemorrhagic shock when delay to definitive medical care is prolonged to 24 h. Methods: Twenty-four pigs were anesthetized, instrumented, given a soft tissue injury, and bled 55% estimated blood volume. Pigs were randomized to receive HBOC-201, HEX, or no resuscitation fluids (NON). At 4h post-injury, surgical sites were repaired and pigs were recovered from anesthesia. Animals were non-invasively monitored, administered blood for anemia or saline for hypotension at 24 and 48 h, and monitored for 72 h. Results: Survival to 72 h was 87.5% (7/8) in HBOC-201 and HEX pigs compared to 25% (2/8) in NON pigs (p=0.01). Increased mean arterial pressure was observed in the HBOC-201 group (p < 0.0001). Cardiac index was highest in HEX pigs (overall p < 0.001, HBOC-201 versus HEX p = 0.002). Transcutaneous tissue oxygenation was higher with HBOC-201 (overall p = 0.04, HBOC-201 versus HEX p < 0.01). HBOC-201 and HEX pigs had comparable heart rates, pulmonary pressures, pre-hospital fluid requirements, venous O-2 saturation, base deficit, and lactic acid. Hemoglobin was decreased with HEX (overall p < 0.0001, HBOC-201 versus HEX p < 0.0002). At 24 h, 14.3% (1/7) HBOC-201 pigs required blood transfusions versus 100% HEX (7/7) and NON (2/2) pigs (p > 0.001). Conclusions: HBOC-201 restored hemodynamics, maintained tissue oxygenation, and decreased blood transfusions in comparison to HEX in severe controlled HS with 24h delay to simulated hospital care. These results support the potential use of HBOC-201 as a bridging resuscitation fluid for HS. (C) 2007 Published by Elsevier Ireland Ltd.	Naval Med Res Ctr, Silver Spring, MD USA; Univ Alabama Birmingham, Birmingham, AL USA		Handrigan, M (corresponding author), Naval Med Res Ctr, Combat Casulaty Care, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	Handriganm.ctr@nmrc.navy.mil					Arnoldo B D, 2001, Curr Opin Crit Care, V7, P431, DOI 10.1097/00075198-200112000-00010; Balogh Z, 2005, J TRAUMA, V58, P778, DOI 10.1097/01.TA.0000158251.40760.B2; Fitzpatrick CM, 2004, J AM COLL SURGEONS, V199, P693, DOI 10.1016/j.jamcollsurg.2004.07.025; Fitzpatrick MCM, 2005, J TRAUMA, V59, P273, DOI 10.1097/01.ta.0000174730.62338.88; Gould SA, 2002, J AM COLL SURGEONS, V195, P445, DOI 10.1016/S1072-7515(02)01335-2; Gurney J, 2004, J TRAUMA, V57, P726, DOI 10.1097/01.TA.0000147520.84792.B4; Hall RI, 2005, CAN J ANAESTH, V52, P895, DOI 10.1007/BF03022048; Handrigan MT, 2005, SHOCK, V23, P337, DOI 10.1097/01.shk.0000156667.04628.1f; Hiippala S, 1998, VOX SANG, V74, P399, DOI 10.1111/j.1423-0410.1998.tb05449.x; Kaplan LJ, 2006, J TRAUMA, V61, P90, DOI 10.1097/01.ta.0000222578.85413.4e; Katz LM, 2002, RESUSCITATION, V54, P77, DOI 10.1016/S0300-9572(02)00053-9; King DR, 2005, J TRAUMA, V59, P553, DOI 10.1097/01.ta.0000177711.52191.62; Knudson MM, 2003, J TRAUMA, V54, P242, DOI 10.1097/01.TA.0000037776.28201.75; Lee SK, 2002, ACAD EMERG MED, V9, P969; Levy JH, 2003, EXPERT OPIN BIOL TH, V3, P509, DOI 10.1517/14712598.3.3.509; Levy JH, 2002, J THORAC CARDIOV SUR, V124, P35, DOI 10.1067/mtc.2002.121505; Mabry RL, 2000, J TRAUMA, V49, P515, DOI 10.1097/00005373-200009000-00021; Manning JE, 2000, SHOCK, V13, P152, DOI 10.1097/00024382-200013020-00010; Martel Marie-Jocelyne, 2002, J Obstet Gynaecol Can, V24, P504; McNeil JD, 2001, J TRAUMA, V50, P1063, DOI 10.1097/00005373-200106000-00015; Patel MB, 2006, J TRAUMA, V61, P46, DOI 10.1097/01.ta.0000219730.71206.3a; Philbin N, 2005, RESUSCITATION, V66, P367, DOI 10.1016/j.resuscitation.2005.03.019; Rhee P, 2003, J TRAUMA, V54, pS52, DOI 10.1097/01.TA.0000064507.80390.10; RICE J, 2006, P 35 CRIT CAR C SOC; Rice J, 2006, SHOCK, V26, P302, DOI 10.1097/01.shk.0000226338.48033.c2; Sampson JB, 2003, J TRAUMA, V55, P747, DOI 10.1097/01.TA.0000084519.47163.77; York GB, 2003, J TRAUMA, V55, P873, DOI 10.1097/01.TA.0000092681.17874.6F	27	13	17	1	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	AUG	2007	74	2					332	343		10.1016/j.resuscitation.2006.12.018			12	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	236EP	WOS:000251286100019	17383073				2022-02-06	
J	Zhou, H; Gupta, A; Zou, T; Zhou, JH				Zhou, Hong; Gupta, Anju; Zou, Tie; Zhou, Jianhua			Photoresist derived carbon for growth and differentiation of neuronal cells	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						cell adhesion; carbon; nerve growth factor; nerve regeneration; scanning electron microscope	NERVE REGENERATION; LAMININ	Apoptosis or necrosis of neurons in the central nervous system (CNS) is the hallmark of many neurodegenerative diseases and Traumatic Brain Injury (TBI). The inability to regenerate in CNS offers little hope for naturally repairing the damaged neurons. However, with the rapid development of new technologies, regenerative medicine offers great promises to patients with these disorders. Among many events for further advancement of regenerative medicine, extracellular matrix (ECM) plays a critical role for cellular migration and differentiation. To develop a biocompatible and electrically conductive substrate that can be potentially used to promote growth and regeneration of neurons and to record intracellular and multisite signals from brain as a probe, a polymeric precursor - SPR 220.7 was fabricated by pyrolysis at temperatures higher than 700 degrees C. Human Neuroblastoma cells - SK-N-MC, SY5Y, mouse teratocarcinoma cells P-19 and rat PC12 cells were found to attach and proliferate on photoresist derived carbon film. Significantly, neuronal differentiation of PC12 cells induced by NGF was demonstrated by observing cell shape and size, and measuring the length of neurites under SEM. Our results indicated that fabricated carbon could potentially be explored in regenerative medicine for promoting neuronal growth and differentiation in CNS with neurodegeneration.	[Zhou, Hong; Gupta, Anju] Worcester Polytech Inst, Dept Chem Engn, Worcester, MA 01609 USA; [Zou, Tie; Zhou, Jianhua] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA		Zhou, H (corresponding author), Worcester Polytech Inst, Dept Chem Engn, 100 Inst Rd, Worcester, MA 01609 USA.	szhou@wpi.edu	Zhou, Hong Susan/AAP-6521-2020	Zhou, Hong Susan/0000-0002-6659-6965			BOKROS JC, 1983, MATERIALS SCI MONOGR, V17, P199; Chen YS, 2000, BIOMATERIALS, V21, P1541, DOI 10.1016/S0142-9612(00)00028-4; Evans GRD, 2000, SEMIN SURG ONCOL, V19, P312, DOI 10.1002/1098-2388(200010/11)19:3<312::AID-SSU13>3.0.CO;2-M; Fromherz P, 2002, CHEMPHYSCHEM, V3, P276, DOI 10.1002/1439-7641(20020315)3:3<276::AID-CPHC276>3.0.CO;2-A; HAYAT MA, 1978, INTRO BIOL SCANNING, P131; Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4; Jenkins G. M., 1980, CLIN PHYS PHYSIOL M, V1, P171, DOI DOI 10.1088/0143-0815/1/3/401; Kim J, 1998, J ELECTROCHEM SOC, V145, P2314, DOI 10.1149/1.1838636; MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089; MASSIA SP, 1993, J BIOL CHEM, V268, P8053; Singh A, 2002, J ELECTROCHEM SOC, V149, pE78, DOI 10.1149/1.1436085; Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009; Yao CJ, 2005, J ALTERN COMPLEM MED, V11, P903, DOI 10.1089/acm.2005.11.903; Zhang X, 2005, SENSOR ACTUAT B-CHEM, V106, P843, DOI 10.1016/j.snb.2004.10.039	14	13	13	0	6	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	AUG	2007	8	8					884	893		10.3390/i8080884			10	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	204PR	WOS:000249057000011		Green Published, Green Submitted, gold			2022-02-06	
J	Kuo, LT; Groves, MJ; Scaravilli, F; Sugden, D; An, SF				Kuo, L.-T.; Groves, M. J.; Scaravilli, F.; Sugden, D.; An, S. F.			Neurotrophin-3 administration alters neurotrophin, neurotrophin receptor and nestin mRNA expression in rat dorsal root ganglia following axotomy	NEUROSCIENCE			English	Article						real-time quantitative PCIR; neurogenesis; immunohistochemistry; in situ hybridization; micro-osmotic pump	NERVE GROWTH-FACTOR; PRIMARY SENSORY NEURONS; RETROGRADE AXONAL-TRANSPORT; TRAUMATIC BRAIN-INJURY; PERIPHERAL-NERVE; SCIATIC-NERVE; ADULT-RAT; DIFFERENTIAL EXPRESSION; FUNCTIONAL INTERACTIONS; PERICELLULAR BASKETS	In the months following transection of adult rat peripheral nerve some sensory neurons undergo apoptosis. Two weeks after sciatic nerve transection some neurons in the L4 and L5 dorsal root ganglia begin to show immunoreactivity for nestin, a filament protein expressed by neuronal precursors and immature neurons, which is stimulated by neurotrophin-3 (NT-3) administration. The aim of this study was to examine whether NT-3 administration could be compensating for decreased production of neurotrophins or their receptors after axotomy, and to determine the effect on nestin synthesis. The levels of mRNA in the ipsilateral and contralateral L4 and L5 dorsal root ganglia were analyzed using real-time polymerase chain reaction, 1 day, 1, 2 and 4 weeks after unilateral sciatic nerve transection and NT-3 or vehicle administration via s.c. micro-osmotic pumps. In situ hybridization was used to identify which cells and neurons expressed mRNAs of interest, and the expression of full-length trkC and p75(NTR) protein was investigated using immunohistochemistry. Systemic NT-3 treatment increased the expression of brain-derived neurotrophic factor, nestin, trkA, trkB and trkC mRNA in ipsilateral ganglia compared with vehicle-treated animals. Some satellite cells surrounding neurons expressed trkA and trkC mRNA and trkC immunoreactivity. NT-3 administration did not affect neurotrophin mRNA levels in the contralateral ganglia, but decreased the expression of trkA mRNA and increased the expression of trkB mRNA and p75(NTR) mRNA and protein. These data suggest that systemically administered NT-3 may counteract the decrease, or even increase, neurotrophin responsiveness in both ipsi- and contralateral ganglia after nerve injury. (c) 2007 IBRO. Published by Elsevier Ltd. All rights reserved.	UCL, Dept Mol Neurosci, Div Neuropathol, London WC1N 3BG, England; Kings Coll London, Sch Biomed & Hlth Sci, Div Reprod & Endocrinol, London SE1 1UL, England		Groves, MJ (corresponding author), UCL, Dept Mol Neurosci, Div Neuropathol, Queen Sq, London WC1N 3BG, England.	m.groves@ion.ucl.ac.uk	Kuo, Lu-Ting/AAU-3205-2021	Kuo, Lu-Ting/0000-0002-1405-8700			Araki T, 2001, J BIOL CHEM, V276, P34131, DOI 10.1074/jbc.M104271200; ARVIDSSON J, 1986, BRAIN RES, V373, P15, DOI 10.1016/0006-8993(86)90310-0; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; Bauer S, 2005, NEUROSCIENCE, V130, P75, DOI 10.1016/j.neuroscience.2004.08.047; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; Benn B, 1998, J COMP NEUROL, V401, P47, DOI 10.1002/(SICI)1096-9861(19981109)401:1<47::AID-CNE4>3.0.CO;2-C; Bergman E, 1999, J COMP NEUROL, V410, P368, DOI 10.1002/(SICI)1096-9861(19990802)410:3<368::AID-CNE2>3.0.CO;2-I; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.ne.18.030195.001255; Brannvall K, 2006, NEUROREPORT, V17, P623; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Ciaroni S, 2000, NEUROSCI LETT, V281, P69, DOI 10.1016/S0304-3940(00)00785-0; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; Corti S, 2002, J NEUROSCI RES, V70, P721, DOI 10.1002/jnr.10455; CURTIS R, 1995, NEURON, V14, P1201, DOI 10.1016/0896-6273(95)90267-8; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; Deng LLYS, 2000, NEUROSCI RES, V38, P183; Edsjo A, 2001, CELL GROWTH DIFFER, V12, P39; Edstrom A, 1996, NEUROSCIENCE, V75, P1165, DOI 10.1016/0306-4522(96)00324-7; ElShamy WM, 1998, NEURON, V21, P1003, DOI 10.1016/S0896-6273(00)80619-4; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; ERNFORS P, 1993, BRAIN RES MOL BRAIN, V17, P217; Fanarraga ML, 1999, EUR J NEUROSCI, V11, P517; Farinas I, 2002, BRAIN RES BULL, V57, P809, DOI 10.1016/S0361-9230(01)00767-5; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; FRIEDE RL, 1967, ACTA NEUROPATHOL, V7, P218, DOI 10.1007/BF00686373; FUNAKOSHI H, 1993, J CELL BIOL, V123, P455, DOI 10.1083/jcb.123.2.455; Geuna S, 2002, INT J DEV NEUROSCI, V20, P475, DOI 10.1016/S0736-5748(02)00059-X; Gratto KA, 2003, EUR J NEUROSCI, V18, P1535, DOI 10.1046/j.1460-9568.2003.02881.x; Groves MJ, 1997, J NEUROCYTOL, V26, P615, DOI 10.1023/A:1018541726460; Groves MJ, 1999, EXP NEUROL, V155, P284, DOI 10.1006/exnr.1998.6985; Groves MJ, 2003, J NEUROCYTOL, V32, P113, DOI 10.1023/B:NEUR.0000005596.88385.ec; Hapner SJ, 1998, DEV BIOL, V201, P90, DOI 10.1006/dbio.1998.8970; Helgren ME, 1997, J NEUROSCI, V17, P372, DOI 10.1523/JNEUROSCI.17-01-00372.1997; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; JACOBS JM, 1976, J NEUROL SCI, V29, P95, DOI 10.1016/0022-510X(76)90083-6; Karchewski LA, 2002, EUR J NEUROSCI, V16, P1449, DOI 10.1046/j.1460-9568.2002.02205.x; Kato T, 1999, NEUROREPORT, V10, P2769, DOI 10.1097/00001756-199909090-00013; Kaya SS, 1999, BRAIN RES, V840, P153, DOI 10.1016/S0006-8993(99)01757-6; Knusel B, 1997, NEUROSCIENCE, V78, P851, DOI 10.1016/S0306-4522(96)00616-1; Koltzenburg M, 1999, TRENDS NEUROSCI, V22, P122, DOI 10.1016/S0166-2236(98)01302-2; Krekoski CA, 1996, J NEUROSCI RES, V43, P1, DOI 10.1002/jnr.490430102; Kruttgen A, 1998, P NATL ACAD SCI USA, V95, P9614, DOI 10.1073/pnas.95.16.9614; Kuo LT, 2005, J COMP NEUROL, V482, P320, DOI 10.1002/cne.20400; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; LAWSON SN, 2005, PERIPHERAL NEUROPATH, V1, P163; Leclere P, 1998, NEUROSCIENCE, V82, P545; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li L, 2001, J COMP NEUROL, V439, P259, DOI 10.1002/cne.1349; Ljungberg C, 1999, NEUROSCI LETT, V262, P29, DOI 10.1016/S0304-3940(99)00040-3; LU X, 1991, J NEUROSCI, V11, P972; Macdonald R, 2001, MOL BRAIN RES, V90, P48, DOI 10.1016/S0169-328X(01)00086-9; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; MCKAY HA, 2002, EXP BRAIN RES, V142, P308; McLachlan EM, 1998, NEUROSCIENCE, V84, P961, DOI 10.1016/S0306-4522(97)00680-5; Michael GJ, 1999, EUR J NEUROSCI, V11, P3539, DOI 10.1046/j.1460-9568.1999.00767.x; Mischel PS, 2001, J BIOL CHEM, V276, P11294, DOI 10.1074/jbc.M005132200; Mizisin AP, 1997, J NEUROPATH EXP NEUR, V56, P1290, DOI 10.1097/00005072-199712000-00004; Mori T, 2005, CURR TOP DEV BIOL, V69, P67, DOI 10.1016/S0070-2153(05)69004-7; Mujtaba T, 1998, DEV BIOL, V200, P1, DOI 10.1006/dbio.1998.8913; Munson JB, 1997, J NEUROSCI, V17, P470, DOI 10.1523/JNEUROSCI.17-01-00470.1997; Namaka MP, 2001, EXP NEUROL, V172, P60, DOI 10.1006/exnr.2001.7761; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pannese E, 2002, J NEUROCYTOL, V31, P755, DOI 10.1023/A:1025708132119; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; RICH KM, 1989, J NEUROCYTOL, V18, P569, DOI 10.1007/BF01187077; Romero MI, 2001, J NEUROSCI, V21, P8408, DOI 10.1523/JNEUROSCI.21-21-08408.2001; SCHMALBRUCH H, 1987, ANAT REC, V219, P323, DOI 10.1002/ar.1092190314; SEBERT ME, 1993, J NEUROSCI RES, V36, P357, DOI 10.1002/jnr.490360402; Shen H, 1999, EXP BRAIN RES, V127, P141, DOI 10.1007/s002210050783; Shubayev VI, 2005, J PERIPHER NERV SYST, V10, P86; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; Takahashi N, 2003, NEUROSCIENCE, V121, P441, DOI 10.1016/S0306-4522(03)00432-9; Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x; TRIA MA, 1994, EXP NEUROL, V127, P178, DOI 10.1006/exnr.1994.1093; Walcott JC, 2003, CLIN EXP OPHTHALMOL, V31, P246, DOI 10.1046/j.1442-9071.2003.00638.x; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302; Xu B, 2002, NEUROSCIENCE, V115, P1295, DOI 10.1016/S0306-4522(02)00384-6; Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1111/j.1460-9568.2000.01312.x; Zhou XF, 1999, EUR J NEUROSCI, V11, P1711, DOI 10.1046/j.1460-9568.1999.00589.x; Zhou XF, 1996, J NEUROSCI, V16, P2901	83	13	19	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUN 29	2007	147	2					491	507		10.1016/j.neuroscience.2007.04.023			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	187NA	WOS:000247853400021	17532148				2022-02-06	
J	Corneli, G; Gasco, V; Prodam, F; Grottoli, S; Aimaretti, G; Ghigo, E				Corneli, Ginevra; Gasco, Valentina; Prodam, Flavia; Grottoli, Silvia; Aimaretti, Gianluca; Ghigo, Ezio			Growth hormone levels in the diagnosis of growth hormone deficiency in adulthood	PITUITARY			English	Article						growth hormone deficiency; GHRH; ITT	GH-RELEASING HORMONE; TRAUMATIC BRAIN-INJURY; INSULIN TOLERANCE-TEST; BODY-MASS INDEX; GH/IGF-I AXIS; ANTERIOR-PITUITARY DYSFUNCTION; PLUS ARGININE TEST; IGF-I; (GH)-RELEASING HORMONE; STIMULATION TEST	Current guidelines for the diagnosis of adult growth hormone deficiency (GHD) state that the diagnosis must be proven biochemically by provocative testing that is done within the appropriate clinical context. The need for reliance on provocative testing is based on evidence that the evaluation of spontaneous growth hormone (GH) secretion over 24 h and the measurement of IGF-I and IGFBP-3 levels do not distinguish between normal and GHD subjects. Regarding IGF-I, it has been demonstrated that very low levels in patients highly suspected for GHD (i. e., patients with childhood-onset, severe GHD, or with multiple hypopituitarism acquired in adulthood) may be considered definitive evidence for severe GHD obviating the need for provocative tests. However, normal IGF-I levels do not rule out severe GHD and therefore adults suspected for GHD and with normal IGF-I levels must undergo a provocative test of GH secretion. The insulin tolerance test (ITT) is the test of choice, with severe GHD being defined by a GH peak less than 3 mu g/ l, the cut-off that distinguishes normal from GHD adults. The ITT is contraindicated in the presence of ischemic heart disease, seizure disorders, and in the elderly. Other tests are as reliable as the ITT, provided they are used with appropriate cut-off limits. Glucagon stimulation, a classical test, and especially new maximal tests such as GHRH in combination with arginine or GHS (i. e., GHRP-6) have welldefined cut-off limits, are reproducible, are independent of age and gender, and are able to distinguish between normal and GHD subjects. The confounding effect of overweight or obesity on the interpretation of the GH response to provocative tests needs to be considered as the somatotropic response to all stimuli is negatively correlated with body mass index. Appropriate cut-offs for lean, overweight, and obese subjects must be used in order to avoid false-positive diagnoses of severe GHD in obese adults.	[Corneli, Ginevra; Prodam, Flavia; Aimaretti, Gianluca] Amedeo Avogadro Univ, Dept Clin & Expt Med, I-28100 Novara, Italy; [Gasco, Valentina; Grottoli, Silvia; Ghigo, Ezio] Univ Turin, Dept Internal Med, Div Endocrinol & Metab, Turin, Italy		Aimaretti, G (corresponding author), Amedeo Avogadro Univ, Dept Clin & Expt Med, Via Solaroli 17, I-28100 Novara, Italy.	gianluca.aimaretti@med.unipmn.it		Prodam, Flavia/0000-0001-9660-5335			Abs R, 2003, EUR J ENDOCRINOL, V148, pS3, DOI 10.1530/eje.0.148S003; Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 1998, J ENDOCRINOL INVEST, V21, P506, DOI 10.1007/BF03347336; Aimaretti G, 2005, ENDOCRIN DEV, V9, P76, DOI 10.1159/000085758; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, HORM RES, V62, P26, DOI 10.1159/000080755; Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P247, DOI 10.1007/BF03345381; Aimaretti G, 2001, Pituitary, V4, P129, DOI 10.1023/A:1015306705154; Aimaretti G, 1998, J CLIN ENDOCR METAB, V83, P1615, DOI 10.1210/jc.83.5.1615; Aimaretti G, 2003, CLIN ENDOCRINOL, V59, P56, DOI 10.1046/j.1365-2265.2003.01794.x; Aimaretti G, 2002, CLIN ENDOCRINOL, V56, P765, DOI 10.1046/j.1365-2265.2002.01547.x; Aimaretti G, 2000, EUR J ENDOCRINOL, V142, P347, DOI 10.1530/eje.0.1420347; Aimaretti Gianluca, 2004, Pediatr Endocrinol Rev, V2 Suppl 1, P86; Arafah BM, 2001, ENDOCR-RELAT CANCER, V8, P287, DOI 10.1677/erc.0.0080287; Arvat E, 1997, ACTA PAEDIATR, V86, P92; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Baldelli R, 2001, ENDOCRINE, V14, P95, DOI 10.1385/ENDO:14:1:095; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Bjork J, 2005, J CLIN ENDOCR METAB, V90, P6048, DOI 10.1210/jc.2005-0304; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bonert VS, 2004, J CLIN ENDOCR METAB, V89, P3397, DOI 10.1210/jc.2003-032213; Broglio F, 2006, FRONT HORM RES, V35, P102, DOI 10.1159/000094313; Camanni F, 2006, J ENDOCRINOL INVEST, V29, P190, DOI 10.1007/BF03344096; Casanueva FF, 2005, J ENDOCRINOL INVEST, V28, P299; Casanueva FF, 1999, TRENDS ENDOCRIN MET, V10, P30, DOI 10.1016/S1043-2760(98)00116-7; Cianfarani S, 2005, J CLIN ENDOCR METAB, V90, P6028, DOI 10.1210/jc.2005-0721; Clasey JL, 2001, J CLIN ENDOCR METAB, V86, P3845, DOI 10.1210/jc.86.8.3845; Clayton PE, 2005, EUR J ENDOCRINOL, V152, P165, DOI 10.1530/eje.1.01829; Conceicao FL, 2003, J ENDOCRINOL INVEST, V26, P1065, DOI 10.1007/BF03345251; Cook D M, 2000, Adv Intern Med, V45, P297; Cordido F, 2003, EUR J ENDOCRINOL, V149, P117, DOI 10.1530/eje.0.1490117; Cordido F, 1998, J CLIN ENDOCR METAB, V83, P4350, DOI 10.1210/jc.83.12.4350; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Cornelia G, 2003, GROWTH HORM IGF RES, V13, P104, DOI 10.1016/S1096-6374(03)00010-8; CUNEO RC, 1992, CLIN ENDOCRINOL, V37, P387, DOI 10.1111/j.1365-2265.1992.tb02347.x; Darzy KH, 2003, J CLIN ENDOCR METAB, V88, P95, DOI 10.1210/jc.2002-021094; DEBOER H, 1995, ENDOCR REV, V16, P63, DOI 10.1210/er.16.1.63; Gasperi M, 1999, J CLIN ENDOCR METAB, V84, P2633, DOI 10.1210/jc.84.8.2633; Gharib Hossein, 2003, Endocr Pract, V9, P64; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Ghigo E, 2001, ENDOCRINE, V15, P29, DOI 10.1385/ENDO:15:1:029; GHIGO E, 1992, METABOLISM, V41, P560, DOI 10.1016/0026-0495(92)90220-5; Giordano Giulio, 2005, Pituitary, V8, P227, DOI 10.1007/s11102-006-6045-1; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; Gottero C, 2002, J Endocrinol Invest, V25, P42; Granada ML, 2000, EUR J ENDOCRINOL, V142, P243, DOI 10.1530/eje.0.1420243; Haijma SV, 2005, EUR J ENDOCRINOL, V152, P575, DOI 10.1530/eje.1.01887; Ham JN, 2005, CLIN ENDOCRINOL, V62, P628, DOI 10.1111/j.1365-2265.2005.02272.x; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; HOECK HC, 1995, EUR J ENDOCRINOL, V133, P305, DOI 10.1530/eje.0.1330305; HOFFMAN DM, 1994, LANCET, V343, P1064, DOI 10.1016/S0140-6736(94)90181-3; Iglesias P, 2001, THYROID, V11, P1043, DOI 10.1089/105072501753271734; IRANMANESH A, 1991, J CLIN ENDOCR METAB, V73, P1081, DOI 10.1210/jcem-73-5-1081; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; JONES SL, 1994, CLIN ENDOCRINOL, V41, P123, DOI 10.1111/j.1365-2265.1994.tb03793.x; Kelestimur F, 2006, CLIN ENDOCRINOL, V64, P667, DOI 10.1111/j.1365-2265.2006.02525.x; KOPELMAN PG, 1985, CLIN ENDOCRINOL, V23, P87, DOI 10.1111/j.1365-2265.1985.tb00187.x; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; Lanzi R, 1999, METABOLISM, V48, P1152, DOI 10.1016/S0026-0495(99)90130-0; Leal A, 2002, CLIN ENDOCRINOL, V57, P377, DOI 10.1046/j.1365-2265.2002.01623.x; Maccario M, 1999, J ENDOCRINOL INVEST, V22, P424, DOI 10.1007/BF03343585; Maccario M, 2002, ANN ENDOCRINOL-PARIS, V63, P140; Maccario M, 2000, INT J OBESITY, V24, pS96, DOI 10.1038/sj.ijo.0801289; Maccario M, 1997, INT J OBESITY, V21, P27, DOI 10.1038/sj.ijo.0800356; Maghnie M, 2002, J CLIN ENDOCR METAB, V87, P2740, DOI 10.1210/jc.87.6.2740; Maghnie M, 2001, J CLIN ENDOCR METAB, V86, P1574, DOI 10.1210/jc.86.4.1574; Mahajan T, 2000, J CLIN ENDOCR METAB, V85, P1473, DOI 10.1210/jc.85.4.1473; Marzullo P, 2001, J CLIN ENDOCR METAB, V86, P3001, DOI 10.1210/jc.86.7.3001; Masel Brent E, 2005, Pituitary, V8, P263, DOI 10.1007/s11102-006-6052-2; Merriam GR, 2003, ENDOCRINE, V22, P41, DOI 10.1385/ENDO:22:1:41; Molitch ME, 2006, J CLIN ENDOCR METAB, V91, P1621, DOI 10.1210/jc.2005-2227; Muller EE, 2002, NEUROBIOL AGING, V23, P907, DOI 10.1016/S0197-4580(02)00026-X; *NAT I CLIN EXC, 2006, HUM GROWTH HARM SOM, P64; Popovic V, 2005, GROWTH HORM IGF RES, V15, P177, DOI 10.1016/j.ghir.2005.02.003; Popovic V, 2004, CLIN ENDOCRINOL, V60, P185, DOI 10.1046/j.1365-2265.2003.01955.x; Popovic V, 2003, CLIN ENDOCRINOL, V59, P251, DOI 10.1046/j.1365-2265.2003.01835.x; Popovic V, 2002, J CLIN ENDOCR METAB, V87, P2095, DOI 10.1210/jc.87.5.2095; Popovic V, 2000, LANCET, V356, P1137, DOI 10.1016/S0140-6736(00)02755-0; Procopio M, 1995, CLIN ENDOCRINOL, V43, P665, DOI 10.1111/j.1365-2265.1995.tb00532.x; Qu XD, 2005, J CLIN ENDOCR METAB, V90, P1563, DOI 10.1210/jc.2004-1450; Ross RJM, 2000, INT J OBESITY, V24, pS92, DOI 10.1038/sj.ijo.0801288; Scacchi M, 1999, INT J OBESITY, V23, P260, DOI 10.1038/sj.ijo.0800807; Schneider HJ, 2006, EUR J ENDOCRINOL, V155, P559, DOI 10.1530/eje.1.02272; THORNER MO, 1998, WILLIAMS TXB ENDOCRI, P165; Urban RJ, 2006, GROWTH HORM IGF RES, V16, pS25, DOI 10.1016/j.ghir.2006.03.017; VELDHUIS JD, 1991, J CLIN ENDOCR METAB, V72, P51, DOI 10.1210/jcem-72-1-51; Vestergaard P, 1997, HORM METAB RES, V29, P106, DOI 10.1055/s-2007-979000	88	13	14	1	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1386-341X	1573-7403		PITUITARY	Pituitary	JUN	2007	10	2					141	149		10.1007/s11102-007-0031-0			9	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	250MI	WOS:000252303800006	17429591				2022-02-06	
J	Beal, AL; Deuser, WE; Beilman, GJ				Beal, Alan L.; Deuser, William E.; Beilman, Greg J.			A role for epinephrine in post-traumatic hypokalemia	SHOCK			English	Article						wounds and injuries complications; catecholamines; resuscitation; electrolytes; stress response; Injury Severity Score (ISS); Glasgow Coma Score (GCS)	SYMPATHETIC NERVOUS-SYSTEM; TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; POTASSIUM CONCENTRATIONS; PLASMA-CATECHOLAMINES; BETA-ADRENOCEPTORS; ADRENERGIC CONTROL; SERUM POTASSIUM; INSULIN; STIMULATION	We have previously described a high incidence of admission hypokalemia in trauma patients at our institution. We subsequently performed a prospective study of 112 trauma patients to examine the possible etiologies of post-traumatic hypokalemia. Trauma patients >= 5 years old were evaluated within 6 h of injury with a variety of studies including catecholamines, cortisol, and insulin levels, with studies repeated 24 to 36 h after admission. No potassium replacement was given during this time. Demographic factors such as age, types of injury, and severity of injuries were collected. We found that the mean age of those with post-traumatic hypokalemia (<= 3.5 mEq/L) was significantly younger (29 vs. 37 years old; P = 0.004) and epinephrine levels were significantly higher (863 vs. 406 pg/mL; P = 0.01) when compared with normokalemic patients on admission. At 24 to 36 h, the hypokalemia group compared with the normokalemic patients showed a significant rise in the mean potassium levels (17.2% vs. 4.1%; P < 0.001), a significant fall in mean epinephrine levels (-86.6% vs. -81.4%; P < 0.001), and a significant rise in insulin levels (161% vs. 24%; P < 0.005). Finally, because our previous study had shown that post-traumatic hypokalemia was predictive of injury severity score, 4 trauma admission groups were compared with regard to potassium levels and injury severity score. Those trauma patients with both high injury severity and hypokalemia had significantly higher admission epinephrine levels (1222 vs. 290 pg/mL; P = 0.005), glucose levels (174 vs. 126 mg/dL; P = 0.001), and lower carbon dioxide levels (21.3 vs. 24.6 mEq/L; P < 0.03) than those trauma patients with less severe injury and normokalemia. We conclude that post-traumatic hypokalemia seems to be related to a rise in epinephrine levels, that this rise in epinephrine levels seems to be blunted in older patients, and that post-traumatic hypokalemia is rapidly reversible without specific therapy.	N Mem Hlth Care, Robbinsdale, MN 55422 USA; Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA		Beal, AL (corresponding author), N Mem Hlth Care, 3300 Oakdale Ave N, Robbinsdale, MN 55422 USA.	ALAN.BEAL@NORTHMEMORIAL.COM		Beilman, Gregory/0000-0001-5036-3027			Beal AL, 2002, SHOCK, V18, P107, DOI 10.1097/00024382-200208000-00002; BROWN MJ, 1985, AM J CARDIOL, V56, pD3, DOI 10.1016/0002-9149(85)91107-5; CLAUSEN T, 1983, ACTA MED SCAND, P111; DAVIES CL, 1984, J TRAUMA, V24, P99, DOI 10.1097/00005373-198402000-00002; EPSTEIN FH, 1983, NEW ENGL J MED, V309, P1450, DOI 10.1056/NEJM198312083092308; FELDMAN Z, 1993, J TRAUMA, V34, P806, DOI 10.1097/00005373-199306000-00010; FRANCIS GS, 1990, AM J CARDIOL, V65, pE24, DOI 10.1016/0002-9149(90)90248-Y; Gabow PA, 1992, RENAL ELECTROLYTE DI, P231; Grace G T, 1988, Curr Surg, V45, P463; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HANSEN O, 1990, ANGIOLOGY, V41, P175, DOI 10.1177/000331979004100302; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; JAATTELA A, 1975, BRIT J SURG, V62, P177, DOI 10.1002/bjs.1800620303; Kolloch RE, 1996, J LAB CLIN MED, V127, P50, DOI 10.1016/S0022-2143(96)90165-1; Lakatua D J, 1987, Prog Clin Biol Res, V227B, P31; Lazar L, 1997, J PEDIATR SURG, V32, P88, DOI 10.1016/S0022-3468(97)90102-0; LUNDBORG P, 1983, ACTA MED SCAND, P121; Meguid M M, 1973, Surg Forum, V24, P97; MEGUID MM, 1978, J SURG RES, V25, P389, DOI 10.1016/S0022-4804(78)80002-X; MORATINOS J, 1993, FUNDAM CLIN PHARM, V7, P143, DOI 10.1111/j.1472-8206.1993.tb00228.x; MORGAN DB, 1982, LANCET, V2, P1283; Nicolau G Y, 1985, Endocrinologie, V23, P189; NORDREHAUG JE, 1985, AM HEART J, V110, P944, DOI 10.1016/0002-8703(85)90189-9; POMERANZ S, 1989, ACTA NEUROCHIR, V97, P62, DOI 10.1007/BF01577741; REID JL, 1986, AM J CARDIOL, V57, pF23, DOI 10.1016/0002-9149(86)90884-2; ROSA RM, 1980, NEW ENGL J MED, V302, P431, DOI 10.1056/NEJM198002213020803; SHIN B, 1986, ANESTHESIOLOGY, V65, P90, DOI 10.1097/00000542-198607000-00018; SMITH JS, 1978, SURG GYNECOL OBSTET, V147, P18; STRUTHERS AD, 1984, CLIN ENDOCRINOL, V20, P409; VANEK VW, 1994, SOUTHERN MED J, V87, P41, DOI 10.1097/00007611-199401000-00010; VITEK V, 1979, AM SURGEON, V45, P228; VITEK V, 1979, CLIN CHIM ACTA, V95, P93, DOI 10.1016/0009-8981(79)90341-3; WILLIAMS ME, 1985, NEW ENGL J MED, V312, P823, DOI 10.1056/NEJM198503283121304; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; WOOLF PD, 1992, ARCH SURG-CHICAGO, V127, P899	35	13	17	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1073-2322			SHOCK	Shock	APR	2007	27	4					358	363		10.1097/01.shk.0000245029.47106.db			6	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	152NI	WOS:000245368300004	17414416				2022-02-06	
J	Mace, BE; Wang, HC; Lynch, JR; Moss, J; Sullivan, P; Colton, H; Morgan, K; Renauld, JC; Laskowitz, DT				Mace, Brian E.; Wang, Haichen; Lynch, John R.; Moss, Jason; Sullivan, Patrick; Colton, Heidi; Morgan, Kevin; Renauld, Jean-Christophe; Laskowitz, Daniel T.			Apolipoprotein E modifies the CNS response to injury via a histamine-mediated pathway	NEUROLOGICAL RESEARCH			English	Article						apolipoprotein E; closed head injury; histamine; inflammation; interleukin-9 receptor	E-DEFICIENT MICE; MICROGLIAL ACTIVATION; ALZHEIMERS-DISEASE; TRANSGENIC MICE; E POLYMORPHISM; APOE GENOTYPE; TYPE-4 ALLELE; SUSCEPTIBILITY; ONSET; ASSOCIATION	Recent evidence demonstrates that apolipoprotein E ( apoE) influences the central nervous system (CNS) response to both acute and chronic injury. To address the mechanisms by which apoE influences neurological disease, we examined differential gene expression in the brains of apoE transgenic mice after closed head injury. Apart from confirming the knockout of apoE, the largest differential gene expression occurred for the interleukin-9 receptor (IL-9R), which was > 100-fold up-regulated in apoE-deficient versus wild-type mice. We observed a similar pattern of post-traumatic IL-9R up-regulation in APOE4 targeted replacement mice as compared with their APOE3 counterparts. This difference in gene expression was associated with increased neuronal protein expression of IL-9R in E4 animals compared with E3 as demonstrated by immunohistochemistry. The consequence of IL-9R binding in mast cells is the induction of proliferation and differentiation. This indirectly favors degranulation and release of histamine and inflammatory mediators, which have previously been demonstrated to exacerbate secondary neuronal injury. We found that apoE-deficient animals had increased levels of systemic histamine after injury and that pre-treatment with antihistamines improved functional outcomes in apoE-deficient but not wild-type animals after head injury. These results suggest that apoE modifies secondary neuronal injury caused by histamine release and are consistent with previous observations that apoE affects the CNS inflammatory response in an isoform-specific manner.	Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; GlaxoSmithKline, Res Triangle Pk, NC 27709 USA; Sanofi Aventis, Chapel Hill, NC 27514 USA; Univ Louvain, Ludwig Inst Canc Res, Brussels Branch, Brussels, Belgium; Univ Louvain, Expt Med Unit, Brussels, Belgium		Laskowitz, DT (corresponding author), Duke Univ, Med Ctr, Dept Med Neurol, Bryan Res Bldg Box 2900, Durham, NC 27710 USA.	danl@neuro.duke.edu	; Renauld, Jean-Christophe/B-7268-2012	Mace, Brian/0000-0002-5478-6227; Renauld, Jean-Christophe/0000-0003-1736-2131			ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Anthony JC, 2000, NEUROLOGY, V54, P2066, DOI 10.1212/WNL.54.11.2066; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; Bart RD, 1998, NEUROREPORT, V9, P2615, DOI 10.1097/00001756-199808030-00035; BREITNER JCS, 1995, NEUROBIOL AGING, V16, P523, DOI 10.1016/0197-4580(95)00049-K; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cowell LG, 2002, GENOME BIOL, V3; Demoulin J B, 1998, Int Rev Immunol, V16, P345, DOI 10.3109/08830189809043001; Dines KC, 1997, J NEUROPATH EXP NEUR, V56, P627; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HIXSON JE, 1990, J LIPID RES, V31, P545; Horsburgh K, 2000, EUR J NEUROSCI, V12, P4309, DOI 10.1046/j.1460-9568.2000.01339.x; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Laskowitz DT, 1997, J CEREBR BLOOD F MET, V17, P753; Laskowitz DT, 1997, J NEUROIMMUNOL, V76, P70, DOI 10.1016/S0165-5728(97)00021-0; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Lynch JR, 2001, J NEUROIMMUNOL, V114, P107, DOI 10.1016/S0165-5728(00)00459-8; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; McCarron MO, 2003, ACTA NEUROL SCAND, V107, P106, DOI 10.1034/j.1600-0404.2003.01365.x; Patkai J, 2001, PEDIATR RES, V50, P222, DOI 10.1203/00006450-200108000-00010; Sabo T, 2000, NEUROSCIENCE, V101, P879, DOI 10.1016/S0306-4522(00)00438-3; Schiefermeier M, 2000, STROKE, V31, P2068, DOI 10.1161/01.STR.31.9.2068; Schmidt S, 2002, AM J HUM GENET, V70, P708, DOI 10.1086/339269; Sheng HX, 1998, J CEREBR BLOOD F MET, V18, P361, DOI 10.1097/00004647-199804000-00003; Sheng HX, 1999, STROKE, V30, P1118, DOI 10.1161/01.STR.30.5.1118; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; SZTRIHA L, 1987, NEUROSCI LETT, V75, P334, DOI 10.1016/0304-3940(87)90545-3; Tardiff BE, 1997, ANN THORAC SURG, V64, P715, DOI 10.1016/S0003-4975(97)00757-1; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; UYTTENHOVE C, 1988, P NATL ACAD SCI USA, V85, P6934, DOI 10.1073/pnas.85.18.6934; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249	39	13	14	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	APR	2007	29	3					243	250		10.1179/016164107X158974			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	165JJ	WOS:000246301100005	17509222				2022-02-06	
J	Lo, YL; Yang, TC; Liao, CC; Yang, ST				Lo, Yang-Lan; Yang, Tao-Chieh; Liao, Chen-Chih; Yang, Shun-Tai			Diagnosis of traumatic internal carotid artery injury: The role of craniofacial fracture	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						traumatic internal carotid artery injury; computed tomography; craniofacial fracture; course of internal carotid artery	BLUNT CEREBROVASCULAR INJURIES; DISSECTION; OUTCOMES	Optimally, internal carotid artery (ICA) injury associated with craniofacial trauma should be treated soon after diagnosis. However, diagnosis is difficult and often delayed. The typical symptoms and signs for diagnosis of traumatic ICA injuries are sometimes easily neglected. Clinically, some patients were initially diagnosed by craniofacial fracture nearby the course of ICA. This investigation retrospectively reviews clinical experience in patients with traumatic ICA injury with a focus on the importance of craniofacial fracture nearby the course of ICA observed on brain or facial bone computed tomography. Eighteen patients with traumatic ICA injury were diagnosed at Chang Gung Memorial Hospital, Taiwan, from June 1998 to April 2004, including 10 patients with pseudoaneurysm formation, seven patients with occlusion, and one patient with laceration. Brain or facial bone computed tomography was reviewed retrospectively. The sample included 14 (78%) patients with skull base fractures involving the intracranial course of ICA and three (17%) patients with mandibular and cervical spine fractures near the course of extracranial ICA. Only one (5%) patient did not have evident fracture. Fractures involving the carotid canal were rioted in three (17%) patients. Eight patients received interventional treatments. No further interventional treatments for traumatic ICA occlusion were performed as a result of good collateral flow from contralateral ICA or large infarction noted when diagnosed. Three patients with pseudoaneurysm received expectant management. One patient with arterial laceration with extravasation received no further management. Through meticulously evaluating routine brain and facial bone computed tomography, craniofacial fracture involving intracranial or extracranial course of ICA may be an adjuvant indicator of traumatic ICA injury for early diagnosis.	Chang Gung Univ, Chang Gung Mem Hosp, Dept Neurosurg, Tao Yuan, Taiwan		Yang, ST (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Neurosurg, 5 Fu Shin St, Tao Yuan, Taiwan.	yst0708@adm.cgmh.org.tw					Biffl WL, 1998, ANN SURG, V228, P462, DOI 10.1097/00000658-199810000-00003; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Biffl WL, 1999, AM J SURG, V178, P517, DOI 10.1016/S0002-9610(99)00245-7; Carter DA, 1998, J TRAUMA, V44, P230, DOI 10.1097/00005373-199801000-00039; HABAL MB, 1986, PLAST RECONSTR SURG, V77, P981; Kerwin AJ, 2001, J TRAUMA, V51, P308, DOI 10.1097/00005373-200108000-00013; Lee WW, 2000, J EMERG MED, V19, P35, DOI 10.1016/S0736-4679(00)00190-6; Liu AY, 1999, NEUROSURGERY, V45, P1368, DOI 10.1097/00006123-199912000-00022; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; PERRY MO, 1980, ANN SURG, V192, P74, DOI 10.1097/00000658-198007000-00013; POZZATI E, 1989, STROKE, V20, P412, DOI 10.1161/01.STR.20.3.412; Resnick DK, 1997, NEUROSURGERY, V40, P1177, DOI 10.1097/00006123-199706000-00012; Vishteh AG, 1998, NEUROSURGERY, V43, P761, DOI 10.1097/00006123-199810000-00016; WELLING RE, 1987, J TRAUMA, V27, P1221; Yang ST, 2006, J CLIN NEUROSCI, V13, P123, DOI 10.1016/j.jocn.2005.02.016; Yang WG, 2003, PLAST RECONSTR SURG, V111, P789, DOI 10.1097/01.PRS.0000041541.72469.53; York G, 2005, AM J ROENTGENOL, V184, P1672, DOI 10.2214/ajr.184.5.01841672; ZELENOCK GB, 1982, ARCH SURG-CHICAGO, V117, P425	18	13	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	MAR	2007	18	2					361	368		10.1097/scs.0b013e318033605f			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	153IA	WOS:000245424400021	17414287				2022-02-06	
J	O'Sullivan, JC; Yao, XL; Alam, H; McCabe, JT				O'Sullivan, Joseph C.; Yao, Xiang-Lan; Alam, Hasan; McCabe, Joseph T.			Diazoxide, as a postconditioning and delayed preconditioning trigger, increases HSP25 and HSP70 in the central nervous system following combined cerebral stroke and hemorrhagic shock	JOURNAL OF NEUROTRAUMA			English	Article						HSP; ischemia; ischemic preconditioning; postconditioning; shock	K-ATP CHANNELS; TRAUMATIC BRAIN-INJURY; ISCHEMIC TOLERANCE; CELL-DEATH; PROTEINS; EXPRESSION; REPERFUSION; ACTIVATION; CHAPERONES; APOPTOSIS	Combined hemorrhagic shock (Shock) and unilateral common carotid artery occlusion (Stroke) results in a decrease of oxygen availability to peripheral tissues and organs and the central nervous system (CNS). A variety of biochemical processes ensue, including organ failure, cellular apoptosis, and necrosis. The present study used male, Sprague-Dawley rats to assess the impact of cerebral insult. Using heat-shock protein 25 and 70 (HSP25, HSP70) as biomarkers, measured 24 h after injury, we tested the hypothesis that pharmacological induction of preconditioning can offer cytoprotection from combined Stroke and Shock. The compound, diazoxide (DZ), is known to induce preconditioning through its effect as a mitochondrial potassium ATP (mK(ATP)) channel opener and succinate dehydrogenase inhibitor. When administered 24 h prior to Stroke and Shock (delayed preconditioning), DZ increased cerebral cortical and hippocampal levels of HSP25 and HSP70. A more clinically relevant treatment paradigm was tested, where DZ was administered after the induction of Stroke and Shock (postconditioning). When administered 60 min (but not 10 min) after the induction of Stroke and Shock, DZ significantly increased HSP25 and HSP70 expression in the ipsilateral cerebral cortex and hippocampus. Taken together, these results suggest that DZ treatment may be efficacious for CNS injury resulting from blood loss and anoxia from combined cerebral ischemia and hemorrhagic shock. "Postconditioning" triggered by DZ, immediately before resuscitation, is a potentially effective treatment for ischemia-reperfusion injury from combined Stroke and Shock.	Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; Uniformed Serv Univ Hlth Sci, Grad Program Neurosci, Bethesda, MD 20814 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Trauma Emergency Surg & Surg Crit Care, Boston, MA 02115 USA		McCabe, JT (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	JMcCabe@usuhs.mil	McCabe, Joseph T/J-6293-2014	McCabe, Joseph T/0000-0002-1159-7442			Acarin L, 2002, GLIA, V38, P1, DOI 10.1002/glia.10040; Alemzadeh R, 1999, ENDOCRINOLOGY, V140, P3197, DOI 10.1210/en.140.7.3197; Ardehali H, 2005, J MOL CELL CARDIOL, V39, P7, DOI 10.1016/j.yjmcc.2004.12.003; Argaud L, 2005, CIRCULATION, V111, P194, DOI 10.1161/01.CIR.0000151290.04952.3B; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Boeri D, 2003, EUR J CLIN INVEST, V33, P500, DOI 10.1046/j.1365-2362.2003.01157.x; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Brustovetsky T, 2005, J PHYSIOL-LONDON, V568, P47, DOI 10.1113/jphysiol.2005.091199; Carroll R, 2001, CARDIOVASC RES, V51, P691, DOI 10.1016/S0008-6363(01)00330-3; Chen J, 1996, J CEREBR BLOOD F MET, V16, P566, DOI 10.1097/00004647-199607000-00006; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Concannon CG, 2001, GENE EXPRESSION, V9, P195, DOI 10.3727/000000001783992605; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Dhodda VK, 2004, J NEUROCHEM, V89, P73, DOI 10.1111/j.1471-4159.2004.02316.x; Diaz RJ, 2004, CARDIOVASC RES, V62, P4, DOI 10.1016/j.cardiores.2004.01.036; Downey JM, 2005, CIRCULATION, V111, P120, DOI 10.1161/01.CIR.0000153622.49496.10; Dzeja PP, 2003, AM J PHYSIOL-HEART C, V284, pH1048, DOI 10.1152/ajpheart.00847.2002; Fryer RM, 2000, AM J PHYSIOL-HEART C, V278, pH305, DOI 10.1152/ajpheart.2000.278.1.H305; GLAZIER SS, 1994, J CEREBR BLOOD F MET, V14, P545, DOI 10.1038/jcbfm.1994.68; Hanley PJ, 2005, J MOL CELL CARDIOL, V39, P17, DOI 10.1016/j.yjmcc.2005.04.002; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Kin H, 2004, CARDIOVASC RES, V62, P74, DOI 10.1016/j.cardiores.2004.01.006; MARBER MS, 1993, CIRCULATION, V88, P1264, DOI 10.1161/01.CIR.88.3.1264; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; MIZUMURA T, 1995, CIRCULATION, V92, P1236, DOI 10.1161/01.CIR.92.5.1236; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Moro F, 2006, J MOL BIOL, V358, P1367, DOI 10.1016/j.jmb.2006.03.027; Mounier N, 2002, CELL STRESS CHAPERON, V7, P167, DOI 10.1379/1466-1268(2002)007<0167:ACASHS>2.0.CO;2; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; PANG CY, 1995, CARDIOVASC RES, V29, P782, DOI 10.1016/S0008-6363(96)88613-5; Parcellier A, 2003, BIOCHEM BIOPH RES CO, V304, P505, DOI 10.1016/S0006-291X(03)00623-5; Peralta C, 1996, BIOCHEM BIOPH RES CO, V229, P264, DOI 10.1006/bbrc.1996.1790; Pittet JF, 2002, J TRAUMA, V52, P611, DOI 10.1097/00005373-200204000-00001; Plumier JCL, 1997, MOL BRAIN RES, V45, P239, DOI 10.1016/S0169-328X(96)00255-0; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Seharaseyon J, 2000, J MOL CELL CARDIOL, V32, P1923, DOI 10.1006/jmcc.2000.1226; Shake JG, 2001, ANN THORAC SURG, V72, P1849, DOI 10.1016/S0003-4975(01)03192-7; Tidwell JL, 2004, CELL STRESS CHAPERON, V9, P88, DOI 10.1379/CSC-9R.1; Wang X, 2004, SHOCK, V22, P23, DOI 10.1097/01.shk.0000129200.30965.57; Wang X, 2003, EUR J CARDIO-THORAC, V24, P967, DOI 10.1016/S1010-7940(03)00438-X; Yellon DM, 2003, PHYSIOL REV, V83, P1113, DOI 10.1152/physrev.00009.2003; Yenari MA, 2002, ADV EXP MED BIOL, V513, P281; Zaugg M, 2002, ANESTHESIOLOGY, V97, P4, DOI 10.1097/00000542-200207000-00003; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	45	13	17	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2007	24	3					532	546		10.1089/neu.2006.0128			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	152RQ	WOS:000245379900009	17402858				2022-02-06	
J	Xilouri, M; Avlonitis, N; Calogeropoulou, T; Papazafiri, P				Xilouri, Maria; Avlonitis, Nicolaos; Calogeropoulou, Theodora; Papazafiri, Panagiota			Neuroprotective effects of steroid analogues on P19-N neurons	NEUROCHEMISTRY INTERNATIONAL			English	Article						synthetic neurosteroids; NMDA cytotoxicity; GABA(A) receptor; cytochrome c; neuroprotection	EMBRYONAL CARCINOMA-CELLS; CYTOCHROME-C RELEASE; GLUTAMATE-INDUCED APOPTOSIS; TRAUMATIC BRAIN-INJURY; NEUROSTEROID ANALOGS; GABA(A) RECEPTOR; NEUROACTIVE STEROIDS; PROTEIN-KINASE; IN-VITRO; DEHYDROEPIANDROSTERONE-SULFATE	Naturally occurring neurosteroids are potent allosteric modulators of gamma-aminobutyric acid(A) receptor and through augmentation of gamma-aminobutyric acid(A) receptor function, can protect neuronal cells against N-methyl-D-aspartate receptor over-activation, ischemia and traumatic brain injury. In this study, mouse P19 cells were induced to differentiate into post-mitotic neurons and were subjected to excitotoxicity in the presence of N-methyl-D-aspartate. Novel synthetic analogues of the endogenous neurosteroids allopregnanolone and dehydroepiandrostrone, inhibited excitotoxic cell death of P19-N neurons, by directly maintaining the activation of PKB/Akt kinase, and interfering with the intrinsic mitochondrial apoptotic pathway, preserving cytochrome c in the mitochondria and Bax in the cytoplasm. The efficiency and the potency of these neurosteroids were similar to those of allopregnanolone and dehydroepiandrostrone. Their effects were gamma-aminobutyric acid(A) receptor mediated, since they were abolished in the presence of bicuculline, an antagonist of receptor's function. In addition, the synthetic compounds retained the ability to alter gamma-aminobutyric acid(A) receptor subunit gene expression, but their effects on transcriptional activity were less pronounced than those of allopregnanolone and dehydroepiandrostrone. These results suggest that synthetic neurosteroids may serve as potent, membrane acting, neuroprotectants against N-methyl-D-aspartate receptor neurotoxicity on neuronal cells. (c) 2007 Elsevier Ltd. All rights reserved.	Univ Athens, Dept Anim & Human Physiol, Sch Biol, Fac Sci, Athens 15784, Greece; Natl Hellen Res Fdn, Inst Organ & Pharmaceut Chem, Athens 11635, Greece		Papazafiri, P (corresponding author), Univ Athens, Dept Anim & Human Physiol, Sch Biol, Fac Sci, Athens 15784, Greece.	ppapaz@biol.uoa.gr	Avlonitis, Nicolaos/T-6053-2019; Avlonitis, Nicolaos/A-5161-2009	Xilouri, Maria/0000-0001-7038-0780			Anderson A, 1997, J MED CHEM, V40, P1668, DOI 10.1021/jm960733n; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bain G, 1998, PERSPECT DEV NEUROBI, V5, P175; BAIN G, 1994, BIOESSAYS, V16, P343, DOI 10.1002/bies.950160509; BAULIEU EE, 1991, BIOL CELL, V71, P3, DOI 10.1016/0248-4900(91)90045-O; BAULIEU EE, 1990, J STEROID BIOCHEM, V37, P395, DOI 10.1016/0960-0760(90)90490-C; Baulieu EE, 1997, RECENT PROG HORM RES, V52, P1; Beal M F, 1992, Curr Opin Neurobiol, V2, P657, DOI 10.1016/0959-4388(92)90035-J; Beekman M, 1998, J PHARMACOL EXP THER, V284, P868; Belelli D, 2006, NEUROSCIENCE, V138, P821, DOI 10.1016/j.neuroscience.2005.07.021; BELELLI D, 2005, NAT REV NEUROSCI; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brussard AB, 2003, ANN NY ACAD SCI, V1007, P29, DOI 10.1196/annals.1286.003; Canzoniero LMT, 1996, J NEUROSCI RES, V45, P226; Cascio C, 2002, J NEUROCHEM, V83, P1358, DOI 10.1046/j.1471-4159.2002.01229.x; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; Charalampopoulos L, 2004, P NATL ACAD SCI USA, V101, P8209, DOI 10.1073/pnas.0306631101; Chatman K, 1999, ANAL CHEM, V71, P2358, DOI 10.1021/ac9806411; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Chuang DM, 2002, BIPOLAR DISORD, V4, P129, DOI 10.1034/j.1399-5618.2002.01179.x; Compagnone NA, 2000, FRONT NEUROENDOCRIN, V21, P1, DOI 10.1006/frne.1999.0188; Concas A, 1999, EUR J PHARMACOL, V375, P225, DOI 10.1016/S0014-2999(99)00232-0; Covey DF, 2000, J MED CHEM, V43, P3201, DOI 10.1021/jm0002477; CRAIG CR, 1968, ARCH INT PHARMACOD T, V172, P366; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davies S, 2001, J CLIN PATHOL-MOL PA, V54, P409, DOI 10.1136/mp.54.6.409; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Finley MFA, 1996, J NEUROSCI, V16, P1056; Follesa P, 2002, NEUROPHARMACOLOGY, V42, P325, DOI 10.1016/S0028-3908(01)00187-3; Follesa P, 2004, EUR J PHARMACOL, V500, P413, DOI 10.1016/j.ejphar.2004.07.041; Follesa P, 2004, MOL BRAIN RES, V120, P130, DOI 10.1016/j.molbrainres.2003.10.011; Follesa P, 2001, BRAIN RES REV, V37, P81, DOI 10.1016/S0165-0173(01)00125-4; Follesa P, 2006, PSYCHOPHARMACOLOGY, V186, P267, DOI 10.1007/s00213-005-0126-0; Frank C, 2000, PROG NEURO-PSYCHOPH, V24, P1117, DOI 10.1016/S0278-5846(00)00124-X; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Gasior M, 1999, TRENDS PHARMACOL SCI, V20, P107, DOI 10.1016/S0165-6147(99)01318-8; GEE KW, 1995, CRIT REV NEUROBIOL, V9, P207; Grobin AC, 1999, BRAIN RES, V827, P1; Grobin AC, 2000, EUR J PHARMACOL, V409, pR1, DOI 10.1016/S0014-2999(00)00797-4; Guillon J, 2001, J PHARM PHARMACOL, V53, P1561, DOI 10.1211/0022357011777945; Hamilton Niall M., 2002, Current Topics in Medicinal Chemistry, V2, P887, DOI 10.2174/1568026023393570; Han MC, 1996, J MED CHEM, V39, P4218, DOI 10.1021/jm960304p; HAN MC, 1995, J MED CHEM, V38, P4548, DOI 10.1021/jm00022a021; HU YF, 1993, J MED CHEM, V36, P3956, DOI 10.1021/jm00076a025; Jiang X, 2003, J MED CHEM, V46, P5334, DOI 10.1021/jm030302m; Jung-Testas I, 1999, J STEROID BIOCHEM, V69, P97, DOI 10.1016/S0960-0760(98)00149-6; Kaasik A, 2001, NEUROSCIENCE, V102, P427, DOI 10.1016/S0306-4522(00)00489-9; Keller J, 2005, NEUROCHEM INT, V46, P293, DOI 10.1016/j.neuint.2004.11.003; Kulik G, 1998, MOL CELL BIOL, V18, P6711, DOI 10.1128/MCB.18.11.6711; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lockhart EM, 2002, NEUROSCI LETT, V328, P33, DOI 10.1016/S0304-3940(02)00448-2; Luetjens CM, 2000, J NEUROSCI, V20, P5715; Luo HR, 2003, P NATL ACAD SCI USA, V100, P11712, DOI 10.1073/pnas.1634990100; Macdonald RL, 1997, CURR OPIN NEUROL, V10, P121, DOI 10.1097/00019052-199704000-00009; MacPherson PA, 1997, NEUROSCIENCE, V80, P487, DOI 10.1016/S0306-4522(97)00102-4; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; Marcos J, 2004, STEROIDS, V69, P51, DOI 10.1016/j.steroids.2003.09.013; MCBURNEY MW, 1988, J NEUROSCI, V8, P1063; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; MORLEY P, 1995, J NEUROCHEM, V65, P1093; Nakazawa T, 2005, MOL VIS, V11; Nilsson KR, 1998, J MED CHEM, V41, P2604, DOI 10.1021/jm980148h; NORBERG L, 1987, PHARMACOL TOXICOL, V61, P42, DOI 10.1111/j.1600-0773.1987.tb01770.x; Pi RB, 2004, J NEUROCHEM, V91, P1219, DOI 10.1111/j.1471-4159.2004.02796.x; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Precht TA, 2005, CELL DEATH DIFFER, V12, P255, DOI 10.1038/sj.cdd.4401552; Rupprecht R, 1997, J PSYCHIATR RES, V31, P297, DOI 10.1016/S0022-3956(96)00060-X; Rupprecht R, 1996, J STEROID BIOCHEM, V56, P163, DOI 10.1016/0960-0760(95)00233-2; Rupprecht R, 1999, TRENDS NEUROSCI, V22, P410, DOI 10.1016/S0166-2236(99)01399-5; Scaglione JB, 2006, J MED CHEM, V49, P4595, DOI 10.1021/jm0602920; Souli C, 2005, J MED CHEM, V48, P5203, DOI 10.1021/jm050271q; Steiger JL, 2004, PHARMACOL THERAPEUT, V101, P259, DOI 10.1016/j.pharmthera.2003.12.002; Sunol C, 2006, J MED CHEM, V49, P3225, DOI 10.1021/jm060002f; Tunez I, 2006, NEUROCHEM INT, V48, P367, DOI 10.1016/j.neuint.2005.11.011; TURETSKY DM, 1993, J NEUROBIOL, V24, P1157, DOI 10.1002/neu.480240904; Upasani RB, 1997, J MED CHEM, V40, P73, DOI 10.1021/jm9605344; Vassilopoulos A, 2005, FREE RADICAL RES, V39, P1273, DOI 10.1080/10715760500166685; Weill-Engerer S, 2002, J CLIN ENDOCR METAB, V87, P5138, DOI 10.1210/jc.2002-020878; Xilouri M, 2006, EUR J NEUROSCI, V23, P43, DOI 10.1111/j.1460-9568.2005.04548.x; Zeng CM, 2005, J MED CHEM, V48, P3051, DOI 10.1021/jm049027+; Zeng CM, 2000, J ORG CHEM, V65, P2264, DOI 10.1021/jo991953m; Zhang L, 2002, MOL BRAIN RES, V98, P58, DOI 10.1016/S0169-328X(01)00315-1; Zhang YM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-13; Zorumski C F, 2000, Curr Opin Investig Drugs, V1, P360; Zorumski CF, 1998, SYNAPSE, V29, P162, DOI 10.1002/(SICI)1098-2396(199806)29:2<162::AID-SYN7>3.0.CO;2-5	92	13	13	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	MAR	2007	50	4					660	670		10.1016/j.neuint.2006.12.010			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	152YA	WOS:000245397000010	17316905				2022-02-06	
J	Kit, KA; Mateer, CA; Graves, RE				Kit, Karen A.; Mateer, Catherine A.; Graves, Roger E.			The influence of memory beliefs in individuals with traumatic brain injury	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; metamemory; affective functioning	MILD HEAD-INJURY; POSTCONCUSSION SYMPTOMS; SELF-AWARENESS; EXPECTATION; METAMEMORY; DEPRESSION; SEQUELAE; ANXIETY; STRESS; ADULTS	Objective: To explore metamemory (memory beliefs) and affective functioning in individuals with traumatic brain injury (TBI). Participants: Twenty-six individuals with mild TBI (MTBI), 16 individuals with severe TBI (STBI), and 42 uninjured adults. Outcome Measures: Metamemory in Adulthood questionnaire, Postconcussion Syndrome Checklist, Perceived Stress Scale, Beck Depression Inventory (2nd ed.), Beck Anxiety Inventory. Results: The control group endorsed higher memory self-efficacy, fewer depressive symptoms, fewer memory strategies, and fewer postconcussion symptoms than the MTBI or STBI group. The MTBI group placed high importance on success in memory tasks. Memory self-efficacy and memory-strategies use mediated the relation between TBI and depression. Conclusion: Individuals with brain injury hold negative beliefs about their memory functioning, and such beliefs contribute to depression.	Univ Victoria, Dept Psychol, Victoria, BC V8W 3P5, Canada		Kit, KA (corresponding author), Univ Victoria, Dept Psychol, POB 3050 STN CSC, Victoria, BC V8W 3P5, Canada.	kkit@uvic.ca					BANDURA A, 1989, DEV PSYCHOL, V25, P729, DOI 10.1037/0012-1649.25.5.729; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beck AT, 1993, BECK ANXIETY INVENTO; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; CaprioPrevette MD, 1996, EXP AGING RES, V22, P281, DOI 10.1080/03610739608254012; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Davidson, 1988, COGNITIVE DEV ADULTH, P65, DOI DOI 10.1007/978-1-4612-3852-2; Dellefield KS, 1996, NURS RES, V45, P284, DOI 10.1097/00006199-199609000-00006; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; DIXON RA, 1983, J GERONTOL, V38, P682, DOI 10.1093/geronj/38.6.682; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; FISKE ST, 1982, J EXP SOC PSYCHOL, V18, P105, DOI 10.1016/0022-1031(82)90046-4; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; HERTZOG C, 1999, SOCIAL COGNITION AGI, P43, DOI DOI 10.1016/B978-012345260-3/50004-5; Hertzog C., 1994, METACOGNITION KNOWIN, P227; Hovland D., 2000, NEUROPSYCHOLOGICAL M, P171; HULTSCH DF, 1987, CAN J PSYCHOL, V41, P193, DOI 10.1037/h0084153; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; LEININGER B E, 1991, Brain Injury, V5, P199, DOI 10.3109/02699059109008090; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Perlmutter M, 1987, Annu Rev Gerontol Geriatr, V7, P57; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; TEASDALE G, 1974, LANCET, V2, P81; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2	37	13	13	0	1	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2007	52	1					25	32		10.1037/0090-5550.52.1.25			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	142CI	WOS:000244626200003					2022-02-06	
J	Robinson, Y; Reinke, M; Heyde, CE; Ertel, W; Oberholzer, A				Robinson, Yohan; Reinke, Marcus; Heyde, Christoph E.; Ertel, Wolfgang; Oberholzer, Andreas			Traumatic proximal tibiofibular joint dislocation treated by open reduction and temporary fixation: a case report	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						proximal tibiofibular dislocation; peroneal head dislocation	SUBLUXATION	Isolated dislocations of the proximal tibiofibular joint are a rare condition. Missed diagnosis can lead to chronic knee pain and disability. Early recognition should be followed by immediate closed reduction or open reduction and joint transfixation. We present a young athlete with this injury which was treated successfully by open reduction.	Klin Unfall Wiederherstellungschirurg, Dept Orthopaed & Trauma Surg, Charite, D-12200 Berlin, Germany		Robinson, Y (corresponding author), Klin Unfall Wiederherstellungschirurg, Dept Orthopaed & Trauma Surg, Charite, Campus Benjamin Franklin,Hindenburgdamm 30, D-12200 Berlin, Germany.	yohan.robinson@charite.de	Heyde, Christoph - E./AAV-9440-2021; Robinson, Yohan/V-8177-2017	Robinson, Yohan/0000-0002-2724-6372			Aladin A, 2002, KNEE, V9, P233, DOI 10.1016/S0968-0160(02)00012-1; Dinkelaker F, 1985, Aktuelle Traumatol, V15, P264; Laing AJ, 2003, BRIT J SPORT MED, V37, P366, DOI 10.1136/bjsm.37.4.366; Miettinen H, 1999, ARCH ORTHOP TRAUM SU, V119, P358, DOI 10.1007/s004020050428; OGDEN JA, 1974, J BONE JOINT SURG AM, VA 56, P145, DOI 10.2106/00004623-197456010-00015; SACHSE J, 2005, EXTREMITATENGELENKE; Sekiya Jon K, 2003, J Am Acad Orthop Surg, V11, P120; SEMONIAN RH, 1995, J ORTHOP SPORT PHYS, V21, P248, DOI 10.2519/jospt.1995.21.5.248; van den Bekerom Michel P J, 2004, Acta Orthop Belg, V70, P604	9	13	15	0	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0942-2056			KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	FEB	2007	15	2					199	201		10.1007/s00167-006-0147-1			3	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	133QZ	WOS:000244028900015	16858561				2022-02-06	
J	Bennett, SS; Graffagnino, C; Borel, CO; James, ML				Bennett, Stacey S.; Graffagnino, Carmelo; Borel, Cecil O.; James, Michael L.			Use of High Frequency Oscillatory Ventilation (HFOV) in neurocritical care patients	NEUROCRITICAL CARE			English	Article						high frequency ventilation; intracranial pressure; acute respiratory distress syndrome; traumatic brain injury; neurological intensive care	RESPIRATORY-DISTRESS-SYNDROME; END-EXPIRATORY PRESSURE; INTRACRANIAL-PRESSURE; NEUROLOGIC ILLNESS; BRAIN INJURY; HEAD-INJURY; MANAGEMENT; ADULTS	Introduction Adult respiratory distress syndrome (ARDS) can be a cornmon problem associated with the treatment of acute brain injury. High frequency oscillatory ventilation (HFOV) is a developing therapy for the treatment of ARDS in adult patients that can be life saving. However, often patients with acute, severe brain injury demonstrate intracranial hypertension (hICP) due to a variety of injuries (e.g., traumatic brain injury, mass lesion, acute hydrocephalus). There is concern over the use of HFOV due to its effects on intracranial pressure in patients with hICP. Methods Retrospective case series study. Results We describe the effects of HFOV on hemodynamics, respiratory function, and intracranial pressure in five patients with acute brain injury being treated for ARDS. Conclusions HFOV did not cause unmanageable or sustained increases in ICP in our series of patients. It appears HFOV may be a relatively safe and effective means of oxygenating patients with severe ARDS and concomitant hICP secondary to acute brain injury.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Nursing, Durham, NC USA; Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC USA		James, ML (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	james040@mc.duke.edu	James, Michael L./AAJ-5592-2020	James, Michael L./0000-0002-8715-5210	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008600] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM008600, T32 GM008600-13] Funding Source: Medline		Bein T, 2005, CRIT CARE MED, V33, P667, DOI 10.1097/01.CCM.0000155776.60160.50; Borel CO, 1998, RESP PHYSIOL, V111, P45, DOI 10.1016/S0034-5687(97)00098-4; BOREL CO, 1995, NEUROL CLIN, V13, P627, DOI 10.1016/S0733-8619(18)30036-7; Caricato A, 2005, J TRAUMA, V58, P571, DOI 10.1097/01.TA.0000152806.19198.DB; Derdak S, 2002, AM J RESP CRIT CARE, V166, P801, DOI 10.1164/rccm.2108052; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; Huynh T, 2002, J TRAUMA, V53, P488, DOI 10.1097/00005373-200209000-00016; KAIEDA R, 1989, ANESTHESIOLOGY, V71, P571, DOI 10.1097/00000542-198910000-00016; Mehta S, 2001, CRIT CARE MED, V29, P1360, DOI 10.1097/00003246-200107000-00011; Muench E, 2005, CRIT CARE MED, V33, P2367, DOI 10.1097/01.CCM.0000181732.37319.DF; *RESP CAR SERV DUM, 2004, HIGH FREQ OSC VENT A, P1; Salim A, 2004, J TRAUMA, V57, P542, DOI 10.1097/01.TA.0000135159.94744.5F; SINGH JM, 2003, CRIT CARE ROUNDS, V4, P1; WARNER DS, 1987, STROKE, V18, P142, DOI 10.1161/01.STR.18.1.142; Wijdicks EFM, 1998, NEUROLOGY, V50, P11, DOI 10.1212/WNL.50.1.11	15	13	16	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care		2007	7	3					221	226		10.1007/s12028-007-0084-y			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	237SO	WOS:000251396900007	17805492	Green Accepted			2022-02-06	
J	Frankel, T; Penn, C				Frankel, Tali; Penn, Claire			Perseveration and conversation in TBI: Response to pharmacological intervention	APHASIOLOGY			English	Article							ATTENTION; APHASIA; ORGANIZATION; INHIBITION; DISCOURSE	Background: Perseveration is a frequently encountered characteristic of individuals with organic brain involvement, including individuals with traumatic brain injury (TBI). Current theory implicates disordered executive functioning, particularly deficient inhibitory control, in the manifestation of perseverative phenomena (McNamara & Albert, 2004). To date, no work has been published related to conversational data despite numerous allusions in the literature to the presence of perseveration during conversational discourse. Existing research indicates that pharmacological approaches to reduction of verbal perseveration may be effective, although no full-scale clinical trial of any pharmacological agent targeted specifically at reducing perseveration has been conducted ( McNamara & Albert, 2004). Aims: This study examines conversational correlates of perseveration in TBI, the accompanying executive functioning profiles in relation to Barkley's hybrid model of executive functioning and self-regulation ( 1997) and responses to pharmacotherapy ( Ritalin). Methods & Procedures: Two participants, in chronic stages following TBI with prefrontal and sub-cortical damage, participated in parallel case studies with a quasi-experimental research design. Baseline, active, placebo, and withdrawal phases were included as well as double blind and randomisation precautions. Conversational data were generated using Conversation Analysis. Neuropsychological data were generated following a full battery of tests investigating behavioural inhibition, nonverbal working memory, internalisation of language, regulation of affect, and reconstitution. Outcomes & Results: Conversational data demonstrated disturbed topic management as a result of verbal perseveration. Participant AA demonstrated recurrent perseveration while PB demonstrated stuck-in-set perseveration, which influenced their conversations in highly specific ways. These findings were accompanied by discrete profiles indicating unique disruptions of executive functioning, particularly in relation to behavioural inhibition. Deficits in attention impacted profoundly on self-regulating functions, in particular nonverbal working memory and reconstitution. Improvements were noted during active drug phases related to improved behavioural inhibition and subsequent amelioration of perseverative manifestations with some evidence of improved topic shift and contribution and greater capacity for reconstitution and working memory tasks. Context was found to exert significant effects in relation to perseveration and its conversational manifestations. Conclusions: Perseveration co-exists with marked deficits in behavioural inhibition, which differentially affects executive functioning abilities, resulting in discrete cognitive profiles with corresponding conversational outcomes. Positive responses to pharmacotherapy present optimistic potential for future treatment, while context variables highlight the need for individualised, data-driven intervention programmes with an emphasis on continuous conversational interaction to preserve and improve communicative skills in individuals with chronic TBI.	Univ Witwatersrand, ZA-2050 Johannesburg, South Africa		Frankel, T (corresponding author), Univ Witwatersrand, Private Bag 3, ZA-2050 Johannesburg, South Africa.	tdfranky@absamail.co.za					Adamovich B. B., 1992, SCALES COGNITIVE ABI; ATEN JL, 1994, LANGUAGE INTERVENTIO; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Benton A., 1976, MULTILINGUAL APHASIA; Benton AL, 1991, FRONTAL LOBE FUNCTIO; BLANKEN G, 1993, LINGUISTIC DISORDERS; Booth S, 1999, APHASIOLOGY, V13, P283, DOI 10.1080/026870399402109; Bryant Shannon L., 1994, Seminars in Speech and Language, V15, P71, DOI 10.1055/s-2008-1064134; Christman Sarah S., 2004, Seminars in Speech and Language, V25, P295, DOI 10.1055/s-2004-837243; CODE C, 1982, CHARACTERISTICS APHA; Cohen L, 1998, BRAIN, V121, P1641, DOI 10.1093/brain/121.9.1641; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; Eisenson J, 1973, ADULT APHASIA ASSESS; FEENEY DM, 1993, CRIT REV NEURBIOL, V3, P135; Fuster, 2015, PREFRONTAL CORTEX; Gathercole S.E., 1993, WORKING MEMORY LANGU; GILES M, 1993, BRAIN INJURY REHABIL; GILLIS R, 1996, TRAUMATIC BRAIN INJU; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; Golden J. C., 1978, STROOP COLOR WORD TE; Gotts SJ, 2002, NEUROPSYCHOLOGIA, V40, P1930, DOI 10.1016/S0028-3932(02)00067-2; Gualtieri C T, 1988, Brain Inj, V2, P273, DOI 10.3109/02699058809150898; GUALTIERI CG, 1991, RITALIN THEORY PATIE; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Hauser MD, 1999, CURR OPIN NEUROBIOL, V9, P214, DOI 10.1016/S0959-4388(99)80030-0; HOLMES VF, 1995, INT J PSYCHIAT MED, V25, P1, DOI 10.2190/2TVT-2LH0-AD5A-CP91; Laakso M, 1999, APHASIOLOGY, V13, P345, DOI 10.1080/026870399402136; LANDAUER TK, 1978, PRACTICAL ASPECTS ME; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Lesser R., 1993, LINGUISTICS APHASIA; Lesser R., 1999, COGNITIVE NEUROPSYCH; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; Lock S, 2001, INT J LANG COMM DIS, V36, P25, DOI 10.3109/13682820109177853; LUBINSKI R, 1991, DEMENTIA COMMUNICATI; LUNDGREN K, 1994, BRAIN LANG, V47, P370; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; McNamara Patrick, 2004, Seminars in Speech and Language, V25, P309, DOI 10.1055/s-2004-837244; McNeil M. R., 1995, AM J SPEECH-LANG PAT, V4, P76, DOI [10.1044/1058-0360.0404.76, DOI 10.1044/1058-0360.0404.76]; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MILNER B, 1995, EPILEPSY FUNCTIONAL; MILTON S, 1984, CLIN APH C P MINN; MOSES M, 2001, CAMEL CANDLE UNDERST; NELSON L, 1994, NEUROPSYCHOLOGY BEHA; Nelson LD, 1998, ARCH CLIN NEUROPSYCH, V13, P549, DOI 10.1016/S0887-6177(97)00052-8; NEWCOMBE F, 1997, NEUROLOGICAL REHABIL; Paolo A. M., 1996, ASSESSMENT, V3, P137, DOI [10.1177/107319119600300205, DOI 10.1177/107319119600300205]; PARLOFF MB, 1986, J CONSULT CLIN PSYCH, V54, P79, DOI 10.1037/0022-006X.54.1.79; Pashler H, 1998, ATTENTION; Penn C, 2000, BRAIN LANG, V71, P185, DOI 10.1006/brln.1999.2247; Penn C, 1999, BRAIN LANG, V68, P535, DOI 10.1006/brln.1999.2127; Perkins L, 1999, APHASIOLOGY, V13, P259, DOI 10.1080/026870399402091; Perkins L, 1998, J NEUROLINGUIST, V11, P33, DOI 10.1016/S0911-6044(98)00004-9; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; RASKIN SA, 1992, NEUROPSYCHOLOGIA, V30, P95, DOI 10.1016/0028-3932(92)90018-H; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; SANDSON J, 1987, NEUROLOGY, V37, P1736, DOI 10.1212/WNL.37.11.1736; SCHACHAR R, 1995, J ABNORM CHILD PSYCH, V23, P411, DOI 10.1007/BF01447206; SCHEGLOFF EA, 1977, LANGUAGE, V53, P361, DOI 10.2307/413107; SEHAPIRO SR, 1993, MINOR HEAD TRAUMA AS; Spencer JP, 2004, PSYCHOL SCI, V15, P187, DOI 10.1111/j.0956-7976.2004.01503007.x; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); STUSS DT, 1982, J COMP PHYSIOL PSYCH, V96, P913, DOI 10.1037/0735-7036.96.6.913; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; STUSS DT, 1986, LOCALIZATION NEUROPS; TENHAVE P, 1999, CONVERSATION ANAL; ULATOWSKA HK, 1983, BRAIN LANG, V19, P317, DOI 10.1016/0093-934X(83)90074-3; VANZOMERAN AH, 1994, CLIN NEUROPSYCHOLOGY; Walker-Batson D, 1998, RESTORATIVE NEUROLOGY, P257; Watt N, 2000, S AFR J PSYCHOL, V30, P27, DOI 10.1177/008124630003000305; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wilkinson R, 1999, APHASIOLOGY, V13, P251, DOI 10.1080/026870399402082; WYCKOFF LH, 1984, NARRATIVE PROCEDURAL; YLVISAKER M, 1994, LANGUAGE INTERVENTIO; [No title captured]	77	13	14	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2007	21	10-11					1039	1078		10.1080/02687030701198395			40	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	218HW	WOS:000250007600008					2022-02-06	
J	Greve, KW; Bianchini, KJ; Roberson, T				Greve, Kevin W.; Bianchini, Kevin J.; Roberson, Triche			The booklet category test and malingering in traumatic brain injury: Classification accuracy in known groups	CLINICAL NEUROPSYCHOLOGIST			English	Article							CARD SORTING TEST; MILD HEAD-INJURY; NEUROPSYCHOLOGICAL EVALUATION; NEUROCOGNITIVE DYSFUNCTION; RESPONSE BIAS; PERFORMANCE; VALIDATION; INDICATORS; BATTERY; FAKING	A known-groups design was used to determine the classification accuracy of 12 Booklet Category Test variables in the detection of malingered neurocognitive dysfunction ( MND) in traumatic brain injury ( TBI). Participants were 206 TBI and 60 general clinical patients seen for neuropsychological evaluation. Slick, Sherman, and Iverson's ( 1999) criteria were used to classify the TBI patients into non-malingering, suspect, and MND groups. Classification accuracy of the BCT depended on the specific variable and injury severity examined, with some scores detecting more than 40% of malingerers with false positive error rates of 10% or less. However, the BCT variables are often influenced by cognitive ability as well as malingering, so caution is indicated in applying the BCT to the diagnosis of malingering. Application of these data in clinical practice is discussed.	Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA; Jefferson Neurobehav Grp, Metairie, LA USA		Greve, KW (corresponding author), Univ New Orleans, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu					American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; BINDER LM, 1993, PORTLAND DIGIT RECOG; Bolter J. F., 1985, ANN M NAT AC NEUR OC; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; DeFilippis N., 1997, BOOKLET CATEGORY TES, V2nd; DiCarlo MA, 2000, ARCH CLIN NEUROPSYCH, V15, P399, DOI 10.1016/S0887-6177(99)00031-1; Ellwanger J, 1999, J CLIN EXP NEUROPSYC, V21, P866, DOI 10.1076/jcen.21.6.866.850; Forrest TJ, 2004, CLIN NEUROPSYCHOL, V18, P334, DOI 10.1080/13854040490501673; GOEBEL RA, 1983, J CLIN PSYCHOL, V39, P731, DOI 10.1002/1097-4679(198309)39:5<731::AID-JCLP2270390515>3.0.CO;2-T; Gouvier WD, 1998, CRIT ISS NE, P55; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P783; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; GREVE KW, CLIN NEUROPSYCHOLOGI; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Heaton RK, 1991, COMPREHENSIVE NORMS; Heaton SK, 1993, WISCONSIN CARD SORTI; HENNEKENS CH, 1987, EPIDEMIOLOGY MED; KAGEHIRO DK, 1990, PSYCHOL SCI, V1, P194, DOI 10.1111/j.1467-9280.1990.tb00197.x; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Meyers J E, 2000, Appl Neuropsychol, V7, P133, DOI 10.1207/S15324826AN0703_3; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Millis S. R., 2004, PRINCIPLES PRACTICE, P1077; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P271, DOI 10.1016/0887-6177(95)00040-2; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Sweet J. J., 2002, J FORENSIC NEUROPSYC, V3, P241; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; [No title captured]	43	13	13	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2007	21	2					318	337		10.1080/13854040500488552			20	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	158GW	WOS:000245780800008	17455021				2022-02-06	
J	Kozlowski, KF; Leddy, JJ; Tomita, M; Bergen, A; Willer, BS				Kozlowski, Karl F.; Leddy, John J.; Tomita, Machiko; Bergen, Anne; Willer, Barry S.			Use of the ICECI and ICD-10 E-Coding structures to evaluate causes of head injury and concussion from sport and recreation participation in a school population	NEUROREHABILITATION			English	Article						concussion; sports; ICECI; ICD-10	AGED CHILDREN SURVEY; HEALTH BEHAVIOR; CANADIAN YOUTH; EPIDEMIOLOGY; ADOLESCENTS; CARE	The purpose of this study was to identify the most common causes of head injury and associated symptoms of concussion in a population of school children (n=1,372,979). Using standardized injury report forms, we identified the mechanisms of head injury associated with various sports/recreation activities and assessed each injury for the presence of concussion symptoms. Head injury reports (n=7,765) were coded using the WHO's ICECI and ICD-10 E-codes. 1,338 Cases reported symptoms of concussion. The majority of head injuries occurred during School Free-Play/Recess (59.8%). Combative Sports and Wheeled Non-Motored Sports were the activities most often associated with concussion symptoms (rate of concussion (RC): 48.3% and 44.4%, respectively, p < 0.001). School Free-Play/Recess and Physical Education Classes were significantly less likely to have head injuries associated with concussion (RC: 16.0%, p < 0.001, and 12.4%, p=0.034, respectively). The most common causes of head injury were (1) Struck by an Object (24.9%) and (2) Falling on the Same Level (22.8%). Falling from a Transport was the only etiological code significantly associated with concussion symptoms after head injury (RC: 28.7%, p <.001). Results were similar when using the two coding structures in combination. Prevention efforts should focus on activities where children are moving at high speeds since these are more likely to cause a concussion when a head injury occurs.	SUNY Buffalo, Dept Exercise & Nutr Sci, Program Athlet Training, Buffalo, NY 14214 USA; SUNY Buffalo, Dept Orthoped, Buffalo, NY 14260 USA; SUNY Buffalo, Dept Rehabil Sci, Buffalo, NY 14260 USA; Univ Guelph, Dept Psychol, Guelph, ON N1G 2W1, Canada; SUNY Buffalo, Dept Psychiat, Buffalo, NY 14260 USA		Kozlowski, KF (corresponding author), SUNY Buffalo, Dept Exercise & Nutr Sci, Program Athlet Training, Kimball Tower,Room 214A, Buffalo, NY 14214 USA.	kfk@buffalo.edu	Kozlowski, Karl/H-5253-2019				Agran PF, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.3.e45; ANNEST JL, 2000, CDCS SHORT VERSION I; Ardern C, 2001, CAN J PUBLIC HEALTH, V92, P201, DOI 10.1007/BF03404305; BIJUR PE, 1995, ARCH PEDIAT ADOL MED, V149, P1009, DOI 10.1001/archpedi.1995.02170220075010; BLOEMHOFF A, 2000, TESTING ICECI REV FI; Body C, 1996, BRAIN INJURY, V10, P567, DOI 10.1080/026990596124133; Conn JM, 2003, INJURY PREV, V9, P117, DOI 10.1136/ip.9.2.117; Danseco ER, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.2.e27; Di Scala C, 1997, J SCHOOL HEALTH, V67, P384; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; Evans G D, 1987, J Community Health, V12, P246, DOI 10.1007/BF01324294; Gibson H, 1996, CAN J PUBLIC HEALTH, V87, P106; Hambidge SJ, 2002, PEDIATRICS, V109, P559, DOI 10.1542/peds.109.4.559; HAMMARSTROM A, 1994, SCAND J SOC MED, V22, P120, DOI 10.1177/140349489402200207; HARRISON J, 1999, ORGANIZATION; Hendrick E B, 1964, Clin Neurosurg, V11, P46; Hostetler SG, 2004, PEDIATRICS, V114, pE661, DOI 10.1542/peds.2004-1565; *ICECI, 2003, ICECI VERS 1 1A; King MA, 1998, CAN J PUBLIC HEALTH, V89, P397, DOI 10.1007/BF03404082; Knight S, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.6.e81; Kohen D E, 2000, Inj Prev, V6, P223, DOI 10.1136/ip.6.3.223; Laforest S, 2000, J EPIDEMIOL COMMUN H, V54, P475, DOI 10.1136/jech.54.6.475; Langley J D, 1999, Inj Prev, V5, P247; Peloso PM, 2004, J REHABIL MED, V36, P22, DOI 10.1080/16501960410023714; Pickett W, 2000, Inj Prev, V6, P9, DOI 10.1136/ip.6.1.9; *STAT CAN, 2003, PROV TERR PROF 2001; Vorko-Jovic A, 2001, CROAT MED J, V42, P58; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017	28	13	13	0	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2007	22	3					191	198					8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	216NM	WOS:000249884800005	17917169				2022-02-06	
J	Moiyadi, AV; Devi, BI; Nair, KPS				Moiyadi, Aliasgar V.; Devi, B. Indira; Nair, K. P. Sivaraman			Urinary disturbances following traumatic brain injury: Clinical and urodynamic evaluation	NEUROREHABILITATION			English	Article						traumatic brain injury; urinary disturbances; urodynamics; overactive bladder; rehabilitation	INCONTINENCE; MICTURITION; CONSCIOUSNESS; ACTIVATION; SEVERITY; MODERATE; OUTCOMES; STROKE; INDEX; COMA	Aim: To detect presence of urodynamic abnormalities in patients with traumatic brain injuries. Materials and Methods: A prospective study was conducted recruiting patients sustaining moderate or severe head injuries. Clinical and radiological evaluation was done. Neurocognitive and functional outcomes were assessed. Patients then underwent standardized urodynamic studies. The urodynamic findings were correlated with outcome and statistically analyzed. Results: 11 of 20 patients recruited had urodynamic abnormalities, in spite of only two being symptomatic. An overactive detrussor was detected in 8 (one with sphincter dyssynergia) and reduced detrussor compliance was found in 3. Only presence of motor deficits correlated statistically with the occurrence of these abnormalities. Conclusions: Asymptomatic urodynamic abnormalities may be common in patients with moderate/severe traumatic brain injury. Presence of motor deficits may predict the occurrence of such abnormalities.	Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India; Natl Inst Mental Hlth & Neurosci, Dept Psychiat & Neurol Rehabil, Bangalore 560029, Karnataka, India		Devi, BI (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India.	bindira@nimhans.kar.nic.in	Nair, Krishnan/AAE-3474-2020	Nair, Krishnan/0000-0002-4004-2315			Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; ALLISON SC, 1995, J NEUROL, V242, P699, DOI 10.1007/BF00866923; ANDREW J, 1964, BRAIN, V87, P233, DOI 10.1093/brain/87.2.233; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Blok BFM, 1998, BRAIN, V121, P2033, DOI 10.1093/brain/121.11.2033; Brittain KR, 1998, STROKE, V29, P524, DOI 10.1161/01.STR.29.2.524; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Chua K, 2003, BRAIN INJURY, V17, P469, DOI 10.1080/02699050210154268; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fowler CJ, 1999, BRAIN, V122, P1213, DOI 10.1093/brain/122.7.1213; GELBER DA, 1993, STROKE, V24, P378, DOI 10.1161/01.STR.24.3.378; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; JENNETT B, 1975, LANCET, V1, P480; Jonsson CA, 2004, BRAIN INJURY, V18, P921, DOI 10.1080/02699050410001671900; Krimchansky BZ, 1999, BRAIN INJURY, V13, P899; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Nour S, 2000, BRAIN, V123, P781, DOI 10.1093/brain/123.4.781; Oostra K, 1996, BRAIN INJURY, V10, P459, DOI 10.1080/026990596124313; Rushton DN, 1994, HDB NEUROUROLOGY HDB NEUROUROLOGY; SAKAKIBARA R, 1999, BLUE BOOK PRACT NEUR, V23, P229; Sandvik H, 2000, NEUROUROL URODYNAM, V19, P137, DOI 10.1002/(SICI)1520-6777(2000)19:2<137::AID-NAU4>3.0.CO;2-G; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Stohrer M, 1999, NEUROUROL URODYNAM, V18, P139; TEASDALE G, 1974, LANCET, V2, P81; WADE DT, 1985, Q J MED, V56, P601; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; YOUNGSON HA, 1994, BRAIN INJURY, V8, P23, DOI 10.3109/02699059409150956	29	13	13	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2007	22	2					93	98					6	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	195LB	WOS:000248412600003	17656833				2022-02-06	
J	Oh, EJ; Kim, YM; Jegal, DW; Kahng, J; Park, YJ; Han, K				Oh, Eun-Jee; Kim, Young-Min; Jegal, Dong-Wook; Kahng, Jimin; Park, Yeon-Joon; Han, Kyungja			Diagnostic value of Elecsys S100 as a marker of acute brain injury in the emergency department	JOURNAL OF CLINICAL LABORATORY ANALYSIS			English	Article						elecsys S100; acute brain injury; emergency department; screening; serum marker	ELECSYS(R) S100 IMMUNOASSAY; SERUM S-100 PROTEIN; MINOR HEAD-INJURY; MULTICENTER; S100-BETA; DAMAGE; DISEASE; TRAUMA	The aim of this study was to evaluate the screening and diagnostic validity of the initial serum S100 levels by Elecsys S100 immunoassay in an emergency department. We measured serum S100 in 101 acute brain injury (ABI) patients, in 40 healthy subjects, and in 41 chronic brain injury (CBI) patients (the control group). The ABI patients were divided in several groups according to the Glasgow Coma Scale (GCS), injury type and findings of brain imaging. Of the 101 patients, the 66 cranial computed tomography (CCT) or brain magnetic resonance imaging (MRI)positive patients showed higher S100 levels than did the 35 CCT/MRI-negative patients (P= 0.028). At a cutoff of 0.105 mu g/L, the sensitivity was 84.8% and the specificity 74.3% for all of the ABI patients, and the sensitivity was increased to 96.9% for the traumatic ABI patients for detecting image-positive ABI. There was no significant difference of S100 levels among the groups on the CCT or MRI pathological findings (P = 0.478). In conclusion, serum S100 levels can be used in the emergency department as an additional screening tool to identify CCT- or MRI-positive ABI.	[Oh, Eun-Jee; Jegal, Dong-Wook; Kahng, Jimin; Park, Yeon-Joon; Han, Kyungja] Catholic Univ Korea, Coll Med, Dept Lab Med, Seoul 137040, South Korea; [Kim, Young-Min] Catholic Univ Korea, Coll Med, Dept Emergency Med, Seoul 137040, South Korea		Oh, EJ (corresponding author), Catholic Univ Korea, Coll Med, Dept Lab Med, 505 Banpodong, Seoul 137040, South Korea.	ejoh@catholic.ackr		Oh, Eun-Jee/0000-0001-5870-915X			Abraha HD, 1997, ANN CLIN BIOCHEM, V34, P366, DOI 10.1177/000456329703400405; Alber B, 2005, CLIN CHEM LAB MED, V43, P557, DOI 10.1515/CCLM.2005.097; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Biberthaler P, 2001, SHOCK, V16, P97, DOI 10.1097/00024382-200116020-00002; Buttner T, 1997, STROKE, V28, P1961, DOI 10.1161/01.STR.28.10.1961; Graham ID, 1998, ACAD EMERG MED, V5, P134, DOI 10.1111/j.1553-2712.1998.tb02598.x; GRIFFIN WST, 1995, J NEUROCHEM, V65, P228; HAIMOTO H, 1987, LAB INVEST, V57, P489; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; KAHN HJ, 1991, MODERN PATHOL, V4, P698; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Mussack T, 2006, CLIN CHEM LAB MED, V44, P1140, DOI 10.1515/CCLM.2006.190; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Rothoerl RD, 1998, J TRAUMA, V45, P765, DOI 10.1097/00005373-199810000-00025; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/0968-0004(96)10020-7; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Wiesmann M, 1997, ACTA NEUROCHIR, V139, P1155, DOI 10.1007/BF01410976	19	13	13	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	0887-8013	1098-2825		J CLIN LAB ANAL	J. Clin. Lab. Anal.		2007	21	6					387	392		10.1002/jcla.20201			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	241KC	WOS:000251654300008	18022928	Green Published			2022-02-06	
J	Simpson, G; Franke, B; Gillett, L				Simpson, Grahame; Franke, Bernie; Gillett, Lauren			Suicide prevention training outside the mental health service system - Evaluation of a state-wide program in Australia for rehabilitation and disability staff in the field of traumatic brain injury	CRISIS-THE JOURNAL OF CRISIS INTERVENTION AND SUICIDE PREVENTION			English	Article						traumatic brain injury; training; suicide prevention	INTERVENTION; ASSOCIATION; CONTACT; PEOPLE	The training needs of staff working in mainstream (i.e., noncrisis) health settings with client groups that have moderate levels of suicide risk have not been extensively addressed. An initiative to train rehabilitation and disability staff working in the field of traumatic brain injury TBI) is described. A program was adapted from a generic state health department training program, and disseminated by means of established training networks within the brain injury field. Program efficacy was evaluated as the training was provided across the state of Victoria in a series of 1-day workshops. Participants (n = 86) completed two evaluation measures designed for this purpose (objective knowledge test, self-rating of knowledge and skills) on three occasions (pre- and postworkshop, 6-month follow-up). Compared to a control group of rehabilitation and disability workers who did not receive the training (n = 27), the workshop participants made significant gains in objective knowledge and reported skills, and maintained these gains at the 6-month follow-up. The Suicide Interview Response Inventory-2 (Neimeyer & Pfeiffer, 1994) was administered to a subgroup of participants as a validating measure, and correlated significantly with scores from the objective knowledge test. This process may provide a template for developing more fine-grained suicide prevention strategies among other health-related at-risk groups.	Liverpool Hosp, Brain Ijury Rehabil Unit, Sydney, NSW, Australia; McKellar Ctr, Training & Secondary Consultat Project, Geelong, Vic, Australia		Simpson, G (corresponding author), Liverpool Hosp, Brain Injury Rehabil Unit, Locked Bag 7103, Liverpool bc, NSW 1871, Australia.	grahame.simpson@swsahs.nsw.gov.au	Simpson, Grahame K/W-1074-2019	Simpson, Grahame K/0000-0001-8156-9060			ADRIAN J, 1996, INF TRAINING STRATEG; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Appleby L, 1999, BRIT MED J, V318, P1235; Beautrais AL, 2005, CRISIS, V26, P1, DOI 10.1027/0227-5910.26.1.1; Bongar B., 1992, SUICIDE GUIDELINES A, P16; Booth N, 2000, INT REV PSYCHIATR, V12, P27, DOI 10.1080/09540260074085; Burgess P, 2000, PSYCHIATR SERV, V51, P1555, DOI 10.1176/appi.ps.51.12.1555; Commonwealth Department of Health and Ageing, 2000, LIF FRAM PREV SUIC S; Connolly John, 2002, Crisis, V23, P143, DOI 10.1027//0227-5910.23.4.143; Crawford MJ, 1998, J ACCID EMERG MED, V15, P18; Deb S, 1999, AM J PSYCHIAT, V156, P374; Fleminger S, 2003, NEUROPSYCHOL REHABIL, V13, P65, DOI 10.1080/09602010244000354; Gorsuch R., 1974, FACTOR ANAL; KLONOFF PS, 1995, J HEAD TRAUMA REHAB, V10, P16, DOI 10.1097/00001199-199512000-00005; Kuipers P, 2000, J HEAD TRAUMA REHAB, V15, P1275, DOI 10.1097/00001199-200012000-00007; Metha A, 1998, SUICIDE LIFE-THREAT, V28, P150; Neimeyer RA, 1997, DEATH STUD, V21, P59; NEIMEYER RA, 1994, DEATH STUD, V18, P179; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; *NEW S WAL HLTH, 1999, SUIC RISK ASS MAN RE; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ramberg Inga-Lill, 2004, Arch Suicide Res, V8, P331, DOI 10.1080/13811110490476707; RUTZ W, 1989, ACTA PSYCHIAT SCAND, V80, P151, DOI 10.1111/j.1600-0447.1989.tb01318.x; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2003, J HEAD TRAUMA REHAB, V18, P445, DOI 10.1097/00001199-200309000-00006; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; SIMPSON GK, 2001, SUICIDE PREVENTION T; STREINER DL, 1993, CAN J PSYCHIAT, V38, P140, DOI 10.1177/070674379303800214; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Tierney R J, 1994, Crisis, V15, P69; TURLEY B, 1998, LIVING WORKS AUSTR F; *VICT DEP HUM SERV, 2004, ACQ BRAIN INJ MENT I; *WHO, 1999, FACTS FIG SUIC TECHN; *WHO, 1996, GLOB BURD DIS INJ SE	39	13	13	0	3	HOGREFE & HUBER PUBLISHERS	GOTTINGEN	ROHNSWEG 25, D-37085 GOTTINGEN, GERMANY	0227-5910			CRISIS	Crisis		2007	28	1					35	43		10.1027/0227-5910.28.1.35			9	Psychiatry; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychiatry; Psychology	167GW	WOS:000246440600006	17555031				2022-02-06	
J	Iverson, GL				Iverson, Grant L.			Sensitivity of computerized neuropsychological screening in depressed university students	CLINICAL NEUROPSYCHOLOGIST			English	Article; Proceedings Paper	111th Annual Convention of the American-Psychological-Association	AUG 07-10, 2003	Toronto, CANADA	Amer Psychol Assoc			MAJOR DEPRESSION; EXECUTIVE FUNCTION; NEUROCOGNITIVE IMPAIRMENT; COGNITIVE FUNCTION; TEST-PERFORMANCE; DISORDER; SCHIZOPHRENIA; CONCUSSION; BIPOLAR; DEFICIT	This study examined the sensitivity of a computerized neuropsychological screening (ImPACT) to the cognitive effects of depression in a sample of 20 students with suspected depression and 20 healthy university students matched for gender, age, and education. Students with depression had slower reaction times (p < .02; d=.82, large effect) and processing speeds (p < .03; d = .77, large effect). The brevity and sensitivity of ImPACT to the cognitive effects of depression warrants further research with psychiatric populations.	Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada; Riverview Hosp, Vancouver, BC, Canada		Iverson, GL (corresponding author), Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada.	giverson@interchange.ubc.ca		Iverson, Grant/0000-0001-7348-9570			Austin MP, 1999, PSYCHOL MED, V29, P73, DOI 10.1017/S0033291798007788; Bearden CE, 2001, BIPOLAR DISORD, V3, P106, DOI 10.1034/j.1399-5618.2001.030302.x; Channon S, 1999, J NEUROL NEUROSUR PS, V66, P162, DOI 10.1136/jnnp.66.2.162; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; De Luca CR, 2003, J CLIN EXP NEUROPSYC, V25, P242, DOI 10.1076/jcen.25.2.242.13639; Degl'Innocenti A, 1998, ACTA PSYCHIAT SCAND, V97, P182, DOI 10.1111/j.1600-0447.1998.tb09985.x; Deuschle M, 2004, PHARMACOPSYCHIATRY, V37, P147, DOI 10.1055/s-2004-827168; Di Sclafani V, 2002, DRUG ALCOHOL DEPEN, V66, P161, DOI 10.1016/S0376-8716(01)00197-1; Dorion AA, 2002, NEUROPSYCHOLOGIA, V40, P946, DOI 10.1016/S0028-3932(01)00150-6; Dunkin JJ, 2000, J AFFECT DISORDERS, V60, P13, DOI 10.1016/S0165-0327(99)00157-3; Grant MM, 2001, BIOL PSYCHIAT, V50, P35, DOI 10.1016/S0006-3223(00)01072-6; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Honig A, 1999, INT CLIN PSYCHOPHARM, V14, P167, DOI 10.1097/00004850-199905002-00003; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kampf-Sherf O, 2004, J AFFECT DISORDERS, V82, P453, DOI 10.1016/j.jad.2004.02.006; Keefe RSE, 1999, SCHIZOPHRENIA BULL, V25, P201, DOI 10.1093/oxfordjournals.schbul.a033374; Kempton S, 1999, PSYCHOL MED, V29, P527, DOI 10.1017/S0033291799008338; Lopez SJ, 2001, PSYCHOL REP, V88, P183, DOI 10.2466/PR0.88.1.183-188; Louis WJ, 1999, J HYPERTENS, V17, P1813, DOI 10.1097/00004872-199917121-00005; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Luciana M, 2002, DEV NEUROPSYCHOL, V22, P595, DOI 10.1207/S15326942DN2203_3; Merriam EP, 1999, AM J PSYCHIAT, V156, P780; Mohlman J, 2005, BEHAV RES THER, V43, P447, DOI 10.1016/j.brat.2004.03.007; Moore JL, 2002, EPILEPSY BEHAV, V3, P92, DOI 10.1006/ebeh.2001.0313; Neu P, 2005, J PSYCHIAT RES, V39, P129, DOI 10.1016/j.jpsychires.2004.06.004; NEWMAN P, 1992, HDB NEUROPSYCHOLOGIC; Nielen MMA, 2003, PSYCHOL MED, V33, P917, DOI 10.1017/S0033291703007682; Nieuwenstein MR, 2001, J PSYCHIATR RES, V35, P119, DOI 10.1016/S0022-3956(01)00014-0; Politis A, 2004, COMPR PSYCHIAT, V45, P452, DOI 10.1016/j.comppsych.2004.07.007; Porter RJ, 2003, BRIT J PSYCHIAT, V182, P214, DOI 10.1192/bjp.182.3.214; Purcell R, 1997, PSYCHOL MED, V27, P1277, DOI 10.1017/S0033291797005448; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Sweeney JA, 2000, BIOL PSYCHIAT, V48, P674, DOI 10.1016/S0006-3223(00)00910-0; Voruganti LNP, 1997, CAN J PSYCHIAT, V42, P1066, DOI 10.1177/070674379704201008; Vythilingam M, 2004, BIOL PSYCHIAT, V56, P101, DOI 10.1016/j.biopsych.2004.04.002; Zakzanis KK, 1998, NEUROPSY NEUROPSY BE, V11, P111	39	13	14	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	DEC	2006	20	4					695	701		10.1080/138540491005857			7	Psychology, Clinical; Clinical Neurology; Psychology	Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	085IE	WOS:000240597000007	16980255				2022-02-06	
J	Jiang, JY; Xu, W; Yang, PF; Ga, GY; Gao, YG; Liang, YM; Yin, XL; Zhu, C				Jiang, Ji-Yao; Xu, Wei; Yang, Peng-Feng; Ga, Guo-Yi; Gao, Yong-Gun; Liang, Yu-Min; Yin, Xiao-Lu; Zhu, Cheng			Marked protection by selective cerebral profound hypothermia after complete cerebral ischemia in primates	JOURNAL OF NEUROTRAUMA			English	Article						cerebral anoxia; cerebral protection; selective brain cooling; subhuman primate	TRAUMATIC BRAIN-INJURY; CIRCULATORY ARREST; THERAPEUTIC HYPOTHERMIA; EXTRACORPOREAL-CIRCULATION; DEEP HYPOTHERMIA; CARDIAC-ARREST; ANEURYSMS; TEMPERATURE; MANAGEMENT; OPERATIONS	Hypothermia has been demonstrated to protect the brain from ischemia or traumatic brain injury. Achieving profound hypothermia has relied on techniques requiring total body cooling, which may result in serious cardiovascular and pulmonary complications. A technique to selectively cool the brain could conceivably exert a marked protection on cerebral structures and provide a relatively bloodless operative surgical field without systemic complications. Accordingly, this approach was tried in 7 rhesus monkeys after induction of general anesthesia. The right internal carotid artery and both internal jugular veins were each occlusively cannulated and connected to a circulation pump. The left internal carotid artery, both external carotid arteries, and both external jugular veins were temporarily clamped to establish severe cerebral ischemia. Using a closed-circuit system, cooled Ringer's lactate liquid (4 degrees C) was infused through right internal carotid artery with outflow draining though both internal jugular veins. Cooled perfusate decreased cerebral temperature to the target temperature of 15 degrees C. Thereafter, pump flow was discontinued, and brains were rewarmed spontaneously, while the temporarily clamped carotid arteries and jugular veins were opened to resume normal cerebral blood circulation. Neurological functions were recorded daily and cerebral histology was examined at the conclusion of the experiment. Magnetic resonance (MR) scans were routinely taken before and 3 weeks after ischemia. In the normothermia control group of five rhesus monkeys, Ringer's solution at 37 degrees C was infused in the same manner as the cold solution with cerebral temperature maintained at 36.7 +/- 0.32 degrees C. Right cerebral temperature decreased from 36.5 +/- 0.49 to 15.5 +/- 2.29 degrees C, and simultaneously the left cerebral temperature decreased from 36.4 +/- 0.38 to 16.3 +/- 2.4 degrees C for 62.8 +/- 9.76 min during selective cerebral cooled Ringer's liquid perfusion. In contrast, rectal temperature was only reduced to 32.4 +/- 0.96 degrees C from a baseline of 37.2 +/- 0.76 degrees C. Internal jugular vein hematocrit was 38.2 +/- 0.31% before perfusion and 2.82 +/- 0.46% at the end of perfusion in profound hypothermia group; hematocrit was 39.7 +/- 0.62% before perfusion and 3.42 +/- 0.38% at the end of perfusion in the normothermia group. In the hypothermic group, neurological functions were normal during 6 months of follow-up, and microscopic examination of brain tissue did not show evidence of pathological changes in hippocampus or medulla. MR scans did not show any cerebral infarction. In contrast, none of the monkeys in normothermia group survived for more than several hours, and microscopic examination of the brain revealed extensive neuronal necrosis within the medulla. Selective cerebral profound hypothermia provides significant histologic and neurologic protection after severe cerebral ischemia. In addition, there were no major complications, and the operative field remained relatively bloodless in the profound hypothermic group.	Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200001, Peoples R China; Kunming Med Coll, Affiliated Hosp 2, Dept Neurosurg, Kunming, Peoples R China; Fuzhou Gen Mil Hosp, Dept Neurosurg, Fuzhou, Fujian Province, Peoples R China; Second Mil Med Univ, Changzhen Hosp, Dept Neurosurg, Shanghai, Peoples R China; Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Pathol, Shanghai 200030, Peoples R China		Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200001, Peoples R China.	Jiangjyb@online.sh.cn					ALBERTS MJ, 1995, ANN INTERN MED, V122, P622, DOI 10.7326/0003-4819-122-8-199504150-00013; ALTHAUS U, 1982, ANN SURG, V195, P492, DOI 10.1097/00000658-198204000-00018; AVNDAM LD, 1959, NEW ENGL J MED, V261, P546; BACHET J, 1991, J THORAC CARDIOV SUR, V102, P85; BAUMGARTNER WA, 1983, SURGERY, V94, P242; BIGELOW WG, 1950, ANN SURG, V132, P849, DOI 10.1097/00000658-195011000-00001; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; CONNOLLY JE, 1962, SURGERY, V52, P15; Dietrich WD, 1999, STROKE, V30, P855, DOI 10.1161/01.STR.30.4.855; DRAKE CG, 1964, J NEUROSURG, V21, P575, DOI 10.3171/jns.1964.21.7.0575; GINSBERG MD, 1992, CEREBROVAS BRAIN MET, V4, P189; GRIEPP EB, 1992, J CARDIAC SURG, V7, P134, DOI 10.1111/j.1540-8191.1992.tb00790.x; GUEGAN Y, 1985, SURG NEUROL, V24, P441, DOI 10.1016/0090-3019(85)90306-4; Holzer M, 2002, NEW ENGL J MED, V346, P549; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; KIMOTO S, 1956, SURGERY, V39, P592; Kochanek PA, 2003, JAMA-J AM MED ASSOC, V289, P3007, DOI 10.1001/jama.289.22.3007; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MCMURTRY JG, 1974, J NEUROSURG, V40, P486, DOI 10.3171/jns.1974.40.4.0486; MICHENFELDER JD, 1964, ANESTHESIOLOGY, V25, P131, DOI 10.1097/00000542-196403000-00004; MILLER DL, 1989, RADIOLOGY, V172, P1007, DOI 10.1148/172.3.1007; OHTA T, 1992, NEUROSURGERY, V31, P1049, DOI 10.1227/00006123-199212000-00010; OHTA T, 1966, J NEUROSURG, V24, P994; PARKINS WM, 1954, ANN SURG, V140, P284, DOI 10.1097/00000658-195409000-00004; PATTERSON RH, 1962, ANN SURG, V156, P377, DOI 10.1097/00000658-196209000-00005; Richards P G, 1987, Br J Neurosurg, V1, P261, DOI 10.3109/02688698709035310; Safar PJ, 2002, NEW ENGL J MED, V346, P612, DOI 10.1056/NEJM200202213460811; Schwartz Arthur E., 1996, Neurosurgery (Baltimore), V39, P577, DOI 10.1097/00006123-199609000-00028; SILVERBERG GD, 1980, NEUROSURGERY, V6, P301; SOLOMON RA, 1991, NEUROSURGERY, V29, P732, DOI 10.1227/00006123-199111000-00015; SPETZLER RF, 1988, J NEUROSURG, V68, P868, DOI 10.3171/jns.1988.68.6.0868; SPETZLER RF, 1980, NEUROSURGERY, V7, P257, DOI 10.1227/00006123-198009000-00009; STEEN PA, 1980, ANESTHESIOLOGY, V52, P224, DOI 10.1097/00000542-198003000-00007; WOODHALL B, 1960, ANN SURG, V152, P37, DOI 10.1097/00000658-196007000-00006; ZARINS CK, 1973, J SURG RES, V14, P97, DOI 10.1016/0022-4804(73)90015-2	36	13	16	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2006	23	12					1847	1856		10.1089/neu.2006.23.1847			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	120AP	WOS:000243056100011	17184193				2022-02-06	
J	Lebesgue, D; LeBold, DG; Surles, NO; Morales, DM; Etgen, AM; Zukin, RS; Saatman, KE				Lebesgue, Diane; LeBold, David G.; Surles, Nathan O.; Morales, Diego M.; Etgen, Anne M.; Zukin, R. Suzanne; Saatman, Kathryn E.			Effects of estradiol on cognition and hippocampal pathology after lateral fluid percussion brain injury in female rats	JOURNAL OF NEUROTRAUMA			English	Article						gender; in vivo studies; learning and memory; neuronal cell death; traumatic brain injury	TRANSIENT GLOBAL-ISCHEMIA; ESTROGEN-RECEPTOR-ALPHA; CENTRAL-NERVOUS-SYSTEM; HEAD-INJURY; GENDER-DIFFERENCES; NEURONAL INJURY; CELL-DEATH; PROGESTERONE; MECHANISMS; APOPTOSIS	Studies involving animal models of acute central nervous system (CNS) stroke and trauma strongly indicate that sex and/or hormonal status are important determinants of outcome after brain injury. The present study was undertaken to examine the ability of estradiol to protect hippocampal neurons from lateral fluid percussion brain injury. Sprague-Dawley female rats (211-285 g; n = 119) were ovariectomized, and a subset (it = 66) were implanted with 17 beta-estradiol pellets to provide near physiological levels of estradiol. Animals were subjected to lateral fluid percussion brain injury or sham injury 1 week later. Activation of caspase-3 (n = 26) and TUNEL staining (it = 21) were assessed at 3 and 12 h after injury, respectively, in surviving control and estradiol-treated animals. Memory retention was examined using a Morris water maze test in a separate subset of animals (n = 43) at 8 days after injury. Activated caspase-3 and TUNEL staining were observed in the dentate hilus, granule cell layer, and CA3 regions in all injured rats, indicative of selective hippocampal cell apoptosis in the acute posttraumatic period. Estradiol did not significantly alter the number of hippocampal neurons exhibiting caspase-3 activity or TUNEL staining. Brain injury impaired cognitive ability, assessed at 1 week post-injury (p < 0.001). However, estradiol at physiological levels did not significantly alter injury-induced loss of memory. These data indicate that estradiol at physiological levels does not ameliorate trauma-induced hippocampal injury or cognitive deficits in ovariectomized female rats.	Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA		Saatman, KE (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, B367 BBSRB,741 S Limestone St, Lexington, KY 40536 USA.	k.saatman@uky.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS045693] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045693] Funding Source: NIH RePORTER		Amantea D, 2005, PHARMACOL RES, V52, P119, DOI 10.1016/j.phrs.2005.03.002; Azcoitia I, 1999, J NEUROCYTOL, V28, P699, DOI 10.1023/A:1007025219044; Bagetta G, 2004, NEUROSCI LETT, V368, P87, DOI 10.1016/j.neulet.2004.06.062; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; Bengzon J, 2002, PROG BRAIN RES, V135, P111; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Conti AC, 1998, J NEUROSCI, V18, P5663; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Ekert PG, 1999, CELL DEATH DIFFER, V6, P1081, DOI 10.1038/sj.cdd.4400594; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; EMERSON CS, 1992, NEUROREPORT, V3, P957, DOI 10.1097/00001756-199211000-00002; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Galani R, 2001, RESTOR NEUROL NEUROS, V18, P161; Garcia-Ovejero D, 2005, BRAIN RES REV, V48, P273, DOI 10.1016/j.brainresrev.2004.12.018; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Gulinello M, 2006, HORM BEHAV, V49, P246, DOI 10.1016/j.yhbeh.2005.07.010; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; He Z, 2002, J NEUROL SCI, V193, P79, DOI 10.1016/S0022-510X(01)00648-7; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; Igarashi T, 2001, EXP NEUROL, V172, P332, DOI 10.1006/exnr.2001.7820; Jover T, 2002, J NEUROSCI, V22, P2115, DOI 10.1523/JNEUROSCI.22-06-02115.2002; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; KOTAPKA MJ, 1994, J NEUROTRAUM, V11, P317, DOI 10.1089/neu.1994.11.317; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; McCullough LD, 2003, TRENDS ENDOCRIN MET, V14, P228, DOI 10.1016/S1043-2760(03)00076-6; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Merchenthaler I, 2003, ANN NY ACAD SCI, V1007, P89, DOI 10.1196/annals.1286.009; Miller NR, 2005, ENDOCRINOLOGY, V146, P3070, DOI 10.1210/en.2004-1515; Mouihate A, 2003, ENDOCRINOLOGY, V144, P2454, DOI 10.1210/en.2002-0093; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; PFAFF D, 1973, J COMP NEUROL, V151, P121, DOI 10.1002/cne.901510204; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RINK A, 1995, AM J PATHOL, V147, P1575; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Shughrue PJ, 2003, NEUROSCIENCE, V116, P851, DOI 10.1016/S0306-4522(02)00790-X; Shughrue PJ, 2000, NEUROSCIENCE, V99, P605, DOI 10.1016/S0306-4522(00)00242-6; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Stumpf W E, 1975, Adv Biosci, V15, P77; Sunday L, 2006, AM J PHYSIOL-ENDOC M, V291, pE261, DOI 10.1152/ajpendo.00550.2005; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zhu CL, 2006, J NEUROCHEM, V96, P1016, DOI 10.1111/j.1471-4159.2005.03639.x	66	13	13	0	1	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	2006	23	12					1814	1827		10.1089/neu.2006.23.1814			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	120AP	WOS:000243056100009	17184191				2022-02-06	
J	Ross, SR; Putnam, SH; Millis, SR; Adams, KM; Krukowski, RA				Ross, Scott R.; Putnam, Steven H.; Millis, Scott R.; Adams, Kenneth M.; Krukowski, Rebecca A.			Detecting insufficient effort using the seashore rhythm and speech-sounds perception tests in head injury	CLINICAL NEUROPSYCHOLOGIST			English	Article							RECOGNITION MEMORY TEST; ADULT INTELLIGENCE SCALE; TRAUMATIC BRAIN-INJURY; FAKE-BAD SCALE; INCOMPLETE EFFORT; MMPI-2; IMPAIRMENT; VALIDATION; CATEGORY; IDENTIFICATION	This study examined the capacity of the Seashore Rhythm Test (SRT) and the Speech-Sounds Perception Test (SSPT) to detect insufficient effort in a clinical sample. Forty-six participants with financially compensable mild head injury who obtained scores indicative of insufficient effort on multiple measures were compared to 49 participants with brain injury who were not involved in litigation. Receiver operating characteristic (ROC) curve analysis indicated that both the SRT (AUC= .84) and SSPT (AUC= .80) were significant (p <.001) predictors of insufficient effort. Maximizing sensitivity and specificity, the optimal cutoff scores were 8 errors on the SRT and 10 errors on the SSPT. Combining both variables into a logistic regression function increased the diagnostic efficiency.	Depauw Univ, Dept Psychol, Greencastle, IN 46135 USA; Wayne State Univ, Sch Med, Detroit, MI USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Kessler Med Rehabil Res & Educ Corp, Newark, NJ 07103 USA; VAMC, Ann Arbor, MI USA; Univ Michigan, Med Ctr, Ann Arbor, MI 48109 USA; Univ Vermont, Burlington, VT USA		Ross, SR (corresponding author), Depauw Univ, Dept Psychol, 7 Larabee St, Greencastle, IN 46135 USA.	srross@depauw.edu	Krukowski, Rebecca/AAS-4304-2020	Krukowski, Rebecca/0000-0001-9193-2783			Axelrod B. N., 1999, J FORENSIC NEUROPSYC, V1, P15; Baker R, 2000, Appl Neuropsychol, V7, P111, DOI 10.1207/S15324826AN0702_8; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; BERNARD LC, 1993, ARCH CLIN NEUROPSYCH, V8, P539, DOI 10.1016/0887-6177(93)90054-5; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; BORNSTEIN RA, 1983, PERCEPT MOTOR SKILL, V57, P571, DOI 10.2466/pms.1983.57.2.571; BORNSTEIN RA, 1982, PERCEPT MOTOR SKILL, V55, P203, DOI 10.2466/pms.1982.55.1.203; CHARTER RA, 1994, J CLIN EXP NEUROPSYC, V16, P744, DOI 10.1080/01688639408402687; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Forrest TJ, 2004, CLIN NEUROPSYCHOL, V18, P334, DOI 10.1080/13854040490501673; Franzen M.D., 1994, ASSESSMENT, V1, P323, DOI [DOI 10.1177/1073191, https://doi.org/10.1177/107319119400100401]; Frederick R. I., 1997, VALIDITY INDICATOR P; Gallop RJ, 2003, UNDERSTAND STAT, V2, P219, DOI DOI 10.1207/S15328031US0204_01; Gfeller JD, 1998, J CLIN PSYCHOL, V54, P431, DOI 10.1002/(SICI)1097-4679(199806)54:4<431::AID-JCLP5>3.0.CO;2-Q; Greenhalgh T, 1997, BRIT MED J, V315, P540, DOI 10.1136/bmj.315.7107.540; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Greve KW, 2003, ARCH CLIN NEUROPSYCH, V18, P245, DOI 10.1016/S0887-6177(02)00137-3; Halstead WC, 1947, BRAIN INTELLIGENCE Q; Hardin JW, 2001, GEN LINEAR MODELS EX; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HISCOCK CK, 1994, J PSYCHOPATHOL BEHAV, V16, P95, DOI 10.1007/BF02232721; Iverson GL, 2000, J CLIN EXP NEUROPSYC, V22, P191, DOI 10.1076/1380-3395(200004)22:2;1-1;FT191; Kaemmer, 1989, MINNESOTA MULTIPHASI; Kneebone A C, 1997, J Int Neuropsychol Soc, V3, P159; Larrabee GJ, 1998, CLIN NEUROPSYCHOL, V12, P179, DOI 10.1076/clin.12.2.179.2008; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P54, DOI 10.1076/clin.17.1.54.15627; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Menard S., 2002, APPL LOGISTIC REGRES, V2nd; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Millis S. R., 2002, J FORENSIC NEUROPSYC, V2, P147; Millis Scott R., 1993, Brain Injury, V7, P53, DOI 10.3109/02699059309008156; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; MILLIS SR, 1994, PERCEPT MOTOR SKILL, V79, P384, DOI 10.2466/pms.1994.79.1.384; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P271, DOI 10.1016/0887-6177(95)00040-2; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mutchnick M G, 1991, Arch Clin Neuropsychol, V6, P259, DOI 10.1016/0887-6177(91)90003-R; Putnam S. H., 1996, NEUROPSYCHOLOGICAL A, P529; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Rapport LJ, 1998, J CLIN EXP NEUROPSYC, V20, P89, DOI 10.1076/jcen.20.1.89.1488; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; REITAN RM, 1990, ARCH CLIN NEUROPSYCH, V5, P70; Rogers R, 1998, LAW HUMAN BEHAV, V22, P353, DOI 10.1023/A:1025714808591; Rogers Richard, 1990, BEHAVIORAL SCI LAW, V8, P85, DOI DOI 10.1002/BSL.2370080110; Rohling ML, 2003, PREDICTION IN FORENSIC AND NEUROPSYCHOLOGY, P171; Ross SR, 2003, CLIN NEUROPSYCHOL, V17, P581, DOI 10.1076/clin.17.4.581.27940; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Ross SR, 1999, CLIN NEUROPSYCHOL, V13, P112, DOI 10.1076/clin.13.1.112.1973; Sackett D., 2000, EVIDENCE BASED MED; Schagen S, 1997, J CLIN EXP NEUROPSYC, V19, P43, DOI 10.1080/01688639708403835; Schmand B, 1998, J NEUROL NEUROSUR PS, V64, P339, DOI 10.1136/jnnp.64.3.339; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P301, DOI 10.1016/S0887-6177(99)00018-9; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Tsushima WT, 2001, ASSESSMENT, V8, P205, DOI 10.1177/107319110100800208; WARRINGTON EK, 1994, RECOGNITION MEMORY T; Wechsler, 1997, WECHSLER ADULT INTEL; Wolfson, 1993, HALSTEAD REITAN NEUR; [No title captured]	70	13	13	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	DEC	2006	20	4					798	815		10.1080/13854040500328477			18	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	085IE	WOS:000240597000015	16980263				2022-02-06	
J	Splavski, B; Radanovic, B; Vrankovic, D; Has, B; Muzevic, D; Janculjak, D; Legcevic, J				Splavski, B.; Radanovic, B.; Vrankovic, D.; Has, B.; Muzevic, D.; Janculjak, D.; Legcevic, J.			Transcranial Doppler ultrasonography as an early outcome forecaster following severe brain injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						severe head injury; transcranial Doppler; outcome	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; ISCHEMIA; VELOCITY; ULTRASOUND; PATHOPHYSIOLOGY; HYPERTENSION; THRESHOLDS	Knowledge of post-traumatic cerebral haemodynamic disturbances might be beneficial for predicting the management outcome when measuring the basal cerebral arteries blood flow velocity by ultrasonic transcranial Doppler device immediately after severe head injury. Thirty patients who sustained severe brain injury underwent an early blood velocity measuring by transcranial Doppler ultrasonography during a 1-year period of study. The standard technique of measuring the mean blood flow velocity in the middle cerebral artery was applied. The outcome was assessed at 6-month follow-up by the Glasgow Outcome Score. The middle cerebral artery low blood flow velocity, and the increased values of the pulsatility index significantly correlated to an unfavourable outcome. Transcranial Doppler ultrasonography for measuring the middle cerebral artery blood flow velocity has been proved worthy as a possible predictor of severe head injury management outcome. This non-invasive and simple procedure could be engaged in the daily management of severely brain-injured patients.	Osijek Univ Hosp, Div Neurosurg, Osijek 31000, Croatia; Osijek Univ Hosp, Dept Neurol, Osijek, Croatia; Osijek Univ Hosp, Dept Surg, Osijek, Croatia; Osijek Univ, Fac Law, Dept Econ, Osijek, Croatia		Splavski, B (corresponding author), Osijek Univ Hosp, Div Neurosurg, Huttlerova 4, Osijek 31000, Croatia.	splavski.bruno@kbr.hr	Splavski, Bruno/AAM-1579-2020	Splavski, Bruno/0000-0002-4483-9364			AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; BARZO P, 1991, NEUROSURGERY, V28, P821, DOI 10.1227/00006123-199106000-00006; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Brauer P, 1998, J NEUROSURG ANESTH, V10, P80, DOI 10.1097/00008506-199804000-00003; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Burger R, 1993, Aktuelle Traumatol, V23, P14; CHAN KH, 1992, NEUROSURGERY, V30, P697; CHAN KH, 1993, ACTA NEUROCHIR, P81; CHAN KH, 1992, J NEUROL NEUROSUR PS, V55, P787, DOI 10.1136/jnnp.55.9.787; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; CZOSNYKA M, 1994, ACTA NEUROCHIR, V126, P113, DOI 10.1007/BF01476419; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GORAJ B, 1994, AM J NEURORADIOL, V15, P1333; GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113; JENNETT B, 1975, LANCET, V1, P480; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MORENO JA, 2000, NEUROSURG FOCUS, V8; Schroder ML, 1996, J NEUROTRAUM, V13, P17, DOI 10.1089/neu.1996.13.17; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; Steiner LA, 2002, BRIT J NEUROSURG, V16, P429, DOI 10.1080/0268869021000030221; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; van Santbrink H, 2002, ACTA NEUROCHIR, V144, P1141, DOI 10.1007/s00701-002-1012-8; Visocchi M, 2002, J Neurosurg Sci, V46, P10; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Voulgaris SG, 2005, MED SCI MONITOR, V11, pCR49	31	13	13	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	DEC	2006	20	6					386	390		10.1080/02688690601048104			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	128MC	WOS:000243660800004	17439090				2022-02-06	
J	Arican, N; Kaya, M; Yorulmaz, C; Kalayci, R; Ince, H; Kucuk, M; Fincanci, SK; Elmas, I				Arican, N.; Kaya, M.; Yorulmaz, C.; Kalayci, R.; Ince, H.; Kucuk, M.; Fincanci, S. K.; Elmas, I.			Effect of hypothermia on blood-brain barrier permeability following traumatic brain injury in chronically ethanol-treated rats	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						blood-brain barrier; cold exposure; ethanol; Evans blue; traumatic brain injury	CLOSED-HEAD-INJURY; POSTTRAUMATIC HYPOTHERMIA; ACCIDENTAL HYPOTHERMIA; ALCOHOL; EDEMA; DAMAGE; DEATH; MODEL; PATHOPHYSIOLOGY; HYPOTENSION	The objective of this study was to investigate the effect of hypothermia on the blood-brain barrier (BBB) disruption caused by traumatic brain injury (TBI) in chronically ethanol-treated rats. BBB permeability was measured using Evans blue (EB) dye. Arterial blood pressure levels of animals in hypothermic groups decreased significantly. The EB dye extravasation into the brain significantly increased in hypothermia and at 6 and 24 h after TBI. In ethanol-treated rats that were subjected to TBI, hypothermia led to a significant decrease in EB dye content in the brain at 24 h but not at 6 h after TBI when compared with TBI alone.	Istanbul Univ, Istanbul Fac Med, Dept Physiol, TR-34390 Istanbul, Turkey; Istanbul Univ, Istanbul Fac Med, Dept Forens Med, TR-34390 Istanbul, Turkey; Istanbul Univ, Cerrahpasa Fac Med, Dept Forens Med, Istanbul, Turkey; Istanbul Univ, Expt Med Res Inst, Istanbul, Turkey		Kaya, M (corresponding author), Istanbul Univ, Istanbul Fac Med, Dept Physiol, TR-34390 Istanbul, Turkey.	mehkaya@istanbul.edu.tr	Kalayci, Rivaze/K-6330-2018; elmas, imdat/AAD-6054-2020; ARICAN, Nadir/G-2778-2012; Fincanci, Sebnem Korur/F-6684-2010	Kalayci, Rivaze/0000-0002-7061-4863; ARICAN, Nadir/0000-0002-9736-0277; Fincanci, Sebnem Korur/0000-0003-4484-4961			Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CLASEN RA, 1968, ARCH NEUROL-CHICAGO, V19, P472, DOI 10.1001/archneur.1968.00480050042004; CLIFTON GL, 1995, J NEUROTRAUM, V12, P923, DOI 10.1089/neu.1995.12.923; DANZL DF, 1994, NEW ENGL J MED, V331, P1756, DOI 10.1056/NEJM199412293312607; Dimar JR, 2000, SPINE, V25, P2294, DOI 10.1097/00007632-200009150-00006; Elmas I, 2001, FORENSIC SCI INT, V119, P212, DOI 10.1016/S0379-0738(00)00429-1; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Fischer S, 1999, MOL BRAIN RES, V74, P135, DOI 10.1016/S0169-328X(99)00272-7; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; HATTON DC, 1992, J HYPERTENS, V10, P529, DOI 10.1097/00004872-199206000-00005; HONKANEN R, 1993, ADDICTION, V88, P939, DOI 10.1111/j.1360-0443.1993.tb02111.x; HORN M, 1991, ACTA NEUROPATHOL, V81, P443, DOI 10.1007/BF00293466; ISHIKAWA T, 1983, ANESTHESIOLOGY, V59, P526, DOI 10.1097/00000542-198312000-00007; KELLY DF, 1995, NEUROTRAUMA, V2, P883; Kirkpatrick AW, 1999, CAN J SURG, V42, P333; KRANTIS A, 1983, ACTA NEUROPATHOL, V60, P61, DOI 10.1007/BF00685348; Marion Donald W, 2002, Curr Opin Crit Care, V8, P111, DOI 10.1097/00075198-200204000-00004; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; Milovanovic AV, 1999, AM J FOREN MED PATH, V20, P6, DOI 10.1097/00000433-199903000-00002; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; PHILLIPS SC, 1981, J NEUROL SCI, V50, P81, DOI 10.1016/0022-510X(81)90043-5; SAKAMOTO T, 1989, AM J PHYSIOL, V257, pH785, DOI 10.1152/ajpheart.1989.257.3.H785; SCHINDELMEISER J, 1987, ACTA NEUROPATHOL, V73, P349, DOI 10.1007/BF00688258; Schwab M, 1998, ACTA NEUROBIOL EXP, V58, P29; Shapira Y, 1997, J NEUROSURG ANESTH, V9, P118, DOI 10.1097/00008506-199704000-00003; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Strachan R D, 1989, Brain Inj, V3, P51, DOI 10.3109/02699058909008073; TANAKA M, 1991, INT J BIOMETEOROL, V34, P242, DOI 10.1007/BF01041837; THOMAS D, 1994, DEMOGRAPHY, V31, P185, DOI 10.2307/2061881; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; Yamada Shinichi, 2004, Kurume Medical Journal, V51, P1	38	13	14	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	NOV	2006	116	11					1249	1261		10.1080/00207450600550303			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	087OC	WOS:000240750700001	17000527				2022-02-06	
J	Eftekhari, M; Assadi, M; Kazemi, M; Saghari, M; Mojtahedi, A; Fard-Esfahani, A; Sichani, BF; Beiki, D				Eftekhari, Mohammad; Assadi, Majid; Kazemi, Majid; Saghari, Mohsen; Mojtahedi, Alireza; Fard-Esfahani, Armagan; Sichani, Babak Fallahi; Beiki, Davood			Brain perfusion single photon emission computed tomography findings in patients with posttraumatic anosmia and comparison with radiological imaging	AMERICAN JOURNAL OF RHINOLOGY			English	Article; Proceedings Paper	51st Annual Meeting of the American-Rhinologic-Society	SEP 24, 2005	Los Angeles, CA	Amer Rhinol Soc			CLOSED HEAD-INJURY; OLFACTORY EVOKED-POTENTIALS; POST-TRAUMATIC ANOSMIA; CEREBRAL-BLOOD-FLOW; SMELL DISORDERS; SPECT; CORTEX; CT	Background: Different techniques in neuroimaging have been proposed for assessment of olfactory dysfunction but they are not without limitations. Recently, some studies showed the usefulness of single photon emission-computed tomography (SPECT) in evaluation of patients with posttraumatic anosmia. This study was designed to assess the possible diagnostic value of SPECT findings in patients with posttraumatic anosmia in comparison with magnetic resonance imaging (MRI)/CT imaging. Methods: Sixteen patients who had head trauma and consequently anosmia, which was defined according to Cain's identification test, were included in this study. Two nonanosmic groups, traumatic patients and nontraumatic healthy individuals, were selected as control groups for this study. Qualitative and semiquantitative brain perfusion SPECT was performed by measuring the uptake ratio of the orbital frontal cortex to occipital pole in the sagittal projections (uptake index). All 16 target patients had a previous CT scan and/or MRI. Semiquantitative and qualitative brain perfusion SPECT were compared with radiological imaging. Results: Semiquantitative assessment of brain perfusion SPECT revealed remarkable orbital frontal hypoperfusion as compared with two control groups. 87.5% of anosmic patients showed orbital frontal hypoperfusion (>= 2 SD below the lowest level in healthy controls). In addition, the semiquantitative SPECT method detected more orbitofrontal abnormality than the qualitative method or radiological imaging (MRI and/or CT). Conclusion: Findings suggest that by using SPECT, posttraumatic anosmia corresponds to the hypoperfusion in the orbital frontal cortex in a great number of patients. Because of its availability, rather low cost, technical ease, and possibility to obtain objective quantitative information, brain perfusion SPECT can be complementary to other diagnostic techniques in the evaluation of olfactory function, although additional neurophysiological and imaging studies are needed.	Shariati Hosp, Res Inst Nucl Med, Tehran 14114, Iran; Univ Tehran Med Sci, Amiralam Hosp, Dept Otolaryngol Head & Neck Surg, Tehran, Iran		Assadi, M (corresponding author), Shariati Hosp, Res Inst Nucl Med, Karger Shomali St, Tehran 14114, Iran.	assadipoya@yahoo.com	Assadi, Majid/H-2812-2017; Assadi, Majid/U-5316-2019; Beiki, Davood/J-2595-2016	Assadi, Majid/0000-0003-3862-9472; Assadi, Majid/0000-0002-2166-3765; Beiki, Davood/0000-0002-2862-0581			Abolmaali ND, 2002, AM J NEURORADIOL, V23, P157; ALLISON T, 1967, ELECTROEN CLIN NEURO, V23, P558, DOI 10.1016/0013-4694(67)90022-3; AUFFERMANN H, 1993, ANN OTO RHINOL LARYN, V102, P6, DOI 10.1177/000348949310200102; CAIN WS, 1983, AM J OTOLARYNG, V4, P252, DOI 10.1016/S0196-0709(83)80068-4; COSTANZO RM, 1991, CIBA F SYMP, V160, P233; COSTANZO RM, 1987, NY ACAD SCI, V510, P242; DEROSSI G, 1992, RADIOL DIAGN, V33, P236; Di Nardo W, 2000, AM J RHINOL, V14, P57, DOI 10.2500/105065800781602984; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Eftekhari Mohammad, 2005, BMC Nucl Med, V5, P6, DOI 10.1186/1471-2385-5-6; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; GRAY BG, 1992, J NUCL MED, V33, P52; GUERRIER Y, 1988, OTORHINOLARYNGOLOG A, V10, P20285; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; Kobal G., 1996, Rhinology (Utrecht), V34, P222; KOIZUKA I, 1994, ORL J OTO-RHINO-LARY, V56, P273, DOI 10.1159/000276672; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; MATERN G, 1995, LARYNGO RHINO OTOL, V74, P118, DOI 10.1055/s-2007-997702; MCLAUGHLIN T, 1992, J CEREBR BLOOD F MET, V12, P535, DOI 10.1038/jcbfm.1992.77; MOOREGILLON V, 1997, BMJ-BRIT MED J, V294, P793; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; Ottaviani F, 1997, AUDIOLOGY, V36, P241; POTTER H, 1980, NEUROPSYCHOLOGIA, V18, P621, DOI 10.1016/0028-3932(80)90101-3; RING HA, 1991, EUR J NUCL MED, V18, P133, DOI 10.1007/BF00950760; Sasajima T, 2000, AM J NEURORADIOL, V21, P717; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; SUMNER D, 1976, HDB CLIN NEUROLOGY, P235; Tokumaru AM, 1999, AM J NEURORADIOL, V20, P845; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; Varney NR, 1998, J HEAD TRAUMA REHAB, V13, P63; WHITTET HB, 1991, J ROY SOC MED, V84, P400, DOI 10.1177/014107689108400707; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	34	13	13	0	2	OCEAN SIDE PUBLICATIONS INC	PROVIDENCE	95 PITMAN ST, PROVIDENCE, RI 02906 USA	1050-6586			AM J RHINOL	Am. J. Rhinol.	NOV-DEC	2006	20	6					577	581		10.2500/ajr.2006.20.2906			5	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Otorhinolaryngology	113JN	WOS:000242594300006	17181096				2022-02-06	
J	Hummel, MC; Morse, BC; Hayes, LE				Hummel, Margaret C.; Morse, Bryan C.; Hayes, Lloyd E.			Reactive thrombocytosis associated with enoxaparin	PHARMACOTHERAPY			English	Article						thrombocytosis; platelets; low-molecular-weight heparin; enoxaparin	MOLECULAR-WEIGHT HEPARINS	A 42-year-old man was hospitalized for a closed head injury caused by a bicycle accident. On hospital day 8, he developed thrombocytosis. Eleven days later, his platelet count reached 1005 x 10(3)/mm(3). A review of his drug therapy indicated enoxaparin as a potential reversible cause of reactive thrombocytosis. Enoxaparin was discontinued, and the patient's platelet count declined, eventually normalizing 6 days later. At that time, enoxaparin was restarted; this resulted in an increase in his platelet count that peaked 8 days later at 920 x 10(3)/mm(3). After each occurrence of thrombocytosis, enoxaparin was switched to unfractionated heparin in combination with sequential compression devices for deep vein thrombosis prophylaxis. No complications secondary to thrombocytosis were noted. Our patient's experience suggests that unfractionated heparin may be substituted for enoxaparin if this adverse effect is suspected.	Greensville Hosp Syst Univ, Med Ctr, Dept Gen Surg, Greenville, SC 29605 USA; Greensville Hosp Syst Univ, Med Ctr, Dept Pharm, Clin Serv, Greenville, SC 29605 USA; Greensville Hosp Syst Univ, Med Ctr, Div Pulm Crit Care Med, Greenville, SC 29605 USA		Morse, BC (corresponding author), Greensville Hosp Syst Univ, Med Ctr, Dept Gen Surg, 701 Grove Rd, Greenville, SC 29605 USA.						[Anonymous], 2003, Prescrire Int, V12, P183; BRACE LD, 2002, HEMATOLOGY CLIN PRIN, P683; Cestac P, 2003, DRUG SAFETY, V26, P197, DOI 10.2165/00002018-200326030-00005; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; KLASCO RK, DRUGDEX SYSTEM; Liautard C, 2002, ANN PHARMACOTHER, V36, P1351; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Rizzieri DA, 1996, ANN INTERN MED, V125, P157, DOI 10.7326/0003-4819-125-2-199607150-00031; SHEN ZX, 1994, BRIT J HAEMATOL, V88, P608, DOI 10.1111/j.1365-2141.1994.tb05080.x; Williams E, 1997, ANN INTERN MED, V126, P742, DOI 10.7326/0003-4819-126-9-199705010-00024; Wyrick-Glatzel Janis, 1997, P509; Ziaja K, 1999, INT ANGIOL, V18, P65	12	13	15	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-0008	1875-9114		PHARMACOTHERAPY	Pharmacotherapy	NOV	2006	26	11					1667	1670		10.1592/phco.26.11.1667			4	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	101ZG	WOS:000241779600018	17064215				2022-02-06	
J	Zhang, XP; Alber, S; Watkins, SC; Kochanek, PM; Marion, DW; Graham, SH; Clark, RSB				Zhang, Xiaopeng; Alber, Sean; Watkins, Simon C.; Kochanek, Patrick M.; Marion, Donald W.; Graham, Steven H.; Clark, Robert S. B.			Proteolysis consistent with activation of caspase-7 after severe traumatic brain injury in humans	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; cysteine protease; head injury; inflammation; programmed cell death	NEURONAL APOPTOSIS; EXPRESSION; DEATH; RATS; RECRUITMENT; SUBSTRATE; PATHWAYS; ISCHEMIA; CLEAVAGE; EPILEPSY	The expression and proteolysis of caspase family proteins are involved in the initiation and execution of apoptosis, which has been reported to occur in human and experimental traumatic brain injury (TBI). Caspase-3, -6, and -7 belong to the group of executioner caspases, which are cleaved and activated at the late, irreversible stage of apoptosis. Our previous studies demonstrated roles for caspase-1, -3, and -8 in humans after severe TBI. Here we report expression of caspase-7 mRNA and protein in humans after TBI (n = 16) and control brain-bank tissue (n = 6). Semiquantitative reverse transcription polymerase chain reaction showed no differences between caspase-7 mRNA in TBI patients versus controls (73 +/- 24 vs. 85 +/- 56 relative optical density [ROD], respectively). In contrast, Western blot analysis showed increased pro-caspase-7 in TBI patients versus controls (214 +/- 30 vs. 1 +/- 1 ROD, respectively), as well as an increase in the similar-to-20 kD proteolytic fragment in TBI patients versus controls (86 +/- 13 vs. 22 +/- 12 ROD, respectively), consistent with activation of caspase-7 after TBI in humans. Immunohistochemical analysis showed that cells expressing caspase-7 included astrocytes and neurons and possibly other glial cell types and infiltrated inflammatory cells. These data show that caspase-7 and its cleavage product are increased in human brain after TBI in many central nervous system, as well as noncentral nervous system, cell types. Thus, caspase-7 may play a role in the glial and inflammatory responses, and possibly neuronal death, after TBI in humans.	Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15260 USA; Safar Ctr Resuscitat Res, Dept Cell Biol & Physiol, Pittsburgh, PA USA; Safar Ctr Resuscitat Res, Dept Neurol Surg, Pittsburgh, PA USA; Safar Ctr Resuscitat Res, Dept Neurol, Pittsburgh, PA USA; Univ Pittsburgh, Brain Tumor Res Ctr, Pittsburgh, PA USA; VA Pittsburgh Hlth Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA; Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA		Clark, RSB (corresponding author), Safar Ctr Resuscitat Res, Dept Crit Care Med, 3434 5th Ave, Pittsburgh, PA 15260 USA.	clarkrs@ccm.upmc.edu	Watkins, Simon/ABG-2590-2021; Marion, Donald/AAR-5749-2021; Kochanek, Patrick M/D-2371-2015	Watkins, Simon/0000-0003-4092-1552; Kochanek, Patrick M/0000-0002-2627-913X	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS 30318, R01 NS 38620] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038620, P50NS030318] Funding Source: NIH RePORTER		Araya R, 2002, CELL DEATH DIFFER, V9, P322, DOI 10.1038/sj.cdd.4400949; Basu A, 2002, J BIOL CHEM, V277, P41850, DOI 10.1074/jbc.M205997200; Behrensdorf HA, 2000, FEBS LETT, V466, P143, DOI 10.1016/S0014-5793(99)01777-9; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; Clark D, 1999, IEEE INTERNET COMPUT, V3, P13; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Duan HJ, 1996, J BIOL CHEM, V271, P1621, DOI 10.1074/jbc.271.3.1621; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Fellin T, 2004, J PHYSIOL-LONDON, V559, P3, DOI 10.1113/jphysiol.2004.063214; Guegn C, 2001, J NEUROSCI, V21, P6569, DOI 10.1523/JNEUROSCI.21-17-06569.2001; Henshall DC, 2000, NEUROLOGY, V55, P250, DOI 10.1212/WNL.55.2.250; Henshall DC, 2000, J NEUROCHEM, V74, P1215; Houde C, 2004, J NEUROSCI, V24, P9977, DOI 10.1523/JNEUROSCI.3356-04.2004; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Larner SF, 2005, J NEUROCHEM, V94, P97, DOI 10.1111/j.1471-4159.2005.03172.x; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Namura S, 1998, J NEUROSCI, V18, P3659; Pompl PN, 2003, ARCH NEUROL-CHICAGO, V60, P369, DOI 10.1001/archneur.60.3.369; Qiu JH, 2002, J NEUROSCI, V22, P3504; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Saelens X, 2001, J BIOL CHEM, V276, P41620, DOI 10.1074/jbc.M103674200; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zhang H, 2003, RESPIROLOGY, V8, P17, DOI 10.1046/j.1440-1843.2003.00433.x; Zhang Y, 2000, J NEUROSCI, V20, P8384, DOI 10.1523/JNEUROSCI.20-22-08384.2000; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283	27	13	15	0	0	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	2006	23	11					1583	1590		10.1089/neu.2006.23.1583			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	106RK	WOS:000242118200001	17115905				2022-02-06	
J	Belabed, L; Charrueau, C; Besson, V; Gupta, S; Walrand, S; Marchand-Verrecchia, C; Richon, S; Nafziger, J; Plotkine, M; Chaumeil, JC; Cynober, L; Moinard, C				Belabed, Linda; Charrueau, Christine; Besson, Valerie; Gupta, Severine; Walrand, Stephane; Marchand-Verrecchia, Catherine; Richon, Sophie; Nafziger, Joelle; Plotkine, Michel; Chaumeil, Jean-Claude; Cynober, Luc; Moinard, Christophe			Impairment of lymphocyte function in head-injured rats: Effects of standard and immune-enhancing diets for enteral nutrition	CLINICAL NUTRITION			English	Article; Proceedings Paper	23rd Congress of the Societe-Francophone-de-Nutrition-Enterale-et-Parenterale (SFNEP)	NOV 30-DEC 03, 2003	Ghent, BELGIUM	Soc Francophone Nutr Enterale & Parenterale		head injury; dysimmunity; lymphocytes; CD25 receptor; immune-enhancing diet	TRAUMATIC BRAIN-INJURY; INFECTIOUS COMPLICATIONS; ENDOTOXEMIC RATS; CRITICALLY ILL; IMMUNONUTRITION; TRANSLOCATION; ARGININE; SUPPORT	Background: The metabolic response to head injury (HI) is characterized by a dysimmunity which may be a risk factor of a septic state. The use of immune enhancing diets (IEDs) could be a promising approach to improve immune functions. The aim of the study was to investigate the consequences of HI on lymphocyte function and to determine the effects of an enteral IED comparatively to a standard enteral. nutrition. Method: A rat model of HI by fluid percussion was used. Twenty-five mate Sprague-Dawley rats were randomized into 4 groups: rats receiving standard chow diet ad libitum (AL), rats sustaining HI and receiving standard chow diet and enteral satine (HI), rats receiving the enterat standard diet Sondalis HP((R)) (HIS), and rats receiving the IED Crucial((R)) (HIC). The two enterat diets were infused continuously during 4 days after the HI and were isocaloric, isonitrogenous and isovolumic. Results: HI induced a thymus atrophy (HI vs. AL, P < 0.05), and an impairment in lymphocyte CD25 receptor density responsiveness to stimulation. The IED blunted thymus atrophy and allowed to preserve the stimulation of blood and Peyer patches lymphocytes (HIC: Stimulated vs. Basal, P < 0.05). Conclusion: IED seems more adapted for preserving lymphocyte function than standard diet in HI patients. (c) 2006 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.	Univ Paris 05, Fac Pharm, EA2498, Pharm Galen Lab, F-75270 Paris 06, France; Lab Biol Nutr, F-75270 Paris 06, France; Univ Paris 05, Fac Pharm, Lab Pharmacol Circulat Cerebrale, EA2510, F-75270 Paris 06, France; Human Nutr Lab, F-63000 Clermont Ferrand, France; Univ Paris 05, Fac Pharm, CNRS, FRE 2443,Lab Immunol Tumeurs, F-75270 Paris 06, France; Univ Paris 05, Fac Pharm, Hematol Lab, F-75270 Paris 06, France		Charrueau, C (corresponding author), Univ Paris 05, Fac Pharm, EA2498, Pharm Galen Lab, 4 Ave Observ, F-75270 Paris 06, France.	christine.charrueau@univ-paris5.fr	BESSON, VALERIE/AAZ-9989-2020; Cynober, Luc/ABB-2368-2020; besson, valerie C/L-7388-2017; MARCHAND-LEROUX, Catherine/L-7453-2017	BESSON, VALERIE/0000-0002-1491-2380; besson, valerie C/0000-0002-1491-2380; MARCHAND-LEROUX, Catherine/0000-0003-0113-5348; Walrand, Stephane/0000-0002-4349-3664			Abumrad NN, 2004, METABOLIC THERAPEUTI, P595; BARBUL A, 1984, J SURG RES, V36, P620, DOI 10.1016/0022-4804(84)90149-5; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Berger MM, 2003, NES NUTR WS, V8, P99, DOI 10.1159/000072750; Berger MM, 2001, INTENS CARE MED, V27, P91, DOI 10.1007/s001340000757; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Biffl WL, 2002, NUTRITION, V18, P960, DOI 10.1016/S0899-9007(02)00987-5; Calder PC, 2001, LIPIDS, V36, P1007, DOI 10.1007/s11745-001-0812-7; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Heyland DK, 2001, JAMA-J AM MED ASSOC, V286, P944, DOI 10.1001/jama.286.8.944; Loi C, 2005, NUTRITION, V21, P255, DOI 10.1016/j.nut.2004.05.021; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Moinard C, 2005, INTENS CARE MED, V31, P281, DOI 10.1007/s00134-004-2489-9; Porter JM, 1999, AM SURGEON, V65, P478; QUATTROCCHI K B, 1990, Journal of Neurotrauma, V7, P77, DOI 10.1089/neu.1990.7.77; SACKS GS, 1995, JPEN-PARENTER ENTER, V19, P387, DOI 10.1177/0148607195019005387; Schauder P, 2002, BRIT J NUTR, V87, pS103, DOI 10.1079/BJN2001463; Schlegel L, 1999, CRIT CARE MED, V27, P1511, DOI 10.1097/00003246-199908000-00019; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Suchner U, 2002, BRIT J NUTR, V87, pS121, DOI 10.1079/BJN2001465; Ulusoy H, 2003, J CLIN NEUROSCI, V10, P596, DOI 10.1016/S0967-5868(03)00142-5; Walrand S, 2004, AM J PHYSIOL-CELL PH, V286, pC1474, DOI 10.1152/ajpcell.00563.2002; Young B, 1996, J NEUROTRAUM, V13, P25, DOI 10.1089/neu.1996.13.25; [No title captured]	24	13	14	0	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0261-5614			CLIN NUTR	Clin. Nutr.	OCT	2006	25	5					832	841		10.1016/j.clnu.2006.02.003			10	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Nutrition & Dietetics	099SL	WOS:000241615800016	16678308				2022-02-06	
J	Brewer, BR; Klatzky, RL; Matsuoka, Y				Brewer, Bambi R.; Klatzky, Roberta L.; Matsuoka, Yoky			Visual-feedback distortion in a robotic rehabilitation environment	PROCEEDINGS OF THE IEEE			English	Article						feedback distortion; hand; rehabilitation robotics; stroke; traumatic brain injury	RESEARCH ARM TEST; HAPTIC DOMINANCE; ASSESSMENT SCALE; FORM PERCEPTION; VISION; MOVEMENT; STROKE; PROPRIOCEPTION; RELIABILITY; TOUCH	We create a robotic rehabilitation environment that distorts the visual feedback of a movement representation to restore lost movements. The use of visual-feedback distortion produces a perceptual gap between the perceived (visual) and actual somatosensory experiences, in which movements can be manipulated without patients' knowledge. Previously, we reported the smallest amount of distortion that is imperceptible by measuring just noticeable difference (JND), the distortion size that is tolerable without detection, and the invariance of perceived physical effort under visual-feedback distortion. In this paper, we report the performance changes under visual-feedback distortion in a robotic rehabilitation environment. By interleaving trials with no visual feedback, we showed that the internal somatosensory representation of the movement goal changed along with visual distortion for unimpaired and motor-impaired subjects. In addition, a gradual change of visual-feedback distortion within one experiment allowed movement changes significantly larger than the JND. These changes were robust under sudden lack of visual feedback and even when subjects were informed of possible distortion ahead of time. Finally, preliminary results of a six-week rehabilitation paradigm are reported. Improvements in the patient's hand condition were found, particularly in the range of motion of the index and middle fingers.	Inst Robot, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA		Brewer, BR (corresponding author), Inst Robot, Pittsburgh, PA 15213 USA.	bambi@andrew.cmu.edu; klatzky@cmu.edu; yoky@cs.cmu.edu					Atkinson JW, 1964, INTRO MOTIVATION; BANDURA A, 1983, J PERS SOC PSYCHOL, V45, P1017, DOI 10.1037/0022-3514.45.5.1017; BANDURA A, 1986, ORGAN BEHAV HUM DEC, V38, P92, DOI 10.1016/0749-5978(86)90028-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOCK O, 1990, BEHAV BRAIN RES, V41, P167, DOI 10.1016/0166-4328(90)90106-O; Brashear A, 2002, ARCH PHYS MED REHAB, V83, P1349, DOI 10.1053/apmr.2002.35474; Brewer B. R., 2003, P 8 INT C REH ROB DA, P258; Brewer BR, 2005, IEEE T NEUR SYS REH, V13, P1, DOI 10.1109/TNSRE.2005.843443; BREWER BR, P 2004 IEEE INT C RO, P2080; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2000, NAT NEUROSCI, V3, P69, DOI 10.1038/71140; Fagan M, 2003, 11TH SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS - HAPTICS 2003, PROCEEDINGS, P159, DOI 10.1109/HAPTIC.2003.1191263; HELLER MA, 1983, PERCEPTION, V12, P607, DOI 10.1068/p120607; HELLER MA, 1992, PERCEPTION, V21, P655, DOI 10.1068/p210655; Heller MA, 1999, PERCEPT PSYCHOPHYS, V61, P1384, DOI 10.3758/BF03206188; JONES LA, 1989, PERCEPTION, V18, P681, DOI 10.1068/p180681; Kopp B, 1997, ARCH PHYS MED REHAB, V78, P615, DOI 10.1016/S0003-9993(97)90427-5; Lateiner JE, 2003, EXP BRAIN RES, V151, P446, DOI 10.1007/s00221-003-1503-8; LEDERMAN SJ, IN PRESS HDB MULTISE; Lum PS, 2002, ARCH PHYS MED REHAB, V83, P952, DOI 10.1053/apmr.2001.33101; Matsuoka Y, 2002, PHYSIOL BEHAV, V77, P651, DOI 10.1016/S0031-9384(02)00914-9; PATTON JL, 2005, IN PRESS EXP BRAIN R; Reinkensmeyer DJ, 2000, J REHABIL RES DEV, V37, P653; ROCK I, 1964, SCIENCE, V143, P594, DOI 10.1126/science.143.3606.594; ROSSETTI Y, 1995, J NEUROPHYSIOL, V74, P457, DOI 10.1152/jn.1995.74.1.457; Schrater PR, 2000, INT J COMPUT VISION, V40, P73; SINGER G, 1969, PERCEPT PSYCHOPHYS, V5, P315, DOI 10.3758/BF03209572; Sober SJ, 2003, J NEUROSCI, V23, P6982, DOI 10.1523/JNEUROSCI.23-18-06982.2003; Srinivasan M. A., 1996, Proceedings of the ASME Dynamic Systems and Control Division, P555; TAUB E, ARM MOTOR ABILITY TE; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; van der Lee JH, 2001, J REHABIL MED, V33, P110; Van der Lee JH, 2001, ARCH PHYS MED REHAB, V82, P14, DOI 10.1053/apmr.2001.18668; vanBeers RJ, 1996, EXP BRAIN RES, V111, P253, DOI 10.1007/BF00227302; Volpe BT, 2000, NEUROLOGY, V54, P1938, DOI 10.1212/WNL.54.10.1938; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; 2004, HEART DIS STROKE STA	37	13	13	0	5	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9219	1558-2256		P IEEE	Proc. IEEE	SEP	2006	94	9					1739	1751		10.1109/JPROC.2006.880715			13	Engineering, Electrical & Electronic	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering	101ZK	WOS:000241780000010					2022-02-06	
J	Saeki, S; Okazaki, T; Hachisuka, K				Saeki, Satoru; Okazaki, Tetsuya; Hachisuka, Kenji			Concurrent validity of the community integration questionnaire in patients with traumatic brain injury in Japan	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; community integration; validity	QUALITY-OF-LIFE	Objective: To examine the concurrent validity of the Community Integration Questionnaire (CIQ) by comparing actual participation in community activities by individuals with traumatic brain injury. Design: Cross-sectional survey. Subjects: A total of 148 community-dwelling patients in Japan with a medical diagnosis of traumatic brain injury. Methods: A postal questionnaire survey examined the relationships between individual's actual participation in community activities ( working or attending school; undergoing rehabilitation at home or hospital; other) and productive activities evaluated by the CIQ in the community. Results: Responses were received from 115 subjects ( response rate 78%). Total CIQ scores and scores on the 3 subscales of the CIQ significantly differed among the 3 groups based on community participation. Total CIQ scores among individuals in the "working or attending school'' group were significantly higher than for individuals in the "undergoing rehabilitation at home or hospital'' and "other'' groups. In addition, scores on the Productive Activity subscale of the CIQ were significantly higher among the "working or attending school'' group than for the other 2 groups. Conclusion: These results suggest that the CIQ has concurrent validity for patients with traumatic brain injury.	Univ Occupat & Environm Hlth, Dept Rehabil Med, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan		Saeki, S (corresponding author), Univ Occupat & Environm Hlth, Dept Rehabil Med, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	sae@med.uoeh-u.ac.jp					CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; WANGER AK, 2002, ARCH PHYS MED REHAB, V83, P107; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Zhang L, 2002, J HEAD TRAUMA REHAB, V17, P497, DOI 10.1097/00001199-200212000-00002	11	13	14	0	1	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2006	38	5					333	335		10.1080/16501970600780245			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	088AC	WOS:000240782900010	16931465	gold			2022-02-06	
J	Baranova, AI; Whiting, MD; Hamm, RJ				Baranova, Anna I.; Whiting, Mark D.; Hamm, Robert J.			Delayed, post-injury treatment with aniracetam improves cognitive performance after traumatic brain injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						aniracetam; brain injury; cognitive recovery; Morris water maze; rat; traumatic brain injury	FOREBRAIN CHOLINE-ACETYLTRANSFERASE; NOREPINEPHRINE TURNOVER; MOTOR RECOVERY; RECEPTOR; CORTEX; IMPAIRMENT; STROKE; MEMORY; PHARMACOTHERAPY; HIPPOCAMPUS	Chronic cognitive impairment is an enduring aspect of traumatic brain injury (TBI) in both humans and animals. Treating cognitive impairment in the post-traumatic stages of injury often involves the delivery of pharmacologic agents aimed at specific neurotransmitter systems. The current investigation examined the effects of the nootropoic drug aniracetam on cognitive recovery following TBI in rats. Three experiments were performed to determine (1) the optimal dose of aniracetam for treating cognitive impairment, (2) the effect of delaying drug treatment for a period of days following TBI, and (3) the effect of terminating drug treatment before cognitive assessment. In experiment 1, rats were administered moderate fluid percussion injury and treated with vehicle, 25, or 50 mg/kg aniracetam for 15 days. Both doses of aniracetam effectively reduced injury-induced deficits in the Morris water maze (MWM) as measured on postinjury days 11-15. In experiment 2, injured rats were treated with 50 mg/kg aniracetam or vehicle beginning on day 11 postinjury and continuing for 15 days. MWM performance, assessed on days 26-30, indicates that aniracetam-treated animals performed as well as sham-injured controls. In experiment 3, animals were injured and treated with aniracetam for 15 days. Drug treatment was terminated during MWM testing on postinjury days 16-20. In this experiment, aniracetam-treated rats did not perform better than vehicle-treated rats. The results of these experiments indicate that aniracetam is an effective treatment for cognitive impairment induced by TBI, even when treatment is delayed for a period of days following injury.	Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA		Hamm, RJ (corresponding author), Virginia Commonwealth Univ, Dept Psychol, Box 842018,808 W Franklin St, Richmond, VA 23284 USA.	rhamm@vcu.edu					BOYESON MG, 1993, AM J PHYS MED REHAB, V72, P286, DOI 10.1097/00002060-199310000-00007; BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; DIXON CE, 1994, NEUROSCI LETT, V180, P127, DOI 10.1016/0304-3940(94)90503-7; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1997, J NEUROTRAUM, V14, P159; DUNNMEYNELL A, 1994, BRAIN RES, V660, P88, DOI 10.1016/0006-8993(94)90842-7; FEENEY DM, 1993, J NEURAL TRANSP PLAS, V4, P199, DOI 10.1155/NP.1993.199; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; Feeney DM, 1997, ADV NEUROL, V73, P383; FEENEY DM, 1991, J NEUROL REHABIL, V5, P113; FUSHIKI S, 1995, NEUROSCI LETT, V199, P171, DOI 10.1016/0304-3940(95)12054-8; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; Jolkkonen J, 2000, EUR J PHARMACOL, V400, P211, DOI 10.1016/S0014-2999(00)00409-X; Kikuchi K, 2000, BRAIN RES, V860, P130, DOI 10.1016/S0006-8993(00)02034-5; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Lebrun C, 2000, EUR J PHARMACOL, V401, P205, DOI 10.1016/S0014-2999(00)00429-5; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LEVIN BE, 1995, BRAIN RES, V674, P307, DOI 10.1016/0006-8993(95)00032-L; Lu Y, 1997, BRAIN RES, V768, P197, DOI 10.1016/S0006-8993(97)00644-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maas AIR, 2001, EXPERT OPIN INV DRUG, V10, P753, DOI 10.1517/13543784.10.4.753; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Nakamura K, 1999, EUR J PHARMACOL, V380, P81, DOI 10.1016/S0014-2999(99)00534-8; ODELL DM, 1995, J NEUROSURG, V83, P878, DOI 10.3171/jns.1995.83.5.0878; Ouchi Y, 1999, J NEUROL SCI, V164, P7, DOI 10.1016/S0022-510X(99)00036-2; Pike BR, 1997, EXP NEUROL, V147, P55, DOI 10.1006/exnr.1997.6582; Pike BR, 1997, PHARMACOL BIOCHEM BE, V57, P785, DOI 10.1016/S0091-3057(96)00453-4; PIKE BR, 1995, BRAIN RES, V686, P37, DOI 10.1016/0006-8993(95)00448-Y; PIZZI M, 1993, J NEUROCHEM, V61, P683; SATOH M, 1986, NEUROSCI LETT, V68, P216, DOI 10.1016/0304-3940(86)90145-X; Togashi H, 1996, STROKE, V27, P520, DOI 10.1161/01.STR.27.3.520; Togashi H, 2002, NEUROSCI LETT, V320, P109, DOI 10.1016/S0304-3940(01)02436-3; Von Monakow C., 1969, BRAIN BEHAV, VI, P27; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zajaczkowski W, 1997, PHARMACOL BIOCHEM BE, V56, P21, DOI 10.1016/S0091-3057(96)00133-5; Zhu J, 2000, EXP NEUROL, V166, P136, DOI 10.1006/exnr.2000.7484	41	13	14	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2006	23	8					1233	1240		10.1089/neu.2006.23.1233			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	075CF	WOS:000239859300005	16928181				2022-02-06	
J	Mazzeo, AT; Kunene, NK; Choi, S; Gilman, C; Bullock, RM				Mazzeo, Anna Teresa; Kunene, Niki K.; Choi, Sung; Gilman, Charlotte; Bullock, Ross M.			Quantitation of ischemic events after severe traumatic brain injury in humans: A simple scoring system	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						severe head injury; cerebral ischemia; outcome; microdialysis; scoring system	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; EXCITATORY AMINO-ACIDS; INTERSTITIAL GLYCEROL; INTRACEREBRAL MICRODIALYSIS; TISSUE OXYGENATION; LACTATE; METABOLISM; GLUCOSE; HYPOXIA	Background: Cerebral ischemia is recognized as one of the most important mechanisms responsible for secondary brain damage following severe traumatic brain injury (TBI), contributing to an increased mortality and a worse neurologic outcome. Method: A simple 5-item scoring system, taking into account the occurrence of specific potentially brain-damaging events (hypoxemia, hypotension, low cerebral blood flow, herniation, and low cerebral perfusion pressure) has been tested in a large population of severe TBI patients. Aims of this retrospective study were to validate the ability of the proposed ischemic score to predict neurologic outcome and to correlate the ischemic score with the results of microdialysis-based neurochemical monitoring and brain tissue oxygen monitoring. Findings: In a population of 172 severe TBI patients, a significant correlation was found between ischemic score and neurologic outcome, both at 3 months (r = -0.32; P < 0.01) and at 6 months (r = -0.31; P < 0.01). Significant correlations were also found with the most important neurochemical analytes. Conclusions: The ischemic score proposed here, may be determined during the acute intensive care unit period, and correlates closely with outcome, which can only be determined 3 to 6 months, after injury. It also shows a correlation with neurochemical analytes.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Div Neurosurg, Richmond, VA 23219 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Informat Syst, Richmond, VA 23219 USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Biostat, Richmond, VA 23219 USA; Univ Messina, Dept Neurosci Psychiat & Anesthesiol Sci, Messina, Italy		Bullock, RM (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Neurosurg, Div Neurosurg, 417 N 11th St,ACC 6th Floor,Harold F Young Neuros, Richmond, VA 23219 USA.	robulloc@hsc.vcu.edu		Mazzeo, Anna Teresa/0000-0002-8454-7243	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 12587] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587] Funding Source: NIH RePORTER		Alessandri B, 1999, ACT NEUR S, V75, P21; Atkinson JLD, 1998, J TRAUMA, V45, P941, DOI 10.1097/00005373-199811000-00016; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BELL BA, 1985, J NEUROSURG, V62, P31, DOI 10.3171/jns.1985.62.1.0031; BOSE B, 1988, STROKE, V19, P28, DOI 10.1161/01.STR.19.1.28; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Chawda MN, 2004, INJURY, V35, P347, DOI 10.1016/S0020-1383(03)00140-2; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Clausen T, 2005, J NEUROSURG, V103, P233, DOI 10.3171/jns.2005.103.2.0233; Clausen T, 2001, BRAIN RES, V908, P35, DOI 10.1016/S0006-8993(01)02566-5; Cornford EM, 2002, EPILEPSIA, V43, P1360, DOI 10.1046/j.1528-1157.2002.01602.x; Frykholm P, 2001, J NEUROL NEUROSUR PS, V71, P455, DOI 10.1136/jnnp.71.4.455; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; Haitsma Iain K, 2002, Curr Opin Crit Care, V8, P115, DOI 10.1097/00075198-200204000-00005; HILLERED L, 1990, ACTA NEUROCHIR, V102, P91, DOI 10.1007/BF01405420; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hong SS, 2004, BRAIN RES, V1009, P195, DOI 10.1016/j.brainres.2004.03.004; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; JENNETT B, 1975, LANCET, V1, P480; Jones SC, 2002, ANESTHESIOLOGY, V97, P488, DOI 10.1097/00000542-200208000-00028; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koura SS, 1998, ACT NEUR S, V71, P244; LANGEMANN H, 1995, CLIN NEUROL NEUROSUR, V97, P149, DOI 10.1016/0303-8467(94)00067-G; Lewandowski K, 2003, ANAESTHESIST, V52, P965, DOI 10.1007/s00101-003-0550-7; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marrif H, 1999, J NEUROSCI RES, V57, P255; Mendelowitsch A, 2001, METHODS, V23, P73, DOI 10.1006/meth.2000.1107; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; MORAWETZ RB, 1979, FED PROC, V38, P2493; Peerdeman SM, 2003, INTENS CARE MED, V29, P1825, DOI 10.1007/s00134-003-1850-8; Ridley SA, 2002, ANAESTHESIA, V57, P761, DOI 10.1046/j.1365-2044.2002.02619.x; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SAHUQUILLO J, 1993, ACTA NEUROCHIR, V122, P204, DOI 10.1007/BF01405530; Schneweis S, 2001, STROKE, V32, P1863, DOI 10.1161/01.STR.32.8.1863; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Siddiqui MM, 2001, METHODS, V23, P83, DOI 10.1006/meth.2000.1108; Soukup J, 2002, NEUROL RES, V24, P161, DOI 10.1179/016164102101199710; Stahl N, 2001, ACTA ANAESTH SCAND, V45, P977, DOI 10.1034/j.1399-6576.2001.450810.x; Staub F, 2000, NEUROSURGERY, V47, P1106, DOI 10.1097/00006123-200011000-00016; SYMON L, 1976, STROKE, V7, P547, DOI 10.1161/01.STR.7.6.547; Symon L, 1977, Adv Exp Med Biol, V94, P775; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Winchell RJ, 1996, ARCH SURG-CHICAGO, V131, P533; ZAUNER A, 1995, J NEUROTRAUM, V12, P547, DOI 10.1089/neu.1995.12.547; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; Zauner A, 2002, J NEUROSURG, V97, P643, DOI 10.3171/jns.2002.97.3.0643; Zauner A, 1996, ACT NEUR S, V67, P40; Zwienenberg M, 2001, HEAD TRAUMA, P303	63	13	14	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2006	18	3					170	178		10.1097/01.ana.0000210999.18033.f6			9	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	059FQ	WOS:000238719100002	16799343				2022-02-06	
J	Miller, A				Miller, Ariel			Pseudobulbar affect in multiple sclerosis: Toward the development of innovative therapeutic strategies	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article; Proceedings Paper	Symposium on Cognitive Decline in Multiple Sclerosis	NOV 11-13, 2004	Taormina, ITALY	European Charcot Fdn		pseudobulbar affect; multiple sclerosis; affect; emotion; crying; laughing	DEXTROMETHORPHAN; LAUGHTER; CITALOPRAM; PREVALENCE; PAROXETINE; QUINIDINE; LABILITY; STROKE; ALS	Pseudobulbar affect (PBA), a condition involving involuntary and uncontrollable episodes of crying and/or laughing, occurs frequently in patients with a variety of neurological disorders, including amyotrophic lateral sclerosis (ALS), stroke, traumatic brain injury, dementia including Alzheimer's disease, and multiple sclerosis (MS). Although PBA results in considerable distress for patients and caretakers, it is underrecognized and undertreated. Agents used to treat psychiatric disorders-particularly tricyclic antidepressants and selective serotonin reuptake inhibitors-are useful in alleviating PBA, but act on diffuse neural networks rather than targeting those involved in emotional motor expression. As a result of their nonspecific activity, these agents are associated with a range of unwanted effects that preclude many patients from using them. Dextromethorphan, a common cough suppressant, specifically targets sigma, receptors concentrated in the brainstem and cerebellum, thus providing the possibility of targeting regions implicated in emotional expression. When administered in a fixed combination with quinidine, dextromethorphan is effective in treating PBA in patients with ALS, and preliminary results suggest that this therapy also is effective in treating MS-related PBA. (c) 2006 Elsevier B.V. All rights reserved.	Technion Israel Inst Technol, Ctr Multiple Sclerosis, Dept Neurol, Carmel Med Ctr,Rappaport Fac Med, IL-32000 Haifa, Israel; Technion Israel Inst Technol, Res Inst, IL-32000 Haifa, Israel		Miller, A (corresponding author), Technion Israel Inst Technol, Ctr Multiple Sclerosis, Dept Neurol, Carmel Med Ctr,Rappaport Fac Med, IL-32000 Haifa, Israel.	millera@tx.technion.ac.il					ANDERSEN G, 1993, LANCET, V342, P837, DOI 10.1016/0140-6736(93)92696-Q; Arciniegas D B, 2000, Semin Clin Neuropsychiatry, V5, P290, DOI 10.1053/scnp.2000.9554; Baldessarini R., 2001, PHARM BASIS THERAPEU, P447; Benedict RHB, 2004, J NEUROIMAGING, V14, p36S, DOI 10.1111/j.1552-6569.2004.tb00277.x; Brooks BR, 2004, NEUROLOGY, V63, P1364; Burns A, 1999, INT J GERIATR PSYCH, V14, P681, DOI 10.1002/(SICI)1099-1166(199908)14:8<681::AID-GPS49>3.3.CO;2-Q; CAROSCIO JT, 1987, NEUROL CLIN, V5, P1; Dark FL, 1996, AUST NZ J PSYCHIAT, V30, P472, DOI 10.3109/00048679609065020; Darwin C., 1965, EXPRESS EMOT MAN; Feinstein A, 1997, ARCH NEUROL-CHICAGO, V54, P1116, DOI 10.1001/archneur.1997.00550210050012; GALLAGHER JP, 1989, ACTA NEUROL SCAND, V80, P114, DOI 10.1111/j.1600-0404.1989.tb03851.x; HOUSE A, 1989, BMJ-BRIT MED J, V298, P991, DOI 10.1136/bmj.298.6679.991; Huffman Jeff C., 2003, Prim Care Companion J Clin Psychiatry, V5, P85; IRONSIDE R, 1956, BRAIN, V79, P589, DOI 10.1093/brain/79.4.589; LIEBERMAN A, 1977, ARCH NEUROL-CHICAGO, V34, P717, DOI 10.1001/archneur.1977.00500230087017; Matthews PM, 2004, CURR OPIN NEUROL, V17, P453, DOI 10.1097/01.wco.0000137537.06986.b0; Maurice T, 1997, PROG NEURO-PSYCHOPH, V21, P69, DOI 10.1016/S0278-5846(96)00160-1; Moore SR, 1997, J NEUROL NEUROSUR PS, V63, P89, DOI 10.1136/jnnp.63.1.89; MORRIS PLP, 1993, AUST NZ J PSYCHIAT, V27, P601, DOI 10.3109/00048679309075822; Muller U, 1999, BRAIN INJURY, V13, P805, DOI 10.1080/026990599121197; MUSACCHIO JM, 1989, LIFE SCI, V45, P1721, DOI 10.1016/0024-3205(89)90510-9; PANITCH HS, IN PRESS ANN NEUROL, V59; Parvizi J, 2001, BRAIN, V124, P1708, DOI 10.1093/brain/124.9.1708; Poeck K, 1969, Ger Med Mon, V14, P394; Pollock BG, 1998, AM J PSYCHIAT, V155, P1110, DOI 10.1176/ajp.155.8.1110; Pope LE, 2004, J CLIN PHARMACOL, V44, P1132, DOI 10.1177/0091270004269521; PRATT RTC, 1951, J NEUROL NEUROSUR PS, V14, P326, DOI 10.1136/jnnp.14.4.326; ROBINSON RG, 1993, AM J PSYCHIAT, V150, P286; SCHIFFER RB, 1985, NEW ENGL J MED, V312, P1480, DOI 10.1056/NEJM198506063122303; Smith RA, 2004, MULT SCLER, V10, P1; STARKSTEIN SE, 1995, J NEUROL NEUROSUR PS, V59, P55, DOI 10.1136/jnnp.59.1.55; SURRIDGE D, 1969, BRIT J PSYCHIAT, V115, P749, DOI 10.1192/bjp.115.524.749; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; TORTELLA FC, 1989, TRENDS PHARMACOL SCI, V10, P501, DOI 10.1016/0165-6147(89)90050-3; UDAKA F, 1984, ARCH NEUROL-CHICAGO, V41, P1095, DOI 10.1001/archneur.1984.04050210093023; Wilson SAK, 1924, J NEUROL PSYCHOPATHO, V4, P299; ZHANG Y, 1992, CLIN PHARMACOL THER, V51, P647, DOI 10.1038/clpt.1992.77; Zivadinov R, 2004, J NEUROIMAGING, V14, p27S, DOI 10.1111/j.1552-6569.2004.tb00276.x	38	13	13	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	JUN 15	2006	245	1-2			SI		153	159		10.1016/j.jns.2005.09.018			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	055PK	WOS:000238462500026	16674978				2022-02-06	
J	Duhem, R; Vinchon, M; Tonnelle, V; Soto-Ares, G; Leclerc, X				Duhem, R.; Vinchon, M.; Tonnelle, V.; Soto-Ares, G.; Leclerc, X.			Main temporal aspects of the MRI signal of subdural hematomas and practical contribution to dating head injury	NEUROCHIRURGIE			French	Article						subdural hematoma; MRI; head injury	CHILD-ABUSE; INTRACRANIAL HEMORRHAGE; INTRACEREBRAL HEMATOMA; DIAGNOSIS; BRAIN; SEQUENCES; INFANTS; TISSUE	Background and purpose. - MRI signal of a subdural hematoma (SDH) is often regarded as similar to that of an intracerebral hematoma but no precise study has analyzed the evolution of the signal of subdural hematomas. Their dating is however significant, in particular in the child, within the context of the diagnosis of child abuse. The objective of this study is to compare with MRI a group of adult patients having a subdural and/or intracerebral, in order to study the evolution of the signals of these two types of hematomas. Material and methods. - This prospective study included patients hospitalized for post-traumatic acute subdural or intracerebral hematoma. The protocol included an emergency brain CT and 4 MRI at fixed times: in emergency (early phase), between the third and the seventh day (early subacute phase), during the third week (late subacute phase), and after four months after the hemorrhage. The protocol included T1-weighted sequences before and after injection of gadolinium, T2-weighted, fluid-attenuated inversion-recovery (FLAIR), gradient echo and diffusion. Results. - Eighteen patients were included and all 72 MRI were interpretable. The time course of the cerebral hematomas was similar to that described in the literature, whereas that of subdural hematomas was different in 1.5 patients. This distinction was significant in the early phase for subdural hematomas, which displayed hypersignal in T2 and FLAIR, whereas cerebral hematomas showed a hyposignal in the same sequences. The variation was also notable in the early subacute period during which subdural hematomas displayed hypersignal in T1, FLAIR and diffusion, and isosignal in T2, whereas cerebral hematomas showed isosignal in T1, and hyposignal in T2, FLAIR and diffusion. Conclusion. - The time course of MRI signal of subdural hematomas is different from that of cerebral hematomas. This difference is significant in T2 sequence and FLAIR, especially in the early subacute period. These radiographic observations in adults can be useful for the MRI dating of subdural hematomas in shaken-baby syndrome.	Ctr Hosp Reg & Univ Lille, Clin Neurochirurg, F-59037 Lille, France; Ctr Hosp Reg & Univ Lille, Serv Neuroradiol, F-59037 Lille, France		Duhem, R (corresponding author), Ctr Hosp Reg & Univ Lille, Clin Neurochirurg, Pl Verdun, F-59037 Lille, France.	rduhem@yahoo.fr		Vinchon, Matthieu/0000-0002-9122-6165			Al-Sarraj S, 2004, CLIN NEUROPATHOL, V23, P62; BARKOVICH AJ, 1988, RADIOL CLIN N AM, V26, P801; Barnes PD, 2000, PEDIATR RADIOL, V30, P74, DOI 10.1007/s002470050018; Biousse V, 2002, AM J OPHTHALMOL, V133, P249, DOI 10.1016/S0002-9394(01)01366-6; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; BROOKS RA, 1989, MAGNET RESON MED, V12, P241, DOI 10.1002/mrm.1910120210; Chabrol B, 1999, CHILD ABUSE NEGLECT, V23, P217, DOI 10.1016/S0145-2134(98)00128-8; CHIN HY, 1991, NEURORADIOLOGY, V33, P79; FOBBEN ES, 1989, AM J ROENTGENOL, V153, P589, DOI 10.2214/ajr.153.3.589; Gomori J M, 1988, Radiographics, V8, P427; GOMORI JM, 1993, AM J NEURORADIOL, V14, P871; Grossman R I, 1986, Acta Radiol Suppl, V369, P56; JANICK P A, 1991, Magnetic Resonance Quarterly, V7, P57; JENKINS A, 1989, MAGN RESON IMAGING, V7, P395, DOI 10.1016/0730-725X(89)90488-8; Kleinman PK, 1996, AM J ROENTGENOL, V167, P893, DOI 10.2214/ajr.167.4.8819377; Kuker W, 2000, ACTA RADIOL, V41, P544, DOI 10.1034/j.1600-0455.2000.041006544.x; Leclerc X, 2003, J NEURORADIOLOGY, V30, P303; Nakamura S, 1989, Brain Inj, V3, P129, DOI 10.3109/02699058909004543; Orlin JR, 1997, ACTA RADIOL, V38, P610; SATO Y, 1989, RADIOLOGY, V173, P653, DOI 10.1148/radiology.173.3.2813768; Silvera S, 2005, AM J NEURORADIOL, V26, P236; Soto-Ares G, 2003, J RADIOL, V84, P1757; STROOBANDT G, 1978, NEUROCHIRURGIE, V24, P47; Vinchon M, 2004, J NEUROSURG, V101, P44, DOI 10.3171/ped.2004.101.2.0044; Vinchon M, 2003, PEDIATR NEUROSURG, V39, P122, DOI 10.1159/000071648; Vinchon M, 2002, PEDIATR NEUROSURG, V37, P245, DOI 10.1159/000066216	26	13	14	0	6	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770			NEUROCHIRURGIE	Neurochirurgie	JUN	2006	52	2-3	1				93	104		10.1016/S0028-3770(06)71203-6			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	060XY	WOS:000238836500002	16840968				2022-02-06	
J	Kawata, M; Takamoto, S; Kitahori, K; Tsukihara, H; Morota, T; Ono, M; Motomura, N; Murakami, A; Suematsu, Y				Kawata, Mitsuhiro; Takamoto, Shinichi; Kitahori, Kazuo; Tsukihara, Hiroyuki; Morota, Tetsuro; Ono, Minoru; Motomura, Noboru; Murakami, Arata; Suematsu, Yoshihiro			Erythropoietin protects the central nervous system during prolonged hypothermic circulatory arrest: An experimental study in a canine model	JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY			English	Article							ISCHEMIA	Objective: Current data suggest that erythropoietin protects the brain and the spinal cord from ischemic and traumatic injury. In this study, we determined whether erythropoietin protects the central nervous system during prolonged hypothermic circulatory arrest in an experimental canine model. Methods: Ten adult beagle dogs were randomly and intravenously injected with either 5000 U/kg recombinant human erythropoietin or normal saline. Each dog was then subjected to a cardiopulmonary bypass and 120 minutes of deep hypothermic circulatory arrest ( 18 C). The level of tau proteins in the cerebrospinal fluid, a modified marker of neurologic deficit in dogs, and the histopathologic characteristics of the brains and spinal cords were then examined. Results: The level of tau proteins was significantly lower in the erythropoietin-treated group than in the untreated group at 6 hours ( 20 +/- 12 vs 144 +/- 54 pg/mL; P =.036) and 12 hours ( 64 +/- 35 vs 478 +/- 103 pg/mL; P =.01) after the operation. The total Neurologic Deficit Score was 59 +/- 31 ( 0, normal; 500, brain death) in the erythropoietin-treated group, compared with 376 +/- 30 in the untreated group ( P =.0117). Histopathologic examination revealed that ischemic neuronal changes and apoptosis in the hippocampus CA1 were significantly lower in the erythropoietin-treated group ( P <.01 and P =.028, respectively). Conclusions: This study showed that erythropoietin protected the central nervous system during prolonged hypothermic circulatory arrest, partly by preventing both necrosis ( ischemic neuronal changes) and apoptosis.	Univ Tokyo, Grad Sch Med, Dept Cardiothorac Surg, Bunkyo Ku, Tokyo 1138655, Japan		Kawata, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cardiothorac Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	mkawata-ths@umin.ac.jp	Motomura, Noboru/AAK-6000-2020; ac°, a a/AAY-7569-2020	ac°, a a/0000-0001-8547-4499			Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Castella M, 2005, ANN THORAC SURG, V79, P646, DOI 10.1016/j.athoracsur.2004.07.007; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Fiordaliso F, 2005, P NATL ACAD SCI USA, V102, P2046, DOI 10.1073/pnas.0409329102; Frosch MP, 2005, ROBBINS COTRAN PATHO, P1347; Kongstad L, 2005, ACTA ANAESTH SCAND, V49, P614, DOI 10.1111/j.1399-6576.2005.00680.x; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; Romsi P, 2002, J THORAC CARDIOV SUR, V124, P714, DOI 10.1067/mtc.2002.123704; Safar P, 1996, STROKE, V27, P105, DOI 10.1161/01.STR.27.1.105; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; TISHERMAN SA, 1991, J TRAUMA, V31, P1051, DOI 10.1097/00005373-199131080-00002; WELLER RO, 1990, SYSTEMIC PATHOLOGY, V4, P38; Ye J, 1998, CIRCULATION, V98, pII313; Ye J, 1996, ANN THORAC SURG, V61, P1316	17	13	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-5223	1097-685X		J THORAC CARDIOV SUR	J. Thorac. Cardiovasc. Surg.	JUN	2006	131	6					1331	1337		10.1016/j.jtcvs.2005.10.035			7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Respiratory System; Surgery	049NM	WOS:000238023300023	16733166	Bronze			2022-02-06	
J	Ang, BT; Xuo, G; Xiao, ZC				Ang, BT; Xuo, G; Xiao, ZC			Therapeutic vaccination for central nervous system repair	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						axonal regeneration; myelin-associated glycoprotein; neurodegeneration; Nogo; tenascin; vaccine	MYELIN-ASSOCIATED GLYCOPROTEIN; SPINAL-CORD-INJURY; NEURITE OUTGROWTH; TENASCIN-R; NOGO-A; AXON REGENERATION; NEURODEGENERATIVE DISORDERS; FUNCTIONAL RECOVERY; PROMOTES RECOVERY; MESSENGER-RNA	1. Vaccination against infectious agents has been heralded as a triumph in modern medicine and, more recently, cancer vaccines have risen in prominence. The present review looks towards the use of vaccine therapy to attenuate damage after injury to the central nervous system (CNS). 2. Significant debility is associated with brain injury, most commonly occurring as a result of physical trauma or stroke. This end result reflects the inability of neurons and axons to regenerate following injury to the CNS. This unconducive environment is due, in large part, to the presence of myelin and oligodendrocyte-related inhibitors of neurite outgrowth. 3. We review how a vaccine-based approach has been variably used to circumvent this issue and promote axonal regeneration and repair following traumatic injury and other neurodegenerative disorders. In addition, emerging evidence suggests that the immune response to injury in the CNS may be manipulated so as to reduce cellular damage. Vaccine-directed approaches using this concept are also outlined.	Singapore Gen Hosp, Dept Neurosurg, Natl Inst Neurosci, Singapore 0316, Singapore; Singapore Gen Hosp, Ctr Mol Med, Singapore 0316, Singapore; Singapore Gen Hosp, Dept Clin Res, Singapore 0316, Singapore; Natl Univ Singapore, Dept Anat, Singapore 117548, Singapore; Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore		Ang, BT (corresponding author), Natl Inst Neurosci, Dept Neurosurg, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	beng_ti_ang@nni.com.sg	xiao, zhicheng/A-1529-2011	xiao, zhicheng/0000-0001-5172-762X			Angelov DN, 2003, P NATL ACAD SCI USA, V100, P4790, DOI 10.1073/pnas.0530191100; Angelov DN, 1998, J NEUROSCI, V18, P6218; Avidan H, 2004, EUR J IMMUNOL, V34, P3434, DOI 10.1002/eji.200424883; BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0; Benner EJ, 2004, P NATL ACAD SCI USA, V101, P9435, DOI 10.1073/pnas.0400569101; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; CADELLI D, 1991, EUR J NEUROSCI, V3, P825, DOI 10.1111/j.1460-9568.1991.tb00093.x; CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; DOHERTY P, 1995, NEURON, V14, P57, DOI 10.1016/0896-6273(95)90240-6; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; During MJ, 2000, SCIENCE, V287, P1453, DOI 10.1126/science.287.5457.1453; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; FUSS B, 1993, J CELL BIOL, V120, P1237, DOI 10.1083/jcb.120.5.1237; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Hauben E, 2000, J NEUROSCI, V20, P6421, DOI 10.1523/JNEUROSCI.20-17-06421.2000; Hauben E, 2001, P NATL ACAD SCI USA, V98, P15173, DOI 10.1073/pnas.011585298; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Huber AB, 2000, BIOL CHEM, V381, P407, DOI 10.1515/BC.2000.053; Karnezis T, 2004, NAT NEUROSCI, V7, P736, DOI 10.1038/nn1261; Kim GM, 2001, J NEUROSCI, V21, P6617, DOI 10.1523/JNEUROSCI.21-17-06617.2001; Kipnis J, 2003, J NEUROTRAUM, V20, P559, DOI 10.1089/089771503767168483; Kipnis J, 2002, TRENDS MOL MED, V8, P319, DOI 10.1016/S1471-4914(02)02373-0; Kipnis J, 2002, J NEUROIMMUNOL, V130, P78, DOI 10.1016/S0165-5728(02)00219-9; Kipnis J, 2001, J NEUROSCI, V21, P4564, DOI 10.1523/JNEUROSCI.21-13-04564.2001; Kottis V, 2002, J NEUROCHEM, V82, P1566, DOI 10.1046/j.1471-4159.2002.01146.x; Liao H, 2005, J BIOL CHEM, V280, P8316, DOI 10.1074/jbc.M412730200; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; LOTAN M, 1994, FASEB J, V8, P1026, DOI 10.1096/fasebj.8.13.7926367; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MIKOL DD, 1988, J CELL BIOL, V106, P1273, DOI 10.1083/jcb.106.4.1273; MIKOL DD, 1990, J CELL BIOL, V110, P471, DOI 10.1083/jcb.110.2.471; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Nie DY, 2003, EMBO J, V22, P5666, DOI 10.1093/emboj/cdg570; Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144; Pesheva P, 2000, PROG NEUROBIOL, V61, P465, DOI 10.1016/S0301-0082(99)00061-1; PESHEVA P, 1989, J CELL BIOL, V109, P1765, DOI 10.1083/jcb.109.4.1765; Popovich PG, 2003, TRENDS PHARMACOL SCI, V24, P13, DOI 10.1016/S0165-6147(02)00006-8; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Raineteau O, 1999, EUR J NEUROSCI, V11, P1486, DOI 10.1046/j.1460-9568.1999.00560.x; RODRIGUEZ M, 1987, J NEUROPATH EXP NEUR, V46, P84, DOI 10.1097/00005072-198701000-00008; RODRIGUEZ M, 1990, ANN NEUROL, V27, P12, DOI 10.1002/ana.410270104; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; Schwartz M, 2005, ANN NY ACAD SCI, V1051, P701, DOI 10.1196/annals.1361.114; Schwartz M, 2004, TRENDS PHARMACOL SCI, V25, P407, DOI 10.1016/j.tips.2004.06.010; Schwartz M, 2003, INVEST OPHTH VIS SCI, V44, P1407, DOI 10.1167/iovs.02-0594; Sicotte M, 2003, MOL CELL NEUROSCI, V23, P251, DOI 10.1016/S1044-7431(03)00053-8; Tang S, 1997, MOL CELL NEUROSCI, V9, P333, DOI 10.1006/mcne.1997.0633; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; WEIBEL D, 1994, BRAIN RES, V642, P259, DOI 10.1016/0006-8993(94)90930-X; WINTERGERST ES, 1993, EUR J NEUROSCI, V5, P299, DOI 10.1111/j.1460-9568.1993.tb00497.x; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Xiao ZC, 1999, J BIOL CHEM, V274, P26511, DOI 10.1074/jbc.274.37.26511; Xu G, 2004, NEUROREPORT, V15, P2167, DOI 10.1097/00001756-200410050-00004; Xu G, 2004, J NEUROCHEM, V91, P1018, DOI 10.1111/j.1471-4159.2004.02803.x; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010	65	13	14	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1870	1440-1681		CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	MAY-JUN	2006	33	5-6					541	545		10.1111/j.1440-1681.2006.04404.x			5	Pharmacology & Pharmacy; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Physiology	040YY	WOS:000237420800020	16700891				2022-02-06	
J	Cruise, CM; Sasson, N; Lee, MHM				Cruise, Cathy M.; Sasson, Nicole; Lee, Mathew H. M.			Rehabilitation outcomes in the older adult	CLINICS IN GERIATRIC MEDICINE			English	Article							BRAIN-INJURY; FRAIL; FALLS; HIP; INPATIENT; EXERCISE; PROGRAM; STROKE; TRIAL; RISK	Numerous studies support the use of rehabilitative interventions in the older adult. Given the many fiscal challenges in health care today, it is of utmost importance that funding for rehabilitation result in fruitful outcomes. Specific rehabilitative interventions have been found to be very effective in the elderly and can be demonstrated through numerous studies. Outcomes for conditions including stroke, traumatic brain injury, spinal cord injury, amputation, hip fracture, and joint replacement are discussed. There is great need for ongoing research to determine optimal rehabilitative interventions in the elderly.	NYU, Sch Med, Rusk Inst Rehabil, New York, NY 10016 USA; Northport Vet Affairs Med Ctr, Phys Med & Rehabil Serv 117, Vet Integrated Serv Network, Northport, NY 11768 USA; New York Harbor Healthcare Syst, Dept Vet Affairs, Phys Med & Rehabil Serv 117, New York, NY 10010 USA		Cruise, CM (corresponding author), NYU, Sch Med, Rusk Inst Rehabil, Suite 600,400 E 34th St, New York, NY 10016 USA.	cmcruise@optonline.net					Ades PA, 1996, ANN INTERN MED, V124, P568, DOI 10.7326/0003-4819-124-6-199603150-00005; American Heart Association, HEART DIS STROK STAT; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; Chumbler NR, 2004, TELEMED J E-HEALTH, V10, P129, DOI 10.1089/1530562041641200; Cohen HJ, 2002, NEW ENGL J MED, V346, P905, DOI 10.1056/NEJMsa010285; *DEP VET AFF, 2005, PHYS MED REH; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; GRISSO JA, 1991, NEW ENGL J MED, V324, P1326, DOI 10.1056/NEJM199105093241905; HOWARD MA, 1989, J NEUROSURG, V71, P858, DOI 10.3171/jns.1989.71.6.0858; Jette DU, 2005, ARCH PHYS MED REHAB, V86, P1089, DOI 10.1016/j.apmr.2004.11.018; Jette DU, 2005, ARCH PHYS MED REHAB, V86, P373, DOI 10.1016/j.apmr.2004.10.018; KEITH RA, 1995, ARCH PHYS MED REHAB, V76, P495, DOI 10.1016/S0003-9993(95)80501-X; Kramer AM, 1997, JAMA-J AM MED ASSOC, V277, P396, DOI 10.1001/jama.277.5.396; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; LEE MHM, 1988, REHABILITATION MED, P393; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; McGlinchey-Berroth R, 1995, J Spinal Cord Med, V18, P183; MEYERS AR, 2000, REHABILITATION PEOPL, P13; MOREY MC, 1989, J AM GERIATR SOC, V37, P348, DOI 10.1111/j.1532-5415.1989.tb05503.x; Munin MC, 2005, ARCH PHYS MED REHAB, V86, P367, DOI 10.1016/j.apmr.2004.10.004; MUNIN MC, 1995, AM J PHYS MED REHAB, V74, P294, DOI 10.1097/00002060-199507000-00006; Murray PK, 2005, ARCH PHYS MED REHAB, V86, P876, DOI 10.1016/j.apmr.2004.10.045; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; PENTLAND W, 1995, PARAPLEGIA, V33, P367, DOI 10.1038/sc.1995.84; SCHERER T, 2000, REHABILITATION PEOPL, P1110; Scivoletto G, 2005, ARCH PHYS MED REHAB, V86, P512, DOI 10.1016/j.apmr.2004.05.021; Stineman MG, 2003, ARCH PHYS MED REHAB, V84, P38, DOI 10.1053/apmr.2003.50060; Sullivan DH, 2001, AM J PHYS MED REHAB, V80, P503, DOI 10.1097/00002060-200107000-00007; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P140; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806	32	13	13	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0690	1879-8853		CLIN GERIATR MED	Clin. Geriatr. Med.	MAY	2006	22	2					257	+		10.1016/j.cger.2005.12.015			12	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	044VX	WOS:000237702200004	16627077				2022-02-06	
J	Wiese, H; Tonnes, C; de Greiff, A; Nebel, K; Diener, HC; Stude, P				Wiese, Holger; Toennes, Christina; de Greiff, Armin; Nebel, Katharina; Diener, Hans-Christoph; Stude, Philipp			Self-initiated movements in chronic prefrontal traumatic brain injury: An event-related functional MR1 study	NEUROIMAGE			English	Article							EXTERNALLY TRIGGERED MOVEMENTS; SUPPLEMENTARY MOTOR AREA; VOLUNTARY MOVEMENT; POTENTIALS; FMRI; ACTIVATION; CORTEX; LESIONS	Electrophysiological studies found traumatic lesions of the prefrontal cortex (PFC) to affect the preparation of self-initiated movements. However, a precise localization of the observed effects has not been reported yet. Moreover, previous reports did not account for effects of lesion location. Therefore, the present study utilized functional MRI to investigate the influence of predominantly left or right hemispheric PFC lesions on movement preparation in chronic traumatic brain injury (TBI) patients. 18 TBI patients with MRI-defined contusions of the PFC as well as 18 healthy control subjects matched for age and gender were examined. Patients were divided into subgroups of predominantly left or right hemispheric lesions. During functional image acquisition, subjects performed self-initiated abductions of their right index finger. Neuropsychological tests of attention and working memory, which are supposed to modulate preparatory processes, were conducted. Patients with predominantly left contusions demonstrated enhanced activity of the dorsal lateral premotor cortex in comparison to healthy control subjects. In predominantly right lesioned patients, reduced activity within the right caudate head was observed. Compared to predominantly left lesioned patients, neuropsychological tests yielded reduced task performances in the right lesion subgroup. In line with previous electrophysiological research, imaging results of the present study are interpreted to represent altered preparatory networks in chronic prefrontal TBI patients. Since attentional and working memory functions are supposed to modulate preparatory processes, differences between the patient subgroups are suggested to result from the more pronounced cognitive impairments in the right-lesioned group. (c) 2005 Elsevier Inc. All rights reserved.	Univ Duisburg Gesamthsch, Dept Neurol, Essen, Germany; Univ Duisburg Gesamthsch, Inst Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany		Wiese, H (corresponding author), Univ Jena, Dept Gen Psychol, Steiger 3,Haus 1, D-07743 Jena, Germany.	holger.wiese@uni-jena.de	Wiese, Holger/M-5281-2014; Diener, Hans-Christoph/AAF-7275-2019	Wiese, Holger/0000-0003-4928-0771; 			Ball T, 1999, NEUROIMAGE, V10, P682, DOI 10.1006/nimg.1999.0507; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Cui RQ, 1999, NEUROIMAGE, V9, P124, DOI 10.1006/nimg.1998.0388; Cunnington R, 2003, NEUROIMAGE, V20, P404, DOI 10.1016/S1053-8119(03)00291-X; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; Erdler M, 2000, NEUROIMAGE, V11, P697, DOI 10.1006/nimg.2000.0579; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Hamano T, 1997, EVOKED POTENTIAL, V104, P257, DOI 10.1016/S0168-5597(97)96107-4; Henson RNA, 2002, NEUROIMAGE, V15, P83, DOI 10.1006/nimg.2001.0940; Hopfinger JB, 2000, NEUROIMAGE, V11, P326, DOI 10.1006/nimg.2000.0549; Ikeda A, 1996, ELECTROEN CLIN NEURO, V98, P206, DOI 10.1016/0013-4694(95)00239-1; Jahanshahi M, 2001, NEUROCASE, V7, P495, DOI 10.1093/neucas/7.6.495; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Jenkins IH, 2000, BRAIN, V123, P1216, DOI 10.1093/brain/123.6.1216; Knight R. T., 2002, PRINCIPLES FRONTAL L, P573; Knight RT., 2002, PRINCIPLES FRONTAL L, P261, DOI [10.1093/acprof:oso/9780195134971.003.0017, DOI 10.1093/ACPROF:OSO/9780195134971.003.0017]; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Luria A.R., 1973, WORKING BRAIN; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PAPA SM, 1991, MOVEMENT DISORD, V6, P217, DOI 10.1002/mds.870060305; PRAAMSTRA P, 2003, BEREITSCHAFTSPOTENTI, P131; REKTOR I, 2003, BEREITSCHAFTSPOTENTI, P61; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Rockstroh B, 1989, SLOW BRAIN POTENTIAL; Shallice T., 1998, FRONTAL CORTEX, P22; SINGH J, 1990, BRAIN RES, V531, P45, DOI 10.1016/0006-8993(90)90756-2; SINGH J, 1992, SCHIZOPHR RES, V8, P31, DOI 10.1016/0920-9964(92)90058-D; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Talairach J., 1988, COPLANAR STEREOTAXIC; TEASDALE G, 1974, LANCET, V2, P81; Toma K, 2003, BEREITSCHAFTSPOTENTI, P113; Weilke F, 2001, J NEUROPHYSIOL, V85, P1858, DOI 10.1152/jn.2001.85.5.1858; WEINBERGER DR, 1988, TRENDS NEUROSCI, V11, P367, DOI 10.1016/0166-2236(88)90060-4; Westphal K. P., 2003, BEREITSCHAFTSPOTENTI, P155; Wiese H, 2005, NEUROIMAGE, V28, P691, DOI 10.1016/j.neuroimage.2005.06.044; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P2677, DOI 10.1016/j.clinph.2004.06.015; Wiese H, 2004, NEUROSCI LETT, V371, P220, DOI 10.1016/j.neulet.2004.08.078; Wiese H, 2004, CLIN NEUROPHYSIOL, V115, P289, DOI 10.1016/S1388-2457(03)00348-1; Wildgruber D, 1997, NEUROSCI LETT, V227, P161, DOI 10.1016/S0304-3940(97)00329-7; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8; Zimmermann P., 1994, TEST ATTENTIONAL PER	43	13	14	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	MAY 1	2006	30	4					1292	1301		10.1016/j.neuroimage.2005.11.012			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	043LB	WOS:000237601500021	16380271				2022-02-06	
J	Driver, S				Driver, S			Applying physical activity motivation theories to people with brain injuries	ADAPTED PHYSICAL ACTIVITY QUARTERLY			English	Article							SELF-EFFICACY; PERCEPTIONS; PERFORMANCE; COMPETENCE; ESTEEM; PARTICIPATION; INDIVIDUALS; PREDICTORS; AQUATICS; PROGRAM	The purpose of the paper is to provide specialists with theoretical frameworks that can be used to guide the creation of physical activity interventions as well as facilitating participation for people with traumatic brain injuries. Two frameworks for examining the physical activity motivation of people with brain injuries are presented. The theories include Bandura's (1986) self-efficacy theory and Harter's (1987) mediational model of self-worth. The constructs within both theories are explained and then applied to people with brain injuries. Suggestions for practitioners are also provided about how to manipulate the physical activity environment to promote physical activity participation.	Univ N Texas, Dept Kinesiol Hlth Promot & Recreat, Denton, TX 76203 USA		Driver, S (corresponding author), Univ N Texas, Dept Kinesiol Hlth Promot & Recreat, Denton, TX 76203 USA.	SDriver@coe.unt.edu					American College of Sports Medicine, 2000, ACSM GUID EX TEST PR; ARMSTRONG C, 1991, J REHABIL, V57, P15; Babkes ML, 1999, PEDIATR EXERC SCI, V11, P44, DOI 10.1123/pes.11.1.44; Bandura A, 1986, SOCIAL FDN THOUGHT A; Bandura A., 1997, SELF EFFICACY EXERCI; Biddle S, 1994, PHYS ACTIVITY PROMOT; BOSLEY CM, 1995, EUR RESPIR J, V8, P899; Clark NM, 1999, HEALTH EDUC BEHAV, V26, P72, DOI 10.1177/109019819902600107; Dault MC, 2002, BRAIN INJURY, V16, P231, DOI 10.1080/02699050110103300; DILORIO C, 1996, NURS RES, V45, P211, DOI DOI 10.1097/00006199-199607000-00004; Driver S, 2006, BRAIN INJURY, V20, P133, DOI 10.1080/02699050500443822; Driver S, 2006, ADAPT PHYS ACT Q, V23, P1; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; DRIVER S, IN PRESS BRAIN INJUR; DRIVER S, 2005, UNPUB BARRIERS PHYS; DUNCAN TE, 1993, J BEHAV MED, V16, P199, DOI 10.1007/BF00844893; Ebbeck V, 1996, PEDIATR EXERC SCI, V8, P368, DOI 10.1123/pes.8.4.368; Ebbeck V, 1998, PEDIATR EXERC SCI, V10, P285, DOI 10.1123/pes.10.3.285; EWART CK, 1989, MED SCI SPORT EXER, V21, P683, DOI 10.1249/00005768-198912000-00011; FELTZ DL, 1982, J PERS SOC PSYCHOL, V42, P764, DOI 10.1037/0022-3514.42.4.764; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Fox K, 1997, BRIT J GEN PRACT, V47, P367; FOX KR, 1989, J SPORT EXERCISE PSY, V11, P408, DOI 10.1123/jsep.11.4.408; GEORGE TR, 1992, J SPORT EXERCISE PSY, V14, P237, DOI 10.1123/jsep.14.3.237; HARTER S, 1978, HUM DEV, V21, P34, DOI 10.1159/000271574; Harter S., 1987, CONT ISSUES DEV PSYC, P219; Harter S., 1999, CONSTRUCTION SELF; Heller T, 2001, EXERCISE NUTR ED CUR; HORN T, 2003, DEV SPORT EXERCISE P, P101; Kennedy P, 2000, BRIT J HEALTH PSYCH, V5, P157, DOI 10.1348/135910700168838; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Li FZ, 2001, J AGING PHYS ACTIV, V9, P161, DOI 10.1123/japa.9.2.161; LORIG K, 1993, HEALTH EDUC QUART, V20, P17, DOI 10.1177/109019819302000104; Lox CL, 1999, REHABIL PSYCHOL, V44, P1; Martin JJ, 2002, SPORT PSYCHOL, V16, P384, DOI 10.1123/tsp.16.4.384; MCAULEY E, 1993, J BEHAV MED, V16, P103, DOI 10.1007/BF00844757; McAuley E, 1999, J GERONTOL B-PSYCHOL, V54, pP283, DOI 10.1093/geronb/54B.5.P283; MCAULEY E, 1993, J GERONTOL, V48, pP218, DOI 10.1093/geronj/48.4.P218; MCAULEY E, 1985, J SPORT PSYCHOL, V7, P283, DOI 10.1123/jsp.7.3.283; McAuley E, 2000, Exerc Sport Sci Rev, V28, P85; MCAULEY E, 2002, ADV SPORT PSYCHOL, P185; MCCULLAGH P, 2002, EXPLORING SPORT EXER, P00131; Messent PR, 1998, BRIT J LEARN DISABIL, V26, P17, DOI DOI 10.1111/J.1468-3156.1998.TB00041.X; Nahas MV., 2003, PHYS EDUCATOR, V60, P42; *NIH, 1999, REH PERS TRAUM BRAIN, V16, P1; PESCATELLO LS, 1993, SPORTS MED, V15, P353, DOI 10.2165/00007256-199315060-00001; Smith AL, 1999, J SPORT EXERCISE PSY, V21, P329, DOI 10.1123/jsep.21.4.329; STANDAGE M, 2003, DEV SPORT EXERCISE P, P101; Treasure DC, 1996, SPORT PSYCHOL, V10, P73, DOI 10.1123/tsp.10.1.73; *US DEP HHS, 2002, PUBL US DEP HHS; US Department of Health and Human Services, 2000, HLTH PEOPL 2010; Weiss MR, 1997, J SPORT EXERCISE PSY, V19, P52, DOI 10.1123/jsep.19.1.52; Weiss MR, 1998, RES Q EXERCISE SPORT, V69, P380, DOI 10.1080/02701367.1998.10607712; Weiss MR, 2002, ADV SPORT PSYCHOL, P101; WEISS MR, 2003, DEV SPORT EXERCISE P, P101; WEISS MR, 1991, SPORT PSYCHOL, V5, P335, DOI DOI 10.1123/TSP.5.4.335; Weiss MR., 1996, ENCY SPORTS MED VOLU, Veditor., P364; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	63	13	13	0	7	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	0736-5829	1543-2777		ADAPT PHYS ACT Q	Adapt. Phys. Act. Q.	APR	2006	23	2					148	162		10.1123/apaq.23.2.148			15	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	032ZD	WOS:000236814500003					2022-02-06	
J	Sagar, P; Grant, PE				Sagar, P; Grant, PE			Diffusion-weighted MR imaging: Pediatric clinical applications	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article							SYRUP-URINE-DISEASE; ACUTE DISSEMINATED ENCEPHALOMYELITIS; TRAUMATIC BRAIN-INJURY; KEARNS-SAYRE-SYNDROME; MULTIPLE-SCLEROSIS; WATER DIFFUSION; WHITE-MATTER; MITOCHONDRIAL ENCEPHALOMYOPATHY; HEPATIC-ENCEPHALOPATHY; LACTIC-ACIDOSIS	We have summarized the diffusion-weighed imaging (DWI) findings in a number of different cerebral disorders. in many cases, DWI with the accompanying apparent diffusion coefficient (ADC) map provides additional useful information to the standard imaging sequences. Pathophysiologic mechanisms resulting in baseline normal ADC values and changes with disease processes are not well understood; therefore, caution should be used when prognosticating the outcome of regions with abnormal ADCs. DWI should be used as an adjunct to routine imaging and interpreted in the context of the routine imaging findings and clinical scenario. As our understanding of ADC mechanisms increases and we begin to incorporate information about tissue organization from diffusion tensor imaging or diffusion spectrum imaging, the role of these methods in clinical diagnosis should continue to increase.	Massachusetts Gen Hosp, Dept Radiol, Div Pediat Radiol, Boston, MA 02114 USA		Sagar, P (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Div Pediat Radiol, 34 Fruit St, Boston, MA 02114 USA.	psagar@partners.org					Abe K, 2004, NEURORADIOLOGY, V46, P113, DOI 10.1007/s00234-003-1138-2; Albayram S, 2004, AM J NEURORADIOL, V25, P792; Asao C, 2005, AM J NEURORADIOL, V26, P1455; Axer H, 2005, J NEUROL NEUROSUR PS, V76, P996, DOI 10.1136/jnnp.2004.045500; Barker PB, 2004, J CHILD NEUROL, V19, P559, DOI 10.1177/088307380401900801; Barkovich AJ, 1998, AM J NEURORADIOL, V19, P523; Barkovich AJ, 2001, AM J NEURORADIOL, V22, P1786; Bernarding J, 2002, J MAGN RESON IMAGING, V15, P96, DOI 10.1002/jmri.10045; Buttner A, 2000, FORENSIC SCI INT, V113, P435, DOI 10.1016/S0379-0738(00)00204-8; Casey SO, 2004, NEURORADIOLOGY, V46, P272, DOI 10.1007/s00234-003-1053-6; Cavalleri F, 2002, NEURORADIOLOGY, V44, P499, DOI 10.1007/s00234-002-0771-5; Chan YL, 2003, PEDIATR RADIOL, V33, P574, DOI 10.1007/s00247-003-0949-y; Chang SC, 2002, CLIN IMAG, V26, P227, DOI 10.1016/S0899-7071(02)00436-9; Chang YW, 2003, PEDIATR RADIOL, V33, P836, DOI 10.1007/s00247-003-0968-8; Chu BC, 1999, NEURORADIOLOGY, V41, P759, DOI 10.1007/s002340050838; Covarrubias DJ, 2002, AM J NEURORADIOL, V23, P1038; Darquie A, 2001, P NATL ACAD SCI USA, V98, P9391, DOI 10.1073/pnas.151125698; De Vries LS, 2005, NEUROPEDIATRICS, V36, P12, DOI 10.1055/s-2005-837544; deVeber G, 2001, NEW ENGL J MED, V345, P417, DOI 10.1056/NEJM200108093450604; Dublin AB, 2002, AM J NEURORADIOL, V23, P484; Ducreux D, 2001, AM J NEURORADIOL, V22, P261; duPlessis AJ, 1997, CLIN PERINATOL, V24, P627, DOI 10.1016/S0095-5108(18)30162-3; Eichler FS, 2002, AM J NEURORADIOL, V23, P833; Elster AW, 2004, J COMPUT ASSIST TOMO, V28, P98, DOI 10.1097/00004728-200401000-00016; Engelbrecht V, 2002, RADIOLOGY, V222, P410, DOI 10.1148/radiol.2222010492; Erdem E, 2001, NEURORADIOLOGY, V43, P927, DOI 10.1007/s002340100603; Fisher MJ, 2005, AM J NEURORADIOL, V26, P1686; Forbes KPN, 2002, RADIOLOGY, V222, P405, DOI 10.1148/radiol.2222010179; Gabis LV, 2004, PEDIATR NEUROL, V30, P324, DOI 10.1016/j.pediatrneurol.2003.11.005; Ganesan V, 2003, ANN NEUROL, V53, P167, DOI 10.1002/ana.10423; Gaviani P, 2005, AM J NEURORADIOL, V26, P1115; GEAN A, 1994, WHITE MATTER SHEARIN, P207; Grant P Ellen, 2003, Magn Reson Imaging Clin N Am, V11, P493, DOI 10.1016/S1064-9689(03)00070-9; Grant PE, 2001, RADIOLOGY, V221, P43, DOI 10.1148/radiol.2211001523; GRANT PE, IN PRESS MAGN RESON; Ha JS, 2004, PEDIATR RADIOL, V34, P163, DOI 10.1007/s00247-003-1058-7; Harada M, 2000, JMRI-J MAGN RESON IM, V11, P559, DOI 10.1002/(SICI)1522-2586(200005)11:5<559::AID-JMRI12>3.0.CO;2-C; Huisman TAGM, 2003, J COMPUT ASSIST TOMO, V27, P5, DOI 10.1097/00004728-200301000-00002; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hunt RW, 2004, PEDIATRICS, V114, P999, DOI 10.1542/peds.2003-0935-L; Inglese M, 2002, AM J NEURORADIOL, V23, P267; Jalan R, 2005, NEUROCHEM INT, V47, P78, DOI 10.1016/j.neuint.2005.04.010; Jan W, 2003, NEURORADIOLOGY, V45, P634, DOI 10.1007/s00234-003-1035-8; Jan W, 2003, NEURORADIOLOGY, V45, P393, DOI 10.1007/s00234-003-0955-7; JENNETTE JC, 1994, SEMIN NEUROL, V14, P291, DOI 10.1055/s-2008-1041088; Kawamata T, 2000, ACTA NEUROCHIR SUPPL, V76, P9; Khong PL, 2004, J CHILD NEUROL, V19, P872, DOI 10.1177/08830738040190110501; Kim JA, 2001, AM J NEURORADIOL, V22, P1149; Kuker W, 2004, CHILD NERV SYST, V20, P742, DOI 10.1007/s00381-004-0988-1; Kuker W, 2004, NEURORADIOLOGY, V46, P421, DOI 10.1007/s00234-004-1203-5; Lansberg MG, 1999, NEUROLOGY, V52, P1021, DOI 10.1212/WNL.52.5.1021; Leite CC, 2005, RADIOLOGY, V235, P190, DOI 10.1148/radiol.2351031963; Lie JT, 1997, NEUROL CLIN, V15, P805, DOI 10.1016/S0733-8619(05)70348-0; Lin JT, 2003, AM J NEURORADIOL, V24, P102; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Lonergan GJ, 2003, RADIOGRAPHICS, V23, P811, DOI 10.1148/rg.234035030; LOREK A, 1994, PEDIATR RES, V36, P699, DOI 10.1203/00006450-199412000-00003; Lovblad KO, 2003, NEURORADIOLOGY, V45, P400, DOI 10.1007/s00234-003-1009-x; Lynch JK, 2002, PEDIATRICS, V109, P116, DOI 10.1542/peds.109.1.116; Mader I, 2002, STROKE, V33, P1142, DOI 10.1161/hs0402.105883; Majoie CB, 2002, AM J NEURORADIOL, V23, P813; Majoie CBLM, 2004, AM J NEURORADIOL, V25, P32; Mazumdar A, 2003, AM J NEURORADIOL, V24, P1057; Miyasaka N, 2000, RADIOLOGY, V215, P199, DOI 10.1148/radiology.215.1.r00ap24199; Moran CJ, 1998, RADIOLOGY, V206, P311, DOI 10.1148/radiology.206.2.9457180; Moritani T, 2004, CLIN IMAG, V28, P261, DOI 10.1016/S0899-7071(03)00191-8; Naegele T, 2000, RADIOLOGY, V216, P683, DOI 10.1148/radiology.216.3.r00se27683; Neil JJ, 1998, RADIOLOGY, V209, P57, DOI 10.1148/radiology.209.1.9769812; Nusbaum AO, 2000, AM J ROENTGENOL, V175, P821, DOI 10.2214/ajr.175.3.1750821; Oguz KK, 2005, NEURORADIOLOGY, V47, P229, DOI 10.1007/s00234-005-1350-3; Oksuzler YF, 2005, PEDIATR NEUROL, V32, P325, DOI 10.1016/j.pediatrneurol.2004.12.007; Oppenheim C, 2000, J NEUROL NEUROSUR PS, V69, P248, DOI 10.1136/jnnp.69.2.248; Patay Z, 2005, EUR RADIOL, V15, P2284, DOI 10.1007/s00330-005-2846-2; PECTASIDES M, 2004, 12 ANN INT SOC MAGN; PECTASIDES M, 2005, 48 ANN SOC PED RAD N; Roach E S, 2000, Semin Pediatr Neurol, V7, P244; Rollins N, 2004, AM J NEURORADIOL, V25, P1688; ROSS BD, 1994, RADIOLOGY, V193, P457, DOI 10.1148/radiology.193.2.7972763; Roychowdhury S, 2000, AM J NEURORADIOL, V21, P869; Sacher M, 2005, NEURORADIOLOGY, V47, P241, DOI 10.1007/s00234-004-1314-z; Scanderberg AC, 2000, AM J NEURORADIOL, V21, P862; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; Steen RG, 2003, RADIOLOGY, V228, P216, DOI 10.1148/radiol.2281020943; Szabo K, 2005, BRAIN, V128, P1369, DOI 10.1093/brain/awh454; Teixeira J, 2001, NEURORADIOLOGY, V43, P1031, DOI 10.1007/s002340100625; Thornton JS, 1998, MAGN RESON MED, V39, P920, DOI 10.1002/mrm.1910390609; Toft PB, 1996, J COMPUT ASSIST TOMO, V20, P1006, DOI 10.1097/00004728-199611000-00029; VALENTE RM, 1994, SEMIN NEUROL, V14, P380, DOI 10.1055/s-2008-1041098; Vella S, 2003, NEUROPEDIATRICS, V34, P100; Volpe JJ, 1997, BRAIN DEV-JPN, V19, P519, DOI 10.1016/S0387-7604(97)00078-8; Wang XY, 2003, NEURORADIOLOGY, V45, P640, DOI 10.1007/s00234-003-1029-6; Wong AM, 2004, AM J NEURORADIOL, V25, P1016; Yonemura K, 2001, AM J NEURORADIOL, V22, P269; Zarifi MK, 2002, RADIOLOGY, V225, P859, DOI 10.1148/radiol.2253011797	95	13	13	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1052-5149	1557-9867		NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	FEB	2006	16	1					45	+		10.1016/j.nic.2005.11.003			31	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	029DI	WOS:000236538200005	16543085				2022-02-06	
J	Stapert, S; Houx, P; De Kruijk, J; Ponds, R; Jolles, J				Stapert, S; Houx, P; De Kruijk, J; Ponds, R; Jolles, J			Neurocognitive fitness in the sub-acute stage after mild TBI: The effect of age	BRAIN INJURY			English	Article						mild TBI; age; brain reserve capacity; neurocognitive performance	TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURIES; SYMPTOMS; CONCUSSION; SEQUELAE	Objective: Age is assumed to be a negative prognostic factor in recovery from moderate-to-severe traumatic brain injury (TBI). Little is known on cognitive performance after mild TBI in relation to age in the sub-acute stage after injury. Method: Ninety-nine mild TBI subjects (age 15-75) were compared with 91 healthy control subjects (age 14-74) in a case-control design. Patients were matched on age, sex and level of education, with control subjects. Mean interval between injury and cognitive assessment was 13 days. Neurocognitive test battery contained tests of verbal memory, selective attention, general speed of information processing and verbal fluency. Results: An overall effect was found of a single mild TBI on neurocognitive performance in the sub-acute stage after injury. Age did not add significantly to the effect of mild TBI on cognitive functioning. Conclusion: Patients suffering from mild TBI are characterized by subtle neurocognitive deficits in the weeks directly following the trauma. The notion that elderly subjects have a worse outcome in the sub-acute period after mild TBI is at least not in line with the results of this study.	Maastricht Univ, Dept Psychol, Inst Brain & Behav, NL-6200 MD Maastricht, Netherlands; Univ Hosp, Dept Neurol, Maastricht, Netherlands; Maastricht Univ, Dept Psychiat & Neuropsychol, Inst Brain & Behav, NL-6200 MD Maastricht, Netherlands		Stapert, S (corresponding author), Maastricht Univ, Dept Psychol, Inst Brain & Behav, POB 616, NL-6200 MD Maastricht, Netherlands.	s.stapert@psychology.unimaas.nl		ponds, rudolf/0000-0002-9748-4659			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ALEXANDER MP, 1982, PSYCHIAT ASPECTS NEU, P219; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; BRAND N, 1985, J GEN PSYCHOL, V112, P201, DOI 10.1080/00221309.1985.9711004; FIELDS RB, 1994, TXB GERIATRIC NEUROP, P479; Fogel Barry S., 1994, P413; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; HOUX PJ, 1991, BRAIN COGNITION, V15, P246, DOI 10.1016/0278-2626(91)90029-8; Jennett B., 1982, NEUROLOGICAL DISORDE, P202; Jolles J., 1995, MAASTRICHT AGING STU; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Klein M, 1997, J CLIN EXP NEUROPSYC, V19, P77, DOI 10.1080/01688639708403838; Levin HS., 1982, NEUROBEHAVIORAL CONS; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Luteijn F., 1983, HANDLEIDING GRONINGE; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Miller JR, 1989, MILD MODERATE HEAD I, P125; MOULTON RJ, 1992, CAN J SURG, V35, P35; Rapoport MJ, 2001, BRAIN INJURY, V15, P857, DOI 10.1080/02699050110065303; REY A, 1964, EXAMEN PSYCHOL ENCEP; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Smith A., 1968, LEARN DISORD, V3, P83, DOI 10.1080/13803390591004428; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010	29	13	14	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2006	20	2					161	165		10.1080/02699050500442949			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	003KX	WOS:000234681700006	16421065				2022-02-06	
J	Bishop, CV; Drummond, KJ				Bishop, CV; Drummond, KJ			Rural neurotrauma in Australia: Implications for surgical training	ANZ JOURNAL OF SURGERY			English	Article						Australia; craniocerebral trauma; education; neurosurgical procedures; rural health services	PERIPHERAL NERVOUS SYSTEMS; ROAD TRAFFIC FATALITIES; NEW-SOUTH-WALES; I TRAUMA CENTER; HEAD-INJURY; MANAGEMENT; MORTALITY; EPIDEMIOLOGY; CRANIOTOMY; VICTORIA	Australia's vast size and small population preclude a neurosurgical service in most rural areas. Thus, general surgeons often initially manage rural neurotrauma. This study aimed to define the neurotrauma surgical caseload in rural Australia and to examine the level of training and confidence of rural surgeons for neurotrauma management. A questionnaire was sent to all Australian members of the Division of Rural Surgery of the Royal Australasian College of Surgeons. Responses were grouped by distance from a neurosurgical centre and analysed using one-way ANOVA. The response rate was 91%, and 161 rural surgeons were included. In total, 90 surgeons carried out approximately 600 procedures for neurotrauma in 5 years. The number of procedures per surgeon increased with distance from a neurosurgical centre (P < 0.0001), as did pretransport delays (P < 0.001). Combined pretransport and transport time was at least 2 h for 84% of surgeons. The majority (75% or more) of rural surgeons accessed hospitals with necessary basic infrastructure, including 24-h computed tomography scan, emergency department, and intensive care unit. There was no association between distance from a neurosurgical centre and level of neurosurgical training. Only 28% of rural surgeons had neurosurgery training more advanced than resident level. However, confidence with management of cranial trauma increased significantly with distance. More distant surgeons felt more confident with computed tomography reading (P = 0.02); burr hole (P = 0.02); craniotomy (P = 0.03) and intracranial pressure monitor insertion (P < 0.0001). A significant volume of neurotrauma is managed surgically in rural Australia as dictated by distance. However, neurotrauma training of rural surgeons has occurred on an ad hoc basis, with those most exposed and most distant developing some confidence. Evidence for specific adequate training is lacking, but this study suggests that it is necessary.	Royal Melbourne Hosp, Dept Neurosurg, Melbourne, Vic, Australia; Univ Melbourne, Dept Surg, Melbourne, Vic, Australia		Drummond, KJ (corresponding author), Royal Melbourne Hosp, Dept Neurosurg, Parkville, Vic 3050, Australia.	kjd@unimelb.edu.au					Atkinson L, 2001, WORLD J SURG, V25, P1224, DOI 10.1007/s00268-001-0086-4; *AUSTR MED WORKF A, 2000, NEUR WORKF AUSTR SUP; Cooper DJ, 1998, J TRAUMA, V45, P772, DOI 10.1097/00005373-199810000-00027; Cornwell EE, 2003, ARCH SURG-CHICAGO, V138, P838, DOI 10.1001/archsurg.138.8.838; Cowan JA, 2003, NEUROSURGERY, V52, P48, DOI 10.1097/00006123-200301000-00005; Green A, 2003, ANZ J SURG, V73, P232, DOI 10.1046/j.1445-1433.2003.02565.x; Kiroff G, 2003, ANZ J SURG, V73, P172, DOI 10.1046/j.1445-1433.2003.02593.x; Long DM, 2003, NEUROSURGERY, V52, P1056, DOI 10.1227/01.NEU.0000057745.48813.93; *NEUR SOC AUSTR, 2000, MAN AC NEUR RUR REM; Newcombe R, 1999, J CLIN NEUROSCI, V6, P85, DOI 10.1016/S0967-5868(99)90619-7; Pasquale MD, 2001, J TRAUMA, V50, P465, DOI 10.1097/00005373-200103000-00010; RING IT, 1986, AUST NZ J SURG, V56, P557, DOI 10.1111/j.1445-2197.1986.tb07099.x; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; Rosenfeld JV, 2000, J CLIN NEUROSCI, V7, P507, DOI 10.1054/jocn.1999.0694; *ROYAL AUSTR COLL, 2004, SURG ED TRAIN HDB, P67; SCHECTER WP, 1985, ARCH SURG-CHICAGO, V120, P1163; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SELECKI BR, 1982, AUST NZ J SURG, V52, P111, DOI 10.1111/j.1445-2197.1982.tb06081.x; SELECKI BR, 1982, AUST NZ J SURG, V52, P93, DOI 10.1111/j.1445-2197.1982.tb05297.x; SIMPSON D, 1984, AUST NZ J SURG, V54, P29, DOI 10.1111/j.1445-2197.1984.tb06681.x; Tulloh B, 2001, AUST NZ J SURG, V71, P215, DOI 10.1046/j.1440-1622.2001.02075.x; VANE DW, 1995, J TRAUMA, V38, P867, DOI 10.1097/00005373-199506000-00006; Wong K, 2004, ANZ J SURG, V74, P760, DOI 10.1111/j.1445-1433.2004.03138.x; WOODWARD A, 1984, MED J AUSTRALIA, V141, P13, DOI 10.5694/j.1326-5377.1984.tb132660.x	24	13	13	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1445-1433	1445-2197		ANZ J SURG	ANZ J. Surg.	JAN-FEB	2006	76	1-2					53	59		10.1111/j.1445-2197.2006.03642.x			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	011HI	WOS:000235258500012	16483297				2022-02-06	
J	Du, CJ; Ma, HS; Ruo, M; Zhang, ZJ; Yu, XJ; Zeng, YJ				Du, CJ; Ma, HS; Ruo, M; Zhang, ZJ; Yu, XJ; Zeng, YJ			An experimental study on the biomechanical properties of the cancellous bones of distal femur	BIO-MEDICAL MATERIALS AND ENGINEERING			English	Article						mechanical properties; cancellous bones; distal femur; biomechanics	MECHANICAL-PROPERTIES; MODEL	Objectives: To study the comprehensive biomechanical properties of the cancellous bone of distal femur through a series of mechanical tests, and provide relevant subjects with the basic technical data. Backgrounds: The study on bone mechanics is a commonly used approach to evaluate the biomechanical competency of bone. The biomechanical properties of bone have come to be the precondition of the further research of these relevant clinical subjects. Methods: In this paper, comprehensive items of mechanical properties of the cancellous bones of distal femur were conducted, and many valuable test results were obtained through a series of mechanical tests, which comprised tensile test, compression test, torsion test, shear test, bending test and impact test. The specimens were extracted from the normal corpses of Chinese donors died from acute head injury. As another key problem in this kind of experiment, the sampling and fixing method of cancellous bones specimens was developed and optimized in this research. Results: A series of the experimental data of mechanical properties of cancellous bones were obtained in the tests, these experimental data include tensile strength, compression strength, yield tensile strength, modulus of elasticity, torsion strength, shear strength, torsion modulus, bending strength, yield shear limit and impact toughness, which can reflect the complex mechanical competency of bone, being of great value and practice in clinic and further research on cancellous bones. The mechanical properties of the cancellous bones of distal femur were analyzed and discussed. Conclusions: The biomechanical properties of the cancellous bones have a close relationship with individual difference. Comprehensive items of the mechanical properties of the bone can evaluate the mechanical performance of the bone better, and can provide more valuable data to relevant research.	Beijing Univ Technol, Biomech & Med Informat Inst, Beijing 100022, Peoples R China; Jilin Univ, Changchun 130022, Peoples R China; Shantou Univ, Coll Med, Shantou 515031, Peoples R China		Zeng, YJ (corresponding author), Beijing Univ Technol, Biomech & Med Informat Inst, Beijing 100022, Peoples R China.	yjzeng@bjpu.edu.cn					ASHMAN RB, 1988, J BIOMECH, V21, P177, DOI 10.1016/0021-9290(88)90167-4; Bohatyrewicz A, 1999, FLUORIDE, V32, P47; BOYD SK, P N AM C BIOM 98; BROWN SJ, 2002, HLTH OSTEOARTHRITIS; Ding M, 2002, J BONE JOINT SURG BR, V84B, P900, DOI 10.1302/0301-620X.84B6.11994; Giesen EBW, 2001, J BIOMECH, V34, P799, DOI 10.1016/S0021-9290(01)00030-6; GILSON J, 1985, J BIOMECH, V18, P317; GOLDSTEIN SA, 1993, CALCIFIED TISSUE INT, V53, pS127, DOI 10.1007/BF01673421; GUO Y, 1999, CHINESE J BIOMEDICAL, V18, P250; Hogan HA, 2000, J BONE MINER RES, V15, P284, DOI 10.1359/jbmr.2000.15.2.284; KEAVENY TM, 1993, J BIOMECH ENG-T ASME, V115, P534, DOI 10.1115/1.2895536; Leung KS, 2001, J BONE MINER RES, V16, P2348, DOI 10.1359/jbmr.2001.16.12.2348; Lill CA, 2002, OSTEOPOROSIS INT, V13, P407, DOI 10.1007/s001980200047; MARTENS M, 1983, J BIOMECH, V16, P971, DOI 10.1016/0021-9290(83)90098-2; Matter HP, 2001, J BIOMED MATER RES, V55, P40, DOI 10.1002/1097-4636(200104)55:1<40::AID-JBM60>3.3.CO;2-Y; Orr TE, 2001, BIOMATERIALS, V22, P1953, DOI 10.1016/S0142-9612(00)00370-7; van der Linden JC, 2001, J BIOMECH, V34, P1573, DOI 10.1016/S0021-9290(01)00146-4; van der Linden JC, 2001, J BONE MINER RES, V16, P457, DOI 10.1359/jbmr.2001.16.3.457; van Loon C J, 1999, Acta Orthop Belg, V65, P154; VESTERBY A, 1993, BONE, V14, P193, DOI 10.1016/8756-3282(93)90140-6; Yeni YN, 2001, J BIOMECH, V34, P1649, DOI 10.1016/S0021-9290(01)00155-5	21	13	15	3	23	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0959-2989	1878-3619		BIO-MED MATER ENG	Bio-Med. Mater. Eng.		2006	16	3					215	222					8	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	016ZY	WOS:000235665100006	16518020				2022-02-06	
J	Verheyden, G; Hughes, J; Jelsma, J; Nieuwboer, A; De Weerdt, W				Verheyden, G.; Hughes, J.; Jelsma, J.; Nieuwboer, A.; De Weerdt, W.			ASSESSING MOTOR IMPAIRMENT OF THE TRUNK IN PATIENTS WITH TRAUMATIC BRAIN INJURY: RELIABILITY AND VALIDITY OF THE TRUNK IMPAIRMENT SCALE	SOUTH AFRICAN JOURNAL OF PHYSIOTHERAPY			English	Article						TRAUMATIC BRAIN INJURY; OUTCOME ASSESSMENT; REPRODUCIBILITY OF RESULTS		Introduction: Literature regarding trunk assessment after Traumatic Brain Injury (TBI) is limited. The Trunk Impairment Scale (TIS) is a newly developed tool which is intended to assess static and dynamic sitting balance and trunk co-ordination. Aim: It was the aim of this study to examine the reliability and validity of the TIS in TBI patients. Methods: Thirty TBI subjects were recruited from within a rehabilitation setting. Two researchers observed each subject simultaneously, but scored independently. Each subject was re-examined by one of the raters. Results: Kappa and weighted kappa values for all items ranged from 0.34 to 1. All percentages of agreement were 70% or higher. Intraclass correlation (ICC) coefficients for the sub-scale scores were between 0.72 and 0.88. Test-retest and inter-rater reliability for the total TIS score (ICC) was 0.88 and 0.95, respectively. The 95% limits of agreement for the test-retest and interexaminer measurement error interval were -4,4 and -3,3, respectively. The construct validity was evaluated by means of the Spearman rank correlation coefficient between the TIS and the Barthel Index (r=0.59, p=.0007). Discussion and conclusion: Fair to perfect item agreement was found but the reliability of certain items requires further attention. Acceptable sub-scale and total TIS reliability and validity justify the use of the TIS in TBI treatment and research.	[Verheyden, G.; Nieuwboer, A.; De Weerdt, W.] Katholieke Univ Leuven, Dept Rehabil Sci, Tervuursevest 101, B-3001 Leuven, Belgium; [Hughes, J.; Jelsma, J.] Univ Cape Town, Div Physiotherapy, Cape Town, South Africa		Verheyden, G (corresponding author), Katholieke Univ Leuven, Dept Rehabil Sci, Tervuursevest 101, B-3001 Leuven, Belgium.	Geert.Verheyden@faber.kuleuven.be					Black K, 2000, BRAIN INJURY, V14, P141, DOI 10.1080/026990500120808; Choy NL, 2002, AUST J PHYSIOTHER, V48, P35, DOI 10.1016/S0004-9514(14)60280-4; Collin C, 1988, Int Disabil Stud, V10, P61; Davies P.M., 1990, RIGHT MIDDLE, P31, DOI DOI 10.1007/978-3-642-61502-3_4; Davies PM, 1994, STARTING EARLY REHAB, P391; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; HAAS M, 1991, J MANIP PHYSIOL THER, V14, P119; Hinkle DE, 1988, APPL STAT BEHAV SCI, pp117; KATZ JN, 1992, MED CARE, V30, P917, DOI 10.1097/00005650-199210000-00004; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mazaux JM, 2001, J REHABIL MED, V33, P99; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Quinn B, 2000, BRAIN INJURY, V14, P1063; Reed AR, 2002, SAMJ S AFR MED J, V92, P221; Sohlberg MM, 1989, INTRO COGNITIVE REHA, P93; Verheyden G, 2004, CLIN REHABIL, V18, P326, DOI 10.1191/0269215504cr733oa; Wade DT, 1992, MEASUREMENT NEUROLOG, P37	17	13	13	0	0	AOSIS	CAPE TOWN	POSTNET SUITE 55, PRIVATE BAG X22, TYGERVALLEY, CAPE TOWN, 00000, SOUTH AFRICA	0379-6175	2410-8219		SOUTH AFR J PHYSIOTH	South Afr. J. Physiother.		2006	62	2					23	27					5	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V8J7M	WOS:000421698900005		gold, Green Submitted			2022-02-06	
J	Zhu, Q; Prange, M; Margulies, S				Zhu, Qiliang; Prange, Michael; Margulies, Susan			Predicting unconsciousness from a pediatric brain injury threshold	DEVELOPMENTAL NEUROSCIENCE			English	Article						pediatric traumatic brain injury; biomechanics; axonal injury; tissue injury threshold; finite element analysis	DIFFUSE AXONAL INJURY; CLOSED-HEAD INJURY; DAMAGE; MODEL; COMA	The objective of this study was to utilize tissue deformation thresholds associated with acute axonal injury in the immature brain to predict the duration of unconsciousness. Ten anesthetized 3- to 5-day-old piglets were subjected to non-impact axial rotations (110-260 rad/s) producing graded injury, with periods of unconsciousness from 0 to 80 min. Coronal sections of the perfusion-fixed brain were immunostained with neurofilament antibody (NF-68) and examined microscopically to identify regions of swollen axons and terminal retraction balls. Each experiment was simulated with a finite element computational model of the piglet brain and the recorded head velocity traces to estimate the local tissue deformation (strain), the strain rate and their product. Using thresholds associated with 50, 80 and 90% probability of axonal injury, white matter regions experiencing suprathreshold responses were determined and expressed as a fraction of the total white matter volume. These volume fractions were then correlated with the duration of unconsciousness, assuming a linear relationship. The thresholds for 80 and 90% probability of predicting injury were found to correlate better with injury severity than those for 50%, and the product of strain and strain rate was the best predictor of injury severity (p = 0.02). Predictive capacity of the linear relationship was confirmed with additional (n = 13) animal experiments. We conclude that the suprathreshold injured volume can provide a satisfactory prediction of injury severity in the immature brain. Copyright (c) 2006 S. Karger AG, Basel.	Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA		Margulies, S (corresponding author), Univ Penn, Dept Bioengn, 3320 Smith Walk, Philadelphia, PA 19104 USA.	margulies@seas.upenn.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS39679] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49-CCR312712] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039679] Funding Source: NIH RePORTER		Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bandak F.A., 1994, STAPP CAR CRASH C SO, V38, P145; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; DUHAIME AC, 1992, PEDIATRICS, V90, P179; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Gennarelli TA, 1996, NEUROPATH APPL NEURO, V22, P509, DOI 10.1111/j.1365-2990.1996.tb01126.x; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GOSCH HH, 1970, J TRAUM, V10, P370, DOI 10.1097/00005373-197005000-00002; GURDJIAN ES, 1968, J NEUROSURG, V29, P70, DOI 10.3171/jns.1968.29.1.0070; Hardy W N, 2001, Stapp Car Crash J, V45, P337; HODGSON VR, 1966, J NEUROSURG, V25, P549, DOI 10.3171/jns.1966.25.5.0549; Ikonomidou C, 1996, METAB BRAIN DIS, V11, P125, DOI 10.1007/BF02069500; King A. I., 2003, IRCOBI C LISB PORT; LANGLOIS L, 2004, TRAUMATIC BRAIN INJU; LAU IV, 1986, P 30 STAPP CAR CRASH, P123; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LUERSSEN T, 1993, PEDIAT TRAUMA; LUERSSEN TG, 1991, CONC PED N, V11, P87; Lusardi TA, 2003, BIORHEOLOGY, V40, P401; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; MARGULIES SS, 1999, COMP DIFFUSE BRAIN I; McElhaney JH, 1976, HDB HUMAN TOLERANCE; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; NEWMAN J, 1975, STAPP CAR CRASH C P, V19, P615; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PRANGE M, 1999, 43 STAPP CAR CRASH C; PRANGE M, 2002, BIOMECHANICS TRAUMAT; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; WANG JT, 1989, J BIOMECH ENG-T ASME, V111, P128, DOI 10.1115/1.3168353; YOSHIKAWA T, 1968, ATLAS BRAINS DOMESTI, P1	41	13	13	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2006	28	4-5					388	395		10.1159/000094165			8	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	080ZS	WOS:000240287600016	16943662				2022-02-06	
J	[Anonymous]				[Anonymous]			Concussion (mild traumatic brain injury) and the team physician: A consensus statement	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article																	*AM COLL SPORTS ME, 2001, MED SCI SPORTS EXERC, V33, P846; Herring SA, 2002, MED SCI SPORT EXER, V34, P1212	2	13	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	NOV	2005	37	11					2012	2015		10.1249/01.mss.0000186726.18341.70			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	986LL	WOS:000233451000026	16286874				2022-02-06	
J	Krismer, AC; Wenzel, V; Lindner, KH; Haslinger, CW; Oroszy, S; Stadlbauer, KH; Konigsrainer, A; Boville, B; Hormann, C				Krismer, AC; Wenzel, V; Lindner, KH; Haslinger, CW; Oroszy, S; Stadlbauer, KH; Konigsrainer, A; Boville, B; Hormann, C			Influence of positive end-expiratory pressure ventilation on survival during severe hemorrhagic shock	ANNALS OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	76th Annual Scientific Session of the American-Heart-Association	NOV 07-12, 2003	ORLANDO, FL	Amer Heart Assoc			SEVERE HEAD-INJURY; TRAUMATIC BRAIN-INJURY; ENDOTRACHEAL INTUBATION; CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; FIELD; PEEP	Study objective: Although a moderate positive end-expiratory pressure (PEEP) level is widely recommended, it is unknown whether moderate PEEP during mechanical ventilation has adverse effects during severe hemorrhagic shock. Therefore, the purpose of our study was to evaluate the effects of O cm H2O PEEP versus 5 cm H2O PEEP versus 10 cm H2O PEEP on short-term survival in a porcine model of severe hemorrhagic shock. Secondary study endpoints were hemodynamic variables and blood gases. Methods: Twenty-four anesthetized pigs were bled approximately 45 mL/kg, randomized into 3 groups, and then ventilated with 0, 5, or 10 cm H2O PEEP. Survival rates were compared using Kaplan-Meier methods with log rank (Mantel Cox) comparison of cumulative survival by treatment group. Results: Seven of 8 O cm H2O PEEP animals survived the 120-minute study period, but 8 of 8 5 cm H2O PEEP animals died within 30 minutes, and 8 of 8 10 cm H2O PEEP animals were dead within 20 minutes (P<.0001). Ventilation with O cm H2O PEEP prevented a further reduction of mean arterial blood pressure and cardiac output. When compared with the O cm H2O PEEP group, end-tidal CO2 declined in the 5 cm H2O PEEP and 10 cm H2O PEEP animals. Compared with the O cm H2O PEEP animals, those ventilated with 5 or 10 cm H2O PEEP had higher lactate levels after 10 minutes. Conclusion: When compared with pigs ventilated with either 5 or 10 cm H2O PEEP, those ventilated with O cm H2O PEEP during untreated, severe hemorrhagic shock had significantly improved short-term survival.	Innsbruck Med Univ, Dept Anesthesiol & Crit Care Med, A-6020 Innsbruck, Austria; Innsbruck Med Univ, Dept Surg, A-6020 Innsbruck, Austria; Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA		Krismer, AC (corresponding author), Innsbruck Med Univ, Dept Anesthesiol & Crit Care Med, Anichstr 35, A-6020 Innsbruck, Austria.	anette.krismer@uibk.ac.at					Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Brown LH, 1996, AM J EMERG MED, V14, P43, DOI 10.1016/S0735-6757(96)90012-1; DAMMANN JF, 1979, CRIT CARE MED, V7, P14, DOI 10.1097/00003246-197901000-00004; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Falk J L, 1999, Prehosp Emerg Care, V3, P273, DOI 10.1080/10903129908958953; Falke KJ, 2003, INTENS CARE MED, V29, P1233, DOI 10.1007/s00134-003-1832-x; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; HANNON JP, 1990, LAB ANIM SCI, V40, P293; HEINRICHS W, 1992, ANAESTHESIST, V41, P653; Helm M, 2003, BRIT J ANAESTH, V90, P327, DOI 10.1093/bja/aeg069; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; Jellinek H, 2000, CRIT CARE MED, V28, P672, DOI 10.1097/00003246-200003000-00012; MCSWAIN NE, 2003, PHTLS BASIC ADV PREH; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; PEPE PE, 1993, ANN EMERG MED, V22, P393, DOI 10.1016/S0196-0644(05)80470-6; PUTENSEN C, 1994, CRIT CARE MED, V22, P67, DOI 10.1097/00003246-199401000-00015; Roberts I, 2001, LANCET, V357, P385, DOI 10.1016/S0140-6736(00)03653-9; ROSEMURGY AS, 1993, J TRAUMA, V35, P468, DOI 10.1097/00005373-199309000-00022; Trupka A, 1994, Eur J Emerg Med, V1, P1, DOI 10.1097/00063110-199403000-00002; Wenzel V, 2000, COMPARATIVE MED, V50, P644; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	22	13	13	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	OCT	2005	46	4					337	342		10.1016/j.annemergmed.2005.02.022			6	Emergency Medicine	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	972CC	WOS:000232430500008	16187467				2022-02-06	
J	Lind, CRP; Heppner, PA; Robins, TM; Mee, EW				Lind, CRP; Heppner, PA; Robins, TM; Mee, EW			Transfer of intubated patients with traumatic brain injury to Auckland City Hospital	ANZ JOURNAL OF SURGERY			English	Article						intracranial haematoma; neurosurgery; patient transfer; traumatic brain injury; triage	ACUTE SUBDURAL-HEMATOMA; SPECIALIST RETRIEVAL TEAM; EXTRADURAL HEMATOMA; EPIDURAL HEMATOMAS; COMATOSE PATIENTS; TRANSPORT; CARE; MANAGEMENT; HEMORRHAGE; REDUCTION	Background: Delays in patient transfer to definitive neurosurgical care after traumatic brain injury are important in determining neurological outcome. The efficiency of interhospital transfer of patients to Auckland City Hospital (ACH) was analysed and compared with international standards. Methods: The ACH Department of Critical Care Medicine database for the year 2002 was reviewed, with supplementary information obtained from transfer organizations, hospital notes, radiology archives. and operative loghooks, Results: Thirty-four adult patients with traumatic brain injury and no special reasons for delayed transfer were transported intubated from other hospitals in the North Island of New Zealand. The median time from injury to arrival it ACH was 6.5 h. It took a median 4.4 h for patients to get from initial computed tornographic imaging to ACH, For those requiring evacuation of haematomas, the mean time from arrival at ACH to the start of the operation was 1.4 h. Only 33% of patients from other metropolitan Auckland hospitals, and none from hospitals outside the city arrived within 4 h from the time of injury. Conclusion: Transfer times for brain trauma patients are currently longer than recommended for optimal neurological outcome. Referring hospitals and transfer organizations should review their systems to identify areas for improvement. Direct admission to theatre needs to be expedited within ACH when required. Triage of all trauma patients in metropolitan Auckland with it Glasgow Coma Scale score of less than 14 to ACH would be likely to improve time to treatment. A mobile acute neurosurgical service based in Auckland that would support general surgeons initiating acute decompressive cranial operations would be likely to reduce time to surgery and improve outcomes for patients admitted to hospitals outside Auckland, The development ofa mobile acute neurosurgery service which would complete decompressive procedures started by general surgeons would likely improve trauma outcomes for patients injured outside Auckland.	Auckland City Hosp, Dept Neurosurg, Auckland, New Zealand		Heppner, PA (corresponding author), Auckland City Hosp, Dept Neurosurg, Auckland, New Zealand.	peterheppner@hotmail.com	Lind, Christopher/K-3629-2012	Lind, Christopher/0000-0001-9991-1725			American College of Surgeons Committee on Trauma, 1997, ADV TRAUM LIF SUPP D; Bartlett J, 1998, BRIT J NEUROSURG, V12, P349, DOI 10.1080/02688699844871; Beddingfield FC, 1996, PEDIATR EMERG CARE, V12, P416, DOI 10.1097/00006565-199612000-00007; Bellingan G, 2000, INTENS CARE MED, V26, P740; Brain Trauma Foundation, SURG MAN TRAUM BRAIN; Civil I, 2003, INJURY, V34, P740, DOI 10.1016/j.injury.2003.08.013; CIVIL ID, 2004, NZ MED J, V117, P1042; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Gilligan JE, 1999, MED J AUSTRALIA, V171, P617, DOI 10.5694/j.1326-5377.1999.tb123822.x; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; HAVILL JH, 1995, NEW ZEAL MED J, V108, P378; Holmen CD, 2002, J TRAUMA, V53, P345, DOI 10.1097/00005373-200208000-00026; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marsh H, 1989, Br J Neurosurg, V3, P13, DOI 10.3109/02688698909001021; MENDELOW AD, 1979, BRIT MED J, V2, P134, DOI 10.1136/bmj.2.6182.134-a; *NEUR SOC AUSTR TR, 2000, MAN AC NEUR RUR REM; POON WS, 1991, INJURY, V22, P323, DOI 10.1016/0020-1383(91)90016-8; *ROYAL AUSTR COLL, 1994, GUID STRUCT APPR PRO; Schoettker P, 2003, INJURY, V34, P187, DOI 10.1016/S0020-1383(02)00280-2; *SCOTT INT GUID NE, 2000, SCOTT INT GUID NETW; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SIMPSON DA, 1988, INJURY, V19, P307, DOI 10.1016/0020-1383(88)90100-3; Vos GD, 2004, INTENS CARE MED, V30, P302, DOI 10.1007/s00134-003-2066-7; Wester K, 1999, NEUROSURGERY, V44, P495, DOI 10.1097/00006123-199903000-00034; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Young JS, 1998, AM SURGEON, V64, P88	28	13	13	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1445-1433	1445-2197		ANZ J SURG	ANZ J. Surg.	OCT	2005	75	10					858	862		10.1111/j.1445-2197.2005.03574.x			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	987RV	WOS:000233535900006	16176225				2022-02-06	
J	March, K				March, Karen			Intracranial Pressure Monitoring Why Monitor?	AACN ADVANCED CRITICAL CARE			English	Article						accuracy; complications; drift; infections; hemorrhage; intracranial pressure	TRAUMATIC BRAIN-INJURY; FULMINANT HEPATIC-FAILURE; VENTRICULOSTOMY-RELATED INFECTIONS; CLINICAL-EVALUATION; HEAD-INJURY; ANTIBIOTIC-PROPHYLAXIS; NEUROSURGICAL PATIENTS; CEREBROSPINAL-FLUID; CEREBRAL PERFUSION; CODMAN MICROSENSOR	Evidence suggests that the mortality and morbidity of acquired brain injury could be reduced if clinicians used an aggressive intracranial pressure guided approach to care. Despite nearly 50 years of evidence that intracranial pressure monitoring benefits patient care, only about half of the patients who could benefit are monitored. Some clinicians express concerns regarding risks such as bleeding, infections, and inaccuracy of the technology. Others cite cost as the reason. This article discusses the risks and benefits of intracranial pressure monitoring and the current state of evidence of why patients should be monitored.	[March, Karen] Integra NeuroSci, Dept Clin Dev, Plainsboro, NJ USA; [March, Karen] Univ Washington, Sch Biobehav Nursing, Seattle, WA 98195 USA		March, K (corresponding author), 929 232nd Lane NE, Sammamish, WA 98074 USA.	Ksmarch@aol.com					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; ADInstruments, 670 DIAP BP TRANSD S; Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; Attia J., 2003, AUST PRESCR, V26, P111, DOI DOI 10.18773/AUSTPRESCR.2003.082; BADER MK, 1995, HEART LUNG, V24, P166, DOI 10.1016/S0147-9563(05)80012-3; Banister K, 2000, PHYSIOL MEAS, V21, P473, DOI 10.1088/0967-3334/21/4/304; Bavetta S, 1997, J NEUROSURG, V86, P927, DOI 10.3171/jns.1997.86.6.0927; Blaha M, 2003, PEDIATR NEUROSURG, V39, P27, DOI 10.1159/000070877; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; BLEI AT, 1993, LANCET, V341, P157, DOI 10.1016/0140-6736(93)90016-A; Bochicchio M, 1996, INTENS CARE MED, V22, P1070, DOI 10.1007/BF01699230; Brisnaire D, 1997, J NEUROSCI NURS, V29, P261; BRUDER N, 1995, INTENS CARE MED, V21, P850, DOI 10.1007/BF01700971; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CHAMBERS IR, 1993, NEUROSURGERY, V33, P866; CLARK WC, 1989, NEUROSURGERY, V25, P20; CRUTCHFIELD JS, 1990, J NEUROSURG, V72, P482, DOI 10.3171/jns.1990.72.3.0482; D'Ambrosio AL, 2002, SURG NEUROL, V58, P295, DOI 10.1016/S0090-3019(02)00817-0; Darovic G, 2002, HEMODYNAMIC MONITORI, P111; Davis JW, 2004, J TRAUMA, V57, P1173, DOI 10.1097/01.TA.0000151257.79108.FB; Detry O, 1999, TRANSPLANTATION, V67, P767, DOI 10.1097/00007890-199903150-00024; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Fernandes HM, 1998, ACT NEUR S, V71, P44; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; FRIEDMAN WA, 1980, J NEUROSURG, V53, P662, DOI 10.3171/jns.1980.53.5.0662; GAMBARDELLA G, 1992, NEUROSURGERY, V31, P918, DOI 10.1227/00006123-199211000-00014; Gardner RM, 1996, CRIT CARE MED, V24, P879, DOI 10.1097/00003246-199605000-00025; GOPINATH SP, 1993, J NEUROSCI METH, V49, P11, DOI 10.1016/0165-0270(93)90104-Y; Guyot LL, 1998, ACT NEUR S, V71, P47; Hader WJ, 2000, NEUROSURGERY, V46, P1149, DOI 10.1097/00006123-200005000-00025; Harris CH, 2002, AM SURGEON, V68, P787; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; Holzschuh M, 1998, BRAIN INJURY, V12, P191, DOI 10.1080/026990598122665; Hugo Sachs Elektronik-Harvard Apparatus, TRANSD HEM MEAS; Integra Neuroscience, CAM DIR US; Integra Neuroscience, VENTR DIR US; JENNETT B, 1975, LANCET, V1, P480; Jensen RL, 1997, SURG NEUROL, V47, P16, DOI 10.1016/S0090-3019(96)00276-5; Johnson and Johnson, CODMAN DIRECTIONS US; Kaups KL, 1998, J TRAUMA, V45, P884, DOI 10.1097/00005373-199811000-00007; Kerr ME, 2000, J NEUROSURG ANESTH, V12, P324, DOI 10.1097/00008506-200010000-00005; KERR ME, 2001, NEUROSURG FOCUS, V11, P1; Khan SH, 1998, ACT NEUR S, V71, P50; KHANNA RK, 1995, J NEUROSURG, V83, P791, DOI 10.3171/jns.1995.83.5.0791; KIM DK, 1995, J NEUROL NEUROSUR PS, V58, P444, DOI 10.1136/jnnp.58.4.444; Kirkness C, 2004, AANN CORE CURRICULUM; Ko K, 2003, J TRAUMA, V55, P480, DOI 10.1097/01.TA.0000074111.04885.28; Lang JM, 2003, NEUROSURGERY, V52, P1455, DOI 10.1227/01.NEU.0000065136.70455.6F; Lieberman DM, 2002, J TRAUMA, V52, P172, DOI 10.1097/00005373-200201000-00032; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Lyke KE, 2001, CLIN INFECT DIS, V33, P2028, DOI 10.1086/324492; Maitinez-Manas RM, 2000, J NEUROL NEUROSUR PS, V69, P82, DOI 10.1136/jnnp.69.1.82; March K, 2004, AANN CORE CURRICULUM; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; MILLER JD, 1986, NEUROSURGERY, V19, P253, DOI 10.1227/00006123-198608000-00012; Morgalla MH, 1999, J MED ENG TECHNOL, V23, P144; Morgalla MH, 1999, J MED ENG TECHNOL, V23, P10, DOI 10.1080/030919099294375; Munch E, 1998, ACTA NEUROCHIR, V140, P1113, DOI 10.1007/s007010050224; Narayan R, 1987, AM ASS NEUR SURG MAY; North B, HEAD INJURY; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Park P, 2004, NEUROSURGERY, V55, P594, DOI 10.1227/01.NEU.0000134289.04500.EE; Piper I, 2001, NEUROSURGERY, V49, P1158, DOI 10.1097/00006123-200111000-00026; Poca MA, 2002, J NEUROTRAUM, V19, P439, DOI 10.1089/08977150252932398; Poon WS, 1998, ACT NEUR S, V71, P146; POPLE IK, 1995, PEDIATR NEUROSURG, V23, P64, DOI 10.1159/000120938; Prabhu VC, 1999, SURG NEUROL, V52, P226, DOI 10.1016/S0090-3019(99)00084-1; Rebuck JA, 2000, J NEUROL NEUROSUR PS, V69, P381, DOI 10.1136/jnnp.69.3.381; Rehau Company, NEUR REH DIR US; Rice W P, 2000, Crit Care Nurse, V20, P22; Rossi S, 1998, ACT NEUR S, V71, P91; Ruchholtz S, 1998, J TRAUMA, V45, P505, DOI 10.1097/00005373-199809000-00013; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; SAUNDERS RL, 1979, CRIT CARE MED, V7, P556, DOI 10.1097/00003246-197912000-00010; SCHICKNER DJ, 1992, SURG NEUROL, V37, P251, DOI 10.1016/0090-3019(92)90147-F; Schultz M, 1993, J Neurosci Nurs, V25, P158; Schurer L, 1997, ACT NEUR S, V70, P296; Shapiro S, 1996, SURG NEUROL, V45, P278, DOI 10.1016/0090-3019(95)00359-2; Signorini DF, 1998, BRIT J NEUROSURG, V12, P223; Slavin KV, 2003, NEUROL RES, V25, P880, DOI 10.1179/016164103771954014; Stangl AP, 1998, SURG NEUROL, V50, P77, DOI 10.1016/S0090-3019(97)00301-7; STENAGER E, 1986, ACTA NEUROCHIR, V83, P20, DOI 10.1007/BF01420503; TAYLOR WAS, 1992, ACTA NEUROCHIR, V117, P1, DOI 10.1007/BF01400627; Tofteng F, 2004, J CEREBR BLOOD F MET, V24, P798, DOI 10.1097/01.WCB.0000125648.03213.1D; Tofteng F, 2002, HEPATOLOGY, V36, P1333, DOI 10.1053/jhep.2002.36944; Utah Medical Products Ltd, DEXTR TRANSD; Valentin A, 2003, CRIT CARE MED, V31, P1539, DOI 10.1097/01.CCM.0000065270.53951.9E; Walter H, 2000, NEUROSURGERY, V46, P1149; WEINSTABL C, 1992, J CLIN MONITOR, V8, P116, DOI 10.1007/BF01617429; WINFIELD JA, 1993, NEUROSURGERY, V33, P424; Wolfla CE, 1996, J NEUROSURG, V84, P642, DOI 10.3171/jns.1996.84.4.0642; YABLON JS, 1993, J CLIN MONITOR, V9, P171, DOI 10.1007/BF01617024; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661; Zingale A, 1999, J Neurosurg Sci, V43, P125	99	13	16	1	1	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1559-7768	1559-7776		AACN ADV CRIT CARE	AACN Adv. Crit. Care	OCT-DEC	2005	16	4					456	475		10.1097/00044067-200510000-00004			20	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	VF0BG	WOS:000441621700004	16269892				2022-02-06	
J	Keel, M; Mica, L; Stover, J; Stocker, R; Trentz, O; Harter, L				Keel, M; Mica, L; Stover, J; Stocker, R; Trentz, O; Harter, L			Thiopental-induced apoptosis in lymphocytes is independent of CD95 activation	ANESTHESIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; DRUG-INDUCED APOPTOSIS; APO-1/FAS RECEPTOR/LIGAND SYSTEM; SEVERE HEAD-INJURY; CELL-DEATH; KAPPA-B; NEUTROPHIL APOPTOSIS; CEREBROSPINAL-FLUID; LEUKEMIA-CELLS; NUCLEAR-FACTOR	Background. Barbiturate coma is used in patients with traumatic brain injury whenever increases in intracranial pressure remain unresponsive to less aggressive therapeutic regimens. However, barbiturate-mediated neuroprotection correlates with lymphopenia, which increases the risk of infection. The mechanisms by which barbiturates lead to lymphopenia remain to be determined. Methods: Freshly isolated human lymphocytes and Jurkat cells were incubated with the barbiturate thiopental for 24 and 48 h. Apoptosis was measured by fluorescein isothiocyanate-Annexin and propidium iodide staining, rhodamine 123 staining, and the terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling method. Caspase-3 activity was detected by Western blot and substrate cleavage assay. Results: Thiopental dose-dependently (5-500 mu g/ml) increased apoptosis in Jurkat cells from basal levels (4.4 +/- 1.9%) to 29.7 +/- 2.8% after 24 h and 39.7 +/- 3.2% after 48 h, whereas in lymphocytes, thiopental-induced necrosis was observed. Parallel to apoptosis, thiopental dose-dependently increased caspase-3-like activity in Jurkat cells. However, the pan-caspase inhibitor z-VAD-fmk (20 mu m) only marginally reduced thiopental-induced (250 mu g/ml) apoptosis in Jurkat cells (20.2 +/- 2.5 to 17.2 +/- 2.5%) and necrosis in lymphocytes (39.2 +/- 7.5 to 30.7 +/- 14%). In contrast, anti-CD95-induced apoptosis in Jurkat cells (27.0 +/- 2.0%) was completely blocked by z-VAD-fmk (8.1 +/- 1.8%). Neither expression of CD95 on Jurkat cells nor pretreatment with a neutralizing anti-CD95 antibody influenced thiopental-induced apoptosis, indicating that thiopental induces apoptosis independently of the CD95 system. The nuclear factor kappa B inhibitor gliotoxin accelerated both thiopental- and CD95-mediated apoptosis, indicating a mutual control mechanism of thiopental- and CD95-induced apoptosis. Conclusions: Thiopental directly induces cell death in lymphocytes and Jurkat cells by a CD95-independent mechanism.	Univ Zurich Hosp, Div Trauma Surg, Dept Surg, CH-8091 Zurich, Switzerland		Keel, M (corresponding author), Univ Zurich Hosp, Div Trauma Surg, Dept Surg, Raemisstr 100, CH-8091 Zurich, Switzerland.	marius.keel@usz.ch					Borner C, 1999, CELL DEATH DIFFER, V6, P497, DOI 10.1038/sj.cdd.4400525; Cohen JJ, 1999, J ALLERGY CLIN IMMUN, V103, P548, DOI 10.1016/S0091-6749(99)70222-8; Deiss LP, 1996, EMBO J, V15, P3861, DOI 10.1002/j.1460-2075.1996.tb00760.x; Delogu G, 2004, J CLIN ANESTH, V16, P189, DOI 10.1016/j.jclinane.2003.07.007; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; DONEGAN JH, 1985, AM J PHYSIOL, V249, pH421, DOI 10.1152/ajpheart.1985.249.2.H421; Ertel W, 1997, J NEUROIMMUNOL, V80, P93, DOI 10.1016/S0165-5728(97)00139-2; Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2; Grimm L M, 1999, Results Probl Cell Differ, V23, P209; Harter L, 2001, J NEUROIMMUNOL, V121, P76, DOI 10.1016/S0165-5728(01)00409-X; Harter L, 2001, J TRAUMA, V50, P982; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Humar M, 2004, J PHARMACOL EXP THER, V311, P1232, DOI 10.1124/jpet.104.071332; Humar M, 2004, MOL PHARMACOL, V65, P350, DOI 10.1124/mol.65.2.350; Jaattela M, 2003, NAT IMMUNOL, V4, P416, DOI 10.1038/ni0503-416; Keel M, 1997, BLOOD, V90, P3356, DOI 10.1182/blood.V90.9.3356; Loop T, 2003, ANESTHESIOLOGY, V99, P360, DOI 10.1097/00000542-200308000-00017; MICHENFE.JD, 1974, ANESTHESIOLOGY, V41, P231, DOI 10.1097/00000542-197409000-00004; MILLER JD, 1971, BRAIN RES, V34, P411; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Nair MPN, 1997, CLIN DIAGN LAB IMMUN, V4, P127, DOI 10.1128/CDLI.4.2.127-132.1997; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; NEUWELT EA, 1982, J NEUROSURG, V56, P254, DOI 10.3171/jns.1982.56.2.0254; Oka M, 1996, ANN SURG, V223, P434, DOI 10.1097/00000658-199604000-00013; PAHL HL, 1999, ONCOGENE, V189, P321; Rathmell JC, 1999, ANNU REV IMMUNOL, V17, P781, DOI 10.1146/annurev.immunol.17.1.781; Roberts Lewis R., 1999, Cell Biochemistry and Biophysics, V30, P71, DOI 10.1007/BF02737885; SATO M, 1989, RESUSCITATION, V17, P233, DOI 10.1016/0300-9572(89)90039-7; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; SMETS LA, 1994, ANTI-CANCER DRUG, V5, P3, DOI 10.1097/00001813-199402000-00001; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; Stover JF, 1998, EUR J CLIN PHARMACOL, V54, P529, DOI 10.1007/s002280050508; Stover JF, 1998, EUR NEUROL, V39, P223, DOI 10.1159/000007938; Thornberry NA, 1998, CHEM BIOL, V5, pR97, DOI 10.1016/S1074-5521(98)90615-9; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Vermes I, 1997, ACTA HAEMATOL-BASEL, V98, P8; Villunger A, 1997, CANCER RES, V57, P3331; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Ward C, 1999, J BIOL CHEM, V274, P4309, DOI 10.1074/jbc.274.7.4309; Wolf BB, 1999, BLOOD, V94, P1683, DOI 10.1182/blood.V94.5.1683.417k37_1683_1692; Xie HJ, 1997, MOL IMMUNOL, V34, P987, DOI 10.1016/S0161-5890(97)00128-4; Yin DL, 1999, NATURE, V397, P218, DOI 10.1038/16612; Yin DL, 2000, J EXP MED, V191, P1423, DOI 10.1084/jem.191.8.1423	47	13	14	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	SEP	2005	103	3					576	584		10.1097/00000542-200509000-00021			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	960EZ	WOS:000231574300019	16129983	Green Accepted			2022-02-06	
J	Schuster, R; Waxman, K				Schuster, R; Waxman, K			Is repeated head computed tomography necessary for traumatic intracranial hemorrhage?	AMERICAN SURGEON			English	Article; Proceedings Paper	Annual Meeting of the Southern California Chapter of the American-College-of-Surgeons	JAN 21-23, 2005	Santa Barbara, CA	Amer Coll Surg, So Calif Chapter			BRAIN-INJURY; MANAGEMENT	This study was performed to determine the need for repeat head computed tomography (CT) in patients with blunt traumatic intracranial hemorrhage (ICH) who were initially treated nonoperatively and to determine which factors predicted observation failure or success. A total of 1,462 patients were admitted to our level 11 trauma center for treatment of head injury. Seventeen per cent (255/1,462) were diagnosed with ICH on initial head CT. Craniotomy was initially performed in 15.7 per cent (40/255) of patients with ICH. Two hundred sixteen patients with ICH were initially observed. Ninety-seven per cent (179/184) of observed patients with ICH and repeat head CT never underwent a craniotomy, 2.7 per cent (5/184) of patients with ICH initially observed underwent craniotomy after repeat head CT, and four patients (80%) had deteriorating neurologic status. Multivariate analysis revealed the following significant admission risk factors were associated with a need for repeat head CT indicating the need for craniotomy: treatment with anticoagulation and/or antiplatelet medications, elevated prothrombin time (PT), and age greater than 70 years. In patients with blunt traumatic intracranial hemorrhage initially observed, there is little utility of repeated head CT in the absence of deteriorating neurologic status. The only admission risk factors for a repeat CT indicating the need for craniotomy were advanced age and coagulopathy.	Santa Barbara Cottage Hosp, Dept Surg Educ, Santa Barbara, CA 93102 USA		Waxman, K (corresponding author), Santa Barbara Cottage Hosp, Dept Surg Educ, POB 689, Santa Barbara, CA 93102 USA.						Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; COOPER PR, 1979, NEUROSURGERY, V5, P566, DOI 10.1227/00006123-197911000-00004; *COTT HOSP RAD DEP, 2004, 2004 HOSP CHARG COMP; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Valadka A, 2000, TRAUMA, P377	12	13	13	0	0	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	SEP	2005	71	9			SI		701	704					4	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	969NP	WOS:000232241300001	16468501				2022-02-06	
J	Ashwal, S				Ashwal, S			Recovery of consciousness and life expectancy of children in a vegetative state	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Proceedings Paper	Conference of the International-Neuropsychological-Society	JUL 16-19, 2003	Berlin, GERMANY	Int Neuropsychol Soc			MEDICAL ASPECTS	The vegetative state does occur in children and is most commonly due to acquired traumatic and non-traumatic injuries. However, neurometabolic and degenerative diseases, as well as certain developmental brain malformations such as anencephaly, can also cause this condition. There are limited data available in children concerning recovery of consciousness and function from the vegetative state as well as life expectancy. This review concentrates on these issues and is based primarily on the data published in the Multi-Society Task Force Report on PVS which was published in 1994 as well as other epidemiological studies. Children in a vegetative state do have a poor prognosis for recovery of consciousness and function and do have a shortened life expectancy. Further research is needed to better understand what variables might contribute to recovery and what therapies might be of benefit.	Loma Linda Univ, Sch Med, Dept Pediat, Loma Linda, CA 92350 USA		Ashwal, S (corresponding author), Loma Linda Univ, Sch Med, Dept Pediat, 11175 Campus St, Loma Linda, CA 92350 USA.	sashwal@ahs.llumc.edu					ASHWAL S, 1994, PEDIATR NEUROL, V10, P27, DOI 10.1016/0887-8994(94)90063-9; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; ASHWAL S, 1992, ANN NEUROL, V32, P570, DOI 10.1002/ana.410320414; Heindl UT, 1996, NEUROPEDIATRICS, V27, P94, DOI 10.1055/s-2007-973756; KRIEL RL, 1993, PEDIATR NEUROL, V9, P362, DOI 10.1016/0887-8994(93)90104-K; Strauss DJ, 1999, PEDIATR NEUROL, V21, P626, DOI 10.1016/S0887-8994(99)00051-X; Strauss DJ, 2000, PEDIATR NEUROL, V23, P312, DOI 10.1016/S0887-8994(00)00194-6; STUMPF DA, 1990, NEW ENGL J MED, V322, P669	9	13	14	0	2	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL-SEP	2005	15	3-4					190	197		10.1080/09602010443000281			8	Neurosciences; Psychology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	965PE	WOS:000231961900006	16350962				2022-02-06	
J	Pickard, JD; Coleman, MR; Czosnyka, M				Pickard, JD; Coleman, MR; Czosnyka, M			Hydrocephalus, ventriculomegaly and the vegetative state: A review	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Proceedings Paper	Conference of the International-Neuropsychological-Society	JUL 16-19, 2003	Berlin, GERMANY	Int Neuropsychol Soc			NORMAL-PRESSURE HYDROCEPHALUS; CLOSED-HEAD-INJURY; POSTTRAUMATIC HYDROCEPHALUS; COMPUTERIZED TOMOGRAPHY; EXTERNAL HYDROCEPHALUS; ALZHEIMERS-DISEASE; MANAGEMENT; DIAGNOSIS; ENLARGEMENT; TRAUMA	The revised guidelines from the Royal College of Physicians make it clear that structural problems such as hydrocephalus should be excluded before the diagnosis of vegetative state (VS) can be made. Ventriculornegaly is common after severe head injury but the distinction between atrophy and potentially treatable hydrocephalus cannot be made on the basis of conventional computerised tomographic (CT) or magnetic resonance (MR) scanning alone-physiological measurements of intracranial pressure (ICP) and cerebrospinal fluid (CSF) outflow resistance may be helpful. These techniques are reviewed together with the limited literature available that documents the effect of CSF diversion on outcome in "vegetative" patients.	Univ Cambridge, Addenbrookes Hosp, Cambridge CB2 2QQ, England		Pickard, JD (corresponding author), Univ Cambridge, Acad Neurosurg Unit, Box 167, Cambridge CB2 2QQ, England.	jdp.secretary@medschl.cam.ac.uk			Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390] Funding Source: UKRI		Bates D, 2003, CLIN MED, V3, P249; BEYERL B, 1984, NEUROSURGERY, V15, P257, DOI 10.1227/00006123-198408000-00020; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; COHADON F, 2000, SORTIR COMA; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1996, J NEUROL NEUROSUR PS, V60, P549, DOI 10.1136/jnnp.60.5.549; Czosnyka M, 2000, J NEUROL NEUROSUR PS, V68, P246; Dandy WE, 1914, AM J DIS CHILD, V8, P406; DOLCE G, 2002, POST TRAUMATIC VEGET; EARNEST MP, 1974, ARCH NEUROL-CHICAGO, V31, P262, DOI 10.1001/archneur.1974.00490400076009; FRENCH BN, 1977, SURG NEUROL, V7, P171; Fujimoto Y, 2004, PEDIATR NEUROSURG, V40, P32, DOI 10.1159/000076575; GRANHOLM L, 1972, J REHABILITATION MED, V4, P31; Groswasser Z, 1988, Brain Inj, V2, P267, DOI 10.3109/02699058809150897; GUDEMAN SK, 1981, RADIOLOGY, V141, P397, DOI 10.1148/radiology.141.2.6974874; GURDJIAN E, 1966, HEAD INJURY C P, P550; Hakim S, 1965, J Neurol Sci, V2, P307, DOI 10.1016/0022-510X(65)90016-X; HAWKINS TD, 1976, CLIN RADIOL, V27, P279, DOI 10.1016/S0009-9260(76)80069-4; Iddon JL, 1999, J NEUROL NEUROSUR PS, V67, P723, DOI 10.1136/jnnp.67.6.723; JENNETT B, 1972, LANCET, V1, P734; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; JENNETT B, 2002, VEGETATIVE STATE MED; KALISKY Z, 1985, ARCH PHYS MED REHAB, V66, P25; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; KATZ RT, 1989, AM J PHYS MED REHAB, V68, P91, DOI 10.1097/00002060-198904000-00009; KISHORE PRS, 1978, NEURORADIOLOGY, V16, P261, DOI 10.1007/BF00395266; KOO AH, 1977, RADIOLOGY, V123, P345, DOI 10.1148/123.2.345; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LEWIN W, 1968, BRIT J SURG, V55, P747, DOI 10.1002/bjs.1800551008; Licata C, 2001, J Neurosurg Sci, V45, P141; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; MERINODEVILLASANTE J, 1976, AM J ROENTGENOL, V126, P765, DOI 10.2214/ajr.126.4.765; MEYERS CA, 1983, J NEUROL NEUROSUR PS, V46, P1092, DOI 10.1136/jnnp.46.12.1092; Paoletti P, 1983, J Neurosurg Sci, V27, P171; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; Silver B V, 1997, Pediatr Rehabil, V1, P123; Silverberg GD, 2003, LANCET NEUROL, V2, P506, DOI 10.1016/S1474-4422(03)00487-3; Tribl G, 2000, BRAIN INJURY, V14, P345; Yoshimoto Y, 1998, J NEUROSURG, V88, P485, DOI 10.3171/jns.1998.88.3.0485	40	13	14	0	2	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL-SEP	2005	15	3-4					224	236		10.1080/09602010443000614			13	Neurosciences; Psychology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	965PE	WOS:000231961900009	16350965				2022-02-06	
J	Prigatano, GP; Borgaro, S; Baker, J; Wethe, J				Prigatano, GP; Borgaro, S; Baker, J; Wethe, J			Awareness and distress after traumatic brain injury - A relative's perspective	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						impaired awareness; relative's distress; TBI	CLOSED-HEAD-INJURY; BEHAVIORAL LIMITATIONS; ALZHEIMERS-DISEASE; SELF-AWARENESS; REHABILITATION; INSIGHT	Objective: To examine the relationship between relatives' distress level and their ratings of impaired awareness for persons with traumatic brain injury (TBI). Design and outcome Measures: Participants were 25 patients with TBI, 16 with probably dementia, and 15 with memory complaints but no dementia. Participants completed the Barrow Neurological Institute Screen for Higher Cerebral Functions. Relatives of all patients completed the Patient Competency Rating Scale (Relative Form). Relatives also rated their distress level on a scale from 0 (no distress) to 10 (severe distress) and then rated the patient's level of awareness of their difficulties, also on a scale from 0 (not aware) to 10 (completely aware). Setting: Clinical neuropsychology outpatient service of a neurological institute and medical center. Results: For relatives of patients with TBI, a significant correlation of -0.52 (P =.006) was found. Correlations for the dementia and memory complaint groups were -0.62 (P =.03) and -0-39 (P =.20), respectively. Conclusions: The presence of brain dysfunction associated with neuropsychological disturbances appears to influence the magnitude of the relationship between the distress level of family members and their ratings of impaired awareness in persons with TBI.	St Josephs Hosp, Barrow Neurol Inst, Clin Neuropsychol, Div Neurol, Phoenix, AZ 85013 USA		Prigatano, GP (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Clin Neuropsychol, Div Neurol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	gprigat@chw.edu					Attix DK, 2003, NEURO S B C, P201; Borgaro SR, 2002, J HEAD TRAUMA REHAB, V17, P526, DOI 10.1097/00001199-200212000-00004; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; DEBETTIGNIES BH, 1990, J CLIN EXP NEUROPSYC, V12, P355, DOI 10.1080/01688639008400980; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Panting A, 1972, REHABILITATION, V38, P33; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano George P, 1993, Clin Neuropsychol, V7, P123, DOI 10.1080/13854049308401514; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1997, NEUROPSY NEUROPSY BE, V10, P135; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Prigatano GP, 1996, NEUROPSYCHOL REHABIL, V6, P305, DOI 10.1080/713755515; PRIGATANO GP, 2004, BNI Q, V20, P21; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; PRIGATANO GP, 1995, ADM SCORING MAN BNI; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; Sherer M, 2003, NEURO S B C, P39; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260	31	13	14	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2005	20	4					359	367		10.1097/00001199-200507000-00007			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	941MV	WOS:000230219800007	16030442				2022-02-06	
J	Schalamon, J; Singer, G; Kurschel, S; Hollwarth, M				Schalamon, J; Singer, G; Kurschel, S; Hollwarth, M			Somatosensory evoked potentials in children with severe head trauma	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						children; head trauma; prognosis; somatosensory evoked potentials	SEVERE BRAIN INJURY; COMATOSE CHILDREN; PREDICTION	We evaluated the predictive value of somatosensory evoked potentials (SEP) in a series of children with severe traumatic brain injury (TBI). The prospective clinical investigation was performed in a Level I paediatric trauma centre. We included 26 consecutive comatose paediatric patients aged from 1 month to 17 years (median age 11 years) following severe TBI (initial Glasgow Coma Score (GCS) 8 or below). Besides SEP recordings, the intracranial pressure and the results of an initial cranial CT scan were filed. The Glasgow Outcome Scale (GOS) was used to assess outcome at discharge. Thirteen children had normal SEP measurements, three patients had abnormal SEP recordings and a cortical response was bilaterally absent in ten children. Out of 26 children, 10 died whereas two remained in a persistent vegetative state. Only one child suffered from significant neurological deficits (GOS 3) at discharge. Seven patients survived with a GOS of 4 and six children survived without neurological impairment (GOS 5). Normal SEP indicated a favourable outcome in most children but did not rule out the occurrence of death, while absence of SEP was related to unfavourable outcome in all cases. Conclusion: Measurement of somatosensory evoked potentials provides valuable data for determining the prognosis at early coma stages. Our data show that an unfavourable outcome can be predicted with higher precision than a favourable outcome.	Med Univ Graz, Dept Paediat Surg, A-8036 Graz, Austria; Med Univ Graz, Dept Neurosurg, Graz, Austria		Schalamon, J (corresponding author), Med Univ Graz, Dept Paediat Surg, Auenbruggerpl 34, A-8036 Graz, Austria.	johannes.schalamon@meduni-graz.at		Singer, Georg/0000-0003-4770-3144			Airey CM, 2001, DISABIL REHABIL, V23, P509; BECA J, 1995, J PEDIATR-US, V126, P44, DOI 10.1016/S0022-3476(95)70498-1; Carter BG, 2001, CRIT CARE MED, V29, P178, DOI 10.1097/00003246-200101000-00036; DAWSON GD, 1954, ELECTROEN CLIN NEURO, V6, P65, DOI 10.1016/0013-4694(54)90007-3; Facco E, 2002, CLIN NEUROPHYSIOL, V113, P1855, DOI 10.1016/S1388-2457(02)00259-6; GOODWIN SR, 1991, CRIT CARE MED, V19, P518, DOI 10.1097/00003246-199104000-00011; Harris C, 2003, J AM COLL SURGEONS, V197, P711, DOI 10.1016/S1072-7515(03)00729-4; Hirsch W, 2002, PAEDIATR ANAESTH, V12, P337, DOI 10.1046/j.1460-9592.2002.00837.x; JENNETT B, 1975, LANCET, V2, P480; Lehmann U, 1997, UNFALLCHIRURG, V100, P705, DOI 10.1007/s001130050180; Maas Andrew I.R., 2000, Curr Opin Crit Care, V6, P281, DOI 10.1097/00075198-200008000-00008; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; TEASDALE G, 1974, LANCET, V2, P81; Wohlrab G, 2001, NEUROPEDIATRICS, V32, P271, DOI 10.1055/s-2001-19123	15	13	13	1	1	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0340-6199			EUR J PEDIATR	Eur. J. Pediatr.	JUL	2005	164	7					417	420		10.1007/s00431-005-1656-5			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	937AO	WOS:000229897100005	15812665				2022-02-06	
J	Shiel, A; Wilson, BA				Shiel, A; Wilson, BA			Can behaviours observed in the early stages of recovery after traumatic brain injury predict poor outcome?	NEUROPSYCHOLOGICAL REHABILITATION			English	Article; Proceedings Paper	Joint Conference of the International-Neuropsychological-Society/German-Society-for-Neuropsychology	JUL 16-19, 2003	Berlin, GERMANY	Int Neuropsychol Soc, German Soc Neuropsychol			SEVERE HEAD-INJURY; GLASGOW COMA SCALE	Diagnosis of the vegetative state (VS) or minimally conscious state (MCS) is dependent on the presence or absence of behavioural variables. Diagnosis of the VS in the case of those who have had a severe head injury does not occur for several months after injury. If such outcomes could be predicted it would facilitate appropriate and timely referrals to specialist rehabilitation units. This paper describes a follow up study of patients observed prospectively after severe head injury and followed up four years later. Thirty patients had made a moderate or good recovery and eight met criteria for MCS. Analysis of early observations together with outcome data suggest that the duration of time taken to achieve some early behaviours may be predictive of poorer outcome.	NUI, Fac Med & Hlth Sci, Galway, Ireland; MRC, Cognit & Brain Sci Unit, Cambridge, England		Shiel, A (corresponding author), NUI, Fac Med & Hlth Sci, Galway, Ireland.	agnes.shiel@nuigalway.ie	Shiel, Agnes/AAA-4211-2019				ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Black D, 1996, J ROY COLL PHYS LOND, V30, P119; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; Combes P, 1996, INTENS CARE MED, V22, P1391, DOI 10.1007/BF01709556; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KOHI YM, 1984, INJURY, V16, P25, DOI 10.1016/0020-1383(84)90110-4; PHUENPATHOM N, 1993, SURG NEUROL, V40, P22, DOI 10.1016/0090-3019(93)90164-V; POLIN RS, 1995, NEUROSURG CLIN N AM, V6, P689; Quigley MR, 1997, J TRAUMA, V42, P7, DOI 10.1097/00005373-199701000-00003; Reeder KP, 1996, J HEAD TRAUMA REHAB, V11, P22, DOI 10.1097/00001199-199606000-00006; SALCMAN M, 1981, NEUROSURGERY, V8, P15; SAZBON L, 1991, J NEUROL NEUROSUR PS, V54, P149, DOI 10.1136/jnnp.54.2.149; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; Shiel A, 2000, WESSEX HEAD INJURY M; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; STAMBROOK M, 1993, ARCH CLIN NEUROPSYCH, V8, P95; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; Zasler ND, 1996, NEUROREHABILITATION, V6, P3, DOI 10.3233/NRE-1996-6102	23	13	13	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JUL-SEP	2005	15	3-4					494	502		10.1080/09602010443000551			9	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Psychology	965PE	WOS:000231961900034	16350990				2022-02-06	
J	Falk, AC; Cederfjall, C; von Wendt, L; Soderkvist, BK				Falk, AC; Cederfjall, C; von Wendt, L; Soderkvist, BK			Management and classification of children with head injury	CHILDS NERVOUS SYSTEM			English	Article						classification; paediatric; symptoms; traumatic brain injury	BRAIN INJURY	Background: Traumatic brain injury is the most common cause of morbidity and mortality during childhood. Aim: This study was conducted to describe the primary management and classification of children admitted to the emergency department for head trauma. Series: All children (0-15 years) with a history of head injury who were admitted to the outpatient emergency department at a single paediatric trauma centre in the Stockholm region during 1 month were included. Results: There were 242 children (137 girls and 105 boys; mean age 5.3 +/- 4.4 years) who fulfilled the inclusion criteria. Based on the Scandinavian Head Injury Classification, 73% were classified as minimal, 17% mild and 2% moderate head injury. This classification seemed to be more accurately reflective than the ICD-10-based classification in the management of the children with head trauma.	Karolinska Hosp, Astrid Lindgren Childrens Hosp, Pediat ICU, S-17176 Stockholm, Sweden; Karolinska Inst, Dept Women & Child Hlth, Stockholm, Sweden; Univ Helsinki, Cent Hosp, Dept Child Neurol, Helsinki, Finland; Karolinska Inst, Dept Nursing, Stockholm, Sweden		Falk, AC (corresponding author), Karolinska Hosp, Astrid Lindgren Childrens Hosp, Pediat ICU, S-17176 Stockholm, Sweden.	ann-charlotte.falk@karolinska.se	Falk, Ann-Charlotte/ABA-1730-2020	Falk, Ann-Charlotte/0000-0003-2246-7894			Adelson D, 1997, J CHILD NEUROL, V13, P1; *EM NURS ASS, 1995, PROV MAN PED COM SCA, P313; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; KOURTOPOULOS H, 1994, BRAIN INJURY S1, V17, P7; KRAUS JF, 1987, PEDIATRICS, V79, P501; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P165; TEASDALE G, 1974, LANCET, V2, P81; World Health Organization, 1992, ICD10 WHO; 2000, 153 SBU	11	13	14	1	2	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	JUN	2005	21	6					430	436		10.1007/s00381-005-1142-4			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	935SE	WOS:000229802900002	15800789				2022-02-06	
J	Miller, BA; Sun, F; Christensen, RN; Ferguson, AR; Bresnahan, JC; Beattie, MS				Miller, BA; Sun, F; Christensen, RN; Ferguson, AR; Bresnahan, JC; Beattie, MS			A sublethal dose of TNF alpha potentiates kainate-induced excitotoxicity in optic nerve oligodendrocytes	NEUROCHEMICAL RESEARCH			English	Article						AMPA; excitotoxicity; glutamate; oligodendrocyte; TNF alpha	TUMOR-NECROSIS-FACTOR; SPINAL-CORD-INJURY; MULTIPLE-SCLEROSIS LESIONS; EXCITATORY AMINO-ACIDS; TRAUMATIC BRAIN-INJURY; DEATH IN-VITRO; AMPA RECEPTORS; MATURE OLIGODENDROCYTES; SYNAPTIC PLASTICITY; WHITE-MATTER	Glutamate receptor-induced cell death, known as excitotoxicity in both neurons and oligodendrocytes, has been implicated as a common pathway of cell death in numerous central nervous system (CNS) diseases and trauma. Research in both neuronal and oligodendrocyte excitotoxicity has examined glutamate's receptor-mediated effects on CNS cells, and explored strategies to protect cells exposed to the elevated glutamate levels that occur in CNS trauma and disease. Proinflammatory cytokines are also elevated in the injured CNS, and have also been implicated in CNS cell death. Recently, several laboratories have examined cytokines' effects on neuronal and glial excitotoxicity. Here, we review literature concerning the dynamic susceptibility of both neurons and oligodendrocytes to excitotoxicity, and present new data from our laboratory showing that the susceptibility of oligodendrocytes to excitotoxicity is acutely potentiated by the proinflammatory cytokine TNF alpha.	Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA		Bresnahan, JC (corresponding author), Ohio State Univ, Coll Med, Dept Neurosci, 333 W 10th Ave, Columbus, OH 43210 USA.	bresnahan.1@osu.edu	Beattie, Michael S/A-8953-2009	Christensen, Randolph/0000-0002-3528-2074; Ferguson, Adam/0000-0001-7102-1608	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 38079] Funding Source: Medline		Alberch J, 2002, BRAIN RES BULL, V57, P817, DOI 10.1016/S0361-9230(01)00775-4; Alberdi E, 2002, NEUROBIOL DIS, V9, P234, DOI 10.1006/nbdi.2001.0457; Arevalo-Martin A, 2003, J NEUROSCI, V23, P2511; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Beal MF, 1998, ANN NEUROL, V44, pS110; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Benjamins JA, 2003, NEUROCHEM RES, V28, P143, DOI 10.1023/A:1021612615554; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; Bitsch A, 2000, GLIA, V29, P366, DOI 10.1002/(SICI)1098-1136(20000215)29:4<366::AID-GLIA7>3.0.CO;2-Y; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Chew LJ, 1997, J NEUROSCI, V17, P227, DOI 10.1523/JNEUROSCI.17-01-00227.1997; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Cohen J, 1977, STAT POWER ANAL BEHA; Du J, 2004, J NEUROSCI, V24, P6578, DOI 10.1523/JNEUROSCI.1258-04.2004; Eskes C, 2003, J NEUROSCI RES, V71, P583, DOI 10.1002/jnr.10508; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Follett PL, 2000, J NEUROSCI, V20, P9235; Ha BK, 2002, J NEUROCHEM, V83, P934, DOI 10.1046/j.1471-4159.2002.01203.x; Hayes KC, 2002, J NEUROTRAUM, V19, P753, DOI 10.1089/08977150260139129; Haynes RL, 2003, J NEUROPATH EXP NEUR, V62, P441, DOI 10.1093/jnen/62.5.441; Hermann GE, 2001, NEUROBIOL DIS, V8, P590, DOI 10.1006/nbdi.2001.0414; Himi T, 2003, J NEUROSCI RES, V71, P679, DOI 10.1002/jnr.10510; HOFMAN FM, 1989, J EXP MED, V170, P607, DOI 10.1084/jem.170.2.607; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Ito A, 2001, J IMMUNOL, V167, P542, DOI 10.4049/jimmunol.167.1.542; Itoh T, 2002, J NEUROCHEM, V81, P390, DOI 10.1046/j.1471-4159.2002.00866.x; Jensen FE, 2002, INT J DEV NEUROSCI, V20, P339, DOI 10.1016/S0736-5748(02)00012-6; Jones TL, 2004, J PHARMACOL EXP THER, V310, P223, DOI 10.1124/jpet.103.064741; Kadhim H, 2001, NEUROLOGY, V56, P1278, DOI 10.1212/WNL.56.10.1278; Leuchtmann EA, 2003, NEUROBIOL DIS, V14, P336, DOI 10.1016/j.nbd.2003.07.004; Li JR, 2003, J NEUROSCI, V23, P5816; LI S, 1999, J NEUROSCI, V19, P1; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2000, CELL MOL LIFE SCI, V57, P1526, DOI 10.1007/PL00000637; Matute C, 2001, TRENDS NEUROSCI, V24, P224, DOI 10.1016/S0166-2236(00)01746-X; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; McAdoo DJ, 1999, EXP NEUROL, V159, P538, DOI 10.1006/exnr.1999.7166; McDonald JW, 1998, NEUROREPORT, V9, P2757, DOI 10.1097/00001756-199808240-00014; MCLAURIN J, 1995, INT J DEV NEUROSCI, V13, P369, DOI 10.1016/0736-5748(95)00012-6; Mergenthaler P, 2004, METAB BRAIN DIS, V19, P151, DOI 10.1023/B:MEBR.0000043966.46964.e6; Michaelis EK, 1998, PROG NEUROBIOL, V54, P369, DOI 10.1016/S0301-0082(97)00055-5; Nargi-Aizenman JL, 2004, ANN NEUROL, V55, P541, DOI 10.1002/ana.20033; Nicholas R, 2003, NEUROREPORT, V14, P1001, DOI 10.1097/00001756-200305230-00019; Nicholas RS, 2002, J NEUROIMMUNOL, V124, P36, DOI 10.1016/S0165-5728(02)00011-5; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Pan WH, 2003, J MOL NEUROSCI, V21, P173, DOI 10.1385/JMN:21:2:173; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; Park E, 2003, EXP NEUROL, V182, P35, DOI 10.1016/S0014-4886(03)00084-0; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Peterson JW, 2002, J NEUROPATH EXP NEUR, V61, P539, DOI 10.1093/jnen/61.6.539; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Pitt D, 2003, NEUROLOGY, V61, P1113, DOI 10.1212/01.WNL.0000090564.88719.37; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Ritz MF, 2004, BRAIN RES, V1022, P157, DOI 10.1016/j.brainres.2004.07.004; Rosenberg PA, 2003, J NEUROSCI RES, V71, P237, DOI 10.1002/jnr.10472; Rosin C, 2004, J NEUROCHEM, V90, P1173, DOI 10.1111/j.1471-4159.2004.02584.x; Sanchez-Gomez MV, 1999, NEUROBIOL DIS, V6, P475, DOI 10.1006/nbdi.1999.0264; Sanchez-Gomez MV, 2003, J NEUROSCI, V23, P9519; SELMAJ KW, 1988, ANN NEUROL, V23, P339, DOI 10.1002/ana.410230405; Shaked I, 2005, J NEUROCHEM, V92, P997, DOI 10.1111/j.1471-4159.2004.02954.x; SHARIEF MK, 1991, NEW ENGL J MED, V325, P467, DOI 10.1056/NEJM199108153250704; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Springer JE, 1997, J NEUROCHEM, V69, P1592, DOI 10.1046/j.1471-4159.1997.69041592.x; Sriram S, 1997, NEUROLOGY, V48, P464, DOI 10.1212/WNL.48.2.464; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Takahashi JL, 2003, ANN NEUROL, V53, P588, DOI 10.1002/ana.10519; Tanaka H, 2000, BRAIN RES, V886, P190, DOI 10.1016/S0006-8993(00)02951-6; Wang CX, 2002, NEUROREPORT, V13, P1391, DOI 10.1097/00001756-200208070-00008; Werner P, 2001, ANN NEUROL, V50, P169, DOI 10.1002/ana.1077; Wilke SR, 2004, J NEUROPATH EXP NEUR, V63, P872, DOI 10.1093/jnen/63.8.872; Wisman LAB, 2003, NEUROREPORT, V14, P1967, DOI 10.1097/00001756-200310270-00017; Wosik K, 2004, BRAIN, V127, P2636, DOI 10.1093/brain/awh302; Wrathall JR, 1997, EXP NEUROL, V145, P565, DOI 10.1006/exnr.1997.6506; Ye P, 1999, ENDOCRINOLOGY, V140, P3063, DOI 10.1210/en.140.7.3063; YOSHIOKA A, 1995, J NEUROCHEM, V64, P2442; ZAJICEK JP, 1992, BRAIN, V115, P1611, DOI 10.1093/brain/115.6.1611; Zhao LX, 2004, J NEUROSCI, V24, P2226, DOI 10.1523/JNEUROSCI.4922-03.2004	80	13	13	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JUN	2005	30	6-7					867	875		10.1007/s11064-005-6880-x			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	968LG	WOS:000232163400017	16187221				2022-02-06	
J	Andres, AGC; Herrero, PA; Diez, FJM; Diaz-Hellin, V; Cabrero, EL; Anton, JAP; de Nicolas, JLM				Andres, AGC; Herrero, PA; Diez, FJM; Diaz-Hellin, V; Cabrero, EL; Anton, JAP; de Nicolas, JLM			Medical and surgical management of noniatrogenic traumatic tracheobronchial injuries	ARCHIVOS DE BRONCONEUMOLOGIA			Spanish	Article						tracheobronchial injuries; trauma; bronchial rupture; subcutaneous emphysema; bronchoscopy; thoracotomy	TRACHEAL RUPTURE; IATROGENIC RUPTURES; EARLY-DIAGNOSIS; INTUBATION; EXPERIENCE; LACERATION; BRONCHI; BLUNT; TREE	OBJECTIVE: To describe the medical and surgical management of noniatrogenic traumatic tracheobronchial injuries. PATIENTS AND METHOD: From January 1993 to July 2004, 15 cases of traumatic tracheobronchial injury were treated in our department. The diagnosis was established by bronchoscopy and a computed tomography chest scan was performed on all patients. Surgical treatment was selected for patients with unstable vital signs, an open tracheal wound, associated esophageal lesions, progression of subcutaneous or mediastinal emphysema, mediastinitis or suspicious mediastinal secretions on imaging tests, or difficulties with mechanical ventilation due to the traumatic tracheobronchial injury. Results: The mean (SD) age of the patients was 35.5 (18.9) years and 12 (80%) were male. Of the 15 cases, 13 (86.7%) had penetrating trauma and 2 (13.3%) blunt trauma. The most common location of the injury was in the bronchi (9 cases; 60%) followed by the cervical trachea (4 cases; 26.6%), followed by both the thoracic trachea and bronchi (2 cases; 13.4%). The most common initial symptom was Subcutaneous emphysema, which presented in 11 (73.3%) patients. Chest (12 cases; 86.7%) and orthopedic injuries (9 cases; 60%) were the most common associated injuries. Surgery was the treatment of choice in 11 (73.3%) cases and conservative medical treatment in 4 (26.7%). An irreversible brain injury caused the death of 1 patient receiving conservative treatment. CONCLUSIONS: Tracheobronchial injuries may be treated conservatively if they meet strict selection criteria. Size and location should not be used as selection criteria for surgical treatment.	Hosp Univ 12 Octubre, Serv Cirugia Torac, Madrid 28041, Spain; Hosp Univ 12 Octubre, Serv Neumol, Madrid 28041, Spain		Andres, AGC (corresponding author), Hosp Univ 12 Octubre, Serv Cirugia Torac, Ctra Andalucia,Km 5,400, Madrid 28041, Spain.	abelitov@yahoo.es					ANGELILLOMACKINLAY T, 1995, ANN THORAC SURG, V59, P531, DOI 10.1016/0003-4975(94)00882-8; ANGOOD PB, 1986, J TRAUMA, V26, P869, DOI 10.1097/00005373-198610000-00002; Balci AE, 2002, EUR J CARDIO-THORAC, V22, P984, DOI 10.1016/S1010-7940(02)00591-2; Borasio P, 1997, EUR J CARDIO-THORAC, V12, P98, DOI 10.1016/S1010-7940(97)00111-5; Buitrago L J, 1997, Arch Bronconeumol, V33, P151; BURKE JF, 1962, JAMA-J AM MED ASSOC, V181, P682, DOI 10.1001/jama.1962.03050340020005; Carbognani P, 2004, ANN THORAC SURG, V77, P406, DOI 10.1016/S0003-4975(03)01344-4; Cassada DC, 2000, ANN THORAC SURG, V69, P1563, DOI 10.1016/S0003-4975(00)01077-8; Gabor S, 2001, EUR J CARDIO-THORAC, V20, P399, DOI 10.1016/S1010-7940(01)00798-9; Hofmann HS, 2002, EUR J CARDIO-THORAC, V21, P649, DOI 10.1016/S1010-7940(02)00037-4; Huh J, 1997, AM SURGEON, V63, P896; Jougon J, 2000, ANN THORAC SURG, V69, P216, DOI 10.1016/S0003-4975(99)01129-7; Kaloud H, 1997, CHEST, V112, P774, DOI 10.1378/chest.112.3.774; Kaptanoglu M, 2002, INT J PEDIATR OTORHI, V62, P123, DOI 10.1016/S0165-5876(01)00600-0; Kiser AC, 2001, ANN THORAC SURG, V71, P2059, DOI 10.1016/S0003-4975(00)02453-X; Mussi A, 2001, EUR J CARDIO-THORAC, V20, P46, DOI 10.1016/S1010-7940(01)00702-3; Richardson JD, 2004, J TRAUMA, V56, P30, DOI 10.1097/01.TA.0000108631.72315.78; Ross HM, 1997, ANN THORAC SURG, V63, P240; Rossbach MM, 1998, ANN THORAC SURG, V65, P182, DOI 10.1016/S0003-4975(97)01001-1; Sternfeld D, 2003, ANN EMERG MED, V42, P88, DOI 10.1067/mem.2003.278; Tcherveniakov A, 2001, EUR J CARDIO-THORAC, V19, P19, DOI 10.1016/S1010-7940(00)00610-2; Zapatero J, 1996, Arch Bronconeumol, V32, P222	22	13	15	0	0	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	0300-2896	1579-2129		ARCH BRONCONEUMOL	Arch. Bronconeumol.	MAY	2005	41	5					249	254					6	Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Respiratory System	934QE	WOS:000229722500003	15919005				2022-02-06	
J	Lange, RT; Sullivan, K; Anderson, D				Lange, RT; Sullivan, K; Anderson, D			Ecological validity of the WMS-III Rarely Missed Index in personal injury litigation	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							MILD HEAD-INJURY; ADULT INTELLIGENCE SCALE; RECOGNITION MEMORY TEST; TRAUMATIC BRAIN INJURY; VERBAL-LEARNING TEST; CARD SORTING TEST; NEUROPSYCHOLOGICAL TESTS; INCOMPLETE EFFORT; CROSS-VALIDATION; PERFORMANCE	The purpose of this study was to evaluate the clinical utility of the Rarely Missed Index (RMI) to detect cognitive exaggeration in 78 nonlitigant patients (i.e., Mixed Clinical group) and 158 personal injury litigants (i.e., 20 Suspected Exaggerators, 12 Borderline Exaggerators, 126 Genuine Responders). The base rate for probable malingered neurocognitive dysfunction in the litigant sample was 12.7%. The false positive error rate of the RMI in the Genuine Responder and Mixed Clinical group ranged from 5.4% to 8.6%. Positive RMI scores were found in 25% and 41.7% of the Suspected Exaggerator and Borderline Exaggerator groups respectively. The clinical utility of the RMI to identify Suspected Exaggerators versus individuals in the Genuine Responder and Mixed Clinical groups revealed low sensitivity (sensitivity = .25), very high specificity (range = .91 to .95), moderate positive predictive power (range = .50 to .71), and moderate to high negative predictive power (range = .68 to .83). These results do not support the use of the RMI as a reliable predictor of cognitive exaggeration.	Riverview Hosp, ECT & Neuropsychiat Program, Coquitlam, BC V3C 4J2, Canada; Queensland Univ Technol, Brisbane, Qld, Australia		Lange, RT (corresponding author), Riverview Hosp, ECT & Neuropsychiat Program, Room 124,Adm Bldg,2601 Lougheed Highway, Coquitlam, BC V3C 4J2, Canada.	rlange@bcmbs.bc.ca	Anderson, Debra/I-9637-2012	Anderson, Debra/0000-0001-8996-9624			Allen L., 1997, CARB 97 MANUAL COMPU; Ashendorf L, 2004, ARCH CLIN NEUROPSYCH, V19, P125, DOI 10.1016/S0887-6177(02)00218-4; Axelrod B. N., 1999, J FORENSIC NEUROPSYC, V1, P15; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Coleman RD, 1998, J CLIN EXP NEUROPSYC, V20, P201, DOI 10.1076/jcen.20.2.201.1164; Doss R.C., 1999, J FORENSIC NEUROPSYC, V1, P5, DOI [https://doi.org/10.1300/J151v01n04_02, DOI 10.1300/J151V01N04_02, 10.1300/J151v01n04_02]; Franzen M.D., 1994, ASSESSMENT, V1, P323, DOI [DOI 10.1177/1073191, https://doi.org/10.1177/107319119400100401]; Gfeller JD, 1998, J CLIN PSYCHOL, V54, P431, DOI 10.1002/(SICI)1097-4679(199806)54:4<431::AID-JCLP5>3.0.CO;2-Q; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 1996, WORD MEMORY TEST USE; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; Iverson GL, 2000, J CLIN EXP NEUROPSYC, V22, P191, DOI 10.1076/1380-3395(200004)22:2;1-1;FT191; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; IVERSON GL, 2001, AM J FORENSIC PSYCH, V19, P5; Johnson JL, 1997, ARCH CLIN NEUROPSYCH, V12, P231, DOI 10.1016/S0887-6177(96)00040-6; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; LANGE R, 2003, NAT AC NEUR ANN C DA; LANGE RT, IN PRESS J CLIN EXPT; Langeluddecke PM, 2003, ARCH CLIN NEUROPSYCH, V18, P181, DOI 10.1016/S0887-6177(01)00195-0; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; MATEER CA, 2000, NEUROPSYCHOLOGICAL M; Meyers J E, 1999, Appl Neuropsychol, V6, P208, DOI 10.1207/s15324826an0604_3; Meyers JE, 1998, APPL NEUROPSYCHOL, V5, P120, DOI 10.1207/s15324826an0503_2; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 1998, J CLIN EXP NEUROPSYC, V20, P167, DOI 10.1076/jcen.20.2.167.1171; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; Slick D J, 2001, Appl Neuropsychol, V8, P185, DOI 10.1207/S15324826AN0803_9; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Sullivan K, 2002, ARCH CLIN NEUROPSYCH, V17, P223, DOI 10.1016/S0887-6177(01)00110-X; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TOMBAUGH TN, 2003, J FORENSIC NEUROPSYC, V2, P69, DOI DOI 10.1300/J151V02N03_04; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; WARRINGTON, 1984, RECOGNITION MEMORY T; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weinborn M, 2003, J CLIN EXP NEUROPSYC, V25, P979, DOI 10.1076/jcen.25.7.979.16481; [No title captured]	56	13	13	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAY	2005	27	4					412	424		10.1080/13803390490520319			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	914XH	WOS:000228260900003	15962688	Green Published			2022-02-06	
J	Steiner, LA; Balestreri, M; Johnston, AJ; Coles, JP; Smielewski, P; Pickard, JD; Menon, DK; Czosnyka, M				Steiner, LA; Balestreri, M; Johnston, AJ; Coles, JP; Smielewski, P; Pickard, JD; Menon, DK; Czosnyka, M			Predicting the response of intracranial pressure to moderate hyperventilation	ACTA NEUROCHIRURGICA			English	Article						traumatic brain injury; hyperventilation; intracranial compliance; intracranial pressure	VOLUME INDEX; HEAD-INJURY; DYNAMICS; MONITOR	Background. Hyperventilation may cause brain ischaemia after traumatic brain injury. However, moderate reductions in PaCO2 are still an option in the management of raised intracranial pressure (ICP) under some circumstances. Being able to predict the ICP-response to such an intervention would be advantageous. We investigated the ability of pre-hyperventilation ICP and cerebrospinal compensatory reserve to predict the reduction in ICP achievable with moderate hyperventilation in head injured patients. Methods. Thirty head injured patients requiring sedation and mechanical ventilation were investigated. ICP was monitored via an intraparenchymal probe and intracranial cerebrospinal compensatory reserve was assessed using an index (R-ap) based on the relationship between mean ICP and its pulse amplitude. Measurements were made at a constant level of PaCO2 during a 20-minute baseline period. The patients were then subjected to an acute decrease in PaCO2 of approximately 1 kPa and, after an equilibration period of 10 minutes, measurements were again made at a constant level of PaCO2 for a further 20 minutes. A multiple linear regression model, incorporating baseline PaCO2, ICP, and R-ap was used to identify the relevant predictors of ICP reduction. Findings. Baseline ICP and R-ap were both significant predictors of ICP-reduction (p=0.02 and 0.001 respectively) with R-ap being the more powerful parameter. Conclusions. A model based on cerebrospinal compensatory reserve and ICP can predict the achievable ICP-reduction and may potentially be used to optimise patient selection and intensity of hyperventilation.	Addenbrookes Hosp, Univ Dept Anaesthesia, Cambridge, England; Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Cambridge, England		Steiner, LA (corresponding author), Univ Basel Hosp, Dept Anaesthesia, CH-4031 Basel, Switzerland.	lsteiner@uhbs.ch	Steiner, Luzius/J-1987-2019; Steiner, Luzius/C-9836-2011	Smielewski, Peter/0000-0001-5096-3938; Coles, Jonathan/0000-0003-4013-679X	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390] Funding Source: UKRI		AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; GOPINATH SP, 1995, NEUROSURGERY, V36, P1137, DOI 10.1227/00006123-199506000-00011; GRAY WJ, 1987, J NEUROSURG, V67, P377, DOI 10.3171/jns.1987.67.3.0377; Gray WP, 1996, NEUROSURGERY, V39, P927, DOI 10.1097/00006123-199611000-00008; Imberti R, 2002, J NEUROSURG, V96, P97, DOI 10.3171/jns.2002.96.1.0097; Kiening KL, 2002, ACT NEUR S, V81, P177; LOFGREN J, 1973, ACTA NEUROL SCAND, V49, P557; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; ROBERTSON CS, 1989, J NEUROSURG, V71, P673, DOI 10.3171/jns.1989.71.5.0673; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; SHAPIRO K, 1980, ANN NEUROL, V7, P508, DOI 10.1002/ana.410070603; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; Werner CKE, 1997, TXB NEUROANESTHESIA, P21; Yau Y, 2002, ACTA NEUROCHIR SUPPL, V81, P167; Yau YH, 2002, ACT NEUR S, V81, P181; YOSHIHARA M, 1995, J NEUROSURG, V82, P386, DOI 10.3171/jns.1995.82.3.0386; ZABLOTNY W, 1994, INTRACRANIAL PRESSUR, V9, P439	28	13	13	0	7	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAY	2005	147	5					477	483		10.1007/s00701-005-0510-x			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	918MK	WOS:000228545700005	15770347				2022-02-06	
J	De Guise, E; Leblanc, J; Feyz, M; Thomas, H; Gosselin, N				De Guise, E; Leblanc, J; Feyz, M; Thomas, H; Gosselin, N			Effect of an integrated reality orientation programme in acute care on post-traumatic amnesia in patients with traumatic brain injury	BRAIN INJURY			English	Article						orientation; amnesia; traumatic brain injury; acute care; rehabilitation	HEAD-INJURY; ALCOHOL	Primary objective: To assess the effect of an integrated reality orientation programme (North Star Project) in acute care on the duration of post-traumatic amnesia (PTA) of patients suffering from traumatic brain injury (TBI). It was hypothesized that those patients having participated in this programme would show a shorter PTA than those patients that did not. Method: Duration of PTA for 12 patients with TBI who were part of the North Star Project was compared with that of 26 patients matched for initial GCS and age for whom this approach was not available (control group). Results: Length of PTA was shorter by 5 days for the North Star patients. This result was not statistically significant (p=0.19) but is clinically relevant. No between-group difference was found for Glasgow Coma Scale. Conclusions: Consequences of shorter PTA would include increased and more appropriate patient interaction and earlier transfer to rehabilitation. The North Star project also allows the family to become more actively involved in the treatment of their loved one. Further study is required to evaluate this intervention strategy to improve orientation for the patient with TBI.	McGill Univ, Ctr Hlth, Montreal Gen Hosp, Traumat Brain Injury Program,N Star Project, Montreal, PQ H3G 1A4, Canada		Thomas, H (corresponding author), McGill Univ, Ctr Hlth, Montreal Gen Hosp, Traumat Brain Injury Program,N Star Project, Montreal Gen Hosp Site,Room D13-124,1650 Cedar Av, Montreal, PQ H3G 1A4, Canada.	harle.thomas@muhc.mcgill.ca					BARNES J, 1974, GERONTOLOGIST, P138; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; CERNY J, 1983, REHABILITATION HEAD, pCH24; CORRIGAN JD, 1985, ARCH PHYS MED REHAB, V66, P626; DEGUISE E, UNPUB PREDICTION LEV; Folsom J C, 1967, Curr Psychiatr Ther, V7, P209; Grainger K, 1998, J AGING STUD, V12, P39, DOI 10.1016/S0890-4065(98)90019-6; JONES A, 1993, BR J NURS, V4, P519; KASCHEL R, 1995, BRAIN INJURY, V9, P619, DOI 10.3109/02699059509008220; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEZAC M, 1995, NEUROPSYCHOLOGICAL A; MCNENY R, 1990, REHABILITATION ADULT, pCH25; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Spector A, 2000, GERONTOLOGIST, V40, P206, DOI 10.1093/geront/40.2.206; TAULBEE LR, 1966, HOSP COMMUNITY PSYCH, V17, P133; TEASDALE G, 1974, LANCET, V2, P81; Thomas H, 2003, J HEAD TRAUMA REHAB, V18, P292, DOI 10.1097/00001199-200305000-00007; Watanabe TK, 1998, BRAIN INJURY, V12, P81; Woodrow P, 1998, Br J Nurs, V7, P1018; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0; Zencius AH, 1998, BRAIN INJURY, V12, P53, DOI 10.1080/026990598122854	26	13	15	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2005	19	4					263	269		10.1080/02699050400004971			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	917MN	WOS:000228466400004	15832872				2022-02-06	
J	Schuerer, DJE; Whinney, RR; Freeman, BD; Nash, J; Prasad, S; Krem, MM; Mazuski, JE; Buchman, TG				Schuerer, DJE; Whinney, RR; Freeman, BD; Nash, J; Prasad, S; Krem, MM; Mazuski, JE; Buchman, TG			Evaluation of the applicability, efficacy, and safety of a thromboembolic event prophylaxis guideline designed for quality improvement of the traumatically injured patient	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	63rd Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 29-OCT 02, 2004	Maui, HI	Amer Assoc Surg Trauma		deep vein thrombosis; trauma; pulmonary embolism; prophylaxis; heparin	MOLECULAR-WEIGHT HEPARIN; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM; TRAUMA PATIENTS; MAJOR TRAUMA; THROMBOSIS	Background:. Thromboembolic events (TE) such as deep venous thrombosis (DVT) and pulmonary embolism (PE) are common after trauma. Our Trauma Practice Management Committee developed an evidence-based DVT/PE prophylaxis guideline using a modified Delphi approach to standardize care and reduce TE rates. Our objective was to evaluate the applicability, efficacy, and safety of this guideline in the traumatized patient, especially those admitted first to the intensive care unit (ICU). Methods: We developed a risk-stratifled DVT/PE prophylaxis guideline incorporating specific injuries, pertinent history, and physiologic parameters, favoring aggressive therapy in those at highest risk of dying from a PE. We prospectively collected data using this guideline in all patients admitted to the trauma or orthopedic-trauma services that were expected to stay for more than 48 hours (March-December 2003). Comparison was made with historical controls. Data collected included DVT, PE, prophylaxis level chosen, inferior vena cava filters, admission service and location, TRISS scores, length of stay, outcomes, adverse events, and specific risk factors. Results: TE rates after implementation of the guideline were lower than historical controls for all patients (1.9% vs. 1.0%, p = 0.059) and for patients admitted first to the ICU (6.3% vs. 2%, p = 0.018). Completed sheets were collected for 46% of the targeted population. No bleeding events caused by guideline anticoagulation were noted, and one death occurred after inferior vena. cava filter placement. Nine of the 12 TEs in the treatment group were in patients with spine or closed-head injury, delaying chemical prophylaxis. Conclusion: Form-based, risk-adjusted prophylaxis against TE leads to lower TE rates in a general and orthopedic ICU trauma population. Protocol compliance should be enforced.	Washington Univ, Dept Surg, Crit Care Sect, St Louis, MO 63130 USA; Barnes Jewish Hosp, St Louis, MO 63110 USA		Schuerer, DJE (corresponding author), 660 S Euclid Ave,Campus Box 8109, St Louis, MO 63110 USA.	schuererd@wustl.edu		Buchman, Timothy/0000-0001-7350-5921			GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Ibrahim EH, 2002, CRIT CARE MED, V30, P771, DOI 10.1097/00003246-200204000-00008; Knudson MM, 1996, J TRAUMA, V41, P446, DOI 10.1097/00005373-199609000-00010; Maxwell RA, 2002, J TRAUMA, V52, P902, DOI 10.1097/00005373-200205000-00013; McMurtry AL, 1999, J AM COLL SURGEONS, V189, P314, DOI 10.1016/S1072-7515(99)00137-4; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; ROGER FB, MANAGEMENT VENOUS TH	9	13	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2005	58	4					731	+		10.1097/01.TA.0000158247.77198.AD			8	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	919VS	WOS:000228646300020	15824649				2022-02-06	
J	Barnes, EF; Frank, EM; Montgomery, A; Nichols, M				Barnes, EF; Frank, EM; Montgomery, A; Nichols, M			Factors predicting rehabilitative service provision in adults with traumatic brain injury	JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY			English	Article							RETURN; WORK	Approximately 300,000 people sustain a traumatic brain injury (TBI) each year; however, a limited number receive formal speech-language, occupational, and physical therapy rehabilitation. Consequently, a large number of individuals may not meet their maximum potential outcomes following TBI. Little is known about the factors that may affect access to rehabilitation, the amount of rehabilitation provided in varying settings, or participation patterns in rehabilitation programs. This project addressed three research goals: defining the relationship between a number of independent variables following TBI and patient access to rehabilitative services, the relationship between the independent variables and the amount of TBI rehabilitative service provided, and the relationship between independent variables and discharge disposition following inpatient care for TBI. The medical records of 712 adults incurring TBI as a result of motor vehicle accidents were examined. Logistic regression, odds ratio, t-tests, analysis of variance, analysis of covariance, and multinomial regression were used to evaluate the relationship between the independent and dependent variables in the study. Results indicate that admission to the intensive care unit (ICU), diagnosis of orthopedic impairment, and discharge disposition were significant predictors of physical, occupational, and speech therapy service provision following TBI. Gender and primary insurance provider were significant predictors of speech therapy, but not physical or occupational therapies. Admission to the ICU was a significant predictor of the amount of occupational and speech therapy provided following TBI. Age, admission to the ICU, length of stay, and primary insurance provider were significant predictors of discharge disposition following initial hospitalization.	Univ S Carolina, Columbia, SC 29208 USA		Barnes, EF (corresponding author), 1012 Broyhill Hall Court, Wake Forest, NC 27587 USA.	barnes@mail.fpg.unc.edu					Brzuzy S, 1996, J HEAD TRAUMA REHAB, V11, P74, DOI 10.1097/00001199-199606000-00011; Chan L, 2001, ARCH PHYS MED REHAB, V82, P1151, DOI 10.1053/apmr.2001.24892; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; HALL KM, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199502000-00003; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P64, DOI 10.1097/00001199-199508000-00007; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Horn W, 2000, DISABIL REHABIL, V22, P358, DOI 10.1080/096382800296601; Kramer AM, 1997, JAMA-J AM MED ASSOC, V277, P396, DOI 10.1001/jama.277.5.396; Liu XF, 2000, MED CARE RES REV, V57, P182, DOI 10.1177/107755870005700203; Rosenfeld M, 2002, REPORT ASHA SPEECH L REPORT ASHA SPEECH L; YLVISAKER M, 1994, TOP LANG DISORD, V15, P37, DOI 10.1097/00011363-199411000-00005	13	13	13	0	10	DELMAR LEARNING	CLIFTON PARK	EXECUTIVE WOODS, 5 MAXWELL DR, CLIFTON PARK, NY 12065 USA	1065-1438			J MED SPEECH-LANG PA	J. Med. Speech-Lang. Pathol.	MAR	2005	13	1					69	84					16	Audiology & Speech-Language Pathology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Neurosciences & Neurology	914WM	WOS:000228258700007					2022-02-06	
J	Mendez, DR; Corbett, R; Macias, C; Laptook, A				Mendez, DR; Corbett, R; Macias, C; Laptook, A			Total and ionized plasma magnesium concentrations in children after traumatic brain injury	PEDIATRIC RESEARCH			English	Article							PHOSPHOLIPASE-C ACTIVITY; HEAD-INJURY; BLOOD; SERUM	This study examined 1) whether plasma total Mg (TMg) and ionized Mg (IMg) concentrations in children are reduced by traumatic brain injury (TBI) and 2) whether the extent of reduction correlates with severity of trauma assessed by the Glasgow Coma Scale (GSC) score. This was a prospective cohort study of 98 pediatric patients who had TBI and were admitted through the emergency department. A GCS score was assigned and blood was obtained upon presentation and 24 h later. Plasma was analyzed for TMg and IMg. Patients were grouped into three categories-GCS scores 13-15, 8-12, and <8-to designate mild (n = 21), moderate (n = 37), and severe (n = 40) TBI, respectively. Blood was obtained from 50 healthy children before elective surgery as controls. Control subjects had a TMg and an IMg of 0.94 +/- 0.08 and 0.550 +/- 0.06 mM. TBI patients had an initial TMg and IMg of 0.83 +/- 0.09 and 0.520 +/- 0.05 mM, respectively. Initial TMg for mild, moderate, and severe TBI subgroups (0.87 +/- 0.16, 0.81 +/- 0.15, and 0.83 +/- 0.14 mM, respectively) was reduced from control subjects (p < 0.01). IMg was reduced only in the severe TBI subgroup (0.516 +/- 0.07 mM; p = 0.016). Twenty-four hours later, TMg remained lower than in control subjects for all subgroups of TBI; however, IMg normalized. TBI in children is associated with a reduction in TMg, whereas IMg decreased only with severe TBI. IMg returned to control values by 24 h despite a continued lower TMg, suggesting mechanisms to maintain IMg. Changes in plasma IMg may serve as a marker for TBI but only over a limited time interval.	Baylor Coll Med, Dept Pediat Emergency Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Univ Texas, SW Med Ctr, Dept Radiol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pediat Neonatol, Dallas, TX 75390 USA		Mendez, DR (corresponding author), Baylor Coll Med, Dept Pediat Emergency Med, 6211 Fannin St,Room A210, Houston, TX 77030 USA.	drmendez@texaschildrenshospital.org					ALTURA BM, 1980, PROSTAG LEUKOTR ESS, V4, P255, DOI 10.1016/0161-4630(80)90020-8; ALTURA BM, 1984, MICROCIRC ENDOTH LYM, V1, P185; ALTURA BT, 1992, METHOD FIND EXP CLIN, V14, P297; ALTURA BT, 1980, MED HYPOTHESES, V6, P753, DOI 10.1016/0306-9877(80)90093-6; Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; Batista A, 2000, MAGNESIUM RES, V13, P3; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Corbett R, 1999, MAGNESIUM RES, V12, P79; DEMEDIUK P, 1988, Journal of Neurotrauma, V5, P105, DOI 10.1089/neu.1988.5.105; DOLAN M, 1997, PEDIAT EMERGENCY MED, P243; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; Heath DL, 1998, SCAND J CLIN LAB INV, V58, P161, DOI 10.1080/00365519850186751; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Heath DL, 1998, J NEUROTRAUM, V15, P183, DOI 10.1089/neu.1998.15.183; Hoane MR, 1998, BRAIN RES BULL, V45, P45, DOI 10.1016/S0361-9230(97)00288-8; Hoshino K, 2001, MAGNESIUM RES, V14, P203; JOBORN H, 1985, CLIN ENDOCRINOL, V23, P219, DOI 10.1111/j.1365-2265.1985.tb00217.x; KING LR, 1973, ANN SURG, V177, P126, DOI 10.1097/00000658-197301000-00022; KRAUS JF, 1987, PEDIATRICS, V79, P501; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; KRAUS JF, 1995, TRAUMATIC HEAD INJUR, P23; MATTHEWS DSF, 1995, PEDIATR RES, V37, P409, DOI 10.1203/00006450-199504000-00005; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MCLAURIN RL, 1976, HDB CLIN NEUROLOGY, P109; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; RAYSSIGUIER Y, 1977, HORM METAB RES, V9, P309, DOI 10.1055/s-0028-1093519; RYZEN E, 1990, J AM COLL NUTR, V9, P114; SEGLERSTAHL K, 1985, NEUROCHEM RES, V10, P563, DOI 10.1007/BF00964658; SIESJO BK, 1985, CENTRAL NERVOUS SYST, P513; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; VINK R, 1989, BIOCHEM BIOPH RES CO, V165, P913, DOI 10.1016/S0006-291X(89)80053-1; Vink R, 1990, Magnes Res, V3, P163; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; WEI EP, 1982, J NEUROSURG, V56, P695, DOI 10.3171/jns.1982.56.5.0695; WHYTE KF, 1987, CLIN SCI, V72, P135, DOI 10.1042/cs0720135; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617	39	13	14	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.	MAR	2005	57	3					347	352		10.1203/01.PDR.0000150803.36315.FF			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	899NU	WOS:000227152100007	15585675	Bronze			2022-02-06	
J	Warschausky, S; Kay, JB; Chi, P; Donders, J				Warschausky, S; Kay, JB; Chi, P; Donders, J			Hierarchical linear modeling of California Verbal Learning Test-Children's Version learning curve characteristics following childhood traumatic head injury	NEUROPSYCHOLOGY			English	Article						traumatic brain injury; memory; neuropsychology	BRAIN-INJURY; WORKING-MEMORY; RECOVERY; PATTERNS; GROWTH	California Verbal Learning Test-Children's Version (CVLT-C) indices have been shown to be sensitive to the neurocognitive effects of traumatic brain injury (TBI). The effects of TBI on the learning process were examined with a growth curve analysis of CVLT-C raw scores across the 5 learning trials. The sample with history of TBI comprised 86 children, ages 6-16 years, at a mean of 10.0 (SD = 19.5) months postinjury: 37.2% had severe injury, 27.9% moderate, and 34.9% mild. The best-fit model for verbal learning was with I quadratic function. Greater TBI severity was associated with lower rate of acquisition and more gradual deceleration in the rate of acquisition. Intelligence test index scores, previously shown to be sensitive to severity of TBI, were positively correlated with rate of acquisition. Results provide evidence that the CVLT-C learning slope is not a simple linear function and further support for specific effects of TBI on verbal learning.	Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA		Warschausky, S (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower,Suite 100, Ann Arbor, MI 48109 USA.	sethaw@umich.edu					Anastasi A., 1988, PSYCHOL TESTING; Anderson VA, 2000, BRAIN INJURY, V14, P679; BLACHSTEIN H, 1993, NEUROPSYCHOLOGY, V7, P530, DOI DOI 10.1037/0894-4105.7.4.530; Bryk, 1992, HIERARCHICAL LINEAR; BRYK AS, 1987, PSYCHOL BULL, V101, P147, DOI 10.1037/0033-2909.101.1.147; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Delis DC., 1994, CALIFORNIA VERBAL LE; Donders J, 2002, NEUROPSYCHOLOGY, V16, P491, DOI 10.1037//0894-4105.16.4.491; FRANCIS DJ, 1991, J CONSULT CLIN PSYCH, V59, P27, DOI 10.1037/0022-006X.59.1.27; Fry AF, 1996, PSYCHOL SCI, V7, P237, DOI 10.1111/j.1467-9280.1996.tb00366.x; Hoffman N, 2000, ARCH CLIN NEUROPSYCH, V15, P47, DOI 10.1016/S0887-6177(98)00156-5; Kay JB, 1999, J CLIN EXP NEUROPSYC, V21, P186, DOI 10.1076/jcen.21.2.186.927; LESCOHIER I, 1993, PEDIATRICS, V91, P721; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Stricker JL, 2002, J INT NEUROPSYCH SOC, V8, P425, DOI 10.1017/S1355617702813224; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Towse JN, 1998, J MEM LANG, V39, P195, DOI 10.1006/jmla.1998.2574; van Strien JW, 1999, CHILD NEUROPSYCHOL, V5, P145, DOI 10.1076/chin.5.3.145.7336; WECHSLEER D, 1991, WECHSLER INTELLIGENC; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78	23	13	13	0	4	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAR	2005	19	2					193	198		10.1037/0894-4105.19.2.193			6	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	906DE	WOS:000227619900006	15769203				2022-02-06	
J	Heitger, MH; MacAskill, MR; Jones, RD; Anderson, TJ				Heitger, MH; MacAskill, MR; Jones, RD; Anderson, TJ			The impact of mild closed head injury on involuntary saccadic adaptation: Evidence for the preservation of implicit motor learning	BRAIN INJURY			English	Article							TRAUMATIC BRAIN-INJURY; EYE-MOVEMENTS; ADAPTIVE-CONTROL; TECHNETIUM-99M-HMPAO SPECT; COMPUTED-TOMOGRAPHY; WHIPLASH SYNDROME; GAIN ADAPTATION; LESIONS; MECHANISMS; PURSUIT	Objective: Mild closed head injury (CHI) can impair performance on volitional saccades (fast eye movements), with poorer saccade accuracy being one of the principal deficits. Assessing a patient group with known deficits of volitional saccades, the authors investigated whether mild CHI similarly impairs the implicit adaptation of visually-guided (reflexive) saccades, an important process which maintains saccadic accuracy. Methods: Within 2 weeks following mild CHI, 30 patients and 30 matched controls were compared on a computerized paradigm, which artificially induced saccadic adaptation. In response to an initial stimulus, subjects made a saccade during which the stimulus was displaced centripetally causing the initial (primary) saccade to be inaccurate. While these intra-saccadic changes remained unnoticed by the subjects, the displacements gradually caused adaptive saccadic hypometria. Results: No differences in adaptation were found between the CHI group and the controls (F(l, 29) = 0.5 1, p = 0.48). This finding indicates that mild CHI does not impair implicit reflexive saccade adaptation and suggests that cerebellar function and functions of deeper brain structures such as the thalamus, superior colliculus and the basal ganglia may be largely preserved following mild CHI. The current results support the notion that the profile of oculomotor function after mild CHI reflects a centripetal gradient of impairment and relates closely to the functional integrity of the injured brain.	Christchurch Brain Res Grp, Christchurch, New Zealand; Christchurch Sch Med & Hlth Sci, Dept Med, Christchurch, New Zealand; Christchurch Hosp, Dept Neurol, Christchurch, New Zealand; Christchurch Hosp, Dept Med Phys & Bioengn, Christchurch, New Zealand		Heitger, MH (corresponding author), Van der Veer Inst Parkinsons & Brain Res, POB 2682,16 St Asaph St, Christchurch 8001, New Zealand.	marcus.heitger@chmeds.ac.nz	MacAskill, Michael/C-3467-2009	MacAskill, Michael/0000-0001-9073-0346; Jones, Richard/0000-0003-2287-3358			ABEL LA, 1978, ANN NEUROL, V4, P313, DOI 10.1002/ana.410040405; Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; Bicik I, 1998, NEUROLOGY, V51, P345, DOI 10.1212/WNL.51.2.345; BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; CHERASKIN E, 1992, J NATL MED ASSOC, V84, P873; Desmurget M, 2000, EXP BRAIN RES, V132, P243, DOI 10.1007/s002210000342; Deubel H, 1996, VISION RES, V36, P985, DOI 10.1016/0042-6989(95)00203-0; DEUBEL H, 1995, VISION RES, V35, P3529, DOI 10.1016/0042-6989(95)00058-M; Deubel H, 1999, ATTENTION PERFORM, V17, P697; DEUBEL H, 1995, EYE MOVEMENT RES, P117; Frens MA, 1997, BRAIN RES BULL, V43, P473, DOI 10.1016/S0361-9230(97)80001-9; FRENS MA, 1994, EXP BRAIN RES, V100, P293, DOI 10.1007/BF00227199; Gaymard B, 2001, EUR J NEUROSCI, V14, P554, DOI 10.1046/j.0953-816x.2001.01669.x; GRAY BG, 1992, J NUCL MED, V33, P52; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Heitger MH, 2002, PROG BRAIN RES, V140, P433; HEITGER MH, 2003, BRAIN INJURY, V17, P49; Hofman PAM, 2002, J NEUROPSYCH CLIN N, V14, P176, DOI 10.1176/appi.neuropsych.14.2.176; Inaba N, 2003, NEUROSCI RES, V46, P359, DOI 10.1016/S0168-0102(03)00098-1; Jacobs A, 1996, J NUCL MED, V37, P1605; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; KANAYAMA R, 1994, J NEUROL NEUROSUR PS, V57, P1081, DOI 10.1136/jnnp.57.9.1081; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Lorberboym M, 2002, AM J EMERG MED, V20, P310, DOI 10.1053/ajem.2002.34201; MacAskill MR, 1999, CURRENT OCULOMOTOR RESEARCH, P93; MacAskill MR, 2002, BRAIN, V125, P1570, DOI 10.1093/brain/awf168; MacAskill MR, 2002, PROG BRAIN RES, V140, P417; McDowall J, 1996, NEW ZEAL J PSYCHOL, V25, P2; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Muir S. R., 2003, Australasian Physical & Engineering Sciences in Medicine, V26, P18; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPTICAN LM, 1980, J NEUROPHYSIOL, V44, P1058, DOI 10.1152/jn.1980.44.6.1058; OPTICAN LM, 1986, EXP BRAIN RES, V64, P596, DOI 10.1007/BF00340497; OPTICAN LM, 1985, J NEUROPHYSIOL, V54, P110, DOI 10.1152/jn.1985.54.1.110; Otte A, 1997, J NEUROL NEUROSUR PS, V63, P368, DOI 10.1136/jnnp.63.3.368; Pierrot-Deseilligny C, 1992, Baillieres Clin Neurol, V1, P435; Reitan RM, 2003, ARCH CLIN NEUROPSYCH, V18, P11, DOI 10.1016/S0887-6177(01)00177-9; REULEN JPH, 1988, MED BIOL ENG COMPUT, V26, P20, DOI 10.1007/BF02441823; Servadei P, 1994, J Neurosurg Sci, V38, P129; Shum D, 1996, J HEAD TRAUMA REHAB, V11, P43, DOI 10.1097/00001199-199604000-00005; Straube A, 1997, ANN NEUROL, V42, P891, DOI 10.1002/ana.410420611; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; Straube A, 2001, NEUROLOGY, V57, P2105, DOI 10.1212/WNL.57.11.2105; SWAINE BR, 1992, ARCH PHYS MED REHAB, V73, P55; Takagi M, 1998, J NEUROPHYSIOL, V80, P1911, DOI 10.1152/jn.1998.80.4.1911; VAKIL E, 1994, J CLIN EXP NEUROPSYC, V16, P539, DOI 10.1080/01688639408402665; WAESPE W, 1992, BRAIN, V115, P1125, DOI 10.1093/brain/115.4.1125; WILSON J T L, 1990, Brain Injury, V4, P349; Wrightson P, 1998, NEW ZEAL MED J, V111, P99; Zee D.S., 1999, NEUROLOGY EYE MOVEME, V3rd	54	13	13	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2005	19	2					109	117		10.1080/02699050410001720095			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	990JR	WOS:000233739600005	15841755	Green Accepted			2022-02-06	
J	Lange, RT; Schoenberg, MR; Chelune, GJ; Scott, JG; Adams, RL				Lange, RT; Schoenberg, MR; Chelune, GJ; Scott, JG; Adams, RL			Development of the WAIS-III General Ability Index Estimate (GAI-E)	CLINICAL NEUROPSYCHOLOGIST			English	Article							TRAUMATIC BRAIN INJURY; PREMORBID INTELLIGENCE; DEMOGRAPHIC-VARIABLES; COMBINED PERFORMANCE; CLINICAL UTILITY; SAMPLES; OPIE-3	The WAIS-III General Ability Index (GAI; Tulsky, Saklofske, Wilkins, T Weiss, 2001) is a recently developed, 6-subtest measure of global intellectual functioning. However, clinical use of the GAI is currently limited by the absence of a method to estimate premorbid functioning as measured by this index. The purpose of this study was to develop regression equations to estimate GAI scores from demographic variables and WAIS-III subtest performance. Participants consisted of those subjects in the WAIS-III standardization sample that had complete demographic data (N = 2,401) and were randomly divided into two groups. The first group (n = 1,200) was used to develop the formulas (i.e., Development group) and the second (n 1,201) group was used to validate the prediction algorithms (i.e., Validation group). Demographic variables included age, education, ethnicity, gender, and region of the country. Subtest variables included vocabulary, information, picture completion, and matrix reasoning raw scores. Ten regression algorithms were generated designed to estimate GAL The GAI-Estimate (GAI-E) algorithms accounted for 58% to 82% of the variance. The standard error of estimate ranged from 6.44 to 9.57. The correlation between actual and estimated GAI ranged from r = .76 to r = .90. These algorithms provided accurate estimates of GAI in the WAIS-III standardization sample. Implications for estimating GAI in patients with known or suspected neurological dysfunction is discussed and future research is proposed.	Riverview Hosp, ECT & Neuropsychiat Program, Coquitlam, BC V3C 4J2, Canada; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; Cleveland Clin Fdn, Cleveland, OH 44195 USA; Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA		Lange, RT (corresponding author), Riverview Hosp, ECT & Neuropsychiat Program, Room 318,HEY Bldg,2601 Lougheed Highway, Coquitlam, BC V3C 4J2, Canada.	rlange@bcmhs.bc.ca	Schoenberg, Mike R/J-9018-2012	Schoenberg, Mike/0000-0003-1355-3651			Axelrod BN, 1999, ARCH CLIN NEUROPSYCH, V14, P341, DOI 10.1016/S0887-6177(98)00028-6; Baade LE, 2004, ARCH CLIN NEUROPSYCH, V19, P227, DOI 10.1016/S0887-6177(03)00092-1; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; IVERSON GL, 2004, IN PRESS ARCH CLIN N; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; KRULL KR, 1995, CLIN NEUROPSYCHOL, V9, P83, DOI 10.1080/13854049508402063; LARRABEE GJ, 1985, J CLIN EXP NEUROPSYC, V7, P497, DOI 10.1080/01688638508401281; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; *PSYCH CORP, 1997, WAIS III WMS III TEC; Psychological Corporation, 2001, MAN WECHSL TEST AD R; Schoenberg MR, 2003, CLIN NEUROPSYCHOL, V17, P308, DOI 10.1076/clin.17.3.308.18088; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; SCHOENBERG MR, 2004, INT NEUR SOC ANN M P, P104; SCHOENBERG MR, IN PRESS ARCH CLIN N; Scott JG, 1997, CLIN NEUROPSYCHOL, V11, P146, DOI 10.1080/13854049708407043; SELLERS AH, 1999, AM PSYCH ASS ANN C B; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Tulsky DS, 2000, PSYCHOL ASSESSMENT, V12, P253, DOI [10.1037/1040-3590.12.3.253, 10.1037//1040-3590.12.3.253]; Tulsky DS, 2001, PSYCHOL ASSESSMENT, V13, P566, DOI 10.1037/1040-3590.13.4.566; Urbina S, 1997, PSYCHOL TESTING; VANDERPLOEG RD, 1995, ARCH CLIN NEUROPSYCH, V10, P225, DOI 10.1016/0887-6177(94)00042-O; Veiel HOF, 2001, PSYCHOL ASSESSMENT, V13, P356, DOI 10.1037/1040-3590.13.3.356; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	29	13	13	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB	2005	19	1					73	86		10.1080/13854040490888549			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	912YF	WOS:000228115300005	15814479				2022-02-06	
J	Cahill, LM; Murdoch, BE; Theodoros, DG				Cahill, LM; Murdoch, BE; Theodoros, DG			Articulatory function following traumatic brain injury in childhood: A perceptual and instrumental analysis	BRAIN INJURY			English	Article							TONGUE STRENGTH; SPEECH; DYSARTHRIA; FORCE	Primary objective: To investigate the articulatory function of a group of children with traumatic brain injury (TBI), using both perceptual and instrumental techniques. Research design: The performance of 24 children with TBI was assessed on a battery of perceptual (Frenchay Dysarthria Assessment, Assessment of Intelligibility of Dysarthric Speech and speech sample analysis) and instrumental ( lip and tongue pressure transduction systems) assessments and compared with that of 24 non-neurologically impaired children matched for age and sex. Main outcomes: Perceptual assessment identified consonant and vowel imprecision, increased length of phonemes and overall reduction in speech intelligibility, while instrumental assessment revealed significant impairment in lip and tongue function in the TBI group, with rate and pressure in repetitive lip and tongue tasks particularly impaired. Significant negative correlations were identified between the degree of deviance of perceptual articulatory features and decreased function on many non-speech measures of lip function, as well as maximum tongue pressure and fine force tongue control at 20% of maximum tongue pressure. Additionally, sub-clinical articulatory deficits were identified in the children with TBI who were non-dysarthric. Conclusion: The results of the instrumental assessment of lip and tongue function support the finding of substantial articulatory dysfunction in this group of children following TBI. Hence, remediation of articulatory function should be a therapeutic priority in these children.	Univ Queensland, Brisbane, Qld, Australia		Cahill, LM (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Div Speech Pathol, St Lucia, Qld 4072, Australia.	l.cahill@uq.edu.au	Cahill, Louise/C-7919-2012	Cahill, Louise/0000-0003-3662-896X			Abbs J. H., 1983, CLIN DYSARTHRIA, P21; ABBS JH, 1973, PHONETICA, V28, P65, DOI 10.1159/000259446; ABBS JH, 1986, INVARIANCE VARIABILI, P202; Barlow S. W., 1989, NEURAL BASES SPEECH, P146; BARLOW SM, 1983, J SPEECH HEAR RES, V26, P616, DOI 10.1044/jshr.2604.616; BARLOW SM, 1986, EXP NEUROL, V94, P699, DOI 10.1016/0014-4886(86)90248-7; BARLOW SM, 1989, RECENT ADVANCES IN CLINICAL DYSARTHRIA, P53; BARLOW SM, 1990, J SPEECH HEAR RES, V33, P660, DOI 10.1044/jshr.3304.660; BARLOW SM, 1988, ASS RES OT ABSTR, V11, P218; Brown J.R., 1975, MOTOR SPEECH DISORDE; Cahill LM, 2002, BRAIN INJURY, V16, P415, DOI 10.1080/02699050110119871; Cahill LM, 2000, J MED SPEECH-LANG PA, V8, P347; CAHILL LM, 2001, ASIA PAC J SPEECH LA, V6, P33; DWORKIN JP, 1986, J COMMUN DISORD, V19, P115, DOI 10.1016/0021-9924(86)90015-8; ENDERBY P, 1986, BRIT J DISORD COMMUN, V21, P189; Enderby P, 1983, FRENCHAY DYSARTHRIA; Goozee J V, 2001, Logoped Phoniatr Vocol, V26, P51; Goozee JV, 2002, FOLIA PHONIATR LOGO, V54, P177, DOI 10.1159/000063191; Hartelius L., 1993, SCAN J LOGOP PHONIAT, V18, P131, DOI [10.3109/14015439309101359, DOI 10.3109/14015439309101359]; HINTON VA, 1992, J SPEECH HEAR RES, V35, P245, DOI 10.1044/jshr.3502.245; HIROSE H, 1978, J SPEECH HEAR DISORD, V43, P96, DOI 10.1044/jshd.4301.96; HUGHES OM, 1976, PHONETICA, V33, P199; Jaeger M, 2000, FOLIA PHONIATR LOGO, V52, P187, DOI 10.1159/000021533; KENNEDY JG, 1989, NEURAL BASES SPEECH, P111; LANGMORE SE, 1994, J SPEECH HEAR RES, V37, P28, DOI 10.1044/jshr.3701.28; LUBKER JF, 1970, J ACOUST SOC AM, V42, P625; Ludlow C., 1984, DYSARTHRIAS PHYSL AC, P163; LUSCHEI ES, 1991, DYSARTHRIA AND APRAXIA OF SPEECH, P3; Muller E. M., 1985, Mathematics and computers in biomedical applications, P363; Murdoch B E, 1998, Motor Control, V2, P148; Murdoch BE, 1998, DYSARTHRIA PHYSL APP, P176; MURDOCH BE, 1998, DYSARTHRIA PHYSL APP, P373; Netsell R., 1982, SPEECH MOTOR CONTROL, P247, DOI [10.1016/B978-0-08-028892-5.50024-4, DOI 10.1016/B978-0-08-028892-5.50024-4]; ORSTRY DJ, 1997, J SPEECH LANG HEAR R, V40, P1341; ROBIN DA, 1991, DYSARTHRIA AND APRAXIA OF SPEECH, P173; ROBIN DA, 1992, J SPEECH HEAR RES, V35, P1239, DOI 10.1044/jshr.3506.1239; ROSENBEK JC, 1978, CLIN MANAGEMENT NEUR, P251; Stierwalt JAG, 1996, DISORDERS MOTOR SPEE, P241; TEASDALE G, 1974, LANCET, V2, P81; Theodoros D G, 1998, Pediatr Rehabil, V2, P107; Theodoros D. G., 2001, TRAUMATIC BRAIN INJU, p[53, 75]; THEODOROS DG, 1995, BRAIN INJURY, V9, P237, DOI 10.3109/02699059509008196; Thompson EC, 1995, EUR J DISORDER COMM, V30, P451; THOMPSON EC, 1997, J MED SPEECH-LANG PA, V5, P191; Yorkston K.M., 1981, ASSESSMENT INTELLIGI; ZIEGLER W, 1986, BRIT J DISORD COMMUN, V21, P173; [No title captured]	47	13	13	0	8	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	2005	19	1					41	58		10.1080/02699050410001719961			18	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	875AS	WOS:000225392600005	15762100				2022-02-06	
J	Hoofien, D; Barak, O; Vakil, E; Gilboa, A				Hoofien, D; Barak, O; Vakil, E; Gilboa, A			Symptom checklist-90 revised scores in persons with traumatic brain injury: Affective reactions or neurobehavioral outcomes of the injury?	APPLIED NEUROPSYCHOLOGY			English	Article						affective-disorders; psychological-assessment; symptom-checklists; traumatic-brain-injury	BECK DEPRESSION INVENTORY; PSYCHIATRIC-DISORDERS; SCL 90-R; HEAD-INJURY; INDIVIDUALS; SCL-90-R; TUMOR; MMPI	The goal of this study was to examine the concurrent validity of the Symptom Checklist-90 Revised (SCL-90-R) as a measure of emotional distress among persons with traumatic brain injuries (TBI). Following previous studies, the scale was divided into a "Brain Injury Subscale " (BIS), composed of items that are confounded with the neurobehavioral outcomes of TBI, and a "Non Brain Injury Subscale" (NBIS), composed of items unrelated to the neurobehavioral outcomes. The scores of 94 persons with TBI were analyzed on the two subscales. Although more frequently endorsed, the BIS items were equally related to the cognitive and behavioral outcomes of the injury and to the respondents' affective dispositions. The same pattern of correlations was evident with the NBIS items. In addition, both scales were predicted by measures of emotional reactions to the injury. These results were interpreted as supporting the validity of the SCL-90-R as a measure of emotional distress among persons with brain injuries.	Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel; Natl Inst Rehabil Persons Brain Injury, Dept Psychol, Tel Aviv, Israel; Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel; Univ Toronto, Dept Psychol, Toronto, ON, Canada		Hoofien, D (corresponding author), Hebrew Univ Jerusalem, Dept Psychol, IL-91905 Jerusalem, Israel.	mshoofi@msec.huji.ac.il		Gilboa, Asaf/0000-0002-4530-7490			ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P111; ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; ALMAGOR M, 1978, J ABNORM PSYCHOL, V3, P377; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anderson S. W., 1989, CLIN NEUROPSYCHOL, V3, P327, DOI DOI 10.1080/13854048908401482; Brooks D N, 1979, Int Rehabil Med, V1, P160; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; COREY MR, 1987, COGNITIVE REHABILITA, V5, P28; Couture, 1984, BEHAV ASSESSMENT REH, P247; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; Derogatis LR, 1994, SCL 90 R SYMPTOM CHE; GASS CS, 1991, J CLIN PSYCHOL, V47, P253, DOI 10.1002/1097-4679(199103)47:2<253::AID-JCLP2270470210>3.0.CO;2-A; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; Green A, 2001, BRAIN INJURY, V15, P1021, DOI 10.1080/02699050110074187; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoofien D, 2001, BRAIN INJURY, V15, P189; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kaplan CP, 1998, J HEAD TRAUMA REHAB, V13, P94, DOI 10.1097/00001199-199806000-00009; Kaplan CP, 1998, BRAIN INJURY, V12, P977, DOI 10.1080/026990598122025; Kaplan CP, 1998, BRAIN INJURY, V12, P199, DOI 10.1080/026990598122674; Langer KG, 1999, PSYCHOTHERAPEUTIC INTERVENTIONS FOR ADULTS WITH BRAIN INJURY OR STROKE: A CLINICIAN'S TREATMENT RESOURCE, P75; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LINKOWSKI DC, 1971, REHABIL COUNS BULL, V14, P236; MELAMED S, 1992, Brain Injury, V6, P233, DOI 10.3109/02699059209029665; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nadler A, 1982, SERIES CLIN COMMUNIT, V8, P375; Newburn G, 1998, CNS DRUGS, V9, P441, DOI 10.2165/00023210-199809060-00003; NOVACK TA, 1984, INT J CLIN NEUROPSYC, V6, P139; ODONNELL WE, 1984, J CLIN PSYCHOL, V40, P241, DOI 10.1002/1097-4679(198401)40:1<241::AID-JCLP2270400147>3.0.CO;2-6; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; ROSKIN M, 1984, ISRAEL J PSYCHIAT, V21, P73; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; SILBERG S, 1983, THESIS TEL AVIV U IS; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; SOLOMON Z, 1989, SOC PSYCH PSYCH EPID, V24, P41, DOI 10.1007/BF01788199; SOLOMON Z, 1992, FAM PROCESS, V31, P289, DOI 10.1111/j.1545-5300.1992.00289.x; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); TIFFIN J, 1968, PURDUE PEG BOARD EXA; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Wechsler, 1997, WECHSLER ADULT INTEL; WOESSNER R, 1995, J HEAD TRAUMA REHAB, V10, P78, DOI 10.1097/00001199-199504000-00009	44	13	14	0	0	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282	1532-4826		APPL NEUROPSYCHOL	Appl. Neuropsychol.		2005	12	1					30	39		10.1207/s15324826an1201_6			10	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	916UT	WOS:000228412400006	15788221				2022-02-06	
J	Kaymaz, M; Emmez, H; Bukan, N; Dursun, A; Kurt, G; Pasaoglu, H; Pasaoglu, A				Kaymaz, M; Emmez, H; Bukan, N; Dursun, A; Kurt, G; Pasaoglu, H; Pasaoglu, A			Effectiveness of FK506 on lipid peroxidation in the spinal cord following experimental traumatic injury	SPINAL CORD			English	Article						spinal cord injury; FK-506; lipid peroxidation; methylprednisolone	NITRIC-OXIDE; CYCLOSPORINE-A; SIGNAL TRANSDUCTION; RAT-BRAIN; CALCINEURIN; ISCHEMIA; FK-506; ACTIVATION; PROTEIN; ENZYME	Study design: An in vivo study in Wistar albino rats with injured spinal cord. Setting Department of Neurosurgery, Biochemistry and Pathology, Gazi University, Ankara, Turkey. Objectives: The aim of this study was to investigate and compare the effects of FK506 an immunosupressive agent with methylprednisolone (MP) on lipid peroxidation (LP) in injured spinal cord tissue. Method: A total of 28 adult healthy Wistar albino rats were subjected to traumatic spinal cord injuries (SCI) by using an aneurysmal clip compression technique, and they were divided into four groups. The G1 group (n=8) received FK506 (1 mg/kg); the G2 group (n=8) received FK506 (1 mg/kg) and MP (30 mg/kg); the G3 group (n=6) received only MP (30 mg/kg); and the G4 group (n=6) received no medication. The injured spinal cord tissue was studied by means of lipid peroxides, malondialdehyde (MDA), with thiobarbituric acid reaction and additionally the FK506 (G1); the MP ( G3) groups were studied for histopathologic alterations 72 h after SCI with eight separate animals. Results: Although LP values of G1, G2, G3 showed no statistical difference between intergroup analyses (P=0.547), a histopathological examination revealed that in the group that received MP, the oedema pattern was more significant than the group that received FK506. Another interesting finding was the presence of polymorphonuclear leucocytes in the MP group, whereas no infiltration was found in the FK506 group. Conclusion: Analysis of the results indicated that FK506 is a valuable pharmacological agent that could be used to decrease the LP and polymorphonuclear leucocyte infiltration and in. amatory reactions in the injured spinal cord tissue.	Gazi Univ, Sch Med, Dept Neurosurg, Ankara, Turkey; Gazi Univ, Sch Med, Dept Biochem, Ankara, Turkey; Gazi Univ, Sch Med, Dept Pathol, Ankara, Turkey		Kaymaz, M (corresponding author), Hokukcu Dostlar Sitesi 31, TR-06530 Ankara, Turkey.						Adams DH, 1996, HEPATOLOGY, V23, P1476, DOI 10.1002/hep.510230626; AMSTRONG DL, 1989, TRENDS NEUROSCI, V12, P117; Anderson D K, 1985, Cent Nerv Syst Trauma, V2, P257; ASPBERG A, 1994, FREE RADICAL BIO MED, V17, P511, DOI 10.1016/0891-5849(94)90090-6; Banik N L, 1984, Cent Nerv Syst Trauma, V1, P131; Bavetta S, 1999, EXP NEUROL, V158, P382, DOI 10.1006/exnr.1999.7119; BLIGHT AR, 1992, J NEUROTRAUM, V9, P147, DOI 10.1089/neu.1992.9.147; BRAUGHLER JM, 1985, J NEUROSURG, V62, P806, DOI 10.3171/jns.1985.62.6.0806; BRAUGHLER JM, 1982, J NEUROSURG, V56, P838, DOI 10.3171/jns.1982.56.6.0838; BULKLEY GB, 1983, SURGERY, V94, P407; BURNETT D, 1994, BIOCHEM PHARMACOL, V48, P1081, DOI 10.1016/0006-2952(94)90143-0; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; DAWSON TM, 1993, P NATL ACAD SCI USA, V90, P9808, DOI 10.1073/pnas.90.21.9808; DEFRANCO AL, 1991, NATURE, V352, P754, DOI 10.1038/352754a0; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; GOTO S, 1986, BRAIN RES, V397, P161, DOI 10.1016/0006-8993(86)91381-8; HALL ED, 1986, J NEUROSURG, V64, P951, DOI 10.3171/jns.1986.64.6.0951; HALLIWELL B, 1985, TRENDS NEUROSCI, V8, P22, DOI 10.1016/0166-2236(85)90010-4; Hamada Y, 1996, FREE RADICAL BIO MED, V20, P1, DOI 10.1016/0891-5849(95)02017-9; HAPPEL RD, 1981, BRAIN RES, V211, P476, DOI 10.1016/0006-8993(81)90976-8; HOM JT, 1993, CLIN IMMUNOL IMMUNOP, V68, P293, DOI 10.1006/clin.1993.1130; KANDEL ER, 1991, VOLTAGE GATED ION CH, P104; Kaptanoglu E, 2000, J NEUROSURG, V93, P77, DOI 10.3171/spi.2000.93.1.0077; Kaptanoglu E, 1999, J NEUROSURG, V91, P200, DOI 10.3171/spi.1999.91.2.0200; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; LIU J, 1992, BIOCHEMISTRY-US, V31, P3896, DOI 10.1021/bi00131a002; Morioka M, 1999, PROG NEUROBIOL, V58, P1, DOI 10.1016/S0301-0082(98)00073-2; NISHINAKA Y, 1993, J CARDIOVASC PHARM, V21, P448, DOI 10.1097/00005344-199303000-00015; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; SIEKIERKA JJ, 1989, J IMMUNOL, V143, P1580; SIGAL NH, 1992, ANNU REV IMMUNOL, V10, P519, DOI 10.1146/annurev.iy.10.040192.002511; STARZL TE, 1989, LANCET, V2, P1000; Taoka Y, 1998, J NEUROSCI, V18, P1393; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Toung TJ, 1999, STROKE, V30, P1279, DOI 10.1161/01.STR.30.6.1279; Vaquero J, 1999, J NEUROSURG, V90, P220, DOI 10.3171/spi.1999.90.2.0220; YOUNG W, 1986, BRAIN RES, V365, P42, DOI 10.1016/0006-8993(86)90720-1	39	13	18	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393			SPINAL CORD	Spinal Cord	JAN	2005	43	1					22	26		10.1038/sj.sc.3101621			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	884ZP	WOS:000226125500003	15111998	Bronze			2022-02-06	
J	Logan, MP; Parker, S; Shi, RY				Logan, MP; Parker, S; Shi, RY			Glutathione and ascorbic acid enhance recovery of guinea pig spinal cord white matter following ischemia and acrolein exposure	PATHOBIOLOGY			English	Article						neurotrauma; oxygen glucose deprivation; reperfusion; membrane; antioxidants	AXONAL MEMBRANE DISRUPTION; LIPID-PEROXIDATION; MYELINATED AXONS; CONDUCTION LOSS; PROTEIN DAMAGE; INJURY; AUGMENTATION; IMPAIRMENT; MECHANISMS; RESISTANCE	Objective:We have shown that acrolein, a lipid peroxidation byproduct, can inflict significant damage in isolated spinal cord white matter following oxygen glucose deprivation (OGD). The mechanism of such acrolein-induced damage is unclear. The aim of this study was to examine whether glutathione (GSH) and ascorbic acid, two reactive oxygen species (ROS) scavengers, can alleviate functional and anatomical damage due to acrolein. Methods: We used an OGD injury model with isolated guinea pig spinal cord white matter. Sucrose gap recording was used to monitor axonal impulse conduction, and a horseradish peroxidase exclusion test was employed to determine membrane integrity. The functional and anatomical parameters were compared in three groups: acrolein, acrolein/GSH and acrolein/ascorbic acid. Results:We found that while GSH resulted in an 87% recovery of compound action potential conductance, ascorbic acid produced a 97% recovery, compared with a 69% recovery in an injured group without treatment. It is noted that GSH, and to a lesser extent ascorbic acid, preferentially enhanced functional recovery in smaller axons. Conclusion: Acrolein-induced neuronal damage is likely mediated by ROS. Furthermore, GSH and ascorbic acid are effective in suppressing acrolein and free radical-induced injury in spinal cord white matter. Copyright (C) 2005 S. Karger AG, Basel.	Purdue Univ, Sch Vet Med, Dept Basic Med Sci, Ctr Paralysis Res, W Lafayette, IN 47907 USA; Purdue Univ, Sch Vet Med, Lafayette Ctr Med Educ, W Lafayette, IN 47907 USA		Shi, RY (corresponding author), Purdue Univ, Sch Vet Med, Dept Basic Med Sci, Ctr Paralysis Res, W Lafayette, IN 47907 USA.	riyi@purdue.edu					ALLEN BT, 1995, VASCULAR SURG THEORY, P1402; Arai M, 1999, J BIOL CHEM, V274, P4924, DOI 10.1074/jbc.274.8.4924; BEMENT SL, 1969, EXP NEUROL, V24, P147, DOI 10.1016/0014-4886(69)90012-0; BLIGHT AR, 1985, NEUROSCIENCE, V15, P13, DOI 10.1016/0306-4522(85)90119-8; Chakraborty H, 2001, NEUROCHEM INT, V39, P311, DOI 10.1016/S0197-0186(00)00117-0; CHAN PH, 1993, PROG BRAIN RES, V96, P97; CHAN WCW, 2000, P SOC PHOTO-OPT INS, V1, P2; HAENEN GRMM, 1988, BIOCHEM PHARMACOL, V37, P1933, DOI 10.1016/0006-2952(88)90539-4; Hall E D, 1991, J Neurotrauma, V8 Suppl 1, pS31; HALL ED, 1989, CRIT CARE CLIN, V5, P793; HALL ED, 1992, J NEUROTRAUM, V9, pS425; Hall ED, 1991, J NEUROTRAUM, V8, pS1; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Heales SJR, 2002, NEUROCHEM INT, V40, P469, DOI 10.1016/S0197-0186(01)00117-6; Kamencic H, 2001, FASEB J, V15, P243, DOI 10.1096/fj.00-0228com; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lucas JH, 2003, J NEUROTRAUM, V20, P1067; Lucas JH, 2002, J NEUROTRAUM, V19, P763, DOI 10.1089/08977150260139138; Luo H, 2004, NEUROCHEM INT, V44, P475, DOI 10.1016/j.neuint.2003.09.006; LUO J, 2003, NEUROBIOL LIPIDS, V2; LUO J, 2003, NEUROBIOL LIPIDS, V3; Nardini M, 2002, TOXICOLOGY, V170, P173, DOI 10.1016/S0300-483X(01)00540-6; Peasley MA, 2003, J NEUROL SCI, V216, P23, DOI 10.1016/S0022-510X(03)00201-6; Peasley MA, 2002, AM J PHYSIOL-CELL PH, V283, pC980, DOI 10.1152/ajpcell.00591.2001; Pocernich CB, 2001, NEUROCHEM INT, V39, P141, DOI 10.1016/S0197-0186(01)00012-2; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; RICE ME, 1994, J NEUROPHYSIOL, V71, P1591, DOI 10.1152/jn.1994.71.4.1591; ROSE RC, 1993, FASEB J, V7, P1135, DOI 10.1096/fasebj.7.12.8375611; SATRAN R, 1988, Stroke, V19, P529; Shi R., 1996, Society for Neuroscience Abstracts, V22, P1185; Shi R, 1999, J NEUROPHYSIOL, V81, P2406, DOI 10.1152/jn.1999.81.5.2406; Shi R, 1997, NEUROSCIENCE, V77, P553, DOI 10.1016/S0306-4522(96)00477-0; Shi R, 2002, NEUROSCIENCE, V115, P337, DOI 10.1016/S0306-4522(02)00457-8; Shi R, 2000, J NEUROCYTOL, V29, P633, DOI 10.1023/A:1010879219775; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shi R, 1996, J NEUROPHYSIOL, V76, P1572, DOI 10.1152/jn.1996.76.3.1572; Shi RY, 2000, J NEUROPHYSIOL, V84, P1763, DOI 10.1152/jn.2000.84.4.1763; Stys PK, 1998, J CEREBR BLOOD F MET, V18, P2, DOI 10.1097/00004647-199801000-00002; Stys PK, 1998, NEUROSCIENCE, V82, P21; WAXMAN SG, 1993, ANN NEUROL, V33, P121, DOI 10.1002/ana.410330202; WEST DC, 1983, J PHYSIOL-LONDON, V337, P37, DOI 10.1113/jphysiol.1983.sp014610; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5	42	13	18	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-2008	1423-0291		PATHOBIOLOGY	Pathobiology		2005	72	4					171	178		10.1159/000086786			8	Cell Biology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Pathology	961ZE	WOS:000231700000001	16127292				2022-02-06	
J	Mulholland, PJ; Stepanyan, TD; Self, RL; Hensley, AK; Harris, BR; Kowalski, A; Littleton, JM; Prendergast, MA				Mulholland, PJ; Stepanyan, TD; Self, RL; Hensley, AK; Harris, BR; Kowalski, A; Littleton, JM; Prendergast, MA			Corticosterone and dexamethasone potentiate cytotoxicity associated with oxygen-glucose deprivation in organotypic cerebellar slice cultures	NEUROSCIENCE			English	Article						glucocorticoids; stroke; RU486; trolox; neuronal damage	METHYL-D-ASPARTATE; TRAUMATIC BRAIN-INJURY; GLOBAL CEREBRAL-ISCHEMIA; PITUITARY-ADRENAL AXIS; MESSENGER-RNA LEVELS; NEURONAL CELL-DEATH; RAT-BRAIN; HIPPOCAMPAL-NEURONS; ACUTE STROKE; IN-VITRO	Many patients display elevated levels of serum cortisol following acute ischemic stroke. Given that glucocorticoids may potentiate some forms of insult, these studies examined the effects of corticosterone or dexamethasone exposure on cytotoxicity following oxygen-glucose deprivation in the cerebellum, a brain region susceptible to stroke. In organotypic cerebellar slice cultures prepared from neonatal rat pups, 90-min of oxygen-glucose deprivation at 15 days in vitro resulted in significant cytotoxicity at 24-, 48-, and 72-h post-oxygen-glucose deprivation, as measured by uptake of propidium iodide. Exposure of cultures following oxygen-glucose deprivation to the antioxidant trolox (500 mu M), but not to the glucocorticoid receptor antagonist RU486 (10 mu M), completely blocked oxygen-glucose deprivation-induced cytotoxicity. Corticosterone (1 mu M) or dexamethasone (10 mu M) exposure alone did not significantly increase propidium iodide uptake above levels observed in control cultures. However, corticosterone or dexamethasone exposure after oxygen-glucose deprivation potentiated oxygen-glucose deprivation-mediated propidium iodide uptake at each time point. Trolox, as well as RU486, co-exposure of cultures to corticosterone or dexamethasone after oxygen-glucose deprivation abolished all cytotoxicity. In conclusion, these data demonstrated that glucocorticoid exposure modulated oxygen-glucose deprivation-mediated propidium iodide uptake, which likely involved glucocorticoid receptor activation and pro-oxidant effects. (c) 2005 IBRO. Published by Elsevier Ltd. All rights reserved.	Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA; Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40506 USA; Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, AB Chandler Med Ctr, Lexington, KY 40536 USA		Mulholland, PJ (corresponding author), Med Univ S Carolina, Ctr Drug & Alcohol Progams IOP4N, Charleston, SC 29425 USA.	mulholl@musc.edu	Mulholland, Patrick J/L-9353-2017				Adachi N, 1998, J CEREBR BLOOD F MET, V18, P274, DOI 10.1097/00004647-199803000-00005; AGARDH CD, 1981, J CEREBR BLOOD F MET, V1, P71, DOI 10.1038/jcbfm.1981.8; AGARWAL MK, 1993, NEUROENDOCRINOLOGY, V58, P575, DOI 10.1159/000126593; AMARENCO P, 1991, NEUROLOGY, V41, P973, DOI 10.1212/WNL.41.7.973; Antonawich FJ, 1999, NEUROSCIENCE, V88, P319, DOI 10.1016/S0306-4522(98)00213-9; ARMANINI MP, 1990, BRAIN RES, V532, P7, DOI 10.1016/0006-8993(90)91734-X; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; BARTANUSZ V, 1995, NEUROSCIENCE, V66, P247, DOI 10.1016/0306-4522(95)00084-V; BAULIEU E, 1986, J STEROID BIOCHEM, V25, P847, DOI 10.1016/0022-4731(86)90315-8; BAULIEU EE, 1989, SCIENCE, V245, P1351, DOI 10.1126/science.2781282; Behl C, 1997, EUR J NEUROSCI, V9, P912, DOI 10.1111/j.1460-9568.1997.tb01442.x; BIRMINGHAM MK, 1993, CELL MOL NEUROBIOL, V13, P373, DOI 10.1007/BF00711578; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; CERVOSNAVARRO J, 1991, CRIT REV NEUROBIOL, V6, P149; Cherubini A, 2000, STROKE, V31, P2295, DOI 10.1161/01.STR.31.10.2295; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Christensen H, 2004, J NEUROL SCI, V217, P175, DOI 10.1016/j.jns.2003.09.013; CLEMENS JA, 1994, ANN NY ACAD SCI, V738, P250; DEKLOET R, 1975, ENDOCRINOLOGY, V96, P598, DOI 10.1210/endo-96-3-598; DOBKIN B, 1995, NEUROLOGY, V45, P6; Dobkin B H, 1991, Clin Geriatr Med, V7, P507; FASSBENDER K, 1994, STROKE, V25, P1105, DOI 10.1161/01.STR.25.6.1105; FEIBEL JH, 1977, JAMA-J AM MED ASSOC, V238, P1374, DOI 10.1001/jama.238.13.1374; FRANCESCHINI R, 1994, STROKE, V25, P2142, DOI 10.1161/01.STR.25.11.2142; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Gonzalez-Vidal MD, 1998, ARCH MED RES, V29, P117; Gottesman RF, 2003, INT REV PSYCHIATR, V15, P302, DOI 10.1080/09540260310001606683; Guerra-Araiza C, 2001, BRAIN RES BULL, V54, P13, DOI 10.1016/S0361-9230(00)00410-X; HEROS RC, 1982, STROKE, V13, P106, DOI 10.1161/01.STR.13.1.106; HEROS RC, 1992, STROKE, V23, P937, DOI 10.1161/01.STR.23.7.937; Jauss M, 1999, J NEUROL, V246, P257, DOI 10.1007/s004150050344; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; JUURLINK BHJ, 1993, DEV BRAIN RES, V71, P239, DOI 10.1016/0165-3806(93)90175-A; Kaasik A, 2001, NEUROSCIENCE, V102, P427, DOI 10.1016/S0306-4522(00)00489-9; KARST H, 1994, EUR J PHARM-ENVIRON, V270, P357, DOI 10.1016/0926-6917(94)90012-4; Kil HY, 1996, J CEREBR BLOOD F MET, V16, P100, DOI 10.1097/00004647-199601000-00012; KINUTA Y, 1989, J NEUROSURG, V71, P421, DOI 10.3171/jns.1989.71.3.0421; Krugers HJ, 2000, STROKE, V31, P1162, DOI 10.1161/01.STR.31.5.1162; KRUGERS HJ, 1995, BRAIN RES, V690, P41, DOI 10.1016/0006-8993(95)00585-E; KRUGERS HJ, 1993, NEUROSCI LETT, V154, P73, DOI 10.1016/0304-3940(93)90174-J; LAWRENCE MS, 1994, BRAIN RES, V646, P303, DOI 10.1016/0006-8993(94)90094-9; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P745, DOI 10.1016/j.cbpc.2004.09.014; McCullers D, 2002, NEUROSCIENCE, V109, P219, DOI 10.1016/S0306-4522(01)00477-8; Meijer OC, 1998, ENDOCRINOLOGY, V139, P1789, DOI 10.1210/en.139.4.1789; Mizuhashi S, 2000, NEUROSCI RES, V38, P35, DOI 10.1016/S0168-0102(00)00137-1; MJAATVEDT AE, 1991, J NEUROCYTOL, V20, P2, DOI 10.1007/BF01187130; MORSE JK, 1990, EXP NEUROL, V110, P86, DOI 10.1016/0014-4886(90)90053-U; Mulholland PJ, 2004, NEUROSCIENCE, V125, P671, DOI 10.1016/j.neuroscience.2004.02.007; MURROS K, 1993, J NEUROL SCI, V116, P12, DOI 10.1016/0022-510X(93)90083-B; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; OLSSON T, 1992, STROKE, V23, P1573, DOI 10.1161/01.STR.23.11.1573; OZMEN I, 1992, J ENZYM INHIB MED CH, V20, P19; PACKAN DR, 1990, NEUROENDOCRINOLOGY, V51, P613, DOI 10.1159/000125400; PARTHASARATHY S, 1994, J CLIN INVEST, V94, P1990, DOI 10.1172/JCI117551; Payne RS, 2003, BRAIN RES, V971, P9, DOI 10.1016/S0006-8993(03)02276-5; Payne RS, 2001, NEUROREPORT, V12, P1261, DOI 10.1097/00001756-200105080-00041; QIZILBASH N, 2002, COCHRANE DB SYST REV, V2; SAKAMOTO A, 1991, FREE RADICAL BIO MED, V11, P385, DOI 10.1016/0891-5849(91)90155-V; SAPOLSKY RM, 1985, SCIENCE, V229, P1397, DOI 10.1126/science.4035356; SAPOLSKY RM, 1986, J NEUROSCI, V6, P2240; Schurr A, 2002, NEUROCHEM INT, V41, P1, DOI 10.1016/S0197-0186(01)00142-5; Sherrard RM, 1997, J ANAT, V191, P177, DOI 10.1046/j.1469-7580.1997.19120177.x; Sousa N, 1999, NEUROSCIENCE, V89, P1079, DOI 10.1016/S0306-4522(98)00311-X; SOUSA RJ, 1989, MOL ENDOCRINOL, V3, P481, DOI 10.1210/mend-3-3-481; STEINBEHRENS BA, 1994, J NEUROCHEM, V63, P596; STEINBEHRENS BA, 1992, J NEUROCHEM, V58, P1730, DOI 10.1111/j.1471-4159.1992.tb10047.x; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Takahashi T, 2002, J NEUROCHEM, V83, P1441, DOI 10.1046/j.1471-4159.2002.01251.x; TOHGI H, 1993, STROKE, V24, P1697, DOI 10.1161/01.STR.24.11.1697; TRACEY F, 1993, Q J MED, V86, P439; Turgut M, 1996, ANGIOLOGY, V47, P841, DOI 10.1177/000331979604700902; TYMIANSKI M, 1994, BRAIN RES, V648, P291, DOI 10.1016/0006-8993(94)91129-0; VIELKIND U, 1990, J NEUROSCI RES, V27, P360, DOI 10.1002/jnr.490270315; VIRGIN CE, 1991, J NEUROCHEM, V57, P1422, DOI 10.1111/j.1471-4159.1991.tb08309.x; WADDINGTON G, 1982, J NEUROCHEM, V38, P1588, DOI 10.1111/j.1471-4159.1982.tb06637.x; Weiland NG, 1997, NEUROSCIENCE, V78, P653, DOI 10.1016/S0306-4522(96)00619-7; WHITE BC, 1993, ANN EMERG MED, V22, P970, DOI 10.1016/S0196-0644(05)82737-4; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523; Yuan HB, 2004, ANESTHESIOLOGY, V100, P331, DOI 10.1097/00000542-200402000-00023; Yusim A, 2000, BRAIN RES, V870, P109, DOI 10.1016/S0006-8993(00)02407-0; Zheng S, 2003, NEUROSCIENCE, V118, P99, DOI 10.1016/S0306-4522(02)00767-4; Zimmer J, 2000, AMINO ACIDS, V19, P7, DOI 10.1007/s007260070029; ZINI I, 1992, NEUROSCI LETT, V138, P279, DOI 10.1016/0304-3940(92)90933-X	84	13	13	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		2005	136	1					259	267		10.1016/j.neuroscience.2005.07.043			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	985OH	WOS:000233386900023	16182452				2022-02-06	
J	Ryan, JJ; Carruthers, CA; Miller, LJ; Souheaver, GT; Gontkovsky, ST; Zehr, MD				Ryan, JJ; Carruthers, CA; Miller, LJ; Souheaver, GT; Gontkovsky, ST; Zehr, MD			Brief communication - the WASI matrix reasoning subtest: Performance in traumatic brain injury, stroke, and dementia	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						dementia; matrix reasoning; sensitivity; stroke; traumatic brain injury		Previous research reported that the WAIS-III Matrix Reasoning (MR) subtest was insensitive to the effects of traumatic brain injury (TBI), learning disability, and attention deficit hyperactivity disorder. This study was conducted to determine whether these findings generalize to the Wechsler Abbreviated Scale of Intelligence (WASI) MR subtest and to explore the subtest's sensitivity to other brain disorders. When 81 brain-damaged patients completed the WASI, the MR subtest was the highest score in the profile. For subgroups of TBI and Dementia, MR yielded the highest mean T-score. For patients with stroke, MR was the second highest mean. Subtest comparisons with estimated premorbid IQ suggested MR might show selective sensitivity. Results indicated no predictive validity for TBI, whereas MR was sensitive to the cognitive sequelae of stroke and dementia.	Cent Missouri State Univ, Dept Psychol, Warrensburg, MO 64093 USA; McClellan VAMC, Little Rock, AR USA; Methodist Rehabil Ctr, Jackson, MS USA; Med Res Ctr, Kansas City, MO USA		Ryan, JJ (corresponding author), Cent Missouri State Univ, Dept Psychol, Warrensburg, MO 64093 USA.	ryan@cmsu1.emsu.edu					BRODY N, 1992, INTELLIGENCE, P18; CATTELL RB, 1963, J EDUC PSYCHOL, V54, P1, DOI 10.1037/h0046743; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; KEEDY S, 1999, 107 ANN CONV AM PSYC; *PSYCH CORP, 2001, WECHSL TEST AD READ; Psychological Corporation, 1999, WECHSL ABBR SCAL INT; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M	8	13	14	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.	JAN	2005	115	1					129	136		10.1080/00207450490512704			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	885ED	WOS:000226139000011	15768857				2022-02-06	
J	Carre, E; Cantais, E; Darbin, O; Terrier, JP; Lonjon, M; Palmier, B; Risso, JJ				Carre, E; Cantais, E; Darbin, O; Terrier, JP; Lonjon, M; Palmier, B; Risso, JJ			Technical aspects of an impact acceleration traumatic brain injury rat model with potential suitability for both microdialysis and PtiO2 monitoring	JOURNAL OF NEUROSCIENCE METHODS			English	Article; Proceedings Paper	10th International Conference on In Vivo Methods	JUN 24-27, 2003	Karolinska Inst, Stockholm, SWEDEN		Karolinska Inst	traumatic brain injury; microdialysis; PuO2; weight-drop; impact acceleration; diffuse axonal injury; neuroprotection; methodology	AXONAL INJURY; HEAD-INJURY; NEUROPROTECTION	This report describes technical adaptations of a traumatic brain injury (TBI) model-largely inspired by Marmarou-in order to monitor microdialysis data and PtiO2 (brain tissue oxygen) before, during and after injury. We particularly focalize on our model requirements which allows us to re-create some drastic pathological characteristics experienced by severely head-injured patients: impact on a closed skull. no ventilation immediately after impact. presence of diffuse axonal injuries and secondary brain insults from systemic origin... We notably give priority to minimize anaesthesia duration in order to tend to banish any neuroprotection. Our new model will henceforth allow a better understanding of neurochemical and biochemical alterations resulting from traumatic brain injury, using microdialysis and PtiO2 techniques already monitored in our Intensive Care Unit. Studies on efficiency and therapeutic window of neuroprotective pharmacological molecules are now conceivable to ameliorate severe head-injury treatment. (C) 2004 Elsevier B.V. All rights reserved.	IMNSSA, Dept Neurochem, F-83800 Toulon, France; HIA St Anne, Intens Care Unit, F-83800 Toulon, France; Sch Med, Dept Neurol, Springfield, IL USA; HIA St Anne, Dept Pathol, F-83800 Toulon, France; CHU Pasteur, Dept Neurosurg, Nice, France		Carre, E (corresponding author), IMNSSA, Dept Neurochem, BP 610, F-83800 Toulon, France.	emilie_carre@hotmail.com		Darbin, Olivier/0000-0003-1461-8517			Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; *FRENCH SOC AN INT, 1999, ANN FR ANESTH, V18, P1; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Kawaguchi M, 2000, ANESTHESIOLOGY, V92, P1335, DOI 10.1097/00000542-200005000-00023; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; PAXINOS J, 1982, RAT BRAIN STEREOTAXI; Piper IR, 1996, J NEUROSCI METH, V69, P171, DOI 10.1016/S0165-0270(96)00046-5; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Warner DS, 2000, ANESTHESIOLOGY, V92, P1226	12	13	15	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	DEC 30	2004	140	1-2					23	28		10.1016/j.jneumeth.2004.04.037			6	Biochemical Research Methods; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	885TO	WOS:000226180100005	15589330	Green Submitted			2022-02-06	
J	Krakowski, MI; Czobor, P				Krakowski, MI; Czobor, P			Psychosocial risk factors associated with suicide attempts and violence among psychiatric inpatients	PSYCHIATRIC SERVICES			English	Article							TRAUMATIC BRAIN INJURY; CHILDREN; BEHAVIOR; PERSONALITY; AGGRESSION	Objectives: To better understand the relationship between suicidal behavior and violence directed toward others among patients with major psychiatric disorders, this study examined how suicide attempts and violent behaviors were associated with various psychosocial problems. Methods: Participants were inpatients in two psychiatric state hospitals. They included 216 inpatients who had physically assaulted another patient or a staff member and a comparison group of 81 inpatients who had not assaulted anyone. History of suicide attempts and historical information about various risk factors for violence and suicide were obtained through chart review and patient interviews. Results: Patients in the violent group did not differ from those in the nonviolent group in whether they had attempted suicide. Suicide attempts and violence were associated with different historical variables. Suicide attempts were associated with a history of head trauma, harsh parental discipline, and parental psychopathology. Violence against others was associated with having a history of school truancy and foster home placement. Conclusions: Among inpatients with major psychiatric disorders, violence and suicide attempts were not related to each other and were associated with dissimilar psychosocial risk factors.	Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; NYU, Dept Psychiat, New York, NY USA; Nathan S Kline Inst Psychiat Res, Orangeburg, NY USA; DOV Pharmaceut, Hackensack, NJ USA		Krakowski, MI (corresponding author), Nathan S Kline Inst Psychiat Res, 140 Old Orangeburg Rd, Orangeburg, NY 10962 USA.	krakow@nki.rfmh.org			NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH058341] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01-MH-58341] Funding Source: Medline		ANGST J, 1986, COMPR PSYCHIAT, V27, P511, DOI 10.1016/0010-440X(86)90055-6; BERG I, 1982, BRIT J PSYCHIAT, V141, P208, DOI 10.1192/bjp.141.2.208; Brodsky BS, 1997, AM J PSYCHIAT, V154, P1715, DOI 10.1176/ajp.154.12.1715; CAMPBELL SB, 1995, J CHILD PSYCHOL PSYC, V36, P113, DOI 10.1111/j.1469-7610.1995.tb01657.x; CICCHETTI D, 1991, ROCH S DEV PSYCH, V16; DOWNEY G, 1990, PSYCHOL BULL, V108, P50, DOI 10.1037/0033-2909.108.1.50; FERGUSSON DM, 1995, NEW ZEAL J EDUC STUD, V30, P25; GARFINKEL BD, 1982, AM J PSYCHIAT, V139, P1257; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; KIENHORST CWM, 1990, SUICIDE LIFE-THREAT, V20, P101; Krakowski M, 1999, SCHIZOPHRENIA BULL, V25, P505, DOI 10.1093/oxfordjournals.schbul.a033397; Krakowski M, 1988, NEUROPSY NEUROPSY BE, V1, P21; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; LISHMAN WA, 1987, PSYCHOL CONSEQUENCES; Mann JJ, 1999, AM J PSYCHIAT, V156, P181; Monahan J., 2001, RETHINKING RISK ASSE; ROMANOV K, 1994, PSYCHOSOM MED, V56, P328, DOI 10.1097/00006842-199407000-00008; ROY A, 1986, SUICIDE LIFE-THREAT, V16, P244; Rutter M, 1999, J CHILD PSYCHOL PSYC, V40, P19, DOI 10.1111/1469-7610.00423; Santa Mina EE, 1998, CAN J PSYCHIAT, V43, P793, DOI 10.1177/070674379804300803; Schwab-Stone M, 1999, J AM ACAD CHILD PSY, V38, P359, DOI 10.1097/00004583-199904000-00007; SHAUNESEY K, 1993, AM J ORTHOPSYCHIAT, V63, P113, DOI 10.1037/h0079411; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Steadman HJ, 1998, ARCH GEN PSYCHIAT, V55, P393, DOI 10.1001/archpsyc.55.5.393; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; VANDERKOLK BA, 1991, AM J PSYCHIAT, V148, P1665; WEISS B, 1992, CHILD DEV, V63, P1321, DOI 10.2307/1131558; Zuravin SJ, 1997, SOC WORK RES, V21, P34, DOI 10.1093/swr/21.1.34; 1991, BLUEPRINT FOSTERING	30	13	13	0	7	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	1075-2730	1557-9700		PSYCHIAT SERV	Psychiatr. Serv.	DEC	2004	55	12					1414	1419		10.1176/appi.ps.55.12.1414			6	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	876LU	WOS:000225499200011	15572570				2022-02-06	
J	Parry, L; Shores, A; Rae, C; Kemp, A; Waugh, MC; Chaseling, R; Joy, P				Parry, L; Shores, A; Rae, C; Kemp, A; Waugh, MC; Chaseling, R; Joy, P			An investigation of neuronal integrity in severe paediatric traumatic brain injury	CHILD NEUROPSYCHOLOGY			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; PROTON MR SPECTROSCOPY; HEAD-INJURY; LOCALIZED PROTON; AXONAL INJURY; WHITE-MATTER; QUANTIFICATION; DAMAGE	Magnetic Resonance Spectroscopy (MRS) and its association with neuropsychological functioning was examined in the chronic injury phase of paediatric traumatic brain injury (TBI), Fifteen children, aged 10-16 years, with severe TBIs were compared with 15 controls, matched for age and gender. The TBI group was found to have significantly lower levels of N-acetyl aspartate (NAA) and Choline (Cho) in the right frontal lobe and generally displayed reduced performances on neuropsychological tests. A correlation between metabolites and reaction times was also obtained. Findings indicate a role of proton MRS as a measure of neuronal integrity following severe paediatric TBI and suggest a potential association of MRS with specific neuropsychological impairments.	Childrens Hosp, Rehabil Dept, Westmead, NSW 2145, Australia; Childrens Hosp, Dept Radiol, Westmead, NSW, Australia; Childrens Hosp, Dept Neurosurg, Westmead, NSW, Australia; Childrens Hosp, Dept Dev Cognit Neuropsychol Res Unit, Westmead, NSW, Australia; Macquarie Univ, Dept Psychol & Linguist, Epping, NSW, Australia; Univ Sydney, Dept Biochem, Sydney, NSW 2006, Australia; Childrens Hosp, Child Dev Unit, Westmead, NSW, Australia		Parry, L (corresponding author), Childrens Hosp, Rehabil Dept, Cnr Hainsworth St,Hawkesbury Rd, Westmead, NSW 2145, Australia.		Rae, Caroline/B-7537-2008	Rae, Caroline/0000-0003-0673-8084; Shores, Edwin A/0000-0003-1553-5131			Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Ashwal S, 2000, PEDIATR NEUROL, V23, P114, DOI 10.1016/S0887-8994(00)00176-4; Bigler ED, 1999, J HEAD TRAUMA REHAB, V14, P406, DOI 10.1097/00001199-199908000-00009; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Brenner T, 2003, PEDIATR NEUROL, V28, P104, DOI 10.1016/S0887-8994(02)00491-5; BROMAN M, 1995, TRAUMATIC HEAD INJUR; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; *CENES, 1999, CANTAB WIND; Cheng L. L., 2001, P INT SOC MAGN RES M, V9, P1672; CHOE BY, 1995, INVEST RADIOL, V30, P502, DOI 10.1097/00004424-199508000-00008; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Condon B, 1998, J NEUROTRAUM, V15, P563, DOI 10.1089/neu.1998.15.563; DANIELSEN ER, 1999, MAGNETIC RESONANCE S; Elliot CD., 1990, DIFFERENTIAL ABILITY; FLETCHER JM, 1995, TRAUMATIC HEAD INJUR, P3; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2001, CURR OPIN NEUROL, V14, P753, DOI 10.1097/00019052-200112000-00012; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; JENNETT B, 1975, LANCET, V1, P480; Jones NR, 1998, J CLIN NEUROSCI, V5, P73, DOI 10.1016/S0967-5868(98)90207-7; Jung RE, 1999, NEUROREPORT, V10, P3327, DOI 10.1097/00001756-199911080-00014; Jung RE, 1999, P ROY SOC B-BIOL SCI, V266, P1375, DOI 10.1098/rspb.1999.0790; KOLB B, 1996, FUNDAMENTALS HUMAN N; Komoroski RA, 1999, MAGN RESON IMAGING, V17, P427, DOI 10.1016/S0730-725X(98)00186-6; MAROSSZEKY NEV, 1993, CLIN NEUROPSYCHOL, V7, P85, DOI 10.1080/13854049308401890; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1007/BF02668096; Novotny E, 1998, PEDIATR RES, V44, P1, DOI 10.1203/00006450-199807000-00001; PIJNAPPEL WWF, 1992, J MAGN RESON, V97, P122, DOI 10.1016/0022-2364(92)90241-X; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; ROSS BD, 1998, J MAGNETIC RESONANCE, V8; Sinson G, 2001, AM J NEURORADIOL, V22, P143; TZIKA AA, 1993, JMRI-J MAGN RESON IM, V3, P719, DOI 10.1002/jmri.1880030506; Valenzuela MJ, 2000, NEUROIMAGE, V12, P747, DOI 10.1006/nimg.2000.0629; VANDERKNAAP MS, 1990, RADIOLOGY, V176, P509, DOI 10.1148/radiology.176.2.2164237; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Wang Y, 1998, MAGNET RESON MED, V39, P28, DOI 10.1002/mrm.1910390107; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zakzanis KK, 2001, ARCH CLIN NEUROPSYCH, V16, P653, DOI 10.1016/S0887-6177(00)00076-7	44	13	14	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	DEC	2004	10	4					248	261		10.1080/09297040490909279			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	888KR	WOS:000226373300002	15621848				2022-02-06	
J	Powell, EC; Tanz, RR				Powell, EC; Tanz, RR			Incidence and description of scooter-related injuries among children	AMBULATORY PEDIATRICS			English	Article						child injury; in-line skates; scooters; skateboards		Objective.-To describe trends in scooter-related injuries among US youth and compare scooter injuries to those related to in-line skates and skateboards. Design.-Retrospective review of data for children 1-19 years old from the National Electronic Injury Surveillance System of the US Consumer Product Safety Commission for 1997-2002. Results.-There were an estimated 190 878 scooter-related injuries (95% confidence interval: 145984-235773) among children treated in US emergency departments; 90% were in those 15 years old or younger. There was a marked increase in scooter-related injuries in 2000, injuries peaked in 2001, and declined. In 2002, the number of scooter-related injuries was similar to in-line skates and lower than skateboard-related injuries. Scooter- and in-fine skate-associated injuries primarily involved children 5-12 years old: rates of scooter-related injuries were higher than rates of in-line skate-associated injuries among those 1-9 years old. Skateboard-related injuries more often involved teens. Forearm fractures accounted for 56% of fractures related to scooters (vs 74% in-line skates and 49% skateboards, chi-square, P < .01). Five percent of children injured using scooters had a closed head injury or skull fracture, similar to in-line skates and skateboards. Conclusions.-The annual number of injuries related to scooters, which peaked in 2001, is now similar to the number of injuries related to in-line skates. Injuries related to scooters primarily involve children 5-12 years old, and forearm fractures are common. These data suggest helmets should be used, and protective equipment should be developed to reduce forearm fractures.	Childrens Mem Hosp, Div Pediat Emergency Med, Chicago, IL 60614 USA; Childrens Mem Hosp, Div Gen Acad Pediat, Chicago, IL 60614 USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL USA		Powell, EC (corresponding author), Childrens Mem Hosp, Div Pediat Emergency Med, Box 62,2300 Childrens Plaza, Chicago, IL 60614 USA.	epowell@northwestern.edu		Powell, Elizabeth/0000-0003-3147-9889			Bull MJ, 2002, PEDIATRICS, V109, P542; Chapman S, 2001, J PAEDIATR CHILD H, V37, P567, DOI 10.1046/j.1440-1754.2001.00763.x; *CONS PROD SAF COM, SCOOT SAL SKYR INJ S; Forjuoh SN, 2002, ARCH PEDIAT ADOL MED, V156, P656, DOI 10.1001/archpedi.156.7.656; HANNON B, 2004, TAIPEI TIMES; Kubiak R, 2003, ACTA PAEDIATR, V92, P50; Levine DA, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e64; Schieber RA, 1996, NEW ENGL J MED, V335, P1630, DOI 10.1056/NEJM199611283352202; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; *US BUR CENS, 2000 CENS POP HOUS; *US CONS PROD SAF, 1993, EXPL SHEET NEISS EST; *US CONS PROD SAF, 1996, CONSUMER PROD SAFETY, V1, P4; *US CONS PROD SAF, 1986, US CONS PROD SAF COM; US Consumer Product Safety Commission, TOY REL DEATHS INJ C; *USDHHS, NAT EL INJ SURV SYST; Weir E, 2002, CAN MED ASSOC J, V167, P55; 2000, MMWR, V49, P1108	17	13	13	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1530-1567			AMBUL PEDIATR	Ambul. Pediatr.	NOV-DEC	2004	4	6					495	499		10.1367/A04-074R1.1			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	873JI	WOS:000225275400006	15548100				2022-02-06	
J	Hartemink, KJ; Wisselink, W; Rauwerda, JA; Girbes, ARJ; Polderman, KH				Hartemink, KJ; Wisselink, W; Rauwerda, JA; Girbes, ARJ; Polderman, KH			Novel applications of therapeutic hypothermia: report of three cases	CRITICAL CARE			English	Article						neurological injury; neuroprotection; outcome; postanoxic injury; spinal cord ischaemia; therapeutic hypothermia	TRAUMATIC BRAIN-INJURY; PROMISING TREATMENT MODALITY; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; CARDIAC-ARREST; SPINAL-CORD; ISCHEMIA; OPPORTUNITIES; HYPERTHERMIA; TEMPERATURE	Therapeutic hypothermia can provide neuroprotection in various situations where global or focal neurological injury has occurred. Hypothermia has been shown to be effective in a large number of animal experiments. In clinical trials, hypothermia has been used in patients with postanoxic injury following cardiopulmonary resuscitation, in traumatic brain injury with high intracranial pressure, in the perioperative setting during various surgical procedures and for various other indications. There is thus evidence that hypothermia can be effective in various situations of neurological injury, although a number of questions remain unanswered. We describe three patients with unusual causes of neurological injury, whose clinical situation was in fundamental aspects analogous to conditions where hypothermia has been shown to be effective.	VU Univ Med Ctr, Dept Intens Care, Amsterdam, Netherlands; VU Univ Med Ctr, Dept Intens Care & Surg, Amsterdam, Netherlands; VU Univ Med Ctr, Dept Surg, Div Vasc Surg, Amsterdam, Netherlands		Polderman, KH (corresponding author), VU Univ Med Ctr, Dept Intens Care, Amsterdam, Netherlands.	k.polderman@tip.nl	Polderman, Kees H/K-3623-2012				Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Cambria RP, 1997, J VASC SURG, V25, P234, DOI 10.1016/S0741-5214(97)70365-3; Dixon SR, 2002, J AM COLL CARDIOL, V40, P1928, DOI 10.1016/S0735-1097(02)02567-6; FRANK SM, 1994, J VASC SURG, V19, P687, DOI 10.1016/S0741-5214(94)70043-5; Ginsberg MD, 1998, STROKE, V29, P529, DOI 10.1161/01.STR.29.2.529; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1250; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Kim Y, 1996, STROKE, V27, P2274, DOI 10.1161/01.STR.27.12.2274; Kimura A, 2002, CRIT CARE MED, V30, P1499, DOI 10.1097/00003246-200207000-00017; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MELLERGARD P, 1991, NEUROSURGERY, V28, P709, DOI 10.1227/00006123-199105000-00012; MEZROW CK, 1992, ANN THORAC SURG, V54, P609, DOI 10.1016/0003-4975(92)91002-Q; Nagao S, 2003, J CLIN NEUROSCI, V10, P208, DOI 10.1016/S0967-5868(02)00322-3; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Polderman KH, 2001, J NEUROSURG, V94, P853; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; Svensson LG, 1998, ANN THORAC SURG, V66, P132, DOI 10.1016/S0003-4975(98)00359-2; Thome C, 2001, ACTA NEUROCHIR SUPPL, V77, P255; WISSELINK W, 1994, J VASC SURG, V19, P788, DOI 10.1016/S0741-5214(94)70003-6	28	13	16	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	OCT	2004	8	5					R343	R346		10.1186/cc2928			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	869SG	WOS:000225003800036	15469578	gold, Green Published			2022-02-06	
J	Kim, MD; Min, DS; Sim, KB; Cho, HJ; Shin, T				Kim, MD; Min, DS; Sim, KB; Cho, HJ; Shin, T			Expression and potential role of phospholipase D1 in cryoinjured cerebral cortex of rats	HISTOLOGY AND HISTOPATHOLOGY			English	Article						brain injury; cryoinjury; macrophage; phospholipase D1	TRAUMATIC BRAIN-INJURY; UP-REGULATION; SPINAL-CORDS; CELLS; MACROPHAGES; DIFFERENTIATION; ASTROCYTES; APOPTOSIS	The expression and potential role of phospholipase D1 (PLD1) were studied in the cerebral cortex of rats after freeze injury. Histopathologic ally, cryoinjury, by exposing cerebral cortex to a prechilled rod for 1 minute, produced consistent pathological lesions, specifically neuronal death, infiltration of macrophages into the center of the cryoinjury, and reactive astrogliosis at the periphery, which caused the lesion site to become encased. Western blot analysis showed that PLD1 expression in the ipsilateral cerebral cortex increased significantly during days 1 to 3 after cryoinjury and declined slightly at post-injury day 7. PLD1 immunoreactivity was very low in the brains of sham-operated control adults. After cryoinjury, there was substantial PLD1 immunostaining of numerous inflammatory cells in the ipsilateral cortex, which were identical to ED1-positive macrophages. In addition, PLD1 immunoreactivity was increased in some neurons and astrocytes at the periphery of the cryoinjury at postinjury days 3 and 7. These findings suggest that cryoinjury by means of prechilled rods induced consistent histopathological changes in the cerebral cortex. In addition, expression of a cell activation signal, PLD1, was upregulated in macrophages and astrocytes in the ipsilateral cerebral cortex after cryoinjury.	Jeju Natl Univ, Dept Vet Med, Cheju 690756, South Korea; Jeju Natl Univ, Coll Med, Dept Psychiat, Cheju, South Korea; Pusan Natl Univ, Coll Nat Sci, Dept Biol Mol, Pusan 609735, South Korea; Jeju Natl Univ, Coll Med, Dept Neurosurg, Cheju, South Korea; Kyungpook Natl Univ, Sch Med, Dept Anat, Taegu 702701, South Korea		Shin, T (corresponding author), Jeju Natl Univ, Dept Vet Med, Cheju 690756, South Korea.	shint@cheju.ac.kr		SHIN, Taekyun/0000-0002-9851-4354			Ahn M, 2001, NEUROSCI LETT, V316, P95, DOI 10.1016/S0304-3940(01)02383-7; AIHARA N, 1995, J NEUROTRAUM, V12, P53, DOI 10.1089/neu.1995.12.53; Baldwin SA, 1996, GLIA, V16, P266; BOARDER MR, 1994, TRENDS PHARMACOL SCI, V15, P57, DOI 10.1016/0165-6147(94)90111-2; Cockcroft S, 1996, CHEM PHYS LIPIDS, V80, P59, DOI 10.1016/0009-3084(96)02546-7; Colley WC, 1997, BIOCHEM J, V326, P745, DOI 10.1042/bj3260745; diMarzo V, 1996, BIOCHEM J, V316, P977, DOI 10.1042/bj3160977; Frohman MA, 1999, BBA-MOL CELL BIOL L, V1439, P175, DOI 10.1016/S1388-1981(99)00093-1; Jung KS, 2003, NEUROSCI LETT, V336, P126, DOI 10.1016/S0304-3940(02)01155-2; Lee MY, 2000, BRAIN RES, V864, P52, DOI 10.1016/S0006-8993(00)02134-X; Lee MY, 2000, GLIA, V30, P311, DOI 10.1002/(SICI)1098-1136(200005)30:3<311::AID-GLIA10>3.0.CO;2-K; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Min DS, 1999, FEBS LETT, V454, P197, DOI 10.1016/S0014-5793(99)00798-X; Min DS, 2001, NEUROSCI LETT, V310, P125, DOI 10.1016/S0304-3940(01)02091-2; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nakashima S, 1999, CHEM PHYS LIPIDS, V98, P153, DOI 10.1016/S0009-3084(99)00027-4; Prewitt CMF, 1997, EXP NEUROL, V148, P433, DOI 10.1006/exnr.1997.6694; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Soares HD, 1995, J NEUROSCI, V15, P8223; Sun D, 2000, J NEUROPATH EXP NEUR, V59, P1031, DOI 10.1093/jnen/59.12.1031; Yoshimura S, 1997, J NEUROCHEM, V69, P713	22	13	14	0	0	F HERNANDEZ	MURCIA	PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN	0213-3911	1699-5848		HISTOL HISTOPATHOL	Histol. Histopath.	OCT	2004	19	4					1015	1019					5	Cell Biology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Pathology	864NF	WOS:000224639500001	15375744				2022-02-06	
J	Hung, YC; Montazem, A; Costello, MA				Hung, YC; Montazem, A; Costello, MA			The correlation between mandible fractures and loss of consciousness	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							CLOSED-HEAD INJURIES; FACIAL FRACTURES; IMPACT	Purpose: The purpose of the study was to evaluate the relationship between mandible fractures and loss of consciousness (LOC) in patients sustaining maxillofacial trauma in a level I trauma center. Patients and Methods: The study was a retrospective chart review performed at Lincoln Medical and Mental Health Center, a level I trauma center. A total of 225 hospital charts of patients who sustained mandible fractures during the period from 1997 to 2001 were reviewed. The site of fracture, number of fractures per mandible, degree of displacement, and mechanism of injury were recorded. Percentages of each category were compared among patients with positive and negative LOC. Patients with any concomitant craniofacial fractures or injuries were excluded from the study. Results: The incidence of LOC in patients sustaining mandible fractures was 17.6%. Young men were most likely to sustain mandibular fractures. The male-to-female ratio was 5.6:1. More than 70% of mandible fractures were due to interpersonal violence. Among various causes of interpersonal violence, use of a fist was most common. Overall, the number of fractures per patient, the incidence of singular versus multiple mandibular fractures, and the degree of displacement were less in the group with positive LOC. Body and angle regions were subjected to higher numbers of fractures, with slight variation among the 2 groups. The most common locations for mandibular fractures were the body (26% in negative LOC group; 42% in positive LOC group) and the angle (31% in negative LOC group; 26% in positive LOC group). Conclusion: Nearly 1 in 5 mandible fractures was associated with positive LOC. The patient group with a positive LOC, on average, sustained fewer fractures. It is possible that when the mandible sustained fewer fractures, the dissipation of energy was reduced and more force was transmitted to the cranial vault, thereby resulting in a higher incidence of LOC. (C) 2004 American Association of Oral and Ataxillofacial Surgeons.	Mt Sinai Hosp, Dept Oral & Maxillofacial Surg, Residency Training Program, New York, NY 10029 USA; Lincoln Med & Mental Hlth Ctr, Bronx, NY 10451 USA		Montazem, A (corresponding author), Mt Sinai Hosp, Dept Oral & Maxillofacial Surg, Residency Training Program, 1 Gustave L Levy Pl,Box 1187, New York, NY 10029 USA.	Andre.Montazem@mssm.edu					BAILEY BJ, 1967, LARYNGOSCOPE, V77, P1137, DOI 10.1288/00005537-196707000-00007; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; ELLIS E, 1985, ORAL SURG ORAL MED O, V59, P120, DOI 10.1016/0030-4220(85)90002-7; FRIDRICH KL, 1992, J ORAL MAXIL SURG, V50, P586, DOI 10.1016/0278-2391(92)90438-6; Halazonetis J A, 1968, Br J Oral Surg, V6, P37, DOI 10.1016/S0007-117X(68)80025-3; HAUG HZ, 1992, J ORAL MAXIL SURG, V50, P218, DOI 10.1016/0278-2391(92)90315-Q; HAUG RH, 1990, J ORAL MAXIL SURG, V48, P926, DOI 10.1016/0278-2391(90)90004-L; KELLY DE, 1975, J ORAL SURG, V33, P146; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; Murray J F, 1975, Clin Plast Surg, V2, P131; Nahum A M, 1975, Clin Plast Surg, V2, P59; OLSON RA, 1982, J ORAL MAXIL SURG, V40, P23, DOI 10.1016/S0278-2391(82)80011-6	12	13	13	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	AUG	2004	62	8					938	942		10.1016/j.joms.2004.01.018			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	842RS	WOS:000223022300006	15278857				2022-02-06	
J	Tai, PC; Gross, DW				Tai, PC; Gross, DW			Exacerbation of pre-existing epilepsy by mild head injury: a five patient series	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							SEIZURES; POPULATION	Objective: While the risk of developing seizures following a mild head injury has been reported and is thought to be low, the effect of mild head injury on patients with a pre-existing seizure disorder has not been reported. We present a series of cases where a strong temporal relationship between mild head injury and worsening of seizure frequency was observed. Methods: Five cases were identified and reviewed in detail. Information was derived from clinic and hospital charts with attention to the degree of injury, pre- and postinjury seizure patterns and frequency. Results: One patient has primary generalized epilepsy and four have localization related epilepsy. Prior to the head injury, three of the patients were seizure free (range: two to 24 years). The patients suffered from mild head injuries with no or transient loss of consciousness and no focal neurological deficits. In all cases, the patients experienced a worsening of seizure control within days of the injury. In one case, the patient's seizure pattern returned to baseline one year after the accident, while in the remaining four cases, the patients continue to have medically refractory seizures. Conclusions: A close temporal relationship between mild head injury and a worsening of seizure control was observed in five patients with epilepsy. Although further study is required, this observation suggests that a head injury that would be considered benign in the general population can have serious consequences such as recurrence of seizures and medical intractability in patients with epilepsy.	Univ Alberta, Walter Mckenzie Ctr, Div Neurol, Edmonton, AB T6G 2B7, Canada		Gross, DW (corresponding author), Univ Alberta, Walter Mckenzie Ctr, Div Neurol, 2E3-19, Edmonton, AB T6G 2B7, Canada.		, DWG/AAF-9259-2020	Gross, Donald/0000-0003-1344-4092			ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; Clear D, 2000, EPILEPSIA, V41, P243, DOI 10.1111/j.1528-1157.2000.tb00147.x; Haut SR, 2003, EPILEPSY BEHAV, V4, P511, DOI 10.1016/S1525-5050(03)00182-3; Hosokawa C, 1998, J COMPUT ASSIST TOMO, V22, P980, DOI 10.1097/00004728-199811000-00025; MILLER VS, 2000, NEUROLOGY CLIN PRACT, P1683; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Westbrook LE, 1998, EPILEPSIA, V39, P978, DOI 10.1111/j.1528-1157.1998.tb01447.x	9	13	13	0	0	CANADIAN J NEUROL SCI INC	CALGARY	PO BOX 4220, STATION C EDITORIAL & SUBSCRIPTION SERV, CALGARY, AB T2T 5N1, CANADA	0317-1671			CAN J NEUROL SCI	Can. J. Neurol. Sci.	AUG	2004	31	3					394	397		10.1017/S0317167100003516			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	849OZ	WOS:000223549600019	15376487	Bronze			2022-02-06	
J	Shafe, M; Blaivas, M; Hooker, E; Straus, L				Shafe, M; Blaivas, M; Hooker, E; Straus, L			Noninvasive intracranial cerebral flow velocity evaluation in the emergency department by emergency physicians	ACADEMIC EMERGENCY MEDICINE			English	Article						emergency ultrasound; transcranial Doppler; head injury; elevated intracranial pressure; intubation; emergency medicine	TRANSCRANIAL DOPPLER; ULTRASONOGRAPHY; ULTRASOUND; PRESSURE	Transcranial Doppler (TCD) is an accepted modality for the evaluation of cerebral blood flow velocities. Objectives: The purpose of this study was to test the feasibility of bedside TCD measurement in the emergency department (ED) with critically ill, intubated patients. Methods: A prospective convenience sample of patients presenting to a university hospital over a two-month period underwent TCD evaluation of the middle cerebral artery. Intubated patients with head trauma and any patient requiring tracheal intubation were eligible. A 2-MHz Doppler probe was positioned over the temporal bone to acquire blood flow velocities. An emergency medicine resident and research assistant obtained measurements. Continuous TCD tracings were recorded on a video cassette recorder tape for quality assurance review and data collection. Vital signs and therapeutic interventions were also recorded. Flow velocities were measured in cm/s; the peak Resistance Index (RI) was calculated for each patient. Results: A total of 30 patients were enrolled in the study. Adequate tracings were obtained in 25 patients (83%) without a disruption of resuscitation. Tracings could not be obtained in five patients; they were listed as TCD failures. However, in two of these patients, adequate flow velocity tracings were obtained after resuscitation. Four patients were evaluated during tracheal intubation. One patient was monitored successfully during cardiopulmonary resuscitation. The median time required for data acquisition was 1.9 minutes. The mean highest RI for those who expired was 0.84. For those who survived, the mean highest RI was 0.52. The difference of 0.32 was statistically significant (p = 0.04). Conclusions: Noninvasive blood flow velocity monitoring of the middle cerebral artery using TCD is feasible in the ED when performed at the bedside on intubated patients with traumatic brain injury and others during tracheal intubation and resuscitation.	Med Coll Georgia, Dept Emergency Med, Augusta, GA 30912 USA; Univ Louisville, Dept Emergency Med, Louisville, KY USA		Blaivas, M (corresponding author), Med Coll Georgia, Dept Emergency Med, 1120 15th St,AF-2056, Augusta, GA 30912 USA.	blaivas@pyro.net					AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Blaivas M, 2000, ACAD EMERG MED, V7, P120, DOI 10.1111/j.1553-2712.2000.tb00512.x; Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1197/aemj.10.4.376; Blaivas M, 2002, ACAD EMERG MED, V9, P791, DOI 10.1111/j.1553-2712.2002.tb02166.x; CHADDUCK WM, 1989, SURG NEUROL, V31, P122, DOI 10.1016/0090-3019(89)90324-8; Heller MB, 2002, ACAD EMERG MED, V9, P835, DOI 10.1111/j.1553-2712.2002.tb02174.x; KLINGELHOFER J, 1988, J NEUROL, V235, P159, DOI 10.1007/BF00314307; LEWIS LM, 1994, J CRIT CARE, V9, P169, DOI 10.1016/0883-9441(94)90013-2; LUNDAR T, 1990, ACTA NEUROCHIR, V102, P85, DOI 10.1007/BF01405419; NAKATANI S, 1989, INTRACRANIAL PRESSUR, V7	10	13	13	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	JUL	2004	11	7					774	777		10.1197/j.aem.2004.02.518			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	835EM	WOS:000222463300013	15231470	Bronze			2022-02-06	
J	Davis, JE; Eberwine, JH; Hinkle, DA; Marciano, PG; Meaney, DF; McIntosh, TK				Davis, JE; Eberwine, JH; Hinkle, DA; Marciano, PG; Meaney, DF; McIntosh, TK			Methodological considerations regarding single-cell gene expression profiling for brain injury	NEUROCHEMICAL RESEARCH			English	Article						brain injury; cDNA array; gene expression profiling; microarray standardization; RNA amplification; single cell	MESSENGER-RNA; MICROARRAY ANALYSIS; SERIAL ANALYSIS; ALTERED EXPRESSION; MOUSE HIPPOCAMPUS; CEREBRAL-ISCHEMIA; RAT; CORTEX; NEURONS; TISSUE	Genomic microarrays are rapidly becoming ubiquitous throughout a wide variety of biological disciplines. As their use has grown during the past few years, many important discoveries have been made in the fields of central nervous system (CNS) injury and disease using this emerging technology. In addition, single-cell mRNA amplification techniques are now being used along with microarrays to overcome many of the difficulties associated with the cellular heterogeneity of the brain. This development has extended the utility of gene expression pro. ling and has provided researchers with exciting new insights into the neuropathology of CNS injury and disease at a molecular and cellular level. New methodological, standardization, and statistical techniques are currently being developed to improve the reproducibility of microarrays and facilitate the analysis of large amounts of data. In this review, we will discuss the application of these techniques to experimental, clinically relevant models of traumatic brain injury.	Univ Penn, Sch Med, Head Injury Ctr, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Bioengn, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; Vet Adm Med Ctr, Philadelphia, PA 19104 USA		McIntosh, TK (corresponding author), Univ Penn, Sch Med, Head Injury Ctr, Dept Neurosurg, 105C Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.	mcintosh@seas.upenn.edu	Eberwine, James/B-2247-2010	Meaney, David/0000-0002-0954-4122	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS08803, NS40978] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [41699] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040978, P50NS008803, P01NS008803] Funding Source: NIH RePORTER		Ball CA, 2002, SCIENCE, V298, P539; BENES V, 2000, TRENDS BIOCHEM SCI, V28, P244; Blalock EM, 2003, J NEUROSCI, V23, P3807; *BRAIN INJ ASS AM, 2004, DAT COMP ARR BAS DAT; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Butte A, 2002, NAT REV DRUG DISCOV, V1, P951, DOI 10.1038/nrd961; Centers for Disease Control, 2001, TRAUM BRAIN INJ US R; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Clark RSB, 1997, J NEUROSCI, V17, P9172; Constans A, 2003, SCIENTIST, V17, P34; Conti AC, 1998, J NEUROSCI, V18, P5663; Crino PB, 1996, P NATL ACAD SCI USA, V93, P14152, DOI 10.1073/pnas.93.24.14152; Datson NA, 1999, NUCLEIC ACIDS RES, V27, P1300, DOI 10.1093/nar/27.5.1300; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Eberwine J, 2001, J NEUROSCI, V21, P8310, DOI 10.1523/JNEUROSCI.21-21-08310.2001; EBERWINE J, 1997, CURR PROTOCOLS NEURS, V5, P1; Elliott RC, 2003, J NEUROSCI, V23, P2218; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Evans SJ, 2002, EUR J NEUROSCI, V16, P409, DOI 10.1046/j.1460-9568.2002.02097.x; French PJ, 2001, EUR J NEUROSCI, V14, P2037, DOI 10.1046/j.0953-816x.2001.01818.x; Geschwind DH, 2000, P NATL ACAD SCI USA, V97, P10676, DOI 10.1073/pnas.97.20.10676; Hemby SE, 2002, ARCH GEN PSYCHIAT, V59, P631, DOI 10.1001/archpsyc.59.7.631; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Jain K K, 2000, Pharmacogenomics, V1, P289, DOI 10.1517/14622416.1.3.289; Kamme F, 2003, J NEUROSCI, V23, P3607; Kobori N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5; KOGURE K, 1993, STROKE, V24, P2121, DOI 10.1161/01.STR.24.12.2121; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; LEWIN ICF, 1992, COST DISORDERS BRAIN; Long Y, 2003, J NEUROSCI RES, V71, P710, DOI 10.1002/jnr.10524; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Lukasiuk K, 2003, EUR J NEUROSCI, V17, P271, DOI 10.1046/j.1460-9568.2003.02461.x; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; MARCIANO PG, IN PRESS J NEUROSCIE; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Mirnics K, 2001, NAT REV NEUROSCI, V2, P444, DOI 10.1038/35077587; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; Nogawa S, 1997, J NEUROSCI, V17, P2746; O'Dell DM, 2000, J NEUROSCI, V20, P4821; RAGHUPATHI R, 1995, BRAIN PATHOL, V5, P437, DOI 10.1111/j.1750-3639.1995.tb00622.x; Rall JM, 2003, NEUROPATH APPL NEURO, V29, P118, DOI 10.1046/j.1365-2990.2003.00439.x; Rao SA, 2002, GENET RESOUR CROP EV, V49, P83; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; Schmidt-Kastner R, 2002, MOL BRAIN RES, V108, P81, DOI 10.1016/S0169-328X(02)00516-8; Shilling PD, 2002, PHARMACOGENOMICS, V3, P31, DOI 10.1517/14622416.3.1.31; SUTCLIFFE JG, 1988, ANNU REV NEUROSCI, V11, P157, DOI 10.1146/annurev.ne.11.030188.001105; Telfeian AE, 2003, EPILEPSIA, V44, P143, DOI 10.1046/j.1528-1157.2003.06102.x; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Todd R, 2002, TRENDS MOL MED, V8, P254, DOI 10.1016/S1471-4914(02)02350-X; Trendelenburg G, 2002, J NEUROSCI, V22, P5879; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; YANG K, 1994, BRAIN RES, V664, P141, DOI 10.1016/0006-8993(94)91964-X; Zhang HT, 2001, P NATL ACAD SCI USA, V98, P5497, DOI 10.1073/pnas.101124598	58	13	13	0	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JUN	2004	29	6					1113	1121		10.1023/B:NERE.0000023598.04937.83			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	812CB	WOS:000220816500009	15176468	Green Published			2022-02-06	
J	Mokhosi, MT; Grieve, KW				Mokhosi, MT; Grieve, KW			African, families' perceptions of traumatic brain injury	SOUTH AFRICAN JOURNAL OF PSYCHOLOGY			English	Article							QUALITATIVE RESEARCH; HEAD-INJURY	Using semi-structured interviews, this study explored the perceptions of traumatic brain injury (TBI) held by a group of 22 brain-injured individuals and their caregivers living in rural African communities. While there are similarities between these findings and those in other parts of the world regarding the cognitive, emotional, personality and behavioural changes experienced by brain-injured individuals, the perceived aetiology of brain injury differed according to the individuals' worldview. Most of the participants believed that the accidents considered in this study as well as the injuries they gave rise to were the result of witchcraft, ancestral anger, God's will or thwasa. The reactions of family members to caring for, and living with, a brain-injured person appeared to be influenced by specific social practices and local cultural beliefs. It is important to incorporate these beliefs into the rehabilitation process. Suggestions for rehabilitation are discussed.	Univ North, Psychol Unit, Sch Social Sci, ZA-9866 Phuthaditjhaba, South Africa; Univ S Africa, Dept Psychol, ZA-0001 Pretoria, South Africa		Mokhosi, MT (corresponding author), Univ North, Psychol Unit, Sch Social Sci, QwaQwa Campus,Private Bag X13, ZA-9866 Phuthaditjhaba, South Africa.						Airhihenbuwa C O, 1989, AIDS Educ Prev, V1, P57; BROWN R, 1999, HOMOLOGY HOMOTOPY AP, V0001, P00001, DOI DOI 10.4310/HHA.1999.V1.N1.A1; HAMMONDTOOKE WD, 1975, PSYCHOL AFR, V16, P25; HAMMONDTOOKE WD, 1989, RITUALS MED; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; HENWOOD K, 1996, HDB QUALITATIVE RES, P86; Hickson J., 1992, J MULTICULT COUNS D, V20, P11; HUBERT J, 1995, LIFE HEAD INJURY; Judd J, 2001, HEALTH PROMOT INT, V16, P367, DOI 10.1093/heapro/16.4.367; Kay, 1991, HEAD INJURY FAMILY M, P81; Kinsella GJ, 1998, NEUROPSYCHOL REHABIL, V8, P351, DOI 10.1080/713755576; Kosciulek JF, 1997, REHABIL COUNS BULL, V41, P43; KVALE S, 1994, J PHENOMENOL PSYCHOL, V25, P147, DOI 10.1163/156916294X00016; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Massarik F., 1981, HUMAN INQUIRY SOURCE, P201; Mbiti J. S., 1969, AFRICAN RELIGION PHI; MOKHOSI MT, 2000, THESIS U S AFRICA PR; MOON SM, 1990, J MARITAL FAM THER, V16, P357, DOI 10.1111/j.1752-0606.1990.tb00056.x; Nell V, 1999, S AFR J PSYCHOL, V29, P128, DOI 10.1177/008124639902900305; NELL V, 1990, 901 UN HLTH PSYCH UN; ORTO AE, 1994, COMMUNITY INTEGRATIO, P225; Pidgeon N., 1996, HDB QUALITATIVE RES, P86; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 1997, NEUROPSY NEUROPSY BE, V10, P135; Rosenthal M, 1988, J HEAD TRAUMA REHAB, V3, P42; Selby M. J., 2000, NEUROPSYCHOLOGICAL A, P48; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tyerman A., 1996, BRAIN INJURY IMPROVE, P97; UZZELL B, 1997, NEUROPSYCHOL REHABIL, P41; Vanderploeg R. D, 2000, CLIN GUIDE NEUROPSYC CLIN GUIDE NEUROPSYC, V2nd; Workman Jr J., 1995, STUDYING ELITES USIN, P65; World Health Organisation Collaborating Centers for Neurotrauma, 1995, PREV CRIT CAR REH NE	33	13	13	0	3	PSYCHOLOGICAL SOC SOUTH AFRICA	BROADWAY	PO BOX 66083, BROADWAY 2020, SOUTH AFRICA	0081-2463			S AFR J PSYCHOL	South Afr. J. Psychol.	JUN	2004	34	2					301	317		10.1177/008124630403400208			17	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	997ST	WOS:000234268800008					2022-02-06	
J	Cahill, LM; Turner, AB; Stabler, PA; Addis, PE; Theodoros, DG; Murdoch, BE				Cahill, LM; Turner, AB; Stabler, PA; Addis, PE; Theodoros, DG; Murdoch, BE			An evaluation of continuous positive airway pressure (CPAP) therapy in the treatment of hypernasality following traumatic brain injury - A report of 3 cases	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						continuous positive airway pressure (CPAP); dysarthria; hypernasality; traumatic brain injury (TBI); velopharyngeal dysfunction (VPD)	CLOSED-HEAD-INJURY; NASALITY	Objective: To evaluate the effectiveness of continuous positive airway pressure (CPAP) therapy in the treatment of hypernasality following traumatic brain injury (17111). Design: An A-B-A experimental research design. Assessments were conducted prior to commencement of the program, midway, immediately posttreatment, and 1 month after completion of the CPAP therapy program. Participants: Three adults with dysarthria and moderate to severe hypernasality subsequent to TBI. Outcome Measures: Perceptual evaluation using the Frenchay Dysarthria Assessment, the Assessment of Intelligibility of Dysarthric Speech, and a speech sample analysis, and instrumental evaluation using the Nasometer. Results: Between assessment periods, varying degrees of improvement in hypernasality and sentence intelligibility were noted. At the 1-month post-CPAP assessment, all 3 participants demonstrated reduced nasalance values, and 2 exhibited increased sentence intelligibility. Conclusions: CPAP may be a valuable treatment of impaired velopharyngeal function in the TBI population.	Univ Queensland, Div Speech Pathol, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; Princess Alexandra Hosp, Brisbane, Qld 4102, Australia		Cahill, LM (corresponding author), Univ Queensland, Div Speech Pathol, Brisbane, Qld 4072, Australia.	L.Cahill@uq.edu.au	Theodoros, Deborah/F-1362-2010; Cahill, Louise/C-7919-2012; Murdoch, Bruce E/C-1397-2012	Cahill, Louise/0000-0003-3662-896X			Brown J.R., 1975, MOTOR SPEECH DISORDE; Cahill LM, 2002, BRAIN INJURY, V16, P415, DOI 10.1080/02699050110119871; CAHILL LM, 2001, ASIA PAC J SPEECH LA, V6, P33; Enderby P, 1983, FRENCHAY DYSARTHRIA; FLETCHER SG, 1972, J SPEECH HEAR DISORD, V37, P329, DOI 10.1044/jshd.3703.329; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; KEARNS KP, 1988, HDB SPEECH LANGUAGE, P592; KUEHN DP, 1991, PLAST RECONSTR SURG, V88, P959, DOI 10.1097/00006534-199112000-00003; Kuehn DP, 1994, MOTOR SPEECH DISORDE, P207; Massengill R Jr, 1968, Cleft Palate J, V5, P44; McHenry MA, 1998, ARCH PHYS MED REHAB, V79, P545, DOI 10.1016/S0003-9993(98)90071-5; McHenry MA, 1999, BRAIN INJURY, V13, P281, DOI 10.1080/026990599121656; MCWILLIAMS BJ, 1965, CLEFT PALATE J, V2, P46; MOLLER KT, 1991, PLAST RECONSTR SURG, V88, P967; POWERS GL, 1974, CLEFT PALATE J, V11, P28; Ramig L. O., 1994, J MED SPEECH-LANG PA, V2, P191; Sharma RK, 2002, INDIAN J ANIM SCI, V72, P31; TEASDALE G, 1974, LANCET, V2, P81; THEODOROS D, 1993, BRAIN INJURY, V7, P59, DOI 10.3109/02699059309008157; THEODOROS DG, 1995, BRAIN INJURY, V9, P671, DOI 10.3109/02699059509008225; Theodoros DG, 2001, TRAUMATIC BRAIN INJU, P75; Yorkston K.M., 1981, ASSESSMENT INTELLIGI; Yorkston KM., 1999, MANAGEMENT MOTOR SPE; [No title captured]	24	13	14	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2004	19	3					241	253		10.1097/00001199-200405000-00005			13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	826JB	WOS:000221824300005	15247846				2022-02-06	
J	Morgan, A; Ward, E; Murdoch, B				Morgan, A; Ward, E; Murdoch, B			Clinical characteristics of acute dysphagia in pediatric patients following traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; dysphagia; laryngeal; oral-motor; pediatric	CHILDREN; SPEECH; INGESTION; IMPROVES	Primary Objective: To document the clinical characteristics of acute dysphagia in a group of pediatric patients after traumatic brain injury (TBI). Research Design: Prospective group study. Methods: Fourteen subjects (7 males, 7 females), aged 4 years 1 month to 15 years, with moderate or severe TBI (Glasgow Coma Scale [GCS] < 12). Subjects were assessed via clinical bedside examination documenting cognitive status, oromotor function, feeding function, dietary recommendations, and an indication of overall feeding severity Results: A pattern of impaired cognition, altered behavior related to feeding, severe tonal and postural deficits, oromotor, respiratory, and laryngeal impairments, and oral sensitivity issues was revealed. Conclusions: Swallowing impairment was affected by multilevel deficits, which both individually and in combination had a negative impact on swallowing competence and safety. In light of deficits identified, which could not be observed on videofluoroscopic investigation alone, this study highlighted the importance of the clinical bedside examination in assessing dysphagia in pediatric patients post-TBI for identifying targets for intervention.	Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld, Australia; Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia		Morgan, A (corresponding author), Inst Child Hlth, Dev Cognit Neurosci Unit, 30 Guilford St, London WC1N 1EH, England.	angela.morgan@ich.ucl.ac.uk	Ward, Elizabeth/F-9652-2010; Murdoch, Bruce E/C-1397-2012; Morgan, Angela/J-5235-2017	Ward, Elizabeth/0000-0002-2680-8978; Morgan, Angela/0000-0003-1147-7405			BROOKE MM, 1991, ARCH PHYS MED REHAB, V72, P106; Cahill LM, 2002, BRAIN INJURY, V16, P415, DOI 10.1080/02699050110119871; Christensen J R, 1989, Dysphagia, V3, P131, DOI 10.1007/BF02407131; Enderby P, 1983, FRENCHAY DYSARTHRIA; Field L H, 1989, Brain Inj, V3, P19, DOI 10.3109/02699058909008069; Gisel E G, 1998, Int J Orofacial Myology, V24, P27; GISEL EG, 1995, DYSPHAGIA, V10, P268, DOI 10.1007/BF00431421; Hagen C., 1972, LEVELS COGNITIVE FUN; Hayden D., 1999, VERBAL MOTOR PRODUCT; LARNERT G, 1995, ACTA PAEDIATR, V84, P689, DOI 10.1111/j.1651-2227.1995.tb13730.x; Lefton-Greif MA, 1998, PEDIAT VIDEOFLUOROSC; Leopold NA, 1997, DYSPHAGIA, V12, P202, DOI 10.1007/PL00009537; LEOPOLD NA, 1983, ARCH PHYS MED REHAB, V64, P371; Logemann JA, 1999, DYSPHAGIA, V14, P44, DOI 10.1007/PL00009583; LOGEMANN JA, 1988, OTOLARYNG CLIN N AM, V21, P613; Logemann JA, 1998, EVALUATION TREATMENT; Logemann JA, 1994, J HEAD TRAUMA REHAB, V9, P43; LOGEMANN JA, 1989, J HEAD TRAUMA REHAB, V4, P24; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; McHenry M, 2000, LARYNGOSCOPE, V110, P1157, DOI 10.1097/00005537-200007000-00017; Morgan AT, 2001, ASIA PACIFIC J SPEEC, V6, P9; MURDOCH BE, 1994, EUR J DISORDER COMM, V29, P379; NEWMAN I, 2000, SEMIN SPEECH LANG, V21, P281; PERLMAN A, 1999, NUTR CLIN PRACT, V14, pS1; REILLY JJ, 1995, TUNN UNDERGR SP TECH, V10, P3, DOI 10.1016/0886-7798(95)93307-S; Rowe LA, 1999, J HEAD TRAUMA REHAB, V14, P497, DOI 10.1097/00001199-199910000-00010; Schurr MJ, 1999, J TRAUMA, V46, P817, DOI 10.1097/00005373-199905000-00009; STARR S, 1998, FEEDING ASSESSMENT R, V2; Sullivan PB, 1997, BAILLIERE CLIN GASTR, V11, P529, DOI 10.1016/S0950-3528(97)90030-0; *WESTM HOSP COMM H, 1998, PARR HOSP ASS DYSPH; WINSTEIN CJ, 1983, PHYS THER, V63, P1992, DOI 10.1093/ptj/63.12.1992; Ylvisaker M, 1985, HEAD INJURY REHABILI, P195; YLVISAKER M, 1989, J HEAD TRAUMA REHAB, V4, P51	33	13	13	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2004	19	3					226	240		10.1097/00001199-200405000-00004			15	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	826JB	WOS:000221824300004	15247845				2022-02-06	
J	Rouxel, JPM; Tazarourte, K; Le Moigno, S; Ract, C; Vigue, B				Rouxel, JPM; Tazarourte, K; Le Moigno, S; Ract, C; Vigue, B			Medical prehospital rescue in head injury	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						head injury; medical prehospital transport; secondary brain damage; hypoxemia; hypotension; outcome	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; MANAGEMENT; HYPOTENSION; MANNITOL; SCALE; SCORE; CARE; GUIDELINES; MORTALITY	Objective. - To evaluate the effectiveness of prehospital medical care in head-injured patients. Patients and methods. - All head-injured patients admitted in Bicetre hospital from 1995 to 1999 were retrospectively studied. Glasgow Coma Scale (GCS) score, mean arterial pressure (MAP) and SpO(2) measured on the field were compared to GCS, MAP and SpO(2) on arrival in the hospital. All treatments given during transport and first data recorded in the hospital were noted. Each parameter was compared to outcome at 6 months. Then, significant parameters were compared with a multivariate analysis. Results. - Three hundred and four patients were included, 80% had a GCS less than or equal to8 and 45% a GCS = 3. At 6 months, 43% of the patients had no or mild sequelae and 45% died. Prehospital time was 2 h 55 min +/-1 h 40 min. During transport, 75% of hypoxemic events were corrected, but GCS and MAP decreased significantly. None of the patients with non-reactive mydriasis received any osmotherapy and all patients with non-reactive mydriasis until hospital admission died (n = 55). After multivariate analysis, parameters significantly related to outcome were, on the field, MAP (p < 0.025) and at hospital SAPS II (p < 0.001), GCS (p < 0.001), non-reactive mydriasis (p < 0.025), hyperglycernia (p < 0.025) and low haemoglobinemia (p < 0.001). Conclusion. - Respect of guidelines is important to improve medical care. Prehospital management corrected hypoxemia but not hypotension. The lack of osmotherapy after mydriasis cannot be explained and is probably an error. Patient route must be simplified to decrease time delay from field to hospital. Improvement in prehospital care may decrease mortality in head-injured patients. (C) 2003 Elsevier SAS. Tous droits reserves.	CHU Bicetre, Dept Anesthesie Reanimat, F-94275 Le Kremlin Bicetre, France; Ctr Hosp Marc Jacquet, F-77000 Melun, France		Vigue, B (corresponding author), CHU Bicetre, Dept Anesthesie Reanimat, F-94275 Le Kremlin Bicetre, France.	bemard.vigue@bct.ap-hop-paris.fr		tazarourte, karim/0000-0002-3376-1258			Agenor PR, 1999, J INT MONEY FINANC, V18, P1, DOI 10.1016/S0261-5606(98)00043-6; ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bissonnette B, 2000, ANN FR ANESTH, V19, P270; Bruder N, 2000, ANN FR ANESTH, V19, P316; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CARLI P, 1990, JEUR, V3, P23; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1997, J TRAUMA, V42, pS4, DOI 10.1097/00005373-199705001-00002; Clavier N, 2000, ANN FR ANESTH, V19, P304; Cruz J, 2002, NEUROSURGERY, V51, P628, DOI 10.1097/00006123-200209000-00006; Cruz J, 2001, NEUROSURGERY, V49, P864; DUPONT M, 2000, JEUR, V13, pA78; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GRAHAM DI, 1971, LANCET, V1, P265; Grol R, 2001, JAMA-J AM MED ASSOC, V286, P2578, DOI 10.1001/jama.286.20.2578; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; JEFFREYS RV, 1981, LANCET, V2, P459; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENNETT B, 1975, LANCET, V1, P480; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lenfant F, 1997, ANN FR ANESTH, V16, P239, DOI 10.1016/S0750-7658(97)86408-8; Liberman M, 2000, J TRAUMA, V49, P584, DOI 10.1097/00005373-200010000-00003; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Maas Andrew I.R., 2000, Curr Opin Crit Care, V6, P281, DOI 10.1097/00075198-200008000-00008; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Peytel E, 2001, INTENS CARE MED, V27, P1756, DOI 10.1007/s00134-001-1119-z; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; RUMMOND JC, 1994, ANESTHESIA, P630; Schrot RJ, 2002, LANCET, V359, P1633, DOI 10.1016/S0140-6736(02)08545-8; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Trupka A, 1994, Eur J Emerg Med, V1, P1, DOI 10.1097/00063110-199403000-00002; Vigue B, 1999, INTENS CARE MED, V25, P445, DOI 10.1007/s001340050878; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	48	13	13	0	2	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	FEB	2004	23	1					6	14		10.1016/j.annfar.2003.09.021			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	800DR	WOS:000220009600003	14980318				2022-02-06	
J	Swan, L; Alderman, N				Swan, L; Alderman, N			Measuring the relationship between overt aggression and expectations: a methodology for determining clinical outcomes	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; BRAIN-INJURY; OAS-MNR; BEHAVIOR; MANAGEMENT; REHABILITATION; CARBAMAZEPINE; VERSION; SCALE; MILD	The presence of aggressive behaviour following traumatic brain injury imposes special challenges within rehabilitation centres. Survivors of traumatic brain injury constitute a heterogeneous population amongst whom problems with increased irritability and aggression are characteristic. There is a clear need to determine what treatment approaches might be helpful in reducing aggressive behaviour. Whilst single-case experimental methodologies including reversal and multiple baseline designs seem ideal for this purpose, the compelling need to minimize risk can compromise their deployment, especially when aggression takes the form of physical assaults on others. When this is the case, there are difficulties in assessing whether a change in aggressive behaviour represents a successful response to treatment or is simply a function of reduced demand in the environment. The contributions made to understanding the relationship between aggression and expectations made on patients participating within rehabilitation will be explored here. A possible means of quantifying demands using the Neurobehavioural Expectations Scale will be described. Three case studies are presented that suggest that a methodology that employs concurrent use of this tool with the Overt Aggression Scale Modified for Neurorehabilitation, can enable objective evaluation to be made of the effects of rehabilitation on behaviour, without increasing risk.	St Andrews Hosp, Kemsley Div, Northampton NN1 5DG, England		Alderman, N (corresponding author), St Andrews Hosp, Kemsley Div, Billing Rd, Northampton NN1 5DG, England.	nalderman@standrew.co.uk		Alderman, Nick/0000-0002-8523-4142			Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Alderman N, 2001, BRAIN DAM B, P175; ALDERMAN N, 1991, Brain Injury, V5, P77, DOI 10.3109/02699059108998516; Alderman N, 2002, BRAIN INJURY, V16, P469, DOI 10.1080/02699050110118458; Alderman N, 1997, BRAIN INJURY, V11, P503, DOI 10.1080/713802182; Alderman N, 1999, BRAIN INJURY, V13, P669; Alderman N, 1997, BRAIN INJURY, V11, P79, DOI 10.1080/026990597123683; ALDERMAN N, 1992, PHYSIOTHERAPY, V78, P335; Azouvi P, 1999, BRAIN INJURY, V13, P797, DOI 10.1080/026990599121188; BARLOW PH, 1984, SINGLE CASE EXPT DES; BOLTON D, 2002, EVIDENCE MENTAL HLTH, P3; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Burgess P, 1996, BEHAV ASSESSMENT DYS; BURKE WH, 1988, INT J REHABIL RES, V11, P235, DOI 10.1097/00004356-198809000-00003; COLTHEART M, 1991, HDB BEHAV THERAPY PS, P216; DAVIS JR, 1994, BRAIN INJURY, V8, P589, DOI 10.3109/02699059409151011; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; EAMES P, 1985, J NEUROL NEUROSUR PS, V48, P613, DOI 10.1136/jnnp.48.7.613; EAMES P, 1988, J HEAD TRAUMA REHAB, V3, P1; Eames PG, 2001, BRAIN DAM B, P29; FOSTER HG, 1989, PROG NEURO-PSYCHOPH, V13, P865, DOI 10.1016/0278-5846(89)90038-9; FUSSEY I, 1988, REHABILITATION SEVER; GILES GM, 1988, REHABILITATION SEVER, P69; GLOAG D, 1985, BRIT MED J, V290, P913, DOI 10.1136/bmj.290.6472.913; Greenwood R. J., 1993, CLIN REHABIL, V7, P248; JAMES P, 2002, EVIDENCE MENTAL HLTH, P28; Johnson R., 1996, CLIN REHABIL, V10, P173, DOI [DOI 10.1177/026921559601000215, 10.1177/026921559601000215]; Knight C, 2002, BRAIN INJURY, V16, P75, DOI 10.1080/02699050110082188; Mattes J A, 1990, J Neuropsychiatry Clin Neurosci, V2, P159; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; McLean A Jr, 1987, Brain Inj, V1, P145, DOI 10.3109/02699058709034453; McMillan TM, 2001, BRAIN DAM B, P257; MILLER E, 1981, BRIT J CLIN PSYCHOL, V20, P69, DOI 10.1111/j.2044-8260.1981.tb00498.x; MILLER L, 1994, J OFFENDER REHABILIT, V21, P91, DOI DOI 10.1300/J076; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1987, BNI Q, V3, P2; Treadwell K, 1996, J HEAD TRAUMA REHAB, V11, P62, DOI 10.1097/00001199-199602000-00008; UOMOTO JM, 1992, ARCH PHYS MED REHAB, V73, P674; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Warrington E. K., 1991, VISUAL OBJECT SPACE; Wechsler, 1997, WECHSLER ADULT INTEL; WILSON BA, 1991, HDB BEHAV THERAPY PS, P227; Wood R. L., 1987, BRAIN INJURY REHABIL; Wood RL, 2001, BRAIN DAM B, P133; Wood RL, 2001, BRAIN DAM B, P107; Wood RL, 2001, BRAIN DAM B, P3; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35; [No title captured]; [No title captured]	53	13	13	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2004	18	2					143	160		10.1080/02699050310001596923			18	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	751DR	WOS:000187038000004	14660227				2022-02-06	
J	Miller, LA; Caine, D; Watson, JDG				Miller, LA; Caine, D; Watson, JDG			A role for the thalamus in memory for unique entities	NEUROCASE			English	Article							FOCAL RETROGRADE-AMNESIA; CLOSED-HEAD INJURY; TEMPORAL-LOBE; ANTEROGRADE AMNESIA; AUTOBIOGRAPHICAL MEMORY; SEMANTIC AMNESIA; PATIENT; KNOWLEDGE; PEOPLE; DISSOCIATION	Recent case studies of amnesic patients have yielded patterns of impairment that challenge Tulving's (1972) division of retrograde memory into two categories (namely, episodic and semantic memory). Here we describe a patient (JIG) who developed partially blocked access to previously stored knowledge following the onset of a medial thalamic infarction. Having previously demonstrated that JG has a dense, pervasive amnesia for autobiographical material, famous people and famous events (Miller et al, 2001), in this study, we show that he is unable to access information about unique entities across a range of domains. In contrast, his memory for more general semantic knowledge (such as word meanings) is intact. JG's memory impairment is discussed in the context of a model of neural functioning put forward by Damasio (1990), in which it was proposed that recall of unique entities depends on many cortical regions being activated in synchrony. This activity, thought to be triggered and coordinated by anterior temporal and frontal lobe regions is, in turn, modulated by projections from the thalamus. We propose that JG's thalamic lesion has disrupted the coordination of the diffuse cortical networks necessary to generate highly specific memories from the past, be they episodic or semantic.	Royal Prince Alfred Hosp, Neuropsychol Unit, Camperdown, NSW 2050, Australia; Univ Sydney, Sydney, NSW 2006, Australia		Miller, LA (corresponding author), Royal Prince Alfred Hosp, Neuropsychol Unit, Camperdown, NSW 2050, Australia.	lamiller@mail.usyd.edu.au		Watson, John/0000-0003-0988-2583; Miller, Laurie/0000-0001-6329-2969			Aggleton JP, 1997, MEMORY, V5, P49, DOI 10.1080/741941143; AGGLETON JP, 1986, J COMP NEUROL, V243, P409, DOI 10.1002/cne.902430310; Bozeat S, 2000, NEUROPSYCHOLOGIA, V38, P1207, DOI 10.1016/S0028-3932(00)00034-8; CERMAK LS, 1983, NEUROPSYCHOLOGIA, V21, P213, DOI 10.1016/0028-3932(83)90039-8; Cipolotti L, 2001, NEUROPSYCHOLOGIA, V39, P151, DOI 10.1016/S0028-3932(00)00103-2; Damasio A.R., 1990, SEMIN NEUROSCI, V2, P287; DAMASIO AR, 1990, BEHAV BRAIN RES, V40, P193, DOI 10.1016/0166-4328(90)90076-Q; De Renzi E, 2002, CORTEX, V38, P678, DOI 10.1016/S0010-9452(08)70036-4; DERENZI E, 1987, CORTEX, V23, P575, DOI 10.1016/S0010-9452(87)80050-3; DERENZI E, 1993, CORTEX, V29, P449, DOI 10.1016/S0010-9452(13)80253-5; DERENZI E, 1995, CORTEX, V31, P531, DOI 10.1016/S0010-9452(13)80064-0; EDDY JK, 1981, J VERB LEARN VERB BE, V20, P333, DOI 10.1016/S0022-5371(81)90483-7; ELLIS AW, 1989, BRAIN, V112, P1469, DOI 10.1093/brain/112.6.1469; Eslinger PJ, 1996, CEREB CORTEX, V6, P530, DOI 10.1093/cercor/6.3.530; EVANS JJ, 1995, BRAIN, V118, P1, DOI 10.1093/brain/118.1.1; Gentileschi V, 2001, COGN NEUROPSYCHOL, V18, P439, DOI 10.1080/02643290125835; GROSSI D, 1988, CORTEX, V24, P457, DOI 10.1016/S0010-9452(88)80009-1; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; HANLEY JR, 1989, COGNITIVE NEUROPSYCH, V6, P179, DOI 10.1080/02643298908253418; Haslam C, 2001, NEUROCASE, V7, P189, DOI 10.1093/neucas/7.3.189; Hodges JR, 2002, CORTEX, V38, P674, DOI 10.1016/S0010-9452(08)70035-2; HODGES JR, 1993, BRAIN, V116, P921, DOI 10.1093/brain/116.4.921; Howard D, 1992, PYRAMIDS PALM TREES; HUNKIN NM, 1995, NEUROPSYCHOLOGIA, V33, P509, DOI 10.1016/0028-3932(94)00136-D; JACKENDOFF R, 1987, COGNITION, V26, P89, DOI 10.1016/0010-0277(87)90026-6; Jones RD, 1998, NEUROCASE, V4, P471, DOI 10.1080/13554799808410640; Kapur N, 2000, COGN NEUROPSYCHOL, V17, P623, DOI 10.1080/026432900750002181; Kapur N, 2002, CORTEX, V38, P660, DOI 10.1016/S0010-9452(08)70032-7; KAPUR N, 1992, BRAIN, V115, P73, DOI 10.1093/brain/115.1.73; Kartsounis LD, 1996, CORTEX, V32, P109, DOI 10.1016/S0010-9452(96)80020-7; KARTSOUNIS LD, 1995, J NEUROL NEUROSUR PS, V59, P95, DOI 10.1136/jnnp.59.1.95; Kitchener EG, 1999, COGNITIVE NEUROPSYCH, V16, P589, DOI 10.1080/026432999380744; Kopelman MD, 2000, COGNITIVE NEUROPSYCH, V17, P585, DOI 10.1080/026432900750002172; Kopelman MD, 2002, CORTEX, V38, P655, DOI 10.1016/S0010-9452(08)70031-5; Kroll NEA, 1997, BRAIN, V120, P1377, DOI 10.1093/brain/120.8.1377; Lucchelli F, 1998, NEUROCASE, V4, P447, DOI 10.1093/neucas/4.6.447; Lucchelli F, 2002, CORTEX, V38, P665, DOI 10.1016/S0010-9452(08)70033-9; Luzzi S, 2000, CORTEX, V36, P427, DOI 10.1016/S0010-9452(08)70851-7; MACKENZIE SJ, 1997, CORTEX, V33, P733; Mai JK, 1997, ATLAS HUMAN BRAIN; MARKOWITSCH HJ, 1993, J CLIN EXP NEUROPSYC, V15, P627, DOI 10.1080/01688639308402586; Markowitsch HJ, 2002, CORTEX, V38, P651, DOI 10.1016/S0010-9452(08)70030-3; MARKOWITSCH HJ, 1993, J CLIN EXP NEUROPSYC, V15, P947, DOI 10.1080/01688639308402610; Mayes AR, 1997, CORTEX, V33, P197, DOI 10.1016/S0010-9452(08)70001-7; Mayes AR, 2002, CORTEX, V38, P670, DOI 10.1016/S0010-9452(08)70034-0; MCCARTHY RA, 1992, NEUROPSYCHOLOGIA, V30, P633, DOI 10.1016/0028-3932(92)90068-W; Miller LA, 2001, NEUROPSYCHOLOGIA, V39, P1037, DOI 10.1016/S0028-3932(01)00041-0; OCONNOR M, 1992, J CLIN EXP NEUROPSYC, V14, P159, DOI 10.1080/01688639208402821; Peru A, 1997, BRAIN COGNITION, V33, P278, DOI 10.1006/brcg.1997.0868; Rogers TT, 2002, BRAIN DAM B, P251; Ross SJM, 1997, CORTEX, V33, P733, DOI 10.1016/S0010-9452(08)70730-5; SANDERS H I, 1975, Cortex, V11, P397; Schmidtke K, 1997, NEUROPSYCHOLOGIA, V35, P505, DOI 10.1016/S0028-3932(96)00109-1; Sirigu A, 1996, CORTEX, V32, P83, DOI 10.1016/S0010-9452(96)80018-9; Spinnler, 1998, COGNITIVE NEUROPSYCH, V3, P91, DOI https://doi.org/10.1080/135468098396189; STRACCIARI A, 1994, CORTEX, V30, P459, DOI 10.1016/S0010-9452(13)80341-3; STUSS DT, 1988, BRAIN COGNITION, V8, P348, DOI 10.1016/0278-2626(88)90059-0; STUSS DT, 1988, BRAIN COGNITION, V8, P21, DOI 10.1016/0278-2626(88)90036-X; Takahashi N, 1997, NEUROLOGY, V49, P464, DOI 10.1212/WNL.49.2.464; Tulving E., 1972, ORG MEMORY, P381; Verfaellie M, 1995, J Int Neuropsychol Soc, V1, P443; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; WILSON SJ, 1999, MUSIC MED MUSIC THER, P47; Yasuda K, 1997, CORTEX, V33, P623, DOI 10.1016/S0010-9452(08)70721-4	64	13	13	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase	DEC	2003	9	6					504	514		10.1076/neur.9.6.504.29375			11	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	754HC	WOS:000187309200004	16210232				2022-02-06	
J	Wilson, FC; Manly, T				Wilson, FC; Manly, T			Sustained attention training and errorless learning facilitates self-care functioning in chronic ipsilesional neglect following severe traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							UNILATERAL LEFT NEGLECT; REHABILITATION; ACTIVATION; RECOVERY; PATTERNS; HAND; HEMIPLEGIA	Limb activation studies involving contralesional spatiomotor cueing document a reduction of neglect for left space (Robertson & North, 1992, 1993, 1994; Samuel et al., 2000). A number of studies applying this approach have produced positive findings (Robertson, Hogg, McMillan, 1998; Robertson, North, Geggie, 1992; Robertson, McMillan, MacLeod, Edgeworth, Brock, 2002; Samuel et al., 2000). An alternative theoretical approach which aims to facilitate spatial awareness via the modulation of non-lateralised deficits in sustained attention/arousal (Robertson et al., 1997; Samuelsson et al., 1998) has also shown promising results (Robertson et al., 1995; Wilson, Manly, Coyle, & Robertson, 2000) in terms of improved contralesional unilateral neglect as well as activities of daily living.	Green Pk Healthcare Trust, Joss Cardwell Ctr, Belfast BT4 2LS, Antrim, North Ireland; MRC, Cognit & Brain Sci Unit, Cambridge, England		Wilson, FC (corresponding author), Green Pk Healthcare Trust, Joss Cardwell Ctr, 401 Holywood Rd, Belfast BT4 2LS, Antrim, North Ireland.	f.colinwilson@btopenworld.com					ANTONUCCI G, 1995, J CLIN EXP NEUROPSYC, V17, P383, DOI 10.1080/01688639508405131; Beschin N, 1997, CORTEX, V33, P379, DOI 10.1016/S0010-9452(08)70013-3; BLANCGARIN J, 1994, NEUROPSYCHOL REHABIL, V4, P359, DOI 10.1080/09602019408401606; BRADSHAW JL, 1995, CLIN NEUROPSYCHOLOGY, P124; DENES G, 1982, BRAIN, V105, P543, DOI 10.1093/brain/105.3.543; Edgeworth J. A., 1998, BALLOONS TEST; Eskes GA, 2003, ARCH PHYS MED REHAB, V84, P323, DOI 10.1053/apmr.2003.50012; Gottman J. M., 1978, SINGLE SUBJECT RES S, P197; Kerkhoff G, 2003, PROG BRAIN RES, V142, P255; Kinsella G, 1985, Int Rehabil Med, V7, P102; KINSELLA G, 1980, MED J AUSTRALIA, V2, P663; Maguire AM, 2002, NEUROPSYCHOLOGIA, V40, P879, DOI 10.1016/S0028-3932(01)00169-5; Mahoney F, 1965, MD STATE MED J, V14, P62; Mattioli F., 1992, NEUROPSYCHOL REHABIL, V2, P169, DOI [10.1080/09602019208401406, DOI 10.1080/09602019208401406]; McIntosh RD, 2000, CORTEX, V36, P289, DOI 10.1016/S0010-9452(08)70530-6; McIntosh RD, 2002, CORTEX, V38, P309, DOI 10.1016/S0010-9452(08)70662-2; POSNER MI, 1993, ATTENTION SELECTION, P390; Robertson I., 1994, TEST EVERYDAY ATTENT; Robertson I.H., 1999, SPATIAL NEGLECT CLIN; ROBERTSON IH, 1993, NEUROPSYCHOLOGIA, V31, P293, DOI 10.1016/0028-3932(93)90093-F; ROBERTSON IH, 1992, J NEUROL NEUROSUR PS, V55, P799, DOI 10.1136/jnnp.55.9.799; ROBERTSON IH, 1992, NEUROPSYCHOLOGIA, V30, P553, DOI 10.1016/0028-3932(92)90058-T; ROBERTSON IH, 1994, NEUROPSYCHOLOGIA, V32, P1, DOI 10.1016/0028-3932(94)90064-7; ROBERTSON IH, 1995, J CLIN EXP NEUROPSYC, V17, P416, DOI 10.1080/01688639508405133; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P1527, DOI 10.1016/S0028-3932(97)00084-5; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; Robertson IH, 1998, NEUROPSYCHOL REHABIL, V8, P19, DOI 10.1080/713755556; Robertson IH, 2002, NEUROPSYCHOL REHABIL, V12, P439, DOI 10.1080/09602010244000228; ROBERTSON IH, 1994, NEUROPSYCHOLOGIA, V32, P1495, DOI 10.1016/0028-3932(94)90121-X; Rossetti Y, 1998, NATURE, V395, P166, DOI 10.1038/25988; Samuel C, 2000, NEUROPSYCHOL REHABIL, V10, P385, DOI 10.1080/096020100411970; Samuelsson H, 1998, J CLIN EXP NEUROPSYC, V20, P73, DOI 10.1076/jcen.20.1.73.1481; SEA MJC, 1993, ARCH PHYS MED REHAB, V74, P355; SHEIL A, 1990, CLIN REHABIL, V4, P173; Tham K, 1996, NEUROPSYCHOL REHABIL, V6, P19, DOI 10.1080/713755496; Vallar G, 1993, UNILATERAL NEGLECT C, P27; WEBSTER JS, 1984, BEHAV THER, V15, P129, DOI 10.1016/S0005-7894(84)80015-5; WEINBERG J, 1977, ARCH PHYS MED REHAB, V58, P479; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8; Wilson B., 1999, BEHAVIOURAL INATTENT BEHAV INATTENTION TE; Wilson FC, 2000, RESTOR NEUROL NEUROS, V16, P1	41	13	13	0	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	DEC	2003	13	5					537	548		10.1080/09602010343000200			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	742PB	WOS:000186525500003					2022-02-06	
J	Cui, FZ; Tian, WM; Fan, YW; Hou, SP; Xu, QY; Lee, IS				Cui, FZ; Tian, WM; Fan, YW; Hou, SP; Xu, QY; Lee, IS			Cerebrum repair with PHPMA hydrogel immobilized with neurite-promoting peptides in traumatic brain injury of adult rat model	JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS			English	Article						CNS repair; peptide immobilization; hydrogel; angiogenesis	CELL-BINDING SEQUENCES; AXONAL REGENERATION; SCHWANN-CELLS; A-CHAIN; LAMININ; IDENTIFICATION; EXPRESSION; OUTGROWTH; GROWTH; EXTENSION	A poly[N-(2-hydroxypropyl) methacrylamidel (PHPMA) hydrogel immobilized with the neurite-promoting peptide sequence of xIKVAVx was synthesized and its structure was characterized. The PHPMA-IKVAV hydrogel displayed an interconnected porous structure. The ability of the hydrogel to support axonal outgrowth in the injured adult rats cerebrum cavity and to promote tissue regeneration was evaluated. After implantation for 4, 6, 12 and 18 weeks, the brain sections were processed for histological staining. The observations of the sections showed that the polymer hydrogel provided a structural, three-dimensional continuity across the defect and favoured reorganization of local wound-repair cells, angiogenesis and axonal growth into the hydrogel scaffold. Compared with the unmodified PHPMA hydrogel, the PHPMA-IKVAV hydrogel displayed greater ability to repair tissue defects in the cerebrum nervous system.	Tsinghua Univ, Dept Mat Sci & Engn, Biomat Lab, Beijing 100084, Peoples R China; Capital Univ Med Sci, Beijing Inst Neurosci, Beijing 100054, Peoples R China; Yonsei Univ, Atom Scale Surface Sci Res Ctr, Seoul 120749, South Korea		Cui, FZ (corresponding author), Tsinghua Univ, Dept Mat Sci & Engn, Biomat Lab, Beijing 100084, Peoples R China.	cuifz@mail.tsinghua.edu.cn	Fan, Yuwei/A-2951-2009	Fan, Yuwei/0000-0001-8477-8458; Tian, Weiming/0000-0003-4958-4118			BARKER RA, 1999, NEUROPSY REHABIL MOD, P1; Bartsch U, 1996, J NEUROCYTOL, V25, P303, DOI 10.1007/BF02284804; BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409; Chamberlain LJ, 1998, EXP NEUROL, V154, P315, DOI 10.1006/exnr.1998.6955; COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S; Dillon GP, 1998, J BIOMAT SCI-POLYM E, V9, P1049, DOI 10.1163/156856298X00325; Dubey N, 2001, BIOMATERIALS, V22, P1065, DOI 10.1016/S0142-9612(00)00341-0; FAWCETT JW, 1989, DEV BIOL, V135, P449, DOI 10.1016/0012-1606(89)90193-0; Gao J, 1998, MICROSC RES TECHNIQ, V41, P323, DOI 10.1002/(SICI)1097-0029(19980515)41:4<323::AID-JEMT5>3.0.CO;2-R; Goldberg JL, 1998, CURR BIOL, V8, pR310, DOI 10.1016/S0960-9822(98)70195-2; Gong HP, 2000, J BIOMED MATER RES, V52, P285; HEARN MTW, 1987, METHOD ENZYMOL, V135, P102; Herbert CB, 1998, J BIOMED MATER RES, V40, P551, DOI 10.1002/(SICI)1097-4636(19980615)40:4<551::AID-JBM6>3.0.CO;2-E; Iivanainen A, 1999, J BIOL CHEM, V274, P14107, DOI 10.1074/jbc.274.20.14107; Imaizumi T, 2000, BRAIN RES, V854, P70, DOI 10.1016/S0006-8993(99)02285-4; KANEMOTO T, 1990, P NATL ACAD SCI USA, V87, P2279, DOI 10.1073/pnas.87.6.2279; KOPECEK J, 1973, EUR POLYM J, V9, P7, DOI 10.1016/0014-3057(73)90063-3; KREWSON CE, 1986, BIOTECHNOL ENG, V43, P555; LIUZZI FJ, 1987, SCIENCE, V237, P642, DOI 10.1126/science.3603044; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198; Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491; NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583; Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828; NOVOTNY E, 1974, STAIN TECHNOL, V49, P273, DOI 10.3109/10520297409116993; Plant GW, 1997, EXP NEUROL, V143, P287, DOI 10.1006/exnr.1997.6407; PLANT GW, 1995, BRAIN RES, V671, P119, DOI 10.1016/0006-8993(94)01312-6; RUDGE JS, 1990, J NEUROSCI, V10, P3594; SCHWAB ME, 1991, PHILOS T ROY SOC B, V331, P303, DOI 10.1098/rstb.1991.0021; Spilker MH, 2001, RESTOR NEUROL NEUROS, V18, P23; STICHEL CC, 1994, J NEUROCYTOL, V23, P615, DOI 10.1007/BF01191556; TASHIRO K, 1989, J BIOL CHEM, V264, P16174; Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3; TOMASELLI KJ, 1988, NEURON, V1, P33, DOI 10.1016/0896-6273(88)90207-3; Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091; Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9; WOERLY S, 1990, BIOMATERIALS, V11, P97, DOI 10.1016/0142-9612(90)90123-8; WOERLY S, 1999, Patent No. 5863551	38	13	13	4	18	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0883-9115	1530-8030		J BIOACT COMPAT POL	J. Bioact. Compat. Polym.	NOV	2003	18	6					413	432		10.1177/0883911503040470			20	Biotechnology & Applied Microbiology; Materials Science, Biomaterials; Polymer Science	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Materials Science; Polymer Science	767FP	WOS:000188429800001					2022-02-06	
J	Lang, EW; Yip, K; Griffith, J; Lagopoulos, J; Mudaliar, Y; Dorsch, NW				Lang, EW; Yip, K; Griffith, J; Lagopoulos, J; Mudaliar, Y; Dorsch, NW			Hemispheric asymmetry and temporal profiles of cerebral pressure autoregulation in head injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article; Proceedings Paper	Annual Scientific Meeting of the Neurosurgical-Society-of-Australasia	JUL, 2002	BROOME, AUSTRALIA	Neurosurg Soc Australasia		dynamic cerebral pressure autoregulation; transcranial Doppler ultrasound; hemisphere asymmetry; temporal profiles	TRAUMATIC BRAIN-INJURY; ARTERIAL-BLOOD-PRESSURE; TRANSCRANIAL DOPPLER; CEREBROVASCULAR AUTOREGULATION; PHASE RELATIONSHIP; FLOW VELOCITY; REACTIVITY; VALIDATION; HEALTHY; HUMANS	A moving correlation index (Mx-ABP) between arterial blood pressure (ABP) and mean middle cerebral artery blood flow velocity (CBFV) can be used to monitor dynamic cerebrovascular autoregulation (CA) after traumatic brain injury (TBI). In this study we examined hemispheric CA asymmetry and temporal CA profiles, their relationship with ABP and CBFV, and their prognostic relevance. Mx-ABP was calculated for each hemisphere in 25 TBI patients second-daily for as long as they were receiving sedation and analgesia. Forty-nine recordings were obtained, between one and six per patient. Four time periods were defined: immediate - postinjury days (PID) 0 and 1; early PID 2 and 3; intermediate - PID 4 and 5, and late - PID 6 and later. GOS was estimated at discharge, GOS 4 and 5 were considered favorable (15 patients) and GOS 1-3 unfavorable outcome (10 patients). A Mx difference >0.2 was classified as hemispheric asymmetry (HA). HA was observed at least once in 12 of the 25 patients (48%) and in 18 of 49 recordings (37%). It was observed during all time periods: 35%, 43%, 25%, 43%, respectively, and was not related to outcome. There was no difference in mean CBFV or ABP between patients with and without HA. HA was not related to interhemispheric CBFV differences. A significant improvement in Mx was seen over time. Hemispheric CA asymmetry is common after traumatic brain injury. It does not bear significant clinical or predictive relevance, and it is unrelated to CBFV or ABP. CA is most profoundly disturbed during the immediate postinjury phase and improves gradually during the ICU course. Further studies are needed to investigate CA during post ICU recovery and rehabilitation. Crown Copyright (C) 2003 Published by Elsevier Ltd. All rights reserved.	Univ Sydney, Westmead Hosp, Dept Neurosurg, Sydney, NSW 2006, Australia; Univ Sydney, Westmead Hosp, Dept Neurol, Sydney, NSW 2006, Australia; Univ Sydney, Westmead Hosp, Dept Intens Care, Sydney, NSW 2006, Australia		Lang, EW (corresponding author), Univ Kiel, Dept Neurosurg, Weimarer Str 8, D-24106 Kiel, Germany.						AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; BIRCH AA, 1995, STROKE, V26, P834, DOI 10.1161/01.STR.26.5.834; BULLOCK R, 1996, GUIDELINES MANAGEMEN; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Dawson SL, 2000, CEREBROVASC DIS, V10, P126, DOI 10.1159/000016041; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; GILLER CA, 1991, ACTA NEUROCHIR, V108, P7, DOI 10.1007/BF01407660; Heckmann JG, 1999, NEUROL RES, V21, P457, DOI 10.1080/01616412.1999.11740959; JENNETT B, 1975, LANCET, V1, P480; Lang E W, 1994, Neurosurg Clin N Am, V5, P573; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; Lang EW, 2002, J NEUROL NEUROSUR PS, V72, P583, DOI 10.1136/jnnp.72.5.583; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; Lang EW, 1999, NEUROL RES, V21, P665, DOI 10.1080/01616412.1999.11740995; LARSEN FS, 1994, STROKE, V25, P1985, DOI 10.1161/01.STR.25.10.1985; MARION DW, 1991, NEUROSURGERY, V29, P869, DOI 10.1227/00006123-199112000-00011; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Piechnik SK, 2001, J CEREBR BLOOD F MET, V21, P182, DOI 10.1097/00004647-200102000-00010; Schmidt EA, 2002, ACT NEUR S, V81, P133; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; STEINMEIER R, 1999, J NEUROSURG, V90, P427; SYMON L, 1971, EUR NEUROL, V6, P11, DOI 10.1159/000114458; Vavilala MS, 2002, ACTA ANAESTH SCAND, V46, P393, DOI 10.1034/j.1399-6576.2002.460411.x; Wallis SJ, 1996, STROKE, V27, P2287, DOI 10.1161/01.STR.27.12.2287	27	13	13	0	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2003	10	6					670	673		10.1016/S0967-5868(03)00197-8			4	Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	748AJ	WOS:000186839100005	14592614				2022-02-06	
J	Armstead, WM				Armstead, WM			Cyclooxygenase-2-dependent superoxide generation contributes to age-dependent impairment of G protein-mediated cerebrovasodilation	ANESTHESIOLOGY			English	Article							TRAUMATIC BRAIN INJURY; K-ATP; CEREBRAL-CORTEX; ACTIVATION; RAT; EXPRESSION; NEURONS; COX-2; MASTOPARAN; RESPONSES	Background: Previous studies have observed that activation of cyclooxygenase-2 contributes to generation of superoxide anion after fluid percussion brain injury (FPI). This study was designed to characterize the effects of FPI on the vascular activity of two activators of a pertussis toxin-sensitive G protein, mastoparan and mastoparan-7, and the role of cyclooxygenase-2-dependent superoxide anion generation in such effects as a function of age. Methods: Lateral FPI was induced in anesthetized newborn (1-5-day-old) and juvenile (3-4-week-old) pigs equipped with a closed cranial window. Results: Mastoparan (10(-8), 10(-6) M) elicited pial artery dilation that was blunted more in newborn versus juvenile pigs (9 +/- 1 and 16 +/- 1 vs. 3 +/- 1 and 5 +/- 1%, newborn; 9 +/- 1 and 15 +/- 1 vs. 6 +/- 1 and 9 +/- 1%, juveniles). similar results were observed for mastoparan-7 but the inactive analog mastoparan-17 had no effect on pial artery diameter. Indomethacin (a cyclooxygenase-1 and cyclooxygenase-2 inhibitor), NS398 (a cyclooxygenase-2 inhibitor), and polyethylene glycol superoxide dismutase and catalase (free radical scavengers) partially restored impaired mastoparan dilation after FPI in the newborn in a roughly equivalent manner but not in the juvenile (3 1 and 5 +/- 1 vs. 8 +/- 1 and 13 +/- 1% newborn, 6 +/- 1 and 9 +/- 1 vs. 7 +/- 1 and 10 +/- 1% juvenile for NS398 pretreatment). Conclusions: These data show that G protein activation elicits cerebrovasodilation that is blunted following FPI in an age-dependent manner, and suggest that cyclooxygenase-2-dependent superoxide anion generation contributes to G protein activation-induced dilator impairment after the insult in an age-dependent manner.	Univ Penn, Dept Anesthesia, Philadelphia, PA 19104 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesia, 3400 Spruce St, Philadelphia, PA 19104 USA.						Armstead WM, 1996, AM J PHYSIOL-HEART C, V270, pH1272; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 2002, BRAIN RES, V957, P369, DOI 10.1016/S0006-8993(02)03698-3; Armstead WM, 1999, BRAIN RES, V816, P158, DOI 10.1016/S0006-8993(98)01146-9; Armstead WM, 1999, J NEUROTRAUM, V16, P391, DOI 10.1089/neu.1999.16.391; ARMSTEAD WM, 1999, AM J PHYSIOL, V274, pH1888; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Dobbing J., 1981, SCI F PAEDIATRICS, P744; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4; Gong C, 2001, BRAIN RES, V901, P38, DOI 10.1016/S0006-8993(01)02186-2; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; KLINKER JF, 1994, BIOCHEM J, V304, P377, DOI 10.1042/bj3040377; Klinker JF, 1996, BIOCHEM PHARMACOL, V51, P217, DOI 10.1016/0006-2952(95)02119-1; KONRAD RJ, 1995, J BIOL CHEM, V270, P12869, DOI 10.1074/jbc.270.21.12869; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Kulkarni M, 2002, J NEUROTRAUM, V19, P965, DOI 10.1089/089771502320317113; Kulkarni M, 2000, STROKE, V31, P1990, DOI 10.1161/01.STR.31.8.1990; Lapchak PA, 2001, STROKE, V32, P1220, DOI 10.1161/01.STR.32.5.1220; Leffler CW, 1993, REGULATION CEREBRAL, P297; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Niwa K, 2001, CIRC RES, V88, P600, DOI 10.1161/01.RES.88.6.600; Niwa K, 2000, J NEUROSCI, V20, P763, DOI 10.1523/JNEUROSCI.20-02-00763.2000; Resnick DK, 1998, J NEUROTRAUM, V15, P1005, DOI 10.1089/neu.1998.15.1005; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P625, DOI 10.1001/archpedi.1990.02150300019014; Sairanen T, 1998, ANN NEUROL, V43, P738, DOI 10.1002/ana.410430608; Schwab JM, 2001, J NEUROTRAUM, V18, P881, DOI 10.1089/089771501750451802; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Tepas J J 3rd, 1995, Semin Pediatr Surg, V4, P120; Thorogood MC, 1996, ANESTHESIOLOGY, V84, P614, DOI 10.1097/00000542-199603000-00017; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T	37	13	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-3022			ANESTHESIOLOGY	Anesthesiology	JUN	2003	98	6					1378	1383		10.1097/00000542-200306000-00012			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	682DE	WOS:000183075400011	12766646				2022-02-06	
J	Butterwick, DJ; Meeuwisse, WH				Butterwick, DJ; Meeuwisse, WH			Bull riding injuries in professional rodeo - Data for prevention and care	PHYSICIAN AND SPORTSMEDICINE			English	Article							EPIDEMIOLOGIC ANALYSIS	BACKGROUND: Recent tragedies in bull riding have highlighted the need for prospective epidemiologic investigation of injury patterns. OBJECTIVE: To document the frequency, type, severity, anatomic location, and mechanism of injury to bull riders participating in professional rodeo in Canada. DESIGN: Five-year prospective cohort study examining 4,375 competitor exposures during bull riding events at selected rodeos. Certified athletic therapists gathered data at 63 of 323 professional rodeos in Canada from 1995 through 1999. Data were included when a registered bull rider was injured and the Canadian Pro Rodeo Sport Medicine Team was officially present and providing services. The main outcome measures were the frequency, severity, and anatomic location of injuries to bull riders. RESULTS: According to the injury classification system (severe, minor, or other), 36% of injuries to bull riders were severe. Fractures were the most common severe injury. Concussions constituted 10.6% of all injuries; neck injuries and concussion with other head and facial injuries accounted for 28.9%. About half (48%) of injuries were minor. The knee and shoulder were the most commonly injured joints. CONCLUSION: Injuries to the head, neck, and face may deserve more attention by both researchers and those interested in preventing injury to bull riders. Epidemiologic information will give on-site physicians a better foundation in preparing to care for injured rodeo participants.	Univ Calgary, Fac Kinesiol, Ctr Sports Med, Calgary, AB T2N 1N4, Canada		Butterwick, DJ (corresponding author), Univ Calgary, Fac Kinesiol, Ctr Sports Med, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.						Brandenburg MA, 2002, CLIN J SPORT MED, V12, P360, DOI 10.1097/00042752-200211000-00007; Butterwick DJ, 1996, CLIN J SPORT MED, V6, P171, DOI 10.1097/00042752-199607000-00006; Butterwick DJ, 2002, CLIN J SPORT MED, V12, P30, DOI 10.1097/00042752-200201000-00009; Butterwick DJ, 2002, AM J SPORT MED, V30, P193, DOI 10.1177/03635465020300020801; GRIFFIN R, 1987, Physician and Sportsmedicine, V15, P105; Griffin R, 1983, Phys Sportsmed, V11, P110, DOI 10.1080/00913847.1983.11708608; Ketai LH, 2000, INJURY, V31, P757, DOI 10.1016/S0020-1383(00)00108-X; MEYERS MC, 1990, AM J SPORT MED, V18, P87, DOI 10.1177/036354659001800114; NEBERGALL RW, 1992, PHYSICIAN SPORTSMED, V20, P85, DOI 10.1080/00913847.1992.11947504	9	13	13	0	7	MCGRAW HILL HEALTHCARE PUBLICATIONS	MINNEAPOLIS	4530 WEST 77TH ST, MINNEAPOLIS, MN 55435-5000 USA	0091-3847			PHYSICIAN SPORTSMED	Physician Sportsmed.	JUN	2003	31	6					37	41		10.1080/00913847.2003.11440607			5	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	686DV	WOS:000183306800007	20086479				2022-02-06	
J	Stierman, KL; Lloyd, KM; De Luca-Pytell, DM; Phillips, LG; Calhoun, KH				Stierman, KL; Lloyd, KM; De Luca-Pytell, DM; Phillips, LG; Calhoun, KH			Treatment and outcome of human bites in the head and neck	OTOLARYNGOLOGY-HEAD AND NECK SURGERY			English	Article; Proceedings Paper	105th Annual Meeting of the American-Academy-of-Otolaryngology-Head-and-Neck-Surgery	SEP 09-14, 2001	DENVER, COLORADO	Amer Acad Otolaryngol Head & Neck Surg			PRIMARY CLOSURE; WOUNDS; MANAGEMENT; FACE; INJURIES	OBJECTIVE., Our goal was to review head and neck human bite injuries for demographic, treatment, and outcome data to identify factors influencing infection. STUDY DESIGN: Retrospective chart review of all human bite injuries (adult and pediatric) over 10 years. SETTING: Tertiary referral medical center. RESULTS: We reviewed 40 human bites (average follow-up, 139 days). Young males were the most common victims, altercation was the most common etiology, and auricular avulsion was the most common injury. Six wounds closed primarily became infected (40%) versus no wound infection with delayed closure. Primary wound closure (P < .01), exposed cartilage (P < .07), and less than 48 hours of intravenous antibiotics. (P < .06) were associated with postoperative infection (P < .01). CONCLUSION: Human bites to the head and neck, especially those with, exposed cartilage, are best, treated with at least 48 hours of intravenous antibiotics and delayed surgical closure (>24 hours postinjury) to prevent infection. SIGNIFICANCE: This information enables the clinician who sees these bite wounds infrequently to understand the treatment associated with avoiding infection.	Univ Texas, Med Branch, Dept Otolaryngol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Div Plast Surg, Galveston, TX 77550 USA		Calhoun, KH (corresponding author), Univ Texas, Med Branch, Dept Otolaryngol, Galveston, TX 77555 USA.						Bunzli WF, 1998, PHARMACOTHERAPY, V18, P227; Burgess L P, 1985, Ear Nose Throat J, V64, P546; CALLAHAM M, 1988, ANN EMERG MED, V17, P1321, DOI 10.1016/S0196-0644(88)80359-7; Chidzonga MM, 1998, S AFR MED J, V88, P150; Donkor P, 1997, J ORAL MAXIL SURG, V55, P479, DOI 10.1016/S0278-2391(97)90695-9; EARLEY MJ, 1984, BRIT J PLAST SURG, V37, P458, DOI 10.1016/0007-1226(84)90130-9; GOLDSTEIN EJC, 1989, J AM ACAD DERMATOL, V21, P1275, DOI 10.1016/S0190-9622(89)70343-1; GRIEGO RD, 1995, J AM ACAD DERMATOL, V33, P1019, DOI 10.1016/0190-9622(95)90296-1; HANER ML, 1975, ANN SURG, V181, P819; HEGGERS JP, 1991, QUANTITATIVE BACTER, P74; Presutti RJ, 1997, POSTGRAD MED, V101, P243, DOI 10.3810/pgm.1997.04.207; RUSKIN JD, 1993, J ORAL MAXIL SURG, V51, P174, DOI 10.1016/S0278-2391(10)80017-5; Ruskin JD, 1997, J ORAL MAXIL SURG, V55, P481, DOI 10.1016/S0278-2391(97)90696-0; Smith PF, 2000, J CLIN PHARM THER, V25, P85; STUCKER FJ, 1990, ARCH OTOLARYNGOL, V116, P789	15	13	13	0	0	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0194-5998			OTOLARYNG HEAD NECK	Otolaryngol. Head Neck Surg.	JUN	2003	128	6					795	801		10.1016/S0194-5998(03)00254-7			7	Otorhinolaryngology; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Surgery	694CC	WOS:000183755400005	12825029				2022-02-06	
J	Thomas, H; Feyz, M; LeBlanc, J; Brosseau, J; Champoux, MC; Christopher, A; Desormeaux, N; Dorais, L; Lin, H				Thomas, H; Feyz, M; LeBlanc, J; Brosseau, J; Champoux, MC; Christopher, A; Desormeaux, N; Dorais, L; Lin, H			North Star Project - Reality orientation in an acute care setting for patients with traumatic brain injuries	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acute care rehabilitation; brain injury; reality orientation	LOG	Objective: The North Star Project is an acute care rehabilitation approach for patients with moderate and severe traumatic brain injuries. This patient-centered project uses the concepts of Reality Orientation Therapy to develop a unique approach that focuses "environment," "consistency" and "standardization" to promote a total team effort. Patients, treatment staff and members of the patient's family collaborate in a unified bedside protocol that stimulates orientation, encourages patients' appropriate interactions and aims to decrease the length of post-traumatic amnesia. Development of materials, protocols, training and outcome measurement initiatives are described.	McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal, PQ H3G 1A4, Canada		Thomas, H (corresponding author), McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal Gen Hosp Site,1650 Cedar Ave,Room D13-124, Montreal, PQ H3G 1A4, Canada.						BARNES J, 1974, GERONTOLOGIST, P138; CERNY J, 1983, REHABILITATION HEAD; CORRIGAN JD, 1985, ARCH PHYS MED REHAB, V66, P626; Folsom J C, 1967, Curr Psychiatr Ther, V7, P209; Hagen C., 1972, COMMUNICATION DISORD; HOLDEN P, 1995, POSITIVE APPROACHES; HOWIE P, 1997, INT J GERIATR PSYCH, V12, P718; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; JENNETT B, 1975, LANCET, V1, P480; JONES A, 1993, BR J NURS, V4, P519; Keith R A, 1987, Adv Clin Rehabil, V1, P6; LEVIN H, 1975, J NERV MENT DIS, V167, P675; MANZI DB, 1987, HEAD INJURY ACUTE CA; MCNENY R, 1990, REHABILITATION ADULT; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Spector A, 2000, GERONTOLOGIST, V40, P206, DOI 10.1093/geront/40.2.206; TAULBEE LR, 1966, HOSP COMMUNITY PSYCH, V17, P133; TEASDALE G, 1974, LANCET, V2, P81; Woodrow P, 1998, Br J Nurs, V7, P1018; Woodrow P, 1998, Br J Nurs, V7, P1247; Zencius AH, 1998, BRAIN INJURY, V12, P53, DOI 10.1080/026990598122854	21	13	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2003	18	3					292	302		10.1097/00001199-200305000-00007			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	682HM	WOS:000183085700007	12802171				2022-02-06	
J	Othman, MM; Klueber, KM; Roisen, FJ				Othman, MM; Klueber, KM; Roisen, FJ			Identification and culture of olfactory neural progenitors from GFP mice	BIOTECHNIC & HISTOCHEMISTRY			English	Article						GFP mouse; green fluorescent protein; olfactory epithelium; progenitors; stem cells	GREEN FLUORESCENT PROTEIN; EPITHELIUM IN-VITRO; GLOBOSE BASAL-CELLS; NERVE GROWTH-FACTOR; CNS STEM-CELLS; ADULT-MOUSE; SENSORY NEURONS; TRANSGENIC MICE; SPINAL-CORD; RECEPTOR NEURONS	The olfactory epithelium (OE) is one of the best sources for obtaining adult stem cells from the nervous system, because it contains neural progenitors that regenerate continuously throughout life. The OE is accessible through the nasal cavity, which facilitates stem cell harvest for examination and transplantation. The mitotic activity of CE progenitors can be stimulated by intranasal irrigation with zinc sulfate (ZnSO4). In the study reported here, we focused on OE from a transgenic mouse line transfected with green fluorescent protein (GFP). Histological examination demonstrated the site of highest yield of CE in the transgenic and wild type littermates. Cultures were established from that site four days in vitro following ZnSO4 exposure. The GFP-derived primary cultures contained a heterogeneous population of fluorescent cells. After 10-12 days, a population of round, mitotically active cells emerged that formed fluorescent neurospheres. The neurosphere forming cells (NSFCs) were collected and subcultured up to four times. The NSFCs were primarily neuronal with only a few cells of glial lineage. Furthermore, the NSFCs were nestin positive and keratin negative, suggesting that they were neural progenitors. The endogenous GFP fluorescence of these cells provides a readily identifiable label that will facilitate their identification following transplantation into nontransfected hosts. They should provide a useful model for evaluating the potential therapeutic utility of OE progenitors in neurodegenerative diseases and neurotrauma repair.	Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA		Roisen, FJ (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA.	fjrois01@gwise.louisville.edu			NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR015576] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [1920RR15576] Funding Source: Medline		ALBERTS JR, 1971, PHYSIOL BEHAV, V6, P619, DOI 10.1016/0031-9384(71)90218-6; ALLISON AC, 1953, BIOL REV, V28, P195, DOI 10.1111/j.1469-185X.1953.tb01376.x; ANDREWS PM, 1974, AM J ANAT, V139, P399, DOI 10.1002/aja.1001390308; AUBIN JE, 1979, J HISTOCHEM CYTOCHEM, V27, P36, DOI 10.1177/27.1.220325; BAYER SA, 1982, SCIENCE, V216, P890, DOI 10.1126/science.7079742; BENSON RC, 1979, J HISTOCHEM CYTOCHEM, V27, P44, DOI 10.1177/27.1.438504; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CAGGIANO M, 1994, NEURON, V13, P339, DOI 10.1016/0896-6273(94)90351-4; CALOF AL, 1989, NEURON, V3, P115, DOI 10.1016/0896-6273(89)90120-7; Carpenter MK, 1997, EXP NEUROL, V148, P187, DOI 10.1006/exnr.1997.6657; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHUAH MI, 1991, J NEUROSCI RES, V29, P172, DOI 10.1002/jnr.490290206; COON HG, 1989, P NATL ACAD SCI USA, V86, P1703, DOI 10.1073/pnas.86.5.1703; CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; DOUCETTE R, 1990, GLIA, V3, P433, DOI 10.1002/glia.440030602; DUPREY P, 1995, INT J DEV BIOL, V39, P443; Farbman AI, 1996, J NEUROBIOL, V30, P267, DOI 10.1002/(SICI)1097-4695(199606)30:2<267::AID-NEU8>3.0.CO;2-3; Farbman Albert I., 1994, Seminars in Cell Biology, V5, P3; Feron F, 1999, NEUROSCIENCE, V88, P571, DOI 10.1016/S0306-4522(98)00233-4; Franklin RJM, 1996, EXP NEUROL, V137, P263, DOI 10.1006/exnr.1996.0025; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.ne.18.030195.001111; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; Goldstein BJ, 1996, J NEUROSCI, V16, P4005; Goldstein BJ, 1997, J NEUROBIOL, V33, P411; GRAZIADEI PP, 1973, TISSUE CELL, V5, P113, DOI 10.1016/S0040-8166(73)80010-2; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Gritti A, 1999, J NEUROSCI, V19, P3287; Guntinas-Lichius O, 2002, J NEUROSCI, V22, P7121; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Huard JMT, 1998, J COMP NEUROL, V400, P469; IKAWA M, 1995, FEBS LETT, V375, P125, DOI 10.1016/0014-5793(95)01162-8; Ishii K, 2001, J NEUROSCI RES, V65, P500, DOI 10.1002/jnr.1180; Kalyani AJ, 1998, BIOCHEM CELL BIOL, V76, P1051, DOI 10.1139/bcb-76-6-1051; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; KELLER A, 1975, J NEUROCHEM, V24, P1101, DOI 10.1111/j.1471-4159.1975.tb03883.x; KSANDER GA, 1990, J HISTOCHEM CYTOCHEM, V38, P1831, DOI 10.1177/38.12.2254647; Kukekov VG, 1997, GLIA, V21, P399, DOI 10.1002/(SICI)1098-1136(199712)21:4<399::AID-GLIA7>3.0.CO;2-Z; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LEVEY MS, 1991, J NEUROSCI, V11, P3556; Liem RKH, 1993, CURR OPIN CELL BIOL, V5, P12, DOI 10.1016/S0955-0674(05)80003-1; Liu N, 1998, EXP NEUROL, V151, P173, DOI 10.1006/exnr.1998.6810; Liu Y, 1999, J NEUROSCI, V19, P4370; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Lu J, 2001, BRAIN RES, V889, P344, DOI 10.1016/S0006-8993(00)03235-2; MacDonald KPA, 1996, J NEUROSCI RES, V44, P27, DOI 10.1002/(SICI)1097-4547(19960401)44:1<27::AID-JNR4>3.0.CO;2-K; MAHANTHAPPA NK, 1993, NEURON, V10, P293, DOI 10.1016/0896-6273(93)90319-M; MARUNIAK JA, 1990, BRAIN RES, V526, P65, DOI 10.1016/0006-8993(90)90250-F; MENCO BPM, 1987, J ANAT, V152, P145; Mumm JS, 1996, P NATL ACAD SCI USA, V93, P11167, DOI 10.1073/pnas.93.20.11167; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Newman MP, 2000, NEUROSCIENCE, V99, P343, DOI 10.1016/S0306-4522(00)00194-9; NISWENDER KD, 1995, J MICROSC-OXFORD, V180, P109, DOI 10.1111/j.1365-2818.1995.tb03665.x; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; PIXLEY SK, 1992, GLIA, V5, P269, DOI 10.1002/glia.440050405; Pratt T, 2000, DEV BIOL, V228, P19, DOI 10.1006/dbio.2000.9935; Raaf J, 1944, AM J ANAT, V75, P151, DOI 10.1002/aja.1000750203; Raisman G, 2001, NAT REV NEUROSCI, V2, P369, DOI 10.1038/35072576; Rao MS, 1999, ANAT RECORD, V257, P137; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Roisen FJ, 2001, BRAIN RES, V890, P11, DOI 10.1016/S0006-8993(00)03016-X; Roskams AJI, 1996, J NEUROSCI, V16, P1294; SATOH M, 1995, DEV BRAIN RES, V87, P111, DOI 10.1016/0165-3806(95)00057-K; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; SCHULTZ EW, 1960, AM J PATHOL, V37, P1; SCHWOB JE, 1994, CHEM SENSES, V19, P671, DOI 10.1093/chemse/19.6.671; SCHWOB JE, 1995, J COMP NEUROL, V359, P15, DOI 10.1002/cne.903590103; SCHWOB JE, 1992, J NEUROSCI, V12, P3896; SCHWOB JE, 1986, J NEUROSCI, V6, P208; SOSNOWSKI JS, 1995, BRAIN RES, V702, P37, DOI 10.1016/0006-8993(95)00960-7; Suzuki Y, 1998, ANAT EMBRYOL, V198, P43, DOI 10.1007/s004290050163; SUZUKI Y, 1991, CELL TISSUE RES, V266, P239, DOI 10.1007/BF00318179; Suzuki Y, 2000, EXP NEUROL, V165, P35, DOI 10.1006/exnr.2000.7465; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; WOLOZIN B, 1992, J MOL NEUROSCI, V3, P137, DOI 10.1007/BF02919405; Yasuno H, 2000, BRAIN RES, V887, P53, DOI 10.1016/S0006-8993(00)02966-8	76	13	16	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1052-0295	1473-7760		BIOTECH HISTOCHEM	Biotech. Histochem.	APR	2003	78	2					57	70		10.1080/10520290310001593801			14	Biotechnology & Applied Microbiology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Cell Biology	724RJ	WOS:000185500300001	14533842				2022-02-06	
J	Mewasingh, LD; Christophe, C; Fonteyne, C; Dachy, B; Ziereisen, F; Christiaens, F; Deltenre, P; De Maertelaer, V; Dan, B				Mewasingh, LD; Christophe, C; Fonteyne, C; Dachy, B; Ziereisen, F; Christiaens, F; Deltenre, P; De Maertelaer, V; Dan, B			Predictive value of electrophysiology in children with hypoxic coma	PEDIATRIC NEUROLOGY			English	Article							SOMATOSENSORY-EVOKED-POTENTIALS; MORTALITY PRISM SCORE; ANOXIC-ISCHEMIC COMA; VEGETATIVE STATE; PEDIATRIC RISK; BRAIN INJURY; PROGNOSTIC VALUE; HEAD-INJURY; SEPS	Assessment of prognosis of children in hypoxic coma is difficult. The value of clinical evaluation is often limited. The usefulness of electrophysiologic tests has been documented mostly in adults and neonates and in cases of traumatic coma. We reviewed retrospectively 39 consecutive children with nontraumatic hypoxic coma to assess the prognostic value of EEG, visual, and auditory evoked potentials. Correlation between electrophysiology and neurologic outcome after mean follow-up period of 30 months was significant (r(s) = 0.6, P < 0.001). In contrast there was no correlation between Pediatric Risk of Mortality score (PRISM) and outcome (r(s) = -0.42, P = 0.8). Combining magnetic resonance imaging with electrophysiology further enhanced their prognostic value (r(s) = 0.69, P < 0.001). Neuroimaging was highly sensitive but less specific, and electrophysiologic tests were highly specific but less sensitive. We conclude that early electrophysiology can contribute to predicting outcome in pediatric hypoxic coma. (C) 2003 by Elsevier Inc. All rights reserved.	Univ Brussels, Childrens Hosp Queen Fabiola, Dept Neurol, B-1020 Brussels, Belgium; Univ Brussels, Childrens Hosp Queen Fabiola, Dept Neuroradiol, B-1020 Brussels, Belgium; Univ Brussels, Childrens Hosp Queen Fabiola, Intens Care Unit, B-1020 Brussels, Belgium; Hop Univ Brugmann, Dept Neurophysiol, Brussels, Belgium; Free Univ Brussels, IRIBHM, Stat Unit, Brussels, Belgium		Mewasingh, LD (corresponding author), Univ Brussels, Childrens Hosp Queen Fabiola, Dept Neurol, Ave JJ Crocq 15, B-1020 Brussels, Belgium.			Dan, Bernard/0000-0002-2051-9876			Biagioni E, 2001, PEDIATRICS, V107, P461, DOI 10.1542/peds.107.3.461; Carter BG, 1999, INTENS CARE MED, V25, P722, DOI 10.1007/s001340050936; Chen R, 1996, CRIT CARE MED, V24, P672, DOI 10.1097/00003246-199604000-00020; Christophe C, 2002, AM J NEURORADIOL, V23, P716; Christophe C, 2000, J RADIOL, V81, P25; DEUSCHL G, 1999, ELECTROENCEPHALOGR S, V52; DOUGHERTY JH, 1981, NEUROLOGY, V31, P991, DOI 10.1212/WNL.31.8.991; FRANK LM, 1985, NEUROLOGY, V35, P931, DOI 10.1212/WNL.35.6.931; HECOX KE, 1981, NEUROLOGY, V31, P832, DOI 10.1212/WNL.31.7.832; Heindl UT, 1996, NEUROPEDIATRICS, V27, P94, DOI 10.1055/s-2007-973756; KARMEL BZ, 1988, ELECTROEN CLIN NEURO, V71, P429, DOI 10.1016/0168-5597(88)90047-0; KOHT A, 1988, ANESTH ANALG, V67, P435; KRUUS S, 1979, ACTA PAEDIATR SCAND, V68, P315, DOI 10.1111/j.1651-2227.1979.tb05013.x; LINDSAY K, 1990, NEUROSURGERY, V26, P278, DOI 10.1227/00006123-199002000-00015; LUTSCHG J, 1983, AM J DIS CHILD, V137, P421; MaulenRadovan I, 1996, ARCH MED RES, V27, P553; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; PAMPIGLI.G, 1968, LANCET, V1, P1261; PARAIN D, 1989, Neurophysiologie Clinique, V19, P489, DOI 10.1016/S0987-7053(89)80005-X; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; Rothstein TL, 2000, J CLIN NEUROPHYSIOL, V17, P486, DOI 10.1097/00004691-200009000-00007; ROTHSTEIN TL, 1991, ELECTROEN CLIN NEURO, V79, P101, DOI 10.1016/0013-4694(91)90046-7; SCOLLOLAVIZZARI G, 1987, EUR NEUROL, V26, P161, DOI 10.1159/000116329; Shewmon DA, 2000, J CLIN NEUROPHYSIOL, V17, P467, DOI 10.1097/00004691-200009000-00005; Sonnet M. L., 1993, Neurophysiologie Clinique, V23, P227, DOI 10.1016/S0987-7053(05)80232-1; STRICKBINEVANREET P, 1984, AM J DIS CHILD, V138, P492; TAYLOR MJ, 1989, PEDIATR NEUROL, V5, P145, DOI 10.1016/0887-8994(89)90063-5; van Brakel MJM, 2000, EUR J PEDIATR, V159, P232, DOI 10.1007/s004310050060; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Zandbergen EGJ, 1998, LANCET, V352, P1808, DOI 10.1016/S0140-6736(98)04076-8; Zuckerman GB, 1998, ARCH PEDIAT ADOL MED, V152, P134	31	13	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994			PEDIATR NEUROL	Pediatr. Neurol.	MAR	2003	28	3					178	183		10.1016/S0887-8994(02)00509-X			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	684LV	WOS:000183209600003	12770669				2022-02-06	
J	Murakami, M; Kakita, K; Hosokawa, Y				Murakami, M; Kakita, K; Hosokawa, Y			Ruptured traumatic aneurysm after trivial injury mimicking acute spontaneous subdural hematoma - Case report	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						traumatic aneurysm; acute spontaneous subdural hematoma; middle cerebral artery	CEREBRAL-ARTERIES	A 75-year-old man suffered acute subdural hematoma shortly after trivial head trauma. Thirteen hours after a trivial brow to the occipital region, caused by contact with a mat, he suddenly deteriorated to the level of a Glasgow Coma Scale score of 6. Computed tomography demonstrated an acute subdural hematoma on the left and angiography revealed an aneurysm of the distal middle cerebral artery. An emergent craniotomy disclosed no skull fracture and exposed a thick subdural hematoma with no brain contusions. After evacuation of the hematoma, an aneurysm was found on the distal portion of posterior temporal artery, which was compatible with the angiographical findings. The neck of aneurysm was so fragile that neck clipping could not be successfully performed. Therefore, the aneurysm was extirpated, and the bleeding site coagulated with oxidized cellulose reinforcement. Histological examination of the aneurysm indicated a pseudoaneurysm during the early phase of clot formation. The acute subdural hematoma resulted from rupture of this pseudoaneurysm which was formed shortly after the minor head trauma. Rupture of a pseudoaneurysm caused by trivial trauma might be one of the origins for so-called acute "spontaneous" subdural hematoma.	Kyoto 1st Red Cross Hosp, Dept Neurosurg, Kyoto, Japan; Kyoto 1st Red Cross Hosp, Dept Pathol, Kyoto, Japan		Murakami, M (corresponding author), Kyoto Prefectural Univ Med, Dept Neurosurg, 465 Kajii Cho,Kaaramachi Hirokoji, Kyoto 6028566, Japan.	mamoru@koto.kpu-m.ac.jp					ACOSTA C, 1972, J NEUROSURG, V36, P531, DOI 10.3171/jns.1972.36.5.0531; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; BURTON C, 1968, J NEUROSURG, V28, P468, DOI 10.3171/jns.1968.28.5.0468; EICHLER A, 1969, J NEUROSURG, V31, P72, DOI 10.3171/jns.1969.31.1.0072; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; GELABERT M, 1989, CLIN NEUROL NEUROSUR, V91, P75, DOI 10.1016/S0303-8467(89)80012-5; GREENBERG MS, 1997, HDB NEUROSURGERY, P853; HESSELBROCK R, 1984, SURG NEUROL, V21, P363, DOI 10.1016/0090-3019(84)90115-0; JAKOBSSON KE, 1984, ACTA NEUROCHIR, V71, P91, DOI 10.1007/BF01401153; Koc RK, 1997, SURG NEUROL, V47, P9, DOI 10.1016/S0090-3019(96)00150-4; Komiyama M, 2001, NEUROL MED-CHIR, V41, P264, DOI 10.2176/nmc.41.264; Matsuyama T, 1997, SURG NEUROL, V47, P423, DOI 10.1016/S0090-3019(96)00398-9; MCDERMOTT M, 1984, NEUROSURGERY, V14, P13, DOI 10.1227/00006123-198401000-00004; NAKASHIMA H, 1992, Neurological Surgery, V20, P391; OBRIEN PK, 1974, J NEUROSURG, V41, P435, DOI 10.3171/jns.1974.41.4.0435; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; RUMBAUGH CL, 1970, RADIOLOGY, V96, P49, DOI 10.1148/96.1.49; SADAR ES, 1973, SURG GYNECOL OBSTET, V137, P59; SEDZIMIR CB, 1968, J NEUROSURG, V29, P636, DOI 10.3171/jns.1968.29.6.0636; SERIZAWA T, 1991, Neurological Surgery, V19, P1061; SMITH DR, 1970, J NEUROSURG, V32, P357, DOI 10.3171/jns.1970.32.3.0357; TOKORO K, 1988, SURG NEUROL, V29, P159, DOI 10.1016/0090-3019(88)90076-6; Yagi T, 1996, NEUROL SURG TOKYO, V24, P665; YANAI Y, 1985, SURG NEUROL, V23, P417, DOI 10.1016/0090-3019(85)90221-6; YASUI T, 1995, SURG NEUROL, V43, P61, DOI 10.1016/0090-3019(95)80041-E	26	13	13	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	MAR	2003	43	3					130	133		10.2176/nmc.43.130			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	656ZP	WOS:000181641200011	12699120	Bronze			2022-02-06	
J	Kaptanoglu, E; Palaoglu, S; Demirpence, E; Akbiyik, F; Solaroglu, I; Kilinc, A				Kaptanoglu, E; Palaoglu, S; Demirpence, E; Akbiyik, F; Solaroglu, I; Kilinc, A			Different responsiveness of central nervous system tissues to oxidative conditions and to the antioxidant effect of melatonin	JOURNAL OF PINEAL RESEARCH			English	Article						antioxidant; brain; melatonin; optic nerve; spinal cord; white matter	SPINAL-CORD INJURY; LIPID-PEROXIDATION; FREE-RADICALS; DAMAGE; PROTECTION; MODEL; EXCITOTOXICITY; ISCHEMIA; NEURONS; ACID	Melatonin, a product of the pineal gland, is an effective free-radical scavenger both in vitro and in vivo. Free-radical-mediated lipid peroxidation has been increasingly considered as an important factor in post-traumatic neuronal degeneration. The aim of the present study was (i) to examine the responses of different regions of central nervous system (CNS) to free-radical generation induced in vitro and (ii) to test the efficacy of melatonin in reducing oxidative damage in different regions of the CNS. Rat brain, total spinal cord, spinal cord white matter and optic nerves were dissected with the rats under general anesthesia and immediately frozen at -20degreesC. Thiobarbituric acid reactive substances were measured as an index of lipid peroxidation. Peroxidation was induced with ferrous iron (0.02 mm), ascorbate (1 mm), and hydrogen peroxide (H-2 O-2 ) (0.5 mm). All tissue samples showed increased lipid peroxidation levels after treatment with free-radical generating agents. The highest amount of damage was observed in the presence of ferrous iron, ascorbate, and H-2 O-2 . Melatonin showed antioxidant effects in the brain, total spinal cord, optic nerve, and spinal cord white matter. The results show that melatonin has differential protective effects on CNS tissues in vitro and the most potent effect is observed in the spinal cord white matter.	Hacettepe Univ, Dept Neurosurg, Sch Med, Spinal Res Lab,Inst Neurol Sci & Psychiat,Fac Med, TR-06100 Ankara, Turkey; Hacettepe Univ, Dept Neurosurg, Spinal Res Lab, Inst Neurol Sci & Psychiat,Ankara Numune Educ & R, TR-06100 Ankara, Turkey; Hacettepe Univ, Dept Biochem, Fac Med, TR-06100 Ankara, Turkey		Palaoglu, S (corresponding author), Hacettepe Univ, Dept Neurosurg, Sch Med, Spinal Res Lab,Inst Neurol Sci & Psychiat,Fac Med, TR-06100 Ankara, Turkey.	palaoglu@hacettepe.edu.tr	Solaroglu, Ihsan/ABF-7606-2020; Demirpence, Ediz/P-6050-2015; Solaroglu, Ihsan/ABE-8816-2020	Demirpence, Ediz/0000-0002-8922-7329; Solaroglu, Ihsan/0000-0002-9472-1735			ACUNACASTROVIEJ.D, 1997, LIFE SCI, V60, P23; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; ANDERSON DK, 1985, ANN EMERG MED, V14, P816, DOI 10.1016/S0196-0644(85)80064-0; Blask DE, 1999, CANCER RES, V59, P4693; Carneiro RCG, 1998, NEUROSCIENCE, V82, P293; Cazevieille C, 1997, BRAIN RES, V768, P120, DOI 10.1016/S0006-8993(97)00611-2; Cho S, 1997, BRAIN RES, V755, P335, DOI 10.1016/S0006-8993(97)00188-1; Cirak B, 1999, PEDIATR NEUROSURG, V31, P298, DOI 10.1159/000028879; Cuzzocrea S, 2000, J PINEAL RES, V28, P52, DOI 10.1034/j.1600-079x.2000.280108.x; Fehlings MG, 1997, J NEUROSCI METH, V71, P215, DOI 10.1016/S0165-0270(96)00147-1; FREEMAN BA, 1982, LAB INVEST, V47, P412; Gorgulu AK, 2001, NEUROSURGERY, V49, P1434; HALL ED, 1993, ANN EMERG MED, V22, P1022, DOI 10.1016/S0196-0644(05)82745-3; Hardeland R, 1997, INT J BIOMETEOROL, V41, P47, DOI 10.1007/s004840050053; IANAS O, 1991, ROM J ENDOCR, V29, P117; Kaptanoglu E, 2000, J NEUROSURG, V93, P77, DOI 10.3171/spi.2000.93.1.0077; Kaptanoglu E, 2002, J NEUROSURG, V97, P49, DOI 10.3171/spi.2002.97.1.0049; Kaptanoglu E, 1999, J NEUROSURG, V91, P200, DOI 10.3171/spi.1999.91.2.0200; Karbownik M, 2000, P SOC EXP BIOL MED, V225, P9, DOI 10.1046/j.1525-1373.2000.22502.x; MELCHIORRI D, 1995, FASEB J, V9, P1205, DOI 10.1096/fasebj.9.12.7672513; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; Pablos MI, 1997, J APPL PHYSIOL, V83, P354, DOI 10.1152/jappl.1997.83.2.354; Pappolla MA, 1997, J NEUROSCI, V17, P1683; POEGGELER B, 1993, J PINEAL RES, V14, P151, DOI 10.1111/j.1600-079X.1993.tb00498.x; Reiter R, 1997, LIFE SCI, V60, P2255, DOI 10.1016/S0024-3205(97)00030-1; Reiter RJ, 1998, PROG NEUROBIOL, V56, P359, DOI 10.1016/S0301-0082(98)00052-5; REITER RJ, 1993, NEUROENDOCRINOL LETT, V15, P103; REITER RJ, 1992, BIOESSAYS, V14, P169, DOI 10.1002/bies.950140307; REITER RJ, 1999, MOL CELL ENDOCRINOL, V79, pC53; SCHULZ JB, 1995, J NEUROCHEM, V64, P2239; Sewerynek E, 1996, HEPATO-GASTROENTEROL, V43, P898; Tan DX, 1998, J PINEAL RES, V25, P184, DOI 10.1111/j.1600-079X.1998.tb00558.x; WAN Q, 1994, NEUROSCI LETT, V180, P253, DOI 10.1016/0304-3940(94)90532-0	33	13	14	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0742-3098	1600-079X		J PINEAL RES	J. Pineal Res.	JAN	2003	34	1					32	35		10.1034/j.1600-079X.2003.02934.x			4	Endocrinology & Metabolism; Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology; Physiology	627CD	WOS:000179910500005	12485369				2022-02-06	
J	Verburg, G; Borthwick, B; Bennett, B; Rumney, P				Verburg, G; Borthwick, B; Bennett, B; Rumney, P			Online support to facilitate the reintegration of students with brain injury: Trials and errors	NEUROREHABILITATION			English	Article						telerehabilitation; reintegration; students; acquired/traumatic brain injury (ABI/TBI) online	WORLD-WIDE-WEB; EDUCATION; CHILDREN; INTERNET; TELEREHABILITATION; PROFESSIONALS; TELEHEALTH; QUALITY; NEEDS	The reintegration of students after acquired/traumatic brain injury (ABI/TBI) continues to be fraught with difficulties. Presented are (1) case studies exploring the potential of online support for teachers of students with ABI after returning from a paediatric rehabilitation centre; (2) results of Internet-based courses about reintegrating students with ABI; (3) outcomes of videoconferencing-based and Internet email-based support; (4) development of an online support process that uses Questions and Answers as a quick and immediate resource for teachers. The authors recommend that a collaborative process be instituted, in order to generate a relatively small number of high quality online resources about re-integrating students into their school and community. A second recommendation focuses on the development of online support network which may be text or email based or which may use videoconferencing over the Internet. Such networks allow students with ABI to maintain contact with their family and friends in the home community and facilitate their reintegration An Internet-based support structure also allows professionals to provide consultation, collaboration and continuing input.	BMCC, Toronto, ON M4G 1R8, Canada; Bloorview MacMillan Sch Author, Toronto, ON, Canada		Verburg, G (corresponding author), BMCC, 350 Rumsey Rd, Toronto, ON M4G 1R8, Canada.	gverburg@bloorview-macmillan.on.ca					Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; Bashshur RL, 2002, TELEMED J E-HEALTH, V8, P95, DOI 10.1089/15305620252933437; Berkowicz DA, 1998, J AM MED INFORM ASSN, P116; Borowitz SM, 2001, MED INFORM INTERNET, V26, P283, DOI 10.1080/14639230110086295; BROWN E, 2002, CANADIAN HEALTHCARE, P39; Chapman PM, 2000, ENVIRON TOXICOL CHEM, V19, P3, DOI [10.1002/etc.5620190102, 10.1897/1551-5028(2000)019&lt;0003:WETTUL&gt;2.3.CO;2]; Chen HC, 1998, J AM SOC INFORM SCI, V49, P582, DOI 10.1002/(SICI)1097-4571(1998)49:7<582::AID-ASI2>3.0.CO;2-V; Cimino JJ, 2000, J AM MED INFORM ASSN, P151; Cumbo A, 2002, CANCER PRACT, V10, P155, DOI 10.1046/j.1523-5394.2002.103007.x; DePompei R, 1987, LANG SPEECH HEAR SER, V18, P292, DOI 10.1044/0161-1461.1804.292; DOWNES S, 2000, LEARNING OBJECTS; Eysenbach G, 2002, JAMA-J AM MED ASSOC, V287, P2691, DOI 10.1001/jama.287.20.2691; FEENEY T, 1997, STUDENTS ACQUIRED BR, P229; Glang A, 1997, J HEAD TRAUMA REHAB, V12, P32, DOI 10.1097/00001199-199704000-00005; GLANG A, 1993, 387967 ERIC ED US DE, P1; Hailey D, 2001, J TELEMED TELECARE, V7, P73, DOI 10.1258/1357633011937218; Harris JR, 1997, J HEAD TRAUMA REHAB, V12, P67, DOI 10.1097/00001199-199704000-00007; HILL HC, 2002, AM CLIN LAB, V21, P21; Hughes E, 2002, J TELEMED TELECARE, V8, P36, DOI 10.1258/13576330260440790; Jones JM, 2001, PATIENT EDUC COUNS, V44, P271, DOI 10.1016/S0738-3991(00)00204-4; JONES JM, 2001, PATIENT ED CONSELLIN, V44, P398; Kaplan B, 2001, J AM MED INFORM ASSN, V8, P309, DOI 10.1136/jamia.2001.0080309; Krupinski E, 2002, TELEMED J E-HEALTH, V8, P13, DOI 10.1089/15305620252933374; Lemaire ED, 2002, J TELEMED TELECARE, V8, P19, DOI 10.1258/1357633021937415; Liu LL, 2000, J TELEMED TELECARE, V6, P47, DOI 10.1258/1357633001935554; RADER MC, 1995, J JUST CARING ED, V1, P191; Ricker JH, 2002, J HEAD TRAUMA REHAB, V17, P242, DOI 10.1097/00001199-200206000-00005; Savage RC, 2001, NEUROREHABILITATION, V16, P49; Sax CL, 2002, DISABIL REHABIL, V24, P144, DOI 10.1080/09638280110066802; SCHATZ B, 2001, SHEAF LINDS DIG LIB; Simpson J, 2001, J TELEMED TELECARE, V7, P90, DOI 10.1258/1357633011936219; Steckler A, 2001, HEALTH EDUC RES, V16, P735, DOI 10.1093/her/16.6.735; STRECHNER VJ, 2002, CANADIAN HEALTHCARE, P34; Wagner TH, 2001, J HEALTH ECON, V20, P1059, DOI 10.1016/S0167-6296(01)00107-2; WITTE R, 1998, TEACHING EXCEPTIONAL, P56; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009	36	13	13	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2003	18	2					113	123					11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	743ZU	WOS:000186604100004	12867674				2022-02-06	
J	Alaca, R; Yilmaz, B; Gunduz, S				Alaca, R; Yilmaz, B; Gunduz, S			Anterior hypopituitarism with unusual delayed onset of diabetes insipidus after penetrating head injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						traumatic brain injury; neuroendocrine dysfunctions; diabetes insipidus; anterior hypopituitarism	LESIONS	Neuroendocrine dysfunctions are among the various complications that occur after traumatic brain injury. We report a case of onset of diabetes insipidus during acute rehabilitation of a 20-yr-old patient with a traumatic brain injury caused by a gunshot wound. Our case is the latest onset of diabetes insipidus after traumatic brain injury that has been reported in the literature.	Gulhane Mil Med Acad, Dept Phys Med & Rehabil, Ankara, Turkey; Gulhane Mil Med Acad, Rehabil & Care Ctr, Ankara, Turkey		Alaca, R (corresponding author), TSK Rehabil Bakim Merkezi, TR-06530 Bilkent, Turkey.		YILMAZ, Bilge/W-6481-2019; YILMAZ, Bilge/A-7428-2013	YILMAZ, Bilge/0000-0003-1173-9399; YILMAZ, Bilge/0000-0003-1173-9399			BARRECA T, 1980, J CLIN ENDOCR METAB, V51, P1279, DOI 10.1210/jcem-51-6-1279; BARZILAY Z, 1988, J MED, V19, P47; Childers MK, 1998, BRAIN INJURY, V12, P517, DOI 10.1080/026990598122476; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; HADANI M, 1985, J NEUROSURG, V63, P456, DOI 10.3171/jns.1985.63.3.0456; Iglesias P, 1996, J ENDOCRINOL INVEST, V19, P320, DOI 10.1007/BF03347870; KAWAI K, 1995, J NEUROSURG, V83, P368, DOI 10.3171/jns.1995.83.2.0368; KLINGBEIL GEG, 1985, ARCH PHYS MED REHAB, V66, P44; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; LEE SC, 1994, BRAIN INJURY, V8, P571; STEINBOK P, 1979, NEUROSURGERY, V5, P559, DOI 10.1227/00006123-197911000-00003; TATOIAN JA, 1975, J ORAL SURG, V33, P548; ZACHARIADES N, 1982, ORAL SURG ORAL MED O, V53, P141, DOI 10.1016/0030-4220(82)90278-X	13	13	14	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	OCT	2002	81	10					788	791		10.1097/00002060-200210000-00013			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	599KA	WOS:000178332500011	12362120				2022-02-06	
J	Rollins, S; Perkins, E; Mandybur, G; Zhang, JH				Rollins, S; Perkins, E; Mandybur, G; Zhang, JH			Oxyhemoglobin produces necrosis, not apoptosis, in astrocytes	BRAIN RESEARCH			English	Article						apoptosis; OxyHb; astrocyte; necrosis	SMOOTH-MUSCLE CELLS; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; CEREBRAL ENDOTHELIAL-CELLS; RAT-BRAIN; DNA FRAGMENTATION; HEME OXYGENASE-1; LYSED BLOOD; HEMOGLOBIN; VASOSPASM	Objective: Subarachnoid blood, resulting from traumatic brain injury or subarachnoid hemorrhage, has been linked with cell injury and stress gene induction. We investigated whether oxyhemoglobin (OxyHb), a major component in blood clots, exerts a cytotoxic effect on cultured astrocyte cells, and the pattern of cell death. Methods: A murine astrocyte cell line was used (passages 28-35). Cell growth studies were performed 24, 48, and 72 h after exposure to OxyHb (1, 10, and 30 muM). Western blot analysis of poly adenosine diphosphate [ADP]-ribose polymerase (PARP) cleavage and TUNEL stain analysis were performed to determine the presence of apoptosis. Cells treated with OxyHb were also evaluated with transmission electron microscopy to determine changes that may have occurred at the ultra-structural level. Results: OxyHb (10-30 muM), after 72-h incubation, inhibited cell growth. Western blot analysis of PARP and TUNEL staining for the presence of apoptosis were essentially negative in all groups. Ultrastructural analysis revealed an abundance of necrosis and random occurrences of apoptosis in a few cells. Conclusion: Cultured astrocytes exposed to OxyHb causing cell growth inhibition could possibly be a result of cellular cytotoxicity and necrosis. (C) 2002 Elsevier Science B.V. All rights reserved.	Univ Mississippi, Med Ctr, Dept Neurosurg, Jackson, MS 39216 USA		Zhang, JH (corresponding author), LSU Hlth Sci Ctr, Dept Neurosurg, 1501 Kings Highway, Shreveport, LA 71130 USA.						Chen JW, 2000, J BIOMED SCI, V7, P459, DOI 10.1007/BF02253361; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; Findlay JM, 1997, CAN J NEUROL SCI, V24, P161; FOLEY PL, 1994, J NEUROSURG, V81, P87, DOI 10.3171/jns.1994.81.1.0087; KASSELL NF, 1985, STROKE, V16, P562, DOI 10.1161/01.STR.16.4.562; Kwan Aij Lie, 1997, Kaohsiung Journal of Medical Sciences, V13, P67; Lennihan L, 2000, STROKE, V31, P383, DOI 10.1161/01.STR.31.2.383; MACDONALD RL, 1991, J NEUROSURG, V75, P415, DOI 10.3171/jns.1991.75.3.0415; Maiese K, 1997, ANN NY ACAD SCI, V835, P255, DOI 10.1111/j.1749-6632.1997.tb48636.x; Maiese K, 2000, CELL MOL NEUROBIOL, V20, P383, DOI 10.1023/A:1007070311203; Matsushita K, 2000, J CEREBR BLOOD F MET, V20, P396, DOI 10.1097/00004647-200002000-00022; Matz P, 1996, BRAIN RES, V713, P211, DOI 10.1016/0006-8993(95)01511-6; Matz PG, 1997, NEUROSURGERY, V40, P152, DOI 10.1097/00006123-199701000-00034; Matz PG, 2001, STROKE, V32, P506, DOI 10.1161/01.STR.32.2.506; Matz PG, 1996, J NEUROSURG, V85, P892, DOI 10.3171/jns.1996.85.5.0892; Matz PG, 2000, STROKE, V31, P2450, DOI 10.1161/01.STR.31.10.2450; Matz PG, 2000, BRAIN RES, V858, P312, DOI 10.1016/S0006-8993(99)02454-3; Mayberg MR, 1998, NEUROSURG CLIN N AM, V9, P615; Meguro T, 2001, STROKE, V32, P561, DOI 10.1161/01.STR.32.2.561; Meguro T, 2000, J NEUROSURG, V93, P640, DOI 10.3171/jns.2000.93.4.0640; Meguro T, 2001, J NEUROCHEM, V77, P1128, DOI 10.1046/j.1471-4159.2001.00313.x; MISRA HP, 1972, J BIOL CHEM, V247, P6960; Mori T, 2001, STROKE, V32, P636, DOI 10.1161/01.STR.32.3.636; Ogihara K, 2000, ACT NEUR S, V76, P507; Ogihara K, 2001, BRAIN RES, V889, P89, DOI 10.1016/S0006-8993(00)03120-6; Ogihara K, 1999, J NEUROSURG, V91, P459, DOI 10.3171/jns.1999.91.3.0459; PETERSON JW, 1990, J NEUROSURG, V72, P775, DOI 10.3171/jns.1990.72.5.0775; Pluta RM, 1998, J NEUROSURG, V88, P557, DOI 10.3171/jns.1998.88.3.0557; Regan RF, 2000, NEUROSCI LETT, V282, P1, DOI 10.1016/S0304-3940(00)00817-X; Stoodley M, 2000, J NEUROSURG, V93, P463, DOI 10.3171/jns.2000.93.3.0463; TAKENAKA K, 1993, STROKE, V24, P839, DOI 10.1161/01.STR.24.6.839; Turner CP, 1999, MOL BRAIN RES, V65, P87, DOI 10.1016/S0169-328X(98)00340-4; Turner CP, 1998, J CEREBR BLOOD F MET, V18, P257, DOI 10.1097/00004647-199803000-00004; VOLLRATH BAM, 1994, J NEUROSURG, V80, P261, DOI 10.3171/jns.1994.80.2.0261; Wang XY, 1999, NEUROSCI LETT, V274, P79, DOI 10.1016/S0304-3940(99)00682-5; Weir B, 1999, ACT NEUR S, V72, P27; Xi GH, 1998, J NEUROSURG, V89, P991, DOI 10.3171/jns.1998.89.6.0991; Xi GH, 1998, STROKE, V29, P2580, DOI 10.1161/01.STR.29.12.2580; Yip S, 2000, BRAIN RES, V864, P1, DOI 10.1016/S0006-8993(00)02067-9; Zhang H, 1996, J PHARMACOL EXP THER, V277, P1501; Zhang H, 1995, AM J PHYSIOL-HEART C, V269, pH1874, DOI 10.1152/ajpheart.1995.269.6.H1874; Zubkov AY, 2000, SURG NEUROL, V53, P260, DOI 10.1016/S0090-3019(99)00187-1	42	13	14	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUL 26	2002	945	1					41	49	PII S0006-8993(02)02562-3	10.1016/S0006-8993(02)02562-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	580FK	WOS:000177224300006	12113950				2022-02-06	
J	Dolberg, OT; Klag, E; Gross, Y; Schreiber, S				Dolberg, OT; Klag, E; Gross, Y; Schreiber, S			Relief of serotonin selective reuptake inhibitor induced sexual dysfunction with low-dose mianserin in patients with traumatic brain injury	PSYCHOPHARMACOLOGY			English	Article						serotonin selective reuptake inhibitor; sxual dysfunction; traumatic brain injury; SSRI-induced sexual dysfunction; mianserin	ANTAGONIST; FLUOXETINE; PAROXETINE	Rationale: Serotonin selective reuptake inhibitors (SSRI) are commonly used in the treatment of many psychiatric disorders. Although possessing a relatively mild side effect profile, these drugs can cause a number of difficulties, including sexual dysfunction. A variety of strategies have been reported in the management of SSRI-induced sexual dysfunction, including dose reduction, drug holidays, substitution of another antidepressant drug, and various augmentation strategies, including use of sildenafil citrate (Viagra), buspirone, and others. Objectives: We aimed to examine the effect of adding another medication, mianserin, a mainly postsynaptic serotonin 2A agonist, to ongoing SSRI treatment in order to alleviate sexual side effects caused by SSRIs. Methods: The patients included in this study suffered from traumatic brain injury and from psychiatric complications that necessitated the use of SSRIs. Seventeen patients were included in this study, all were being treated with SSRIs, and all complained of sexual dysfunction. Mianserin was added to on-going treatment at low doses, 7.5-15 mg/day. Patients were followed for at least 3 months. Results: Fifteen of the 17 patients (88%) included in this study reported improvement in sexual dysfunction following this intervention. Ten (59%) reported that sexual function achieved pretreatment level. Five (29%) reported "significant improvement," and two (12%) did not respond to this intervention and were given sildenafil citrate, with good results. Side effects were minimal and included dry mouth, drowsiness, headaches, and agitation. Conclusions: The use of low-dose mianserin as an add-on treatment to SSRIs appears to be an effective and well tolerated intervention for sexual dysfunction caused by SSRIs.	Psychiat Day Hosp, Sheba Med Ctr, Div Psychiat, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; Neuropsychol Unit Treatment & Rehabil, Tel Aviv, Israel; Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel; Bar Ilan Univ, Dept Psychol, Bar Ilan, Israel; Tel Aviv Sourasky Med Ctr, Dept Psychiat, Tel Aviv, Israel		Dolberg, OT (corresponding author), Psychiat Day Hosp, Sheba Med Ctr, Div Psychiat, IL-52621 Tel Hashomer, Israel.	otdol@email.com	Schreiber, Shaul/E-5821-2010	Schreiber, Shaul/0000-0002-2189-0693			AIZENBERG D, 1995, CLIN NEUROPHARMACOL, V18, P320, DOI 10.1097/00002826-199508000-00003; Aizenberg D, 1997, CLIN NEUROPHARMACOL, V20, P210, DOI 10.1097/00002826-199706000-00004; Aizenberg D, 1999, CLIN NEUROPHARMACOL, V22, P347; Clayton AH, 2001, J CLIN PSYCHIAT, V62, P185, DOI 10.4088/JCP.v62n0309; FINBERG N, 1991, SEROTONIN SLEEP MENT, P131; HERMAN JB, 1990, J CLIN PSYCHIAT, V51, P25; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Hirschfeld RMA, 1999, J CLIN PSYCHIAT, V60, P27; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; Kennedy SH, 2000, J CLIN PSYCHIAT, V61, P276, DOI 10.4088/JCP.v61n0406; KOPERA H, 1983, ACTA PSYCHIAT SCAND, V302, pS81; Kotler M, 2000, PSYCHOTHER PSYCHOSOM, V69, P309, DOI 10.1159/000012413; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Masand PS, 1999, HARVARD REV PSYCHIAT, V7, P69, DOI 10.1093/hrp/7.2.69; Norden MJ., 1994, DEPRESSION, V2, P109, DOI DOI 10.1002/depr.3050020208; Rosen RC, 1999, J CLIN PSYCHOPHARM, V19, P67, DOI 10.1097/00004714-199902000-00013; Schreiber S, 1998, EUR NEUROPSYCHOPHARM, V8, P297, DOI 10.1016/S0924-977X(97)00088-6; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Waldinger MD, 1998, J CLIN PSYCHOPHARM, V18, P274, DOI 10.1097/00004714-199808000-00004	19	13	13	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0033-3158	1432-2072		PSYCHOPHARMACOLOGY	Psychopharmacology	JUN	2002	161	4					404	407		10.1007/s00213-002-1097-z			4	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	568YV	WOS:000176573300010	12073168				2022-02-06	
J	Murillo-Cabezas, F; Arteta-Arteta, D; Flores-Cordero, JM; Munoz-Sanchez, MA; Rincon-Ferrari, MD; Rivera-Fernandez, MV; Alarcon-Cruz, JC				Murillo-Cabezas, F; Arteta-Arteta, D; Flores-Cordero, JM; Munoz-Sanchez, MA; Rincon-Ferrari, MD; Rivera-Fernandez, MV; Alarcon-Cruz, JC			Usefulness of transcranial Doppler ultrasound in the early phase of the acute head injury	NEUROCIRUGIA			Spanish	Article						head injury; transcranial Doppler ultrasound; cerebral hypoperfusion; intracranial hypertension status	CEREBRAL BLOOD-FLOW; INTRACRANIAL HYPERTENSION; CARBON-DIOXIDE; BRAIN INJURY; VELOCITY; VASOSPASM; HYPEREMIA; HEMODYNAMICS; ISCHEMIA; PRESSURE	Objectives: 1) To know the transcranial Doppler (TCD) patterns in the early phase of the severe and moderate head injury and its prognostic implications. 2) To ascertain the TCD measurements concordance among different operators. Material and methods: A prospective observational study in 275 consecutive intensive care unit patients with severe or moderate head injury was designed. Within 12 hrs. of the traumatic event a TCD study was done and a second one within the first 24 hrs. All patients were managed following a protocol made with the aim of promoting the early evacuation of the intracranial space occupying mass, preventing delayed brain damage and keeping the intracranial pressure (ICP) < 20 mm Hg and the cerebral perfusion pressure (CPP) > 60 mm Hg. The patient outcome was categorized with the Glasgow Outcome Score (GOS) at the discharge of the ICU. The mean velocity (MV) and the pulsatily index (PI) were measured in both middle cerebral arteries (MCA) and in the intracranial part of the internal carotid arteries in order to calculate the Lindegaard index. The presence of hypoperfusion, hyperaemia, vasospasm and cerebral circulatory arrest was registered. The presence of high intracranial pressure (HICP), the ICP peak and mode, the lowest CPP, the CPP mode, the minor medium arterial pressure (MAP) and the MAP mode were also recorded. A concordance analysis was made to ascertain the validity of the TCD data obtained by different operators. Results: The concordance analysis among observers showed a kappa index of 0,7863 (p<0,0001). The median stay in ICU was 7 days (Q1-Q3 of 3-15 days). The intra-ICU mortality was 20,72% (57/275) and the 53,44% of patients (147/275) showed favourable outcome (GOS 4-5) at the discharge of the ICU. The initial TCD showed a MV decreased and a PI increased in the MCA. Eighty of the e 275 patients showed a normal haemodynamic pattern whereas the pattern was abnormal in the remaining 195,1 the hypoperfusion pattern predominated overall (181/275, 61,87%). HIPO was registered in 123 patients (58,01) an not in 89 (41,99%). A statistic significant correlation was found between the HICP and the DTC data. The early hypoperfusion pattern was related with a higher incidence of HICP (p>0,05). The decrease in the MV and the increase in the PI were significantly associated with a higher mortality and a worse functional outcome (except for the MV within the first day). The PI was high within the first 24 h in the group of patients who died but was normalised among the survivals group. Conclusions: Early TCD detects a cerebral hypoperfusion status in the severe and moderate head injury that may imply therapeutic considerations. This hypoperfusion strongly correlates with the severity of the injury, the incidence of HICP and the functional outcome at the ICU discharge. In experienced hands, TCD measurements are reliable when done by different operators.	Hosp Univ Virgen Rocio, Serv Cuidados Crit & Urgencias, Unidad Neurotraumatol, Seville, Spain; Hosp Univ Virgen Rocio, Serv Neurocirugia, Seville, Spain				Murillo-Cabezas, Francisco/AAO-3348-2021; IBIS, NEUROCRITICOS/C-1805-2016; Arteta-Arteta, Donaldo S/D-3894-2014	Arteta-Arteta, Donaldo S/0000-0001-8909-563X			AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; AUER L, 1978, EUR NEUROL, V17, P351, DOI 10.1159/000114974; BISHOP CCR, 1986, STROKE, V17, P913, DOI 10.1161/01.STR.17.5.913; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CABEZAS FM, 1993, MONITORIZACION PACIE, P69; CABEZAS FM, 1993, MED INTENSIVA, V17, P490; CHAN KH, 1992, NEUROSURGERY, V30, P697; de Nadal M, 2000, ANESTHESIOLOGY, V92, P11, DOI 10.1097/00000542-200001000-00008; Ducrocq X, 1998, J NEUROL SCI, V159, P145, DOI 10.1016/S0022-510X(98)00158-0; Egido JA, 2000, REV NEUROLOGIA, V31, P179, DOI 10.33588/rn.3102.2000064; Fukushima U, 1999, J VET MED SCI, V61, P1293, DOI 10.1292/jvms.61.1293; GILLER CA, 1993, NEUROSURGERY, V32, P737, DOI 10.1227/00006123-199305000-00006; GOMEZ CR, 1991, SURG NEUROL, V35, P30, DOI 10.1016/0090-3019(91)90198-I; Hadani M, 1997, J NEUROTRAUM, V14, P629, DOI 10.1089/neu.1997.14.629; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; HOMBURG AM, 1993, ACTA NEUROL SCAND, V87, P488; Iida K, 1997, AM J EMERG MED, V15, P587, DOI 10.1016/S0735-6757(97)90164-9; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; LEE EJ, PROGNOSTIC SIGNIFICA; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; MARSHALL LF, 1991, J NEUROSURG, V75, pS59; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; McQuire JC, 1998, J NEUROSURG, V89, P526, DOI 10.3171/jns.1998.89.4.0526; Minassian AT, 1998, J NEUROSURG, V88, P996, DOI 10.3171/jns.1998.88.6.0996; RINGELSTEIN EB, 1989, NUEVAS TENDENCIAS DI, P3; Romner B, 1996, J NEUROSURG, V85, P90, DOI 10.3171/jns.1996.85.1.0090; Sahuquillo J, 1997, NEUROCIRUGIA, V8, P260; Schramm WM, 1997, ACTA ANAESTH SCAND, V41, P1319, DOI 10.1111/j.1399-6576.1997.tb04651.x; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; SHIGEMORI M, 1989, Neurological Research, V11, P165; SHIGEMORI M, 1990, ACTA NEUROCHIR, V107, P5, DOI 10.1007/BF01402605; Smielewski P, 1997, J NEUROSURG, V86, P773, DOI 10.3171/jns.1997.86.5.0773; Steiger HJ, 1996, STROKE, V27, P2048, DOI 10.1161/01.STR.27.11.2048; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; VANSANTBRINK H, 1994, INTRACRANIAL PRESSUR, V9, P585; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; ZURYNSKI YA, 1995, J NEUROL SCI, V134, P41, DOI 10.1016/0022-510X(95)00178-X; ZURYNSKI YA, 1995, J NEUROL SCI, V134, P33, DOI 10.1016/0022-510X(95)00172-9	42	13	13	0	4	ELSEVIER DOYMA SL	BARCELONA	TRAVESERA DE GARCIA, 17-21, BARCELONA, 08021, SPAIN	1130-1473			NEUROCIRUGIA	Neurocirugia	JUN	2002	13	3					196	208					13	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	575YY	WOS:000176977100005	12148164				2022-02-06	
J	Castejon, OJ; Castejon, HV; Zavala, M; Sanchez, E; Diaz, M				Castejon, OJ; Castejon, HV; Zavala, M; Sanchez, E; Diaz, M			A light and electron microscopic study of oedematous human cerebral cortex in two patients with post-traumatic seizures	BRAIN INJURY			English	Article							INDUCED STATUS EPILEPTICUS; CA3 PYRAMIDAL CELLS; DENTATE GYRUS; NEURONS; SYNAPSES; EPILEPSY; RATS; INJURY; DEATH	Primary objective: Brain cortical biopsies of two patients with clinical diagnosis of complicated brain trauma who had seizures, were studied by means of light and electron microscopes in order to correlate structural alterations with seizure activity. Methods and procedures: Biopsy samples of left frontal cortex and right parietal cortex were processed by current techniques for light and transmission electron microscopy. Results: The tissue showed severe vasogenic oedema with perivascular and intraparenchymatous haemorrhages. At the capillary wall, increased vesicular and vacuolar transendothelial transport, open endothelial junctions, thickened basement membrane and swollen perivascular astrocytic end-feet were observed. Some pyramidal and non-pyramidal nerve cells appeared dense and shrunken and others exhibited marked intraneuronal enlargement of membrane compartment. The myelinated axons displayed signs of degeneration and a process of axonal sprouting. Numerous swollen asymmetrical axo-dendritic synaptic contacts were observed in the neuropil, which exhibited mostly closely aggregated spheroidal synaptic vesicles toward the presynaptic membrane and numerous exocytotic vesicles sites. The perisynaptic astrocytic ensheathment appeared retracted or absent, whereas the extracellular space appeared notably dilated. Synaptic disassembly was also observed. Conclusion: The findings demonstrate, in two patients with post-traumatic seizure activity, brain brarrier dysfunction, vasogenic oedema, anoxic-ischaemic neurons, axonal sprouting, numerous altered excitatory synapses and synaptic disassembly. Some considerations on clinical and research applications are discussed.	Univ Zulia, Fac Med, Inst Invest Biol, Maracaibo 4003A, Venezuela		Castejon, OJ (corresponding author), Univ Zulia, Fac Med, Inst Invest Biol, Apartado 526, Maracaibo 4003A, Venezuela.	ocastejo@cantv.net					BECKER DP, 1989, J CEREBRAL BLOOD S1, V9, P302; BULLOCK R, 1992, J NEUROTRAUM, V9, pS443; BUNDMAN MC, 1994, HIPPOCAMPUS, V4, P611, DOI 10.1002/hipo.450040511; Castejon O J, 1995, J Neurosurg Sci, V39, P47; CASTEJON OJ, 1990, J SUBMICR CYTOL PATH, V22, P281; Castejon OJ, 1999, BRAIN INJURY, V13, P291, DOI 10.1080/026990599121665; Castejon OJ, 1997, BRAIN INJURY, V11, P363, DOI 10.1080/026990597123520; Castejon OJ, 1998, BRAIN INJURY, V12, P409, DOI 10.1080/026990598122539; DELANEROLLE NC, 1992, EPILEPSY RES, P235; Drakew A, 1996, NEUROSCIENCE, V70, P31, DOI 10.1016/0306-4522(95)00379-W; Friedman LK, 1998, HIPPOCAMPUS, V8, P511, DOI 10.1002/(SICI)1098-1063(1998)8:5<511::AID-HIPO9>3.0.CO;2-W; Fujikawa DG, 1999, EUR J NEUROSCI, V11, P1605, DOI 10.1046/j.1460-9568.1999.00573.x; Kotti T, 1997, EXP NEUROL, V146, P323, DOI 10.1006/exnr.1997.6553; LERANTH C, 1992, EPILEPSY RES, P49; LU CH, 1991, CHUNG HUA PING LI HS, V20, P198; Marco P, 1997, BRAIN RES BULL, V44, P47, DOI 10.1016/S0361-9230(97)00090-7; MCDONALD JW, 1993, J NEUROSCI, V13, P4445; Morin F, 1999, NEUROSCIENCE, V93, P457, DOI 10.1016/S0306-4522(99)00199-2; Pierce JP, 1999, HIPPOCAMPUS, V9, P255, DOI 10.1002/(SICI)1098-1063(1999)9:3<255::AID-HIPO6>3.0.CO;2-S; POLLARD H, 1994, NEUROSCIENCE, V63, P7, DOI 10.1016/0306-4522(94)90003-5; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; REPRESA A, 1992, EPILEPSY RES, P261; Ribak CE, 1996, DEV BRAIN RES, V91, P245, DOI 10.1016/0165-3806(95)00183-2; Ribak CE, 1998, J COMP NEUROL, V401, P266; Salin P, 1995, J NEUROSCI, V15, P8234; Sankar R, 1998, J NEUROSCI, V18, P8382; SCHORMAIR C, 1993, BRAIN RES BULL, V32, P329, DOI 10.1016/0361-9230(93)90196-I; Zavala M, 2001, REV NEUROLOGIA, V33, P401, DOI 10.33588/rn.3305.2001093	28	13	14	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2002	16	4					331	346		10.1080/02699050110088209			16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	541CM	WOS:000174967700005	11953004				2022-02-06	
J	Dieterich, DC; Bockers, TM; Gundelfinger, ED; Kreutz, MR				Dieterich, DC; Bockers, TM; Gundelfinger, ED; Kreutz, MR			Screening for differentially expressed genes in the rat inner retina and optic nerve after optic nerve crush	NEUROSCIENCE LETTERS			English	Article						subtractive hybridization; differential gene expression; kinesin light chain; ferritin; rat Y-box binding protein-A; retinal ganglion cells	RECEPTOR; INJURY; IRON; METABOLISM; FERRITIN; PROTEIN; BRAIN	Limited optic nerve crush is a model of diffuse mechanical axon injury, the most prevalent cause of secondary neurodegeneration after closed head neurotrauma. In this report, a protocol is presented which allows for the rapid screening of differential gene expression in the inner retina, as well as the optic nerve, in response to partial nerve crush. To prove the reliability of the method, prototypically, the differential expression profiles of three candidate genes (kinesin light chain, ferritin, RYB-A) were verified. The method seems to be suitable to address the question of how differential gene expression contributes to degeneration, survival and axonal repair after partial nerve crush. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.	Leibniz Inst Neurobiol, Dept Neurochem Mol Biol, AG Mol Mech Plast, D-39108 Magdeburg, Germany; Univ Munster, Inst Anat, AG Mol Neurobiol, D-4400 Munster, Germany		Kreutz, MR (corresponding author), Leibniz Inst Neurobiol, Dept Neurochem Mol Biol, AG Mol Mech Plast, POB 1860, D-39108 Magdeburg, Germany.			Dieterich, Daniela C./0000-0002-9880-1214			Bien A, 1999, J NEUROTRAUM, V16, P153, DOI 10.1089/neu.1999.16.153; Cheepsunthorn P, 1998, J COMP NEUROL, V400, P73; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; Engelmann R, 2001, BRAIN RES, V889, P251, DOI 10.1016/S0006-8993(00)03145-0; GERLACH M, 1994, J NEUROCHEM, V63, P793, DOI 10.1046/j.1471-4159.1994.63030793.x; HARRIS ZL, 1995, P NATL ACAD SCI USA, V92, P2539, DOI 10.1073/pnas.92.7.2539; Hirokawa Nobutaka, 1993, Current Opinion in Neurobiology, V3, P724, DOI 10.1016/0959-4388(93)90144-N; ITO K, 1994, NUCLEIC ACIDS RES, V22, P2036, DOI 10.1093/nar/22.11.2036; Kreutz MR, 1998, J NEUROSCI, V18, P8278; Kreutz MR, 1997, MOL BRAIN RES, V45, P283, DOI 10.1016/S0169-328X(96)00264-1; Levin LA, 1998, INVEST OPHTH VIS SCI, V39, P157; Sambrook J, 1989, MOL CLONING LAB MANU; SO QN, 1997, EUR J NEUROSCI, V9, P1542; Waggoner DJ, 1999, NEUROBIOL DIS, V6, P221, DOI 10.1006/nbdi.1999.0250; Yefimova MG, 2000, INVEST OPHTH VIS SCI, V41, P2343	15	13	13	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	JAN 4	2002	317	1					29	32		10.1016/S0304-3940(01)02418-1			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	512HZ	WOS:000173320100008	11750989				2022-02-06	
J	Gagnon, I; Friedman, D; Swaine, B; Forget, R				Gagnon, I; Friedman, D; Swaine, B; Forget, R			Balance findings in a child before and after a mild head injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						balance; mild head injuries	TRAUMATIC BRAIN INJURY; POSTCONCUSSION SYNDROME; POSTURAL CONTROL; PERFORMANCE; CONCUSSION; SEQUELAE	Objective: This case study reviews the preinjury and postinjury balance performance of an 11-year-old child who sustained a mild head injury. Design: A prospective design was used to document balance 5 days before injury and 1, 4, and 12 weeks after injury. Outcome Measures: The assessments used were the balance subtest of the Bruininks-Oseretsky Test of Motor Proficiency, the Pediatric Clinical Test of Sensory Interaction for Balance, and the Postural Stress Test. Results: One week after the trauma, balance deficits were observed in the three tests. The deficits improved 4 weeks after the injury and performance remained stable over the following 2 months for two of the evaluations except for the Postural Stress Test performance, which failed to improve in the 3-month period after trauma. Conclusions: The good recovery of balance skills observed over the first month after injury seems to validate the current activity restrictions imposed on children after a mild head injury. However, the persistence of poor performance in the area of reactions to external perturbations indicates that some deficits may persist beyond what is expected with this population.	McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Phys Therapy, Montreal, PQ H3H 1P3, Canada; McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Pediat & Adolescent Trauma & Neurotrauma Program, Montreal, PQ H3H 1P3, Canada; Univ Montreal, Fac Med, Ecole Readaptat, Montreal, PQ, Canada		Gagnon, I (corresponding author), McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Phys Therapy, 2300 Tupper, Montreal, PQ H3H 1P3, Canada.			Gagnon, Isabelle/0000-0003-2043-1644			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; BIJUR P, 1988, AM J DIS CHILD, V142, P1307, DOI 10.1001/archpedi.1988.02150120061041; BIJUR PE, 1990, PEDIATRICS, V86, P337; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; Bruininks, 1978, BRUININKS OSERETSKY; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; CHANDLER JM, 1990, PHYS THER, V70, P410, DOI 10.1093/ptj/70.7.410; CROWE T K, 1990, Physical and Occupational Therapy in Pediatrics, V10, P1; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; FORSSBERG H, 1982, J NEUROSCI, V2, P545; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; GUSKIEWICZ KM, 1997, MED SCI SPORTS EXERC, V29, P213; Harvey AG, 1998, J NERV MENT DIS, V186, P333, DOI 10.1097/00005053-199806000-00002; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; LEMMON J, 1995, J COGN REHABIL   SEP, P4; MATHENY AP, 1971, J PEDIATR-US, V79, P122, DOI 10.1016/S0022-3476(71)80071-9; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; MONTGOMERY EA, 1991, PSYCHOL MED, V21, P375, DOI 10.1017/S0033291700020481; Parker RS, 1996, J CLIN PSYCHOL, V52, P32, DOI 10.1002/(SICI)1097-4679(199601)52:1<32::AID-JCLP5>3.3.CO;2-1; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Swaine BR, 2001, J HEAD TRAUMA REHAB, V16, P292, DOI 10.1097/00001199-200106000-00008; SZYMANSKI HV, 1992, INT J PSYCHIAT MED, V22, P357, DOI 10.2190/XARA-B1EF-J2HC-VAE0; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514; WOLFSON LI, 1986, J AM GERIATR SOC, V34, P845, DOI 10.1111/j.1532-5415.1986.tb07256.x	31	13	13	0	4	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	2001	16	6					595	602		10.1097/00001199-200112000-00007			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	501AL	WOS:000172660800007	11732974				2022-02-06	
J	Jaeger, M; Frohlich, M; Hertrich, I; Ackermann, H; Schonle, PW				Jaeger, M; Frohlich, M; Hertrich, I; Ackermann, H; Schonle, PW			Dysphonia subsequent to severe traumatic brain injury: Comparative perceptual, acoustic and electroglottographic analyses	FOLIA PHONIATRICA ET LOGOPAEDICA			English	Article						traumatic brain injury; dysphonia; perceptual analysis; acoustic analysis; electroglottographic analysis	CLOSED-HEAD-INJURY; COMBINED GLOTTOGRAPHY; PATHOLOGICAL VOICES; DYSFUNCTIONS; FEATURES	We tested the applicability of the Goettinger Hoarseness Diagram (GHD) for quantitative evaluation of voice disorders after severe traumatic brain injury (TBI) and compared the obtained data with those from established voice analysis systems such as the Multi-Dimensional Voice Program (MDVP), electroglottography (EGG) and perceptual ratings using sustained vowel productions from 10 patients with TBI dysarthrophonia at late stages postinjury and of 10 healthy control speakers. Statistical analyses revealed significant intergroup differences with re-spect to various acoustic and perceptual measures, i.e., irregularity component, noise component, noise-to-harmonic ratio, shimmer, jitter, roughness, creakiness, strained-strangledness, hypernasality. By contrast, the considered EGG estimates, i.e., open quotient and speed quotient, did not allow for separation of patients and controls. In addition, the two GHD components exhibited close correlations to perceived roughness and creakiness, on the one hand, and breathiness and, to some degree, nasality, on the other, whereas the MDVP parameters failed to differentiate between these two perceptual modes of phonation. Copyright (C) 2001 S. Karger AG, Basel.	Univ Konstanz, Lurija Inst Hlth & Rehabil Sci, D-7750 Constance, Germany; Rehabil Clin Schmieder, Allensbach, Germany; Univ Tubingen, Dept Neurol, D-7400 Tubingen, Germany; Univ Gottingen, Inst Phys 3, D-3400 Gottingen, Germany		Jaeger, M (corresponding author), Kliniken Schmieder Allensbach, Lurija Inst, Postfach 240, D-78473 Allensbach, Germany.		Hertrich, Ingo/T-1154-2018	Hertrich, Ingo/0000-0001-8965-6249			ABBERTON ERM, 1989, CLIN LINGUIST PHONET, V3, P281, DOI 10.3109/02699208908985291; ACKERMANN H, 1994, ANN OTO RHINOL LARYN, V103, P98, DOI 10.1177/000348949410300203; ARONSON AE, 1994, BRAIN INJURY, V8, P663, DOI 10.3109/02699059409151019; BLAUSTEIN S, 1983, J COMMUN DISORD, V16, P157, DOI 10.1016/0021-9924(83)90046-1; CHILDERS DG, 1985, CRC CLIN REV BIOMED, V12, P14; COLTON RH, 1990, J VOICE, V4, P10, DOI 10.1016/S0892-1997(05)80077-3; GERRATT BR, 1987, LARYNGEAL FUNCTION P, P521; HAMMARBERG B, 1980, ACTA OTO-LARYNGOL, V90, P441, DOI 10.3109/00016488009131746; HARTMANN E, 1984, J COMMUN DISORD, V17, P425, DOI 10.1016/0021-9924(84)90004-2; HERTRICH I, 1995, ANN OTO RHINOL LARYN, V104, P197, DOI 10.1177/000348949510400304; Hertrich I, 1997, J ACOUST SOC AM, V102, P652, DOI 10.1121/1.419711; HERTRICH I, 1996, SPRACHE-STIMME-GEHOR, V20, P169; HERTRICH I, 1998, CLIN PHONETICS LINGU, P448; HOUBEN GB, 1992, FOLIA PHONIATR, V44, P269, DOI 10.1159/000266161; Michaelis D, 1997, ACUSTICA, V83, P700; Michaelis D, 1998, J ACOUST SOC AM, V103, P1628, DOI 10.1121/1.421305; MORASCH H, 1987, LARYNGO RHINO OTOL, V66, P214, DOI 10.1055/s-2007-998641; MOTTA G, 1990, FOLIA PHONIATR, V42, P111, DOI 10.1159/000266054; MURTY GE, 1991, CLIN OTOLARYNGOL, V16, P399, DOI 10.1111/j.1365-2273.1991.tb00957.x; MURTY GE, 1991, CLIN OTOLARYNGOL, V16, P298, DOI 10.1111/j.1365-2273.1991.tb00935.x; Ondrackova J, 1972, Folia Phoniatr (Basel), V24, P405; ORLIKOFF RF, 1991, J SPEECH HEAR RES, V34, P1066, DOI 10.1044/jshr.3405.1066; Schonle PW., 2000, INT HDB NEUROPSYCHOL, P327, DOI [10.1007/978-1-4757-5569-5_22, DOI 10.1007/978-1-4757-5569-5_22]; THEODOROS D, 1993, BRAIN INJURY, V7, P59, DOI 10.3109/02699059309008157; THEODOROS DG, 1994, BRAIN INJURY, V8, P667, DOI 10.3109/02699059409151021; THEODOROS DG, 1995, BRAIN INJURY, V9, P671, DOI 10.3109/02699059509008225; VOGEL M, 1982, FOLIA PHONIATR, V34, P150, DOI 10.1159/000265644; WOO P, 1989, LARYNGOSCOPE, V99, P725; YORKSTON KM, 1988, CLIN MANAGEMENT DYSA, P97; ZWIRNER P, 1998, AKTUELLE PHONIATRISC, P63	30	13	13	0	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7762			FOLIA PHONIATR LOGO	Folia Phoniatr. Logop.	NOV-DEC	2001	53	6					326	337		10.1159/000052686			12	Audiology & Speech-Language Pathology; Otorhinolaryngology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Otorhinolaryngology; Rehabilitation	498LZ	WOS:000172513800004	11721139				2022-02-06	
J	Bartnik, BL; Kendall, EJ; Obenaus, A				Bartnik, BL; Kendall, EJ; Obenaus, A			Cortical devascularization: quantitative diffusion weighted magnetic resonance imaging and histological findings	BRAIN RESEARCH			English	Article						cortical devascularization; ischemia; rat; traumatic brain injury; diaschisis	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; WATER DIFFUSION; ARTERY OCCLUSION; TIME-COURSE; RATS; TISSUE; DAMAGE; MRI; DIASCHISIS	This study investigates the development of a small focal cortical lesion produced in a model of brain injury. Two approaches were chosen: diffusion weighted magnetic resonance imaging (DWI) and histology. DW images were collected before devascularization and at 0.5, 1, 2, 3, 5, 7 and 14 days after treatment. Apparent diffusion coefficient (ADC) maps were calculated from the DW images to quantify lesion development. As a second measure of injury, tissue morphology was analyzed using cresyl violet histochemistry. A significant reduction in ADC values within the cortex below the injury site by 0.5 days after surgery was observed. Between 5 and 14 days the ADC values recovered to control levels. ADC changes were also observed in the contralateral cortex at 0.5, 1 and 5 days. The decrease in ADC observed at the early time points suggested cytotoxic edema, whereas the recovery to control levels at later time points suggested infarct formation. This model of brain injury resulted in progressive but relatively slow formation of a pan-necrotic infarct within 14 days. In particular, substantial amounts of cell death were not observed until 2 days after surgery.. Overall, the quantitative and histological measures of this lesion are consistent with those observed for an ischemic type of injury, however, the time course of these lesions' development are consistent with other models of traumatic brain injury. Our data demonstrates that DWI is a highly sensitive metric for ischemic-type damage that results from brain injury. (C) 2001 Elsevier Science BY. All rights reserved.	Univ Saskatchewan, Coll Med, Dept Anat & Cell Biol, Saskatoon, SK S7N 5E5, Canada; Univ Saskatchewan, Coll Med, Acad Dept Med Imaging, Saskatoon, SK S7N 0W8, Canada; Loma Linda Univ, Dept Radiat Med, Radiobiol Program, Loma Linda, CA 92354 USA		Obenaus, A (corresponding author), Univ Saskatchewan, Coll Med, Dept Anat & Cell Biol, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	aobenaus@dominion.llumc.edu		Bartnik-Olson, Brenda/0000-0002-1137-9437; Kendall, Edward/0000-0002-9638-9254			Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Alsop DC, 1996, J NEUROTRAUM, V13, P515, DOI 10.1089/neu.1996.13.515; ANDREWS RJ, 1991, STROKE, V22, P943, DOI 10.1161/01.STR.22.7.943; Armitage PA, 1998, MAGN RESON MATER PHY, V6, P28, DOI 10.1016/S1352-8661(98)00007-6; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; BENVENISTE H, 1992, STROKE, V23, P746, DOI 10.1161/01.STR.23.5.746; Berezovskaya O, 1996, ACTA NEUROPATHOL, V92, P479, DOI 10.1007/s004010050550; BUSZA AL, 1992, STROKE, V23, P1602, DOI 10.1161/01.STR.23.11.1602; Calamante F, 1999, MAGN RESON MED, V41, P479; CLARK RK, 1993, BRAIN RES BULL, V31, P565, DOI 10.1016/0361-9230(93)90124-T; de Crespigny A, 1998, J CEREBR BLOOD F MET, V18, P1008, DOI 10.1097/00004647-199809000-00010; Dijkhuizen RM, 1999, BRAIN RES, V840, P194, DOI 10.1016/S0006-8993(99)01769-2; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; GILL R, 1995, J CEREBR BLOOD F MET, V15, P1, DOI 10.1038/jcbfm.1995.1; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; HERRERA DG, 1992, NEUROSCIENCE, V49, P781, DOI 10.1016/0306-4522(92)90356-7; Iadecola C, 1997, ANN NY ACAD SCI, V835, P203, DOI 10.1111/j.1749-6632.1997.tb48631.x; Kastrup A, 1999, J NEUROL SCI, V166, P91, DOI 10.1016/S0022-510X(99)00121-5; KEMPINSKY WH, 1958, ARCH NEURO PSYCHIATR, V79, P376, DOI 10.1001/archneurpsyc.1958.02340040020002; KNIGHT RA, 1994, STROKE, V25, P1252, DOI 10.1161/01.STR.25.6.1252; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; Li FH, 2000, STROKE, V31, P946, DOI 10.1161/01.STR.31.4.946; MATSUMOTO K, 1995, AM J NEURORADIOL, V16, P1107; Merten CL, 1999, NEURORADIOLOGY, V41, P242, DOI 10.1007/s002340050740; MINEMATSU K, 1992, NEUROLOGY, V42, P235, DOI 10.1212/WNL.42.1.235; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Park HK, 1999, CRIT REV NEUROSURG, V9, P44, DOI 10.1007/s003290050108; PIERPAOLI C, 1993, RADIOLOGY, V189, P439, DOI 10.1148/radiology.189.2.8210373; REITH W, 1995, AM J NEURORADIOL, V16, P53; Rumpel H, 1997, PEDIATR RES, V42, P54, DOI 10.1203/00006450-199707000-00009; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; Small DL, 1999, PROG CARDIOVASC DIS, V42, P185, DOI 10.1016/S0033-0620(99)70002-2; Sweeney MI, 1995, CAN J PHYSIOL PHARM, V73, P1525, DOI 10.1139/y95-211; Sykova E, 1997, NEUROSCIENTIST, V3, P28, DOI 10.1177/107385849700300113; SYKOVA E, 1993, J CHEM NEUROANAT, V6, P247, DOI 10.1016/0891-0618(93)90046-7; VANBRUGGEN N, 1994, BRAIN METAB REV, V6, P180; VANGELDEREN P, 1994, MAGNET RESON MED, V31, P154, DOI 10.1002/mrm.1910310209; WAHNSCHAFFE U, 1993, BRAIN RES, V615, P295, DOI 10.1016/0006-8993(93)90041-K; Wall CJ, 2000, AM J NEURORADIOL, V21, P1841; Zilles Karl, 1995, P649; [No title captured]	44	13	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	OCT 12	2001	915	2					133	142		10.1016/S0006-8993(01)02805-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	486JC	WOS:000171813800002	11595202				2022-02-06	
J	Hotz, G; Helm-Estabrooks, N; Nelson, NW				Hotz, G; Helm-Estabrooks, N; Nelson, NW			Development of the pediatric test of brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment; brain injury; children and adolescents; language; neurocognitive	CLOSED-HEAD-INJURY; CHILDREN; ADOLESCENTS; PLASTICITY; CHILDHOOD; RECOVERY; ATTENTION; DISCOURSE; SEQUELAE; TRAUMA	Objective: The Pediatric Test of Traumatic Brain Injury (PTBI)(1) (currently in its research edition) is a tool for assessing the cognitive-linguistic skills of school-aged children and adolescents in acute care and rehabilitation settings after traumatic brain injury. Development of the PTBI was motivated by the fact that, to date, no standardized test has been available to assess the full range of cognitive-linguistic impairments associated with pediatric brain injury. In this article we describe how the research edition of the PTBI was developed, provide rationale for the areas of assessment, discuss a plan for standardization, and illustrate its use with three children with TBI. Design: The PTBI was constructed to sample the attention, memory, language, reading, writing, metalinguistic, and metacognitive skills that are particularly at risk in pediatric brain injury and that are relevant to the general education curriculum. Material: The test material for the PTBI was selected on the basis of clinical and experimental evidence that children and adolescents with TBI demonstrate a wide range of cognitive and language deficits. These first appear in the early stages of recovery and often persist but change over time. Conclusion: Our goal is to standardize the PTBI so it can he used to establish baseline behaviors and track cognitive-linguistic recovery.	Univ Miami, Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; Boston Univ, Sch Med, Dept Speech Pathol, Boston, MA 02215 USA; Western Michigan Univ, Dept Speech Pathol & Audiol, Kalamazoo, MI 49008 USA		Hotz, G (corresponding author), Ryder Trauma Ctr T405, Div Neurorehabil, 1800 NW 10th Ave, Miami, FL 33136 USA.						*AG HLTH CAR POL R, 1999, 2 AG HLTH CAR POL RE; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; ANNEGERS JF, 1983, PEDIAT HEAD TRAUMA; BISHOP DVM, 1981, DEV MED CHILD NEUROL, V23, P251; BLOSSER J, 1994, PEDIAT TRAUMATIC BRA; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; BUCHWALD JS, 1990, CLIN PERINATOL, V17, P57, DOI 10.1016/S0095-5108(18)30588-8; CAMPBELL TF, 1990, J SPEECH HEAR DISORD, V55, P567, DOI 10.1044/jshd.5503.567; Catts H.W., 2005, LANGUAGE READING DIS; CHADWICK O, 1981, J CHILD PSYCHOL PSYC, V22, P117, DOI 10.1111/j.1469-7610.1981.tb00538.x; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; CHAPMAN SB, 1995, J HEAD TRAUMA REHAB, V10, P3; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P89; DENNIS MB, 1994, HDB PERCEPTION COGNI, V15, P210; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; EWINGCOBBS L, 1985, HEAD INJURY REHABILI, P71; Fletcher JM, 1987, NEUROBEHAVIORAL RECO, P279; FULD PA, 1977, DEV MED CHILD NEUROL, V19, P495; GOLDSTEIN FC, 1989, CORTEX, V25, P541, DOI 10.1016/S0010-9452(89)80016-4; Goldstein FC, 1985, DEV NEUROPSYCHOL, V1, P195, DOI 10.1080/87565648509540310; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; Hagen C, 1979, LEVELS COGNITIVE FUN; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Helm-Estabrooks N., 1990, BRIEF TEST HEAD INJU; HOTZ GH, 2000, PEDIAT TEST BRAIN IN; Idol L, 1990, DIMENSIONS THINKING, P15; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; KRAUS JF, 1995, TRAUMATIC HEAD INJUR; Lahey M., 1988, LANGUAGE DISORDERS L; Lenneberg E.H., 1967, BIOL FDN LANGUAGE; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; MATTINGLY IG, 1984, LANGUAGE AWARENESS L, P00009, DOI DOI 10.1007/978-1-4613-8248-5_2; MCKAY KE, 1994, DEV NEUROPSYCHOL, V10, P121, DOI 10.1080/87565649409540572; MILTON SB, 1991, J HEAD TRAUMA REHAB, V6, P35; Morse S, 1999, Pediatr Rehabil, V3, P139; Nelson N. W., 1998, CHILDHOOD LANGUAGE D; NELSON NW, 1991, COMMUNICATION DISORD, P191; NELSON NW, 2000, TEST INTEGRATED CURR; Nippold M., 1998, LATER LANGUAGE DEV S; PARIS SG, 1987, INTELLIGENCE EXCEPTI, P215; Paul R., 1995, LANGUAGE DISORDERS I; Paul R., 2000, LANGUAGE DISORDERS I; RICHARDS J, 1985, LONGMAN DICT APPL LI; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; RUTTER M, 1981, AM J PSYCHIAT, V17, P187; SCHAFFER D, 1980, J AM ACAD CHILD PSY, V19, P592; SCHNEIDER GE, 1979, NEUROPSYCHOLOGIA, V17, P557, DOI 10.1016/0028-3932(79)90033-2; SZEKERES SF, 1994, TOP LANG DISORD, V15, P21, DOI 10.1097/00011363-199411000-00004; Taylor HG, 1996, DEV NEUROPSYCHOL, V12, P35, DOI 10.1080/87565649609540639; TEASDALE G, 1974, LANCET, V2, P81; Timmermans SR, 1991, COGNITIVE REHABILITA, V9, P26; Wilde MC, 1995, J CLIN EXP NEUROPSYC, V17, P849, DOI 10.1080/01688639508402434; YLVISAKER M, 1994, TOP LANG DISORD, V15, P1, DOI 10.1097/00011363-199411000-00003; [No title captured]; [No title captured]	63	13	13	0	7	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	2001	16	5					426	440		10.1097/00001199-200110000-00003			15	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	483JF	WOS:000171631700003	11574039				2022-02-06	
J	Williams, G; Goldie, P				Williams, G; Goldie, P			Validity of motor tasks for predicting running ability in acquired brain injury	BRAIN INJURY			English	Article							PROFILE	Introduction: Rehabilitation of running following traumatic brain injury (TBI) has the potential to enhance quality of life. Retraining of running following TBI has not been previously reported in the literature. In response to a lack of information about which motor tasks should be included in a retraining programme, this study aimed to investigate performance predictors of running ability. Method: Forty TBI subjects (20 runners and 20 non-runners) performed four specific motor tasks which were selected on the basis of theory and clinical experience with TBI subjects. The four tasks included bounding onto a leg, walking on toes, stepping backwards up a step, and balancing on one leg. Subjects were generally extremely severely brain damaged (median post-traumatic amnesia > 28 days), had suffered multiple leg fractures and had received greater than 8 months rehabilitation. Results: The four motor tasks differentiated significantly between the two groups (p < 0.001) and were all strong predictors of running ability. The presence of a non-support phase (NSP) during the bounding task was the strongest predictor of running ability. Logistic regression indicated that TBI subjects who could execute a NSP into a single bound were 24.6 times more likely to be able to run than subjects who could not. When the four tasks were used in combination, two tasks were identified by logistic regression: (1) ability to execute a free-float phase during a bound, and (2) balancing on one leg. All four motor tasks had high retest reliability, with proportional indices of reliability ranging from 0.92-0.97. No statistically significant difference was found between runners and non-runners for group charateristics such as age, severity of injury (length of PTA), orthopaedic leg injuries and time post-injury (p > 0.05). These characteristics were not shown to influence the ability to run following TBI. Clinical implications: The four motor tasks were strong predictors of running ability. Severity and type of injury were not factors influencing ability to run. This study provides preliminary evidence about the motor tasks which have the potential to be used in a running programme. No casual relationship has been identified. The next step is to investigate whether training in these tasks is effective in the rehabilitation of running following TBI.	Epworth Med Fdn, Physiotherapy Dept, Richmond, Vic 3121, Australia; La Trobe Univ, Fac Hlth Sci, Sch Physiotherapy, Bundoora, Vic, Australia		Williams, G (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 29 Erin St, Richmond, Vic 3121, Australia.			Williams, Gavin/0000-0003-2758-7473			BAYLEY N, 1919, MANUAL BAYLEY SALES; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Burdon B., 1993, AUSTR DEV SCREENING; Folio MR, 1983, PEABODY DEV MOTOR SC; FRANKENBURG WK, 1975, REVISED DENVER DEV S; GALLAGHUE DL, 1982, UNDERSTANDING MOTOR; Guttman L, 1950, MEASUREMENT PREDICTI; Hillier SL, 1997, BRAIN INJURY, V11, P661; Lincoln N, 1979, Physiotherapy, V65, P48; LUKE C, THESIS LA TROBE U ME; Miller L. J., 1994, TIME TODDLER INFANT; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Roberton M.A., 1984, DEV CHILDREN THEIR C; Russell, 1993, GROSS MOTOR FUNCTION; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; TUEL S M, 1992, Brain Injury, V6, P363, DOI 10.3109/02699059209034951; Wickstrom R., 1983, FUNDAMENTAL MOTOR PA; WONG PP, 1994, BRAIN INJURY, V8, P509, DOI 10.3109/02699059409151003; [No title captured]	19	13	13	0	4	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2001	15	9					831	841					11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	462ZM	WOS:000170452400008	11516351				2022-02-06	
J	Thomale, UW; Schaser, KD; Unterberg, AW; Stover, JF				Thomale, UW; Schaser, KD; Unterberg, AW; Stover, JF			Visualization of rat pial microcirculation using the novel orthogonal polarized spectral (OPS) imaging after brain injury	JOURNAL OF NEUROSCIENCE METHODS			English	Article						arterioles; cerebral blood flow; intravital microscopy; traumatic brain injury; venules	CRANIAL WINDOW TECHNIQUE; CORTICAL IMPACT INJURY; CEREBRAL MICROCIRCULATION; DETAILED DESCRIPTION; VELOCITY	Recently, the novel optical system, orthogonal polarized spectral (OPS) imaging was developed to visualize microcirculation. Investigation of changes in microcirculation is essential for physiological, pathophysiological, and pharmacological studies. In the present study applicability of OPS imaging was assessed to study,pial microcirculation in normal and traumatized rat brain. High quality images of rat pial microcirculation in normal and traumatized rats were generated with the OPS imaging, allowing to easily differentiate arterioles and venules with the dura remaining intact. In non-traumatized rats, mean vessel diameter of arterioles and venules of five different cortical regions was 19.1 +/- 2.7 and 22.2 +/- 1.4 gm, respectively. In the early phase following focal cortical contusion vessel diameter was significantly decreased in arterioles by 28% while diameter in venules was significantly increased by 27%. For technical reasons velocity in arterioles was not measurable. In venules, mean flow velocity of 0.68 +/- 0.08 mm/s was significantly decreased by 50% at 30 min after trauma. OPS imaging is an easy to use optical system allowing to generate high quality images and to reliably investigate pial microcirculation without having to remove the dura. This technique opens the possibility to perform longitudinal studies investigating changes in pial microcirculation. (C) 2001 Elsevier Science B.V. All rights reserved.	Humboldt Univ, Dept Neurosurg, Charite Virchow Med Ctr, D-13353 Berlin, Germany; Charite Virchow Med Ctr, Dept Trauma & Reconstruct Surg, D-13353 Berlin, Germany		Stover, JF (corresponding author), Humboldt Univ, Dept Neurosurg, Charite Virchow Med Ctr, Augustenburger Pl 1, D-13353 Berlin, Germany.						Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; BAEZ S, 1974, MICROCIRCULATION, V1, P23; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Forbes HS, 1928, ARCH NEURO PSYCHIATR, V19, P751, DOI 10.1001/archneurpsyc.1928.02210110003001; Golding EM, 1999, AM J PHYSIOL-HEART C, V277, pH1457, DOI 10.1152/ajpheart.1999.277.4.H1457; Groner W, 1999, NAT MED, V5, P1209, DOI 10.1038/13529; Harris AG, 2000, J VASC RES, V37, P469, DOI 10.1159/000054079; Hartl R, 1997, J CEREBR BLOOD F MET, V17, P1210; Klyscz T, 1997, BIOMED TECH, V42, P168, DOI 10.1515/bmte.1997.42.6.168; KUSHCHINKSY W, 1980, MICROVASC RES, V19, P385; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; MA YP, 1974, MICROVASC RES, V8, P1, DOI 10.1016/0026-2862(74)90059-4; MORII S, 1986, J CEREBR BLOOD F MET, V6, P34, DOI 10.1038/jcbfm.1986.5; NAVARI RM, 1978, MICROVASC RES, V16, P304, DOI 10.1016/0026-2862(78)90064-X; RAJADHYAKSHA M, 1995, J INVEST DERMATOL, V104, P946, DOI 10.1111/1523-1747.ep12606215; ROSENBLUM WI, 1963, ARCH NEUROL-CHICAGO, V9, P414, DOI 10.1001/archneur.1963.00460100102012; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Uhl E, 2000, PROG APPL MICROCIR, V24, P72; UNTERBERG A, 1984, J CEREBR BLOOD F MET, V4, P574, DOI 10.1038/jcbfm.1984.82; WOLF S, 1994, HYPERTENSION, V23, P464, DOI 10.1161/01.HYP.23.4.464; ZWEIFACH BW, 1974, CIRC RES, V34, P843, DOI 10.1161/01.RES.34.6.841	21	13	13	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	JUL 15	2001	108	1					85	90		10.1016/S0165-0270(01)00375-2			6	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	465FH	WOS:000170578600010	11459621				2022-02-06	
J	Rowin, ME; Xue, V; Irazuzta, J				Rowin, ME; Xue, V; Irazuzta, J			Hypothermia attenuates beta 1 integrin expression on extravasated neutrophils in an animal model of meningitis	INFLAMMATION			English	Article						integrin; hypothermia; meningitis; neutrophils	TRAUMATIC BRAIN-INJURY; INFANT RAT MODEL; BACTERIAL-MENINGITIS; POSTTRAUMATIC HYPOTHERMIA; ALPHA-5-BETA-1 INTEGRIN; CARDIOPULMONARY BYPASS; MONOCLONAL-ANTIBODIES; MODERATE HYPOTHERMIA; REDUCES INJURY; CELL-ADHESION	Brain injury in meningitis occurs in part as a consequence of leukocyte migration and activation. Leukocyte integrins are pivotal in the inflammatory response by mediating adhesion to vascular endothelium and extracellular matrix proteins. We have demonstrated that moderate hypothermia early in the course of meningitis decreases leukocyte sequestration within the brain parenchyma. This study examines whether hypothermia alters neutrophil integrin expression in a rabbit model of bacterial meningitis. Prior to the induction of meningitis, peripheral blood samples were obtained and the neutrophils isolated. Sixteen hours after inducing group B streptococcal meningitis, animals were treated with antibiotics, IV fluids, and mechanically ventilated. Animals were randomized to hypothermia (32-33 degreesC) or normothermia conditions. After 10 hours of hypothermia or normothermia, neutrophils were isolated from the blood and cerebral spinal fluid (CSF), stained for beta1 and beta2 integrins, and analyzed using flow cytometry. Cerebral spinal fluid neutrophil beta1 integrin expression was significantly decreased in hypothermic animals. Beta-1 integrins can assume a higher affinity or "activated" state following inflammatory stimulation. Expression of "activated" beta1 integrins was also significantly decreased in hypothermic animals. Beta2 CSF neutrophil integrin expression was decreased in hypothermic animals, but failed to reach significance. These data suggest hypothermia may attenuate extravasated leukocyte expression of both total and "activated" beta1 integrins.	Childrens Hosp, Med Ctr, Div Pediat Crit Care Med, Cincinnati, OH 45229 USA		Rowin, ME (corresponding author), Childrens Hosp, Med Ctr, Div Pediat Crit Care Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.						ALBELDA SM, 1990, FASEB J, V4, P2868, DOI 10.1096/fasebj.4.11.2199285; ARNAOUT MA, 1990, BLOOD, V75, P1037; ATTIBELE N, 1993, J VIROL, V67, P1075, DOI 10.1128/JVI.67.2.1075-1079.1993; Bavbek M, 1998, STROKE, V29, P1930, DOI 10.1161/01.STR.29.9.1930; BERGELSON JM, 1993, J CLIN INVEST, V92, P232, DOI 10.1172/JCI116555; BERING EA, 1961, AM J PHYSIOL, V200, P417; Bogdan I, 1997, J INFECT DIS, V176, P693, DOI 10.1086/514092; BOHNSACK JF, 1990, J EXP MED, V171, P1221, DOI 10.1084/jem.171.4.1221; BOHNSACK JF, 1992, J IMMUNOL, V149, P1340; Boldt J, 1996, J CARDIOTHOR VASC AN, V10, P342, DOI 10.1016/S1053-0770(96)80094-2; Brower DL, 1997, P NATL ACAD SCI USA, V94, P9182, DOI 10.1073/pnas.94.17.9182; Chatzipanteli K, 2000, J NEUROTRAUM, V17, P321, DOI 10.1089/neu.2000.17.321; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; CHRISTENSEN JP, 1995, J IMMUNOL, V154, P5293; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Cornejo CJ, 1998, SHOCK, V9, P116, DOI 10.1097/00024382-199802000-00007; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DOERSCHUK CM, 1990, J IMMUNOL, V144, P2327; EnomotoIwamoto M, 1997, J BONE MINER RES, V12, P1124, DOI 10.1359/jbmr.1997.12.7.1124; Espinosa G, 1996, KIDNEY INT, V50, P776, DOI 10.1038/ki.1996.376; FINN A, 1993, AGENTS ACTIONS, V38, pC44, DOI 10.1007/BF01991132; Gao JX, 1997, IMMUNOLOGY, V90, P448, DOI 10.1111/j.1365-2567.1997.00448.x; GAO JX, 1995, IMMUNOLOGY, V85, P485; GARBULINSKI T, 1991, Polish Journal of Pharmacology and Pharmacy, V43, P353; GRANERT C, 1994, J CLIN INVEST, V93, P929, DOI 10.1172/JCI117098; Hansbrough JF, 1996, J SURG RES, V61, P17, DOI 10.1006/jsre.1996.0074; HANSEN PR, 1994, CARDIOVASC RES, V28, P565, DOI 10.1093/cvr/28.4.565; HAWKINS HK, 1992, PEDIATR PATHOL, V12, P119, DOI 10.3109/15513819209023288; HELLEWELL PG, 1994, AM J RESP CELL MOL, V10, P391, DOI 10.1089/aid.1994.10.391; IRAZUZTA J, 2000, IN PRESS BRAIN RES; Irazuzta JE, 1999, BRAIN RES, V847, P143, DOI 10.1016/S0006-8993(99)02120-4; Jaeschke H, 1996, SHOCK, V6, P351, DOI 10.1097/00024382-199611000-00009; JAESCHKE H, 1990, FASEB J, V4, P3355, DOI 10.1096/fasebj.4.15.2253850; KORNELISSE RF, 1995, EUR J PEDIATR, V154, P85; KUBES P, 1995, FASEB J, V9, P1103; Lahrtz F, 1998, J NEUROIMMUNOL, V85, P33, DOI 10.1016/S0165-5728(97)00267-1; Leblond V, 2000, AIDS RES HUM RETROV, V16, P423, DOI 10.1089/088922200309089; Leib SL, 1996, J CLIN INVEST, V98, P2632, DOI 10.1172/JCI119084; MARCANTONIO EE, 1988, J CELL BIOL, V106, P1765, DOI 10.1083/jcb.106.5.1765; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Matthay M A, 1993, New Horiz, V1, P613; MENASCHE P, 1995, CIRCULATION, V92, P334, DOI 10.1161/01.CIR.92.9.334; Miotla JM, 1996, AM J RESP CELL MOL, V14, P363, DOI 10.1165/ajrcmb.14.4.8600941; Paugam C, 1997, J CARDIOTHOR VASC AN, V11, P575, DOI 10.1016/S1053-0770(97)90007-0; Pretzlaff R, 1999, CRIT CARE MED, V27, pA129, DOI 10.1097/00003246-199901001-00357; RAO SP, 1993, INFECT IMMUN, V61, P663, DOI 10.1128/IAI.61.2.663-670.1993; Reinhardt PH, 1997, BLOOD, V89, P3837, DOI 10.1182/blood.V89.10.3837.3837_3837_3846; Rogers C, 1998, P NATL ACAD SCI USA, V95, P10134, DOI 10.1073/pnas.95.17.10134; Rowin ME, 1999, PEDIATR RES, V45, p173A, DOI 10.1203/00006450-199904020-01028; Rowin ME, 2000, INFLAMMATION, V24, P157, DOI 10.1023/A:1007085627268; SAEZLLORENS X, 1991, J CLIN INVEST, V88, P2003, DOI 10.1172/JCI115527; Tan TQ, 1997, J ANTIMICROB CHEMOTH, V39, P209, DOI 10.1093/jac/39.2.209; TUOMANEN E, 1989, Pediatric Infectious Disease Journal, V8, P923, DOI 10.1097/00006454-198912000-00047; VEDDER NB, 1988, J CLIN INVEST, V81, P939, DOI 10.1172/JCI113407; WEEKS BS, 1991, J CELL BIOL, V114, P847, DOI 10.1083/jcb.114.4.847; Whalen MJ, 1997, ACT NEUR S, V70, P260; Whalen MJ, 1997, J NEUROTRAUM, V14, P561, DOI 10.1089/neu.1997.14.561; Williams HJ, 1998, PERFUSION-UK, V13, P322, DOI 10.1177/026765919801300507; YEDNOCK TA, 1995, J BIOL CHEM, V270, P28740, DOI 10.1074/jbc.270.48.28740; Yenari MA, 1998, EXP NEUROL, V153, P223, DOI 10.1006/exnr.1998.6876	61	13	14	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0360-3997	1573-2576		INFLAMMATION	Inflammation	JUN	2001	25	3					137	144		10.1023/A:1011044312536			8	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	438FR	WOS:000169043400001	11403204	Green Published			2022-02-06	
J	Kaipio, ML; Novitski, N; Tervaniemi, M; Alho, K; Ohman, J; Salonen, O; Naatanen, R				Kaipio, ML; Novitski, N; Tervaniemi, M; Alho, K; Ohman, J; Salonen, O; Naatanen, R			Fast vigilance decrement in closed head injury patients as reflected by the mismatch negativity (MMN)	NEUROREPORT			English	Article						attention; audition; closed bead injury (CHI); event-related brain potential (ERP); mismatch negativity (MMN); vigilance	EVENT-RELATED POTENTIALS; TRAUMATIC BRAIN INJURY; DISTRACTIBILITY; ATTENTION; FREQUENCY	Event-related potentials (ERPs) were measured from 24 chronic closed head injury (CHI) patients and 18 age- and education-matched controls. The oddball paradigm was applied while subjects were watching a silent movie. The standard (P=0.8) sound of 75 ms duration had a basic frequency of 500 Hz with harmonic partials of 1000 Hz and 1500 Hz, whereas these frequencies for the pitch deviant were each 10% higher. The frequencies of the duration deviant matched with those of the standard but was 25 ms in duration. The MMN (mismatch negativity), generated by the brain's automatic auditory change-detector mechanism, was elicited by both deviants. No significant differences in the MMN latency or amplitude for either pitch or duration deviants were found between the groups. However, the MMN amplitude for the pitch deviant decreased in the patient group during the experiment considerably faster than in controls, suggesting a faster vigilance decrement in the patients. NeuroReport 12:1517-1522 (C) 2001 Lippincott Williams & Wilkins.	Univ Helsinki, Dept Psychol, Cognit Brain Res Unit, FIN-00014 Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Neurosurg, SF-00260 Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Radiol, SF-00260 Helsinki, Finland		Kaipio, ML (corresponding author), Univ Helsinki, Dept Psychol, Cognit Brain Res Unit, POB 13, FIN-00014 Helsinki, Finland.		Novitskiy, Nikolay/ABF-3029-2020; Novitskiy, Nikolay/G-8703-2015; Alho, Kimmo/G-2997-2013	Novitskiy, Nikolay/0000-0002-4039-5209; Novitskiy, Nikolay/0000-0002-4039-5209; Alho, Kimmo/0000-0001-8563-2792; Tervaniemi, Mari/0000-0002-9651-2929; Ohman, Juha/0000-0002-6592-1367			Alain C, 1998, BRAIN RES, V812, P23, DOI 10.1016/S0006-8993(98)00851-8; ALHO K, 1994, ELECTROEN CLIN NEURO, V91, P353, DOI 10.1016/0013-4694(94)00173-1; Damasio A., 1994, DESCARTES ERROR EMOT; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Hsiang JNK, 1998, J NEUROSURG, V88, P613; Kaipio ML, 1999, NEUROREPORT, V10, P2125, DOI 10.1097/00001756-199907130-00024; Kaipio ML, 2000, NEUROREPORT, V11, P1463; Kane NM, 1996, INTENS CARE MED, V22, P39, DOI 10.1007/BF01728329; LANG AH, 1995, EAR HEARING, V16, P118, DOI 10.1097/00003446-199502000-00009; LEVIN HS, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P89; MCGEE TJ, 1999, ASS RES OT FLOR US F; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 2000, AUDIOL NEURO-OTOL, V5, P105, DOI 10.1159/000013874; NAATANEN R, 1993, PSYCHOPHYSIOLOGY, V30, P436, DOI 10.1111/j.1469-8986.1993.tb02067.x; Niemann H, 1996, NEUROPSYCHOL REV, V6, P11, DOI 10.1007/BF01875418; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; PEKKONEN E, 1995, EVOKED POTENTIAL, V96, P546, DOI 10.1016/0013-4694(95)00148-R; Schroger E, 1998, BEHAV RES METH INS C, V30, P131, DOI 10.3758/BF03209423; Sinkkonen J, 2000, AUDIOL NEURO-OTOL, V5, P235, DOI 10.1159/000013885; Tervaniemi M, 1999, CLIN NEUROPHYSIOL, V110, P1388, DOI 10.1016/S1388-2457(99)00108-X; TREJO LJ, 1995, PSYCHOPHYSIOLOGY, V32, P319, DOI 10.1111/j.1469-8986.1995.tb01214.x; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; VANZOMEREN AH, 1994, CLIN NEUROPSYCHOLOGY, P63	24	13	13	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965			NEUROREPORT	Neuroreport	MAY 25	2001	12	7					1517	1522		10.1097/00001756-200105250-00043			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	438WT	WOS:000169077800039	11388440				2022-02-06	
J	Pelegrin-Valero, C; Gomez-Hernandez, R; Munoz-Cespedes, JM; Fernandez-Guinea, S; Tirapu-Ustarroz, J				Pelegrin-Valero, C; Gomez-Hernandez, R; Munoz-Cespedes, JM; Fernandez-Guinea, S; Tirapu-Ustarroz, J			Nosologic aspects of personality change due to head trauma	REVISTA DE NEUROLOGIA			Spanish	Article						head injury; neuropsychiatric posttraumatic disorders personality change; prevalence	INJURY	Introduction. Personality change due to head injury is one of the most prevalent neuropsychiatric posttraumatic disorders and causes significant impairment in familial, social or occupational functioning. Objectives. To study the prevalence and clinical characteristics of personality changes secondary to severe closed head injuries, according to DSM-IV criteria. Patients and methods. Fifty-five patients (aged 15-65 years) with severe head trauma were studied during the chronic stage (11-3 months) with the following instruments, the Revised Iowa Collateral Head Injury Interview for the assessment of posttraumatic frontal symptoms, the Standardized Polyvalent Psychiatric interview of Lobo et al, assessment of premorbid personality and its exacerbation, and the Scale of Aggressiveness of Yudofsky. Results. thirty-three patients (60% of the sample) fulfilled DSM-IV criteria for 'personality change due to head injury; two thirds of them were combined or mixed type, which consists in the association of two or more types specified in the DSM-IV. The most prevalent types were apathic, unstable, desinhibited, aggressive, which are related with lesions in prefrontal cortex. There were nine patients with 'unspecified' symptoms, stich as 'unappropriate euphoria' and 'poor insight', and other symptoms related to executive dysfunction. Conclusions. One third of cases of personality changes were related to premorbid features; this fact argues against the exclusion of the criterium 'excerbation of premorbid personality traits' in DSM-IV Only one third of posttraumatic personality changes can be classified according to DSM-IV and ICD-10 criteria. The high prevalence of symptoms related to deficit in self-awareness and executive dysfunction suggest the need of further investigations about nosology in this field.	Hosp Miguel Servet, Serv Psiquiatria, E-50009 Zaragoza, Spain; Hosp Miguel Servet, Serv Psiquiatria, E-50009 Zaragoza, Spain; Univ Complutense Madrid, Fac Psicol, Madrid, Spain; Fdn Argibide, Serv Neuropsicol, Pamplona, Spain; Univ Jaen, Dept Psicol, Jaen, Spain			cpelegrinv@medynet.com					*AS PSIQ AM, 1995, DSM 4 MAN DIAGN EST; *AS PSIQ AM, 1988, DSM 3 R MAN DIAGN ES; Berrios G E, 1990, Behav Neurol, V3, P247, DOI 10.3233/BEN-1990-3404; BLUMER D, 1976, PSYCHIAT ASPECTS NEU, P151; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CASSILETH BR, 1984, NEW ENGL J MED, V311, P506, DOI 10.1056/NEJM198408233110805; FORDYCE JJ, 1983, J NEUROL NEUROSUR PS, V43, P373; JABLENSKY A, 1991, PSYCHOL MED S, V20; JASPERS K, 1980, PSICOPATOLOGIA GEN, P559; KLEIST K, 1931, MONATSSCH PSYCHIAT, V71, P338; Lezak, 1989, ASSESSMENT BEHAV CON, V7, P113; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LOBO A, 1993, PSYCHOL MED, V23, P505, DOI 10.1017/S0033291700028592; Mann R. S., 1996, REV PSYCHIAT, V15, P205; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V0005, P00213, DOI DOI 10.1037/0894-4105.5.3.213; MORENO P, 1996, NEUROPSIQUIATRIA DAN, P11; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; *ORG MUND SAL, 1994, CIE 10 TRAST MENT CO; PELEGRIN C, 1996, NEUROPSIQUIATRIA DAN, P97; PELEGRIN C, 1996, ANN M AM PSYCH ASS N; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; SANCHEZ P, 1999, INFORMACIONES PSIQUI; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; Tyrer P, 1996, AM J PSYCHIAT, V153, P1593; URBACH JR, 1991, PSYCHOSOMATICS, V32, P24, DOI 10.1016/S0033-3182(91)72108-7; Widiger TA, 1995, DIAG TR MEN, P433; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35; Yudofsky SC, 1987, TXB NEUROPSYCHIATRY, P179; 1995, B OFICIAL ESTADO, V268	31	13	14	0	4	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	APR 1	2001	32	7					681	687		10.33588/rn.3207.2000180			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	435VB	WOS:000168901900016	11391499				2022-02-06	
J	Seguin, P; Bleichner, JP; Branger, B; Guillou, YM; Feuillu, A; Malledant, Y				Seguin, P; Bleichner, JP; Branger, B; Guillou, YM; Feuillu, A; Malledant, Y			End-tidal carbon dioxide tension is not a pertinent parameter for monitoring severe head trauma	CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE			French	Article							MECHANICAL VENTILATION; ARTERIAL; CAPNOGRAPHY; GRADIENT; PCO2	Purpose: To evaluate the agreement between end-tidal carbon dioxide (PETCO2) and arterial CO2 (PaCO2) in patients with traumatic brain injury and to document the course of the (PaCO2 - PETCO2) gradient over time. Methods: Twenty one traumatic brain injury patients (Coma Glasgow Scale less than or equal to 8) were included in this prospective observational study over a period of sir months. Simultaneous determinations of PoCO2 and PETCO2 (by infrared capnometry) were recorded. Agreement between PaCO2 and PETCO2 was determined by the statistical method described by Blond and Altman, Changes in PETCO2 over time were compared with changes in PaCO2. Factors likely to explain a gradient superior to +/- 4 mmHg were explored. Results: One hundred and eleven data pairs were obtained. The bios was 5.5 mmHg with a precision of 5.1 mmHg and limits of agreement ranged from -4.5 mmHg to 15.5 mmHg. The latter exceeded the predefined limits of agreement established to determine interchange-ability between methods (+/- 4 mmHg). PETCO2 and PaCO2 changed in opposite directions in 20% of 90 consecutive measurements. Only the duration of ventilation was found to be significantly associated with a gradient superior to +/- 4 mmHg. Conclusions In this selected population of patients with severe traumatic brain injury, measurements of PETCO2 and PaCO2 ore not interchangeable. Further, the PaCO2 - PETCO2 gradient is not stable over time and cannot predict variations of PaCO2. The use of PETCO2 instead of PaCO2 could be deleterious in patients in whom strict control of PaCO2 values is required.	Serv Anesthesie Reanimat Chirurg, Rennes, France; Hosp Rennes, Dept Hyg, Rennes, France; Biochim Lab, Rennes, France		Seguin, P (corresponding author), CHRU Pontchaillou, Serv Reanimat Chirurg, 2 Rue Henri Courriel, F-35033 Rennes, France.		Seguin, Philippe/P-9487-2019	Seguin, Philippe/0000-0002-7774-4257; Malledant, yannick/0000-0001-6680-5184			BHAVANISHANKAR K, 1992, CAN J ANAESTH, V39, P617, DOI 10.1007/BF03008330; BLANCH L, 1987, CHEST, V92, P451, DOI 10.1378/chest.92.3.451; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bullock MR, 1996, J NEUROTRAUM, V13, P653; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; ENGOREN M, 1992, J NEUROSURG ANESTH, V4, P241, DOI 10.1097/00008506-199210000-00002; HEALEY CJ, 1987, CRIT CARE MED, V15, P764, DOI 10.1097/00003246-198708000-00011; HOFFMAN RA, 1989, AM REV RESPIR DIS, V140, P1265, DOI 10.1164/ajrccm/140.5.1265; ISERT P, 1994, ANAESTH INTENS CARE, V22, P435, DOI 10.1177/0310057X9402200419; Kerr ME, 1996, CRIT CARE MED, V24, P785, DOI 10.1097/00003246-199605000-00010; MACKERSIE RC, 1990, CRIT CARE MED, V18, P764, DOI 10.1097/00003246-199007000-00017; RUSSELL GB, 1994, J TRAUMA, V36, P317, DOI 10.1097/00005373-199403000-00006; RUSSELL GB, 1990, CAN J ANAESTH, V37, P560, DOI 10.1007/BF03006326; RUSSELL GB, 1992, J NEUROSURG ANESTH, V4, P245, DOI 10.1097/00008506-199210000-00003; TOBIN MJ, 1990, JAMA-J AM MED ASSOC, V264, P244, DOI 10.1001/jama.264.2.244; WAHBA RWM, 1991, CAN J ANAESTH, V38, P384, DOI 10.1007/BF03007630; YAMANAKA MK, 1987, CHEST, V92, P832, DOI 10.1378/chest.92.5.832	17	13	13	1	2	CANADIAN ANESTHESIOLOGISTS SOC	TORONTO	1 EGLINTON AVE EAST, SUITE 208, TORONTO, ONTARIO M4P 3A1, CANADA	0832-610X			CAN J ANAESTH	Can. J. Anaesth.-J. Can. Anesth.	APR	2001	48	4					396	400		10.1007/BF03014971			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	422QU	WOS:000168131400015	11341245	Bronze			2022-02-06	
J	Azian, AA; Nurulazman, AA; Shuaib, IL; Mahayidin, M; Ariff, AR; Naing, NN; Abdullah, J				Azian, AA; Nurulazman, AA; Shuaib, IL; Mahayidin, M; Ariff, AR; Naing, NN; Abdullah, J			Computed tomography of the brain in predicting outcome of traumatic intracranial haemorrhage in Malaysian patients	ACTA NEUROCHIRURGICA			English	Article						computed tomography; head injury; predictors; Malaysia	SEVERE HEAD-INJURY; INTRA-CRANICAL PRESSURE; SUBARACHNOID HEMORRHAGE; CT SCAN; INTRACEREBRAL HEMATOMA; EXTRADURAL HEMATOMAS; PROGNOSTIC FACTORS; SYSTEM	Head injury is a significant economic, social and medical problem all over the world. Road accidents are the most frequent cause of head injury in Malaysia with highest risk in the young (15 to 24 years old). The associated outcomes include good recovery, possibility of death for the severely injured, which may cause disruption of the lives of their family members. It is important to predict the outcome as it will provide sound information to assist clinicians in Malaysia in providing prognostic information to patients and their families, to assess the effectiveness of different modes of treatment in promoting recovery and to document the significance of head injury as a public health problem. Results. A total of 103 cases with intracranial haemorrhage i.e. intracerebral haemorrhage, extradural haemorrhage, subdural haemorrhage, intraventricular haemorrhage, haemorrhagic contusion and subarachnoid haemorrhage, following motor vehicle accidents was undertaken to study factors contributing to either good or poor outcome according to the Glasgow Outcome Scale. Patients below 12 years of age were excluded. The end point of the study was taken at 24 months post injury. The selected variables were incorporated into models generated by logistic regression techniques of multivariate analysis to see the significant predictors of outcome as well as the correlation between the CT findings with GCS. Conclusion. Significant predictors of outcome were GCS on arrival in the accident emergency department, papillary reflex and the CT scan findings. The CT predictors of outcome include ICH, EDH, IVH, present of SAH, site of ICH, volumes of EDH and SDH as well as midline shift.	Hosp Univ Sains Malaysia, Dept Radiol, Kelantan, Malaysia; Univ Sci Malaysia, Sch Med Sci, Unit Epidemiol & Med Stat, Kelantan, Malaysia; Hosp Univ Sains Malaysia, Dept Neurosci, Div Neurosurg, Kelantan, Malaysia		Abdullah, J (corresponding author), Hosp Univ Sci Malaysia, Dept Neurosci, Div Neurosurg, Kubang Kerian Kelantan 16150, Malaysia.		Naing, Nyi Nyi/M-3455-2015; Shuaib, Ibrahim Lutfi/B-5380-2009; Naing, Nyi Nyi/AAB-3851-2021; Abdullah, J/C-2828-2011	Naing, Nyi Nyi/0000-0001-8308-5625; Abdullah, J/0000-0002-0258-7410			Abraszko RA, 1995, BRIT J NEUROSURG, V9, P769, DOI 10.1080/02688699550040747; Alex BV, 1996, NEUROTRAUMA, P119; Athiappan S., 1993, Annals Academy of Medicine Singapore, V22, P452; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; CAPLAN LR, 1994, INTRACEREBRAL HEMORR, P221; CHOKSEY M, 1993, BRIT J NEUROSURG, V7, P611, DOI 10.3109/02688699308995090; COOK RJ, 1988, ACTA NEUROCHIR, V95, P90, DOI 10.1007/BF01790766; COOPER PR, 1979, NEUROSURGERY, V5, P566, DOI 10.1227/00006123-197911000-00004; DEWEERD AW, 1979, J NEUROL, V222, P45; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; FELDMAN Z, 1996, NEUROTRAUMA, P805; FRANKE CL, 1992, J NEUROL NEUROSUR PS, V55, P653, DOI 10.1136/jnnp.55.8.653; GAETANI P, 1995, J NEUROL NEUROSUR PS, V59, P635, DOI 10.1136/jnnp.59.6.635; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GERBER CJ, 1993, ACTA NEUROCHIR, V122, P11, DOI 10.1007/BF01446981; Graham D.I., 1996, NEUROTRAUMA, P43; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; HIJDRA A, 1990, STROKE, V21, P1156, DOI 10.1161/01.STR.21.8.1156; HIJDRA A, 1988, STROKE, V19, P1250, DOI 10.1161/01.STR.19.10.1250; ISHIBASHI A, 1991, Kurume Medical Journal, V38, P167; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; KASE CS, 1994, INTRACEREBRAL HEMORR, P467; KIDO DK, 1992, RADIOLOGY, V182, P777, DOI 10.1148/radiology.182.3.1535893; KISHORE PRS, 1981, AM J ROENTGENOL, V137, P829, DOI 10.2214/ajr.137.4.829; KUDAY C, 1994, ACTA NEUROCHIR, V131, P203, DOI 10.1007/BF01808613; Kunishio Katsuzo, 1992, Neurological Surgery, V20, P959; LANE B, 1999, DIAGNOSTIC RADIOLOGY, P2001; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; LIPPER MH, 1985, AM J ROENTGENOL, V144, P483, DOI 10.2214/ajr.144.3.483; LOBATO RD, 1983, J NEUROSURG, V12, P161; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Orrison William W. Jr., 1996, P71; PAPO I, 1982, ACTA NEUROCHIR, V62, P47, DOI 10.1007/BF01402210; SELLADURAI BM, 1992, BRIT J NEUROSURG, V6, P549, DOI 10.3109/02688699209002372; SERVADEI F, 1997, ACTA NEUROCHIR WIEN, V139, P272; SERVADEI F, 2000, EUR BRAIN INJ CONSUT, V46, P70; STEINER I, 1984, STROKE, V15, P279, DOI 10.1161/01.STR.15.2.279; SWEET RC, 1978, NEUROSURGERY, V3, P16, DOI 10.1227/00006123-197807000-00003; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P140; Torner James C., 1996, P19; TOUTANT SM, 1984, J NEUROSURG, V2, P323; TSAI FY, 1978, J COMPUT ASSIST TOMO, V2, P323, DOI 10.1097/00004728-197807000-00018; TUHRIM S, 1988, ANN NEUROL, V24, P258, DOI 10.1002/ana.410240213; Woertgen C, 1999, J TRAUMA, V47, P1126, DOI 10.1097/00005373-199912000-00026; WOODRUFF WW, 1993, FUNDAMENTALS NEUROIM, P121; YAMAURA A, 1981, Neurologia Medico-Chirurgica, V21, P685; YASUKAWA K, 1988, Neurological Surgery, V16, P482; YOUNG B, 1981, J NEUROSURG, V54, P300, DOI 10.3171/jns.1981.54.3.0300; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	54	13	14	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		2001	143	7					711	720		10.1007/s007010170051			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	456NW	WOS:000170089900025	11534693				2022-02-06	
J	Toms, AD; Williams, S; White, SH				Toms, AD; Williams, S; White, SH			Obturator dislocation of the hip	JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME			English	Article								We describe two patients with obturator dislocation of the hip which was irreducible by described techniques of closed reduction. The first required open reduction using the iliofemoral approach with release of rectus femoris, The second was treated on a traction table which allowed disengagement of the head and, when combined with simultaneous lateral traction, adduction and gradual release of the longitudinal traction, facilitated a smooth reduction, Since the hip is stable in flexion, early mobilisation in an extension-limiting brace avoids the prolonged bed rest traditionally recommended for this injury.	Royal Shrewsbury Hosp, Shrewsbury, Salop, England		Toms, AD (corresponding author), Robert Jones & Agnes Hunt Orthopaed Hosp NHS Trus, Inst Orthopaed, Oswestry SY10 7AG, Shrops, England.						AMIHOOD S, 1975, INJURY, V7, P107, DOI 10.1016/0020-1383(75)90007-8; Bigelow H., 1878, LANCET, V111, P860, DOI DOI 10.1016/S0140-6736(02)43952-9; CAMPBELL WC, CAMPBELLS OPERATIVE, V3, P2232; DAWSON I, 1989, ARCH ORTHOP TRAUM SU, V108, P55, DOI 10.1007/BF00934160; EPSTEIN HC, 1972, J BONE JOINT SURG AM, VA 54, P1561; Epstein HC, 1985, ORTHOPEDICS, V8, P132; HENDERSON RS, 1951, J BONE JOINT SURG BR, V33, P602, DOI 10.1302/0301-620X.33B4.602; MOWERY C, 1986, J TRAUMA, V26, P1041, DOI 10.1097/00005373-198611000-00014; POLESKY RE, 1972, J BONE JOINT SURG AM, VA 54, P1097, DOI 10.2106/00004623-197254050-00020; ROCKWOOD, FRACTURES ADULTS, V2, P1756; SCHLICKEWWI W, 1993, INJURY, V1, P27; SIMPSON L, 1986, TECH ORTHOP, V1, P23; Stewart WJ, 1933, J BONE JOINT SURG, V15, P413	13	13	13	0	0	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	0301-620X			J BONE JOINT SURG BR	J. Bone Joint Surg.-Br. Vol.	JAN	2001	83B	1					113	115		10.1302/0301-620X.83B1.10289			3	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	408BU	WOS:000167307300024	11245517				2022-02-06	
J	Mayr, JM; Seebacher, U; Lawrenz, K; Pesendorfer, P; Berghold, A; Baradaran, S				Mayr, JM; Seebacher, U; Lawrenz, K; Pesendorfer, P; Berghold, A; Baradaran, S			Bunk beds - a still underestimated risk for accidents in childhood?	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						injury prevention; bunk bed; child; fall; side-rail	CHILDREN FALL; INJURIES; TRAUMA	A retrospective analysis of 218 bunk-bed accidents and a random sample survey with 991 family interviews were performed in order to establish guidelines for bunk-bed accident prevention. Falls from the top bed during sleep (35.1%) or while playing (34.4%) and falling off the ladder (23.2%) are the leading causes of bunk-bed accidents. Of the 218 children. 91 (41.7%) had sustained major injuries, including 3 polytrauma, 7 skull fractures, 44 cerebral concussions. 33 long bone fractures, 2 Lisfranc injuries, and 2 lacerations of the spleen. Of these accidents, 58.3% resulted in minor injuries with 18 fractures in other locations than the long bones or cranial vault, 89 contusions and sprains, 18 skin lacerations and 2 tooth fractures. A total of 23.8% of the accidents occurred in children under 3 years of age. The random sample survey demonstrated that in relation to age groups of children 30.8% (0%-45.8%) of families interviewed had been using bunk beds, with peaks at 3 years (29.8%), 7 years (36.5%) and 11 years (45.8%) of age. Of these bunk beds, 75.3% were equipped with side-rails, 57.3% had placed carpets alongside the bunk bed and 43.0% had used night lights. Conclusion There is only one recommendation: no bunk beds!!!	Graz Univ, Dept Paediat Surg, A-8036 Graz, Austria; Graz Univ, Inst Med Informat, A-8036 Graz, Austria		Mayr, JM (corresponding author), Graz Univ, Dept Paediat Surg, Auenbruggerpl 34, A-8036 Graz, Austria.						*AS NZS, 1994, 4220 ASNZS; DAKLIA F, 1995, ARCH PEDIATR, V2, P185; Gaig P, 1999, ANN ALLERG ASTHMA IM, V82, P531, DOI 10.1016/S1081-1206(10)63160-2; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; HELFER RE, 1977, PEDIATRICS, V60, P533; JAFFE D, 1991, NEW ENGL J MED, V324, P1477; JOHNSON GF, 1981, AM J ROENTGENOL, V137, P1041, DOI 10.2214/ajr.137.5.1041; LYONS TJ, 1993, PEDIATRICS, V92, P125; NIMITYONGSKUL P, 1987, J PEDIATR ORTHOPED, V7, P184, DOI 10.1097/01241398-198703000-00014; SELBST SM, 1990, AM J DIS CHILD, V144, P721, DOI 10.1001/archpedi.1990.02150300121031; *US CONS PROD SAF, 1985, 71 US CONS PROD SAF; *US CONS PROD SAF, 1987, UN FURN PROV BUNK BE; *US CONS PROD SAF, 1996, 828296 US CPSC; *US CONS PROD SAF, 1997, 97095 US CPSC; Watson W, 1999, INT J CONSUM PROD SA, V6, P87	15	13	13	0	2	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0340-6199			EUR J PEDIATR	Eur. J. Pediatr.	JUN	2000	159	6					440	443		10.1007/s004310051303			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	320VQ	WOS:000087421900009	10867850				2022-02-06	
J	Kaplan, CP				Kaplan, CP			Community integration questionnaire for patients with brain tumor - A comparative study	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						community integration; handicap; brain tumor; assessment		Objectives: This study compares mean scores obtained on the Community Integration Questionnaire among patients with brain tumor and published data for traumatic brain injury and nonpatient groups. Design: Subjects included 33 adult outpatients with biopsy-confirmed high-grade malignant brain tumors. Both sexes were represented. Subjects were older and better educated than historic samples. The Community Integration Questionnaire was positively skewed. Results: Subjects had higher scores on the Social Integration Scale than on Productivity. Higher education was associated with Productivity and the Community Integration Questionnaire total score. However, greater age was associated with lower scores. Significant gender effects were obtained. Conclusions: Women with brain tumors had significantly higher Home Integration Scores than males with tumors. However, Home Integration was lower for persons with brain tumors than for either the corresponding gender in the traumatic brain injury model systems group for males and females, respectively. Similarly, compared with community-dwelling persons with traumatic brain injury, males, but not females, with cerebral tumors had significantly lower Social Integration scores. When compared with nondisabled adults, persons with brain tumors reported significantly lower Productivity and Community Integration Questionnaire total scores.	Med Univ S Carolina, Dept Phys Med & Rehabil, Charleston, SC 29425 USA		Kaplan, CP (corresponding author), Med Univ S Carolina, Dept Phys Med & Rehabil, 150 Ashley Ave,POB 250583, Charleston, SC 29425 USA.						Dijkers M, 1997, J HEAD TRAUMA REHAB, V12, P74, DOI 10.1097/00001199-199712000-00007; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Kaplan CP, 1997, BRAIN INJURY, V11, P129; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; Willer B., 1993, BRAIN INJURY REHABIL, P355; World Health Organization, 1980, INT CLASS IMP DIS HA	7	13	13	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAY-JUN	2000	79	3					243	246		10.1097/00002060-200005000-00005			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	313FK	WOS:000086989500005	10821309				2022-02-06	
J	Mills, WJ; Chapman, JR; Robinson, LR; Slimp, JC				Mills, WJ; Chapman, JR; Robinson, LR; Slimp, JC			Somatosensory evoked potential monitoring during closed humeral nailing: A preliminary report	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						humerus; nailing; radial nerve; SSEP; somatosensory evoked potential	FRACTURES; SHAFT	Objectives: To assess the role of intraoperative somatosensory evoked potential (SSEP) monitoring of the radial and median nerves in preventing iatrogenic nerve injury during closed, locked intramedullary (IM) nailing of the humerus. Design: Prospective clinical study. Setting: Pacific Northwest Level One trauma center and Southern California military medical center. Patients: Thirteen patients with indications for surgical stabilization of fractures of the humeral diaphysis and either unknown neurologic status of the affected Limb or anticipated difficult reduction maneuvers due to fracture complexity or displacement. Intervention: Closed, antegrade or retrograde locked IM nailing: of the humerus was attempted while intraoperative monitoring of the radial and median nerves with SSEP was performed. Main Outcome Measurements: Intraoperative radial and median nerve SSEP changes during closed fracture manipulation, guide rod insertion, reaming, and humeral nail placement. Results: Baseline recordings were obtained in twelve of thirteen patients for both the radial and median nerves. An absence of radial nerve signal in one patient with a closed head injury prompted an open procedure, revealing entrapment of the radial nerve in the fracture. Intraoperative SSEP changes were observed in two of the twelve remaining patients during fracture manipulation and distal interlocking. The signal amplitude returned after discontinuation of manipulation and traction, and alteration of the interlocking maneuver. No neurologic deficits were noted in these two patients. Conclusions: Intraoperative radial nerve SSEP monitoring appears to reliably reflect the status of the radial nerve in those patients with a humerus fracture. Ln three of eleven patients, intraoperative signal changes prompted a change in surgical plan. In no patient did there appear to be evidence of iatrogenic nerve injury.	Univ Washington, Harborview Med Ctr, Sch Med, Dept Orthopaed Surg, Seattle, WA 98104 USA; Univ Washington, Harborview Med Ctr, Sch Med, Dept Rehabil Med, Seattle, WA 98104 USA		Mills, WJ (corresponding author), Univ Washington, Harborview Med Ctr, Sch Med, Dept Orthopaed Surg, 325 9Th Ave,Box 359798, Seattle, WA 98104 USA.		Robinson, Lawrence/D-8455-2013	Robinson, Lawrence/0000-0002-9590-8745			BALFOUR GW, 1982, J BONE JOINT SURG AM, V64, P11, DOI 10.2106/00004623-198264010-00002; BLASIER RB, 1996, AM J ORTHOP S, V25, P31; BRUMBACK RJ, 1986, J BONE JOINT SURG AM, V68A, P960, DOI 10.2106/00004623-198668070-00002; CHAPMAN JR, 1988, TECH ORTHOP, V3, P88; FOSTER RJ, 1983, ORTHOP T, V7, P69; HELFET DL, 1994, CLIN ORTHOP RELAT R, V301, P213; Henley M B, 1991, J Orthop Trauma, V5, P14, DOI 10.1097/00005131-199103000-00003; HOLSTEIN A, 1963, J BONE JOINT SURG AM, V45, P1382, DOI 10.2106/00004623-196345070-00004; MAST JW, 1975, CLIN ORTHOP RELAT R, V112, P254; Miller WR, 1996, PSYCHOL ADDICT BEHAV, V10, P81, DOI 10.1037/0893-164X.10.2.81; NASH CL, 1989, J BONE JOINT SURG AM, V71A, P627, DOI 10.2106/00004623-198971040-00019; RIEMER BL, 1991, ORTHOPEDICS, V14, P239; ROBINSON LR, 1993, SPINE, V18, P1793, DOI 10.1097/00007632-199310000-00013; RUEDI T, 1974, RECONS SURG, V14, P65; RUSSELL TA, 1992, ORTHOPAEDIC T, V16, P334; SARMIENTO A, 1977, J BONE JOINT SURG AM, V59, P596, DOI 10.2106/00004623-197759050-00004; STERN PJ, 1984, J BONE JOINT SURG AM, V66A, P639, DOI 10.2106/00004623-198466050-00001; Yang KH, 1997, J ORTHOP TRAUMA, V11, P224, DOI 10.1097/00005131-199704000-00015	19	13	13	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	MAR-APR	2000	14	3					167	170		10.1097/00005131-200003000-00003			4	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	305JJ	WOS:000086536100003	10791666				2022-02-06	
J	Penn, C				Penn, C			Paying attention to conversation	BRAIN AND LANGUAGE			English	Article							TRAUMATIC BRAIN INJURY; FLUENT APHASIA; DOUBLE-BLIND; PIRACETAM; COMPREHENSION; INDIVIDUALS; DISORDERS; LANGUAGE; DEMENTIA; STROKE		Univ Witwatersrand, Dept Speech Pathol & Audiol, ZA-2050 Johannesburg, South Africa		Penn, C (corresponding author), Univ Witwatersrand, Dept Speech Pathol & Audiol, ZA-2050 Johannesburg, South Africa.						CROISILE B, 1993, NEUROLOGY, V43, P301, DOI 10.1212/WNL.43.2.301; Davis GA, 1997, BRAIN LANG, V56, P183; ENDERBY P, 1994, CLIN NEUROPHARMACOL, V17, P320, DOI 10.1097/00002826-199408000-00003; Ferguson A, 1998, APHASIOLOGY, V12, P1007, DOI 10.1080/02687039808249466; FRIEDLAND D, 1996, BRAIN INJURY, V12, P1; Haarmann HJ, 1997, BRAIN LANG, V59, P76, DOI 10.1006/brln.1997.1814; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Homma A, 1995, Int Psychogeriatr, V7, P363, DOI 10.1017/S1041610295002109; Huber W, 1997, ARCH PHYS MED REHAB, V78, P245, DOI 10.1016/S0003-9993(97)90028-9; Kagan A, 1998, APHASIOLOGY, V12, P816, DOI 10.1080/02687039808249575; Kinsella GJ, 1998, NEUROPSYCHOL REHABIL, V8, P351, DOI 10.1080/713755576; KLIPPI A, 1996, CONVERSATION ACHIEVE; Mateer CA, 1996, J HEAD TRAUMA REHAB, V11, P1; McNeil M.R, 1991, CLIN APHASIOLOGY C; MIYAKE A, 1994, COGNITIVE NEUROPSYCH, V11, P671, DOI 10.1080/02643299408251989; Murray LL, 1998, J SPEECH LANG HEAR R, V41, P213, DOI 10.1044/jslhr.4101.213; Orange JB, 1996, J SPEECH HEAR RES, V39, P881, DOI 10.1044/jshr.3904.881; Perkins L, 1998, J NEUROLINGUIST, V11, P33, DOI 10.1016/S0911-6044(98)00004-9; PERKINS L, 1995, INT J PSYCHOLINGUIST, V11, P167; POSNER MI, 1990, ANNU REV NEUROSCI, V1, P25; RUDOLPH K, 1998, 8 INT APH REH C S AF; SchmitterEdgecombe M, 1996, J HEAD TRAUMA REHAB, V11, P17, DOI 10.1097/00001199-199604000-00003; SHERRATT SM, 1990, APHASIOLOGY, V4, P539, DOI 10.1080/02687039008248506; SMALL SL, 1994, STROKE, V25, P1282, DOI 10.1161/01.STR.25.6.1282; Tanaka Y, 1997, LANCET, V350, P116, DOI 10.1016/S0140-6736(05)61820-X; TSENG CH, 1993, BRAIN LANG, V45, P276, DOI 10.1006/brln.1993.1046	26	13	13	0	2	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X			BRAIN LANG	Brain Lang.	JAN	2000	71	1					185	189		10.1006/brln.1999.2247			5	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	291GK	WOS:000085725600053	10716842				2022-02-06	
J	Sarno, S; Erasmus, LP; Lipert, G; Frey, M; Lipp, B; Schlaegel, W				Sarno, S; Erasmus, LP; Lipert, G; Frey, M; Lipp, B; Schlaegel, W			Electrophysiological correlates of visual impairments after traumatic brain injury	VISION RESEARCH			English	Article						visual evoked potentials; traumatic brain injury; visual attention; synchronization	CONTRAST LETTER CHARTS; SELECTIVE ATTENTION; CORTEX; SYNCHRONIZATION	Our aims were to investigate: (i) the VEP correlates of functional visual impairments following traumatic brain injury (TBI), in particular of the reduced spatial form perception; and (ii) the VEP correlates of visual sustained arousal in TBI patients. We used two approaches: (i) the analysis of latency and amplitude of the peaks; and (ii) the study of the correlations among the latencies of the peaks as a label of temporal synchronization. Thirty-five severe TBI outcome inpatients and 35 matching controls were studied. Pattern-reversal VEPs were recorded at Oz-Fz and Cz-Al, first without counting, then with counting of the reversals. Seven peaks of the waveform at Oz and eight peaks at Cz were measured. We found several differences in amplitude and latency between patients and controls, and between nocount/count. The temporal binding of the peaks within each channel and between the two channels was calculated by correlation matrices, and tested by factor analysis. Results indicated that the synchronization of the peaks within each channel did not differ between patients and controls. The temporal covariation between peaks occurring at Oz and Cz, however, was highly significantly altered in patients. This suggests that visual impairments in TBI patients may be due to a deranged synchronization of the activity of different brain regions. (C) 2000 Elsevier Science Ltd. All rights reserved.	Therapiezentrum Burgau, D-89331 Burgau, Germany; Marianne Strauss Klin, D-82335 Berg Kempfenhausen, Germany		Sarno, S (corresponding author), Therapiezentrum Burgau, Dr Friedl Str 1, D-89331 Burgau, Germany.	lerasmus@aol.com					AKSIONOFF EB, 1992, J AM OPTOMETRY ASS, V63, P542; ALTER I, 1990, Brain Injury, V4, P19, DOI 10.3109/02699059009026144; CELESIA CG, 1985, EVOKED POTENTIALS NE, P245; CIGANEK L, 1967, ELECTROEN CLIN NEURO, V26, P70; Clark VP, 1996, J COGNITIVE NEUROSCI, V8, P387, DOI 10.1162/jocn.1996.8.5.387; CREMONAMETEYARD SL, 1994, BRAIN INJURY, V8, P541, DOI 10.3109/02699059409151006; Daffner KR, 2000, J NEUROL NEUROSUR PS, V68, P18, DOI 10.1136/jnnp.68.1.18; DOWNING CJ, 1988, J EXP PSYCHOL HUMAN, V14, P188, DOI 10.1037/0096-1523.14.2.188; EASON RG, 1969, PHYSIOL BEHAV, V4, P283, DOI 10.1016/0031-9384(69)90176-0; EASON RG, 1981, B PSYCHONOMIC SOC, V18, P203; Engel AK, 1997, CEREB CORTEX, V7, P571, DOI 10.1093/cercor/7.6.571; Freed S, 1997, BRAIN INJURY, V11, P25, DOI 10.1080/026990597123782; GARCIAAUSTT E, 1994, ELECTROEN CLIN NEURO, V17, P136; GUPTA NK, 1986, NEUROLOGY, V36, P578, DOI 10.1212/WNL.36.4.578; Hebb DO, 1949, ORG BEHAV NEUROPSYCH; Husain M, 1996, J NEUROL, V243, P652, DOI 10.1007/BF00878662; KEITH RA, 1987, ADV CLIN REHABILITAT, V2, P6; KONIG P, 1993, EUR J NEUROSCI, V5, P501, DOI 10.1111/j.1460-9568.1993.tb00516.x; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P887, DOI 10.1037/0096-1523.20.4.887; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; NAKAMURA RK, 1986, EXP BRAIN RES, V63, P173; PADULA WV, 1994, BRAIN INJURY, V8, P125, DOI 10.3109/02699059409150964; PRATTJOHNSON JA, 1973, BRIT J OPHTHALMOL, V57, P347, DOI 10.1136/bjo.57.5.347; REGAN D, 1983, OPHTHALMOLOGY, V90, P1192; REGAN D, 1984, BRIT J OPHTHALMOL, V68, P885, DOI 10.1136/bjo.68.12.885; REGAN D, 1977, BRAIN, V100, P563, DOI 10.1093/brain/100.3.563; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; ROELFSEMA PR, 1994, EUR J NEUROSCI, V6, P1645, DOI 10.1111/j.1460-9568.1994.tb00556.x; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; SPONG P, 1968, ELECTROEN CLIN NEURO, V24, P396; Staiman K, 1998, CLIN EYE VISUAL CARE, V10, P119; Tierney D W, 1988, J Am Optom Assoc, V59, P614; Whyte J, 1998, J INT NEUROPSYCH SOC, V4, P127, DOI 10.1017/S1355617798001271; ZIHL J, 1989, ELECTROEN CLIN NEURO, V74, P394, DOI 10.1016/0168-5597(89)90007-5	35	13	13	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0042-6989	1878-5646		VISION RES	Vision Res.		2000	40	21					3029	3038		10.1016/S0042-6989(00)00137-1			10	Neurosciences; Ophthalmology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Ophthalmology; Psychology	349EP	WOS:000089030900011	11000399	Bronze			2022-02-06	
J	Viola, L; Zotta, D; Martino, V; Barbato, R; Schisano, G				Viola, L; Zotta, D; Martino, V; Barbato, R; Schisano, G			Minor head injuries: One year experience according to the new Italian guideline	ACTA NEUROCHIRURGICA			English	Article						Italian guideline; mild head injury; Glasgow Coma Scale score	HEMATOMA; MANAGEMENT; CLASSIFICATION; CONCUSSION; SEQUELAE; SYMPTOMS; RISK	Background The data concerning a consecutive series of 4,536 adult patients suffering from minor head injuries treated at the Department of Neurosurgery over a period of one year are reported. Method The patients' age, sex and the circumstances of the injury have been taken into consideration. The patients, according to the new method, were divided into four groups. Group 0 (3,864 patients) included all patients with Glasgow Coma Scale (GCS) score 15. They did not present any clinical features such as loss of consciousness (LOC), post-traumatic amnesia (PTA), headache or vomiting. No risk factors (RF) such as coagulopaties, alcoholism, drug abuse, epilepsy, previous neurological treatment or disabled elderly patients were detected. Group 1 (600 patients) included patients with GCS score 15. The patients presented one or more clinical features (LOC, PTA, headache, vomiting). No RF were presented. Group 2 (24 patients) included patients with GCS score 14 with or without clinical features (LOC, PTA, headache, vomiting) and with or without RF. Group 0-1R (48 patients) included patients with GCS score 15 with or without clinical features (LOC, PTA, headache, vomiting). All of them presented RF. The presence of focal neurological signs, open injury and GCS score less than or equal to 13 were considered criteria for exclusion. Findings. All the patients from groups 1, 0-1R, 2 and 187 patients from group 0 underwent CT scan for a total of 859 exams which are analyzed and discussed. 458 patients were admitted and are divided as follows: 216 from group 0, 192 from group 1, 26 from group 0-1R and all the 24 belonging to group 2. Six patients were treated surgically (3 extradural haematomas, 2 lobe contusions, 1 acute subdural haematoma) and one of them (0.02% of the total) died (extradural haematoma). The patients who were not admitted were sent home with an information sheet after at least a six hour observation period. Interpretation. The authors draw the conclusion that they have evaluated the applicability and efficacy of guidelines, developed by the study group on head injury of the Italian Society of Neurosurgery [19]. A critical parr of our guidelines is not only to identify all the intracranial lesions, but to identify patients harbouring relevant intracranial mass before clinical deterioration.	Nuovo Pellegrini Hosp, Dept Neurosurg, ASL Naples 1, I-80144 Naples, Italy		Viola, L (corresponding author), Nuovo Pellegrini Hosp, Dept Neurosurg, ASL Naples 1, Via Filippo Maria Briganti 255, I-80144 Naples, Italy.						Arienta C, 1997, SURG NEUROL, V48, P213, DOI 10.1016/S0090-3019(97)00019-0; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; CHAN KH, 1990, J NEUROSURG, V72, P189, DOI 10.3171/jns.1990.72.2.0189; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; LUCCHI S, 1995, RIV NEURORADIOL, V8, P415, DOI 10.1177/197140099500800308; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; MILLER JD, 1990, NEUROSURGERY, V27, P669, DOI 10.1227/00006123-199011000-00001; POON WS, 1992, NEUROSURGERY, V30, P681; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; SMITH HK, 1991, NEUROSURGERY, V29, P258, DOI 10.1227/00006123-199108000-00016; STEIN SC, 1992, J NEUROSURG, V77, P562, DOI 10.3171/jns.1992.77.4.0562; Study Group on Head Injury of the Italian Society for Neurosurgery, 1996, J NEUROSURG SCI, V40, P11; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YOUNG HA, 1984, NEUROSURGERY, V14, P22, DOI 10.1227/00006123-198401000-00006	21	13	13	0	2	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		2000	142	11					1281	1285		10.1007/s007010070026			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	387GW	WOS:000166115700024	11201644				2022-02-06	
J	Lang, JK; Ludwig, HC; Mursch, K; Zimmerer, B; Markakis, E				Lang, JK; Ludwig, HC; Mursch, K; Zimmerer, B; Markakis, E			Elevated cerebral perfusion pressure and low colloid osmotic pressure as a risk factor for subdural space-occupying hygromas?	SURGICAL NEUROLOGY			English	Article						traumatic brain injury; cerebral perfusion pressure; colloid osmotic pressure; subdural hygroma		BACKGROUND Space-occupying subdural hygromas are a late complication of severe traumatic brain injury (TBI) and may delay the patient's recovery. To evaluate the risk factors involved, we performed a semiretrospective, -prospective analysis of three groups of patients, which differed with regard to the techniques used in the management of their cerebral perfusion pressure (CPP) and colloid osmotic pressure (COP) to determine the occurrence of space-occupying subdural hygromas. PATIENTS AND METHODS Between 1989 and 1997 we examined 696 patients after a severe TBI: Group 1. 1989-1994 mean CPP: 67 (elevated for therapeutic reasons by catecholamines, if necessary), mean COP: 19. Group 2. January 1995-October 1996, mean CPP: 77, mean COP: 20. Group 3. November 1996-December 1997, mean CPP: 79, mean COP: 23 (elevated for therapeutic reasons by infusions of colloids). The groups were comparable for other criteria. RESULTS Compared to Group 1, Group 2, with a high CPP but lower COP, showed a significantly higher (p < 0.01; chi(2)-test with correction of Yates) percentage of posttraumatic subdural hygromas with space-occupying aspects, clinical signs of bradycardia, hypertension and impaired consciousness requiring surgery (Group 1: 1.75%; Group 2. 10.46%; Group 3. 0%). In Group 3 we saw no patient with a space-occupying hygroma. CONCLUSION We conclude that iatrogenic elevated CPP, which has been reported to be helpful in preventing secondary ischemic damage after a severe TBI, may be harmful to a patient if the COP is not maintained within physiological ranges. (C) 1999 by Elsevier Science Inc.	Univ Gottingen, Dept Neurosurg, D-37075 Gottingen, Germany		Lang, JK (corresponding author), Univ Gottingen, Dept Neurosurg, Robert-Koch-Str 40, D-37075 Gottingen, Germany.						BALDWIN AL, 1993, LYMPHOLOGY, V26, P4; CHAN KH, 1993, NEUROSURGERY, V32, P547, DOI 10.1227/00006123-199304000-00009; da Costa DG, 1941, ARCH SURG-CHICAGO, V43, P559, DOI 10.1001/archsurg.1941.01210160020003; FRENCH BN, 1978, SURG NEUROL, V9, P145; Giulioni M, 1996, NEUROSURGERY, V39, P1005, DOI 10.1097/00006123-199611000-00024; GUTIERREZ FA, 1974, AM J DIS CHILD, V128, P327, DOI 10.1001/archpedi.1974.02110280057007; HANS P, 1994, ANN FR ANESTH, V13, P123, DOI 10.1016/S0750-7658(94)80195-9; HEISEY SR, 1983, AM J PHYSIOL, V244, P224; HOFF J, 1973, J TRAUMA, V13, P870, DOI 10.1097/00005373-197313100-00005; Ishibashi Akira, 1994, Kurume Medical Journal, V41, P81; JACCARD E, 1983, NEUROCHIRURGIE, V29, P333; KARANKO MS, 1987, CRIT CARE MED, V15, P737, DOI 10.1097/00003246-198708000-00005; KUNZ U, 1993, UNFALLCHIRURG, V96, P595; LAMKE L O, 1976, Resuscitation, V5, P85, DOI 10.1016/0300-9572(76)90028-9; LANG J, 1997, ZENTRALBL NEUROCHI S; LUSINS JO, 1993, MT SINAI J MED, V60, P161; MIRCEVSKI M, 1986, CHILD NERV SYST, V2, P314, DOI 10.1007/BF00271946; NAFFZIGER HC, 1924, JAMA-J AM MED ASSOC, V82, P1751; NILSSON C, 1991, J CEREBR BLOOD F MET, V11, P861, DOI 10.1038/jcbfm.1991.146; Prior FGR, 1996, INT J ARTIF ORGANS, V19, P487, DOI 10.1177/039139889601900810; SIBBALD WJ, 1981, J APPL PHYSIOL, V50, P1337, DOI 10.1152/jappl.1981.50.6.1337; VanderLinden P, 1996, ANN FR ANESTH, V15, P456, DOI 10.1016/0750-7658(96)83206-0; WEISS MH, 1978, ARCH NEUROL-CHICAGO, V35, P527, DOI 10.1001/archneur.1978.00500320047010; WETTERLING T, 1986, ACTA NEUROCHIR, V83, P99, DOI 10.1007/BF01402385; WETTERLING T, 1988, ACTA NEUROCHIR, V91, P79, DOI 10.1007/BF01400533; WINESTOCK DP, 1975, RADIOLOGY, V115, P373, DOI 10.1148/115.2.373	26	13	14	0	0	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0090-3019			SURG NEUROL	Surg. Neurol.	DEC	1999	52	6					630	637		10.1016/S0090-3019(99)00144-5			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	277LQ	WOS:000084935400033	10660033				2022-02-06	
J	Talmor, D; Merkind, V; Artru, AA; Shapiro, O; Geva, D; Roytblat, L; Shapira, Y				Talmor, D; Merkind, V; Artru, AA; Shapiro, O; Geva, D; Roytblat, L; Shapira, Y			Treatments to support blood pressure increases bleeding and/or decreases survival in a rat model of closed head trauma combined with uncontrolled hemorrhage	ANESTHESIA AND ANALGESIA			English	Article							INDUCED HYPERTENSION; HYPOTENSION; INJURY; SALINE; EDEMA	Hemorrhagic hypotension may aggravate the detrimental effects of head trauma on neurologic outcome. Our study examined whether using phenylephrine or large volumes of saline IV to increase mean arterial blood pressure (MAP) to 70, 80, or 90 mm Hg during the combination of head trauma and uncontrolled hemorrhage would improve neurologic outcome. Rats were assigned to one of 17 groups. In Groups 1-5, the variables were head trauma (yes/no), hemorrhage (yes/no), 0 or 3 mL saline per milliliter of blood lost, and no target MAP. In Groups 6-11, hemorrhage was or was not combined with head trauma, and large volumes of saline were given IV to achieve target MAPs of 70, 80, or 90 mm Hg. Groups 12-17 were similar to Groups 6-11 except that phenylephrine was used rather than saline to achieve target MAPs. Saline increased blood loss at 2 h to approximately 16 and 25 mL at a MAP of 80 and 90 mm Hg respectively, increased (worsened) the neurodeficit score but not cerebral edema at 24 h, and decreased survival rate at 2 and 24 h. Because phenylephrine was fatal for 62 of 63 rats, group mean values for blood loss, neurodeficit score, and brain tissue specific gravity could not be calculated. We conclude that supporting MAP with either phenylephrine or large volumes of saline worsened the neurodeficit score and/or survival and did not affect cerebral edema formation in our rat model of head trauma combined with hemorrhage. Implications: The results of this study indicate that maintaining mean arterial blood pressure at 70, 80, or 90 mm Hg with either phenylephrine or large volumes of saline worsened the neurodeficit score and/or survival and did not affect cerebral edema formation in our rat model of head trauma combined with hemorrhage.	Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; Ben Gurion Univ Negev, Fac Hlth Sci, Div Anesthesiol, Soroka Med Ctr, Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Div Neurosurg, Soroka Med Ctr, Beer Sheva, Israel; Kaplan Hosp, Dept Anesthesiol, IL-76100 Rehovot, Israel		Artru, AA (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol, Box 356540, Seattle, WA 98195 USA.						AVELLINO AM, 1997, TXB NEUROANESTHESIA, P1137; Bedell EA, 1998, ANESTH ANALG, V87, P751; DRUMMOND JC, 1992, STROKE, V75, P238; Feldman Z, 1997, J TRAUMA, V43, P667, DOI 10.1097/00005373-199710000-00017; Gurevich B, 1998, RESUSCITATION, V38, P25, DOI 10.1016/S0300-9572(98)00067-7; KRAUSZ MM, 1992, J TRAUMA, V33, P6, DOI 10.1097/00005373-199207000-00002; RABINOVICI R, 1989, SURG GYNECOL OBSTET, V169, P137; SHAFTAN GW, 1965, SURGERY, V58, P851; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Talmor D, 1998, ANESTH ANALG, V87, P574, DOI 10.1097/00000539-199809000-00014	11	13	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	OCT	1999	89	4					950	956		10.1097/00000539-199910000-00024			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	240LP	WOS:000082827700024	10512270				2022-02-06	
J	Shiller, AD; Burke, DT; Kim, HJ; Calvanio, R; Dechman, KG; Santini, C				Shiller, AD; Burke, DT; Kim, HJ; Calvanio, R; Dechman, KG; Santini, C			Treatment with amantadine potentiated motor learning in a patient with traumatic brain injury of 15 years' duration	BRAIN INJURY			English	Article								This study sought to determine whether pharmacotherapy with amantadine potentiates motor recovery in an 18-year-old man with traumatic brain injury (TBI) of 15 years' duration. This uncontrolled single-case multiple-baseline design allowed preliminary evaluation of amantadine within the context of standard data-collection procedures on the TBI unit. Measurements tracked speed of wheelchair propulsion, wheelchair transfer, donning shirt, and inserting pegs into holes. Data were collected during a 3-week practice period, followed by a 6-week period of practice plus daily treatment with amantadine. The rate at which performance improved was significantly increased with drug treatment in the wheelchair transfer task. There was a statistically insignificant trend toward improvement in donning shia. Amantadine did not appear to potentiate recovery in the wheelchair propulsion or peg placement tasks. The results suggest that amantadine facilitates some measures of motor recovery in chronic brain injury. Further trials are warranted to investigate this issue.	Spaulding Rehabil Hosp, Dept PM&R, Boston, MA 02114 USA		Shiller, AD (corresponding author), Spaulding Rehabil Hosp, Dept PM&R, 125 Nashua St, Boston, MA 02114 USA.	ashiller@alum.mit.edu					GIANUTSOS G, 1985, EUR J PHARMACOL, V110, P357, DOI 10.1016/0014-2999(85)90564-3; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; Kraus MF, 1997, BRAIN INJURY, V11, P455, DOI 10.1080/026990597123430; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Vogenthaler D R, 1987, Brain Inj, V1, P113	7	13	16	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	1999	13	9					715	721					7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	239YX	WOS:000082799300004	10507453				2022-02-06	
J	Togher, L; Hand, L				Togher, L; Hand, L			The macrostructure of the interview: Are traumatic brain injury interactions structured differently to control interactions?	APHASIOLOGY			English	Article							HEAD-INJURY; DISCOURSE; POPULATION; ADULTS	Previous descriptions of discourse deficits following traumatic brain injury (TBI) at a macrostructural level have used analyses such as cohesion and story structure. This paper proposes a macrolinguistic analysis called generic structure potential analysis (GSP) (Ventola 1979) which describes the overall structuring of the unfolding process of two types of interviews. Seven TBI subjects are compared with matched control subjects across two conditions: a community education information-giving encounter to two 16 year old school students and an information requesting interaction with the researcher. The possible GSP elements of these types of encounters include greeting, identification, approaches which enable interactants to establish interpersonal links, centring which directly relate to the purpose of the interviews, leave-taking and goodbye. The GSP of student interactions was similar for TBI and control subjects but differences were noted in the researcher condition. The value of placing TBI subjects in information giving roles and the importance of the communication partner's contributions to the interaction is highlighted. GSP analysis allows the clinician/researcher to analyse the interview context by taking the contextual configuration into account. It map provide a valuable clinical tool in the assessment and treatment of discourse deficits which commonly follow TBI.	Univ Sydney, Sch Commun Sci & Disorders, Fac Hlth Sci, Lidcombe, NSW 2141, Australia; Liverpool Area Hlth Serv, Brain Injury Rehabil Unit, Sydney, NSW, Australia		Togher, L (corresponding author), Univ Sydney, Sch Commun Sci & Disorders, Fac Hlth Sci, POB 170, Lidcombe, NSW 2141, Australia.		Togher, Leanne/AAC-7083-2019	Togher, Leanne/0000-0002-4518-6748			Adamovich B. B., 1992, SCALES COGNITIVE ABI; BONDCHAPMAN S, 1995, J HEAD TRAUMA REHAB, V10, P36; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; EGGINS S, 1990, THESIS U SYDNEY SYDN; FLANAGAN S, 1995, BRAIN INJURY, V9, P321, DOI 10.3109/02699059509005773; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hartley L. L, 1995, COGNITIVE COMMUNICAT; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; MARSH NV, 1991, J CLIN EXP NEUROPSYC, V13, P729, DOI 10.1080/01688639108401086; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; Perkins M. R., 1995, CASE STUDIES CLIN LI, P293; PRUTTING CA, 1987, J SPEECH HEAR DISORD, V52, P105, DOI 10.1044/jshd.5202.105; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Szekeres Shirley F., 1992, Seminars in Speech and Language, V13, P293, DOI 10.1055/s-2008-1064204; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; VENTOLA E, 1979, J PRAGMATICS, V3, P267, DOI 10.1016/0378-2166(79)90034-1	18	13	14	0	4	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0268-7038			APHASIOLOGY	Aphasiology	SEP-NOV	1999	13	9-11					709	723		10.1080/026870399401821			15	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	248MM	WOS:000083279200009					2022-02-06	
J	Kuhnen, G; Bauer, R; Walter, B				Kuhnen, G; Bauer, R; Walter, B			Controlled brain hypothermia by extracorporeal carotid blood cooling at normothermic trunk temperatures in pigs	JOURNAL OF NEUROSCIENCE METHODS			English	Article						ECoG; hypothermia; isolated brain cooling; regional brain temperatures; arterial blood pressure	MODERATE HYPOTHERMIA; CEREBRAL-ISCHEMIA; CANINE BRAIN; INJURY; SIGNALS; DAMAGE; PERFUSION; GOAT; RATS	Cerebral hypothermia improves outcomes after brain injury. A technique is presented for isolated brain cooling in pigs by cooling the natural blood supply of the brain. Under general anesthesia both common carotid arteries were exteriorized. One proximal carotid artery was connected to both distal carotid arteries and a heat exchanger in this line controlled brain temperature. The second proximal carotid artery was connected to an external jugular vein and a heat exchanger in this arteriovenous shunt was used to clamp trunk temperature. Thalamic brain temperatures of anesthetized juvenile pigs (N = 8) were clamped at 38, 25, and 30 degrees C while trunk core temperature was clamped at 38 degrees C. Approximately 7 min were needed to decrease brain temperature from 38 to 25 degrees C, reducing brain electric activity by 76% and increasing the temperature differences between different brain sites. Mean arterial blood pressure, heart rate, and cardiac output showed no significant change. Re-establishment of normothermic brain temperature led to a virtually complete recovery of brain electric activity. The technique is suitable for investigations of ischemic and traumatic injuries. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Giessen, Inst Physiol, D-35392 Giessen, Germany; Klinikum Friedrich Schiller Univ, Inst Pathophysiol, Jena, Germany		Kuhnen, G (corresponding author), Univ Giessen, Inst Physiol, Aulweg 129, D-35392 Giessen, Germany.						*AM PHYSL SOC, 1996, AM J PHYSIOL, P271; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CLIFTON GL, 1992, J NEUROTRAUM, V9, pS487; Commission for Thermal Physiology of the International Union of Physiological Sciences (IUPS), 1987, PFLUGERS ARCH, V410, P567; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Dietrich WD, 1996, NEUROTRAUMA, P1491; Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; Gelman B, 1996, CRIT CARE MED, V24, P1009, DOI 10.1097/00003246-199606000-00022; Ginsberg MD, 1997, CEREBROVASC DIS, V7, P7, DOI 10.1159/000108237; HAYWARD JN, 1969, BRAIN RES, V16, P417, DOI 10.1016/0006-8993(69)90236-4; HORN M, 1991, ACTA NEUROPATHOL, V81, P443, DOI 10.1007/BF00293466; HUNTER WS, 1966, J APPL PHYSIOL, V21, P873, DOI 10.1152/jappl.1966.21.3.873; INGRAM DL, 1973, PFLUG ARCH EUR J PHY, V339, P299, DOI 10.1007/BF00594165; JESSEN C, 1990, PFLUG ARCH EUR J PHY, V416, P428, DOI 10.1007/BF00370750; JESSEN C, 1984, AM J PHYSIOL, V247, pR456, DOI 10.1152/ajpregu.1984.247.3.R456; KUHNEN G, 1991, PFLUG ARCH EUR J PHY, V418, P176, DOI 10.1007/BF00370468; KUHNEN G, 1994, AM J PHYSIOL, V267, pR355, DOI 10.1152/ajpregu.1994.267.2.R355; KULUZ JW, 1992, STROKE, V23, P1792, DOI 10.1161/01.STR.23.12.1792; KULUZ JW, 1993, AM J PHYSIOL, V265, pH824, DOI 10.1152/ajpheart.1993.265.3.H824; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; LANGER T, 1994, TEMPERATURE REGULATI, P145; LYETH BG, 1993, J NEUROTRAUM, V10, P57, DOI 10.1089/neu.1993.10.57; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MELLERGARD P, 1992, NEUROSURGERY, V31, P671; MICHENFELDER JD, 1991, ANESTHESIOLOGY, V75, P130, DOI 10.1097/00000542-199107000-00021; Ohta T, 1996, NEUROSURGERY, V38, P1211, DOI 10.1097/00006123-199606000-00032; Schmied H, 1996, LANCET, V347, P289, DOI 10.1016/S0140-6736(96)90466-3; Schwartz AE, 1996, NEUROSURGERY, V39, P577; STEEN PA, 1983, ANESTHESIOLOGY, V58, P527, DOI 10.1097/00000542-198306000-00009; TAYLOR CA, 1991, THERMOREGULATION PAT, P363; WASS CT, 1995, ANESTHESIOLOGY, V83, P325, DOI 10.1097/00000542-199508000-00013; WHITE RJ, 1983, RESUSCITATION, V10, P193, DOI 10.1016/0300-9572(83)90008-4	32	13	14	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	JUL 15	1999	89	2					167	174		10.1016/S0165-0270(99)00070-9			8	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	231XE	WOS:000082336000011	10491948				2022-02-06	
J	McCrory, P				McCrory, P			The eighth wonder of the world: the mythology of concussion management	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							2ND IMPACT SYNDROME; STANDARDIZED ASSESSMENT; FOOTBALL PLAYERS; AUSTRALIAN RULES		Olymp Pk Sports Med Ctr, Melbourne, Vic 3004, Australia		McCrory, P (corresponding author), Olymp Pk Sports Med Ctr, Melbourne, Vic 3004, Australia.		McCrory, Paul/Q-8688-2019				Barth JT, 1989, MILD HEAD INJURY, P257; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; CANTU RC, 1992, PHYSICIAN SPORTSMED, V20, P55, DOI 10.1080/00913847.1992.11947483; Congress of Neurological Surgeons, 1966, CLIN NEUROSURG, VIn: Vol 12, P386; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GRONWALL D, 1975, LANCET, V2, P995; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; MADDOCKS DL, 1991, J CLIN EXP NEUROPSYC, V13, P439; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McCrory PR, 1997, MED SCI SPORT EXER, V29, pS207; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; STENGER JM, 1964, J AM DENT ASSOC, V69, P273, DOI 10.14219/jada.archive.1964.0290; TYSVAER AT, 1992, SPORTS MED, V14, P200, DOI 10.2165/00007256-199214030-00006	18	13	13	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	APR	1999	33	2					136	137		10.1136/bjsm.33.2.136			2	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	184CT	WOS:000079592300028	10205701	Green Published			2022-02-06	
J	Turkstra, LS				Turkstra, LS			Language testing in adolescents with brain injury: A consideration of the CELF-3	LANGUAGE SPEECH AND HEARING SERVICES IN SCHOOLS			English	Article						assessment; communication; traumatic; head injury	TEST-PERFORMANCE; WORKING-MEMORY; SYNTAX	The validity of the Clinical Evaluation of Language Fundamentals-Third Edition (CELF-3, Semel, Wiig, & Secord, 1995 for the identification and description of language disorders following traumatic brain injury :TBI) was considered in 11 adolescents with TBI. In general, the CELF-3 identified only the individuals who had previously been diagnosed as language impaired,, not the individuals with verbal information processing impairments but no diagnosis of language impairment. the test did not permit the identification of strengths acid weaknesses. Intercorrelations among subtest standard scores were as high in the TBI group as in the standardization sample, which is consistent with the CELF-3 beina a one-factor test, Test performance may have been influenced by the interaction of the subjects memory abilities and the subtests' memory demands, although this relationship was not statistically significant in the present data.	Univ Arizona, Tucson, AZ 85721 USA		Turkstra, LS (corresponding author), Case Western Reserve Univ, Dept Commun Sci, Cleveland, OH 44106 USA.		Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921			BLOSSER J, 1994, PEDIAT TRAUMATIC BRA; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Fletcher RH, 1988, CLIN EPIDEMIOLOGY ES; GAULIN CA, 1994, PERCEPT MOTOR SKILL, V79, P55, DOI 10.2466/pms.1994.79.1.55; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; HAMMILL D, 1991, DETROIT TESTS LEARNI; Hartley L. L, 1995, COGNITIVE COMMUNICAT; McCauley RJ, 1996, LANG SPEECH HEAR SER, V27, P122, DOI 10.1044/0161-1461.2702.122; OBRZUT JE, 1987, J LEARN DISABIL, V20, P596, DOI 10.1177/002221948702001005; Plante E, 1996, LANG SPEECH HEAR SER, V27, P99, DOI 10.1044/0161-1461.2702.99; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; PRIGATANO GP, 1987, J LEARN DISABIL-US, V20, P603, DOI 10.1177/002221948702001006; SEMEL E, 1987, CLIN EVALUATION LANG; SEMEL W, 1995, CLIN EVALUATION LANG; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Towne R.L., 1993, LANG SPEECH HEAR SER, V24, P100; Turkstra LS, 1998, APHASIOLOGY, V12, P421, DOI 10.1080/02687039808249541; Turkstra LS, 1998, J SPEECH LANG HEAR R, V41, P137, DOI 10.1044/jslhr.4101.137; TURKSTRA LS, 1997, UNPUB SUPPLEMENTARY; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU	20	13	13	0	6	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	10801 ROCKVILLE PIKE, ROCKVILLE, MD 20852-3279 USA	0161-1461			LANG SPEECH HEAR SER	Lang. Speech Hear. Serv. Sch.	APR	1999	30	2					132	140		10.1044/0161-1461.3002.132			9	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	186BN	WOS:000079707100003	27764275				2022-02-06	
J	Uhl, E; Pickelmann, S; Rohrich, F; Baethmann, A; Schurer, L				Uhl, E; Pickelmann, S; Rohrich, F; Baethmann, A; Schurer, L			Influence of platelet-activating factor on cerebral microcirculation in rats part 2. Local application	STROKE			English	Article						cerebral circulation; leukocytes; microcirculation; platelet activating factor; rats	FACTOR PAF; INTRAVITAL MICROSCOPY; LEUKOCYTE ADHESION; ENDOTHELIAL-CELLS; ARTERY OCCLUSION; BRAIN INJURY; BOVINE BRAIN; DAMAGE; ARTERIOLES; ANTAGONIST	Background and Pupose-Platelet-activating factor (AF) is involved in the development of secondary brain damage after ischemic and traumatic brain injury. On the basis of data from studies in peripheral organs, we hypothesized that PAF-mediated effects after cerebral injury could be secondary to alterations in cerebral microcirculation. Methods-Changes in cerebral microcirculation focusing on leukocyte-endothelium interactions were quantified with the use of a closed cranial window model in Sprague-Dawley rats (n=33) by means of intravital fluorescence microscopy. The brain surface was superfused with PAF in concentrations from 10(-3) (n=3) to 10(-12) mol/L (n=6) for 20 minutes (5 mL/h), Results-PAF 10(-4) mol/L (n=4) increased the number of rolling and adherent leukocytes in venules from 9.7+/-0.4 to 19.7+/-2.3 cells/100 mm min (P=NS versus control) and from 2.2+/-0.5 to 4.3+/-0.7 cells/100 mm min (P<0.05 versus control), respectively. Lower concentrations did not elicit leukocyte-endothelium interactions. Vessel diameters remained unchanged except for a transient increase of arteriolar diameters during superfusion with PAF 10(-4) and 10(-6) mol/L (n=6). Although only a limited area of the brain surface was exposed to PAF, the mediator induced a significant dose-dependent transitory arterial hypotension and caused irreversible circulatory shock at the high concentration (PAF 10(-3) mol/L), Arterial hypotension after administration of PAF 10(-3) mol/L could be attenuated by the intravenous pretreatment with the PAF antagonist WEB 2170BS. Conclusions-PAF, when locally released after brain injury, can penetrate the blood-brain barrier and induce systemic effects, including arterial hypotension. Its role as a mediator in the development of secondary brain damage seems, at least in the initial phase, nut to be associated with disturbances of cerebral microcirculation or activation of leukocytes.	Grosshadern Univ Hosp, Dept Neurosurg, D-81377 Munich, Germany; Grosshadern Univ Hosp, Dept Surg, D-81377 Munich, Germany; Grosshadern Univ Hosp, Inst Surg Res, D-81377 Munich, Germany; Zent Klinikum Bad Berka, Dept Neurosurg, Bad Berka, Germany; Univ Hosp, Dept Neurosurg, Mannheim, Germany		Uhl, E (corresponding author), Grosshadern Univ Hosp, Dept Neurosurg, Marchioninistr 15, D-81377 Munich, Germany.	Eberhard.Uhl@nc.med.uni-muenchen.de	Hungerer, Sven/H-5818-2013	Hungerer, Sven/0000-0002-1615-1423			ARMSTEAD WM, 1988, CIRC RES, V62, P1, DOI 10.1161/01.RES.62.1.1; BEKKER AY, 1988, MICROCIRC ENDOTH LYM, V4, P433; BJORK J, 1983, EUR J PHARMACOL, V96, P87, DOI 10.1016/0014-2999(83)90532-0; BLANK ML, 1981, J BIOL CHEM, V256, P175; BRAQUET P, 1987, PHARMACOL REV, V39, P97; BUSSOLINO F, 1987, J IMMUNOL, V139, P2439; CHIBA Y, 1990, N-S ARCH PHARMACOL, V341, P68; CHOPP M, 1994, STROKE, V25, P869, DOI 10.1161/01.STR.25.4.869; DILLON PK, 1988, CIRC RES, V62, P732, DOI 10.1161/01.RES.62.4.732; DILLON PK, 1988, INFLAMMATION, V12, P563, DOI 10.1007/BF00914318; DOMINGO MT, 1994, BRAIN RES, V640, P268, DOI 10.1016/0006-8993(94)91882-1; EDWARDS RM, 1991, J LIPID MEDIATOR, V3, P161; Feuerstein G, 1988, Prog Biochem Pharmacol, V22, P181; FRERICHS KU, 1990, J NEUROSURG, V73, P223, DOI 10.3171/jns.1990.73.2.0223; GRIGORIAN GY, 1987, CIRC RES, V61, P389, DOI 10.1161/01.RES.61.3.389; HEUER HO, 1990, J PHARMACOL EXP THER, V255, P962; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; KUMAR R, 1988, BIOCHIM BIOPHYS ACTA, V963, P375, DOI 10.1016/0005-2760(88)90304-9; LAI FM, 1983, LIFE SCI, V32, P1159, DOI 10.1016/0024-3205(83)90122-4; LINDSBERG PJ, 1990, J LIPID MEDIATOR, V2, P41; MATSUO Y, 1995, J CEREBR BLOOD F MET, V15, P941, DOI 10.1038/jcbfm.1995.119; MUACEVIC G, 1992, ARZNEIMITTEL-FORSCH, V42-2, P1001; NAMM DH, 1982, THROMB RES, V25, P341, DOI 10.1016/0049-3848(82)90234-1; OBERPICHLER H, 1990, J CEREBR BLOOD F MET, V10, P133, DOI 10.1038/jcbfm.1990.17; SATOH K, 1992, ACTA NEUROL SCAND, V85, P122, DOI 10.1111/j.1600-0404.1992.tb04010.x; SAWYER DB, 1989, BIOCHIM BIOPHYS ACTA, V987, P129, DOI 10.1016/0005-2736(89)90464-1; SPINNEWYN B, 1987, PROSTAGLANDINS, V34, P337, DOI 10.1016/0090-6980(87)90079-7; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; TOKUMURA A, 1987, BIOCHEM BIOPH RES CO, V145, P415, DOI 10.1016/0006-291X(87)91338-6; Uhl E, 1999, STROKE, V30, P873, DOI 10.1161/01.STR.30.4.873; USKI TK, 1990, J CEREBR BLOOD F MET, V10, P428, DOI 10.1038/jcbfm.1990.74; YOSHIDA JI, 1986, J PHARM PHARMACOL, V38, P878, DOI 10.1111/j.2042-7158.1986.tb03375.x; YUE TL, 1994, CRIT REV NEUROBIOL, V8, P11; ZEINTL H, 1989, INT J MICROCIRC, V8, P293	34	13	14	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	APR	1999	30	4					880	886		10.1161/01.STR.30.4.880			7	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	180TP	WOS:000079401500034	10187895	Green Published, Bronze			2022-02-06	
J	Overweg-Plandsoen, WCG; Kodde, A; van Straaten, M; van der Linden, EAM; Neyens, LGJ; Aldenkamp, AP; Vermeulen, M				Overweg-Plandsoen, WCG; Kodde, A; van Straaten, M; van der Linden, EAM; Neyens, LGJ; Aldenkamp, AP; Vermeulen, M			Mild closed head injury in children compared to traumatic fractured bone; neurobehavioural sequelae in daily life 2 years after the accident	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						mild head injury; fractured bone; late sequelae; children	ADOLESCENTS; SCALE; COMA; PARAMETERS; RECOVERY	Two years after an accident resulting in either a mild head injury or a fractured bone, two groups of 22 children each, aged 4-14 years, were examined for the existence of any neurobehavioural symptoms by means of a standardized questionnaire filled out by their caretakers. Selection of the children was based on reports of the Accident and Emergency Department in 1 year. Significantly more symptoms were reported after mild head injury. The main symptoms reported were headache, dizziness, fatigue and memory problems. The total number of symptoms in the children with mild head injury exceeded four times this in the group of children with a fractured bone. Conclusion Even 2 years after a mild head injury there are still residual symptoms in daily life.	Univ Amsterdam, Dept Neurol, Acad Med Ctr, NL-1100 DE Amsterdam, Netherlands; Epilepsy Ctr Meer & Bosch, Dept Psychol, NL-2103 SW Heemstede, Netherlands; Epilepsy Ctr Kempenhaeghe, Dept Behav Sci & Psychol Serv, NL-5590 AB Heeze, Netherlands		Overweg-Plandsoen, WCG (corresponding author), Epilepsy Ctr Kempenhaeghe, Dept Neurol, POB 61, NL-5590 AB Heeze, Netherlands.						ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BINDER LM, 1989, ASSESSMENT BEHAV CON, P37; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; BRUYN GW, 1990, HDB CLIN NEUROLOGY, V13, P421; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; HOCKADAY JM, 1986, HDB CLIN NEUROLOGY, V4, P31; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEVIN HS, 1989, MILD HEAD INJURY, P189; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; PARKER RS, 1994, SEMIN NEUROL, V14, P67, DOI 10.1055/s-2008-1041061; RUIJS MBM, 1994, CLIN NEUROL NEUROSUR, V96, P273, DOI 10.1016/0303-8467(94)90114-7; RUIJS MBM, 1993, EUR J PEDIATR, V152, P844, DOI 10.1007/BF02073384; SCHANK SC, 1993, BIOMASS BIOENERG, V4, P1, DOI 10.1016/0961-9534(93)90021-U; SIEGEL S, 1956, NONPARAMETRIC STAT; SIMPSON D, 1982, LANCET, V2, P450; TEASDALE G, 1974, LANCET, V2, P81; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21	22	13	13	0	2	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0340-6199			EUR J PEDIATR	Eur. J. Pediatr.	MAR	1999	158	3					249	252		10.1007/s004310051061			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	171VL	WOS:000078884700015	10094450	Green Submitted			2022-02-06	
J	Armstead, WM				Armstead, WM			Cerebral hemodynamics after traumatic brain injury of immature brain	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article; Proceedings Paper	IIIrd International Congress of Pathophysiology	JUN 28-JUL 03, 1998	LAHTI, FINLAND			newborn, cerebral circulation; brain injury; fluid percussion; cerebral hemodynamic effects; cerebral oxygenation; K+ channels; K-ATP channel function; dilator responsiveness	SENSITIVE K+ CHANNELS; PIAL ARTERY VASODILATION; SPINAL-CORD INJURY; SUPEROXIDE-DISMUTASE; ENDOGENOUS OPIOIDS; HEAD-INJURY; BLOOD-FLOW; FLUID; NEWBORN; CATS	These studies were designed to characterize the cerebral hemodynamic effects of fluid percussion brain injury (FPI) in the newborn pig equipped with a closed cranial window. Reductions in cerebral blood flow, pial artery diameter, and cerebral oxygenation following FPI were greater in newborn (1-3 days old) vs. juvenile (3-4 weeks old) pigs, suggesting that newborns were exquisitely sensitive to brain injury. Additionally, in piglets, there was decremented dilation to nitric oxide, cGMP, and cAMP dependent stimuli following FPI. The membrane potential of vascular muscle is an important contributor to vascular tone and the activity of K+ channels is an important regulator of membrane potential. Recent studies indicate that altered dilator responsiveness and cerebral hemodynamic control following FPI results from impaired K+ ATP sensitive (K-ATP) and calcium sensitive (K-Ca(+2)) channel function. Impaired K-ATP channel function results, at least in part, from protein kinase C activation by the peptide endothelin-l. These observations indicate that the effects of brain injury on cerebral hemodynamics in the newborn are multifaceted and multifactorial.	Childrens Hosp Philadelphia, Dept Anesthesia, Philadelphia, PA 19104 USA; Univ Penn, Dept Anesthesia, Philadelphia, PA 19104 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA		Armstead, WM (corresponding author), Childrens Hosp Philadelphia, Dept Anesthesia, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.						ARMSTEAD WM, 1994, BRAIN RES, V660, P19, DOI 10.1016/0006-8993(94)90834-6; ARMSTEAD WM, 1991, CIRC RES, V68, P922, DOI 10.1161/01.RES.68.4.922; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 1997, BRAIN RES, V747, P252, DOI 10.1016/S0006-8993(96)01284-X; Armstead WM, 1997, BRAIN RES, V768, P177, DOI 10.1016/S0006-8993(97)00641-0; Armstead WM, 1997, STROKE, V28, P2273, DOI 10.1161/01.STR.28.11.2273; Armstead WM, 1997, AM J PHYSIOL-HEART C, V272, pH1785, DOI 10.1152/ajpheart.1997.272.4.H1785; Armstead WM, 1996, AM J PHYSIOL-HEART C, V270, pH423, DOI 10.1152/ajpheart.1996.270.2.H423; Bari F, 1996, STROKE, V27, P1874, DOI 10.1161/01.STR.27.10.1874; BASKIN DS, 1985, NEUROPEPTIDES, V5, P307, DOI 10.1016/0143-4179(85)90014-9; CROCKARD HA, 1977, SURG NEUROL, V7, P281; DEVINE JO, 1995, BRAIN RES, V675, P257, DOI 10.1016/0006-8993(95)00081-Z; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; FADEN AI, 1988, J PHARMACOL EXP THER, V245, P742; FADEN AI, 1986, ARCH NEUROL-CHICAGO, V43, P501, DOI 10.1001/archneur.1986.00520050073026; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; HALL ED, 1987, BRAIN RES, V435, P174, DOI 10.1016/0006-8993(87)91599-X; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; IMAIZUMI S, 1990, STROKE, V21, P1312, DOI 10.1161/01.STR.21.9.1312; Kasemsri T, 1997, AM J PHYSIOL-HEART C, V273, pH2639; Kasemsri T, 1997, STROKE, V28, P190, DOI 10.1161/01.STR.28.1.190; KITAZONO T, 1995, STROKE, V26, P1713, DOI 10.1161/01.STR.26.9.1713; KITAZONO T, 1993, AM J PHYSIOL, V265, pH581, DOI 10.1152/ajpheart.1993.265.2.H581; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KUBO M, 1994, CIRC RES, V74, P471, DOI 10.1161/01.RES.74.3.471; LEFFLER CW, 1990, AM J PHYSIOL, V259, pH1230, DOI 10.1152/ajpheart.1990.259.4.H1230; MCINTOSH TK, 1992, J NEUROTRAUM, V9, pS201; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P373, DOI 10.1089/neu.1993.10.373; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MCINTOSH TK, 1988, PHARM APPROACH TREAT, P89; MUIZELAAR JP, 1993, J NEUROSURG, V78, P375, DOI 10.3171/jns.1993.78.3.0375; NELSON MT, 1990, AM J PHYSIOL, V259, pC3; NELSON MT, 1995, AM J PHYSIOL-CELL PH, V268, pC799, DOI 10.1152/ajpcell.1995.268.4.C799; SHANKAR V, 1995, AM J PHYSIOL, pH997; Thorogood MC, 1996, ANESTHESIOLOGY, V84, P614, DOI 10.1097/00000542-199603000-00017; THOROGOOD MC, 1995, AM J PHYSIOL-HEART C, V269, pH1776; UNTERBERG AW, 1988, J NEUROSURG, V68, P594, DOI 10.3171/jns.1988.68.4.0594; VINK R, 1990, J NEUROSCI, V10, P3524; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1985, CIRC RES, V57, P781, DOI 10.1161/01.RES.57.5.781; WEI EP, 1986, AM J PHYSIOL, pH693; Wilderman MJ, 1996, AM J PHYSIOL-HEART C, V270, pH869, DOI 10.1152/ajpheart.1996.270.3.H869; ZIMMERMAN RS, 1990, J NEUROSURG, V6, P764	48	13	14	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	FEB	1999	51	2					137	142		10.1016/S0940-2993(99)80087-6			6	Pathology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pathology; Toxicology	177NZ	WOS:000079218000005	10192582				2022-02-06	
J	Beni-Adani, L; Flores, I; Spektor, S; Umansky, F; Constantini, S				Beni-Adani, L; Flores, I; Spektor, S; Umansky, F; Constantini, S			Epidural hematoma in infants: A different entity?	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	4th International Neuro-Trauma Symposium	SEP, 1997	SEOUL, SOUTH KOREA			head trauma; infants; EDH; score; GCS; CT	TRAUMATIC EXTRADURAL HEMATOMAS; PEDIATRIC COMA SCALE; HEAD-INJURIES; POSTERIOR-FOSSA; YOUNG-CHILDREN; AGE; TOMOGRAPHY; CHILDHOOD	Background: Epidural hematoma (EDH) in infants may be difficult to diagnose. The mechanism of injury and the clinical presentation are different from those in older children.We characterized the clinical and radiologic parameters of EDH in infants and correlated them with outcome. Because there are no optimal prognostic tools or clear guidelines to perform computed tomography in this unique population, a new approach of neurotrauma scoring is suggested. Methods: Eleven infants (<2 years old) operated on for EDH were studied. Children's Glasgow Coma Scale (CCS) score was applied, and diagnosis was confirmed by computed tomography. Results: Age was 13 +/- 5 months. Seven infants (63.6%) fell from less than 1 m, CCS score on admission was 10.7 +/- 3.9. Five infants (45%) were unconscious, yet two (18.2%) had CCS scores of 15, Pupillary abnormalities were found in two infants and lateralizing signs in five infants, Eight infants (72.7%) had subgaleal hematomas. Mortality and morbidity were 9% each. Conclusion: We suggest that a Trauma Infant Neurologic Score be used when dealing with EDH in infants. Lateralizing signs, pupillary abnormalities, mechanism of trauma, and scalp injuries should be included because these are objective relevant parameters.	Hadassah Univ Hosp, Dept Neurosurg, IL-91120 Jerusalem, Israel; Sourasky Med Ctr, Dana Childrens Hosp, Div Pediat Neurosurg, Tel Aviv, Israel		Beni-Adani, L (corresponding author), Hadassah Ein Karem, Dept Neurosurg, IL-91120 Jerusalem, Israel.						ASHKENAZI E, 1994, J TRAUMA, V36, P406, DOI 10.1097/00005373-199403000-00023; ASHKENAZI E, 1990, J TRAUMA, V30, P613, DOI 10.1097/00005373-199005000-00015; Bejjani GK, 1996, PEDIATR NEUROSURG, V25, P302, DOI 10.1159/000121144; BERNEY J, 1994, CHILD NERV SYST, V10, P517, DOI 10.1007/BF00335074; BOWER A J, 1990, British Journal of Neurosurgery, V4, P253, DOI 10.3109/02688699008992734; Clara JMC, 1996, CHILD NERV SYST, V12, P145, DOI 10.1007/BF00266818; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; HAHN YS, 1993, PEDIATR NEUROSURG, V19, P135, DOI 10.1159/000120718; HAHN YS, 1988, CHILD NERV SYST, V4, P34; HENNES H, 1988, AM J DIS CHILD, V142, P1045, DOI 10.1001/archpedi.1988.02150100039021; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; MOHANTY A, 1995, PEDIATR NEUROSURG, V23, P57, DOI 10.1159/000120936; MOLLOY CJ, 1990, CHILD NERV SYST, V6, P383, DOI 10.1007/BF00302223; MORRAY JP, 1984, CRIT CARE MED, V12, P1018, DOI 10.1097/00003246-198412000-00002; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; PASAOGLU A, 1990, ACTA NEUROCHIR, V106, P136, DOI 10.1007/BF01809456; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; REILLY PL, 1988, CHILD NERV SYST, V4, P30; RORKE LB, 1992, BRAIN PATHOL, V2, P211, DOI 10.1111/j.1750-3639.1992.tb00694.x; SCHUTZMAN SA, 1993, ANN EMERG MED, V22, P535, DOI 10.1016/S0196-0644(05)81938-9; SESHIA SS, 1977, DEV MED CHILD NEUROL, V19, P614; SIMPSON D, 1982, LANCET, V2, P450; SIMPSON DA, 1991, CHILD NERV SYST, V7, P183; YAGER JY, 1990, AM J DIS CHILD, V144, P1088, DOI 10.1001/archpedi.1990.02150340032019	24	13	17	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	1999	46	2					306	311		10.1097/00005373-199902000-00018			6	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	166TT	WOS:000078593800020	10029038				2022-02-06	
J	Marciani, RD; Caldwell, GT; Levine, HJ				Marciani, RD; Caldwell, GT; Levine, HJ			Maxillofacial injuries associated with all-terrain vehicles	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article								Purpose: The purpose of this article is to report the pattern and frequency of maxillofacial injuries resulting from all-terrain vehicle (ATV) accidents, to evaluate the mechanisms of injury, to document the length of hospital stay, and to characterize other associated injuries in patients presenting to a level 1 trauma center. Patients and Methods: The records of patients admitted to the University of Kentucky Medical Center from July 1, 1995 through August 1996 with an ATV-related injury were reviewed. Patients were included in the study if the events of their injury, demographic data, and the specifics of their perioperative care were sufficiently documented to provide the information pertinent to the investigation. Age, sex, mechanism of injury, facial injuries, associated injuries, and length of stay were the factors considered for the study. Results: Seventy-two patients met the criteria for the study. Fifty-nine (82%) were male, and 13 (18%) were female. Forty patients required operative intervention. Twenty-five (35%) had soft tissue or bony injuries to the maxillofacial region. One mandibular and 13 midface fractures were identified. Twelve of the patients with midface injuries had multiple facial fractures. Orbital floor fractures occurred in seven patients. Two patients required unilateral enucleation of the globe. Ten soft tissue injuries were diagnosed. Extremity fractures (n = 16) and closed head injuries (n = 17) were the most commonly associated injuries. The length of hospital stay for all the subjects identified in the study averaged 4.7 days. ATV rollover and being thrown from a moving ATV were the most common mechanisms of injury. Conclusions: Head and maxillofacial injuries, particularly midface injuries, are common findings after Ani accidents. Orbital trauma with serious globe injury was a striking feature of this study. Multiple systems injuries should always be anticipated and identified. The public should be alerted to the hazards of imprudent recreational vehicle use.	Univ Kentucky, Coll Dent, Div Oral & Maxillofacial Surg, Lexington, KY 40536 USA; Dept Vet Affairs, Lexington, KY USA		Marciani, RD (corresponding author), Univ Kentucky, Coll Dent, Div Oral & Maxillofacial Surg, Lexington, KY 40536 USA.						ALLAN DG, 1988, CAN J SURG, V31, P233; BENEL D, 1986, ALL TERRAIN VEHICLE, P19; DEMAS PN, 1992, J ORAL MAXIL SURG, V50, P1280, DOI 10.1016/0278-2391(92)90227-Q; DOLAN MA, 1989, PEDIATRICS, V84, P694; FRIEDMAN R, 1988, LARYNGOSCOPE, V98, P1251; GANOS D, 1988, AM SURGEON, V54, P429; GREENE MA, 1988, J TRAUMA, V28, P391, DOI 10.1097/00005373-198803000-00016; HARGARTEN SW, 1991, AM J EMERG MED, V9, P149, DOI 10.1016/0735-6757(91)90178-M; MARGOLIS JL, 1988, J TRAUMA, V28, P395, DOI 10.1097/00005373-198803000-00017; POLLACK CV, 1990, J TRAUMA, V30, P888, DOI 10.1097/00005373-199007000-00021; RODGERS GB, 1990, ACCIDENT ANAL PREV, V22, P47, DOI 10.1016/0001-4575(90)90006-7; RODGERS GB, 1993, ACCIDENT ANAL PREV, V25, P335, DOI 10.1016/0001-4575(93)90027-T; *US CONS PROD SAF, 1991, UPD ALL TERR VEH DEA; *US CONS PROD SAF, 1997, UPD ALL TERR VEH DEA; *US PUBL INT RES G, 1989, ATVS CHILDR STILL RI	15	13	13	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0278-2391			J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	FEB	1999	57	2					119	123		10.1016/S0278-2391(99)90221-5			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	163ED	WOS:000078389300005	9973117				2022-02-06	
J	Clark, E; Russman, S; Orme, S				Clark, E; Russman, S; Orme, S			Traumatic brain injury: Effects on school functioning and intervention strategies	SCHOOL PSYCHOLOGY REVIEW			English	Article							CHILDREN; ADOLESCENTS; REMEDIATION; PREDICTORS; CHILDHOOD	Children and adolescents who sustain traumatic brain injuries are at risk for both acute and chronic problems. Although research indicates that the majority of brain injuries are mild and have minimal impact upon learning and development, in cases in which injuries are more severe children are often left with serious cognitive and behavioral impairments, some of which are permanent. This article is intended to provide information for educators about the range of problems that children and their families face following a brain injury. Suggestions for assessment and intervention practices are included with brief case examples.	Univ Utah, Salt Lake City, UT 84112 USA		Clark, E (corresponding author), Univ Utah, 1705 E Campus Ctr Dr,Room 327, Salt Lake City, UT 84112 USA.						Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; BAKER SP, 1994, AM J PUBLIC HEALTH, V84, P649, DOI 10.2105/AJPH.84.4.649; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; Bowen JM, 1997, DEV MED CHILD NEUROL, V39, P17; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; CLARK E, 1995, TRAUMATIC BRAIN INJU; D'Amato R. C., 1997, CHILDHOOD TRAUMATIC, P213; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; FARMER JE, 1997, CHILDHOOD TRAUMATIC, P33; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; FLETCHER JM, 1995, TRAUMATIC HEAD INJUR, P3; Franzen KM, 1996, CHILD NEUROPSYCHOL, V2, P176, DOI 10.1080/09297049608402250; Glang A, 1997, J HEAD TRAUMA REHAB, V12, P32, DOI 10.1097/00001199-199704000-00005; GLANG A, 1992, J HEAD TRAUMA REHAB, V7, P93; JANNETT B, 1984, CLOSED HEAD INJURY P; Kehle T. J., 1997, CHILDHOOD TRAUMATIC, P135; Kehle TJ, 1996, J LEARN DISABIL, V29, P633, DOI 10.1177/002221949602900607; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; KREUTZER JS, 1989, REHABIL PSYCHOL, V34, P117; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Mateer C., 1997, CHILDHOOD TRAUMATIC, P153; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; ORME SF, 1997, THESIS U UTAH SALT L; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; RUSSMAN S, 1997, THESIS U UTAH SALT L; Suzman KB, 1997, J BEHAV THER EXP PSY, V28, P203, DOI 10.1016/S0005-7916(97)00023-2; Tate R, 1997, J HEAD TRAUMA REHAB, V12, P16, DOI 10.1097/00001199-199712000-00003; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; WADE SL, 1997, CHILDHOOD TRAUMATIC, P115; [No title captured]	35	13	13	0	1	NATL ASSOC SCHOOL PSYCHOLOGISTS	BETHESDA	4340 EAST WEST HWY, STE 402, BETHESDA, MD 20814 USA	0279-6015			SCHOOL PSYCHOL REV	Sch. Psychol. Rev.		1999	28	2					242	250					9	Psychology, Educational	Social Science Citation Index (SSCI)	Psychology	214XB	WOS:000081351900008					2022-02-06	
J	DeHope, E; Finegan, J				DeHope, E; Finegan, J			The self determination model: an approach to develop awareness for survivors of traumatic brain injury	NEUROREHABILITATION			English	Article						brain injury; clinical treatment; self-awareness; self-determination; community re-entry	CLOSED HEAD-INJURY; REHABILITATION	This article reports on the use of a theoretical model addressing integrated self-awareness in the treatment of individuals with traumatic brain injury. The Self- Determination Model, developed by ReMed a community-based provider of post-acute services, is presented here along with three case studies. The ability for an individual with a traumatic brain injury to monitor their own behavior is essential to increase their levels of independence in their activities of daily living and in handling social situations. The Self-determination Model is an interventive practice model to assist individuals in home and community based long-term rehabilitation settings in developing self-awareness.	ReMed, Supported Living Syst, Conshohocken, PA 19428 USA		DeHope, E (corresponding author), ReMed, Supported Living Syst, 625 Ridge Pike,Bldg C, Conshohocken, PA 19428 USA.	edehop@remed.com; finegan@remed.com					BANDURA A, 1986, SOCIAL FDN ACTION SO; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BURLEIGH S, 1997, AM J OCCUPATIONA SEP; COLE JR, 1985, ARCH PHYS MED REHAB, V66, P38; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Dattilo J, 1994, INCLUSIVE LEISURE SE; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; HPAY H, 1971, INT S HEAD INJ ED SC; KARPMAN T, 1985, J APPL REHABILITATIO, V0017, P00028; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1984, CLOSED HEAD INJURY, P109; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Rogers P M, 1984, J Neurosurg Nurs, V16, P343; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; WARD MJ, 1988, NICHCY TRANSITION SU, V5, P2; WEHMEYER ML, 1994, EDUC TRAIN MENT RET, V29, P9; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; YLKVISAKER M, 1987, COMMUNITY REENTRY HE	23	13	13	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		1999	13	1					3	12					10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	244UT	WOS:000083069700002					2022-02-06	
J	Finnie, J; Lewis, S; Manavis, J; Blumbergs, P; Van den Heuvel, C; Jones, N				Finnie, J; Lewis, S; Manavis, J; Blumbergs, P; Van den Heuvel, C; Jones, N			Traumatic axonal injury in lambs: a model for paediatric axonal damage	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						multifocal axonal injury; amyloid precursor protein; cerebellar granular layer necrosis; paediatric head injury model; lambs	AMYLOID PRECURSOR PROTEIN; CEREBRAL BLOOD-FLOW; CLOSED-HEAD-INJURY; CHILDREN; IMMATURE; BRAIN; MATURE; SHEEP; MICE; RATS	Axonal injury (Al), an important determinant of clinical outcome after traumatic head injury in adults, has been little studied in child neurotrauma. In this experimental model, 10 anaesthetised, ventilated and physiologically monitored 4-5 week old lambs sustained a temporal impact to an unconstrained head. Examination of the brain 2 hours post-impact using amyloid precursor protein immunostaining, a sensitive marker of axonal damage, revealed widespread multifocal Al in the ipsilateral and contralateral hemispheres, brain stem and cerebellum in all cases. Impact contusions (predominantly microscopic) (8/10), contralateral contusions (2/10), parenchymal haemorrhage (10/10) and focal subarachnoid haemorrhage (10/10) were also present. Unusual multifocal cerebellar granular layer necrosis occurred in all impacted lambs. The pattern of Al in these lamb brains 2 hours post-impact was similar to that found in adult sheep using the same experimental paradigm.	Inst Med & Vet Sci, Neuropathol Lab, Adelaide, SA 5000, Australia; Inst Med & Vet Sci, Vet Serv Div, Adelaide, SA 5000, Australia; Royal Adelaide Hosp, Dept Neurosurg, Adelaide, SA 5000, Australia		Blumbergs, P (corresponding author), Inst Med & Vet Sci, Neuropathol Lab, Adelaide, SA 5000, Australia.			, Corinna/0000-0003-0664-8935			Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; BENDOTTI C, 1988, P NATL ACAD SCI USA, V85, P3628, DOI 10.1073/pnas.85.10.3628; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Blumbergs PC, 1997, HEAD INJURY PATHOPHY, P39; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; DOBBING J, 1981, SCI FDN PAEDIAT, P747; Faden AI., 1994, NEUROBIOLOGY CENTRAL, P3; FEARNSIDE MR, 1997, HEAD INJURY PATHOPHY, P3; FINNIE JW, 1988, ACTA NEUROPATHOL, V75, P411, DOI 10.1007/BF00687795; Finnie JW, 1997, AUST VET J, V75, P204, DOI 10.1111/j.1751-0813.1997.tb10067.x; FINNIE JW, 1993, PATHOLOGY, V25, P99, DOI 10.3109/00313029309068912; FINNIE JW, 1984, J COMP PATHOL, V94, P363, DOI 10.1016/0021-9975(84)90024-0; FRANKOWSKI RF, 1985, DESCRIPTIVE EPIDEMIO, P33; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; Graham DI, 1997, GREENFIELDS NEUROPAT, P197; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; LINDENBERG R, 1982, HISTOL HISTOPATHOL, P1018; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MENDELOW AD, 1997, HEAD INJURY PATHOPHY, P71; MOYA KL, 1994, DEV BIOL, V161, P597, DOI 10.1006/dbio.1994.1055; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SIMPSON DA, 1992, WORLD J SURG, V16, P403, DOI 10.1007/BF02104439; SMITH ML, 1995, J NEUROTRAUM, V12, P143; UPTON R, 1994, J CEREBR BLOOD F MET, V14, P680, DOI 10.1038/jcbfm.1994.85; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185; Ward JD, 1996, NEUROTRAUMA, P859; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; [No title captured]	36	13	13	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	JAN	1999	6	1					38	42		10.1016/S0967-5868(99)90601-X			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	169QZ	WOS:000078761200009	18639121				2022-02-06	
J	Ross, RT; Ochsner, MG; Boyd, CR				Ross, RT; Ochsner, MG; Boyd, CR			Acute intracranial boxing-related injuries in US Marine Corps recruits: Report of two cases	MILITARY MEDICINE			English	Article								Serious acute intracranial injuries from boxing are a recognized, albeit rare, event. Acute brain injuries such as concussion, hemorrhage, and contusion are easily recognized because of their rapid onset of neurological impairment. The sequelae of such injuries range from transient diminished cognitive function to irreversible brain damage and, on occasion, death. The more serious injuries are certainly minimized as a result of regulatory policy, improved medical awareness, and the use of safety equipment. The incidence of serious acute head injury in amateur boxing and noncompetitive boxing is lower than that found in the professional ranks. Our survey of instructional boxing in U.S. Marine Corps basic training during an 8-year period detected only three serious acute brain injuries incurred by approximately 180,000 participants, equating to one serious head injury per 60,000 participants. Serious head injuries constituted an extremely small percentage (0.3%) of the approximately 1,100 total boxing-related Injuries surveyed during the period. We present two cases of serious acute brain injury incurred during noncompetitive boxing skills instruction as a part of U.S. Marine Corps basic training. A review of the data leads us to conclude that the risk of serious head injury in a well-supervised, instructional boxing program is relatively minimal. In any case, we recommend that any boxing be appropriately supervised and that specialized trauma care and an adequate transport mechanism to secure that care be readily available.	Mem Med Ctr, Savannah, GA 31403 USA		Ross, RT (corresponding author), Mem Med Ctr, POB 22084, Savannah, GA 31403 USA.						HAGLUND Y, 1993, AM J SPORT MED, V21, P97, DOI 10.1177/036354659302100117; JORDAN BD, 1987, ARCH NEUROL-CHICAGO, V44, P453, DOI 10.1001/archneur.1987.00520160083020; LEGWOLD G, 1982, PHYSICIAN SPORTSMED, V10, P43; RYAN AJ, 1987, CLIN SPORT MED, V6, P31; Sawauchi S, 1996, NEUROL SURG TOKYO, V24, P905; UNTERHARNSCHEIDT F, 1970, TEX REP BIOL MED, V28, P421	6	13	14	0	1	ASSN MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	JAN	1999	164	1					68	70		10.1093/milmed/164.1.68			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	157HH	WOS:000078055200016	9922649	Bronze			2022-02-06	
J	Keller, TM; Holland, MC				Keller, TM; Holland, MC			Chronic subdural haematoma, an unusual injury from playing basketball	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						subdural haematoma; basketball injury; computed tomography	HEMATOMA	Although the literature records instances of acute epidural haematoma and acute subdural haematoma related to playing basketball, there has not been a report of chronic subdural haematoma as a basketball injury. With the burgeoning interest in this sport in the United Kingdom and Europe, the possibility of this particular neurotrauma increases. Such an injury, along with the diagnosis and management of this often insidious lesion, is documented in this case report.	Pacific Neurosci Inst, Orinda, CA 94563 USA; Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA		Keller, TM (corresponding author), Pacific Neurosci Inst, 15 Altarinda Rd,Suite 102, Orinda, CA 94563 USA.						ALARCON RD, 1983, AM J PSYCHIAT, V140, P1360; Allen AM, 1940, NEW ENGL J MED, V223, P324, DOI 10.1056/NEJM194008292230903; AMBROSE J, 1974, J NEUROSURG, V40, P679, DOI 10.3171/jns.1974.40.6.0679; BECKER DP, 1990, NEUROLOGICAL SURG, P2017; BENDER MB, 1974, ARCH NEUROL-CHICAGO, V31, P73, DOI 10.1001/archneur.1974.00490380021001; DATTI R, 1995, BRIT J SPORT MED, V29, P95, DOI 10.1136/bjsm.29.2.95; HENRY JH, 1982, AM J SPORT MED, V10, P16, DOI 10.1177/036354658201000104; LEHMAN LB, 1987, AM J SPORT MED, V15, P494, DOI 10.1177/036354658701500512; OSLER W, 1907, MODERN MED, V3, P436; THOMAS LM, 1973, NEUROLOGICAL SUG, P960; TSAI FY, 1979, J NEUROSURG, V50, P64, DOI 10.3171/jns.1979.50.1.0064; Tudor R B, 1979, Am J Sports Med, V7, P136, DOI 10.1177/036354657900700211; VIRCHOW R, 1863, KRANKHAFTEN GESCHWUL, P128; WELSH JE, 1979, STROKE, V10, P564, DOI 10.1161/01.STR.10.5.564; WEPFER JJ, 1658, OBSERVATIONES ANATOM, P1	15	13	13	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	DEC	1998	32	4					338	339		10.1136/bjsm.32.4.338			2	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	143PD	WOS:000077263800029	9865409	Green Published, Bronze			2022-02-06	
J	Stilwell, P; Stilwell, J; Hawley, C; Davies, C				Stilwell, P; Stilwell, J; Hawley, C; Davies, C			Measuring outcome in community-based rehabilitation services for people who have suffered traumatic brain injury: the Community Outcome Scale	CLINICAL REHABILITATION			English	Article							MODEL	Objective: To develop a way of measuring long-term outcomes after traumatic brain injury (TBI) that takes account of individual circumstances. Design: Reports by head-injured people and their families about problems and coping strategies were elicited via semi-structured interviews. Specially designed computer software was used to record problems and strengths and to measure their impact for the individual on four handicap dimensions. Setting: Interviews took place in the respondents' homes. Subjects: Between 1992 and 1997 the services at 10 rehabilitation centres in England were evaluated. Subjects were men and women aged between 16 and 65 who had suffered TBI and who had been referred for treatment to one of the centres under study. Interventions: Head-injured people and their families were interviewed three months, 18 months and in some cases 36 months after recruitment. Main outcome measures: The Hospital Anxiety and Depression Scale (HAD) and the Functional Independence/Assessment Measure (FIM/FAM) were used to validate relevant dimensions of the new scale. Results: A measure of long-term outcome was developed and called the Community Outcome Scale. Relevant dimensions of the scale showed significant correlation with the HAD and with items of the FIM/FAM. Conclusion: The scale captures information which no other instrument does, and merits further validation.	Univ Warwick, Ctr Hlth Serv Studies, Coventry CV4 7AL, W Midlands, England		Stilwell, P (corresponding author), Lower Farm Cottage, Stourbridge DY9 0EJ, W Midlands, England.		Hawley, Carol/AAG-3830-2019				AITKEN C, 1982, LANCET          1106, P1034; Brisenden S., 1986, DISABILITY HANDICAP, V1, P173, DOI [10.1080/02674648666780171, DOI 10.1080/02674648666780171]; BROOKS N, 1991, Brain Injury, V5, P103, DOI 10.3109/02699059109008082; *CAN I HLTH INT, 1996, CIHI DIR ICIS, P3; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; *MED DIS SOC, 1988, REP WORK PART MAN TR; SCHALEN W, 1994, BRAIN INJURY, V8, P37, DOI 10.3109/02699059409150957; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; *STAT U BUFF, 1987, FUNCT IND MEAS; STILWELL J, 1998, NATL TRAUMATIC BRAIN; TAPPE MK, 1992, HEALTH EDUC RES, V7, P277, DOI 10.1093/her/7.2.277; TEASDALE G, 1974, LANCET, V2, P81; Tennant A, 1997, DISABIL REHABIL, V19, P278, DOI 10.3109/09638289709166539; TENNANT A, 1995, BRAIN INJURY, V9, P595, DOI 10.3109/02699059509008218; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; *WHO, 1980, INT CLASS IMP DIS HA, P42; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; Wong Pauline P., 1993, Brain Injury, V7, P283, DOI 10.3109/02699059309034955; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	21	13	13	0	1	ARNOLD, HODDER HEADLINE PLC	LONDON	338 EUSTON ROAD, LONDON, ENGLAND NW1 3BH	0269-2155			CLIN REHABIL	Clin. Rehabil.	DEC	1998	12	6					521	531		10.1191/026921598673761855			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	146HL	WOS:000077423200009	9869256				2022-02-06	
J	Body, R; Perkins, MR				Body, R; Perkins, MR			Ecological validity in assessment of discourse in traumatic brain injury: ratings by clinicians and non-clinicians	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; PRAGMATIC LANGUAGE-SKILLS; ADULTS	Researcher; studying discourse after traumatic brain injury (TBI) increasingly recognize the need to take account of variation within the non-brain-damaged (NBD) population in order to validate their findings. This study investigated the use of ratings by professional clinicians trained in speech pathology (P raters) and by peers of TBI individuals (NP raters) as a method of placing TBI individuals' communication in context. Twenty TBI adults and 20 NBD controls matched for age, sex, education and social background retold a 1400 word story presented on audiotape, following which the narratives were transcribed and segmented. Raters used two ii-point scales, representing independent parameters of Content and Clarity, to rate the transcripts. Statistical analysis demonstrated that P raters tended to give higher ratings across the board than NP rates but that P and NP ratings were also highly correlated. In general, the ratings assigned to the two subject groups overlapped and exhibited an even spread across the range of mean ratings. On the evidence of this study clinicians appear to share perceptions regarding discourse performance with peers of the TBI subjects. In addition, many TBI subjects perform as well or better than NBD controls on high-level tasks.	St Georges Community Hlth Ctr, Community Brain Injury Rehabil Team, Sheffield S3 7ND, S Yorkshire, England; Univ Sheffield, Dept Human Commun Sci, Sheffield, S Yorkshire, England		Body, R (corresponding author), St Georges Community Hlth Ctr, Community Brain Injury Rehabil Team, Winter St, Sheffield S3 7ND, S Yorkshire, England.		Body, Richard/C-2736-2010	Body, Richard/0000-0001-9089-8130			ARMSTRONG EM, 1987, CLIN APHASIOLOGY, P210; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; DIKMEN S, 1987, NEUROBEHAVIORAL RECO, P73; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; Ehrlich J, 1989, Brain Inj, V3, P193, DOI 10.3109/02699058909004552; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; ELLMO WJ, 1995, MEASURE COGNITIVE LI; FLANAGAN S, 1995, BRAIN INJURY, V9, P321, DOI 10.3109/02699059509005773; Glosser G., 1990, BRAIN LANG, V40, P67; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; LEINONEN E, 1993, INTERDISCIPLINARY PE, P252; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCDONALD S, 1995, BRAIN INJURY, V9, P255, DOI 10.3109/02699059509008197; MCGANN W, 1995, BRAIN INJURY, V9, P93, DOI 10.3109/02699059509004575; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; MILLER TK, 1991, CLIN MANAGEMENT COMM, P27; SNOW P, 1995, APHASIOLOGY, V9, P365, DOI 10.1080/02687039508248210; Snow P, 1997, BRAIN INJURY, V11, P409; SPENCE SE, 1993, BRIT J CLIN PSYCHOL, V32, P309, DOI 10.1111/j.2044-8260.1993.tb01061.x; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; TYKKYLAINEN T, 1992, STUDIES LOGOPEDICS P, V3, P253; ULATOWSKA HK, 1981, BRAIN LANG, V13, P345, DOI 10.1016/0093-934X(81)90100-0	29	13	13	0	10	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	1998	12	11					963	976		10.1080/026990598122016			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	143NR	WOS:000077262300005	9839029				2022-02-06	
J	Garnier, C; Enot-Joyeux, F; Jokic, C; Le Thiec, F; Desgranges, B; Eustache, F				Garnier, C; Enot-Joyeux, F; Jokic, C; Le Thiec, F; Desgranges, B; Eustache, F			Evaluation of executive functions in head-injured patients: a French adaptation of the Six Element Task	REVUE DE NEUROPSYCHOLOGIE			French	Article						head injury; frontal syndrome; assessment; executive function	FRONTAL-LOBE DAMAGE; PERFORMANCE; COGNITION; DEFICITS	An impairment of executive functions is frequently observed after a severe head injury and often compromises the patient autonomy. If there are numerous tests to detect such a dysfunction in a post-traumatic period, they are often insufficient in case of minor disorders as observed in long delay post onset. To improve evaluation of executive functions, Shallice and Burgess (1991) have elaborated the sir element task, which requires the patient to organize himself a situation close to every day activities. We have adapted this test and we suggested an original scoring. Classical tests to assess executive functions and the six element task have been proposed to three head injured patients and to thirty controls. We observed a dissociation between normal or subnormal performance in classical tests and disorders in the six element task. These results demonstrate the higher sensitivity of this test as compared to the results obtained in classical tests assessing executive functions. The disorders are interpreted within the Norman and Shallice (1980) model.	CHU Cote Nacre, INSERM, U320, F-14033 Caen, France; Ctr Hosp, Serv Reeduc Neurol, F-14260 Aunay Sur Odon, France; CHU Cote Nacre, Serv Neurol, F-14033 Caen, France; Univ Caen, F-14032 Caen, France				Eustache, Francis/J-9465-2015; DESGRANGES, BEATRICE/AAK-4756-2021; Desgranges, Beatrice/L-7739-2015	Eustache, Francis/0000-0003-4460-8686; DESGRANGES, BEATRICE/0000-0002-3657-9996; 			BAYLESS JD, 1989, J CLIN EXP NEUROPSYC, V11, P913, DOI 10.1080/01688638908400944; Benson D.F., 1986, FRONTAL LOBES; BOYD TM, 1993, APPL COGNITIVE PSYCH, V7, P171, DOI 10.1002/acp.2350070208; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Damasio Antonio R., 1995, ERREUR DESCARTES RAI; Dimitrov M, 1996, CORTEX, V32, P357, DOI 10.1016/S0010-9452(96)80057-8; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Fuster JM, 1989, PREFRONTAL CORTEX, V2nd; Godefroy O, 1997, NEUROLOGY, V49, P695, DOI 10.1212/WNL.49.3.695; GOLDSTEIN LH, 1993, J NEUROL NEUROSUR PS, V56, P274, DOI 10.1136/jnnp.56.3.274; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; Harlow J.M., 1993, PUBLICATIONS MASSACH, V4, P274, DOI [DOI 10.1177/0957154X9300401407, https://doi.org/10.1177/0957154X9300401407]; JOKIC C, 1997, REEDUCATIONS NEUROPS, P237; LETHIEC F, IN PRESS ANN READAPT; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Lezak MD., 1993, J HEAD TRAUMA REHAB, V8, P24, DOI DOI 10.1097/00001199-199303000-00004; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Luria A. R., 1978, FONCTIONS CORTICALES; Luria AR, 1969, HDB CLINICAL NEUROLO, P725; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V0005, P00213, DOI DOI 10.1037/0894-4105.5.3.213; Milner B., 1964, FRONTAL GRANULAR COR, P313; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; PORTEUS SD, 1965, TEST LABYRINTHES SD; Raven J. C., 1947, PROGR MATRICES STAND; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; REY A, 1959, TEST COPIE UNE FIGUR; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Wechsler D., 1989, ECHELLE INTELLIGENCE; [No title captured]	32	13	16	0	3	ADRSC-ASSOC DIFFUSION RECHERCHES SCIENCES COGNITIVES	MARSEILLE CEDEX 20	C N R S-C R N C, 31, CHEMIN JOSEPH ALGUIER, 13402 MARSEILLE CEDEX 20, FRANCE	1155-4452			REV NEUROPSYCHOL	Rev. Neuropsychol.	SEP	1998	8	3					385	414					30	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	131EB	WOS:000076561800003					2022-02-06	
J	Hiscock, M; Caroselli, JS; Kimball, LE				Hiscock, M; Caroselli, JS; Kimball, LE			Paced serial addition: Modality-specific and arithmetic-specific factors	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							NUMBER; RETRIEVAL; MECHANISMS; BILINGUALS; CONCUSSION; MEMORY; TESTS	Tests of paced serial addition are used to detect diminished information-processing capacity. Nonetheless, performance might be influenced by modality-specific interference or by variables that specifically affect numerical processing. In a series of three experiments with normal adults, we manipulated, respectively, the modality in which addends were presented, the modality in which responses were produced, and the format in which visual addends were displayed. Performance was enhanced when stimuli were presented visually and when responses were made manually. When visual addends were used, Arabic numerals were processed more effectively than number words. Thus, performance was influenced by modality-specific interference and by presentation format. We conclude that paced serial addition tasks may not provide a pure measure of general information-processing capacity.	Univ Houston, Dept Psychol, Houston, TX 77204 USA		Hiscock, M (corresponding author), Univ Houston, Dept Psychol, Houston, TX 77204 USA.						CAMPBELL JID, 1988, J EXP PSYCHOL GEN, V117, P204, DOI 10.1037/0096-3445.117.2.204; CAMPBELL JID, 1994, COGNITION, V53, P1, DOI 10.1016/0010-0277(94)90075-2; CAMPBELL JID, 1991, MEM COGNITION, V19, P197, DOI 10.3758/BF03197119; CAMPBELL JID, 1990, CAN J PSYCHOL, V44, P445, DOI 10.1037/h0084266; CAMPBELL JID, 1989, J EXP PSYCHOL LEARN, V15, P920, DOI 10.1037/0278-7393.15.5.920; CLARK JM, 1991, BRAIN COGNITION, V17, P204, DOI 10.1016/0278-2626(91)90075-J; Diamond BJ, 1997, J CLIN EXP NEUROPSYC, V19, P34, DOI 10.1080/01688639708403834; FEINSTEIN A, 1994, J CLIN EXP NEUROPSYC, V16, P436, DOI 10.1080/01688639408402654; FRENCKMESTRE C, 1993, MEM COGNITION, V21, P809, DOI 10.3758/BF03202748; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Kahneman D., 1973, ATTENTION EFFORT; MCCLOSKEY M, 1991, BRAIN COGNITION, V17, P154, DOI 10.1016/0278-2626(91)90074-I; MCCLOSKEY M, 1985, BRAIN COGNITION, V4, P171, DOI 10.1016/0278-2626(85)90069-7; NAVON D, 1984, PSYCHOL REV, V91, P216, DOI 10.1037/0033-295X.91.2.216; ODONNELL JP, 1994, J CLIN PSYCHOL, V50, P596, DOI 10.1002/1097-4679(199407)50:4<596::AID-JCLP2270500416>3.0.CO;2-S; SOKOL SM, 1989, J EXP PSYCHOL GEN, V118, P105; Stuss D.T., 1987, CLIN NEUROPSYCHOL, V1, P139, DOI [DOI 10.1080/13854048708520046, 10.1080/13854048708520046]; VAID J, 1991, BRAIN COGNITION, V17, P272, DOI 10.1016/0278-2626(91)90077-L	21	13	13	0	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG	1998	20	4					463	472		10.1076/jcen.20.4.463.1466			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	153JY	WOS:000077831000004	9892050				2022-02-06	
J	Jacobs, DG; Westerband, A				Jacobs, DG; Westerband, A			Antibiotic prophylaxis for intracranial pressure monitors	JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION			English	Article; Proceedings Paper	54th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 29-OCT 01, 1994	SAN DIEGO, CALIFORNIA	Amer Assoc Surg Trauma		antibiotic prophylaxis; intracranial pressure monitor	RISK-FACTORS; SURGERY; PNEUMONIA; INFECTIONS; VENTRICULOSTOMY; TRIAL	To determine the safety and efficacy of prophylactic antibiotics in head-injured patients requiring intracranial pressure monitors, the Files of 30 consecutive patients with isolated, severe head injuries admitted over a 1-year period were reviewed. Patients .15 years with severe closed-head injury who did not have severe concomitant, extracranial injury (Abbreviated Injury Score ,3) and survived .48 hours following hospital admission were included. Fourteen patients underwent intracranial pressure monitor placement and received prophylactic antibiotics for the duration of monitoring and the remaining 16 patients were neither monitored nor given prophylactic antibiotics. Length of hospital stay, length of intensive care stay, overall and septic complication rate, and death rate were compared For the two treatment groups. The groups were similar with regard to patient characteristics, associated injuries, and injury severity. Patients who received prophylactic antibiotics demonstrated statistically higher septic morbidity rates (78.6% versus 31.3%) and statistically higher pneumonia rates (57.1% ver sus 18.8%) compared with patients who did not. No patient developed central nervous system infection related to the monitor itself. These results indicate that the administration of prophylactic antibiotics to head-injured patients for the duration of intracranial pressure monitoring is unnecessary and potentially detrimental. Antibiotics, if given at all, should be limited to the period immediately surrounding intracranial pressure monitor placement.	Carolinas Med Ctr, Dept Surg, Charlotte, NC 28232 USA		Jacobs, DG (corresponding author), Carolinas Med Ctr, Dept Surg, POB 32861, Charlotte, NC 28232 USA.						AUCOIN PJ, 1986, AM J MED, V80, P369, DOI 10.1016/0002-9343(86)90708-4; BLOMSTEDT GC, 1985, J NEUROSURG, V62, P694, DOI 10.3171/jns.1985.62.5.0694; BURNETT JW, 1980, J BONE JOINT SURG AM, V62, P457, DOI 10.2106/00004623-198062030-00017; CHOLE RA, 1987, ARCH OTOLARYNGOL, V113, P1055; CONDON RE, 1991, CURR PROB SURG, V28, P801; CRAVEN DE, 1986, AM REV RESPIR DIS, V133, P792; DRIKS MR, 1987, NEW ENGL J MED, V317, P1376, DOI 10.1056/NEJM198711263172204; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; HAINES SJ, 1989, NEUROSURGERY, V24, P401, DOI 10.1227/00006123-198903000-00016; HAUSER WE, 1982, AM J MED, V72, P711, DOI 10.1016/0002-9343(82)90534-4; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; KAISER AB, 1986, NEW ENGL J MED, V315, P1129; Luerssen T.G., 1993, INTRACRANIAL PRESSUR, VVIII, P42; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; NAZIRI W, 1994, ANN SURG, V219, P632, DOI 10.1097/00000658-199406000-00006; OSTRUP RC, 1987, J NEUROSURG, V67, P206, DOI 10.3171/jns.1987.67.2.0206; PATZAKIS MJ, 1974, J BONE JOINT SURG AM, VA 56, P532, DOI 10.2106/00004623-197456030-00010; PLATT R, 1990, NEW ENGL J MED, V322, P153, DOI 10.1056/NEJM199001183220303; RODRIGUEZ JL, 1991, J TRAUMA, V31, P907, DOI 10.1097/00005373-199107000-00005; ROWLANDS BJ, 1982, ARCH SURG-CHICAGO, V117, P195; Sirvent JM, 1997, AM J RESP CRIT CARE, V155, P1729, DOI 10.1164/ajrccm.155.5.9154884; STONE HH, 1976, ANN SURG, V184, P443, DOI 10.1097/00000658-197610000-00007; ULUALP K, 1992, INFECT DIS CLIN N AM, V6, P613	23	13	14	0	0	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0027-9684			J NATL MED ASSOC	J. Natl. Med. Assoc.	JUL	1998	90	7					417	423					7	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	103HB	WOS:000075151000006	9685777				2022-02-06	
J	Hermann, DM; Mies, G; Hossmann, KA				Hermann, DM; Mies, G; Hossmann, KA			Effects of a traumatic neocortical lesion on cerebral metabolism and gene expression of rats	NEUROREPORT			English	Article						bioluminescence imaging; cerebral protein synthesis rate; cortical spreading depression; umbelliferone fluoroscopy	CORTICAL SPREADING DEPRESSION; NUCLEAR-MAGNETIC-RESONANCE; EXPERIMENTAL BRAIN INJURY; LACTATE; PROTEIN; DAMAGE; FLUID; P-31; H-1	THE effects of a traumatic neocortical lesion, induced by transcranial cold injury, on brain metabolism and gene expression were examined. The surrounding of the lesions was characterized by increased glucose and lactate levels without major disturbances of protein synthesis or energy state. A transient pH decrease by 0.4 units was noticed Ih post-injury, which shifted towards alkaline values by 3 h. The metabolic disturbances did not differ between injured animals with spontaneous spreading depressions (SD, n = 14) and those without SD (n = 7). In SD animals, c-fos mRNA was strongly elevated in the injury-remote cortex, but hsp72 mRNA was not enhanced. Thus, in contrast to focal ischemia, the metabolic dysfunction around traumatic cortical lesions is not aggravated by SD. (C) 1998 Rapid Science Ltd.	Max Planck Inst Neurol Res, Dept Expt Neurol, D-50931 Cologne, Germany		Hermann, DM (corresponding author), Max Planck Inst Neurol Res, Dept Expt Neurol, Gleueler Str 50, D-50931 Cologne, Germany.		Hermann, Dirk M/AAP-5538-2020; Hermann, Dirk M./AAT-3652-2021	Hermann, Dirk M./0000-0003-0198-3152			BACK T, 1994, J CEREBR BLOOD F MET, V14, P12, DOI 10.1038/jcbfm.1994.3; CORBETT RJT, 1992, J NEUROCHEM, V59, P216, DOI 10.1111/j.1471-4159.1992.tb08894.x; Dhillon HS, 1997, EXP NEUROL, V146, P240, DOI 10.1006/exnr.1997.6524; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; DRAGUNOW M, 1988, BRAIN RES, V455, P295, DOI 10.1016/0006-8993(88)90088-1; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; HUSZ T, 1992, NEUROREPORT, V3, P51, DOI 10.1097/00001756-199201000-00013; INAO S, 1988, J NEUROSURG, V69, P736, DOI 10.3171/jns.1988.69.5.0736; KAMEZAWA T, 1994, ACTA NEUROCHIR, P499; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KOCHER M, 1990, J CEREBR BLOOD F MET, V10, P564, DOI 10.1038/jcbfm.1990.99; Marmarou A, 1993, Acta Neurochir Suppl (Wien), V57, P160; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; MIES G, 1993, J NEUROCHEM, V60, P360, DOI 10.1111/j.1471-4159.1993.tb05860.x; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; NEUMANNHAEFELIN T, 1994, J CEREBR BLOOD F MET, V14, P206, DOI 10.1038/jcbfm.1994.27; NOWAK TS, 1990, STROKE, V21, P107; PRASAD MR, 1994, J NEUROCHEM, V63, P1086; Siesjo BK, 1996, ADV NEUROL, V71, P209; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; UNTERBERG AW, 1988, J NEUROSURG, V68, P594, DOI 10.3171/jns.1988.68.4.0594; WOLF AL, 1993, J NEUROSURG, V78, P54, DOI 10.3171/jns.1993.78.1.0054	24	13	13	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	JUN 1	1998	9	8					1917	1921		10.1097/00001756-199806010-00046			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZU455	WOS:000074198700046	9665626				2022-02-06	
J	Saeki, N; Yamaura, A; Sunami, K				Saeki, N; Yamaura, A; Sunami, K			Brain stem contusion due to tentorial coup injury: case report and pathomechanical analysis from normal cadavers	BRITISH JOURNAL OF NEUROSURGERY			English	Article						brain stem; head injury; MRI; tentorial incisura	LESIONS	This report is in two parts. First, a case report on a 20-year-old man with a localized brain stem contusion. Second, in order to elucidate the mechanism of this injury, an anatomical study was performed. Ten cadaver heads were analysed to reveal the variations of spatial anatomy around the tentorial incisura. The lateral tentorial incisura (lateral to brain stem) was situated at the level of pontomesencephalic junction and nearest to the brain stem along its course. The shortest distance between them averaged 1.0 mm (0-4 mm). Based on these findings, primary brain stem injury caused by tentorial incisura occurs at its lateral portion due to the shortest distance to the brain stem and near the level of pontomesencephalic junction. In patients with a tentorial incisura closely related to or touching the brain stem, tentorial coup injury to the brain stem may occur even with a relatively minor injury. In our case, repeated CT and MRI proved that the location of contusion was at the pontomesencephalic junction, coinciding with the level of the tentorial edge. The injury started at the surface of brain stem. The tentorial edge was close to brain stem in this case. These radiological findings support the hypothesis that the brain stem contusion was caused by a tentorial coup injury.	Kawatetsu Chiba Hosp, Sch Med, Dept Neurol Surg, Chiba, Japan		Saeki, N (corresponding author), 1-8-1 Inohana,Chuhoh Ku, Chiba 260, Japan.						ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; BRITT RH, 1980, NEUROSURGERY, V6, P623, DOI 10.1227/00006123-198006000-00002; CORSELLIS JAN, 1958, J NEUROL NEUROSUR PS, V21, P279, DOI 10.1136/jnnp.21.4.279; COURVILLE CB, 1945, P ASS RES NERV MENTA, V21, P131; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; HASHIMOTO T, 1993, NEUROSURG REV, V16, P291, DOI 10.1007/BF00383839; Lindenberg R, 1964, Clin Neurosurg, V12, P129; MEYER CA, 1991, RADIOLOGY, V179, P813, DOI 10.1148/radiology.179.3.2027997; MICHELL DE, 1973, LANCET, V2, P215; Ommaya AK, 1976, HEAD INJURIES, P49; ONO M, 1984, J NEUROSURG, V60, P365, DOI 10.3171/jns.1984.60.2.0365; THOMPSON RK, 1988, NEUROSURGERY, V22, P629, DOI 10.1227/00006123-198804000-00002; TSAI FY, 1980, AM J ROENTGENOL, V134, P717, DOI 10.2214/ajr.134.4.717; ZIMMERMAN RA, 1978, AM J ROENTGENOL, V131, P27, DOI 10.2214/ajr.131.1.27; ZUCCARELLO M, 1983, ACTA NEUROCHIR, V67, P103, DOI 10.1007/BF01401670	15	13	14	0	0	CARFAX PUBL CO	ABINGDON	PO BOX 25, ABINGDON, OXFORDSHIRE, ENGLAND OX14 3UE	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.	APR	1998	12	2					151	155		10.1080/02688699845302			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	ZM366	WOS:000073531300010	11013669				2022-02-06	
J	Watanabe, TK; Black, KL; Zafonte, RD; Millis, SR; Mann, NR				Watanabe, TK; Black, KL; Zafonte, RD; Millis, SR; Mann, NR			Do calendars enhance posttraumatic temporal orientation? a pilot study	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; REALITY ORIENTATION; PSYCHOGERIATRIC PATIENTS; RECOVERY	The purpose of this study was to determine the effectiveness of an in-room calendar to correct temporal disorientation in a brain-injured population. Thirty consecutive brain injured patients (16 traumatic, 14 non-traumatic) admitted to a brain injury rehabilitation unit were randomly assigned to either a group with in-room calendars (n = 14) or a group without calendars (n = 16). A baseline Temporal Orientation Test (TOT) score was obtained. Daily TOT scores were obtained for patients throughout their rehabilitation stay or until two consecutive normal scores were obtained. When orientation errors were made, they were corrected and the attention of the patient was drawn to the calendar. There were no statistically significant associations between group and age, gender or mean GCS (for patients with traumatic etiology). Only baseline length of post-traumatic amnesia (PTA) had a significant association with eventual emergence from PTA (as defined by a normal score on the TOT). Age and presence of calendar were not significant. In-room calendars have been espoused as orientation aides. The data from this pilot study suggest that calendars do not hasten re-orientation. This finding suggests that other widely held but not rigorously tested beliefs regarding cognitive rehabilitation may need to be examined.	Wayne State Univ, Rehabil Inst Michigan, Detroit, MI 48201 USA		Black, KL (corresponding author), Wayne State Univ, Rehabil Inst Michigan, 261 Mack Blvd, Detroit, MI 48201 USA.						Benton A.L., 1983, CONTRIBUTIONS NEUROP; BROOK P, 1975, BRIT J PSYCHIAT, V127, P42, DOI 10.1192/bjp.127.1.42; CORRIGAN JD, 1985, ARCH PHYS MED REHAB, V66, P626; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; GREENE JG, 1979, BEHAV RES THER, V17, P615, DOI 10.1016/0005-7967(79)90106-2; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; KASCHEL R, 1995, BRAIN INJURY, V9, P619, DOI 10.3109/02699059509008220; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Levin HS., 1982, NEUROBEHAVIORAL CONS; LINCOLN NB, 1988, BRIT J OCCUPATIONAL, V51, P195; MCNENY R, 1989, REHABILITATION ADULT, P366; NEVILLE A, 1980, AM J OCCUP THER, V34, P328, DOI 10.5014/ajot.34.5.328; ZAFONTE RD, IN PRESS ARCH PHYSIC	14	13	15	1	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	1998	12	1					81	85					5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	YT347	WOS:000071592500009	9483341				2022-02-06	
J	Zencius, AH; Wesolowski, MD; Rodriguez, IM				Zencius, AH; Wesolowski, MD; Rodriguez, IM			Improving orientation in head injured adults by repeated practice, multi-sensory input and peer participation	BRAIN INJURY			English	Article							CONFABULATION	The efficacy of using antecedent control procedures (practice, multi-sensory input and peer participation) in facilitating orientation to person, place and time with two survivors of traumatic brain injuries were tested in two studies. In the first investigation, a 23-year-old male was treated by presenting the orientation questions orally while being shown questions on written flashcards. Results suggest that correct responses to orientation questions only occurred when flashcards were coupled with oral questioning. The participant responded correctly to nearly 100% of all orientation questions within 2 weeks of initiating flashcards. In the second study, a 19-year-old male was asked to respond in writing to 20 orientation questions in a small group. The group had a leader and 4 TBI patients. Following this, group members who correctly answered the orientation questions, took turns reading orientation questions and providing the correct responses.	Premier Chicago Rehabil Ctr, Downer Grove, IL USA; Florida Dept Children & Families, Miami, FL USA; Florida Int Univ, Miami, FL 33199 USA		Wesolowski, MD (corresponding author), 401 NW 2 Ave,Room N826, Miami, FL 33128 USA.						Arnie Zencius, 1991, BEHAV RESIDENTIAL TR, V6, P1, DOI DOI 10.1002/BIN.2360060102; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; KAPUR N, 1980, J NEUROL NEUROSUR PS, V43, P461, DOI 10.1136/jnnp.43.5.461; KLEMENT JJ, 1973, LEARNING ED TECHNOLO, V10, P65; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LIN CS, 1979, B ED PSYCHOL, V12, P115; LUCHOW JP, 1981, LEARN DISABILITY Q, V4, P38, DOI 10.2307/1510711; MAGOON RA, 1977, CONTEMP EDUC PSYCHOL, V12, P55; MERCER B, 1977, ARCH NEUROL-CHICAGO, V34, P429, DOI 10.1001/archneur.1977.00500190063009; SHAPIRO BE, 1981, NEUROLOGY, V31, P1070, DOI 10.1212/WNL.31.9.1070; SISLER G, 1975, CAN PSYCHIAT ASSOC J, V20, P333, DOI 10.1177/070674377502000502; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; STUSS DT, 1978, NEUROLOGY, V28, P1166, DOI 10.1212/WNL.28.11.1166; Wesolowski M.D., 1993, PRACTICAL GUIDE HEAD; ZENCIUS A, 1991, Brain Injury, V5, P321, DOI 10.3109/02699059109008102; ZENCIUS A, 1990, Brain Injury, V4, P33, DOI 10.3109/02699059009026146; Zencius A H, 1989, Brain Inj, V3, P199, DOI 10.3109/02699058909004553; ZENCIUS AH, 1991, BRAIN INJURY, V5, P288	19	13	13	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	1998	12	1					53	61		10.1080/026990598122854			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	YT347	WOS:000071592500005	9483337				2022-02-06	
J	Jaffe, MS; Dijkers, MP; Zametis, M				Jaffe, MS; Dijkers, MP; Zametis, M			A population-based survey of in-line skaters' injuries and skating practices	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article								Objective: To describe in-line skating interests and practices, protective gear usage, and injury patterns in a population-based group of in-line skaters. Design: A two-page questionnaire with multiple choice questions and one write-in response question. Participants: The survey was sent to 1,000 members of an in-line skating club in Detroit, MI and 45 other states. Main Outcome Measures: The study was designed to profile skater injury patterns. The effects of protective gear and skater lessons on injury were examined. Results: Of the 435 skaters returning questionnaires, 56.7% were men. The mean age was 35 years. The frequency of inline skating lessons was 31.7%. Of respondents, 72.5% wear some kind of protective gear while skating, and 79.8% reported that they had been injured while skating. Of those who had skated for 5 or more years, 93.7% had been injured. Upper extremity injuries were reported by 58.8% of skaters and lower extremity injuries by 66.7%. The majority suffered abrasions and bruises only. More serious injuries were reported by very few skaters: fractures by 5.5% and concussions by 2.1%. Only 3% of respondents required orthopedic surgery. Conclusion: Lessons and protective gear decrease the risk of injury. However, risk of incurring minor injury exists even if full protective gear is used. Those who have skated for more than 5 years are almost certain to report having been injured. (C) 1997 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	INST REHABIL,DETROIT,MI					Dijkers, Marcel/0000-0002-8362-5596			*AM SPORTS DAT, 1995, AM SPROTS AN REP; CALLE SC, 1993, J TRAUMA, V35, P946, DOI 10.1097/00005373-199312000-00024; FEDEL FJ, 1995, MED SCI SPORT EXER, V27, P682; SCHIEBER RA, 1994, JAMA-J AM MED ASSOC, V271, P1856, DOI 10.1001/jama.271.23.1856; *US CONS PROD SAF, 1993, NAT EL INJ SURV SYST	5	13	13	0	4	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	1997	78	12					1352	1357		10.1016/S0003-9993(97)90309-9			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	YK894	WOS:A1997YK89400012	9421990				2022-02-06	
J	Pike, BR; Hamm, RJ; Temple, MD; Buck, DL; Lyeth, BG				Pike, BR; Hamm, RJ; Temple, MD; Buck, DL; Lyeth, BG			Effect of tetrahydroaminoacridine, a cholinesterase inhibitor, on cognitive performance following experimental brain injury	JOURNAL OF NEUROTRAUMA			English	Article						cholinergic; cholinesterase; Morris water maze; muscarinic; rats; tacrine (THA); traumatic brain injury; treatment	CLOSED-HEAD-INJURY; MUSCARINIC RECEPTOR SUBTYPES; FLUID-PERCUSSION INJURY; EXCITATORY AMINO-ACIDS; ALZHEIMERS-DISEASE; CHOLINERGIC MODULATION; CONTROLLED TRIAL; SENILE DEMENTIA; TIME-COURSE; RATS	An emerging literature exists in support of deficits in cholinergic neurotransmission days to weeks following experimental traumatic brain injury (TBI). In addition, novel cholinomimetic therapeutics have been demonstrated to improve cognitive outcome following TBI in rats. We examined the effects of repeated postinjury administration of a cholinesterase inhibitor, tetrahydroaminoacridine (THA), on cognitive performance following experimental TBI. Rats were either injured at a moderate level of central fluid percussion TBI (2.1 +/- 0.1 atm) or were surgically prepared but not delivered a fluid pulse (sham injury). Beginning 24 h after TBI or sham injury, rats were injected (IF) daily for 15 days with an equal volume (1.0 ml/kg) of either 0.0, 1.0, 3.0, or 9.0 mg/kg THA (TBI: n = 8, 8, 10, and 7, respectively, and Sham: n = 5, 7, 8, 7, respectively). Cognitive performance was assessed on Days 11-15 after injury in a Morris water maze (MWM). Analysis of maze latencies over days indicated that chronic administration of THA produced a dose-related impairment in MWM performance in both the injured and sham groups, with the 9.0 mg/kg dose producing the largest deficit. The 1.0 and 3.0 mg/kg doses of THA impaired MWM performance without affecting swimming speeds. Thus, the results of this investigation do not support the use of THA as a cholinomimetic therapeutic for the treatment of cognitive deficits following TBI.	Virginia Commonwealth Univ, Med Coll Virginia, Dept Psychol, Richmond, VA 23284 USA; Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23284 USA		Hamm, RJ (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Psychol, Box 842018,808 W Franklin St, Richmond, VA 23284 USA.			Lyeth, Bruce/0000-0003-4811-1474	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 12587] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587] Funding Source: NIH RePORTER		ALBIN RL, 1988, NEUROSCI LETT, V88, P303, DOI 10.1016/0304-3940(88)90228-5; ALONSO R, 1990, NEUROCHEM INT, V17, P457, DOI 10.1016/0197-0186(90)90028-R; BECKER RE, 1988, DRUG DEVELOP RES, V12, P163, DOI 10.1002/ddr.430120302; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; BUYUKUYSAL RL, 1989, BRAIN RES, V482, P371; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; CHOU C-L, 1991, Society for Neuroscience Abstracts, V17, P722; DAVIS KL, 1992, NEW ENGL J MED, V327, P1253, DOI 10.1056/NEJM199210293271801; DEWITT DS, 1988, ANESTHESIOLOGY REV, V15, P31; Dixon C. E., 1995, Society for Neuroscience Abstracts, V21, P762; DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; DIXON CE, 1995, NEUROSCI LETT, V198, P111, DOI 10.1016/0304-3940(95)11979-7; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DOODS H, 1993, EUR J PHARMACOL, V242, P23, DOI 10.1016/0014-2999(93)90005-3; Doods Henri N., 1995, Drugs of the Future, V20, P157; DOODS HN, 1993, LIFE SCI, V52, P497, DOI 10.1016/0024-3205(93)90307-O; EAGGER S, 1992, BRIT J PSYCHIAT, V160, P36, DOI 10.1192/bjp.160.1.36; ENZ A, 1993, PROG BRAIN RES, V98, P431; FARLOW M, 1992, JAMA-J AM MED ASSOC, V268, P2523, DOI 10.1001/jama.268.18.2523; FLOOD JF, 1981, BRAIN RES, V215, P177, DOI 10.1016/0006-8993(81)90500-X; FLYNN DD, 1989, J PHARMACOL EXP THER, V250, P573; FORTUNA S, 1994, NEUROTOXICOLOGY, V15, P735; GAITHER S, 1991, CAN J NEUROL SCI, V18, P439; GAITHIER S, 1990, NEW ENGL J MED, V322, P1272; Grady M. S., 1992, Society for Neuroscience Abstracts, V18, P172; GRAY JA, 1989, TRENDS PHARM SCI S, V10, P85; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HAMM RJ, 1994, J NEUROSURG, V81, P267, DOI 10.3171/jns.1994.81.2.0267; HAROUTUNIAN V, 1985, PSYCHOPHARMACOLOGY, V87, P266, DOI 10.1007/BF00432705; HODGES H, 1990, PHARMACOL BIOCHEM BE, V36, P291, DOI 10.1016/0091-3057(90)90406-8; KIEFERDAY JS, 1992, PHARMACOLOGY, V44, P71, DOI 10.1159/000138875; KNAPP MJ, 1994, JAMA-J AM MED ASSOC, V271, P985, DOI 10.1001/jama.271.13.985; KWOONYUEN PF, 1990, EXP NEUROL, V108, P221, DOI 10.1016/0014-4886(90)90126-D; LEONARD JR, 1994, J NEUROTRAUM, V11, P379, DOI 10.1089/neu.1994.11.379; LEVIN HS, 1992, J NEUROTRAUM, V9, pS359; Liu S. J., 1993, Society for Neuroscience Abstracts, V19, P1881; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MARCHI M, 1989, J PHARMACOL EXP THER, V248, P1255; MOLLOY DW, 1991, CAN MED ASSOC J, V144, P29; Moltzen Ejner K., 1995, Drugs of the Future, V20, P37; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; MRZLJAK L, 1993, P NATL ACAD SCI USA, V90, P5194, DOI 10.1073/pnas.90.11.5194; NIELSEN JA, 1989, EUR J PHARMACOL, V173, P53, DOI 10.1016/0014-2999(89)90008-3; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODELL DM, 1995, J NEUROSURG, V83, P878, DOI 10.3171/jns.1995.83.5.0878; Pierce J. E. S., 1994, Society for Neuroscience Abstracts, V20, P196; PIERCE JES, 1993, BRAIN RES, V624, P199, DOI 10.1016/0006-8993(93)90078-2; Pike BR, 1997, PHARMACOL BIOCHEM BE, V57, P785, DOI 10.1016/S0091-3057(96)00453-4; PIKE BR, 1995, BRAIN RES, V686, P37, DOI 10.1016/0006-8993(95)00448-Y; PINTOR A, 1994, NEUROCHEM RES, V19, P1311, DOI 10.1007/BF01006823; POTTER LT, 1984, TRENDS PHARM SCI S, V5, P22; RICHARDS MH, 1990, BRIT J PHARMACOL, V99, P753, DOI 10.1111/j.1476-5381.1990.tb13002.x; RIEKKINEN P, 1991, PHYSIOL BEHAV, V49, P1147, DOI 10.1016/0031-9384(91)90342-L; RIEKKINEN P, 1990, PHARMACOL BIOCHEM BE, V36, P237, DOI 10.1016/0091-3057(90)90397-Z; SANTUCCI AC, 1989, PSYCHOPHARMACOLOGY, V99, P70, DOI 10.1007/BF00634455; SARTER M, 1990, PSYCHOPHARMACOLOGY, V101, P1, DOI 10.1007/BF02253710; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; SCHMITTEREDGECOMBE ME, 1992, J CLIN EXP NEUROPSYC, V14, P717, DOI 10.1080/01688639208402858; Sinson G., 1995, Society for Neuroscience Abstracts, V21, P2121; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SUMMERS WK, 1986, NEW ENGL J MED, V315, P1241, DOI 10.1056/NEJM198611133152001; Temple MD, 1996, BRAIN RES, V741, P246, DOI 10.1016/S0006-8993(96)00940-7; UEKI A, 1989, J NEUROL SCI, V90, P775; VILARO MT, 1992, NEUROSCIENCE, V47, P367, DOI 10.1016/0306-4522(92)90253-X; VIZI ES, 1989, NEUROSCIENCE, V31, P259, DOI 10.1016/0306-4522(89)90048-1; WHITEHOUSE PJ, 1988, NEUROLOGY, V38, P307, DOI 10.1212/WNL.38.2.307; WLKER TM, 1995, HUM EXP TOXICOL, V14, P469	71	13	13	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	1997	14	12					897	905		10.1089/neu.1997.14.897			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	YU127	WOS:000071685000002	9475371				2022-02-06	
J	McAllister, TW				McAllister, TW			Evaluation of brain injury related behavioral disturbances in community mental health centers	COMMUNITY MENTAL HEALTH JOURNAL			English	Article							CLOSED-HEAD-INJURY; RIGHT-HEMISPHERE; DEPRESSION; MANIA; MILD; TRAUMA; DISORDER; SEQUELAE; DIAGNOSIS; DEFICITS	As a result of improved emergency trauma services, more individuals suffering a traumatic brain injury are surviving. Unfortunately, most of these survivors suffer chronic neuropsychiatric sequelae related to both the brain damage and the psychosocial impact of the injury on self-esteem, self-image, primary role, and vocational function. Current community supports are often inadequate to deal with the complex array of neurologic and psychiatric difficulties. This article outlines common features of brain injury, explores the link between these features and the common neuropsychiatric sequelae of brain injury, and suggests some principles helpful in the evaluation of the behaviorally challenged brain injured patient.	DARTMOUTH COLL SCH MED, HANOVER, NH USA								ADAMS RD, 1985, PRINCIPLES NEUROLOGY; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; AUERBACH SH, 1989, PHYSICAL MED REHABIL, V3, P1; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BRACKEN P, 1987, BRIT J PSYCHIAT, V150, P690, DOI 10.1192/bjp.150.5.690; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; BURKE J M, 1990, Brain Injury, V4, P223, DOI 10.3109/02699059009026171; Burke J M, 1989, Brain Inj, V3, P35, DOI 10.3109/02699058909008071; COPE DN, 1987, J HEAD TRAUMA REHAB, V2, P1; Cripe LI, 1987, COGNITIVE REHABILITA, V5, P18; Cummings J, 1985, CLIN NEUROPSYCHIATRY; DAVIS DL, 1990, J HEAD TRAUMA REHAB, V5, P31, DOI DOI 10.1097/00001199-199005020-00006; Davison K, 1969, BRIT J PSYCHIATRY SP, V4, P113; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; FREEDMAN PE, 1987, J NEUROL NEUROSUR PS, V50, P398, DOI 10.1136/jnnp.50.4.398; GAULTIERI CT, 1988, BRAIN INJURY, V2, P101; Gaultieri T, 1991, BRAIN INJURY, V5, P219; Gennarelli T. A., 1987, HEAD INJURY, P108; GENTILINI M, 1989, MILD HEAD INJURY, P163; GRAHAM DI, 1987, HEAD INJURY; GREEN RL, 1987, AM J PSYCHIAT, V144, P442; Gronwall D, 1989, MILD HEAD INJURY, P153; HALE MS, 1982, J NERV MENT DIS, V170, P362, DOI 10.1097/00005053-198206000-00006; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; HOOPER R S, 1945, J Ment Sci, V91, P458; Horn LJ, 1990, J HEAD TRAUMA REHAB, V5, P1; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; KRAUS JF, 1987, HEAD INJURY; KWENTUS JA, 1985, PSYCHOSOMATICS, V26, P8, DOI 10.1016/S0033-3182(85)72900-3; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEVIN HS, 1987, HEAD INJURY; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MCALLISTER TW, 1992, COMPR PSYCHIAT, V33, P296, DOI 10.1016/0010-440X(92)90036-P; MCALLISTER TW, 1987, COMPR PSYCHIAT, V28, P14, DOI 10.1016/0010-440X(87)90039-3; MCALLISTER TW, 1994, PSYCHIAT ASPECTS TRA; MCALLISTER TW, 1990, DEPRESSION NEW DIREC; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MCMILLAN TM, 1987, J NEUROL NEUROSUR PS, V50, P393, DOI 10.1136/jnnp.50.4.393; MEYER A, 1974, BRAIN, V97, P565, DOI 10.1093/brain/97.1.565; MONRADKROHN GH, 1947, BRAIN, V70, P405, DOI 10.1093/brain/70.4.405; NASRALLAH HA, 1981, PSYCHOSOMATICS, V22, P359; NIZAMIE SH, 1988, ACTA PSYCHIAT SCAND, V77, P637, DOI 10.1111/j.1600-0447.1988.tb05181.x; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; POPE HG, 1988, COMPR PSYCHIAT, V29, P34, DOI 10.1016/0010-440X(88)90035-1; RIESS H, 1987, J CLIN PSYCHIAT, V48, P29; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Robinson R G, 1990, J Neuropsychiatry Clin Neurosci, V2, P1; ROBINSON RG, 1988, AM J PSYCHIAT, V145, P172; ROSS ED, 1979, ARCH NEUROL-CHICAGO, V36, P144, DOI 10.1001/archneur.1979.00500390062006; ROSS ED, 1981, ARCH GEN PSYCHIAT, V38, P1344; Ruff R. M., 1989, MILD HEAD INJURY, P176; Rutherford W. H., 1989, MILD HEAD INJURY, P217; SARAN AS, 1985, J CLIN PSYCHIAT, V46, P335; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; Sorenson SB, 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [10.1097/00001199-199106000-00003, DOI 10.1097/00001199-199106000-00003]; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; STARKSTEIN SE, 1990, ANN NEUROL, V27, P652, DOI 10.1002/ana.410270612; STARKSTEIN SE, 1988, J NERV MENT DIS, V176, P87, DOI 10.1097/00005053-198802000-00004; STEWART JT, 1988, J CLIN PSYCHIAT, V49, P74; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; TEASDALE G, 1974, LANCET, V2, P81; Trimble M R, 1991, Adv Neurol, V55, P143; TRIMBLE MR, 1982, TEMPORAL LOBE EPILEP; TYERMAN A, 1984, INT J REHABIL RES, V7, P11, DOI 10.1097/00004356-198403000-00002; *US DEP HHS, 1989, DEP HLTH HUM SERV IN; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WEINTRAUB S, 1981, ARCH NEUROL-CHICAGO, V38, P742, DOI 10.1001/archneur.1981.00510120042004; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILSON J T L, 1990, Brain Injury, V4, P349; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; WOOD RL, 1989, TRAUMATIC BRAIN INJU, V3; ZASLER ND, 1990, J HEAD TRAUMA REHAB, V5, P14, DOI DOI 10.1097/00001199-199005020-00004; ZWIL AS, 1992, INT J PSYCHIAT MED, V22, P377, DOI 10.2190/J71J-FTML-JY1E-RKKG; ZWIL AS, 1993, BRAIN INJURY, V7, P147, DOI 10.3109/02699059309008168; [No title captured]	95	13	13	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0010-3853	1573-2789		COMMUNITY MENT HLT J	Community Ment. Health J.	AUG	1997	33	4					341	358		10.1023/A:1025055426260			18	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	XK755	WOS:A1997XK75500009	9250431				2022-02-06	
J	Prielipp, RC; Robinson, JC; Wilson, JA; MacGregor, DA; Scuderi, PE				Prielipp, RC; Robinson, JC; Wilson, JA; MacGregor, DA; Scuderi, PE			Dose response, recovery, and cost of doxacurium as a continuous infusion in neurosurgical intensive care unit patients	CRITICAL CARE MEDICINE			English	Article						doxacurium; drug cost; drug therapy; intensive care unit; intracranial pressure; muscle relaxants; neuromuscular blocking drugs; neurosurgery; paralytic agents	NEUROMUSCULAR BLOCKING-DRUGS; CRITICALLY ILL PATIENTS; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; PROLONGED PARALYSIS; NITROUS-OXIDE; VECURONIUM; BLOCKADE; ATRACURIUM; CHLORIDE	Objectives: To determine the optimal dosing of doxacurium as a continuous infusion in neurosurgical patients with traumatic brain injury; to determine the effects of bolus administration of doxacurium on heart rate (HR), blood pressure (BP), and intracranial pressure (ICP); to monitor neuromuscular recovery after discontinuation of prolonged doxacurium infusion; and to compare the cost of doxacurium with other current neuromuscular blocking drugs. Design: Prospective, open-label study. Setting: Neurosurgical intensive care unit (ICU) of a university-affiliated teaching hospital. Patients: Eight critically ill, mechanically ventilated patients with traumatic head injury and normal renal and hepatic function. Patients had ICP monitoring. Interventions: A bolus injection of doxacurium (0.05 mg/kg) followed by a continuous infusion (0.015 mg/kg/hr), adjusted to maintain one twitch during Train-of-Four nerve stimulation of the adductor pollicis muscle. Measurements and Main Results: Bolus injections of doxacurium did not alter the HR, BP, or ICP. Patients were paralyzed 66 +/- 12 (SEM) hrs, with recovery of the fourth twitch occurring 118 +/- 19 mins after infusion of the doxacurium was discontined. There were no incidences of prolonged weakness, myopathy, or other adverse events. Conclusions: Continuous infusion of doxacurium provides stable neuromuscular blockade for neurosurgical patients with traumatic brain injury. Doxacurium is devoid of clinically important interactions with HR, BP, or ICP and is less costly than other neuromuscular blockers used in the ICU.	WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT NEUROSURG,WINSTON SALEM,NC; WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT MED,WINSTON SALEM,NC 27103		Prielipp, RC (corresponding author), WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT ANESTHESIOL,SECT CRIT CARE,300 S HAWTHORNE RD,WINSTON SALEM,NC 27103, USA.						BAROHN RJ, 1994, MUSCLE NERVE, V17, P647, DOI 10.1002/mus.880170613; BASTA SJ, 1988, ANESTHESIOLOGY, V69, P478, DOI 10.1097/00000542-198810000-00006; BOLTON CF, 1994, CHEST, V106, P1; COOK DR, 1991, ANESTH ANALG, V72, P145; COURSIN DB, 1995, AM J HEALTH-SYST PH, V52, P635, DOI 10.1093/ajhp/52.6.635; COURSIN DB, 1992, CHEST, V102, P988, DOI 10.1378/chest.102.4.988; Coursin DB, 1993, CURRENT OPINION ANES, V6, P341; DANON MJ, 1991, MUSCLE NERVE, V14, P1131, DOI 10.1002/mus.880141115; DECOUL AAWO, 1985, CLIN NEUROL NEUROSUR, V87, P17, DOI 10.1016/0303-8467(85)90060-5; EMMOTT RS, 1990, BRIT J ANAESTH, V65, P480, DOI 10.1093/bja/65.4.480; ERKOLA O, 1993, ANESTHESIOL CLIN N A, V11, P426; FERNANDO PUE, 1987, ACTA ANAESTH SCAND, V31, P593, DOI 10.1111/j.1399-6576.1987.tb02627.x; HANSENFLASCHEN J, 1993, AM REV RESPIR DIS, V147, P234, DOI 10.1164/ajrccm/147.1.234; HARPER NJN, 1993, INTENS CARE MED, V19, pS80, DOI 10.1007/BF01708806; Hoyt J W, 1994, New Horiz, V2, P48; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; HUNTER JM, 1995, NEW ENGL J MED, V332, P1691, DOI 10.1056/NEJM199506223322507; JENSEN E, 1988, ACTA ANAESTH SCAND, V32, P49, DOI 10.1111/j.1399-6576.1988.tb02687.x; KATZ JA, 1989, ANESTHESIOLOGY, V70, P432, DOI 10.1097/00000542-198903000-00012; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LENNON RL, 1989, ANESTH ANALG, V68, P255; Marik PE, 1996, CRIT CARE MED, V24, P1266, DOI 10.1097/00003246-199607000-00034; MEYER KC, 1994, ANESTH ANALG, V78, P772; MILLER RD, 1995, ANESTH ANALG, V81, P1; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; MURRAY MJ, 1993, INTENS CARE MED, V19, pS40, DOI 10.1007/BF01708799; MURRAY MJ, 1995, CRIT CARE MED, V23, P450, DOI 10.1097/00003246-199503000-00007; Prielipp R C, 1995, New Horiz, V3, P456; PRIELIPP RC, 1995, ANESTH ANALG, V81, P3, DOI 10.1097/00000539-199507000-00002; PRIELIPP RC, 1994, ANESTH ANALG, V78, P775; PROUGH DS, 1994, CRIT CARE MED, V22, P1349; SEGREDO V, 1992, NEW ENGL J MED, V327, P524, DOI 10.1056/NEJM199208203270804; STOOPS CM, 1988, ANESTHESIOLOGY, V69, P365, DOI 10.1097/00000542-198809000-00013; WATLING SM, 1994, CRIT CARE MED, V22, P884, DOI 10.1097/00003246-199405000-00028; WERBA A, 1993, ANAESTHESIA, V48, P301, DOI 10.1111/j.1365-2044.1993.tb06947.x; WERBA A, 1991, ANAESTHESIST, V40, P328; WILSON JA, 1994, J NEUROSURG ANESTHES, V2, P139	37	13	14	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0090-3493			CRIT CARE MED	Crit. Care Med.	JUL	1997	25	7					1236	1241		10.1097/00003246-199707000-00028			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XL366	WOS:A1997XL36600038	9233753				2022-02-06	
J	Young, CC; Jacobs, BA; Clavette, K; Mark, DH; Guse, CE				Young, CC; Jacobs, BA; Clavette, K; Mark, DH; Guse, CE			Serial sevens: Not the most effective test of mental status in high school athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						mental status testing; concussion evaluation; high school athletes	CONCUSSION	Objective: To evaluate the ability of uninjured high school athletes to pass three mental status tests that are commonly used on the sidelines for the evaluation of concussions: the serial sevens test, the serial threes test, and recitation of months of year in reverse order (MOYR). Participants: High school student athletes in grades 9, 10, 11, and 12 having sports preparticipation physical examinations. The initial study tested 522 consecutive athletes. The follow-up study tested 109 consecutive athletes. Intervention: The athletes of the initial group were asked to perform a serial sevens test, followed by a serial threes test, and finally to recite the MOYR. The second group was asked to perform the same tests in a random order. Main Outcome Measures: Participants were given 1-min time limits for each test, with passing defined as either 7 consecutive correct iterations or 11 correct with one mistake. Results: For the initial group, 51.3% successfully performed serial sevens, 78.7% successfully performed serial threes, and 89.5% successfully recited the MOYR. For the second group, 52.7% successfully performed serial sevens, 78.1% success fully performed serial threes, and 88.9% successfully recited the MOYR. The pass rates were significantly different for both groups. The pass rates were similar for both sexes, all grade levels, and all sports in both test groups. Participants, both overall and in all subgroups, failed serial sevens more often than serial threes and MOYR (p < 0.001 for the initial group. p < 0.0001 for the second group,. They failed serial threes more often than MOYR (p < 0.001 for the initial group; p < 0.01 for the second group). Conclusions: The percentage of uninjured high school athletes successfully completing serial sevens is too low to make the test useful for evaluation of concussion: the test lacks specificity. The percentage of athletes passing the MOYR was great est, perhaps making this a better sideline test than the traditional serial sevens test. However, resting needs to be done in injured athletes before clinical application can be recommended.	MED COLL WISCONSIN,DEPT COMMUNITY & FAMILY MED,MILWAUKEE,WI 53226; MED COLL WISCONSIN,DIV BIOSTAT,MILWAUKEE,WI 53226		Young, CC (corresponding author), MED COLL WISCONSIN,DEPT ORTHOPAED SURG,9200 W WISCONSIN AVE,POB 26099,MILWAUKEE,WI 53226, USA.						BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; CANTU RC, 1992, PHYSICIAN SPORTSMED, V20, P55, DOI 10.1080/00913847.1992.11947483; CANTU RC, 1988, CLIN SPORT MED, V7, P459; *COL MED SOC SCH S, 1990, GUID MAN CONC SPORTS; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; IRRGNAG J, 1994, SPORTS INJURIES MECH, P349; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; MANNING RT, 1982, ARCH INTERN MED, V142, P1192; MILSTEIN V, 1972, ARCH GEN PSYCHIAT, V26, P439; SMITH A, 1967, ARCH NEUROL-CHICAGO, V17, P78, DOI 10.1001/archneur.1967.00470250082008; TORG JS, 1994, ORTHOPAEDIC SPORTS M, P417	12	13	13	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	1050-642X			CLIN J SPORT MED	Clin. J. Sport Med.	JUL	1997	7	3					196	198		10.1097/00042752-199707000-00008			3	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	XP440	WOS:A1997XP44000008	9262887				2022-02-06	
J	Crepeau, F; Scherzer, BP; Belleville, S; Desmarais, G				Crepeau, F; Scherzer, BP; Belleville, S; Desmarais, G			A qualitative analysis of central executive disorders in a real-life work situation	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							FRONTAL-LOBE DAMAGE; HEAD-INJURY; TEST-PERFORMANCE; DEFICITS	This paper addresses the problem of understanding the performance of an individual with traumatic brain injury (TBI) in a real-life work situation. The approach is based on a four-component problem-solving model: analysis, formulation of a solution, planning, and monitoring. Four target and control tests were selected to measure performance of each component and their underlying cognitive processes. Participants were seven adults with severe TBI and seven paired normal controls. Performances on neuropsychological tests were compared with those on four corresponding work tasks on a photocopy machine. Performance of the control group was superior to that of the TBI group on the tests and tasks. Inter-individual comparisons on work tasks revealed various patterns of deficits, suggesting the partial independence of problem-solving components. Specific associations between tests and photocopy tasks were not as predicted. Some alternative explanations raised by qualitative observations are discussed.	CTR HOSP COTE DES NEIGES, CTR RECH, MONTREAL, PQ H3W 1W5, CANADA; UNIV MONTREAL, DEPT PSYCHOL, MONTREAL, PQ H3C 3J7, CANADA; UNIV QUEBEC, DEPT PSYCHOL, MONTREAL, PQ H3C 3P8, CANADA								AINSLEY J, 1989, COGNITIVE REHABI NOV, P28; ANDERSON SW, 1991, J CLIN EXP NEUROPSYC, V13, P909, DOI 10.1080/01688639108405107; BAYLESS JD, 1989, J CLIN EXP NEUROPSYC, V11, P913, DOI 10.1080/01688638908400944; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Benson D.F., 1986, FRONTAL LOBES; BENYISHAY Y, 1983, REHABILITATION HEAD; BUTLER RW, 1989, CLIN NEUROPSYCHOL, V3, P235; CHRISTENSEN AL, 1989, NEUROPSYCHOLOGICAL T; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; GOLDSTEIN FC, 1987, NEUROPSYCHOL REHABIL, P327; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Kaplan E.F., 1978, BOSTON NAMING TEST; LACROIX J, 1991, EMPLOYMENT IMMIGRATI; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; LHERMITTE F, 1972, REV NEUROL-FRANCE, V127, P415; LURIA AR, 1967, TROUBLES RESOLUTION; MATHESON LN, 1982, UNPUB WORK CAPACITY; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MELAMED S, 1985, SCAND J REHABIL MED, P21; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; Najenson T, 1980, Int Rehabil Med, V2, P17; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; NORMAN DA, 1986, CONSCIOUSNESS SELF R, V0004; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; SERON X, 1991, SCHWEIZ Z PSYCHOL, V50, P186; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shallice T., 1991, FRONTAL LOBE FUNCTIO; Shallice T., 1988, NEUROPSYCHOLOGY MENT; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; STUSS DT, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P157; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VILKKI J, 1988, CORTEX, V24, P119, DOI 10.1016/S0010-9452(88)80020-0; VILKKI J, 1989, NEUROPSYCHOLOGIA, V27, P971, DOI 10.1016/0028-3932(89)90072-9; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; VONCRAMON DY, 1992, NEUROPSYCHOL REHABIL, V2, P207; Wechsler, 1997, WECHSLER ADULT INTEL; WIEGERSMA S, 1990, NEUROPSYCHOLOGIA, V28, P95, DOI 10.1016/0028-3932(90)90089-7; [No title captured]	40	13	13	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	APR	1997	7	2					147	165		10.1080/713755525			19	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	XA640	WOS:A1997XA64000004					2022-02-06	
J	DiTrapani, G; Carnevale, A; Scerrati, M; Colosimo, C; Vaccario, ML; Mei, D				DiTrapani, G; Carnevale, A; Scerrati, M; Colosimo, C; Vaccario, ML; Mei, D			Post-traumatic malignant glioma. Report of a case	ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						brain tumor; head injury; oligodendroglioma	EXPLORATORY CASE-CONTROL; BRAIN-TUMORS	Only a few cases reported in the literature fulfil the currently established criteria for accepting the traumatic origin of some intracranial tumors. A case of post-traumatic glioma is presented. Several years after sustaining a commotive left parietal trauma, our patient developed symptoms of intracranial tumor. Neuroimaging (CT and MRI) show,ed a large neoplasia in the left temporo-parietal-occipital region, and stereotactic biopsy revealed a mixed glioma in continuity with the scar resulting from the trauma.	UNIV CATTOLICA SACRO CUORE,IST NEUROSURG,I-00168 ROME,ITALY; UNIV CATTOLICA SACRO CUORE,IST RADIOL,I-00168 ROME,ITALY								ANNEGERS JF, 1979, NEUROSURGERY, V4, P203, DOI 10.1227/00006123-197903000-00001; BOKER DK, 1991, FORTSCHR NEUROL PSYC, V59, P488, DOI 10.1055/s-2007-1000724; BURCH JD, 1987, J NATL CANCER I, V78, P601; CHOI NW, 1970, AM J EPIDEMIOL, V91, P467, DOI 10.1093/oxfordjournals.aje.a121158; HOCHBERG F, 1984, NEUROLOGY, V34, P1511, DOI 10.1212/WNL.34.11.1511; HOWE GR, 1989, CANCER RES, V49, P4349; Manuelidis EE., 1972, PATHOLOGY NERVOUS SY, V2, P2237; MORANTZ RA, 1978, NEUROSURGERY, V3, P181, DOI 10.1227/00006123-197809000-00009; PEREZDIAZ C, 1985, SURG NEUROL, V24, P581, DOI 10.1016/0090-3019(85)90278-2; POVLISHOCK J, 1980, ADV EXPT MED BIOL, V31, P227; SCHIFFER D, 1991, ACTA NEUROPATHOL, V83, P30, DOI 10.1007/BF00294427; TROOST D, 1984, CLIN NEUROPATHOL, V3, P139; ZULCH KJ, 1953, AERZTL FORSCH, V7, P535	13	13	13	0	2	MASSON DIVISIONE PERIODICI	MILAN	VIA FRATELLI BRESSAN 2, 20126 MILAN, ITALY	0392-0461			ITAL J NEUROL SCI	Ital. J. Neurol. Sci.	AUG	1996	17	4					283	286		10.1007/BF01997787			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VN369	WOS:A1996VN36900004	8915759				2022-02-06	
J	Keenan, MAE; Haider, T				Keenan, MAE; Haider, T			The formation of heterotopic ossification after traumatic brain injury: A biopsy study with ultrastructural analysis	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						calcification; heterotopic ossification; spastic quadriparesis	BONE; HIP	Heterotopic bone with different maturation stages was obtained from seven patients with spasticity secondary to traumatic brain injury. The specimens were studied under light and electron microscopy to determine the nature and sequence of formation of heterotopic ossification (HO). The findings revealed that immature heterotopic bone was made up of well-ordered collagen fibers with speckles of calcification distributed throughout the collagen network. No osteoid was observed in any specimen. Inflammation appears to be a secondary process beginning after the initial stages of calcification. The appearance of osteoblasts and osteoclasts with remodeling of the immature bone occurs as a very late process. These findings provide a new insight into the nature of HO and may influence future treatments.	TEMPLE UNIV, SCH MED, PHILADELPHIA, PA 19122 USA; UNIV COLORADO, DEPT ORTHOPAED SURG, DENVER, CO 80202 USA		Keenan, MAE (corresponding author), ALBERT EINSTEIN MED CTR, DEPT ORTHOPAED SURG, 5501 OLD YORK RD, PHILADELPHIA, PA 19141 USA.		Keenan, Mary Ann/ABB-1551-2020				BLANE CE, 1981, SKELETAL RADIOL, V7, P21, DOI 10.1007/BF00347167; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; CONOR JM, 1983, SOFT TISSUE OSSIFICA; COVENTRY MB, 1981, J BONE JOINT SURG AM, V63, P201, DOI 10.2106/00004623-198163020-00004; FREED JH, 1982, PARAPLEGIA, V20, P208, DOI 10.1038/sc.1982.39; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1988, CLIN ORTHOP RELAT R, V233, P86; HURVITZ EA, 1992, ARCH PHYS MED REHAB, V73, P459; ILIZAROV GA, 1989, CLIN ORTHOP RELAT R, P249, DOI 10.1097/00003086-198901000-00038; ILIZAROV GA, 1989, CLIN ORTHOP RELAT R, P263; ORZEL JA, 1985, J NUCL MED, V26, P125; REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601; REDDI AH, 1976, J CELL BIOL, V69, P557, DOI 10.1083/jcb.69.3.557; RITTER MA, 1977, J BONE JOINT SURG AM, V59, P345, DOI 10.2106/00004623-197759030-00009; RITTER MA, 1985, CLIN ORTHOP RELAT R, V196, P217; SODEMANN B, 1988, CLIN ORTHOP RELAT R, P150; THOMAS BJ, 1985, J BONE JOINT SURG AM, V67A, P400, DOI 10.2106/00004623-198567030-00008; Tsur Atzmon, 1992, Harefuah, V123, P86; URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; URIST MR, 1982, CLIN ORTHOP RELAT R, P219; WHARTON GW, 1975, CLIN ORTHOP RELAT R, P142	23	13	13	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1996	11	4					8	22		10.1097/00001199-199608000-00004			15	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	VA386	WOS:A1996VA38600004					2022-02-06	
J	Kolessar, DJ; Katz, SD; Keenan, MA				Kolessar, DJ; Katz, SD; Keenan, MA			Functional outcome following surgical resection of heterotopic ossification in patients with brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						heterotopic ossification; surgical resection; traumatic brain injury	LONG-TERM COMA; BONE-FORMATION; HEAD-INJURIES; MANAGEMENT	Significant periarticular heterotopic ossification (HO) may occur following traumatic brain injury (TBI). This can result in profound functional loss of motion, disability, and pain. Thirty-three consecutive cases of surgical resection of heterotopic bone were retrospectively reviewed. Twenty-four cases (11 hips, 10 elbows, 3 knees) were suitable for study. Clinical results demonstrated dramatic improvement in motion in all patients. Functional goals were achieved in 83.3% of patients and ambulatory level advancement occurred in 75% of suitable candidates. Subjective satisfaction with functional outcome was 91.3%. The overall radiographic recurrence rate was 23.8%, but only one (4.8%) was considered functionally significant. In summary, surgical excision of periarticular HO following TBI results in a significant improvement in functional range of motion, quality of life, independence, and social integration.	ALBERT EINSTEIN MED CTR, DEPT ORTHOPAED SURG, PHILADELPHIA, PA USA; TEMPLE UNIV, SCH MED, DEPT ORTHOPAED SURG, PHILADELPHIA, PA 19122 USA		Kolessar, DJ (corresponding author), GEISINGER WYOMING VALLEY HOSP, GEISINGER MED GRP, DEPT SURG, 1000 E MT DR, WILKES BARRE, PA 18711 USA.		Keenan, Mary Ann/ABB-1551-2020				BINDER SM, 1990, J BONE JOINT SURG AM, V72, P1144; BONTKE CB, 1988, J HEAD TRAUMA REHAB, V3, P86; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; COHEN RB, 1993, J BONE JOINT SURG AM, V75A, P215, DOI 10.2106/00004623-199302000-00008; CONNOR JM, 1982, J BONE JOINT SURG BR, V64, P76, DOI 10.1302/0301-620X.64B1.7068725; COVENTRY MB, 1981, J BONE JOINT SURG AM, V63, P201, DOI 10.2106/00004623-198163020-00004; FREED JH, 1982, PARAPLEGIA, V20, P208, DOI 10.1038/sc.1982.39; GARLAND DE, 1978, CLIN ORTHOP RELAT R, P111; GARLAND DE, 1983, PHYS THER, V63, P2004, DOI 10.1093/ptj/63.12.2004; GARLAND DE, 1984, ARCH PHYS MED REHAB, V65, P531; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P59; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P133; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; GARLAND DE, 1993, PHYS MED REHABIL STA, V7, P611; Gennarelli T A, 1988, Brain Inj, V2, P175, DOI 10.3109/02699058809150942; HAIDER T, 1990, T ORTHOP RES SOC, V14, P309; HUNTER T, 1980, RHEUMATOL REHABIL, V19, P97, DOI 10.1093/rheumatology/19.2.97; KAPLAN FS, 1993, J BONE JOINT SURG AM, V75A, P220, DOI 10.2106/00004623-199302000-00009; LARSON JM, 1981, RHEUMATOL REHABIL, V20, P193, DOI 10.1093/rheumatology/20.4.193; MENDELSON L, 1975, SCAND J REHABIL MED, V7, P141; MIELANTS H, 1975, ACTA ORTHOP SCAND, V46, P190, DOI 10.3109/17453677508989207; MINAIRE P, 1980, ARCH PHYS MED REHAB, V61, P214; MITAL MA, 1987, J PEDIATR ORTHOPED, V7, P83, DOI 10.1097/01241398-198701000-00017; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; Pittenger D E, 1991, Orthop Rev, V20, P33; ROBERTS JB, 1979, J BONE JOINT SURG AM, V61, P760, DOI 10.2106/00004623-197961050-00018; Rogers R C, 1988, Brain Inj, V2, P169, DOI 10.3109/02699058809150941; SAZBON L, 1981, J BONE JOINT SURG BR, V63, P120, DOI 10.1302/0301-620X.63B1.7204466; SCHMIDT SA, 1988, J BONE JOINT SURG AM, V70A, P834, DOI 10.2106/00004623-198870060-00005; SPIELMAN G, 1983, ARCH PHYS MED REHAB, V64, P539; STOVER SL, 1991, CLIN ORTHOP RELAT R, P71; STOVER SL, 1986, MANAGEMENT SPINAL CO; VARGHESE G, 1992, PHYS MED REH CLIN N, V3, P407; WEISS S, 1979, J RHEUMATOL, V6, P88; WENNER SM, 1986, CLIN ORTHOP RELAT R, P231	37	13	14	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	AUG	1996	11	4					78	87		10.1097/00001199-199608000-00010			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	VA386	WOS:A1996VA38600010					2022-02-06	
J	Keller, T; Chappell, T				Keller, T; Chappell, T			The rise and fall of Erichsen's disease (railroad spine)	SPINE			English	Article						Erichsen's disease; spinal concussion; traumatic neurosis		The railroad represented one of the major technologic achievements of the 19th century. Sadly, railroad collisions, which resulted in major injuries, and loss of life, began to tarnish the image of this popular mode of transportation. Public alarm about rail travel intensified in 1866, when notes British surgeion John Eric Erichsen described a peculiar progressive spinal disorder, similar to spinal concussion, that was a sequela to railroad accident or injury. The history of this disorder, which came to be known as ''railroad spine'' or ''Erichsen's disease,'' represents a little known yet important chapter in the evolution of the modern comprehension of functional illness that can complicate or even replace an initial substrate of organic disease.			Keller, T (corresponding author), UNIV CALIF DAVIS E BAY,DIV NEUROSURG,DEPT SURG,PACIFIC NEUROSCI INST,1411 E 31ST ST,OAKLAND,CA 94602, USA.						Beard GM, 1869, BOSTON MED SURG J, V80, P217; BUZZARD T, 1867, LANCET, V1, P389; CAPLAN EM, 1995, B HIST MED, V69, P387; CHARCOT JM, 1895, LECONS MALADIES SYST, V3, P344; CLEVENGER SV, 1989, SPINAL CONCUSSION SU; ERB WH, 1878, CYCLOPEDIA PRACTICE, P344; Erichsen, 1866, RAILWAY OTHER INJURI; ERICHSEN JE, 1896, BRIT MED J, V2, P885; ERICHSEN JE, 1894, TEXAS SANITARIAN, V3, P448; GOETZ CG, 1995, CHARCOTS MAJOR NEURO, P99; HAMILTON AM, 1894, RAILWAY OTHER ACCIDE, P15; LEYDEN E, 1875, KLINIK RUCKENMARKS K, V3, P84; LIDELL JA, 1864, AM J MED SCI, V48, P305; Mitchell SW, 1908, J AMER MED ASSOC, V50, P2033; PAGE H, 1885, INJURIES SPINE SPINA, P14; PHILLIPS L, 1905, YONDER COMES TRAIN, P30; POWER D, 1930, JE ERICHSEN PLARRS L, V1, P378; RONTGEN K, 1895, SITZBER PHYSICK MED, V137, P132; SPARHAWK CW, 1887, BOSTON MED SURG J, V116, P477; Walton G. L., 1881, BOSTON MED SURG J, V109, P337, DOI 10.1056/NEJM188310111091501; 1862, LANCET, V1, P79	21	13	13	0	2	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0362-2436			SPINE	SPINE	JUL 1	1996	21	13					1597	1601		10.1097/00007632-199607010-00022			5	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	UV647	WOS:A1996UV64700022	8817791				2022-02-06	
J	Sessa, S; Lascombes, P; Prevot, J; Gagneux, E				Sessa, S; Lascombes, P; Prevot, J; Gagneux, E			Fractures of the radial head and associated elbow injuries in children	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						associated injuries; children; closed intramedullary pinning; radial head fracture; treatment	NECK FRACTURES	Fractures of the radial head are frequently associated with elbow injuries in children. Thirty-seven patients with this association treated at the Nancy Children's Hospital were analyzed to ascertain the mechanism and the unfavorable factors of prognosis. The mechanism responsible was a valgus strain on the elbow at the moment of impact, associated with forces of compression and distraction. At an average follow-up of 2 years, 76% excellent and good results were obtained. Conservative treatment was always effective in minimally displaced fractures. With surgical reduction by closed intramedullary pinning (CIMP), there were only three failures in severely displaced fractures. With open reduction, results were always poor; 88% patients with fair and poor results had an associated fracture of the olecranon. The unfavorable prognostic factors were the severity of the initial tilting and displacement, the presence of associated elbow injuries, the inadequacy of reduction, and the open reduction procedure.	HOP ENFANTS,DEPT PEDIAT ORTHOPED,F-54511 VANDOEUVRE NANCY,FRANCE				Sessa, Sergio/AAA-7655-2020				DSOUZA S, 1993, J PEDIATR ORTHOPED, V13, P233; FOWLES JV, 1986, J PEDIATR ORTHOPED, V6, P51; HENRIKSON B, 1969, ACTA ORTHOP SCAND, V40, P246, DOI 10.3109/17453676908989505; Jeffery C C, 1972, J Bone Joint Surg Br, V54, P717; JEFFERY CC, 1950, J BONE JOINT SURG BR, V32, P314, DOI 10.1302/0301-620X.32B3.314; JONES E R L, 1971, Journal of Bone and Joint Surgery British Volume, V53, P429; JUDET R, 1962, ANN CHIR, V16, P1377; KOLHER R, 1991, REV CHIR ORTHOP S1, V77, P140; LINDHAM S, 1979, ACTA ORTHOP SCAND, V50, P79, DOI 10.3109/17453677909024093; MARION J, 1962, REV CHIR ORTHOP, V48, P333; MCBRIDE ED, 1960, CLIN ORTHOP RELAT R, V16, P264; METAIZEAU JP, 1980, REV CHIR ORTHOP, V66, P47; METAIZEAU JP, 1993, J PEDIATR ORTHOPED, V13, P355, DOI 10.1097/01241398-199305000-00015; METAIZEAU JP, 1990, FRACTURES MEMBRES CH, P233; NEWMAN JH, 1977, INJURY, V9, P114, DOI 10.1016/0020-1383(77)90004-3; Pennecot G F, 1987, Rev Chir Orthop Reparatrice Appar Mot, V73, P473; REIDY JA, 1963, J BONE JOINT SURG AM, V45, P1355, DOI 10.2106/00004623-196345070-00002; SALTER RB, 1963, J BONE JOINT SURG AM, V45, P587, DOI 10.2106/00004623-196345030-00019; TACHDJIAN MO, 1990, PEDIAT ORTHOPAEDICS, V4, P3137; THEODOROU S D, 1969, Journal of Bone and Joint Surgery British Volume, V51, P700; TIBONE JE, 1981, J BONE JOINT SURG AM, V63, P90; WILKINS KE, 1984, FRACTURES CHILDREN, V3, P501	22	13	15	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	1060-152X			J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	SUM	1996	5	3					200	209		10.1097/01202412-199605030-00012			10	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	VG424	WOS:A1996VG42400012	8866287				2022-02-06	
J	Hamilton, SM; Breakey, P				Hamilton, SM; Breakey, P			Fluid resuscitation of the trauma patient: How much is enough?	CANADIAN JOURNAL OF SURGERY			English	Article							SEVERE HEAD-INJURY; MULTIPLE-ORGAN-FAILURE; BACTERIAL TRANSLOCATION; HEMORRHAGIC-SHOCK; MORTALITY; GUT; SWINE; PERMEABILITY; PERSPECTIVE; PRESSURE	Patient management in the prehospital resuscitative phase after trauma is vitally important to the outcome. Early definitive care remains the essential element in improving morbidity and mortality. In Canada, where a large proportion of trauma occurs at sites distant From a trauma centre, the prehospital resuscitative phase is long and has even greater potential to affect outcome. Conventional teaching about the end points of resuscitation has promoted the concept of normalization of hemodynamic parameters with maintenance of end-organ perfusion, as measured by the hourly urine output. Recent work in patients with a closed head injury and in patients with penetrating torso trauma challenge the notion that trauma patients are homogeneous with respect to these end points. In the Canadian setting of blunt injury, where a dosed head injury is usually suspected and often present, the evidence from clinical studies suggests that an aggressive approach to maintaining blood pressure is warranted. In penetrating torso injury in an urban setting, there is evidence to suggest that delaying resuscitation until hemorrhage is controlled is beneficial. More Canadian clinical trials are required in this area. In the meantime, the priorities of resuscitation must be carefully assessed for each patient and pattern of injury.	UNIV ALBERTA HOSP,DEPT SURG,EDMONTON,AB T6G 2B7,CANADA								ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; ALEXANDER JW, 1991, ANN SURG, V213, P558, DOI 10.1097/00000658-199106000-00005; ALEXANDER JW, 1990, ANN SURG, V212, P496, DOI 10.1097/00000658-199010000-00012; BAKER J W, 1987, Surgical Forum (Chicago), V38, P73; BAKER JW, 1988, J TRAUMA, V28, P896, DOI 10.1097/00005373-198807000-00002; BAKER SP, 1988, J TRAUMA, V28, P741, DOI 10.1097/00005373-198806000-00003; BAKER SP, 1987, NEW ENGL J MED, V316, P1384, DOI 10.1056/NEJM198705283162206; BICKELL WH, 1991, SURGERY, V110, P529; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BICKELL WH, 1992, ANN EMERG MED, V21, P1077, DOI 10.1016/S0196-0644(05)80648-1; BORDER JR, 1987, ANN SURG, V206, P427, DOI 10.1097/00000658-198710000-00004; BORDER JR, 1983, J TRAUMA, V23, P708, DOI 10.1097/00005373-198308000-00005; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Capono A, 1993, J TRAUMA, V35, P984; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; CHANG MC, 1994, J TRAUMA, V37, P488, DOI 10.1097/00005373-199409000-00026; DEITCH EA, 1990, CRIT CARE MED, V18, P529, DOI 10.1097/00003246-199005000-00014; DEITCH EA, 1987, ARCH SURG-CHICAGO, V122, P185; DEITCH EA, 1989, J CLIN INVEST, V84, P36, DOI 10.1172/JCI114164; DEITCH EA, 1992, ANN SURG, V216, P177; DEMLING R, 1993, CURR PROB SURG, V30, P345; FINK MP, 1991, SURGERY, V110, P154; FINK MP, 1991, CRIT CARE MED, V19, P627, DOI 10.1097/00003246-199105000-00009; GELFAND GAJ, 1991, J TRAUMA, V31, P867, DOI 10.1097/00005373-199106000-00020; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; JACOBS LM, 1984, J TRAUMA, V24, P8, DOI 10.1097/00005373-198401000-00002; JOHNSON KD, 1985, J TRAUMA, V25, P375, DOI 10.1097/00005373-198505000-00001; MARSHALL JC, 1988, ARCH SURG-CHICAGO, V123, P309; MOORE FA, 1992, ARCH SURG-CHICAGO, V127, P893; MOORE FA, 1991, J TRAUMA, V31, P629, DOI 10.1097/00005373-199105000-00006; MORRIS JA, 1991, J TRAUMA, V31, P1584, DOI 10.1097/00005373-199112000-00003; NACHT A, 1992, CRIT CARE CLIN, V8, P255; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; SMITH JP, 1983, J TRAUMA, V23, P317, DOI 10.1097/00005373-198304000-00008; Southard P, 1990, J Emerg Nurs, V16, P321; TURNBULL RG, 1995, J TRAUMA, V38, P705, DOI 10.1097/00005373-199505000-00005; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; 1993, CANADIAN MOTOR VEHIC; 1989, ADV TRAUMA LIFE SUPP	39	13	13	0	0	CANADIAN MEDICAL ASSOCIATION	OTTAWA	1867 ALTA VISTA DR, OTTAWA ON K1G 3Y6, CANADA	0008-428X			CAN J SURG	Can. J. Surg.	FEB	1996	39	1					11	16					6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	TV948	WOS:A1996TV94800006	8599784				2022-02-06	
J	Buder, EH; Kent, RD; Kent, JF; Milenkovic, P; Workinger, M				Buder, EH; Kent, RD; Kent, JF; Milenkovic, P; Workinger, M			FORMOFFA: An automated formant, moment, fundamental frequency, amplitude analysis of normal and disordered speech	CLINICAL LINGUISTICS & PHONETICS			English	Article						acoustic analysis; dysarthria; spectral moments	STATISTICAL-ANALYSIS; ANALYSIS SYSTEMS; CHILDREN; INTELLIGIBILITY; DYSARTHRIA; KURTOSIS	A system for semi-automatic, multi-parameter acoustic analysis is described. The system, called FORMOFFA (For = FORmants, Mo = MOments, FF = Fundamental Frequency, A = Amplitude), operates on a PC microcomputer by adaptations of commercially available software. Data displays include a deterministic time record of instantaneous values, and an ergodic time-compressed distribution. In this report the technique is developed with a one-word example, and some measurement and reliability issues are described. The analysis possibilities are then illustrated with several applications: (1) segmental analysis of normal speech, (2) acoustic assessment of the effects of a progressive neurological disease (amyotrophic lateral sclerosis) on sentence production, (3) acoustic study of palatal lift management of a patient with traumatic brain injury, and (4) phonetic assessment of word production by a subject with dysarthria. Although the current technique is recommended as a research tool, this kind of analysis promises several advantages for clinical application, including semi-automaticity, efficiency, parsimony, and relevance to both segmental and suprasegmental levels of analysis.	UNIV WISCONSIN,WAISMAN CTR,MADISON,WI 53705; UNIV WISCONSIN,DEPT ELECT & COMP ENGN,MADISON,WI 53706; MARSHFIELD CLIN FDN MED RES & EDUC,MARSHFIELD,WI 54449		Buder, EH (corresponding author), UNIV WASHINGTON,DEPT SPEECH & HEARING SCI,SEATTLE,WA 98195, USA.		Kent, Raymond D/AAI-1928-2020				ATLAS L, 1991, IEEE P PACIFIC RIM C; BAKEN R, 1991, READINGS CLIN SPECTR; Baken RJ, 1987, CLIN MEASUREMENT SPE; BARLOW S M, 1989, Journal of Voice, V3, P283, DOI 10.1016/S0892-1997(89)80050-5; COLLINS M, 1984, COMMUNICATION DISORD, V5, P159; DARLINGT.RB, 1970, AM STAT, V24, P19, DOI 10.2307/2681925; Davis S. B., 1979, SPEECH LANGUAGE ADV, V1; DEJONCKERE PH, 1991, 1ST INT CLIN PHON LI; ELASHOFF JD, 1978, INT ENCY STATISTICS; FORREST K, 1988, J ACOUST SOC AM, V84, P115, DOI 10.1121/1.396977; FORREST K, 1990, CLIN LINGUIST PHONET, V4, P327, DOI 10.3109/02699209008985495; Frokjaer-Jensen B., 1976, Bruel and Kjaer Technical Review, P3; HARMEGNIES B, 1988, THESIS U MONS FRANCE; JOHNSON M, 1993, J ACOUST SOC AM, V94, P1865; Kent R.D., 1992, INTELLIGIBILITY SPEE; KENT RD, 1991, J SPEECH HEAR RES, V34, P1269, DOI 10.1044/jshr.3406.1269; KENT RD, 1989, J SPEECH HEAR DISORD, V54, P482, DOI 10.1044/jshd.5404.482; KENT RD, 1992, NIDCD MONOGRAPH, P17; KITAWAKI N, 1991, ADV SPEECH SIGNAL PR; KLINGHOLZ F, 1989, FOLIA PHONIATR, V41, P23, DOI 10.1159/000265929; MICCERI T, 1989, PSYCHOL BULL, V105, P156, DOI 10.1037/0033-2909.105.1.156; MILENKOVIC P, 1994, CSPEECH VERSION 4 X; NEWELL KM, 1984, J MOTOR BEHAV, V16, P320; NITTROUER S, 1989, J SPEECH HEAR RES, V32, P120, DOI 10.1044/jshr.3201.120; PINTO NB, 1990, J ACOUST SOC AM, V87, P1278, DOI 10.1121/1.398803; POBURKA BJ, 1993, J ACOUST SOC AM, V94, P1782; READ C, 1992, J SPEECH HEAR RES, V35, P314, DOI 10.1044/jshr.3502.314; READ C, 1990, J SPEECH HEAR RES, V33, P363, DOI 10.1044/jshr.3302.363; SHEARD C, 1991, J SPEECH HEAR RES, V34, P285, DOI 10.1044/jshr.3402.285; SHIKANO K, 1991, ADV SPEECH SIGNAL PR; SOUTHWOOD J, 1990, THESIS U WISCONSIN M; STOELGAMMON C, 1994, PHONETICA, V51, P146, DOI 10.1159/000261966; STRAND EA, 1994, J VOICE, V8, P327, DOI 10.1016/S0892-1997(05)80281-4; WALDSTEIN RS, 1991, J SPEECH HEAR RES, V34, P1276, DOI 10.1044/jshr.3406.1276; WEISMER G, 1988, J ACOUST SOC AM, V38, P1281; ZYSKI BJ, 1987, J COMMUN DISORD, V20, P367, DOI 10.1016/0021-9924(87)90025-6	36	13	13	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9206			CLIN LINGUIST PHONET	Clin. Linguist. Phon.	JAN-MAR	1996	10	1					31	54		10.3109/02699209608985160			24	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	TR033	WOS:A1996TR03300003	20426513				2022-02-06	
J	Kossmann, T; Hans, V; Stocker, R; Imhof, HG; Joos, B; Trentz, O; MorgantiKossmann, MC				Kossmann, T; Hans, V; Stocker, R; Imhof, HG; Joos, B; Trentz, O; MorgantiKossmann, MC			Penetration of cefuroxime into the cerebrospinal fluid of patients with traumatic brain injury	JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY			English	Article							HEAD-INJURY	Cefuroxime levels were measured in cerebrospinal fluid (CSF) and serum of four patients with traumatic brain injury following the implantation of intraventricular catheters. The levels ranged from 0.15 to 2.03 mu g/mL in CSF and from 1.8 to 66.9 mu g/mL in serum. No ventriculostomy related infections were detected.	UNIV ZURICH,SCH MED,DEPT SURG,DIV TRAUMA SURG,CH-8091 ZURICH,SWITZERLAND; UNIV ZURICH,SCH MED,DEPT INTERNAL MED,DIV INFECT DIS,CH-8091 ZURICH,SWITZERLAND; UNIV ZURICH,SCH MED,DEPT NEUROSURG,CH-8091 ZURICH,SWITZERLAND				Joos, Beda/D-5547-2009	Joos, Beda/0000-0002-3082-8875; Morganti-Kossmann, Cristina/0000-0002-0807-2063			CLARK WC, 1989, NEUROSURGERY, V25, P20; Daikos G K, 1977, Proc R Soc Med, V70, P38; JENNETT B, 1976, LANCET, V1, P1031; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; REIBER H, 1987, CLIN CHIM ACTA, V163, P319, DOI 10.1016/0009-8981(87)90250-6; Ristuccia A M, 1992, Antibiot Chemother (1971), V45, P118; Rosner M J, 1976, Clin Neurosurg, V23, P494; SIRINAVIN S, 1984, ANTIMICROB AGENTS CH, V25, P273, DOI 10.1128/AAC.25.2.273; STOCKER R, 1995, UPD INT CAR, V22, P196; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862	10	13	13	0	4	W B SAUNDERS CO LTD	LONDON	24-28 OVAL RD, LONDON, ENGLAND NW1 7DX	0305-7453			J ANTIMICROB CHEMOTH	J. Antimicrob. Chemother.	JAN	1996	37	1					161	167		10.1093/jac/37.1.161			7	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Microbiology; Pharmacology & Pharmacy	TT399	WOS:A1996TT39900019	8647759	Green Accepted, Green Published			2022-02-06	
J	Varney, NR; Roberts, RJ; Struchen, MA; Hanson, TV; Franzen, KM; Connell, SK				Varney, NR; Roberts, RJ; Struchen, MA; Hanson, TV; Franzen, KM; Connell, SK			Design fluency among normals and patients with closed head injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article								A Design Fluency task was administered to 86 patients who had suffered closed head injury (CHI) with loss of consciousness and 87 normal control subjects. Subjects were asked to draw as many novel designs as they could in 5 minutes without scribbling, drawing a nameable object, or repeating a design that had been drawn previously. The mean performance of the CHI group was significantly poorer than that of the control group, with 47% of head injured performing defectively (below the 5th percentile of controls). There was no significant relationship between Design Fluency and prorated Ia psychomotor speed, or Word Fluency. The findings demonstrate that a standardized version of the ''free condition'' of Design Fluency is likely to be useful in the evaluation of patients with closed head injury.			Varney, NR (corresponding author), VET ADM MED CTR, PSYCHIAT SERV 116B, IOWA CITY, IA 52246 USA.						AXELROD BN, 1989, THESIS WAYNE STATE U; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; BIGLER E, IN PRESS APPL NEUROP; Bigler ED, 1988, NEUROPSYCHOLOGY, V2, P127, DOI 10.1037//0894-4105.2.3-4.127; DAIGNEAULT S, 1992, DEV NEUROPSYCHOL, V8, P99, DOI 10.1080/87565649209540518; DAIGNEAULT S, 1988, J CLIN EXP NEUROPSYC, V10, P58; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; Hamsher K., 1989, MULTILINGUAL APHASIA; Jennett B, 1981, MANAGEMENT HEAD INJU; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; JONESGOTMAN M, 1991, EPILEPSIA, V32, pS41; Lezak MD., 1993, J HEAD TRAUMA REHAB, V8, P24, DOI DOI 10.1097/00001199-199303000-00004; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LIM YK, 1984, SPINE, V9, P329; MCCARTHY RA, 1990, COGNITIVE NEUROPSYCH; MITTENBERG W, 1989, J CLIN EXP NEUROPSYC, V11, P918, DOI 10.1080/01688638908400945; RUFF RM, 1994, ARCH CLIN NEUROPSYCH, V9, P41, DOI 10.1016/0887-6177(94)90013-2; RUFF RM, 1987, DEV NEUROPSYCHOL, V3, P37, DOI 10.1080/87565648709540362; Ruff RM, 1988, RUFF FIGURAL FLUENCY; VARNEY NR, 1995, J HEAD TRAUMA REHAB, V10, P18; VARNEY NR, 1995, APPL NEUROPSYCHOLOGY, V2, P1	21	13	13	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.		1996	11	4					345	353		10.1016/0887-6177(95)00015-1			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	UN858	WOS:A1996UN85800009	14588939	Bronze			2022-02-06	
J	Williams, MA; LaMarche, JA; Alexander, RW; Stanford, LD; Fielstein, EM; Boll, TJ				Williams, MA; LaMarche, JA; Alexander, RW; Stanford, LD; Fielstein, EM; Boll, TJ			Serial 7s and alphabet backwards as brief measures of information processing speed	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; ATTENTION	The construct and discriminant validity of Serial 7s and Alphabet Backwards as measures of information processing speed were examined In Study 1, seven commonly used speeded neuropsychological measures, including Serial 7s and Alphabet Backwards, were subjected to factor analysis. Two factors emerged. Factor I was labeled visual-motor scanning speed. Factor 2 was labeled information processing speed and included Serial 7s and Alphabet Backwards. Study 2 compared 42 cardiac transplant candidates and 46 age, education, and Ie matched college student controls on Serial 7s and Alphabet Backwards. The cardiac patients were significantly slower on both Serial 7s and Alphabet Backwards but did not make more errors. These results suggest that Serial 7s and Alphabet Backwards can be used as brief and technically simple measures of information processing speed. Copyright (C) 1996 National Academy of Neuropsychology			Williams, MA (corresponding author), UNIV ALABAMA,NEUROPSYCHOL LAB,1521 11TH AVE S,BIRMINGHAM,AL 35294, USA.						BOLL TJ, 1978, CLIN DIAGNOSIS MENTA, P601; BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO;2-C; BORNSTEIN RA, 1989, J CLIN EXPT NEUROPSY, V11, P364; BRITTAIN JL, 1991, CLIN NEUROPSYCHOL, V5, P163, DOI DOI 10.1080/13854049108403300; BROUWER WH, 1985, CORTEX, V21, P111, DOI 10.1016/S0010-9452(85)80019-8; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gronwall D, 1974, PSYCHOL EFFECTS CONC; Hamster K., 1983, MULTILINGUAL APHASIA; HOWELL DC, 1982, STATISTICAL METHODS; LAMARCHE JA, 1994, ARCH CLIN NEUROPSYCH, V9, P152; LAMARCHE JA, 1992, ARCH CLIN NEUROPSYCH, V7, P341; MATTHEWS CG, 1964, INSTRUCTION MANUAL A; MOORE PN, 1980, PERCEPT MOTOR SKILL, V50, P940, DOI 10.2466/pms.1980.50.3.940; Phay A. J., 1990, MED PSYCHOTHERAPY, V3, P17; PICANO JJ, 1992, ARCH CLIN NEUROPSYCH, V7, P271, DOI 10.1016/0887-6177(92)90168-M; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; ROSEN AM, 1986, J CLIN PSYCHIAT, V47, P495; Shum DHK, 1990, CLIN NEUROPSYCHOL, V4, P151, DOI DOI 10.1080/13854049008401508; Smith, 1973, SYMBOL DIGIT MODALIT; Tabachnick B. G., 1989, USING MULTIVARIATE S; Treves T. A., 1990, DEMENTIA, V1, P102; Zachary R. A., 1986, SHIPLEY I LIVING SCA	22	13	13	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.		1996	11	8					651	659		10.1016/S0887-6177(96)80002-3			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	VY435	WOS:A1996VY43500002		Bronze			2022-02-06	
J	EWINGCOBBS, L; DUHAIME, AC; FLETCHER, JM				EWINGCOBBS, L; DUHAIME, AC; FLETCHER, JM			INFLICTED AND NONINFLICTED TRAUMATIC BRAIN INJURY IN INFANTS AND PRESCHOOLERS	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							CLOSED-HEAD-INJURY; PHYSICAL CHILD-ABUSE; FOLLOW-UP; ADOLESCENTS; SEQUELAE; COMA; AGE; EPIDEMIOLOGY; RETARDATION; MECHANISMS	Infants and preschoolers sustaining traumatic brain injury represent a distinct group in terms of injury characteristics, medical management, and outcome. Although the majority of traumatic brain injuries occurring during early childhood are mild, severe injuries are associated with high rates of mortality and morbidity. The less favorable neurobehavioral outcome frequently identified in infants and preschoolers in relation to outcome in other pediatric age groups is likely due to the high rate of inflicted injury in young children. inflicted injury often subjects the brain to rotational acceleration-deceleration forces that produce diffuse damage, leading to a high rate of death or persistent disability.	UNIV PENN,SCH MED,PHILADELPHIA,PA 19104; CHILDRENS HOSP PHILADELPHIA,PHILADELPHIA,PA 19104		EWINGCOBBS, L (corresponding author), UNIV TEXAS,HLTH SCI CTR,HOUSTON,TX 77225, USA.		fletcher, jack/Q-5975-2019; Fletcher, Jack/AAX-2931-2020				APPELBAUM AS, 1977, J ABNORM CHILD PSYCH, V5, P417, DOI 10.1007/BF00915089; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; CAFFEY J, 1974, PEDIATRICS, V54, P396; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHRISTOFFEL KK, 1990, AM J DIS CHILD, V144, P697, DOI 10.1001/archpedi.1990.02150300095025; Cohn Anne, 1983, APPROACH PREVENTING; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; DUHAIME AC, 1992, PEDIATRICS, V90, P179; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; DUHAIME AC, IN PRESS PRACTICE NE; DUHAIME AC, IN PRESS NEUROLOGICA; ERICKSON MF, 1989, CHILD MALTREATMENT T; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; EWINGCOBBS L, 1994, NEUROSURGERY, V35, P225, DOI 10.1227/00006123-199408000-00007; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; FITCH MJ, 1976, J PEDIATR PSYCHOL, V1, P32; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FRIEDRICH WN, 1983, J CONSULT CLIN PSYCH, V51, P313, DOI 10.1037/0022-006X.51.2.313; GENNARELLI TA, 1985, NEUROSURGERY, V2; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; HAHN YS, 1983, CHILD BRAIN, V10, P229; HAHN YS, 1988, CHILD NERV SYST, V4, P34; HELFER RE, 1977, PEDIATRICS, V60, P533; HELFER RE, 1984, PEDIATR ANN, V13, P745; HOFFMANPLOTKIN D, 1984, CHILD DEV, V55, P794, DOI 10.2307/1130130; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V1, P480; JOFFE M, 1988, PEDIATRICS, V82, P457; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; LANGECOSACK H, 1979, NEUROPADIATRIE, V10, P105, DOI 10.1055/s-0028-1085318; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MICHAUD LJ, 1993, ARCH PHYS MED REHAB, V74, P368; OATES RK, 1984, AM J DIS CHILD, V138, P764, DOI 10.1001/archpedi.1984.02140460053018; PANG D, 1989, J TRAUMA, V29, P654, DOI 10.1097/00005373-198905000-00021; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; RIVARA FP, 1994, PEDIATR ANN, V23, P12, DOI 10.3928/0090-4481-19940101-06; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; SATO Y, 1989, RADIOLOGY, V173, P653, DOI 10.1148/radiology.173.3.2813768; TEASDALE G, 1974, LANCET, V2, P81; TRICKETT PK, 1991, DEV PSYCHOL, V27, P148, DOI 10.1037/0012-1649.27.1.148; WOLFF DA, 1988, BEHAVIORAL ASSESSMEN; YAGER JY, 1990, AM J DIS CHILD, V144, P1088, DOI 10.1001/archpedi.1990.02150340032019; ZIMMERMAN RA, 1979, RADIOLOGY, V130, P687, DOI 10.1148/130.3.687; 1990, AM J DIS CHILD, V144, P627	58	13	13	0	3	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	1995	10	5					13	24		10.1097/00001199-199510000-00004			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RY617	WOS:A1995RY61700004					2022-02-06	
J	SHURTLEFF, HA; MASSAGLI, TL; HAYS, RM; ROSS, B; SPRUNKGREENFIELD, H				SHURTLEFF, HA; MASSAGLI, TL; HAYS, RM; ROSS, B; SPRUNKGREENFIELD, H			SCREENING CHILDREN AND ADOLESCENTS WITH MILD OR MODERATE TRAUMATIC BRAIN INJURY TO ASSIST SCHOOL REENTRY	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							MINOR HEAD-INJURY; WISC-R; ACADEMIC-ACHIEVEMENT; BEHAVIORAL SEQUELAE; HALSTEAD-REITAN; AMNESIA TEST; SEVERITY; INTELLIGENCE; ORIENTATION; BATTERY	Children with mild to moderate traumatic brain injury (TBI) do not usually require inpatient rehabilitation treatment and thus do not receive the extensive school reentry pi arming activated for children with more severe injuries. Yet such children are at risk for frustration or failure at school as a result of their brain injuries. A screening tool of selected neuropsychological tests was developed and a clinical protocol for evaluation implemented to assess children with mild to moderate TBI. The screening tool and clinical protocol are described and illustrative cases presented.	UNIV WASHINGTON,DEPT REHABIL MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PEDIAT,SEATTLE,WA 98195; GREEN MT REHABIL MED,BREMERTON,WA; CHILDRENS HOSP & MED CTR,DEPT EDUC,SEATTLE,WA 98105		SHURTLEFF, HA (corresponding author), CHILDRENS HOSP & MED CTR,DIV REHABIL PSYCHOL,SEATTLE,WA 98105, USA.			Shurtleff, Hillary/0000-0003-0959-2842			BIJUR PE, 1990, PEDIATRICS, V86, P337; Blosser JL, 1991, J HEAD TRAUMA REHAB, V6, P73; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; CARNEY J, 1994, PEDIATR ANN, V23, P47, DOI 10.3928/0090-4481-19940101-10; CARNEY J, 1990, Pediatrician, V17, P222; CLARREN SGB, 1987, THESIS U WASHINGTON; DAMATO RC, 1988, J SCHOOL PSYCHOL, V26, P283, DOI 10.1016/0022-4405(88)90007-6; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; FLETCHER JM, 1984, J CLIN NEUROPSYCHOL, V6, P39, DOI 10.1080/01688638408401195; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; Halstead WC, 1949, J SPEECH HEAR DISORD, V14, P9, DOI 10.1044/jshd.1401.09; HINSHAW SP, 1986, INT J CLIN NEUROPSYC, V8, P3; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; KLESGES RC, 1983, INT J CLIN NEUROPSYC, V5, P28; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KREUTZER JS, 1993, J HEAD TRAUMA REHAB, V8, P47; Lehr E, 1990, PSYCHOL MANAGEMENT T; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MASSAGLI TL, 1994, PEDIATR ANN, V23, P29, DOI 10.3928/0090-4481-19940101-08; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MILTON SB, 1991, J HEAD TRAUMA REHAB, V6, P35; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; REITAN RM, 1985, J CLIN PSYCHOL, V41, P245, DOI 10.1002/1097-4679(198503)41:2<245::AID-JCLP2270410219>3.0.CO;2-D; REITAN RM, 1985, J CLIN PSYCHOL, V41, P643, DOI 10.1002/1097-4679(198509)41:5<643::AID-JCLP2270410510>3.0.CO;2-A; REITAN RM, 1994, J CLIN PSYCHOL, V50, P47, DOI 10.1002/1097-4679(199401)50:1<47::AID-JCLP2270500106>3.0.CO;2-X; REITAN RM, 1992, CLIN NEUROPSYCHOL, V6, P287; RETZLAFF P, 1992, J CLIN PSYCHOL, V48, P666, DOI 10.1002/1097-4679(199209)48:5<666::AID-JCLP2270480514>3.0.CO;2-J; Rosen CD, 1986, HEAD TRAUMA ED REINT; RUIJS MBM, 1992, DEV MED CHILD NEUROL, V34, P885; SAVAGE RC, 1991, J HEAD TRAUMA REHAB, V6, P1; SEIDENBERG M, 1983, J CONSULT CLIN PSYCH, V51, P406, DOI 10.1037/0022-006X.51.3.406; Shurtleff H. A., 1988, J PSYCHOEDUCATIONAL, V6, P298, DOI 10.1177/073428298800600313; SHURTLEFF HA, 1993, DEV NEUROPSYCHOL, V9, P55, DOI 10.1080/87565649309540544; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Strang J.D., 1983, CHILD NEUROPSYCHOLOG; STROM DA, 1987, J PSYCHOEDUCATIONAL, V5, P157; Sutter E. G., 1986, J PSYCHOEDUCATIONAL, V4, P73; SWEET JJ, 1986, INT J CLIN NEUROPSYC, V8, P177; TELZROW CF, 1987, J SCHOOL PSYCHOL, V25, P93, DOI 10.1016/0022-4405(87)90064-1; TELZROW CF, 1991, J HEAD TRAUMA REHAB, V6, P23; TOWNES BD, 1980, J CONSULT CLIN PSYCH, V48, P675, DOI 10.1037/0022-006X.48.6.675; TRAMONTANA MG, 1984, INT J CLIN NEUROPSYC, V6, P1; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1974, WECHSLER INTELLIGENC; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006; [No title captured]	61	13	13	1	5	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	1995	10	5					64	79		10.1097/00001199-199510000-00008			16	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RY617	WOS:A1995RY61700008					2022-02-06	
J	GOTSCHALL, CS; PAPERO, PH; SNYDER, HM; JOHNSON, DL; SACCO, WJ; EICHELBERGER, MR				GOTSCHALL, CS; PAPERO, PH; SNYDER, HM; JOHNSON, DL; SACCO, WJ; EICHELBERGER, MR			COMPARISON OF 3 MEASURES OF INJURY SEVERITY IN CHILDREN WITH TRAUMATIC BRAIN INJURY	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	Head Injury 1994 - International Symposium on Head Injury Research	OCT 12-14, 1994	WASHINGTON, DC	Natl Highway Traff Safety Adm, Head Injury Res Program, George Washington Univ		BRAIN INJURY; CHILDREN; INJURY SEVERITY; GLASGOW COMA SCALE; OUTCOME; TRAUMA; HEAD INJURY	CLOSED-HEAD-INJURY; MORTALITY; SCORE; ADOLESCENTS; TRISS	Eighty-six traumatically brain-injured children aged 6 to 15 years who were consecutively admitted to a pediatric Level I trauma center were recruited for participation in the study. A comprehensive battery of behavioral, cognitive, commuuicative, social, motoric, and neurological tests was administered to the children from 12 to 36 months postinjury. The performance of three severity indices, the Glasgow Coma Scale (GCS), the ASCOT probability of survival, and the head injury component of the Anatomic Profile, was compared with respect to their association with longterm outcomes in five neurological domains, as assessed by linear regression models. The ASCOT probability of survival was correlated to test scores in all five domains. The GCS and the head injury component of the Anatomic Profile were each correlated to outcome in only one domain. The ASCOT probability of survival, which includes coded variables for the GCS, systolic blood pressure, and respiratory rates on admission, as well as a measure of multisystem anatomic injury, was the most sensitive indicator of head injury severity and was associated with outcomes beyond survival and death in this population. Probability of survival is a promising brain injury severity index that may be useful in efforts to assess new medical and rehabilitative therapies for children with traumatic brain injury.	CHILDRENS NATL MED CTR,DEPT PSYCHOL,WASHINGTON,DC 20010; CHILDRENS NATL MED CTR,DEPT NEUROSURG,WASHINGTON,DC 20010; TRI ANALYT INC,BEL AIR,MD		GOTSCHALL, CS (corresponding author), CHILDRENS NATL MED CTR,EMERGENCY TRAUMA SERV,111 MICHIGAN AVE NW,WASHINGTON,DC 20010, USA.				PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [MCH-114001] Funding Source: Medline		BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BRAAKMAN R, 1980, NEUROSURGERY, V6, P595; BRUCE DA, 1979, CHILD BRAIN, V5, P174; BRUCE DA, 1993, PEDIATRIC TRAUMA PRE, P353; CHAMPION HR, 1990, J TRAUMA, V30, P539, DOI 10.1097/00005373-199005000-00003; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHOI SC, 1983, J NEUROSURG, V75, P251; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; DACEY R, 1991, J TRAUMA, V31, P217, DOI 10.1097/00005373-199131020-00011; EICHELBERGER MR, 1989, ANN EMERG MED, V18, P939, DOI 10.1016/S0196-0644(89)80457-3; EICHELBERGER MR, 1993, J TRAUMA, V34, P319, DOI 10.1097/00005373-199303000-00001; EICHELBERGER MR, 1990, EMSC ASSESSMENT BATT; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; Flach J, 1972, Scand J Rehabil Med, V4, P9; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; Hammill DD, 1985, DETROIT TESTS LEARNI; HENNES H, 1988, AM J DIS CHILD, V142, P1045, DOI 10.1001/archpedi.1988.02150100039021; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KNIGHTS RM, 1968, PERCEPT MOTOR SKILL, V26, P463; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEVIN HS, 1994, J CHILD NEUROL, V9, P81, DOI 10.1177/088307389400900121; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; LUERSSEN TG, 1993, PEDIATRIC TRAUMA PRE, P345; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; PAPERO PH, 1993, NEUROPSYCHOL REHABIL, V3, P321, DOI 10.1080/09602019308401445; PECLET MH, 1990, J PEDIATR SURG, V25, P961, DOI 10.1016/0022-3468(90)90238-5; Reitan R, 1985, HALSTEAD REITAN NEUR; TEASDALE G, 1974, LANCET, V2, P81; Tukey JW, 1977, EXPLORATORY DATA ANA, P498; WALKER ML, 1985, CONCEPTS PEDIATR NEU, V6, P84; Wechsler D., 1974, WECHSLER ADULT INTEL; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; ZUCCARELLO M, 1985, CHILD NERV SYST, V1, P158, DOI 10.1007/BF00735731; 1985, ABBREVIATED INJURY S	39	13	15	0	8	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	1995	12	4					611	619		10.1089/neu.1995.12.611			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	RY920	WOS:A1995RY92000012	8683612				2022-02-06	
J	SCHWARTZ, SM				SCHWARTZ, SM			ADULTS WITH TRAUMATIC BRAIN INJURY - 3 CASE-STUDIES OF COGNITIVE REHABILITATION IN THE HOME SETTING	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						ACTIVITIES OF DAILY LIVING; MEMORY	CLOSED-HEAD-INJURY; MEMORY DISORDERS; AMNESIC PATIENTS; ACQUISITION; RETENTION; KNOWLEDGE; COMPUTER; LEARN; SKILL	This article discusses the use of occupational therapy in the home setting and the individual application of treatment methods. Three case studies are presented that involve adults with acquired brain injury with memory deficits. The treatment methods used were (a) saturational cuing with behavioral chaining and positive reinforcement, (b) a coordinated team approach incorporating family or significant others and other therapists, and (c) environmental adaptations. A decision-making model and the dynamic assessment approach were used as framework for treatment planning. The treatment technique chosen depended on the skill to be learned and the patient's learning style. Each case required the selection of environmental adaptations including (a) use of family and attendants as cotherapists; (b) a tape-recorded message, played daily; and (c) an appointment book for daily things to do. Each case demonstrated prolonged therapy for skill acquisition with this patient population.	REHAB PLUS,NEW YORK,NY; MANHATTAN CTR EARLY INTERVENT INC,EARLY INTERVENT PROGRAM,NEW YORK,NY								AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; BATT RC, 1990, AM J OCCUP THER, V44, P364, DOI 10.5014/ajot.44.4.364; BEN-YISHAY Y, 1970, Journal of Abnormal Psychology, V76, P378, DOI 10.1037/h0030404; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BENYISHAY Y, 1970, J ABNORM PSYCHOL, V75, P248, DOI 10.1037/h0029368; BROOKS DN, 1976, NEUROPSYCHOLOGIA, V14, P111, DOI 10.1016/0028-3932(76)90012-9; Campione J. C., 1987, DYNAMIC ASSESSMENT I, P82; CARBERRY H, 1992, J COGNITIVE REHABILI, V10, P24; CERMAK LS, 1976, NEUROPSYCHOLOGIA, V14, P311, DOI 10.1016/0028-3932(76)90025-7; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; CROSSAN B, 1989, J HEAD TRAUMA REHABI, V4, P35; CROSSON B, 1984, J CLIN NEUROPSYCHOL, V6, P287, DOI 10.1080/01688638408401219; DEPOY E, 1990, OCCUPATIONAL THERAPY, P55; DILLER L, 1986, HDB CLIN NEUROPSYCHO, V2, P702; DOLAN MP, 1977, J CLIN PSYCHOL, V33, P496, DOI 10.1002/1097-4679(197704)33:2<496::AID-JCLP2270330236>3.0.CO;2-X; DURGIN C, 1989, COGNITIVE REHABILITA, V7, P22; EAMES P, 1988, J HEAD TRAUMA REHAB, V3, P1; GIANUTSOS R, 1979, Journal of Clinical Neuropsychology, V1, P117, DOI 10.1080/01688637908414446; GILES G, 1989, AM J OCCUPATIONAL TH, V43, P404; GILES GM, 1989, ARCH PHYS MED REHAB, V70, P156; GILES GM, 1988, AM J OCCUP THER, V42, P658, DOI 10.5014/ajot.42.10.658; GLISKY EL, 1988, J LEARN DISABIL-US, V21, P333, DOI 10.1177/002221948802100604; GLISKY EL, 1986, NEUROPSYCHOLOGIA, V24, P313, DOI 10.1016/0028-3932(86)90017-5; GOODWIN R, 1991, J COGNITIVE REHABILI, V9, P12; GRAF P, 1984, J EXP PSYCHOL LEARN, V10, P164, DOI 10.1037/0278-7393.10.1.164; Hagen C., 1972, LEVELS COGNITIVE FUN; HARRELL MM, 1991, COGNITIVE REHABILITA, V9, P12; HARRIS J, 1983, EVERYDAY MEMORY ACTI, P70; KAY T, 1988, J HEAD TRAUMA REHAB, V3, P65; Kreutzer J S, 1988, Brain Inj, V2, P205, DOI 10.3109/02699058809150945; Kreutzer JS, 1989, COGNITIVE REHABILITA, V7, P30; LAWSON MJ, 1989, J CLIN EXP NEUROPSYC, V11, P842, DOI 10.1080/01688638908400939; LIDZ C, 1991, PRACTITIONERS GUIDE, P117; LIDZ CS, 1991, PRACTITIONERS GUIDE, P3; LURIA A, 1968, HDB CLIN NEUROLOGY, P368; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; McKinlay WW, 1988, J HEAD TRAUMA REHAB, p[3, 64]; MEACHAM JA, 1977, J PSYCHOL, V97, P191, DOI 10.1080/00223980.1977.9923962; MILLER L, 1991, COGNITIVE REHABILITA, V9, P16; Moffat N., 1984, CLIN MANAGEMENT MEMO, P63; NAUGLE R, 1988, COGNITIVE REHABILITA, V6, P22; NISSEN M, 1986, J HEAD TRAUMA REHAB, V1, P13; PARENTE R, 1991, COGNITIVE REHABILITA, P147; Parente R., 1989, J HEAD TRAUMA REHAB, V4, P55; Pollens RD, 1988, COGNITIVE REHABILITA, V6, P26; PRIGATANO G, 1986, NEUROPSYCHOLOGICAL R, P51; Prigatano GP, 1986, CLIN NEUROPSYCHOLOGY, P135; Romano M. D., 1989, J HEAD TRAUMA REHAB, V4, P33; Ryan T V, 1988, Arch Clin Neuropsychol, V3, P165, DOI 10.1016/0887-6177(88)90061-3; SCHACTER DL, 1985, J CLIN EXP NEUROPSYC, V7, P79, DOI 10.1080/01688638508401243; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; STARCH S, 1990, COGNITIVE REHABILITA, V8, P28; Toglia J. P., 1989, OCCUPATIONAL THERAPY, V1, P36; TOGLIA JP, 1991, AM J OCCUP THER, V45, P505, DOI 10.5014/ajot.45.6.505; Vygotsky Lev., 1978, MIND SOC DEV HIGHER; WEBB D, 1991, COGNITIVE REHABILITA, V9, P28; WHEATLEY CJ, 1989, WORK PROGRESS OCCUPA, P197; WILSON B, 1982, CORTEX, V18, P581, DOI 10.1016/S0010-9452(82)80055-5; WILSON B, 1983, EVERYDAY MEMORY ACTI, P209; Wilson B. A, 1984, CLIN MANAGEMENT MEMO, P89; WILSON BA, 1989, CORTEX, V25, P115, DOI 10.1016/S0010-9452(89)80011-5; [No title captured]	63	13	13	0	2	AMER OCCUPATION THERAPY ASSN	ROCKVILLE	1383 PICCARD DRIVE PO BOX ROCKVILLE, MD 20850-4375	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	JUL-AUG	1995	49	7					655	667		10.5014/ajot.49.7.655			13	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	RK198	WOS:A1995RK19800009	7573337				2022-02-06	
J	SJOSTROM, A; UVEBRANT, P; ROOS, A				SJOSTROM, A; UVEBRANT, P; ROOS, A			THE LIGHT-FLASH-EVOKED RESPONSE AS A POSSIBLE INDICATOR OF INCREASED INTRACRANIAL-PRESSURE IN HYDROCEPHALUS	CHILDS NERVOUS SYSTEM			English	Article						HYDROCEPHALUS; INTRACRANIAL PRESSURE; VISUAL EVOKED RESPONSE; VISUAL EVOKED POTENTIALS; PSEUDOTUMOR CEREBRI	HYPERTENSION PSEUDOTUMOR-CEREBRI; BRAIN-STEM RESPONSES; INFANTILE HYDROCEPHALUS; VENTRICULAR DILATATION; POTENTIALS; CHILDREN; EPIDEMIOLOGY; PRETERM; SWEDEN; SIZE	Surgical treatment of in fantile hydrocephalus by shunt implantation may result in suboptimal intracranial pressure. Major neurological impairments and death are usually prevented by shunt treatment, but minor sequelae may persist or develop. The introduction of adjustable shunts has improved the possibilities of optimizing shunt function and minimizing the risk of such impairments. However, it is still impossible to determine the intracranial pressure without invasive measurements. Clinical findings and procedures such as computed tomography (CT) are not always enough to allow a conclusion as to whether a child's signs and symptoms are the result of suboptimal intracranial pressure (shunt dysfunction) or are of another etiology. With the aim of reducing the number of invasive pressure measurements and CT scans, we investigated the effect of increased intracranial pressure on the visual evoked response (VER). Binocular light flash stimuli of supramaximal intensity were used and VER recordings were performed from Oz and Ct. The VER results from a group of 31 infants and children with hydrocephalus and 2 children with pseudotumor cerebri were compared with responses from a control group of 35 healthy children. The results show that a subpotential, P' (P-prime), usually just preceding P1 (P100), had an increased latency (>96 ms) in all hydrocephalic children before surgery. The P' latency in this group was usually even above 110 ms. The latencies of other VER potentials were also increased but not as consistently as P'. After surgical intervention the VER latencies decreased and usually normalized. The P' latency in four children in the control group was just above the borderline latency, but was less than 110 ms. In the remaining 31 children the VER P' latency was 96 ms or below. The VER provides information about the physiological condition of the visual system and seems to be related to intracranial pressure. The method was found to be useful in the clinical examination of hydrocephalic children. In addition, the VER may be used to monitor patients' clinical condition and the effect of treatment, e.g., in cases of pseudotumor cerebri or traumatic brain injury.	GOTHENBURG UNIV,INST CLIN NEUROSCI,DEPT PEDIAT NEUROL,GOTHENBURG,SWEDEN; GOTHENBURG UNIV,INST CLIN NEUROSCI,DEPT NEUROSURG,GOTHENBURG,SWEDEN		SJOSTROM, A (corresponding author), OSTRA HOSP,INST CLIN NEUROSCI,PEDIAT EYE CLIN,S-41685 GOTHENBURG,SWEDEN.						ALANI SM, 1985, J NEUROSURG, V62, P234, DOI 10.3171/jns.1985.62.2.0234; BAKER RS, 1989, PEDIATR NEUROL, V5, P5, DOI 10.1016/0887-8994(89)90002-7; BAKER RS, 1985, ARCH OPHTHALMOL-CHIC, V103, P1681, DOI 10.1001/archopht.1985.01050110075029; CONNOLLY MB, 1991, ARCH NEUROL-CHICAGO, V48, P956, DOI 10.1001/archneur.1991.00530210082028; CONSTANTINI S, 1987, CHILD NERV SYST, V3, P379, DOI 10.1007/BF00270713; COUPLAND SG, 1987, DOC OPHTHALMOL, V66, P321, DOI 10.1007/BF00213660; Creutzfeldt O.D., 1973, HDB SENSORY PHYSL, P595; DEVRIES LS, 1990, NEUROPEDIATRICS, V21, P136, DOI 10.1055/s-2008-1071480; FAULHAUER K, 1978, ACTA NEUROCHIR, V45, P89, DOI 10.1007/BF01774384; FERNELL E, 1993, ACTA PAEDIATR, V82, P45, DOI 10.1111/j.1651-2227.1993.tb12513.x; FERNELL E, 1986, ACTA PAEDIATR SCAND, V75, P975, DOI 10.1111/j.1651-2227.1986.tb10326.x; FERNELL E, 1990, ACTA PAEDIATR SCAND, V79, P1080, DOI 10.1111/j.1651-2227.1990.tb11387.x; FERNELL E, 1988, NEUROPEDIATRICS, V19, P143, DOI 10.1055/s-2008-1052418; FERNELL E, 1991, ACTA PAEDIATR SCAND, V80, P451, DOI 10.1111/j.1651-2227.1991.tb11881.x; FERNELL E, 1988, NEUROPEDIATRICS, V19, P135, DOI 10.1055/s-2008-1052417; FERNELL E, 1991, DEV MED CHILD NEUROL, V33, P388; FERNELL E, 1994, ARCH DIS CHILD, V70, P123; GUTHKELCH AN, 1982, NEUROSURGERY, V11, P599; GUTHKELCH AN, 1984, NEUROSURGERY, V14, P283; HADENIUS AM, 1962, ACTA PAEDIATR SCAND, V51, P117; HAGBERG B, 1970, ACTA PAEDIATR SCAND, V59, P328, DOI 10.1111/j.1651-2227.1970.tb09012.x; JAMES HE, 1990, PEDIATR NEUROSURG, V16, P305; KRAUS N, 1984, ELECTROEN CLIN NEURO, V59, P310, DOI 10.1016/0168-5597(84)90048-0; LARY S, 1989, ARCH DIS CHILD-FETAL, V64, P17, DOI 10.1136/adc.64.1_Spec_No.17; MCSHERRY JW, 1982, ELECTROEN CLIN NEURO, V53, P331, DOI 10.1016/0013-4694(82)90092-X; SJOSTROM A, 1994, ACTA OPHTHALMOL, V72, P195; SJOSTROM A, 1993, NEUROSCI LETT S, V6, P375; SKLAR FH, 1979, NEUROSURGERY, V4, P529, DOI 10.1227/00006123-197906000-00007; SUTTON LN, 1986, NEUROSURGERY, V18, P756, DOI 10.1227/00006123-198606000-00013; UVEBRANT P, 1992, CHILD NERV SYST, V8, P76, DOI 10.1007/BF00298444; YORK D, 1984, NEUROSURGERY, V14, P456, DOI 10.1227/00006123-198404000-00011	31	13	15	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	JUL	1995	11	7					381	387		10.1007/BF00717400			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	RJ664	WOS:A1995RJ66400003	7585664				2022-02-06	
J	MAYR, J; RUSSE, O; SPITZER, P; MAYRKOCI, M; HOLLWARTH, ME				MAYR, J; RUSSE, O; SPITZER, P; MAYRKOCI, M; HOLLWARTH, ME			PLAYGROUND ACCIDENTS	ACTA PAEDIATRICA			English	Article						ACCIDENT; CHILDREN; EQUIPMENT; PLAYGROUND; SAFETY		To study the causes and sequelae of playground accidents we analysed, in a retrospective study, 374 playground accidents. Questionnaires were sent to the parents and 103 parents (28%) provided detailed information on the playground accidents of their children. Thirty-one percent of the children injured in playground accidents sustained fractures of the extremities or concussion of the brain. Swings, slides, climbing frames, metal bars and merry-go-round accidents accounted for 71% of the 338 playground equipment-related accidents, whereas 36 accidents (10%) occurred without the use of playground equipment. The majority of these accidents were caused by children fighting. Rope-plank-type swings were frequently involved in backward falling accidents and 86% of the slide accidents were fall accidents. Climbing frames should not be taller than 1.6 m. Further efforts are mandatory to create and maintain playgrounds which help children develop their skills with a minimal risk to injury.	RUHR UNIV BOCHUM,BERUFSGENOSSENSCHAFTLICHE KLINIKEN BERGSMANNSHEIL,BOCHUM,GERMANY; AUSTRIAN COMM PAEDIAT ACCID PREVENT,GRAZ,AUSTRIA		MAYR, J (corresponding author), GRAZ UNIV,DEPT PAEDIAT SURG,AUENBRUGGERPL 34,A-8036 GRAZ,AUSTRIA.						BAUER R, 1993, UNFALLSTATISTIK 1992, P20; BOULTON MJ, 1993, BRIT J EDUC PSYCHOL, V63, P231, DOI 10.1111/j.2044-8279.1993.tb01054.x; LEWIS LM, 1993, J TRAUMA, V35, P932, DOI 10.1097/00005373-199312000-00020; SACKS JJ, 1989, JAMA-J AM MED ASSOC, V262, P1641, DOI 10.1001/jama.262.12.1641; TIPP G, 1987, P C PLAYGROUND RELAT, P53	5	13	14	4	9	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0803-5253			ACTA PAEDIATR	Acta Paediatr.	MAY	1995	84	5					573	576		10.1111/j.1651-2227.1995.tb13698.x			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	RA524	WOS:A1995RA52400022	7633157				2022-02-06	
J	COPPENS, P				COPPENS, P			SUBPOPULATIONS IN CLOSED-HEAD INJURY - PRELIMINARY-RESULTS	BRAIN INJURY			English	Article							VERBAL IMPAIRMENT; NARRATIVES; LANGUAGE; COHESION; TRAUMA; ADULTS; SCALE; COMA	The classification systems currently utilized to categorize closed-head injury (CHI) patients are all based on severity levels. However, these scales are unable to account for the wide variability among CHI patients. Another way to classify these patients is to use the clinical picture independent of the overall severity level. That approach is used with aphasic patients but not with the CHI population. These preliminary data indicate that there are distinct subgroups in the CHI population. These subgroups can be identified by their overall pattern of performance on a battery of tests covering language, memory, visuospatial, cognitive and discourse skills. The characteristics of the tentative subgroups are described, but a more extensive study is needed to confirm the robustness of this classification.			COPPENS, P (corresponding author), MOORHEAD STATE UNIV,MOORHEAD,MN 56563, USA.						ADAMOVICH BL, 1981, CLIN APHASIOLOGY C P, P244; BERNSTEINELLIS E, 1985, CLIN APHASIOLOGY C P, P97; BOLLER F, 1966, BRAIN, V89, P815, DOI 10.1093/brain/89.4.815; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Goodglass H, 1983, ASSESSMENT APHASIA R; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; Hagen C, 1981, TOP LANG DIS, V1, P73; Hagen C, 1979, REHABILITATION HEAD; HAGEN C, 1982, COGNITIVE REHABILITA, P131; Hagen C, 1984, LANGUAGE DISORDERS A, P245; Halliday M. K., 1976, COHESION ENGLISH; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; HARTLEY LL, 1990, APHASIOLOGY, V4, P353, DOI 10.1080/02687039008249088; Hooper HE., 1983, HOOPER VISUAL ORG TE; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Kaplan E, 1983, BOSTON NAMING TEST; Kertesz A., 1982, W APHASIA BATTERY; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; LILES BZ, 1985, J SPEECH HEAR RES, V28, P123, DOI 10.1044/jshr.2801.123; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; MANDLEBERG IA, 1976, J NEUROL NEUROSUR PS, V39, P1001, DOI 10.1136/jnnp.39.10.1001; McNeil MR, 1978, REVISED TOKEN TEST; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MILTON SB, 1984, CLIN APHASIOLOGY C P, P114; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; PARSONS CL, 1989, AUSTR J HUMAN COMMUN, V17, P37; PEACH R, 1988, AM SPEECH LANGUAGE H; Penn C, 1988, Brain Inj, V2, P3, DOI 10.3109/02699058809150928; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P18; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Raven J., 1990, COLOURED PROGR MATRI; Raven J., 1984, MANUAL RAVENS PROGR; Rey A, 1970, EXAMEN CLIN PSYCHOL; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; Stevens J., 1986, APPLIED MULTIVARIATE; TAYLOR EM, 1959, PSYCHOL APPRAISAL CH, P396; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; THOMSEN IV, 1976, FOLIA PHONIATR, V28, P362, DOI 10.1159/000264060; Wechsler, 1997, WECHSLER ADULT INTEL; Wiig E. H., 1988, NEUROPSYCHOLOGICAL S, P186; WILSON B, 1991, Brain Injury, V5, P189, DOI 10.3109/02699059109008089; WILSON J T L, 1990, Brain Injury, V4, P349; YORKSTON KM, 1980, J SPEECH HEAR DISORD, V45, P27, DOI 10.1044/jshd.4501.27; [No title captured]	52	13	13	0	0	TAYLOR & FRANCIS LTD LONDON	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	FEB-MAR	1995	9	2					195	208		10.3109/02699059509008192			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QN628	WOS:A1995QN62800008	7787839				2022-02-06	
J	FICK, DS				FICK, DS			MANAGEMENT OF CONCUSSION IN COLLISION SPORTS - GUIDELINES FOR THE SIDELINES	POSTGRADUATE MEDICINE			English	Article							2ND IMPACT; HEAD; FOOTBALL; PREVENTION; INJURY	During high-risk sports events, it is important for team physicians to be alert to the possibility of concussion in athletes who may not realize they have been injured or may want to conceal their injury. If concussion is suspected and the player is conscious, history taking should include inquiries about loss of consciousness, loss of memory of events before and after the impact, headache, visual abnormalities, motor and sensory changes, and back, neck, and extremity pain. In an unconscious player, the airway, breathing, circulation, and cervical spine should be checked. The cervical spine must be stabilized before the player is moved if injury to it is suspected. Athletes with such an injury and those who have lost consciousness require hospital evaluation. If there is no cervical spine injury, a complete neurologic evaluation should be carried out on the sidelines and the player checked for signs of skull fracture. The Colorado Medical Society guidelines for grading concussions and deciding when athletes may return to competition are an excellent aid to clinical judgment.	UNIV IOWA,COLL MED,DEPT ORTHOPAED SURG,IOWA CITY,IA 52242		FICK, DS (corresponding author), UNIV IOWA,COLL MED,DEPT FAMILY PRACTICE,IOWA CITY,IA 52242, USA.						ALBRIGHT JP, 1985, AM J SPORT MED, V13, P147, DOI 10.1177/036354658501300301; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; CANTU RC, 1992, PHYSICIAN SPORTSMED, V20, P55, DOI 10.1080/00913847.1992.11947483; CANTU RC, 1988, SPORTS MED DIGEST, V10, P1; FRANKOWSKI RF, 1985, BETHESDA NATIONAL I, P33; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; MCQUILLEN JB, 1988, AM J FOREN MED PATH, V9, P12, DOI 10.1097/00000433-198803000-00004; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; ROBERTS WO, 1992, PHYSICIAN SPORTSMED, V20, P66, DOI 10.1080/00913847.1992.11710295; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; TORG JS, 1985, JAMA-J AM MED ASSOC, V254, P3439, DOI 10.1001/jama.254.24.3439; WHITE RJ, 1992, NEW ENGL J MED, V327, P1507; 1992, PREPARTICIPATION PHY; 1991, REPORT SPORTS MED CO	15	13	13	0	5	MCGRAW HILL HEALTHCARE PUBLICATIONS	MINNEAPOLIS	4530 WEST 77TH ST, MINNEAPOLIS, MN 55435-5000	0032-5481			POSTGRAD MED	Postgrad. Med.	FEB	1995	97	2					53	&		10.1080/00325481.1995.11945958			0	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QF766	WOS:A1995QF76600005	7855035				2022-02-06	
S	Boller, F; Traykov, L; DaoCastellana, MH; FontaineDabernard, A; Zilbovicius, M; Rancurel, G; Pappata, S; Samson, Y		Grafman, J; Holyoak, KJ; Boller, F		Boller, F; Traykov, L; DaoCastellana, MH; FontaineDabernard, A; Zilbovicius, M; Rancurel, G; Pappata, S; Samson, Y			Cognitive functioning in 'diffuse' pathology - Role of prefrontal and limbic structures	STRUCTURE AND FUNCTIONS OF THE HUMAN PREFRONTAL CORTEX	ANNALS OF THE NEW YORK ACADEMY OF SCIENCES		English	Article; Proceedings Paper	Workshop on Structure and Functions of the Human Prefrontal Cortex	MAR 02-04, 1995	NEW YORK, NY	New York Acad Sci			MARCHIAFAVA-BIGNAMI DISEASE; FRONTAL-LOBE DEGENERATION; CEREBRAL BLOOD-FLOW; POSITRON EMISSION TOMOGRAPHY; CLOSED HEAD-INJURY; NON-ALZHEIMER TYPE; ALCOHOLICS; CORTEX; SPECT	The precise anatomical correlates of ''executive functions'' are still a matter of debate. The assessment of cognitive functions in patients with frontal lobe lesions has led to the term frontal functions'' and ''frontal lobe syndrome'' to characterize patients with disorders of executive functions. The very nature of executive functions implies a process of integration and the coordination of several cognitive processes. A fairly large number of tests are currently used to assess executive functions, but their specificity has not always been clearly established. These tests may at times be affected by lesions of nonfrontal areas or, paradoxically, may be spared by lesions that clearly affect the frontal lobes.' This does not necessarily imply that the tasks are not specific for the evaluation of executive functions, but rather that several nonfrontal structures, neural networks, and subordinate cognitive operations may participate in their performance. The frontal lobes are not a homogeneous anatomical entity, but rather an agglomerate of structures which differ from a cytoarchitectonic viewpoint, reflecting differences in myelogenesis and ontogenesis of the human brain.(2) In addition, from the point of view of anatomy, the frontal lobe represents a ''crossroads'' dense with extrinsic connections that cannot always be taken into account in focal lesions studies. Numerous studies using functional imaging and particularly positron emission tomography (PET) have attempted to define changes that occur at the level of the frontal lobes as a result of pathology, either focal or more widespread. This paper reviews clinical data and previous PET studies and combines them with some new data to show that impairments in executive functions occur in lesions not limited to the frontal lobes and that cortical structures outside the prefrontal areas may play an important role in these functions.	CEA,SERV HOSP FREDERIC JOLIOT,F-91406 ORSAY,FRANCE; INSERM,U334,ORSAY,FRANCE; HOP LA PITIE SALPETRIERE,PARIS,FRANCE		Boller, F (corresponding author), INSERM,U324,2TER RUE ALESIA,F-75014 PARIS,FRANCE.		samson, yves/C-5647-2013	samson, yves/0000-0002-8080-1427			ADAMS RD, 1989, PRINCIPLES NEUROLOGY, P837; ALBERT M, 1993, NEUROBIOL AGING, V14, P623, DOI 10.1016/0197-4580(93)90049-H; BENCH CJ, 1993, NEUROPSYCHOLOGIA, V31, P907, DOI 10.1016/0028-3932(93)90147-R; BOLLER F, NEUROPSYCHOLOGIE CLI; BOWEN M, 1989, BRAIN INJURY, V2, P109; CANNAPLE S, 1992, REV NEUROL, V148, P638; CHANG KH, 1992, NEURORADIOLOGY, V34, P480, DOI 10.1007/BF00598954; CHELUNE GJ, 1981, CLIN PSYCHOL REV, V1, P181; DAIGNEAULT S, 1992, DEV NEUROPSYCHOL, V8, P99, DOI 10.1080/87565649209540518; ELFGREN C, 1993, DEMENTIA, V4, P214, DOI 10.1159/000107325; FRISTON KJ, 1991, P ROY SOC B-BIOL SCI, V244, P101, DOI 10.1098/rspb.1991.0057; FRITH CD, 1991, NEUROPSYCHOLOGIA, V29, P1137, DOI 10.1016/0028-3932(91)90029-8; GILMAN S, 1990, ANN NEUROL, V28, P775, DOI 10.1002/ana.410280608; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; GUSTAFSON L, 1993, DEMENTIA, V4, P143, DOI 10.1159/000107313; HARPER C, 1989, J NEUROL SCI, V92, P81, DOI 10.1016/0022-510X(89)90177-9; HEEPE P, 1988, EUR ARCH PSY CLIN N, V237, P74, DOI 10.1007/BF00382370; HESSELINK JR, 1988, AM J ROENTGENOL, V150, P1133; HUMBERT T, 1992, EUR ARCH PSY CLIN N, V242, P69, DOI 10.1007/BF02191548; JAGUST W J, 1989, American Journal of Physiologic Imaging, V4, P89; KAWAMURA M, 1985, ANN NEUROL, V18, P103, DOI 10.1002/ana.410180123; KNOPMAN D, 1993, HDB NEUROPSYCHOLOGY, V8, P295; LANGFITT TW, 1987, NEUROBEHAVIORAL RECO, P30; Levin HS, 1989, NEUROPSYCHOLOGY, V3, P243, DOI 10.1037//0894-4105.3.4.243; LEVIN HS, 1987, NEUROBEHAVIORAL RECO, P321; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; LHERMITTE F, 1977, ARCH NEUROL-CHICAGO, V34, P254, DOI 10.1001/archneur.1977.00500160068015; LONG JA, 1974, Q J STUD ALCOHOL, V35, P1220; MANGIN JF, 1994, J CEREBR BLOOD F MET, V14, P749, DOI 10.1038/jcbfm.1994.96; MARTIN AJ, 1991, J CEREBR BLOOD F MET, V11, P684, DOI 10.1038/jcbfm.1991.121; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MILLER BL, 1991, NEUROLOGY, V41, P1374, DOI 10.1212/WNL.41.9.1374; NAUTA WJH, 1971, J PSYCHIAT RES, V8, P167, DOI 10.1016/0022-3956(71)90017-3; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; Pandya DN, 1987, FRONTAL LOBES REVISI, P41; PAPPATA S, 1994, J NEURAL TRANSM-PARK, V8, P131, DOI 10.1007/BF02250924; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Petrides M, 1995, HDB NEUROPSYCHOLOGY, P17; RENNER JA, 1994, HDB DEMENTING ILLNES, V22, P393; RISBERG J, 1987, ARCH GERONTOL GERIAT, V6, P225, DOI 10.1016/0167-4943(87)90023-9; Ruff R. M., 1989, NEUROPSY NEUROPSY BE, V2, P103; RYAN C, 1980, ALCOHOL CLIN EXP RES, V4, P288, DOI 10.1111/j.1530-0277.1980.tb04816.x; SAMSON Y, 1986, J NEUROL NEUROSUR PS, V49, P1165, DOI 10.1136/jnnp.49.10.1165; SMITH JW, 1973, Q J STUD ALCOHOL, V34, P414; TARTER RE, 1983, RECENT DEV ALCOHOLIS, P449; TERRY RD, 1987, ANN NEUROL, V21, P530, DOI 10.1002/ana.410210603; TRANEL D, 1994, HDB NEUROPSYCHOLOGY, P125; Whelihan WM, 1985, DEV NEUROPSYCHOL, V1, P371, DOI 10.1080/87565648509540321; Wiedmann KD, 1989, NEUROPSYCHOLOGY, V3, P267, DOI 10.1037//0894-4105.3.4.267; ZILBOVICIUS M, 1993, NEUROLOGY, V43, pA213; ZILBOVICIUS M, 1989, J CEREB BLOOD FLO S1, V9, pS521	51	13	14	0	5	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021	0077-8923		0-89766-991-6	ANN NY ACAD SCI	Ann.NY Acad.Sci.		1995	769						23	39		10.1111/j.1749-6632.1995.tb38129.x			17	Multidisciplinary Sciences; Neurosciences; Psychology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Neurosciences & Neurology; Psychology	BE92F	WOS:A1995BE92F00003	8595028				2022-02-06	
J	Freeman, MR; Ryan, JJ; Lopez, SJ; Mittenberg, W				Freeman, MR; Ryan, JJ; Lopez, SJ; Mittenberg, W			Cognitive estimation in traumatic brain injury: Relationships with measures of intelligence, memory, and affect	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						cognitive estimation; traumatic brain injury; prose memory		Brain injury is associated with a reduced capacity to engage in effective cognitive estimation. The current study utilized two measures of this construct, the Cognitive Estimation Test (GET) and Luria Memory Test (Luria), to investigate the relationships between cognitive estimation and intelligence, memory, and affect in a sample of 30 traumatically brain-injured individuals. Results demonstrated significant correlations between cognitive estimation and tests of intelligence and memory. However, measures of depression and state anxiety were not meaningfully associated with cognitive estimation. The ability to recall stories accounted for the greatest portion of the variance for both the CET and Luria. Specifically, the 30-minute Logical Memory subtest from the Wechsler Memory Scale-Revised accounted for 38% of the variance in the GET, while the Logical Memory 30-minute savings score accounted for 47% of the variance in the Luria. intellectual and affective variables explained only negligible amounts of variance on cognitive estimation tasks.	NOVA SE UNIV,SCH PSYCHOL,FT LAUDERDALE,FL		Freeman, MR (corresponding author), DWIGHT D EISENHOWER VET AFFAIRS MED CTR,PSYCHOL SERV 116B,LEAVENWORTH,KS 66048, USA.						AXELROD BN, 1994, ASSESSMENT, V0001, P00269, DOI DOI 10.1177/107319119400100307; Christensen AL., 1975, LURIAS NEUROPSYCHOLO; DELLIS DC, 1987, CALIFORNIA VERBAL LE; Golden CJ., 1980, LURIA NEBRASKA NEURO; HARRISPETERSON MR, 1991, FEB ANN C INT NEUR S; Kaufman A.S., 1990, KAUFMAN BRIEF INTELL; OCARROLL R, 1994, BRIT J CLIN PSYCHOL, V33, P193, DOI 10.1111/j.2044-8260.1994.tb01110.x; Schretlen D, 1992, J CLIN EXPT NEUROPSY, V14, P77; SHALLICE T, 1978, CORTEX, V14, P294, DOI 10.1016/S0010-9452(78)80055-0; SMITH ML, 1984, NEUROPSYCHOLOGIA, V22, P697, DOI 10.1016/0028-3932(84)90096-4; SMITH ML, 1988, NEUROPSYCHOLOGIA, V26, P297, DOI 10.1016/0028-3932(88)90082-6; SPIELBERGER CD, 1983, MANUAL STATE TRAIT A; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; YOUNG RK, 1982, COMMUNITY NURSING WO	15	13	14	0	1	GORDON BREACH SCI PUBL LTD	READING	C/O STBS LTD PO BOX 90, READING, BERKS, ENGLAND RG1 8JL	0020-7454			INT J NEUROSCI	Int. J. Neurosci.		1995	83	3-4					269	273		10.3109/00207459508986343			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TQ880	WOS:A1995TQ88000010	8869432				2022-02-06	
J	LITOFSKY, NS; CHIN, LS; TANG, G; BAKER, S; GIANNOTTA, SL; APUZZO, MLJ				LITOFSKY, NS; CHIN, LS; TANG, G; BAKER, S; GIANNOTTA, SL; APUZZO, MLJ			THE USE OF LOBECTOMY IN THE MANAGEMENT OF SEVERE CLOSED-HEAD TRAUMA	NEUROSURGERY			English	Article						GLASGOW COMA SCALE; GLASGOW OUTCOME SCALE; HEAD INJURY; LOBECTOMY; SEVERE BRAIN INJURY; TRANSTENTORIAL HERNIATION	DECOMPRESSIVE CRANIECTOMY; PROGNOSTIC FEATURES; CEREBRAL EDEMA; INJURY	A RETROSPECTIVE REVIEW is presented of 20 patients with traumatic brain injury who were treated during the course of their illness by lobectomies either after a herniation or other significant deterioration or to reduce elevated intracranial pressure. All the patients suffered from blunt head trauma. Patient ages ranged from 19 to 59 years (average, 34 yr). The initial Glasgow Coma Scale score ranged from 3 to 15 (average, 8.2). There were 14 frontal lobectomies, 2 temporal, 3 frontal and temporal, and 1 occipital. Surgery was performed between 0 and 8 days after injury (average, 2.8). Outcome was favorable (good or moderately disabled) in 11 patients and unfavorable (severely disabled, persistently vegetative, or dead) in 9. No patients survived in a persistently vegetative state. A higher initial Glasgow Coma Scale score was positively correlated with a more favorable outcome (P < 0.03). Younger patients also showed a significant positive relationship to outcome (P < 0.0005). Better pupillary reactivity showed a significant trend toward a more favorable outcome (P < 0.04). The type of lesions identified on computed tomographic scans had no association with outcome. A lobectomy can be a useful adjuvant in the management of severe brain injury, especially in younger patients with relatively higher initial Glasgow Coma Scale scores who subsequently deteriorate or develop elevated intracranial pressure.	UNIV MASSACHUSETTS, GRAD SCH BIOMED SCI, WORCESTER, MA 01655 USA; UNIV SO CALIF, SCH MED, DEPT NEUROSURG, LOS ANGELES, CA 90033 USA		LITOFSKY, NS (corresponding author), UNIV MASSACHUSETTS, MED CTR, SCH MED, DIV NEUROSURG, 55 LAKE AVE N, WORCESTER, MA 01655 USA.		Baker, Stephen P/B-8562-2008				ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; BRITT RH, 1978, NEUROSURGERY, V2, P195, DOI 10.1227/00006123-197805000-00001; CLARK K, 1968, J NEUROSURG, V29, P367, DOI 10.3171/jns.1968.29.4.0367; Cooper P R, 1976, Surg Neurol, V5, P25; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; CUSHING HW, 1908, J HOPKINS HOSP B, V19, P48; EVANS J P, 1951, U S Armed Forces Med J, V2, P1001; FREEDMAN H, 1952, J NEUROSURG, V9, P52, DOI 10.3171/jns.1952.9.1.0052; GOWER DJ, 1988, NEUROSURGERY, V23, P417, DOI 10.1227/00006123-198810000-00002; GUTTERMAN P, 1970, J NEUROSURG, V32, P330, DOI 10.3171/jns.1970.32.3.0330; Heiden J.S., 1979, NEURAL TRAUMA, P181; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; KJELLBERG RN, 1971, J NEUROSURG, V34, P488, DOI 10.3171/jns.1971.34.4.0488; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MEHTA CR, 1986, COMMUN STAT THEORY, V15, P387, DOI 10.1080/03610928608829128; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MOODY RA, 1968, J NEUROSURG, V29, P586, DOI 10.3171/jns.1968.29.6.0586; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; NUSSBAUM ES, 1991, NEUROSURGERY, V29, P62, DOI 10.1227/00006123-199107000-00010; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; Reid WL, 1940, SURGERY, V8, P756; Sarabia R, 1988, Acta Neurochir Suppl (Wien), V42, P40; SCOVILLE WB, 1979, ACTA NEUROCHIR, V47, P149, DOI 10.1007/BF01406400; STABLEIN DM, 1980, NEUROSURGERY, V6, P243; VENES JL, 1975, J NEUROSURG, V42, P429, DOI 10.3171/jns.1975.42.4.0429; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; WALKER AE, 1960, J NEUROSURG, V26, P184; 1992, STATXACT TURBO; [No title captured]	34	13	15	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	APR	1994	34	4					628	632		10.1227/00006123-199404000-00009			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NC633	WOS:A1994NC63300025	8008159				2022-02-06	
J	MUTTER, SA; HOWARD, JH; HOWARD, DV				MUTTER, SA; HOWARD, JH; HOWARD, DV			SERIAL PATTERN LEARNING AFTER HEAD-INJURY	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							MEMORY FUNCTION; AMNESIA; IMPLICIT; DISSOCIATION; PERFORMANCE; KNOWLEDGE; EXPLICIT; SYSTEMS	Nonverbal serial pattern learning in patients with traumatic brain injury was examined using a serial reaction time task developed by Nissen and Bullemer (1987). During four blocks of pattern acquisition trials, subjects responded to asterisks appearing in repetitions of a 10-element spatial sequence. An indirect measure of pattern learning was obtained by comparing response times in the fourth pattern acquisition block with response times in a fifth block where asterisks occurred in random sequence. A direct measure of pattern memory was provided by accuracy scores in a final pattern generation block in which subjects predicted the spatial sequence of asterisks. Prior research with this task has shown that individuals from several special populations - including the normal elderly, Korsakoff's syndrome patients, and Alzheimer's patients - show intact performance on the indirect measure of pattern learning, but are impaired on the direct measure. In contrast to these earlier findings, the results of this study showed that mild to moderately severe traumatic brain injury does not cause a marked disruption in the ability to learn and remember serial pattern information. There was evidence that the amount of practice required to learn the serial pattern increases after moderately severe head injury; however, the ability to use pattern memory to enhance prediction accuracy appears to be normal.	CATHOLIC UNIV AMER,WASHINGTON,DC 20064; GEORGETOWN UNIV,WASHINGTON,DC 20057		MUTTER, SA (corresponding author), WESTERN KENTUCKY UNIV,DEPT PSYCHOL,TATE C PAGE HALL,BOWLING GREEN,KY 42101, USA.				NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R37 AG02751] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49 CCR302583-0] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R37AG002751] Funding Source: NIH RePORTER		BADDELEY A, 1986, Q J EXP PSYCHOL-A, V38, P527, DOI 10.1080/14640748608401613; Brooks D N, 1979, Int Rehabil Med, V1, P166; BROOKS D N, 1974, Cortex, V10, P224; BROOKS DN, 1976, NEUROPSYCHOLOGIA, V14, P111, DOI 10.1016/0028-3932(76)90012-9; BROOKS DN, 1974, J NEUROL NEUROSUR PS, V37, P794, DOI 10.1136/jnnp.37.7.794; BROOKS DN, 1972, J NERV MENT DIS, V155, P350; BROOKS N, 1984, CLOSED HEAD INJURY P; CAINE ED, 1981, PSYCHOPHARMACOLOGY, V74, P74, DOI 10.1007/BF00431761; Cohen N. J., 1984, NEUROPSYCHOLOGY MEMO, P83; COHEN NJ, 1985, ANN NY ACAD SCI, V444, P54, DOI 10.1111/j.1749-6632.1985.tb37579.x; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; DRACHMAN DA, 1974, ARCH NEUROL-CHICAGO, V30, P113, DOI 10.1001/archneur.1974.00490320001001; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P501, DOI 10.1037/0278-7393.11.3.501; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; HOWARD DV, 1989, PSYCHOL AGING, V4, P357, DOI 10.1037/0882-7974.4.3.357; JACOBY LL, 1983, J EXP PSYCHOL LEARN, V9, P21, DOI 10.1037/0278-7393.9.1.21; JOHNSON MK, 1987, ANNU REV PSYCHOL, V38, P631, DOI 10.1146/annurev.ps.38.020187.003215; Kemper T.N., 1984, CLIN NEUROLOGY AGING, P9; KNOPMAN DS, 1987, NEUROLOGY, V37, P784, DOI 10.1212/WNL.37.5.784; Levin HS., 1982, NEUROBEHAVIORAL CONS; Moscovitch M., 1984, NEUROPSYCHOLOGY MEMO, P104; MUTTER SA, 1990, COGNITIVE NEUROPSYCH, V7, P329, DOI 10.1080/02643299008253447; NISSEN MJ, 1989, NEUROPSYCHOLOGIA, V27, P341, DOI 10.1016/0028-3932(89)90023-7; NISSEN MJ, 1987, NEUROLOGY, V37, P789, DOI 10.1212/WNL.37.5.789; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; RICHARDSONKLAVEHN A, 1988, ANNU REV PSYCHOL, V39, P475, DOI 10.1146/annurev.ps.39.020188.002355; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Roediger HL, 1987, MEMORY COGNITIVE PRO, P349; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; SHIMAMURA AP, 1986, Q J EXP PSYCHOL-A, V38, P619, DOI 10.1080/14640748608401617; TWEEDY JR, 1988, J CLIN EXP NEUROPSYC, V10, P664, DOI 10.1080/01688638808402803; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; WARRINGTON EK, 1968, NATURE, V217, P972, DOI 10.1038/217972a0; WARRINGTON EK, 1970, NATURE, V228, P629; Wechsler, 1997, WECHSLER ADULT INTEL; WILLINGHAM DB, 1989, J EXP PSYCHOL LEARN, V15, P1047, DOI 10.1037/0278-7393.15.6.1047; [No title captured]; [No title captured]	40	13	13	0	1	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR	1994	16	2					271	288		10.1080/01688639408402638			18	Psychology, Clinical; Clinical Neurology; Psychology	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychology; Neurosciences & Neurology	NG556	WOS:A1994NG55600012	8021314				2022-02-06	
J	FULLER, MG; FISHMAN, E; TAYLOR, CA; WOOD, RB				FULLER, MG; FISHMAN, E; TAYLOR, CA; WOOD, RB			SCREENING PATIENTS WITH TRAUMATIC BRAIN INJURIES FOR SUBSTANCE-ABUSE	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article								Substance abuse frequently accompanies and complicates serious traumatic brain injury (TBI). An important prerequisite to providing assistance to TBI patients is the ability to identify substance abuse accurately. The authors prospectively evaluated 10 consecutive admissions to a TBI program using four substance abuse screening tools: the CAGE questions, the Brief Michigan Alcohol Screening Test (BMAST) the Substance Abuse Subtle Screening Inventory, and the Addiction Severity Index. The CAGE questions and the BMAST were found to be easy to administer and very sensitive as well as specific for substance abuse in this population. The authors conclude that all patients with traumatic brain injuries should be screened for substance abuse by using either the CAGE questions or the BMAST.			FULLER, MG (corresponding author), ALLEGHENY GEN HOSP,ALLEGHENY NEUROPSYCHIAT INST,320 E N AVE,PITTSBURGH,PA 15212, USA.						EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; LANGLEY M J, 1990, Brain Injury, V4, P77, DOI 10.3109/02699059009026151; MCCLELLAND AT, 1980, J NERV MENT DIS, V168, P26; Miller, 1985, SUBSTANCE ABUSE SUBT; Parkerson J B Jr, 1990, Md Med J, V39, P259; PORKORNY AD, 1972, AM J PSYCHIAT, V129, P342; SODERSTROM CA, 1987, ARCH SURG-CHICAGO, V122, P1067; 1988, SPSS PCPLUS V2 0 BAS; 1988, WHITE PAPER SUBSTANC; 1990, ALCOHOL ALERT, V8, P1; 1988, MANUAL NEUROBEHAVIOR; 1989, ALCOHOL ALERT, V3, P1	14	13	13	0	3	AMER PSYCHIATRIC ASSOCIATION	WASHINGTON	1400 K ST NW, WASHINGTON, DC 20005	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	1994	6	2					143	146					4	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	NJ963	WOS:A1994NJ96300006	8044035				2022-02-06	
J	CARNEY, J; SCHOENBRODT, L				CARNEY, J; SCHOENBRODT, L			EDUCATIONAL-IMPLICATIONS OF TRAUMATIC BRAIN INJURY	PEDIATRIC ANNALS			English	Article											CARNEY, J (corresponding author), KENNEDY KRIEGER INST,707 N BROADWAY,BALTIMORE,MD 21205, USA.							0	13	13	0	0	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086	0090-4481			PEDIATR ANN	Pediatr. Annu.	JAN	1994	23	1					47	52		10.3928/0090-4481-19940101-10			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	MU563	WOS:A1994MU56300007	8152864				2022-02-06	
J	DOBERSTEIN, C; FINEMAN, I; HOVDA, DA; MARTIN, NA; KEENLY, L; BECKER, DP				DOBERSTEIN, C; FINEMAN, I; HOVDA, DA; MARTIN, NA; KEENLY, L; BECKER, DP			METABOLIC ALTERATIONS ACCOMPANY IONIC DISTURBANCES AND CELLULAR SWELLING DURING A HYPOXIC INSULT TO THE RETINA - AN IN-VITRO STUDY	ACTA NEUROCHIRURGICA			English	Article						BRAIN INJURY; HYPOXIA; IONIC FLUX; METABOLISM	POTASSIUM; DEATH	To study the ionic, metabolic, and morphologic derangements that occur following brain injury we utilized a retina in vitro model of hypoxia. Retinas were dissected into oxygenated (95% O2, 5% CO2) Ames medium, a physiologic solution resembling cerebrospinal fluid, and randomly assigned to either experimental hypoxic conditions (95% N2, 5% CO2) or control conditions. All retinas were incubated and maintained at 37-degrees-C. Changes in extracellular K+ and lactate concentration, intracellular incorporation of Ca-45 and C-14-leucine, uptake of glucose using [C-14]-2-deoxy-D-glucose (2DG), and cell size were determined at 10, 20, 30, and 60 minute time intervals. The results show that compared to control retinas hypoxia produced: (1) an early increase in extracellular concentration of K+ and lactate, (2) a delayed increase in the intracellular incorporation of Ca-45, (3) an early onset of cellular swelling, and (4) a decrease in the intracellular incorporation of C-14-leucine, and (5) increased glucose utilization. All of the results were statistically significant (p < 0.05) and exhibited a dose response relationship with the exception of intracellular incorporation of Ca-45 which did not become significantly different until 30 minutes post-hypoxia. A 16% increase in cell size was noted after 10 minutes of hypoxia. Increased hypoxic cell size persisted for 30 minutes but after 60 minutes the control retinas appeared enlarged as well. Our results suggest that ionic, metabolic, and morphologic derangements can be demonstrated utilizing an in vitro model of hypoxia which are similar to those seen following in vivo traumatic brain injury. With use of this model the mechanisms behind these ionic-metabolic relationships can be addressed at the molecular level.	UNIV CALIF LOS ANGELES, SCH MED, DIV NEUROSURG, 74-140 CHS, LOS ANGELES, CA 90024 USA					Martin, Neil/0000-0002-6565-4131			AMES A, 1983, STROKE, V14, P219, DOI 10.1161/01.STR.14.2.219; AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; FINEMAN I, 1993, IN PRESS BRAIN RES; HUBSCHMANN OR, 1983, J NEUROSURG, V59, P289, DOI 10.3171/jns.1983.59.2.0289; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; NEDERGAARD M, 1988, J CEREBR BLOOD F MET, V8, P763, DOI 10.1038/jcbfm.1988.125; SCHANNE FAX, 1979, SCIENCE, V206, P700, DOI 10.1126/science.386513; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169	8	13	13	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1994				60			41	44					4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NX226	WOS:A1994NX22600011	7526627				2022-02-06	
J	MELLER, D; BELLANDER, BM; SCHMIDTKASTNER, R; INGVAR, M				MELLER, D; BELLANDER, BM; SCHMIDTKASTNER, R; INGVAR, M			IMMUNOHISTOCHEMICAL STUDIES WITH ANTIBODIES TO NEUROFILAMENT PROTEINS ON AXONAL DAMAGE IN EXPERIMENTAL FOCAL LESIONS IN RAT	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						NEUROFILAMENT PROTEIN; IMMUNOHISTOCHEMISTRY; AXONAL DAMAGE; FOCAL CORTICAL LESION; STATUS EPILEPTICUS	FIBRILLARY ACIDIC PROTEIN; MONOCLONAL-ANTIBODIES; NERVOUS-SYSTEM; CYTOSKELETAL PROTEINS; STATUS EPILEPTICUS; SUBSTANTIA-NIGRA; SPINAL-CORD; PHOSPHORYLATION; NEURONS; BRAIN	Immunohistochemistry with monoclonal antibodies against neurofilament (NF) proteins of middle and high molecular weight class, NF-M and NF-H, was used to study axonal injury in the borderzone of focal lesions in rats. Focal injury in the cortex was produced by infusion of lactate at acid pH or by stab caused by needle insertion. Infarcts in substantia nigra pars reticulata were evoked by prolonged pilocarpine-induced status epilepticus. Immunohistochemical staining for NFs showed characteristic terminal clubs of axons in the borderzone of lesions. Differences in the labelling pattern occurred with different antibodies which apparently depended on molecular weight class of NFs and phosphorylation state. These immunohistochemical changes of NFs can serve as a marker for axonal damage in various experimental traumatic or ischemic lesions	KAROLINSKA INST,DEPT CLIN NEUROPHYSIOL,S-10401 STOCKHOLM 60,SWEDEN; KAROLINSKA HOSP,DEPT NEUROSURG,S-10401 STOCKHOLM 60,SWEDEN; KAROLINSKA INST,DEPT NEUROSURG,S-10401 STOCKHOLM 60,SWEDEN		INGVAR, M (corresponding author), KAROLINSKA HOSP,DEPT CLIN NEUROPHYSIOL,POB 60500,S-10401 STOCKHOLM 60,SWEDEN.			Ingvar, Martin/0000-0002-9041-5714			Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; ADAMS JH, 1984, GREENFIELDS NEUROPAT, P85; BIGNAMI A, 1981, J NEUROPATH EXP NEUR, V40, P537, DOI 10.1097/00005072-198109000-00005; Brierly J, 1984, GREENFIELDS NEUROPAT, P125; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CREUTZFELDT OD, 1977, EXP BRAIN RES, V27, P419; DAHL D, 1988, J COMP NEUROL, V271, P445, DOI 10.1002/cne.902710311; DAHL D, 1983, EXP CELL RES, V149, P397, DOI 10.1016/0014-4827(83)90352-X; DAHL D, 1989, BRAIN RES BULL, V22, P225, DOI 10.1016/0361-9230(89)90047-6; DEBUS E, 1983, DIFFERENTIATION, V25, P193, DOI 10.1111/j.1432-0436.1984.tb01355.x; DRAGER UC, 1984, NATURE, V309, P624, DOI 10.1038/309624a0; ERIKSDOTTERNILSSON M, 1987, EXP BRAIN RES, V69, P155; GIACOBINI MMJ, 1991, EXP BRAIN RES, V86, P73; GOLDSTEIN ME, 1987, J NEUROSCI, V7, P1586; Guillery R., 1970, CONT RES METHODS NEU, P77; HICKEY WF, 1983, J HISTOCHEM CYTOCHEM, V31, P1126, DOI 10.1177/31.9.6193166; HIROKAWA N, 1984, J CELL BIOL, V98, P1523, DOI 10.1083/jcb.98.4.1523; HOLLENBECK PJ, 1989, J CELL BIOL, V108, P223, DOI 10.1083/jcb.108.2.223; IIZUKA H, 1990, STROKE, V21, P790, DOI 10.1161/01.STR.21.5.790; IIZUKA H, 1989, STROKE, V20, P1396, DOI 10.1161/01.STR.20.10.1396; INGVAR M, 1987, J CEREBR BLOOD F MET, V7, P103, DOI 10.1038/jcbfm.1987.15; KAO CC, 1983, SPINAL CORD RECONSTR, P41; KATAOKA K, 1989, STROKE, V20, P1226, DOI 10.1161/01.STR.20.9.1226; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; KOEPPEN AH, 1985, HDB NEUROCHEMISTRY, V9, P443; KOLIATSOS VE, 1989, BRAIN RES, V482, P205, DOI 10.1016/0006-8993(89)91183-9; KRAIG RP, 1987, J CEREBR BLOOD F MET, V7, P379, DOI 10.1038/jcbfm.1987.80; KRISTT DA, 1987, J NEUROPATH EXP NEUR, V46, P668, DOI 10.1097/00005072-198711000-00006; LEE VMY, 1987, J NEUROSCI, V7, P3474; MANSOUR H, 1989, J COMP NEUROL, V283, P481, DOI 10.1002/cne.902830404; MATTHEWS MA, 1973, J NEUROCYTOL, V2, P265, DOI 10.1007/BF01104030; MATUS A, 1988, TRENDS NEUROSCI, V11, P291, DOI 10.1016/0166-2236(88)90086-0; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121; MELLER D, 1993, IN PRESS J COMP NEUR, V330; MOSS TH, 1983, J NEUROL SCI, V60, P267, DOI 10.1016/0022-510X(83)90068-0; NAGASAWA H, 1990, BRAIN RES, V524, P196, DOI 10.1016/0006-8993(90)90690-D; NIXON RA, 1991, TRENDS NEUROSCI, V14, P501, DOI 10.1016/0166-2236(91)90062-Y; OESTREICHER AB, 1988, BRAIN RES BULL, V21, P713, DOI 10.1016/0361-9230(88)90037-8; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; PETITO CK, 1987, J CEREBR BLOOD F MET, V7, P625, DOI 10.1038/jcbfm.1987.115; Ramon y Cajal S, 1928, DEGENERATION REGENER, V2; ROBINSON PA, 1988, REV NEUROSCI, V2, P1; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SCHLAEPFER WW, 1987, J NEUROPATH EXP NEUR, V46, P117, DOI 10.1097/00005072-198703000-00001; SCHMIDT ML, 1991, LAB INVEST, V64, P352; SCHMIDTKASTNER R, 1991, EXP BRAIN RES, V86, P125; SCHMIDTKASTNER R, 1988, ACTA NEUROPATHOL, V76, P411, DOI 10.1007/BF00686979; SHAW G, 1981, EUR J CELL BIOL, V26, P68; SHAW G, 1986, EUR J CELL BIOL, V42, P1; SHAW G, 1988, BRAIN RES, V460, P227, DOI 10.1016/0006-8993(88)90367-8; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; TETZLAFF W, 1988, J NEUROSCI, V8, P3181; TROJANOWSKI JQ, 1985, J HISTOCHEM CYTOCHEM, V33, P557, DOI 10.1177/33.6.3889140; TROJANOWSKI JQ, 1986, J NEUROSCI, V6, P650; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; [No title captured]	57	13	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X			J NEUROL SCI	J. Neurol. Sci.	JUL	1993	117	1-2					164	174		10.1016/0022-510X(93)90169-Y			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LN639	WOS:A1993LN63900025	8410052				2022-02-06	
J	SHELL, D; CARICO, GA; PATTON, RM				SHELL, D; CARICO, GA; PATTON, RM			CAN SUBDURAL-HEMATOMA RESULT FROM REPEATED MINOR HEAD-INJURY	PHYSICIAN AND SPORTSMEDICINE			English	Article								A 17-year-old male high school football player sustained two mild concussions in 7 days. Five weeks later, he ran 50 yd in a game and fell to his knees complaining of severe headache, nausea, facial pain, and difficulty breathing. An immediate on-field physical examination was normal, but the boy progressively became lethargic, stuporous, then comatose. CT scan revealed a right subdural hematoma, perhaps a long-term complication of the two mild concussions. Rules requiring neurocognitive testing after head injury and a physician's written clearance to return to play may be needed to prevent life-threatening injury or permanent neuropsychological sequelae in head-injured athletes.			SHELL, D (corresponding author), OHIO STATE UNIV,UNIV HOSP CLIN,DEPT FAMILY MED,456 W 10TH AVE,COLUMBUS,OH 43210, USA.							0	13	14	0	4	MCGRAW HILL HEALTHCARE PUBLICATIONS	MINNEAPOLIS	4530 WEST 77TH ST, MINNEAPOLIS, MN 55435-5000	0091-3847			PHYSICIAN SPORTSMED	Physician Sportsmed.	APR	1993	21	4					74	&					0	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	KU264	WOS:A1993KU26400008	27447770				2022-02-06	
J	DENNIS, M				DENNIS, M			WORD FINDING IN CHILDREN AND ADOLESCENTS WITH A HISTORY OF BRAIN INJURY	TOPICS IN LANGUAGE DISORDERS			English	Article							CLOSED-HEAD-INJURY; ACQUIRED APHASIA; HEMIDECORTICATE ADOLESCENTS; SPINA-BIFIDA; LANGUAGE; DISCOURSE; ANOMIA; COMPREHENSION; HYDROCEPHALUS; RETRIEVAL				DENNIS, M (corresponding author), HOSP SICK CHILDREN, DEPT PSYCHOL, TORONTO M5G 1X8, ONTARIO, CANADA.						ALAJOUANINE T, 1965, BRAIN, V88, P653, DOI 10.1093/brain/88.4.653; ANDERSON EM, 1977, CHILD SPINA BIFIDA; ARAM DM, 1987, BRAIN LANG, V31, P61, DOI 10.1016/0093-934X(87)90061-7; Baddeley A.D., 1987, WORKING MEMORY; BADELLRIBERA A, 1966, PEDIATRICS, V37, P787; Bagnato SJ, 1986, DEV NEUROPSYCHOL, V2, P213, DOI 10.1080/87565648609540343; BENEDET MJ, 1989, J PSYCHOLINGUIST RES, V18, P485, DOI 10.1007/BF01067312; CAMPBELL TF, 1990, J SPEECH HEAR DISORD, V55, P567, DOI 10.1044/jshd.5503.567; CHEVRIEMULLER C, 1987, APHASIOLOGY, V1, P347; CROSS JA, 1990, ACQUIRED NEUROLOGICA, P66; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; DENNIS M, 1976, BRAIN LANG, V3, P147, DOI 10.1016/0093-934X(76)90013-4; DENNIS M, 1987, J CLIN EXP NEUROPSYC, V9, P593, DOI 10.1080/01688638708410771; DENNIS M, 1980, LANGUAGE DEV APHASIA, P45; DENNIS M, IN PRESS BRAIN LANGU; Dennis M., 1979, STUDIES NEUROLINGUIS, V4, P211; DENNIS M, 1992, UNPUB WORD FINDING B; DENNIS M, 1992, UNPUB NEUROPSYCHOLOG; DENNIS M, 1980, BIOL STUDIES MENTAL, P159; DENNIS M, 1992, CANADIAN PSYCHOL, V33, P435; DENNIS M, 1990, DISCOURSE ABILITY BR, P199; DENNIS M, 1988, MASTER LECTURE SERIE, P85; DILLER L, 1966, REHABILITATION MONOG, V31; Ewing-Cobbs L., 1985, SPEECH LANGUAGE EVAL, P97; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; FLEMING CP, 1968, DEV MED CHILD NE S15, V10, P74; Fodor J.A., 1983, MODULARITY MIND; GAIDOLFI E, 1980, ITAL J NEUROL SCI, V1, P65; Garrett Merril F, 1975, PSYCHOL LEARNING MOT, P133, DOI DOI 10.1016/S0079-7421(08)60270-4; German D.J., 1991, TEST WORD FINDING DI; GERMAN DJ, 1989, BRIT J DISORD COMMUN, V24, P21; GOODGLASS H, 1976, BRAIN LANG, V3, P359, DOI 10.1016/0093-934X(76)90032-8; Goodglass H., 1976, STUDIES NEUROLINGUIS, V1, P237; Goodglass H., 1972, ASSESSMENT APHASIA R; GROSSMAN M, 1981, BRAIN LANG, V12, P313, DOI 10.1016/0093-934X(81)90022-5; Guttmann E, 1942, BRAIN, V65, P205, DOI 10.1093/brain/65.2.205; HADENIUS AM, 1962, ACTA PAEDIATR SCAND, V51, P117; HART J, 1985, NATURE, V316, P439, DOI 10.1038/316439a0; HARWOODNASH DCF, 1976, NEURORADIOLOGY INFAN, V2, P609; HECAEN H, 1976, BRAIN LANG, V3, P114, DOI 10.1016/0093-934X(76)90009-2; HOFFMAN HJ, 1989, PERINATAL BRAIN LESI, P219; HORN DG, 1985, DEV MED CHILD NEUROL, V27, P713; HOWARD D, 1984, ADV NEUROLOGY, V42; HOWES D, 1979, PSYCHOLINGUISTIC RES, P435; INGRAM TTS, 1962, DEV MED CHILD NEUROL, V4, P287; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; JORDAN FM, 1990, ACQUIRED NEUROLOGICA, P124; KEMPEN G, 1978, RECENT ADV PSYCHOL L, V2, P103; KEMPEN G, 1977, SENTENCE PRODUCTION, P259; KHAN AU, 1975, DEV MED CHILD NEUROL, V17, P116; KIESSLING LS, 1983, DEV MED CHILD NEUROL, V25, P727; LECOURS AR, 1979, APHASIA; LEDORZE G, 1989, BRAIN LANG, V37, P381; LESSER R, 1989, COGNITIVE APPROACHES, P65; Levelt W.J.M., 1989, SPEAKING INTENTION A; LEVELT WJM, 1991, PSYCHOL REV, V98, P122, DOI 10.1037/0033-295X.98.1.122; LEVIN HS, 1979, CHILD BRAIN, V5, P281; LOVETT MW, 1986, BRAIN LANG, V29, P224, DOI 10.1016/0093-934X(86)90046-5; MACNAB GH, 1965, DEV MED CHILD NE S11, V8, P1; MARCHMAN VA, 1991, APPL PSYCHOLINGUIST, V12, P1, DOI 10.1017/S0142716400009358; Markman EM, 1989, CATEGORIZATION NAMIN; MCCLEARY C, 1986, BRAIN LANG, V27, P199, DOI 10.1016/0093-934X(86)90015-5; NEWMAN JE, 1986, TOP LANG DISORD, V7, P31, DOI 10.1097/00011363-198612000-00006; NIEBERGALL G, 1976, Z KLIN PSYCHOL-FORSC, V5, P194; OELSCHLAEGER ML, 1976, J COMMUN DISORD, V9, P281; Ozanne AE, 1990, ACQUIRED NEUROLOGICA, P1; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; SATZ P, 1981, ACQUIRED APHASIA, P399; SCHILDER P, 1964, CONTRIBUTIONS DEV NE; SWISHER LP, 1971, DEV MED CHILD NEUROL, V13, P746; TAYLOR EM, 1961, PSYCHOL APPRAISAL CH; TEW B, 1979, Z KINDERCHIR, V28, P360; TEW B, 1979, BRIT J DISORD COMMUN, V14, P89, DOI 10.3109/13682827909011349; TEW BJ, 1972, DEV MED CHILD NEUROL, V14, P124; THAL DJ, 1991, BRAIN LANG, V40, P491, DOI 10.1016/0093-934X(91)90145-Q; VANDONGEN HR, 1977, CORTEX, V13, P131, DOI 10.1016/S0010-9452(77)80004-X; VISCHBRINK EG, 1984, BRAIN LANG, V23, P258, DOI 10.1016/0093-934X(84)90067-1; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; WHITEHOUSE P, 1978, BRAIN LANG, V6, P63, DOI 10.1016/0093-934X(78)90044-5; WIEGELCRUMP CA, 1986, BRAIN LANG, V27, P1, DOI 10.1016/0093-934X(86)90001-5; Wiig E. H., 1984, TOP LANG DISORD, V4, P1; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; ZINGESER LB, 1990, BRAIN LANG, V39, P14, DOI 10.1016/0093-934X(90)90002-X; ZINGESER LB, 1988, COGNITIVE NEUROPSYCH, V5, P473, DOI 10.1080/02643298808253270	85	13	13	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-8294	1550-3259		TOP LANG DISORD	Top. Lang. Disord.	NOV	1992	13	1					66	82		10.1097/00011363-199211000-00008			17	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	JT442	WOS:A1992JT44200008					2022-02-06	
J	PANIAK, CE; SHORE, DL; ROURKE, BP; FINLAYSON, MAJ; MOUSTACALIS, E				PANIAK, CE; SHORE, DL; ROURKE, BP; FINLAYSON, MAJ; MOUSTACALIS, E			LONG-TERM VOCATIONAL FUNCTIONING AFTER SEVERE CLOSED HEAD-INJURY - A CONTROLLED-STUDY	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	MEETING OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOC	FEB   16, 1991	SAN ANTONIO, TX	INT NEUROPSYCHOL SOC			FOLLOW-UP; SOCIAL-ADJUSTMENT; BRAIN INJURY; PROGNOSIS; LIFE	Vocational functioning at least 2 years postinjury was examined in a group of 57 severely closed-head injured (CHI) patients and 50 nonbrain-injured spinal-cord injured (SCI) patients. The two groups were equated on the following preinjury parameters: age, education, socioeconomic status (SES), male/female ratio, and marital status. The CHI and SCI patients had a similar number of members who were employed at follow-up. However mean follow-up socioeconomic status was significantly lower in the CHI group and premorbidly employed CHI patients suffered a greater loss of SES than did premorbidly employed SCI patients. These results indicate that the degree of vocational impairment after severe CHI goes beyond impairment seen with another chronic disabling condition (i.e., SCI) that is associated with severe physical impairment but not neuropsychological impairment. In the CHI group, the following variables were all correlated with SES at follow-up: preinjury education, posttraumatic amnesia duration, degree of neuropsychological impairment soon after injury, and emotional adjustment at follow-up.	UNIV WINDSOR,WINDSOR N9B 3P4,ONTARIO,CANADA; CHEDOKE MCMASTER HOSP,HAMILTON L8N 3Z5,ONTARIO,CANADA; MCMASTER UNIV,HAMILTON L8S 4L8,ONTARIO,CANADA		PANIAK, CE (corresponding author), GLENROSE REHAB HOSP,DEPT PSYCHOL,10230-111 AVE,EDMONTON T5G 0B7,ALBERTA,CANADA.						ADEY C, 1963, BRISTOL MEDICO CHIRU, V82, P58; BLISHEN BR, 1976, CAN REV SOC ANTHROP, V13, P71, DOI 10.1111/j.1755-618X.1976.tb00759.x; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Bruckner F E, 1972, Rheumatol Phys Med, V11, P344, DOI 10.1093/rheumatology/11.7.344; Cartlidge N E, 1981, HEAD INJURY; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DEROGATIS LR, 1983, PSYCHOSOCIAL ADJUSTM, V1; EGGERT GM, 1973, THESIS BRANDEIS U WA; GILCHRIST E, 1979, ARCH NEUROL-CHICAGO, V36, P355, DOI 10.1001/archneur.1979.00500420065008; HEISKANEN O, 1970, ACTA NEUROL SCAND, V46, P343, DOI 10.1111/j.1600-0404.1970.tb05798.x; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; KREUTZER JS, 1990, SEP COGN REH COMM IN; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEWIN W, 1979, BRIT MED J, V2, P1533, DOI 10.1136/bmj.2.6204.1533; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Rimel R W, 1981, J Neurosurg Nurs, V13, P132; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Russell E. W., 1970, ASSESSMENT BRAIN DAM; STAMBROOK M, 1989, JUN M CAN PSYCH ASS; STAPLETON M, 1989, COGNITIVE REHABILITA, V7, P18; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019	30	13	13	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV-DEC	1992	7	6					529	540		10.1016/0887-6177(92)90143-B			12	Psychology, Clinical; Psychology	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Psychology	JQ229	WOS:A1992JQ22900007	14591404				2022-02-06	
J	WILLMORE, LJ				WILLMORE, LJ			POSTTRAUMATIC EPILEPSY	NEUROLOGIC CLINICS			English	Article							POST-TRAUMATIC EPILEPSY; STIMULATED LIPID-PEROXIDATION; PENETRATING HEAD-INJURY; HUMAN TEMPORAL-LOBE; VITAMIN-E; SUPEROXIDE RADICALS; GROWTH-FACTOR; RAT-BRAIN; SEIZURES; PHENYTOIN				WILLMORE, LJ (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT NEUROL,6431 FANNIN 7044,HOUSTON,TX 77030, USA.						AISEN P, 1977, CIBA F S, P1; Anderson D.K., 1983, NEUROCHEM PATHOL, V1, P249; AUST SD, 1982, FREE RADICALS BIOL, P1; BAKER N, 1966, J LIPID RES, V7, P341; CALLAGHAN N, 1988, NEW ENGL J MED, V318, P942, DOI 10.1056/NEJM198804143181502; CARLSSON J, 1980, J BACTERIOL, V142, P319, DOI 10.1128/JB.142.1.319-321.1980; CAVENESS WF, 1976, EPILEPSIA, V17, P207, DOI 10.1111/j.1528-1157.1976.tb03398.x; CHADWICK D, 1985, BRIT MED J, V290, P1885, DOI 10.1136/bmj.290.6485.1885; CHAN PH, 1980, J NEUROCHEM, V35, P1004, DOI 10.1111/j.1471-4159.1980.tb07100.x; CZAPSKI G, 1978, PHOTOCHEM PHOTOBIOL, V28, P651, DOI 10.1111/j.1751-1097.1978.tb06988.x; DECAROLIS P, 1984, J NEUROL NEUROSUR PS, V47, P1345, DOI 10.1136/jnnp.47.12.1345; DICHTER MA, 1987, SCIENCE, V237, P157, DOI 10.1126/science.3037700; DIPLOCK AT, 1973, FEBS LETT, V29, P205, DOI 10.1016/0014-5793(73)80020-1; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAUGHT E, 1989, NEUROLOGY, V39, P1089, DOI 10.1212/WNL.39.8.1089; FEENEY DM, 1979, ARCH NEUROL-CHICAGO, V36, P8, DOI 10.1001/archneur.1979.00500370038005; FISHMAN RA, 1979, NEUROLOGY, V29, P546; FONG KL, 1976, CHEM-BIOL INTERACT, V15, P77, DOI 10.1016/0009-2797(76)90130-7; FONG KL, 1973, J BIOL CHEM, V248, P7792; FRIDOVICH I, 1974, ADV ENZYMOL RAMB, V41, P35; GALL CM, 1989, SCIENCE, V245, P758, DOI 10.1126/science.2549634; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GREEN RC, 1989, ANN NEUROL, V26, P347, DOI 10.1002/ana.410260307; GUTTERIDGE JMC, 1987, BIOCHIM BIOPHYS ACTA, V917, P219, DOI 10.1016/0005-2760(87)90125-1; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; JENNETT B, 1975, J NEUROL NEUROSUR PS, V38, P378, DOI 10.1136/jnnp.38.4.378; Jennett B, 1981, MANAGEMENT HEAD INJU; KAPLAN HA, 1961, EPILEPSIA, V2, P111; KOPPENOL WH, 1978, PHOTOCHEM PHOTOBIOL, V28, P655, DOI 10.1111/j.1751-1097.1978.tb06989.x; LANGFITT TW, 1966, HEAD INJURY, P172; LEVITT P, 1971, J NEUROSURG, V35, P185, DOI 10.3171/jns.1971.35.2.0185; LINGREN SO, 1966, ACTA CHIR SCAND S360, V132, P1; LUCY JA, 1972, ANN NY ACAD SCI, V203, P4, DOI 10.1111/j.1749-6632.1972.tb27849.x; McCay P. B., 1980, Vitamin E, P289; NIEHAUS WG, 1968, EUR J BIOCHEM, V6, P126, DOI 10.1111/j.1432-1033.1968.tb00428.x; NIETOSAMPEDRO M, 1988, SCIENCE, V240, P1784, DOI 10.1126/science.3289118; Orlowski M, 1976, Int Rev Neurobiol, V19, P75, DOI 10.1016/S0074-7742(08)60702-3; PANTER SS, 1985, J EXP MED, V161, P748, DOI 10.1084/jem.161.4.748; PAYAN H, 1970, EPILEPSIA, V11, P81, DOI 10.1111/j.1528-1157.1970.tb03869.x; PENRY JK, 1979, NEUROLOGY, V29, P600; PRINCE DA, 1984, ANN NEUROL, V16, pS59, DOI 10.1002/ana.410160710; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; RAPPORT RL, 1972, EPILEPSIA, V13, P295; REHNCRONA S, 1980, J NEUROCHEM, V34, P1630, DOI 10.1111/j.1471-4159.1980.tb11254.x; RIBAK CE, 1979, SCIENCE, V205, P211, DOI 10.1126/science.109922; RICHARDSON E P Jr, 1954, Epilepsia, V3, P49, DOI 10.1111/j.1528-1157.1954.tb03153.x; RISH BL, 1973, J NEUROSURG, V38, P155, DOI 10.3171/jns.1973.38.2.0155; SAJI M, 1987, SCIENCE, V235, P66, DOI 10.1126/science.3798095; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SMITH GJ, 1962, ARCH BIOCHEM BIOPHYS, V98, P46, DOI 10.1016/0003-9861(62)90142-X; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; SVINGEN BA, 1978, PHOTOCHEM PHOTOBIOL, V28, P803, DOI 10.1111/j.1751-1097.1978.tb07022.x; TAPPEL AL, 1972, ANN NY ACAD SCI, V203, P12, DOI 10.1111/j.1749-6632.1972.tb27851.x; TAPPEL AL, 1973, FED PROC, V32, P1870; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; TORNHEIM PA, 1983, J NEUROSURG, V59, P431, DOI 10.3171/jns.1983.59.3.0431; TRIGGS WJ, 1984, J NEUROCHEM, V42, P976, DOI 10.1111/j.1471-4159.1984.tb12699.x; WAGNER FC, 1981, J NEUROSURG, V54, P8802; WALKER AE, 1970, EPILEPSIA, V11, P17, DOI 10.1111/j.1528-1157.1970.tb03861.x; WEISS GH, 1986, ARCH NEUROL-CHICAGO, V43, P771, DOI 10.1001/archneur.1986.00520080019013; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006; WILLMORE LJ, 1983, BRAIN RES, V277, P393, DOI 10.1016/0006-8993(83)90954-X; WILLMORE LJ, 1981, NEUROLOGY, V31, P63, DOI 10.1212/WNL.31.1.63; WILLMORE LJ, 1990, EPILEPSIA, V31, pS67, DOI 10.1111/j.1528-1157.1990.tb05861.x; WILLMORE LJ, 1984, EXP NEUROL, V83, P62, DOI 10.1016/0014-4886(84)90046-3; WILLMORE LJ, 1978, ANN NEUROL, V4, P329, DOI 10.1002/ana.410040408; WILLMORE LJ, 1991, MED TREATMENT EPILEP, P73; WITTING LA, 1980, FREE RADICAL BIO MED, V4, P295; WOHNS RNW, 1979, J NEUROSURG, V51, P507, DOI 10.3171/jns.1979.51.4.0507; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236; YOUNG B, 1979, EPILEPSIA, V20, P671, DOI 10.1111/j.1528-1157.1979.tb04851.x; [No title captured]	73	13	14	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0733-8619			NEUROL CLIN	Neurol. Clin.	NOV	1992	10	4					869	878		10.1016/S0733-8619(18)30184-1			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JW158	WOS:A1992JW15800004	1435661				2022-02-06	
J	KOIZUMI, MS				KOIZUMI, MS			INJURY PATTERNS IN MOTORCYCLE ACCIDENT VICTIMS	REVISTA DE SAUDE PUBLICA			Portuguese	Article						WOUNDS AND INJURIES, EPIDEMIOLOGY; ACCIDENTS, TRAFFIC; MOTORCYCLES	SAO-PAULO CITY; SEVERITY SCORE; VEHICLE ACCIDENTS; HEAD-INJURY; TRAUMA; SCALE; MORTALITY; BRAZIL; COST; COMA	An analysis of the injury patterns presented by inpatients of a government teaching hospital, known as one of the emergency centers of S. Paulo city, Brazil, is given the majority of victims are young, male adults and most of them were later discharged from the hospital. In relation to the injuries the majority of the patients were classified as being of minor injury grade (ISS between 1 and 9) and the most frequent injuries were extremity and pelvic fractures, surface trauma, traumatic brain injury and extremity and pelvic dislocations. Besides extremity and pelvic fractures, the victims who died showed abdominal organ injury and traumatic brain injury and the ISS was over 20. Head injury patients who had a high Glasgow Coma Scale score had a low ISS and vice-versa.	UNIV SAO PAULO,ESCOLA ENFERMAGEM,DEPT ENFERMAGEN MEDICO CIRURG,SAO PAULO,BRAZIL								ANDREW TA, 1979, INJURY, V10, P317, DOI 10.1016/0020-1383(79)90053-6; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BRAY T, 1985, JAMA-J AM MED ASSOC, V254, P2452, DOI 10.1001/jama.254.17.2452; BRIED JM, 1987, CLIN ORTHOPAEDICS, V223, P252; BULL JP, 1985, ACCIDENT ANAL PREV, V17, P387, DOI 10.1016/0001-4575(85)90093-4; CAIN CMJ, 1989, AUST NZ J SURG, V59, P15; CANNELL H, 1982, BRIT J ORAL SURG, V20, P183, DOI 10.1016/S0007-117X(82)80036-X; CARR WP, 1981, MINN MED, V64, P521; CARROL CL, 1980, ANAL FATAL NONFATAL; COOKRO DV, 1979, ARIZ MED, V36, P605; CRAIG GR, 1983, INJURY, V15, P163, DOI 10.1016/0020-1383(83)90005-0; Dodson C F Jr, 1976, J Ark Med Soc, V73, P115; EDNA TH, 1987, ACTA NEUROCHIR, V85, P40, DOI 10.1007/BF01402368; FIUZA RM, 1988, ARQ BRAS NEUROCIRURG, V7, P191; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; HADDAD JP, 1976, J TRAUMA, V16, P550, DOI 10.1097/00005373-197607000-00006; HARMS PL, 1981, TRRL651 CROWTH TRANS; HENDERSON SA, 1987, BRIT MED J, V294, P1259, DOI 10.1136/bmj.294.6582.1259; KEANE JR, 1989, ARCH NEUROL-CHICAGO, V46, P761, DOI 10.1001/archneur.1989.00520430055017; KNIGHT RL, 1987, CRIT CARE NURSE, V6, P65; KOIZUMI MS, 1985, REV SAUDE PUBL, V19, P475, DOI 10.1590/S0034-89101985000500011; KOIZUMI MS, 1985, REV SAUDE PUBL, V19, P543, DOI 10.1590/S0034-89101985000600006; KOIZUMI MS, 1984, THESIS FACULDADE SAU; KOIZUMI MS, 1990, THESIS ESCOLA ENFERM; KUMAR B, 1989, MED SCI LAW, V29, P333, DOI 10.1177/002580248902900414; LEUNG PC, 1983, INJURY, V15, P23, DOI 10.1016/0020-1383(83)90157-2; MACDONALD JW, 1987, INJURY, V18, P196; May C, 1989, J Emerg Nurs, V15, P389; McGinnis G S, 1989, J Neurosci Nurs, V21, P201; MORGAN TO, 1988, HEART LUNG, V17, P258; *ORG MUND SAUD, 1975, MAN CLASS EST INT DO; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; PURDUE GF, 1985, J TRAUMA, V25, P216, DOI 10.1097/00005373-198503000-00008; RIVARA FP, 1988, JAMA-J AM MED ASSOC, V260, P221; ROSS DJ, 1983, INJURY, V15, P75, DOI 10.1016/0020-1383(83)90030-X; ROSSON JW, 1988, INJURY, V19, P4, DOI 10.1016/0020-1383(88)90162-3; SURACI AJ, 1986, J TRAUMA, V26, P458, DOI 10.1097/00005373-198605000-00008; TEASDALE G, 1974, LANCET, V2, P81; ZETTAS JP, 1979, J TRAUMA, V19, P833, DOI 10.1097/00005373-197911000-00007	39	13	21	0	4	REVISTA DE SAUDE PUBLICA	SAO PAULO	FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01255 SAO PAULO, BRAZIL	0034-8910			REV SAUDE PUBL	Rev. Saude Publica	OCT	1992	26	5					306	315		10.1590/S0034-89101992000500002			10	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	KR631	WOS:A1992KR63100002	1342518	Green Published, gold			2022-02-06	
J	SCHELLER, D; KOLB, J; TEGTMEIER, F; LEHMENKUHLER, A				SCHELLER, D; KOLB, J; TEGTMEIER, F; LEHMENKUHLER, A			EXTRACELLULAR CHANGES OF INORGANIC-PHOSPHATE ARE DIFFERENT DURING SPREADING DEPRESSION AND GLOBAL CEREBRAL-ISCHEMIA OF RATS	NEUROSCIENCE LETTERS			English	Article						SPREADING DEPRESSION; ISCHEMIA; TRAUMATIC INJURY; EXTRACELLULAR INORGANIC PHOSPHATE; EXTRACELLULAR LACTATE; MICRODIALYSIS; MEMBRANE PERMEABILITY	BRAIN	Tissue levels of inorganic phosphate (iP-) and lactate (lac) increase during cerebral ischemia and cortical spreading depression (SD). Since cell membranes become leaky during these insults, iP- and lac were expected to leak into the extracellular space (ECS). In order to find out whether this occurs or does not, a microdialysis (MD) fiber was implanted into the cortex of anesthetized rats and extracellular lactate (lac(c)) and extracellular iP- (iP(e)-) were determined during various insults. Extracellular lactate increased to about the same extent during ischemia and SD. In contrast, iP(e)- increased during ischemia but not during SD. Instead, iP(e)- started to rise after SD and reached its maximum about 45 min later. The distinct pattern of iP(e)- in comparison to lac(e) during the above mentioned insults points to a qualitative difference of the underlying mechanisms: whereas lac appears within the ECS at any stressful situation, elevation of iP- within the ECS indicates depletion of energy stores in parallel to the lack of control of ion homeostasis.	UNIV MUNICH,INST PHYSIOL,W-8000 MUNICH 2,GERMANY		SCHELLER, D (corresponding author), JANSSEN RES FDN,RAIFFEISENSTR 8,W-4040 NEUSS 21,GERMANY.		, Lehmenkuhler/AAG-3679-2019				BURES J, 1974, MECHANISM APPLICATIO; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; HORIKAWA Y, 1985, J CEREBR BLOOD F MET, V5, P235, DOI 10.1038/jcbfm.1985.30; KRAIG RP, 1978, NEUROSCIENCE, V3, P1045, DOI 10.1016/0306-4522(78)90122-7; KRIVANEK J, 1961, J NEUROCHEM, V6, P183, DOI 10.1111/j.1471-4159.1961.tb13463.x; LAURITZEN M, 1990, J CEREBR BLOOD F MET, V10, P115, DOI 10.1038/jcbfm.1990.14; LEHMENKUHLER A, 1990, EEG-EMG-Z ELEK ELEKT, V21, P1; MUTCH WAC, 1984, J CEREBR BLOOD F MET, V4, P17, DOI 10.1038/jcbfm.1984.3; Nicholson C, 1981, APPLICATION ION SELE, P217; PHILLIPS JM, 1979, BRAIN RES, V173, P567, DOI 10.1016/0006-8993(79)90254-3; SCHELLER D, 1991, J NEUROSCI METH, V40, P31, DOI 10.1016/0165-0270(91)90114-F; SCHELLER D, 1992, NEUROSCI LETT, V135, P83, DOI 10.1016/0304-3940(92)90141-S; Siesj? BK., 1978, BRAIN ENERGY METABOL; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; STRAUB RW, 1979, TRENDS PHARMACOL SCI, V12, P106; STRAUB RW, 1976, TRANSMEMBRANE TRANSP; TOMSIG JL, 1991, BRAIN RES, V568, P92, DOI 10.1016/0006-8993(91)91383-C; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; WALZ W, 1990, GLIA, V3, P522, DOI 10.1002/glia.440030611	19	13	13	0	2	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	JUL 20	1992	141	2					269	272		10.1016/0304-3940(92)90911-P			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JH045	WOS:A1992JH04500034	1436648				2022-02-06	
J	HART, RP; COLENDA, CC; DOUGHERTY, LM; WADE, JB				HART, RP; COLENDA, CC; DOUGHERTY, LM; WADE, JB			RECALL OF CLUSTERED AND UNCLUSTERED WORD LISTS IN ELDERLY ADULTS	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; COGNITIVE-PROCESSES; PARKINSONS-DISEASE; VERBAL MEMORY; DEPRESSION; DEMENTIA; COMPREHENSION	We present descriptive data for alternate forms of clustered and unclustered word list recall in 102 healthy elderly adults and test results for 11 patients with Parkinson's disease. The word list test provided a relatively stable measure of verbal memory. Alternate forms were equivalent except for a tendency of the unclustered list of Form 1 to be easier than those of the other three forms. Verbal intelligence, total word recall, and the ability to cluster related words at recall were related significantly. There were modest effects of education on word recall; female subjects tended to recall more words than males.	WAKE FOREST UNIV,WINSTON SALEM,NC 27109		HART, RP (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHIAT,BOX 268,RICHMOND,VA 23298, USA.				NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [1T01MH19071] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T01MH019071] Funding Source: NIH RePORTER		BATTIG WF, 1969, J EXP PSYCHOL, V80, P1, DOI 10.1037/h0027577; CAVANAUGH JC, 1983, J GERONTOL, V38, P190, DOI 10.1093/geronj/38.2.190; Craik FIM, 1977, HDB PSYCHOL AGING, P384; Derogatis LR, 1975, SCL 90 R; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; HANNAY HJ, 1985, J CLIN EXP NEUROPSYC, V7, P251, DOI 10.1080/01688638508401258; HART RP, 1987, J CONSULT CLIN PSYCH, V55, P101, DOI 10.1037/0022-006X.55.1.101; HART RP, 1991, AM J PSYCHIAT, V148, P73; HART RP, 1987, J CONSULT CLIN PSYCH, V55, P236; LAWSON MJ, 1989, J CLIN EXP NEUROPSYC, V11, P842, DOI 10.1080/01688638908400939; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; POON LW, 1985, HDB PSYCHOL AGING, P427; PORKORNY AD, 1972, AM J PSYCHIAT, V129, P342; RUFF RM, 1988, J CLIN EXPT NEUROPSY, V11, P539; SATZ P, 1962, J CLIN PSYCHOL, V18, P77, DOI 10.1002/1097-4679(196201)18:1<77::AID-JCLP2270180124>3.0.CO;2-R; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; TAUB HA, 1979, EXP AGING RES, V5, P3, DOI 10.1080/03610737908257184; TAYLOR AE, 1986, BRAIN, V109, P845, DOI 10.1093/brain/109.5.845; Wechsler D, 1987, MEMORY SCALE REVISED; WEINGARTNER H, 1981, J ABNORM PSYCHOL, V90, P187, DOI 10.1037/0021-843X.90.3.187; WEINGARTNER H, 1981, ARCH GEN PSYCHIAT, V38, P42; WEINGARTNER H, 1984, PSYCHIAT RES, V11, P223, DOI 10.1016/0165-1781(84)90071-4	22	13	13	0	0	CLINICAL PSYCHOLOGY PUBL CO	BRANDON	4 CONANT SQUARE, BRANDON, VT 05733	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.	MAY	1992	48	3					341	354		10.1002/1097-4679(199205)48:3<341::AID-JCLP2270480312>3.0.CO;2-U			14	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	HV121	WOS:A1992HV12100011	1602024				2022-02-06	
J	KULBER, DA; SANTORA, TA; SHABOT, MM; HIATT, JR				KULBER, DA; SANTORA, TA; SHABOT, MM; HIATT, JR			EARLY DIAGNOSIS AND TREATMENT OF SINUSITIS IN THE CRITICALLY ILL TRAUMA PATIENT	AMERICAN SURGEON			English	Article; Proceedings Paper	1991 ANNUAL MEETING OF THE SOUTHERN CALIFORNIA CHAPTER OF THE AMERICAN COLLEGE OF SURGEONS	JAN 18-20, 1991	SAN DIEGO, CA	AMER COLL SURGEONS, SO CALIF CHAPTER			PARA-NASAL SINUSITIS; NASOTRACHEAL INTUBATION; SEPSIS	Sinusitis is as an important cause of sepsis in the critically ill patient and may be difficult to diagnose. Four patients admitted to the surgical intensive care unit with closed head trauma were found to have sinusitis as the cause of persistent bacteremia. All patients received pharmacologic doses of corticosteroids for treatment of head injury and had prolonged nasotracheal and/or nasogastric intubation. A bedside procedure was used for diagnosis and management. Under local anesthesia, a 16-gauge angiocatheter was inserted under the inferior turbinate and into the maxillary sinus. After purulent fluid was aspirated, the sinuses were irrigated with normal saline. All four patients defervesced within 24 to 48 hours of this procedure, and facial x rays demonstrated clearing of the maxillary sinus. It was concluded that: 1) Sinusitis is a complication of closed head trauma in critically ill patients and should be included in the differential diagnosis when persistent bacteremia occurs; 2) The use of corticosteroids in the treatment of head injury may increase the risk of sinus infection; 3) Facial x rays showing air-fluid levels and/or opacification are a valuable screening test for paranasal sinusitis; and 4) bedside aspiration of the maxillary sinus is an effective diagnostic and therapeutic technique for management of sinusitis in the critically ill.	CEDARS SINAI MED CTR,DEPT SURG,SUITE 8215,8700 BEVERLY BLVD,LOS ANGELES,CA 90048; MED COLL PENN,DEPT SURG,SURG INTENS CARE UNIT,PHILADELPHIA,PA 19129; UNIV CALIF LOS ANGELES,SCH MED,DEPT SURG,LOS ANGELES,CA 90024		HIATT, JR (corresponding author), CEDARS SINAI MED CTR,DEPT SURG,SUITE 8215,8700 BEVERLY BLVD,LOS ANGELES,CA 90048, USA.			Shabot, Myron M/0000-0001-5141-0657			AEBERT H, 1988, INTENS CARE MED, V15, P27; BERG O, 1990, ANN OTO RHINOL LARYN, V99, P192; BILANIUK LT, 1982, RADIOL CLIN N AM, V20, P51; CAPLAN ES, 1982, JAMA-J AM MED ASSOC, V247, P639, DOI 10.1001/jama.247.5.639; CARENFELT C, 1981, ACTA OTOLARYNGOL STO, V93, P237; CARTER BL, 1983, RADIOLOGY, V147, P739, DOI 10.1148/radiology.147.3.6844609; CHIDEKEL N, 1970, ACTA RADIOL DIAGN, V10, P433, DOI 10.1177/028418517001000510; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; ENGQUIST S, 1983, ACTA OTOLARYNGOL STO, V93, P153; GRINDLINGER GA, 1987, CRIT CARE MED, V15, P214, DOI 10.1097/00003246-198703000-00006; HAMMORY BH, 1979, J INFECT DIS, V139, P197; HANSEN M, 1988, BRIT J ANAESTH, V61, P231, DOI 10.1093/bja/61.2.231; KRONBERG FG, 1985, LARYNGOSCOPE, V95, P936; Kurien M, 1989, Singapore Med J, V30, P565; MANN W, 1981, J OTORHINOLARYNGOL, V43, P274; OREILLY MJ, 1984, AM J SURG, V147, P601, DOI 10.1016/0002-9610(84)90122-3	16	13	13	0	0	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	1776 PEACHTREE RD, NW., SUITE 410N, ATLANTA, GA 30309-2352	0003-1348			AM SURGEON	Am. Surg.	DEC	1991	57	12					775	779					5	Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GU984	WOS:A1991GU98400008	1746793				2022-02-06	
J	CROOKS, DA; SCHOLTZ, CL; VOWLES, G; GREENWALD, S; EVANS, S				CROOKS, DA; SCHOLTZ, CL; VOWLES, G; GREENWALD, S; EVANS, S			THE GLIAL REACTION IN CLOSED HEAD-INJURIES	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						HEAD INJURY; PATHOLOGY; GLIAL REACTION; ASTROCYTES	DIFFUSE AXONAL INJURY; BRAIN-DAMAGE	The development of the glial reaction in human closed head injury has been investigated using morphometry and statistical analysis. The brains of eight individuals that survived less than 48 h following closed head injury were analysed using immunoperoxidase for glial fibrillary acidic protein (GFAP). Controls were eight patients without neurological disease. The density of reactive astrocytes was estimated in 25 fields in each of 10 different areas sampled bilaterally avoiding the subpial and subependymal zones, and the perivascular white matter. There was great variation between the zones within and between groups, and considerable variation between individuals. The raw data were expressed as logarithms averaged and analysed using the median and non-parametric statistics. The corpus callosum in the head injury group showed the highest densities of reactive astrocytes, particularly in the splenium which achieved statistical significance using the non-parametric tests. This pattern was not reproduced in the control group. Although there was overlap between the head injured and control individuals, the head injury group had relatively higher densities in all zones, and showed an overall increase in the density of reactive astrocytes. This achieved statistical significance in the corpus callosum, the occipital subcortical white matter, and the cerebellum. This study has shown that the glial reaction is often prominent in the corpus callosum irrespective of the presence of a primary lesion although the pattern varies from case to case.	LONDON HOSP,DEPT EPIDEMIOL & MED STAT,LONDON E1 1BB,ENGLAND		CROOKS, DA (corresponding author), ROYAL LONDON HOSP,DEPT MORBID ANAT,LONDON E1 1BB,ENGLAND.		Greenwald, Stephen E/C-6928-2012	Greenwald, Stephen/0000-0002-8471-7070			ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1985, MED SCI LAW, V25, P265, DOI 10.1177/002580248502500407; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; BARRON KD, 1988, ACTA NEUROPATHOL, V75, P295, DOI 10.1007/BF00690538; BLINKOV SM, 1968, HUMAN BRAIN FIGURES, P1; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; LINDENBERG R, 1955, AM J PATHOL, V31, P297; MORI S, 1969, J COMP NEUROL, V137, P197, DOI 10.1002/cne.901370206; RIPPERGER EA, 1973, P INT C BIOKINETICS, P259; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; UNTERHARNSCHEID.FJ, 1972, 15TH STAPP CAR CRASH, P767; UNTERHARNSCHEIDT F, 1969, ACTA NEUROPATHOL, V12, P200, DOI 10.1007/BF00692508; [No title captured]	15	13	14	0	1	BLACKWELL SCIENCE LTD	OXFORD	OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL	0305-1846			NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	OCT	1991	17	5					407	414		10.1111/j.1365-2990.1991.tb00740.x			8	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	GL170	WOS:A1991GL17000006	1758571				2022-02-06	
J	MOULTON, R; KRESTA, P; RAMIREZ, M; TUCKER, W				MOULTON, R; KRESTA, P; RAMIREZ, M; TUCKER, W			CONTINUOUS AUTOMATED MONITORING OF SOMATOSENSORY EVOKED-POTENTIALS IN POSTTRAUMATIC COMA	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	50TH ANNUAL SESSION OF THE AMERICAN ASSOC FOR THE SURGERY OF TRAUMA	SEP 06-08, 1990	TUCSON, AZ	AMER ASSOC SURG TRAUMA			SEVERE HEAD-INJURY; BRAIN-FUNCTION; DYSFUNCTION; CONDUCTION; PREDICTION; TRAUMA	Using a microcomputer system, 36 patients were continuously monitored with somatosensory evoked potentials (SSEPs) following closed head injury. The mean duration of monitoring was five days. The patients' GCS scores at the start of monitoring ranged from 3-10. Mortality was 44%. Of 14 patients who had initial absence of SSEP activity after the N20 wave or lost this activity during the period of monitoring, 12 died and two remained vegetative. Eighteen of 22 patients who had preservation or enhancement of this activity had a functional survival (3-month outcomes, p < 0.001). The best outcomes were observed in the patients with the greatest number of peaks and highest amplitudes in the SSEPs, often in spite of increased intracranial pressure (ICP). The management of three patients was altered as a result of SSEP monitoring. We conclude that continuous monitoring of SSEPs is a useful adjunct in the management of comatose head-injured patients.	UNIV TORONTO,ST MICHAELS HOSP,DEPT SURG,TORONTO M5B 1W8,ONTARIO,CANADA; UNIV TORONTO,ST MICHAELS HOSP,DEPT BIOMED ENGN,TORONTO M5B 1W8,ONTARIO,CANADA								BERTRAND O, 1987, ELECTROEN CLIN NEURO, V68, P433, DOI 10.1016/0168-5597(87)90055-4; FRIEDMAN VA, 1988, CLIN NEUROSURG, V34, P187; GARCIALARREA L, 1987, ELECTROEN CLIN NEURO, V68, P446, DOI 10.1016/0168-5597(87)90056-6; GREENBERG RP, 1977, J NEUROSURG, V47, P150, DOI 10.3171/jns.1977.47.2.0150; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; GREENBERG RP, 1982, J NEUROSURG, V56, P1, DOI 10.3171/jns.1982.56.1.0001; HUME AL, 1981, ANN NEUROL, V10, P411, DOI 10.1002/ana.410100503; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1975, LANCET, V1, P480; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; LINDSAY K, 1990, NEUROSURGERY, V26, P278, DOI 10.1227/00006123-199002000-00015; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; NEWLON PG, 1982, J NEUROSURG, V57, P168, DOI 10.3171/jns.1982.57.2.0168; PAPANICOLAOU AC, 1986, NEUROSURGERY, V18, P173, DOI 10.1227/00006123-198602000-00009; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P154, DOI 10.1177/155005948101200402; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P167, DOI 10.1177/155005948101200403; TEASDALE G, 1974, LANCET, V2, P81; YAMADA T, 1988, NEUROL CLIN, V6, P705, DOI 10.1016/S0733-8619(18)30839-9	20	13	13	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	1991	31	5					676	685		10.1097/00005373-199105000-00012			10	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	FM521	WOS:A1991FM52100012	2030515				2022-02-06	
J	LEHRER, PM; GROVEMAN, A; RANDOLPH, C; MILLER, MH; POLLACK, I				LEHRER, PM; GROVEMAN, A; RANDOLPH, C; MILLER, MH; POLLACK, I			PHYSIOLOGICAL-RESPONSE PATTERNS TO COGNITIVE TESTING IN ADULTS WITH CLOSED HEAD-INJURIES	PSYCHOPHYSIOLOGY			English	Article											LEHRER, PM (corresponding author), UNIV MED & DENT NEW JERSEY, ROBERT WOOD JOHNSON MED SCH, DEPT PSYCHIAT, 675 HOES LANE, PISCATAWAY, NJ 08854 USA.		Lehrer, Paul/AAE-8257-2020	Lehrer, Paul/0000-0002-9010-6129			ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; DROHOCKI Z, 1948, REV NEUROL, V80, P619; DRUDGE OW, 1984, J CLIN PSYCHOL, V40, P259, DOI 10.1002/1097-4679(198401)40:1<259::AID-JCLP2270400149>3.0.CO;2-C; EVANS RW, 1987, J NERV MENT DIS, V175, P106, DOI 10.1097/00005053-198702000-00007; FOWLES DC, 1981, PSYCHOPHYSIOLOGY, V18, P232, DOI 10.1111/j.1469-8986.1981.tb03024.x; FRANZ SI, 1920, HDB MENTAL EXAMINATI; GARDEUR D, 1979, J RADIOL ELEC MED N, V60, P79; GOLDSTEIN HS, 1985, J PSYCHOSOM RES, V29, P419, DOI 10.1016/0022-3999(85)90028-5; Goldstein L, 1965, Int Rev Neurobiol, V8, P265, DOI 10.1016/S0074-7742(08)60760-6; Groveman AM, 1987, NEUROPSYCHOLOGY, V1, P19, DOI 10.1037//0894-4105.1.1.19; HOLLOWAY FA, 1969, PSYCHOPHYSIOLOGY, V6, P138, DOI 10.1111/j.1469-8986.1969.tb02893.x; HOLLOWAY FA, 1971, PSYCHOPHYSIOLOGY, V8, P623, DOI 10.1111/j.1469-8986.1971.tb00498.x; KISHORE PRS, 1978, NEURORADIOLOGY, V16, P261, DOI 10.1007/BF00395266; KLOVE H, 1987, J CLIN EXP NEUROPSYC, V9, P297, DOI 10.1080/01688638708402792; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; LIPPER S, 1976, J NERV MENT DIS, V162, P366, DOI 10.1097/00005053-197605000-00008; LISHMAN WA, 1973, PSYCHOL CONSEQUENCES; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; OBRIST PA, 1982, PERSPECTIVES CARDIOV, P644; PARSONS OA, 1969, PSYCHOPHYSIOLOGY, V5, P644, DOI 10.1111/j.1469-8986.1969.tb02867.x; Pollack I W, 1984, J Med Soc N J, V81, P311; REITAN R M, 1955, AMA Arch Neurol Psychiatry, V73, P28; Spielberger CD, 1970, STAI MANUAL; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; TAHMOUSH AJ, 1976, PSYCHOPHYSIOLOGY, V13, P357, DOI 10.1111/j.1469-8986.1976.tb03090.x; Wechsler, 1997, WECHSLER ADULT INTEL; WEINSTEIN GS, 1981, J CLIN PSYCHIAT, V42, P120; ZAHN TP, 1982, OCT ANN M SOC PSYCH; [No title captured]	34	13	13	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	NOV	1989	26	6					668	675		10.1111/j.1469-8986.1989.tb03169.x			8	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	CQ553	WOS:A1989CQ55300004	2629014				2022-02-06	
J	KONDZIOLKA, D; SCHWARTZ, ML; WALTERS, BC; MCNEILL, I				KONDZIOLKA, D; SCHWARTZ, ML; WALTERS, BC; MCNEILL, I			THE SUNNYBROOK NEUROTRAUMA ASSESSMENT RECORD - IMPROVING TRAUMA DATA-COLLECTION	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article									UNIV TORONTO,SUNNYBROOK MED CTR,DIV NEUROL,2075 BAYVIEW AVE,TORONTO M4N 3M5,ONTARIO,CANADA; UNIV TORONTO,SUNNYBROOK MED CTR,REG TRAUMA UNIT,TORONTO M4N 3M5,ONTARIO,CANADA				Walters, Beverly/R-8411-2019	Walters, Beverly/0000-0002-5244-4282			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; GREENES RA, 1970, NEW ENGL J MED, V282, P307, DOI 10.1056/NEJM197002052820605; MCDONALD CJ, 1976, NEW ENGL J MED, V295, P1351, DOI 10.1056/NEJM197612092952405; TASKER RR, 1982, PHYSL ATLAS USING EL, P41	4	13	14	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	1989	29	6					730	735		10.1097/00005373-198906000-00005			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AC920	WOS:A1989AC92000005	2738969				2022-02-06	
J	PROCTOR, HJ; PALLADINO, GW; FILLIPO, D				PROCTOR, HJ; PALLADINO, GW; FILLIPO, D			FAILURE OF AUTO-REGULATION AFTER CLOSED HEAD-INJURY - AN EXPERIMENTAL-MODEL	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article											PROCTOR, HJ (corresponding author), UNIV N CAROLINA,SCH MED,DEPT SURG,TRAUMA SECT,215 BURNETT WOMACK CLIN SCI BLDG 229H,CHAPEL HILL,NC 27514, USA.						AUER LM, 1978, ACTA NEUROCHIM S, V28, P1; BRAZY JE, 1985, PEDIATRICS, V75, P217; DUCKROW RB, 1981, J NEUROSURG, V54, P607, DOI 10.3171/jns.1981.54.5.0607; FILLIPO DC, 1983, SURG FORUM, V34, P523; FOX EJ, IN PRESS ADV EXP MED; KONTOS HA, 1981, AM J PHYSIOL, V240, pH511, DOI 10.1152/ajpheart.1981.240.4.H511; KREISMAN NR, 1983, J CEREBR BLOOD F MET, V3, P330, DOI 10.1038/jcbfm.1983.48; Lowry O. H., 1972, A Flexible System of Enzymatic Analysis, P146; MACKENZIE ET, 1976, CIRC RES, V39, P33, DOI 10.1161/01.RES.39.1.33; PONTEN U, 1966, ACTA PHYSIOL SCAND, V68, P152, DOI 10.1111/j.1748-1716.1966.tb03413.x; POVLISHOCK JT, 1983, AM J PATHOL, V110, P148; PROCTOR HJ, 1985, SURG GYNECOL OBSTET, V161, P145; PROCTOR HJ, 1984, SURGERY, V96, P278; RAMSAY F, 1984, ADV EPILEPTOLOGY, P105; ROSNER MJ, 1982, 4TH CHIC S NEUR TRAU, pCH10; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95	18	13	13	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	1988	28	3					347	352		10.1097/00005373-198803000-00010			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	M8911	WOS:A1988M891100010	2832618				2022-02-06	
J	RANDOLPH, C; MILLER, MH				RANDOLPH, C; MILLER, MH			EEG AND COGNITIVE PERFORMANCE FOLLOWING CLOSED HEAD-INJURY	NEUROPSYCHOBIOLOGY			English	Article									UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT PSYCHIAT,POB 101,PISCATAWAY,NJ 08854								AMOCHAEV S, 1979, PSYCHOPHYSIOLOGY, V16, P247; Benton A. L., 1969, EMBEDDED FIGURES TES; BUCY PC, 1970, JOM-J OCCUP MED, V12, P318; DOLCE G, 1974, ELECTROEN CLIN NEURO, V36, P577, DOI 10.1016/0013-4694(74)90224-7; DROHOCKI Z, 1948, REV NEUROL, V80, P619; DYE OA, 1981, J CLIN PSYCHOL, V37, P472, DOI 10.1002/1097-4679(198107)37:3<472::AID-JCLP2270370304>3.0.CO;2-Q; FRANZ SI, 1920, HDB MENTAL EXAMINATI; GIANUTSOS R, 1981, COGNITIVE REHABILITA; GOLDSTEIN L, 1975, HEMISPHERIC ASYMMETR, P237; GRUBB RL, 1978, NEUROLOGICAL PATHOPH; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KOUFEN H, 1978, FORTSCHR NEUROL PSYC, V46, P165; LEVIN HS, 1985, ARCH NEUROL-CHICAGO, V42, P963, DOI 10.1001/archneur.1985.04060090045012; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; MCGEE DH, 1981, THESIS RUTGERS U NEW; SCHERZER E, 1970, ELECTROENCEPH CLIN N, V29; SHAW JC, 1976, PSYCHOL MED, V6, P307, DOI 10.1017/S0033291700013878; SHAW JC, 1976, PSYCHOL MED, V6, P316; VOGEL W, 1968, ELECTROEN CLIN NEURO, V24, P166, DOI 10.1016/0013-4694(68)90122-3; Walsh K.W, 1978, NEUROPSYCHOLOGY; 1985, SAS STATTM DISCRIM P	21	13	14	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0302-282X			NEUROPSYCHOBIOLOGY	Neuropsychobiology		1988	20	1					43	50		10.1159/000118471			8	Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	T3131	WOS:A1988T313100007	3231300				2022-02-06	
J	MIZRAHI, EM; KELLAWAY, P				MIZRAHI, EM; KELLAWAY, P			CEREBRAL CONCUSSION IN CHILDREN - ASSESSMENT OF INJURY BY ELECTROENCEPHALOGRAPHY	PEDIATRICS			English	Article									METHODIST HOSP,BAYLOR COLL MED,DEPT PEDIAT,PEDIAT NEUROL SECT,HOUSTON,TX 77030; TEXAS CHILDRENS HOSP,HOUSTON,TX 77030		MIZRAHI, EM (corresponding author), METHODIST HOSP,BAYLOR COLL MED,DEPT NEUROL,NEUROPHYSIOL SECT,HOUSTON,TX 77030, USA.						Bricolo A, 1979, Acta Neurochir Suppl (Wien), V28, P35; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DENNYBROWN D, 1961, ARCH NEUROL-CHICAGO, V5, P1; DENNYBROWN D, 1945, PHYSIOL REV, V25, P296, DOI 10.1152/physrev.1945.25.2.296; DEVIVO DC, 1971, PEDIATRICS, V48, P129; GROAT R, 1950, J NEUROPATH EXP NEUR, V9, P150, DOI 10.1097/00005072-195004000-00003; HAYES RL, 1984, SCIENCE, V223, P301, DOI 10.1126/science.6701514; JASPER H, 1945, RES PUBL ASS NERV ME, V24, P388; Jennett B, 1981, MANAGEMENT HEAD INJU; JENNETT B, 1975, EPILEPSY NONMISSILE; KELLAWAY P, 1955, ELECTROEN CLIN NEURO, V7, P497; Kellaway P, 1981, CURRENT CLIN NEUROPH, P151; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KOUFEN H, 1977, EEG-EMG-Z ELEK ELEKT, V8, P29; LANDAUFEREY J, 1980, ELECTROEN CLIN NEURO, V49, P173, DOI 10.1016/0013-4694(80)90364-8; MENKES JH, 1980, TXB NEUROLOGY, P411; OLOFSON O, 1971, NEUROPADIATRIE, V2, P375; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OMMAYA AK, 1966, HEAD INJURY, P260; Posner JB., 1980, DIAGNOSIS STUPOR COM, V3; SILVERMAN D, 1962, NEUROLOGY, V12, P273, DOI 10.1212/WNL.12.4.273; SINGER HS, 1978, PEDIATRICS, V62, P819; SYMONDS C, 1962, LANCET, V1, P1; Trotter W, 1924, LANCET, V1, P935; WALKER AE, 1966, HEAD INJURY, P18; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561; WINDLE WF, 1945, ANAT REC, V93, P201, DOI 10.1002/ar.1090930210; [No title captured]	28	13	13	0	0	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD, ELK GROVE VILLAGE, IL 60007-1098	0031-4005			PEDIATRICS	Pediatrics		1984	73	4					419	425					7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	SL090	WOS:A1984SL09000001	6709421				2022-02-06	
J	LEVIN, HS; GROSSMAN, RG; KELLY, PJ				LEVIN, HS; GROSSMAN, RG; KELLY, PJ			IMPAIRMENT OF FACIAL RECOGNITION AFTER CLOSED HEAD-INJURIES OF VARYING SEVERITY	CORTEX			English	Article									UNIV TEXAS,MED BRANCH,DEPT SURG,DIV NEUROSURG,GALVESTON,TX 77550						NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [2P01 NS 07377-06] Funding Source: Medline		BENTON AL, 1969, J NEUROL SCI, V9, P39, DOI 10.1016/0022-510X(69)90057-4; BENTON AL, 1964, J NERV MENT DIS, V139, P110, DOI 10.1097/00005053-196408000-00003; BROOKS DN, 1974, J NEUROL NEUROSUR PS, V37, P794, DOI 10.1136/jnnp.37.7.794; DERENZI E, 1966, NEUROLOGY, V16, P145, DOI 10.1212/WNL.16.2_Part_1.145; Klove H, 1972, Scand J Rehabil Med, V4, P55; LEVIN HS, 1975, J PSYCHOL, V91, P223, DOI 10.1080/00223980.1975.9923946; LEVIN HS, 1976, CORTEX, V12, P175, DOI 10.1016/S0010-9452(76)80021-4; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ruesch J, 1944, AM J PSYCHIAT, V100, P480, DOI 10.1176/ajp.100.4.480; SPREEN O, 1966, MANUAL NEUROSENSORY; Van Allen MW, 1968, CORTEX, V93, P38, DOI [10.1016/S0010-9452(68)80018-8, DOI 10.1016/S0010-9452(68)80018, 10.1016/S0010-9452(68)80018]; Warrington E. K., 1967, CORTEX, V3, P317	12	13	13	1	1	MASSON DIVISIONE PERIODICI	MILAN	VIA FRATELLI BRESSAN 2, 20126 MILAN, ITALY	0010-9452			CORTEX	Cortex		1977	13	2					119	130		10.1016/S0010-9452(77)80003-8			12	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	DN815	WOS:A1977DN81500002	16295956	Bronze			2022-02-06	
J	JACOBSON, SA				JACOBSON, SA			PROTRACTED UNCONSCIOUSNESS DUE TO CLOSED HEAD INJURY	NEUROLOGY			English	Article																	CAIRNS H, 1952, BRAIN, V75, P109, DOI 10.1093/brain/75.2.109; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; ECHOLS D H, 1949, New Orleans Med Surg J, V102, P97; ECHOLS DH, 1950, SURGERY, V28, P801; FOREGGER R, 1947, JAMA-J AM MED ASSOC, V133, P1200, DOI 10.1001/jama.1947.02880160026005; JASPER H, 1943, A RES NERV MENT DIS, V24, P388; MUNRO D, TREATMENT INJURIES C, P86; SHIENKER M, 1949, NEUROSURGICAL PATHOL, P42; Williams D, 1941, BRAIN, V64, P223, DOI 10.1093/brain/64.4.223; Williams D, 1941, J NEUROL PSYCHIATRY, V4, P107, DOI 10.1136/jnnp.4.2.107	10	13	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0028-3878			NEUROLOGY	Neurology		1956	6	4					281	287		10.1212/WNL.6.4.281			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WC989	WOS:A1956WC98900005	13309608				2022-02-06	
J	Eagle, SR; Nindl, BC; Johnson, CD; Kontos, AP; Connaboy, C				Eagle, Shawn R.; Nindl, Bradley C.; Johnson, Caleb D.; Kontos, Anthony P.; Connaboy, Chris			Autonomic Dysregulation in Adolescent Concussion Is Sex- and Posture-Dependent	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						adolescent concussion; heart rate variability; blood pressure; sex differences; autonomic nervous system; sport-related concussion	HEART-RATE-VARIABILITY; TRAUMATIC BRAIN-INJURY; POWER SPECTRAL-ANALYSIS; MENSTRUAL-CYCLE; YOUNG-WOMEN; HIGH-SCHOOL; SPORT; CHILDREN; AGE; RELIABILITY	Objective: To study autonomic responses to postural changes in concussed adolescents. The influence of sex was also studied. Design: Longitudinal cohort observational study. Participants: Concussed adolescents (CONC; n = 65; 26 male adolescents; age 15 +/- 1 years, range = 12-18 years) and a control (CTRL) group of nonconcussed adolescents of similar age and sport (CTRL; n = 54; 29 male adolescents; age 14 +/- 1 years, range = 12-18 years). Interventions: Concussed participants were monitored through 6 weekly visits throughout usual physician care. Control participants underwent 2 visits separated by at least 1 week to account for intrapersonal variation in testing measures. Main Outcome Measures: Heart rate variability as the root mean square of successive differences in R-R intervals (RMSSD), heart rate (HR), and blood pressure [mean arterial pressure (MAP) and diastolic blood pressure (DBP)] were measured in supine, sitting, and standing postures. Results: A mixed analysis of variance revealed a group x sex x posture interaction (P = 0.04) where seated values of RMSSD were less in concussed female participants versus control female participants (42 +/- 4 vs 61 +/- 7 ms; P = 0.01; Mann-Whitney rank test). Compared with CTRL, CONC exhibited increased pretesting seated DBP (69 +/- 1 vs 74 +/- 1 mm Hg; P < 0.01), MAP (83 +/- 1 vs 86 +/- 1 mm Hg; P = 0.02), and baseline seated HR (72 +/- 1 vs 77 +/- 2 bpm; P = 0.03). Values of DBP (P = 0.03) and MAP (P < 0.01) improved at clinical discharge, whereas the RMSSD in female participants did not (P > 0.5). Data are mean +/- SEM. Conclusions: A modest reduction in female cardiac autonomic regulation was observed during seated postures. Alterations in seated concussed DBP and MAP, but not RMSSD, resolved at clinical discharge (median = 37 days). The results indicate that, in adolescents, concussion may impair cardiovagal function in a sex- and posture-dependent manner. The findings also suggest that BP metrics, but not RMSSD, are associated with clinical concussion recovery.	[Eagle, Shawn R.; Nindl, Bradley C.; Connaboy, Chris] Univ Pittsburgh, Dept Sports Med & Nutr, Neuromuscular Res Lab, Pittsburgh, PA 15203 USA; [Johnson, Caleb D.] Harvard Univ, Spaulding Natl Running Ctr, Harvard Med Sch, Cambridge, MA 02138 USA; [Kontos, Anthony P.] Univ Pittsburgh, UPMC Sports Med Concuss Program, Dept Orthopaed Surg, Pittsburgh, PA 15203 USA		Eagle, SR (corresponding author), Univ Pittsburgh, Dept Sports Med & Nutr, 3860 S Water St, Pittsburgh, PA 15203 USA.	seagle@pitt.edu		Connaboy, Christopher/0000-0002-9031-2192	National Athletic Trainer's Association Research and Education Foundation grant [1516DGP003]	This study was funded by a National Athletic Trainer's Association Research and Education Foundation grant, #1516DGP003.	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Benarroch EE, 2008, NEUROLOGY, V71, P1733, DOI 10.1212/01.wnl.0000335246.93495.92; Bishop S, 2017, BRAIN INJURY, V31, P247, DOI 10.1080/02699052.2016.1226385; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Boyce SH, 2003, SCOT MED J, V48, P88, DOI 10.1177/003693300304800308; Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; CAMM AJ, 1996, CIRCULATION, V93, P1043; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; COYLE EF, 1986, J APPL PHYSIOL, V60, P95, DOI 10.1152/jappl.1986.60.1.95; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faulkner MS, 2003, HEART LUNG, V32, P10, DOI 10.1067/mhl.2003.6; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gamelin FX, 2007, INT J SPORTS MED, V28, P564, DOI 10.1055/s-2007-964861; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goldberger JJ, 2001, CIRCULATION, V103, P1977; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Goodman B., 2013, NEUROLOGY, V80, pP01; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hansen AL, 2004, EUR J APPL PHYSIOL, V93, P263, DOI 10.1007/s00421-004-1208-0; Heyer GL, 2016, CLIN J SPORT MED, V26, P40, DOI 10.1097/JSM.0000000000000183; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; KATONA PG, 1975, J APPL PHYSIOL, V39, P801, DOI 10.1152/jappl.1975.39.5.801; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; King DR, 2009, J TRAUMA, V67, P436, DOI 10.1097/TA.0b013e3181ad67de; KOTCHEN JM, 1982, HYPERTENSION, V4, P128; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leicht AS, 2003, EXP PHYSIOL, V88, P441, DOI 10.1113/eph8802535; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McNames J, 2006, MED BIOL ENG COMPUT, V44, P747, DOI 10.1007/s11517-006-0097-2; Mullen TJ, 1997, AM J PHYSIOL-HEART C, V272, pH448, DOI 10.1152/ajpheart.1997.272.1.H448; Munoz ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138921; Nussinovitch U, 2011, ANN NONINVAS ELECTRO, V16, P117, DOI 10.1111/j.1542-474X.2011.00417.x; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Saboul D, 2014, EUR J SPORT SCI, V14, pS282, DOI 10.1080/17461391.2012.691116; SATO N, 1995, PSYCHOSOM MED, V57, P331, DOI 10.1097/00006842-199507000-00004; Silvetti MS, 2001, INT J CARDIOL, V81, P169, DOI 10.1016/S0167-5273(01)00537-X; Stein PK, 1997, AM J CARDIOL, V80, P302, DOI 10.1016/S0002-9149(97)00350-0; Sufrinko AM, 2017, CLIN J SPORT MED, V27, P133, DOI 10.1097/JSM.0000000000000324; Sugawara J, 2001, EUR J APPL PHYSIOL, V85, P259, DOI 10.1007/s004210100443; Teixeira AL, 2015, PSYCHOPHYSIOLOGY, V52, P1451, DOI 10.1111/psyp.12510; Tenan MS, 2014, PSYCHOPHYSIOLOGY, V51, P996, DOI 10.1111/psyp.12250; Thong T, 2003, P ANN INT IEEE EMBS, V25, P2424, DOI 10.1109/IEMBS.2003.1280405	61	12	12	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2021	31	3					273	280		10.1097/JSM.0000000000000731			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	SO2PJ	WOS:000658818900013	30829684				2022-02-06	
J	Leddy, J; Lesh, K; Haider, MN; Czuczman, N; Baker, JG; Miecznikowski, J; Willer, B				Leddy, John; Lesh, Kevin; Haider, Mohammad N.; Czuczman, Natalie; Baker, John G.; Miecznikowski, Jeffrey; Willer, Barry			Derivation of a Focused, Brief Concussion Physical Examination for Adolescents With Sport-Related Concussion	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sport-related concussion; buffalo; physical examination; vestibular; oculomotor; cervical		Objective: To describe the derivation of a brief but pertinent physical examination (PE) for adolescents who have sustained sport-related concussion (SRC). Design: Prospective cohort. Setting: University concussion management clinic. Participants: Acutely concussed (AC, n = 52, 15.5 +/- 1.4 years, 4.4 +/- 2 days since injury, 26.2 +/- 38 days to recovery, 71% males) and healthy control (HC) adolescents (n = 30, 15.8 +/- 1.4 years, 73% males). Intervention: Acutely concussed had a PE on visit 1 and were retested at visit 2 (13.6 +/- 1 day after visit 1). Acutely concussed were further characterized as normal recovery (NR, n = 41, 15.5 +/- 1.5 years, recovery time 13.0 +/- 7 days) and delayed recovery (DR, n = 11, 15.5 +/- 1.2 years, recovery time 75.4 +/- 63 days). Main Outcome Measure: Physical examination findings, including cervical, vestibular, and oculomotor systems. Results: Visit 1 abnormal PE signs were significantly greater in AC versus HC (2.79 +/- 2.13 vs 0.07 +/- 0.37, P < 0.0001) but not in NR versus DR (2.61 +/- 2.2 vs 3.45 +/- 1.8, P = 0.246). Visit 2 abnormal PE signs differentiated NR versus DR (0.17 +/- 0.7 vs 2.45 +/- 2.1, P < 0.0001). Conclusions: A brief focused PE can help to diagnose SRC, establish recovery, and may have prognostic value.	[Leddy, John; Lesh, Kevin; Haider, Mohammad N.; Baker, John G.] SUNY Buffalo, UBMD Orthoped & Sports Med, Dept Orthoped & Sports Med, Buffalo, NY USA; [Haider, Mohammad N.] SUNY Buffalo, Dept Neurosci, Buffalo, NY USA; [Czuczman, Natalie] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA; [Baker, John G.] SUNY Buffalo, Dept Nucl Med, Buffalo, NY USA; [Miecznikowski, Jeffrey] SUNY Buffalo, Dept Biostat, Buffalo, NY USA; [Willer, Barry] SUNY Buffalo, Dept Psychiat, Buffalo, NY USA		Haider, MN (corresponding author), SUNY Buffalo, 160 Farber Hall,3435 Main St, Buffalo, NY 14214 USA.	haider@buffalo.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS094444]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412]	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number 1R01NS094444. Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR001412 to the University at Buffalo.	Abraham Neethu G, 2015, Oman J Ophthalmol, V8, P14, DOI 10.4103/0974-620X.149856; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; [Anonymous], 2013, R LANGUAGE ENV STAT; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Armstrong B, 2008, SPORTS MED, V38, P101, DOI 10.2165/00007256-200838020-00002; Boutis K, 2015, J PEDIATR-US, V166, P1214, DOI 10.1016/j.jpeds.2015.02.013; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Crutchfield K., 2014, NEUROLOGY, V82; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2015, CURR SPORT MED REP, V14, P20, DOI 10.1249/JSR.0000000000000108; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Giza CC, 2011, SPORTS HEALTH, V3, P46, DOI 10.1177/1941738110391732; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Haider MN., 2017, CONCUSSION, V2; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heitger MH., 2008, ENG MED BIOL SOC AUG; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Kim HA, 2008, NEUROLOGY, V70, P449, DOI 10.1212/01.wnl.0000297554.21221.a0; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Leslie O, 2013, CLIN J SPORT MED, V23, P331, DOI 10.1097/JSM.0b013e318295bbb1; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Polak P, 2015, J HEAD TRAUMA REHAB, V30, pE32, DOI 10.1097/HTR.0000000000000037; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Treleaven J, 2011, SPINE, V36, pS211, DOI 10.1097/BRS.0b013e3182387f78; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Von Noorden G., 2002, BINOCULAR VISION OCU, V6th ed, P52; Whiteside JW, 2006, AM FAM PHYSICIAN, V74, P1357; Willer BS, 2016, ACAD EMERG MED, V23, P495, DOI 10.1111/acem.12940; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	53	12	12	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2021	31	1					7	14		10.1097/JSM.0000000000000686			8	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	PR5RY	WOS:000607294800003	30418219	Green Accepted			2022-02-06	
J	Zrzavy, T; Schwaiger, C; Wimmer, I; Berger, T; Bauer, J; Butovsky, O; Schwab, JM; Lassmann, H; Hoftberger, R				Zrzavy, Tobias; Schwaiger, Carmen; Wimmer, Isabella; Berger, Thomas; Bauer, Jan; Butovsky, Oleg; Schwab, Jan M.; Lassmann, Hans; Hoeftberger, Romana			Acute and non-resolving inflammation associate with oxidative injury after human spinal cord injury	BRAIN			English	Article						oxidative injury; adaptive immunity; microglia; blood-derived macrophages; spinal cord injury	MULTIPLE-SCLEROSIS LESIONS; TRAUMATIC BRAIN-INJURY; NEUROLOGIC RECOVERY; MICROGLIA; ACTIVATION; MACROPHAGES; DAMAGE; NEURODEGENERATION; NEUROTOXICITY; REMYELINATION	Traumatic spinal cord injury is a devastating insult followed by progressive cord atrophy and neurodegeneration. Dysregulated or non-resolving inflammatory processes can disturb neuronal homeostasis and drive neurodegeneration. Here, we provide an in-depth characterization of innate and adaptive inflammatory responses as well as oxidative tissue injury in human traumatic spinal cord injury lesions compared to non-traumatic control cords. In the lesion core, microglia were rapidly lost while intermediate (co-expressing pro- as well as anti-inflammatory molecules) blood-borne macrophages dominated. In contrast, in the surrounding rim, TMEM119(+) microglia numbers were maintained through local proliferation and demonstrated a predominantly pro-inflammatory phenotype. Lymphocyte numbers were low and mainly consisted of CD8(+) T cells. Only in a subpopulation of patients, CD138(+)/IgG(+) plasma cells were detected, which could serve as candidate cellular sources for a developing humoral immunity. Oxidative neuronal cell body and axonal injury was visualized by intracellular accumulation of amyloid precursor protein (APP) and oxidized phospholipids (e06) and occurred early within the lesion core and declined over time. In contrast, within the surrounding rim, pronounced APP(+)/e06(+) axon-dendritic injury of neurons was detected, which remained significantly elevated up to months/years, thus providing mechanistic evidence for ongoing neuronal damage long after initial trauma. Dynamic and sustained neurotoxicity after human spinal cord injury might be a substantial contributor to (i) an impaired response to rehabilitation; (ii) overall failure of recovery; or (iii) late loss of recovered function (neuro-worsening/degeneration).	[Zrzavy, Tobias; Wimmer, Isabella; Berger, Thomas] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Schwaiger, Carmen; Hoeftberger, Romana] Med Univ Vienna, Dept Neurol, Div Neuropathol & Neurochem, Vienna, Austria; [Bauer, Jan; Lassmann, Hans] Med Univ Vienna, Ctr Brain Res, Vienna, Austria; [Butovsky, Oleg] Harvard Med Sch, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Dept Neurol, Boston, MA 02115 USA; [Butovsky, Oleg] Harvard Med Sch, Brigham & Womens Hosp, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Schwab, Jan M.] Ohio State Univ, Belford Ctr Spinal Cord Injury, Columbus, OH 43210 USA; [Schwab, Jan M.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; [Schwab, Jan M.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Schwab, Jan M.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA		Hoftberger, R (corresponding author), Med Univ Vienna, Dept Neurol, Div Neuropathol & Neurochem, Vienna, Austria.	romana.hoeftberger@meduniwien.ac.at	Wimmer, Isabella/ABI-6331-2020	Wimmer, Isabella/0000-0003-2231-2120; Schwab, Jan/0000-0001-6784-4919; Zrzavy, Tobias/0000-0001-8909-1591; Schwaiger, Carmen/0000-0002-4029-1733; Hoftberger, Romana/0000-0002-5769-1100	Austrian Science Fund (FWF)Austrian Science Fund (FWF); Era-Net-NEURON Program (SILENCE) [I 3334-B27]; Jubilaumsfonds der Osterreichischen Nationalbank [16919]; Craig H. Neilsen Foundation (CHNF) [596764]; Wings-for-Life Spinal Cord Research Foundation [DE-047/14, DE-16/16]; Era-Net-NEURON Program of the European Union (EU) [01EW170A, 01EW1710]; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90SI5020]; W.E. Hunt & C.M. Curtis Endowment	This work was supported by grants from the Austrian Science Fund (FWF), Era-Net-NEURON Program (SILENCE; No. I 3334-B27) and the Jubilaumsfonds der Osterreichischen Nationalbank', project 16919. J.M.S. received funding support from the Craig H. Neilsen Foundation (CHNF#596764), the Wings-for-Life Spinal Cord Research Foundation (#DE-047/14, DE-16/16); the Era-Net-NEURON Program of the European Union (EU) (SILENCE #01EW170A and SCI-Net #01EW1710); the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR #90SI5020); and the W.E. Hunt & C.M. Curtis Endowment. J.M.S. is a Discovery Theme Initiative Scholar (Chronic Brain Injury) of the Ohio State University.	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Ankeny DP, 2006, J NEUROCHEM, V99, P1073, DOI 10.1111/j.1471-4159.2006.04147.x; Ankeny DP, 2009, J CLIN INVEST, V119, P2990, DOI 10.1172/JCI39780; Bao F, 2004, J NEUROCHEM, V88, P1335, DOI 10.1046/j.1471-4159.2003.02240.x; Bao F, 2008, EXP NEUROL, V214, P160, DOI 10.1016/j.expneurol.2008.09.006; Bastani NE, 2012, ARCH PHYS MED REHAB, V93, P2223, DOI 10.1016/j.apmr.2012.06.021; Bauer J, 2016, METHODS MOL BIOL, V1304, P211, DOI 10.1007/7651_2014_151; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bien CG, 2012, BRAIN, V135, P1622, DOI 10.1093/brain/aws082; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; David Samuel, 2012, Handb Clin Neurol, V109, P485, DOI 10.1016/B978-0-444-52137-8.00030-9; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Dinkel K, 2004, P NATL ACAD SCI USA, V101, P331, DOI 10.1073/pnas.0303510101; Dirnagl U, 2014, STROKE, V45, pE177, DOI 10.1161/STROKEAHA.114.005640; Enzmann G, 2013, ACTA NEUROPATHOL, V125, P395, DOI 10.1007/s00401-012-1076-3; Fischer MT, 2012, BRAIN, V135, P886, DOI 10.1093/brain/aws012; Fischer MT, 2013, BRAIN, V136, P1799, DOI 10.1093/brain/awt110; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Friese MA, 2014, NAT REV NEUROL, V10, P225, DOI 10.1038/nrneurol.2014.37; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Greenhalgh AD, 2014, J NEUROSCI, V34, P6316, DOI 10.1523/JNEUROSCI.4912-13.2014; Gris D, 2004, J NEUROSCI, V24, P4043, DOI 10.1523/JNEUROSCI.5343-03.2004; Haider L, 2016, BRAIN, V139, P807, DOI 10.1093/brain/awv398; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; HALL ED, 1993, CELL MOL NEUROBIOL, V13, P415, DOI 10.1007/BF00711581; Hametner S, 2013, ANN NEUROL, V74, P848, DOI 10.1002/ana.23974; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hayes KC, 2002, J NEUROTRAUM, V19, P753, DOI 10.1089/08977150260139129; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Kerr BJ, 2008, GLIA, V56, P436, DOI 10.1002/glia.20630; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kirshblum S, 2004, ARCH PHYS MED REHAB, V85, P1811, DOI 10.1016/j.apmr.2004.03.015; Kotter MR, 2005, NEUROBIOL DIS, V18, P166, DOI 10.1016/j.nbd.2004.09.019; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Machado-Santos J, 2018, BRAIN, V141, P2066, DOI 10.1093/brain/awy151; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Marino RJ, 1999, ARCH PHYS MED REHAB, V80, P1391, DOI 10.1016/S0003-9993(99)90249-6; Miron VE, 2014, J NEUROCHEM, V130, P165, DOI 10.1111/jnc.12705; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Nguyen HX, 2007, J NEUROCHEM, V102, P900, DOI 10.1111/j.1471-4159.2007.04643.x; Orr MB, 2018, NEUROTHERAPEUTICS, V15, P541, DOI 10.1007/s13311-018-0631-6; Pajoohesh-Ganji A, 2011, NEUROTHERAPEUTICS, V8, P195, DOI 10.1007/s13311-011-0036-2; Peferoen LAN, 2015, J NEUROPATH EXP NEUR, V74, P48, DOI 10.1097/NEN.0000000000000149; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Popovich PG, 2001, J NEUROPATH EXP NEUR, V60, P676, DOI 10.1093/jnen/60.7.676; Pruss H, 2011, BRAIN PATHOL, V21, P652, DOI 10.1111/j.1750-3639.2011.00488.x; Ramer LM, 2014, LANCET NEUROL, V13, P1241, DOI 10.1016/S1474-4422(14)70144-9; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Satoh J, 2016, NEUROPATHOLOGY, V36, P39, DOI 10.1111/neup.12235; Schuh C, 2014, ACTA NEUROPATHOL, V128, P247, DOI 10.1007/s00401-014-1263-5; Schwab JM, 2014, EXP NEUROL, V258, P121, DOI 10.1016/j.expneurol.2014.04.023; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; Taoka Y, 1997, NEUROSCIENCE, V79, P1177, DOI 10.1016/S0306-4522(97)00011-0; Troscher AR, 2019, ACTA NEUROPATHOL, V137, P619, DOI 10.1007/s00401-019-01958-5; Ulrich JD, 2017, NEURON, V94, P237, DOI 10.1016/j.neuron.2017.02.042; Van Gorp H, 2010, MOL IMMUNOL, V47, P1650, DOI 10.1016/j.molimm.2010.02.008; van Nierop GP, 2017, ACTA NEUROPATHOL, V134, P383, DOI 10.1007/s00401-017-1744-4; Vogel DYS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-35; Wardlaw JM, 2020, NAT REV NEUROL, V16, P137, DOI 10.1038/s41582-020-0312-z; Williams PR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6683; Zajarias-Fainsod D, 2012, EUR SPINE J, V21, P964, DOI 10.1007/s00586-011-2060-7; Ziegler G, 2018, NEUROLOGY, V90, pE1257, DOI 10.1212/WNL.0000000000005258; Zrzavy T, 2019, NEUROPATH APPL NEURO, V45, P278, DOI 10.1111/nan.12502; Zrzavy T, 2018, BRAIN PATHOL, V28, P791, DOI 10.1111/bpa.12583; Zrzavy T, 2017, BRAIN, V140, P1900, DOI 10.1093/brain/awx113	71	12	12	7	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JAN	2021	144		1				144	161		10.1093/brain/awaa360			18	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	SA6XJ	WOS:000649444700028	33578421	Green Published, hybrid			2022-02-06	
J	Bossers, SM; Loer, SA; Bloemers, FW; Den Hartog, D; Van Lieshout, EMM; Hoogerwerf, N; van der Naalt, J; Absalom, AR; Peerdeman, SM; Schwarte, LA; Boer, C; Schober, P				Bossers, Sebastiaan M.; Loer, Stephan A.; Bloemers, Frank W.; Den Hartog, Dennis; Van Lieshout, Esther M. M.; Hoogerwerf, Nico; van der Naalt, Joukje; Absalom, Anthony R.; Peerdeman, Saskia M.; Schwarte, Lothar A.; Boer, Christa; Schober, Patrick		BRAIN-PROTECT Collaborators	Association Between Prehospital Tranexamic Acid Administration and Outcomes of Severe Traumatic Brain Injury	JAMA NEUROLOGY			English	Article							COAGULOPATHY; HEMORRHAGE; EVENTS	Question Is there an association between prehospital tranexamic acid administration and outcomes after severe traumatic brain injury (TBI)? Findings In this multicenter cohort study of 1827 patients, prehospital administration of tranexamic acid was associated with a statistically significant increase in the odds of mortality in patients with isolated severe TBI. No evidence of an association was observed in the overall cohort, including in patients with combined intracranial and extracranial injuries. Meaning Results of this study suggest that prehospital administration of tranexamic acid could lead to increased mortality in patients with isolated severe TBI. This cohort study investigates the mortality and functional outcomes of individuals who received a prehospital dose of tranexamic acid for suspected severe traumatic brain injury. Importance The development and expansion of intracranial hematoma are associated with adverse outcomes. Use of tranexamic acid might limit intracranial hematoma formation, but its association with outcomes of severe traumatic brain injury (TBI) is unclear. Objective To assess whether prehospital administration of tranexamic acid is associated with mortality and functional outcomes in a group of patients with severe TBI. Design, Setting, and Participants This multicenter cohort study is an analysis of prospectively collected observational data from the Brain Injury: Prehospital Registry of Outcome, Treatments and Epidemiology of Cerebral Trauma (BRAIN-PROTECT) study in the Netherlands. Patients treated for suspected severe TBI by the Dutch Helicopter Emergency Medical Services between February 2012 and December 2017 were included. Patients were followed up for 1 year after inclusion. Data were analyzed from January 10, 2020, to September 10, 2020. Exposures Administration of tranexamic acid during prehospital treatment. Main Outcomes and Measures The primary outcome was 30-day mortality. Secondary outcomes included mortality at 1 year, functional neurological recovery at discharge (measured by Glasgow Outcome Scale), and length of hospital stay. Data were also collected on demographic factors, preinjury medical condition, injury characteristics, operational characteristics, and prehospital vital parameters. Results A total of 1827 patients were analyzed, of whom 1283 (70%) were male individuals and the median (interquartile range) age was 45 (23-65) years. In the unadjusted analysis, higher 30-day mortality was observed in patients who received prehospital tranexamic acid (odds ratio [OR], 1.34; 95% CI, 1.16-1.55; P < .001), compared with patients who did not receive prehospital tranexamic acid. After adjustment for confounders, no association between prehospital administration of tranexamic acid and mortality was found across the entire cohort of patients. However, a substantial increase in the odds of 30-day mortality persisted in patients with severe isolated TBI who received prehospital tranexamic acid (OR, 4.49; 95% CI, 1.57-12.87; P = .005) and after multiple imputations (OR, 2.05; 95% CI, 1.22-3.45; P = .007). Conclusions and Relevance This study found that prehospital tranexamic acid administration was associated with increased mortality in patients with isolated severe TBI, suggesting the judicious use of the drug when no evidence for extracranial hemorrhage is present.	[Bossers, Sebastiaan M.; Loer, Stephan A.; Schwarte, Lothar A.; Boer, Christa; Schober, Patrick] Vrije Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Anesthesiol, Amsterdam, Netherlands; [Bloemers, Frank W.] Vrije Univ Amsterdam, Dept Surg, Amsterdam Univ Med Ctr, Amsterdam, Netherlands; [Den Hartog, Dennis; Van Lieshout, Esther M. M.] Univ Med Ctr Rotterdam, Erasmus MC, Trauma Res Unit, Dept Surg, Rotterdam, Netherlands; [Hoogerwerf, Nico] Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol, Nijmegen, Netherlands; [Hoogerwerf, Nico] Helicopter Emergency Med Serv Lifeliner 3, Nijmegen, Netherlands; [van der Naalt, Joukje] Univ Groningen, Dept Neurol, Univ Med Ctr Groningen, Groningen, Netherlands; [Absalom, Anthony R.] Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, Groningen, Netherlands; [Peerdeman, Saskia M.] Vrije Univ Amsterdam, Dept Neurosurg, Amsterdam Univ Med Ctr, Amsterdam, Netherlands; [Schwarte, Lothar A.; Schober, Patrick] Helicopter Emergency Med Serv Lifeliner 1, Amsterdam, Netherlands		Schober, P (corresponding author), Univ Amsterdam, Med Ctr, Dept Anesthesiol, Locat VUmc, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	p.schober@amsterdamumc.nl	Schober, Patrick/G-7400-2012	Schober, Patrick/0000-0003-0814-081X; van Ditshuizen, Jan/0000-0003-0765-0092; Absalom, Anthony/0000-0001-7563-9157; van der Naalt, Joukje/0000-0001-9873-2418	Dutch Brain Foundation; Achmea Healthcare Foundation (Stichting Achmea Gezondheidszorg)	This study was funded by a grant from the Dutch Brain Foundation and a grant from the Achmea Healthcare Foundation (Stichting Achmea Gezondheidszorg).	Bossers SM, 2021, PREHOSP EMERG CARE, V25, P644, DOI 10.1080/10903127.2020.1824049; Bossers SM, 2019, PREHOSP EMERG CARE, V23, P820, DOI 10.1080/10903127.2019.1587126; Dekker SE, 2016, J SURG RES, V205, P147, DOI 10.1016/j.jss.2016.06.023; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Franschman G, 2012, INJURY, V43, P1838, DOI 10.1016/j.injury.2012.05.020; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Huebner BR, 2017, WILD ENVIRON MED, V28, pS50, DOI 10.1016/j.wem.2016.12.006; Ker K, 2013, BRIT J SURG, V100, P1271, DOI 10.1002/bjs.9193; Kyriacou DN, 2016, JAMA-J AM MED ASSOC, V316, P1818, DOI 10.1001/jama.2016.16435; Lier H, 2019, ANESTH ANALG, V129, P1574, DOI 10.1213/ANE.0000000000004389; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Queensland Ambulance Service, DRUG THER PROT TRAN; Ringdal KG, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-7; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Roberts I, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0685-8; Rowell SE, 2020, JAMA-J AM MED ASSOC, V324, P961, DOI 10.1001/jama.2020.8958; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Schober P, 2020, ANESTH ANALG, V131, P1419, DOI 10.1213/ANE.0000000000005068; Schober P, 2020, LANCET, V396, P164, DOI 10.1016/S0140-6736(20)30542-0; Schober P, 2020, ANESTH ANALG, V130, P635, DOI 10.1213/ANE.0000000000004627; Schober P, 2020, ANESTH ANALG, V130, P99, DOI 10.1213/ANE.0000000000004545; Schober P, 2019, ANESTH ANALG, V129, P1445, DOI 10.1213/ANE.0000000000004480; Schober P, 2018, ANESTH ANALG, V127, P792, DOI 10.1213/ANE.0000000000003653; Schober P, 2018, ANESTH ANALG, V127, P569, DOI 10.1213/ANE.0000000000003511; Shah Jahan M Y, 2019, Med J Malaysia, V74, P300; Shakur H, 2017, LANCET, V389, P2105, DOI 10.1016/S0140-6736(17)30638-4; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Skrifvars MB, 2017, INTENS CARE MED, V43, P419, DOI 10.1007/s00134-016-4655-2; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Vetter TR, 2018, ANESTH ANALG, V127, P1085, DOI 10.1213/ANE.0000000000003698; Vetter TR, 2018, ANESTH ANALG, V127, P277, DOI 10.1213/ANE.0000000000003424; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wafaisade A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1322-5; Weng ST, 2019, WORLD NEUROSURG, V123, P128, DOI 10.1016/j.wneu.2018.11.214; West Midlands Ambulance Service, TRAUM MAN GUID	37	12	12	2	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	MAR	2021	78	3					338	345		10.1001/jamaneurol.2020.4596		DEC 2020	8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QV3UL	WOS:000598558500002	33284310	Green Published			2022-02-06	
J	Joseph, JR; Swallow, JS; Willsey, K; Almeida, AA; Lorincz, MT; Fraumann, RK; Oppenlander, ME; Szerlip, NJ; Broglio, SP				Joseph, Jacob R.; Swallow, Jennylee S.; Willsey, Kylene; Almeida, Andrea A.; Lorincz, Matthew T.; Fraumann, Robert K.; Oppenlander, Mark E.; Szerlip, Nicholas J.; Broglio, Steven P.			Pupillary changes after clinically asymptomatic high-acceleration head impacts in high school football athletes	JOURNAL OF NEUROSURGERY			English	Article						pupillometry; traumatic brain injury; concussion; accelerometry; pediatrics; trauma	TRAUMATIC BRAIN-INJURY; CONCUSSION; PLAYERS	OBJECTIVE Previous studies have shown that clinically asymptomatic high-acceleration head impacts (HHIs) may be associated with neuronal and axonal injury, as measured by advanced imaging and biomarkers. Unfortunately, these methods of measurement are time-consuming, invasive, and costly. A quick noninvasive measurement tool is needed to aid studies of head injury and its biological impact. Quantitative pupillometry is a potential objective, rapid, noninvasive measurement tool that may be used to assess the neurological effects of HHIs. In this study, the authors investigated the effect of HHIs on pupillary metrics, as measured using a pupillometer, in the absence of a diagnosed concussion. METHODS A prospective observational cohort study involving 18 high school football athletes was performed. These athletes were monitored for both the frequency and magnitude of head impacts that they sustained throughout a playing season by using the Head Impact Telemetry System. An HHI was defined as an impact exceeding 95g linear acceleration and 3760 rad/sec2 rotational acceleration. Pupillary assessments were performed at baseline, midseason, after occurrence of an HHI, and at the end of the season by using the NeurOptics NPi-200 pupillometer. The Sport Concussion Assessment Tool, 5th Edition (SCAT5), was also used at each time point. Comparisons of data obtained at the various time points were calculated using a repeated-measures analysis of variance and a t-test. RESULTS Seven athletes sustained HHIs without a related diagnosed concussion. Following these HHIs, the athletes demonstrated decreases in pupil dilation velocity (mean difference 0.139 mm/sec; p = 0.048), percent change in pupil diameter (mean difference 3.643%; p = 0.002), and maximum constriction velocity (mean difference 0.744 mm/sec; p = 0.010), compared to measurements obtained at the athletes' own midseason evaluations. No significant changes occurred between the SCAT5 subtest scores calculated at midseason and those after a high impact, although the effect sizes (Cohen's d) on individual components ranged from 0.41 to 0.65. CONCLUSIONS Measurable changes in pupil response were demonstrated following an HHI. These results suggest that clinically asymptomatic HHIs may affect brain reflex pathways, reflecting a biological injury previously seen when more invasive methods were applied.	[Joseph, Jacob R.; Oppenlander, Mark E.; Szerlip, Nicholas J.] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Swallow, Jennylee S.; Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [Willsey, Kylene] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Almeida, Andrea A.; Lorincz, Matthew T.] Univ Michigan, NeuroSport, Ann Arbor, MI 48109 USA; [Fraumann, Robert K.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA		Joseph, JR (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	jrjosephmd1@gmail.com					Asken BM, 2018, NEUROLOGY, V91, pE2133, DOI 10.1212/WNL.0000000000006617; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bin Zahid A, 2018, CLIN J SPORT MED; Broglio SP, 2017, J ATHL TRAINING, V52, P160, DOI 10.4085/1062-6050-51.9.05; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Capo-Aponte JE, 2013, J SPINE; Couret D, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1239-z; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Gurdjian E, 1966, NEUROSURGERY S1, V12, P386; Joseph JR, 2019, J NEUROSURG, V130, P1642, DOI 10.3171/2017.12.JNS172386; Joseph JR, 2017, WORLD NEUROSURG, V103, P73, DOI 10.1016/j.wneu.2017.03.106; Kroshus E, 2017, CLIN J SPORT MED, V27, P542, DOI 10.1097/JSM.0000000000000409; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Larson MD, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1349-7; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nauman EA, 2018, HAND CLINIC, V158, P245, DOI 10.1016/B978-0-444-63954-7.00024-0; Olson DM, 2016, NEUROCRIT CARE, V24, P251, DOI 10.1007/s12028-015-0182-1; Rowson B, 2018, HAND CLINIC, V158, P235, DOI 10.1016/B978-0-444-63954-7.00023-9; Samadani U, 2015, CONCUSSION, V1, pCNC3; Smith DH, 2019, NAT REV NEUROL, V15, P179, DOI 10.1038/s41582-018-0114-8; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sussman ES, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15610; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Thiagarajan P, 2015, BRAIN INJURY, V29, P1420, DOI 10.3109/02699052.2015.1045029; Zetterberg H, 2019, J INTERN MED, V285, P624, DOI 10.1111/joim.12863; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	32	12	12	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2020	133	6					1886	1891		10.3171/2019.7.JNS191272			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QE5RY	WOS:000616265500003	31770721	Bronze			2022-02-06	
J	Li, HC; Lu, CX; Yao, WF; Xu, LX; Zhou, J; Zheng, B				Li, Hengchang; Lu, Chengxiang; Yao, Wenfei; Xu, Lixin; Zhou, Jun; Zheng, Bin			Dexmedetomidine inhibits inflammatory response and autophagy through the circLrp1b/miR-27a-3p/Dram2 pathway in a rat model of traumatic brain injury	AGING-US			English	Article						dexmedetomidine; traumatic brain injury; autophagy; circLrp1b; inflammatory response	ACUTE LUNG INJURY; ISCHEMIA-REPERFUSION INJURY; APOPTOSIS; DEFICITS; ACTIVATION; MIR-27A; STROKE; MOUSE; BLOOD	Circular RNAs (circRNAs) have a regulatory function on inflammation and autophagy, of which rno-circRNA_010705 (circLrp1b) appears to be significantly up-regulated following traumatic brain injury (TBI). Dexmedetomidine (DEX) shows improvement effects in TBI by inhibiting NLRP3/caspase-1. However, whether circLrp1b plays critical roles in DEX-mediated TBI attenuation and the underlying mechanisms remain unclear. After TBI was established in rats by controlled cortical impact (CCI) to cause brain trauma, they received an intracerebroventricular injection of lentiviral vector, followed by intraperitoneal injection of DEX. Administration of DEX ameliorated autophagy in rats following TBI, accompanied by up-regulated circLrp1b and Dram2 and down-regulated miR-27a-3p. DEX promoted the effects of circLrp1b in attenuating TBI-induced neurologic impairment, autophagy, and inflammation, which was significantly reversed by inhibition of miR-27a-3p or Dram2 overexpression. Mechanistically, northern blot and luciferase reporter assays indicated that circLrp1b up-regulated Dram2 expression by functioning as a sponge for miR-27a-3p to promote autophagy involved in TBI, which was reversed by DEX treatment. Collectively, this study demonstrated that DEX inhibits inflammatory response and autophagy involved in TBI in vivo through inactivation of the circLrp1b/miR-27a-3p/Dram2 signaling pathway.	[Li, Hengchang; Lu, Chengxiang; Yao, Wenfei; Xu, Lixin; Zheng, Bin] South China Univ Technol, Sch Med, Guangzhou Peoples Hosp 1, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China; [Zhou, Jun] Southern Med Univ, Affiliated Hosp 3, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China		Zheng, B (corresponding author), South China Univ Technol, Sch Med, Guangzhou Peoples Hosp 1, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China.; Zhou, J (corresponding author), Southern Med Univ, Affiliated Hosp 3, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China.	zhoujun7843@126.com; eyzhengbin@scut.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [8187051539]; Natural Science Foundation of Guangdong ProvinceNational Natural Science Foundation of Guangdong Province [2017A030313534, 2016A030313440]; Guangzhou Planned Project of Science and Technology [201607010132]	This study was supported by the National Natural Science Foundation of China (No. 8187051539), the Natural Science Foundation of Guangdong Province (No. 2017A030313534 and 2016A030313440), and the Guangzhou Planned Project of Science and Technology (No. 201607010132).	Afonso J, 2012, REV BRAS ANESTESIOL, V62, P118, DOI 10.1016/S0034-7094(12)70110-1; Ammar AS, 2016, SAUDI J ANAESTH, V10, P395, DOI 10.4103/1658-354X.177340; Au AK, 2017, NEUROCRIT CARE, V26, P348, DOI 10.1007/s12028-016-0351-x; Bai S, 2016, EYE, V30, P1630, DOI 10.1038/eye.2016.189; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen XR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00117; Chen XY, 2020, AUTOPHAGY, V16, P659, DOI 10.1080/15548627.2019.1634945; Chi GN, 2019, CHEM-BIOL INTERACT, V308, P198, DOI 10.1016/j.cbi.2019.05.030; de Carvalho ALR, 2015, RENAL FAILURE, V37, P526, DOI 10.3109/0886022X.2015.1006118; Ding DF, 2018, EXP THER MED, V15, P3516, DOI 10.3892/etm.2018.5832; Ding MY, 2019, EXP THER MED, V18, P2323, DOI 10.3892/etm.2019.7790; Fu CL, 2017, MOL MED REP, V15, P131, DOI 10.3892/mmr.2016.6012; Han B, 2018, AUTOPHAGY, V14, P1164, DOI 10.1080/15548627.2018.1458173; Han D, 2017, HEPATOLOGY, V66, P1151, DOI 10.1002/hep.29270; HATASHITA S, 1988, J CEREBR BLOOD F MET, V8, P552, DOI 10.1038/jcbfm.1988.96; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Kaur Manpreet, 2011, Anesth Essays Res, V5, P128, DOI 10.4103/0259-1162.94750; Kim JK, 2017, AUTOPHAGY, V13, P423, DOI 10.1080/15548627.2016.1241922; Kolias AG, 2019, LANCET NEUROL, V18, P136, DOI 10.1016/S1474-4422(18)30494-0; Kucukebe OB, 2017, REV BRAS ANESTESIOL, V67, P139, DOI [10.1016/j.bjan.2016.09.004, 10.1016/j.bjane.2015.08.002]; Li FY, 2018, NEUROPEPTIDES, V72, P58, DOI 10.1016/j.npep.2018.10.004; Li XB, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0976-0; Liu C, 2018, BRAIN RES, V1701, P246, DOI 10.1016/j.brainres.2018.09.007; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Liu CZ, 2006, EXP NEUROL, V201, P452, DOI 10.1016/j.expneurol.2006.04.025; Luo C, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00197; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Peng K, 2016, CLIN THER, V38, P192, DOI 10.1016/j.clinthera.2015.11.016; Rong DW, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0958-6; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Shen M, 2017, BIOMED PHARMACOTHER, V95, P885, DOI 10.1016/j.biopha.2017.08.125; Sun LQ, 2018, BEHAV BRAIN RES, V340, P126, DOI 10.1016/j.bbr.2016.09.020; Sun LQ, 2017, BIOCHEM BIOPH RES CO, V482, P1141, DOI 10.1016/j.bbrc.2016.12.001; Tanabe K, 2014, INT J MOL MED, V34, P1032, DOI 10.3892/ijmm.2014.1863; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang LJ, 2017, BIOMOL THER, V25, P383, DOI 10.4062/biomolther.2015.180; Wang Q, 2019, MOL MED REP, V19, P805, DOI 10.3892/mmr.2018.9742; Wang X, 2018, BIOL PSYCHIAT, V83, P395, DOI 10.1016/j.biopsych.2017.07.023; Wang X, 2019, DRUG DES DEV THER, V13, P153, DOI 10.2147/DDDT.S163197; Wu FF, 2019, J NEUROSCI, V39, P7369, DOI 10.1523/JNEUROSCI.0299-19.2019; Wu J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23003-3; Wudu M, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1068-4; Xi TY, 2018, J BIOL CHEM, V293, P20041, DOI 10.1074/jbc.RA118.001858; Xiao T, 2018, METALLOMICS, V10, P1328, DOI 10.1039/c8mt00207j; Xie BS, 2018, J NEUROTRAUM, V35, P1659, DOI 10.1089/neu.2017.5468; Xu JG, 2014, BRAIN RES, V1582, P237, DOI 10.1016/j.brainres.2014.07.042; Xu LL, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1041-2; Zhang JW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102418; Zhang L, 2019, WORLD ENVIRONMENTAL AND WATER RESOURCES CONGRESS 2019: HYDRAULICS, WATERWAYS, AND WATER DISTRIBUTION SYSTEMS ANALYSIS, P89; Zhang Lijuan, 2016, Zhongguo Zhen Jiu, V36, P131; Zhang P, 2018, EUR REV MED PHARMACO, V22, P5416, DOI 10.26355/eurrev_201809_15800; Zhang XF, 2019, BIOL CHEM, V400, P1059, DOI 10.1515/hsz-2018-0422; Zheng B, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180892; Zhou LY, 2019, CELL DEATH DIFFER, V26, P1299, DOI 10.1038/s41418-018-0206-4; Zhu YL, 2019, INFLAMMATION, V42, P2181, DOI 10.1007/s10753-019-01082-2	56	12	12	2	4	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1945-4589			AGING-US	Aging-US	NOV 15	2020	12	21					21687	21705		10.18632/aging.103975			19	Cell Biology; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Geriatrics & Gerontology	OS1QJ	WOS:000589939800019	33147167	Green Published, gold			2022-02-06	
J	Lara-Reyna, J; Yaeger, KA; Rossitto, CP; Camara, D; Wedderburn, R; Ghatan, S; Bederson, JB; Margetis, K				Lara-Reyna, Jacques; Yaeger, Kurt A.; Rossitto, Christina P.; Camara, Divaldo; Wedderburn, Raymond; Ghatan, Saadi; Bederson, Joshua B.; Margetis, Konstantinos			"Staying Home"-Early Changes in Patterns of Neurotrauma in New York City During the COVID-19 Pandemic	WORLD NEUROSURGERY			English	Article						Coronavirus; COVID-19; Trauma; Traumatic brain injury		OBJECTIVE: New York City is the epicenter of the novel coronavirus disease 2019 (COVID-19) pandemic in the United States. Traumatic brain injury accounts for a significant proportion of admissions to our trauma center. We sought to characterize the effect of the pandemic on neurotraumas, given the cancellation of nonessential activities during the crisis. METHODS: Retrospective and prospective reviews were performed from November 2019 to April 2020. General demographics, clinical status, mechanism of trauma, diagnosis, and treatment instituted were recorded. We dichotomized the data between pre-COVID-19 (before 1 March) and COVID-19 periods and compared the differences between the 2 groups. We present the timeline of events since the beginning of the crisis in relation to the number of neurotraumas. RESULTS: A total of 150 patients composed our cohort with a mean age of 66.2 years (standard deviation 18.9), and 66% were male. More males sustained neurotrauma in the COVID-19 period compared with the pre-COVID-19 (60.4% vs. 77.6%, P = 0.03). The most common mechanism of trauma was mechanical fall, but it was observed less frequently compared with the pre-COVID-19 period (61.4% vs. 40.8; P = 0.03). Subdural hematoma, traumatic subarachnoid hemorrhage, and intracerebral contusion accounted for the most common pathologies in both periods. Nonoperative management was selected for most patients (79.2 vs. 87.8%, P = 0.201) in both periods. CONCLUSIONS: A decrease in the frequency of neurotraumas was observed during the COVID-19 crisis concomitant with the increase in COVID-19 patients in the city. This trend began after the cancellation of nonessential activities and implementation of social distancing recommendations.	[Lara-Reyna, Jacques; Yaeger, Kurt A.; Rossitto, Christina P.; Camara, Divaldo; Ghatan, Saadi; Bederson, Joshua B.; Margetis, Konstantinos] Icahn Sch Med Mt Sinai, Dept Neurol Surg, New York, NY 10029 USA; [Wedderburn, Raymond] Mt Sinai Morningside, Dept Surg, New York, NY USA		Lara-Reyna, J (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol Surg, New York, NY 10029 USA.	jacques.lara.r@gmail.com		Lara-Reyna, Jacques/0000-0003-2762-6460			Ahmed F, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5446-1; [Anonymous], 2020, LANCET INFECT DIS, V20, P383, DOI 10.1016/S1473-3099(20)30180-8; [Anonymous], 2019, TRAUM BRAIN INJ US E; [Anonymous], PAND VIOL WOM CHILDR; [Anonymous], MOT VEH FAT RAT 14 P; Bradbury-Jones C, 2020, J CLIN NURS, V29, P2047, DOI 10.1111/jocn.15296; Burke JF, 2020, NEUROSURGERY, V87, pE50, DOI 10.1093/neuros/nyaa116; Calvert S, 2020, WSJ ONLINE; Chadra K, MOTOR VEHICLE FATALI; Christey G, 2020, NEW ZEAL MED J, V133, P81; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cucinotta Domenico, 2020, Acta Biomed, V91, P157, DOI 10.23750/abm.v91i1.9397; DeBlasio Mayor, 2020, NYC HLTH THORN HOSP; Ducharme J., 2020, TIME; DYER O, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1846; Farrell TW, 2020, J AM GERIATR SOC, V68, P1143, DOI 10.1111/jgs.16539; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Goldstein J., 2020, NEW YORK TIMES; Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0; Jernigan DB, 2020, MMWR-MORBID MORTAL W, V69, P216, DOI 10.15585/mmwr.mm6908e1; Mazza M, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113046; Richards C, 2017, AM J PHYS MED REHAB, V96, pS124, DOI 10.1097/PHM.0000000000000620; Sen-Crowe B, 2020, AM J EMERG MED, V38, P1519, DOI 10.1016/j.ajem.2020.03.063; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Tan YT, 2020, CURR MED SCI, V40, P281, DOI 10.1007/s11596-020-2173-5; Usher K, 2020, INT J MENT HEALTH NU, V29, P549, DOI 10.1111/inm.12735; Velavan TP, 2020, TROP MED INT HEALTH, V25, P278, DOI 10.1111/tmi.13383; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; Zoia C, 2020, ACTA NEUROCHIR, V162, P1221, DOI 10.1007/s00701-020-04305-w	29	12	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2020	143						E344	E350		10.1016/j.wneu.2020.07.155			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	OS2GK	WOS:000589984400038	32730975	Green Published, Bronze			2022-02-06	
J	Wang, J; Hou, YS; Zhang, LX; Liu, M; Zhao, JS; Zhang, Z; Ma, YL; Hou, WG				Wang, Jin; Hou, Yushu; Zhang, Lixia; Liu, Min; Zhao, Jianshuai; Zhang, Zhen; Ma, Yulong; Hou, Wugang			Estrogen Attenuates Traumatic Brain Injury by Inhibiting the Activation of Microglia and Astrocyte-Mediated Neuroinflammatory Responses	MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury (TBI); 17 beta-estradiol (E2); Neuroinflammation; Microglia; Astrocyte; Neuroprotection	NEUROPROTECTION; RATS; INFLAMMATION; MODEL	Traumatic brain injury (TBI), which leads to high mortality and morbidity, is a prominent public health problem worldwide. Neuroinflammation involving microglia and astrocyte activation has been demonstrated to play critical role in the secondary injury induced by TBI. A1 astrocytes, which are induced by activated microglia, can directly kill neurons by secreting neurotoxic complement C3. Estrogen has been proved to possess neuroprotective effects, but the effect and underlying mechanism of estrogen on TBI-induced neuroinflammatory injury remain largely unclear. In this study, we constructed an adult male mouse model of TBI and immediately after injury treated the mice with 17 beta-estradiol (E2) (100 mu g/kg, once every day via intraperitoneal injection) for 3 days. We found that E2 treatment significantly alleviated TBI-induced neurological deficits, neuronal injuries, and brain edema and significantly inhibited Iba1 and GFAP expression, which are markers of microglia and astrocyte activation, respectively. E2 treatment also significantly inhibited TLR4 and NF-kappa B protein expression, and significantly reduced the expression of theproinflammatory factorsIL-1 beta, IL-6, and TNF-alpha. Moreover, E2 treatment significantly decreased the number of complement C3d/GFAP-positive cells and complement C3d protein expression. Taking these results together, we concluded that E2 treatment dramatically alleviates TBI neuroinflammatory injury by inhibiting TLR4/NF-kappa B pathway-mediated microglia and astrocyte activation and neuroinflammation and reducing A1-phenotype neurotoxic astrocyte activation. Our findings indicate that E2 treatment may be a potential therapy strategy for TBI-induced neuroinflammation injury.	[Wang, Jin; Zhao, Jianshuai; Zhang, Zhen; Hou, Wugang] Air Force Mil Med Univ, Xijing Hosp, Dept Anesthesiol & Perioperat Med, Xian 710032, Peoples R China; [Hou, Yushu] Xian Hosp Tradit Chinese Med, Dept Anesthesiol, Xian 710001, Peoples R China; [Zhang, Lixia] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 4, Dept Burn & Plast Surg, Beijing 100048, Peoples R China; [Liu, Min; Ma, Yulong] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Anesthesia & Operat Ctr, 28 Fuxing Rd, Beijing 100853, Peoples R China		Hou, WG (corresponding author), Air Force Mil Med Univ, Xijing Hosp, Dept Anesthesiol & Perioperat Med, Xian 710032, Peoples R China.; Ma, YL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Anesthesia & Operat Ctr, 28 Fuxing Rd, Beijing 100853, Peoples R China.	yulongma123@163.com; gangwuhou@163.com	Ma, Yulong/AAG-7533-2021	Ma, Yulong/0000-0003-0982-9571	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801138, 81971226, 81771411]; Key R&D projects in Shaanxi Province [2017ZDXMSF059]; Defense Science and Technology project [2019-JCJQ-JJ-089]; Beijing Natural Science FoundationBeijing Natural Science Foundation [7194321]	This work was supported by the National Natural Science Foundation of China (no.81801138, 81971226, 81771411), Key R&D projects in Shaanxi Province (no.2017ZDXMSF059), Defense Science and Technology project (no. 2019-JCJQ-JJ-089), The Beijing Natural Science Foundation (no.7194321).	Abdelmalik PA, 2019, TRANSFUSION, V59, P1529, DOI 10.1111/trf.15171; Bao YJ, 2011, MOL CELL NEUROSCI, V48, P185, DOI 10.1016/j.mcn.2011.07.004; Baraka AM, 2011, LIFE SCI, V88, P879, DOI 10.1016/j.lfs.2011.03.010; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chakrabarti M, 2016, REV NEUROSCIENCE, V27, P271, DOI 10.1515/revneuro-2015-0032; Choudhury GR, 2016, NEUROBIOL DIS, V85, P234, DOI 10.1016/j.nbd.2015.05.003; Clark DPQ, 2019, NEUROCHEM RES, V44, P1410, DOI 10.1007/s11064-019-02721-8; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Dekmak A, 2018, BEHAV BRAIN RES, V340, P49, DOI 10.1016/j.bbr.2016.12.039; Deng YL, 2018, ANESTHESIOLOGY, V128, P574, DOI 10.1097/ALN.0000000000002044; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Guo H, 2020, BRAIN RES, V1726, DOI 10.1016/j.brainres.2019.146536; Hajmohammadi M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01043; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kovacs SK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00047; Lee JY, 2018, BBA-MOL BASIS DIS, V1864, P2472, DOI 10.1016/j.bbadis.2018.04.006; Li ZZ, 2014, J NEUROL SCI, V338, P112, DOI 10.1016/j.jns.2013.12.027; Lian H, 2015, NEURON, V85, P101, DOI 10.1016/j.neuron.2014.11.018; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lu HH, 2018, J CELL PHYSIOL, V233, P1712, DOI 10.1002/jcp.26083; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marder K, 2000, NEUROLOGY, V54, P2035, DOI 10.1212/WNL.54.11.2035; Martin-Jimenez C, 2019, NEUROENDOCRINOLOGY, V108, P142, DOI 10.1159/000495078; McClean J, 2008, EXP NEUROL, V210, P41, DOI 10.1016/j.expneurol.2007.09.027; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Ng SY, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00528; Oklinski MK, 2014, J HISTOCHEM CYTOCHEM, V62, P598, DOI 10.1369/0022155414537495; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Rao KVR, 2014, NEUROBIOL DIS, V63, P222, DOI 10.1016/j.nbd.2013.11.018; Rudolfson N, 2019, J NEUROSURG, V130, P1149, DOI 10.3171/2017.12.JNS17281; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wen L, 2018, J NEUROTRAUM, V35, P2330, DOI 10.1089/neu.2017.5540; Yasar P, 2017, REPROD MED BIOL, V16, P4, DOI 10.1002/rmb2.12006; Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5; Zhang ZL, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1246-x	45	12	12	5	9	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	MAR	2021	58	3					1052	1061		10.1007/s12035-020-02171-2		OCT 2020	10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QG0KD	WOS:000580961000001	33085047				2022-02-06	
J	Lange, RT; Lippa, SM; French, LM; Bailie, JM; Gartner, RL; Driscoll, AE; Wright, MM; Sullivan, JK; Varbedian, NV; Barnhart, EA; Holzinger, JB; Schaper, AL; Reese, MA; Brandler, BJ; Camelo-Lopez, V; Brickell, TA				Lange, Rael T.; Lippa, Sara M.; French, Louis M.; Bailie, Jason M.; Gartner, Rachel L.; Driscoll, Angela E.; Wright, Megan M.; Sullivan, Jamie K.; Varbedian, Nicole V.; Barnhart, Elizabeth A.; Holzinger, Jayne B.; Schaper, Ashley L.; Reese, Maryetta A.; Brandler, Brian J.; Camelo-Lopez, Vanessa; Brickell, Tracey A.			Long-term neurobehavioural symptom reporting following mild, moderate, severe, and penetrating traumatic brain injury in US military service members	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Long-term outcome; Neurobehavioural symptom reporting; Military; Traumatic brain injury; Quality of life	POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; CLINICAL UTILITY; VALIDITY-10 SCALE; HEALTH; OUTCOMES; TBI; EXAGGERATION; PREDICTORS; RECOVERY	The purpose of this study was to examine long-term neurobehavioural symptom reporting following mild, moderate, severe, or penetrating TBI in U.S. military service members and veterans (SMV). Participants were 445 SMVs divided into four groups: 158 uncomplicated mild TBI ("unMTBI" group), 105 penetrating, severe, moderate, or complicated mild TBI ("smcTBI" group), 101 injured controls (IC), and 81 non-injured controls (NIC). Two independent cohorts were examined that included participants 5-years or 10-year post-injury. Participants completed the TBI-Quality of Life, Neurobehavioural Symptom Inventory, and Posttraumatic Stress Disorder Checklist. At 5-years and 10-years post-injury, there were significant main effects for the majority of measures (all p's < .005). At 10-years post-injury, the NIC group had consistently better scores compared to the IC, unMTBI, and smcTBI groups. At 5-years post-injury, either (a) the IC and NIC group had better scores compared to both TBI groups, or (b) the NIC group had better scores compared to the IC, unMTBI, and smcTBI groups. A high proportion of SMVs reported poor long-term neurobehavioural symptoms following TBI or bodily injury without TBI. Injured SMVs (regardless of injury type) can have long-term symptoms that impact mental health and overall quality of life requiring long-term follow-up and care.	[Lange, Rael T.; Lippa, Sara M.; French, Louis M.; Gartner, Rachel L.; Driscoll, Angela E.; Wright, Megan M.; Sullivan, Jamie K.; Varbedian, Nicole V.; Barnhart, Elizabeth A.; Holzinger, Jayne B.; Schaper, Ashley L.; Reese, Maryetta A.; Brandler, Brian J.; Camelo-Lopez, Vanessa; Brickell, Tracey A.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Room 5003,Bldg 19,8901 Wisconsin Ave, Bethesda, MD 20814 USA; [Lange, Rael T.; Lippa, Sara M.; French, Louis M.; Gartner, Rachel L.; Driscoll, Angela E.; Wright, Megan M.; Sullivan, Jamie K.; Varbedian, Nicole V.; Barnhart, Elizabeth A.; Holzinger, Jayne B.; Schaper, Ashley L.; Reese, Maryetta A.; Brandler, Brian J.; Camelo-Lopez, Vanessa; Brickell, Tracey A.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Bailie, Jason M.] Naval Hosp Camp Pendleton, Def & Vet Brain Injury Ctr, Oceanside, CA USA; [Lange, Rael T.; Lippa, Sara M.; Driscoll, Angela E.; Wright, Megan M.; Sullivan, Jamie K.; Varbedian, Nicole V.; Barnhart, Elizabeth A.; Holzinger, Jayne B.; Schaper, Ashley L.; Reese, Maryetta A.; Brandler, Brian J.; Camelo-Lopez, Vanessa; Brickell, Tracey A.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA		Lange, RT (corresponding author), Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Room 5003,Bldg 19,8901 Wisconsin Ave, Bethesda, MD 20814 USA.	rlange@dvbic.org	Brandler, Brian/Q-2779-2019	Gartner, Rachel/0000-0001-8327-9737; french, louis/0000-0002-9451-0604	Defense and Veterans Brain Injury Center, Silver Spring, Maryland, USA	This work was supported by the Defense and Veterans Brain Injury Center, Silver Spring, Maryland, USA.	American Psychiatric Association (APA), 1994, DIAGN STAT MAN MENT; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; Andrews RJ, 2018, NEUROLOGY, V91, pE732, DOI 10.1212/WNL.0000000000006034; [Anonymous], 2015, C TRAUM BRAIN INJ US; Armistead-Jehle P, 2018, J CLIN EXP NEUROPSYC, V40, P213, DOI 10.1080/13803395.2017.1329406; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Defense and Veterans Brain Injury Center D., 2018, DOD NUMB TRAUM BRAIN; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Dretsch MN, 2017, APPL NEUROPSYCH-ADUL, V24, P376, DOI 10.1080/23279095.2016.1220947; Haarbauer-Krupa J, 2017, J NEUROTRAUM, V34, P50, DOI 10.1089/neu.2015.4158; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hurst FG, 2020, DISABIL REHABIL, V42, P651, DOI 10.1080/09638288.2018.1504993; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P663, DOI 10.1007/978-0-387-76978-3_21; Jackson CE, 2016, J TRAUMA STRESS, V29, P309, DOI 10.1002/jts.22110; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Khan F, 2016, J REHABIL MED, V48, P442, DOI 10.2340/16501977-2084; Lange RT, 2020, J TRAUMA STRESS, V33, P318, DOI 10.1002/jts.22480; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lippa SM, 2016, J REHABIL RES DEV, V53, P379, DOI 10.1682/JRRD.2015.01.0009; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McCrae M., 2008, MILD TRAUMATIC BRAIN; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Miller KJ, 2017, MIL MED, V182, P137, DOI 10.7205/MILMED-D-16-00175; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Peltz CB, 2017, J HEAD TRAUMA REHAB, V32, pE8, DOI 10.1097/HTR.0000000000000245; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Senathi-Raja D, 2010, J HEAD TRAUMA REHAB, V25, P330, DOI 10.1097/HTR.0b013e3181ccc893; Sullivan KA, 2016, APPL NEUROPSYCH-ADUL, V23, P353, DOI 10.1080/23279095.2015.1079714; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; World Health Organization, 2004, ICD 10 INT STAT CLAS; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	48	12	12	1	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	OCT 20	2020	30	9					1762	1785		10.1080/09602011.2019.1604385			24	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	OE5UC	WOS:000580594300001	31003592				2022-02-06	
J	Mikolic, A; van Klaveren, D; Groeniger, JO; Wiegers, EJA; Lingsma, HF; Zeldovich, M; von Steinbuchel, N; Maas, AIR; van Lennep, JRE; Polinder, S				Mikolic, Ana; van Klaveren, David; Oude Groeniger, Joost; Wiegers, Eveline J. A.; Lingsma, Hester F.; Zeldovich, Marina; von Steinbuechel, Nicole; Maas, Andrew I. R.; Roeters van Lennep, Jeanine E.; Polinder, Suzanne		CTR-TBI Participants	Differences between Men and Women in Treatment and Outcome after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						care pathway; outcomes; sex differences; traumatic brain injury; treatment	CONCUSSION SYMPTOMS QUESTIONNAIRE; INTIMATE-PARTNER-VIOLENCE; QUALITY-OF-LIFE; GENDER-DIFFERENCES; HEAD-INJURY; CENTER CARE; SEX; MILD; HEALTH; PREVALENCE	Traumatic brain injury (TBI) is a significant cause of disability, but little is known about sex and gender differences after TBI. We aimed to analyze the association between sex/gender, and the broad range of care pathways, treatment characteristics, and outcomes following mild and moderate/severe TBI. We performed mixed-effects regression analyses in the prospective multi-center Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study, stratified for injury severity and age, and adjusted for baseline characteristics. Outcomes were various care pathway and treatment variables, and 6-month measures of functional outcome, health-related quality of life (HRQoL), post-concussion symptoms (PCS), and mental health symptoms. The study included 2862 adults (36% women) with mild (mTBI; Glasgow Coma Scale [GCS] score 13-15), and 1333 adults (26% women) with moderate/severe TBI (GCS score 3-12). Women were less likely to be admitted to the intensive care unit (ICU; odds ratios [OR] 0.6, 95% confidence interval [CI]: 0.4-0.8) following mTBI. Following moderate/severe TBI, women had a shorter median hospital stay (OR 0.7, 95% CI: 0.5-1.0). Following mTBI, women had poorer outcomes; lower Glasgow Outcome Scale Extended (GOSE; OR 1.4, 95% CI: 1.2-1.6), lower generic and disease-specific HRQoL, and more severe PCS, depression, and anxiety. Among them, women under age 45 and above age 65 years showed worse 6-month outcomes compared with men of the same age. Following moderate/severe TBI, there was no difference in GOSE (OR 0.9, 95% CI: 0.7-1.2), but women reported more severe PCS (OR 1.7, 95% CI: 1.1-2.6). Men and women differ in care pathways and outcomes following TBI. Women generally report worse 6-month outcomes, but the size of differences depend on TBI severity and age. Future studies should examine factors that explain these differences.	[Mikolic, Ana; van Klaveren, David; Oude Groeniger, Joost; Wiegers, Eveline J. A.; Lingsma, Hester F.; Polinder, Suzanne] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands; [Oude Groeniger, Joost] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Adm & Sociol, Rotterdam, Netherlands; [Roeters van Lennep, Jeanine E.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Internal Med, Rotterdam, Netherlands; [van Klaveren, David] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Predict Analyt & Comparat Effectiveness Ctr, Boston, MA 02111 USA; [Zeldovich, Marina; von Steinbuechel, Nicole] Georg August Univ, Inst Med Psychol & Med Sociol, Gottingen, Germany; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Antwerp, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Antwerp, Belgium		Mikolic, A (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	a.mikolic@erasmusmc.nl	Castano-Leon, Ana M/ABF-6322-2020; Sahuquillo, Juan/B-3577-2008; Posti, Jussi P./Y-2908-2019; Vande Vyvere, Thijs/AAB-5180-2022; Gomez, Pedro/E-2411-2014	Castano-Leon, Ana M/0000-0002-7918-5049; Sahuquillo, Juan/0000-0003-0713-5875; Posti, Jussi P./0000-0002-5925-5193; Vande Vyvere, Thijs/0000-0003-4032-5443; Kondziella, Daniel/0000-0001-5562-9808; Gomez, Pedro/0000-0002-4185-5238; Pirinen, Matti/0000-0002-1664-1350; Stewart, William/0000-0003-2199-2582; Newcombe, Virginia/0000-0001-6044-9035; Coles, Jonathan/0000-0003-4013-679X; Van Essen, Thomas/0000-0003-4657-5283; Radoi, Andreea/0000-0002-0677-3544; Dark, Paul/0000-0003-3309-0164; Rossi, Sandra/0000-0002-9963-8121; Zeiler, Frederick/0000-0003-1737-0510; Sanchez-Porras, Renan/0000-0002-9084-8114; Sakowitz, Oliver/0000-0003-3248-6335; Palotie, Aarno/0000-0002-2527-5874	Netherlands Organisation for Health Research and Development (ZonMw)Netherlands Organization for Health Research and Development; European UnionEuropean Commission [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); Neurotrauma Sciences (USA)	This study was supported by The Netherlands Organisation for Health Research and Development (ZonMw). The authors A. Mikolic, S. Polinder, A.I.R. Maas, N. von Steinbuechel, M. Zeldovich, E.J.A. Wiegers, and H.F. Lingsma were supported by the European Union 7th Framework Programme (EC grant 602150). Additional support was obtained from the Hannelore Kohl Stiftung (Germany), OneMind (USA), Integra LifeSciences Corporation (USA), and Neurotrauma Sciences (USA).	Albrecht JS, 2017, J HEAD TRAUMA REHAB, V32, pE45, DOI 10.1097/HTR.0000000000000297; Alston M, 2012, AUST SOC WORK, V65, P39, DOI 10.1080/0312407X.2011.594898; Amoroso T, 2017, J NERV MENT DIS, V205, P318, DOI 10.1097/NMD.0000000000000621; Andelic N, 2016, BEHAV NEUROL, V2016, DOI 10.1155/2016/2678081; [Anonymous], 2013, DIAGNOSTIC STAT MANU; Baeten R, 2018, INEQUALITIES ACCESS; Barsky AJ, 2001, J GEN INTERN MED, V16, P266, DOI 10.1046/j.1525-1497.2001.016004266.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Bonow RH, 2019, NEUROCRIT CARE, V30, P157, DOI 10.1007/s12028-018-0590-0; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Cancelliere C, 2016, ARCH PHYS MED REHAB, V97, pS5, DOI 10.1016/j.apmr.2014.11.028; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Clayton JA, 2016, JAMA-J AM MED ASSOC, V316, P1863, DOI 10.1001/jama.2016.16405; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Cnossen MC, 2021, J NEUROTRAUM, V38, P1072, DOI 10.1089/neu.2015.4121; Colantonio A, 2016, ARCH PHYS MED REHAB, V97, pS1, DOI 10.1016/j.apmr.2015.12.002; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; de Guise Elaine, 2014, Int Sch Res Notices, V2014, P263241, DOI 10.1155/2014/263241; DeAngelis J, 2017, WEST J EMERG MED, V18, P821, DOI 10.5811/westjem.2017.6.33685; Doyal L, 2001, BRIT MED J, V323, P1061, DOI 10.1136/bmj.323.7320.1061; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fausto-Sterling A., 2012, SEX GENDER BIOL SOCI; FitzGerald C, 2017, BMC MED ETHICS, V18, DOI 10.1186/s12910-017-0179-8; Fowler RA, 2007, CAN MED ASSOC J, V177, P1513, DOI 10.1503/cmaj.071112; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gomez D, 2012, SURGERY, V152, P179, DOI 10.1016/j.surg.2012.04.006; Gordon M., 2019, PACKAGE FORESTPLOT; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Gupte R, 2019, J NEUROTRAUM, V36, P3063, DOI 10.1089/neu.2018.6171; Gustavson K, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1647-5; Haag HL, 2016, ARCH PHYS MED REHAB, V97, pS64, DOI 10.1016/j.apmr.2014.12.018; Haag H, 2019, J WOMENS HEALTH, V28, P990, DOI 10.1089/jwh.2018.7299; Hay K, 2019, LANCET, V393, P2535, DOI 10.1016/S0140-6736(19)30648-8; Heise L, 2019, LANCET, V393, P2440, DOI 10.1016/S0140-6736(19)30652-X; Hoffmann DE, 2001, J LAW MED ETHICS, V29, P13, DOI 10.1111/j.1748-720X.2001.tb00037.x; Iverson KM, 2019, COMPR PSYCHIAT, V92, P13, DOI 10.1016/j.comppsych.2019.05.001; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Krieger N, 2003, INT J EPIDEMIOL, V32, P652, DOI 10.1093/ije/dyg156; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Larsson E, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0693-4; Larsson E, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0191-2; Linden W, 2012, J AFFECT DISORDERS, V141, P343, DOI 10.1016/j.jad.2012.03.025; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Maas AHEM, 2010, NETH HEART J, V18, P598, DOI 10.1007/s12471-010-0841-y; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MacLean A, 2010, SOC SCI MED, V70, P597, DOI 10.1016/j.socscimed.2009.10.042; Malmusi D, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23189; Marcolini Evie G, 2019, Anesthesiol Clin, V37, P107, DOI 10.1016/j.anclin.2018.09.007; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Niemeier JP, 2014, J WOMENS HEALTH, V23, P573, DOI 10.1089/jwh.2013.4535; O'Donnell ML, 2010, J TRAUMA, V69, P627, DOI 10.1097/TA.0b013e3181bc0923; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Pape M, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0589-3; Parker G, 2010, INT REV PSYCHIATR, V22, P429, DOI 10.3109/09540261.2010.492391; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Poritz JMP, 2019, REHABIL PSYCHOL, V64, P65, DOI 10.1037/rep0000234; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; R Core Team, 2017, R LANG ENV STAT COMP; Raine R, 2000, J Health Serv Res Policy, V5, P237; Russell AL, 2018, ENDOCRINOLOGY, V159, P2363, DOI 10.1210/en.2018-00203; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Slewa-Younan S, 2008, BRAIN INJURY, V22, P183, DOI 10.1080/02699050801888808; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; van Buuren S, 2011, J STAT SOFTW, V45, P1; Volovici V, 2019, J CRIT CARE, V49, P158, DOI 10.1016/j.jcrc.2018.11.002; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weathers F.W., 1993, 9 ANN C ISTSS; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2017, J NEUROTRAUM, V34, P59, DOI 10.1089/neu.2015.4287; Wright DW, 2014, ACAD EMERG MED, V21, P1414, DOI 10.1111/acem.12532; Yue JK, 2019, NEUROL RES, V41, P609, DOI 10.1080/01616412.2019.1602312	91	12	13	4	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2021	38	2					235	251		10.1089/neu.2020.7228		OCT 2020	17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	PP0TL	WOS:000581638600001	32838645	Green Published, Green Submitted, hybrid			2022-02-06	
J	Bailey, AM; Sanchez, EJ; Park, G; Gabler, LF; Funk, JR; Crandall, JR; Wonnacott, M; Withnall, C; Myers, BS; Arbogast, KB				Bailey, Ann M.; Sanchez, Erin J.; Park, Gwansik; Gabler, Lee F.; Funk, James R.; Crandall, Jeff R.; Wonnacott, Michael; Withnall, Chris; Myers, Barry S.; Arbogast, Kristy B.			Development and Evaluation of a Test Method for Assessing the Performance of American Football Helmets	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Helmet; Kinematics; Biomechanics; Football	IMPACT PERFORMANCE; PROFESSIONAL FOOTBALL; HYBRID III; CONCUSSION	As more is learned about injury mechanisms of concussion and scenarios under which injuries are sustained in football games, methods used to evaluate protective equipment must adapt. A combination of video review, videogrammetry, and laboratory reconstructions was used to characterize concussive impacts from National Football League games during the 2015-2017 seasons. Test conditions were generated based upon impact locations and speeds from this data set, and a method for scoring overall helmet performance was created. Head kinematics generated using a linear impactor and sliding table fixture were comparable to those from laboratory reconstructions of concussive impacts at similar impact conditions. Impact tests were performed on 36 football helmet models at two laboratories to evaluate the reproducibility of results from the resulting test protocol. Head acceleration response metric, a head impact severity metric, varied 2.9-5.6% for helmet impacts in the same lab, and 3.8-6.0% for tests performed in a separate lab when averaged by location for the models tested. Overall inter-lab helmet performance varied by 1.1 +/- 0.9%, while the standard deviation in helmet performance score was 7.0%. The worst helmet performance score was 33% greater than the score of the best-performing helmet evaluated by this study.	[Bailey, Ann M.; Sanchez, Erin J.; Park, Gwansik; Gabler, Lee F.; Funk, James R.; Crandall, Jeff R.] Biomech Consulting & Res LLC, Charlottesville, VA 22911 USA; [Wonnacott, Michael; Withnall, Chris] Biokinet & Associates Ltd, Ottawa, ON, Canada; [Myers, Barry S.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA		Bailey, AM (corresponding author), Biomech Consulting & Res LLC, Charlottesville, VA 22911 USA.	abailey@bicorellc.com			Football Research, Inc. (FRI); NFL	The research presented in this paper was made possible by a grant from Football Research, Inc. (FRI). FRI is a nonprofit corporation that receives funding from sources including the NFL and is dedicated to the research and development of novel methods to prevent, mitigate, and treat traumatic head injury. The views expressed are solely those of the authors and do not represent those of FRI or any of its affiliates or funding sources. The authors would also like to acknowledge Biokinetics and Associates Ltd., Next Generation Stats, and Kineticorp.	Alem N. M, 1980, UMHSRI80721; Bailey A, 2020, SPORT BIOMECH, V19, P678, DOI 10.1080/14763141.2018.1513059; Bailey AM, 2020, ANN BIOMED ENG, V48, P2678, DOI 10.1007/s10439-020-02637-3; Bartsch A, 2012, ACCIDENT ANAL PREV, V48, P285, DOI 10.1016/j.aap.2012.01.032; Biomechanics Consulting and Research LLC, 2019, HELM TEST PROT; Breedlove KM, 2018, J BIOMECH, V79, P227, DOI 10.1016/j.jbiomech.2018.08.007; Campolettano E. T., 2019, YOUTH FOOTBALL HELME; Cobb B., P IMECHE P, V232, P176; Cobb BR, 2015, P I MECH ENG P-J SPO, V229, P39, DOI 10.1177/1754337114548245; DiMasi F. P., 1995, TRANSFORMATION NINE; Elkin BS, 2019, CLIN BIOMECH, V64, P49, DOI 10.1016/j.clinbiomech.2018.03.021; Ellenbogen RG, 2018, BRIT J SPORT MED, V52, P894, DOI 10.1136/bjsports-2018-099203; Funk J. R, ANN BIOMED ENG; Gabler L. F, 2019, P 2019 BIM ENG SOC C; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Kent R, 2020, J BIOMECH, V99, DOI 10.1016/j.jbiomech.2019.109551; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; Mertz H.J., 1985, SAE T, V94, P97; National Football League and National Football League Players Association, 2020, NFL NFLPA 2020 HELM; National Operating Committee on Standards for Athletic Equipment, 2019, STAND LIN IMP TEST M; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Rowson, 2018, VARSITY FOOTBALL HEL; Rowson B, 2018, P I MECH ENG P-J SPO, V232, P94, DOI 10.1177/1754337117707859; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Society of Automotive Engineers, 2014, 2111201403 SAE INT; Takhounts E, 2003, INJURY BIOMECHANICS; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Versace J, 1971, SAE TECHNICAL PAPER, DOI [10.4271/710881, DOI 10.4271/710881]; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1	35	12	12	1	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	NOV	2020	48	11			SI		2566	2579		10.1007/s10439-020-02626-6		OCT 2020	14	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	PB5UI	WOS:000575717000002	33025321				2022-02-06	
J	Post, EG; Trigsted, SM; Schaefer, DA; Cadmus-Bertram, LA; Watson, AM; McGuine, TA; Brooks, MA; Bell, DR				Post, Eric G.; Trigsted, Stephanie M.; Schaefer, Daniel A.; Cadmus-Bertram, Lisa A.; Watson, Andrew M.; McGuine, Timothy A.; Brooks, Margaret Alison; Bell, David R.			Knowledge, Attitudes, and Beliefs of Youth Sports Coaches Regarding Sport Volume Recommendations and Sport Specialization	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						youth sport coaching; overuse injury; club sports	PITCH COUNT RECOMMENDATIONS; PARTICIPATION; ASSOCIATION; CONCUSSION; INJURIES; EPIDEMIOLOGY; BEHAVIORS; RISK	Post, EG, Trigsted, SM, Schaefer, DA, Cadmus-Bertram, LA, Watson, AM, McGuine, TA, Brooks, MA, and Bell, DR. Knowledge, attitudes, and beliefs of youth sports coaches regarding sport volume recommendations and sport specialization.J Strength Cond Res34(10): 2911-2919, 2020-Overuse injuries in youth athletes are becoming increasingly common, which may be a result of the prevalence of year-round specialized sport participation. Previous research has identified sport volume recommendations related to months per year, hours per week, and simultaneous participation in multiple sports leagues. Coaches are a primary influence on a youth athlete's decision to specialize in a single sport. Therefore, identifying coaches' baseline beliefs and perceptions is important for developing strategies to educate coaches about safe sport participation. A total of 253 youth sport coaches (207 males) completed an anonymous online questionnaire regarding knowledge of sport volume recommendations and attitudes and beliefs regarding sport specialization. Eligible participants were required to serve as a head or assistant coach of a youth sport team in the past 12 months whose members were between the ages of 12 and 18 years. Most coaches were unaware of recommendations regarding the maximum number of months per year (79.4%), hours per week in 1 sport (79.3%), or number of simultaneous leagues for an athlete to participate in to reduce injury (77.6%). Fewer than half (43.2%) of all coaches were "very" or "extremely" concerned about the risk of injury in youth sports. A majority (60.1%) believed that sport specialization was either "quite a bit" or "a great deal" of a problem. Two-thirds (67.2%) responded that year-round participation in a single sport was either "very" or "extremely" likely to increase an athlete's risk of injury. Although the responses to this survey were predominantly from coaches from 1 state, our results suggest that coaches are unaware of sport volume recommendations but are concerned about specialization. Future efforts are needed to communicate these recommendations to coaches to reduce the risk of overuse injury in youth sports.	[Post, Eric G.; Schaefer, Daniel A.; Cadmus-Bertram, Lisa A.; Bell, David R.] Univ Wisconsin, Dept Kinesiol, Madison, WI 53706 USA; [Post, Eric G.; Schaefer, Daniel A.; Bell, David R.] Univ Wisconsin, Dept Kinesiol, Wisconsin Injury Sport Lab, Madison, WI 53706 USA; [Trigsted, Stephanie M.] High Point Univ, Dept Athlet Training, High Point, NC USA; [Watson, Andrew M.; McGuine, Timothy A.; Brooks, Margaret Alison; Bell, David R.] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI USA		Post, EG (corresponding author), Univ Wisconsin, Dept Kinesiol, Madison, WI 53706 USA.; Post, EG (corresponding author), Univ Wisconsin, Dept Kinesiol, Wisconsin Injury Sport Lab, Madison, WI 53706 USA.	egpost@wisc.edu			Great Lakes Athletic Trainers' Association [1K07CA178870]	This study was supported by a grant that was funded by the Great Lakes Athletic Trainers' Association but this sponsor played no role in study design, collection/analysis/interpretation of data, writing of the manuscript, and decision to submit the manuscript for publication. Dr. Cadmus-Bertram's time is supported by 1K07CA178870.	Baxter-Jones ADG, 2003, J SPORT MED PHYS FIT, V43, P250; Belanger M, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0237-x; Bell DR, 2016, AM J SPORT MED, V44, P1469, DOI 10.1177/0363546516629943; Brenner JS, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2148; Butcher J., 2002, Journal of Sport Behavior, V25, P145; Cameron K, 2017, STOP SPORT INJ; Fazarale JJ, 2012, SPORTS HEALTH, V4, P202, DOI 10.1177/1941738111435632; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; Jayanthi N, 2013, SPORTS HEALTH, V5, P251, DOI 10.1177/1941738112464626; Jayanthi NA, 2015, AM J SPORT MED, V43, P794, DOI 10.1177/0363546514567298; Kroshus E, 2017, HEALTH COMMUN, V32, P963, DOI 10.1080/10410236.2016.1196417; LaPrade RF, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116644241; Lewis, 2002, HLTH BEHAV HLTH ED T, P45; Lloyd RS, 2016, J STRENGTH COND RES, V30, P1491, DOI 10.1519/JSC.0000000000001387; Malina RM, 2010, CURR SPORT MED REP, V9, P364, DOI 10.1249/JSR.0b013e3181fe3166; McLeod TCV, 2011, J ATHL TRAINING, V46, P206, DOI 10.4085/1062-6050-46.2.206; Myer GD, 2015, SPORTS HEALTH, V7, P437, DOI 10.1177/1941738115598747; Neuharth-Keusch A, 2016, US TODAY; Olsen SJ, 2006, AM J SPORT MED, V34, P905, DOI 10.1177/0363546505284188; Parker EM, 2015, J HEAD TRAUMA REHAB, V30, P198, DOI 10.1097/HTR.0000000000000097; Post EG, 2017, SPORTS HEALTH, V9, P518, DOI 10.1177/1941738117714160; Post EG, 2017, AM J SPORT MED, V45, P1405, DOI 10.1177/0363546517690848; Roos KG, 2017, BRIT J SPORT MED, V51, P1029, DOI 10.1136/bjsports-2015-095718; Roos KG, 2017, AM J SPORT MED, V45, P201, DOI 10.1177/0363546516660980; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Small EW, 2007, PEDIATRICS, V119, P1242, DOI 10.1542/peds.2007-0887; Tirabassi J, 2016, AM J SPORT MED, V44, P2925, DOI 10.1177/0363546516644604; Vella SA, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-113; Yukutake T, 2013, SPORTS HEALTH, V5, P239, DOI 10.1177/1941738113480341	29	12	12	6	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1064-8011	1533-4287		J STRENGTH COND RES	J. Strength Cond. Res.	OCT	2020	34	10					2911	2919		10.1519/JSC.0000000000002529			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	NX8ZO	WOS:000575992200027	29481449				2022-02-06	
J	Chen, YF; Li, J; Ma, BT; Li, N; Wang, SH; Sun, Z; Xue, CL; Han, Q; Wei, JJ; Zhao, RC				Chen, Yunfei; Li, Jing; Ma, Baitao; Li, Na; Wang, Shihua; Sun, Zhao; Xue, Chunling; Han, Qin; Wei, Junji; Zhao, Robert Chunhua			MSC-derived exosomes promote recovery from traumatic brain injury via microglia/macrophages in rat	AGING-US			English	Article						human adipose-derived mesenchymal stem cells; microglia; exosomes; traumatic brain injury; neurogenesis	MESENCHYMAL STEM-CELLS; EXTRACELLULAR VESICLES; STROMAL CELLS; IMMUNE-SYSTEM; NEUROGENESIS; MICROGLIA; BIODISTRIBUTION; DYSFUNCTION; SECRETION; RESPONSES	Traumatic brain injury (TBI) is a leading cause of morbidity and mortality in young individuals worldwide. There is currently no effective clinical treatment for TBI, but mesenchymal stem cell-derived exosomes have exhibited promising therapeutic effects. In this study, we performed intracerebroventricular microinjection of human adipose mesenchymal stem cell (hADSC)-derived exosomes (hADSC-ex) in a weight-drop-induced TBI rat model. We found that hADSC-ex promoted functional recovery, suppressed neuroinflammation, reduced neuronal apoptosis, and increased neurogenesis in TBI rats. The therapeutic effects of hADSC-ex were comparable to those of hADSC. Sequential in vivo imaging revealed increasing aggregation of DiR-labeled hADSC-ex in the lesion area. Immunofluorescent staining of coronal brain sections and primary mixed neural cell cultures revealed distinct overlap between CM-DiI-labeled hADSC-ex and microglia/macrophages, indicating that hADSC-ex were mainly taken up by microglia/macrophages. In a lipopolysaccharide-induced inflammatory model, hADSC-ex suppressed microglia/macrophage activation by inhibiting nuclear factor kappa B and P38 mitogen-activated protein kinase signaling. These data suggest that hADSC-ex specifically enter microglia/macrophages and suppress their activation during brain injury, thereby inhibiting inflammation and facilitating functional recovery. They also offer new insight into the cellular targeting, uptake and migration of hADSC-ex, and provide a theoretical basis for new therapeutic strategies for central nervous system diseases.	[Chen, Yunfei; Li, Jing; Li, Na; Wang, Shihua; Xue, Chunling; Han, Qin; Zhao, Robert Chunhua] Chinese Acad Med Sci & Peking Union Med Coll, Ctr Excellence Tissue Engn, Inst Basic Med Sci, Beijing 100005, Peoples R China; [Chen, Yunfei; Li, Jing; Li, Na; Wang, Shihua; Xue, Chunling; Han, Qin; Zhao, Robert Chunhua] Chinese Acad Med Sci & Peking Union Med Coll, Sch Basic Med, Beijing Key Lab New Drug Dev & Clin Trial Stem Ce, Beijing 100005, Peoples R China; [Ma, Baitao] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Vasc Surg, Beijing 100005, Peoples R China; [Sun, Zhao] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Oncol, Beijing 100005, Peoples R China; [Wei, Junji] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Neurosurg, Beijing 100005, Peoples R China		Han, Q; Zhao, RC (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Ctr Excellence Tissue Engn, Inst Basic Med Sci, Beijing 100005, Peoples R China.; Han, Q; Zhao, RC (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Sch Basic Med, Beijing Key Lab New Drug Dev & Clin Trial Stem Ce, Beijing 100005, Peoples R China.; Wei, JJ (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Neurosurg, Beijing 100005, Peoples R China.	hanqin@ibms.pumc.edu.cn; weijunji@pumch.cn; zhaochunhua@ibms.pumc.edu.cn			National Key Research and Development Program of China [2016YFA0101000, 2016YFA0101003, 2018YFA0109800]; Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences [2017-I2M-3-006, 2017-I2M-3-007]; 111 ProjectMinistry of Education, China - 111 Project [B18007]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81971324, 81672313, 81700782, 81601033, 81974183]	This work was supported by the National Key Research and Development Program of China (2016YFA0101000, 2016YFA0101003, 2018YFA0109800), the Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2017-I2M-3-006, 2017-I2M-3-007), the 111 Project (B18007) and the National Natural Science Foundation of China (81971324, 81672313, 81700782, 81601033, 81974183).	Bao XJ, 2011, EUR J NEUROSCI, V34, P87, DOI 10.1111/j.1460-9568.2011.07733.x; Bao XJ, 2011, BRAIN RES, V1367, P103, DOI 10.1016/j.brainres.2010.10.063; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Betzer O, 2017, ACS NANO, V11, P10883, DOI 10.1021/acsnano.7b04495; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Butovsky O, 2018, NAT REV NEUROSCI, V19, P622, DOI 10.1038/s41583-018-0057-5; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0963-x; Chinchalongporn V, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0129-y; Cui GH, 2018, FASEB J, V32, P654, DOI 10.1096/fj.201700600R; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; de Miranda AS, 2017, J NEUROL SCI, V372, P482, DOI 10.1016/j.jns.2016.10.052; DeKosky, 1998, Semin Clin Neuropsychiatry, V3, P176; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feng NH, 2019, J NEUROIMMUNOL, V334, DOI 10.1016/j.jneuroim.2019.576996; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gorabi AM, 2019, MOL NEUROBIOL, V56, P8157, DOI 10.1007/s12035-019-01663-0; Grange C, 2014, INT J MOL MED, V33, P1055, DOI 10.3892/ijmm.2014.1663; Griffin GD, 2011, MIL MED, V176, P364, DOI 10.7205/MILMED-D-10-00021; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Holm MM, 2018, TRENDS NEUROSCI, V41, P360, DOI 10.1016/j.tins.2018.03.006; Hu LH, 2016, SCI REP-UK, V6, DOI 10.1038/srep28924; Imai T, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26238; Jarmalaviciute A, 2016, PHARMACOL RES, V113, P816, DOI 10.1016/j.phrs.2016.02.002; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kim DK, 2016, P NATL ACAD SCI USA, V113, P170, DOI 10.1073/pnas.1522297113; Kiraly MA, 2007, THESCIENTIFICWORLDJO, V7, P1768, DOI 10.1100/tsw.2007.269; Lai CP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8029; Lee Jae-Kyung, 2013, Methods Mol Biol, V1041, P17, DOI 10.1007/978-1-62703-520-0_3; Lener T, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.30087; Lin RZ, 2013, MOL CELL BIOCHEM, V383, P13, DOI 10.1007/s11010-013-1746-z; Lindvall O, 2012, CELL STEM CELL, V10, P660, DOI [10.1016/j.stem.2012.04.004, 10.1016/j.stem.2012.01.009]; Liu YC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17543; Luarte A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5736059; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mathieu M, 2019, NAT CELL BIOL, V21, P9, DOI 10.1038/s41556-018-0250-9; Nasr IW, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112957; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Sun D, 2016, EXP NEUROL, V275, P405, DOI 10.1016/j.expneurol.2015.04.017; SUZUMURA A, 1991, BRAIN RES, V545, P301, DOI 10.1016/0006-8993(91)91302-H; Takahashi Y, 2017, METHODS MOL BIOL, V1660, P245, DOI 10.1007/978-1-4939-7253-1_20; Tam WY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07279; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Wang Z, 2015, STEM CELLS, V33, P456, DOI 10.1002/stem.1878; Wei Gao, 2017, Sci Rep, V7, P42996, DOI 10.1038/srep42996; Wen YC, 2017, BIOCHEM BIOPH RES CO, V487, P923, DOI 10.1016/j.bbrc.2017.05.005; Wiklander OPB, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26316; Wojtowicz JM, 2006, NAT PROTOC, V1, P1399, DOI 10.1038/nprot.2006.224; Xin HQ, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00377; Zhang YL, 2017, NEUROCHEM INT, V111, P69, DOI 10.1016/j.neuint.2016.08.003; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhuang XY, 2011, MOL THER, V19, P1769, DOI 10.1038/mt.2011.164	64	12	12	5	16	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA	1945-4589			AGING-US	Aging-US	SEP 30	2020	12	18					18274	18296					23	Cell Biology; Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Geriatrics & Gerontology	OD4OD	WOS:000579830900004	32966240	Green Published, gold			2022-02-06	
J	Estraneo, A; Fiorenza, S; Magliacano, A; Formisano, R; Mattia, D; Grippo, A; Romoli, AM; Angelakis, E; Cassol, H; Thibaut, A; Gosseries, O; Lamberti, G; No, E; Bagnato, S; Edlow, BL; Chatelle, C; Lejeune, N; Veeramuthu, V; Bartolo, M; Toppi, J; Zasler, N; Schnakers, C; Trojano, L				Estraneo, Anna; Fiorenza, Salvatore; Magliacano, Alfonso; Formisano, Rita; Mattia, Donatella; Grippo, Antonello; Romoli, Anna Maria; Angelakis, Efthymios; Cassol, Helena; Thibaut, Aurore; Gosseries, Olivia; Lamberti, Gianfranco; No, Enrique; Bagnato, Sergio; Edlow, Brian L.; Chatelle, Camille; Lejeune, Nicolas; Veeramuthu, Vigneswaran; Bartolo, Michelangelo; Toppi, Jlenia; Zasler, Nathan; Schnakers, Caroline; Trojano, Luigi		IBIA DoC-SIG	Multicenter prospective study on predictors of short-term outcome in disorders of consciousness	NEUROLOGY			English	Article							BRAIN-INJURED PATIENTS; VEGETATIVE STATE; RECOVERY; SCALE; COMA; EEG; POTENTIALS; PAIN	Objective This international multicenter, prospective, observational study aimed at identifying predictors of short-term clinical outcome in patients with prolonged disorders of consciousness (DoC) due to acquired severe brain injury. Methods Patients in vegetative state/unresponsive wakefulness syndrome (VS/UWS) or in minimally conscious state (MCS) were enrolled within 3 months from their brain injury in 12 specialized medical institutions. Demographic, anamnestic, clinical, and neurophysiologic data were collected at study entry. Patients were then followed up for assessing the primary outcome, that is, clinical diagnosis according to standardized criteria at 6 months postinjury. Results We enrolled 147 patients (44 women; mean age 49.4 [95% confidence interval 46.1-52.6] years; VS/UWS 71, MCS 76; traumatic 55, vascular 56, anoxic 36; mean time postinjury 59.6 [55.4-63.6] days). The 6-month follow-up was complete for 143 patients (VS/UWS 70; MCS 73). With respect to study entry, the clinical diagnosis improved in 72 patients (VS/UWS 27; MCS 45). Younger age, shorter time postinjury, higher Coma Recovery Scale-Revised total score, and presence of EEG reactivity to eye opening at study entry predicted better outcome, whereas etiology, clinical diagnosis, Disability Rating Scale score, EEG background activity, acoustic reactivity, and P300 on event-related potentials were not associated with outcome. Conclusions Multimodal assessment could identify patients with higher likelihood of clinical improvement in order to help clinicians, families, and funding sources with various aspects of decision-making. This multicenter, international study aims to stimulate further research that drives international consensus regarding standardization of prognostic procedures for patients with DoC.	[Estraneo, Anna; Grippo, Antonello; Romoli, Anna Maria] IRCCS Fdn Don Carlo Gnocchi, Florence, Italy; [Fiorenza, Salvatore] SB SpA, Ist Clin Sdentifid Maugeri IRCCS, Telese Terme, Italy; Lab Valutaz Multimodale Disordini Cosdenza, Telese Terme, Italy; [Magliacano, Alfonso; Trojano, Luigi] Univ Campania L Vanvitelli, Dept Psychol, Caserta, Italy; [Formisano, Rita; Mattia, Donatella] Fdn Santa Lucia, Rome, Italy; [Angelakis, Efthymios] Univ Athens, Neurosurg Dept, Med Sch, Athens, Greece; [Cassol, Helena; Thibaut, Aurore; Gosseries, Olivia] Univ & Univ Hosp Liege, GIGA Consciousness, Coma Sci Grp, Liege, Belgium; [Lamberti, Gianfranco] E Viglietta, Neurorehabilirat & Vegetat State Unit, Cuneo, Italy; [No, Enrique] NEURORHB Serv Neurorrehabil Hosp Vithas, Valencia, Spain; [Bagnato, Sergio] Giuseppe Giglio Fdn, Rehabil Deparunent, Unit Neurophysiol, Cefalu, Italy; [Bagnato, Sergio] Giuseppe Giglio Fdn, Rehabil Deparunent, Unit Severe Acquired Brain Injuries, Cefalu, Italy; [Edlow, Brian L.; Chatelle, Camille] Massachusetts Gen Hosp, Dept Neurol, Ctr Neurotechnol & Neurorecovery, Boston, MA USA; [Lejeune, Nicolas] CHN William Lennox, Ottignies, Belgium; [Veeramuthu, Vigneswaran] Univ Reading, Dept Psychol, Nusajaya, Malaysia; [Bartolo, Michelangelo] HABILITA Zingonia, Neurorehabil Unit, Bergamo, Italy; [Toppi, Jlenia] Sapienza Univ Rome, Dept Comp Control & Management Engn, Rome, Italy; [Zasler, Nathan] Concuss Care Ctr Virginia Ltd, Richmond, CA USA; [Schnakers, Caroline] Casa Colina Hosp Rehabil Med, Res Inst, Pomona, CA USA; [Schnakers, Caroline] Casa Colina Hosp Rehabil Med, Ctr Healthcare, Pomona, CA USA		Estraneo, A (corresponding author), IRCCS Fdn Don Carlo Gnocchi, Florence, Italy.	aestraneo@gmail.com	Casanova, Emanuela/AAD-3643-2022; Trojano, Luigi/F-2396-2016; Bagnato, Sergio/H-6842-2013; Magliacano, Alfonso/AAZ-5974-2020; Laureys, Steven/A-3349-2011; Magliacano, Alfonso AM/V-7498-2018; Veeramuthu, Vigneswaran/F-2220-2015; mattia, donatella/D-7569-2012; estraneo, anna/K-5409-2016	Casanova, Emanuela/0000-0002-5727-3769; Trojano, Luigi/0000-0002-0328-9642; Bagnato, Sergio/0000-0002-6289-1887; Magliacano, Alfonso/0000-0003-3834-6392; Magliacano, Alfonso AM/0000-0003-3834-6392; Veeramuthu, Vigneswaran/0000-0003-2052-0858; mattia, donatella/0000-0002-3092-2511; estraneo, anna/0000-0001-6646-5626; Formisano, Rita/0000-0002-2516-0540; Grippo, Antonello/0000-0002-9997-8564; Cassol, Helena/0000-0001-6616-7688; Fiorenza, Salvatore/0000-0002-7035-8628	European UnionEuropean Commission [778234-DoCMA]; NIH National Institute of Neurologic Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538, R21NS109627, RF1NS115268]; NIH Director's Office [DP2HD101400]; James S. McDonnell Foundation; Tiny Blue Dot Foundation; European Union's Horizon 2020 Framework Programme for Research and Innovation [785907]; Luminous project [U-H2020-fetopenga686764]; Belgian National Funds for Scientific Research (FRS-FNRS)Fonds de la Recherche Scientifique - FNRS; ItalianMinistry of HealthMinistry of Health, Italy	This work was supported by grants fromthe European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement 778234-DoCMA project, the NIH National Institute of Neurologic Disorders and Stroke (K23NS094538, R21NS109627, RF1NS115268), the NIH Director's Office (DP2HD101400), the James S. McDonnell Foundation, the Tiny Blue Dot Foundation, the European Union's Horizon 2020 Framework Programme for Research and Innovation under Specific Grant Agreement 785907 (Human Brain Project SGA2), the Luminous project (EU-H2020-fetopenga686764), the Belgian National Funds for Scientific Research (FRS-FNRS), and the ItalianMinistry of Health (Current research program 2016-2017).	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bagnato S, 2010, CLIN NEUROPHYSIOL, V121, P274, DOI 10.1016/j.clinph.2009.11.008; Bagnato S, 2015, CLIN NEUROPHYSIOL, V126, P959, DOI 10.1016/j.clinph.2014.08.005; Baricich A, 2017, FUNCT NEUROL, V32, P131; Berger H, 1929, ARCH PSYCHIAT NERVEN, V87, P527, DOI 10.1007/BF01797193; Chatelle C, 2018, ARCH PHYS MED REHAB, V99, P1755, DOI 10.1016/j.apmr.2018.03.009; Chatelle C, 2012, J NEUROL NEUROSUR PS, V83, P1233, DOI 10.1136/jnnp-2012-302987; Cheng LJ, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-27; Cruccu G, 2008, CLIN NEUROPHYSIOL, V119, P1705, DOI 10.1016/j.clinph.2008.03.016; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Estraneo A, 2019, BRAIN INJURY, V33, P1633, DOI 10.1080/02699052.2019.1658220; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2018, ARCH PHYS MED REHAB, V99, P2523, DOI 10.1016/j.apmr.2018.04.024; Estraneo A, 2016, CLIN NEUROPHYSIOL, V127, P2379, DOI 10.1016/j.clinph.2016.03.021; Estraneo A, 2015, CLIN REHABIL, V29, P803, DOI 10.1177/0269215514556002; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Faugeras F, 2018, BRAIN INJURY, V32, P72, DOI 10.1080/02699052.2017.1364421; Fins JJ, 2018, NEUROLOGY, V91, P471, DOI 10.1212/WNL.0000000000005927; Forgacs PB, 2014, ANN NEUROL, V76, P869, DOI 10.1002/ana.24283; Formisano R, 2017, NEUROL SCI, V38, P181, DOI 10.1007/s10072-016-2724-5; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gutchess A, 2014, SCIENCE, V346, P579, DOI 10.1126/science.1254604; Kennedy P., 2003, GUIDE ECONOMETRICS; Kotchoubey B, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00315; Laureys S., 2018, COMA DISORDERS CONSC, P17, DOI 10.1007/978-3-319-55964-3; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Leblanc G, 2018, CLIN TRIALS, V15, P398, DOI 10.1177/1740774518771233; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Pascarella A, 2018, FUNCT NEUROL, V33, P19, DOI 10.11138/FNeur/2018.33.1.019; Pascarella A, 2016, J NEUROL, V263, P2048, DOI 10.1007/s00415-016-8232-y; Portaccio E, 2018, BRAIN INJURY, V32, P730, DOI 10.1080/02699052.2018.1440420; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Risetti M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00775; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Scarpino M, 2018, RESUSCITATION, V129, P114, DOI 10.1016/j.resuscitation.2018.04.016; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Steppacher I, 2014, ANN CLIN TRANSL NEUR, V1, P401, DOI 10.1002/acn3.63; Steppacher I, 2013, ANN NEUROL, V73, P594, DOI 10.1002/ana.23835; Striano S, 1992, Acta Neurol (Napoli), V14, P275; Toppi J, 2016, IEEE T BIO-MED ENG, V63, P2461, DOI 10.1109/TBME.2016.2621668; Tsetsou S, 2015, RESUSCITATION, V97, P34, DOI 10.1016/j.resuscitation.2015.09.380; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Whyte J, 2009, PROG BRAIN RES, V177, P63, DOI 10.1016/S0079-6123(09)17706-3; Zhang Y, 2017, NEUROSCI LETT, V653, P332, DOI 10.1016/j.neulet.2017.06.013	50	12	12	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	SEP 15	2020	95	11					E1488	E1499		10.1212/WNL.0000000000010254			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NX9ML	WOS:000576025700017	32661102	Green Published, hybrid			2022-02-06	
J	Nasution, RA; Islam, AA; Hatta, M; Prihantono; Turchan, A; Nasrullah; Faruk, M				Nasution, Rizha Anshori; Islam, Andi Asadul; Hatta, Mochammad; Prihantono; Turchan, Agus; Nasrullah; Faruk, Muhammad			Role of CAPE in reducing oxidative stress in animal models with traumatic brain injury	ANNALS OF MEDICINE AND SURGERY			English	Article						Traumatic brain injury; F2-isoprostane; Oxidative stress	ACID PHENETHYL ESTER; ANTIOXIDANT ACTIVITY; F-2-ISOPROSTANES; F-4-NEUROPROSTANES; NEUROPROSTANES; ISOPROSTANES; INFLAMMATION; TISSUE	Introduction: The central nervous system (CNS) is the most metabolically active organ characterized by high oxygen demand and relatively low anti-oxidative activity, which makes neurons and glia highly susceptible to damage by reactive oxygen and nitrogen byproducts as well as neurodegeneration. Free radicals are associated with secondary injuries that occur after a primary brain injury. Some of these free radical products include F2Isoprostane (F2-IsoPs), malondialdehyde (MDA), 4-hydroxy-2-nonenal (4-HNE) and acrolein. Methods: In this study we measured serum F2-IsoPs levels as markers of free radical activity in 10-12 week-old male Sprague-Dawley rats weighing 200-300 g, all rats (n = 10) subjected with a head injury according to the modified marmourou model, then divided into 2 groups, one group treated with CAPE (Caffeic Acid Phenethyl Ester) (n = 5) and the other not treated with CAPE (n = 5), serum levels in the two groups were compared starting from day-0 (before brain injury), day-4 and day-7. Results: We found lower F2-IsoPs levels in the group that received the CAPE treatment compared to the group that did not receive the CAPE treatment. Conclusion: CAPE is capable of significantly reducing oxidative stress in brain injury.	[Nasution, Rizha Anshori] Pelamonia Hosp, Dept Neurosurg, Jalan Jend Sudirman 27, Makassar 90157, Indonesia; [Nasution, Rizha Anshori] Hasanuddin Univ, Fac Med, Doctoral Program Biomed Sci, Makassar, Indonesia; [Islam, Andi Asadul; Nasrullah] Hasanuddin Univ, Fac Med, Dept Neurosurg, Makassar, Indonesia; [Hatta, Mochammad] Hasanuddin Univ, Fac Med, Clin Microbiologist Program, Makassar, Indonesia; [Prihantono; Faruk, Muhammad] Hasanuddin Univ, Dept Surg, Fac Med, Makassar, Indonesia; [Turchan, Agus] Airlangga Univ, Fac Med, Dept Neurosurg, Surabaya, Indonesia		Nasution, RA (corresponding author), Pelamonia Hosp, Dept Neurosurg, Jalan Jend Sudirman 27, Makassar 90157, Indonesia.	rizha_nst@yahoo.com; andiasadul@yahoo.com; hattaram@yahoo.com; prihantono.md@gmail.com; agusturchan@gmail.com; nasrullah.makassar@gmail.com; faroex8283@gmail.com	Hatta, Mochammad/D-3742-2019; , prihantono/AAK-2259-2020	Hatta, Mochammad/0000-0002-8456-4203; , prihantono/0000-0002-8247-0457; Faruk, Muhammad/0000-0002-7079-4585			Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Garcia-Flores LA, 2016, FREE RADICAL RES, V50, P485, DOI 10.3109/10715762.2015.1111514; Aloutaibi G. T., 2017, African Journal of Traditional, Complementary and Alternative Medicines, V14, P138, DOI 10.21010/ajtcam.v14i5.17; Ayla S, 2018, ACTA HISTOCHEM, V120, P117, DOI 10.1016/j.acthis.2018.01.001; Branton, 2017, INT J CLIN DEV ANAT, V3, P9, DOI [10.11648/j.ijcda.20170303.11, DOI 10.11648/J.IJCDA.20170303.11]; Cetin A, 2019, FOLIA MORPHOL, V78, P221, DOI 10.5603/FM.a2018.0085; Chu JJ, 2015, ENVIRON TOXICOL PHAR, V39, P683, DOI 10.1016/j.etap.2015.01.020; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dunn JD, 2015, REDOX BIOL, V6, P472, DOI 10.1016/j.redox.2015.09.005; Foret MK, 2019, FREE RADICAL BIO MED, V130, P471, DOI 10.1016/j.freeradbiomed.2018.11.019; Galano JM, 2017, PROG LIPID RES, V68, P83, DOI 10.1016/j.plipres.2017.09.004; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Khoubnasabjafari M, 2015, BIOIMPACTS, V5, P123, DOI 10.15171/bi.2015.20; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; McCullough PA, 2016, THROMB RES, V148, P85, DOI 10.1016/j.thromres.2016.10.022; Melton CD, 2017, ANN EPIDEMIOL, V27, P391, DOI 10.1016/j.annepidem.2017.05.005; Moosavi F, 2017, BIOORGAN MED CHEM, V25, P3233, DOI 10.1016/j.bmc.2017.04.026; Nasution RA, 2020, ANN MED SURG, V54, P89, DOI 10.1016/j.amsu.2020.04.015; Niedzielska E, 2016, MOL NEUROBIOL, V53, P4094, DOI 10.1007/s12035-015-9337-5; Nikolaidis MG, 2011, PROG LIPID RES, V50, P89, DOI 10.1016/j.plipres.2010.10.002; Proudfoot JM, 2018, FREE RADICAL BIO MED, V126, P142, DOI 10.1016/j.freeradbiomed.2018.08.007; Proudfoot JM, 2016, FREE RADICAL RES, V50, P1374, DOI 10.1080/10715762.2016.1250262; Redza-Dutordoir M, 2016, BBA-MOL CELL RES, V1863, P2977, DOI 10.1016/j.bbamcr.2016.09.012; Salmas RE, 2017, CELL BIOCHEM FUNCT, V35, P304, DOI 10.1002/cbf.3277; Schoneich C, 2017, FREE RADICAL BIO MED, V108, pS100, DOI 10.1016/j.freeradbiomed.2017.04.321; Signorini C, 2018, FREE RADICAL BIO MED, V115, P261, DOI 10.1016/j.freeradbiomed.2017.12.009; Stoiber W, 2015, BIOMOLECULES, V5, P702, DOI 10.3390/biom5020702; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Tolba MF, 2016, CRIT REV FOOD SCI, V56, P2183, DOI 10.1080/10408398.2013.821967; Wisniewski K, 2018, NEUROL NEUROCHIR POL, V52, P643, DOI 10.1016/j.pjnns.2018.09.009; Yen HC, 2015, FREE RADICAL RES, V49, P1419, DOI 10.3109/10715762.2015.1080363; Yen HC, 2015, FREE RADICAL RES, V49, P861, DOI 10.3109/10715762.2015.1014812	32	12	12	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2049-0801			ANN MED SURG	Ann. Med. Surg.	SEP	2020	57						118	122		10.1016/j.amsu.2020.07.036			5	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	NO4BQ	WOS:000569430900027	32760580	gold, Green Published			2022-02-06	
J	Orchard, JW; Jomaa, MC; Orchard, JJ; Rae, K; Hoffman, DT; Reddin, T; Driscoll, T				Orchard, John W.; Chaker Jomaa, Mohammad; Orchard, Jessica J.; Rae, Katherine; Hoffman, Daniel Tyler; Reddin, Tom; Driscoll, Tim			Fifteen-week window for recurrent muscle strains in football: a prospective cohort of 3600 muscle strains over 23 years in professional Australian rules football	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						muscle injury; Australian football; hamstring; quadriceps; groin	DATA-COLLECTION PROCEDURES; UEFA CHAMPIONS LEAGUE; RISK-FACTORS; CONSENSUS STATEMENT; INJURY DEFINITIONS; HAMSTRING INJURIES; EPIDEMIOLOGY; INCREASE; SOCCER; RETURN	Objectives To determine the rates of muscle strain injury recurrence over time after return to play in Australian football and to quantify risk factors. Methods We analysed Australian Football League player data from 1992 to 2014 for rates of the four major muscle strain injury types (hamstring, quadriceps, calf and groin) diagnosed by team health professionals. Covariates for analysis were: recent history (<= 8 weeks) of each of the four muscle strains; non-recent history (>8 weeks) of each; history of hip, knee anterior cruciate ligament, knee cartilage, ankle sprain, concussion or lumbar injury; age; indigenous race; match level and whether a substitute rule was in place. Results 3647 (1932 hamstring, 418 quadriceps, 458 calf and 839 groin) muscle strain injuries occurred in 272 759 player matches. For all muscle strains combined, the risk of injury recurrence gradually reduced, with recurrence risks of 9% (hamstring), 5% (quadriceps), 2% (calf) and 6% (groin) in the first match back and remaining elevated for 15 weeks after return to play. The strongest risk factor for each muscle injury type was a recent history of the same injury (hamstring: adjusted OR 13.1, 95% CI 11.5 to 14.9; calf OR 13.3, 95% CI 9.6 to 18.4; quadriceps: OR 25.2, 95% CI 18.8 to 33.8; groin OR 20.6, 95% CI 17.0 to 25.0), followed by non-recent history of the same injury (hamstring: adjusted OR 3.5, 95% CI 3.2 to 3.9; calf OR 4.4, 95% CI 3.6 to 5.4; quadriceps OR 5.2, 95% CI 4.2 to 6.4; groin OR 3.5, 95% CI 3.0 to 4.0). Age was an independent risk factor for calf muscle strains (adjusted OR 1.6, 95% CI 1.3 to 2.0). Recent hamstring injury increased the risk of subsequent quadriceps (adjusted OR 1.8, 95% CI 1.2 to 2.7) and calf strains (OR 1.8, 95% CI 1.2 to 2.6). During the 'substitute rule' era (2011-2014), hamstring (adjusted OR 0.76, 95% CI 0.67 to 0.86), groin (OR 0.78, 95% CI 0.65 to 0.93) and quadriceps (OR 0.70, 95% CI 0.53 to 0.92) strains were less likely than outside of that era but calf (OR 1.6, 95% CI 1.3 to 1.9) strains were more likely than before the substitute rule era. Conclusion Recent injury is the greatest risk factor for the four major muscle strains, with increased risk persisting for 15 weeks after return to play.	[Orchard, John W.; Chaker Jomaa, Mohammad; Orchard, Jessica J.; Driscoll, Tim] Univ Sydney, Sch Publ Hlth, Med Sch, Sydney, NSW 2006, Australia; [Rae, Katherine] Univ Sydney, Sports Clin, Sydney, NSW, Australia; [Hoffman, Daniel Tyler] Deakin Univ, Fac Hlth, Ctr Sport Res, Sch Exercise & Nutr Sci, Burwood, Vic, Australia; [Reddin, Tom] Sydney Univ Australian Natl Football Club, Camperdown, NSW, Australia		Orchard, JW (corresponding author), Univ Sydney, Sch Publ Hlth, Med Sch, Sydney, NSW 2006, Australia.	john.orchard@sydney.edu.au	Orchard, John W/AAY-7216-2020; Orchard, Jessica/O-4350-2019	Orchard, John W/0000-0003-3530-1711; Orchard, Jessica/0000-0002-5702-7277; Hoffman, Daniel/0000-0002-5147-5829; Reddin, Tom/0000-0002-8210-7623; Chaker Jomaa, Mohammad/0000-0001-7916-2755			Bengtsson H, 2013, BRIT J SPORT MED, V47, P743, DOI 10.1136/bjsports-2013-092383; Duhig S, 2016, BRIT J SPORT MED, V50, P1536, DOI 10.1136/bjsports-2015-095679; Eckard TG, 2017, J ATHL TRAINING, V52, P474, DOI 10.4085/1062-6050-52.2.17; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Ekstrand J, 2016, BRIT J SPORT MED, V50, P731, DOI 10.1136/bjsports-2015-095359; Ekstrand J, 2012, BRIT J SPORT MED, V46, P112, DOI 10.1136/bjsports-2011-090155; Ekstrand J, 2011, AM J SPORT MED, V39, P1226, DOI 10.1177/0363546510395879; Elliott MCCW, 2011, AM J SPORT MED, V39, P843, DOI 10.1177/0363546510394647; Emery CA, 1999, CLIN J SPORT MED, V9, P151, DOI 10.1097/00042752-199907000-00006; Freckleton G, 2013, BRIT J SPORT MED, V47, P351, DOI 10.1136/bjsports-2011-090664; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2006, BRIT J SPORT MED, V40, P193, DOI 10.1136/bjsm.2005.025270; Gissane C, 2003, AM J SPORT MED, V31, P954, DOI 10.1177/03635465030310063501; Green B, 2017, BRIT J SPORT MED, V51, P1189, DOI 10.1136/bjsports-2016-097177; Greenland S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1981; Hagglund M, 2013, AM J SPORT MED, V41, P327, DOI 10.1177/0363546512470634; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Mosler AB, 2018, BRIT J SPORT MED, V52, P292, DOI 10.1136/bjsports-2016-097277; Orchard J, 1997, AM J SPORT MED, V25, P81, DOI 10.1177/036354659702500116; Orchard J, 2002, CLIN J SPORT MED, V12, P3, DOI 10.1097/00042752-200201000-00004; Orchard J., 2002, NZ J SPORTS MED, V30, P92; Orchard JW, 2012, J SCI MED SPORT, V15, P201, DOI 10.1016/j.jsams.2011.11.250; Orchard JW, 2001, AM J SPORT MED, V29, P300, DOI 10.1177/03635465010290030801; Orchard JW, 2014, MINERVA ORTOP TRAUMA, V65, P355; Roberts SP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003998; Stares JJ, 2019, AM J SPORT MED, V47, P2225, DOI 10.1177/0363546519852622; Walden M, 2005, BRIT J SPORT MED, V39, P542, DOI 10.1136/bjsm.2004.014571	27	12	12	3	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	SEP	2020	54	18					1103	+		10.1136/bjsports-2019-100755			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	NS5UP	WOS:000572326300008	32024646				2022-02-06	
J	Wu, YC; Harezlak, J; Elsaid, NMH; Lin, ZK; Wen, QT; Mustafi, SM; Riggen, LD; Koch, KM; Nencka, AS; Meier, TB; Mayer, AR; Wang, Y; Giza, CC; DiFiori, JP; Guskiewicz, KM; Mihalik, JP; LaConte, SM; Duma, SM; Broglio, SP; Saykin, AJ; McCrea, MA; McAllister, TW				Wu, Yu-Chien; Harezlak, Jaroslaw; Elsaid, Nahla M. H.; Lin, Zikai; Wen, Qiuting; Mustafi, Sourajit M.; Riggen, Larry D.; Koch, Kevin M.; Nencka, Andrew S.; Meier, Timothy B.; Mayer, Andrew R.; Wang, Yang; Giza, Christopher C.; DiFiori, John P.; Guskiewicz, Kevin M.; Mihalik, Jason P.; LaConte, Stephen M.; Duma, Stefan M.; Broglio, Steven P.; Saykin, Andrew J.; McCrea, Michael A.; McAllister, Thomas W.		Diffusion MRI Study	Longitudinal white-matter abnormalities in sports-related concussion A diffusion MRI study	NEUROLOGY			English	Article								Objective To study longitudinal recovery trajectories of whitematter after sports-related concussion (SRC) by performing diffusion tensor imaging (DTI) on collegiate athletes who sustained SRC. Methods Collegiate athletes (n = 219, 82 concussed athletes, 68 contact-sport controls, and 69 non-contactsport controls) were included from the Concussion Assessment, Research and Education Consortium. The participants completed clinical assessments and DTI at 4 time points: 24 to 48 hours after injury, asymptomatic state, 7 days after return-to-play, and6months after injury. Tract-based spatial statistics was used to investigate group differences in DTI metrics and to identify whitematter areas with persistent abnormalities. Generalized linear mixed models were used to study longitudinal changes and associations between outcome measures and DTI metrics. Cox proportional hazards model was used to study effects of white-matter abnormalities on recovery time. Results In the white matter of concussed athletes, DTI-derived mean diffusivity was significantly higher than in the controls at 24 to 48 hours after injury and beyond the point when the concussed athletes became asymptomatic. While the extent of affected white matter decreased over time, part of the corpus callosum had persistent group differences across all the time points. Furthermore, greater elevation of mean diffusivity at acute concussion was associated with worse clinical outcome measures (i.e., Brief Symptom Inventory scores and symptom severity scores) and prolonged recovery time. No significant differences in DTI metrics were observed between the contact-sport and non-contact-sport controls. Conclusions Changes in white matter were evident after SRC at 6 months after injury but were not observed in contact-sport exposure. Furthermore, the persistent white-matter abnormalities were associated with clinical outcomes and delayed recovery time.	[Wu, Yu-Chien; Elsaid, Nahla M. H.; Wen, Qiuting; Mustafi, Sourajit M.; Saykin, Andrew J.] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [Lin, Zikai; McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Riggen, Larry D.] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Harezlak, Jaroslaw] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN USA; [Mustafi, Sourajit M.] Nanoscope Technol LLC, Bedford, TX USA; [Koch, Kevin M.; Nencka, Andrew S.; Wang, Yang] Med Coll Wisconsin, Dept Radiol, Milwaukee, WI 53226 USA; [Meier, Timothy B.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Mayer, Andrew R.] Mind Res Network, Albuquerque, NM USA; [Giza, Christopher C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Giza, Christopher C.] Univ Calif Los Angeles, Div Pediat Neurol, Mattel Childrens Hosp, Los Angeles, CA USA; [DiFiori, John P.] Univ Calif Los Angeles, Dept Family Med & Orthoped, Div Sports Med, Los Angeles, CA USA; [DiFiori, John P.] Hosp Special Surg, Primary Care Sports Med, 535 E 70th St, New York, NY 10021 USA; [Guskiewicz, Kevin M.; Mihalik, Jason P.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [LaConte, Stephen M.] Wake Forest & Virginia Tech Univ, Virginia Tech Caril Res Inst, Sch Biomed Engn & Sci, Roanoke, VA USA; [Duma, Stefan M.] Wake Forest & Virginia Tech Univ, Sch Biomed Engn & Sci, Blacksburg, VA USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA		Wu, YC (corresponding author), Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA.	yucwu@iu.edu	Elsaid, Nahla/AAC-8531-2020; Harezlak, Jaroslaw/P-8557-2014	Elsaid, Nahla/0000-0002-8832-3087; Harezlak, Jaroslaw/0000-0002-3070-7686; Wen, Qiuting/0000-0002-7885-4036	Grand Alliance CARE Consortium - NCAA; DoDUnited States Department of Defense [W81XWH-14-2-0151]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS075791, R01 AG053993, P30 AG010133, R01 AG019771]	This publication was made possible, in part, by support from the Grand Alliance CARE Consortium, funded, in part by the NCAA and the DoD under award W81XWH-14-2-0151. Other funding support includes NIH grant R21 NS075791 to Y.C.W. and T.W.M., R01 AG053993 to Y.C.W., and P30 AG010133 and R01 AG019771 to A.J.S.	Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Beckwith J, 2018, ANN BIOMED ENG, V46, P819, DOI 10.1007/s10439-018-1999-5; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Derogatis L.R., 1993, BSI BRIEF SYMPTOM IN; Field AS, 2004, J MAGN RESON IMAGING, V20, P555, DOI 10.1002/jmri.20169; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Ibrahim JG, 2009, TEST-SPAIN, V18, P1, DOI 10.1007/s11749-009-0138-x; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kinoshita M, 2010, J NEURO-ONCOL, V96, P409, DOI 10.1007/s11060-009-9979-0; Klawiter EC, 2011, NEUROIMAGE, V55, P1454, DOI 10.1016/j.neuroimage.2011.01.007; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Lancaster MA, 2018, HUM BRAIN MAPP, V39, P4276, DOI 10.1002/hbm.24245; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee JE, 2007, NEUROSCI LETT, V424, P127, DOI 10.1016/j.neulet.2007.07.042; Lepage C, 2018, BRAIN IMAGING BEHAV, V12, P870, DOI 10.1007/s11682-017-9744-5; Levin B, 2014, NEUROCRIT CARE, V20, P334, DOI 10.1007/s12028-013-9931-1; Manjon JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073021; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1996, STANDARDIZED ASSESSM; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Mustafi SM, 2018, INT SOC MAGN RES MED; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Nencka AS, 2018, BRAIN IMAGING BEHAV, V12, P1121, DOI 10.1007/s11682-017-9775-y; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Rocca MA, 2016, MULT SCLER J, V22, P620, DOI 10.1177/1352458515596600; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sporns O, 2016, ANNU REV PSYCHOL, V67, P613, DOI 10.1146/annurev-psych-122414-033634; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wechsler D., 1987, MANUAL WECHSLER ADUL; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215; Wu YC, 2019, INT SOC MAG RES MED; Wu YC, 2011, NEUROIMAGE, V58, P829, DOI 10.1016/j.neuroimage.2011.06.067	50	12	12	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	AUG 18	2020	95	7					E781	E792		10.1212/WNL.0000000000009930			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QI8ZW	WOS:000619277100001	32641518	hybrid, Green Published			2022-02-06	
J	Edlow, BL; Barra, ME; Zhou, DW; Foulkes, AS; Snider, SB; Threlkeld, ZD; Chakravarty, S; Kirsch, JE; Chan, ST; Meisler, SL; Bleck, TP; Fins, JJ; Giacino, JT; Hochberg, LR; Solt, K; Brown, EN; Bodien, YG				Edlow, Brian L.; Barra, Megan E.; Zhou, David W.; Foulkes, Andrea S.; Snider, Samuel B.; Threlkeld, Zachary D.; Chakravarty, Sourish; Kirsch, John E.; Chan, Suk-tak; Meisler, Steven L.; Bleck, Thomas P.; Fins, Joseph J.; Giacino, Joseph T.; Hochberg, Leigh R.; Solt, Ken; Brown, Emery N.; Bodien, Yelena G.			Personalized Connectome Mapping to Guide Targeted Therapy and Promote Recovery of Consciousness in the Intensive Care Unit	NEUROCRITICAL CARE			English	Article						Coma; Consciousness; Brain injury; Connectome; Clinical trial; Biomarker	TRAUMATIC BRAIN-INJURY; AREA INDUCES REANIMATION; ASCENDING AROUSAL SYSTEM; DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; METHYLPHENIDATE HYDROCHLORIDE; INTRAVENOUS METHYLPHENIDATE; STEM INJURY; DOPAMINE; STATE	There are currently no therapies proven to promote early recovery of consciousness in patients with severe brain injuries in the intensive care unit (ICU). For patients whose families face time-sensitive, life-or-death decisions, treatments that promote recovery of consciousness are needed to reduce the likelihood of premature withdrawal of life-sustaining therapy, facilitate autonomous self-expression, and increase access to rehabilitative care. Here, we present the Connectome-based Clinical Trial Platform (CCTP), a new paradigm for developing and testing targeted therapies that promote early recovery of consciousness in the ICU. We report the protocol for STIMPACT (Stimulant Therapy Targeted to Individualized Connectivity Maps to Promote ReACTIvation of Consciousness), a CCTP-based trial in which intravenous methylphenidate will be used for targeted stimulation of dopaminergic circuits within the subcortical ascending arousal network (ClinicalTrials.gov NCT03814356). The scientific premise of the CCTP and the STIMPACT trial is that personalized brain network mapping in the ICU can identify patients whose connectomes are amenable to neuromodulation. Phase 1 of the STIMPACT trial is an open-label, safety and dose-finding study in 22 patients with disorders of consciousness caused by acute severe traumatic brain injury. Patients in Phase 1 will receive escalating daily doses (0.5-2.0 mg/kg) of intravenous methylphenidate over a 4-day period and will undergo resting-state functional magnetic resonance imaging and electroencephalography to evaluate the drug's pharmacodynamic properties. The primary outcome measure for Phase 1 relates to safety: the number of drug-related adverse events at each dose. Secondary outcome measures pertain to pharmacokinetics and pharmacodynamics: (1) time to maximal serum concentration; (2) serum half-life; (3) effect of the highest tolerated dose on resting-state functional MRI biomarkers of connectivity; and (4) effect of each dose on EEG biomarkers of cerebral cortical function. Predetermined safety and pharmacodynamic criteria must be fulfilled in Phase 1 to proceed to Phase 2A. Pharmacokinetic data from Phase 1 will also inform the study design of Phase 2A, where we will test the hypothesis that personalized connectome maps predict therapeutic responses to intravenous methylphenidate. Likewise, findings from Phase 2A will inform the design of Phase 2B, where we plan to enroll patients based on their personalized connectome maps. By selecting patients for clinical trials based on a principled, mechanistic assessment of their neuroanatomic potential for a therapeutic response, the CCTP paradigm and the STIMPACT trial have the potential to transform the therapeutic landscape in the ICU and improve outcomes for patients with severe brain injuries.	[Edlow, Brian L.; Barra, Megan E.; Zhou, David W.; Snider, Samuel B.; Threlkeld, Zachary D.; Chakravarty, Sourish; Meisler, Steven L.; Hochberg, Leigh R.; Bodien, Yelena G.] Harvard Med Sch, Ctr Neurotechnol & Neurorecovery, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Edlow, Brian L.; Kirsch, John E.; Chan, Suk-tak] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Barra, Megan E.] Massachusetts Gen Hosp, Dept Pharm, Boston, MA 02114 USA; [Zhou, David W.; Brown, Emery N.] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Foulkes, Andrea S.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Threlkeld, Zachary D.] Stanford Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Chakravarty, Sourish; Solt, Ken; Brown, Emery N.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Chakravarty, Sourish; Brown, Emery N.] MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bleck, Thomas P.] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol, Chicago, IL 60611 USA; [Fins, Joseph J.] Weill Cornell Med Coll, Div Med Eth, New York, NY USA; [Fins, Joseph J.] Weill Cornell Med Coll, Consortium Adv Study Brain Injury, New York, NY USA; [Fins, Joseph J.] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA; [Fins, Joseph J.] Yale Law Sch, Solomon Ctr Hlth Law & Policy, New Haven, CT USA; [Giacino, Joseph T.; Bodien, Yelena G.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Hochberg, Leigh R.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Hochberg, Leigh R.] Brown Univ, Carney Inst Brain Sci, Providence, RI 02912 USA; [Hochberg, Leigh R.] VA Med Ctr, Vet Affairs RR&D Ctr Neurorestorat & Neurotechnol, Providence, RI USA		Edlow, BL (corresponding author), Harvard Med Sch, Ctr Neurotechnol & Neurorecovery, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA.; Edlow, BL (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	bedlow@mgh.harvard.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Fins, Joseph/0000-0002-7221-0053	NIH Director's Office [DP2HD101400]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538, R21NS109627, RF1NS115268]; American Academy of Neurology/American Brain Foundation; James S. McDonnell Foundation; Rappaport Foundation; Tiny Blue Dot Foundation; National Institute of Neurological Disorders and Stroke Clinical Trial Methodology Course [R25NS088248]; Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL 1TR002541]; Harvard University	The study was funded by the NIH Director's Office (DP2HD101400), National Institute of Neurological Disorders and Stroke (K23NS094538, R21NS109627, RF1NS115268), American Academy of Neurology/American Brain Foundation, James S. McDonnell Foundation, Rappaport Foundation, and Tiny Blue Dot Foundation. We also acknowledge support from the National Institute of Neurological Disorders and Stroke Clinical Trial Methodology Course (R25NS088248). This work was conducted with support from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award UL 1TR002541) and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Barra ME, 2020, J INTENSIVE CARE MED, V35, P1196, DOI 10.1177/0885066619841603; Bodien YG, 2019, CORTEX, V119, P571, DOI 10.1016/j.cortex.2019.01.014; CARTER CH, 1957, DIS NERV SYST, V18, P146; CHAN YPM, 1983, PEDIATRICS, V72, P56; CHRISTENSEN R O, 1958, Oral Surg Oral Med Oral Pathol, V11, P999, DOI 10.1016/0030-4220(58)90139-7; Cimenser A, 2011, P NATL ACAD SCI USA, V108, P8832, DOI 10.1073/pnas.1017041108; Claassen J, 2019, NEW ENGL J MED, V380, P2497, DOI 10.1056/NEJMoa1812757; CLARK CR, 1986, PSYCHOPHARMACOLOGY, V90, P35; Cribben I, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00143; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Demertzi A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat7603; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; DODSON ME, 1980, BRIT J ANAESTH, V52, P1265, DOI 10.1093/bja/52.12.1265; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Edlow BL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01077; Edlow BL, 2016, BRAIN CONNECT, V6, P187, DOI 10.1089/brain.2015.0378; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Engemann DA, 2018, BRAIN, V141, P3179, DOI 10.1093/brain/awy251; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Faugeras F, 2018, BRAIN INJURY, V32, P72, DOI 10.1080/02699052.2017.1364421; Fins JJ, 2015, RIGHTS COME MIND BRA; Fridman EA, 2019, BRAIN, V142, P1887, DOI 10.1093/brain/awz118; Fridman EA, 2014, CURR OPIN NEUROBIOL, V29, P172, DOI 10.1016/j.conb.2014.09.008; GALE AS, 1961, ANESTHESIOLOGY, V22, P210, DOI 10.1097/00000542-196103000-00009; GALE AS, 1958, ANESTHESIOLOGY, V19, P521, DOI 10.1097/00000542-195807000-00009; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.3.CO;2-5; Hammond FM, 2019, J NEUROTRAUM, V36, P1136, DOI 10.1089/neu.2018.5954; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Izzy S, 2017, NEUROCRIT CARE, V27, P199, DOI 10.1007/s12028-017-0399-2; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Jang SH, 2014, NEURORADIOLOGY, V56, P965, DOI 10.1007/s00234-014-1419-y; JANOWSKY DS, 1978, PSYCHOPHARMACOLOGY, V59, P75, DOI 10.1007/BF00428034; Jenkins PO, 2019, BRAIN, V142, P2367, DOI 10.1093/brain/awz149; JOYCE PR, 1986, BIOL PSYCHIAT, V21, P1015, DOI 10.1016/0006-3223(86)90282-9; JOYCE PR, 1984, LIFE SCI, V34, P1707, DOI 10.1016/0024-3205(84)90568-X; Killick R, 2014, J STAT SOFTW, V58, P1; Koch C, 2016, NAT REV NEUROSCI, V17, P307, DOI 10.1038/nrn.2016.22; Kochanek PM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00640; Kondziella D, 2017, NEUROCRIT CARE, V27, P401, DOI 10.1007/s12028-017-0407-6; Li CSR, 2010, P NATL ACAD SCI USA, V107, P14455, DOI 10.1073/pnas.1002467107; Lindquist MA, 2007, NEUROIMAGE, V35, P1125, DOI 10.1016/j.neuroimage.2007.01.004; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McNab JA, 2013, NEUROIMAGE, V80, P234, DOI 10.1016/j.neuroimage.2013.05.074; Morales M, 2017, NAT REV NEUROSCI, V18, P73, DOI 10.1038/nrn.2016.165; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Norton L, 2012, NEUROLOGY, V78, P175, DOI 10.1212/WNL.0b013e31823fcd61; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Parvizi J, 2001, COGNITION, V79, P135, DOI 10.1016/S0010-0277(00)00127-X; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; PERCHESON P B, 1959, Can Anaesth Soc J, V6, P277; Piarulli A, 2016, J NEUROL, V263, P1746, DOI 10.1007/s00415-016-8196-y; Rosenblum WI, 2015, J NEUROPATH EXP NEUR, V74, P198, DOI 10.1097/NEN.0000000000000170; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; SMITH B, 1958, ANESTHESIOLOGY, V19, P115, DOI 10.1097/00000542-195801000-00042; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Snider SB, 2019, NEUROLOGY, V93, pE1281, DOI 10.1212/WNL.0000000000008163; Solt K, 2014, ANESTHESIOLOGY, V121, P311, DOI 10.1097/ALN.0000000000000117; Solt K, 2011, ANESTHESIOLOGY, V115, P791, DOI 10.1097/ALN.0b013e31822e92e5; Swanson JM, 2003, NEUROSCI BIOBEHAV R, V27, P615, DOI 10.1016/j.neubiorev.2003.08.013; Taylor NE, 2016, P NATL ACAD SCI USA, V113, P12826, DOI 10.1073/pnas.1614340113; Taylor NE, 2013, ANESTHESIOLOGY, V118, P30, DOI 10.1097/ALN.0b013e318278c896; Thibaut A, 2019, LANCET NEUROL, V18, P600, DOI 10.1016/S1474-4422(19)30031-6; Threlkeld ZD, 2018, CORTEX, V106, P299, DOI 10.1016/j.cortex.2018.05.004; TICKTIN H, 1958, NEUROLOGY, V8, P267, DOI 10.1212/WNL.8.4.267; Tononi G, 2016, NAT REV NEUROSCI, V17, P450, DOI 10.1038/nrn.2016.44; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Volkow ND, 1996, PSYCHOPHARMACOLOGY, V123, P26, DOI 10.1007/BF02246277; Volkow ND, 1999, LIFE SCI, V65, pPL7, DOI 10.1016/S0024-3205(99)00225-8; Volkow ND, 2003, PSYCHOPHARMACOLOGY, V166, P264, DOI 10.1007/s00213-002-1340-7; Volkow ND, 1998, AM J PSYCHIAT, V155, P1325, DOI 10.1176/ajp.155.10.1325; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wang GJ, 1997, EUR ADDICT RES, V3, P49, DOI 10.1159/000259147; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3	84	12	12	3	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2020	33	2					364	375		10.1007/s12028-020-01062-7		AUG 2020	12	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	NS0NU	WOS:000559449600006	32794142	Green Submitted, Green Accepted			2022-02-06	
J	Gao, GY; Wu, X; Feng, JF; Hui, JY; Mao, Q; Lecky, F; Lingsma, H; Maas, AIR; Jiang, JY				Gao, Guoyi; Wu, Xiang; Feng, Junfeng; Hui, Jiyuan; Mao, Qing; Lecky, Fiona; Lingsma, Hester; Maas, Andrew I. R.; Jiang, Jiyao		China CENTER-TBI Registry Particip	Clinical characteristics and outcomes in patients with traumatic brain injury in China: a prospective, multicentre, longitudinal, observational study	LANCET NEUROLOGY			English	Article							HEAD TRAUMA; CENTER-TBI; EPIDEMIOLOGY; MANAGEMENT; CARE; TRIAL	Summary Background Large-scale studies are required to better characterise traumatic brain injury (TBI) and to identify the most effective treatment approaches for TBI. However, evidence is scarce and mostly originates from high-income countries. We aimed to describe the existing care for patients with TBI and the outcomes in China. Methods The Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) China registry is a prospective, multicentre, longitudinal, observational study done in 56 neurosurgical centres across China. We collected data of patients who were admitted to hospital with a clinical diagnosis of TBI and an indication for CT. Patients who were discharged directly from the emergency room were excluded. The primary endpoint was survival on discharge. Prognostic analyses were applied to identify predictors of mortality. Variations in mortality were compared between centres and provinces within China. Mortality was compared with expected mortality, estimated using the CRASH basic model. This study was registered with ClinicalTrials.gov, NCT02210221. Findings From Dec 22, 2014, to Aug 1, 2017, 13 627 patients with TBI from 56 centres were enrolled in the registry. Data from 13 138 patients from 52 hospitals in 22 provinces of China were analysed. Most patients were male (9782 [74%]), with a median age of 48 years (IQR 33-61). The median Glasgow Coma Scale (GCS) score was 13 (IQR 9-15), and the leading cause of injury was road-traffic incident (6548 [50%]). Overall, 637 (5%) patients died, including 552 (20%) patients with severe TBI. Age, GCS score, injury severity score, pupillary light reflex, CT findings (compressed basal cistern and midline shift >= 5 mm), presence of hypoxia, systemic hypotension, altitude higher than >500 m, and GDP per capita were significantly associated with survival in all patients with TBI. Variation in mortality existed between centres and regions. The expected 14-day mortality was 1116 (13%), but 544 (7%) deaths within 14 days were observed (observed to expected ratio 0 center dot 49 [95% CI 0 center dot 45-0 center dot 53]). I nterpretation The results show differences in mortality between centres and regions across China, which indicates potential for identifying best practices through comparative effectiveness research. The risk factors identified in prognostic analyses might contribute to developing benchmarks for assessing quality of care. Funding None. Copyright (c) 2020 Elsevier Ltd. All rights reserved.	[Gao, Guoyi; Wu, Xiang; Feng, Junfeng; Hui, Jiyuan; Mao, Qing; Jiang, Jiyao] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Neurosurg, Shanghai 200127, Peoples R China; [Gao, Guoyi; Wu, Xiang; Feng, Junfeng; Hui, Jiyuan; Mao, Qing; Jiang, Jiyao] Shanghai Inst Head Trauma, Shanghai, Peoples R China; [Lecky, Fiona] Univ Sheffield, Ctr Urgent & Emergency Care Res, Sch Hlth & Related Res, Hlth Serv Res Sect, Sheffield, S Yorkshire, England; [Lingsma, Hester] Erasmus MC, Dept Publ Hlth, Univ Med Ctr Rotterdam, Rotterdam, Netherlands; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Jiang, Jiyao] Southwest Med Univ, Dept Neurosurg, Affiliated Hosp, Luzhou, Peoples R China; [Jiang, Jiyao] Shenzhen Univ, Shenzhen Peoples Hosp 2, Dept Neurosurg, Affiliated Hosp 1, Shenzhen, Peoples R China		Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Neurosurg, Shanghai 200127, Peoples R China.	jiyaojiang@126.com			European CommissionEuropean CommissionEuropean Commission Joint Research Centre [602150]	We are immensely grateful to our patients with TBI for helping us in our efforts to improve care and outcomes for patients with TBI. We would like to thank Biyun Qian and Li Xie from the Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China, for their critical contributions to data analysis. The coordinating centre (Department of Neurosurgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University) received support from the European Commission 7th Framework program (602150), in the context of CENTER-TBI.	Bales JW, 2019, NEUROCRIT CARE, V31, P11, DOI 10.1007/s12028-019-00712-9; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Dijkland SA, 2020, J NEUROSURG, V133, P1132, DOI 10.3171/2019.5.JNS19483; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gravesteijn BY, 2020, ANAESTHESIA, V75, P45, DOI 10.1111/anae.14838; Hawley C, 2017, EMERG MED J, V34, P509, DOI 10.1136/emermed-2016-206506; Huijben JA, 2020, INTENS CARE MED, V46, P995, DOI 10.1007/s00134-020-05965-z; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Jiang JY, 2013, INJURY, V44, P1453, DOI 10.1016/j.injury.2012.08.045; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Ma JH, 2017, J TRAUMA SURG, V19, P411; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Murphy LS, 1999, BRIT J NEUROSURG, V13, P564, DOI 10.1080/02688699943060; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Timmons SD, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.6.FOCUS1296; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; van Essen TA, 2017, J NEUROTRAUM, V34, P881, DOI 10.1089/neu.2016.4495; WANG CC, 1986, ARCH NEUROL-CHICAGO, V43, P570, DOI 10.1001/archneur.1986.00520060034013; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803	30	12	14	3	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	AUG	2020	19	8					670	677					8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NT8ZY	WOS:000573228000012	32702336	Green Accepted			2022-02-06	
J	Williams, AM; Wu, ZY; Bhatti, UF; Biesterveld, BE; Kemp, MT; Wakam, GK; Vercruysse, CA; Chtraklin, K; Siddiqui, AZ; Pickell, Z; Dekker, SE; Tian, YZ; Liu, BL; Li, YQ; Buller, B; Alam, HB				Williams, Aaron M.; Wu, Zhenyu; Bhatti, Umar F.; Biesterveld, Ben E.; Kemp, Michael T.; Wakam, Glenn K.; Vercruysse, Claire A.; Chtraklin, Kiril; Siddiqui, Ali Z.; Pickell, Zachary; Dekker, Simone E.; Tian, Yuzi; Liu, Baoling; Li, Yongqing; Buller, Benjamin; Alam, Hasan B.			Early single-dose exosome treatment improves neurologic outcomes in a 7-day swine model of traumatic brain injury and hemorrhagic shock	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Exosomes; neuroprotection; traumatic brain injury; hemorrhagic shock; swine	MECHANISMS; APOPTOSIS; RESPONSES; RECOVERY	BACKGROUND Early single-dose treatment with human mesenchymal stem cell-derived exosomes promotes neuroprotection and promotes blood-brain barrier integrity in models of traumatic brain injury (TBI) and hemorrhagic shock (HS) in swine. The impact of an early single dose of exosomes on late survival (7 days), however, remains unknown. We sought to evaluate the impact of early single-dose exosome treatment on neurologic outcomes, brain lesion size, inflammatory cytokines, apoptotic markers, and mediators of neural plasticity in a 7-day survival model. METHODS Yorkshire swine were subjected to a severe TBI (8-mm cortical impact) and HS (40% estimated total blood volume). After 1 hour of shock, animals were randomized (n = 4/cohort) to receive either lactated Ringer's (5 mL) or lactated Ringer's with exosomes (1 x 10(12) exosome particles). After an additional hour of shock, animals were resuscitated with normal saline. Daily neurologic severity scores were compared. At 7 days following injury, lesion size, inflammatory markers, and mediators of inflammation (NF-kappa B), apoptosis (BAX), and neural plasticity (brain-derived neurotrophic factor) in brain tissue were compared between groups. RESULTS Exosome-treated animals had significantly lower neurologic severity scores (first 4 days; p < 0.05) and faster neurologic recovery. At 7 days, exosome-treated animals had significantly smaller (p < 0.05) brain lesion sizes. Exosome-treated animals also had significantly lower levels of inflammatory markers (interleukin [IL]-1, IL-6, IL-8, and IL-18) and higher granulocyte-macrophage colony-stimulating factor levels compared with the control animals, indicating specific impacts on various cytokines. The BAX and NF-kappa B levels were significantly lower (p < 0.05) in exosome-treated animals, while brain-derived neurotrophic factor levels were significantly higher (p < 0.05) in the exosome-treated animals. CONCLUSION In a large animal model of TBI and HS, early single-dose exosome treatment attenuates neurologic injury, decreases brain lesion size, inhibits inflammation and apoptosis, and promotes neural plasticity over a 7-day period.	[Williams, Aaron M.; Wu, Zhenyu; Bhatti, Umar F.; Biesterveld, Ben E.; Kemp, Michael T.; Wakam, Glenn K.; Vercruysse, Claire A.; Chtraklin, Kiril; Siddiqui, Ali Z.; Pickell, Zachary; Dekker, Simone E.; Tian, Yuzi; Liu, Baoling; Li, Yongqing; Alam, Hasan B.] Univ Michigan, Dept Surg, 2920 Taubman Ctr 5331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [Wu, Zhenyu] Cent South Univ, Xiangya 2nd Hosp, Changsha, Hunan, Peoples R China; [Buller, Benjamin] Henry Ford Hlth Syst, Dept Neurol, 2799 W Grand Blvd,Neurol Res Educ & Res Bldg, Detroit, MI 48202 USA		Alam, HB (corresponding author), Univ Michigan, Dept Surg, 2920 Taubman Ctr 5331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.; Buller, B (corresponding author), Henry Ford Hlth Syst, Dept Neurol, 2799 W Grand Blvd,Neurol Res Educ & Res Bldg, Detroit, MI 48202 USA.	bbuller1@hfhs.org; alamh@med.umich.edu	Biesterveld, Ben/AAM-1087-2021	Pickell, Zachary/0000-0002-0142-9031			Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Alam HB, 2002, SURGERY, V132, P278, DOI 10.1067/msy.2002.125787; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Butler FK Jr., 2018, J SPEC OPER MED, V18, P37; Calabrese F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00430; Chang PP, 2019, CURR MOL MED, V19, P673, DOI 10.2174/1566524019666190724102755; Charoenviriyakul C, 2018, INT J PHARMACEUT, V553, P1, DOI 10.1016/j.ijpharm.2018.10.032; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Edlich F, 2018, BIOCHEM BIOPH RES CO, V500, P26, DOI 10.1016/j.bbrc.2017.06.190; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Georgoff PE, 2017, J NEUROTRAUM, V34, P2167, DOI 10.1089/neu.2016.4859; KALTSCHMIDT C, 1993, MECH DEVELOP, V43, P135, DOI 10.1016/0925-4773(93)90031-R; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kelso ML, 2015, J NEUROIMMUNOL, V278, P162, DOI 10.1016/j.jneuroim.2014.11.002; Lee JC, 2015, INJURY, V46, P854, DOI 10.1016/j.injury.2014.12.023; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Ni HQ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00014; Nikolian VC, 2019, J TRAUMA ACUTE CARE, V86, P232, DOI 10.1097/TA.0000000000002119; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Otero-Ortega L, 2018, J CEREBR BLOOD F MET, V38, P767, DOI 10.1177/0271678X17708917; Patel NA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1240-3; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rhee P, 2000, J TRAUMA, V48, P439, DOI 10.1097/00005373-200003000-00011; Schober ME, 2012, METAB BRAIN DIS, V27, P167, DOI 10.1007/s11011-012-9309-7; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; Wang B, 2019, ASAIO J, V65, P285, DOI 10.1097/MAT.0000000000000810; Williams AM, 2020, J TRAUMA ACUTE CARE, V88, P207, DOI [10.109711-A.0000000000002563, 10.1097/TA.0000000000002563]; Williams AM, 2018, CURR MOL MED, V18, P711, DOI 10.2174/1566524019666190208102729; Williams AM, 2019, J TRAUMA ACUTE CARE, V86, P415, DOI 10.1097/TA.0000000000002149; Williams AM, 2019, J NEUROTRAUM, V36, P54, DOI 10.1089/neu.2018.5711; Yang YX, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00055; Zhang ZG, 2019, NAT REV NEUROL, V15, P193, DOI 10.1038/s41582-018-0126-4; Zhao Bo, 2012, Sichuan Da Xue Xue Bao Yi Xue Ban, V43, P236	43	12	12	2	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2020	89	2					388	396		10.1097/TA.0000000000002698			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	NA4GO	WOS:000559775000030	32218019				2022-02-06	
J	Yadikar, H; Torres, I; Aiello, G; Kurup, M; Yang, ZH; Lin, F; Kobeissy, F; Yost, R; Wang, KK				Yadikar, Hamad; Torres, Isabel; Aiello, Gabrielle; Kurup, Milin; Yang, Zhihui; Lin, Fan; Kobeissy, Firas; Yost, Richard; Wang, Kevin K.			Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; GLYCOGEN-SYNTHASE KINASE-3; PAIRED HELICAL FILAMENTS; OKADAIC ACID; IN-VITRO; ALZHEIMERS-DISEASE; PHOSPHORYLATION SITES; SELECTIVE INHIBITOR; ABNORMAL-BEHAVIOR; CALPAIN INHIBITOR	Tauopathies are a class of neurodegenerative disorders characterized by abnormal deposition of post-translationally modified tau protein in the human brain. Tauopathies are associated with Alzheimer's disease (AD), chronic traumatic encephalopathy (CTE), and other diseases. Hyperphosphorylation increases tau tendency to aggregate and form neurofibrillary tangles (NFT), a pathological hallmark of AD. In this study, okadaic acid (OA, 100 nM), a protein phosphatase 1/2A inhibitor, was treated for 24h in mouse neuroblastoma (N2a) and differentiated rat primary neuronal cortical cell cultures (CTX) to induce tau-hyperphosphorylation and oligomerization as a cell-based tauopathy model. Following the treatments, the effectiveness of different kinase inhibitors was assessed using the tauopathy-relevant tau antibodies through tau-immunoblotting, including the sites: pSer202/pThr205 (AT8), pThr181 (AT270), pSer202 (CP13), pSer396/pSer404 (PHF-1), and pThr231 (RZ3). OA-treated samples induced tau phosphorylation and oligomerization at all tested epitopes, forming a monomeric band (46-67 kDa) and oligomeric bands (170 kDa and 240 kDa). We found that TBB (a casein kinase II inhibitor), AR and LiCl (GSK-3 inhibitors), cyclosporin A (calcineurin inhibitor), and Saracatinib (Fyn kinase inhibitor) caused robust inhibition of OA-induced monomeric and oligomeric p-tau in both N2a and CTX culture. Additionally, a cyclin-dependent kinase 5 inhibitor (Roscovitine) and a calcium chelator (EGTA) showed contrasting results between the two neuronal cultures. This study provides a comprehensive view of potential drug candidates (TBB, CsA, AR, and Saracatinib), and their efficacy against tau hyperphosphorylation and oligomerization processes. These findings warrant further experimentation, possibly including animal models of tauopathies, which may provide a putative Neurotherapy for AD, CTE, and other forms of tauopathy-induced neurodegenerative diseases.	[Yadikar, Hamad; Torres, Isabel; Aiello, Gabrielle; Kurup, Milin; Yang, Zhihui; Lin, Fan; Kobeissy, Firas; Wang, Kevin K.] Univ Florida, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Emergency Med, Gainesville, FL 32611 USA; [Yadikar, Hamad; Torres, Isabel; Aiello, Gabrielle; Kurup, Milin; Yang, Zhihui; Lin, Fan; Kobeissy, Firas; Wang, Kevin K.] Univ Florida, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Psychiat, Gainesville, FL 32611 USA; [Yadikar, Hamad; Torres, Isabel; Aiello, Gabrielle; Kurup, Milin; Yang, Zhihui; Lin, Fan; Kobeissy, Firas; Wang, Kevin K.] Univ Florida, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Neurosci & Chem, Gainesville, FL 32611 USA; [Yadikar, Hamad] Kuwait Univ, Fac Sci, Dept Biol Sci, Safat, Kuwait; [Yadikar, Hamad; Yost, Richard] Univ Florida, Dept Chem, Chem Lab Bldg, Gainesville, FL 32611 USA; [Kobeissy, Firas] Amer Univ Beirut, Med Ctr, Fac Med, Beirut, Lebanon; [Wang, Kevin K.] Malcom Randall VA Med Ctr, Brain Rehabil Res Ctr, Gainesville, FL USA		Yadikar, H (corresponding author), Univ Florida, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Emergency Med, Gainesville, FL 32611 USA.; Yadikar, H (corresponding author), Univ Florida, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Psychiat, Gainesville, FL 32611 USA.; Yadikar, H (corresponding author), Univ Florida, Program Neurotrauma Neuroprote & Biomarkers Res, Dept Neurosci & Chem, Gainesville, FL 32611 USA.; Yadikar, H (corresponding author), Kuwait Univ, Fac Sci, Dept Biol Sci, Safat, Kuwait.; Yadikar, H (corresponding author), Univ Florida, Dept Chem, Chem Lab Bldg, Gainesville, FL 32611 USA.	hamad.yadikar@ku.edu.kw	Kobeissy, Firas/E-7042-2017	Kobeissy, Firas/0000-0002-5008-6944	University of Florida Departments of Emergency Medicine and Psychiatry	This work was supported by funding from the University of Florida Departments of Emergency Medicine and Psychiatry.	Acker CM, 2013, NEUROBIOL AGING, V34, P338, DOI 10.1016/j.neurobiolaging.2012.05.010; Aldag M, 2017, J NEUROTRAUM, V34, pS26, DOI 10.1089/neu.2017.5218; Alonso AD, 2010, J BIOL CHEM, V285, P30851, DOI 10.1074/jbc.M110.110957; Amundsen R, 2012, DRUG METAB DISPOS, V40, P655, DOI 10.1124/dmd.111.043018; Ando K, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005917; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; AVILA J, 1994, CELL MOL BIOL RES, V40, P573; Avila J, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00262; Baker S, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0300-0; Bennett PC, 2001, NEUROBIOL LEARN MEM, V75, P91, DOI 10.1006/nlme.1999.3959; Besser LM, 2019, J NEUROPATH EXP NEUR, V78, P219, DOI 10.1093/jnen/nly132; Bhat R, 2003, J BIOL CHEM, V278, P45937, DOI 10.1074/jbc.M306268200; Bhat RV, 2018, J ALZHEIMERS DIS, V64, pS547, DOI 10.3233/JAD-179934; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Boban M, 2019, J NEUROSCI METH, V319, P60, DOI 10.1016/j.jneumeth.2018.09.030; Bretteville A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00480; Broetto N, 2016, BRAIN RES BULL, V124, P136, DOI 10.1016/j.brainresbull.2016.04.014; Chen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011886; Chen Y, 2012, PLANTA MED, V78, P1337, DOI 10.1055/s-0032-1314965; Chopra P, 2009, CYTOTECHNOLOGY, V60, P77, DOI 10.1007/s10616-009-9217-9; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Congdon EE, 2018, NAT REV NEUROL, V14, P399, DOI 10.1038/s41582-018-0013-z; d'Abramo C, 2016, NEUROBIOL AGING, V37, P58, DOI 10.1016/j.neurobiolaging.2015.09.017; DAVIS DR, 1995, BIOCHEM J, V309, P941, DOI 10.1042/bj3090941; Dolan PJ, 2010, CURR OPIN DRUG DISC, V13, P595; Drognitz O, 2004, AM J TRANSPLANT, V4, P1042, DOI 10.1111/j.1600-6143.2004.00457.x; Ercan E, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0229-1; Espinoza M, 2008, J ALZHEIMERS DIS, V14, P1; Fu ZQ, 2010, J ALZHEIMERS DIS, V21, P1107, DOI 10.3233/JAD-2010-100687; Funk KE, 2014, BIOCHEM J, V462, P77, DOI 10.1042/BJ20140372; Georgievska B, 2013, J NEUROCHEM, V125, P446, DOI 10.1111/jnc.12203; Gerson JE, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0245-9; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; Gong CX, 2008, CURR MED CHEM, V15, P2321, DOI 10.2174/092986708785909111; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; Gould TD, 2004, INT J NEUROPSYCHOPH, V7, P387, DOI 10.1017/S1461145704004535; Green TP, 2009, MOL ONCOL, V3, P248, DOI 10.1016/j.molonc.2009.01.002; GREENWOOD JA, 1994, J BIOL CHEM, V269, P4373; Guan PP, 2019, CELL MOL IMMUNOL, V16, P892, DOI 10.1038/s41423-019-0294-1; Henkins KM, 2012, BRAIN PATHOL, V22, P826, DOI 10.1111/j.1750-3639.2012.00598.x; Henzing AJ, 2006, J MED CHEM, V49, P7636, DOI 10.1021/jm060385h; Ho YS, 2012, J ALZHEIMERS DIS, V28, P839, DOI 10.3233/JAD-2011-111037; Hubinger G, 2008, J ALZHEIMERS DIS, V13, P281; Huseby CJ, 2019, J ALZHEIMERS DIS, V71, P979, DOI 10.3233/JAD-190604; IIMOTO DS, 1990, BRAIN RES, V507, P273, DOI 10.1016/0006-8993(90)90282-G; Jones NC, 2012, NEUROBIOL DIS, V45, P897, DOI 10.1016/j.nbd.2011.12.005; Kamat PK, 2013, NEUROSCIENCE, V238, P97, DOI 10.1016/j.neuroscience.2013.01.075; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Kaufman AC, 2015, ANN NEUROL, V77, P953, DOI 10.1002/ana.24394; Khelifa T, 1999, BIOCHEM PHARMACOL, V58, P1247, DOI 10.1016/S0006-2952(99)00213-0; Kimura T, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00044; Knaryan VH, 2014, J NEUROCHEM, V130, P280, DOI 10.1111/jnc.12629; Kobeissy FH, 2015, MOL NEUROBIOL, V52, P696, DOI 10.1007/s12035-014-8898-z; Koumura A, 2008, NEUROSCIENCE, V157, P309, DOI 10.1016/j.neuroscience.2008.09.007; Kovacs GG, 2018, HAND CLINIC, V145, P355, DOI 10.1016/B978-0-12-802395-2.00025-0; Kramer Thomas, 2012, Int J Alzheimers Dis, V2012, P381029, DOI 10.1155/2012/381029; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Le Corre S, 2006, P NATL ACAD SCI USA, V103, P9673, DOI 10.1073/pnas.0602913103; Lee G, 2012, PROG MOL BIOL TRANSL, V107, P263, DOI 10.1016/B978-0-12-385883-2.00004-7; Lee S, 2013, BRAIN RES, V1495, P30, DOI 10.1016/j.brainres.2012.10.023; Li CZ, 2017, EMBO J, V36, P3120, DOI 10.15252/embj.201797724; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084849; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Liu JH, 2017, CELL PHYSIOL BIOCHEM, V44, P423, DOI 10.1159/000485008; Liu W, 2016, BIOCHEM BIOPH RES CO, V478, P852, DOI 10.1016/j.bbrc.2016.08.037; Llorens-Martin M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00046; Lovestone S, 2015, J ALZHEIMERS DIS, V45, P75, DOI 10.3233/JAD-141959; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Ludolph AC, 2009, EUR J NEUROL, V16, P297, DOI 10.1111/j.1468-1331.2008.02513.x; Makrides V, 2003, J BIOL CHEM, V278, P33298, DOI 10.1074/jbc.M305207200; Martin L, 2013, AGEING RES REV, V12, P289, DOI 10.1016/j.arr.2012.06.003; Martin L, 2011, NEUROCHEM INT, V58, P458, DOI 10.1016/j.neuint.2010.12.023; Mathuram TL, 2018, DRUG RES, V68, P436, DOI 10.1055/s-0044-100186; Medina M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041160; Medina M, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00024; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Mohamed AZ, 2019, EUR J NUCL MED MOL I, V46, P1139, DOI 10.1007/s00259-018-4241-7; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; Ni RQ, 2018, J NUCL MED, V59, P960, DOI 10.2967/jnumed.117.201632; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Nygaard HB, 2018, BIOL PSYCHIAT, V83, P369, DOI 10.1016/j.biopsych.2017.06.004; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; Orena SJ, 2000, J BIOL CHEM, V275, P15765, DOI 10.1074/jbc.M910002199; Pacifici M, 2012, JOVE-J VIS EXP, DOI 10.3791/3965; Panza F, 2019, EXPERT REV NEUROTHER, V19, P397, DOI 10.1080/14737175.2019.1606715; Panza F, 2016, IMMUNOTHERAPY-UK, V8, P1119, DOI 10.2217/imt-2016-0019; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Perrine K, 2017, WORLD NEUROSURG, V102, P533, DOI 10.1016/j.wneu.2017.02.084; Petry FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094251; Pir GJ, 2017, FASEB J, V31, P5137, DOI 10.1096/fj.201701007; Polanco JC, 2018, NAT REV NEUROL, V14, P22, DOI 10.1038/nrneurol.2017.162; Prabhakaran J, 2017, ACS CHEM NEUROSCI, V8, P1697, DOI 10.1021/acschemneuro.6b00376; Qin M, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0663-0; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rabano A, 2016, METHODS MOL BIOL, V1303, P143, DOI 10.1007/978-1-4939-2627-5_7; Rosenberger AFN, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0470-x; Rubenstein R, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00124; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Ryves WJ, 2001, BIOCHEM BIOPH RES CO, V280, P720, DOI 10.1006/bbrc.2000.4169; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; Sahara N, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00663; Sarno S, 2011, CURR TOP MED CHEM, V11, P1340, DOI 10.2174/156802611795589638; Schlachetzki JCM, 2013, REV BRAS PSIQUIATR, V35, pS92, DOI 10.1590/1516-4446-2013-1159; Segura-Egea JJ, 2003, J ENDODONT, V29, P211, DOI 10.1097/00004770-200303000-00012; Serkova N, 1996, BBA-MOL CELL RES, V1314, P93, DOI 10.1016/S0167-4889(96)00081-X; Shen XY, 2018, INT J MOL MED, V41, P1138, DOI 10.3892/ijmm.2017.3281; Simic G, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010006; Sontag JM, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00016; Sparks P, 2020, CLIN J SPORT MED, V30, pS1, DOI 10.1097/JSM.0000000000000541; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; Strang KH, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0458-0; Swingle Mark, 2007, V365, P23; Tan CC, 2018, J ALZHEIMERS DIS, V61, P487, DOI 10.3233/JAD-170187; TAPLEY P, 1992, ONCOGENE, V7, P371; Tell V, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00189; Theendakara V, 2017, MOL CELL NEUROSCI, V83, P83, DOI 10.1016/j.mcn.2017.07.002; Thuret G, 2003, BRIT J OPHTHALMOL, V87, P346, DOI 10.1136/bjo.87.3.346; Toledo FD, 2014, ARCH TOXICOL, V88, P1695, DOI 10.1007/s00204-014-1219-5; Tolosa E, 2014, MOVEMENT DISORD, V29, P470, DOI 10.1002/mds.25824; Valdiglesias V, 2013, MAR DRUGS, V11, P4328, DOI 10.3390/md11114328; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Voss K, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-18; Wang JZ, 2001, FEBS LETT, V507, P81, DOI 10.1016/S0014-5793(01)02944-1; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wang L, 2016, JAMA NEUROL, V73, P1070, DOI 10.1001/jamaneurol.2016.2078; Wang QB, 2002, CHINESE MED J-PEKING, V115, P884; Yu DY, 2006, BIOL CHEM, V387, P977, DOI 10.1515/BC.2006.121; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200; Zhang Q, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00146; Zhang Z, 2010, BRAIN RES, V1359, P233, DOI 10.1016/j.brainres.2010.08.077; Zhao L, 2016, EXP BIOL MED, V241, P1825, DOI 10.1177/1535370216650759; Zhao ZB, 2019, GENE DEV, V33, P61, DOI 10.1101/gad.319830.118; ZIMMERMANN A, 1992, BRIT J CANCER, V66, P1077, DOI 10.1038/bjc.1992.413	137	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2020	15	7							e0224952	10.1371/journal.pone.0224952			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MS9QL	WOS:000554606400013	32692785	Green Published, Green Submitted, gold			2022-02-06	
J	Shen, LS; Lin, DF; Li, XY; Wu, HJ; Lenahan, C; Pan, YB; Xu, WL; Chen, YD; Shao, AW; Zhang, JM				Shen, Lesang; Lin, Danfeng; Li, Xiaoyi; Wu, Haijian; Lenahan, Cameron; Pan, Yuanbo; Xu, Weilin; Chen, Yiding; Shao, Anwen; Zhang, Jianmin			Ferroptosis in Acute Central Nervous System Injuries: The Future Direction?	FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY			English	Article						ferroptosis; iron metabolism; lipid metabolism; stroke; traumatic brain injury; spinal cord injury; therapy	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; CEREBRAL-ARTERY OCCLUSION; NONAPOPTOTIC CELL-DEATH; ACUTE ISCHEMIC-STROKE; OXIDATIVE STRESS; N-ACETYLCYSTEINE; INTRACEREBRAL HEMORRHAGE; FUNCTIONAL RECOVERY; LIPID-PEROXIDATION	Acute central nervous system (CNS) injuries, such as stroke, traumatic brain injury (TBI), and spinal cord injury (SCI) present a grave health care challenge worldwide due to high morbidity and mortality, as well as limited clinical therapeutic strategies. Established literature has shown that oxidative stress (OS), inflammation, excitotoxicity, and apoptosis play important roles in the pathophysiological processes of acute CNS injuries. Recently, there have been many studies on the topic of ferroptosis, a form of regulated cell death characterized by the accumulation of iron-dependent lipid peroxidation. Some studies have revealed an emerging connection between acute CNS injuries and ferroptosis. Ferroptosis, induced by the abnormal metabolism of lipids, glutathione (GSH), and iron, can accelerate acute CNS injuries. However, pharmaceutical agents, such as iron chelators, ferrostatin-1 (Fer-1), and liproxstatin-1 (Lip-1), can inhibit ferroptosis and may have neuroprotective effects after acute CNS injuries. However, the specific mechanisms underlying this connection has not yet been clearly elucidated. In this paper, we discuss the general mechanisms of ferroptosis and its role in stroke, TBI, and SCI. We also summarize ferroptosis-related drugs and highlight the potential therapeutic strategies in treating various acute CNS injuries. Additionally, this paper suggests a testable hypothesis that ferroptosis may be a novel direction for further research of acute CNS injuries by providing corresponding evidence.	[Shen, Lesang; Chen, Yiding] Zhejiang Univ, Affiliated Hosp 2, Dept Breast Surg, Sch Med, Hangzhou, Peoples R China; [Lin, Danfeng] Zhejiang Univ, Affiliated Hosp 2, Dept Surg Oncol, Sch Med, Hangzhou, Peoples R China; [Li, Xiaoyi] Zhejiang Univ, Hosp 2, Dept Nucl Med, Sch Med, Hangzhou, Peoples R China; [Li, Xiaoyi] Zhejiang Univ, Hosp 2, PET CT Ctr, Sch Med, Hangzhou, Peoples R China; [Wu, Haijian; Shao, Anwen; Zhang, Jianmin] Zhejiang Univ, Affiliated Hosp 2, Dept Neurosurg, Sch Med, Hangzhou, Peoples R China; [Lenahan, Cameron; Pan, Yuanbo; Xu, Weilin] Burrell Coll Osteopath Med, Las Cruces, NM USA; [Lenahan, Cameron; Pan, Yuanbo; Xu, Weilin] Loma Linda Univ, Sch Med, Ctr Neurosci Res, Loma Linda, CA USA		Chen, YD (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Dept Breast Surg, Sch Med, Hangzhou, Peoples R China.; Shao, AW (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Dept Neurosurg, Sch Med, Hangzhou, Peoples R China.	ydchen@zju.edu.cn; 21118116@zju.edu.cn		Shao, Anwen/0000-0001-9986-6290	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701144, 81371433, 81870916]; Major Science and Technology Project in the medical and health of Zhejiang Province [WKJ-ZJ-1615:2016149634]	This work was funded by the National Natural Science Foundation of China (81701144, 81371433, and 81870916), and Major Science and Technology Project in the medical and health of Zhejiang Province (WKJ-ZJ-1615:2016149634).	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Alim I, 2019, CELL, V177, P1262, DOI 10.1016/j.cell.2019.03.032; Tran AP, 2018, PHYSIOL REV, V98, P881, DOI 10.1152/physrev.00017.2017; Angeli JPF, 2018, FREE RADICAL BIO MED, V127, P153, DOI 10.1016/j.freeradbiomed.2018.03.001; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Ayton S, 2014, FREE RADICAL BIO MED, V69, P331, DOI 10.1016/j.freeradbiomed.2014.01.041; Badhiwala JH, 2019, J NEUROSURG-SPINE, V30, P1, DOI 10.3171/2018.9.SPINE18682; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Berk M, 2013, TRENDS PHARMACOL SCI, V34, P167, DOI 10.1016/j.tips.2013.01.001; Bersuker K, 2019, NATURE, V575, P688, DOI 10.1038/s41586-019-1705-2; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bogdan AR, 2016, TRENDS BIOCHEM SCI, V41, P274, DOI 10.1016/j.tibs.2015.11.012; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Brown RAM, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00476; Castellanos M, 2002, BRAIN RES, V952, P1, DOI 10.1016/S0006-8993(02)03179-7; Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; Chang CF, 2014, ANN CLIN TRANSL NEUR, V1, P258, DOI 10.1002/acn3.54; Chen LJ, 2015, J BIOL CHEM, V290, P28097, DOI 10.1074/jbc.M115.680090; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen X, 2020, FEBS J, V287, P4747, DOI 10.1111/febs.15266; Cho S, 2007, J BIOL CHEM, V282, P4634, DOI 10.1074/jbc.M609388200; Codenotti S, 2018, J CANCER RES CLIN, V144, P1717, DOI 10.1007/s00432-018-2699-0; Cui HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127256; DeGregorio-Rocasolano N, 2018, REDOX BIOL, V15, P143, DOI 10.1016/j.redox.2017.11.026; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Dharmalingam P, 2020, ACS NANO, V14, P2827, DOI 10.1021/acsnano.9b05821; DIETRICH RB, 1988, RADIOLOGY, V168, P203, DOI 10.1148/radiology.168.1.3380958; Dinc C, 2013, SPINE, V38, pE1649, DOI 10.1097/BRS.0000000000000055; Dixon SJ, 2015, ACS CHEM BIOL, V10, P1604, DOI 10.1021/acschembio.5b00245; Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dodson M, 2019, REDOX BIOL, V23, DOI 10.1016/j.redox.2019.101107; Doll S, 2019, NATURE, V575, P693, DOI 10.1038/s41586-019-1707-0; Doll S, 2017, NAT CHEM BIOL, V13, P91, DOI [10.1038/NCHEMBIO.2239, 10.1038/nchembio.2239]; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Domingues RM, 2013, J PROTEOMICS, V92, P110, DOI 10.1016/j.jprot.2013.06.004; Duan JL, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1406-7; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Farr SA, 2003, J NEUROCHEM, V84, P1173, DOI 10.1046/j.1471-4159.2003.01580.x; Feng SJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007230.pub2; Forcina GC, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800311; Freret T, 2006, EUR J NEUROSCI, V23, P1757, DOI 10.1111/j.1460-9568.2006.04699.x; Gammella E, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/230182; Gangadhar NM, 2007, CURR OPIN CHEM BIOL, V11, P83, DOI 10.1016/j.cbpa.2006.11.033; Gao MH, 2015, MOL CELL, V59, P298, DOI 10.1016/j.molcel.2015.06.011; Garcia-Yebenes I, 2012, NEUROCHEM INT, V61, P1364, DOI 10.1016/j.neuint.2012.09.014; GILBERT KR, 1991, NEUROSCI LETT, V133, P11, DOI 10.1016/0304-3940(91)90045-U; Gong C, 2001, BRAIN RES, V901, P38, DOI 10.1016/S0006-8993(01)02186-2; Gout PW, 2001, LEUKEMIA, V15, P1633, DOI 10.1038/sj.leu.2402238; Grossman RG, 2012, J NEUROSURG-SPINE, V17, P119, DOI 10.3171/2012.5.AOSPINE12127; Guan XY, 2019, LIFE SCI, V235, DOI 10.1016/j.lfs.2019.116795; Guo J, 2015, MOL MED REP, V12, P37, DOI 10.3892/mmr.2015.3390; Guo YZ, 2019, J MOL NEUROSCI, V67, P622, DOI 10.1007/s12031-019-01272-5; Hadian K, 2020, CELL, V181, P1188, DOI 10.1016/j.cell.2020.04.039; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hanson LR, 2009, J PHARMACOL EXP THER, V330, P679, DOI 10.1124/jpet.108.149807; Hao J, 2017, NEURAL REGEN RES, V12, P959, DOI 10.4103/1673-5374.208591; Hatakeyama T, 2013, TRANSL STROKE RES, V4, P546, DOI 10.1007/s12975-013-0270-5; Hayano M, 2016, CELL DEATH DIFFER, V23, P270, DOI 10.1038/cdd.2015.93; He YJ, 2020, BIOMATERIALS, V241, DOI 10.1016/j.biomaterials.2020.119911; Hinman A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201369; Hirschhorn T, 2019, FREE RADICAL BIO MED, V133, P130, DOI 10.1016/j.freeradbiomed.2018.09.043; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Homma T, 2019, EXP CELL RES, V384, DOI 10.1016/j.yexcr.2019.111592; Hsieh CH, 2017, J PATHOL, V241, P337, DOI 10.1002/path.4838; Hu W, 2017, NEUROSCI LETT, V642, P107, DOI 10.1016/j.neulet.2017.02.004; Hu X, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3215391; Hu ZX, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2256-z; Huang LL, 2019, J CELL MOL MED, V23, P4153, DOI 10.1111/jcmm.14302; Ingold I, 2018, CELL, V172, P409, DOI 10.1016/j.cell.2017.11.048; ISHII T, 1981, J BIOL CHEM, V256, P2387; Jackman NA, 2012, ASN NEURO, V4, P23, DOI 10.1042/AN20110030; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Johnson CO, 2019, LANCET NEUROL, V18, P439, DOI 10.1016/S1474-4422(19)30034-1; Kagan VE, 2017, NAT CHEM BIOL, V13, P81, DOI [10.1038/NCHEMBIO.2238, 10.1038/nchembio.2238]; Karalija A, 2014, NEUROSCIENCE, V269, P143, DOI 10.1016/j.neuroscience.2014.03.042; Karalija A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041086; Karuppagounder SS, 2018, ANN NEUROL, V84, P854, DOI 10.1002/ana.25356; Kawai H, 1997, J PHARMACOL EXP THER, V281, P921; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kenny EM, 2019, CRIT CARE MED, V47, P410, DOI 10.1097/CCM.0000000000003555; Khalaf S, 2019, J NEUROTRAUM, V36, P43, DOI 10.1089/neu.2017.5617; Khoshnam SE, 2017, NEUROL SCI, V38, P1167, DOI 10.1007/s10072-017-2938-1; KONDO Y, 1995, J CEREBR BLOOD F MET, V15, P216, DOI 10.1038/jcbfm.1995.27; Lan B, 2020, J INTEGR MED; Lapchak PA, 2009, EXP NEUROL, V215, P95, DOI 10.1016/j.expneurol.2008.09.004; Lei PX, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00139; LESLIE SW, 1992, MOL PHARMACOL, V41, P308; Lewerenz J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00214; Li J, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2298-2; Li Q, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00581; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; Li SY, 2019, NANO LETT, V19, P7334, DOI 10.1021/acs.nanolett.9b02958; Li X, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6493081; Li X, 2019, AM J TRANSL RES, V11, P6544; Li X, 2019, BIOCHEM BIOPH RES CO, V519, P240, DOI 10.1016/j.bbrc.2019.08.165; Li YC, 2020, CELL DEATH DIFFER, V27, P2635, DOI 10.1038/s41418-020-0528-x; Liang W, 2017, AGING DIS, V8, P850, DOI 10.14336/AD.2017.0829; Lipscomb DC, 1998, STROKE, V29, P487, DOI 10.1161/01.STR.29.2.487; Liu Jin-bo, 2004, Chin J Traumatol, V7, P229; Liu JB, 2011, INJURY, V42, P742, DOI 10.1016/j.injury.2010.08.028; Liu Y, 2015, BIOL PHARM BULL, V38, P1234, DOI 10.1248/bpb.b15-00048; Lorente L, 2015, J NEUROTRAUM, V32, P1, DOI 10.1089/neu.2014.3456; Lorincz T, 2015, PATHOL ONCOL RES, V21, P1115, DOI 10.1007/s12253-015-9946-3; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu LY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/470676; Lv HH, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3150145; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Morris G, 2018, BEHAV BRAIN RES, V341, P154, DOI 10.1016/j.bbr.2017.12.036; Morris G, 2013, MOL NEUROBIOL, V48, P883, DOI 10.1007/s12035-013-8477-8; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; Nasoohi S, 2019, NUTR NEUROSCI, V22, P264, DOI 10.1080/1028415X.2017.1376928; Nazemi Z, 2020, J CONTROL RELEASE, V321, P145, DOI 10.1016/j.jconrel.2020.02.009; NISHI H, 1989, STROKE, V20, P1236, DOI 10.1161/01.STR.20.9.1236; Nour M, 2012, INTERV NEUROL, V1, P185, DOI 10.1159/000353125; Ottestad-Hansen S, 2018, GLIA, V66, P951, DOI 10.1002/glia.23294; Park TJ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2061-8; Park UJ, 2011, ACTA NEUROPATHOL, V121, P459, DOI 10.1007/s00401-010-0785-8; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Paterniti I, 2010, FREE RADICAL RES, V44, P694, DOI 10.3109/10715761003742993; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Portbury SD, 2017, METALLOMICS, V9, P402, DOI 10.1039/c6mt00260a; Portbury SD, 2016, METALLOMICS, V8, P193, DOI 10.1039/c5mt00234f; Qureshi AI, 2003, NEUROSURGERY, V52, P1041, DOI 10.1227/01.NEU.0000057694.96978.BC; Qureshi AI, 2001, CRIT CARE MED, V29, P152, DOI 10.1097/00003246-200101000-00030; Rai G, 2014, J MED CHEM, V57, P4035, DOI 10.1021/jm401915r; Ramezani M, 2020, NUTR NEUROSCI, V23, P640, DOI 10.1080/1028415X.2018.1541269; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Sauerbeck A, 2013, EXP NEUROL, V248, P53, DOI 10.1016/j.expneurol.2013.05.011; Savelev SU, 2004, PHYTOTHER RES, V18, P315, DOI 10.1002/ptr.1451; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Selim MH, 2004, AGEING RES REV, V3, P345, DOI 10.1016/j.arr.2004.04.001; Senol N, 2014, NEUROCHEM RES, V39, P685, DOI 10.1007/s11064-014-1255-9; Shang YX, 2020, CELL SIGNAL, V72, DOI 10.1016/j.cellsig.2020.109633; Shen LD, 2021, ANAT REC, V304, P313, DOI 10.1002/ar.24378; Shimada K, 2016, NAT CHEM BIOL, V12, P497, DOI [10.1038/NCHEMBIO.2079, 10.1038/nchembio.2079]; Siddiq A, 2009, J NEUROSCI, V29, P8828, DOI 10.1523/JNEUROSCI.1779-09.2009; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Soria FN, 2014, J CLIN INVEST, V124, P3645, DOI 10.1172/JCI71886; Speer RE, 2013, FREE RADICAL BIO MED, V62, P26, DOI 10.1016/j.freeradbiomed.2013.01.026; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Su YW, 2020, CANCER LETT, V483, P127, DOI 10.1016/j.canlet.2020.02.015; Sun Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0794-4; Thorn TL, 2015, ASN NEURO, V7, DOI 10.1177/1759091415614301; Tomimoto H, 2002, ACTA NEUROPATHOL, V104, P601, DOI 10.1007/s00401-002-0590-0; Tsai TH, 2002, BRIT J PHARMACOL, V137, P1314, DOI 10.1038/sj.bjp.0704959; Tuo QZ, 2017, MOL PSYCHIATR, V22, P1520, DOI 10.1038/mp.2017.171; Varga V, 1997, NEUROCHEM RES, V22, P1165, DOI 10.1023/A:1027377605054; Visavadiya NP, 2016, REDOX BIOL, V8, P59, DOI 10.1016/j.redox.2015.12.011; Viswanathan VS, 2017, NATURE, V547, P453, DOI 10.1038/nature23007; Wang KY, 2015, EUR NEUROL, V74, P28, DOI 10.1159/000434631; Ward R, 2014, LANCET NEUROL, V13, P1045, DOI 10.1016/S1474-4422(14)70117-6; Watanabe K, 2018, J CLIN BIOCHEM NUTR, V62, P20, DOI 10.3164/jcbn.17-62; Wenzel SE, 2017, CELL, V171, P628, DOI 10.1016/j.cell.2017.09.044; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; WITSCHI A, 1992, EUR J CLIN PHARMACOL, V43, P667, DOI 10.1007/BF02284971; Wolpaw AJ, 2011, P NATL ACAD SCI USA, V108, pE771, DOI 10.1073/pnas.1106149108; Wu CH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18935-1; Wu H, 2012, NEUROBIOL DIS, V45, P388, DOI 10.1016/j.nbd.2011.08.028; Wu H, 2011, J CEREBR BLOOD F MET, V31, P1243, DOI 10.1038/jcbfm.2010.209; Wu J, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01777-6; Wu JM, 2003, STROKE, V34, P2964, DOI 10.1161/01.STR.0000103140.52838.45; Xiao X, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0501-0; Xie BS, 2019, CNS NEUROSCI THER, V25, P465, DOI 10.1111/cns.13069; Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yamada N, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2334-2; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2016, P NATL ACAD SCI USA, V113, pE4966, DOI 10.1073/pnas.1603244113; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yao X, 2019, NEURAL REGEN RES, V14, P532, DOI 10.4103/1673-5374.245480; Ye LF, 2020, ACS CHEM BIOL, V15, P469, DOI 10.1021/acschembio.9b00939; Yigitkanli K, 2013, ANN NEUROL, V73, P129, DOI 10.1002/ana.23734; Yu HL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033584, 10.1371/journal.pone.0051239]; Yuan H, 2016, BIOCHEM BIOPH RES CO, V478, P1338, DOI 10.1016/j.bbrc.2016.08.124; Zeng LL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193615; Zhang K, 2019, NANO LETT, V19, P2812, DOI 10.1021/acs.nanolett.8b04729; Zhang LJ, 2013, NEUROL SCI, V34, P639, DOI 10.1007/s10072-012-1090-1; Zhang Y, 2019, BRAIN RES, V1706, P48, DOI 10.1016/j.brainres.2018.10.023; Zhang ZW, 2018, BRAIN RES, V1701, P112, DOI 10.1016/j.brainres.2018.09.012; Zhao XR, 2007, J NEUROCHEM, V101, P652, DOI 10.1111/j.1471-4159.2006.04414.x; Zhong HQ, 2015, REDOX BIOL, V4, P193, DOI 10.1016/j.redox.2014.12.011; Zhou Y, 2018, DRUG DES DEV THER, V12, P4117, DOI 10.2147/DDDT.S179227; Zille M, 2017, STROKE, V48, P1033, DOI 10.1161/STROKEAHA.116.015609	188	12	12	7	18	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	2296-634X			FRONT CELL DEV BIOL	Front. Cell. Dev. Biol.	JUL 15	2020	8								594	10.3389/fcell.2020.00594			16	Cell Biology; Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Developmental Biology	MV6AT	WOS:000556439000001	32760721	Green Published, gold			2022-02-06	
J	Bernard, F; Gallagher, C; Griesdale, D; Kramer, A; Sekhon, M; Zeiler, FA				Bernard, Francis; Gallagher, Clare; Griesdale, Donald; Kramer, Andreas; Sekhon, Mypinder; Zeiler, Frederick A.			The CAnadian High-Resolution Traumatic Brain Injury (CAHR-TBI) Research Collaborative	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						Brain injury; Traumatic; Physiology	NEUROTRAUMA EFFECTIVENESS RESEARCH; INTRACRANIAL HYPERTENSION; PRESSURE; ADULT; CARE	In traumatic brain injury (TBI), future integration of multimodal monitoring of cerebral physiology and high-frequency signal processing techniques, with advanced neuroimaging, proteomic and genomic analysis, provides an opportunity to explore the molecular pathways involved in various aspects of cerebral physiologic dysfunctionin vivo. The main issue with early and rapid discovery in this field of personalized medicine is the expertise and complexity of data involved. This brief communication highlights the CAnadian High-Resolution Traumatic Brain Injury (CAHR-TBI) Research Collaborative, which has been formed from centers with specific expertise in the area of high-frequency physiologic monitoring/processing, and outlines its objectives.	[Bernard, Francis] Univ Montreal, Dept Med, Sect Crit Care, Montreal, PQ, Canada; [Gallagher, Clare; Kramer, Andreas] Univ Calgary, Dept Clin Neurosci, Sect Neurosurg, Calgary, AB, Canada; [Griesdale, Donald; Sekhon, Mypinder] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada; [Kramer, Andreas] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Sect Neurosurg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Fac Engn, Biomed Engn, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Cambridge, Dept Med, Div Anaesthesia, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Ctr Aging, Winnipeg, MB, Canada		Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Sect Neurosurg, Winnipeg, MB, Canada.	Frederick.Zeiler@umanitoba.ca		Zeiler, Frederick/0000-0003-1737-0510	United States NIH through the National Institute of Neurological Disorders and Stroke; Canadian Institutes for Health Research (CIHR), University of Manitoba Thorlakson Chair in Surgical Research Establishment FundCanadian Institutes of Health Research (CIHR); University of Manitoba VPRI Research Investment Fund (RIF); University of Manitoba Rudy Falk Clinician-Scientist Professorship; Health Sciences Centre Foundation Winnipeg; Manitoba Public Insurance (MPI) TBI Research Endowment	FAZ receives research support from the United States NIH through the National Institute of Neurological Disorders and Stroke, the Canadian Institutes for Health Research (CIHR), University of Manitoba Thorlakson Chair in Surgical Research Establishment Fund, the University of Manitoba VPRI Research Investment Fund (RIF), the University of Manitoba Rudy Falk Clinician-Scientist Professorship, the Health Sciences Centre Foundation Winnipeg, and the Manitoba Public Insurance (MPI) TBI Research Endowment.	Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Dakson A, 2017, CAN J NEUROL SCI, V44, P204, DOI 10.1017/cjn.2016.437; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; Guiza F, 2017, J NEUROTRAUM, V34, P2425, DOI 10.1089/neu.2016.4807; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Hasen M, 2019, J NEUROTRAUM, V36, P1491, DOI 10.1089/neu.2018.6073; Helbok R, 2018, INTENS CARE MED, V44, P1318, DOI 10.1007/s00134-018-5249-y; Hutchison JS, 2018, J NEUROTRAUM, V35, P1858, DOI 10.1089/neu.2018.5871; Korngut L, 2013, CAN J NEUROL SCI, V40, P698, DOI 10.1017/S0317167100014943; Kramer AH, 2019, NEUROCRIT CARE, V30, P51, DOI 10.1007/s12028-018-0570-4; Le Roux P, 2014, NEUROCRIT CARE, V21, P297, DOI 10.1007/s12028-014-0081-x; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Zeiler FA, 2019, J NEUROTRAUM, V36, P1505, DOI 10.1089/neu.2018.6182; Zeiler FA, 2021, J NEUROSURG ANESTH, V33, P28, DOI 10.1097/ANA.0000000000000616; Zeiler FA, 2019, NAT REV NEUROL, V15, P25, DOI 10.1038/s41582-018-0105-9; Zeiler FA, 2018, ACTA NEUROCHIR, V160, P2277, DOI 10.1007/s00701-018-3681-y; Zeiler FA, 2017, J NEUROTRAUM, V34, P3224, DOI 10.1089/neu.2017.5086	22	12	12	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	JUL	2020	47	4					551	556	PII S0317167120000542	10.1017/cjn.2020.54			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MI5WY	WOS:000547479000017	32174295	Bronze			2022-02-06	
J	Chisholm, DA; Black, AM; Palacios-Derflingher, L; Eliason, PH; Schneider, KJ; Emery, CA; Hagel, BE				Chisholm, Dirk A.; Black, Amanda Marie; Palacios-Derflingher, Luz; Eliason, Paul H.; Schneider, Kathryn J.; Emery, Carolyn A.; Hagel, Brent E.			Mouthguard use in youth ice hockey and the risk of concussion: nested case-control study of 315 cases	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; FOOTBALL PLAYERS; PROTECTIVE EQUIPMENT; BODY CHECKING; PREVENTION; SPORT; RATES	Background Concussion is the most common injury in youth ice hockey. Whether mouthguard use lowers the odds of concussion remains an unanswered question. Objective To determine the association between concussion and mouthguard use in youth ice hockey. Methods Nested case-control design. Cases and controls were identified from two prospective cohort studies using valid injury surveillance methods. Cases were players concussed during a game or practice; controls were players who sustained a non-concussion injury during a game or practice. The primary exposure was mouthguard use at time of injury; mouthguard type (dental custom fit or off the shelf) was a secondary exposure. Physician-diagnosed or therapist-suspected concussion was the primary outcome. Dental injury was a secondary outcome. Multilevel logistic regression with random effect at a team level was used to obtain ORs for the mouthguard effect, adjusted for level of play, age group, position, concussion history, mechanism of injury, cohort, session type and body checking policy. Results Among cases, 236/315 (75%) were wearing a mouthguard at time of injury, while 224/270 (83%) controls were wearing a mouthguard at time of injury. Any mouthguard use was associated with an adjusted OR for concussion of 0.36 (95% CI 0.17 to 0.73). Off-the-shelf mouthguards were associated with a 69% lower odds of concussion (adjusted OR: 0.31; 95% CI 0.14 to 0.65). Dental custom-fit mouthguards were associated with a non-significant 49% lower odds of concussion (adjusted OR: 0.51; 95% CI 0.22 to 1.10). No dental injuries were identified in either cohort. Conclusion Mouthguard use was associated with lower odds of concussion. Players should be required to wear mouthguards in youth ice hockey.	[Chisholm, Dirk A.; Black, Amanda Marie; Palacios-Derflingher, Luz; Eliason, Paul H.; Schneider, Kathryn J.; Emery, Carolyn A.; Hagel, Brent E.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Chisholm, Dirk A.; Black, Amanda Marie; Eliason, Paul H.; Emery, Carolyn A.; Hagel, Brent E.] Univ Calgary, Cumming Sch Med, Dept Paediat, Calgary, AB T2N 1N4, Canada; [Chisholm, Dirk A.; Black, Amanda Marie; Palacios-Derflingher, Luz; Eliason, Paul H.; Emery, Carolyn A.; Hagel, Brent E.] Univ Calgary, Dept Community Hlth Sci, Cumming Sch Med, Calgary, AB, Canada; [Chisholm, Dirk A.; Black, Amanda Marie; Eliason, Paul H.; Schneider, Kathryn J.; Emery, Carolyn A.] Univ Calgary, Hotchkiss Brain Inst, Cumming Sch Med, Calgary, AB, Canada; [Chisholm, Dirk A.; Black, Amanda Marie; Eliason, Paul H.; Emery, Carolyn A.; Hagel, Brent E.] Univ Calgary, OBrien Inst Publ Hlth, Cumming Sch Med, Calgary, AB, Canada; [Chisholm, Dirk A.; Black, Amanda Marie; Eliason, Paul H.; Schneider, Kathryn J.; Emery, Carolyn A.; Hagel, Brent E.] Univ Calgary, Alberta Childrens Hosp, Cumming Sch Med, Res Inst, Calgary, AB, Canada		Hagel, BE (corresponding author), Univ Calgary, Cumming Sch Med, Dept Paediat, Calgary, AB T2N 1N4, Canada.	brent.hagel@albertahealthservices.ca	Eliason, Paul/ABC-7702-2021; Black, Amanda/O-7675-2017	Emery, Carolyn Ann/0000-0002-9499-6691; Chisholm, Dirk/0000-0001-7185-0625; Black, Amanda/0000-0001-5668-9706	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Alberta Children's Hospital Research Institute (ACHRI); Alberta Innovates Health Solutions (AIHS); AIHS Summer Studentship Program; Markin Undergraduate Student Research Program for Health and Wellness Research; International Olympic Committee	This study was supported by funding from the Canadian Institutes of Health Research (CIHR), Alberta Children's Hospital Research Institute (ACHRI) and Alberta Innovates Health Solutions (AIHS). DAC was funded through the AIHS Summer Studentship Program and the Markin Undergraduate Student Research Program for Health and Wellness Research. The University of Calgary Sport Injury Prevention Research Centre is one of the International Research Centres for Prevention of Injury and Protection of Athlete Health supported by the International Olympic Committee.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Barbic D, 2005, CLIN J SPORT MED, V15, P294, DOI 10.1097/01.jsm.0000171883.74056.21; Black AM, 2017, BRIT J SPORT MED, V51, P1767, DOI 10.1136/bjsports-2016-097392; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Blignaut J B, 1987, Br J Sports Med, V21, P5; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Finch C, 2005, INJURY PREV, V11, P242, DOI 10.1136/ip.2004.006882; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Haider A, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.6506; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Knapik JJ, 2019, SPORTS MED, V49, P1217, DOI 10.1007/s40279-019-01121-w; Kobelka K., MOUTH GUARD POLICY R; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Lim D, 2005, CLIN J SPORT MED, V15, P313, DOI 10.1097/01.jsm.0000180019.22018.3c; Mantri SS, 2014, J CLIN DIAGN RES, V8, P299, DOI 10.7860/JCDR/2014/6470.3872; Marshall SW, 2005, INT J EPIDEMIOL, V34, P113, DOI 10.1093/ije/dyh346; Mascarenhas Ana Karina, 2012, J Evid Based Dent Pract, V12, P90, DOI 10.1016/j.jebdp.2012.03.021; McCrory P, 2001, BRIT J SPORT MED, V35, P81, DOI 10.1136/bjsm.35.2.81; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGuine TA, 2014, AM J SPORT MED, V42, P2470, DOI 10.1177/0363546514541926; MCNUTT T, 1989, Pediatric Dentistry, V11, P209; Momsen KM, 2003, ASS INCIDENCE CEREBR; Newsome P R, 2001, Int J Paediatr Dent, V11, P396, DOI 10.1046/j.0960-7439.2001.00304.x; Nichols C., CLARIFICATION RULE E; Ozawa T, 2014, DENT TRAUMATOL, V30, P204, DOI 10.1111/edt.12063; R Development Core Team, 2012, R LANG ENV STAT COMP; Raaii F, 2011, CLIN J SPORT MED, V21, P320, DOI 10.1097/JSM.0b013e31821f5cd7; Singh GD, 2009, DENT TRAUMATOL, V25, P515, DOI 10.1111/j.1600-9657.2009.00808.x; StataCorp, 2013, STATA STAT SOFTW REL; STENGER JM, 1964, J AM DENT ASSOC, V69, P273, DOI 10.14219/jada.archive.1964.0290; Takeda T, 2005, DENT TRAUMATOL, V21, P134, DOI 10.1111/j.1600-9657.2005.00320.x; Tuna EB, 2014, SPORTS MED, V44, P777, DOI 10.1007/s40279-014-0167-9; Viano DC, 2012, ANN BIOMED ENG, V40, P47, DOI 10.1007/s10439-011-0399-x; Winters Jackson, 2014, General Dentistry, V62, P34; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x	44	12	12	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JUL	2020	54	14					866	+		10.1136/bjsports-2019-101011			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	NQ9VI	WOS:000571213700009	31937578				2022-02-06	
J	Pino, IP; Hoover, C; Venkatesh, S; Ahmadi, A; Sturtevant, D; Patrick, N; Freeman, D; Parr, A; Samadani, U; Balser, D; Krassioukov, A; Phillips, A; Netoff, TI; Darrow, D				Pino, Isabela Pena; Hoover, Caleb; Venkatesh, Shivani; Ahmadi, Aliya; Sturtevant, Dylan; Patrick, Nick; Freeman, David; Parr, Ann; Samadani, Uzma; Balser, David; Krassioukov, Andrei; Phillips, Aaron; Netoff, Theoden I.; Darrow, David			Long-Term Spinal Cord Stimulation After Chronic Complete Spinal Cord Injury Enables Volitional Movement in the Absence of Stimulation	FRONTIERS IN SYSTEMS NEUROSCIENCE			English	Article						spinal cord injury; spinal cord stimulation; volitional movement; traumatic spinal cord injury; neuromodulation; human	EPIDURAL STIMULATION; RECOVERY; EXCITABILITY; WALKING; HUMANS; SPASMS; BRAIN; PAIN	Background: Chronic spinal cord injury (SCI) portends a low probability of recovery, especially in the most severe subset of motor-complete injuries. Active spinal cord stimulation with or without intensive locomotor training has been reported to restore movement after traumatic SCI. Only three cases have been reported where participants developed restored volitional movement with active stimulation turned off after a period of chronic stimulation and only after intensive rehabilitation with locomotor training. It is unknown whether restoration of movement without stimulation is possible after stimulation alone. Objective: We describe the development of spontaneous volitional movement (SVM) without active stimulation in a subset of participants in the Epidural Stimulation After Neurologic Damage (ESTAND) trial, in which locomotor training is not prescribed as part of the study protocol, and subject's rehabilitation therapies are not modified. Methods: Volitional movement was evaluated with the Brain Motor Control Assessment using sEMG recordings and visual examination at baseline and at follow-up visits with and without stimulation. Additional functional assessment with a motor-assisted bicycle exercise at follow-up with and without stimulation identified generated work with and without effort. Results: The first seven participants had ASIA Impairment Scale (AIS) A or B thoracic SCI, a mean age of 42 years, and 7.7 years post-injury on average. Four patients developed evidence of sustained volitional movement, even in the absence of active stimulation after undergoing chronic epidural spinal cord stimulation (eSCS). Significant increases in volitional power were found between those observed to spontaneously move without stimulation and those unable (p < 0.0005). The likelihood of recovery of spontaneous volitional control was correlated with spasticity scores prior to the start of eSCS therapy (p = 0.048). Volitional power progressively improved over time (p = 0.016). Additionally, cycling was possible without stimulation (p < 0.005). Conclusion: While some SVM after eSCS has been reported in the literature, this study demonstrates sustained restoration without active stimulation after long-term eSCS stimulation in chronic and complete SCI in a subset of participants. This finding supports previous studies suggesting that "complete" SCI is likely not as common as previously believed, if it exists at all in the absence of transection and that preserved pathways are substrates for eSCS-mediated recovery in clinically motor-complete SCI.	[Pino, Isabela Pena; Patrick, Nick; Netoff, Theoden I.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN USA; [Hoover, Caleb; Venkatesh, Shivani; Ahmadi, Aliya; Sturtevant, Dylan; Freeman, David; Parr, Ann; Darrow, David] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA; [Samadani, Uzma] Univ Minnesota, Dept Bioinformat & Computat Biol, Minneapolis, MN USA; [Samadani, Uzma] VA Healthcare Syst, Div Neurosurg, Minneapolis, MN USA; [Balser, David; Krassioukov, Andrei] Univ British Columbia, Div Phys Med & Rehabil, Int Collaborat Repair Discoveries, Vancouver, BC, Canada; [Phillips, Aaron] Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Darrow, David] Hennepin Cty Med Ctr, Div Neurosurg, Minneapolis, MN 55415 USA		Darrow, D (corresponding author), Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA.; Darrow, D (corresponding author), Hennepin Cty Med Ctr, Div Neurosurg, Minneapolis, MN 55415 USA.	darro015@umn.edu		Netoff, Theoden/0000-0002-0115-1930	Minnesota Office of Higher Education [159800]	This study was funded by a MN State SCI/TBI grant from the Minnesota Office of Higher Education (grant number 159800).	Angeli CA, 2018, NEW ENGL J MED, V379, P1244, DOI 10.1056/NEJMoa1803588; Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; Barolat G, 1995, STEREOT FUNCT NEUROS, V64, P153, DOI 10.1159/000098744; BAROLAT G, 1988, APPL NEUROPHYSIOL, V51, P29; Carhart MR, 2004, IEEE T NEUR SYS REH, V12, P32, DOI 10.1109/TNSRE.2003.822763; Cook A W, 1976, Hosp Pract, V11, P51; D'Amico JM, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00036; Darrow D, 2019, J NEUROTRAUM, V36, P2325, DOI 10.1089/neu.2018.6006; de Andrade EM, 2016, NEUROSURG REV, V39, P27, DOI 10.1007/s10143-015-0651-1; Dimitrijevic M M, 1986, Cent Nerv Syst Trauma, V3, P129; Dimitrijevic M R, 1986, Cent Nerv Syst Trauma, V3, P145; French DD, 2007, J SPINAL CORD MED, V30, P477, DOI 10.1080/10790268.2007.11754581; Freund PAB, 2010, J MAGN RESON IMAGING, V32, P1242, DOI 10.1002/jmri.22340; Frostell A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00238; Gill ML, 2018, NAT MED, V24, P1677, DOI 10.1038/s41591-018-0175-7; Gorgey AS, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3560-8; Kirshblum S, 2004, ARCH PHYS MED REHAB, V85, P1811, DOI 10.1016/j.apmr.2004.03.015; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P535, DOI 10.1179/204577211X13207446293695; Kumar R, 2018, WORLD NEUROSURG, V113, pE345, DOI 10.1016/j.wneu.2018.02.033; Lam Tania, 2007, Top Spinal Cord Inj Rehabil, V13, P32, DOI 10.1310/sci1301-32; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Meseguer-Henarejos AB, 2018, EUR J PHYS REHAB MED, V54, P576, DOI 10.23736/S1973-9087.17.04796-7; Minassian K, 2004, SPINAL CORD, V42, P401, DOI 10.1038/sj.sc.3101615; Rejc E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14003-w; RStudio, 2015, RSTUDIO; Sangari S, 2019, ANN NEUROL, V86, P28, DOI 10.1002/ana.25505; SEDGWICK EM, 1980, J NEUROL NEUROSUR PS, V43, P15, DOI 10.1136/jnnp.43.1.15; SHEALY CN, 1967, ANESTH ANAL CURR RES, V46, P489; Shen CL, 2018, CLIN REHABIL, V32, P1569, DOI 10.1177/0269215518790782; SHERWOOD AM, 1992, J NEUROL SCI, V110, P90, DOI 10.1016/0022-510X(92)90014-C; Sherwood AM, 1996, MUSCLE NERVE, V19, P966, DOI 10.1002/(SICI)1097-4598(199608)19:8<966::AID-MUS5>3.0.CO;2-6; Wagner FB, 2018, NATURE, V563, P65, DOI 10.1038/s41586-018-0649-2; Wilson JR, 2012, J NEUROSURG-SPINE, V17, P11, DOI 10.3171/2012.4.AOSPINE1245	33	12	12	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5137		FRONT SYST NEUROSCI	Front. Syst. Neurosci.	JUN 30	2020	14								35	10.3389/fnsys.2020.00035			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QI1QP	WOS:000618748300001	32714156	gold, Green Published			2022-02-06	
J	Raizman, R; Tavor, I; Biegon, A; Harnof, S; Hoffmann, C; Tsarfaty, G; Fruchter, E; Tatsa-Laur, L; Weiser, M; Livny, A				Raizman, Reut; Tavor, Ido; Biegon, Anat; Harnof, Sagi; Hoffmann, Chen; Tsarfaty, Galia; Fruchter, Eyal; Tatsa-Laur, Lucian; Weiser, Mark; Livny, Abigail			Traumatic Brain Injury Severity in a Network Perspective: A Diffusion MRI Based Connectome Study	SCIENTIFIC REPORTS			English	Article							STRUCTURAL CONNECTOME; COGNITIVE IMPAIRMENT; TENSOR; CHILDREN; CONNECTIVITY; HUBS; NEUROPATHOLOGY; DISCONNECTION; CONSEQUENCES; PRECUNEUS	Traumatic brain injury (TBI) is often characterized by alterations in brain connectivity. We explored connectivity alterations from a network perspective, using graph theory, and examined whether injury severity affected structural connectivity and modulated the association between brain connectivity and cognitive deficits post-TBI. We performed diffusion imaging network analysis on chronic TBI patients, with different injury severities and healthy subjects. From both global and local perspectives, we found an effect of injury severity on network strength. In addition, regions which were considered as hubs differed between groups. Further exploration of graph measures in the determined hub regions showed that efficiency of six regions differed between groups. An association between reduced efficiency in the precuneus and nonverbal abstract reasoning deficits (calculated using actual pre-injury scores) was found in the controls but was lost in TBI patients. Our results suggest that disconnection of network hubs led to a less efficient network, which in turn may have contributed to the cognitive impairments manifested in TBI patients. We conclude that injury severity modulates the disruption of network organization, reflecting a "dose response" relationship and emphasize the role of efficiency as an important diagnostic tool to detect subtle brain injury specifically in mild TBI patients.	[Raizman, Reut; Hoffmann, Chen; Tsarfaty, Galia; Livny, Abigail] Sheba Med Ctr, Div Diagnost Imaging, Tel Hashomer, Israel; [Raizman, Reut; Tavor, Ido; Harnof, Sagi; Hoffmann, Chen; Tsarfaty, Galia; Weiser, Mark; Livny, Abigail] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Tavor, Ido] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Biegon, Anat] SUNY Stony Brook, Dept Radiol & Neurol, Stony Brook, NY 11794 USA; [Harnof, Sagi] Rabin Med Ctr, Dept Neurosurg, Belinson, Israel; [Fruchter, Eyal; Tatsa-Laur, Lucian] Israel Def Forces, Med Corps, Dept Mental Hlth, Tel Hashomer, Israel; [Weiser, Mark] Sheba Med Ctr, Dept Psychiat, Tel Hashomer, Israel; [Livny, Abigail] Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Tel Hashomer, Israel		Livny, A (corresponding author), Sheba Med Ctr, Div Diagnost Imaging, Tel Hashomer, Israel.; Livny, A (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.; Livny, A (corresponding author), Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Tel Hashomer, Israel.	abigail.livnyezer@gmail.com	Tavor, Ido/AAB-1345-2019; Laur, Lucian/J-9351-2014	Tavor, Ido/0000-0002-9117-4449; Laur, Lucian/0000-0003-4727-4474; Livny, Abigail/0000-0003-2216-7357			Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Cook LG, 2013, J INT NEUROPSYCH SOC, V19, P508, DOI 10.1017/S1355617712001452; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Dennis EL, 2017, 2017 IEEE 14TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI 2017), P105, DOI 10.1109/ISBI.2017.7950479; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Graham DI, 2005, PROG BRAIN RES, V150, P445, DOI 10.1016/S0079-6123(05)50031-1; Griffa A, 2013, NEUROIMAGE, V80, P515, DOI 10.1016/j.neuroimage.2013.04.056; Hart MG, 2016, J NEUROSURG, V124, P1665, DOI 10.3171/2015.4.JNS142683; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Imms P, 2019, NEUROSCI BIOBEHAV R, V99, P128, DOI 10.1016/j.neubiorev.2019.01.002; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones DK, 2002, NEUROIMAGE, V17, P592, DOI 10.1006/nimg.2002.1148; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kim J, 2014, J INT NEUROPSYCH SOC, V20, P887, DOI 10.1017/S1355617714000812; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Konigs M, 2017, HUM BRAIN MAPP, V38, P3603, DOI 10.1002/hbm.23614; Latora V, 2001, NETWORKS; Leemans A., 2009, 17 ANN M INT SOC MAG, DOI DOI 10.1093/OCCMED/KQR069; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Livny A, 2016, J NEUROTRAUM, V33, P1; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Mitra J, 2016, NEUROIMAGE, V129, P247, DOI 10.1016/j.neuroimage.2016.01.056; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Pandit AS, 2013, TRAUMATIC BRAIN INJU, V80, P1; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Raven J. C, 1958, GUIDE USING MILL HIL; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P181, DOI 10.1017/S1355617710001414; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilde, 2012, LONGITUDINAL CHANGES, V30, P267, DOI [10.1016/j.ijdevneu.2012.01.003.Longitudinal, DOI 10.1016/J.IJDEVNEU.2012.01.003.LONGITUDINAL]; Yuan WH, 2017, NEUROREHAB NEURAL RE, V31, P190, DOI 10.1177/1545968316675430; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Zhou YX, 2017, J MAGN RESON IMAGING, V46, P518, DOI 10.1002/jmri.25548	63	12	12	2	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	JUN 4	2020	10	1							9121	10.1038/s41598-020-65948-4			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LY3VC	WOS:000540455400032	32499553	gold, Green Published			2022-02-06	
J	Yu, Y; Li, LX; Nguyen, DT; Mustafa, SM; Moore, BM; Jiang, JX				Yu, Ying; Li, Lexiao; Nguyen, Davis T.; Mustafa, Suni M.; Moore, Bob M.; Jiang, Jianxiong			Inverse Agonism of Cannabinoid Receptor Type 2 Confers Anti-inflammatory and Neuroprotective Effects Following Status Epileptics	MOLECULAR NEUROBIOLOGY			English	Article						CB2; Epilepsy; Excitotoxicity; Inverse agonist; Kainate; Neuroinflammation; Neuroprotection; NMDA; Seizure; Status epilepticus	TRAUMATIC BRAIN-INJURY; BEHAVIORAL IMPAIRMENTS; ALZHEIMERS-DISEASE; NEURONAL INJURY; CB2 RECEPTORS; SEIZURES; EP2; ACTIVATION; MICROGLIA; CYCLOOXYGENASE-2	Prolonged status epilepticus (SE) in humans causes high mortality and brain inflammation-associated neuronal injury and morbidity in survivors. Currently, the only effective treatment is to terminate the seizures swiftly to prevent brain damage. However, reliance on acute therapies alone would be imprudent due to the required short response time. Follow-on therapies that can be delivered well after the SE onset are in an urgent need. Cannabinoid receptor type 2 (CB2), a G protein-coupled receptor that can be expressed by activated brain microglia, has emerged as an appealing anti-inflammatory target for brain conditions. In the current study, we reported that the CB2 inverse agonism by our current lead compound SMM-189 largely prevented the rat primary microglia-mediated inflammation and showed moderate neuroprotection against N-methyl-d-aspartic acid (NMDA) receptor-mediated excitotoxicity in rat primary hippocampal cultures containing both neurons and glia. Using a classical mouse model of epilepsy, in which SE was induced by systemic administration of kainate (30 mg/kg, i.p.) and proceeded for 1 h, we demonstrated that SE downregulated the CB1 but slightly upregulated CB2 receptor in the hippocampus. Transient treatment with SMM-189 (6 mg/kg, i.p., b.i.d.) after the SE was interrupted by diazepam (10 mg/kg, i.p.) prevented the seizure-induced cytokine surge in the brain, neuronal death, and behavioral impairments 24 h after SE. Our results suggest that CB2 inverse agonism might provide an adjunctive anti-inflammatory therapy that can be delivered hours after SE onset, together with NMDA receptor blockers and first-line anti-convulsants, to reduce brain injury and functional deficits following prolonged seizures.	[Yu, Ying; Li, Lexiao; Nguyen, Davis T.; Mustafa, Suni M.; Moore, Bob M.; Jiang, Jianxiong] Univ Tennessee, Coll Pharm, Dept Pharmaceut Sci, Hlth Sci Ctr, Memphis, TN 38163 USA		Jiang, JX (corresponding author), Univ Tennessee, Coll Pharm, Dept Pharmaceut Sci, Hlth Sci Ctr, Memphis, TN 38163 USA.	jjiang18@uthsc.edu	; Jiang, Jianxiong/A-1987-2010	Li, Lexiao/0000-0002-3693-5452; Jiang, Jianxiong/0000-0003-3955-8928	National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R00NS082379, R01NS100947, R21NS109687]	This work was supported by the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) grants R00NS082379 (J.J.), R01NS100947 (J.J.), and R21NS109687 (J.J.).	Alhouayek M, 2014, TRENDS PHARMACOL SCI, V35, P284, DOI 10.1016/j.tips.2014.03.001; ANNEGERS JF, 1987, NEW ENGL J MED, V316, P493, DOI 10.1056/NEJM198702263160901; Aronica E, 2017, EPILEPSIA, V58, P27, DOI 10.1111/epi.13783; Baek JH, 2013, J NEUROSCI METH, V216, P87, DOI 10.1016/j.jneumeth.2013.03.021; Betjemann JP, 2015, LANCET NEUROL, V14, P615, DOI 10.1016/S1474-4422(15)00042-3; Bu W, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00449; Buisseret B, 2019, TRENDS MOL MED, V25, P882, DOI 10.1016/j.molmed.2019.04.009; Cabral GA, 2008, BRIT J PHARMACOL, V153, P240, DOI 10.1038/sj.bjp.0707584; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Chin J, 2013, EPILEPSY BEHAV, V26, P343, DOI 10.1016/j.yebeh.2012.11.040; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Dey A, 2016, TRENDS PHARMACOL SCI, V37, P463, DOI 10.1016/j.tips.2016.03.001; Dhopeshwarkar A, 2014, MOL PHARMACOL, V86, P430, DOI 10.1124/mol.114.094649; Dingledine R, 2014, ADV EXP MED BIOL, V813, P109, DOI 10.1007/978-94-017-8914-1_9; Du YF, 2016, EXPERT REV NEUROTHER, V16, P123, DOI 10.1586/14737175.2016.1134322; Falenski KW, 2009, BRAIN RES, V1262, P64, DOI 10.1016/j.brainres.2009.01.036; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Friedman D, 2015, NEW ENGL J MED, V373, P1048, DOI 10.1056/NEJMra1407304; Fu YJ, 2015, MOL PHARMACOL, V88, P161, DOI 10.1124/mol.115.098202; Guley NM, 2019, EXP EYE RES, V182, P109, DOI 10.1016/j.exer.2019.03.013; Hartings JA, 2017, BRAIN, V140, P2673, DOI 10.1093/brain/awx214; Hermanson DJ, 2014, TRENDS PHARMACOL SCI, V35, P358, DOI 10.1016/j.tips.2014.04.006; Horvath L, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00427; Huizenga MN, 2017, EPILEPSIA, V58, P1593, DOI 10.1111/epi.13842; Jiang JX, 2019, NEUROPHARMACOLOGY, V149, P149, DOI 10.1016/j.neuropharm.2019.02.011; Jiang JX, 2018, ACS CHEM NEUROSCI, V9, P699, DOI 10.1021/acschemneuro.7b00486; Jiang JX, 2017, TRENDS CANCER, V3, P75, DOI 10.1016/j.trecan.2016.12.002; Jiang JX, 2015, NEUROBIOL DIS, V76, P126, DOI 10.1016/j.nbd.2014.12.032; Jiang JX, 2013, TRENDS PHARMACOL SCI, V34, P413, DOI 10.1016/j.tips.2013.05.003; Jiang JX, 2013, P NATL ACAD SCI USA, V110, P3591, DOI 10.1073/pnas.1218498110; Jiang JX, 2012, P NATL ACAD SCI USA, V109, P3149, DOI 10.1073/pnas.1120195109; Jiang JX, 2010, P NATL ACAD SCI USA, V107, P2307, DOI 10.1073/pnas.0909310107; Kang X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09528-z; Klein P, 2018, EPILEPSIA, V59, P37, DOI 10.1111/epi.13965; Lenck-Santini PP, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022772; Liu Y, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0387-16.2017; Loscher W, 2013, NAT REV DRUG DISCOV, V12, P757, DOI 10.1038/nrd4126; Loscher W, 2017, NEUROCHEM RES, V42, P1873, DOI 10.1007/s11064-017-2222-z; Magloczky Z, 2010, EPILEPSIA, V51, P115, DOI 10.1111/j.1528-1167.2010.02624.x; Marcheselli VL, 1996, J BIOL CHEM, V271, P24794, DOI 10.1074/jbc.271.40.24794; Mecha M, 2016, PHARMACOL THERAPEUT, V166, P40, DOI 10.1016/j.pharmthera.2016.06.011; Nagib MM, 2020, PHARMACOL THERAPEUT, V209, DOI 10.1016/j.pharmthera.2020.107504; Navarro G, 2018, BRAIN BEHAV IMMUN, V67, P139, DOI 10.1016/j.bbi.2017.08.015; Pineda E, 2014, EPILEPSY BEHAV, V31, P267, DOI 10.1016/j.yebeh.2013.10.004; Presley C, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.159; Presley CS, 2015, BIOORGAN MED CHEM, V23, P5390, DOI 10.1016/j.bmc.2015.07.057; Qiu JG, 2019, BRIT J PHARMACOL, V176, P1680, DOI 10.1111/bph.14622; Qiu JG, 2017, DRUG DISCOV TODAY, V22, P148, DOI 10.1016/j.drudis.2016.09.017; Quan Y, 2013, J BIOL CHEM, V288, P9293, DOI 10.1074/jbc.M113.455816; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Reddy DS, 2013, INT J MOL SCI, V14, P18284, DOI 10.3390/ijms140918284; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; Rojas A, 2014, EPILEPSIA, V55, P17, DOI 10.1111/epi.12461; Rossetti AO, 2011, LANCET NEUROL, V10, P922, DOI 10.1016/S1474-4422(11)70187-9; Roux Sylvain, 2005, Curr Protoc Pharmacol, VChapter 10, DOI 10.1002/0471141755.ph1010s27; Rowley S, 2017, EPILEPSIA, V58, pE162, DOI 10.1111/epi.13930; Fernandez IS, 2015, NEUROLOGY, V84, P2304, DOI 10.1212/WNL.0000000000001673; Sathe AG, 2019, ACAD EMERG MED, V26, P940, DOI 10.1111/acem.13811; Schartz ND, 2018, NEUROBIOL DIS, V109, P163, DOI 10.1016/j.nbd.2017.10.012; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Shapiro L, 2019, EPILEPSIA, V60, P2359, DOI 10.1111/epi.16388; Soltesz I, 2015, NAT REV NEUROSCI, V16, P264, DOI 10.1038/nrn3937; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Trinka E, 2015, EPILEPSIA, V56, P1515, DOI 10.1111/epi.13121; Trinka E, 2015, DRUGS, V75, P1499, DOI 10.1007/s40265-015-0454-2; Tsai MH, 2009, QJM-INT J MED, V102, P57, DOI 10.1093/qjmed/hcn149; Varvel NH, 2015, ANNU REV PHARMACOL, V55, P229, DOI 10.1146/annurev-pharmtox-010814-124607; Vezzani A, 2013, NEUROPHARMACOLOGY, V69, P16, DOI 10.1016/j.neuropharm.2012.04.004; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; von Bartheld CS, 2016, J COMP NEUROL, V524, P3865, DOI 10.1002/cne.24040; Wu Q, 2018, EPILEPSY RES, V148, P8, DOI 10.1016/j.eplepsyres.2018.10.002; Yu Y, 2019, PROG NEUROBIOL, V183, DOI 10.1016/j.pneurobio.2019.101682; Zhang J, 2018, MOL NEUROBIOL, V55, P4802, DOI 10.1007/s12035-017-0689-x	75	12	12	0	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUN	2020	57	6					2830	2845		10.1007/s12035-020-01923-4		MAY 2020	16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LW8SJ	WOS:000530803500002	32378121	Green Accepted			2022-02-06	
J	Gamdzyk, M; Doycheva, DM; Araujo, C; Ocak, U; Luo, YJ; Tang, JP; Zhang, JH				Gamdzyk, Marcin; Doycheva, Desislava Met; Araujo, Camila; Ocak, Umut; Luo, Yujie; Tang, Jiping; Zhang, John H.			cGAS/STING Pathway Activation Contributes to Delayed Neurodegeneration in Neonatal Hypoxia-Ischemia Rat Model: Possible Involvement of LINE-1	MOLECULAR NEUROBIOLOGY			English	Article						cGAS; STING; Neurodegeneration; LINE-1; Apoptosis	CGAS-STING PATHWAY; CYCLIC GMP-AMP; BRAIN-INJURY; SECONDARY DEGENERATION; TRANSPOSABLE ELEMENTS; SENSING PATHWAY; I INTERFERON; CATHEPSIN-B; CELL-DEATH; DNA	cGAS is a sensor of cytosolic DNA and responds equally to exogenous and endogenous DNA. After recognition of cytosolic dsDNA or ssDNA, cGAS synthesizes the second messenger 2 ' 3 '-cGAMP, which then binds to and activates stimulator of interferon genes (STING). STING plays an essential role in responding to pathogenic DNA and self-DNA in the context of autoimmunity. In pathologic conditions, such as stroke or hypoxia-ischemia (HI), DNA can gain access into the cytoplasm of the cell and leak from the dying cells into the extracellular environment, which potentially activates cGAS/STING. Recent in vivo studies of myocardial ischemia, traumatic brain injury, and liver damage models suggest that activation of cGAS/STING is not only a side-effect of the injury, but it can also actively contribute to cell death and apoptosis. We found, for the first time, that cGAS/STING pathway becomes activated between 24 and 48 h after HI in a 10-day-old rat model. Silencing STING with siRNA resulted in decreased infarction area, reduced cortical neurodegeneration, and improved neurobehavior at 48 h, suggesting that STING can contribute to injury progression after HI. STING colocalized with lysosomal marker LAMP-1 and blocking STING reduced the expression of cathepsin B and decreased the expression of Bax and caspase 3 cleavage. We observed similar protective effects after intranasal treatment with cGAS inhibitor RU.521, which were reversed by administration of STING agonist 2 ' 3 '-cGAMP. Additionally, we showed that long interspersed element 1 (LINE-1) retrotransposon, a potential upstream activator of cGAS/STING pathway was induced at 48 h after HI, which was evidenced by increased expression of ORF1p and ORF2p proteins and increased LINE-1 DNA content in the cytosol. Blocking LINE-1 with the nucleoside analog reverse-transcriptase inhibitor (NRTI) stavudine reduced infarction area, neuronal degeneration in the cerebral cortex, and reduced the expression of Bax and cleaved caspase 3. Thus, our results identify the cGAS/STING pathway as a potential therapeutic target to inhibit delayed neuronal death after HI.	[Gamdzyk, Marcin; Doycheva, Desislava Met; Araujo, Camila; Ocak, Umut; Luo, Yujie; Tang, Jiping; Zhang, John H.] Loma Linda Univ, Sch Med, Dept Physiol & Pharmacol, Basic Sci, 11041 Campus St,Risley Hall,Room 219, Loma Linda, CA 92354 USA; [Ocak, Umut] Univ Hlth Sci, Bursa Yuksek Ihtisas Training & Res Hosp, Dept Emergency Med, TR-16310 Bursa, Turkey; [Zhang, John H.] Loma Linda Univ, Sch Med, Dept Anesthesiol Neurosurg & Neurol, 11041 Campus St,Risley Hall,Room 219, Loma Linda, CA 92354 USA		Zhang, JH (corresponding author), Loma Linda Univ, Sch Med, Dept Physiol & Pharmacol, Basic Sci, 11041 Campus St,Risley Hall,Room 219, Loma Linda, CA 92354 USA.; Zhang, JH (corresponding author), Loma Linda Univ, Sch Med, Dept Anesthesiol Neurosurg & Neurol, 11041 Campus St,Risley Hall,Room 219, Loma Linda, CA 92354 USA.	johnzhang3910@yahoo.com	OCAK, UMUT/O-5167-2018	OCAK, UMUT/0000-0002-6549-4246	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS104083]	The study was supported by a grant from National Institute of Health NS104083 to Dr. John H. Zhang.	Abdullah A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1354-7; Ablasser A, 2014, J IMMUNOL, V192, P5993, DOI 10.4049/jimmunol.1400737; Badr LK, 2006, J PERINAT NEONAT NUR, V20, P163, DOI 10.1097/00005237-200604000-00011; Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921; BEILHARZ EJ, 1995, MOL BRAIN RES, V29, P1; Bregnard C, 2016, EBIOMEDICINE, V8, P184, DOI 10.1016/j.ebiom.2016.05.005; Cao DJ, 2018, CIRCULATION, V137, P2613, DOI 10.1161/CIRCULATIONAHA.117.031046; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Cho K, 2019, AGING DIS, V10, P652, DOI 10.14336/AD.2019.0118; Dai LX, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-18; de Castro MAG, 2016, CELL DEATH DISCOV, V2, DOI 10.1038/cddiscovery.2016.12; De Cecco M, 2019, NATURE, V566, P73, DOI 10.1038/s41586-018-0784-9; de The FXB, 2018, EMBO J, V37, DOI 10.15252/embj.201797374; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Fang CJ, 2016, PROTEIN CELL, V7, P11, DOI 10.1007/s13238-015-0222-9; Fathali N, 2013, TRANSL STROKE RES, V4, P208, DOI 10.1007/s12975-012-0239-9; Feather-Schussler D.N., 2016, J VIS EXP, V117; Ferriero DM, 2010, J ANAT, V217, P429, DOI 10.1111/j.1469-7580.2010.01226.x; Gaidt MM, 2017, CELL, V171, P1110, DOI 10.1016/j.cell.2017.09.039; Gill MB, 2008, NEUROCHEM RES, V33, P2379, DOI 10.1007/s11064-008-9649-1; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Hossain MA, 2004, J NEUROSCI, V24, P4187, DOI 10.1523/JNEUROSCI.0347-04.2004; Ivancevic AM, 2016, GENOME BIOL EVOL, V8, P3301, DOI 10.1093/gbe/evw243; Jiang B, 2017, TRANSL STROKE RES, V8, P183, DOI 10.1007/s12975-016-0506-2; Jones RB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001547; Jones RB, 2013, J VIROL, V87, P13307, DOI 10.1128/JVI.02257-13; Kilinc M, 2010, NEUROBIOL DIS, V40, P293, DOI 10.1016/j.nbd.2010.06.003; King KR, 2017, NAT MED, V23, P1481, DOI 10.1038/nm.4428; Kirilyuk A, 2008, NUCLEIC ACIDS RES, V36, P648, DOI 10.1093/nar/gkm1045; Kreisman NR, 2000, J NEUROPHYSIOL, V83, P1031, DOI 10.1152/jn.2000.83.2.1031; Krug L, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006635; Larkin B, 2017, J IMMUNOL, V199, P397, DOI 10.4049/jimmunol.1601999; Li P, 2017, NUCLEIC ACIDS RES, V45, P4619, DOI 10.1093/nar/gkx178; Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139; Li WH, 2013, NAT NEUROSCI, V16, P529, DOI 10.1038/nn.3368; Li WD, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044230, 10.1371/journal.pone.0044099]; Liu NW, 2017, TRANSL STROKE RES, V8, P244, DOI 10.1007/s12975-016-0512-4; Liu S, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/1202797; Lucchinetti E, 2006, PHYSIOL GENOMICS, V25, P314, DOI 10.1152/physiolgenomics.00251.2005; Luecke S, 2017, EMBO REP, V18, P1707, DOI 10.15252/embr.201744017; Ma F, 2015, EMBO REP, V16, P202, DOI 10.15252/embr.201439366; Moszczynska A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14356; Nakajima H, 2012, J BIOTECHNOL, V157, P326, DOI 10.1016/j.jbiotec.2011.10.003; Nakajima W, 2000, J NEUROSCI, V20, P7994; Nakaya Y, 2017, MBIO, V8, DOI 10.1128/mBio.00944-17; Northington FJ, 2011, ANN NEUROL, V69, P743, DOI 10.1002/ana.22419; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Penzkofer T, 2017, NUCLEIC ACIDS RES, V45, pD68, DOI 10.1093/nar/gkw925; Pereira GC, 2018, MOBILE DNA-UK, V9, DOI 10.1186/s13100-018-0138-z; Petrasek J, 2013, P NATL ACAD SCI USA, V110, P16544, DOI 10.1073/pnas.1308331110; Pizarro JG, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00014; Pokatayev V, 2016, J EXP MED, V213, P329, DOI 10.1084/jem.20151464; Qiao JT, 2018, METABOLISM, V81, P13, DOI 10.1016/j.metabol.2017.09.010; Qin Ai-Ping, 2008, Neurosci Bull, V24, P117, DOI 10.1007/s12264-008-0117-3; Rangasamy D, 2015, CURR MOL MED, V15, P588, DOI 10.2174/1566524015666150831130827; Reilly MT, 2013, J NEUROSCI, V33, P17577, DOI 10.1523/JNEUROSCI.3369-13.2013; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; SERVOMAA K, 1988, CELL TISSUE KINET, V21, P33, DOI 10.1111/j.1365-2184.1988.tb00769.x; Shankaran S, 2012, CLIN PERINATOL, V39, P919, DOI 10.1016/j.clp.2012.09.008; Sharma R, 2016, METHODS MOL BIOL, V1400, P261, DOI 10.1007/978-1-4939-3372-3_17; Shetty J, 2015, DEV MED CHILD NEUROL, V57, P40, DOI 10.1111/dmcn.12724; Simon M, 2019, CELL METAB, V29, P871, DOI 10.1016/j.cmet.2019.02.014; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Suarez NA, 2018, DEV NEUROBIOL, V78, P434, DOI 10.1002/dneu.22567; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tang CHA, 2016, CANCER RES, V76, P2137, DOI 10.1158/0008-5472.CAN-15-1885; Thomas CA, 2017, CELL STEM CELL, V21, P319, DOI 10.1016/j.stem.2017.07.009; Thornton C, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00248; Unal-Cevik I, 2004, STROKE, V35, P2189, DOI 10.1161/01.STR.0000136149.81831.c5; Vannucci RC, 1997, ANN NY ACAD SCI, V835, P234, DOI 10.1111/j.1749-6632.1997.tb48634.x; Vincent J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00833-9; Volpe JJ, 2001, MENT RETARD DEV D R, V7, P56, DOI 10.1002/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A; Wang ZS, 2017, MOL IMMUNOL, V87, P76, DOI 10.1016/j.molimm.2017.04.007; Wei XT, 2016, MOL NEUROBIOL, V53, P163, DOI 10.1007/s12035-014-8993-1; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xiao TS, 2013, MOL CELL, V51, P135, DOI 10.1016/j.molcel.2013.07.004; Xu M, 2014, GLIA, V62, P855, DOI 10.1002/glia.22645; Yamashima T, 2009, PROG NEUROBIOL, V89, P343, DOI 10.1016/j.pneurobio.2009.09.003; Yang Q, 2019, EBIOMEDICINE, V47, P470, DOI 10.1016/j.ebiom.2019.08.050; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhu H, 2012, J NEUROCHEM, V120, P574, DOI 10.1111/j.1471-4159.2011.07550.x; Zuo XL, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00125; Zuo XL, 2016, J NEUROPATH EXP NEUR, V75, P816, DOI 10.1093/jnen/nlw054	84	12	12	6	23	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUN	2020	57	6					2600	2619		10.1007/s12035-020-01904-7		APR 2020	20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LW8SJ	WOS:000524408200001	32253733	Green Accepted			2022-02-06	
J	Du, J; Deng, YJ; Li, H; Qiao, SG; Yu, MN; Xu, QY; Wang, C				Du, Jie; Deng, Yanjun; Li, Hua; Qiao, Shigang; Yu, Mengnan; Xu, Qingya; Wang, Chen			Ratio of Optic Nerve Sheath Diameter to Eyeball Transverse Diameter by Ultrasound Can Predict Intracranial Hypertension in Traumatic Brain Injury Patients: A Prospective Study	NEUROCRITICAL CARE			English	Article						Eyeball transverse diameter; Intracranial hypertension; Optic nerve ultrasound; Traumatic brain injury	PRESSURE; ASSOCIATION	Background Measuring optic nerve sheath diameter (ONSD), an indicator to predict intracranial hypertension, is noninvasive and convenient, but the reliability of ONSD needs to be improved. Instead of using ONSD alone, this study aimed to evaluate the reliability of the ratio of ONSD to eyeball transverse diameter (ONSD/ETD) in predicting intracranial hypertension in traumatic brain injury (TBI) patients. Methods We performed a prospective study on patients admitted to the Surgery Intensive Care Unit. The included 52 adults underwent craniotomy for TBI between March 2017 and September 2018. The ONSD and ETD of each eyeball were measured by ultrasound and computed tomography (CT) scan within 24 h after a fiber optic probe was placed into lateral ventricle. Intracranial pressure (ICP) > 20 mmHg was regarded as intracranial hypertension. The correlations between invasive ICP and ultrasound-ONSD/ETD ratio, ultrasound-ONSD, CT-ONSD/ETD ratio, and CT-ONSD were each analyzed separately. Results Ultrasound measurement was successfully performed in 94% (n = 49) of cases, and ultrasound and CT measurement were performed in 48% (n = 25) of cases. The correlation efficiencies between ultrasound-ONSD/ETD ratio, ultrasound-ONSD, CT-ONSD/ETD ratio, and ICP were 0.613, 0.498, and 0.688, respectively (P < 0.05). The area under the curve (AUC) values of the receiver operating characteristic (ROC) curve for the ultrasound-ONSD/ETD ratio and CT-ONSD/ETD ratio were 0.920 (95% CI 0.877-0.964) and 0.896 (95% CI 0.856-0.931), respectively. The corresponding threshold values were 0.25 (sensitivity of 90%, specificity of 82.3%) and 0.25 (sensitivity of 85.7%, specificity of 83.3%), respectively. Conclusion The ratio of ONSD to ETD tested by ultrasound may be a reliable indicator for predicting intracranial hypertension in TBI patients.	[Du, Jie; Deng, Yanjun; Li, Hua; Qiao, Shigang; Yu, Mengnan; Xu, Qingya; Wang, Chen] Nanjing Med Univ, Suzhou Sci & Technol Town Hosp, Affiliated Suzhou Sci & Technol Town Hosp, Dept Anesthesiol & Perioperat Med, 1 Lijiang Rd, Suzhou 215153, Jiangsu, Peoples R China; [Qiao, Shigang; Wang, Chen] Nanjing Med Univ, Suzhou Sci & Technol Town Hosp, Affiliated Suzhou Sci & Technol Town Hosp, Inst Clin Med Res, 1 Lijiang Rd, Suzhou 215153, Jiangsu, Peoples R China		Wang, C (corresponding author), Nanjing Med Univ, Suzhou Sci & Technol Town Hosp, Affiliated Suzhou Sci & Technol Town Hosp, Dept Anesthesiol & Perioperat Med, 1 Lijiang Rd, Suzhou 215153, Jiangsu, Peoples R China.	anesthesia_chen@163.com					Godoy DA, 2019, NEUROCRIT CARE, V31, P176, DOI 10.1007/s12028-018-0658-x; Bauerle J, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-187; Bekerman I, 2016, AM J EMERG MED, V34, P2336, DOI 10.1016/j.ajem.2016.08.045; Bekerman I, 2016, J NEUROL SCI, V368, P285, DOI 10.1016/j.jns.2016.07.023; Blaivas M, 2002, ACAD EMERG MED, V9, P791, DOI 10.1111/j.1553-2712.2002.tb02166.x; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ertl M, 2017, EUR J NEUROL, V24, P461, DOI 10.1111/ene.13225; Galgano M, 2017, CELL TRANSPLANT, V26, P1118, DOI 10.1177/0963689717714102; Hassen GW, 2015, J EMERG MED, V48, P450, DOI 10.1016/j.jemermed.2014.09.060; Kalantari H, 2013, AM J EMERG MED, V31, P1595, DOI 10.1016/j.ajem.2013.07.028; Kim DH, 2018, J CLIN NEUROL, V14, P345, DOI 10.3988/jcn.2018.14.3.345; Kim DH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16173-z; Malekpour Babak, 2012, Acta Med Iran, V50, P113; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Raffiz M, 2017, AM J EMERG MED, V35, P150, DOI 10.1016/j.ajem.2016.09.044; Rajajee V, 2018, NEUROCRIT CARE, V29, P280, DOI 10.1007/s12028-018-0540-x; Robba C, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002356; Shirodkar CG, 2015, INDIAN J CRIT CARE M, V19, P466, DOI 10.4103/0972-5229.162465; Strumwasser A, 2011, J SURG RES, V170, P265, DOI 10.1016/j.jss.2011.03.009; Toscano M, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1621428; Vaiman M, 2016, J NEUROTRAUM, V33, P2147, DOI 10.1089/neu.2015.4293; Vaiman M, 2016, J CLIN NEUROSCI, V34, P177, DOI 10.1016/j.jocn.2016.06.008; Vaiman M, 2014, HEAD FACE MED, V10, DOI 10.1186/1746-160X-10-32; Yuan Q, 2016, NEUROSURGERY, V78, P361, DOI 10.1227/NEU.0000000000001050	24	12	14	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2020	32	2					478	485		10.1007/s12028-019-00762-z			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	KV8ES	WOS:000520711600018	31218637				2022-02-06	
J	Kara, S; Crosswell, H; Forch, K; Cavadino, A; McGeown, J; Fulcher, M				Kara, Stephen; Crosswell, Hannah; Forch, Katherine; Cavadino, Alana; McGeown, Josh; Fulcher, Mark			Less Than Half of Patients Recover Within 2 Weeks of Injury After a Sports-Related Mild Traumatic Brain Injury: A 2-Year Prospective Study	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sports-related concussion; sports-related mTBI; recovery; rehabilitation	INTERNATIONAL-CONFERENCE; POSTCONCUSSION SYMPTOMS; AGREEMENT STATEMENT; CONSENSUS STATEMENT; ACUTE CONCUSSION; HIGH-SCHOOL; EXERCISE; RELIABILITY; SEVERITY; CHILDREN	Objective: To describe clinical recovery time and factors that might impact on recovery after a sports-related mild traumatic brain injury (SR-mTBI; concussion). Design: Prospective cohort study (level IV evidence). Setting: New Zealand Sports Concussion Clinic. Participants: Eight hundred twenty-two patients presenting within 14 days of a SR-mTBI/concussion over a 2-year period. Main Outcome Measures: Clinical recovery measured as number of days after injury. Interventions Methods: Participants were assessed and managed using a standardized protocol consisting of relative rest followed by controlled cognitive and physical loading. A reassessment was performed 14 days after injury with initiation of an active rehabilitation program consisting of a subsymptom threshold exercise program +/- cervicovestibular rehabilitation (if required) for participants who remained symptomatic. Participants were then assessed every 2 weeks until clinical recovery. Results: A total of 594 participants were eligible for analysis (mean age 20.2 +/- 8.7 years, 77% males) and were grouped into 3 age cohorts: children (<= 12 years), adolescents (13-18 years), and adults (>= 19 years). Forty-five percent of participants showed clinical recovery within 14 days of injury, 77% by 4 weeks after injury, and 96% by 8 weeks after injury. There was no significant difference in recovery time between age groups. Prolonged recovery was more common in females (P = 0.001), participants with "concussion modifiers" (P = 0.001), and with increased time between injury and the initial appointment (P = 0.003). Conclusions: This study challenges current perceptions that most people with a SR-mTBI (concussion) recover within 10 to 14 days and that age is a determinant of recovery rate. Active rehabilitation results in high recovery rates after SR-mTBI.	[Kara, Stephen; Crosswell, Hannah; Forch, Katherine; Fulcher, Mark] Axis Sports Med Specialists, Auckland, New Zealand; [Cavadino, Alana] Univ Auckland, Sch Populat Hlth, Sect Epidemiol & Biostat, Auckland, New Zealand; [McGeown, Josh] Auckland Univ Technol, SPRINZ, Fac Hlth & Environm Sci, Auckland, New Zealand		Kara, S (corresponding author), Axis Sports Med Clin, 71 Merton Rd, Auckland 1072, New Zealand.	s.kara@axissportsmedicine.co.nz			Accident Compensation Corporation (ACC), NZ	The clinic was supported by funding from the Accident Compensation Corporation (ACC), NZ. The content is solely the responsibility of the authors and does not necessarily represent the official views of ACC, NZ.	Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barrera-Gomez J, 2015, EPIDEMIOLOGY, V26, pE16, DOI 10.1097/EDE.0000000000000247; Cantu R, 2004, LANCET NEUROL, V3, P437; Chan C, 2018, ARCH PHYS MED REHAB, V99, P242, DOI 10.1016/j.apmr.2017.09.108; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Forrest RHJ, 2018, J PRIM HEALTH CARE, V10, P159, DOI 10.1071/HC17071; Fuller GW, 2015, BRIT J SPORT MED, V49, P529, DOI 10.1136/bjsports-2014-093498; Gianotti SM, 2009, J SCI MED SPORT, V12, P371, DOI 10.1016/j.jsams.2008.01.002; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Hall TM, 2008, J MANIP PHYSIOL THER, V31, P293, DOI 10.1016/j.jmpt.2008.03.012; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hinton-Bayre AD, 2002, NEUROLOGY, V59, P1068, DOI 10.1212/WNL.59.7.1068; Hughes, 2019, CONCUSSION SPORT AUS; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; McGeown JP, 2019, SPORTS MED; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2010, AM J SPORTS MED, V42, P2479; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Schafer A, 2018, PHYSIOTHER THEOR PR, V34, P622, DOI 10.1080/09593985.2017.1423523; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Thomas DJ, 2018, CLIN J SPORT MED, V28, P56, DOI 10.1097/JSM.0000000000000413; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	36	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2020	30	2					96	101		10.1097/JSM.0000000000000811			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	LB0XP	WOS:000524361100004	32132366				2022-02-06	
J	Ma, XT; Agas, A; Siddiqui, Z; Kim, K; Iglesias-Montoro, P; Kalluru, J; Kumar, V; Haorah, J				Ma, Xiaotang; Agas, Agnieszka; Siddiqui, Zain; Kim, KaKyung; Iglesias-Montoro, Patricia; Kalluru, Jagathi; Kumar, Vivek; Haorah, James			Angiogenic peptide hydrogels for treatment of traumatic brain injury	BIOACTIVE MATERIALS			English	Article						Traumatic brain injury; Cerebrovascular injury; Regenerative medicine; Angiogenesis; Self-assembling peptide hydrogels	ENDOTHELIAL GROWTH-FACTOR; NEUROGENESIS; VEGF; ASSOCIATION; SIMVASTATIN; MECHANISMS; ISCHEMIA; RECOVERY	Traumatic brain injury (TBI) impacts over 3.17 million Americans. Management of hemorrhage and coagulation caused by vascular disruption after TBI is critical for the recovery of patients. Cerebrovascular pathologies play an important role in the underlying mechanisms of TBI. The objective of this study is to evaluate a novel regenerative medicine for the injured tissue after brain injury. We utilized a recently described synthetic growth factor with angiogenic potential to facilitate vascular growth in situ at the injury site. Previous work has shown how this injectable self-assembling peptide-based hydrogel (SAPH) creates a regenerative microenvironment for neovascularization at the injury site. Supramolecular assembly allows for thixotropy; the injectable drug delivery system provides sustained in vivo efficacy. In this study, a moderate blunt injury model was used to cause physical vascular damage and hemorrhage. The angiogenic SAPH was then applied directly on the injured rat brain. At day 7 post-TBI, significantly more blood vessels were observed than the sham and injury control group, as well as activation of VEGF-receptor 2, demonstrating the robust angiogenic response elicited by the angiogenic SAPH. Vascular markers von-Willebrand factor (vWF) and alpha-smooth muscle actin (alpha-SMA) showed a concomitant increase with blood vessel density in response to the angiogenic SAPH. Moreover, blood brain barrier integrity and blood coagulation were also examined as the parameters to indicate wound recovery post TBI. Neuronal rescue examination by NeuN and myelin basic protein staining showed that the angiogenic SAPH may provide and neuroprotective benefit in the long-term recovery.	[Ma, Xiaotang; Agas, Agnieszka; Siddiqui, Zain; Kim, KaKyung; Iglesias-Montoro, Patricia; Kalluru, Jagathi; Kumar, Vivek; Haorah, James] New Jersey Inst Technol, Ctr Injury Biomech Mat & Med, Dept Biomed Engn, Newark, NJ 07102 USA; [Kumar, Vivek] New Jersey Inst Technol, Dept Chem & Mat Engn, Newark, NJ 07102 USA; [Kumar, Vivek] Rutgers Sch Dent Med, Dept Restorat Dent, Newark, NJ USA		Kumar, V; Haorah, J (corresponding author), New Jersey Inst Technol, Ctr Injury Biomech Mat & Med, Dept Biomed Engn, Newark, NJ 07102 USA.	vak@njit.edu; jhaorah@njit.edu	Ma, Xiaotang/AAX-9062-2020	Kumar, Vivek/0000-0001-7536-9281; Agas, Agnieszka/0000-0001-8564-3168; Kalluru, Jagathi/0000-0003-1396-8291	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21AA022734-01A1]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R15 EY029504]; NSFNational Science Foundation (NSF) [IIP 1903617]; NJIT Undergraduate Research and Innovation (URI) Program; NJIT Startup funds	This work was supported by grant 1R21AA022734-01A1 (to JH) from National Institutes of Health, and NIH R15 EY029504, NSF IIP 1903617, the NJIT Undergraduate Research and Innovation (URI) Program and NJIT Startup funds (to V.A.K.).	Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Guo H, 2016, NEURAL REGEN RES, V11, P174, DOI 10.4103/1673-5374.175067; Hitscherich P, 2018, J BIOMED NANOTECHNOL, V14, P802, DOI 10.1166/jbn.2018.2583; Hochstadter E, 2014, NEUROCRIT CARE, V21, P505, DOI 10.1007/s12028-014-9986-7; Hopp S, 2016, ANN NEUROL, V79, P970, DOI 10.1002/ana.24655; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Krum JM, 2008, EXP NEUROL, V212, P108, DOI 10.1016/j.expneurol.2008.03.019; Kumar VA, 2016, BIOMATERIALS, V98, P113, DOI 10.1016/j.biomaterials.2016.04.032; Kumar VA, 2016, EXP BIOL MED, V241, P899, DOI 10.1177/1535370216640941; Kumar VA, 2015, ACS BIOMATER SCI ENG, V1, P1300, DOI 10.1021/acsbiomaterials.5b00356; Kumar VA, 2015, J AM CHEM SOC, V137, P4823, DOI 10.1021/jacs.5b01549; Kumar VA, 2015, BIOMATERIALS, V52, P71, DOI 10.1016/j.biomaterials.2015.01.079; Kumar VA, 2015, ACS NANO, V9, P860, DOI 10.1021/nn506544b; Lafuente JV, 2006, J NEURAL TRANSM, V113, P487, DOI 10.1007/s00702-005-0407-0; Lee C, 2010, J NEUROTRAUM, V27, P541, DOI 10.1089/neu.2009.0905; Lu KT, 2011, J NEUROTRAUM, V28, P441, DOI 10.1089/neu.2010.1473; Lyeth BG, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00217; Ma XT, 2020, J NEUROIMMUNE PHARM, V15, P181, DOI 10.1007/s11481-019-09882-x; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Moore AN, 2017, ACCOUNTS CHEM RES, V50, P714, DOI 10.1021/acs.accounts.6b00553; Nguyen PK, 2018, ACS APPL BIO MATER, V1, P865, DOI 10.1021/acsabm.8b00283; Nguyen PK, 2018, ACS OMEGA, V3, P5980, DOI 10.1021/acsomega.8b00347; Ortuzar N, 2013, BEHAV BRAIN RES, V246, P36, DOI 10.1016/j.bbr.2013.02.036; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Petrak K, 2019, MOLECULES, V24, DOI 10.3390/molecules24071219; Sarkar B, 2019, ACS BIOMATER SCI ENG, V5, P4657, DOI 10.1021/acsbiomaterials.9b00967; Sarkar B, 2018, BIOMACROMOLECULES, V19, P3597, DOI 10.1021/acs.biomac.8b01137; Shi SY, 2016, BIOACT MATER, V1, P109, DOI 10.1016/j.bioactmat.2016.09.004; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thau-Zuchman O, 2012, NEUROSCIENCE, V202, P334, DOI 10.1016/j.neuroscience.2011.11.071; Tovar-y-Romo LB, 2016, J NEUROCHEM, V136, P13, DOI 10.1111/jnc.13362; Wang B, 2012, J NEUROL SCI, V319, P117, DOI 10.1016/j.jns.2012.04.015; Wang TW, 2017, NANOSCALE, V9, P16281, DOI 10.1039/c7nr06528k; Wang YM, 2007, J NEUROSCI RES, V85, P740, DOI 10.1002/jnr.21169; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Wu HT, 2011, NEUROSURGERY, V68, P1363, DOI 10.1227/NEU.0b013e31820c06b9; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2011, J NEUROSURG, V114, P549, DOI 10.3171/2010.10.JNS10925; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298	47	12	13	3	22	KEAI PUBLISHING LTD	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING, DONGHENG DISTRICT 100717, PEOPLES R CHINA		2452-199X		BIOACT MATER	Bioact. Mater.	MAR	2020	5	1					124	132		10.1016/j.bioactmat.2020.01.005			9	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	KR7NK	WOS:000517802700015	32128463	gold, Green Published			2022-02-06	
J	Hurtubise, J; Baher, T; Messa, I; Cutler, L; Shahein, A; Hastings, M; Carignan-Querqui, M; Erdodi, LA				Hurtubise, Jessica; Baher, Tabarak; Messa, Isabelle; Cutler, Laura; Shahein, Ayman; Hastings, Maurissa; Carignan-Querqui, Marilou; Erdodi, Laszlo A.			Verbal fluency and digit span variables as performance validity indicators in experimentally induced malingering and real world patients with TBI	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Experimental malingering; performance validity; population-specific cutoffs; verbal fluency	TRAUMATIC BRAIN-INJURY; RECOGNITION MEMORY TEST; FINGER TAPPING TEST; INTELLIGENCE SCALE-4TH EDITION; COMPLEX IDEATIONAL MATERIAL; IMMEDIATE POST-CONCUSSION; COGNITIVE TESTING IMPACT; FALSE-POSITIVE RATES; RAW SCORE CUTOFFS; CARD SORTING TEST	Objective: This study was designed to examine the classification accuracy of verbal fluency (VF) measures as performance validity tests (PVT). Method: Student volunteers were assigned to the control (n = 57) or experimental malingering (n = 24) condition. An archival sample of 77 patients with TBI served as a clinical comparison. Results: Among students, FAS T-score <= 29 produced a good combination of sensitivity (.40-.42) and specificity (.89-.95). Animals T-score <= 31 had superior sensitivity (.53-.71) at .86-.93 specificity. VF tests performed similarly to commonly used PVTs embedded within Digit Span: RDS <= 7 (.54-.80 sensitivity at .93-.97 specificity) and age-corrected scaled score (ACSS) <= 6 (.54-.67 sensitivity at .94-.96 specificity). In the clinical sample, specificity was lower at liberal cutoffs [animals T-score <= 31 (.89-.91), RDS <= 7 (.86-.89) and ACSS <= 6 (.86-.96)], but comparable at conservative cutoffs [animals T-score <= 29 (.94-.96), RDS <= 6 (.95-.98) and ACSS <= 5 (.92-.96)]. Conclusions: Among students, VF measures had higher signal detection performance than previously reported in clinical samples, likely due to the absence of genuine impairment. The superior classification accuracy of animal relative to letter fluency was replicated. Results suggest that existing validity cutoffs can be extended to cognitively high functioning examinees, and emphasize the importance of population-specific cutoffs.	[Hurtubise, Jessica; Baher, Tabarak; Messa, Isabelle; Cutler, Laura; Hastings, Maurissa; Erdodi, Laszlo A.] Univ Windsor, Dept Psychol, Windsor, ON, Canada; [Shahein, Ayman] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Carignan-Querqui, Marilou] Univ Windsor, Dept Languages Literature & Cultures, Windsor, ON, Canada		Erdodi, LA (corresponding author), Univ Windsor, Dept Psychol, Windsor, ON, Canada.	lerdodi@gmail.com	Cutler, Laura/AAI-6283-2021	Cutler, Laura/0000-0003-2957-8693; Baher, Tabarak/0000-0003-1247-1566			Abeare C, 2019, PSYCHOL INJ LAW, V12, P170, DOI 10.1007/s12207-019-09353-x; Abeare C, 2019, J HEAD TRAUMA REHAB, V34, pE20, DOI 10.1097/HTR.0000000000000451; Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; Abeare CA, 2017, J CLIN EXP NEUROPSYC, V39, P738, DOI 10.1080/13803395.2016.1259396; An KY, 2019, J CLIN EXP NEUROPSYC, V41, P15, DOI 10.1080/13803395.2018.1483488; An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Backhaus SL, 2004, CLIN NEUROPSYCHOL, V18, P591, DOI 10.1080/13854040490888558; Bailey KC, 2018, ARCH CLIN NEUROPSYCH, V33, P895, DOI 10.1093/arclin/acx111; Bain KM, 2019, ASSESSMENT, V26, P1320, DOI 10.1177/1073191117725172; Barhon LI, 2015, APPL NEUROPSYCH-ADUL, V22, P114, DOI 10.1080/23279095.2013.863775; Bashem JR, 2014, CLIN NEUROPSYCHOL, V28, P851, DOI 10.1080/13854046.2014.927927; Benedict, 2001, HOPKINS VERBAL LEARN; Berger C, 2021, J ATTEN DISORD, V25, P1032, DOI 10.1177/1087054719864656; Bialystok E, 2014, NEUROPSYCHOLOGY, V28, P290, DOI 10.1037/neu0000023; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Bodner T, 2019, J CLIN EXP NEUROPSYC, V41, P476, DOI 10.1080/13803395.2019.1579783; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P355, DOI 10.1016/j.acn.2007.01.010; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Boskovic I, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01195; Brennan A, 2009, CLIN NEUROPSYCHOL, V23, P314, DOI 10.1080/13854040802054151; Browndyke JN, 2008, BRAIN INJURY, V22, P481, DOI 10.1080/02699050802084894; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone DA, 2014, APPL NEUROPSYCH-ADUL, V21, P155, DOI 10.1080/09084282.2012.755533; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Coleman RD, 1998, J CLIN EXP NEUROPSYC, V20, P201, DOI 10.1076/jcen.20.2.201.1164; Cottingham ME, 2014, CLIN NEUROPSYCHOL, V28, P1030, DOI 10.1080/13854046.2014.951397; Critchfield E, 2019, CLIN NEUROPSYCHOL, V33, P1083, DOI 10.1080/13854046.2018.1508615; CROWE SF, 1996, PSYCHIAT PSYCHOL LAW, V3, P39, DOI DOI 10.1080/13218719609524873; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Dandachi-FitzGerald B, 2017, J CLIN EXP NEUROPSYC, V39, P257, DOI 10.1080/13803395.2016.1223278; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1278, DOI 10.1080/13854046.2014.975844; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Davis JJ, 2013, J CLIN EXP NEUROPSYC, V35, P413, DOI 10.1080/13803395.2013.781134; Delis DC., 2001, DELIS KAPLAN EXECUTI; DenBoer JW, 2007, CLIN NEUROPSYCHOL, V21, P943, DOI 10.1080/13854040601020783; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Eglit GML, 2020, CLIN NEUROPSYCHOL, V34, P332, DOI 10.1080/13854046.2019.1643923; Erdodi, 2018, J PEDIAT NEUROPSYCHO, V4, P94, DOI [10.1007/s40817-018-0057-4, DOI 10.1007/s40817-018-0057-4, DOI 10.1007/S40817-018-0057-4]; Erdodi L. A., 2019, ASSESSMENT FEIGNED C; Erdodi L.A., 2017, PSYCHOL NEUROSCIENCE, V10, P325, DOI [10.1037/pne0000103, DOI 10.1037/PNE0000103, https://doi.org//10.1037/pne0000103, DOI https://doi.org/10.1037/pne0000103]; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2020, ARCH CLIN NEUROPSYCH, V35, P188, DOI 10.1093/arclin/acz032; Erdodi LA, 2019, PSYCHOL INJ LAW, V12, P113, DOI 10.1007/s12207-019-09352-y; Erdodi LA, 2019, PSYCHOL INJ LAW, V12, P155, DOI 10.1007/s12207-019-09356-8; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P307, DOI 10.1007/s12207-018-9337-7; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P1082, DOI 10.1037/pas0000561; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P1, DOI 10.1007/s12207-017-9309-3; Erdodi LA, 2018, ARCH CLIN NEUROPSYCH, V33, P845, DOI 10.1093/acn/acx110; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, PSYCHOL INJ LAW, V10, P96, DOI 10.1007/s12207-017-9282-x; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Frazier TW, 2008, ARCH CLIN NEUROPSYCH, V23, P501, DOI 10.1016/j.acn.2008.04.001; Fuermaier ABM, 2017, PSYCHOL ASSESSMENT, V29, P1466, DOI 10.1037/pas0000534; Fuermaier ABM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164297; Gaudet CE, 2017, CLIN NEUROPSYCHOL, V31, P43, DOI 10.1080/13854046.2016.1220622; Giromini L, 2019, PSYCHOL INJ LAW, V12, P212, DOI 10.1007/s12207-019-09357-7; Giromini L, 2018, PSYCHOL INJ LAW, V11, P340, DOI 10.1007/s12207-018-9314-1; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Glassmire DM, 2019, PSYCHOL ASSESSMENT, V31, P120, DOI 10.1037/pas0000650; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; HAYWARD L, 1987, AUST NZ J PSYCHIAT, V21, P87, DOI 10.3109/00048678709160904; Heaton R. K., 2004, REVISED COMPREHENSIV; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Higgins KL, 2017, ARCH CLIN NEUROPSYCH, V32, P259, DOI 10.1093/arclin/acw108; Hilsabeck RC, 2017, CLIN NEUROPSYCHOL, V31, P995, DOI 10.1080/13854046.2017.1350752; Hopwood CJ, 2007, J PERS ASSESS, V88, P43, DOI 10.1207/s15327752jpa8801_06; Hosmer DW, 2000, WILEY PS TX, V2nd, P147; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Iverson GL, 1999, CLIN NEUROPSYCHOL, V13, P437, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT437; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; IVERSON GL, 1994, ARCH CLIN NEUROPSYCH, V9, P437, DOI 10.1016/0887-6177(94)90006-X; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Johnson SC, 2012, CLIN NEUROPSYCHOL, V26, P1230, DOI 10.1080/13854046.2012.709886; Johnstone B, 1996, ARCH CLIN NEUROPSYCH, V11, P513, DOI 10.1016/0887-6177(96)82330-4; Kanser RJ, 2019, CLIN NEUROPSYCHOL, V33, P90, DOI 10.1080/13854046.2018.1440006; Kanser RJ, 2017, CLIN NEUROPSYCHOL, V31, P644, DOI 10.1080/13854046.2016.1278040; Kiewel NA, 2012, CLIN NEUROPSYCHOL, V26, P965, DOI 10.1080/13854046.2012.694478; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kongs S. K., 2000, WCST 64 WISCONSIN CA; Kura K, 2013, INTELLIGENCE, V41, P512, DOI 10.1016/j.intell.2013.07.001; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larochette AC, 2012, APPL NEUROPSYCH-CHIL, V1, P38, DOI 10.1080/21622965.2012.665777; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2019, CLIN NEUROPSYCHOL, V33, P1354, DOI 10.1080/13854046.2019.1614227; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Larsen JD, 2010, BRAIN INJURY, V24, P89, DOI 10.3109/02699050903508218; Leighton A, 2014, J INT NEUROPSYCH SOC, V20, P873, DOI 10.1017/S135561771400085X; Leon FR, 2014, INTELLIGENCE, V46, P291, DOI 10.1016/j.intell.2014.07.011; Lichtenstein JD, 2019, PSYCHOL INJ LAW, V12, P127, DOI 10.1007/s12207-019-09354-w; Lichtenstein JD, 2019, DEV NEUROPSYCHOL, V44, P159, DOI 10.1080/87565641.2019.1565535; Lichtenstein JD, 2018, APPL NEUROPSYCH-CHIL, V7, P334, DOI 10.1080/21622965.2017.1340158; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; LORING DW, 1995, NEUROLOGY, V45, P1329, DOI 10.1212/WNL.45.7.1329; Lupu T, 2018, APPL NEUROPSYCH-ADUL, V25, P532, DOI 10.1080/23279095.2017.1341410; Lynn R, 2010, INTELLIGENCE, V38, P93, DOI 10.1016/j.intell.2009.07.004; MacAllister WS, 2019, CHILD NEUROPSYCHOL, V25, P1035, DOI 10.1080/09297049.2019.1569606; Martin PK, 2018, ASSESSMENT, V25, P640, DOI 10.1177/1073191116656796; Martin PK, 2017, CLIN NEUROPSYCHOL, V31, P829, DOI 10.1080/13854046.2017.1284265; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; Matthews CG., 1964, INSTRUCTION MANUAL A; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McDaniel MA, 2006, INTELLIGENCE, V34, P607, DOI 10.1016/j.intell.2006.08.007; McFarlane J, 2006, BRIT J CLIN PSYCHOL, V45, P453, DOI 10.1348/014466505X71245; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Merten T, 2017, BEHAV SCI LAW, V35, P97, DOI 10.1002/bsl.2274; Meyers JE, 2014, ARCH CLIN NEUROPSYCH, V29, P224, DOI 10.1093/arclin/acu001; Miller LJ, 2004, CLIN NEUROPSYCHOL, V18, P327, DOI 10.1080/13854040490501592; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Pearson, 2009, ADV CLIN SOLUTIONS W; Persinger VC, 2018, CLIN NEUROPSYCHOL, V32, P1039, DOI 10.1080/13854046.2017.1419507; Piatt AL, 1999, J CLIN EXP NEUROPSYC, V21, P435, DOI 10.1076/jcen.21.4.435.885; Piatt AL, 1999, NEUROPSYCHOLOGIA, V37, P1499, DOI 10.1016/S0028-3932(99)00066-4; Powell MR, 2011, CLIN NEUROPSYCHOL, V25, P108, DOI 10.1080/13854046.2010.532912; Poynter K, 2019, ARCH CLIN NEUROPSYCH, V34, P1367, DOI 10.1093/arclin/acy087; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Rai J., 2019, PSYCHOL NEUROSCIENCE, V12, P451, DOI [10.1037/pne0000175, DOI 10.1037/PNE0000175]; Rai JK, 2021, APPL NEUROPSYCH-ADUL, V28, P185, DOI 10.1080/23279095.2019.1613994; Rapport LJ, 1998, J CLIN EXP NEUROPSYC, V20, P89, DOI 10.1076/jcen.20.1.89.1488; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rogers R, 2003, ASSESSMENT, V10, P160, DOI 10.1177/1073191103010002007; Rose FE, 1998, ARCH CLIN NEUROPSYCH, V13, P349, DOI 10.1016/S0887-6177(97)00025-5; Rosenfeld B, 2000, ARCH CLIN NEUROPSYCH, V15, P349, DOI 10.1016/S0887-6177(99)00025-6; Roth RM, 2015, CHILD NEUROPSYCHOL, V21, P225, DOI 10.1080/09297049.2014.897318; Roye S, 2019, CLIN NEUROPSYCHOL, V33, P1138, DOI 10.1080/13854046.2018.1520303; Savla GN, 2011, J INT NEUROPSYCH SOC, V17, P14, DOI 10.1017/S1355617710001177; Sawyer RJ, 2017, CLIN NEUROPSYCHOL, V31, P207, DOI 10.1080/13854046.2016.1245787; Schroeder RW, 2019, CLIN NEUROPSYCHOL, V33, P466, DOI 10.1080/13854046.2018.1484517; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schroeder RW, 2010, CLIN NEUROPSYCHOL, V24, P326, DOI 10.1080/13854040903369441; Schutte C, 2015, PSYCHOL INJ LAW, V8, P100, DOI 10.1007/s12207-015-9225-3; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Shura RD, 2020, CLIN NEUROPSYCHOL, V34, P1025, DOI 10.1080/13854046.2019.1635209; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Silverberg ND, 2008, CLIN NEUROPSYCHOL, V22, P140, DOI 10.1080/13854040601160597; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith A, 2007, SYMBOL DIGIT MODALIT; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Stevens A, 2008, PSYCHIAT RES, V157, P191, DOI 10.1016/j.psychres.2007.01.003; Steward KA, 2017, ARCH CLIN NEUROPSYCH, V32, P98, DOI 10.1093/arclin/acw081; Suchotzi K, 2015, INT J PSYCHOPHYSIOL, V95, P395, DOI 10.1016/j.ijpsycho.2015.01.010; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Tomer E, 2020, APPL NEUROPSYCH-ADUL, V27, P49, DOI 10.1080/23279095.2018.1480483; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Tsushima WT, 2021, APPL NEUROPSYCH-CHIL, V10, P209, DOI 10.1080/21622965.2019.1642202; Tyson BT, 2018, EPILEPSY BEHAV, V87, P39, DOI 10.1016/j.yebeh.2018.08.010; van Helvoort D, 2019, CLIN NEUROPSYCHOL, V33, P1069, DOI 10.1080/13854046.2018.1559359; Vickery CD, 2004, ARCH CLIN NEUROPSYCH, V19, P37, DOI 10.1016/S0887-6177(02)00170-1; Viglione DJ, 2019, J PERS ASSESS, V101, P653, DOI 10.1080/00223891.2018.1492413; Webber TA, 2018, CLIN NEUROPSYCHOL, V32, P657, DOI 10.1080/13854046.2017.1415374; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whiteside DM, 2019, APPL NEUROPSYCH-ADUL, V26, P472, DOI 10.1080/23279095.2018.1443935; Whiteside DM, 2015, CLIN NEUROPSYCHOL, V29, P788, DOI 10.1080/13854046.2015.1093660; Whiteside DM, 2015, J CLIN EXP NEUROPSYC, V37, P220, DOI 10.1080/13803395.2014.1002758; Whitney KA, 2009, ARCH CLIN NEUROPSYCH, V24, P263, DOI 10.1093/arclin/acp034; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Yu JH, 2019, NEUROSCI BIOBEHAV R, V104, P43, DOI 10.1016/j.neubiorev.2019.06.027; Zakzanis KK, 2013, BRAIN INJURY, V27, P903, DOI 10.3109/02699052.2013.775505; Zakzanis KK, 2011, J CLIN EXP NEUROPSYC, V33, P785, DOI 10.1080/13803395.2011.558496; Zuccato BG, 2018, PSYCHOL ASSESSMENT, V30, P1491, DOI 10.1037/pas0000596	193	12	12	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child	OCT 1	2020	9	4			SI		337	354		10.1080/21622965.2020.1719409		FEB 2020	18	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	OD0AY	WOS:000515046600001	32081042				2022-02-06	
J	Patrick, SD; Rapport, LJ; Kanser, RJ; Hanks, RA; Bashem, JR				Patrick, Sarah D.; Rapport, Lisa J.; Kanser, Robert J.; Hanks, Robin A.; Bashem, Jesse R.			Performance validity assessment using response time on the Warrington Recognition Memory Test	CLINICAL NEUROPSYCHOLOGIST			English	Article						Malingering; performance validity; response time; traumatic brain injury	BRAIN-INJURY; COMPENSATION-SEEKING; CROSS-VALIDATION; DIGIT SPAN; IMPAIRMENT; SPECIFICITY; SENSITIVITY; SIMULATION; STRATEGIES; IMPROVES	Objective: The present study tested the incremental utility of response time (RT) on the Warrington Recognition Memory Test - Words (RMT-W) in classifying bona fide versus feigned TBI. Method: Participants were 173 adults: 55 with moderate to severe TBI, 69 healthy comparisons (HC) instructed to perform their best, and 49 healthy adults coached to simulate TBI (SIM). Participants completed a computerized version of the RMT-W in the context of a comprehensive neuropsychological battery. Groups were compared on RT indices including mean RT (overall, correct trials, incorrect trials) and variability, as well as the traditional RMT-W accuracy score. Results: Several RT indices differed significantly across groups, although RMT-W accuracy predicted group membership more strongly than any individual RT index. SIM showed longer average RT than both TBI and HC. RT variability and RT for incorrect trials distinguished SIM-HC but not SIM-TBI comparisons. In general, results for SIM-TBI comparisons were weaker than SIM-HC results. For SIM-HC comparisons, classification accuracy was excellent for all multivariable models incorporating RMT-W accuracy with one of the RT indices. For SIM-TBI comparisons, classification accuracies for multivariable models ranged from acceptable to excellent discriminability. In addition to mean RT and RT on correct trials, the ratio of RT on correct items to incorrect items showed incremental predictive value to accuracy. Conclusion: Findings support the growing body of research supporting the value of combining RT with PVTs in discriminating between verified and feigned TBI. The diagnostic accuracy of the RMT-W can be improved by incorporating RT.	[Patrick, Sarah D.; Rapport, Lisa J.; Kanser, Robert J.; Hanks, Robin A.; Bashem, Jesse R.] Wayne State Univ, Dept Psychol, 71 W Warren Ave, Detroit, MI 48202 USA; [Hanks, Robin A.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; [Kanser, Robert J.] James A Haley Vet Hosp, Tampa, FL 33612 USA		Rapport, LJ (corresponding author), Wayne State Univ, Dept Psychol, 71 W Warren Ave, Detroit, MI 48202 USA.	rapport@wayne.edu		Rapport, Lisa/0000-0001-8014-9523	National Institute on Disability, Independent Living and Rehabilitation ResearchUnited States Department of Health & Human Services [90IFOO92]; Wayne State University Graduate School; NIGMS/NIH grant [R25 GM 058905 - 21]; Blue Cross Blue Shield of Michigan Foundation [2365.SAP]	This research was supported by grants from the National Institute on Disability, Independent Living and Rehabilitation Research (90IFOO92, Rapport), Wayne State University Graduate School (Kanser), NIGMS/NIH grant R25 GM 058905 - 21 (Patrick), and Blue Cross Blue Shield of Michigan Foundation (Kanser, 2365.SAP).	Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bashem JR, 2014, CLIN NEUROPSYCHOL, V28, P851, DOI 10.1080/13854046.2014.927927; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; Bodner T, 2019, J CLIN EXP NEUROPSYC, V41, P476, DOI 10.1080/13803395.2019.1579783; Bolan B, 2002, J CLIN EXP NEUROPSYC, V24, P154, DOI 10.1076/jcen.24.2.154.1000; Boone K. B., 2002, DOT DOUNTING TEST MA; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Brennan A, 2009, CLIN NEUROPSYCHOL, V23, P314, DOI 10.1080/13854040802054151; Carone DA, 2015, NEUROREHABILITATION, V36, P387, DOI 10.3233/NRE-151228; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Coleman RD, 1998, J CLIN EXP NEUROPSYC, V20, P201, DOI 10.1076/jcen.20.2.201.1164; Constantinou M, 2005, ARCH CLIN NEUROPSYCH, V20, P191, DOI 10.1016/j.acn.2004.06.002; D W, 2009, WECHSLER MEMORY SCAL; Dandachi-FitzGerald B, 2017, J CLIN EXP NEUROPSYC, V39, P257, DOI 10.1080/13803395.2016.1223278; Davis JJ, 2018, J CLIN EXP NEUROPSYC, V40, P1013, DOI 10.1080/13803395.2018.1472221; Dijkers MP, 2018, J HEAD TRAUMA REHAB, V33, P363, DOI 10.1097/HTR.0000000000000454; Erdodi LA, 2018, ARCH CLIN NEUROPSYCH, V33, P845, DOI 10.1093/acn/acx110; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Franzen M.D., 1994, ASSESSMENT, V1, P323, DOI [DOI 10.1177/1073191, https://doi.org/10.1177/107319119400100401]; Goldberg H.E., 2007, ASSESSMENT FEIGNED C, P281; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Henry GK, 2013, CLIN NEUROPSYCHOL, V27, P864, DOI 10.1080/13854046.2013.786758; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; Hurley KE, 2006, MENT RETARD, V44, P112, DOI 10.1352/0047-6765(2006)44[112:AIMMUW]2.0.CO;2; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Jennett B, 1981, MANAGEMENT HEAD INJU; Kanser RJ, 2019, CLIN NEUROPSYCHOL, V33, P90, DOI 10.1080/13854046.2018.1440006; Kanser RJ, 2017, CLIN NEUROPSYCHOL, V31, P644, DOI 10.1080/13854046.2016.1278040; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kireev M, 2013, INT J PSYCHOPHYSIOL, V90, P291, DOI 10.1016/j.ijpsycho.2013.09.005; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P841, DOI 10.1080/13854040902796735; Lupu T, 2018, APPL NEUROPSYCH-ADUL, V25, P532, DOI 10.1080/23279095.2017.1341410; Maiman M, 2019, ARCH CLIN NEUROPSYCH, V34, P259, DOI 10.1093/arclin/acy027; McGuire C, 2019, ARCH CLIN NEUROPSYCH, V34, P114, DOI 10.1093/arclin/acy012; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; MILLIS SR, 1994, PERCEPT MOTOR SKILL, V79, P384, DOI 10.2466/pms.1994.79.1.384; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; Neudecker JJ, 2009, ARCH CLIN NEUROPSYCH, V24, P59, DOI 10.1093/arclin/acp008; Osimani A, 1997, J NEUROL NEUROSUR PS, V62, P617, DOI 10.1136/jnnp.62.6.617; Rapport LJ, 1998, J CLIN EXP NEUROPSYC, V20, P89, DOI 10.1076/jcen.20.1.89.1488; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Reicker LI, 2008, ARCH CLIN NEUROPSYCH, V23, P419, DOI 10.1016/j.acn.2008.02.003; ROSE FE, 1995, CLIN NEUROPSYCHOL, V9, P124, DOI 10.1080/13854049508401594; Ross SR, 2006, J CLIN EXP NEUROPSYC, V28, P111, DOI 10.1080/13803390590929270; Russeler J, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-37; Shelley-Tremblay JE, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9050109; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Soble JR, 2018, J CLIN EXP NEUROPSYC, V40, P317, DOI 10.1080/13803395.2017.1342773; Suchotzki K, 2017, PSYCHOL BULL, V143, P428, DOI 10.1037/bul0000087; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr J.A., 2007, ASSESSMENT MALINGERE, P287; Tabachnick B., 2018, USING MULTIVARIATE S, V7th; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tardif HP, 2000, INT J PSYCHOPHYSIOL, V36, P1, DOI 10.1016/S0167-8760(00)00083-0; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; van Hooff JC, 2009, INT J PSYCHOPHYSIOL, V73, P246, DOI 10.1016/j.ijpsycho.2009.04.002; Warrington E, 1984, RECOGNITION MEMORY T, V1; WechslerD, 2001, WECHSLER TEST ADULT; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00595; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	68	12	12	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL 9	2021	35	6					1154	1173		10.1080/13854046.2020.1716997		FEB 2020	20	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	TJ2MU	WOS:000514740100001	32068486				2022-02-06	
J	Xu, C; Diao, YF; Wang, J; Liang, J; Xu, HH; Zhao, ML; Zheng, B; Luan, Z; Wang, JJ; Yang, XP; Wei, MG; Duan, JH; Wang, KQ; Chen, C; Chen, F; Ming, D; Zhang, S; Sun, HT; Li, XH				Xu, Chao; Diao, Yun-Feng; Wang, Jing; Liang, Jun; Xu, Hai-Huan; Zhao, Ming-Liang; Zheng, Bin; Luan, Zuo; Wang, Jing-Jing; Yang, Xi-Ping; Wei, Meng-Guang; Duan, Jing-Hao; Wang, Ke-Qiang; Chen, Chong; Chen, Feng; Ming, Dong; Zhang, Sai; Sun, Hong-Tao; Li, Xiao-Hong			Intravenously Infusing the Secretome of Adipose-Derived Mesenchymal Stem Cells Ameliorates Neuroinflammation and Neurological Functioning After Traumatic Brain Injury	STEM CELLS AND DEVELOPMENT			English	Article						traumatic brain injury; secretome; neuroinflammation; the polarization of microglia; neurological function	MACROPHAGES; EDEMA; NEUROPROTECTION; INFLAMMATION; POLARIZATION; MICROGLIA; MODULATE; STROKE; RATS	The secretome of mesenchymal stem cell (MSC) offers a series of immunoregulatory properties and is regarded as an effective method of mitigating secondary neuroinflammation induced by traumatic brain injury (TBI). The secretome of adipose-derived MSCs (ASC-ST) was collected under hypoxia conditions. Proteomics data were analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS), and concentrations of major components were tested. After the TBI caused by an electric cortical contusion impactor, rats were injected ASC-ST through caudal veins for 7 days. The neurological functional prognosis of TBI rats was significantly improved, and the vasogenic edema of brain tissues that was measured 14 days after TBI was relieved by ASC-ST, corresponding to brain water content levels. ASC-ST ameliorated TBI-induced neuroinflammatory environments that caused the edema, the apoptosis of the neural cells, and the nerve fiber damage by increasing the number of M2 phenotypes present while reducing the number of M1 phenotype microglia present. Furthermore, interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) levels were reduced, whereas transforming growth factor-beta (TGF-beta) and tumor necrosis factor-stimulated gene 6 protein (TSG-6) levels were increased after secretome treatment. Altogether, ASC-ST is capable of improving neural functioning by modulating TBI-induced neuroinflammation and its related secondary insults. ASC-ST may be one of the most promising candidates for regulating the secondary inflammatory reactions of central nervous systems for clinical use.	[Xu, Chao; Liang, Jun; Xu, Hai-Huan; Zheng, Bin; Duan, Jing-Hao; Wang, Ke-Qiang; Chen, Chong; Ming, Dong; Li, Xiao-Hong] Tianjin Univ, Acad Med Engn & Translat Med, Tianjin 300072, Peoples R China; [Xu, Chao; Diao, Yun-Feng; Wang, Jing; Xu, Hai-Huan; Zhao, Ming-Liang; Wang, Jing-Jing; Yang, Xi-Ping; Wei, Meng-Guang; Chen, Chong; Chen, Feng; Zhang, Sai; Sun, Hong-Tao] Characterist Med Ctr PAPF, Inst Traumat Brain Injury & Neurol, 220 Chenglin Rd, Tianjin 300162, Peoples R China; [Wang, Jing] Shanxi Dayi Hosp, Dept Neurosurg, Taiyuan, Peoples R China; [Luan, Zuo] Navy Gen Hosp, Dept Pediat, Pediat Surg, Beijing, Peoples R China		Li, XH (corresponding author), Tianjin Univ, Acad Med Engn & Translat Med, Tianjin 300072, Peoples R China.; Sun, HT (corresponding author), Characterist Med Ctr PAPF, Inst Traumat Brain Injury & Neurol, 220 Chenglin Rd, Tianjin 300162, Peoples R China.	chenmo333@163.com; lixiaohong12@hotmail.com					Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Bartosh TJ, 2013, STEM CELLS, V31, P2443, DOI 10.1002/stem.1499; Bierbach B, 2008, STROKE, V39, P213, DOI 10.1161/STROKEAHA.107.496620; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Danielyan L, 2014, CELL TRANSPLANT, V23, pS123, DOI 10.3727/096368914X684970; Freytes DO, 2013, J CELL BIOCHEM, V114, P220, DOI 10.1002/jcb.24357; Ghosh M, 2012, GLIA, V60, P1839, DOI 10.1002/glia.22401; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Horn AP, 2011, STEM CELLS DEV, V20, P1171, DOI 10.1089/scd.2010.0157; Kalladka D, 2016, LANCET, V388, P787, DOI 10.1016/S0140-6736(16)30513-X; Ke CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069658; Kim JE, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-6; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Lan YW, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0081-6; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Mahmood A, 2008, J NEUROTRAUM, V25, P1441, DOI 10.1089/neu.2007.0495; Mattar P, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00560; Mazzeo AT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0624-5; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Noh MY, 2016, STEM CELL TRANSL MED, V5, P1538, DOI 10.5966/sctm.2015-0217; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Peng WJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0034-0; Piao CS, 2012, NEUROBIOL DIS, V46, P745, DOI 10.1016/j.nbd.2012.03.018; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Schafer S, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0157-8; Schober ME, 2016, J NEUROTRAUM, V33, P390, DOI 10.1089/neu.2015.3945; Shapey J, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00023; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Steinberg GK, 2016, STROKE, V47, P1817, DOI 10.1161/STROKEAHA.116.012995; Su P, 2016, NEUROSCIENCE, V319, P155, DOI 10.1016/j.neuroscience.2016.01.035; Sukho P, 2018, STEM CELLS DEV, V27, P922, DOI 10.1089/scd.2017.0275; Tan B, 2011, NEUROSCIENCE, V181, P40, DOI 10.1016/j.neuroscience.2011.02.038; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Walker PA, 2010, STEM CELLS DEV, V19, P867, DOI 10.1089/scd.2009.0188; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Wei X, 2009, STEM CELLS, V27, P478, DOI 10.1634/stemcells.2008-0333; Xu C, 2017, INT J NEUROSCI, V127, P1124, DOI 10.1080/00207454.2017.1325884; Yarborough Mark, 2012, AJOB Neurosci, V3, DOI 10.1080/21507740.2012.675010; Ylostalo JH, 2012, STEM CELLS, V30, P2283, DOI 10.1002/stem.1191; Zarovni N, 2015, METHODS, V87, P46, DOI 10.1016/j.ymeth.2015.05.028	44	12	12	3	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1547-3287	1557-8534		STEM CELLS DEV	Stem Cells Dev.	FEB 15	2020	29	4					222	234		10.1089/scd.2019.0173			13	Cell & Tissue Engineering; Hematology; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Hematology; Research & Experimental Medicine; Transplantation	KL0GC	WOS:000513110300006	31830866	Bronze			2022-02-06	
J	Krukowski, K; Nolan, A; Frias, ES; Grue, K; Becker, M; Ureta, G; Delgado, L; Bernales, S; Sohal, VS; Walter, P; Rosi, S				Krukowski, Karen; Nolan, Amber; Frias, Elma S.; Grue, Katherine; Becker, McKenna; Ureta, Gonzalo; Delgado, Luz; Bernales, Sebastian; Sohal, Vikaas S.; Walter, Peter; Rosi, Susanna			Integrated Stress Response Inhibitor Reverses Sex-Dependent Behavioral and Cell-Specific Deficits after Mild Repetitive Head Trauma	JOURNAL OF NEUROTRAUMA			English	Article						integrated stress response; prefrontal cortex; repetitive mild traumatic brain injury; risk-taking behavior; synaptic function	BRAIN-INJURY; SYNAPTIC PLASTICITY; TRANSLATION INITIATION; IMPACT MODEL; MOUSE MODEL; TERM; CONCUSSION; PHOSPHORYLATION; MEMORY; BACE1	Mild repetitive traumatic brain injury (rTBI) induces chronic behavioral and cognitive alterations and increases the risk for dementia. Currently, there are no therapeutic strategies to prevent or mitigate chronic deficits associated with rTBI. Previously we developed an animal model of rTBI that recapitulates the cognitive and behavioral deficits observed in humans. We now report that rTBI results in an increase in risk-taking behavior in male but not female mice. This behavioral phenotype is associated with chronic activation of the integrated stress response and cell-specific synaptic alterations in the type A subtype of layer V pyramidal neurons in the medial prefrontal cortex. Strikingly, by briefly treating animals weeks after injury with ISRIB, a selective inhibitor of the integrated stress response (ISR), we (1) relieve ISR activation, (2) reverse the increased risk-taking behavioral phenotype and maintain this reversal, and (3) restore cell-specific synaptic function in the affected mice. Our results indicate that targeting the ISR even at late time points after injury can permanently reverse behavioral changes. As such, pharmacological inhibition of the ISR emerges as a promising avenue to combat rTBI-induced behavioral dysfunction.	[Krukowski, Karen; Nolan, Amber; Frias, Elma S.; Grue, Katherine; Becker, McKenna; Rosi, Susanna] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA; [Krukowski, Karen; Nolan, Amber; Frias, Elma S.; Grue, Katherine; Becker, McKenna; Rosi, Susanna] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Nolan, Amber] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Frias, Elma S.] Univ Calif San Francisco, Dept Biomed Sci, San Francisco, CA 94143 USA; [Sohal, Vikaas S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Walter, Peter] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Walter, Peter] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Rosi, Susanna] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Rosi, Susanna] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Rosi, Susanna] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94143 USA; [Ureta, Gonzalo; Delgado, Luz; Bernales, Sebastian] Fdn Ciencia & Vida, Santiago, Chile		Rosi, S (corresponding author), San Francisco Gen Hosp, 1001 Potrero Ave,Bldg Room 101, San Francisco, CA 94110 USA.	susanna.rosi@ucsf.edu			National Institutes of Health NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG056770]; Roger's family; Weill Innovation Award; Calico Life Sciences; Programa de Apoyo a Centros con Financiamiento Basal at Fundacion Ciencia Vida [AFB 170004]; NRSAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIA F32AG054126]; National Institute for General Medicine (NIGMS) Initiative for Maximizing Student Development [R25GM056847]; National Science Foundation (NSF)National Science Foundation (NSF); National Center for Advanced Translational Sciences at NIH (UCSF-CTSI) [TL1 TR001871]; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS114170]	This work was supported by National Institutes of Health NIA grants R01AG056770 (SR), the generous support of the Roger's family to SR and PW, the Weill Innovation Award to SR and PW, Calico Life Sciences to PW, and "Programa de Apoyo a Centros con Financiamiento Basal AFB 170004" to SB at Fundacion Ciencia & Vida. PW is an Investigator of the Howard Hughes Medical Institute. KK was supported by an NRSA post-doctoral fellowship from the NIA F32AG054126. EF is supported by the National Institute for General Medicine (NIGMS) Initiative for Maximizing Student Development (R25GM056847) and the National Science Foundation (NSF) Graduate Fellowship Program. AN is supported by the National Center for Advanced Translational Sciences at NIH (UCSF-CTSI Grant Number TL1 TR001871) and the NIH/NINDS (K08NS114170).	Batista G, 2016, ELIFE, V5, DOI 10.7554/eLife.17197; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bogg T, 2012, DRUG ALCOHOL DEPEN, V122, P112, DOI 10.1016/j.drugalcdep.2011.09.018; Brumback A C, 2018, Mol Psychiatry, V23, P2078, DOI 10.1038/mp.2017.213; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4; Chou A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061616; Chou A, 2017, P NATL ACAD SCI USA, V114, pE6420, DOI 10.1073/pnas.1707661114; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Dash PK, 2015, J NEUROTRAUM, V32, P1608, DOI 10.1089/neu.2014.3772; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Di Prisco GV, 2014, NAT NEUROSCI, V17, P1073, DOI 10.1038/nn.3754; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; HATSKEVICH CW, 1992, INT J PSYCHOPHYSIOL, V12, P179, DOI 10.1016/0167-8760(92)90009-Z; Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868; Jiang Z, 2010, J NEUROSCI, V30, P2582, DOI 10.1523/JNEUROSCI.3971-09.2010; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Kim Y, 2017, CELL, V171, P456, DOI 10.1016/j.cell.2017.09.020; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753; Lammich S, 2004, EMBO REP, V5, P620, DOI 10.1038/sj.embor.7400166; Lasry O, 2017, NEUROLOGY, V89, P2198, DOI 10.1212/WNL.0000000000004671; Lee AT, 2014, NEURON, V81, P61, DOI 10.1016/j.neuron.2013.10.031; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mihailovich M, 2007, NUCLEIC ACIDS RES, V35, P2975, DOI 10.1093/nar/gkm191; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Mollayeva Tatyana, 2018, Concussion, V3, pCNC51, DOI 10.2217/cnc-2017-0015; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Nelson LD, 2020, J NEUROTRAUM, V37, P675, DOI 10.1089/neu.2019.6719; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Nolan A, 2018, J NEUROTRAUM, V35, P2425, DOI 10.1089/neu.2018.5731; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Pasini S, 2015, CELL REP, V11, P183, DOI 10.1016/j.celrep.2015.03.025; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Placzek A.N., 2016, ELIFE, V5; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Riga D, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00230; Ron D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013177; Rubovitch V, 2015, NEUROMOL MED, V17, P58, DOI 10.1007/s12017-015-8340-3; Ruigrok ANV, 2014, NEUROSCI BIOBEHAV R, V39, P34, DOI 10.1016/j.neubiorev.2013.12.004; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; St Onge JR, 2010, CEREB CORTEX, V20, P1816, DOI 10.1093/cercor/bhp250; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; SULLIVAN P, 1987, JAMA-J AM MED ASSOC, V257, P2289, DOI 10.1001/jama.1987.03390170045014; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Tonelli DD, 2004, NUCLEIC ACIDS RES, V32, P1808, DOI 10.1093/nar/gkh348; Tsai JC, 2018, SCIENCE, V359, P1483, DOI 10.1126/science.aaq0939; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Yamakawa GR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187218; Zyryanova AF, 2018, SCIENCE, V359, P1533, DOI 10.1126/science.aar5129	72	12	12	2	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2020	37	11					1370	1380		10.1089/neu.2019.6827		FEB 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LT0OT	WOS:000512704000001	31884883	Bronze, Green Published			2022-02-06	
J	Chan, TLH; Woldeamanuel, YW				Chan, T. L. H.; Woldeamanuel, Y. W.			Exploring naturally occurring clinical subgroups of post-traumatic headache	JOURNAL OF HEADACHE AND PAIN			English	Article						Post-traumatic headache; Post-traumatic headache disorder; Acute post-traumatic headache; Persistent post-traumatic headache; Headache attributable to traumatic injury to the head and; or neck	TRAUMATIC BRAIN-INJURY; PSYCHIATRIC COMORBIDITY; MILITARY PERSONNEL; PATHOPHYSIOLOGY; DISORDERS; MIGRAINE; RISK; PAIN	Objective To explore naturally occurring clinical subgroups of post-traumatic headache. Background Persistent post-traumatic headache (PTH) is defined as a headache developing within 7 days of an injury that lasts for greater than 3 months. However, there is no evidence available from the International Classification of Headache Disorders (ICHD) based classification between persistent and acute PTH based on clinical phenotypes. Methods We conducted a retrospective study using the Stanford Research Repository Cohort Discovery Tool. We reviewed 500 electronic patient charts between January 2015 to September 2019 using inclusion criteria of adults older than 18 years with a diagnosis of PTH. The following variables were extracted from each patient's chart: diagnosis of PTH as dependent variable, and predictor variables as age, sex, history of migraine, loss of consciousness during head injury, pre-existing psychological history, duration of PTH and new PTH-associated comorbidities (e.g. new onset vertigo, post-traumatic stress disorder). Logistic regression was employed to identify clinical phenotypes predicting persistent PTH. All predictor variables were tested in one block to determine their predictive capacity while controlling for other predictors in the model. Two-step cluster analysis was conducted to identify naturally occurring PTH subgroups. Results A total of 300 patients were included (150 acute, 150 persistent PTH) with a median age of 47 years (IQR 31, 59) and female: male ratio of 2.7:1. Two hundred patients were excluded due to misdiagnoses. Pre-existing psychological history (standardized beta 0.16), history of migraine (0.20), new PTH-associated comorbidities (0.23) and medication overuse (0.37) statistically significantly predicted the presence of persistent PTH (p < 0.0001). Clustering analysis revealed PTH subgrouping comparable to ICHD-based classification: 140 patients in Cluster 1 (76% persistent PTH) and 160 patients in Cluster 2 (83% acute PTH). Four distinct clusters were found within persistent PTH. Conclusion Pre-existing psychological history, history of migraine, new PTH-associated comorbidities and medication overuse predicted the occurrence of persistent PTH as well as two naturally occurring PTH clusters correlating to acute and persistent PTH. Management emphasis should focus on these phenotypes.	[Chan, T. L. H.; Woldeamanuel, Y. W.] Stanford Univ, Div Headache & Facial Pain, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA		Chan, TLH (corresponding author), Stanford Univ, Div Headache & Facial Pain, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA.	tlhchan@stanford.edu	Chan, Tommy Lik Hang/AAM-8280-2020; Woldeamanuel, Yohannes W./N-7642-2018	Chan, Tommy Lik Hang/0000-0003-0252-7757; Woldeamanuel, Yohannes W./0000-0003-4879-6098			Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Bartsch T, 2003, BRAIN, V126, P1801, DOI 10.1093/brain/awg190; Baskin SM, 2006, HEADACHE, V46, pS76, DOI 10.1111/j.1526-4610.2006.00559.x; BERNARD JF, 1990, J NEUROPHYSIOL, V63, P473, DOI 10.1152/jn.1990.63.3.473; Bienvenu OJ, 2013, PSYCHOL MED, V43, P2657, DOI 10.1017/S0033291713000214; Chowdhury D, 2012, ANN INDIAN ACAD NEUR, V15, P83, DOI 10.4103/0972-2327.100023; Defrin R, 2011, EUR J PAIN S, V5, P138, DOI DOI 10.1016/S1754-3207(11)70471-0; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Garcia-Larrea L, 2018, PROG NEURO-PSYCHOPH, V87, P193, DOI 10.1016/j.pnpbp.2017.10.007; Goadsby PJ, 2017, PHYSIOL REV, V97, P553, DOI 10.1152/physrev.00034.2015; Goadsby PJ, 2012, ANN INDIAN ACAD NEUR, V15, P15, DOI 10.4103/0972-2327.99993; Headache Classification Committee of the International Headache Society (IHS), 2018, CEPHALALGIA, V38, P1, DOI [10.1177/0333102417738202., DOI 10.1177/0333102413485658]; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hooten WM, 2016, MAYO CLIN PROC, V91, P955, DOI 10.1016/j.mayocp.2016.04.029; IBM Corp. Released, 2012, IBM SPSS STAT WIND V; Jouzdani SR, 2014, ENVIRON HEALTH PREV, V19, P422, DOI 10.1007/s12199-014-0409-3; Lane Judy C., 2002, Curr Treat Options Neurol, V4, P89, DOI 10.1007/s11940-002-0007-3; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Lucas S., 2015, BRAIN NEUROTRAUMA; Lukaszewicz AC, 2015, ANESTH ANALG, V120, P1297, DOI 10.1213/ANE.0000000000000609; Mares C, 2019, CAN J NEUROL SCI, V46, P14, DOI 10.1017/cjn.2018.361; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Mustafa G, 2016, NEUROPHARMACOLOGY, V107, P27, DOI 10.1016/j.neuropharm.2016.03.016; Navratilova E, 2019, CEPHALALGIA, V39, P1762, DOI 10.1177/0333102419877662; Nordhaug LH, 2019, J NEUROTRAUM, V36, P3244, DOI 10.1089/neu.2018.6328; Nordhaug LH, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0838-2; Paemeleire K, 2006, NEUROLOGY, V67, P109, DOI 10.1212/01.wnl.0000223332.35936.6e; Pompili M, 2010, NEUROPSYCH DIS TREAT, V6, P81; Serafini G, 2012, EUR REV MED PHARMACO, V16, P1389; Smitherman TA, 2008, HEADACHE, V48, P45, DOI 10.1111/j.1526-4610.2007.00974.x; Stilling J, 2020, J NEUROTRAUM, V37, P312, DOI 10.1089/neu.2019.6692; Stovner LJ, 2018, LANCET NEUROL, V17, P954, DOI 10.1016/S1474-4422(18)30322-3; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Torelli P, 2006, NEUROL SCI, V27, pS73, DOI 10.1007/s10072-006-0574-2	38	12	12	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	FEB 7	2020	21	1							12	10.1186/s10194-020-1080-2			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KL2NC	WOS:000513264700002	32033526	Green Published, gold			2022-02-06	
J	Boneau, RD; Richardson, BK; McGlynn, J				Boneau, Rebecca D.; Richardson, Brian K.; McGlynn, Joseph			"We Are a Football Family": Making Sense of Parents' Decisions to Allow Their Children to Play Tackle Football	COMMUNICATION & SPORT			English	Article						tackle football; parental decision-making; sensemaking theory; risk assessment; family identity	CONCUSSION; COMMUNICATION; SENSEMAKING; IDENTITIES; KNOWLEDGE; GENDER; FIELD	Parents of middle school-aged children face a true dilemma as they consider whether to allow their children to play tackle football. The sport is cited as one that fosters a number of intangible benefits but is increasingly mentioned as dangerous for youth participants. This study employed a sensemaking theory framework to explore the family, community, and media dynamics that influence how parents made sense of their football decisions. We interviewed 12 married couples about their decisions allowing their child to play middle school football. Results indicate parents were affected by family identities, community and social influences, and information sources in their football decisions. We developed a typology describing three parental approaches to the football decision: the football-first family, the safety-first family, and the laissez-faire family. We drew connections between family type, decision agency, and risk assessment for the pro-football decision. To conclude, we offer theoretical and practical implications related to this key parental decision.	[Boneau, Rebecca D.; Richardson, Brian K.; McGlynn, Joseph] Univ North Texas, 1155 Union Circle,305268, Denton, TX 76203 USA		Boneau, RD (corresponding author), Univ North Texas, 1155 Union Circle,305268, Denton, TX 76203 USA.	rebeccaboneau@gmail.com					Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Armstrong K., 2017, NEW YORK DAILY NEWS; Auerbach P. S., 2018, WALL STREET J, pA11; Banks SP, 2000, J SOC PERS RELAT, V17, P299, DOI 10.1177/0265407500173001; Billings AC, 2003, J COMMUN, V53, P569, DOI 10.1093/joc/53.4.569; Cassilo D, 2018, COMMUN SPORT, V6, P86, DOI 10.1177/2167479516654513; Charmaz K., 2014, BROKERAGE CLOSURE IN; Cho HC, 2011, J COMMUN, V61, DOI 10.1111/j.1460-2466.2010.01532.x; Clark E., 2017, BANGOR DAILY NE 0902; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Craig-Lees M, 2001, PSYCHOL MARKET, V18, P513, DOI 10.1002/mar.1019; Cranmer GA, 2018, WESTERN J COMM, V82, P631, DOI 10.1080/10570314.2018.1441431; Cranmer GA, 2018, COMMUN SPORT, V6, P349, DOI 10.1177/2167479517714458; Creswell J., 2009, RES DESIGN, V3rd; Dixon MA, 2008, SOCIOL SPORT J, V25, P538, DOI 10.1123/ssj.25.4.538; Dougherty DS, 2006, COMMUN STUD, V57, P215, DOI 10.1080/10510970600667030; Dougherty DS, 2004, J APPL COMMUN RES, V32, P293, DOI 10.1080/0090988042000275998; Dunham G., 2018, FOOTBALL HAS PROBLEM; Dunn JS, 2003, AM BEHAV SCI, V46, P1359, DOI 10.1177/0002764203046010006; ENTMAN RM, 1993, J COMMUN, V43, P51, DOI 10.1111/j.1460-2466.1993.tb01304.x; Findler P, 2015, J PHILOS SPORT, V42, P443, DOI 10.1080/00948705.2015.1079132; Frank E, 2011, GLOBAL ENVIRON CHANG, V21, P66, DOI 10.1016/j.gloenvcha.2010.11.001; Fredricks JA, 2005, J SPORT EXERCISE PSY, V27, P3, DOI 10.1123/jsep.27.1.3; Giannini GA, 2011, WESTERN J COMM, V75, P541, DOI 10.1080/10570314.2011.608406; Gilbert F., 2011, AJOB NEUROSCIENCE, V2, P48, DOI [DOI 10.1080/21507740.2011.611125, https://doi.org/10.1080/21507740.2011.611125]; Giuffre L, 2015, METRO, P52; Glaser B., 1967, DISCOVERY GROUNDED T; Hamel S.A., 2009, J BUS COMMUN, V46, P234, DOI DOI 10.1177/0021943608328079; Holt NL, 2009, J SPORT EXERCISE PSY, V31, P37, DOI 10.1123/jsep.31.1.37; Hunt John L., 2004, Mammalian Species, P1; KASSING JW, 2004, ANN INT COMMUNICATIO, V28, P373, DOI DOI 10.1080/23808985.2004.11679040; Kroshus E, 2017, J LAW MED ETHICS, V45, P421, DOI 10.1177/1073110517737542; Lindlof T. R., 2002, QUALITATIVE RES METH; Manasse-Cohick NJ, 2014, COMMUN DISORD Q, V35, P182, DOI 10.1177/1525740113506605; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McGlynn Joseph, 2019, Health Commun, V34, P689, DOI 10.1080/10410236.2018.1431025; Miller-Day M, 2010, HEALTH COMMUN, V25, P293, DOI 10.1080/10410231003698952; Morgan LJ, 2015, SOUTHEAST GEOGR, V55, P214, DOI 10.1353/sgo.2015.0008; Moser RS, 2007, PROF PSYCHOL-RES PR, V38, P699, DOI 10.1037/0735-7028.38.6.699; Mueller FO, 2012, ANN SURVEY FOOTBALL; Omalu B., 2017, TRUTH DOESNT HAVE SI; Peter J., 2017, US TODAY SPORTS 0129; Pilon M., 2013, NY TIMES, pB13; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Richardson BK, 2011, MANAGE COMMUN Q, V25, P121, DOI 10.1177/0893318910380344; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Sanderson J, 2016, COMMUN SPORT, V4, P3, DOI 10.1177/2167479514536982; Schweizer M., 2018, DAILY J         0210; Seltzer T., 2009, Journal of Sports Media, V4, P1, DOI 10.1353/jsm.0.0040; Starbuck W. H., 1988, EXECUTIVE EFFECT CON, P35; Stefanik-Sidener K, 2013, HEALTH COMMUN, V28, P351, DOI 10.1080/10410236.2012.688187; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Tamminen KA, 2017, SPORT EXERC PERFORM, V6, P325, DOI 10.1037/spy0000093; Tracy S.J., 2013, QUALITATIVE RES METH; Ulmer R.R., 1997, COMMUN STUD, V48, P215, DOI [https://doi.org/10.1080/10510979709368502, DOI 10.1080/10510979709368502]; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Vigso O, 2016, NORD REV, V37, P71, DOI 10.1515/nor-2016-0003; Wagner PE, 2016, COMMUN Q, V64, P251, DOI 10.1080/01463373.2015.1103286; Waterman RH., 1990, ADHOCRACY POWER CHAN; Weick K.E., 1995, SENSEMAKING ORG; Weick KE, 2005, ORGAN SCI, V16, P409, DOI 10.1287/orsc.1050.0133; Weiner N., 2017, BLEACHER REPORT 0825	63	12	12	2	20	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2167-4795	2167-4809		COMMUN SPORT	Commun. Sport	FEB	2020	8	1					26	49		10.1177/2167479518816104			24	Communication; Hospitality, Leisure, Sport & Tourism	Social Science Citation Index (SSCI)	Communication; Social Sciences - Other Topics	KB5LH	WOS:000506536200002					2022-02-06	
J	Urban, RJ; Pyles, RB; Stewart, CJ; Ajami, N; Randolph, KM; Durham, WJ; Danesi, CP; Dillon, EL; Summons, JR; Singh, CK; Morrison, M; Kreber, LA; Masel, B; Miller, AL; Wright, TJ; Sheffield-Moore, M				Urban, Randall J.; Pyles, Richard B.; Stewart, Christopher J.; Ajami, Nadim; Randolph, Kathleen M.; Durham, William J.; Danesi, Christopher P.; Dillon, E. Lichar; Summons, Jennifer R.; Singh, Charan K.; Morrison, Melissa; Kreber, Lisa A.; Masel, Brent; Miller, Aaron L.; Wright, Traver J.; Sheffield-Moore, Melinda			Altered Fecal Microbiome Years after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						long-term care; microbiome; moderate-to-severe TBI	CENTRAL-NERVOUS-SYSTEM; GUT MICROBIOTA; AXIS; DYSBIOSIS; SILVA	Patients with chronic traumatic brain injury (TBI) requiring long-term, permanent care suffer a myriad of clinical symptoms (i.e., impaired cognition, fatigue, and other conditions) that persist for years beyond the acute brain injury. In addition to these comorbid clinical symptoms, chronic TBI patients exhibit altered amino acid and hormonal profiles with distinct cytokine patterns suggesting chronic inflammation. This metabolic link suggests a role of the gut-brain axis in chronic TBI. Thus, we utilized a two-site trial to investigate the role of the gut-brain axis in comorbidities of chronic TBI. The fecal microbiome profile of 22 moderate/severe TBI patients residing in permanent care facilities in Texas and California was compared to 18 healthy age-matched control subjects working within the participating facilities. Each fecal microbiome was characterized by 16S(V4) ribosomal RNA (rRNA) gene sequencing and metagenomic genome sequencing approaches followed by confirmatory full 16S rRNA gene sequencing or focused tuf gene speciation and specific quantitative polymerase chain reaction evaluation of selected genera or species. The average chronic TBI patient fecal microbiome structure was significantly different compared to the control cohort, and these differences persisted after group stratification analysis to identify any unexpected confounders. Notably, the fecal microbiome of the chronic TBI cohort had absent or reduced Prevotella spp. and Bacteroidies spp. Conversely, bacteria in the Ruminococcaceae family were higher in abundance in TBI compared to control profiles. Previously reported hypoaminoacidemia, including significantly reduced levels of l-tryptophan, l-sarcosine, ss-alanine, and alanine, positively correlated with the reduced levels of Prevotella spp. in the TBI cohort samples compared to controls. Although the sequelae of gut-brain axis disruption after TBI is not fully understood, characterizing TBI-related alterations in the fecal microbiome may provide biomarkers and therapeutic targets to address patient morbidity.	[Urban, Randall J.; Randolph, Kathleen M.; Durham, William J.; Danesi, Christopher P.; Dillon, E. Lichar; Wright, Traver J.; Sheffield-Moore, Melinda] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Pyles, Richard B.; Miller, Aaron L.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Stewart, Christopher J.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Stewart, Christopher J.; Ajami, Nadim] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA; [Randolph, Kathleen M.; Wright, Traver J.; Sheffield-Moore, Melinda] Texas A&M Univ, Dept Hlth & Kinesiol, 155 Ireland St, College Stn, TX 77845 USA; [Summons, Jennifer R.; Singh, Charan K.; Morrison, Melissa; Kreber, Lisa A.; Masel, Brent] Ctr Neuroskills, Bakersfield, CA USA; [Masel, Brent] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA; [Masel, Brent] Brain Injury Assoc Amer, Vienna, VA USA		Sheffield-Moore, M (corresponding author), Texas A&M Univ, Dept Hlth & Kinesiol, 155 Ireland St, College Stn, TX 77845 USA.	msheffield-moore@tamu.edu	Stewart, Christopher/M-4615-2017	Stewart, Christopher/0000-0002-6033-338X; Wright, Traver/0000-0001-7020-930X	Moody Endowment; Centre for Neuroskills (Bakersfield, CA); TideWay, Transitional Learning Center (Galveston, TX)	This study was funded by the Moody Endowment (funding M.S.M.) and conducted with the support of TideWay, part of the Transitional Learning Center (Galveston, TX) and the Centre for Neuroskills (Bakersfield, CA).	Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berer K, 2017, P NATL ACAD SCI USA, V114, P10719, DOI 10.1073/pnas.1711233114; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Durham WJ, 2017, J NEUROTRAUM, V34, P385, DOI 10.1089/neu.2015.4350; Duvallet C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01973-8; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grimes L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166770; HERBECK JL, 1974, APPL MICROBIOL, V28, P1018, DOI 10.1128/AEM.28.6.1018-1022.1974; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Javurek AB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02880-0; Jiang WW, 2015, SCI REP-UK, V5, DOI 10.1038/srep08096; Katzenberger RJ, 2015, FLY, V9, P68, DOI 10.1080/19336934.2015.1085623; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larsen JM, 2017, IMMUNOLOGY, V151, P363, DOI 10.1111/imm.12760; Le Cao KA, 2009, BIOINFORMATICS, V25, P2855, DOI 10.1093/bioinformatics/btp515; Le Cao KA, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1390; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Martin CR, 2017, NESTLE NUTR WORKS SE, V88, P45, DOI 10.1159/000461732; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mayer EA, 2015, J CLIN INVEST, V125, P926, DOI 10.1172/JCI76304; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Miller PG, 2015, J IMMUNOL, V195, P4668, DOI 10.4049/jimmunol.1501664; Morgan BP, 2015, NAT REV DRUG DISCOV, V14, P857, DOI 10.1038/nrd4657; Nagy-Szakal D, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0261-y; Olsen AB, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12121; Paramsothy S, 2019, GASTROENTEROLOGY, V156, P1440, DOI 10.1053/j.gastro.2018.12.001; Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646; Pianta A, 2017, ARTHRITIS RHEUMATOL, V69, P964, DOI 10.1002/art.40003; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2014, R LANG ENV STAT COMP; Rogers GB, 2016, MOL PSYCHIATR, V21, P738, DOI 10.1038/mp.2016.50; Roland BC, 2015, J CLIN GASTROENTEROL, V49, P571, DOI 10.1097/MCG.0000000000000257; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Smeets ETHC, 2017, PHYSIOL REP, V5; Smith Katherine, 2013, Nat Rev Gastroenterol Hepatol, V10, P260, DOI 10.1038/nrgastro.2013.68; Sun MF, 2018, AGEING RES REV, V45, P53, DOI 10.1016/j.arr.2018.04.004; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Urban RJ, 2020, J NEUROTRAUM, V37, P1124, DOI 10.1089/neu.2019.6689; Winter G, 2018, REV NEUROSCIENCE, V29, P629, DOI 10.1515/revneuro-2017-0072; Wright T, 2020, J NEUROTRAUM, V37, P1052, DOI 10.1089/neu.2019.6690; Yamamoto S, 2018, MOLECULES, V23, DOI 10.3390/molecules23020245; Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Zhu CS, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060113	52	12	12	2	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2020	37	8					1037	1051		10.1089/neu.2019.6688		JAN 2020	15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LC5EK	WOS:000508672300001	31868094				2022-02-06	
J	Snider, SB; Hsu, J; Darby, RR; Cooke, D; Fischer, D; Cohen, AL; Grafman, JH; Fox, MD				Snider, Samuel B.; Hsu, Joey; Darby, R. Ryan; Cooke, Danielle; Fischer, David; Cohen, Alexander L.; Grafman, Jordan H.; Fox, Michael D.			Cortical lesions causing loss of consciousness are anticorrelated with the dorsal brainstem	HUMAN BRAIN MAPPING			English	Article						brainstem; coma; functional connectivity; reticular activating system; traumatic brain injury	FUNCTIONAL CONNECTIVITY; NETWORK LOCALIZATION; SEROTONERGIC NEURONS; PREFRONTAL CORTEX; GLOBAL SIGNAL; RECOVERY; STATE; HEAD; PREDICTORS; SYMPTOMS	Brain lesions can provide unique insight into the neuroanatomical substrate of human consciousness. For example, brainstem lesions causing coma map to a specific region of the tegmentum. Whether specific lesion locations outside the brainstem are associated with loss of consciousness (LOC) remains unclear. Here, we investigate the topography of cortical lesions causing prolonged LOC (N = 16), transient LOC (N = 91), or no LOC (N = 64). Using standard voxel lesion symptom mapping, no focus of brain damage was associated with LOC. Next, we computed the network of brain regions functionally connected to each lesion location using a large normative connectome dataset (N = 1,000). This technique, termed lesion network mapping, can test whether lesions causing LOC map to a connected brain circuit rather than one brain region. Connectivity between cortical lesion locations and an a priori coma-specific region of brainstem tegmentum was an independent predictor of LOC (B = 1.2, p = .004). Connectivity to the dorsal brainstem was the only predictor of LOC in a whole-brain voxel-wise analysis. This relationship was driven by anticorrelation (negative correlation) between lesion locations and the dorsal brainstem. The map of regions anticorrelated to the dorsal brainstem thus defines a distributed brain circuit that, when damaged, is most likely to cause LOC. This circuit showed a slight posterior predominance and had peaks in the bilateral claustrum. Our results suggest that cortical lesions causing LOC map to a connected brain circuit, linking cortical lesions that disrupt consciousness to brainstem sites that maintain arousal.	[Snider, Samuel B.; Fischer, David] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Snider, Samuel B.; Fischer, David] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; [Hsu, Joey; Cooke, Danielle; Cohen, Alexander L.; Fox, Michael D.] Beth Israel Deaconess Med Ctr, Berenson Allen Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA; [Hsu, Joey; Cooke, Danielle; Cohen, Alexander L.; Fox, Michael D.] Beth Israel Deaconess Med Ctr, Dept Neurol, Div Cognit Neurol, Boston, MA 02215 USA; [Darby, R. Ryan] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN USA; [Cohen, Alexander L.] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Grafman, Jordan H.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Grafman, Jordan H.] Northwestern Univ, Weinberg Coll Arts & Sci, Neurol Cognit Neurol & Alzheimers Ctr,Dept Phys M, Feinberg Sch Med,Dept Psychiat, Chicago, IL 60611 USA; [Grafman, Jordan H.] Northwestern Univ, Weinberg Coll Arts & Sci, Dept Psychol, Chicago, IL 60611 USA; [Fox, Michael D.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Fox, Michael D.] Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA		Snider, SB (corresponding author), Massachusetts Gen Hosp, Dept Neurol, 8th Floor,Suite 835,15 Parkman St, Boston, MA 02114 USA.	ssnider@partners.org	Cohen, Alexander Li/H-6594-2019; Fox, Michael D./AAZ-3928-2020	Cohen, Alexander Li/0000-0001-6557-5866; Fox, Michael D./0000-0001-8848-6399; Hsu, Joey/0000-0003-4756-958X	G. Harold and Leila Y. Mathers Charitable Foundation; Julius N. Frankel Foundation; Nancy Lurie Marks Family Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23 NS083741, R01 MH113929]; Smart Family Foundation; Therapeutic Cognitive Neuroscience Fund	G. Harold and Leila Y. Mathers Charitable Foundation; Julius N. Frankel Foundation; Nancy Lurie Marks Family Foundation; National Institutes of Health, Grant/Award Numbers: K23 NS083741, R01 MH113929; Smart Family Foundation; Therapeutic Cognitive Neuroscience Fund	Adolphs R, 2016, NEURON, V90, P1151, DOI 10.1016/j.neuron.2016.05.014; Assenza G, 2015, CLIN NEUROPHYSIOL, V126, P1221, DOI 10.1016/j.clinph.2014.09.029; Beliveau V, 2015, NEUROIMAGE, V116, P187, DOI 10.1016/j.neuroimage.2015.04.065; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianchi Matt T, 2008, Open Neuroimag J, V2, P1, DOI 10.2174/1874440000802010001; Blumenfeld H, 2009, BRAIN, V132, P999, DOI 10.1093/brain/awp028; Blumenfeld H, 2012, LANCET NEUROL, V11, P814, DOI 10.1016/S1474-4422(12)70188-6; Boes AD, 2015, BRAIN, V138, P3061, DOI 10.1093/brain/awv228; Boly M, 2017, J NEUROSCI, V37, P9603, DOI 10.1523/JNEUROSCI.3218-16.2017; Bonhomme V, 2016, ANESTHESIOLOGY, V125, P873, DOI 10.1097/ALN.0000000000001275; Busto R, 1997, J NEUROTRAUM, V14, P35, DOI 10.1089/neu.1997.14.35; Celada P, 2001, J NEUROSCI, V21, P9917, DOI 10.1523/JNEUROSCI.21-24-09917.2001; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chau A, 2015, CONSCIOUS COGN, V36, P256, DOI 10.1016/j.concog.2015.06.017; Cho JR, 2017, NEURON, V94, P1205, DOI 10.1016/j.neuron.2017.05.020; Crick FC, 2005, PHILOS T R SOC B, V360, P1271, DOI 10.1098/rstb.2005.1661; Darby RR, 2018, P NATL ACAD SCI USA, V115, P601, DOI 10.1073/pnas.1706587115; Darby RR, 2017, BRAIN, V140, P497, DOI 10.1093/brain/aww288; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; DENOYER M, 1989, NEUROSCIENCE, V28, P83, DOI 10.1016/0306-4522(89)90234-0; Dorocic IP, 2014, NEURON, V83, P663, DOI 10.1016/j.neuron.2014.07.002; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Fasano A, 2017, ANN NEUROL, V81, P129, DOI 10.1002/ana.24845; Ferguson MA., 2019, NAT COMMUN, V10, P1, DOI 10.1038/s41467-018-07882-8; Fischer DB, 2016, NEUROLOGY, V87, P2427, DOI 10.1212/WNL.0000000000003404; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2018, NEW ENGL J MED, V379, P2237, DOI 10.1056/NEJMra1706158; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fuller P, 2011, J COMP NEUROL, V519, P933, DOI 10.1002/cne.22559; Grandjean J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08256-w; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; Guldenmund P, 2013, BRAIN CONNECT, V3, P273, DOI 10.1089/brain.2012.0117; Hindman J, 2018, ANN NEUROL, V84, P926, DOI 10.1002/ana.25377; Holmes AJ, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.31; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Keller CJ, 2013, J NEUROSCI, V33, P6333, DOI 10.1523/JNEUROSCI.4837-12.2013; Koch C, 2016, NAT REV NEUROSCI, V17, P307, DOI 10.1038/nrn.2016.22; Koubeissi MZ, 2014, EPILEPSY BEHAV, V37, P32, DOI 10.1016/j.yebeh.2014.05.027; Laganiere S, 2016, NEUROLOGY, V86, P2187, DOI 10.1212/WNL.0000000000002741; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; MAGOUN HW, 1952, AMA ARCH NEUROL PSY, V67, P145, DOI 10.1001/archneurpsyc.1952.02320140013002; Mensen A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00420; Muehlschlegel S, 2016, NEUROLOGY, V87, P2244, DOI 10.1212/WNL.0000000000003355; Murphy K, 2017, NEUROIMAGE, V154, P169, DOI 10.1016/j.neuroimage.2016.11.052; Odegaard B, 2017, J NEUROSCI, V37, P9593, DOI 10.1523/JNEUROSCI.3217-16.2017; Padmanabhan JL, 2019, BIOL PSYCHIAT, V86, P749, DOI 10.1016/j.biopsych.2019.07.023; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Qiu ML, 2017, NEUROIMAGE, V148, P130, DOI 10.1016/j.neuroimage.2016.12.080; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Rorden C, 2004, NAT REV NEUROSCI, V5, P813, DOI 10.1038/nrn1521; Sakai K, 2011, NEUROSCIENCE, V197, P200, DOI 10.1016/j.neuroscience.2011.09.024; SALAZAR AM, 1986, NEUROLOGY, V36, P178, DOI 10.1212/WNL.36.2.178; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Siclari F, 2017, NAT NEUROSCI, V20, P872, DOI 10.1038/nn.4545; Silva S, 2010, NEUROLOGY, V74, P313, DOI 10.1212/WNL.0b013e3181cbcd96; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Threlkeld ZD, 2018, CORTEX, V106, P299, DOI 10.1016/j.cortex.2018.05.004; TIGGES J, 1983, J COMP NEUROL, V220, P106, DOI 10.1002/cne.902200110; TSUIKI K, 1995, J NEUROCHEM, V64, P1319; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Verstegen AMJ, 2017, J COMP NEUROL, V525, P2287, DOI 10.1002/cne.24215; Wang HL, 2009, EUR J NEUROSCI, V29, P340, DOI 10.1111/j.1460-9568.2008.06576.x; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Weissbourd B, 2014, NEURON, V83, P645, DOI 10.1016/j.neuron.2014.06.024; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wu XH, 2015, J NEUROSCI, V35, P12932, DOI 10.1523/JNEUROSCI.0415-15.2015; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	71	12	12	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	APR 15	2020	41	6					1520	1531		10.1002/hbm.24892		JAN 2020	12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	KV3NW	WOS:000505639200001	31904898	gold, Green Published			2022-02-06	
J	Wu, Q; Huang, ZH; Wang, Y; Zhang, ZM; Lu, HM				Wu, Qian; Huang, Zehui; Wang, Yang; Zhang, Zhimin; Lu, Hongmei			Absolute quantitative imaging of sphingolipids in brain tissue by exhaustive liquid microjunction surface sampling-liquid chromatography-mass spectrometry	JOURNAL OF CHROMATOGRAPHY A			English	Article						Quantitative mass spectrometry imaging; Liquid microjunction surface sampling; Liquid chromatography-mass spectrometry; Sphingolipids; Brain imaging	EXTRACTION EFFICIENCY; MOUSE-BRAIN; IONIZATION; METABOLITES; LIPIDOMICS; LIPIDS; GLUCOSYLCERAMIDE; LOCALIZATION; RESOLUTION; LIVER	It is challenging to achieve absolute quantitation and accurate identification with mass spectrometry imaging (MSI) techniques. The issues facing these techniques include the uncertainty of sampling and ionization efficiencies in a localized environment, the difficulty in defining the concentration of spiked standard on tissue, and the low identification capability of MS in distinguishing isobaric compounds. In this study, we coupled continuous flow liquid microjunction surface sampling (LMJSS) with ultrahigh-performance liquid chromatography (UPLC)-MS for quantitative MSI of brain tissue. LC separation could increase the dimensions of identification and reduce the matrix effects in the tissue. A new LMJSS extraction solvent was developed to achieve exhaustive surface sampling; therefore, direct internal standard addition in the extraction solvent could be used for spot-to-spot absolute quantitation. The results showed that sphingolipids were successfully separated from their isobaric counterparts with LC-MS, and 10 sphingolipids were identified and imaged in brain tissue. The matrix effects in different locations of brain tissue with the new solvent were all in the range of 80%-150%. Compared with the traditional LMJSS solvent (90% methanol-water), the new solvent (10% 1,1,1,3,3,3-Hexafluoro-2-propanol-10% isopropanol-80% methanol) led to higher detection coverage (more lipid features) and 6-10-fold higher sensitivity for 6 identified metabolites in brain tissue. Moreover, extraction efficiencies of 80-98% for targeted sphingolipids in brain tissue were obtained with the new solvent, which allowed direct standard addition in extracts for absolute quantitation. Finally, the absolute quantitation results with LMJSS-LC-MSI were compared with those using traditional bulk tissue extraction-LC-MS, and similar quantitation results with these two methods (relative recoveries=64-119%) were obtained for sphingolipids. The absolute quantitative spatial distributions of targeted metabolites largely matched previously reported results. The method was applied to a study on the quantitative spatial changes of sphingolipids and creatine in brain after traumatic brain injury (TBI). The biological replicate results showed that 2 metabolites had significant changes after TBI in several specific regions of brain tissue. (C) 2019 Elsevier B.V. All rights reserved.	[Wu, Qian; Huang, Zehui; Zhang, Zhimin; Lu, Hongmei] Cent S Univ, Coll Chem & Chem Engn, Changsha 410083, Peoples R China; [Wang, Yang] Cent S Univ, Xiangya Hosp, Inst Integrated Tradit Chinese & Western Med, Lab Ethnopharmacol, Changsha 410008, Peoples R China		Wu, Q; Lu, HM (corresponding author), Cent S Univ, Coll Chem & Chem Engn, Changsha 410083, Peoples R China.	qianwu@csu.edu.cn; hongmeilu@csu.edu.cn		Wu, Qian/0000-0001-7522-1391	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [21804142, 21873116, 21675174, 81874409]	The study was supported by the National Natural Science Foundation of China (Nos. 21804142, 21873116, 21675174 and 81874409). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Abe T, 2018, NEUROL MED-CHIR, V58, P384, DOI 10.2176/nmc.oa.2018-0054; Azzam DJ, 2007, J CHROMATOGR B, V859, P131, DOI 10.1016/j.jchromb.2007.09.005; Barbacci DC, 2017, ACS CHEM NEUROSCI, V8, P2266, DOI 10.1021/acschemneuro.7b00189; Bidmon H.-J., 2018, BRAIN STRUCT FUNCT, V223, P2767; Boutin M, 2016, ANAL CHEM, V88, P1856, DOI 10.1021/acs.analchem.5b04227; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; CHAVKO M, 1992, STROKE, V23, P1000, DOI 10.1161/01.STR.23.7.1000; Chen WQ, 2016, J CHROMATOGR A, V1439, P137, DOI 10.1016/j.chroma.2015.10.093; Chumbley CW, 2016, ANAL CHEM, V88, P2392, DOI 10.1021/acs.analchem.5b04409; Comi TJ, 2017, ANAL CHEM, V89, P7765, DOI 10.1021/acs.analchem.7b01782; de la Monte SM, 2018, ALCOHOL, V67, P51, DOI 10.1016/j.alcohol.2017.08.004; de Oliveira EC, 2010, QUIM NOVA, V33, P984, DOI 10.1590/S0100-40422010000400041; Dolan E, 2019, EUR J SPORT SCI, V19, P1, DOI 10.1080/17461391.2018.1500644; Duncan KD, 2018, ANAL CHEM, V90, P7246, DOI 10.1021/acs.analchem.8b00350; Ellis SR, 2014, ANAL BIOANAL CHEM, V406, P1275, DOI 10.1007/s00216-013-7478-9; ElNaggar MS, 2011, J AM SOC MASS SPECTR, V22, P1157, DOI 10.1007/s13361-011-0145-5; Feider CL, 2016, ANAL CHEM, V88, P11533, DOI 10.1021/acs.analchem.6b02798; Gaissmaier T, 2016, ANALYST, V141, P892, DOI 10.1039/c5an02302e; Gill EL, 2017, ANAL CHEM, V89, P13658, DOI 10.1021/acs.analchem.7b04463; Goodwin RJA, 2011, ANAL CHEM, V83, P9694, DOI 10.1021/ac202630t; Goto-Inoue N, 2011, BBA-MOL CELL BIOL L, V1811, P961, DOI 10.1016/j.bbalip.2011.03.004; Gregory KE, 2013, ANAL CHEM, V85, P1114, DOI 10.1021/ac303011k; Griffiths RL, 2017, ANAL CHEM, V89, P5684, DOI 10.1021/acs.analchem.7b00977; Groseclose MR, 2013, ANAL CHEM, V85, P10099, DOI 10.1021/ac400892z; Hamler R, 2017, ANAL CHEM, V89, P8288, DOI 10.1021/acs.analchem.7b01442; Hankin JA, 2011, J AM SOC MASS SPECTR, V22, P1014, DOI 10.1007/s13361-011-0122-z; Kertesz V., 2015, ANAL BIOANAL CHEM, V407; Kertesz V, 2019, INT J MASS SPECTROM, V437, P17, DOI 10.1016/j.ijms.2018.01.005; Kertesz V, 2016, RAPID COMMUN MASS SP, V30, P1705, DOI 10.1002/rcm.7607; Kertesz V, 2014, RAPID COMMUN MASS SP, V28, P1553, DOI 10.1002/rcm.6931; Kertesz V, 2010, ANAL CHEM, V82, P5917, DOI 10.1021/ac100954p; Lanekoff I, 2014, ANAL CHEM, V86, P1872, DOI 10.1021/ac403931r; Laskin J, 2016, ANAL CHEM, V88, P52, DOI 10.1021/acs.analchem.5b04188; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; MARMAROU A, 1978, J NEUROSURG, V49, P530, DOI 10.3171/jns.1978.49.4.0530; Pirman DA, 2013, ANAL CHEM, V85, P1081, DOI 10.1021/ac302960j; Pirman DA, 2011, ANAL CHEM, V83, P8575, DOI 10.1021/ac201949b; Prideaux B, 2011, ANAL CHEM, V83, P2112, DOI 10.1021/ac1029049; Quanico J, 2017, BBA-PROTEINS PROTEOM, V1865, P891, DOI 10.1016/j.bbapap.2016.11.002; Rocha B, 2015, PROTEOMICS, V15, P702, DOI 10.1002/pmic.201400260; Schaepe K, 2018, ANAL CHEM, V90, P8856, DOI 10.1021/acs.analchem.8b00892; Schwartz SA, 2010, METHODS MOL BIOL, V656, P3, DOI 10.1007/978-1-60761-746-4_1; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Swales JG, 2015, ANAL CHEM, V87, P10146, DOI 10.1021/acs.analchem.5b02998; Taylor AJ, 2018, ANAL CHEM, V90, P5637, DOI 10.1021/acs.analchem.7b05005; Van Berkel GJ, 2013, RAPID COMMUN MASS SP, V27, P1329, DOI 10.1002/rcm.6580; Van Berkel GJ, 2002, ANAL CHEM, V74, P6216, DOI 10.1021/ac020540+; Wohlfarth C., 2008, LANDOLT BORNSTEIN, V47, P1426; Wu Q, 2017, CHEM SCI, V8, P3926, DOI 10.1039/c7sc00937b; Xing Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep26146; Yang K, 2013, ANAL CHEM, V85, P9742, DOI 10.1021/ac402104u; Zhang JZ, 2017, MED SCI MONITOR, V23, P5345, DOI 10.12659/MSM.904399	52	12	12	9	81	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0021-9673	1873-3778		J CHROMATOGR A	J. Chromatogr. A	JAN 4	2020	1609								460436	10.1016/j.chroma.2019.460436			10	Biochemical Research Methods; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	KG0LK	WOS:000509632500063	31409489				2022-02-06	
J	Chen, T; Zhu, J; Wang, YH; Hang, CH				Chen, Tao; Zhu, Jie; Wang, Yu-Hai; Hang, Chun-Hua			Arc silence aggravates traumatic neuronal injury via mGluR1-mediated ER stress and necroptosis	CELL DEATH & DISEASE			English	Article							IMMEDIATE-EARLY GENES; BRAIN-INJURY; CELL-DEATH; DOWN-REGULATION; INDUCED EXCITOTOXICITY; ENDOPLASMIC-RETICULUM; POSTSYNAPTIC DENSITY; GLUTAMATE RECEPTORS; MESSENGER-RNA; DEPENDENT LTD	Delayed neuronal death is associated with neurological deficits and mortality after traumatic brain injury (TBI), where post-synaptic density (PSD) proteins are thought to play key roles. The immediate-early gene (IEG) coded protein Arc is a brain-specific PSD protein that controls synaptic plasticity and learning behaviors. In this study, we investigated the expression and biological function of Arc in neuronal death after TBI in an in vitro model mimicked by traumatic neuronal injury (TNI) in cortical neurons. TNI caused a temporal increase of Arc expression at 3 and 6 h. Knockdown of Arc expression using small interfering RNA (Si-Arc-3) promoted TNI-induced cytotoxicity and apoptosis. The results of western blot showed that Si-Arc-3 transfection further enhanced the activation of endoplasmic reticulum (ER) stress-associated factors, including glucose-regulated protein 78 (GRP78), C/EBP homologous protein (CHOP) and caspase-12 after TNI. In addition, knockdown of Arc significantly increased expression of (receptor-interacting protein kinase 1) RIP1 and the number of necroptotic cells, which were apparently prevented by necrostatin-1 (Nec-1). The results of immunostaining and western blot showed that knockdown of Arc activated the metabotropic glutamate receptor 1 (mGluR1) and intracellular Ca2+ release in neurons. Mechanistically, the Si-Arc-3-induced activation of ER stress-associated factors, RIP1 expression, apoptosis, and necroptosis were partially reversed by the mGluR1 antagonist AIDA. In summary, our data suggest that silence of Arc expression aggravates neuronal death after TNI by promoting apoptosis and necroptosis. These data support for the first time that Arc may represent a novel candidate for therapies against TBI.	[Chen, Tao; Hang, Chun-Hua] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Neurosurg, Nanjing 210000, Jiangsu, Peoples R China; [Chen, Tao; Zhu, Jie; Wang, Yu-Hai] Anhui Med Univ, Sch Med, Hosp 904, Dept Neurosurg,PLA, Wuxi 214044, Jiangsu, Peoples R China		Hang, CH (corresponding author), Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Neurosurg, Nanjing 210000, Jiangsu, Peoples R China.; Wang, YH (corresponding author), Anhui Med Univ, Sch Med, Hosp 904, Dept Neurosurg,PLA, Wuxi 214044, Jiangsu, Peoples R China.	prof_wyh101@163.com; hangch_neuro@126.com		Hang, Chun-Hua/0000-0003-4963-8251	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701932, 81871598, 81771291, 81601719]; Clinical Medical Science and Technology Development Foundation of Jiangsu University [JLY20180028]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2019M651803]	This work was supported by the National Natural Science Foundation of China (no. 81701932, no. 81871598, no. 81771291, and no. 81601719), Clinical Medical Science and Technology Development Foundation of Jiangsu University (no. JLY20180028), and China Postdoctoral Science Foundation funded project (no. 2019M651803).	Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Bloomer WAC, 2008, J BIOL CHEM, V283, P582, DOI 10.1074/jbc.M702451200; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Bruno V, 2001, J CEREBR BLOOD F MET, V21, P1013, DOI 10.1097/00004647-200109000-00001; Carmichael RE, 2018, SEMIN CELL DEV BIOL, V77, P3, DOI 10.1016/j.semcdb.2017.09.007; Chen T, 2017, NEUROSCI LETT, V661, P23, DOI 10.1016/j.neulet.2017.09.024; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Dai MC, 2013, NEUROSCI LETT, V536, P41, DOI 10.1016/j.neulet.2013.01.007; Dong E, 2003, P NATL ACAD SCI USA, V100, P5479, DOI 10.1073/pnas.1031602100; Fei Z, 2006, J CLIN NEUROSCI, V13, P1023, DOI 10.1016/j.jocn.2005.11.042; Gardoni F, 2010, PROG BRAIN RES, V183, P169, DOI 10.1016/S0079-6123(10)83009-2; Greene NH, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000306; Herzog KH, 1996, NEUROPATH APPL NEURO, V22, P484, DOI 10.1111/j.1365-2990.1996.tb01120.x; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Kenny EM, 2019, CRIT CARE MED, V47, P410, DOI 10.1097/CCM.0000000000003555; Kim S, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0025-1; Krajewska M, 2011, BRAIN RES, V1370, P227, DOI 10.1016/j.brainres.2010.11.015; Larner SF, 2004, J NEUROCHEM, V88, P78, DOI 10.1046/j.1471-4159.2003.02141.x; Li Y, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00279; Li YL, 2008, NEUROSCI LETT, V447, P120, DOI 10.1016/j.neulet.2008.08.037; Liu S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/290182; Liu T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24547; Luo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.116; Luo P, 2013, FEBS J, V280, P6114, DOI 10.1111/febs.12531; Luo P, 2012, APOPTOSIS, V17, P975, DOI 10.1007/s10495-012-0736-z; Luo P, 2012, FREE RADICAL RES, V46, P766, DOI 10.3109/10715762.2012.678340; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Mullard A, 2018, NAT REV DRUG DISCOV, V17, P303, DOI 10.1038/nrd.2018.65; Ni HB, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00674; Potter PE, 2011, ACTA NEUROPATHOL, V122, P49, DOI 10.1007/s00401-011-0831-1; Rao W, 2015, BBA-MOL BASIS DIS, V1852, P2402, DOI 10.1016/j.bbadis.2015.08.014; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Sovolyova N, 2014, BIOL CHEM, V395, P1, DOI 10.1515/hsz-2013-0174; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sun DD, 2017, CELL MOL NEUROBIOL, V37, P1349, DOI 10.1007/s10571-017-0484-2; Tabata T, 2004, MOL NEUROBIOL, V29, P261, DOI 10.1385/MN:29:3:261; VENDRELL M, 1993, ANN NY ACAD SCI, V679, P132, DOI 10.1111/j.1749-6632.1993.tb18294.x; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Waung MW, 2009, CURR OPIN NEUROBIOL, V19, P319, DOI 10.1016/j.conb.2009.03.011; Weisel K, 2017, PHARMACOL RES PERSPE, V5, DOI 10.1002/prp2.365; Wilkerson JR, 2018, SEMIN CELL DEV BIOL, V77, P51, DOI 10.1016/j.semcdb.2017.09.035; Wu FF, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00406; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Yuan JY, 2019, NAT REV NEUROSCI, V20, P19, DOI 10.1038/s41583-018-0093-1; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	48	12	12	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	JAN 2	2020	11	1							4	10.1038/s41419-019-2198-5			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	KI5YM	WOS:000511425700002	31919348	Green Published, gold			2022-02-06	
J	Gao, N; Zhang-Brotzge, XH; Wali, B; Sayeed, I; Chern, JJ; Blackwell, LS; Kuan, CY; Reisner, A				Gao, Ning; Zhang-Brotzge, Xiaohui; Wali, Bushra; Sayeed, Iqbal; Chern, Joshua J.; Blackwell, Laura S.; Kuan, Chia-Yi; Reisner, Andrew			Plasma osteopontin may predict neuroinflammation and the severity of pediatric traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article; Proceedings Paper	Journal-of-Cerebral-Blood-Flow-and-Metabolism (JCBFM) Symposium at International Symposium on Cerebral Blood Flow, Metabolism and Function (BRAIN)	JUL 07, 2019	Yokohama, JAPAN	Journal Cerebral Blood Flow & Metab		Diagnostic biomarker; glial fibrillary acidic protein; microglia; outcomes; predictive biomarker		Traumatic brain injury (TBI) is the leading cause of death in children and adolescents in developed countries, but there are no blood-based biomarkers to support the diagnosis or prognosis of pediatric TBI to-date. Here we report that the plasma levels of osteopontin (OPN), a phosphoprotein chiefly secreted by macrophages and/or activated microglia, may contribute to this goal. In animal models of TBI, while OPN, fibrillary acidic protein (GFAP), and matrix metalloproteinase 9 (MMP-9) were all readily induced by controlled cortical impact in the brains of one-month-old mice, only OPN and GFAP ascended in the blood in correlation with high neurological severity scores (NSS). In children with TBI (three to nine years of age, n = 66), the plasma levels of OPN, but not GFAP, correlated with severe TBI (Glasgow Coma Score <= 8) and intracranial lesions at emergency department. In addition, the plasma OPN levels in severe pediatric TBI patients continued to ascend for 72 h and correlated with mortality and the days requiring ventilator or intensive care unit support, whereas the plasma GFAP levels lacked these properties. Together, these results suggest that plasma OPN outperforms GFAP and may be a neuroinflammation-based diagnostic and prognostic biomarker in pediatric TBI.	[Gao, Ning; Zhang-Brotzge, Xiaohui; Kuan, Chia-Yi; Reisner, Andrew] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Gao, Ning; Zhang-Brotzge, Xiaohui; Kuan, Chia-Yi; Reisner, Andrew] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA USA; [Wali, Bushra; Sayeed, Iqbal] Emory Univ, Sch Med, Brain Res Lab, Dept Emergency Med, Atlanta, GA USA; [Chern, Joshua J.; Kuan, Chia-Yi; Reisner, Andrew] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA USA; [Chern, Joshua J.; Blackwell, Laura S.; Reisner, Andrew] Childrens Healthcare Atlanta, Atlanta, GA 30342 USA; [Kuan, Chia-Yi] Univ Virginia, Sch Med, Dept Neurosci, 409 Lane Rd,MR4,4046, Charlottesville, VA 22908 USA		Kuan, CY (corresponding author), Univ Virginia, Sch Med, Dept Neurosci, 409 Lane Rd,MR4,4046, Charlottesville, VA 22908 USA.; Reisner, A (corresponding author), Childrens Healthcare Atlanta, Dept Neurosurg, 1001 Johnson Ferry Rd NE, Atlanta, GA 30342 USA.	alex.kuan@virginia.edu; andrew.reisner@choa.org			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21 HD080429] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 NS100419, R01 NS095064, R21 NS093446, R01 NS084744, R01 NS108763] Funding Source: Medline		Adrian H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0294-16.2016; Antonios A, 2017, 3 INT C NEUR DIS BRA; Au AK, 2017, CURR OPIN NEUROL, V30, P565, DOI 10.1097/WCO.0000000000000504; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; Chan JL, 2014, EXP NEUROL, V261, P757, DOI 10.1016/j.expneurol.2014.08.015; Chen WQ, 2011, STROKE, V42, P764, DOI 10.1161/STROKEAHA.110.599118; Ellison JA, 1998, STROKE, V29, P1698, DOI 10.1161/01.STR.29.8.1698; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Gopal N, 2016, J CLIN DIAGN RES, V10, pBC6, DOI 10.7860/JCDR/2016/20156.8257; Lanteri P, 2012, CLIN CHEM LAB MED, V50, P1979, DOI 10.1515/cclm-2012-0177; Li YK, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0253-16.2016; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Rentsendorj A, 2018, BRAIN BEHAV IMMUN, V67, P163, DOI 10.1016/j.bbi.2017.08.019; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; van Velthoven CTJ, 2011, STROKE, V42, P2294, DOI 10.1161/STROKEAHA.110.608315; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69	22	12	13	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JAN	2020	40	1					35	43		10.1177/0271678X19836412			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	JX2IE	WOS:000503564000004	30866741	Bronze, Green Published			2022-02-06	
J	McDonough, A; Noor, S; Lee, RV; Dodge, R; Strosnider, JS; Shen, J; Davidson, S; Moller, T; Garden, GA; Weinstein, JR				McDonough, Ashley; Noor, Shahani; Lee, Richard V.; Dodge, Ryan; Strosnider, James S.; Shen, Jasmine; Davidson, Stephanie; Moller, Thomas; Garden, Gwenn A.; Weinstein, Jonathan R.			Ischemic preconditioning induces cortical microglial proliferation and a transcriptomic program of robust cell cycle activation	GLIA			English	Article						fractalkine; interferon; ischemia; microglia; preconditioning; proliferation	CEREBRAL-ARTERY-OCCLUSION; SELECTIVE NEURONAL LOSS; TOLL-LIKE RECEPTOR; GENE-EXPRESSION; TRAUMATIC BRAIN; RAT MODEL; INJURY; FRACTALKINE; TOLERANCE; STROKE	Ischemic preconditioning (IPC) is an experimental phenomenon in which a subthreshold ischemic insult applied to the brain reduces damage caused by a subsequent more severe ischemic episode. Identifying key molecular and cellular mediators of IPC will provide critical information needed to develop novel therapies for stroke. Here we report that the transcriptomic response of acutely isolated preconditioned cortical microglia is dominated by marked upregulation of genes involved in cell cycle activation and cellular proliferation. Notably, this transcriptional response occurs in the absence of cortical infarction. We employed ex vivo flow cytometry, immunofluorescent microscopy, and quantitative stereology methods on brain tissue to evaluate microglia proliferation following IPC. Using cellular colocalization of microglial (Iba1) and proliferation (Ki67 and BrdU) markers, we observed a localized increase in the number of microglia and proliferating microglia within the preconditioned hemicortex at 72, but not 24, hours post-IPC. Our quantification demonstrated that the IPC-induced increase in total microglia was due entirely to proliferation. Furthermore, microglia in the preconditioned hemisphere had altered morphology and increased soma volumes, indicative of an activated phenotype. Using transgenic mouse models with either fractalkine receptor (CX3CR1)-haploinsufficiency or systemic type I interferon signaling loss, we determined that microglial proliferation after IPC is dependent on fractalkine signaling but independent of type I interferon signaling. These findings suggest there are multiple distinct targetable signaling pathways in microglia, including CX3CR1-dependent proliferation that may be involved in IPC-mediated protection.	[McDonough, Ashley; Noor, Shahani; Lee, Richard V.; Dodge, Ryan; Strosnider, James S.; Shen, Jasmine; Davidson, Stephanie; Moller, Thomas; Garden, Gwenn A.; Weinstein, Jonathan R.] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA; [Weinstein, Jonathan R.] Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA		Weinstein, JR (corresponding author), Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA.	jweinste@u.washington.edu		Weinstein, Jonathan/0000-0001-6080-9758; Garden, Gwenn/0000-0002-8753-6515; McDonough, Ashley/0000-0003-3864-9449	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS076620, NS100245, HD083091, NS073848, NS065008, NS096334] Funding Source: Medline		ALLIOT F, 1991, P NATL ACAD SCI USA, V88, P1541, DOI 10.1073/pnas.88.4.1541; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Anrather J, 2016, NEUROTHERAPEUTICS, V13, P661, DOI 10.1007/s13311-016-0483-x; Bahjat FR, 2017, TRANSL STROKE RES, V8, P322, DOI 10.1007/s12975-017-0532-8; Brettschneider J, 2008, TECHNOMETRICS, V50, P241, DOI 10.1198/004017008000000334; Butovsky O, 2018, NAT REV NEUROSCI, V19, P622, DOI 10.1038/s41583-018-0057-5; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Costello DA, 2013, HIPPOCAMPUS, V23, P696, DOI 10.1002/hipo.22129; Crotti A, 2016, IMMUNITY, V44, P505, DOI 10.1016/j.immuni.2016.02.013; Denes A, 2007, J CEREBR BLOOD F MET, V27, P1941, DOI 10.1038/sj.jcbfm.9600495; Ejaz S, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00064; Ejaz S, 2015, STROKE, V46, P1084, DOI 10.1161/STROKEAHA.114.007581; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Fitts DA, 2010, BEHAV RES METHODS, V42, P3, DOI 10.3758/BRM.42.1.3; Friedman BA, 2018, CELL REP, V22, P832, DOI 10.1016/j.celrep.2017.12.066; Fumagalli S, 2013, GLIA, V61, P827, DOI 10.1002/glia.22474; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Gesuete R, 2012, J NEUROCHEM, V123, P75, DOI 10.1111/j.1471-4159.2012.07946.x; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Hamner MA, 2015, J NEUROSCI, V35, P15599, DOI 10.1523/JNEUROSCI.2544-15.2015; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hatori K, 2002, J NEUROSCI RES, V69, P418, DOI 10.1002/jnr.10304; He HY, 2019, NEURAL REGEN RES, V14, P280, DOI 10.4103/1673-5374.244793; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Horiuchi M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-227; Howard CV, 2010, UNBIASED STEREOLOGY; Huang YB, 2018, NAT NEUROSCI, V21, P530, DOI 10.1038/s41593-018-0090-8; Jin WN, 2017, J CEREBR BLOOD F MET, V37, P2224, DOI 10.1177/0271678X17694185; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kariko K, 2004, J CEREBR BLOOD F MET, V24, P1288, DOI 10.1097/01.WCB.0000145666.68576.71; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kierdorf K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00044; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Lai AY, 2006, GLIA, V53, P809, DOI 10.1002/glia.20335; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Leung PY, 2012, STROKE, V43, P1383, DOI 10.1161/STROKEAHA.111.641522; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Marsh B, 2009, J NEUROSCI, V29, P9839, DOI 10.1523/JNEUROSCI.2496-09.2009; Maysami S, 2008, J CEREBR BLOOD F MET, V28, P1104, DOI 10.1038/jcbfm.2008.4; McDonough A, 2017, J NEUROSCI, V37, P8292, DOI 10.1523/JNEUROSCI.0725-17.2017; McDonough A, 2016, NEUROTHERAPEUTICS, V13, P748, DOI 10.1007/s13311-016-0465-z; Moraga A, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0314-8; Naylor M, 2005, NEUROCHEM INT, V47, P565, DOI 10.1016/j.neuint.2005.07.003; Nishiyori A, 1998, FEBS LETT, V429, P167, DOI 10.1016/S0014-5793(98)00583-3; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pedrono E, 2010, J NEUROPATH EXP NEUR, V69, P188, DOI 10.1097/NEN.0b013e3181cd331c; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Poniatowski LA, 2017, MOL NEUROBIOL, V54, P2167, DOI 10.1007/s12035-016-9787-4; Rocha-Ferreira E, 2015, NEUROSCIENCE, V311, P292, DOI 10.1016/j.neuroscience.2015.10.035; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; SMYTH GK, 2004, STAT APPL GENET MOL, V0003; Stenzel-Poore MP, 2007, STROKE, V38, P680, DOI 10.1161/01.STR.0000251444.56487.4c; Stenzel-Poore MP, 2004, STROKE, V35, P2683, DOI 10.1161/01.STR.0000143735.89281.bb; Stenzel-Poore MP, 2003, LANCET, V362, P1028, DOI 10.1016/S0140-6736(03)14412-1; Stevens SL, 2011, J NEUROSCI, V31, P8456, DOI 10.1523/JNEUROSCI.0821-11.2011; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Su W, 2014, J IMMUNOL, V192, P358, DOI 10.4049/jimmunol.1301397; Szalay G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11499; Tang ZW, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-26; Tay TL, 2017, NAT NEUROSCI, V20, P793, DOI 10.1038/nn.4547; Venna VR, 2012, NEUROSCIENCE, V201, P280, DOI 10.1016/j.neuroscience.2011.11.014; Weinstein JR, 2010, FUTUR NEUROL, V5, P227, DOI 10.2217/FNL.10.1; Wendeln AC, 2018, NATURE, V556, P332, DOI 10.1038/s41586-018-0023-4; Wieghofer P, 2015, GLIA, V63, P1, DOI 10.1002/glia.22727; Wolf Y, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00026; Wu XM, 2016, MOL NEUROBIOL, V53, P4010, DOI 10.1007/s12035-015-9339-3; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xavier AL, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00037; Zhang J, 2008, STROKE, V39, P967, DOI 10.1161/STROKEAHA.107.497412	77	12	12	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	JAN	2020	68	1					76	94		10.1002/glia.23701			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JM8EX	WOS:000496442500005	31420975				2022-02-06	
J	Haveman, ME; Van Putten, MJAM; Hom, HW; Eertman-Meyer, CJ; Beishuizen, A; Tjepkema-Cloostermans, MC				Haveman, Marjolein E.; Van Putten, Michel J. A. M.; Hom, Harold W.; Eertman-Meyer, Carin J.; Beishuizen, Albertus; Tjepkema-Cloostermans, Marleen C.			Predicting outcome in patients with moderate to severe traumatic brain injury using electroencephalography	CRITICAL CARE			English	Article						Traumatic brain injury; EEG; Prognosis; Random forest; ICU	QUANTITATIVE EEG PARAMETERS; PERCENT-ALPHA-VARIABILITY; HEAD-INJURY; PROPOFOL; CARE	Background: Better outcome prediction could assist in reliable quantification and classification of traumatic brain injury (TBI) severity to support clinical decision-making. We developed a multifactorial model combining quantitative electroencephalography (qEEG) measurements and clinically relevant parameters as proof of concept for outcome prediction of patients with moderate to severe TBI. Methods: Continuous EEG measurements were performed during the first 7 days of ICU admission. Patient outcome at 12 months was dichotomized based on the Extended Glasgow Outcome Score (GOSE) as poor (GOSE 1-2) or good (GOSE 3-8). Twenty-three qEEG features were extracted. Prediction models were created using a Random Forest classifier based on qEEG features, age, and mean arterial blood pressure (MAP) at 24, 48, 72, and 96 h after TBI and combinations of two time intervals. After optimization of the models, we added parameters from the International Mission for Prognosis And Clinical Trial Design (IMPACT) predictor, existing of clinical, CT, and laboratory parameters at admission. Furthermore, we compared our best models to the online IMPACT predictor. Results: Fifty-seven patients with moderate to severe TBI were included and divided into a training set (n = 38) and a validation set (n = 19). Our best model included eight qEEG parameters and MAP at 72 and 96 h after TBI, age, and nine other IMPACT parameters. This model had high predictive ability for poor outcome on both the training set using leave-one-out (area under the receiver operating characteristic curve (AUC) = 0.94, specificity 100%, sensitivity 75%) and validation set (AUC = 0.81, specificity 75%, sensitivity 100%). The IMPACT predictor independently predicted both groups with an AUC of 0.74 (specificity 81%, sensitivity 65%) and 0.84 (sensitivity 88%, specificity 73%), respectively. Conclusions: Our study shows the potential of multifactorial Random Forest models using qEEG parameters to predict outcome in patients with moderate to severe TBI.	[Haveman, Marjolein E.; Van Putten, Michel J. A. M.; Tjepkema-Cloostermans, Marleen C.] Univ Twente, Clin Neurophysiol Grp, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands; [Haveman, Marjolein E.; Van Putten, Michel J. A. M.; Eertman-Meyer, Carin J.; Tjepkema-Cloostermans, Marleen C.] Med Spectrum Twente, Dept Neurol & Clin Neurophysiol C2, Koningspl 1, NL-7512 KZ Enschede, Netherlands; [Hom, Harold W.; Beishuizen, Albertus] Med Spectrum Twente, Intens Care Ctr, Koningspl 1, NL-7512 KZ Enschede, Netherlands		Haveman, ME (corresponding author), Univ Twente, Clin Neurophysiol Grp, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands.; Haveman, ME (corresponding author), Med Spectrum Twente, Dept Neurol & Clin Neurophysiol C2, Koningspl 1, NL-7512 KZ Enschede, Netherlands.	marjoleinhaveman@gmail.com		Haveman, Marjolein/0000-0002-6030-3172			Godoy DA, 2016, NEUROCRIT CARE, V25, P306, DOI 10.1007/s12028-016-0253-y; Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; Das RR, 2009, NEUROCRIT CARE, V10, P368, DOI 10.1007/s12028-008-9142-3; Foreman B, 2012, CRIT CARE, V16, DOI 10.1186/cc11230; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Haneef Z, 2013, J NEUROTRAUM, V30, P653, DOI 10.1089/neu.2012.2585; Hebb MO, 2007, J NEUROTRAUM, V24, P579, DOI 10.1089/neu.2006.0146; Ianof Jéssica Natuline, 2017, Dement. neuropsychol., V11, P3, DOI 10.1590/1980-57642016dn11-010002; Jasper HH, 1940, ARCH NEURO PSYCHIATR, V44, P328, DOI 10.1001/archneurpsyc.1940.02280080088005; Kamousi B, 2019, CLIN NEUROPHYS PRACT, V4, P69, DOI 10.1016/j.cnp.2019.02.002; Kane NM, 1998, ELECTROEN CLIN NEURO, V106, P244, DOI 10.1016/S0013-4694(97)00141-7; Kannathal N, 2005, COMPUT METH PROG BIO, V80, P187, DOI 10.1016/j.cmpb.2005.06.012; Kim SY, 2009, BMC BIOINFORMATICS, V10, P4; Lee H, 2019, CRIT CARE MED, V47, P574, DOI 10.1097/CCM.0000000000003639; Leon-Carrion J, 2009, CLIN NEUROPHYSIOL, V120, P1039, DOI 10.1016/j.clinph.2009.01.021; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Modarres Mo H., 2017, Neurobiology of Sleep and Circadian Rhythms, V2, P59, DOI 10.1016/j.nbscr.2016.06.001; MOULTON RJ, 1988, CAN J NEUROL SCI, V15, P82, DOI 10.1017/S0317167100027244; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nguyen P, 2014, P 22 EUR S ART NEUR, ppp413; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; O'Sullivan M, 2019, SENSORS BASEL NLM ME, V19, P1; RAEGRANT AD, 1991, ELECTROEN CLIN NEURO, V79, P349, DOI 10.1016/0013-4694(91)90199-E; Ruijter BJ, 2019, CLIN NEUROPHYSIOL, V130, P1263, DOI 10.1016/j.clinph.2019.04.707; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sheorajpanday RVA, 2009, CLIN NEUROPHYSIOL, V120, P845, DOI 10.1016/j.clinph.2009.02.171; Stewart CP, 2010, NEUROLOGY, V75, P1501, DOI 10.1212/WNL.0b013e3181f9619e; Steyerberg EW, 2008, PLOS MED; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Tjepkema-Cloostermans MC, 2013, CRIT CARE, V17, DOI 10.1186/cc13078; Tolonen A, 2018, CLIN EEG NEUROSCI, V49, P248, DOI 10.1177/1550059417742232; van Putten MJAM, 2008, J CLIN NEUROPHYSIOL, V25, P63, DOI 10.1097/WNP.0b013e31816bdf85; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Walia S, 2002, INJURY, V33, P339, DOI 10.1016/S0020-1383(02)00053-0; Wang BG, 1997, J NEUROSURG ANESTH, V9, P335, DOI 10.1097/00008506-199710000-00008; Williams D, 1941, J NEUROL PSYCHIATRY, V4, P107, DOI 10.1136/jnnp.4.2.107; Young GB, 2006, CLIN NEUROPHYSIOL, V117, P1376, DOI 10.1016/j.clinph.2006.02.006; Young GB, 2000, J CLIN NEUROPHYSIOL, V17, P473, DOI 10.1097/00004691-200009000-00006	43	12	13	2	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	DEC 11	2019	23	1							401	10.1186/s13054-019-2656-6			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KG7RC	WOS:000510144300001	31829226	gold, Green Published			2022-02-06	
J	Wehrle, E; Betts, DCTN; Kuhn, GA; Scheuren, AC; Hofmann, S; Muller, R				Wehrle, Esther; Betts, Duncan C. Tourolle Ne; Kuhn, Gisela A.; Scheuren, Ariane C.; Hofmann, Sandra; Mueller, Ralph			Evaluation of longitudinal time-lapsed in vivo micro-CT for monitoring fracture healing in mouse femur defect models	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; COMPUTED TOMOGRAPHY ASSESSMENT; BONE ARCHITECTURE; RADIATION; RATS; MINERALIZATION; OSTEOBLAST; CELLS; IRRADIATION; ANESTHESIA	Longitudinal in vivo micro-computed tomography (micro-CT) is of interest to non-invasively capture the healing process of individual animals in preclinical fracture healing studies. However, it is not known whether longitudinal imaging itself has an impact on callus formation and remodeling. In this study, a scan group received weekly micro-CT measurements (week 0-6), whereas controls were only scanned post-operatively and at week 5 and 6. Registration of consecutive scans using a branching scheme (bridged vs. unbridged defect) combined with a two-threshold approach enabled assessment of localized bone turnover and mineralization kinetics relevant for monitoring callus remodeling. Weekly micro-CT application did not significantly change any of the assessed callus parameters in the defect and periosteal volumes. This was supported by histomorphometry showing only small amounts of cartilage residuals in both groups, indicating progression towards the end of the healing period. Also, immunohistochemical staining of Sclerostin, previously associated with mediating adverse radiation effects on bone, did not reveal differences between groups. The established longitudinal in vivo micro-CT-based approach allows monitoring of healing phases in mouse femur defect models without significant effects of anesthesia, handling and radiation on callus properties. Therefore, this study supports application of longitudinal in vivo micro-CT for healing-phase-specific monitoring of fracture repair in mice.	[Wehrle, Esther; Betts, Duncan C. Tourolle Ne; Kuhn, Gisela A.; Scheuren, Ariane C.; Hofmann, Sandra; Mueller, Ralph] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland; [Hofmann, Sandra] Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands; [Hofmann, Sandra] Eindhoven Univ Technol, Inst Complex Mol Syst, Eindhoven, Netherlands		Muller, R (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.	ram@ethz.ch	Muller, Ralph/A-1198-2008; Hofmann, Sandra/F-2832-2010; Wehrle, Esther/AAH-6656-2021	Muller, Ralph/0000-0002-5811-7725; Hofmann, Sandra/0000-0002-2568-8388; Wehrle, Esther/0000-0003-2723-7342	EUEuropean Commission [BIODESIGN FP7-NMP-2012-262948]; EU (ERC)European Research Council (ERC)European Commission [MechAGE ERC-2016-ADG-741883]; ETH Postdoctoral Fellowship Program (MSCA-COFUND) [FEL-25_15-1]	The authors gratefully acknowledge support from the EU (BIODESIGN FP7-NMP-2012-262948 and ERC Advanced MechAGE ERC-2016-ADG-741883). E. Wehrle received funding from the ETH Postdoctoral Fellowship Program (MSCA-COFUND, FEL-25_15-1).	Bao QW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02705-0; Beery AK, 2018, CURR OPIN BEHAV SCI, V23, P143, DOI 10.1016/j.cobeha.2018.06.016; Birkhold AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep23480; Borgiani E, 2019, J BONE MINER RES, V34, P1923, DOI 10.1002/jbmr.3801; Boyd SK, 2006, BONE, V39, P854, DOI 10.1016/j.bone.2006.04.017; Brouwers JEM, 2007, J ORTHOP RES, V25, P1325, DOI 10.1002/jor.20439; Bundkirchen K, 2018, J TRAUMA ACUTE CARE, V85, P359, DOI 10.1097/TA.0000000000001952; Chandra A, 2017, J BONE MINER RES, V32, P360, DOI 10.1002/jbmr.2996; Chandra A, 2014, BONE, V67, P33, DOI 10.1016/j.bone.2014.06.030; Chandra A, 2013, BONE, V55, P449, DOI 10.1016/j.bone.2013.02.023; Chen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104016; David V, 2003, J BONE MINER RES, V18, P1622, DOI 10.1359/jbmr.2003.18.9.1622; Donneys A, 2013, PLAST RECONSTR SURG, V131, p711E, DOI 10.1097/PRS.0b013e3182865c57; Dudziak ME, 2000, PLAST RECONSTR SURG, V106, P1049, DOI 10.1097/00006534-200010000-00015; Freeman TA, 2009, J ORTHOP RES, V27, P673, DOI 10.1002/jor.20771; Graef F, 2017, J MUSCULOSKEL NEURON, V17, P78; Hauser M, 2018, BONE, V112, P107, DOI 10.1016/j.bone.2018.04.017; Hegde V, 2016, OSTEOPOROSIS INT, V27, P861, DOI 10.1007/s00198-015-3331-7; Hildebrandt IJ, 2008, ILAR J, V49, P17, DOI 10.1093/ilar.49.1.17; Hofman M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46278-6; Hohlbaum K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179588; Jegoux F, 2010, ORAL SURG ORAL MED O, V109, P173, DOI 10.1016/j.tripleo.2009.10.001; Jilka RL, 2013, J GERONTOL A-BIOL, V68, P1209, DOI 10.1093/gerona/glt046; Kadar B, 2007, IN VIVO, V21, P861; Kim H, 2006, TOXICOLOGY, V220, P169, DOI 10.1016/j.tox.2005.12.010; Klinck RJ, 2008, MED ENG PHYS, V30, P888, DOI 10.1016/j.medengphy.2007.11.004; Kruck B, 2018, J BONE MINER RES, V33, P1686, DOI 10.1002/jbmr.3454; Kuhn G, 2012, BONE, V50, pS156, DOI 10.1016/j.bone.2012.02.487; Lambers FM, 2015, J BIOMECH, V48, P1179, DOI 10.1016/j.jbiomech.2014.11.020; Lambers FM, 2012, CALCIFIED TISSUE INT, V90, P108, DOI 10.1007/s00223-011-9553-6; Lambers FM, 2011, BONE, V49, P1340, DOI 10.1016/j.bone.2011.08.035; Laperre K, 2011, BONE, V49, P613, DOI 10.1016/j.bone.2011.06.031; Li ZH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184835; Locher RJ, 2015, J MUSCULOSKEL NEURON, V15, P309; Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840; Lukas C, 2013, BONE, V56, P55, DOI 10.1016/j.bone.2013.05.005; Matsumura S, 1996, CALCIFIED TISSUE INT, V59, P307, DOI 10.1007/s002239900129; Meganck JA, 2009, BONE, V45, P1104, DOI 10.1016/j.bone.2009.07.078; Mehta M, 2012, EUR CELLS MATER, V24, P358, DOI 10.22203/eCM.v024a26; Miyagawa K, 2011, J BONE MINER METAB, V29, P422, DOI 10.1007/s00774-010-0241-9; Morgan EF, 2009, BONE, V44, P335, DOI 10.1016/j.bone.2008.10.039; Mulder L, 2004, ACTA RADIOL, V45, P769, DOI 10.1080/02841850410008171; Mustafy T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207323; Nevalainen T, 2014, ILAR J, V55, P392, DOI 10.1093/ilar/ilu035; O'Donovan DA, 2012, PLAST RECONSTR SURG, V129, p636E, DOI 10.1097/PRS.0b013e31824421b6; O'Neill KR, 2012, BONE, V50, P1357, DOI 10.1016/j.bone.2012.03.008; Richardson CA, 2005, ATLA-ALTERN LAB ANIM, V33, P119, DOI 10.1177/026119290503300207; Russel WMS, 1959, PRINCIPLES HUMANE EX; SCHEVEN BAA, 1985, LAB INVEST, V53, P72; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schulte FA, 2011, BONE, V48, P433, DOI 10.1016/j.bone.2010.10.007; STEVENS WC, 1975, ANESTHESIOLOGY, V42, P408, DOI 10.1097/00000542-197504000-00008; Stollings LM, 2016, ANESTHESIOLOGY, V125, P399, DOI 10.1097/ALN.0000000000001195; Taiani JT, 2014, BONE, V64, P263, DOI 10.1016/j.bone.2014.04.019; Tannenbaum J, 2015, J AM ASSOC LAB ANIM, V54, P120; Taylor Carly, 2016, Current Directions in Biomedical Engineering, V2, P449, DOI 10.1515/cdbme-2016-0099; Tourolle ne Betts D.C., 2019, 721365 BIORXIV, DOI [10.1101/721365, DOI 10.1101/721365]; Tremoleda JL, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-11; Tsitsilonis S, 2015, INJURY, V46, P661, DOI 10.1016/j.injury.2015.01.044; Wang AY, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/958908; Wehrle E, 2015, DIS MODEL MECH, V8, P93, DOI 10.1242/dmm.018622; Wehrle E, 2014, J ORTHOP RES, V32, P1006, DOI 10.1002/jor.22629; Willie BM, 2013, BONE, V55, P335, DOI 10.1016/j.bone.2013.04.023; Wu YR, 2018, CLIN ORTHOP RELAT R, V476, P2076, DOI 10.1097/CORR.0000000000000395; Zhang J, 2017, J RADIAT RES, V58, P791, DOI 10.1093/jrr/rrx026; Zwingenberger S, 2013, J SURG RES, V181, pE7, DOI 10.1016/j.jss.2012.06.039	67	12	12	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 25	2019	9								17445	10.1038/s41598-019-53822-x			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JP8PL	WOS:000498520800001	31768003	Green Published, Green Submitted, gold			2022-02-06	
J	Elahi, C; Rocha, TAH; da Silva, NC; Sakita, FM; Ndebea, AS; Fuller, A; Haglund, MM; Mmbaga, BT; Vissoci, JRN; Staton, CA				Elahi, Cyrus; Hernandes Rocha, Thiago Augusto; da Silva, Nubia Cristina; Sakita, Francis M.; Ndebea, Ansbert Sweetbert; Fuller, Anthony; Haglund, Michael M.; Mmbaga, Blandina T.; Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.			An evaluation of outcomes in patients with traumatic brain injury at a referral hospital in Tanzania: evidence from a survival analysis	NEUROSURGICAL FOCUS			English	Article						brain injuries; survival analysis; developing countries; critical care outcomes	ACUTE SUBDURAL-HEMATOMA; EPIDURAL HEMATOMA; BURR HOLES; EPIDEMIOLOGY; MORTALITY; MODELS; NEUROSURGERY; MANAGEMENT; DRAINAGE; COMA	OBJECTIVE The purpose of this study was to determine if patients with traumatic brain injury (TBI) in low- and middle-income countries who receive surgery have better outcomes than patients with TBI who do not receive surgery, and whether this differs with severity of injury. METHODS The authors generated a series of Kaplan-Meier plots and performed multiple Cox proportional hazard models to assess the relationship between TBI surgery and TBI severity. The TBI severity was categorized using admission Glasgow Coma Scale scores: mild (14, 15), moderate (9-13), or severe (3-8). The authors investigated outcomes from admission to hospital day 14. The outcome considered was the Glasgow Outcome Scale-Extended, categorized as poor outcome (1-4) and good outcome (5-8). The authors used TBI registry data collected from 2013 to 2017 at a regional referral hospital in Tanzania. RESULTS Of the final 2502 patients, 609 (24%) received surgery and 1893 (76%) did not receive surgery. There were significantly fewer road traffic injuries and more violent causes of injury in those receiving surgery. Those receiving surgery were also more likely to receive care in the ICU, to have a poor outcome, to have a moderate or severe TBI, and to stay in the hospital longer. The hazard ratio for patients with TBI who underwent operation versus those who did not was 0.17 (95% CI 0.06-0.49; p < 0.001) in patients with moderate TBI; 0.2 (95% CI 0.06-0.64; p = 0.01) for those with mild TBI, and 0.47 (95% CI 0.24-0.89; p = 0.02) for those with severe TBI. CONCLUSIONS Those who received surgery for their TBI had a lower hazard for poor outcome than those who did not. Surgical intervention was associated with the greatest improvement in outcomes for moderate head injuries, followed by mild and severe injuries. The findings suggest a reprioritization of patients with moderate TBI-a drastic change to the traditional practice within low- and middle-income countries in which the most severely injured patients are prioritized for care.	[Elahi, Cyrus; Hernandes Rocha, Thiago Augusto; da Silva, Nubia Cristina; Fuller, Anthony; Haglund, Michael M.; Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.] Duke Univ, Med Ctr, Div Neurosurg & Neurol, Dept Neurosurg, Durham, NC USA; [Elahi, Cyrus; Fuller, Anthony; Haglund, Michael M.; Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Hernandes Rocha, Thiago Augusto] WHO, Pan Amer Hlth Org, Brasilia, DF, Brazil; [da Silva, Nubia Cristina] Methods Analyt & Technol Hlth MATH Consortium, Belo Horizonte, MG, Brazil; [Sakita, Francis M.; Ndebea, Ansbert Sweetbert; Mmbaga, Blandina T.] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.] Duke Univ, Dept Surg, Div Emergency Med, Med Ctr, Durham, NC USA		Elahi, C (corresponding author), Duke Univ, Durham, NC 27706 USA.	cyrusweal@gmail.com	Rocha, Thiago/AAW-3805-2020; Mmbaga, Blandina Theophil/AAR-8707-2021	Rocha, Thiago/0000-0002-6262-3276; Mmbaga, Blandina Theophil/0000-0002-5550-1916; Staton, Catherine/0000-0002-6468-2894	Fogarty International Center of the US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [K01TW010000]; Duke Division of Emergency Medicine; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [K01TW010000] Funding Source: NIH RePORTER	Dr. Staton acknowledges salary support from the Fogarty International Center of the US National Institutes of Health under Award Number K01TW010000 (Principal Investigator, Staton) and the Duke Division of Emergency Medicine.	Aenderl I, 2014, ETHIOP J HEALTH SCI, V24, P27, DOI 10.4314/ejhs.v24i1.4; Bagan M, 1997, SURG NEUROL, V47, P512, DOI 10.1016/S0090-3019(96)00546-0; Bellera CA, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-20; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; COX DR, 1972, J R STAT SOC B, V34, P187; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Donovan DJ, 2006, MIL MED, V171, P12, DOI 10.7205/MILMED.171.1.12; Eaton J, 2017, WORLD NEUROSURG, V108, P650, DOI 10.1016/j.wneu.2017.09.084; Eaton J, 2017, WORLD NEUROSURG, V105, P257, DOI 10.1016/j.wneu.2017.05.153; El Khamlichi A, 2001, NEUROSURGERY, V48, P1344, DOI 10.1097/00006123-200106000-00034; Habibi Z, 2012, J NEUROTRAUM, V29, P2103, DOI 10.1089/neu.2010.1742; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Kuo BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182285; Liu JT, 2006, ACTA NEUROCHIR, V148, P313, DOI 10.1007/s00701-005-0723-z; Ogunlade J, 2018, CUREUS, V10, DOI 10.7759/cureus.3042; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Sitsapesan HA, 2013, WORLD NEUROSURG, V79, P568, DOI 10.1016/j.wneu.2012.09.018; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Stel VS, 2011, NEPHRON CLIN PRACT, V119, pC83, DOI 10.1159/000324758; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; TEASDALE G, 1974, LANCET, V2, P81; Therneau T, USING TIME DEPENDENT; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Vaca SD, 2019, NEUROSURGERY, V84, P95, DOI 10.1093/neuros/nyy004; van Dijk PC, 2008, KIDNEY INT, V74, P705, DOI 10.1038/ki.2008.294; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004	31	12	12	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2019	47	5							E6	10.3171/2019.7.FOCUS19316			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JJ2IT	WOS:000493985900006	31675716	Green Accepted, gold			2022-02-06	
J	Fanelli, A; Vonberg, FW; LaRovere, KL; Walsh, BK; Smith, ER; Robinson, S; Tasker, RC; Heldt, T				Fanelli, Andrea; Vonberg, Frederick W.; LaRovere, Kerri L.; Walsh, Brian K.; Smith, Edward R.; Robinson, Shenandoah; Tasker, Robert C.; Heldt, Thomas			Fully automated, real-time, calibration-free, continuous noninvasive estimation of intracranial pressure in children	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						intracranial pressure; traumatic brain injury; patient monitoring; mathematical modeling; multimodality data analytics; trauma	TRAUMATIC BRAIN-INJURY; BLOOD-PRESSURE; REPRODUCIBILITY; GUIDELINES; MANAGEMENT; ALGORITHM	OBJECTIVE In the search for a reliable, cooperation-independent, noninvasive alternative to invasive intracranial pressure (ICP) monitoring in children, various approaches have been proposed, but at the present time none are capable of providing fully automated, real-time, calibration-free, continuous and accurate ICP estimates. The authors investigated the feasibility and validity of simultaneously monitored arterial blood pressure (ABP) and middle cerebral artery (MCA) cerebral blood flow velocity (CBFV) waveforms to derive noninvasive ICP (nICP) estimates. METHODS Invasive ICP and ABP recordings were collected from 12 pediatric and young adult patients (aged 2-25 years) undergoing such monitoring as part of routine clinical care. Additionally, simultaneous transcranial Doppler (TCD) ultrasonography-based MCA CBFV waveform measurements were performed at the bedside in dedicated data collection sessions. The ABP and MCA CBFV waveforms were analyzed in the context of a mathematical model, linking them to the cerebral vasculature's biophysical properties and ICP. The authors developed and automated a waveform preprocessing, signal-quality evaluation, and waveform-synchronization "pipeline" in order to test and objectively validate the algorithm's performance. To generate one nICP estimate, 60 beats of ABP and MCA CBFV waveform data were analyzed. Moving the 60-beat data window forward by one beat at a time (overlapping data windows) resulted in 39,480 ICP-to-nICP comparisons across a total of 44 data-collection sessions (studies). Moving the 60-beat data window forward by 60 beats at a time (nonoverlapping data windows) resulted in 722 paired ICP-to-nICP comparisons. RESULTS Greater than 80% of all nICP estimates fell within +/- 7 mm Hg of the reference measurement. Overall performance in the nonoverlapping data window approach gave a mean error (bias) of 1.0 mm Hg, standard deviation of the error (precision) of 5.1 mm Hg, and root-mean-square error of 5.2 mm Hg. The associated mean and median absolute errors were 4.2 mm Hg and 3.3 mm Hg, respectively. These results were contingent on ensuring adequate ABP and CBFV signal quality and required accurate hydrostatic pressure correction of the measured ABP waveform in relation to the elevation of the external auditory meatus. Notably, the procedure had no failed attempts at data collection, and all patients had adequate TCD data from at least one hemisphere. Last, an analysis of using study-by-study averaged nICP estimates to detect a measured ICP > 15 mm Hg resulted in an area under the receiver operating characteristic curve of 0.83, with a sensitivity of 71% and specificity of 86% for a detection threshold of nICP = 15 mm Hg. CONCLUSIONS This nICP estimation algorithm, based on ABP and bedside TCD CBFV waveform measurements, performs in a manner comparable to invasive ICP monitoring. These findings open the possibility for rational, point-of- care treatment decisions in pediatric patients with suspected raised ICP undergoing intensive care.	[Fanelli, Andrea; Vonberg, Frederick W.; Heldt, Thomas] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Vonberg, Frederick W.; Walsh, Brian K.; Tasker, Robert C.] Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA USA; [LaRovere, Kerri L.; Tasker, Robert C.] Boston Childrens Hosp, Dept Neurol, Boston, MA USA; [Smith, Edward R.; Robinson, Shenandoah] Boston Childrens Hosp, Dept Neurosurg, Boston, MA USA; [Smith, Edward R.; Robinson, Shenandoah] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD USA		Heldt, T (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	thomas@mit.edu			National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 NS084264]; Maxim Integrated Products; Neurocritical Care Chair Award from the Department of Anesthesiology, Critical Care, and Pain Medicine at Boston Children's Hospital	This study was supported, in part, by the National Institute of Neurological Disorders and Stroke (Grant R21 NS084264); Maxim Integrated Products; and from a Neurocritical Care Chair Award from the Department of Anesthesiology, Critical Care, and Pain Medicine at Boston Children's Hospital.	ALTMAN DG, 1986, J EPIDEMIOL COMMUN H, V40, P274, DOI 10.1136/jech.40.3.274; Bennett TD, 2017, JAMA PEDIATR, V171, P965, DOI 10.1001/jamapediatrics.2017.2127; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Constant I, 1999, J CLIN MONIT COMPUT, V15, P205, DOI 10.1023/A:1009989130561; DEMOLIS P, 1993, CLIN SCI, V84, P599, DOI 10.1042/cs0840599; Fanelli A, 2014, IEEE ENG MED BIO, P2233, DOI 10.1109/EMBC.2014.6944063; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; HINGHOFERSZALKAY H, 1979, KLIN WOCHENSCHR, V57, P1163, DOI 10.1007/BF01491756; Kashif FM, 2012, SCI TRANSL MED, V129, P44; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, pS1, DOI 10.1097/PCC.0000000000001735; Kochanek PM, 2019, PEDIATR CRIT CARE ME, V20, P269, DOI 10.1097/PCC.0000000000001737; MAEDA H, 1990, ULTRASOUND MED BIOL, V16, P9, DOI 10.1016/0301-5629(90)90080-V; Noraky J, 2016, ACTA NEUROCHIR SUPPL, V122, P65, DOI 10.1007/978-3-319-22533-3_13; Odetola FO, 2011, PEDIATR CRIT CARE ME, V12, pE350, DOI 10.1097/PCC.0b013e31820abc83; Pietrangelo SJ, 2018, ACTA NEUROCHIR SUPPL, V126, P111, DOI 10.1007/978-3-319-65798-1_24; Robba C, 2018, INTENS CARE MED, V44, P1284, DOI 10.1007/s00134-018-5305-7; Seo Joohyun, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P3817, DOI 10.1109/EMBC.2018.8513259; Seo J, 2018, IEEE T ULTRASON FERR, V65, P766, DOI 10.1109/TUFFC.2018.2812124; TOTARO R, 1992, ULTRASOUND MED BIOL, V18, P173, DOI 10.1016/0301-5629(92)90128-W; van Belle G., 2004, BIOSTATISTICS METHOD; Wadehn F, 2018, ARXIV180609994; Zacchetti L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1137-9; Zong W, 2003, COMPUT CARDIOL, V30, P259, DOI 10.1109/CIC.2003.1291140	23	12	12	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	NOV	2019	24	5					509	519		10.3171/2019.5.PEDS19178			11	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	JJ2IN	WOS:000493985200004	31443086	Bronze			2022-02-06	
J	Madangarli, N; Bonsack, F; Dasari, R; Sukumari-Ramesh, S				Madangarli, Neha; Bonsack, Frederick; Dasari, Rajaneekar; Sukumari-Ramesh, Sangeetha			Intracerebral Hemorrhage: Blood Components and Neurotoxicity	BRAIN SCIENCES			English	Article						ICH; hemin; thrombin; hemoglobin; iron	PROTEASE-ACTIVATED RECEPTOR-1; TRAUMATIC BRAIN INJURY; HEME OXYGENASE; NITRIC-OXIDE; CELL APOPTOSIS; NEURONAL DEATH; MESSENGER-RNA; HEMOGLOBIN; THROMBIN; EXPRESSION	Intracerebral hemorrhage (ICH) is a subtype of stroke which is associated with the highest mortality and morbidity rates of all strokes. Although it is a major public health problem, there is no effective treatment for ICH. As a consequence of ICH, various blood components accumulate in the brain parenchyma and are responsible for much of the secondary brain damage and ICH-induced neurological deficits. Therefore, the strategies that could attenuate the blood component-induced neurotoxicity and improve hematoma resolution are highly needed. The present article provides an overview of blood-induced brain injury after ICH and emphasizes the need to conduct further studies elucidating the mechanisms of hematoma resolution after ICH.	[Madangarli, Neha; Bonsack, Frederick; Dasari, Rajaneekar; Sukumari-Ramesh, Sangeetha] Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, 1120 15th St, Augusta, GA 30912 USA		Sukumari-Ramesh, S (corresponding author), Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, 1120 15th St, Augusta, GA 30912 USA.	nmadangarli@augusta.edu; fbonsack@augusta.edu; rdasari@augusta.edu; sramesh@augusta.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS107853]; American Heart AssociationAmerican Heart Association [14SDG18730034]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS107853] Funding Source: NIH RePORTER	This work was supported by grants from the National Institutes of Health (R01NS107853) and American Heart Association (14SDG18730034) to SS-R.	Abiko Y, 2011, TOXICOL APPL PHARM, V255, P32, DOI 10.1016/j.taap.2011.05.013; Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; An SJ, 2017, J STROKE, V19, P3, DOI 10.5853/jos.2016.00864; Aronowski J, 2011, STROKE, V42, P1781, DOI 10.1161/STROKEAHA.110.596718; Attucks OC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101044; Augustynek B, 2014, EXP NEUROL, V257, P70, DOI 10.1016/j.expneurol.2014.04.022; Babu R, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11366; Bauer M, 2008, INTENS CARE MED, V34, P640, DOI 10.1007/s00134-008-1010-2; Bin Sayeed MS, 2017, J NEUROIMMUNOL, V313, P46, DOI 10.1016/j.jneuroim.2017.10.007; Bonsack F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0619-2; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; BRODERICK JP, 1993, J NEUROSURG, V78, P188, DOI 10.3171/jns.1993.78.2.0188; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; BUNN HF, 1968, J BIOL CHEM, V243, P465; Cai Y, 2011, J IMMUNOL, V187, P1314, DOI 10.4049/jimmunol.1002925; Cao HQ, 2006, AM J PHYSIOL-CELL PH, V290, pC172, DOI 10.1152/ajpcell.00284.2005; Cao SL, 2016, STROKE, V47, P1626, DOI 10.1161/STROKEAHA.116.013146; Caro JJ, 1999, STROKE, V30, P2574, DOI 10.1161/01.STR.30.12.2574; Chen CW, 2012, AUTOPHAGY, V8, P1510, DOI 10.4161/auto.21289; Chen-Roetling J, 2015, STROKE, V46, P1093, DOI 10.1161/STROKEAHA.115.008686; Cheung RTF, 2003, STROKE, V34, P1717, DOI 10.1161/01.STR.0000078657.22835.B9; Chu X, 2018, STROKE, V49, P2473, DOI 10.1161/STROKEAHA.117.019253; Cooper CE, 2013, ANTIOXID REDOX SIGN, V18, P2264, DOI 10.1089/ars.2012.4547; Copple IM, 2012, ADV PHARMACOL, V63, P43, DOI 10.1016/B978-0-12-398339-8.00002-1; Dai SH, 2019, NEUROBIOL DIS, V126, P76, DOI 10.1016/j.nbd.2018.06.001; Dang TN, 2010, GLIA, V58, P55, DOI 10.1002/glia.20901; Dastur CK, 2017, STROKE VASC NEUROL, V2, P21, DOI 10.1136/svn-2016-000047; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Dore S, 2000, NEUROSCIENCE, V99, P587, DOI 10.1016/S0306-4522(00)00216-5; Duan ZZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep29246; DWYER BE, 1995, MOL BRAIN RES, V30, P37, DOI 10.1016/0169-328X(94)00273-H; Elliott J, 2010, ANESTH ANALG, V110, P1419, DOI 10.1213/ANE.0b013e3181d568c8; Etzerodt A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40286; Ewing JF, 1997, BRAIN RES PROTOC, V1, P165, DOI 10.1016/S1385-299X(96)00027-X; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Flaherty ML, 2005, STROKE, V36, P934, DOI 10.1161/01.STR.0000160756.72109.95; Foresti R, 1997, J BIOL CHEM, V272, P18411, DOI 10.1074/jbc.272.29.18411; FUKUDA K, 1995, NEUROSCI LETT, V199, P127, DOI 10.1016/0304-3940(95)12042-3; Ganti L, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/219097; Garton T, 2016, STROKE VASC NEUROL, V1, P172, DOI 10.1136/svn-2016-000042; Garton TP, 2016, BRAIN RES, V1635, P86, DOI 10.1016/j.brainres.2015.12.060; Gazaryan IG, 2016, NEURAL REGEN RES, V11, P1708, DOI 10.4103/1673-5374.194706; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Gong C, 2001, NEUROSURGERY, V48, P875, DOI 10.1097/00006123-200104000-00037; Gram M, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-100; Grossetete M, 2008, J CEREBR BLOOD F MET, V28, P752, DOI 10.1038/sj.jcbfm.9600572; Gu YX, 2009, STROKE, V40, P2241, DOI 10.1161/STROKEAHA.108.539536; Han Ning, 2008, Neurosci Bull, V24, P351, DOI 10.1007/s12264-008-0711-4; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Hewlings SJ, 2017, FOODS, V6, DOI 10.3390/foods6100092; Holfelder K, 2011, HISTOL HISTOPATHOL, V26, P1007, DOI 10.14670/HH-26.1007; Hua Y, 2006, NEUROSURGERY, V58, P542, DOI 10.1227/01.NEU.0000197333.55473.AD; Hua Y, 2006, J NEUROSURG, V104, P305, DOI 10.3171/jns.2006.104.2.305; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Huang FP, 2002, J NEUROSURG, V96, P287, DOI 10.3171/jns.2002.96.2.0287; Huffman LJ, 2000, EXP LUNG RES, V26, P203; ISHIGURO M, 1995, MOL BRAIN RES, V33, P37, DOI 10.1016/0169-328X(95)00104-Z; Jackson CA, 2006, J NEUROL NEUROSUR PS, V77, P1244, DOI 10.1136/jnnp.2006.089292; Kansanen E, 2011, J BIOL CHEM, V286, P14019, DOI 10.1074/jbc.M110.190710; Kawakita Kenya, 2006, J Stroke Cerebrovasc Dis, V15, P88, DOI 10.1016/j.jstrokecerebrovasdis.2006.01.002; Keep RF, 2008, ACT NEUR S, V105, P73; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Koeppen AH, 2004, J NEUROPATH EXP NEUR, V63, P587, DOI 10.1093/jnen/63.6.587; Kress GJ, 2002, J NEUROSCI, V22, P5848; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Lakovic K, 2014, J CEREBR BLOOD F MET, V34, P1837, DOI 10.1038/jcbfm.2014.154; Leclerc JL, 2018, J CEREBR BLOOD F MET, V38, P262, DOI 10.1177/0271678X17701459; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Lee KR, 1997, J NEUROSURG, V87, P73, DOI 10.3171/jns.1997.87.1.0073; Lee KR, 1996, J NEUROSURG, V84, P91, DOI 10.3171/jns.1996.84.1.0091; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; Lin S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-46; Liu DZ, 2008, NEUROBIOL DIS, V30, P201, DOI 10.1016/j.nbd.2008.01.006; Liu R, 2017, STROKE, V48, P1369, DOI 10.1161/STROKEAHA.117.016850; Longbrake EE., 2015, MULT SCLER J EXP TRA, V1, DOI DOI 10.1177/2055217315596994; McDonald JW, 1998, EXP NEUROL, V150, P21, DOI 10.1006/exnr.1997.6762; Melamed-Frank M, 2001, BLOOD, V98, P3693, DOI 10.1182/blood.V98.13.3693; Mendelow AD, 2005, LANCET, V365, P387; Min H, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0305-z; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Morotti A, 2016, EMERG MED CLIN N AM, V34, P883, DOI 10.1016/j.emc.2016.06.010; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Munoz-Sanchez J, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/604981; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; Nakaso K, 2000, NEUROSCI LETT, V293, P49, DOI 10.1016/S0304-3940(00)01491-9; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Panda Abir Kumar, 2017, J Exp Pharmacol, V9, P31, DOI 10.2147/JEP.S70568; Pompili E, 2011, J HISTOCHEM CYTOCHEM, V59, P302, DOI 10.1369/0022155410397996; Qiu Xia, 2009, Zhejiang Da Xue Xue Bao Yi Xue Ban, V38, P572; Qureshi AI, 2007, STROKE, V38, P2180, DOI 10.1161/STROKEAHA.106.467506; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Raju VS, 1997, BBA-GENE STRUCT EXPR, V1351, P89, DOI 10.1016/S0167-4781(96)00183-2; Reed SD, 2001, NEUROLOGY, V57, P305, DOI 10.1212/WNL.57.2.305; Regan RF, 1996, J NEUROTRAUM, V13, P223, DOI 10.1089/neu.1996.13.223; REGAN RF, 1993, NEUROSCI LETT, V153, P219, DOI 10.1016/0304-3940(93)90326-G; Roy-O'Reilly M, 2017, ANN CLIN TRANSL NEUR, V4, P793, DOI 10.1002/acn3.485; SADRZADEH SMH, 1987, J CLIN INVEST, V79, P662, DOI 10.1172/JCI112865; de la Maza SS, 2019, J NEUROL SCI, V398, P4, DOI 10.1016/j.jns.2019.01.007; Schallner N, 2015, J CLIN INVEST, V125, P2609, DOI 10.1172/JCI78443; Stein M, 2012, STROKE, V43, P1126, DOI 10.1161/STROKEAHA.111.644716; Sukumari-Ramesh S, 2010, GLIA, V58, P1858, DOI 10.1002/glia.21055; Sun HQ, 2013, J MOL HISTOL, V44, P369, DOI 10.1007/s10735-013-9489-4; Sun Z, 2009, MOL BIOL REP, V36, P1119, DOI 10.1007/s11033-008-9287-3; Suo ZM, 2002, J NEUROCHEM, V80, P655, DOI 10.1046/j.0022-3042.2001.00745.x; Taylor TN, 1996, STROKE, V27, P1459, DOI 10.1161/01.STR.27.9.1459; Turkseven S, 2007, J CELL BIOCHEM, V100, P815, DOI 10.1002/jcb.21138; Umeano O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081664; Urday S, 2015, STROKE, V46, P1116, DOI 10.1161/STROKEAHA.114.007565; Urday S, 2015, NAT REV NEUROL, V11, P111, DOI 10.1038/nrneurol.2014.264; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; VINCENT SR, 1994, NEUROSCIENCE, V63, P223, DOI 10.1016/0306-4522(94)90018-3; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Wagner KR, 2000, CELL MOL BIOL, V46, P597; Wang GQ, 2015, INT J CLIN EXP PATHO, V8, P10671; Wang H, 2002, GLIA, V37, P53, DOI 10.1002/glia.10012; Wang JA, 2007, FREE RADICAL BIO MED, V43, P408, DOI 10.1016/j.freeradbiomed.2007.04.020; Wang J, 2006, NEUROBIOL DIS, V22, P473, DOI 10.1016/j.nbd.2005.12.009; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Wang X, 2007, J BIOL CHEM, V282, P1718, DOI 10.1074/jbc.M607610200; Weng X, 2015, CHIN J TRAUMATOL, V18, P254, DOI 10.1016/j.cjtee.2015.11.010; WILLMORE LJ, 1982, BRAIN RES, V246, P113, DOI 10.1016/0006-8993(82)90147-0; Woo D, 2002, NEUROSURG CLIN N AM, V13, P265, DOI 10.1016/S1042-3680(02)00011-6; Wu H, 2011, J CEREBR BLOOD F MET, V31, P1243, DOI 10.1038/jcbfm.2010.209; Xi G, 2003, ACT NEUR S, V86, P449; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 2001, BRAIN RES, V895, P153, DOI 10.1016/S0006-8993(01)02064-9; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Xie WJ, 2016, NEURAL REGEN RES, V11, P1122, DOI 10.4103/1673-5374.187047; Yang SX, 2008, STROKE, V39, P2079, DOI 10.1161/STROKEAHA.107.508911; Yang Y, 2017, EXP CELL RES, V361, P217, DOI 10.1016/j.yexcr.2017.10.020; Yang Y, 2015, NEUROSCI LETT, V599, P133, DOI 10.1016/j.neulet.2015.05.049; Ye XC, 2017, BIOCHEM BIOPH RES CO, V485, P499, DOI 10.1016/j.bbrc.2017.02.019; Zhang Z, 2017, J CEREBR BLOOD F MET, V37, P25, DOI 10.1177/0271678X16655814; Zhao L, 2014, J NEUROCHEM, V131, P147, DOI [10.1111/jnc.12807, 10.1111/jnc.12974]; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506; Zhao XR, 2009, J NEUROSCI, V29, P15819, DOI 10.1523/JNEUROSCI.3776-09.2009; Zhu XX, 2012, STROKE, V43, P524, DOI 10.1161/STROKEAHA.111.635672	140	12	12	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	NOV	2019	9	11							316	10.3390/brainsci9110316			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JV3NV	WOS:000502273900027	31717522	gold, Green Published			2022-02-06	
J	Wu, LM; Chung, JY; Saith, S; Tozzi, L; Buckley, EM; Sanders, B; Franceschini, MA; Lule, S; Izzy, S; Lok, J; Edmiston, WJ; McAllister, LM; Mebane, S; Jin, G; Lu, JX; Sherwood, JS; Willwerth, S; Hickman, S; El Khoury, J; Lo, EH; Kaplan, D; Whalen, MJ				Wu, Limin; Chung, Joon Y.; Saith, Shivani; Tozzi, Lorenzo; Buckley, Erin M.; Sanders, Bharat; Franceschini, Maria A.; Lule, Sevda; Izzy, Saef; Lok, Josephine; Edmiston, William J., III; McAllister, Lauren M.; Mebane, Sloane; Jin, Gina; Lu, Jiaxi; Sherwood, John S.; Willwerth, Sarah; Hickman, Suzanne; El Khoury, Joseph; Lo, Eng H.; Kaplan, David; Whalen, Michael J.			Repetitive head injury in adolescent mice: A role for vascular inflammation	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Animal model; brain trauma; cerebral blood flow; endothelium; inflammation	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; PROFESSIONAL FOOTBALL; SPORT CONCUSSION; 1ST EXPOSURE; CHILDREN; NEUTRALIZATION; SYMPTOMS; DISORDER; RECEPTOR	Repetitive mild traumatic brain injury during adolescence can induce neurological dysfunction through undefined mechanisms. Interleukin-1 (IL-1) contributes to experimental adult diffuse and contusion TBI models, and IL-1 antagonists have entered clinical trials for severe TBI in adults; however, no such data exist for adolescent TBI. We developed an adolescent mouse repetitive closed head injury (rCHI) model to test the role of IL-1 family members in post-injury neurological outcome. Compared to one CHI, three daily injuries (3HD) produced acute and chronic learning deficits and emergence of hyperactivity, without detectable gliosis, neurodegeneration, brain atrophy, and white matter loss at one year. Mature IL-1 beta and IL-18 were induced in brain endothelium in 3HD but not 1HD, three hit weekly, or sham animals. IL-1 beta processing was induced cell-autonomously in three-dimensional human endothelial cell cultures subjected to in vitro concussive trauma. Mice deficient in IL-1 receptor-1 or caspase-1 had improved post-injury Morris water maze performance. Repetitive mild CHI in adolescent mice may induce behavioral deficits in the absence of significant histopathology. The endothelium is a potential source of IL-1 beta and IL-18 in rCHI, and IL-1 family members may be therapeutic targets to reduce or prevent neurological dysfunction after repetitive mild TBI in adolescents.	[Wu, Limin; Chung, Joon Y.; Saith, Shivani; Lule, Sevda; Lok, Josephine; Edmiston, William J., III; McAllister, Lauren M.; Mebane, Sloane; Jin, Gina; Lu, Jiaxi; Sherwood, John S.; Willwerth, Sarah; Whalen, Michael J.] Harvard Med Sch, Massachusetts Gen Hosp, Neurosci Ctr, 149 13th St, Charlestown, MA 02129 USA; [Wu, Limin; Chung, Joon Y.; Saith, Shivani; Lule, Sevda; Lok, Josephine; Edmiston, William J., III; McAllister, Lauren M.; Mebane, Sloane; Jin, Gina; Lu, Jiaxi; Sherwood, John S.; Willwerth, Sarah; Whalen, Michael J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02115 USA; [Tozzi, Lorenzo; Kaplan, David] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Buckley, Erin M.; Sanders, Bharat] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Buckley, Erin M.; Sanders, Bharat] Emory Univ, Atlanta, GA 30322 USA; [Buckley, Erin M.; Lo, Eng H.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Franceschini, Maria A.; Lo, Eng H.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Izzy, Saef] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Hickman, Suzanne; El Khoury, Joseph] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Dept Med, Boston, MA 02115 USA; [Lo, Eng H.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA		Whalen, MJ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Neurosci Ctr, 149 13th St, Charlestown, MA 02129 USA.	mwhalen@mgh.harvard.edu	Franceschini, Maria Angela/AAV-5397-2021; Lule, Sevda/N-8229-2017	Lu, Jiaxi/0000-0001-5076-3047; Lule, Sevda/0000-0001-7066-6471; Chung, Joon Yong/0000-0002-3980-2065	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD086385] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1 AG051506] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21 HD086385] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS091573, R01 NS092847] Funding Source: Medline		Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buckley EM, 2015, J CEREBR BLOOD F MET, V35, P1995, DOI 10.1038/jcbfm.2015.161; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Ekmark-Lewen S, 2016, EUR J NEUROSCI, V43, P1016, DOI 10.1111/ejn.13190; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Grant DA, 2018, J NEUROTRAUM, V35, P94, DOI 10.1089/neu.2017.5042; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; KOSTRZEWA RM, 1994, BRAIN RES BULL, V34, P161, DOI 10.1016/0361-9230(94)90013-2; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lim YC, 2003, AM J PATHOL, V162, P1591, DOI 10.1016/S0002-9440(10)64293-9; Mannix R, 2017, J NEUROTRAUM, V34, P495, DOI 10.1089/neu.2016.4457; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mendiola AS, 2018, J NEURAL TRANSM, V125, P781, DOI 10.1007/s00702-017-1732-9; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Ommaya AK, 1967, SCALING EXPT DATA CE, P1; Pooters T, 2016, BEHAV BRAIN RES, V298, P134, DOI 10.1016/j.bbr.2015.11.001; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Resch JE, 2017, CLIN SPORT MED, V36, P717, DOI 10.1016/j.csm.2017.05.002; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Semple BD, 2017, J NEUROSCI, V37, P7864, DOI 10.1523/JNEUROSCI.0982-17.2017; Semple BD, 2016, DEV NEUROSCI-BASEL, V38, P220, DOI 10.1159/000448089; Smith DE, 2009, IMMUNITY, V30, P817, DOI 10.1016/j.immuni.2009.03.020; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sosa MAG, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0483-z; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stephens JA, 2018, J NEUROTRAUM, V35, P241, DOI 10.1089/neu.2017.5237; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tang-Schomer MD, 2014, P NATL ACAD SCI USA, V111, P13811, DOI 10.1073/pnas.1324214111; Velosky AG, 2017, BEHAV BRAIN RES, V324, P115, DOI 10.1016/j.bbr.2017.02.017; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113	53	12	12	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	2019	39	11					2196	2209		10.1177/0271678X18786633			14	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	JR9MK	WOS:000499940200009	30001646	Bronze, Green Published			2022-02-06	
J	Naeser, MA; Ho, MD; Martin, PI; Hamblin, MR; Koo, BB				Naeser, Margaret A.; Ho, Michael D.; Martin, Paula, I; Hamblin, Michael R.; Koo, Bang-Bon			Increased Functional Connectivity Within Intrinsic Neural Networks in Chronic Stroke Following Treatment With Red/Near-Infrared Transcranial Photobiomodulation: Case Series With Improved Naming in Aphasia	PHOTOBIOMODULATION PHOTOMEDICINE AND LASER SURGERY			English	Article						stroke; aphasia treatment; PBM; default mode network; functional connectivity; fMRI	DEFAULT-MODE NETWORK; LASER-LIGHT THERAPY; TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; MAGNETIC STIMULATION; NONFLUENT APHASIA; ANOMIA TREATMENT; RECOVERY; LANGUAGE; PERFORMANCE	Objective: To examine effects of four different transcranial, red/near-infrared (NIR), light-emitting diode (tLED) protocols on naming ability in persons with aphasia (PWA) due to left hemisphere (LH) stroke. This is the first study to report beneficial effects from tLED therapy in chronic stroke, and parallel changes on functional magnetic resonance imaging (fMRI). Materials and methods: Six PWA, 2-18 years poststroke, in whom 18 tLED treatments were applied (3 x /week, 6 weeks) using LED cluster heads: 500 mW, red (633 nm) and NIR (870 nm), 22.48 cm(2), 22.2 mW/cm(2). Results: After Protocol A with bilateral LED placements, including midline, at scalp vertex over left and right supplementary motor areas (L and R SMAs), picture naming was not improved. P1 underwent pre-/postovert, picture-naming task-fMRI scans; P2 could not. After Protocol A, P1 showed increased activation in LH and right hemisphere, including L and R SMAs. After Protocol B with LEDs only on ipsilesional, LH side, naming ability significantly improved for P1 and P2; the fMRI scans for P1 then showed activation only on the ipsilesional LH side. After Protocol C with LED placements on ipsilesional LH side, plus one midline placement over mesial prefrontal cortex (mPFC) at front hairline, a cortical node of the default mode network (DMN), P3 and P4 had only moderate/poor response, and no increase in functional connectivity on resting-state functional-connectivity MRI. After Protocol D, however, with LED placements on ipsilesional LH side, plus over two midline nodes of DMN, mPFC, and precuneus (high parietal) simultaneously, P5 and P6 each had good response with significant increase in functional connectivity within DMN, p < 0.0005; salience network, p < 0.0005; and central executive network, p < 0.05. Conclusions: NIR photons can affect surface brain cortex areas subjacent to where LEDs are applied on the scalp. Improved naming ability was present with optimal Protocol D. Transcranial photobiomodulation may be an additional noninvasive therapy for stroke.	[Naeser, Margaret A.; Ho, Michael D.; Martin, Paula, I] VA Boston Healthcare Syst 12A, Jamaica Plain Campus,150 So Huntington Ave, Boston, MA 02130 USA; [Naeser, Margaret A.; Martin, Paula, I] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Hamblin, Michael R.] Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA; [Hamblin, Michael R.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA USA; [Koo, Bang-Bon] Boston Univ, Sch Med, Dept Anat & Neurobiol, Brain Imaging & Informat Lab BIL, Boston, MA 02118 USA		Naeser, MA (corresponding author), VA Boston Healthcare Syst 12A, Jamaica Plain Campus,150 So Huntington Ave, Boston, MA 02130 USA.	mnaeser@bu.edu	Hamblin, Michael R/H-2758-2019	Hamblin, Michael R/0000-0001-6431-4605; Ho, Michael/0000-0002-6648-7806	Boston VA Research Institute (BVARI); Department of Veterans AffairsUS Department of Veterans Affairs	The authors thank Andrea Fedoruk for invaluable assistance with article preparation; Ethan Treglia, MS, CCC-SLP, for language testing; and Ronald J. Killiany, PhD, Director, Boston University Center for Biomedical Imaging, and Andy Ellison, MR Technologist, for assistance with MRI acquisition. The MedX Health LED equipment was purchased through funding from the Boston VA Research Institute (BVARI); the authors thank Anita Saltmarche, BScN, MHSc, for assistance with MedX Health, Toronto. The research was supported by the Department of Veterans Affairs. NCT: NCT00467103.	Belin P, 1996, NEUROLOGY, V47, P1504, DOI 10.1212/WNL.47.6.1504; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Brownsett SLE, 2014, BRAIN, V137, P242, DOI 10.1093/brain/awt289; BUCHMAN AS, 1986, J NEUROL NEUROSUR PS, V49, P489, DOI 10.1136/jnnp.49.5.489; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Catani M, 2013, BRAIN, V136, P2619, DOI 10.1093/brain/awt163; Chao LL, 2019, PHOTOBIOMODULATION P, V37, P133, DOI 10.1089/photob.2018.4555; Cornelissen K, 2003, J COGNITIVE NEUROSCI, V15, P444, DOI 10.1162/089892903321593153; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; DAMASIO H, 1979, NEUROLOGY, V29, P644, DOI 10.1212/WNL.29.5.644; de Freitas LF, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2016.2561201; De Taboada L, 2011, J ALZHEIMERS DIS, V23, P521, DOI 10.3233/JAD-2010-100894; Dijkhuizen RM, 2014, CURR OPIN NEUROL, V27, P637, DOI 10.1097/WCO.0000000000000150; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fernandez B, 2004, STROKE, V35, P2171, DOI 10.1161/01.STR.0000139323.76769.b0; Ferraresi C, 2015, PHOTOCHEM PHOTOBIOL, V91, P411, DOI 10.1111/php.12397; Ford A, 2010, NEUROIMAGE, V52, P1230, DOI 10.1016/j.neuroimage.2010.05.018; Fridriksson J, 2007, NEUROPSYCHOLOGIA, V45, P1812, DOI 10.1016/j.neuropsychologia.2006.12.017; Fridriksson J, 2006, NEUROIMAGE, V32, P1403, DOI 10.1016/j.neuroimage.2006.04.194; Geranmayeh F, 2014, BRAIN, V137, P2632, DOI 10.1093/brain/awu163; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hamblin MR, 2017, AIMS BIOPHYS, V4, P337, DOI 10.3934/biophy.2017.3.337; Heiss WD, 2006, BRAIN LANG, V98, P118, DOI 10.1016/j.bandl.2006.02.002; Hipskind SG, 2018, PHOTOMED LASER SURG, DOI 10.1089/pho.2018.4489; Ho M. D., 2016, J INT NEUROPSYCH SOC, V22, P229; Huang YY, 2013, J BIOPHOTONICS, V6, P829, DOI 10.1002/jbio.201200157; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Kaplan E, 1983, BOSTON NAMING TEST; Kaplan E., 2001, ASSESSMENT APHASIA R; Karu TI, 2005, LASER SURG MED, V36, P307, DOI 10.1002/lsm.20148; KARU TI, 1994, B EXP BIOL MED+, V117, P679, DOI 10.1007/BF02444354; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; KOSEL KC, 1981, J COMP NEUROL, V198, P467, DOI 10.1002/cne.901980307; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Lefaucheur JP, 2006, NEUROPHYSIOL CLIN, V36, P105, DOI 10.1016/j.neucli.2006.08.011; Leger A, 2002, NEUROIMAGE, V17, P174, DOI 10.1006/nimg.2002.1238; Marcotte K, 2013, BRAIN LANG, V124, P45, DOI 10.1016/j.bandl.2012.11.004; Martin PI, 2009, BRAIN LANG, V111, P20, DOI 10.1016/j.bandl.2009.07.007; Martin PI, 2005, NEUROIMAGE, V28, P194, DOI 10.1016/j.neuroimage.2005.05.037; Meinzer M, 2008, NEUROIMAGE, V39, P2038, DOI 10.1016/j.neuroimage.2007.10.008; MESTER E, 1971, AM J SURG, V122, P532, DOI 10.1016/0002-9610(71)90482-X; Naeser M, 2012, PROCD SOC BEHV, V61, P138, DOI 10.1016/j.sbspro.2012.10.116; NAESER MA, 1989, BRAIN, V112, P1, DOI 10.1093/brain/112.1.1; Naeser MA, 2004, NEUROIMAGE, V22, P29, DOI 10.1016/j.neuroimage.2003.11.016; Naeser MA, 2016, PHOTOMED LASER SURG, V34, P610, DOI 10.1089/pho.2015.4037; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2012, ARCH PHYS MED REHAB, V93, pS26, DOI 10.1016/j.apmr.2011.04.026; Nawashiro H, 2012, PHOTOMED LASER SURG, V30, P231, DOI 10.1089/pho.2011.3044; Park JY, 2014, EUR J NEUROSCI, V40, P2715, DOI 10.1111/ejn.12640; Petrella JR, 2011, NEUROLOGY, V76, P511, DOI 10.1212/WNL.0b013e31820af94e; Postman-Caucheteux WA, 2010, J COGNITIVE NEUROSCI, V22, P1299, DOI 10.1162/jocn.2009.21261; Ren CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102557; Roach A., 1996, CLIN APHASIOLOGY, V24, P121, DOI DOI 10.1037/t56477-000; Rochon E, 2010, BRAIN LANG, V114, P164, DOI 10.1016/j.bandl.2010.05.005; Rosen HJ, 2000, NEUROLOGY, V55, P1883, DOI 10.1212/WNL.55.12.1883; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Saltmarche AE, 2017, PHOTOMED LASER SURG, V35, P432, DOI 10.1089/pho.2016.4227; Saur D, 2006, BRAIN, V129, P1371, DOI 10.1093/brain/awl090; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Shin L., 2005, STRUCTURAL FUNCTIONA; Siedentopf CM, 2002, NEUROSCI LETT, V327, P53, DOI 10.1016/S0304-3940(02)00383-X; Simic G, 2014, CNS NEUROSCI THER, V20, P692, DOI 10.1111/cns.12260; Skipper-Kallal LM, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/8740353; Small SL, 1998, BRAIN LANG, V62, P298, DOI 10.1006/brln.1998.1951; Sompol P, 2006, J MOL NEUROSCI, V29, P279, DOI 10.1385/JMN:29:3:279; Stemer Andrew B, 2010, Curr Cardiol Rep, V12, P29, DOI 10.1007/s11886-009-0071-3; Tedford CE, 2015, LASER SURG MED, V47, P312, DOI 10.1002/lsm.22343; Thunshelle C, 2016, PHOTOMED LASER SURG, V34, P587, DOI 10.1089/pho.2015.4051; Tuladhar AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066556; Uozumi Y, 2010, LASER SURG MED, V42, P566, DOI 10.1002/lsm.20938; Utevsky AV, 2014, J NEUROSCI, V34, P932, DOI 10.1523/JNEUROSCI.4227-13.2014; van de Ven V, 2009, NEUROIMAGE, V47, P1982, DOI 10.1016/j.neuroimage.2009.05.057; Voloboueva LA, 2011, J NEUROSCI RES, V89, P1989, DOI 10.1002/jnr.22768; WAN S, 1981, PHOTOCHEM PHOTOBIOL, V34, P679, DOI 10.1111/j.1751-1097.1981.tb09424.x; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Xuan WJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.108003; ZHANG YH, 1994, INFECT IMMUN, V62, P4140, DOI 10.1128/IAI.62.10.4140-4144.1994; Zhao JX, 2012, J ATHL TRAINING, V47, P673, DOI 10.4085/1062-6050-47.6.08; Zivin JA, 2009, STROKE, V40, P1359, DOI 10.1161/STROKEAHA.109.547547	83	12	13	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2578-5478		PHOTOBIOMOD PHOTOMED	Photobiomodulation Photomed. Laser Surg.	FEB 1	2020	38	2					115	131		10.1089/photob.2019.4630		OCT 2019	17	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	KL3NK	WOS:000490954500001	31621498				2022-02-06	
J	Guo, SW; Zhen, YW; Zhu, ZQ; Zhou, GS; Zheng, XY				Guo, Shewei; Zhen, Yingwei; Zhu, Zhiqiang; Zhou, Guosheng; Zheng, Xiangyu			Cinnamic acid rescues behavioral deficits in a mouse model of traumatic brain injury by targeting miR-455-3p/HDAC2	LIFE SCIENCES			English	Article						HDAC2; Memory impairments; miRNA; Dendritic spines; Cinnamic acid; TBI	HISTONE DEACETYLASE INHIBITORS; CLOSED-HEAD INJURY; OXIDATIVE STRESS; MEMORY DEFICITS; DEMENTIA; PATHOPHYSIOLOGY; DEATH; ONSET; RISK; MICE	Aims: Traumatic brain injury (TBI) not only induces physiological disabilities but also leads to cognitive impairment. However, no effective therapeutic approach for TBI-related memory decline exists. In this study, we treated TBI mice with cinnamic acid (CNA) to detect whether CNA is able to rescue the memory deficits induced by TBI and to explore the potential mechanisms. Main methods: Mice were divided into the following groups: the sham group, the TBI group, the TBI + CNA group and the CNA group. Basic physiological parameters, neurological severity score and brain water content were analyzed. The Morris water maze and inhibitory avoidance step-down task were used to determine learning and memory. Golgi staining was used to measure alterations in dendritic spines. Western blot analysis and a commercial kit were used to detect the content and activity of HDAC2. qPCR was used to detect the relative level of miR-455. Key findings: CNA did not affect physiological function but effectively restored neurological function and brain edema. CNA alleviated the memory impairments induced by TBI in both the Morris water maze and step-down task. CNA also recovered abnormalities in the synapses of TBI mice by suppressing the activity of HDAC2. Furthermore, CNA did not alter HDAC mRNA because it promoted the expression of miR-455-3p, a miRNA that regulates HDAC2 at the posttranscriptional level. Significance: The application of CNA effectively treats TBI-induced memory deficits by increasing miR-455-3p and by inhibiting HDAC2.	[Guo, Shewei; Zhen, Yingwei; Zhou, Guosheng] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurosurg, 1 Jian She Dong Ave, Zhengzhou 450002, Henan, Peoples R China; [Zhu, Zhiqiang] Zhengzhou Univ, Affiliated Hosp 1, Dept Emergency Surg, Zhengzhou, Henan, Peoples R China; [Zheng, Xiangyu] Zhengzhou Univ, Affiliated Hosp 1, Dept Pathol, Zhengzhou, Henan, Peoples R China		Guo, SW (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Neurosurg, 1 Jian She Dong Ave, Zhengzhou 450002, Henan, Peoples R China.	zdy_neurosurgery@163.com			General Fund of The First Affiliated Hospital of Zhengzhou University	We thank Dr. Na Wei at Department of Pathology of our hospital for her help during the experiments and manuscript preparation. This work was supported by the General Fund of The First Affiliated Hospital of Zhengzhou University.	Almeida OP, 2015, INT J GERIATR PSYCH, V30, P1215, DOI 10.1002/gps.4276; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Anantharaju PG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186208; Chandra S, 2019, NEUROBIOL DIS, V124, P379, DOI 10.1016/j.nbd.2018.12.007; Chen C, 2018, J ALZHEIMERS DIS, V63, P445, DOI [10.3233/jad-171170, 10.3233/JAD-171170]; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Dallavalle S, 2009, EUR J MED CHEM, V44, P1900, DOI 10.1016/j.ejmech.2008.11.005; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Downing LE, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600347; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gibson CL, 2010, J NEUROCHEM, V115, P806, DOI 10.1111/j.1471-4159.2010.06993.x; Gonzalez-Zuniga M, 2014, MOL CELL, V56, P163, DOI 10.1016/j.molcel.2014.08.013; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hafizur RM, 2015, PHYTOMEDICINE, V22, P297, DOI 10.1016/j.phymed.2015.01.003; HATASHITA S, 1988, J CEREBR BLOOD F MET, V8, P552, DOI 10.1038/jcbfm.1988.96; Hemmati AA, 2018, KOREAN J PHYSIOL PHA, V22, P257, DOI 10.4196/kjpp.2018.22.3.257; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Huang DW, 2012, J FUNCT FOODS, V4, P358, DOI 10.1016/j.jff.2012.01.005; Jiang JY, 2019, LANCET NEUROL, V18, P286, DOI 10.1016/S1474-4422(18)30469-1; Kumar S, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00041; Leal G, 2017, VITAM HORM, V104, P153, DOI 10.1016/bs.vh.2016.10.004; Lepeta K, 2016, J NEUROCHEM, V138, P785, DOI 10.1111/jnc.13713; Liu DA, 2017, MOL THER, V25, P752, DOI 10.1016/j.ymthe.2017.01.018; Liu X, 2018, J NAT PROD, V81, P1333, DOI 10.1021/acs.jnatprod.7b00924; Lu J, 2013, P NATL ACAD SCI USA, V110, P10747, DOI 10.1073/pnas.1308950110; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Patra K, 2012, CHEM-BIOL INTERACT, V195, P231, DOI 10.1016/j.cbi.2012.01.001; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Phillips M, 2015, NEUROSCI LETT, V601, P30, DOI 10.1016/j.neulet.2015.01.011; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Prorok T, 2019, NEUROCHEM RES, V44, P751, DOI 10.1007/s11064-018-02705-0; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; Schaffert J, 2018, NEUROPSYCHOLOGY, V32, P410, DOI 10.1037/neu0000423; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; Shimada Y, 2000, PHYTOTHER RES, V14, P466, DOI 10.1002/1099-1573(200009)14:6&lt;466::AID-PTR614&gt;3.0.CO;2-Z; Song F, 2013, J ETHNOPHARMACOL, V150, P125, DOI 10.1016/j.jep.2013.08.019; Song SS, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00336; Su Y, 2019, BIOL PSYCHIAT, V85, P769, DOI 10.1016/j.biopsych.2018.12.008; Sugiura H, 2012, AM J PHYSIOL-LUNG C, V302, pL764, DOI 10.1152/ajplung.00342.2011; Sung YM, 2013, EXP NEUROL, V239, P192, DOI 10.1016/j.expneurol.2012.10.005; Tang H, 2019, AGING CELL, V18, DOI 10.1111/acel.12902; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang X, 2018, BIOL PSYCHIAT, V83, P395, DOI 10.1016/j.biopsych.2017.07.023; Zhu BY, 2016, MOL MED REP, V13, P4159, DOI 10.3892/mmr.2016.5041	51	12	12	1	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	OCT 15	2019	235								116819	10.1016/j.lfs.2019.116819			9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	JG8RS	WOS:000492345900016	31473194				2022-02-06	
J	Giacino, JT; Sherer, M; Christoforou, A; Maurer-Karattup, P; Hammond, FM; Long, D; Bagiella, E				Giacino, Joseph T.; Sherer, Mark; Christoforou, Andrea; Maurer-Karattup, Petra; Hammond, Flora M.; Long, David; Bagiella, Emilia			Behavioral Recovery and Early Decision Making in Patients with Prolonged Disturbance in Consciousness after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						consciousness; MCS; outcome research; TBI; VS	INPATIENT REHABILITATION; DISORDERS; SCALE; COMA; PREDICTORS; NETWORK; VERSION	The extent of behavioral recovery that occurs in patients with traumatic disorders of consciousness (DoC) following discharge from the acute care setting has been under-studied and increases the risk of overly pessimistic outcome prediction. The aim of this observational cohort study was to systematically track behavioral and functional recovery in patients with prolonged traumatic DoC following discharge from the acute care setting. Standardized behavioral data were acquired from 95 patients in a minimally conscious (MCS) or vegetative state (VS) recruited from 11 clinic sites and randomly assigned to the placebo arm of a previously completed prospective clinical trial. Patients were followed for 6 weeks by blinded observers to determine frequency of recovery of six target behaviors associated with functional status. The Coma Recovery Scale-Revised and Disability Rating Scale were used to track reemergence of target behaviors and assess degree of functional disability, respectively. Twenty percent (95% confidence interval [CI]: 13-30%) of participants (mean age 37.2; median 47 days post-injury; 69 men) recovered all six target behaviors within the 6 week observation period. The odds of recovering a specific target behavior were 3.2 (95% CI: 1.2-8.1) to 7.8 (95% CI: 2.7-23.0) times higher for patients in MCS than for those in VS. Patients with preserved language function ("MCS+") recovered the most behaviors (p <= 0.002) and had the least disability (p <= 0.002) at follow-up. These findings suggest that recovery of high-level behaviors underpinning functional independence is common in patients with prolonged traumatic DoC. Clinicians involved in early prognostic counseling should recognize that failure to emerge from traumatic DoC before 28 days does not necessarily portend unfavorable outcome.	[Giacino, Joseph T.; Christoforou, Andrea] Spaulding Rehabil Hosp, Charlestown, MA 02129 USA; [Giacino, Joseph T.; Christoforou, Andrea] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Giacino, Joseph T.] JFK Johnson Rehabil Inst, Edison, NJ USA; [Sherer, Mark] Methodist Rehabil Ctr, Jackson, MS USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Maurer-Karattup, Petra] SRH Fachkrankenhaus Neresheim, Neresheim, Germany; [Hammond, Flora M.] Carolinas Rehabil, Dept Phys Med & Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Long, David] Bryn Mawr Rehab Hosp, Brain Injury Program, Malvern, PA USA; [Bagiella, Emilia] Icahn Sch Med Mt Sinai, Ctr Biostat, New York, NY 10029 USA		Giacino, JT (corresponding author), Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 300 First Ave, Charlestown, MA 02129 USA.	jgiacino@mgh.harvard.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698	National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services; National Institute on Disability and Rehabilitation Research (NIDRR), United States Department of Education [H133A031713]; National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR), Administration for Community Living [90DP0039, 90DP0036, 90DP0028]; Department of DefenseUnited States Department of Defense [W81XWH-14-2-0176]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1U01NS086090, N5065980]; serves on the board of the Brain Injury Association of Pennsylvania; 2015 Council on Brain Injury (COBI) award; NIDILRRUnited States Department of Health & Human Services [90DP0028, 90RT5007, 90DP0060]; National Heart, Lung, and Blood Institute (NHLBI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5U01HL088942-08]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R03NS079875-01A1, 6R37NS043209-14]; NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM111239-01A1]; NHGRIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI) [3U01HG007278-03S1]; NIDDKUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [1R01DK102420-01A1]; NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [1R01CA163772-01A1]; James S. McDonnell Foundation	The contents of this manuscript were developed with grant funding by the National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR), formerly The National Institute on Disability and Rehabilitation Research (NIDRR). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). This article does not reflect the official policy or opinions of NIDILRR or HHS and does not constitute an endorsement by NIDILRR, HHS, or other components of the federal government. NIDILRR had no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication. Dr. Joseph T. Giacino had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The data utilized in this manuscript and the authors' contributions were made possible by grant support from the National Institute on Disability and Rehabilitation Research (NIDRR), United States Department of Education (Award #H133A031713: JFK-Johnson Rehabilitation Institute TBI Model System). Drs. Giacino, Hammond, and Sherer's contributions were also partially supported by awards from the National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR), Administration for Community Living (Award #s 90DP0039, Spaulding-Harvard TBI Model System; 90DP0036, Indiana University TBI Model System; and 90DP0028, TIRR TBI Model System). Dr. Christoforou receives research support from the Department of Defense (grant #W81XWH-14-2-0176). Dr. Long has received financial support through NIH grant N5065980, serves on the board of the Brain Injury Association of Pennsylvania, and is a recipient of the 2015 Council on Brain Injury (COBI) award. Dr. Sherer' research is funded by NIDILRR grants #90DP0028, 90RT5007, and 90DP0060 as well as NIH grant #1U01NS086090. Dr. Bagiella receives funding from National Heart, Lung, and Blood Institute (NHLBI) grant 5U01HL088942-08; NINDS grants 1R03NS079875-01A1 and 6R37NS043209-14, AHRQ grant 5R01HS0229-03; NCATS grant 1UL1TR001433-01; NIGMS grant R25GM111239-01A1; NHGRI grant 3U01HG007278-03S1; NIDDK grant 1R01DK102420-01A1; NCI grant 1R01CA163772-01A1; and the James S. McDonnell Foundation. The contents of this manuscript do not necessarily represent the policy of the U.S. Department of Health and Human Services, and endorsement by the federal government should not be assumed.	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Dolce G, 2011, J NEUROTRAUM, V28, P1149, DOI 10.1089/neu.2010.1405; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Fins JJ, 2003, NAT REV NEUROSCI, V4, P323, DOI 10.1038/nrn1079; Fins JJ, 2015, RIGHTS COME MIND BRA; Giacino JT, 2018, NEUROLOGY, V91, P450, DOI 10.1212/WNL.0000000000005926; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; HOLM S, 1979, SCAND J STAT, V6, P65; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; JENNETT B, 1975, LANCET, V1, P480; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Monti MM, 2015, NEUROLOGY, V84, P167, DOI 10.1212/WNL.0000000000001123; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Noe E, 2012, ARCH PHYS MED REHAB, V93, P428, DOI 10.1016/j.apmr.2011.08.048; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROSENBERG JH, 1995, NEUROLOGY, V45, P1015; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shiel A, 2005, NEUROPSYCHOL REHABIL, V15, P494, DOI 10.1080/09602010443000551; Stender J, 2014, LANCET, V384, P514, DOI 10.1016/S0140-6736(14)60042-8; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Whyte J, 2009, PROG BRAIN RES, V177, P63, DOI 10.1016/S0079-6123(09)17706-3; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Wu XH, 2015, J NEUROSCI, V35, P12932, DOI 10.1523/JNEUROSCI.0415-15.2015; Zheng ZS, 2017, HUM BRAIN MAPP, V38, P431, DOI 10.1002/hbm.23370	35	12	12	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					357	365		10.1089/neu.2019.6429		OCT 2019	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000489735100001	31502498	Green Submitted, Green Published, hybrid			2022-02-06	
J	Chung, JS; Zynda, AJ; Didehbani, N; Hicks, C; Hynan, LS; Miller, SM; Bell, KR; Cullum, CM				Chung, Jane S.; Zynda, Aaron J.; Didehbani, Nyaz; Hicks, Cason; Hynan, Linda S.; Miller, Shane M.; Bell, Kathleen R.; Cullum, C. Munro			Association Between Sleep Quality and Recovery Following Sport-Related Concussion in Pediatrics	JOURNAL OF CHILD NEUROLOGY			English	Article						brain; concussion; pediatric; outcome; sleep	TRAUMATIC BRAIN-INJURY; BASE-LINE; OF-LIFE; INDEX; PREVALENCE; PERFORMANCE; DISTURBANCE; IMPACT; SAMPLE	Our objective was to determine the association between sleep quality, symptom severity, and recovery following sport-related concussion in pediatric athletes. A review of data from the North Texas Concussion Network Prospective Registry (ConTex) was performed. Participants were diagnosed with a sport-related concussion and were <= 18 years old. Participants were categorized based on their initial clinic visit Pittsburgh Sleep Quality Index composite score (0-21) into good sleep quality (GS <= 5) and poor sleep quality (PS>5) groups. The PS group reported higher median total symptom scores at 3-month follow-up (3.0 vs 0.0, P < .01) and took more than a median of 2 weeks longer to recover compared to the GS group (35.0 days vs 20.0 days, P < .01). Poor sleep quality was strongly associated with greater symptom severity and longer time to recovery following sport-related concussion. Early recognition of concussed athletes with poor sleep quality at initial clinic visit may help predict prolonged recovery.	[Chung, Jane S.; Zynda, Aaron J.; Miller, Shane M.] Texas Scottish Rite Hosp Children, 2222 Welborn St, Dallas, TX 75219 USA; [Chung, Jane S.; Didehbani, Nyaz; Hicks, Cason; Hynan, Linda S.; Miller, Shane M.; Bell, Kathleen R.; Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA		Chung, JS (corresponding author), Texas Scottish Rite Hosp Children, 2222 Welborn St, Dallas, TX 75219 USA.	jane.chung@tsrh.org	Cullum, C. Munro/AAC-2496-2019; Zynda, Aaron/P-5353-2018	Cullum, C. Munro/0000-0001-9706-5465; Miller, Shane/0000-0001-5002-5095; Zynda, Aaron/0000-0003-0663-7320; Bell, Kathleen/0000-0002-0928-2046	Texas Institute for Brain Injury and Repair at UT Southwestern Medical Center	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Support for this study was funded by the Texas Institute for Brain Injury and Repair at UT Southwestern Medical Center.	[Anonymous], 2013, Br J Sports Med, V47, P259; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Beck SL, 2004, J PAIN SYMPTOM MANAG, V27, P140, DOI 10.1016/j.jpainsymman.2003.12.002; Bramley H, 2017, CLIN PEDIATR, V56, P1280, DOI 10.1177/0009922816681603; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Copenhaver EA, 2017, PEDIATR ANN, V46, pE106, DOI 10.3928/19382359-20170221-01; de la Vega R, 2015, PSYCHOL ASSESSMENT, V27, pE22, DOI 10.1037/pas0000128; Erwin AM, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00022; Halstead ME, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-3074; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hinz A, 2017, SLEEP MED, V30, P57, DOI 10.1016/j.sleep.2016.03.008; Hoffman NL, 2020, CLIN J SPORT MED, V30, pS29, DOI 10.1097/JSM.0000000000000538; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kostyun RO, 2015, AM J SPORT MED, V43, P633, DOI 10.1177/0363546514560727; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Lo CMH, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-72; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Manzar MD, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3234-x; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Mellman TA, 2006, PSYCHIAT CLIN N AM, V29, P1047, DOI 10.1016/j.psc.2006.08.005; Milewski MD, 2014, J PEDIATR ORTHOPED, V34, P129, DOI 10.1097/BPO.0000000000000151; Murdaugh DL, 2018, ARCH PHYS MED REHAB, V99, P960, DOI 10.1016/j.apmr.2018.01.005; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Raniti MB, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy066; Roeser Karolin, 2012, Front Psychiatry, V3, P76, DOI 10.3389/fpsyt.2012.00076; Sargent C, 2014, CHRONOBIOL INT, V31, P1160, DOI 10.3109/07420528.2014.957306; Sariarslan HA, 2015, NEUROSCIENCES, V20, P236, DOI 10.17712/nsj.2015.3.20150157; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Stone S, 2017, SPORTS HEALTH, V9, P41, DOI 10.1177/1941738116672184; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; Sufrinko A, 2016, NEUROPSYCHOLOGY, V30, P484, DOI 10.1037/neu0000250; Tan E, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-189; Theadom A, 2016, BRAIN INJURY, V30, P1243, DOI 10.1080/02699052.2016.1183171; Ucer O, 2014, WORLD J UROL, V32, P239, DOI 10.1007/s00345-013-1193-1; Walker JM, 2016, UNDERSEA HYPERBAR M, V43, P549	39	12	12	0	14	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	OCT	2019	34	11					639	645		10.1177/0883073819849741			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	IU4LJ	WOS:000483558300002	31113274				2022-02-06	
J	Heuvel, FO; Holl, S; Chandrasekar, A; Li, ZH; Wang, YB; Rehman, R; Forstner, P; Sinske, D; Palmer, A; Wiesner, D; Ludolph, A; Huber-Lang, M; Relja, B; Wirth, T; Roszer, T; Baumann, B; Boeckers, T; Knoll, B; Roselli, F				Heuvel, Florian Olde; Holl, Sarah; Chandrasekar, Akila; Li, Zhenghui; Wang, Yibin; Rehman, Rida; Foerstner, Philip; Sinske, Daniela; Palmer, Annette; Wiesner, Diana; Ludolph, Albert; Huber-Lang, Markus; Relja, Borna; Wirth, Thomas; Roeszer, Tamas; Baumann, Bernd; Boeckers, Tobias; Knoell, Bernd; Roselli, Francesco			STAT6 mediates the effect of ethanol on neuroinflammatory response in TBI	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Traumatic brain injury; Ethanol; IL-13; STAT6	TRAUMATIC BRAIN-INJURY; ACUTE ALCOHOL-INTOXICATION; ALTERNATIVE ACTIVATION; YOUNG-ADULTS; EXPRESSION; MICROGLIA; EXPOSURE; MORTALITY; SUPPRESSION; CONCUSSION	Traumatic brain injury (TBI) and ethanol intoxication (EI) frequently coincide, particularly in young subjects. However, the mechanisms of their interaction remain poorly understood. Among other pathogenic pathways, TBI induces glial activation and neuroinflammation in the hippocampus, resulting in acute and chronic hippocampal dysfunction. In this regard, we investigated the role of EI affecting these responses unfolding after TBI. We used a blunt, weight-drop approach to model TBI in mice. Male mice were pre-administered with ethanol or vehicle to simulate EI. The neuroinflammatory response in the hippocampus was assessed by monitoring the expression levels of > 20 cytokines, the phosphorylation status of transcription factors and the phenotype of microglia and astrocytes. We used AS1517499, a brain-permeable STAT6 inhibitor, to elucidate the role of this pathway in the EI/TBI interaction. We showed that TBI causes the elevation of IL-33, IL-1 beta, IL-38, TNF-alpha, IFN-alpha, IL-19 in the hippocampus at 3 h time point and concomitant EI results in the dose-dependent downregulation of IL-33, IL-1 beta, IL-38, TNF-alpha and IL-19 (but not of IFN-alpha) and in the selective upregulation of IL-13 and IL-12. EI is associated with the phosphorylation of STAT6 and the transcription of STAT6-controlled genes. Moreover, ethanol-induced STAT6 phosphorylation and transcriptional activation can be recapitulated in vitro by concomitant exposure of neurons to ethanol, depolarization and inflammatory stimuli (simulating the acute trauma). Acute STAT6 inhibition prevents the effects of El on IL-33 and TNF-alpha, but not on IL-13 and negates acute EI beneficial effects on TBI-associated neurological impairment. Additionally, EI is associated with reduced microglial activation and astrogliosis as well as preserved synaptic density and baseline neuronal activity 7 days after TBI and all these effects are prevented by acute administration of the STAT6 inhibitor concomitant to EI. EI concomitant to TBI exerts significant immunomodulatory effects on cytokine induction and microglial activation, largely through the activation of STAT6 pathway, ultimately with beneficial outcomes.	[Heuvel, Florian Olde; Holl, Sarah; Chandrasekar, Akila; Li, Zhenghui; Wang, Yibin; Rehman, Rida; Wiesner, Diana; Ludolph, Albert; Roselli, Francesco] Ulm Univ, Dept Neurol, ZBF Helmholtzstr 8-1, D-89081 Ulm, Germany; [Foerstner, Philip; Sinske, Daniela; Wirth, Thomas; Baumann, Bernd; Knoell, Bernd] Ulm Univ, Inst Physiol Chem, N27,Albert Einstein Allee 11, D-9081 Ulm, Germany; [Palmer, Annette; Huber-Lang, Markus] Ulm Univ, Inst Clin & Expt Trauma Immunol, ZBF Helmholtzstr 8-1, D-89081 Ulm, Germany; [Wiesner, Diana; Ludolph, Albert; Boeckers, Tobias; Roselli, Francesco] German Ctr Neurodegenerat Dis DZNE, Ulm, Germany; [Relja, Borna] Goethe Univ Frankfurt Main, Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Roeszer, Tamas] Ulm Univ, Inst Neurobiol, M24,ALbert Einstein Allee 11, D-89081 Ulm, Germany; [Boeckers, Tobias; Roselli, Francesco] Ulm Univ, Inst Anat & Cell Biol, M24,ALbert Einstein Alice 11, D-89081 Ulm, Germany; [Chandrasekar, Akila] Cellular Neurobiol Biozentrum, Zool Inst Braunschweig, Spielmannstr 7, D-38106 Braunschweig, Germany		Roselli, F (corresponding author), DZNE, Helmholtzstr 8-2 R1-44, DE-89081 Ulm, Germany.; Roselli, F (corresponding author), Ulm Univ, Dept Neurol, Ctr Biomed Res ZBF, Helmholtzstr 8-2 R1-44, DE-89081 Ulm, Germany.	francesco.roselli@uni-ulm.de	Wirth, Thomas/X-7172-2019; Relja, Borna/B-6642-2016; roselli, francesco/O-8847-2019; Huber-Lang, Markus/AAJ-2209-2020; Rehman, Rida/AAR-4811-2020; Roszer, Tamas/ABD-4915-2020	Relja, Borna/0000-0002-5625-8823; roselli, francesco/0000-0001-9935-6899; Rehman, Rida/0000-0003-0518-5051; Roszer, Tamas/0000-0003-1903-7922	Deutsche Forschungs Gemeinschaft (DFG)German Research Foundation (DFG) [1149/2]; ERANET-NEURON initiative "External Insults to the Nervous System"; BMBF as part of the MICRONET consortiumFederal Ministry of Education & Research (BMBF) [FKZ 01EW1705A]; Baustein Program of Ulm University; Ulm University-Bundeswehr Krankenhaus Ulm research initiative; Hannelore Kohl Stiftung Forschungsforderung	The work by FR, FoH, BK, TB and TW has been supported by the Deutsche Forschungs Gemeinschaft (DFG) as part of the Collaborative Research Center 1149/2 "Danger Response, Disturbance Factors and Regenerative Potential after Acute Trauma". FR is also supported by the ERANET-NEURON initiative "External Insults to the Nervous System" and BMBF as part of the MICRONET consortium (FKZ 01EW1705A) and by the Baustein Program of Ulm University. BK is supported by an Ulm University-Bundeswehr Krankenhaus Ulm research initiative. RR is supported by Hannelore Kohl Stiftung Forschungsforderung. Technical support by Thomas Lenk and Daniela Sinske was highly appreciated.	Ajami B, 2018, NAT NEUROSCI, V21, P541, DOI 10.1038/s41593-018-0100-x; Albrecht JS, 2018, AM J EPIDEMIOL, V187, P233, DOI 10.1093/aje/kwx254; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Bao K, 2015, CYTOKINE, V75, P25, DOI 10.1016/j.cyto.2015.05.008; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Berry C, 2011, AM SURGEON, V77, P1416; Bjarko V. V, 2018, WORLD NEUROSURG; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Bouchard JC, 2012, AM J PATHOL, V181, P845, DOI 10.1016/j.ajpath.2012.05.020; Brennan JH, 2015, J CLIN NEUROSCI, V22, P1928, DOI 10.1016/j.jocn.2015.05.034; Brennan JH, 2015, J CLIN NEUROSCI, V22, P1375, DOI 10.1016/j.jocn.2015.02.030; Burguillos MA, 2015, CELL REP, V10, P1626, DOI 10.1016/j.celrep.2015.02.012; Catalan-Dibene J, 2018, J INTERF CYTOK RES, V38, P423, DOI 10.1089/jir.2018.0089; Catanese A, 2018, J CEREBR BLOOD F MET, V38, P1924, DOI 10.1177/0271678X18786356; Chandrasekar A, 2018, J NEUROTRAUM, V35, P2718, DOI 10.1089/neu.2017.5270; Chandrasekar A, 2018, EXP NEUROL, V302, P34, DOI 10.1016/j.expneurol.2017.12.017; Chandrasekar A, 2017, INT IMMUNOPHARMACOL, V51, P66, DOI 10.1016/j.intimp.2017.08.002; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; Chen MH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/761454; Chiba Y, 2009, AM J RESP CELL MOL, V41, P516, DOI 10.1165/rcmb.2008-0163OC; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; Cummings P, 2006, INJURY PREV, V12, P148, DOI 10.1136/ip.2005.010975; Czimmerer Z, 2018, IMMUNITY, V48, P75, DOI 10.1016/j.immuni.2017.12.010; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Diamant G, 2013, BBA-GENE REGUL MECH, V1829, P937, DOI 10.1016/j.bbagrm.2013.04.007; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Ding QP, 2017, ALCOHOL CLIN EXP RES, V41, P1532, DOI 10.1111/acer.13436; Dooley D, 2016, STEM CELL REP, V7, P1099, DOI 10.1016/j.stemcr.2016.11.005; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Forstner P, 2018, J NEUROTRAUM, V35, P2317, DOI 10.1089/neu.2017.5593; Franca RFO, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0628-1; Furman JL, 2016, J NEUROSCI, V36, P1502, DOI 10.1523/JNEUROSCI.1930-15.2016; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Guglielmetti C, 2016, GLIA, V64, P2181, DOI 10.1002/glia.23053; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Heise C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00035; Henry R. J, 2018, NEUROTHERAPEUTICS; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Jung JE, 2015, J CEREBR BLOOD F MET, V35, P2043, DOI 10.1038/jcbfm.2015.169; Katada R, 2012, AM J PATHOL, V180, P17, DOI 10.1016/j.ajpath.2011.09.011; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kiu H, 2012, GROWTH FACTORS, V30, P88, DOI 10.3109/08977194.2012.660936; Kratochvill F, 2015, CELL REP, V12, P1902, DOI 10.1016/j.celrep.2015.08.033; Krukowski K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123753; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P478, DOI 10.1093/arclin/acu027; Leh SE, 2017, J NEUROTRAUM, V34, P1402, DOI 10.1089/neu.2016.4591; Levings MK, 1999, J IMMUNOL, V162, P5224; Liu WF, 2015, J IMMUNOL, V195, P317, DOI 10.4049/jimmunol.1401864; Livy DJ, 2003, ALCOHOL, V29, P165, DOI 10.1016/S0741-8329(03)00025-9; Mathur V, 2017, NEURON, V96, P1290, DOI 10.1016/j.neuron.2017.11.032; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mettang M, 2018, FASEB J, DOI [10.1096/.201700826R, DOI 10.1096/.201700826R]; Missault S, 2019, J NEUROTRAUM, V36, P768, DOI 10.1089/neu.2018.5704; Mitamura Y, 2018, J BIOL CHEM, V293, P14646, DOI 10.1074/jbc.RA117.001364; Mitchell PO, 2009, ALCOHOL CLIN EXP RES, V33, P505, DOI 10.1111/j.1530-0277.2008.00863.x; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Mori S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0862-1; Mori S, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6020018; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Ouali Alami N, 2018, EMBO J, V37; Pattoli MA, 2005, J PHARMACOL EXP THER, V315, P382, DOI 10.1124/jpet.105.087569; Polyak MJ, 2013, FASEB J, V27, P2829, DOI 10.1096/fj.13-227868; Przanowski P, 2014, J MOL MED, V92, P239, DOI 10.1007/s00109-013-1090-5; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rahman K, 2017, J CLIN INVEST, V127, P2904, DOI 10.1172/JCI75005; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Relja B, 2012, BRIT J PHARMACOL, V165, P1188, DOI 10.1111/j.1476-5381.2011.01595.x; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Roselli F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006011; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Schmeisser MJ, 2012, NATURE, V486, P256, DOI 10.1038/nature11015; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Sloka S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-56; Sonobe Y, 2009, J BIOL CHEM, V284, P31834, DOI 10.1074/jbc.M109.025940; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Vaagenes IC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120356; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang T, 2013, J NEUROSURG, V118, P390, DOI 10.3171/2012.8.JNS12736; Wang YM, 2009, J NEUROIMMUNOL, V206, P76, DOI 10.1016/j.jneuroim.2008.11.003; Waqas SFH, 2017, J CLIN INVEST, V127, P2842, DOI 10.1172/JCI90152; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Wicher G, 2017, J NEUROTRAUM, V34, P3173, DOI 10.1089/neu.2016.4900; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; Wurster AL, 2000, ONCOGENE, V19, P2577, DOI 10.1038/sj.onc.1203485; Yi MH, 2016, SCI REP-UK, V6, DOI 10.1038/srep34901; Yin XJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40614; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zrzavy T, 2017, BRAIN, V140, P1900, DOI 10.1093/brain/awx113	101	12	12	2	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	OCT	2019	81						228	246		10.1016/j.bbi.2019.06.019			19	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology; Neurosciences & Neurology; Psychiatry	JA8XY	WOS:000488135800030	31207335				2022-02-06	
J	Binder, AS; Lancaster, K; Lengenfelder, J; Chiaravalloti, ND; Genova, HM				Binder, Allison S.; Lancaster, Katie; Lengenfelder, Jean; Chiaravalloti, Nancy D.; Genova, Helen M.			Community Integration in Traumatic Brain Injury: The Contributing Factor of Affect Recognition Deficits	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						TBI; Traumatic brain injury; Facial affect recognition; Emotion recognition; TASIT; Community integration; Social integration; Social cognition	SOCIAL-BEHAVIOR; IMPAIRMENTS; EMOTION	Objective: Individuals with traumatic brain injury (TBI) can experience social isolation, which is damaging to well-being and counterproductive to successful rehabilitation. It has been proposed that social cognitive deficits that commonly result from TBI may contribute to weakened social integration. However, the consequences of specific social cognitive deficits in TBI are still being delineated. The current work sought to better characterize the relationship between community integration and facial affect recognition (FAR) in TBI. Participants and Methods: A total of 27 participants with moderate to severe TBI and 30 healthy controls (HCs) completed two tests of FAR, which employed either static photographic stimuli or dynamic video stimuli (The Awareness of Social Inference Test). The Community Integration Questionnaire was also administered to participants. Results: Participants with TBI were significantly impaired on both the static and dynamic FAR measures, yet the deficits were most pronounced within the dynamic task. Furthermore, participants with TBI reported lower community integration compared with HCs. FAR was positively associated with community integration in both groups, such that participants with proficient affect recognition skills were better integrated into their communities. Conclusions: FAR deficits may contribute to the lack of community integration often observed in TBI; thus, interventions designed to improve FAR may be beneficial to this population's ability to successfully reintegrate into society.	[Binder, Allison S.] Goodwill Ind Cent Texas, Austin, TX USA; [Lancaster, Katie; Lengenfelder, Jean; Chiaravalloti, Nancy D.; Genova, Helen M.] Kessler Fdn, W Orange, NJ USA; [Lancaster, Katie; Lengenfelder, Jean; Chiaravalloti, Nancy D.; Genova, Helen M.] Rutgers NJ Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA		Genova, HM (corresponding author), 120 Eagle Rock Ave,Suite 100, E Hanover, NJ 07936 USA.	hgenova@KesslerFundation.org		Chiaravalloti, Nancy/0000-0003-2943-7567	New Jersey Commission on Brain Injury Research [CBIR13IRG026]	This work was supported by research grant CBIR13IRG026 [JL and HMG], funded by the New Jersey Commission on Brain Injury Research. All the authors report no conflicts of interest.	Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Delis D.C., 2000, CALIFORNIA VERBAL LE; Doninger NA, 2003, REHABIL PSYCHOL, V48, P67, DOI 10.1037/0090-5550.48.2.67; Genova H.M., J NEUROPSYCHOLOGY; Hoofien D, 2001, BRAIN INJURY, V15, P189; Izaute M, 2008, BRAIN INJURY, V22, P758, DOI 10.1080/02699050802366002; Juengst SB, 2014, AM J PHYS MED REHAB, V93, P1086, DOI 10.1097/PHM.0000000000000163; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; May M, 2017, J INT NEUROPSYCH SOC, V23, P400, DOI 10.1017/S1355617717000182; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210	19	12	12	0	8	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2019	25	8					890	895	PII S1355617719000559	10.1017/S1355617719000559			6	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	IV9ZE	WOS:000484621400012	31179968				2022-02-06	
J	Hixson, KM; Cogswell, M; Brooks-Kayal, AR; Russek, SJ				Hixson, Kathryn M.; Cogswell, Meaghan; Brooks-Kayal, Amy R.; Russek, Shelley J.			Evidence for a non-canonical JAK/STAT signaling pathway in the synthesis of the brain's major ion channels and neurotransmitter receptors	BMC GENOMICS			English	Article						JAK/STAT; Neurons; RNAseq; BDNF; HP1 alpha; Epilepsy	LONG-TERM POTENTIATION; NEUROTROPHIC FACTOR; GENE-EXPRESSION; STATUS-EPILEPTICUS; EPILEPSY; BDNF; TRANSCRIPTION; HIPPOCAMPUS; MUTATIONS; SUBUNITS	BackgroundBrain-derived neurotrophic factor (BDNF) is a major signaling molecule that the brain uses to control a vast network of intracellular cascades fundamental to properties of learning and memory, and cognition. While much is known about BDNF signaling in the healthy nervous system where it controls the mitogen activated protein kinase (MAPK) and cyclic-AMP pathways, less is known about its role in multiple brain disorders where it contributes to the dysregulated neuroplasticity seen in epilepsy and traumatic brain injury (TBI). We previously found that neurons respond to prolonged BDNF exposure (both in vivo (in models of epilepsy and TBI) and in vitro (in BDNF treated primary neuronal cultures)) by activating the Janus Kinase/Signal Transducer and Activator of Transcription (JAK/STAT) signaling pathway. This pathway is best known for its association with inflammatory cytokines in non-neuronal cells.ResultsHere, using deep RNA-sequencing of neurons exposed to BDNF in the presence and absence of well characterized JAK/STAT inhibitors, and without non-neuronal cells, we determine the BDNF transcriptome that is specifically regulated by agents that inhibit JAK/STAT signaling. Surprisingly, the BDNF-induced JAK/STAT transcriptome contains ion channels and neurotransmitter receptors coming from all the major classes expressed in the brain, along with key modulators of synaptic plasticity, neurogenesis, and axonal remodeling. Analysis of this dataset has revealed a unique non-canonical mechanism of JAK/STATs in neurons as differential gene expression mediated by STAT3 is not solely dependent upon phosphorylation at residue 705 and may involve a BDNF-induced interaction of STAT3 with Heterochromatin Protein 1 alpha (HP1 alpha).ConclusionsThese findings suggest that the neuronal BDNF-induced JAK/STAT pathway involves more than STAT3 phosphorylation at 705, providing the first evidence for a non-canonical mechanism that may involve HP1 alpha. Our analysis reveals that JAK/STAT signaling regulates many of the genes associated with epilepsy syndromes where BDNF levels are markedly elevated. Uncovering the mechanism of this novel form of BDNF signaling in the brain may provide a new direction for epilepsy therapeutics and open a window into the complex mechanisms of STAT3 transcriptional regulation in neurological disease.	[Hixson, Kathryn M.; Cogswell, Meaghan; Russek, Shelley J.] Boston Univ, Dept Pharmacol & Expt Therapeut, Lab Translat Epilepsy, Sch Med BUSM, Boston, MA 02215 USA; [Hixson, Kathryn M.; Russek, Shelley J.] Boston Univ, Grad Program Neurosci GPN, Boston, MA 02215 USA; [Brooks-Kayal, Amy R.] Univ Colorado, Dept Pediat Neurol, Anschulz Med Campus, Aurora, CO USA; [Russek, Shelley J.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA		Russek, SJ (corresponding author), Boston Univ, Dept Pharmacol & Expt Therapeut, Lab Translat Epilepsy, Sch Med BUSM, Boston, MA 02215 USA.; Russek, SJ (corresponding author), Boston Univ, Grad Program Neurosci GPN, Boston, MA 02215 USA.; Russek, SJ (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	srussek@bu.edu		Hixson, Kathryn/0000-0001-7999-6522; Russek, Shelley/0000-0001-7547-3089	NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008541]; CURE Epilepsy Multidisciplinary Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS051710] Funding Source: NIH RePORTER	Funding was generously provided by the following grants: NIGMS T32GM008541; stipend support and partial graduate training for K. Hixson.; NINDS R01NS051710; supported data collection, design, analysis, interpretation, and writing. PIs A. R. Brooks-Kayal and S. J. Russek. NINDS R21 NS083057; enabled the initial discovery of JAK/STAT inhibitor selection and use in vivo. PIs A. R. Brooks-Kayal and S. J. Russek. CURE Epilepsy Multidisciplinary Award; funding brought together research laboratories and helped build hypotheses for R01 and R21 applications. PIs A. R. Brooks-Kayal and S. J. Russek.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Audenaert D, 2006, NEUROLOGY, V67, P687, DOI 10.1212/01.wnl.0000230145.73496.a2; Bianchi MT, 2002, J NEUROSCI, V22, P5321; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; Binder DK, 2004, RECENT ADV EPILEPSY; Boles NC, 2014, CELL REP, V6, P724, DOI 10.1016/j.celrep.2014.01.026; Bossers K, 2010, BRAIN, V133, P3699, DOI 10.1093/brain/awq258; Brooks-Kayal AR, 2010, EPILEPSIA, V51, P51, DOI 10.1111/j.1528-1167.2010.02837.x; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chou IC, 2007, PEDIATR NEUROL, V36, P40, DOI 10.1016/j.pediatrneurol.2006.09.011; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Danzer Steve C, 2018, Brain Plast, V3, P169, DOI 10.3233/BPL-170056; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Escayg A, 2000, AM J HUM GENET, V66, P1531, DOI 10.1086/302909; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; FRIEDMAN LK, 1994, J NEUROSCI, V14, P2697; Grabenstatter HL, 2014, NEUROBIOL DIS, V62, P73, DOI 10.1016/j.nbd.2013.09.003; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Heinrich C, 2011, NEUROBIOL DIS, V42, P35, DOI 10.1016/j.nbd.2011.01.001; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; Jouvenceau A, 2001, LANCET, V358, P801, DOI 10.1016/S0140-6736(01)05971-2; Kananura C, 2002, ARCH NEUROL-CHICAGO, V59, P1137, DOI 10.1001/archneur.59.7.1137; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; KOKAIA M, 1995, EXP NEUROL, V133, P215, DOI 10.1006/exnr.1995.1024; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kullmann DM, 2000, CELL MOL LIFE SCI, V57, P1551, DOI 10.1007/PL00000640; Kwon SH, 2011, BIOESSAYS, V33, P280, DOI 10.1002/bies.201000138; Lavoie AM, 1997, BIOPHYS J, V73, P2518, DOI 10.1016/S0006-3495(97)78280-8; Li WX, 2008, TRENDS CELL BIOL, V18, P545, DOI 10.1016/j.tcb.2008.08.008; Lipovich L, 2012, GENETICS, V192, P1133, DOI 10.1534/genetics.112.145128; Lund IV, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162396; Mathern GW, 1996, EPILEPSY RES, V26, P151, DOI 10.1016/S0920-1211(96)00052-6; Mazarati AM, 2004, NEUROPEPTIDES, V38, P331, DOI 10.1016/j.npep.2004.07.006; McNamara J. O., 2012, JASPERS BASIC MECH E; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Muller D, 2000, P NATL ACAD SCI USA, V97, P4315, DOI 10.1073/pnas.070022697; Murray KD, 2000, J COMP NEUROL, V418, P411, DOI 10.1002/(SICI)1096-9861(20000320)418:4<411::AID-CNE4>3.0.CO;2-F; Nicolas CS, 2012, NEURON, V73, P374, DOI 10.1016/j.neuron.2011.11.024; O'Sullivan GJ, 2008, NEUROPHARMACOLOGY, V54, P1051, DOI 10.1016/j.neuropharm.2008.02.011; Petryshen TL, 2005, MOL PSYCHIATR, V10, P1074, DOI 10.1038/sj.mp.4001739; Piacentini L, 2003, J CELL BIOL, V161, P707, DOI 10.1083/jcb.200303012; QIAGEN Inc, ING PATHW AN; Qiao Z, 2017, J ELECTROPHOR, V61, P1; Radin DP, 2017, ANTICANCER RES, V37, P3983, DOI 10.21873/anticanres.11783; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Raud S, 2009, NEUROSCI LETT, V460, P138, DOI 10.1016/j.neulet.2009.05.054; Riffault B, 2018, CEREB CORTEX, V28, P510, DOI 10.1093/cercor/bhw385; Roberts DS, 2006, J BIOL CHEM, V281, P29431, DOI 10.1074/jbc.C600167200; Rosch H, 2005, P NATL ACAD SCI USA, V102, P7362, DOI 10.1073/pnas.0502460102; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi S, 2008, NAT CELL BIOL, V10, P491, DOI 10.1038/ncb1713; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; Takahashi M, 1999, BRAIN RES, V818, P579, DOI 10.1016/S0006-8993(98)01355-9; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Thomas AX, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0020-15.2016; Tuvikene J, 2016, J NEUROSCI, V36, P1290, DOI 10.1523/JNEUROSCI.3360-15.2016; Verstovsek S, 2008, CLIN CANCER RES, V14, P788, DOI 10.1158/1078-0432.CCR-07-0524; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; VonDran MW, 2014, ASN NEURO, V6, DOI 10.1177/1759091414552185; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Watson LM, 2017, AM J HUM GENET, V101, P451, DOI 10.1016/j.ajhg.2017.08.005; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Yamada K, 2004, DRUG NEWS PERSPECT, V17, P435, DOI 10.1358/dnp.2004.17.7.863702; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yin B, 2015, ONCOGENE, V34, P761, DOI 10.1038/onc.2014.8; Zhang JX, 2013, NEURO-ONCOLOGY, V15, P279, DOI 10.1093/neuonc/nos306; Zhang SY, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2218-0; Zhou T, 2014, LEUKEMIA, V28, P471, DOI 10.1038/leu.2013.299; Zouein FA, 2011, GROWTH FACTORS, V29, P245, DOI 10.3109/08977194.2011.614949	72	12	12	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2164			BMC GENOMICS	BMC Genomics	AUG 28	2019	20	1							677	10.1186/s12864-019-6033-2			16	Biotechnology & Applied Microbiology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Genetics & Heredity	IX1WI	WOS:000485481600001	31455240	gold, Green Published			2022-02-06	
J	Kim, H; Irimia, A; Hobel, SM; Pogosyan, M; Tang, HT; Petrosyan, P; Blanco, REC; Duffy, B; Zhao, L; Crawford, KL; Liew, SL; Clark, K; Law, M; Mukherjee, P; Manley, GT; Van Horn, JD; Toga, AW				Kim, Hosung; Irimia, Andrei; Hobel, Samuel M.; Pogosyan, Mher; Tang, Haoteng; Petrosyan, Petros; Blanco, Rita Esquivel Castelo; Duffy, Ben A.; Zhao, Lu; Crawford, Karen L.; Liew, Sook-Lei; Clark, Kristi; Law, Meng; Mukherjee, Pratik; Manley, Geoffrey T.; Van Horn, John D.; Toga, Arthur W.			The LONI QC System: A Semi-Automated, Web-Based and Freely-Available Environment for the Comprehensive Quality Control of Neuroimaging Data	FRONTIERS IN NEUROINFORMATICS			English	Article						quality control; magnetic resonance imaging; diffusion tensor imaging; functional magnetic resonance imaging; LONI Pipeline	HEAD MOTION; ALZHEIMERS-DISEASE; DIFFUSION; BRAIN; NOISE; GRAY; INTENSITY; ARTIFACTS; THICKNESS; SOFTWARE	Quantifying, controlling, and monitoring image quality is an essential prerequisite for ensuring the validity and reproducibility of many types of neuroimaging data analyses. Implementation of quality control (QC) procedures is the key to ensuring that neuroimaging data are of high-quality and their validity in the subsequent analyses. We introduce the QC system of the Laboratory of Neuro Imaging (LONI): a web-based system featuring a workflow for the assessment of various modality and contrast brain imaging data. The design allows users to anonymously upload imaging data to the LONI-QC system. It then computes an exhaustive set of QC metrics which aids users to perform a standardized QC by generating a range of scalar and vector statistics. These procedures are performed in parallel using a large compute cluster. Finally, the system offers an automated QC procedure for structural MRI, which can flag each QC metric as being 'good' or 'bad.' Validation using various sets of data acquired from a single scanner and from multiple sites demonstrated the reproducibility of our QC metrics, and the sensitivity and specificity of the proposed Auto QC to 'bad' quality images in comparison to visual inspection. To the best of our knowledge, LONI-QC is the first online QC system that uniquely supports the variety of functionality where we compute numerous QC metrics and perform visual/automated image QC of multi-contrast and multi-modal brain imaging data. The LONI-QC system has been used to assess the quality of large neuroimaging datasets acquired as part of various multi-site studies such as the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Study and the Alzheimer's Disease Neuroimaging Initiative (ADNI). LONI-QC's functionality is freely available to users worldwide and its adoption by imaging researchers is likely to contribute substantially to upholding high standards of brain image data quality and to implementing these standards across the neuroimaging community.	[Kim, Hosung; Irimia, Andrei; Hobel, Samuel M.; Pogosyan, Mher; Tang, Haoteng; Petrosyan, Petros; Blanco, Rita Esquivel Castelo; Duffy, Ben A.; Zhao, Lu; Crawford, Karen L.; Liew, Sook-Lei; Clark, Kristi; Law, Meng; Van Horn, John D.; Toga, Arthur W.] Univ Southern Calif, Mark & Mary Stevens Neuroimaging & Informat Inst, Lab Neuro Imaging, Los Angeles, CA 90007 USA; [Irimia, Andrei] Univ Southern Calif, Dept Gerontol, Los Angeles, CA 90007 USA; [Mukherjee, Pratik; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA		Kim, H; Irimia, A (corresponding author), Univ Southern Calif, Mark & Mary Stevens Neuroimaging & Informat Inst, Lab Neuro Imaging, Los Angeles, CA 90007 USA.; Irimia, A (corresponding author), Univ Southern Calif, Dept Gerontol, Los Angeles, CA 90007 USA.	hosung.kim@loni.usc.edu; Andrek.irimia@loni.usc.edu	Irimia, Andrei/B-8275-2008	Irimia, Andrei/0000-0002-9254-9388; Van Horn, John/0000-0003-1537-0816	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P41EB015922, U54EB020406, K01HD091283, U19AG024904, U01NS086090, 003585-00001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD091283] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Health grants (P41EB015922, U54EB020406, K01HD091283, U19AG024904, U01NS086090, and 003585-00001).	Altman D.G., 1999, PRACTICAL STAT MED R; Anderson AW, 2001, MAGNET RESON MED, V46, P1174, DOI 10.1002/mrm.1315; Bastin ME, 1998, MAGN RESON IMAGING, V16, P773, DOI 10.1016/S0730-725X(98)00098-8; Cao LJ, 2003, NEUROCOMPUTING, V55, P321, DOI 10.1016/S0925-2312(03)00433-8; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Crawford KL, 2016, NEUROIMAGE, V124, P1080, DOI 10.1016/j.neuroimage.2015.04.067; Esteban O., 2017, BIORXIV; Fesl G, 2008, EUR RADIOL, V18, P1031, DOI 10.1007/s00330-008-0850-z; Fonov V., 2018, BIORXIV; Friedman L, 2006, J MAGN RESON IMAGING, V23, P827, DOI 10.1002/jmri.20583; Heim S, 2004, MAGN RESON MED, V52, P582, DOI 10.1002/mrm.20169; Jezzard P, 1998, MAGNET RESON MED, V39, P801, DOI 10.1002/mrm.1910390518; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kang JH, 2016, ACTA NEUROPATHOL, V131, P935, DOI 10.1007/s00401-016-1552-2; Keshavan A, 2018, NEUROIMAGE, V170, P365, DOI 10.1016/j.neuroimage.2017.03.055; Kuperman JM, 2011, PEDIATR RADIOL, V41, P1578, DOI 10.1007/s00247-011-2205-1; Lauzon CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061737; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Le Bihan D, 2006, J MAGN RESON IMAGING, V24, P478, DOI 10.1002/jmri.20683; Li Y, 2013, NEUROLOGY, V80; Liu BL, 2015, MAGN RESON IMAGING, V33, P276, DOI 10.1016/j.mri.2014.10.011; Marcus DS, 2013, NEUROIMAGE, V80, P202, DOI 10.1016/j.neuroimage.2013.05.077; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mortamet B, 2009, MAGN RESON MED, V62, P365, DOI 10.1002/mrm.21992; Oguz I, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00004; Owens SF, 2012, BRAIN, V135, P2231, DOI 10.1093/brain/aws138; Pizarro RA, 2016, FRONT NEUROINFORM, V10, DOI 10.3389/fninf.2016.00052; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Reiser M, 2008, MAGNETIC RESONANCE T; Reuter M, 2015, NEUROIMAGE, V107, P107, DOI 10.1016/j.neuroimage.2014.12.006; Rex DE, 2003, NEUROIMAGE, V19, P1033, DOI 10.1016/S1053-8119(03)00185-X; Roalf DR, 2016, NEUROIMAGE, V125, P903, DOI 10.1016/j.neuroimage.2015.10.068; Salat DH, 2011, NEUROIMAGE, V54, P1795, DOI 10.1016/j.neuroimage.2010.10.034; Salat DH, 2009, NEUROIMAGE, V48, P21, DOI 10.1016/j.neuroimage.2009.06.074; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Skare S, 2000, J MAGN RESON, V147, P340, DOI 10.1006/jmre.2000.2209; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sommer S, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.588; STEEN RG, 1995, J MAGN RESON IMAGING, V5, P43, DOI 10.1002/jmri.1880050111; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Weiner MW, 2015, ALZHEIMERS DEMENT, V11, P730, DOI 10.1016/j.jalz.2015.05.007; Westlye LT, 2009, NEUROIMAGE, V47, P1545, DOI 10.1016/j.neuroimage.2009.05.084; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Yoshida S, 2013, PEDIATR RADIOL, V43, P15, DOI 10.1007/s00247-012-2496-x; Zhou ZY, 2011, MAGN RESON IMAGING, V29, P230, DOI 10.1016/j.mri.2010.06.022	47	12	13	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5196		FRONT NEUROINFORM	Front. Neuroinformatics	AUG 28	2019	13								60	10.3389/fninf.2019.00060			20	Mathematical & Computational Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Neurosciences & Neurology	IT5UR	WOS:000482933200001	31555116	Green Published, gold			2022-02-06	
J	Eisenberg, HM; Shenton, ME; Pasternak, O; Simard, JM; Okonkwo, DO; Aldrich, C; He, F; Jain, S; Hayman, EG				Eisenberg, Howard M.; Shenton, Martha E.; Pasternak, Ofer; Simard, J. Marc; Okonkwo, David O.; Aldrich, Christina; He, Feng; Jain, Sonia; Hayman, Erik G.			Magnetic Resonance Imaging Pilot Study of Intravenous Glyburide in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						contusion; edema; glyburide; MRI; SUR1; TBI	CEREBRAL EDEMA; WHITE-MATTER; DOUBLE-BLIND; GLIBENCLAMIDE; NEUROPROTECTION; ISCHEMIA	Pre-clinical studies of traumatic brain injury (TBI) show that glyburide reduces edema and hemorrhagic progression of contusions. We conducted a small Phase II, three-institution, randomized placebo-controlled trial of subjects with TBI to assess the safety and efficacy of intravenous (IV) glyburide. Twenty-eight subjects were randomized and underwent a 72-h infusion of IV glyburide or placebo, beginning within 10 h of trauma. Of the 28 subjects, 25 had Glasgow Coma Scale (GCS) scores of 6-10, and 14 had contusions. There were no differences in adverse events (AEs) or severe adverse events (ASEs) between groups. The magnetic resonance imaging (MRI) percent change at 72-168 h from screening/baseline was compared between the glyburide and placebo groups. Analysis of contusions (7 per group) showed that lesion volumes (hemorrhage plus edema) increased 1036% with placebo versus 136% with glyburide (p = 0.15), and that hemorrhage volumes increased 11.6% with placebo but decreased 29.6% with glyburide (p = 0.62). Three diffusion MRI measures of edema were quantified: mean diffusivity (MD), free water (FW), and tissue MD (MDt), corresponding to overall, extracellular, and intracellular water, respectively. The percent change with time for each measure was compared in lesions (n = 14) versus uninjured white matter (n = 24) in subjects receiving placebo (n = 20) or glyburide (n = 18). For placebo, the percent change in lesions for all three measures was significantly different compared with uninjured white matter (analysis of variance [ANOVA], p < 0.02), consistent with worsening of edema in untreated contusions. In contrast, for glyburide, the percent change in lesions for all three measures was not significantly different compared with uninjured white matter. Further study of IV glyburide in contusion TBI is warranted.	[Eisenberg, Howard M.; Simard, J. Marc; Aldrich, Christina; Hayman, Erik G.] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Shenton, Martha E.; Pasternak, Ofer] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA; [Shenton, Martha E.; Pasternak, Ofer] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Shenton, Martha E.] VA Boston Healthcare Syst, Dept Res & Dev, Brockton Div, Brockton, MA USA; [Okonkwo, David O.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [He, Feng; Jain, Sonia] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA		Eisenberg, HM (corresponding author), Univ Maryland, Sch Med, 22 South Greene St,Suite S12D, Baltimore, MD 21201 USA.	HEisenberg@som.umaryland.edu			Department of Defense U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC)United States Department of Defense [W81XWH-08-2-0159]; INTRuST; Remedy Pharmaceuticals, Inc.	This study was funded by a grant to HME from the Department of Defense U.S. Army Medical Research and Materiel Command (W81XWH-08-2-0159), INTRuST, and by Remedy Pharmaceuticals, Inc.	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Carnevale JA, 2018, J NEUROSURG, V129, P1305, DOI 10.3171/2017.7.JNS17988; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Gerzanich V, 2019, J NEUROTRAUM, V36, P1060, DOI 10.1089/neu.2018.5986; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Jha RM, 2019, J NEUROTRAUM, V36, P1804, DOI 10.1089/neu.2018.6124; Jha RM, 2017, NEUROCRIT CARE, V26, P213, DOI 10.1007/s12028-016-0309-z; Jha Ruchira M, 2017, Crit Care Med, V45, pe255, DOI 10.1097/CCM.0000000000002079; Jha RM, 2018, J NEUROL NEUROSUR PS, V89, P1152, DOI 10.1136/jnnp-2017-317741; Khalili H, 2017, WORLD NEUROSURG, V101, P130, DOI 10.1016/j.wneu.2017.01.103; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Martinez-Valverde T, 2015, J NEUROTRAUM, V32, P1478, DOI 10.1089/neu.2014.3706; Meier R, 2008, CRIT CARE, V12, DOI 10.1186/cc6974; Ortega FJ, 2012, EXP NEUROL, V235, P282, DOI 10.1016/j.expneurol.2012.02.010; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Redondo-Castro E, 2013, EUR J NEUROSCI, V38, P3786, DOI 10.1111/ejn.12382; Sheth KN, 2016, LANCET NEUROL, V15, P1160, DOI 10.1016/S1474-4422(16)30196-X; Sheth KN, 2014, STROKE, V45, P281, DOI 10.1161/STROKEAHA.113.003352; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Simard JM, 2014, NEUROCRIT CARE, V20, P319, DOI 10.1007/s12028-013-9923-1; Simard JM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000522; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wilkes S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00527; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Xu ZM, 2017, J NEUROTRAUM, V34, P925, DOI 10.1089/neu.2016.4491; Zafardoost P, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.25113; Zhao XR, 2015, J NEUROCHEM, V133, P144, DOI 10.1111/jnc.12974; Zhao XR, 2009, STROKE, V40, pS92, DOI 10.1161/STROKEAHA.108.533158; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	35	12	12	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2020	37	1					185	193		10.1089/neu.2019.6538		AUG 2019	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	KA2YK	WOS:000483893900001	31354055	Green Submitted, Green Published, hybrid			2022-02-06	
J	Merritt, VC; Jurick, SM; Crocker, LD; Hoffman, SN; Keller, AV; DeFord, N; Jak, AJ				Merritt, Victoria C.; Jurick, Sarah M.; Crocker, Laura D.; Hoffman, Samantha N.; Keller, Amber V.; DeFord, Nicole; Jak, Amy J.			Evaluation of objective and subjective clinical outcomes in combat veterans with and without mild TBI and PTSD: A four-group design	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						mTBI; posttraumatic stress disorder; cognition; psychiatric distress; functional outcomes	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; ATYPICAL SYMPTOMS SCALE; NEUROPSYCHOLOGICAL OUTCOMES; COGNITIVE PROBLEMS; PROCESSING SPEED; SERVICE MEMBERS; DEPLOYMENT; PERFORMANCE; PAIN	Introduction: Mildtraumatic brain injury (mTBI) and posttraumatic stress disorder (PTSD) are highly prevalent comorbid conditions in military Veterans. However, lack of appropriate comparison groups has clouded interpretation of the chronic effects of these conditions. The present study evaluated the neuropsychological, psychiatric/neurobehavioral, and functional outcomes associated with mTBI and PTSD in a well-characterized sample of combat-exposed Veterans.Method: Participants included 73 Iraq/Afghanistan Veterans (91.8% male; age: M = 34.00, SD = 6.39) divided into four groups: mTBI-only (n = 23), PTSD-only (n = 14), comorbid mTBI + PTSD (n = 19), and combat-control (CC; n = 17). Participants were administered a neuropsychological assessment and completed questionnaires assessing psychiatric/neurobehavioral symptoms and functional outcomes.Results: Kruskal-Wallis H-tests showed no group differences across measures of neuropsychological functioning; however, there were significant differences across groups on all psychiatric/neurobehavioral variables examined. In general, the comorbid and PTSD-only groups endorsed the most severe symptoms, followed by the mTBI-only and CC groups, respectively. As for functional outcomes, the comorbid and PTSD-only groups had higher rates of service-connection disability and greater perceived decline in work and education-related abilities, relative to the mTBI-only and CC groups, despite similar proportions of Veterans employed or in school in each group.Conclusions: Findings suggest that Veterans with comorbid mTBI + PTSD and PTSD alone are at greatest risk for experiencing long-lasting subjective distress, including negative perceptions of their ability to work or pursue an education, despite being comparable to mTBI-only and CC Veterans on objective measures of functioning. Our results highlight the importance of emphasizing mental health treatment in this population.	[Merritt, Victoria C.; Jurick, Sarah M.; Jak, Amy J.] VA San Diego Healthcare Syst VASDHS, Psychol Serv, San Diego, CA USA; [Jurick, Sarah M.; Crocker, Laura D.; Jak, Amy J.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Crocker, Laura D.; Hoffman, Samantha N.; Keller, Amber V.; DeFord, Nicole] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Jak, Amy J.] Univ Calif San Diego, Sch Med, Dept Psychiat, 9500 Gillman Dr, La Jolla, CA 92093 USA		Jak, AJ (corresponding author), VA San Diego Healthcare Syst 151B, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ajak@ucsd.edu		Hoffman, Samantha/0000-0002-2792-8576; Keller, Amber/0000-0002-2972-784X; Merritt, Victoria/0000-0001-5683-4168	Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) AwardUnited States Department of Defense [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01 CX001135]; VA Rehabilitation Research & Development Service [IK2 RX002459]	This work was supported by grant funding from: Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award [W81XWH-13-2-0095] and Department of Veterans Affairs CENC Award [I01 CX001135]. Additionally, Laura Crocker received salary support during this work from a Career Development Award [IK2 RX002459] from the VA Rehabilitation Research & Development Service.	Aase DM, 2018, PSYCHIAT RES, V268, P460, DOI 10.1016/j.psychres.2018.08.019; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Amick MM, 2018, J HEAD TRAUMA REHAB, V33, pE30, DOI 10.1097/HTR.0000000000000308; Armistead-Jehle P, 2018, J CLIN EXP NEUROPSYC, V40, P213, DOI 10.1080/13803395.2017.1329406; Balba NM, 2018, J CLIN SLEEP MED, V14, P1865, DOI 10.5664/jcsm.7482; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benedict R., 1997, BRIEF VISUOSPATIAL M; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Campbell TA, 2009, PSYCHIAT ANN, V39, P796, DOI 10.3928/00485713-20090728-01; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2018, BRAIN INJURY, V32, P1149, DOI 10.1080/02699052.2018.1496274; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Cooper DB, 2014, J REHABIL RES DEV, V51, P1023, DOI [10.1682/JRRD.2013.05.0104, 10.1682/JRRD.2013.05.0140]; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Delis D. C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS23, DOI 10.1016/j.apmr.2017.05.012; Dismuke-Greer CE, 2018, BRAIN INJURY, V32, P1178, DOI 10.1080/02699052.2018.1482428; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Fredman SJ, 2019, PSYCHOL TRAUMA-US, V11, P415, DOI 10.1037/tra0000363; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; Green P, 2004, GREENS MED SYMPTOM V; Heaton R., 2000, WISCONSIN CARD SORTI; Howe LLS, 2007, ARCH CLIN NEUROPSYCH, V22, P753, DOI 10.1016/j.acn.2007.06.003; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Jurick SM, 2018, BRAIN INJURY, V32, P1256, DOI 10.1080/02699052.2018.1493225; Jurick SM, 2016, J REHABIL RES DEV, V53, P571, DOI 10.1682/JRRD.2015.05.0094; Kansagara D., 2013, COMPLICATIONS MILD T; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lange RT, 2013, J CLIN EXP NEUROPSYC, V35, P192, DOI 10.1080/13803395.2012.761677; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Merritt VC, 2018, NEUROPSYCHOLOGIA, V119, P340, DOI 10.1016/j.neuropsychologia.2018.08.026; Miskey HM, 2015, BRAIN IMAGING BEHAV, V9, P461, DOI 10.1007/s11682-015-9391-7; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Olsen DC, 2018, BRAIN INJURY, V32, P544, DOI 10.1080/02699052.2018.1431845; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Samuelson KW, 2017, J TRAUMA STRESS, V30, P521, DOI 10.1002/jts.22223; Samuelson KW, 2017, PSYCHOL TRAUMA-US, V9, P537, DOI 10.1037/tra0000210; Shackelford JL, 2019, J PSYCHOSOC NURS MEN, V57, P35, DOI 10.3928/02793695-20180924-02; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Sheehan D. V., 2014, MINIINTERNATIONAL NE; Stojanovic MP, 2016, PAIN MED, V17, P2017, DOI 10.1093/pm/pnw042; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tomczak M, 2014, TRENDS SPORT SCI, V21, P19, DOI DOI 10.7326/0003-4819-159-3-201308060-00005; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME	65	12	12	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG 9	2019	41	7					665	679		10.1080/13803395.2019.1610161			15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	IH7LB	WOS:000474684000001	31084252				2022-02-06	
J	Shriberg, LD; Strand, EA; Jakielski, KJ; Mabie, HL				Shriberg, Lawrence D.; Strand, Edythe A.; Jakielski, Kathy J.; Mabie, Heather L.			Estimates of the prevalence of speech and motor speech disorders in persons with complex neurodevelopmental disorders	CLINICAL LINGUISTICS & PHONETICS			English	Article						Apraxia; dysarthria; speech motor delay; speech sound disorders	CHILDHOOD-APRAXIA; LANGUAGE IMPAIRMENT; MULTIGENERATIONAL FAMILY; DEVELOPMENTAL SPEECH; SOUND DISORDERS; CHILDREN; CLASSIFICATION; PERSISTENT; DEFICITS; PROSODY	Estimates of the prevalence of speech and motor speech disorders in persons with complex neurodevelopmental disorders (CND) can inform research in the biobehavioural origins and treatment of CND. The goal of this research was to use measures and analytics in a diagnostic classification system to estimate the prevalence of speech and motor speech disorders in convenience samples of speakers with one of eight types of CND. Audio-recorded conversational speech samples from 346 participants with one of eight types of CND were obtained from a database of participants recruited for genetic and behavioural studies of speech sound disorders (i.e., excluding dysfluency) during the past three decades. Data reduction methods for the speech samples included narrow phonetic transcription, prosody-voice coding, and acoustic analyses. Standardized measures were used to cross-classify participants' speech and motor speech status. Compared to the 17.8% prevalence of four types of motor speech disorders reported in a study of 415 participants with idiopathic Speech Delay (SD), 47.7% of the present participants with CND met criteria for one of four motor speech disorders, including Speech Motor Delay (25.1%), Childhood Dysarthria (13.3%), Childhood Apraxia of Speech (4.3%), and concurrent Childhood Dysarthria and Childhood Apraxia of Speech (4.9%). Findings are interpreted to indicate a substantial prevalence of speech disorders, and notably, a substantial prevalence of motor speech disorders in persons with some types of CND. We suggest that diagnostic classification information from standardized motor speech assessment protocols can contribute to research in the pathobiologies of CND.Abbreviations: 16p: 16p11.2 deletion and duplication syndrome; 22q: 22q11.2 deletion syndrome; ASD: Autism Spectrum Disorder; CAS: Childhood Apraxia of Speech; CD: Childhood Dysarthria; CND: Complex Neurodevelopmental Disorder; DS: Down syndrome; FXS: Fragile X syndrome; GAL: Galactosemia; IID: Idiopathic Intellectual Disability; MSD: Motor Speech Disorder; No MSD: No Motor Speech Disorder; NSA: Normal(ized) Speech Acquisition; PEPPER: Programs to Examine Phonetic and Phonologic Evaluation Records; PSD: Persistent Speech Delay; PSE: Persistent Speech Errors; SD: Speech Delay; SDCS: Speech Disorders Classification System; SDCSS: Speech Disorders Classification System Summary; SE: Speech Errors; SMD: Speech Motor Delay; SSD: Speech Sound Disorders; TBI: Traumatic Brain Injury	[Shriberg, Lawrence D.; Mabie, Heather L.] Univ Wisconsin, Waisman Ctr, Intellectual & Dev Disabil Res Ctr, Madison, WI 53705 USA; [Strand, Edythe A.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Jakielski, Kathy J.] Augustana Coll, Dept Commun Sci & Disorders, Rock Isl, IL 61201 USA		Shriberg, LD (corresponding author), Univ Wisconsin, Waisman Ctr, Room 439,1500 Highland Ave, Madison, WI 53705 USA.	shriberg@waisman.wisc.edu			National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC000496]; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54 HD090256]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD090256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC000496] Funding Source: NIH RePORTER	This work was supported by grants from the National Institute on Deafness and Other Communication Disorders [DC000496] and a core grant to the Waisman Center from the National Institute of Child Health and Human Development [U54 HD090256].	American Speech Language Hearing Association, 2007, CHILDH APR SPEECH, DOI [10.1094/PDIS-91-4-0467B, DOI 10.1094/PDIS-91-4-0467B]; [Anonymous], 2019, PROGR EX PHON PHON E; Beglinger LJ, 2001, J AUTISM DEV DISORD, V31, P411, DOI 10.1023/A:1010616719877; Bernthal J., 2017, ARTICULATION PHONOLO; Bishop DVM, 2002, AM J MED GENET, V114, P56, DOI 10.1002/ajmg.1630; Bowen C., 2015, CHILDRENS SPEECH SOU; Bradford A, 1997, CLIN LINGUIST PHONET, V11, P363, DOI 10.3109/02699209708985201; Byun TM, 2015, SEMIN SPEECH LANG, V36, P215, DOI 10.1055/s-0035-1562904; Carrigg B, 2016, ARCH CLIN NEUROPSYCH, V31, P1006, DOI 10.1093/arclin/acw077; Carrow-Woolfolk E., 1995, ORAL WRITTEN LANGUAG; Chilosi AM, 2015, BRAIN LANG, V150, P177, DOI 10.1016/j.bandl.2015.10.002; Cloete E, 2009, WOODHEAD PUBL FOOD S, P3, DOI 10.1533/9781845697167.1.3; Duffy JR., 2013, MOTOR SPEECH DISORDE; Eadie P, 2015, DEV MED CHILD NEUROL, V57, P578, DOI 10.1111/dmcn.12635; Eaton CT, 2015, SEMIN SPEECH LANG, V36, P247, DOI 10.1055/s-0035-1562908; Eising E, 2019, MOL PSYCHIATR, V24, P1065, DOI 10.1038/s41380-018-0020-x; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Flipsen P, 2015, SEMIN SPEECH LANG, V36, P217, DOI 10.1055/s-0035-1562905; Friederici A.D., 2012, FRONT EVOLUT NEUROSC, V4, P1, DOI DOI 10.3389/fnevo.2012.00001; Gaines R, 2007, CHILD CARE HLTH DEV, V33, P325, DOI 10.1111/j.1365-2214.2006.00677.x; Goffman L, 1999, J SPEECH LANG HEAR R, V42, P1499, DOI 10.1044/jslhr.4206.1499; Guenther FH, 2012, J NEUROLINGUIST, V25, P408, DOI 10.1016/j.jneuroling.2009.08.006; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hill EL, 2001, INT J LANG COMM DIS, V36, P149, DOI 10.1080/13682820010019874; Kaufman NL, 2004, KAUFMAN BRIEF INTELL; Kent RD, 2013, J SPEECH LANG HEAR R, V56, P178, DOI 10.1044/1092-4388(2012/12-0148); Liegeois F, 2011, EUR J PAEDIATR NEURO, V15, P283, DOI 10.1016/j.ejpn.2011.04.006; Liegeois FJ, 2012, NEUROSCI BIOBEHAV R, V36, P439, DOI 10.1016/j.neubiorev.2011.07.011; Ludlow C. L., 2018, MEASURING VOICE SPEE; Maas E, 2008, AM J SPEECH-LANG PAT, V17, P277, DOI 10.1044/1058-0360(2008/025); Maas Edwin, 2014, Curr Dev Disord Rep, V1, P197; Mabie H. L., 2017, 23 U WISC MAD WAISM; McLeod S., 2017, CHILDRENS SPEECH EVI; Morgan A., 2016, GENEREVIEWS; Morgan AT, 2010, FOLIA PHONIATR LOGO, V62, P120, DOI 10.1159/000287210; Nadel L, 2003, GENES BRAIN BEHAV, V2, P156, DOI 10.1034/j.1601-183X.2003.00026.x; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Newmeyer AJ, 2007, CLIN PEDIATR, V46, P604, DOI 10.1177/0009922807299545; Nijland L, 2003, J SPEECH LANG HEAR R, V46, P437, DOI 10.1044/1092-4388(2003/036); Nijland L, 2015, J SPEECH LANG HEAR R, V58, P550, DOI 10.1044/2015_JSLHR-S-14-0084; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; Perkell JS, 2012, J NEUROLINGUIST, V25, P382, DOI 10.1016/j.jneuroling.2010.02.011; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Peter B, 2017, AM J MED GENET A, V173, P2659, DOI 10.1002/ajmg.a.38385; Peterson RL, 2009, J SPEECH LANG HEAR R, V52, P1175, DOI 10.1044/1092-4388(2009/08-0024); Potter N. L., 2012, 18 U WISC MAD WAISM; Rechetinikov RP, 2009, AM J OCCUP THER, V63, P255, DOI 10.5014/ajot.63.3.255; Redle E, 2015, BRAIN RES, V1597, P47, DOI 10.1016/j.brainres.2014.11.047; Rice GM, 2012, AM J MED GENET A, V158A, P174, DOI 10.1002/ajmg.a.34354; Royal College of Speech and Language Therapists, 2011, DEV VERB DYSPR; Rvachew S., 2015, WHATS NAME DOES SSD; Rvachew S., 2012, DEV PHONOLOGICAL DIS; Scheer-Cohen A. R., 2013, 20 U WISC MAD WAISM; Semel E., 2003, CLIN EVALUATION LANG; Shriberg L. D., 2010, SPEECH SOUND DISORDE, P1; Shriberg L. D., 2017, 24 U WISC MAD WAISM; Shriberg L. D., 2016, 18 BIENN C MOT SPEEC; Shriberg L. D., 2019, CLIN LINGUISTICS PHO; Shriberg L. D., 2018, 25 U WISC MAD WAISM; Shriberg L. D., 2017, 7 INT C SPEECH MOT C; Shriberg L. D., 2002, 9 M INT CLIN LING PH; Shriberg L. D., 2010, SPEECH MOTOR CONTROL, P259, DOI [10.1093/acprof:oso/9780199235797.003., DOI 10.1093/ACPROF:OSO/9780199235797.003]; Shriberg LD, 2008, AM J MED GENET A, V146A, P2227, DOI 10.1002/ajmg.a.32363; Shriberg LD, 2006, J SPEECH LANG HEAR R, V49, P500, DOI 10.1044/1092-4388(2006/038); Shriberg LD, 2019, CLIN LINGUIST PHONET, V33, P679, DOI 10.1080/02699206.2019.1595731; Shriberg LD, 2017, J SPEECH LANG HEAR R, V60, P1135, DOI 10.1044/2016_JSLHR-S-15-0298; Shriberg LD, 2012, CLIN LINGUIST PHONET, V26, P445, DOI 10.3109/02699206.2012.655841; Shriberg LD, 2010, CLIN LINGUIST PHONET, V24, P795, DOI 10.3109/02699206.2010.503006; Shriberg LD, 2010, CLIN LINGUIST PHONET, V24, P825, DOI 10.3109/02699206.2010.503007; Shriberg LD, 2009, J SPEECH LANG HEAR R, V52, P1189, DOI 10.1044/1092-4388(2009/08-0047); Shriberg LD, 1999, J SPEECH LANG HEAR R, V42, P1461, DOI 10.1044/jslhr.4206.1461; SHRIBERG LD, 1991, CLIN LINGUIST PHONET, V5, P225, DOI 10.3109/02699209108986113; SHRIBERG LD, 1993, J SPEECH HEAR RES, V36, P105, DOI 10.1044/jshr.3601.105; Shriberg LD, 1997, J SPEECH LANG HEAR R, V40, P723, DOI 10.1044/jslhr.4004.723; SHRIBERG LD, 1985, J SPEECH HEAR DISORD, V50, P323, DOI 10.1044/jshd.5004.323; SHRIBERG LD, 1990, J SPEECH HEAR RES, V33, P627, DOI 10.1044/jshr.3304.627; Terband H, 2014, J COMMUN DISORD, V47, P17, DOI 10.1016/j.jcomdis.2014.01.001; Thorndike R. L., 1986, STANFORD BINET INTEL; Tilkens C. M., 2017, 22 U WISC MAD WAISM; Truong DT, 2016, HUM GENET, V135, P1329, DOI 10.1007/s00439-016-1717-z; Turner SJ, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0554-0; Turner SJ, 2013, AM J MED GENET A, V161, P2321, DOI 10.1002/ajmg.a.36055; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Vick JC, 2014, J SPEECH LANG HEAR R, V57, P2033, DOI 10.1044/2014_JSLHR-S-12-0193; Visscher C, 2007, PEDIATRICS, V120, pE158, DOI 10.1542/peds.2006-2462; Waring R, 2013, INT J LANG COMM DIS, V48, P25, DOI 10.1111/j.1460-6984.2012.00195.x; Weismer G, 2006, CLIN LINGUIST PHONET, V20, P315, DOI 10.1080/02699200400024806; Wilson EM, 2019, CLIN LINGUIST PHONET, V33, P790, DOI 10.1080/02699206.2019.1595736; Wilson EM, 2019, CLIN LINGUIST PHONET, V33, P772, DOI 10.1080/02699206.2019.1595735; Worthey EA, 2013, J NEURODEV DISORD, V5, DOI 10.1186/1866-1955-5-29; Wren Y, 2016, J SPEECH LANG HEAR R, V59, P647, DOI 10.1044/2015_JSLHR-S-14-0282; Yoder PJ, 2016, J SPEECH LANG HEAR R, V59, P446, DOI 10.1044/2015_JSLHR-S-15-0148; Ziegler W, 2013, FOLIA PHONIATR LOGO, V65, P55, DOI 10.1159/000353855; Ziegler W, 2012, J SPEECH LANG HEAR R, V55, pS1485, DOI 10.1044/1092-4388(2012/12-0128); Zwicker JG, 2009, J CHILD NEUROL, V24, P1273, DOI 10.1177/0883073809333537; [No title captured]	97	12	13	1	13	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9206	1464-5076		CLIN LINGUIST PHONET	Clin. Linguist. Phon.	AUG 3	2019	33	8			SI		707	736		10.1080/02699206.2019.1595732			30	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	IH2EG	WOS:000474307400003	31221012	Green Accepted, hybrid			2022-02-06	
J	Ellis, MJ; Russell, K				Ellis, Michael J.; Russell, Kelly			The Potential of Telemedicine to Improve Pediatric Concussion Care in Rural and Remote Communities in Canada	FRONTIERS IN NEUROLOGY			English	Article						concussion; traumatic brain injury; telemedicine; teleneurology; network	SCIENTIFIC STATEMENT; POLICY STATEMENT; STROKE SYSTEMS; PART 2; TELESTROKE; MANAGEMENT; HEALTH; RECOMMENDATIONS; TELECONCUSSION; IMPLEMENTATION	Concussion is a form of mild traumatic brain injury that affects thousands of Canadian children and adolescents annually. Despite national efforts to harmonize the recognition and management of pediatric concussion in Canada, timely access to primary and specialized care following this injury remains a challenge for many patients especially those who live in rural and remote communities. To address similar challenges facing patients with stroke and other neurological disorders, physicians have begun to leverage advances in telemedicine to improve the delivery of specialized neurological care to those living in medically underserved regions. Preliminary studies suggest that telemedicine may be a safe and cost-effective approach to assist in the medical care of select patients with acute concussion and persistent post-concussion symptoms. Here we provide an overview of telemedicine, teleneurology, the principles of concussion assessment and management, as well as the current state of concussion care in Canada. Utilizing preliminary evidence from studies of telemedicine in concussion and experience from comprehensive systems of care for stroke, we outline steps that must be taken to evaluate the potential of telemedicine-based concussion networks to improve the care of pediatric concussion patients living in underserved rural and remote communities in Canada.	[Ellis, Michael J.] Univ Manitoba, Dept Surg, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Pediat & Child Hlth, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Sect Neurosurg, Winnipeg, MB, Canada; [Ellis, Michael J.; Russell, Kelly] Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada; [Ellis, Michael J.] Pan Am Concuss Program, Winnipeg, MB, Canada		Ellis, MJ (corresponding author), Univ Manitoba, Dept Surg, Winnipeg, MB, Canada.; Ellis, MJ (corresponding author), Univ Manitoba, Pediat & Child Hlth, Winnipeg, MB, Canada.; Ellis, MJ (corresponding author), Univ Manitoba, Sect Neurosurg, Winnipeg, MB, Canada.; Ellis, MJ (corresponding author), Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada.; Ellis, MJ (corresponding author), Pan Am Concuss Program, Winnipeg, MB, Canada.	mellis3@panamclinic.com			University of Manitoba, Department of Surgery Thorlakson Fund	Financial support of this manuscript was provided by the University of Manitoba, Department of Surgery Thorlakson Fund.	Adeoye O, 2019, STROKE, V50, pE187, DOI 10.1161/STR.0000000000000173; Akbik F, 2017, J NEUROINTERV SURG, V9, P361, DOI [10.1136/neurintsurg-2016-012340, 10.1136/neurintsurg-2016-012291]; Akbik F, 2017, J NEUROINTERV SURG, V9, P357, DOI [10.1136/neurintsurg-2016-012291, 10.1136/neurintsurg-2016-012340]; Arora S, 2013, CLIN INVEST MED, V36, pE57, DOI 10.25011/cim.v36i2.19567; Blacquiere D, 2017, INT J STROKE, V12, P886, DOI 10.1177/1747493017706239; Canadian Academy of Sport and Exercise Medicine College of Family Physicians of Canada and Canadian Medical Association., 2019, PUBL HLTH STRAT IMPR; Canadian Medical Association, 2019, SCAL VIRT CAR CAN CM; Canadian Medical Protection Agency, 2015, TEL OPP CHALL OBL; Chung S, 2011, J TRAUMA, V70, P873, DOI 10.1097/TA.0b013e3182108823; COACH. Canada's Health Informatics Association, 2015, CAN HLTH INF ASS; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Craig JJ, 1999, J TELEMED TELECARE, V5, P177, DOI 10.1258/1357633991933594; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Demaerschalk BM, 2017, TELEMED E-HEALTH, V23, P376, DOI 10.1089/tmj.2017.0006; Dorsey ER, 2018, NAT REV NEUROL, V14, P285, DOI 10.1038/nrneurol.2018.31; Dumitrascu OM, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0895-1; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Ellis MJ, 2019, PAED CHILD HEALT-CAN, V24, P137, DOI 10.1093/pch/pxy171; Ellis MJ, 2019, INT J CIRCUMPOL HEAL, V78, DOI 10.1080/22423982.2019.1573163; Ellis MJ, 2019, J HEAD TRAUMA REHAB, V34, P103, DOI 10.1097/HTR.0000000000000411; Ellis MJ, 2017, CAN J NEUROL SCI, V44, P24, DOI 10.1017/cjn.2016.312; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Ellis MJ, 2017, CLIN J SPORT MED, V27, P179, DOI 10.1097/JSM.0000000000000305; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Fridman L, 2018, J PEDIATR-US, V192, P184, DOI 10.1016/j.jpeds.2017.09.018; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gordon KE, 2014, BRAIN INJURY, V28, P311, DOI 10.3109/02699052.2013.862740; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Hess DC, 2013, NAT REV NEUROL, V9, P340, DOI 10.1038/nrneurol.2013.86; Hubley S, 2016, WORLD J PSYCHIATR, V6, P269, DOI 10.5498/wjp.v6.i2.269; Huot S, 2019, INT J CIRCUMPOL HEAL, V78, DOI 10.1080/22423982.2019.1571385; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jong M, 2019, INT J CIRCUMPOL HEAL, V78, DOI 10.1080/22423982.2018.1554174; Kamins J, 2016, NEUROSURG CLIN N AM, V27, P441, DOI 10.1016/j.nec.2016.05.005; King M, 2009, LANCET, V374, P76, DOI 10.1016/S0140-6736(09)60827-8; Kruse CS, 2018, J TELEMED TELECARE, V24, P4, DOI 10.1177/1357633X16674087; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Larner A J, 2011, Pract Neurol, V11, P283, DOI 10.1136/practneurol-2011-000090; Levine SR, 1999, STROKE, V30, P464, DOI 10.1161/01.STR.30.2.464; Liddy C, 2019, TELEMED E-HEALTH, V25, P184, DOI 10.1089/tmj.2018.0005; Liddy C, 2017, INT J CIRCUMPOL HEAL, V76, P1, DOI 10.1080/22423982.2017.1323493; Lo MD, 2019, J CHILD NEUROL, V34, P22, DOI 10.1177/0883073818807516; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Matveev R, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6232-9; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meyer BC, 2012, J STROKE CEREBROVASC, V21, P521, DOI 10.1016/j.jstrokecerebrovasdis.2012.06.012; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Nader F, 2017, J HEALTH CARE POOR U, V28, P1286, DOI 10.1353/hpu.2017.0114; Nelson EL, 2017, CHILD ADOL PSYCH CL, V26, P77, DOI 10.1016/j.chc.2016.07.008; O'Gorman LD, 2016, TELEMED E-HEALTH, V22, P473, DOI 10.1089/tmj.2015.0166; Ontario Neurotrauma Foundation, 2018, GUID CONC MTBI PERS; Ontario Neurotrauma Foundation, 2014, GUID DIAGN MAN PED C; Ontario Neurotrauma Foundation, 2017, STAND POSTC CAR DIAG; Oosterveer TM, 2015, INT J CIRCUMPOL HEAL, V74, DOI 10.3402/ijch.v74.29576; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Parachute, 2017, CAN GUID CONC SPORT; Roth DE, 2019, CHILD ADOL PSYCH CL, V28, P377, DOI 10.1016/j.chc.2019.02.007; Russell K, 2017, CAN J NEUROL SCI, V44, P225, DOI 10.1017/cjn.2016.423; Schwamm LH, 2017, CIRCULATION, V135, pE24, DOI 10.1161/CIR.0000000000000475; Schwamm LH, 2009, STROKE, V40, P2635, DOI 10.1161/STROKEAHA.109.192361; Schwamm LH, 2009, STROKE, V40, P2616, DOI 10.1161/STROKEAHA.109.192360; Stiell IG, 2010, CAN MED ASSOC J, V182, P1173, DOI 10.1503/cmaj.091430; Stoller J, 2014, CAN FAM PHYSICIAN, V60, P548; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Strehle EM, 2006, ARCH DIS CHILD, V91, P956, DOI 10.1136/adc.2006.099622; Switzer JA, 2013, CIRC-CARDIOVASC QUAL, V6, P18, DOI 10.1161/CIRCOUTCOMES.112.967125; Tenforde AS, 2017, PM&R, V9, pS51, DOI 10.1016/j.pmrj.2017.02.013; Vargas BB, 2017, NEUROLOGY, V88, P1580, DOI 10.1212/WNL.0000000000003841; Vargas BB, 2012, TELEMED E-HEALTH, V18, P803, DOI 10.1089/tmj.2012.0118; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Vierhile A, 2018, J PEDIATR HEALTH CAR, V32, P500, DOI 10.1016/j.pedhc.2018.02.004; Vimalananda VG, 2015, J TELEMED TELECARE, V21, P323, DOI 10.1177/1357633X15582108; Wechsler LR, 2017, STROKE, V48, pE3, DOI 10.1161/STR.0000000000000114; Wechsler LR, 2015, JAMA NEUROL, V72, P349, DOI 10.1001/jamaneurol.2014.3844; Wechsler LR, 2013, NEUROLOGY, V80, P670, DOI 10.1212/WNL.0b013e3182823361; World Health Organization, 2010, TEL OPP DEV MEMB STA; Young T Kue, 2016, Healthc Policy, V12, P59; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2015, CAN J EMERG MED, V17, P115, DOI 10.1017/cem.2014.38; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	84	12	12	2	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 2	2019	10								840	10.3389/fneur.2019.00840			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IN4JF	WOS:000478640500001	31428043	Green Published, gold			2022-02-06	
J	Cevik, S; Ozgenc, MM; Guneyk, A; Evran, S; Akkaya, E; Calis, F; Katar, S; Soyalp, C; Hanimoglu, H; Kaynar, MY				Cevik, Serdar; Ozgenc, Mustafa Murat; Guneyk, Ahmet; Evran, Sevket; Akkaya, Enes; Calis, Fatih; Katar, Salim; Soyalp, Celaleddin; Hanimoglu, Hakan; Kaynar, Mehmet Yasar			NRGN, S100B and GFAP levels are significantly increased in patients with structural lesions resulting from mild traumatic brain injuries	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Traumatic brain injury; Computed tomography; Glial fibrillary acidic protein; Biomarkers; Neurogranin; Calcium-binding protein S100 beta	FIBRILLARY ACIDIC PROTEIN; KINASE-C SUBSTRATE; INTRACRANIAL LESIONS; MESSENGER-RNA; SERUM; NEUROGRANIN; HEAD; PURIFICATION; BIOMARKERS; MARKER	Objective: To determine whether serum neurogranin (NRGN), glial fibrillary acidic protein (GFAP), and calcium-binding protein S100 beta (S100B) levels are associated with traumatic intracranial lesions compared to computed tomography (CT) findings of patients with mild traumatic brain injury (mTBI). Patients and Methods: The cross-sectional study cohort included 48 patients who were admitted to the Emergency Department with a complaint of mTBI, a Glasgow Coma Scale score of 14-15, and at least one symptom of head trauma (i.e., post-traumatic amnesia, nausea or vomiting, post-traumatic seizures, persistent headache, and transient loss of consciousness). Blood samples and CT scans were obtained for all patients within 4 h of injury. Age-matched patients without intracranial traumatic pathology (CT-) were recruited as a control group. Blood samples were measured for NRGN, GFAP, and S100B levels. Results: Of 48 patients, 24 were CT + and had significantly higher serum NRGN (5.79 vs. 2.95 ng/mL), GFAP (0.59 vs.0.36 ng/mL), and S100B (1.72 vs.0.73 mu g/L) levels than those who were CT- (p = 0.001, p = 0.026, and p < 0.001, respectively). ROC curves showed that NRGN, GFAP, and S100B levels were sufficient to distinguish traumatic brain injury in patients with mTBI. At the cut-off value for NRGN of 1.87 ng/mL, sensivity was 83.3%, and specificity was 58.3%. At the cut-off value for GFAP of 0.23 ng/mL, sensivity was 75% and specificity was 62.5%. The optimal cut-off value for S100B was 0.47 mu g/L (95.8% sensitivity and 62.5% specificity). Conclusion: This is the first study to evaluate NRGN in human serum after mTBI. We confirmed that NRGN levels were significantly higher in CT + patients than CT- patients in the mTBI patient population. Future studies of larger populations and different age groups (especially pediatric) can help reduce the number of CT scans as a reliable and noninvasive diagnostic tool for evaluating NRGN protein levels in mTBI patients with a low probability of intracranial lesions.	[Cevik, Serdar] Bezmialem Vakif Univ, Dept Neurosurg, TR-34093 Istanbul, Turkey; [Ozgenc, Mustafa Murat] Med Pk Hosp, Dept Emergency Med, Antalya, Turkey; [Guneyk, Ahmet] Agri State Hosp, Dept Biochem, Agri, Turkey; [Evran, Sevket] Bahcelievler State Hosp, Dept Neurosurg, Istanbul, Turkey; [Akkaya, Enes] Univ Hlth Sci, Sisli Hamidiye Etfal Training & Res Hosp, Dept Neurosurg, Istanbul, Turkey; [Calis, Fatih] Medeniyet Univ, Goztepe Training & Res Hosp, Dept Neurosurg, Istanbul, Turkey; [Katar, Salim] Selahaddin Eyyubi State Hosp, Dept Neurosurg, Diyarbakir, Turkey; [Soyalp, Celaleddin] Yuzuncu Yil Univ, Sch Med, Dept Anesthesiol & Intens Care, Van, Turkey; [Hanimoglu, Hakan] Biruni Univ, Dept Neurosurg, Istanbul, Turkey; [Kaynar, Mehmet Yasar] Istanbul Univ, Cerrahpasa Med Sch, Dept Neurosurg, Istanbul, Turkey		Cevik, S (corresponding author), Bezmialem Vakif Univ, Dept Neurosurg, TR-34093 Istanbul, Turkey.	dr.serdarcevik@gmail.com	EVRAN, Sevket/AAG-3284-2019; akkaya, enes/AAA-2182-2020; Cevik, Serdar/G-7161-2018	Akkaya, Enes/0000-0003-2503-754X; CEVIK, Serdar/0000-0002-2733-4233			Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; BAUDIER J, 1989, J BIOL CHEM, V264, P1824; BAUDIER J, 1991, J BIOL CHEM, V266, P229; Baydas G, 2003, EUR J PHARMACOL, V462, P67, DOI 10.1016/S0014-2999(03)01294-9; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cervellin G, 2012, CLIN BIOCHEM, V45, P408, DOI 10.1016/j.clinbiochem.2012.01.006; Chang JW, 1997, J NEUROPATH EXP NEUR, V56, P1105, DOI 10.1097/00005072-199710000-00004; DELOULME JC, 1991, FEBS LETT, V282, P183, DOI 10.1016/0014-5793(91)80473-G; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Foerch C, 2006, J NEUROL NEUROSUR PS, V77, P181, DOI 10.1136/jnnp.2005.074823; GERENDASY DD, 1995, J BIOL CHEM, V270, P6741, DOI 10.1074/jbc.270.12.6741; Goncalves Carlos Alberto, 2010, Cardiovasc Psychiatry Neurol, V2010, P790431, DOI 10.1155/2010/790431; Hall EJ, 2008, BRIT J RADIOL, V81, P362, DOI 10.1259/bjr/01948454; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; HUANG KP, 1993, ARCH BIOCHEM BIOPHYS, V305, P570, DOI 10.1006/abbi.1993.1463; Ingebrigtsen T, 1996, ACTA NEUROL SCAND, V93, P207; Diez-Guerra FJ, 2010, IUBMB LIFE, V62, P597, DOI 10.1002/iub.357; Koob AO, 2014, BRAIN RES, V1591, P102, DOI 10.1016/j.brainres.2014.10.013; Missler U, 1999, CLIN CHEM, V45, P138; Miyakawa T, 2001, HIPPOCAMPUS, V11, P763, DOI 10.1002/hipo.1092; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mouser PE, 2006, AM J PATHOL, V168, P936, DOI 10.2353/ajpath.2006.050798; Norlund A, 2006, BMJ-BRIT MED J, V333, P469, DOI 10.1136/bmj.38918.659120.4F; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Papa L, 2015, NEUROCRIT CARE, V22, P52, DOI 10.1007/s12028-014-0028-2; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; REPRESA A, 1990, J NEUROSCI, V10, P3782, DOI 10.1523/JNEUROSCI.10-12-03782.1990; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Thorsell A, 2010, BRAIN RES, V1362, P13, DOI 10.1016/j.brainres.2010.09.073; van Geel WJA, 2002, CLIN CHIM ACTA, V326, P151, DOI 10.1016/S0009-8981(02)00330-3; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; WATSON JB, 1990, J NEUROSCI RES, V26, P397, DOI 10.1002/jnr.490260402; Yang J, 2015, CLIN BIOCHEM, V48, P843, DOI 10.1016/j.clinbiochem.2015.05.015	38	12	12	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	AUG	2019	183								105380	10.1016/j.clineuro.2019.105380			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IT6SU	WOS:000483005900011	31234132				2022-02-06	
J	Cheng, Y; Pereira, M; Raukar, N; Reagan, JL; Queseneberry, M; Goldberg, L; Borgovan, T; LaFrance, WC; Dooner, M; Deregibus, M; Camussi, G; Ramratnam, B; Quesenberry, P				Cheng, Yan; Pereira, Mandy; Raukar, Neha; Reagan, John L.; Queseneberry, Mathew; Goldberg, Laura; Borgovan, Theodor; LaFrance, W. Curt, Jr.; Dooner, Mark; Deregibus, Maria; Camussi, Giovanni; Ramratnam, Bharat; Quesenberry, Peter			Potential biomarkers to detect traumatic brain injury by the profiling of salivary extracellular vesicles	JOURNAL OF CELLULAR PHYSIOLOGY			English	Article						biomarkers; extracellular vesicles (EVs); real-time PCR; traumatic brain injury (TBI)	ALZHEIMERS-DISEASE; ENCEPHALOPATHY; EXOSOMES; CELL; MECHANISMS; DIAGNOSIS; PROTEOMICS; PROGNOSIS; PROTEINS; ONSET	Traumatic brain injury(TBI) is a common cause of death and acquired disability in adults and children. Identifying biomarkers for mild TBI (mTBI) that can predict functional impairments on neuropsychiatric and neurocognitive testing after head trauma is yet to be firmly established. Extracellular vesicles (EVs) are known to traffic from the brain to the oral cavity and can be detected in saliva. We hypothesize the genetic profile of salivary EVs in patients who have suffered head trauma will differ from normal healthy controls, thus constituting a unique expression signature for mTBI. We enrolled a total of 54 subjects including for saliva sampling, 23 controls with no history of head traumas, 16 patients enrolled from an outpatient concussion clinic, and 15 patients from the emergency department who had sustained a head trauma within 24hr. We performed real-time PCR of the salivary EVs of the 54 subjects profiling 96 genes from the TaqMan Human Alzheimer's disease array. Real-time PCR analysis revealed 57 (15 genes, p<0.05) upregulated genes in emergency department patients and 56 (14 genes, p<0.05) upregulated genes in concussion clinic patients when compared with controls. Three genes were upregulated in both the emergency department patients and concussion clinic patients: CDC2, CSNK1A1, and CTSD (p<0.05). Our results demonstrate that salivary EVs gene expression can serve as a viable source of biomarkers for mTBI. This study shows multiple Alzheimer's disease genes present after an mTBI.	[Cheng, Yan; Pereira, Mandy; Reagan, John L.; Queseneberry, Mathew; Goldberg, Laura; Borgovan, Theodor; Dooner, Mark; Quesenberry, Peter] Rhode Isl Hosp, Dept Med, Div Hematol Oncol, Providence, RI 02903 USA; [Raukar, Neha] Rhode Isl Hosp, Dept Emergency Med, Providence, RI USA; [LaFrance, W. Curt, Jr.] Rhode Isl Hosp, Dept Psychiat Neurol, Providence, RI USA; [Ramratnam, Bharat] Rhode Isl Hosp, Dept Med, Div Infect Dis, Providence, RI 02903 USA; [Deregibus, Maria; Camussi, Giovanni] Univ Turin, Dept Med Sci, Turin, Italy		Pereira, M (corresponding author), Rhode Isl Hosp, Coro West,Suite 5-01,1 Hoppin St, Providence, RI 02903 USA.	mpereira7@lifespan.org	LaFrance, W Curt/AAN-6707-2021	LaFrance, W Curt/0000-0002-4901-3852; Pereira, Mandy/0000-0002-3999-9048; Dooner, Mark/0000-0003-0653-6562	National Heart, Lungs, and Blood Institute Grant [T32HL116249]; NIH Centers of Biomedical Research Excellence (COBRE) [P20GM103468]; NIH Common FundUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5UH3TROOO880-05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL116249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM119943] Funding Source: NIH RePORTER	National Heart, Lungs, and Blood Institute Grant, Grant/Award Number: T32HL116249; NIH Centers of Biomedical Research Excellence (COBRE), Grant/Award Number: P20GM103468; NIH Common Fund, Grant/Award Number: 5UH3TROOO880-05	Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Becker RE, 2018, ALZHEIMERS DEMENT, V14, P431, DOI 10.1016/j.jalz.2017.11.007; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Dekker SE, 2014, J TRAUMA ACUTE CARE, V77, P906, DOI 10.1097/TA.0000000000000345; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Goetzl EJ, 2016, FASEB J, V30, P3853, DOI 10.1096/fj.201600756R; Gonzales PA, 2009, J AM SOC NEPHROL, V20, P363, DOI 10.1681/ASN.2008040406; Gonzalez-Begne M, 2009, J PROTEOME RES, V8, P1304, DOI 10.1021/pr800658c; Grinberg LT, 2016, J ALZHEIMERS DIS, V54, P169, DOI 10.3233/JAD-160312; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037; Hu YS, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0252-z; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Julien J, 2017, ANN PHYS REHABIL MED, V60, P347, DOI 10.1016/j.rehab.2017.03.009; Kapsogeorgou EK, 2005, ARTHRITIS RHEUM-US, V52, P1517, DOI 10.1002/art.21005; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Lau CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033037; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mendez MF, 2015, J ALZHEIMERS DIS, V47, P985, DOI 10.3233/JAD-143207; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; Mitchell PJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-4; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Papa L, 2015, BRAIN NEUROTRAUMA MO, DOI [DOI 10.1201/B18126-27, 10.1201/b18126-27]; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Quesenberry PJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0150-x; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Rogg Jeffrey, 2014, R I Med J (2013), V97, P22; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Schneider R, 2018, J NEUROL NEUROSUR PS, V89, P851, DOI 10.1136/jnnp-2017-317492; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; Tan X, 2015, NEUROSCIENCE, V290, P552, DOI 10.1016/j.neuroscience.2015.01.054; Tang HK, 2013, MOL MED REP, V7, P761, DOI 10.3892/mmr.2012.1254; Taylor CA, 2015, J HEAD TRAUMA REHAB, V30, P150, DOI 10.1097/HTR.0000000000000105; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; White TE, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2412-0; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Yousuf MA, 2016, J NEUROCHEM, V138, P317, DOI 10.1111/jnc.13620; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhong L, 2010, COMP IMMUNOL MICROB, V33, P47, DOI 10.1016/j.cimid.2008.07.009	50	12	12	1	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	AUG	2019	234	8					14377	14388		10.1002/jcp.28139			12	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	HX2SA	WOS:000467240800198	30644102	Green Published, hybrid, Green Accepted			2022-02-06	
J	Jenkins, PO; De Simoni, S; Bourke, NJ; Fleminger, J; Scott, G; Towey, DJ; Svensson, W; Khan, S; Patel, MC; Greenwood, R; Friedland, D; Hampshire, A; Cole, JH; Sharp, DJ				Jenkins, Peter O.; De Simoni, Sara; Bourke, Niall J.; Fleminger, Jessica; Scott, Gregory; Towey, David J.; Svensson, William; Khan, Sameer; Patel, Maneesh C.; Greenwood, Richard; Friedland, Daniel; Hampshire, Adam; Cole, James H.; Sharp, David J.			Stratifying drug treatment of cognitive impairments after traumatic brain injury using neuroimaging	BRAIN			English	Article						traumatic brain injury; methylphenidate; dopamine; neuroimaging; cognitive enhancement	DOPAMINE TRANSPORTERS; ATTENTION DEFICITS; METHYLPHENIDATE; SCALE; NEUROTRANSMISSION; I-123-BETA-CIT; INCREASES; NETWORK; SYSTEM; SPECT	Cognitive impairment is common following traumatic brain injury. Dopaminergic drugs can enhance cognition after traumatic brain injury, but individual responses are highly variable. This may be due to variability in dopaminergic damage between patients. We investigate whether measuring dopamine transporter levels using I-123-ioflupane single-photon emission computed tomography (SPECT) predicts response to methylphenidate, a stimulant with dopaminergic effects. Forty patients with moderate-severe traumatic brain injury and cognitive impairments completed a randomized, double-blind, placebo-controlled, crossover study. (123)Iioflupane SPECT, MRI and neuropsychological testing were performed. Patients received 0.3 mg/kg of methylphenidate or placebo twice a day in 2-week blocks. Subjects received neuropsychological assessment after each block and completed daily home cognitive testing during the trial. The primary outcome measure was change in choice reaction time produced by methylphenidate and its relationship to stratification of patients into groups with normal and low dopamine transporter binding in the caudate. Overall, traumatic brain injury patients showed slow information processing speed. Patients with low caudate dopamine transporter binding showed improvement in response times with methylphenidate compared to placebo [median change = -16 ms; 95% confidence interval (CI): -28 to -3 ms; P = 0.02]. This represents a 27% improvement in the slowing produced by traumatic brain injury. Patients with normal dopamine transporter binding did not improve. Daily home-based choice reaction time results supported this: the low dopamine transporter group improved (median change -19 ms; 95% CI: -23 to -7 ms; P = 0.002) with no change in the normal dopamine transporter group (P = 0.50). The low dopamine transporter group also improved on self-reported and caregiver apathy assessments (P = 0.03 and P = 0.02, respectively). Both groups reported improvements in fatigue (P = 0.03 and P = 0.007). The cognitive effects of methylphenidate after traumatic brain injury were only seen in patients with low caudate dopamine transporter levels. This shows that identifying patients with a hypodopaminergic state after traumatic brain injury can help stratify the choice of cognitive enhancing therapy.	[Jenkins, Peter O.; De Simoni, Sara; Bourke, Niall J.; Fleminger, Jessica; Scott, Gregory; Friedland, Daniel; Hampshire, Adam; Cole, James H.; Sharp, David J.] Imperial Coll London, Hammersmith Hosp, Div Brain Sci, Computat Cognit & Clin Neuroimaging Lab, London, England; [Towey, David J.; Svensson, William; Khan, Sameer] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Dept Nucl Med, London, England; [Patel, Maneesh C.] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Imaging Dept, London, England; [Greenwood, Richard] UCL, Inst Neurol, Div Clin Neurol, London, England; [Sharp, David J.] United Kingdom UK Dementia Res Inst, 6th Floor,UCL Maple House Tottenham Court Rd, London W1T 7NF, England		Sharp, DJ (corresponding author), Imperial Coll London, Dept Med, C3NL, Div Brain Sci, Du Cane Rd, London W12 0NN, England.	david.sharp@imperial.ac.uk	Cole, James H/I-5197-2019; Towey, David/I-6571-2016	Cole, James H/0000-0003-1908-5588; Jenkins, Peter/0000-0003-2060-6766; Towey, David/0000-0002-6209-3826; Scott, Gregory/0000-0001-8063-5871; Fleminger, Jessica/0000-0002-5744-5137	National Institute of Health Research Professorship [NIHR-RP-011-048]; NIHR Clinical Research Facility and Biomedical Research Centre at Imperial College Healthcare NHS Trust & NIHR Clinical Research Facility; Guarantors of Brain Clinical Fellowship; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [UKDRI-7006] Funding Source: UKRI	This paper presents independent research funded by a National Institute of Health Research Professorship (NIHR-RP-011-048) awarded to D.J.S. and supported by the NIHR Clinical Research Facility and Biomedical Research Centre at Imperial College Healthcare NHS Trust & NIHR Clinical Research Facility. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. P.O.J. is funded by Guarantors of Brain Clinical Fellowship.	Berridge CW, 2006, BIOL PSYCHIAT, V60, P1111, DOI 10.1016/j.biopsych.2006.04.022; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Delis DC., 2001, DELIS KAPLAN EXECUTI; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Gainetdinov RR, 1998, BRAIN RES REV, V26, P148, DOI 10.1016/S0165-0173(97)00063-5; Granon S, 2000, J NEUROSCI, V20, P1208, DOI 10.1523/JNEUROSCI.20-03-01208.2000; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Jahanshahi M, 2015, NAT REV NEUROSCI, V16, P719, DOI 10.1038/nrn4038; Jenkins PO, 2018, BRAIN, V141, P797, DOI 10.1093/brain/awx357; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; Jenkins PO, 2015, J NEUROL NEUROSUR PS, V86, pe4; Kimko HC, 1999, CLIN PHARMACOKINET, V37, P457, DOI 10.2165/00003088-199937060-00002; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Marie RM, 1999, NEUROSCI LETT, V260, P77, DOI 10.1016/S0304-3940(98)00928-8; McDonald BC, 2017, NEUROPSYCHOPHARMACOL, V42, P1766, DOI 10.1038/npp.2016.261; Mozley LH, 2001, AM J PSYCHIAT, V158, P1492, DOI 10.1176/appi.ajp.158.9.1492; Muller U, 2000, J NEURAL TRANSM, V107, P303, DOI 10.1007/s007020050025; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Seibyl JP, 1997, J NUCL MED, V38, P1453; Sockeel P, 2006, J NEUROL NEUROSUR PS, V77, P579, DOI 10.1136/jnnp.2005.075929; Solanto MV, 1998, BEHAV BRAIN RES, V94, P127, DOI 10.1016/S0166-4328(97)00175-7; van Bregt DR, 2012, EXP NEUROL, V234, P8, DOI 10.1016/j.expneurol.2011.12.003; Volkow ND, 2005, BIOL PSYCHIAT, V57, P1410, DOI 10.1016/j.biopsych.2004.11.006; Volz TJ, 2008, J PHARMACOL EXP THER, V327, P161, DOI 10.1124/jpet.108.139386; Volz TJ, 2007, J PHARMACOL EXP THER, V323, P738, DOI 10.1124/jpet.107.126888; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Wenning GK, 1998, MOVEMENT DISORD, V13, P438, DOI 10.1002/mds.870130311; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	43	12	12	1	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	AUG	2019	142		8				2367	2379		10.1093/brain/awz149			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JH9JO	WOS:000493084400027	31199462				2022-02-06	
J	Kelsen, J; Karlsson, M; Hansson, MJ; Yang, ZH; Fischer, W; Hugerth, M; Nordstrom, CH; Astrand, R; Keep, MF; Kilbaugh, T; Wang, KKW; Moller, K; Juhler, M; Elmer, E				Kelsen, Jesper; Karlsson, Michael; Hansson, Magnus J.; Yang, Zhihui; Fischer, Walter; Hugerth, Matilda; Nordstrom, Carl-Henrik; Astrand, Ramona; Keep, Marcus F.; Kilbaugh, Todd; Wang, Kevin K. W.; Moller, Kirsten; Juhler, Marianne; Elmer, Eskil			Copenhagen Head Injury Ciclosporin (CHIC) Study: A Phase IIa Safety, Pharmacokinetics, and Biomarker Study of Ciclosporin in Severe Traumatic Brain Injury Patients	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; ciclosporin; NeuroSTAT (R); pharmacokinetics; traumatic brain injury	MITOCHONDRIAL PERMEABILITY TRANSITION; DYSFUNCTION; INHIBITION; DEPRESSION; MECHANISM; PROPOFOL; NECROSIS; BARRIER; ASSAY	Traumatic brain injury (TBI) contributes to almost one third of all trauma-related deaths, and those that survive often suffer from long-term physical and cognitive deficits. Ciclosporin (cyclosporine, cyclosporin A) has shown promising neuroprotective properties in pre-clinical TBI models. The Copenhagen Head Injury Ciclosporin (CHIC) study was initiated to establish the safety profile and pharmacokinetics of ciclosporin in patients with severe TBI, using a novel parenteral lipid emulsion formulation. Exploratory pharmacodynamic study measures included microdialysis in brain parenchyma and protein biomarkers of brain injury in the cerebrospinal fluid (CSF). Sixteen adult patients with severe TBI (Glasgow Coma Scale 4-8) were included, and all patients received an initial loading dose of 2.5 mg/kg followed by a continuous infusion for 5 days. The first 10 patients received an infusion dosage of 5 mg/kg/day whereas the subsequent 6 patients received 10 mg/kg/day. No mortality was registered within the study duration, and the distribution of adverse events was similar between the two treatment groups. Pharmacokinetic analysis of CSF confirmed dose-dependent brain exposure. Between- and within-patient variability in blood concentrations was limited, whereas CSF concentrations were more variable. The four biomarkers, glial fibrillary acidic protein, neurofilament light, tau, and ubiquitin carboxy-terminal hydrolase L1, showed consistent trends to decrease during the 5-day treatment period, whereas the samples taken on the days after the treatment period showed higher values in the majority of patients. In conclusion, ciclosporin, as administered in this study, is safe and well tolerated. The study confirmed that ciclosporin is able to pass the blood-brain barrier in a TBI population and provided an initial biomarker-based signal of efficacy.	[Kelsen, Jesper; Karlsson, Michael; Fischer, Walter; Astrand, Ramona; Juhler, Marianne] Rigshosp, Dept Neurosurg, Copenhagen, Denmark; [Karlsson, Michael; Hansson, Magnus J.; Elmer, Eskil] Lund Univ, Dept Clin Sci, Mitochondrial Med, BMC A13, SE-22184 Lund, Sweden; [Karlsson, Michael; Hansson, Magnus J.; Hugerth, Matilda; Keep, Marcus F.; Elmer, Eskil] NeuroVive Pharmaceut AB, Lund, Sweden; [Yang, Zhihui; Wang, Kevin K. W.] Univ Florida, Dept Emergency Med, Program Neurotrauma Neuroprote & Biomarkers Res, Gainesville, FL USA; [Nordstrom, Carl-Henrik] Odense Univ Hosp, Dept Neurosurg, Odense, Denmark; [Keep, Marcus F.] Sanford Med Ctr, Sanford Brain & Spine Inst, Dept Neurosurg, Fargo, ND USA; [Kilbaugh, Todd] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kilbaugh, Todd] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA; [Wang, Kevin K. W.] Malcom Randall Vet Affairs Med Ctr, Brain Rehabil Res Ctr, Gainesville, FL USA; [Moller, Kirsten] Rigshosp, Dept Neuroanesthesiol, Copenhagen, Denmark		Elmer, E (corresponding author), Lund Univ, Dept Clin Sci, Mitochondrial Med, BMC A13, SE-22184 Lund, Sweden.	eskil.elmer@med.lu.se	Karlsson, Michael/AAL-8743-2020; Kelsen, Jesper/AAH-7372-2020; Hansson, Magnus/G-4486-2014	Karlsson, Michael/0000-0002-7247-2133; Wang, Kevin/0000-0002-9343-6473; Hansson, Magnus/0000-0002-0201-0638	NeuroVive Pharmaceutical AB, a public company developing pharmaceuticals for the treatment of traumatic brain injury and owns the intellectual property for NeuroSTAT	The study was sponsored by NeuroVive Pharmaceutical AB, a public company developing pharmaceuticals for the treatment of traumatic brain injury and owns the intellectual property for NeuroSTAT. As indicated by their affiliation, listed authors have received salary support from NeuroVive Pharmaceutical AB. Magnus J. Hansson, Marcus F. Keep, and Eskil Elmer have equity interest in NeuroVive. Carl-Henrik Nordstrom has received consultancy remuneration from NeuroVive.	Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Aminmansour Bahram, 2014, Adv Biomed Res, V3, P35, DOI 10.4103/2277-9175.125031; Baker MT, 2005, ANESTHESIOLOGY, V103, P860, DOI 10.1097/00000542-200510000-00026; Bodien YG, 2018, J HEAD TRAUMA REHAB, V33, P147, DOI 10.1097/HTR.0000000000000367; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Cung TT, 2015, NEW ENGL J MED, V373, P1021, DOI 10.1056/NEJMoa1505489; Ederoth P, 2018, ANESTHESIOLOGY, V128, P710, DOI 10.1097/ALN.0000000000002104; Ehinger KHJ, 2013, CLIN DRUG INVEST, V33, P25, DOI 10.1007/s40261-012-0029-x; Empey PE, 2006, J NEUROTRAUM, V23, P109, DOI 10.1089/neu.2006.23.109; Hansson MJ, 2008, FREE RADICAL BIO MED, V45, P284, DOI 10.1016/j.freeradbiomed.2008.04.021; Hansson MJ, 2004, J NEUROCHEM, V89, P715, DOI 10.1111/j.1471-4159.2004.02400.x; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Karlsson M, 2019, J NEUROTRAUM, V36, P14, DOI 10.1089/neu.2018.5706; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lemasters JJ, 1999, J BIOENERG BIOMEMBR, V31, P305, DOI 10.1023/A:1005419617371; Lemasters JJ, 1999, AM J PHYSIOL-GASTR L, V276, pG1, DOI 10.1152/ajpgi.1999.276.1.G1; List AF, 2001, BLOOD, V98, P3212, DOI 10.1182/blood.V98.12.3212; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mazzeo AT, 2008, ACTA NEUROCHIR, V150, P1019, DOI 10.1007/s00701-008-0021-7; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Redell JB, 2007, J NEUROSCI RES, V85, P1980, DOI 10.1002/jnr.21324; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Snyder SH, 1998, TRENDS PHARMACOL SCI, V19, P21, DOI 10.1016/S0165-6147(97)01146-2; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Trapani G, 2000, CURR MED CHEM, V7, P249, DOI 10.2174/0929867003375335; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vink R, 2004, EXPERT OPIN INV DRUG, V13, P1263, DOI 10.1517/13543784.13.10.1263; Waldmeier PC, 2002, MOL PHARMACOL, V62, P22, DOI 10.1124/mol.62.1.22; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; YAHANDA AM, 1992, J CLIN ONCOL, V10, P1624, DOI 10.1200/JCO.1992.10.10.1624	43	12	12	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2019	36	23					3253	3263		10.1089/neu.2018.6369		AUG 2019	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JO9FY	WOS:000479852200001	31210099	hybrid, Green Published, Green Submitted			2022-02-06	
J	Pfaller, AY; Brooks, MA; Hetzel, S; McGuine, TA				Pfaller, Adam Y.; Brooks, M. Alison; Hetzel, Scott; McGuine, Timothy A.			Effect of a New Rule Limiting Full Contact Practice on the Incidence of Sport-Related Concussion in High School Football Players	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; head injury; football; epidemiology; injury prevention; pediatric sports medicine	TRAUMATIC BRAIN-INJURY; RECURRENT CONCUSSION; HEAD IMPACTS; EPIDEMIOLOGY; COLLEGIATE; YOUTH	Background: Sport-related concussion (SRC) has been associated with cognitive impairment, depression, and chronic traumatic encephalopathy. American football is the most popular sport among males in the United States and has one of the highest concussion rates among high school sports. Measured head impacts and concussions are approximately 4 times more common in contact practices compared with noncontact practices. The Wisconsin Interscholastic Athletic Association passed new rules defining and limiting contact during practice before the 2014 football season. Purpose: To determine if the SRC rate is lower after a rule change that limited the amount and duration of full-contact activities during high school football practice sessions. Study Design: Cohort study; Level of evidence, 2. Methods: A total of 2081 high school football athletes enrolled and participated in the study in 2012-2013 (before the rule change), and 945 players participated in the study in 2014 (after the rule change). Players self-reported previous concussion and demographic information. Athletic trainers recorded athlete exposures (AEs), concussion incidence, and days lost for each SRC. Chi-square tests were used to compare the incidence of SRC in prerule 2012-2013 seasons with the incidence in the postrule 2014 season. Wilcoxon rank sum tests were used to determine differences in days lost because of SRC. Results: A total of 67 players (7.1%) sustained 70 SRCs in 2014. The overall rate of SRC per 1000 AEs was 1.28 in 2014 as compared with 1.58 in 2012-2013 (P = .139). The rate of SRC sustained overall in practice was significantly lower (P = .003) after the rule change in 2014 (15 SRCs, 0.33 per 1000 AEs) as compared with prerule 2012-2013 (86 SRCs, 0.76 per 1000 AEs). There was no difference (P = .999) in the rate of SRC sustained in games before (5.81 per 1000 AEs) and after (5.74 per 1000 AEs) the rule change. There was no difference (P = .967) in days lost from SRC before (13 days lost [interquartile range, 10-18]) and after (14 days lost [interquartile range, 10-16]) the rule change. Conclusion: The rate of SRC sustained in high school football practice decreased by 57% after a rule change limiting the amount and duration of full-contact activities, with no change in competition concussion rate. Limitations on contact during high school football practice may be one effective measure to reduce the incidence of SRC.	[Pfaller, Adam Y.; Brooks, M. Alison; Hetzel, Scott; McGuine, Timothy A.] Univ Wisconsin, Madison, WI USA; [Pfaller, Adam Y.; Brooks, M. Alison; McGuine, Timothy A.] Univ Wisconsin, Div Sports Med, Dept Orthoped & Rehabil, 1685 Highland Ave, Madison, WI 53705 USA; [Hetzel, Scott] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA		McGuine, TA (corresponding author), Univ Wisconsin, Div Sports Med, Dept Orthoped & Rehabil, 1685 Highland Ave, Madison, WI 53705 USA.	mcguine@ortho.wisc.edu					Archer E, 2019, RFPERMUTE ESTIMATE P; Bailey R, 2006, J SCHOOL HEALTH, V76, P397, DOI 10.1111/j.1746-1561.2006.00132.x; Broglio SP, 2016, J ATHL TRAINING, V51, P511; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Kelly JP, 1997, NEUROLOGY, V48, P581; Kim J, REPORT REGARDING IVY; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McGuine TA, 2014, AM J SPORT MED, V42, P2470, DOI 10.1177/0363546514541926; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; McLendon LA, 2016, PEDIATR NEUROL, V62, P9, DOI 10.1016/j.pediatrneurol.2016.03.009; National Federation of High Schools, HIGH SCH ATHL PART S; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; SOSIN DM, 1991, BRAIN INJURY, V10, P47, DOI DOI 10.1080/026990596124719; Taranto E, 2018, J NATL MED ASSOC, V110, P635, DOI 10.1016/j.jnma.2018.10.001; Wiebe DJ, 2018, JAMA-J AM MED ASSOC, V320, P2035, DOI 10.1001/jama.2018.14165; Wisconsin Interscholastic Athletic Association, WIAA FOOTB PLAYER CO	24	12	12	0	15	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	AUG	2019	47	10					2294	2299		10.1177/0363546519860120			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	IN4QK	WOS:000478659700005	31306587				2022-02-06	
J	Wooten, DW; Ortiz-Teran, L; Zubcevik, N; Zhang, XM; Huang, C; Sepulcre, J; Atassi, N; Johnson, KA; Zafonte, RD; El Fakhri, G				Wooten, Dustin W.; Ortiz-Teran, Laura; Zubcevik, Nevena; Zhang, Xiaomeng; Huang, Chuan; Sepulcre, Jorge; Atassi, Nazem; Johnson, Keith A.; Zafonte, Ross D.; El Fakhri, Georges			Multi-Modal Signatures of Tau Pathology, Neuronal Fiber Integrity, and Functional Connectivity in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						MRI; multi-modal imaging; PET imaging; traumatic brain injury	COGNITIVE IMPAIRMENT; HEAD MOTION; NETWORKS; DISEASE; F-18-AV-1451; SPECTRUM; BINDING; IMPACT	[F-18]AV-1451 (aka F-18-Flortaucipir, [F-18]T807) was developed for positron-emission tomography (PET) imaging of paired helical filaments of hyperphosphorylated tau, which are of interest in a range of neuropathologies, including traumatic brain injury (TBI). Magnetic resonance imaging (MRI) techniques like diffusion tensor imaging (DTI) and resting state functional connectivity assess structural and functional characteristics of the brain, complementing the molecular information that can be obtained by PET. The goal herein was to explore the utility of such multi-modal imaging in a case series based on a population of TBI subjects. This study probes the interrelationship between tau deposition, white matter integrity, and gray matter functional connectivity across the spectrum of TBI. Nineteen subjects (11 controls, five former contact sports athletes, one automotive accident, and two with military-related injury) underwent [F-18]AV-1451 PET and magnetic resonance scanning procedures. [F-18]AV-1451 distribution volume ratio (DVR) was estimated using the Logan method and the cerebellum as a reference region. Diffusion tractography images and fractional anisotropy (FA) images were generated using diffusion toolkit and FSL. Resting-state functional MRI (fMRI) analysis was based on a graph theory metric, namely weighted degree centrality. TBI subjects showed greater heterogeneity in [F-18]AV-1451 DVR when compared with control subjects. In a subset of TBI subjects, areas with high [F-18]AV-1451 binding corresponded with increased FA and diminished white matter tract density in DTI. Functional MRI results exhibited an increase in functional connectivity, particularly among local connections, in the areas where tau aggregates were more prevalent. In a case series of a diverse group of TBI subjects, brain regions with elevated tau burden exhibited increased functional connectivity as well as decreased white matter integrity. These findings portray molecular, microstructural, and functional corollaries of TBI that spatially coincide and can be measured in the living human brain using noninvasive neuroimaging techniques.	[Wooten, Dustin W.; Ortiz-Teran, Laura; Zhang, Xiaomeng; Huang, Chuan; Sepulcre, Jorge; Johnson, Keith A.; El Fakhri, Georges] Harvard Med Sch, Massachusetts Gen Hosp, Gordon Ctr Med Imaging, Dept Radiol, Boston, MA 02115 USA; [Atassi, Nazem; Johnson, Keith A.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Zubcevik, Nevena; Zafonte, Ross D.] Harvard Med Sch, Brigham & Womens Hosp, Massachusetts Gen Hosp, Dept Phys Med & Rehabil,Spaulding Rehabil Hosp, Charlestown, MA USA; [Huang, Chuan] SUNY Stony Brook, Dept Radiol, Stony Brook, NY 11794 USA; [Huang, Chuan] SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA		El Fakhri, G (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, White 427,55 Fruit St, Boston, MA 02114 USA.	elfakhri.georges@mgh.harvard.edu	Sepulcre, Jorge/ABE-6375-2020		NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG062421] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG062421] Funding Source: Medline; NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41 EB022544] Funding Source: Medline		Barrio JR, 2018, J NUCL MED, V59, P115, DOI 10.2967/jnumed.117.198960; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Choi JY, 2018, J NUCL MED, V59, P117, DOI 10.2967/jnumed.117.195248; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Foerster BR, 2013, NAT REV NEUROL, V9, P513, DOI 10.1038/nrneurol.2013.153; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Hansen AK, 2018, MOL IMAGING BIOL, V20, P356, DOI 10.1007/s11307-017-1143-1; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; James OG, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00038; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Lowe VJ, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0315-6; Marquie M, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0482-0; Marquie M, 2017, ACTA NEUROPATHOL, V134, P619, DOI 10.1007/s00401-017-1740-8; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Narayana Ponnada A, 2017, Concussion, V2, pCNC35, DOI 10.2217/cnc-2016-0028; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Sepulcre J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000808; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shoup TM, 2013, J LABELLED COMPD RAD, V56, P736, DOI 10.1002/jlcr.3098; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Van Horn JD, 2017, TRENDS NEUROSCI, V40, P39, DOI 10.1016/j.tins.2016.10.007; Vermeiren C, 2018, MOVEMENT DISORD, V33, P273, DOI 10.1002/mds.27271; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Wooten DW, 2017, J NUCL MED, V58, P484, DOI 10.2967/jnumed.115.170910; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Xia CF, 2013, ALZHEIMERS DEMENT, V9, P666, DOI 10.1016/j.jalz.2012.11.008	43	12	12	3	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2019	36	23					3233	3243		10.1089/neu.2018.6178		AUG 2019	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JO9FY	WOS:000479851800001	31210098	Green Published			2022-02-06	
J	Neville, IS; Zaninotto, AL; Hayashi, CY; Rodrigues, PA; Galhardoni, R; de Andrade, DC; Brunoni, AR; Amorim, RLO; Teixeira, MJ; Paiva, WS				Neville, Iuri Santana; Zaninotto, Ana Luiza; Hayashi, Cintya Yukie; Rodrigues, Priscila Aparecida; Galhardoni, Ricardo; de Andrade, Daniel Ciampi; Brunoni, Andre Russowsky; Oliveira Amorim, Robson L.; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva			Repetitive TMS does not improve cognition in patients with TBI	NEUROLOGY			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; MEMORY DYSFUNCTION; WORKING-MEMORY; EXCITABILITY; PERFORMANCE; IMPAIRMENT; MODERATE; DISEASE	Objective To determine whether high-frequency repetitive transcranial magnetic stimulation (rTMS) improves cognition in patients with severe traumatic brain injury. Methods A single-center, randomized, double-blind, placebo-controlled study of rTMS was conducted in patients aged 18-60 years with chronic (> 12 months postinjury) diffuse axonal injury (DAI). Patients were randomized to either a sham or real group in a 1:1 ratio. A 10-session rTMS protocol was used with 10-Hz stimulation over the left dorsolateral prefrontal cortex (DLPFC). Neuropsychological assessments were performed at 3 time points: at baseline, after the 10th rTMS session, and 90 days after intervention. The primary outcome was change in executive function evaluated using the Trail Making Test Part B. Results Thirty patients with chronic DAI met the study criteria. Between-group comparisons of performance on TMT Part B at baseline and after the 10th rTMS session did not differ between groups (p = 0.680 and p = 0.341, respectively). No significant differences were observed on other neuropsychological tests. No differences in adverse events between treatment groups were observed. Conclusions Cognitive function in individuals with chronic DAI is not improved by high-frequency rTMS over the left DLPFC, though it appears safe and well-tolerated in this population.	[Neville, Iuri Santana; Zaninotto, Ana Luiza; Hayashi, Cintya Yukie; Rodrigues, Priscila Aparecida; Galhardoni, Ricardo; de Andrade, Daniel Ciampi; Oliveira Amorim, Robson L.; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva] Univ Sao Paulo, Div Neurosurg LIM 62, Sao Paulo, Brazil; [Brunoni, Andre Russowsky] Univ Sao Paulo, Inst Psiquiatria, Dept Psychiat, Sao Paulo, Brazil; [Neville, Iuri Santana; Hayashi, Cintya Yukie; Galhardoni, Ricardo; de Andrade, Daniel Ciampi; Brunoni, Andre Russowsky; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Sao Paulo, Brazil; [Neville, Iuri Santana; Hayashi, Cintya Yukie; Galhardoni, Ricardo; de Andrade, Daniel Ciampi; Brunoni, Andre Russowsky; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva] Univ Sao Paulo, Serv Interdisciplinary Neuromodulat, Sao Paulo, Brazil; [Zaninotto, Ana Luiza] Harvard Med Sch, Spaulding Rehabil Hosp, Neuromodulat Ctr, Boston, MA 02115 USA; [Galhardoni, Ricardo] Univ Cidade Sao Paulo UNICID, Sch Med, Sao Paulo, Brazil; [Oliveira Amorim, Robson L.] Univ Fed Amazonas, Dept Neurol, Manaus, Amazonas, Brazil		Neville, IS (corresponding author), Univ Sao Paulo, Div Neurosurg LIM 62, Sao Paulo, Brazil.; Neville, IS (corresponding author), Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Sao Paulo, Brazil.; Neville, IS (corresponding author), Univ Sao Paulo, Serv Interdisciplinary Neuromodulat, Sao Paulo, Brazil.	iuri.neville@hc.fm.usp.br	Brunoni, Andre R./H-8394-2012; Zaninotto, Ana Luiza C./I-4095-2016; Rodrigues, Priscila Aparecida/N-9326-2014; Paiva, Wellingson S/G-5517-2013; de Andrade, Daniel Ciampi/O-2205-2013; Neville, Iuri/AAI-2852-2021; Amorim, Robson/AAK-1368-2021; Galhardoni, Ricardo/H-2371-2014	Brunoni, Andre R./0000-0002-6310-3571; Zaninotto, Ana Luiza C./0000-0003-0639-0612; Rodrigues, Priscila Aparecida/0000-0001-6105-1061; Paiva, Wellingson S/0000-0002-5165-7040; de Andrade, Daniel Ciampi/0000-0003-3411-632X; Neville, Iuri/0000-0002-8561-9069; Amorim, Robson/0000-0003-2391-7519; Galhardoni, Ricardo/0000-0002-8947-2770; teixeira, manoel jacobsen/0000-0002-7974-6045	Brazilian National Council for Scientific and Technological DevelopmentConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [459077/2014-7]; Chamada Universal [14/2014]	Supported by Brazilian National Council for Scientific and Technological Development (#459077/2014-7) and Chamada Universal (Universal Call, #14/2014). The study sponsor had no role in the design or execution of the present study, the collection, management, analysis, or interpretation of the data, manuscript preparation, or approval of this manuscript.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Ahmed MA, 2012, J NEUROL, V259, P83, DOI 10.1007/s00415-011-6128-4; Beam W, 2009, BRAIN STIMUL, V2, P50, DOI 10.1016/j.brs.2008.09.006; Bergquist T, 2009, BRAIN INJURY, V23, P790, DOI 10.1080/02699050903196688; Birba A, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00016; Bohning DE, 2000, J MAGN RESON IMAGING, V11, P569, DOI 10.1002/1522-2586(200006)11:6<569::AID-JMRI1>3.0.CO;2-3; Cosentino G, 2010, NEUROCASE, V16, P267, DOI 10.1080/13554790903456191; Costa TL, 2015, NEUROPSYCHOLOGIA, V78, P142, DOI 10.1016/j.neuropsychologia.2015.10.008; Cotelli M, 2011, J NEUROL NEUROSUR PS, V82, P794, DOI 10.1136/jnnp.2009.197848; Cotelli M, 2006, ARCH NEUROL-CHICAGO, V63, P1602, DOI 10.1001/archneur.63.11.1602; Deppermann S, 2016, BEHAV BRAIN RES, V307, P208, DOI 10.1016/j.bbr.2016.03.028; Esbjornsson E, 2013, J REHABIL MED, V45, P771, DOI 10.2340/16501977-1170; Fitzgerald PB, 2011, J ECT, V27, P38, DOI 10.1097/YCT.0b013e3181eb30c6; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Guse B, 2010, J NEURAL TRANSM, V117, P105, DOI 10.1007/s00702-009-0333-7; Hoppner J, 2003, EUR ARCH PSY CLIN N, V253, P103, DOI 10.1007/s00406-003-0416-7; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Johnson NN, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aa8ce3; Julkunen P, 2008, J NEUROSCI METH, V172, P270, DOI 10.1016/j.jneumeth.2008.04.021; Kim YJ, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-124; Ko J.H., 2013, CLIN NEUROL, V116, P77, DOI DOI 10.1016/B978-0-444-53497-2.00008-5; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Kreuzer PM, 2013, J HEAD TRAUMA REHAB, V28, P386, DOI 10.1097/HTR.0b013e318254736e; Lefaucheur JP, 2008, J PSYCHIATR RES, V42, P389, DOI 10.1016/j.jpsychires.2007.03.001; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Lesniak M, 2014, J HEAD TRAUMA REHAB, V29, pE20, DOI 10.1097/HTR.0b013e318292a4c2; Li SS, 2015, NEUROPSYCH DIS TREAT, V11, P1573, DOI 10.2147/NDT.S65816; Livengood M, 2010, BRAIN INJURY, V24, P598, DOI 10.3109/02699051003652815; Lundqvist A, 2010, BRAIN INJURY, V24, P1173, DOI 10.3109/02699052.2010.498007; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; Mir-Moghtadaei A, 2015, BRAIN STIMUL, V8, P965, DOI 10.1016/j.brs.2015.05.008; Moser DJ, 2002, NEUROLOGY, V58, P1288, DOI 10.1212/WNL.58.8.1288; Neville IS, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0944-2; O'Neil-Pirozzi TM, 2017, INT J NEUROSCI, V127, P592, DOI 10.1080/00207454.2016.1216415; Pape TLB, 2014, BRAIN STIMUL, V7, P620, DOI 10.1016/j.brs.2014.03.007; Pape TLB, 2009, BRAIN STIMUL, V2, P22, DOI 10.1016/j.brs.2008.09.004; Perera T, 2016, BRAIN STIMUL, V9, P336, DOI 10.1016/j.brs.2016.03.010; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Rossini PM, 2000, BRAIN RES REV, V33, P131, DOI 10.1016/S0169-328X(00)00090-5; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Sacco K, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00057; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Sole-Padulles C, 2006, CEREB CORTEX, V16, P1487, DOI 10.1093/cercor/bhj083; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Triggs WJ, 1999, BIOL PSYCHIAT, V45, P1440, DOI 10.1016/S0006-3223(99)00031-1; Vanderhasselt MA, 2009, J PSYCHIATR NEUROSCI, V34, P119; Zaninotto AL, 2017, ACTA NEUROPSYCHIATR, V29, P35, DOI 10.1017/neu.2016.29	49	12	12	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JUL 9	2019	93	2					E190	E199		10.1212/WNL.0000000000007748			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IQ5HU	WOS:000480783800009	31175209	hybrid, Green Published			2022-02-06	
J	Hoogenboom, WS; Rubin, TG; Ye, K; Cui, MH; Branch, KC; Liu, JY; Branch, CA; Lipton, ML				Hoogenboom, Wouter S.; Rubin, Todd G.; Ye, Kenny; Cui, Min-Hui; Branch, Kelsey C.; Liu, Jinyuan; Branch, Craig A.; Lipton, Michael L.			Diffusion Tensor Imaging of the Evolving Response to Mild Traumatic Brain Injury in Rats	JOURNAL OF EXPERIMENTAL NEUROSCIENCE			English	Article						Animal model; closed head; concussion; magnetic resonance imaging; modified controlled cortical impact	AXONAL INJURY; ANIMAL-MODELS; MOUSE MODEL; IMPACT; MECHANISMS; TIME; MRI; DTI	Mild traumatic brain injury (mTBI), also known as concussion, is a serious public health challenge. Although most patients recover. a substantial minority suffers chronic disability. The mechanisms underlying mTBI-related detrimental effects remain poorly understood. Although animal models contribute valuable preclinical information and improve our understanding of the underlying mechanisms following mTBI, only few studies have used diffusion tensor imaging (DTI) to study the evolution of axonal injury following mTBI in rodents. It is known that DTI shows changes after human concussion and the role of delineating imaging findings in animals is therefore to facilitate understanding of related mechanisms. In this work, we used a rodent model of mTBI to investigate longitudinal indices of axonal injury. We present the results of 45 animals that received magnetic resonance imaging (MRI) at multiple time points over a 2-week period following concussive or sham injury yielding 109 serial observations. Overall, the evolution of DTI metrics following concussive or sham injury differed by group. Diffusion tensor imaging changes within the white matter were most noticeable 1 week following injury and returned to baseline values after 2 weeks. More specifically, we observed increased fractional anisotropy in combination with decreased radial diffusivity and mean diffusivity, in the absence of changes in axial diffusivity, within the white matter of the genu corpus callosum at 1 week post-injury. Our study shows that DTI can detect microstructural white matter changes in the absence of gross abnormalities as indicated by visual screening of anatomical MRI and hematoxylin and eosin (H&E)-stained sections in a clinically relevant animal model of mTBI. Whereas additional histopathologic characterization is required to better understand the neurobiological correlates of DTI measures. our findings highlight the evolving nature of the brain's response to injury following concussion.	[Hoogenboom, Wouter S.; Rubin, Todd G.; Cui, Min-Hui; Branch, Kelsey C.; Liu, Jinyuan; Branch, Craig A.; Lipton, Michael L.] Montefiore Med Ctr, Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, Jack & Pearl Resnick Campus,1300 Morrispark Ave, Bronx, NY 10461 USA; [Hoogenboom, Wouter S.] Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Clin Invest, Bronx, NY 10467 USA; [Rubin, Todd G.] Montefiore Med Ctr, Albert Einstein Canc Ctr, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA; [Ye, Kenny] Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Cui, Min-Hui; Branch, Craig A.; Lipton, Michael L.] Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Radiol, Bronx, NY 10467 USA; [Branch, Craig A.] Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Physiol & Biophys, Bronx, NY 10467 USA; [Lipton, Michael L.] Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA		Branch, CA; Lipton, ML (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Gruss Magnet Resonance Res Ctr, Jack & Pearl Resnick Campus,1300 Morrispark Ave, Bronx, NY 10461 USA.	craig.branch@einstein.yu.edu; michael.lipton@einstein.yu.edu	Ye, Kenny/U-2341-2019	Ye, Kenny/0000-0002-1466-855X; Rubin, Todd/0000-0002-2821-5877	NIH/National Center for Advancing Translational Sciences (NCATS) Einstein-Montefiore CTSA [TL1TR001072]; Burroughs Wellcome Foundation Grant (PUP program); NIH/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS082432]; Dana Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002556, TL1TR001072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082432] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by NIH/National Center for Advancing Translational Sciences (NCATS) Einstein-Montefiore CTSA (Grant No. TL1TR001072), Burroughs Wellcome Foundation Grant (PUP program), NIH/National Institute of Neurological Disorders and Stroke (R01 NS082432), and a grant from the Dana Foundation.	BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Cullen DK, 2016, METHODS MOL BIOL, V1462, P289, DOI 10.1007/978-1-4939-3816-2_17; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Haber M, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0164-17.2017; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Herrera JJ, 2017, J NEUROTRAUM, V34, P291, DOI 10.1089/neu.2016.4407; Hoogenboom WS, 2019, PHARMACOL THERAPEUT, V198, P109, DOI 10.1016/j.pharmthera.2019.02.016; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hutchinson EB, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00573; Jevtovic-Todorovic V, 2008, ANESTH ANALG, V106, P1659, DOI 10.1213/ane.0b013e3181731ff2; Kikinis Z, 2017, BRAIN INJURY, V31, P1376, DOI 10.1080/02699052.2017.1318450; Kobeissy, 2015, BRAIN NEUROTRAUMA MO; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Ma XT, 2019, MOL NEUROBIOL, V56, P5332, DOI 10.1007/s12035-018-1454-5; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McAuliffe MJ, 2001, IEEE COMP BAS MED SY; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; National Research Council, 2011, GUIDE CARE USE LAB A; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Qin Y, 2018, BEHAV BRAIN RES, V340, P41, DOI 10.1016/j.bbr.2016.08.008; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Vutskits L, 2016, NAT REV NEUROSCI, V17, P705, DOI 10.1038/nrn.2016.128; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x	42	12	13	2	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1179-0695			J EXP NEUROSCI	J. Exp. Neurosci.	JUL 5	2019	13								1179069519858627	10.1177/1179069519858627			12	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	IK4BZ	WOS:000476533400001	31308735	gold, Green Published			2022-02-06	
J	Lyons, TW; Miller, KA; Miller, AF; Mannix, R				Lyons, Todd W.; Miller, Kelsey A.; Miller, Andrew F.; Mannix, Rebekah			Racial and Ethnic Differences in Emergency Department Utilization and Diagnosis for Sports-Related Head Injuries	FRONTIERS IN NEUROLOGY			English	Article						concussion; head injury; children; emergency department; race; ethnicity; disparities	UNITED-STATES; CONCUSSION; DISPARITIES; TRAUMA	Background: Prior studies have shown racial differences in concussion awareness and outcome. Objective: To assess if racial or ethnic differences exist in Emergency Department (ED) utilization and diagnosis for children with sports-related head injuries. Methods: We performed a retrospective, cross-sectional analysis of ED visits from 2008 to 2017 using National Electronic Injury Surveillance System (NEISS) data. Population-weighted ED visits for children age 7-18 years with a sport-related injury were included. We compared the probability of an ED visit being for an injury to the head or diagnosed as a concussion between children of different races/ethnicities. Analyses were adjusted for age, gender, sport, year, and location where the injury occurred. Results: We identified 11,529,994 population-weighted ED visits for pediatric sports-related injuries, of which 1,497,717 (13.0%) were injuries to the head and 619,714 (5.4%) received a diagnosis of concussion. Black children were significantly less likely than non-Hispanic white children to have their ED visit be for an injury to the head [Odds Ratio (OR) 0.72, 95%Cl 0.65-0.79] or concussion (OR 0.58, 95%Cl 0.50-0.68). Black children presenting to the ED with an injury to their head were less likely than non-Hispanic white children to be diagnosed with a concussion (OR = 0.71, 95%Cl 0.59-0.85). Conclusions: Racial differences exist in both ED utilization for pediatric sports-related head injuries and in the diagnosis of concussion. Further work is needed to understand these differences to ensure all brain injured athletes receive optimal care, regardless of race.	[Lyons, Todd W.; Miller, Kelsey A.; Miller, Andrew F.; Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; [Lyons, Todd W.; Miller, Kelsey A.; Miller, Andrew F.; Mannix, Rebekah] Harvard Med Sch, Boston, MA 02115 USA		Lyons, TW (corresponding author), Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA.	todd.lyons@childrens.harvard.edu	Mannix, Rebekah/AAD-8702-2020		Eunice Kennedy Shriver National Institute of Child Health and Human Development (National Institutes of Health) T32 Training Grant [5T32HD040128-12]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040128] Funding Source: NIH RePORTER	TL was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (National Institutes of Health) T32 Training Grant (5T32HD040128-12).	Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Cheng TL, 2015, PEDIATRICS, V135, pE225, DOI 10.1542/peds.2014-3109; Comstock DR, 2017, NATL HIGH SCH SPORTS; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Frame T, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114528460; Gaw CE, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0071-8; Kroshus E, 2017, CLIN J SPORT MED, V27, P542, DOI 10.1097/JSM.0000000000000409; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; Mannix R, 2010, ACAD EMERG MED, V17, P694, DOI 10.1111/j.1553-2712.2010.00797.x; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Miller KN, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3083; Natale JE, 2012, ARCH PEDIAT ADOL MED, V166, P732, DOI 10.1001/archpediatrics.2012.307; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Richards JA, 2019, INJURY, V50, P324, DOI 10.1016/j.injury.2018.12.005; Sanford T, 2015, JAMA-J AM MED ASSOC, V314, P947, DOI 10.1001/jama.2015.8295; Stillman A, 2017, CLEV CLIN J MED, V84, P623, DOI 10.3949/ccjm.84a.16013; Trofa DP, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117741647; US Consumer Product Safety Commission, 2017, NAT EL INJ SURV SYST; van Ryn M, 2003, AM J PUBLIC HEALTH, V93, P248, DOI 10.2105/AJPH.93.2.248; Wallace J, 2018, J RACIAL ETHN HEALTH, V5, P221, DOI 10.1007/s40615-017-0361-1	28	12	12	2	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUL 2	2019	10								690	10.3389/fneur.2019.00690			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IG3BI	WOS:000473674800001	31312172	Green Published, gold			2022-02-06	
J	Baugh, CM; Meehan, WP; Kroshus, E; McGuire, TG; Hatfield, LA				Baugh, Christine M.; Meehan, William P., III; Kroshus, Emily; McGuire, Thomas G.; Hatfield, Laura A.			College Football Players Less Likely to Report Concussions and Other Injuries with Increased Injury Accumulation	JOURNAL OF NEUROTRAUMA			English	Article						concussion; decision making; football; injury reporting; sports medicine	SPORT; PAIN; SOCIALIZATION; SYMPTOMS; COACHES; RISK	Athletes sometimes choose not to report suspected concussions, risking delays in treatment and health consequences. How and why do athletes make these reporting decisions? Using original survey data from a cohort of college football players, we evaluate two assumptions of the current literature on injury reporting: first, that the probability of reporting a concussion or injury is constant over time; second, that athletes make reasoned deliberative decisions about whether to report their concussion or other injury. We find that athletes are much less likely to report a concussion to a medical professional than they are to report another injury (47% vs. 80%), but no association between reporting and a measure of athletes' ability to switch from fast, reactive thinking to reasoned, deliberative thinking. The likelihood of reporting decreases as the number of injuries and concussions increases, and no athlete reported more than four concussions. Sports medicine clinicians sometimes use four concussions as a time to discuss possibly curtailing sports participation, which may influence athletes' subsequent reporting behavior. Sports medicine clinicians may want to consider athlete injury history as a risk factor for concussion and injury under-reporting.	[Baugh, Christine M.; McGuire, Thomas G.; Hatfield, Laura A.] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [Meehan, William P., III] Boston Childrens Hosp, Dept Sports Med, Sports Concuss Clin, Boston, MA USA; [Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kroshus, Emily] Settle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA		Baugh, CM (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	christinebaugh@post.harvard.edu	Baugh, Christine/AAG-2324-2020; Hatfield, Laura A./I-6835-2019	Baugh, Christine/0000-0002-9340-6338; Hatfield, Laura A./0000-0003-0366-3929	National Institute of Mental Health of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733]; Football Players Health Study at Harvard; National Football League Players Association; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733] Funding Source: NIH RePORTER	The authors thank the athletes and athletic trainers who made this study possible. The authors also thank Vish Viswanath for his contributions to this article. Research reported in this publication was supported by the National Institute of Mental Health of the National Institutes of Health under Award Number T32MH019733. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was conducted with the support of the Football Players Health Study at Harvard. The Football Players Health Study is funded by a grant from the National Football League Players Association. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Medical School, Harvard University or its affiliates, or the National Football League Players Association.	Abdullah KG, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0535-3; Albert E., 1999, International Review for the Sociology of Sport, V34, P157, DOI 10.1177/101269099034002005; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Baugh CM, 2017, J NEUROTRAUM, V34, P790, DOI 10.1089/neu.2016.4585; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Cantu RC, 2016, WORLD NEUROSURG, V95, P601, DOI 10.1016/j.wneu.2016.04.056; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; CURRY TJ, 1993, SYMB INTERACT, V16, P273, DOI 10.1525/si.1993.16.3.273; Davis GA, 2018, NEUROSURGERY, V82, P232, DOI 10.1093/neuros/nyx344; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Howe P. D., 2001, International Review for the Sociology of Sport, V36, P289, DOI 10.1177/101269001036003003; HUGHES R, 1991, SOCIOL SPORT J, V8, P307, DOI 10.1123/ssj.8.4.307; Kahneman D., 2012, THINKING FAST SLOW; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2020, J CLIN SPORT PSYCHOL, V14, P41, DOI 10.1123/jcsp.2017-0036; Kroshus E, 2018, SOC SCI MED, V218, P37, DOI 10.1016/j.socscimed.2018.07.050; Kroshus E, 2017, J LAW MED ETHICS, V45, P421, DOI 10.1177/1073110517737542; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Malcom NL, 2006, J CONTEMP ETHNOGR, V35, P495, DOI 10.1177/0891241605283571; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Nixon H. L. II, 1996, Journal of Sport and Social Issues, V20, P33, DOI 10.1177/019372396020001004; NIXON HL, 1994, SOCIOL SPORT J, V11, P79, DOI 10.1123/ssj.11.1.79; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Roderick M., 2000, International Review for the Sociology of Sport, V35, P165, DOI 10.1177/101269000035002003; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279	37	12	12	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2019	36	13					2065	2072		10.1089/neu.2018.6161			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	IF4KG	WOS:000473049600427	30688141	Green Published			2022-02-06	
J	Corwin, DJ; Propert, KJ; Zorc, JJ; Zonfrillo, MR; Wiebe, DJ				Corwin, Daniel J.; Propert, Kathleen J.; Zorc, Joseph J.; Zonfrillo, Mark R.; Wiebe, Douglas J.			Use of the vestibular and oculomotor examination for concussion in a pediatric emergency department	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Pediatric concussion; Mild traumatic brain injury; Vestibular/oculomotor examination	TRAUMATIC BRAIN-INJURY; ACCURACY	Background: Concussion guidelines recommend a vestibular and oculomotor (VOM) examination be performed for all patients with concern for concussion, however the feasibility of performing testing is unknown. We aimed to measure rates of exam performance after implementation of training and support tools in a pediatric emergency department. Methods: We conducted a retrospective study of patients age 6 to 18 years old presenting over a 12-month period. Charts were obtained via natural language processing, where concussion was suggested as a diagnosis in the electronic health record, and then manually reviewed to record patient and provider factors. A multivariable logistic regression was performed to determine factors associated with exam performance, and a classification and regression tree (CART) analysis was performed to determine if a specific patient type was at risk for not having testing performed. Results: Four hundred patients were included in the analysis. Sixty-four percent received a VOM examination (including 73% of those diagnosed with concussion). Provider type, concussion history, symptom burden, injury mechanism, and final diagnosis were all significantly associated with exam performance. CART analysis determined patients with a non-concussion diagnosis, a non-sports injury mechanism, no prior history of concussion, and two or fewer symptoms had the lowest likelihood (46%) of receiving the exam. Conclusion: Performing a VOM examination for concussion is feasible in the acute setting following provider education and using clinical support tools. The exam is more likely to be performed on those children with history or exam findings associated with perceived risk for ongoing symptoms. (C) 2018 Elsevier Inc. All rights reserved.	[Corwin, Daniel J.; Zorc, Joseph J.] Childrens Hosp Philadelphia, Div Emergency Med, Colket Translat Res Bldg, Philadelphia, PA 19104 USA; [Corwin, Daniel J.; Zonfrillo, Mark R.; Wiebe, Douglas J.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Propert, Kathleen J.; Wiebe, Douglas J.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.] Brown Univ, Alpert Med Sch, Dept Pediat, Dept Emergency Med, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Hasbro Childrens Hosp, Providence, RI USA; [Corwin, Daniel J.; Propert, Kathleen J.; Zorc, Joseph J.; Wiebe, Douglas J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA		Corwin, DJ (corresponding author), Childrens Hosp Philadelphia, Div Emergency Med, Colket Translat Res Bldg, Philadelphia, PA 19104 USA.	corwind@email.chop.edu			National Institutes of Health, Neurologic Clinical Epidemiology [T32-NS-061779]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS061779] Funding Source: NIH RePORTER	This studywas supported by a training grant fromthe National Institutes of Health, Neurologic Clinical Epidemiology, Grant #T32-NS-061779 awarded to Dr. Corwin.	Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Boutis K, 2015, J PEDIATR-US, V166, P1214, DOI 10.1016/j.jpeds.2015.02.013; Corwin DJ, 2017, PEDIATR EMERG CARE, V33, P643, DOI 10.1097/PEC.0000000000001252; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Gilboy N, 2012, EMERGENCY SEVERITY I; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2012, PEDIATR ANN, V41, pE174, DOI 10.3928/00904481-20120827-08; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Zonfrillo M., 2017, ED PATHWAY EVALUATIO; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	18	12	13	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JUL	2019	37	7					1219	1223		10.1016/j.ajem.2018.09.008			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	IE8FN	WOS:000472609400001	30197233	Green Accepted			2022-02-06	
J	Hoy, KE; McQueen, S; Elliot, D; Herring, SE; Maller, JJ; Fitzgerald, PB				Hoy, Kate E.; McQueen, Susan; Elliot, David; Herring, Sally E.; Maller, Jerome J.; Fitzgerald, Paul B.			A Pilot Investigation of Repetitive Transcranial Magnetic Stimulation for Post-Traumatic Brain Injury Depression: Safety, Tolerability, and Efficacy	JOURNAL OF NEUROTRAUMA			English	Article						clinical trial; depression; post-traumatic brain injury; TMS	RANDOMIZED-TRIAL; ANTIDEPRESSANT RESPONSE; RTMS TREATMENT; PSYCHIATRY; SERTRALINE; FMRI	Depression following a traumatic brain injury (TBI) is common and difficult to treat using standard approaches. The current study investigated, for the first time, transcranial magnetic stimulation (TMS) for the treatment of post TBI depression. We specifically assessed the safety, tolerability, and efficacy of TMS in this patient population. We also explored cognitive outcomes. Twenty-one patients with a current episode of major depression subsequent to a TBI participated in a randomized double-blind placebo-controlled trial of repetitive TMS (rTMS). Sequential bilateral rTMS (to the left and right dorsolateral prefrontal cortex) was provided in 20 treatments over a period of 4 weeks. Patients were randomly allocated to receive either active or sham stimulation. There were no adverse effects and treatment was well tolerated. There was no significant effect of rTMS on post-TBI depression, with all patients showing a significant improvement in depressive symptoms irrespective of their treatment group (p = 0.002). There were significant improvements in cognition following active rTMS in the areas of working memory (p = 0.021) and executive function (p = 0.029). rTMS was shown to be safe and well tolerated in patients who had developed depression after a TBI. We did not find a therapeutic effect for post-TBI depression; however, this approach may have some utility in improving cognitive function. Future research should focus on alternative rTMS treatment approaches for post-TBI depression and the direct investigation of rTMS as a treatment for cognitive impairment in TBI.	[Hoy, Kate E.; McQueen, Susan; Elliot, David; Maller, Jerome J.; Fitzgerald, Paul B.] Monash Univ, Monash Alfred Psychiat Res Ctr, Clayton, Vic, Australia; [Hoy, Kate E.; McQueen, Susan; Elliot, David; Maller, Jerome J.; Fitzgerald, Paul B.] Alfred Hlth, Cent Clin Sch, Melbourne, Vic, Australia; [Hoy, Kate E.; Herring, Sally E.; Fitzgerald, Paul B.] Epworth HealthCare, Epworth Ctr Innovat Mental Hlth, Camberwell, Vic, Australia		Hoy, KE (corresponding author), Monash Alfred Psychiat Res Ctr, Level 4,607 St Kilda Rd, Melbourne, Vic 3004, Australia.	Kate.Hoy@monash.edu	Maller, Jerome J/H-4963-2014	Maller, Jerome J/0000-0003-4685-1508; Herring, Sally/0000-0003-0996-7413; Hoy, Kate/0000-0003-0694-9674	National Health and Medical Research Council (NHMRC) FellowshipNational Health and Medical Research Council of Australia; NHMRC Practitioner FellowshipNational Health and Medical Research Council of Australia; Victorian Neurotrauma Initiative (VNI)	K.E.H. is supported by a National Health and Medical Research Council (NHMRC) Fellowship. P.B.F. is supported by an NHMRC Practitioner Fellowship. Funding for this study was provided by Victorian Neurotrauma Initiative (VNI).	Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Bombardier CH, 2016, J NEUROTRAUM, V33, P2115, DOI 10.1089/neu.2015.4349; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Coyle HL, 2018, NEUROSCI BIOBEHAV R, V92, P140, DOI 10.1016/j.neubiorev.2018.05.027; De Ridder D, 2011, NEUROSCI LETT, V496, P5, DOI 10.1016/j.neulet.2011.03.074; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Fann JR, 2017, J HEAD TRAUMA REHAB, V32, P332, DOI 10.1097/HTR.0000000000000322; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fitzgerald PB, 2011, PSYCHOL MED, V41, P1187, DOI 10.1017/S0033291710001923; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Fitzgerald PB, 2018, NEUROPSYCHOPHARMACOL, V43, P1565, DOI 10.1038/s41386-018-0009-9; Fitzgerald PB, 2016, DEPRESS ANXIETY, V33, P746, DOI 10.1002/da.22503; Fitzgerald PB, 2012, J AFFECT DISORDERS, V139, P193, DOI 10.1016/j.jad.2012.02.017; Fitzgerald PB, 2009, NEUROPSYCHOPHARMACOL, V34, P1255, DOI 10.1038/npp.2008.233; Fitzgerald PB, 2002, ACTA PSYCHIAT SCAND, V105, P324, DOI 10.1034/j.1600-0447.2002.1r179.x; Fitzgerald PB, 2006, AM J PSYCHIAT, V163, P88, DOI 10.1176/appi.ajp.163.1.88; Fox MD, 2012, NEUROIMAGE, V62, P2232, DOI 10.1016/j.neuroimage.2012.03.035; Furtado CP, 2013, BRAIN STIMUL, V6, P346, DOI 10.1016/j.brs.2012.06.006; Gertler P, 2015, COCHRANE DATABASE SY, V14; Hoy KE, 2016, CEREB CORTEX, V26, P4563, DOI 10.1093/cercor/bhv193; Hoy KE, 2012, BRAIN STIMUL, V5, P539, DOI 10.1016/j.brs.2011.08.010; Hoy KE, 2010, NAT REV NEUROL, V6, P267, DOI 10.1038/nrneurol.2010.30; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Peng HJ, 2012, J AFFECT DISORDERS, V136, P249, DOI 10.1016/j.jad.2011.12.006; Pridmore S, 1998, J ECT, V14, P25; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Sack AT, 2007, CEREB CORTEX, V17, P2841, DOI 10.1093/cercor/bhm013; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; Shine JM, 2016, NEURON, V92, P544, DOI 10.1016/j.neuron.2016.09.018; Slotema CW, 2010, J CLIN PSYCHIAT, V71, P873, DOI 10.4088/JCP.08m04872gre; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; World Health Organization, 2002, PROJ MORT BURD DIS 2; Zafonte RD, 2002, J HEAD TRAUMA REHAB, V17, P322, DOI 10.1097/00001199-200208000-00006	36	12	12	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2019	36	13					2092	2098		10.1089/neu.2018.6097			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IF4KG	WOS:000473049600430	30712461				2022-02-06	
J	Lewine, JD; Plis, S; Ulloa, A; Williams, C; Spitz, M; Foley, J; Paulson, K; Davis, J; Bangera, N; Snyder, T; Weaver, L				Lewine, Jeffrey D.; Plis, Sergey; Ulloa, Alvaro; Williams, Christopher; Spitz, Mark; Foley, John; Paulson, Kim; Davis, John; Bangera, Nitin; Snyder, Travis; Weaver, Lindell			Quantitative EEG Biomarkers for Mild Traumatic Brain Injury	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article						mTBI; EEG; Absolute power; Relative power; Interhemispheric coherence	POSTTRAUMATIC-STRESS-DISORDER; FUNCTIONAL CONNECTIVITY; HEAD TRAUMA; COMPUTED-TOMOGRAPHY; ABNORMALITIES; VETERANS; MEG; CLASSIFICATION; SYMPTOMS; SPECT	Purpose: The development of objective biomarkers for mild traumatic brain injury (mTBI) in the chronic period is an important clinical and research goal. Head trauma is known to affect the mechanisms that support the electrophysiological processing of information within and between brain regions, so methods like quantitative EEG may provide viable indices of brain dysfunction associated with even mTBI. Methods: Resting-state, eyes-closed EEG data were obtained from 71 individuals with military-related mTBI and 82 normal comparison subjects without traumatic brain injury. All mTBI subjects were in the chronic period of injury (> 5 months since the time of injury). Quantitative metrics included absolute and relative power in delta, theta, alpha, beta, high beta, and gamma bands, plus a measure of interhemispheric coherence in each band. Data were analyzed using univariate and multivariate methods, the latter coupled to machine learning strategies. Results: Analyses revealed significant (P < 0.05) group level differences in global relative theta power (increased for mTBI patients), global relative alpha power (decreased for mTBI patients), and global beta-band interhemispheric coherence (decreased for mTBI patients). Single variables were limited in their ability to predict group membership (e.g., mTBI vs. control) for individual subjects, each with a predictive accuracy that was below 60%. In contrast, the combination of a multivariate approach with machine learning methods yielded a composite metric that provided an overall predictive accuracy of 75% for correct classification of individual subjects as coming from control versus mTBI groups. Conclusions: This study indicates that quantitative EEG methods may be useful in the identification, classification, and tracking of individual subjects with mTBI.	[Lewine, Jeffrey D.; Plis, Sergey; Ulloa, Alvaro; Paulson, Kim; Davis, John; Bangera, Nitin] Mind Res Network, Albuquerque, NM USA; [Lewine, Jeffrey D.] Lovelace Family Companies, Albuquerque, NM USA; [Lewine, Jeffrey D.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Lewine, Jeffrey D.] Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA; [Williams, Christopher] Univ Colorado, CHMG Neurosci, Colorado Springs, CO 80907 USA; [Spitz, Mark] Univ Colorado, Hlth Sci Ctr, Aurora, CO USA; [Spitz, Mark] Denver VAMC, Denver, CO USA; [Foley, John] Intermt LDS Hosp, Rocky Mt Neurol Associates, Salt Lake City, UT USA; [Snyder, Travis] Imgen LLC, Las Vegas, NV USA; [Weaver, Lindell] Intermt Med Ctr, Div Hyperbar Med, Murray, UT USA; [Weaver, Lindell] Intermt LDS Hosp, Salt Lake City, UT USA; [Weaver, Lindell] Univ Utah, Sch Med, Salt Lake City, UT USA		Lewine, JD (corresponding author), Mind Res Network, 1101 Yale Blvd NE, Albuquerque, NM 87106 USA.	jlewine@mrn.org	Plis, Sergey/AAA-9928-2022; Ulloa, Alvaro/ABD-3900-2021	Plis, Sergey/0000-0003-0040-0365; Ulloa-Cerna, Alvaro/0000-0001-8899-0026	US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-15-D-0039-0003]	Supported by the US Army Medical Research and Materiel Command under Contract No. W81XWH-15-D-0039-0003.	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Amen DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129659; Begic D, 2001, INT J PSYCHOPHYSIOL, V40, P167, DOI 10.1016/S0167-8760(00)00153-7; BIGLER ED, 1995, ARCH CLIN NEUROPSYCH, V10, P159, DOI 10.1016/0887-6177(94)E0003-8; Blinowska KJ, 2017, CLIN NEUROPHYSIOL, V128, P667, DOI 10.1016/j.clinph.2016.10.002; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Dow RS, 1944, AM J PSYCHIAT, V101, P174, DOI 10.1176/ajp.101.2.174; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; GUALTIERI CT, 1995, NEUROPSY NEUROPSY BE, V8, P127; Hanley D, 2018, J NEUROTRAUM, V35, P41, DOI 10.1089/neu.2017.5004; Hoofien D, 2001, BRAIN INJURY, V15, P189; Huang MX, 2017, J NEUROTRAUM, V34, P1412, DOI 10.1089/neu.2016.4581; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P408, DOI 10.1016/j.nicl.2014.08.004; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Jokic-Begic N, 2003, NORD J PSYCHIAT, V57, P351, DOI 10.1080/08039480310002688; Kotsiantis SB, 2006, ARTIF INTELL REV, V26, P159, DOI 10.1007/S10462-007-9052-3; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; LORENZON.E, 1970, ELECTROEN CLIN NEURO, V28, P216; Margulies S, 2000, J CLIN NEUROSCI, V7, P400, DOI 10.1054/jocn.1999.0681; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Medaglia JD, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00407; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; Nichols J, 2015, CNS NEUROSCI THER, V21, P193, DOI 10.1111/cns.12351; Raji CA, 2018, NEUROIMAG CLIN N AM, V28, P67, DOI 10.1016/j.nic.2017.09.003; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ross DE, 2013, J NEUROPSYCH CLIN N, V25, P32, DOI 10.1176/appi.neuropsych.11120377; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff R. M., 1989, NEUROPSY NEUROPSY BE, V2, P103; Schmitt Sarah, 2015, Handb Clin Neurol, V127, P319, DOI 10.1016/B978-0-444-52892-6.00021-0; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Stovell MG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00426; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Thatcher RW, 2005, CLIN NEUROPHYSIOL, V116, P2129, DOI 10.1016/j.clinph.2005.04.026; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Weaver LK, 2016, UNDERSEA HYPERBAR M, V43, P485; Williams CS, 2016, UNDERSEA HYPERBAR M, V43, P521; Zito G, 2014, NEUROSCIENCE, V266, P47, DOI 10.1016/j.neuroscience.2014.01.039	47	12	12	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0736-0258	1537-1603		J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	JUL	2019	36	4					298	305		10.1097/WNP.0000000000000588			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IQ5RO	WOS:000480810100008	31094883				2022-02-06	
J	Proctor, CJ; Best, LA				Proctor, Cecile J.; Best, Lisa A.			Social and psychological influences on satisfaction with life after brain injury	DISABILITY AND HEALTH JOURNAL			English	Article						Acquired brain injury (ABI); Traumatic brain injury (TBI); Brain injury survivors; Satisfaction with life; Loneliness and isolation; Personality	QUALITY-OF-LIFE; HEALTH; PARTICIPATION; POPULATION; PREVALENCE; DISABILITY; ADULTS; PERSONALITY; LONELINESS; DEPRESSION	Background: In spite of the increased focus of education and awareness programs on prevention and safety surrounding Acquired Brain Injury (ABI), over 50,000 Canadians and 900,000 Americans sustain a brain injury every year. Given the psychological impact of an ABI, there is a growing body of literature examining the links between injury, mental health, and life satisfaction in brain injury survivors; specifically, changes in leisure activities, employment, and the struggles with injury related deficits contribute to increased social isolation, depression, and loneliness. Objectives: The current study examined personality characteristics, unmet needs, and psychosocial risk factors in survivors of brain injuries. Methods: In this cross-sectional online study, 592 brain injury survivors completed questionnaires to assess psychological variables associated with their current life situation. Results: We found high levels of depression among survivors, with 47.6% of participants reporting moderate or severe levels of depression and 41.2% reporting suicidal ideation. Although survivors reported lower life satisfaction than population norms, satisfaction was only slightly lower in those with a recent (less than two years) injury. Overall, regression models accounted for 50.1% of the variability in satisfaction with life. Increased engagement in leisure activities, higher emotional stability (p <.001) and sociability (p <.01) coupled with lower depression (p <.001) and romantic loneliness (p <.001) significantly predicted satisfaction with life. Conclusions: These results could aid in the development of policies and procedures surrounding the discharge of patients that includes a plan for increasing social leisure activities within the community and providing ongoing support for survivors when formal rehabilitation ceases. (C) 2019 Published by Elsevier Inc.	[Proctor, Cecile J.; Best, Lisa A.] Univ New Brunswick, Dept Psychol, 100 Tucker Pk Rd,POB 5050, St John, NB E2L 4L5, Canada		Best, LA (corresponding author), Univ New Brunswick, Dept Psychol, 100 Tucker Pk Rd,POB 5050, St John, NB E2L 4L5, Canada.	c52gj@unb.ca; lbest@unb.ca	Best, Lisa/AAC-8266-2019	Best, Lisa/0000-0002-4596-9814			Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Bier N, 2009, J HEAD TRAUMA REHAB, V24, P187, DOI 10.1097/HTR.0b013e3181a0b15a; COYLE CP, 1994, REHABIL PSYCHOL, V39, P95, DOI 10.1037/0090-5550.39.2.95; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DiTommaso E, 2004, EDUC PSYCHOL MEAS, V64, P99, DOI 10.1177/0013164403258450; Doser K, 2014, BRAIN INJURY, V28, P1230, DOI 10.3109/02699052.2014.915985; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Freeze D, 2017, PSYCHOL APPL DEV 3, P257; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Goverover Y, 2017, NEUROPSYCHOL REHABIL, V27, P472, DOI 10.1080/09602011.2016.1168746; Hart T, 2007, REHABIL PSYCHOL, V52, P152, DOI 10.1037/0090-5550.52.2.152; Hayes AF, 2009, C PAP INT COMM ASS, P1; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; Kearns A, 2015, PSYCHOL HEALTH MED, V20, P332, DOI 10.1080/13548506.2014.940354; Kroenke K, 2014, J AM BOARD FAM MED, V27, P199; Lannoo E, 2004, BRAIN INJURY, V18, P203, DOI 10.1080/02699050310001596905; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; McLean AM, 2014, DISABIL REHABIL, V36, P1409, DOI 10.3109/09638288.2013.834986; Murberg TA, 2001, J PSYCHOSOM RES, V51, P521, DOI 10.1016/S0022-3999(01)00226-4; Norup A, 2012, BRAIN INJURY, V26, P1192, DOI 10.3109/02699052.2012.672790; Pagan R, 2015, APPL RES QUAL LIFE, V10, P557, DOI 10.1007/s11482-014-9333-3; Petrea RE, 2009, STROKE, V40, P1032, DOI 10.1161/STROKEAHA.108.542894; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Sagy R, 2016, INT J PSYCHIAT CLIN, V20, P245, DOI 10.1080/13651501.2016.1223855; Schimmack U, 2002, J PERS SOC PSYCHOL, V82, P582, DOI 10.1037//0022-3514.82.4.582; Shankar A, 2015, PSYCHOL HEALTH, V30, P686, DOI 10.1080/08870446.2014.979823; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Stam K, 2016, WORK EMPLOY SOC, V30, P309, DOI 10.1177/0950017014564602; Tate R, 2014, BRAIN IMPAIR, V15, P157, DOI 10.1017/BrImp.2014.28; Tu YD, 2015, SOC INDIC RES, V124, P963, DOI 10.1007/s11205-014-0809-1; Williamson MLC, 2015, J HEAD TRAUMA REHAB, V31, P1; Winkler D, 2005, J OCCUP SCI, V12, P69, DOI 10.1080/14427591.2005.9686550; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	40	12	12	2	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1936-6574	1876-7583		DISABIL HEALTH J	Disabil. Health J.	JUL	2019	12	3					387	393		10.1016/j.dhjo.2019.01.001			7	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Rehabilitation	ID6FG	WOS:000471771800008	30692055				2022-02-06	
J	Puffenbarger, MS; Ahmad, FA; Argent, M; Gu, HJ; Samson, C; Quayle, KS; Saito, JM				Puffenbarger, Melissa S.; Ahmad, Fahd A.; Argent, Michelle; Gu, Hongjie; Samson, Charles; Quayle, Kimberly S.; Saito, Jacqueline M.			Reduction of Computed Tomography Use for Pediatric Closed Head Injury Evaluation at a Nonpediatric Community Emergency Department	ACADEMIC EMERGENCY MEDICINE			English	Article; Proceedings Paper	Annual National Meeting of the Society-for-Academic-Emergency-Medicine (SAEM)	MAY 15-18, 2018	Indianapolis, IN	Soc Acad Emergency Med			TRAUMATIC BRAIN-INJURIES; RADIATION-EXPOSURE; CT SCANS; CHILDREN; IMPLEMENTATION; RISK	Objective The purpose of this study was to determine if implementation of a Pediatric Emergency Care Applied Research Network (PECARN)-based Closed Head Injury Assessment Tool could safely decrease computed tomography (CT) use for pediatric head injury evaluation at a nonpediatric community emergency department (ED). Methods A quality improvement project was initiated at a nonpediatric community ED to implement an institution-specific, PECARN-based Pediatric Closed Head Injury Assessment Tool. Baseline head CT use at the participating ED was determined for children with closed head injury through retrospective chart review from March 2014 through November 2015. Head injury patients were identified using International Classification of Disease (ICD)-9 codes for head injury, unspecified (959.01) and concussion with and without loss of consciousness (850-850.9) until October 2015, after which ICD-9 was no longer used. To identify eligible patients after October 2015, lists of all pediatric patients evaluated at the participating ED were reviewed, and patients were included in the analysis if they had a physician-assigned discharge diagnosis of head injury or concussion. Exclusion criteria were age >= 18 years, penetrating head trauma, history of brain tumor, ventriculoperitoneal shunt, bleeding disorder, or presentation > 24 hours postinjury. Medical history, injury mechanism, symptoms, head CT use, and disposition were recorded. Implementation of the Pediatric Closed Head Injury Assessment Tool was achieved through provider education sessions beginning in December 2015 and ending in August 2016. Head CT use was monitored for 12 months postimplementation, from September 2016 through August 2017. Patients were classified into low, intermediate, or high risk for clinically important traumatic brain injury (ciTBI) by chart review. ED length of stay (LOS), disposition, and ED returns within 72 hours were recorded. Categorical variables were compared using chi-square test or Fisher's exact test, and continuous variables, using Kruskal-Wallis test. Results A total of 252 children with closed head injury were evaluated preimplementation (March 2014 through November 2015), 132 children were evaluated during implementation (December 2015 through August 2016), and 172 children were evaluated postimplementation (September 2016 through August 2017). Overall CT use decreased from 37.7% (95% confidence interval [CI] = 31.7-43.7) preimplementation to 16.9% (95% CI = 11.3-22.5) postimplementation (p < 0.001). Only 1% (95% CI = 0%-2.9%) of low-risk patients received a head CT postimplementation compared to 22.6% (95% CI = 16.1%-29.1%) preimplementation (p < 0.001). CT use among patients >= 24 months decreased from 42.9% (95% CI = 36.5%-49.6%) to 19.6% (95% CI = 13.1%-26.1%; p < 0.001) and remained low and unchanged for patients ED returns within 72 hours were unchanged, while median ED LOS improved from 1.5 to 1.3 hours (p = 0.03). There were no missed ciTBIs after implementation of the guideline. Conclusion Implementation of the PECARN-based Pediatric Closed Head Injury Assessment Tool reduced head CT use in a nonpediatric ED. The greatest impact was seen among children aged >= 24 months at very low risk for ciTBI.	[Puffenbarger, Melissa S.] Washington Univ, Sch Med, Mercy St Louis Emergency Med, St Louis, MO 63110 USA; [Ahmad, Fahd A.; Samson, Charles] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Gu, Hongjie] Washington Univ, Sch Med, Dept Biostat, St Louis, MO USA; [Saito, Jacqueline M.] Washington Univ, Sch Med, Dept Pediat Surg, St Louis, MO USA; [Quayle, Kimberly S.] Washington Univ, Sch Med, St Louis, MO USA; [Argent, Michelle] Ctr Clin Excellence, St Louis, MO USA		Puffenbarger, MS (corresponding author), Washington Univ, Sch Med, Mercy St Louis Emergency Med, St Louis, MO 63110 USA.	melissa.puffenbarger@gmail.com		Saito, Jacqueline/0000-0002-9477-2436; Ahmad, Fahd/0000-0001-5919-6835			Axon RN, 2011, JAMA-J AM MED ASSOC, V305, P504, DOI 10.1001/jama.2011.72; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Burstein B, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0814; Chen JX, 2014, OTOLARYNG HEAD NECK, V151, P554, DOI 10.1177/0194599814542588; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; Dayan PS, 2015, PEDIATRICS, V135, P504, DOI 10.1542/peds.2014-2695; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jennings RM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1349; Kobe IO, 2017, CHILD NERV SYST, V33, P2147, DOI 10.1007/s00381-017-3577-9; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; NELSON LS, 1984, J QUAL TECHNOL, V16, P237, DOI 10.1080/00224065.1984.11978921; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Niska Richard, 2010, Natl Health Stat Report, P1; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Rui PKK, NATL HOSP AMBULATORY; Smith-Bindman R, 2012, JAMA-J AM MED ASSOC, V307, P2400, DOI 10.1001/jama.2012.5960; Stanley RM, 2014, J PEDIATR-US, V165, P1201, DOI 10.1016/j.jpeds.2014.08.008; Sullivan AF, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-13; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tham E, 2016, APPL CLIN INFORM, V7, P534, DOI 10.4338/ACI-2015-10-CR-0144	22	12	12	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	JUL	2019	26	7					784	795		10.1111/acem.13666			12	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	IJ5VI	WOS:000475970700006	30428150	Bronze			2022-02-06	
J	Turner-Stokes, L; Dzingina, M; Shavelle, R; Bill, A; Williams, H; Sephton, K				Turner-Stokes, Lynne; Dzingina, Mendwas; Shavelle, Robert; Bill, Alan; Williams, Heather; Sephton, Keith			Estimated Life-Time Savings in the Cost of Ongoing Care Following Specialist Rehabilitation for Severe Traumatic Brain Injury in the United Kingdom	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; Economic evaluation; outcome assessment (Healthcare); Rehabilitation; traumatic	LONG-TERM SURVIVAL; DEPENDENCY; EFFICIENCY; BENEFITS	Objectives: To evaluate cost-efficiency of rehabilitation following severe traumatic brain injury (TBI) and estimate the life-time savings in costs of care. Setting/Participants: TBI patients (n = 3578/6043) admitted to all 75 specialist rehabilitation services in England 2010-2018. Design: A multicenter cohort analysis of prospectively collated clinical data from the UK Rehabilitation Outcomes Collaborative national clinical database. Main Measures: Primary outcomes: (a) reduction in dependency (UK Functional Assessment Measure), (b) cost-efficiency, measured in time taken to offset rehabilitation costs by savings in costs of ongoing care estimated by the Northwick Park Dependency Scale/Care Needs Assessment (NPDS/NPCNA), and (c) estimated life-time savings. Results: The mean age was 49 years (74% males). Including patients who remained in persistent vegetative state on discharge, the mean episode cost of rehabilitation was 42 pound 894 (95% CI: 41 pound 512, 44 pound 235), which was offset within 18.2 months by NPCNA-estimated savings in ongoing care costs. The mean period life expectancy adjusted for TBI severity was 21.6 years, giving mean net life-time savings in care costs of 679 pound 776/patient (95% CI: 635 pound 972, 722 pound 786). Conclusions: Specialist rehabilitation proved highly cost-efficient for severely disabled patients with TBI, despite their reduced life-span, potentially generating over 4 pound billion savings in the cost of ongoing care for this 8-year national cohort.	[Turner-Stokes, Lynne; Dzingina, Mendwas] Kings Coll London, Cicely Saunders Inst, Fac Nursing Midwifery & Palliat Care, Dept Palliat Care Policy & Rehabil, London, England; [Turner-Stokes, Lynne; Bill, Alan; Williams, Heather; Sephton, Keith] Northwick Pk Hosp & Clin Res Ctr, Reg Hyperacute Rehabil Unit, UK Rehabil Outcomes Collaborat, Harrow, Middx, England; [Shavelle, Robert] Life Expectancy Project, San Francisco, CA USA		Turner-Stokes, L (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Reg Rehabil Unit, Watford Rd, Harrow HA1 3UJ, Middx, England.	lynne.turner-stokes@doctors.org.uk	Turner-Stokes, Lynne/F-4418-2012	Turner-Stokes, Lynne/0000-0002-3302-9462	NIHRNational Institute for Health Research (NIHR); National Institute for Health Research (NIHR) under its Programme Grants for Applied Research programNational Institute for Health Research (NIHR) [RP-PG-0407-10185]; Dunhill Medical TrustDunhill Medical Trust	The authors gratefully acknowledge the hard work of the clinical teams in the level 1 and 2 rehabilitation units that contribute to the UKROC data set. Special thanks are due to the UKROC programme steering group and co-applicants and to David Strauss and Jordan Brooks of the US Life Expectancy Project for their helpful advice and information regarding the US life-expectancy project data. Lynne Turner-Stokes, Heather Williams, and Keith Sephton have received financial support from the NIHR to attend conferences to disseminate the findings from the UKROC program. This article presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research program (RP-PG-0407-10185). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. Financial support for the preparation of this manuscript was also provided by the Dunhill Medical Trust. Copies of the tools used in this study are available free of charge from the authors. Please visit our website for more details and contact information: http://www.kcl.ac.uk/lsm/research/divisions/cicelysaunders/research/studies/ukroc/tools.aspx. As the UKROC data set is a live clinical data set, for reasons of confidentiality and data protection data sharing is not available at the current time.	[Anonymous], 2009, NATIONAL DEFINITION; [Anonymous], 2017, 2014 16 BAS PER COH; [Anonymous], 2013, NHS STAND CONTR SPEC; Ashley M. J., 1997, J REHABILITATION OUT, V1, P33; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P1000, DOI 10.1016/j.apmr.2015.02.002; Brooks JC, 2015, ARCH PHYS MED REHAB, V96, P994, DOI 10.1016/j.apmr.2015.02.003; Cooney MT, 2016, CLIN MED, V16, P109, DOI 10.7861/clinmedicine.16-2-109; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Griesbach GS, 2015, J NEUROTRAUM, V32, P704, DOI 10.1089/neu.2014.3754; National Institute for Health and Care Excellence, GUID METH TECHN APPR; Oddy M, 2013, BRAIN INJURY, V27, P1500, DOI 10.3109/02699052.2013.830332; Shavelle RM, 2007, BRAIN INJURY MED PRI, P247; Siegert RJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004231; Siegert RJ, 2010, J REHABIL MED, V42, P936, DOI 10.2340/16501977-0602; Torgerson DJ, 1999, BRIT MED J, V319, P914, DOI 10.1136/bmj.319.7214.914; Turner-Stokes L, 2006, J NEUROL NEUROSUR PS, V77, P634, DOI 10.1136/jnnp.2005.073411; Turner-Stokes L, 2004, CLIN MED, V4, P10, DOI 10.7861/clinmedicine.4-1-10; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Turner-Stokes L, 1999, CLIN REHABIL, V13, P253, DOI 10.1191/026921599677787870; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Turner-Stokes L, 1998, CLIN REHABIL, V12, P304, DOI 10.1191/026921598669173600; Turner-Stokes L, 2015, RPPG040710185 NATL I; Turner-Stokes L, 2008, RPPG040710185 NATL I; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Turner-Stokes L, 2007, BRAIN INJURY, V21, P1015, DOI 10.1080/02699050701591445; Turner-Stokes L, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010238; Turner-Stokes L, 2013, DISABIL REHABIL, V35, P1885, DOI 10.3109/09638288.2013.766271; Turner-Stokes L, 2012, CLIN REHABIL, V26, P264, DOI 10.1177/0269215511417467; van Heugten CM, 2011, J REHABIL MED, V43, P647, DOI 10.2340/16501977-0818; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746; Worthington AD, 2006, BRAIN INJURY, V20, P947, DOI 10.1080/02699050600888314	31	12	12	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2019	34	4					205	214		10.1097/HTR.0000000000000473			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IQ4XH	WOS:000480754400009	30801440	Green Published			2022-02-06	
J	Sandusky-Beltran, LA; Kovalenko, A; Ma, C; Calahatian, JIT; Placides, DS; Watler, MD; Hunt, JB; Darling, AL; Baker, JD; Blair, LJ; Martin, MD; Fontaine, SN; Dickey, CA; Lussier, AL; Weeber, EJ; Selenica, MLB; Nash, KR; Gordon, MN; Morgan, D; Lee, DC				Sandusky-Beltran, Leslie A.; Kovalenko, Andrii; Ma, Chao; Calahatian, John Ivan T.; Placides, Devon S.; Watler, Mallory D.; Hunt, Jerry B.; Darling, April L.; Baker, Jeremy D.; Blair, Laura J.; Martin, Mackenzie D.; Fontaine, Sarah N.; Dickey, Chad A.; Lussier, April L.; Weeber, Edwin J.; Selenica, Maj-Linda B.; Nash, Kevin R.; Gordon, Marcia N.; Morgan, Dave; Lee, Daniel C.			Spermidine/spermine-N-1-acetyltransferase ablation impacts tauopathy-induced polyamine stress response	ALZHEIMERS RESEARCH & THERAPY			English	Article						Tau; Polyamine dysregulation; Hippocampus; Alzheimer's disease	TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL SYNAPTIC PLASTICITY; MOUSE MODEL; ORNITHINE-DECARBOXYLASE; CASPASE-CLEAVAGE; TAU PATHOLOGY; NEUROFIBRILLARY TANGLES; PREFRONTAL CORTEX; SPERMINE SYNTHASE; ALZHEIMER-DISEASE	BackgroundTau stabilizes microtubules; however, in Alzheimer's disease (AD) and tauopathies, tau becomes hyperphosphorylated, aggregates, and results in neuronal death. Our group recently uncovered a unique interaction between polyamine metabolism and tau fate. Polyamines exert an array of physiological effects that support neuronal function and cognitive processing. Specific stimuli can elicit a polyamine stress response (PSR), resulting in altered central polyamine homeostasis. Evidence suggests that elevations in polyamines following a short-term stressor are beneficial; however, persistent stress and subsequent PSR activation may lead to maladaptive polyamine dysregulation, which is observed in AD, and may contribute to neuropathology and disease progression.MethodsMale and female mice harboring tau P301L mutation (rTg4510) were examined for a tau-induced central polyamine stress response (tau-PSR). The direct effect of tau-PSR byproducts on tau fibrillization and oligomerization were measured using a thioflavin T assay and a N2a split superfolder GFP-Tau (N2a-ssGT) cell line, respectively. To therapeutically target the tau-PSR, we bilaterally injected caspase 3-cleaved tau truncated at aspartate 421 (AAV9 Tau D421) into the hippocampus and cortex of spermidine/spermine-N-1-acetyltransferase (SSAT), a key regulator of the tau-PSR, knock out (SSAT-/-), and wild type littermates, and the effects on tau neuropathology, polyamine dysregulation, and behavior were measured. Lastly, cellular models were employed to further examine how SSAT repression impacted tau biology.ResultsTau induced a unique tau-PSR signature in rTg4510 mice, notably in the accumulation of acetylated spermidine. In vitro, higher-order polyamines prevented tau fibrillization but acetylated spermidine failed to mimic this effect and even promoted fibrillization and oligomerization. AAV9 Tau D421 also elicited a unique tau-PSR in vivo, and targeted disruption of SSAT prevented the accumulation of acetylated polyamines and impacted several tau phospho-epitopes. Interestingly, SSAT knockout mice presented with altered behavior in therotarod task, theelevated plus maze, and marble burying task, thushighlighting the impact of polyamine homeostasis within the brain.ConclusionThese data represent a novel paradigm linking tau pathology and polyamine dysfunction and that targeting specific arms within the polyamine pathway may serve as new targets to mitigate certain components of the tau phenotype.	[Sandusky-Beltran, Leslie A.; Kovalenko, Andrii; Calahatian, John Ivan T.; Placides, Devon S.; Watler, Mallory D.; Hunt, Jerry B.; Selenica, Maj-Linda B.; Lee, Daniel C.] Univ S Florida, Byrd Alzheimers Inst, Dept Pharmaceut Sci, 4001 E Fletcher Ave, Tampa, FL 33613 USA; [Darling, April L.; Baker, Jeremy D.; Blair, Laura J.; Martin, Mackenzie D.; Fontaine, Sarah N.; Dickey, Chad A.] Univ S Florida, Byrd Alzheimers Inst, Dept Mol Med, Tampa, FL 33613 USA; [Ma, Chao; Lussier, April L.; Weeber, Edwin J.; Nash, Kevin R.; Gordon, Marcia N.; Morgan, Dave] Univ S Florida, Byrd Alzheimers Inst, Dept Mol Pharmacol & Physiol, Tampa, FL 33613 USA; [Sandusky-Beltran, Leslie A.] NYU, Sch Med, Dept Neurosci & Physiol, Neurosci Inst, 1 Pk Ave, New York, NY 10016 USA; [Gordon, Marcia N.; Morgan, Dave] Michigan State Univ, Dept Translat Sci & Mol Med, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA		Lee, DC (corresponding author), Univ S Florida, Byrd Alzheimers Inst, Dept Pharmaceut Sci, 4001 E Fletcher Ave, Tampa, FL 33613 USA.	dlee1@health.usf.edu		Lussier, April/0000-0002-3103-1286; Blair, Laura/0000-0002-4981-5564; Ma, Chao (Marshall)/0000-0001-6970-5613	CurePSP; CBD Foundation; NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG054559]; BrightFocus FoundationBrightFocus Foundation	Funding for this work was provided by the CurePSP & CBD Foundation, NIH/NIA R01AG054559, and BrightFocus Foundation.	Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Basurto-Islas G, 2008, J NEUROPATH EXP NEUR, V67, P470, DOI 10.1097/NEN.0b013e31817275c7; BERNSTEIN HG, 1995, NEUROSCI LETT, V186, P123, DOI 10.1016/0304-3940(95)11301-C; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brunello CA, 2016, SCI REP-UK, V6, DOI 10.1038/srep30498; Buckley RF, 2017, JAMA NEUROL, V74, P1455, DOI 10.1001/jamaneurol.2017.2216; Carty N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059626; Carty N, 2010, J NEUROSCI METH, V194, P144, DOI 10.1016/j.jneumeth.2010.10.010; Chen GG, 2010, NEUROPSYCHOPHARMACOL, V35, P1477, DOI 10.1038/npp.2010.17; Ciarlone SL, 2016, NEUROBIOL DIS, V96, P38, DOI 10.1016/j.nbd.2016.08.002; Connor CM, 2009, BIOL PSYCHIAT, V66, P486, DOI 10.1016/j.biopsych.2009.04.032; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Fiori LM, 2008, J PSYCHIATR NEUROSCI, V33, P102; Fiori LM, 2012, INT J NEUROPSYCHOPH, V15, P1161, DOI 10.1017/S1461145711001520; Fiori LM, 2011, J PSYCHIATR RES, V45, P1229, DOI 10.1016/j.jpsychires.2011.03.015; Fiori LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015146; Fiori LM, 2010, INT J NEUROPSYCHOPH, V13, P725, DOI 10.1017/S1461145709991167; Flori LM, 2009, BIOL PSYCHIAT, V66, P460, DOI 10.1016/j.biopsych.2009.04.002; Fontaine SN, 2015, J BIOL CHEM, V290, P13115, DOI 10.1074/jbc.M115.637595; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gerner EW, 2018, J BIOL CHEM, V293, P18770, DOI 10.1074/jbc.TM118.003343; Gilad GM, 2003, CELL MOL NEUROBIOL, V23, P637, DOI 10.1023/A:1025036532672; Gilad GM, 2002, BRAIN RES, V943, P23, DOI 10.1016/S0006-8993(02)02479-4; Gilad GM, 1998, INT J DEV NEUROSCI, V16, P271, DOI 10.1016/S0736-5748(98)00033-1; Glushakova OY, 2018, J NEUROTRAUM, V35, P157, DOI 10.1089/neu.2017.4999; Graham SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119452; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Guerra GP, 2012, J NEUROCHEM, V122, P363, DOI 10.1111/j.1471-4159.2012.07778.x; Guerra GP, 2016, PHARMACOL RES, V112, P99, DOI 10.1016/j.phrs.2016.03.023; Guillozet-Bongaarts AL, 2005, NEUROBIOL AGING, V26, P1015, DOI 10.1016/j.neurobiolaging.2004.09.019; Guillozet-Bongaarts AL, 2007, ACTA NEUROPATHOL, V113, P513, DOI 10.1007/s00401-007-0209-6; Guipponi M, 2009, AM J MED GENET B, V150B, P799, DOI 10.1002/ajmg.b.30901; Gumru S, 2013, OA BEHAV MED, V1, P1; Gupta VK, 2013, NAT NEUROSCI, V16, P1453, DOI 10.1038/nn.3512; Hethorn WR, 2015, EUR J NEUROSCI, V41, P1372, DOI 10.1111/ejn.12893; Hunt JB, 2015, J NEUROSCI, V35, P14842, DOI 10.1523/JNEUROSCI.3959-14.2015; Inoue K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02364; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Jell J, 2007, J BIOL CHEM, V282, P8404, DOI 10.1074/jbc.M610265200; Johnson KA, 2014, ALZHEIMERS DEMENT, V10, pP242, DOI [10.1016/j.jalz.2014.04.365, DOI 10.1016/J.JALZ.2014.04.365]; Kim Y, 2016, NEUROBIOL DIS, V87, P19, DOI 10.1016/j.nbd.2015.12.006; Le-Niculescu H, 2013, MOL PSYCHIATR, V18, P1249, DOI 10.1038/mp.2013.95; Lee DC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-56; Lewandowski NM, 2010, P NATL ACAD SCI USA, V107, P16970, DOI 10.1073/pnas.1011751107; Limon A, 2016, NEUROSCI BIOBEHAV R, V66, P80, DOI 10.1016/j.neubiorev.2016.04.010; Liu CL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208993; Liu P, 2014, NEUROBIOL AGING, V35, P1992, DOI 10.1016/j.neurobiolaging.2014.03.013; Lopez JP, 2014, INT J NEUROPSYCHOPH, V17, P23, DOI 10.1017/S1461145713000941; Maeda S, 2016, EMBO REP, V17, P530, DOI 10.15252/embr.201541438; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Metcalfe MJ, 2010, MT SINAI J MED, V77, P50, DOI 10.1002/msj.20163; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; Mondragon-Rodriguez S, 2008, NEUROPATH APPL NEURO, V34, P62, DOI 10.1111/j.1365-2990.2007.00853.x; MORRISON LD, 1995, NEUROSCI LETT, V197, P5, DOI 10.1016/0304-3940(95)11881-V; Morrison LD, 1998, J NEUROCHEM, V71, P288; Naini SMA, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/151979; Nash KR, 2013, NEUROBIOL AGING, V34, P1540, DOI 10.1016/j.neurobiolaging.2012.12.011; Newman J, 2005, ACTA NEUROPATHOL, V110, P135, DOI 10.1007/s00401-005-1027-3; Niiranen K, 2006, J CELL MOL MED, V10, P933, DOI 10.2755/jcmm010.004.02; Nilsson T, 2006, BIOCHEM BIOPH RES CO, V344, P640, DOI 10.1016/j.bbrc.2006.03.191; Norton DJ, 2017, NEUROLOGY, V89, P1464, DOI 10.1212/WNL.0000000000004533; Nowotarski SL, 2015, CANCER GROWTH METAST, P17, DOI 10.4137/CGM.S21219; Ozcelik S, 2016, MOL PSYCHIATR, V21, P1790, DOI 10.1038/mp.2015.228; Paik MJ, 2010, CLIN CHIM ACTA, V411, P1532, DOI 10.1016/j.cca.2010.05.034; Park MH, 2013, BIOMOL THER, V21, P1, DOI 10.4062/biomolther.2012.097; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pegg AE, 2011, METHODS MOL BIOL, V720, P3, DOI 10.1007/978-1-61779-034-8_1; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Peron A, 2013, AM J MED GENET A, V161, P2316, DOI 10.1002/ajmg.a.36116; Plouffe V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036873; PORTER CW, 1991, CANCER RES, V51, P3715; Ramani D, 2014, CLIN NUTR, V33, P14, DOI 10.1016/j.clnu.2013.09.019; Rentz DM, 2015, ALZHEIMERS DEMENT, V11, pP51, DOI [10.1016/j.jalz.2015.06.089, DOI 10.1016/J.JALZ.2015.06.089]; Ribeiro DA, 2013, NEUROBIOL LEARN MEM, V104, P9, DOI 10.1016/j.nlm.2013.04.008; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Rogers JT, 2013, J PSYCHOPHARMACOL, V27, P386, DOI 10.1177/0269881112463468; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Fruhauf PKS, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0220-5; Signor C, 2014, EUR J PHARMACOL, V730, P72, DOI 10.1016/j.ejphar.2014.02.035; Sigrist SJ, 2014, AUTOPHAGY, V10, P178, DOI 10.4161/auto.26918; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Sydow A, 2011, J NEUROSCI, V31, P2511, DOI 10.1523/JNEUROSCI.5245-10.2011; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Trotter J, 2013, J NEUROSCI, V33, P15652, DOI 10.1523/JNEUROSCI.2010-13.2013; Turecki G, 2013, MOL PSYCHIATR, V18, P1242, DOI 10.1038/mp.2013.153; Turecki G, 2014, NAT REV NEUROSCI, V15, P802, DOI 10.1038/nrn3839; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wang YL, 2002, BIOCHEM J, V366, P79, DOI 10.1042/bj20020211; Warmus BA, 2014, J NEUROSCI, V34, P16482, DOI 10.1523/JNEUROSCI.3418-14.2014; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; Yang Y, 2011, BIOL PSYCHIAT, V69, P63, DOI 10.1016/j.biopsych.2010.08.020; Yi J, 2009, INT J CLIN EXP PATHO, V2, P211; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zabala-Letona A, 2017, NATURE, V547, P109, DOI 10.1038/nature22964; Zahedi K, 2007, AM J PHYSIOL-CELL PH, V292, pC1204, DOI 10.1152/ajpcell.00451.2006; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097; Zhao YJ, 2015, NEURON, V87, P963, DOI 10.1016/j.neuron.2015.08.020	102	12	12	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1758-9193			ALZHEIMERS RES THER	Alzheimers Res. Ther.	JUN 29	2019	11								58	10.1186/s13195-019-0507-y			24	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IF6ZG	WOS:000473230700003	31253191	gold, Green Published			2022-02-06	
J	Pavlov, V; Thompson-Leduc, P; Zimmer, L; Wen, J; Shea, J; Beyhaghi, H; Toback, S; Kirson, N; Miller, M				Pavlov, Vladislav; Thompson-Leduc, Philippe; Zimmer, Louise; Wen, Jody; Shea, Jerome; Beyhaghi, Hadi; Toback, Seth; Kirson, Noam; Miller, Mark			Mild traumatic brain injury in the United States: demographics, brain imaging procedures, health-care utilization and costs	BRAIN INJURY			English	Article						Concussion; brain injury; traumatic; imaging; computed tomography; cost of illness	EMERGENCY-DEPARTMENT; COMPUTED-TOMOGRAPHY; HEAD-INJURY	Objective: To characterize mild traumatic brain injury (mTBI) patients in the USA, describing location of diagnosis, timing, and modality of imaging procedures, health-care resource utilization (HRU) and costs in the 12-month period post-diagnosis. Research Design: Retrospective claims analysis Methods: Anonymized data from the OptumHealth Care Solutions claims database (2006-2016). The index date was the first date with an mTBI diagnosis. HRU and costs (2016 USD) were assessed in the 12-month post-index period. Results: A total of 80,004 patients with mTBI were included: 60% were under 26 years and 54% were male. Mild TBI was most frequently diagnosed in an emergency department (ED) for all age groups, except patients aged 11-17 years, for whom the outpatient setting was the most frequent place of diagnosis. Almost half (47%) received brain imaging on the index date, with 98% of which receiving computed tomography. Mean follow-up health-care costs were $13,564 (SD = $41,071), primarily from inpatient ($4,675, SD = $29,982) and non-ED outpatient/physician office visits ($4,207, SD = $12,697). Older patients had greater HRU and higher health-care costs. Conclusions: The findings of this claims-based study show substantial HRU and costs associated with mTBI diagnosis during a 12-month follow-up period.	[Pavlov, Vladislav; Miller, Mark] BioMerieux, Med Affairs, Marcy Letoile, France; [Thompson-Leduc, Philippe; Wen, Jody; Shea, Jerome; Kirson, Noam] Anal Grp Inc, Boston, MA USA; [Zimmer, Louise; Beyhaghi, Hadi; Toback, Seth] BioMerieux, Durham, NC USA		Pavlov, V (corresponding author), BioMerieux, 376 Chemin Orme, F-69280 Marcy Letoile, France.	vladislav.pavlov@biomerieux.com			BioMerieux Inc.	This work was supported by the BioMerieux Inc.	Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bell JM, 2015, J HEAD TRAUMA REHAB, V30, P148, DOI 10.1097/HTR.0000000000000143; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Centers for Disease Control and Prevention, 2017, TRAUM BRAIN INJ CONC; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; DoD, 2016, DOD STAND SURV CAS D; Faul M, 2010, TRAUMATIC BRAIN INJU; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Hess ER, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2430; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Melnick ER, 2015, ACAD EMERG MED, V22, P1474, DOI 10.1111/acem.12824; Papa L, 2015, FRONTIERS NEUROENGIN, V22. 1, P1; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sharp AL, 2017, ACAD EMERG MED, V24, P22, DOI 10.1111/acem.13061; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; The Mayo Clinic, 2017, CONC DIAGN MAYO FDN; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014	21	12	15	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 29	2019	33	9					1151	1157		10.1080/02699052.2019.1629022		JUN 2019	7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IO0TH	WOS:000475708600001	31241427				2022-02-06	
J	Chrisman, SPD; Whitlock, KB; Mendoza, JA; Burton, MS; Somers, E; Hsu, A; Fay, L; Palermo, TM; Rivara, FP				Chrisman, Sara P. D.; Whitlock, Kathryn B.; Mendoza, Jason A.; Burton, Monique S.; Somers, Ellie; Hsu, Albert; Fay, Lauren; Palermo, Tonya M.; Rivara, Frederick P.			Pilot Randomized Controlled Trial of an Exercise Program Requiring Minimal In-person Visits for Youth With Persistent Sport-Related Concussion	FRONTIERS IN NEUROLOGY			English	Article						brain concussion; child; fear-avoidance; pain; exercise; traumatic brain injury; treatment; sport	FEAR-AVOIDANCE MODEL; CHRONIC PAIN; PHYSICAL-ACTIVITY; POSTCONCUSSIVE SYMPTOMS; ACTIVE REHABILITATION; PSYCHOLOGICAL-FACTORS; CHILDREN; ADOLESCENTS; PARENTS; RELIABILITY	Objective: To evaluate feasibility and acceptability of a sub-threshold exercise program with minimal in-person visits to treat youth with persistent sport-related concussion, and explore efficacy for improving concussive symptoms, health-related quality of life, and fear-avoidance. Study design: We conducted a pilot randomized controlled trial comparing a 6 week sub-threshold exercise program requiring only two in-person visits to active control (stretching) for 12-18 year old youth with persistent sport-related concussion. We measured moderate-to-vigorous physical activity pre- and post-intervention using accelerometry, and increased goals weekly via phone contact. We examined feasibility and acceptability using qualitative interviews. We used exponential regression to model differences in trajectory of concussive symptoms by experimental group, and linear regression to model differences in trajectory of health-related quality of life and fear-avoidance of pain by experimental group. Results: Thirty-two subjects randomized, 30 completed the study (n = 11 control, n = 19 intervention), 57 % female. Youth and parents reported enjoying participating in the study and appreciated the structure and support, as well as the minimal in-person visits. Exponential regression modeling indicated that concussive symptoms declined more rapidly in intervention youth than control (p = 0.02). Health-related quality of life and fear-avoidance of pain improved over time, but were not significantly different by group. Conclusions: This study indicates feasibility and potential benefit of a 6 week subthreshold exercise program with minimal in-person visits for youth with persistent concussion. Potential factors that may play a role in improvement such as fear-avoidance deserve further study.	[Chrisman, Sara P. D.; Whitlock, Kathryn B.; Mendoza, Jason A.; Hsu, Albert; Fay, Lauren; Palermo, Tonya M.; Rivara, Frederick P.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA 98101 USA; [Chrisman, Sara P. D.; Mendoza, Jason A.; Burton, Monique S.; Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Chrisman, Sara P. D.; Rivara, Frederick P.] Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Burton, Monique S.] Seattle Childrens Hosp, Dept Orthoped & Sports Med, Seattle, WA USA; [Somers, Ellie] Seattle Childrens Hosp, Dept Sports Phys Therapy, Seattle, WA USA; [Palermo, Tonya M.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Somers, Ellie] Sisu Sports Performance, Seattle, WA USA		Chrisman, SPD (corresponding author), Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA 98101 USA.; Chrisman, SPD (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.; Chrisman, SPD (corresponding author), Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA.	sara.chrisman@seattlechildrens.org		Chrisman, Sara/0000-0001-5373-7223	Seattle Pediatric Concussion Research Consortium	Research was supported by a grant from the Seattle Pediatric Concussion Research Consortium.	Asmundson GJG, 2012, PAIN RES MANAG, V17, P397, DOI 10.1155/2012/908061; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; BAILEY RC, 1995, MED SCI SPORT EXER, V27, P1033, DOI 10.1249/00005768-199507000-00012; Baquet G, 2007, PREV MED, V44, P143, DOI 10.1016/j.ypmed.2006.10.004; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chow ET, 2016, J PAIN, V17, P729, DOI 10.1016/j.jpain.2016.02.014; Chrisman SPD, 2017, NEUROREHABILITATION, V40, P493, DOI 10.3233/NRE-161436; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Feinstein AB, 2018, CLIN J PAIN, V34, P1096, DOI 10.1097/AJP.0000000000000639; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gauvin-Lepage J, 2020, CLIN J SPORT MED, V30, P423, DOI 10.1097/JSM.0000000000000634; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Howell DR, 2019, MED SCI SPORT EXER, V51, P647, DOI 10.1249/MSS.0000000000001829; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2019, CLIN J SPORT MED, V29, P353, DOI 10.1097/JSM.0000000000000663; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Levy RL, 2010, AM J GASTROENTEROL, V105, P946, DOI 10.1038/ajg.2010.106; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TV, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000394; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Palermo TM, 2009, PAIN, V146, P205, DOI 10.1016/j.pain.2009.07.034; Palermo TM, 2016, PAIN, V157, P1213, DOI 10.1097/j.pain.0000000000000508; Puccio JA, 2006, AIDS PATIENT CARE ST, V20, P438, DOI 10.1089/apc.2006.20.438; Reynolds S, 2012, CLIN PSYCHOL REV, V32, P251, DOI 10.1016/j.cpr.2012.01.005; Sieberg CB, 2015, CHILD ADOL PSYCH CL, V24, P631, DOI 10.1016/j.chc.2015.02.006; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Simons LE, 2016, PAIN, V157, pS90, DOI 10.1097/j.pain.0000000000000377; Simons LE, 2015, PAIN, V156, P694, DOI 10.1097/j.pain.0000000000000100; Simons LE, 2011, J PAIN, V12, P677, DOI 10.1016/j.jpain.2010.12.008; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Turk DC, 2002, J CONSULT CLIN PSYCH, V70, P678, DOI 10.1037//0022-006X.70.3.678; Turk DC, 2010, CURR PAIN HEADACHE R, V14, P88, DOI 10.1007/s11916-010-0094-x; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551; Wilson AC, 2011, PAIN RES MANAG, V16, P178, DOI 10.1155/2011/296298; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	51	12	13	1	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 17	2019	10								623	10.3389/fneur.2019.00623			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	ID8JP	WOS:000471930500001	31316446	Green Published, gold			2022-02-06	
J	Fani, N; King, TZ; Clendinen, C; Hardy, RA; Surapaneni, S; Blair, JR; White, SF; Powers, A; Ely, TD; Jovanovic, T; Ressler, KJ; Bradley, B				Fani, Negar; King, Tricia Z.; Clendinen, Cherita; Hardy, Raven A.; Surapaneni, Sindhuja; Blair, James R.; White, Stuart F.; Powers, Abigail; Ely, Tim D.; Jovanovic, Tanja; Ressler, Kerry J.; Bradley, Bekh			Attentional control abnormalities in posttraumatic stress disorder: Functional, behavioral, and structural correlates	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Attention; PTSD; fMRI; DTI; Structure; Cognition; Stroop	WHITE-MATTER INTEGRITY; GENERALIZED ANXIETY DISORDER; ANTERIOR CINGULATE CORTEX; TRAUMATIC BRAIN-INJURY; PTSD SYMPTOM SEVERITY; COGNITIVE CONTROL; EMOTIONAL STROOP; QUANTITATIVE METAANALYSIS; MEMORY; MICROSTRUCTURE	Background: Attentional disruptions are common in PTSD, but findings across neuropsychological and neuroimaging studies have been variable. Few PTSD studies have investigated abnormalities in attention networks using a mull-modal imaging approach and attentional tasks that include emotionally-salient images. This study combined a behavioral task that included these images (emotional Stroop) with functional and structural neuroimaging (fMRI and diffusion tensor imaging; DTI) methods to comprehensively investigate attentional control abnormalities in a highly-traumatized civilian sample. Methods: 48 traumatized women with and without PTSD received clinical assessments, fMRI and DTI. During fMRI, the Affective Stroop (AS), an attentional control task that includes emotionally-salient distractor images (trauma-relevant, positive, neutral) and variable task demands, was administered. Results: In response to more difficult AS trials, participants with PTSD demonstrated lower activation in the dorsal and rostral anterior cingulate cortex and greater activation in the insula. This group also showed comparatively poorer performance on positive AS distractor trials, even after adjusting for trauma exposure. Performance on these trials inversely correlated with structural integrity of the cingulum bundle and uncinate fasciculus. Conclusions: Even after adjusting for trauma exposure, participants with PTSD showed worse performance on an attentional control task in the context of emotional stimuli. They also showed relatively lower cognitive control network activation and greater salience network activation. Fronto-parietal and fronto-limbic white matter connectivity corresponded with AS performance. Our findings indicate that attentional control impairments in PTSD are most evident in the context of emotional cues, and are related to decrements in function and structure of cognitive control and salience networks.	[Fani, Negar; Clendinen, Cherita; Hardy, Raven A.; Surapaneni, Sindhuja; Powers, Abigail; Ely, Tim D.; Jovanovic, Tanja; Bradley, Bekh] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [King, Tricia Z.] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; [Blair, James R.; White, Stuart F.] Boystown Natl Res Hosp, Omaha, NE USA; [Ressler, Kerry J.] McLean Hosp, 115 Mill St, Belmont, MA 02178 USA; [Bradley, Bekh] Atlanta VA Med Ctr, Decatur, GA USA		Fani, N (corresponding author), Emory Univ, Dept Psychiat & Behav Sci, 101 Woodruff Circle,Ste 6007, Atlanta, GA 30322 USA.	nfani@emory.edu	Fani, Negar/AAW-1445-2021; Bradley, Bekh/H-8399-2012	Fani, Negar/0000-0002-7720-252X; King, Tricia/0000-0003-1363-9914; Ely, Timothy/0000-0002-5690-5234; Powers, Abigail/0000-0003-3197-7415	National Institutes of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH101380, MH092576]; Emory Medical Care Foundation; American Psychological Association, Society for Clinical Neuropsychology [36496]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH101380] Funding Source: NIH RePORTER	This work was primarily supported by National Institutes of Mental Health (MH101380 to NF, MH092576 to TJ). Support was also received from the Emory Medical Care Foundation and American Psychological Association, Society for Clinical Neuropsychology, award 36496. We wish to thank Amrita Kaimal, Saankari Challa, Jenani Srijeyanthan, Michaela Desrosiers, Katrina Conrad, and Nayan Tiwary for their assistance with data collection, as well as the contributions of our research participants and numerous research volunteers for the Grady Trauma Project.	Allen M, 2012, J NEUROSCI, V32, P15601, DOI 10.1523/JNEUROSCI.2957-12.2012; Badura-Brack AS, 2015, AM J PSYCHIAT, V172, P1233, DOI 10.1176/appi.ajp.2015.14121578; Banich MT, 2009, NEUROSCI BIOBEHAV R, V33, P613, DOI 10.1016/j.neubiorev.2008.09.010; Blair KS, 2007, NEUROIMAGE, V35, P430, DOI 10.1016/j.neuroimage.2006.11.048; Blair KS, 2013, PSYCHOL MED, V43, P85, DOI 10.1017/S0033291712000840; Blair KS, 2012, BIOL PSYCHIAT, V72, P476, DOI 10.1016/j.biopsych.2012.04.013; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Block SR, 2016, EXP NEUROL, V284, P153, DOI 10.1016/j.expneurol.2016.05.009; Bremner JD, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00157; Bremner JD, 2004, BIOL PSYCHIAT, V55, P612, DOI 10.1016/j.biopsych.2003.10.001; Bryant RA, 2008, J PSYCHIATR NEUROSCI, V33, P142; Bubb EJ, 2018, NEUROSCI BIOBEHAV R, V92, P104, DOI 10.1016/j.neubiorev.2018.05.008; Chen NTM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086474; Chen Nigel T. M., 2012, Cognitive Behaviour Therapy, V41, P96, DOI 10.1080/16506073.2012.666562; Cisler JM, 2011, CLIN PSYCHOL REV, V31, P817, DOI 10.1016/j.cpr.2011.03.007; Cohen RA, 1999, NEUROLOGY, V53, P819, DOI 10.1212/WNL.53.4.819; Cohen RA, 2001, EMOTION, V1, P38, DOI 10.1037/1528-3542.1.1.38; d'Arbeloff T. C., 2018, EMOTION; Daniels JK, 2013, DEPRESS ANXIETY, V30, P207, DOI 10.1002/da.22044; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Fani N, 2012, PSYCHOL MED, V42, P533, DOI 10.1017/S0033291711001565; Fani N, 2016, DEPRESS ANXIETY, V33, P300, DOI 10.1002/da.22483; Fani N, 2015, CORTEX, V64, P249, DOI 10.1016/j.cortex.2014.11.006; Fani N, 2012, NEUROPSYCHOPHARMACOL, V37, P2740, DOI 10.1038/npp.2012.146; Fani N, 2011, COGNITIVE THER RES, V35, P57, DOI 10.1007/s10608-010-9294-2; Fine NB, 2018, EUR J PSYCHOTRAUMATO, V9, DOI 10.1080/20008198.2018.1442602; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1002/jts.2490060405; Fox R. J., 2011, AJNR AM J NEURORADIO; Grisanzio KA, 2018, JAMA PSYCHIAT, V75, P201, DOI 10.1001/jamapsychiatry.2017.3951; Hayes JP, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-9; He XF, 2016, NEUROPSYCHOPHARMACOL, V41, P1841, DOI 10.1038/npp.2015.354; Herzog J. I., 2017, EUR ARCH PSYCHIAT CL; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI [10.1586/ern.10.198, 10.1586/ERN.10.198]; JANER KW, 1991, J COGNITIVE NEUROSCI, V3, P231, DOI 10.1162/jocn.1991.3.3.231; Jatzko A, 2006, EUR ARCH PSY CLIN N, V256, P112, DOI 10.1007/s00406-005-0617-3; Jenkins LM, 2016, NEUROIMAGE-CLIN, V12, P1022, DOI 10.1016/j.nicl.2016.09.001; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Kanagaratnam P, 2007, J ANXIETY DISORD, V21, P510, DOI 10.1016/j.janxdis.2006.06.008; Keedwell PA, 2016, CEREB CORTEX, V26, P2850, DOI 10.1093/cercor/bhw030; Kennis M, 2015, NEUROPSYCHOPHARMACOL, V40, P2434, DOI 10.1038/npp.2015.94; Kim CH, 2003, ACTA PSYCHIAT SCAND, V107, P283, DOI 10.1034/j.1600-0447.2003.00087.x; Koch SBJ, 2017, J PSYCHIATR NEUROSCI, V42, P331, DOI 10.1503/jpn.160129; Koppelstaetter F, 2010, J ALZHEIMERS DIS, V20, pS71, DOI 10.3233/JAD-2010-1417; Kubicki M, 2009, BRAIN IMAGING BEHAV, V3, P191, DOI 10.1007/s11682-009-9061-8; LaGarde G, 2010, PSYCHIAT RES, V177, P144, DOI 10.1016/j.psychres.2009.02.002; Laurienti PJ, 2002, NEUROIMAGE, V17, P751, DOI 10.1006/nimg.2002.1237; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Liao M, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-41; Lindner P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19569-7; Ly M., 2013, HUM BRAIN MAPP; Malejko K, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00085; Mori S, 2005, MRI ATLAS HUMAN WHIT; Nawijn L, 2015, NEUROSCI BIOBEHAV R, V51, P189, DOI 10.1016/j.neubiorev.2015.01.019; Palmer LK, 1997, ARCH CLIN NEUROPSYCH, V12, P379, DOI 10.1093/arclin/12.4.379a; Peres JFP, 2011, J PSYCHIATR RES, V45, P727, DOI 10.1016/j.jpsychires.2010.11.004; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Schulte T, 2012, NEUROPSYCHOLOGIA, V50, P2812, DOI 10.1016/j.neuropsychologia.2012.07.042; Schweizer S, 2017, BEHAV RES THER, V93, P88, DOI 10.1016/j.brat.2017.03.017; Scott JC, 2015, PSYCHOL BULL, V141, P105, DOI 10.1037/a0038039; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sylvester CM, 2012, TRENDS NEUROSCI, V35, P527, DOI 10.1016/j.tins.2012.04.012; Takahashi M, 2010, NEUROSCI LETT, V477, P72, DOI 10.1016/j.neulet.2010.04.031; Takei K, 2009, SCHIZOPHR RES, V114, P119, DOI 10.1016/j.schres.2009.05.012; Taylor CT, 2010, J ANXIETY DISORD, V24, P403, DOI 10.1016/j.janxdis.2010.02.004; Thomaes K, 2012, PSYCHOL MED, V42, P2337, DOI 10.1017/S0033291712000499; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Wang HH, 2010, J PSYCHIATR RES, V44, P385, DOI 10.1016/j.jpsychires.2009.10.001; Weathers F. W., 2017, PSYCHOL ASSESS; White SF, 2018, PSYCHIAT RES-NEUROIM, V278, P7, DOI 10.1016/j.pscychresns.2018.06.006; White SF, 2015, NEUROIMAGE-CLIN, V7, P19, DOI 10.1016/j.nicl.2014.11.012; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Yamamoto M, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.375; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020; Zheng K. Z., 2018, CNS NEUROSCI THER	80	12	13	4	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	JUN 15	2019	253						343	351		10.1016/j.jad.2019.04.098			9	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	ID7MA	WOS:000471865800042	31078834	Green Accepted			2022-02-06	
J	Koenig, JB; Cantu, D; Low, C; Sommer, M; Noubary, F; Croker, D; Whalen, M; Kong, D; Dulla, CG				Koenig, Jenny B.; Cantu, David; Low, Cho; Sommer, Mary; Noubary, Farzad; Croker, Danielle; Whalen, Michael; Kong, Dong; Dulla, Chris G.			Glycolytic inhibitor 2-deoxyglucose prevents cortical hyperexcitability after traumatic brain injury	JCI INSIGHT			English	Article							EARLY POSTTRAUMATIC SEIZURES; K-ATP; DENTATE GYRUS; UP-REGULATION; THERAPEUTIC HYPOTHERMIA; MOLECULAR-MECHANISMS; CEREBRAL METABOLISM; NEURONAL APOPTOSIS; GLUCOSE-METABOLISM; RECEPTOR SUBUNITS	Traumatic brain injury (TBI) causes cortical dysfunction and can lead to posttraumatic epilepsy. Multiple studies demonstrate that GABAergic inhibitory network function is compromised following TBI, which may contribute to hyperexcitability and motor, behavioral, and cognitive deficits. Preserving the function of GABAergic interneurons, therefore, is a rational therapeutic strategy to preserve cortical function after TBt and prevent long-term clinical complications. Here, we explored an approach based on the ketogenic diet, a neuroprotective and anticonvulsant dietary therapy that results in reduced glycolysis and increased ketosis. Utilizing a pharmacologic inhibitor of glycolysis (2-deoxyglucose, or 2-DG), we found that acute in vitro application of 2-DG decreased the excitability of excitatory neurons, but not inhibitory interneurons, in cortical slices from naive mice. Employing the controlled cortical impact (al) model of TBI in mice, we found that in vitro 2-DG treatment rapidly attenuated epileptiform activity seen in acute cortical slices 3-5 weeks after TBI. One week of in vivo 2-DG treatment immediately after TBI prevented the development of epileptiform activity, restored excitatory and inhibitory synaptic activity, and attenuated the loss of parvalbumin-expressing inhibitory interneurons. In summary, 2-DG may have therapeutic potential to restore network function following TBI.	[Koenig, Jenny B.; Cantu, David; Low, Cho; Sommer, Mary; Croker, Danielle; Kong, Dong; Dulla, Chris G.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Koenig, Jenny B.] Tufts Univ, Sackler Sch Grad Biomed Sci, Neurosci Program, Boston, MA 02111 USA; [Low, Cho] Tufts Univ, Sackler Sch Grad Biomed Sci, Cellular Mol & Dev Biol Program, Boston, MA 02111 USA; [Noubary, Farzad] Northeastern Univ, Dept Hlth Sci, Bouve Coll Hlth Sci, Boston, MA 02115 USA; [Whalen, Michael] Harvard Med Sch, Massachusetts Gen Hosp, Neurosci Ctr, Charlestown, MA USA; [Whalen, Michael] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02115 USA		Cantu, D; Dulla, CG (corresponding author), 136 Harrison Ave,South Cove 203, Boston, MA 02111 USA.	davidcantu82@gmail.com; chris.dulla@tufts.edu		Sommer, Mary/0000-0001-8339-6159	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21-NS098009, R56-NS076885, R01-NS100076, R21-NS104478, F31-NS101741, R01-NS107315, R21-NS097922]; United States Department of DefenseUnited States Department of Defense [W81XWH-16-ERP-IDA]; National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01-DK108797]; National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21-HD098056]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD098056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK108797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K12GM074869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS098009, R56NS076885, R21NS104478, R01NS107315, R21NS097922, F31NS101741] Funding Source: NIH RePORTER	We would like to thank Christian Bjorbaek for his helpful feedback on the manuscript and Maribel Rios and Jamie Maguire for their helpful comments. We would also like to thank Dominique Ameroso for her assistance with confocal imaging for Figure 6. This work was supported by the National Institute of Neurological Disorders and Stroke (R21-NS098009, R56-NS076885, R01-NS100076, R21-NS104478 [all to CGD], F31-NS101741 to JBK, and R01-NS107315, R21-NS097922 [both to DK]), the United States Department of Defense (W81XWH-16-ERP-IDA to CGD), the National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK108797 to DK), and the National Institute of Child Health and Human Development (R21-HD098056 to DK).	Aarts E, 2014, NAT NEUROSCI, V17, P491, DOI 10.1038/nn.3648; Amorini AM, 2016, BBA-MOL BASIS DIS, V1862, P679, DOI 10.1016/j.bbadis.2016.01.023; ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Avramescu S, 2009, J NEUROTRAUM, V26, P799, DOI 10.1089/neu.2008.0739; Bas-Orth C, 2017, J BIOL CHEM, V292, P5183, DOI 10.1074/jbc.M116.761106; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; BERTONI JM, 1981, J NEUROCHEM, V37, P1523, DOI 10.1111/j.1471-4159.1981.tb06322.x; Boison D, 2017, CURR OPIN NEUROL, V30, P187, DOI 10.1097/WCO.0000000000000432; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; Buckmaster PS, 2017, J COMP NEUROL, V525, P2592, DOI 10.1002/cne.24226; Buritica E, 2009, J NEUROTRAUM, V26, P2145, DOI 10.1089/neu.2009.0894; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Carron SF, 2016, J COMP NEUROL, V524, P3530, DOI 10.1002/cne.24014; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chen S, 2010, NEUROSCIENCE, V166, P341, DOI 10.1016/j.neuroscience.2009.12.023; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Cisternas P, 2019, MOL NEUROBIOL, V56, P3024, DOI 10.1007/s12035-018-1271-x; Crompton EM, 2017, CRIT CARE MED, V45, P575, DOI 10.1097/CCM.0000000000002205; DEFELIPE J, 1993, CEREB CORTEX, V3, P39, DOI 10.1093/cercor/3.1.39; Drexel M, 2017, J NEUROSCI, V37, P8166, DOI 10.1523/JNEUROSCI.3456-16.2017; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Epsztein J, 2006, J NEUROSCI, V26, P7082, DOI 10.1523/JNEUROSCI.1666-06.2006; Floberg JM, 2019, SEMIN RADIAT ONCOL, V29, P33, DOI 10.1016/j.semradonc.2018.10.007; Forte N, 2016, EPILEPSIA, V57, P1987, DOI 10.1111/epi.13578; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Gimenez-Cassina A, 2012, NEURON, V74, P719, DOI 10.1016/j.neuron.2012.03.032; Goel A, 2017, NEUROSURG REV, V40, P37, DOI 10.1007/s10143-016-0782-z; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Gupta PK, 2014, J NEUROTRAUM, V31, P1439, DOI 10.1089/neu.2013.3221; Hanson E, 2015, GLIA, V63, P1784, DOI 10.1002/glia.22844; Hegen H, 2014, CLIN CHEM LAB MED, V52, P1335, DOI 10.1515/cclm-2014-0077; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Hui H, 2016, NEUROCHEM INT, V94, P23, DOI 10.1016/j.neuint.2016.02.002; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Ingram DK, 2011, EXP GERONTOL, V46, P148, DOI 10.1016/j.exger.2010.12.001; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Jang S, 2016, NEURON, V90, P278, DOI 10.1016/j.neuron.2016.03.011; JENNETT WB, 1960, J NEUROL NEUROSUR PS, V23, P295, DOI 10.1136/jnnp.23.4.295; Kalia VK, 2009, J CANCER RES THER, V5, P57, DOI 10.4103/0973-1482.55145; Kane A, 2010, PROBE REPORTS NIH MO; Kann O, 2016, NEUROBIOL DIS, V90, P75, DOI 10.1016/j.nbd.2015.08.005; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kawai N, 2008, ACTA NEUROCHIR SUPPL, V102, P241, DOI 10.1007/978-3-211-85578-2_46; Kim JA, 2018, ANN NEUROL, V83, P858, DOI 10.1002/ana.25211; Koenig JB, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00350; Kuruba R, 2018, BBA-MOL BASIS DIS, V1864, P2845, DOI 10.1016/j.bbadis.2018.05.016; Lee J, 1999, J NEUROSCI RES, V57, P48, DOI 10.1002/(SICI)1097-4547(19990701)57:1<48::AID-JNR6>3.3.CO;2-C; Lewis SR, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub5; Lian XY, 2007, J NEUROSCI, V27, P12007, DOI 10.1523/JNEUROSCI.3163-07.2007; Loup V, 2010, MOL HUM REPROD, V16, P111, DOI 10.1093/molehr/gap105; Lu KT, 2006, EUR J PHARMACOL, V548, P99, DOI 10.1016/j.ejphar.2006.07.048; Lujan B, 2016, J NEUROPHYSIOL, V116, P2523, DOI 10.1152/jn.00629.2016; Lundgaard I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7807; Lutas A, 2014, J NEUROSCI, V34, P16336, DOI 10.1523/JNEUROSCI.1357-14.2014; Ma H, 2012, CURR MOL MED, V12, P1282, DOI 10.2174/156652412803833517; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Martinez-Francois JR, 2018, ELIFE, V7, DOI 10.7554/eLife.32721; Milder J, 2012, EPILEPSY RES, V100, P295, DOI 10.1016/j.eplepsyres.2011.09.021; Minor RK, 2010, TOXICOL APPL PHARM, V243, P332, DOI 10.1016/j.taap.2009.11.025; Miwa H, 2013, ONCOL REP, V29, P2053, DOI 10.3892/or.2013.2299; Munoz-Manchado AB, 2018, CELL REP, V24, P2179, DOI 10.1016/j.celrep.2018.07.053; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Nichols J, 2018, J PHYSIOL-LONDON, V596, P1277, DOI 10.1113/JP275393; Paoli A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/474296; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; Raible DJ, 2015, EXP NEUROL, V271, P445, DOI 10.1016/j.expneurol.2015.07.001; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Rho JM, 2017, NEUROSCI LETT, V637, P4, DOI 10.1016/j.neulet.2015.07.034; Rogawski MA, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a022780; Samokhina E, 2017, J NEUROSCI RES, V95, P2195, DOI 10.1002/jnr.24019; Schierhout G, 1998, J NEUROL NEUROSUR PS, V64, P108, DOI 10.1136/jnnp.64.1.108; Schwaller B, 2004, MOL CELL NEUROSCI, V25, P650, DOI 10.1016/j.mcn.2003.12.006; Shao LR, 2017, J NEUROPHYSIOL, V118, P103, DOI 10.1152/jn.00100.2017; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shiga T, 2006, EUR J NUCL MED MOL I, V33, P817, DOI 10.1007/s00259-005-0033-y; Shintani H, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121821; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Simeone TA, 2018, NEUROPHARMACOLOGY, V133, P233, DOI 10.1016/j.neuropharm.2018.01.011; Stafstrom CE, 2008, EPILEPSIA, V49, P97, DOI 10.1111/j.1528-1167.2008.01848.x; Stafstrom CE, 2009, ANN NEUROL, V65, P435, DOI 10.1002/ana.21603; Staley K, 2015, NAT NEUROSCI, V18, P367, DOI 10.1038/nn.3947; Tekkok S, 1995, J NEUROPHYSIOL, V74, P2763, DOI 10.1152/jn.1995.74.6.2763; Terse PS, 2016, INT J TOXICOL, V35, P284, DOI 10.1177/1091581815624397; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Toth K, 2010, BRAIN, V133, P2763, DOI 10.1093/brain/awq149; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Wang FS, 2017, BRAIN STRUCT FUNCT, V222, P1543, DOI 10.1007/s00429-016-1292-z; Wang Q, 2018, P NATL ACAD SCI USA, V115, pE8104, DOI 10.1073/pnas.1812987115; Wei D, 2015, CNS NEUROSCI THER, V21, P52, DOI 10.1111/cns.12330; WICK AN, 1957, J BIOL CHEM, V224, P963; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Yang H, 2013, NEUROCHEM RES, V38, P677, DOI 10.1007/s11064-012-0958-z; Yellen G, 2008, EPILEPSIA, V49, P80, DOI 10.1111/j.1528-1167.2008.01843.x; Yellen G, 2018, J CELL BIOL, V217, P2235, DOI 10.1083/jcb.201803152; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zhang DS, 2014, CANCER LETT, V355, P176, DOI 10.1016/j.canlet.2014.09.003; Zhao YT, 1997, CAN J PHYSIOL PHARM, V75, P368, DOI 10.1139/cjpp-75-5-368; Zhou J, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00231	112	12	12	2	7	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA		2379-3708		JCI INSIGHT	JCI Insight	JUN 6	2019	4	11							e126506	10.1172/jci.insight.126506			19	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	IC0NU	WOS:000470657800009	31038473	Green Published, gold, Green Submitted			2022-02-06	
J	Franklin, W; Krishnan, B; Taglialatela, G				Franklin, Whitney; Krishnan, Balaji; Taglialatela, Giulio			Chronic synaptic insulin resistance after traumatic brain injury abolishes insulin protection from amyloid beta and tau oligomer-induced synaptic dysfunction	SCIENTIFIC REPORTS			English	Article							ALZHEIMERS-DISEASE; INTRANASAL INSULIN; DEMENTIA; IMPAIRMENT; COGNITION; SYNAPSES	Traumatic brain injury (TBI) is a risk factor for Alzheimer's disease (AD), although the mechanisms contributing to this increased risk are unknown. Insulin resistance is an additional risk factor for AD whereby decreased insulin signaling increases synaptic sensitivity to amyloid beta (A beta) and tau. Considering this, we used rats that underwent a lateral fluid percussion injury at acute and chronic time-points to investigate whether decreased insulin responsiveness in TBI animals is playing a role in synaptic vulnerability to AD pathology. We detected acute and chronic decreases in insulin responsiveness in isolated hippocampal synaptosomes after TBI. In addition to assessing both A beta and tau binding on synaptosomes, we performed electrophysiology to assess the dysfunctional impact of A beta and tau oligomers as well as the protective effect of insulin. While we saw no difference in binding or degree of LTP inhibition by either A beta or tau oligomers between sham and TBI animals, we found that insulin treatment was able to block oligomer-induced LTP inhibition in sham but not in TBI animals. Since insulin treatment has been discussed as a therapy for AD, this gives valuable insight into therapeutic implications of treating AD patients based on one's history of associated risk factors.	[Franklin, Whitney; Krishnan, Balaji; Taglialatela, Giulio] Univ Texas Med Branch, Dept Neurol, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA; [Franklin, Whitney] Univ Texas Med Branch, Dept Neurosci Cell Biol & Anat, Galveston, TX 77555 USA		Taglialatela, G (corresponding author), Univ Texas Med Branch, Dept Neurol, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA.	gtaglial@utmb.edu	Krishnan, Balaji/M-9914-2019	Krishnan, Balaji/0000-0003-2074-4165	NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG042890, F31AG057143]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG042890, F31AG057143] Funding Source: NIH RePORTER	This work was supported by grants from NIH/NIA: R01AG042890 to G.T. and F31AG057143 to W.F. We would like to thank Wen-Ru Zhang for her contribution to experiments that helped lead to the publication of this work.	Arnold SE, 2018, NAT REV NEUROL, V14, P168, DOI 10.1038/nrneurol.2017.185; Bedse G, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00204; Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019; Blazquez E, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00161; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Campdelacreu J, 2014, NEUROLOGIA, V29, P541, DOI 10.1016/j.nrl.2012.04.001; Cao L, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00417; Cerecedo-Lopez CD, 2014, MED HYPOTHESES, V82, P171, DOI 10.1016/j.mehy.2013.11.028; Chapman CD, 2018, NEUROPHARMACOLOGY, V136, P196, DOI 10.1016/j.neuropharm.2017.11.037; Clarke JR, 2018, J ALZHEIMERS DIS, V64, pS405, DOI 10.3233/JAD-179911; Comerota MM, 2019, MOL NEUROBIOL, V56, P3341, DOI 10.1007/s12035-018-1248-9; Comerota MM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15357-x; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; de la Monte S. M, 2012, CURRENT ALZHEIMER RE, V9; Fa M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19393; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Franklin W, 2016, J NEUROSCI METH, V261, P128, DOI 10.1016/j.jneumeth.2016.01.006; Frozza RL, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00037; Hsu WCJ, 2017, EXP NEUROL, V295, P1, DOI 10.1016/j.expneurol.2017.05.005; Karelina K, 2016, EUR J NEUROSCI, V43, P1034, DOI 10.1111/ejn.13194; Krishnan Balaji, 2018, Alzheimers Dement (N Y), V4, P89, DOI 10.1016/j.trci.2018.01.002; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Lee CC, 2009, NEUROBIOL AGING, V30, P377, DOI 10.1016/j.neurobiolaging.2007.06.014; Ley EJ, 2011, J TRAUMA, V70, P1141, DOI 10.1097/TA.0b013e3182146d66; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; McNay EC, 2010, NEUROBIOL LEARN MEM, V93, P546, DOI 10.1016/j.nlm.2010.02.002; Novak V, 2014, DIABETES CARE, V37, P751, DOI 10.2337/dc13-1672; Puig KL, 2016, NEUROBIOL AGING, V40, P22, DOI 10.1016/j.neurobiolaging.2015.12.021; Puzzo D, 2017, ELIFE, V6, DOI 10.7554/eLife.26991; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reddy PH, 2010, J ALZHEIMERS DIS, V20, pS499, DOI 10.3233/JAD-2010-100504; Reese LC, 2008, AGING CELL, V7, P824, DOI 10.1111/j.1474-9726.2008.00434.x; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Rodriguez-Rivera J, 2011, BEHAV BRAIN RES, V216, P255, DOI 10.1016/j.bbr.2010.08.002; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004; Stanley M, 2016, J EXP MED, V213, P1375, DOI 10.1084/jem.20160493; Swerdlow RH, 2009, EXP NEUROL, V218, P308, DOI 10.1016/j.expneurol.2009.01.011; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Titus DJ, 2016, J NEUROSCI, V36, P7095, DOI 10.1523/JNEUROSCI.3212-15.2016; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Veitch DP, 2013, CURR ALZHEIMER RES, V10, P907, DOI 10.2174/15672050113109990142; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; White TE, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2412-0; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5	51	12	13	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 3	2019	9								8228	10.1038/s41598-019-44635-z			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	IA9YJ	WOS:000469913200008	31160730	gold, Green Published			2022-02-06	
J	Agoston, DV; Vink, R; Helmy, A; Risling, M; Nelson, D; Prins, M				Agoston, Denes, V; Vink, Robert; Helmy, Adel; Risling, Marten; Nelson, David; Prins, Mayumi			How to Translate Time: The Temporal Aspects of Rodent and Human Pathobiological Processes in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						axon; edema; glucose; inflammation; timeline	DIFFUSE AXONAL INJURY; CEREBRAL GLUCOSE-UTILIZATION; LONG-TERM CONSEQUENCES; BARRIER DISRUPTION; MICROGLIAL ACTIVATION; CELLULAR EDEMA; ANIMAL-MODELS; INTRACRANIAL-PRESSURE; CORTICAL CONTUSION; CLINICAL-TRIAL	Traumatic brain injury (TBI) triggers multiple pathobiological responses with differing onsets, magnitudes, and durations. Identifying the therapeutic window of individual pathologies is critical for successful pharmacological treatment. Dozens of experimental pharmacotherapies have been successfully tested in rodent models, yet all of them (to date) have failed in clinical trials. The differing time scales of rodent and human biological and pathological processes may have contributed to these failures. We compared rodent versus human time scales of TBI-induced changes in cerebral glucose metabolism, inflammatory processes, axonal integrity, and water homeostasis based on published data. We found that the trajectories of these pathologies run on different timescales in the two species, and it appears that there is no universal "conversion rate" between rodent and human pathophysiological processes. For example, the inflammatory process appears to have an abbreviated time scale in rodents versus humans relative to cerebral glucose metabolism or axonal pathologies. Limitations toward determining conversion rates for various pathobiological processes include the use of differing outcome measures in experimental and clinical TBI studies and the rarity of longitudinal studies. In order to better translate time and close the translational gap, we suggest 1) using clinically relevant outcome measures, primarily in vivo imaging and blood-based proteomics, in experimental TBI studies and 2) collecting data at multiple post-injury time points with a frequency exceeding the expected information content by two or three times. Combined with a big data approach, we believe these measures will facilitate the translation of promising experimental treatments into clinical use.	[Agoston, Denes, V] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Vink, Robert] Univ South Australia, Div Hlth Sci, Adelaide, SA, Australia; [Helmy, Adel] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Risling, Marten] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Nelson, David] Karolinska Inst, Sect Perioperat Med & Intens Care, Dept Physiol & Pharmacol, Stockholm, Sweden; [Prins, Mayumi] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA		Agoston, DV (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	denes.agoston@usuhs.edu	Helmy, Adel/AAS-3084-2020	Helmy, Adel/0000-0002-0531-0556; Nelson, David/0000-0003-2530-8207	Royal College of Surgeons of England [RG90200]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0802251]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0802251] Funding Source: UKRI	Dr. Adel Helmy acknowledges funding support from the Royal College of Surgeons of England (RG90200) and the Medical Research Council (G0802251). The authors thank Ms. Alaa Kamnaksh for her editorial assistance.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Agostoe DV, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00047; Agoston D.V., 2017, FRONT NEUROL, V18, P1; Agoston Denes V, 2017, Concussion, V2, pCNC45, DOI 10.2217/cnc-2016-0013; Agoston DV, 2018, BEHAV BRAIN RES, V340, P172, DOI 10.1016/j.bbr.2017.04.018; Agoston DV, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00091; Agoston Denes V, 2012, Front Neurol, V3, P3, DOI 10.3389/fneur.2012.00003; Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Alberts Bruce, 2016, F1000Res, V5, P135, DOI 10.12688/f1000research.7847.1; Ayata C, 2002, J CLIN NEUROSCI, V9, P113, DOI 10.1054/jocn.2001.1031; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Barzo P, 1997, ACT NEUR S, V70, P119; Bayley MT, 2014, J HEAD TRAUMA REHAB, V29, P268, DOI 10.1097/HTR.0000000000000053; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bhatia A, 2007, INTENS CARE MED, V33, P1263, DOI 10.1007/s00134-007-0678-z; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; BULLOCK R, 1990, ACT NEUR S, V51, P286; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Byrne AB, 2014, NEURON, V81, P561, DOI 10.1016/j.neuron.2013.11.019; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Castejon OJ, 2013, FOLIA NEUROPATHOL, V51, P93, DOI 10.5114/fn.2013.35951; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Chugani HT, 1998, PREV MED, V27, P184, DOI 10.1006/pmed.1998.0274; Cosi C, 1998, BRAIN RES, V809, P58, DOI 10.1016/S0006-8993(98)00829-4; Cox AL, 2006, J NEUROIMMUNOL, V174, P180, DOI 10.1016/j.jneuroim.2006.01.007; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Davceva N, 2015, AM J FOREN MED PATH, V36, P127, DOI 10.1097/PAF.0000000000000168; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; Deselms H, 2016, J NEUROSCI METH, V272, P69, DOI 10.1016/j.jneumeth.2016.02.002; Dhawan V, 2012, J NEUROINTERV SURG, V4, P407, DOI 10.1136/neurintsurg-2011-010158; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Girouard MP, 2018, DEV NEUROBIOL, V78, P978, DOI 10.1002/dneu.22627; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; GRAFE MR, 1980, J NEUROPATH EXP NEUR, V39, P555, DOI 10.1097/00005072-198009000-00005; Grenander U., 1959, NYQUIST FREQUENCY SA, V1; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; Hamberger A, 2003, J NEUROTRAUM, V20, P169, DOI 10.1089/08977150360547080; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; HARADA M, 1992, ANESTHESIOLOGY, V77, P728, DOI 10.1097/00000542-199210000-00017; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Helmy A, 2016, J CEREBR BLOOD F MET, V36, P1434, DOI 10.1177/0271678X15620204; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Ho KM, 2014, J NEUROSURG, V121, P674, DOI 10.3171/2014.6.JNS132838; Horvat CM, 2017, JAMA PEDIATR, V171, P942, DOI 10.1001/jamapediatrics.2017.2390; Hudak AM, 2014, BRAIN INJURY, V28, P1602, DOI 10.3109/02699052.2014.936039; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; Jaerve A, 2011, EXP NEUROL, V231, P284, DOI 10.1016/j.expneurol.2011.07.002; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Ko SB, 2013, J STROKE, V15, P99, DOI 10.5853/jos.2013.15.2.99; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Lavisse S, 2012, J NEUROSCI, V32, P10809, DOI 10.1523/JNEUROSCI.1487-12.2012; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Lollis S Scott, 2008, Handb Clin Neurol, V90, P217, DOI 10.1016/S0072-9752(07)01712-5; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Martinez-Morillo E, 2015, CLIN CHEM LAB MED, V53, P1575, DOI 10.1515/cclm-2014-0908; McGinn Melissa J, 2015, Handb Clin Neurol, V127, P67, DOI 10.1016/B978-0-444-52892-6.00005-2; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; McGonigle P, 2014, BIOCHEM PHARMACOL, V87, P162, DOI 10.1016/j.bcp.2013.08.006; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Nag S, 2007, ACTA NEUROPATHOL, V114, P459, DOI 10.1007/s00401-007-0274-x; Newcombe VFJ, 2016, NEUROREHAB NEURAL RE, V30, P49, DOI 10.1177/1545968315584004; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Perez-Barcena J, 2011, CRIT CARE MED, V39, P533, DOI 10.1097/CCM.0b013e318205c7a4; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Prins ML, 2012, EPILEPSY RES, V100, P218, DOI 10.1016/j.eplepsyres.2011.09.027; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Prins ML, 2001, J NEUROTRAUM, V18, P31, DOI 10.1089/089771501750055758; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Roberts DJ, 2013, J NEUROTRAUM, V30, P1727, DOI 10.1089/neu.2012.2842; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00091; Russo MV, 2018, NAT IMMUNOL, V19, P442, DOI 10.1038/s41590-018-0086-2; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sanchez Jose J, 2013, Acta Neurochir Suppl, V118, P223, DOI 10.1007/978-3-7091-1434-6_42; Saw MM, 2014, NEUROCRIT CARE, V20, P209, DOI 10.1007/s12028-013-9933-z; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schoknecht K, 2012, EPILEPSIA, V53, P7, DOI 10.1111/j.1528-1167.2012.03697.x; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Shibahashi K, 2016, J NEUROTRAUM, V33, P1826, DOI 10.1089/neu.2015.4237; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith C, 2013, NEUROPATH APPL NEURO, V39, P35, DOI 10.1111/nan.12006; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Smith M, 2018, ANESTHESIOLOGY, V128, P401, DOI 10.1097/ALN.0000000000001885; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Stocchetti N, 2013, CRIT CARE, V17, DOI 10.1186/cc11513; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Su E., 2016, TRANSLATIONAL RES TR; SUTTON RL, 1994, ACTA NEUROCHIR, P446; Talevi A, 2012, MINI-REV MED CHEM, V12, P959, DOI 10.2174/138955712802762356; Tenkova Tatyana I., 2007, V399, P31, DOI 10.1007/978-1-59745-504-6_3; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Tshibanda L, 2009, PROG BRAIN RES, V177, P215, DOI 10.1016/S0079-6123(09)17715-4; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vilalta A, 2008, INTENS CARE MED, V34, P1384, DOI 10.1007/s00134-008-1056-1; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; Vivash L, 2016, J NUCL MED, V57, P165, DOI 10.2967/jnumed.114.141713; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Wang Y, 2014, EUR J NUCL MED MOL I, V41, P1440, DOI 10.1007/s00259-014-2727-5; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yang SD, 2014, AM J FOREN MED PATH, V35, P201, DOI 10.1097/PAF.0000000000000103; Yarnell Angela M, 1800, Curr Protoc Neurosci, V75, DOI 10.1002/cpns.10; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Young GB, 2010, CRIT CARE MED, V38, P325, DOI 10.1097/CCM.0b013e3181bfeb89; Zeiler FA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00331	154	12	12	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2019	36	11					1724	1737		10.1089/neu.2018.6261			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IB1EQ	WOS:000470007600003	30628544	Green Published, Green Submitted			2022-02-06	
J	Barmparas, G; Kobayashi, L; Dhillon, NK; Patel, KA; Ley, EJ; Coimbra, R; Margulies, DR				Barmparas, Galinos; Kobayashi, Leslie; Dhillon, Navpreet K.; Patel, Kavita A.; Ley, Eric J.; Coimbra, Raul; Margulies, Daniel R.			The risk of delayed intracranial hemorrhage with direct acting oral anticoagulants after trauma: A two-center study	AMERICAN JOURNAL OF SURGERY			English	Article						Oral anticoagulants; Delayed intracranial hemorrhage; Traumatic brain injury; NOACs; DOACs	ATRIAL-FIBRILLATION; COST-EFFECTIVENESS; HEAD TRAUMA; PRESCRIPTION; PREVENTION; PATIENT; INJURY; STROKE; TRENDS	Background: The aim of this study was to characterize the risk of a delayed intracranial hemorrhage (ICH) in trauma patients on direct-acting oral anticoagulants (DOACs). Methods: Patients on DOACs admitted to two Level I Trauma Centers between 2014 and 2017 were reviewed. Only patients with a negative admission CT brain were included. The primary outcome was a delayed ICH. Results: Overall, 249 patients were included. The median age was 81 years with 82% undergoing a repeat CT. Three patients developed a delayed ICH (1.2%). One developed an ICH after receiving tissue plasminogen activator for a cerebrovascular accident after two negative CTs. Excluding this patient, the incidence dropped to 0.8%. None required neurosurgical intervention. Conclusion: For patients at risk for a TBI who are on DOACs, repeat cross-sectional imaging of the brain when the initial imaging is negative is not necessary. A period of clinical observation may be warranted. (C) 2018 Elsevier Inc. All rights reserved.	[Barmparas, Galinos; Dhillon, Navpreet K.; Patel, Kavita A.; Ley, Eric J.; Margulies, Daniel R.] Cedars Sinai Med Ctr, Div Acute Care Surg & Surg Crit Care, Dept Surg, Los Angeles, CA 90048 USA; [Kobayashi, Leslie; Coimbra, Raul] Univ Calif San Diego, Div Trauma Surg Crit Care Burns & Acute Care Surg, Dept Surg, San Diego, CA 92103 USA		Barmparas, G (corresponding author), Cedars Sinai Med Ctr, Dept Surg, 8635 W 3rd St,Suite 650W, Los Angeles, CA 90048 USA.	Galinos.Barmparas@cshs.org	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851			Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; Alrajhi KN, 2015, J EMERG MED, V48, P137, DOI 10.1016/j.jemermed.2014.08.016; American College of Surgeons, 2016, NTDB REP PUBL; Bennett D, 2015, J UNIV TEACH LEARN P, V12; Chenoweth JA, 2018, JAMA SURG, V153, P570, DOI 10.1001/jamasurg.2017.6159; DiFiori M, 2016, CRIT CARE MED, V44; Docimo S, 2014, AM SURGEON, V80, P610; Ferrera PC, 1999, AM J EMERG MED, V17, P154, DOI 10.1016/S0735-6757(99)90050-5; Friberg L, 2013, J Intern Med, V274, P461, DOI 10.1111/joim.12114; Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Gulati D, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00080; Hobbs FDR, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9400; Karni A, 2001, AM SURGEON, V67, P1098; Kobayashi L, 2017, J TRAUMA ACUTE CARE, V82, P827, DOI 10.1097/TA.0000000000001414; Loo SY, 2017, BRIT J CLIN PHARMACO, V83, P2096, DOI 10.1111/bcp.13299; Miller J, 2015, J TRAUMA ACUTE CARE, V79, P310, DOI 10.1097/TA.0000000000000725; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Monaco L, 2017, BRIT J CLIN PHARMACO, V83, P1532, DOI 10.1111/bcp.13234; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Raskob GE, 2018, NEW ENGL J MED, V378, P615, DOI 10.1056/NEJMoa1711948; Sterne JAC, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21090; Study Group on Head Injury of the Italian Society for Neurosurgery, 1996, J NEUROSURG SCI, V40, P11; Weitz JI, 2015, CLIN THER, V37, P2506, DOI 10.1016/j.clinthera.2015.09.008; Williams TM, 2008, J TRAUMA, V65, P772, DOI 10.1097/TA.0b013e3181877ff7; Yu AYX, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007129	27	12	12	0	1	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	JUN	2019	217	6					1051	1054		10.1016/j.amjsurg.2018.10.016			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	HZ3II	WOS:000468741300013	30336936				2022-02-06	
J	Damani, R; Mayer, S; Dhar, R; Martin, RH; Nyquist, P; Olson, DM; Mejia-Mantilla, JH; Muehlschlegel, S; Jauch, EC; Mocco, J; Mutoh, T; Suarez, JI; Macdonald, RL; Amin-Hanjani, S; Brown, RD; Manoel, ALD; Derdeyn, CP; Etminan, N; Keller, E; LeRoux, PD; Mayer, S; Morita, A; Rinkel, G; Rufennacht, D; Stienen, MN; Torner, J; Vergouwen, MDI; Wong, GKC; Bijlenga, P; Ko, N; McDougall, CG; Mocco, J; Murayama, Y; Werner, MJH; Mayer, S; Suarez, JI; Damani, R; Broderick, J; Dhar, R; Jauch, EC; Kirkpatrick, PJ; Martin, RH; Mocco, J; Muehlschlegel, S; Mutoh, T; Nyquist, P; Olson, D; Mejia-Mantilla, JH; Amin-Hanjani, S; Manoel, ALD; van der Jagt, M; Bambakidis, N; Brophy, G; Bulsara, K; Claassen, J; Connolly, ES; Hoffer, SA; Hoh, BL; Holloway, RG; Kelly, A; Mayer, S; Nakaji, P; Rabinstein, A; Suarez, JI; Vajkoczy, P; Vergouwen, MDI; Woo, H; Zipfel, GJ; Keller, E; Macdonald, RL; Chou, S; Dore, S; Dumont, AS; Gunel, M; Kasuya, H; Roederer, A; Ruigrok, Y; Vespa, PM; Sarrafzadeh-Khorrasani, AS; Derdeyn, CP; Etminan, N; Hackenberg, K; Huston, J; Krings, T; Lanzino, G; Meyers, PM; Rinkel, G; Rufennacht, D; Wintermark, M; Torner, J; Wong, GKC; Broderick, J; Daly, J; Ogilvy, C; Rhoney, DH; Roos, YB; Siddiqui, A; Etminan, N; Rinkel, G; Hackenberg, K; Algra, A; Frosen, J; Hasan, D; Juvela, S; Langer, DJ; Meyers, PM; Morita, A; Salman, RA; Stienen, MN; Vergouwen, MDI; Hanggi, D; Macdonald, RL; Schweizer, T; Visser-Meily, J; Amos, L; Ludet, C; Moy, C; Odenkirchen, J; Ala'i, S; Esterlitz, J; Joseph, K; Sheikh, M				Damani, Rahul; Mayer, Stephan; Dhar, Raj; Martin, Renee H.; Nyquist, Paul; Olson, DaiWai M.; Mejia-Mantilla, Jorge H.; Muehlschlegel, Susanne; Jauch, Edward C.; Mocco, J.; Mutoh, Tatsushi; Suarez, Jose I.; Macdonald, R. Loch; Amin-Hanjani, Sepideh; Brown, Robert D., Jr.; Manoel, Airton Leonardo de Oliveira; Derdeyn, Colin P.; Etminan, Nima; Keller, Emanuela; LeRoux, Peter D.; Mayer, Stephan; Morita, Akio; Rinkel, Gabriel; Rufennacht, Daniel; Stienen, Martin N.; Torner, James; Vergouwen, Mervyn D. I.; Wong, George K. C.; Bijlenga, Philippe; Ko, Nerissa; McDougall, Cameron G.; Mocco, J.; Murayama, Yuuichi; Werner, Marieke J. H.; Mayer, Stephan; Suarez, Jose I.; Damani, Rahul; Broderick, Joseph; Dhar, Raj; Jauch, Edward C.; Kirkpatrick, Peter J.; Martin, Renee H.; Mocco, J.; Muehlschlegel, Susanne; Mutoh, Tatsushi; Nyquist, Paul; Olson, Daiwai; Mejia-Mantilla, Jorge H.; Amin-Hanjani, Sepideh; Manoel, Airton Leonardo de Oliveira; van der Jagt, Mathieu; Bambakidis, Nicholas; Brophy, Gretchen; Bulsara, Ketan; Claassen, Jan; Connolly, E. Sander; Hoffer, S. Alan; Hoh, Brian L.; Holloway, Robert G.; Kelly, Adam; Mayer, Stephan; Nakaji, Peter; Rabinstein, Alejandro; Suarez, Jose I.; Vajkoczy, Peter; Vergouwen, Mervyn D. I.; Woo, Henry; Zipfel, Gregory J.; Keller, Emanuela; Macdonald, R. Loch; Chou, Sherry; Dore, Sylvain; Dumont, Aaron S.; Gunel, Murat; Kasuya, Hidetoshi; Roederer, Alexander; Ruigrok, Ynte; Vespa, Paul M.; Sarrafzadeh-Khorrasani, Asita Simone; Derdeyn, Colin P.; Etminan, Nima; Hackenberg, Katharina; Huston, John, III; Krings, Timo; Lanzino, Giuseppe; Meyers, Philip M.; Rinkel, Gabriel; Rufennacht, Daniel; Wintermark, Max; Torner, James; Wong, George K. C.; Broderick, Joseph; Daly, Janis; Ogilvy, Christopher; Rhoney, Denise H.; Roos, Y. B.; Siddiqui, Adnan; Etminan, Nima; Rinkel, Gabriel; Hackenberg, Katharina; Algra, Ale; Frosen, Juhanna; Hasan, David; Juvela, Seppo; Langer, David J.; Meyers, Philip M.; Morita, Akio; Salman, Rustam Al-Shahi; Stienen, Martin N.; Vergouwen, Mervyn D. I.; Hanggi, Daniel; Macdonald, R. Loch; Schweizer, Tom; Visser-Meily, Johanna; Amos, Liz; Ludet, Christophe; Moy, Claudia; Odenkirchen, Joanne; Ala'i, Sherita; Esterlitz, Joy; Joseph, Kristen; Sheikh, Muniza		Unruptured Intracranial Aneurysms	Common Data Element for Unruptured Intracranial Aneurysm and Subarachnoid Hemorrhage: Recommendations from Assessments and Clinical Examination Workgroup/Subcommittee	NEUROCRITICAL CARE			English	Article						Subarachnoid hemorrhage; Aneurysm; Clinical studies; Common data elements; Assessments; Clinical examination; Standardization; Hemorrhagic stroke; World Federation of Neurological Societies; Glasgow Coma Scale; Data coding; Data collection	GLASGOW COMA SCALE; WORLD-FEDERATION; GRADING SCALES; PREDICTION; VARIABILITY; PROGNOSIS; VASOSPASM; SYSTEM; RISK; TIME	BackgroundClinical studies of subarachnoid hemorrhage (SAH) and unruptured cerebral aneurysms lack uniformity in terms of variables used for assessments and clinical examination of patients which has led to difficulty in comparing studies and performing meta-analyses. The overall goal of the National Institute of Health/National Institute of Neurological Disorders and Stroke Unruptured Intracranial Aneurysms (UIA) and subarachnoid hemorrhage (SAH) Common Data Elements (CDE) Project was to provide common definitions and terminology for future unruptured intracranial aneurysm and SAH research.MethodsThis paper summarizes the recommendations of the subcommittee on SAH Assessments and Clinical Examination. The subcommittee consisted of an international and multidisciplinary panel of experts in UIA and SAH. Consensus recommendations were developed by reviewing previously published CDEs for other neurological diseases including traumatic brain injury, epilepsy and stroke, and the SAH literature. Recommendations for CDEs were classified by priority into core, supplementalhighly recommended, supplemental and exploratory.ResultsWe identified 248 variables for Assessments and Clinical Examination. Only the World Federation of Neurological Societies grading scale was classified as Core. The Glasgow Coma Scale was classified as SupplementalHighly Recommended. All other Assessments and Clinical Examination variables were categorized as Supplemental.ConclusionThe recommended Assessments and Clinical Examination variables have been collated from a large number of potentially useful scales, history, clinical presentation, laboratory, and other tests. We hope that adherence to these recommendations will facilitate the comparison of results across studies and meta-analyses of individual patient data.	[Damani, Rahul] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Mayer, Stephan] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Dhar, Raj] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Martin, Renee H.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Nyquist, Paul; Suarez, Jose I.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Neurosci Crit Care, 1800 Orleans St,Zayed 3014C, Baltimore, MD 21287 USA; [Nyquist, Paul; Suarez, Jose I.] Johns Hopkins Univ, Sch Med, Dept Neurol, Neurosci Crit Care, 1800 Orleans St,Zayed 3014C, Baltimore, MD 21287 USA; [Nyquist, Paul; Suarez, Jose I.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Neurosci Crit Care, 1800 Orleans St,Zayed 3014C, Baltimore, MD 21287 USA; [Olson, DaiWai M.] UT Southwestern Med Ctr, Dept Neurol & Neurotherapeut, Dallas, TX USA; [Mejia-Mantilla, Jorge H.] Fdn Valle del Lili, Cali, Colombia; [Muehlschlegel, Susanne] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA; [Jauch, Edward C.] Med Univ South Carolina, Dept Emergency Med, Charleston, SC 29425 USA; [Mocco, J.] Icahn Sch Med Mt Sinai, Dept Neurosurg, New York, NY 10029 USA; [Mutoh, Tatsushi] Res Inst Brain & Blood Vessels, Dept Neurol Surg, Akita, Japan; [Suarez, Jose I.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Macdonald, R. Loch] Univ Toronto, Toronto, ON, Canada; [Amin-Hanjani, Sepideh] Univ Illinois, Chicago, IL USA; [Brown, Robert D., Jr.] Mayo Clin, Rochester, MN USA; [Manoel, Airton Leonardo de Oliveira] Univ Toronto, Toronto, ON, Canada; [Derdeyn, Colin P.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Etminan, Nima] Univ Hosp Mannheim, Mannheim, Germany; [Keller, Emanuela] Univ Zurich, Zurich, Switzerland; [LeRoux, Peter D.] Main Line Hlth, Wynnewood, PA USA; [Mayer, Stephan] Henry Ford Hosp, Detroit, MI 48202 USA; [Morita, Akio] Nippon Med Sch, Tokyo, Japan; [Rinkel, Gabriel] Univ Med Ctr, Utrecht, Netherlands; [Rufennacht, Daniel] Klin Hirslanden, Zurich, Switzerland; [Stienen, Martin N.] Univ Zurich, FEBNS, Zurich, Switzerland; [Torner, James] Univ Iowa, Iowa City, IA USA; [Vergouwen, Mervyn D. I.] Univ Med Ctr, Utrecht, Netherlands; [Wong, George K. C.] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; [Brown, Robert D., Jr.] Mayo Clin, Rochester, MN USA; [Morita, Akio] Nippon Med Sch, Tokyo, Japan; [Bijlenga, Philippe] Geneva Univ Hosp, Geneva, Switzerland; [Mayer, Stephan] Henry Ford Hosp, Detroit, MI 48202 USA; [Suarez, Jose I.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Damani, Rahul] Baylor Coll Med, Houston, TX 77030 USA; [Amin-Hanjani, Sepideh] Univ Illinois, Chicago, IL USA; [Manoel, Airton Leonardo de Oliveira] Univ Toronto, Toronto, ON, Canada; [van der Jagt, Mathieu] Erasmus MC, Rotterdam, Netherlands; [Keller, Emanuela] Univ Zurich, Zurich, Switzerland; [Macdonald, R. Loch] Univ Toronto, Toronto, ON, Canada; [Derdeyn, Colin P.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Etminan, Nima] Univ Hosp Mannheim, Mannheim, Germany; [Hackenberg, Katharina] Univ Hosp Mannheim, Mannheim, Germany; [Torner, James] Univ Iowa, Iowa City, IA USA; [Wong, George K. C.] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; [Etminan, Nima] Univ Hosp Mannheim, Mannheim, Germany; [Rinkel, Gabriel] Univ Med Ctr, Utrecht, Netherlands; [Hackenberg, Katharina] Univ Hosp Mannheim, Mannheim, Germany; [Stienen, Martin N.] Univ Zurich, FEBNS, Zurich, Switzerland; [Vergouwen, Mervyn D. I.] Univ Med Ctr, Utrecht, Netherlands; [Amos, Liz] Natl Lib Med, Natl Informat Ctr Hlth Serv Res & Hlth Care Techn, Bethesda, MD USA; [Ludet, Christophe] Natl Lib Med, Bethesda, MD USA; [Moy, Claudia; Odenkirchen, Joanne] NINDS, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Ala'i, Sherita; Esterlitz, Joy; Joseph, Kristen; Sheikh, Muniza] Emmes Corp, Rockville, MD USA		Suarez, JI (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Neurosci Crit Care, 1800 Orleans St,Zayed 3014C, Baltimore, MD 21287 USA.; Suarez, JI (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Neurosci Crit Care, 1800 Orleans St,Zayed 3014C, Baltimore, MD 21287 USA.; Suarez, JI (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Neurosci Crit Care, 1800 Orleans St,Zayed 3014C, Baltimore, MD 21287 USA.	jsuarez5@jhmi.edu	Dore, Sylvain/AAG-1470-2020; Claassen, Jan/AAA-5451-2020; de Oliveira Manoel, Airton Leonardo/C-4724-2018; Olson, DaiWai/I-5932-2019; Wong, George Kwok Chu/L-4344-2016; DAMANI, RAHUL/R-7012-2018; van der Jagt, Mathieu/G-1905-2017	de Oliveira Manoel, Airton Leonardo/0000-0002-9593-1013; Olson, DaiWai/0000-0002-9280-078X; Al-Shahi Salman, Rustam/0000-0002-2108-9222; Morita, Akio/0000-0002-2497-5772; DAMANI, RAHUL/0000-0001-7990-0965; van der Jagt, Mathieu/0000-0003-2566-8325; Derdeyn, Colin/0000-0002-5932-2683	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HHSN271201200034C]	Logistical support for this project was provided in part through NIH Contract HHSN271201200034C, the Intramural Research Program of the NIH, NLM, The Neurocritical Care Society and the CHI Baylor St. Luke's Medical Center in Houston, TX.	Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; Degen LAR, 2011, STROKE, V42, P1546, DOI 10.1161/STROKEAHA.110.601211; DRAKE CG, 1988, J NEUROSURG, V68, P985; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; FUJITA S, 1985, NEUROSURGERY, V17, P609, DOI 10.1227/00006123-198510000-00013; Galea JP, 2017, STROKE, V48, P2958, DOI 10.1161/STROKEAHA.117.017777; Gotoh O, 1996, NEUROSURGERY, V39, P19, DOI 10.1097/00006123-199607000-00005; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Jaja BNR, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5745; Jaja BNR, 2013, NEUROCRIT CARE, V18, P143, DOI 10.1007/s12028-012-9792-z; KENNEDY F, 1993, J TRAUMA, V35, P75, DOI 10.1097/00005373-199307000-00013; Kirkpatrick PJ, 2014, LANCET NEUROL, V13, P666, DOI 10.1016/S1474-4422(14)70084-5; Loring DW, 2011, EPILEPSIA, V52, P1186, DOI 10.1111/j.1528-1167.2011.03018.x; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; MASE G, 1995, ACTA NEUROL SCAND, V91, P306, DOI 10.1111/j.1600-0404.1995.tb07011.x; Mees SMD, 2012, LANCET, V380, P44, DOI 10.1016/S0140-6736(12)60724-7; MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Ogilvy CS, 1998, NEUROSURGERY, V42, P959, DOI 10.1097/00006123-199805000-00001; Oshiro EM, 1997, NEUROSURGERY, V41, P140, DOI 10.1097/00006123-199707000-00029; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; POLIN RS, 1995, NEUROSURG CLIN N AM, V6, P689; ROCCA B, 1989, J TRAUMA, V29, P299, DOI 10.1097/00005373-198903000-00004; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; Saver JL, 2012, STROKE, V43, P967, DOI 10.1161/STROKEAHA.111.634352; Siironen J, 2003, J NEUROSURG, V99, P953, DOI 10.3171/jns.2003.99.6.0953; Suarez JI, 2019, NEUROCRIT CARE; TEASDALE G, 1978, J NEUROL NEUROSUR PS, V41, P603, DOI 10.1136/jnnp.41.7.603; VANGIJN J, 1994, STROKE, V25, P1623, DOI 10.1161/01.STR.25.8.1623; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3	32	12	12	3	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2019	30			1			28	35		10.1007/s12028-019-00736-1			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IF3IS	WOS:000472974700004	31090013				2022-02-06	
J	Hanlon, LA; Raghupathi, R; Huh, JW				Hanlon, Lauren A.; Raghupathi, Ramesh; Huh, Jimmy W.			Depletion of microglia immediately following traumatic brain injury in the pediatric rat: Implications for cellular and behavioral pathology	EXPERIMENTAL NEUROLOGY			English	Article						Pediatric TBI; Microglia; Clodronate; Neurodegeneration; Spatial learning; Cortical activity	CEREBROSPINAL-FLUID; UNITED-STATES; AXONAL INJURY; MOUSE MODEL; MINOCYCLINE; ACTIVATION; CHILDREN; MACROPHAGE; MODERATE; CELLS	The inflammatory response is a significant component of the pathophysiology of pediatric traumatic brain injury. High levels of inflammatory mediators have been found in the cerebrospinal fluid of brain-injured children which have been linked to poor prognosis. Targeting aspects of the inflammatory response in the hopes of finding a viable post-injury therapeutic option has gained attention. Microglia are largely responsible for perpetuating the injury-induced inflammatory response but in the developing brain they play beneficial roles in both normal and disease states. Following closed head injury in the neonate rat, depletion of microglia with intracerebral injections of liposomes containing clodronate was associated with an increase in neurodegeneration in the early post-injury period (3 days) relative to those injected with empty liposomes suggestive of a decrease in clearance of dying cells. In sham-injured animals, microglia repopulated the clodrosome-mediated depleted brain regions over a period of 2-4 weeks and exhibited morphology typical of a resting phenotype. In brain-injured animals, the repopulated microglia in clodrosome-injected animals exhibited rod-like and amoeboid morphologies. However, fluoro-Jade B reactivity in these brain regions was more extensive than in empty liposome-injected animals suggesting that the active microglia may be unable to clear dying neurons. This was accompanied by an induction of hyperexcitability in the local cortical circuitry. Depletion of microglia within the white matter tracts and the thalamus did not affect the extent of injury-induced traumatic axonal injury. Increased neurodegeneration in the dorsal subiculum was not accompanied by any changes to injury-induced deficits in spatial learning and memory. These data suggest that activation of microglia may be important for removal of dying neurons in the traumatically-injured immature brain.	[Hanlon, Lauren A.; Raghupathi, Ramesh] Drexel Univ, Grad Sch Biomed Sci & Profess Studies, Program Neurosci, Philadelphia, PA 19104 USA; [Raghupathi, Ramesh] Drexel Univ, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA; [Hanlon, Lauren A.] Univ Penn, Perelman Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Huh, Jimmy W.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care, Wood Bldg 6th Floor,Rm 6035,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA		Huh, JW (corresponding author), Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care, Wood Bldg 6th Floor,Rm 6035,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.; Raghupathi, R (corresponding author), Drexel Univ, Coll Med, Dept Neurobiol & Anat, 2900 Queen Lane, Philadelphia, PA 19129 USA.	RR79@drexel.edu; huh@email.chop.edu	Raghupathi, Ramesh/AAX-5538-2021		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD-061963]; Biomedical Studies Graduate Student Association	The studies were supported, in part, by grants from the National Institutes of Health HD-061963 (RR, JWH) and a fellowship from the Biomedical Studies Graduate Student Association (LAH).	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Bennett RE, 2014, J NEUROTRAUM, V31, P1647, DOI 10.1089/neu.2013.3320; Berger RP, 2004, J NEUROTRAUM, V21, P1123; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Catroppa C, 2006, Pediatr Rehabil, V9, P89, DOI 10.1080/13638490500155458; Centers for Disease and Control, 2016, INJ PREV CONTR TRAUM; Chhor V, 2017, BRAIN BEHAV IMMUN, V63, P197, DOI 10.1016/j.bbi.2016.11.001; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; Domingues HS, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00071; Drabek T, 2012, RESUSCITATION, V83, P517, DOI 10.1016/j.resuscitation.2011.09.016; Emami P, 2017, J NEUROSURG, V126, P760, DOI 10.3171/2016.1.JNS152385; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Faul M, 2010, TRAUMATIC BRAIN INJU; Faustino JV, 2011, J NEUROSCI, V31, P12992, DOI 10.1523/JNEUROSCI.2102-11.2011; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hanlon LA, 2017, EXP NEUROL, V290, P1, DOI 10.1016/j.expneurol.2016.12.010; Hanlon LA, 2016, J NEUROPATH EXP NEUR, V75, P214, DOI 10.1093/jnen/nlv021; Harry GJ, 2012, NEUROTOXICOLOGY, V33, P191, DOI 10.1016/j.neuro.2012.01.012; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Kotter MR, 2005, NEUROBIOL DIS, V18, P166, DOI 10.1016/j.nbd.2004.09.019; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kumamaru H, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-116; Lam TI, 2013, NEUROREHAB NEURAL RE, V27, P889, DOI 10.1177/1545968313491003; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lehenkari PP, 2002, MOL PHARMACOL, V61, P1255, DOI 10.1124/mol.61.5.1255; Liu YQ, 2002, PEDIATR RES, V51, P25, DOI 10.1203/00006450-200201000-00007; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lotocki G, 2011, THER HYPOTHERMIA TEM, V1, DOI 10.1089/ther.2010.0011; Ma YY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0504-z; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Nelson LH, 2017, BEHAV BRAIN RES, V316, P279, DOI 10.1016/j.bbr.2016.09.006; Newell E, 2015, PEDIATR CRIT CARE ME, V16, P549, DOI 10.1097/PCC.0000000000000400; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pont-Lezica L, 2011, J NEUROCHEM, V119, P901, DOI 10.1111/j.1471-4159.2011.07504.x; Power T, 2007, BRAIN INJURY, V21, P279, DOI 10.1080/02699050701253095; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Salorio CF, 2005, J INT NEUROPSYCH SOC, V11, P686, DOI 10.1017/S1355617705050885; Sangobowale MA, 2018, J NEUROTRAUM, V35, P907, DOI 10.1089/neu.2017.5348; Schlegelmilch T, 2011, CURR OPIN NEUROBIOL, V21, P5, DOI 10.1016/j.conb.2010.08.004; Simon DW, 2018, J NEUROTRAUM, V35, P130, DOI 10.1089/neu.2017.5093; Siopi E, 2012, J NEUROTRAUM, V29, P354, DOI 10.1089/neu.2011.2055; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Stoltz S, 1999, BEHAV BRAIN RES, V106, P127, DOI 10.1016/S0166-4328(99)00100-X; Tam WY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07279; Taylor SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097096; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; van Rooijen N, 2003, METHOD ENZYMOL, V373, P3; VanRyzin JW, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0297-16.2016; Wallisch JS, 2017, NEUROCRIT CARE, V27, P44, DOI 10.1007/s12028-017-0378-7; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zhang Z, 2015, J NEUROTRAUM, V32, P1369, DOI 10.1089/neu.2014.3701; 2014, IMMUNOLOGY, V141, P302, DOI DOI 10.1111/IMM.12163; 2004, DEV NEUROPSYCHOL, V26, P487; 2016, J NEUROSCI, V36, P2881, DOI DOI 10.1523/JNEUROSCI.0140-15.2016; 1997, J NEUROTRAUMA, V14, P451	71	12	13	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUN	2019	316						39	51		10.1016/j.expneurol.2019.04.004			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HX8NV	WOS:000467663500005	30980832	Green Accepted			2022-02-06	
J	Mackey, DC; Lachance, CC; Wang, PWT; Feldman, F; Laing, AC; Leung, PM; Hu, XJ; Robinovitch, SN				Mackey, Dawn C.; Lachance, Chantelle C.; Wang, Peiwei T.; Feldman, Fabio; Laing, Andrew C.; Leung, Pet M.; Hu, X. Joan; Robinovitch, Stephen N.			The Flooring for Injury Prevention (FLIP) Study of compliant flooring for the prevention of fall-related injuries in long-term care: A randomized trial	PLOS MEDICINE			English	Article							RISK-FACTORS; NURSING-HOMES; HIP FRACTURE; IMPACT; FORCE; ATTENUATION; SYSTEMS	Background Fall-related injuries exert an enormous health burden on older adults in long-term care (LTC). Softer landing surfaces, such as those provided by low-stiffness "compliant" flooring, may prevent fall-related injuries by decreasing the forces applied to the body during fall impact. Our primary objective was to assess the clinical effectiveness of compliant flooring at preventing serious fall-related injuries among LTC residents. Methods and findings The Flooring for Injury Prevention (FLIP) Study was a 4-year, randomized superiority trial in 150 single-occupancy resident rooms at a single Canadian LTC site. In April 2013, resident rooms were block randomized (1:1) to installation of intervention compliant flooring (2.54 cm SmartCells) or rigid control flooring (2.54 cm plywood) covered with identical hospital-grade vinyl. The primary outcome was serious fall-related injury over 4 years that required an emergency department visit or hospital admission and a treatment procedure or diagnostic evaluation in hospital. Secondary outcomes included minor fall-related injury, any fall-related injury, falls, and fracture. Outcomes were ascertained by blinded assessors between September 1, 2013 and August 31, 2017 and analyzed by intention to treat. Adverse outcomes were not assessed. During follow-up, 184 residents occupied 74 intervention rooms, and 173 residents occupied 76 control rooms. Residents were 64.3% female with mean (SD) baseline age 81.7 (9.5) years (range 51.1 to 104.6 years), body mass index 25.9 (7.7) kg/m(2), and follow-up 1.64 (1.39) years. 1,907 falls were reported; 23 intervention residents experienced 38 serious injuries (from 29 falls in 22 rooms), while 23 control residents experienced 47 serious injuries (from 34 falls in 23 rooms). Compliant flooring did not affect odds of. 1 serious fall-related injury (12.5% intervention versus 13.3% control, odds ratio [OR]: 0.98, 95% CI: 0.52 to 1.84, p = 0.950) or >= 2 serious fall-related injuries (5.4% versus 7.5%, OR: 0.74, 95% CI: 0.31 to 1.75, p = 0.500). Compliant flooring did not affect rate of serious fall-related injuries (0.362 versus 0.422 per 1,000 bed nights, rate ratio [RR]: 1.04, 95% CI: 0.45 to 2.39, p = 0.925; 0.038 versus 0.053 per fall, RR: 0.81, 95% CI: 0.38 to 1.71, p = 0.560), rate of falls with >= 1 serious fall-related injury (0.276 versus 0.303 per 1,000 bed nights, RR: 0.97, 95% CI: 0.52 to 1.79, p = 0.920), or time to first serious fall-related injury (0.237 versus 0.257, hazard ratio [HR]: 0.92, 95% CI: 0.52 to 1.62, p = 0.760). Compliant flooring did not affect any secondary outcome in this study. Study limitations included the following: findings were specific to 2.54 cm SmartCells compliant flooring installed in LTC resident rooms, standard fall and injury prevention interventions were in use throughout the study and may have influenced the observed effect of compliant flooring, and challenges with concussion detection in LTC residents may have prevented estimation of the effect of compliant flooring on fall-related concussions. Conclusions In contrast to results from previous retrospective and nonrandomized studies, this study found that compliant flooring underneath hospital-grade vinyl was not effective at preventing serious fall-related injuries in LTC. Future studies are needed to identify effective methods for preventing fall-related injuries in LTC.	[Mackey, Dawn C.; Lachance, Chantelle C.; Feldman, Fabio; Robinovitch, Stephen N.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [Wang, Peiwei T.; Hu, X. Joan] Simon Fraser Univ, Dept Stat & Actuarial Sci, Burnaby, BC, Canada; [Wang, Peiwei T.] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON, Canada; [Feldman, Fabio] Fraser Hlth Author, Clin Qual Patient Safety, Surrey, BC, Canada; [Laing, Andrew C.] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada; [Leung, Pet M.] New Vista Soc Care Home, Burnaby, BC, Canada; [Lachance, Chantelle C.] CADTH, Toronto, ON, Canada		Mackey, DC (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada.	dmackey@sfu.ca		Laing, Andrew/0000-0001-8128-011X; Lachance, Chantelle/0000-0001-5755-5160; Hu, Joan/0000-0002-1970-2980; Robinovitch, Stephen/0000-0003-3881-6227	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [TIR-103945]; AGE-WELL, Inc., a Canadian National Centre for Excellence; Fraser Health Authority; Centre for Hip Health and Mobility; New Vista Society Care Home; Michael Smith FoundationMichael Smith Foundation for Health Research; Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate ScholarshipCanadian Institutes of Health Research (CIHR); AGE-WELL Graduate Student and Postdoctoral Award in Technology and Aging; Natural Sciences and Engineering Research Council of Canada Discovery GrantNatural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chair Award from 2011-2016	The study received funding from the Canadian Institutes of Health Research (grant TIR-103945 to SNR) and AGE-WELL, Inc., a Canadian National Centre for Excellence (grant to SNR). Financial and in-kind contributions were provided by partner organizations: 1. Fraser Health Authority; 2. Centre for Hip Health and Mobility; and 3. New Vista Society Care Home. SATECH Inc. provided SmartCells flooring, flooring installation materials (e.g., adhesive, tape, and transitions), and labor for flooring installation. DCM was supported by a Michael Smith Foundation for Health Research Scholar Award. CCL was supported by a Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship and an AGE-WELL Graduate Student and Postdoctoral Award in Technology and Aging. XJH was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant. SNR was supported by a Canada Research Chair Award from 2011-2016. URLs of each funder website: http://www.cihr-irsc.gc.ca http://agewell-nce.ca/https://www.fraserhealth.ca/ http://www.hiphealth.ca/ https://newvista.bc.ca/ https://www.smartcellsusa.com/ https://www.msfhr.org/ http://www.chairschaires.gc.ca/ http://www.nserc-crsng.gc.ca/The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentzen H, 2008, INJURY PREV, V14, P306, DOI 10.1136/ip.2007.018275; Cameron ID, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub4; Drahota AK, 2013, AGE AGEING, V42, P633, DOI 10.1093/ageing/aft067; Forsen L, 2004, INJURY PREV, V10, P16, DOI 10.1136/ip.2003.003889; Glinka MN, 2013, J APPL BIOMECH, V29, P563, DOI 10.1123/jab.29.5.563; Glinka MN, 2013, MED ENG PHYS, V35, P108, DOI 10.1016/j.medengphy.2012.04.006; Gustavsson J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201290; Gustavsson J, 2015, INJURY PREV, V21, P320, DOI 10.1136/injuryprev-2014-041468; Hanger HC, 2017, J AM MED DIR ASSOC, V18, P588, DOI 10.1016/j.jamda.2017.01.012; Kannus P, 2000, NEW ENGL J MED, V343, P1506, DOI 10.1056/NEJM200011233432101; Knoefel F, 2013, J AM MED DIR ASSOC, V14, P303, DOI 10.1016/j.jamda.2012.12.077; Korall AMB, 2017, THESIS; Lachance CC, 2018, CAN J AGING, V37, P84, DOI 10.1017/S0714980817000551; Lachance CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171652; Lachance CC, 2016, INJURY PREV, V22, P453, DOI 10.1136/injuryprev-2016-042008; Laing AC, 2006, J ORTHOP RES, V24, P1405, DOI 10.1002/jor.20172; Laing AC, 2009, ACCIDENT ANAL PREV, V41, P642, DOI 10.1016/j.aap.2009.03.001; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; MAKI BE, 1990, APPL ERGON, V21, P107, DOI 10.1016/0003-6870(90)90132-H; OLOUGHLIN JL, 1993, AM J EPIDEMIOL, V137, P342, DOI 10.1093/oxfordjournals.aje.a116681; RUBENSTEIN LZ, 1994, ANN INTERN MED, V121, P442, DOI 10.7326/0003-4819-121-6-199409150-00009; Santesso N, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001255.pub5; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; Simpson AHRW, 2004, AGE AGEING, V33, P242, DOI 10.1093/ageing/afh071; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Vlaeyen E, 2015, J AM GERIATR SOC, V63, P211, DOI 10.1111/jgs.13254; Vu Man Quang, 2006, J Am Med Dir Assoc, V7, pS53, DOI 10.1016/j.jamda.2005.12.016; Wright AD, 2012, MED ENG PHYS, V34, P1071, DOI 10.1016/j.medengphy.2011.11.012; Wright AD, 2011, ACCIDENT ANAL PREV, V43, P1480, DOI 10.1016/j.aap.2011.02.028; Yang Y, 2016, OSTEOPOROSIS INT, V27, P537, DOI 10.1007/s00198-015-3268-x; Yang Y, 2017, J HEAD TRAUMA REHAB, V32, P168, DOI 10.1097/HTR.0000000000000257	31	12	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1549-1277	1549-1676		PLOS MED	PLos Med.	JUN	2019	16	6							e1002843	10.1371/journal.pmed.1002843			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	IG4MP	WOS:000473778000024	31233541	Green Published, gold, Green Submitted			2022-02-06	
J	Magid, L; Heymann, S; Elgali, M; Avram, L; Cohen, Y; Liraz-Zaltsman, S; Mechoulam, R; Shohami, E				Magid, Lital; Heymann, Sami; Elgali, Merav; Avram, Liat; Cohen, Yoram; Liraz-Zaltsman, Sigal; Mechoulam, Raphael; Shohami, Esther			Role of CB2 Receptor in the Recovery of Mice after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cannabinoids; CB2 receptor; HU-910; HU-914; traumatic brain injury	CLOSED-HEAD INJURY; ARACHIDONOYL-L-SERINE; IMPROVES FUNCTIONAL RECOVERY; ISCHEMIA-REPERFUSION INJURY; ACYL AMINO-ACIDS; CANNABINOID RECEPTORS; CORTICOSPINAL TRACT; ACTIVATION; EXPRESSION; ENDOCANNABINOIDS	Cannabis is one of the most widely used plant drugs in the world today. In spite of the large number of scientific reports on medical marijuana, there still exists much controversy surrounding its use and the potential for abuse due to the undesirable psychotropic effects. However, recent developments in medicinal chemistry of novel non-psychoactive synthetic cannabinoids have indicated that it is possible to separate some of the therapeutic effects from the psychoactivity. We have previously shown that treatment with the endocannabinoid 2-AG, which binds to both CB1 and CB2 receptors 1 h after traumatic brain injury in mice, attenuates neurological deficits, edema formation, infarct volume, blood-brain barrier permeability, neuronal cell loss at the CA3 hippocampal region, and neuroinflammation. Recently, we synthesized a set of camphor-resorcinol derivatives, which represent a novel series of CB2 receptor selective ligands. Most of the novel compounds exhibited potent binding and agonistic properties at the CB2 receptors with very low affinity for the CB1 receptor, and some were highly anti-inflammatory. This selective binding correlated with their intrinsic activities. HU-910 and HU-914 were selected in the present study to evaluate their potential effect in the pathophysiology of traumatic brain injury (TBI). In mice and rats subjected to closed-head injury and treated with these novel compounds, we showed enhanced neurobehavioral recovery, inhibition of tumor necrosis factor alpha production, increased synaptogenesis, and partial recovery of the cortical spinal tract. We propose these CB2 agonists as potential drugs for development of novel therapeutic modality to TBI.	[Magid, Lital; Mechoulam, Raphael] Hebrew Univ Jerusalem, Dept Med Chem, Jerusalem, Israel; [Heymann, Sami] Hebrew Univ Jerusalem, Dept Neurosurg, Hadassah Med Ctr, Jerusalem, Israel; [Elgali, Merav; Liraz-Zaltsman, Sigal; Shohami, Esther] Hebrew Univ Jerusalem, Dept Pharmacol, Inst Drug Res, Jerusalem, Israel; [Avram, Liat; Cohen, Yoram] Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Chem, Tel Aviv, Israel; [Liraz-Zaltsman, Sigal] Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Tel Hashomer, Israel		Magid, L (corresponding author), Sheinfine 12-7, IL-4465217 Kefar Sava, Israel.	lital.magid@teva.co.il		Avram, Liat/0000-0001-6535-3470	NIH grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DA-9789]; Kessler Foundation; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF)	This study was supported by a NIH grant DA-9789 to RM; RM thanks the Kessler Foundation for financial support. Part of this study was supported by grants from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (AMRF) to ES.	Amenta PS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0191-6; Ashton JC, 2007, CURR NEUROPHARMACOL, V5, P73, DOI 10.2174/157015907780866884; Beltramo M, 2006, EUR J NEUROSCI, V23, P1530, DOI 10.1111/j.1460-9568.2006.04684.x; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Benito C, 2008, BRIT J PHARMACOL, V153, P277, DOI 10.1038/sj.bjp.0707505; Benowitz LI, 1999, P NATL ACAD SCI USA, V96, P13486, DOI 10.1073/pnas.96.23.13486; Bu W, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00449; Cabral GA, 2005, HANDB EXP PHARMACOL, V168, P385; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cohen-Yeshurun A, 2013, J CEREBR BLOOD F MET, V33, P1242, DOI 10.1038/jcbfm.2013.75; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; Dachir S, 2014, BRAIN RES, V1555, P78, DOI 10.1016/j.brainres.2014.01.044; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Filippo C, 2004, J LEUKOCYTE BIOL, V75, P453, DOI 10.1189/jlb.0703303; Dietrich WD, 2016, BRAIN RES, V1640, P94, DOI 10.1016/j.brainres.2015.12.034; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Golech SA, 2004, MOL BRAIN RES, V132, P87, DOI 10.1016/j.molbrainres.2004.08.025; Gomez M, 2008, CELL ADHES MIGR, V2, P246, DOI 10.4161/cam.2.4.6749; Graham D., 2002, GREENFIELDS NEUROPAT, P821; Hanus L, 1999, P NATL ACAD SCI USA, V96, P14228, DOI 10.1073/pnas.96.25.14228; Hanus L, 2014, BIOFACTORS, V40, P381, DOI 10.1002/biof.1166; Horvath B, 2012, BRIT J PHARMACOL, V165, P2462, DOI 10.1111/j.1476-5381.2011.01381.x; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; Ibrahim MM, 2003, P NATL ACAD SCI USA, V100, P10529, DOI 10.1073/pnas.1834309100; Magid L., 2012, THESIS; Mahmood A, 2013, J NEUROSURG, V118, P381, DOI 10.3171/2012.11.JNS12753; Malan TP, 2001, PAIN, V93, P239, DOI 10.1016/S0304-3959(01)00321-9; Mann Aniv, 2016, Journal of Basic and Clinical Physiology and Pharmacology, V27, P209, DOI 10.1515/jbcpp-2015-0092; Mann A, 2015, J NEUROIMMUNE PHARM, V10, P356, DOI 10.1007/s11481-015-9595-z; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mechoulam R., 2010, US patent, Patent No. 8722938; Mechoulam R., 2014, US patent, Patent No. 9365534; Milman G, 2006, P NATL ACAD SCI USA, V103, P2428, DOI 10.1073/pnas.0510676103; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Pacher P, 2008, BRIT J PHARMACOL, V153, P252, DOI 10.1038/sj.bjp.0707582; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Pertwee RG, 2008, ADDICT BIOL, V13, P147, DOI 10.1111/j.1369-1600.2008.00108.x; Prenderville JA, 2015, BRIT J PHARMACOL, V172, P3950, DOI 10.1111/bph.13186; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schumann J, 2009, J NEUROCHEM, V108, P697, DOI 10.1111/j.1471-4159.2008.05794.x; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Soethoudt M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13958; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Szabo B, 2005, HANDB EXP PHARMACOL, V168, P327; Tan B, 2010, J LIPID RES, V51, P112, DOI 10.1194/jlr.M900198-JLR200; Tchantchou F, 2014, NEUROPHARMACOLOGY, V85, P427, DOI 10.1016/j.neuropharm.2014.06.006; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Zhang YL, 2010, BRAIN RES, V1353, P249, DOI 10.1016/j.brainres.2010.07.046	58	12	12	3	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2019	36	11					1836	1846		10.1089/neu.2018.6063			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IB1EQ	WOS:000470007600014	30489198	Green Published			2022-02-06	
J	Connor, TA; Clark, JM; Jayamohan, J; Stewart, M; McGoldrick, A; Williams, C; Seemungal, BM; Smith, R; Burek, R; Gilchrist, MD				Connor, Thomas A.; Clark, J. Michio; Jayamohan, Jayaratnam; Stewart, Matt; McGoldrick, Adrian; Williams, Claire; Seemungal, Barry M.; Smith, Rebecca; Burek, Roy; Gilchrist, Michael D.			Do equestrian helmets prevent concussion? A retrospective analysis of head injuries and helmet damage from real-world equestrian accidents	SPORTS MEDICINE-OPEN			English	Article						Concussion; Equestrian; Riding; Helmet; Head injury; Certification standards	COIN-TAP METHOD; GREAT-BRITAIN; IRELAND; EPIDEMIOLOGY; FRANCE	Objectives: To collect and analyse helmets from real-world equestrian accidents. To record reported head injuries associated with those accidents. To compare damage to helmets certified to different standards and the injuries associated with them. Methods: Two hundred sixteen equestrian helmets were collected in total. One hundred seventy-six helmets from amateur jockeys were collected via accident helmet return schemes in the UK and USA, while 40 helmets from professional jockeys were collected by The Irish Turf Club. All helmet damage was measured, and associated head injury was recorded. Results: Eighty-eight percent (189) of equestrian fall accidents returned an injury report of which 70% (139) reported a head injury. Fifty-four percent (75) of head injury cases had associated helmet damage while 46% had no helmet damage. Reported head injuries consisted of 91% (126) concussion, 4% (6) skull fractures, 1 (0.7%) subdural hematoma, 1 (0.7%) cerebral edema and 5 (3.6%) diffuse axonal injury (DAI). It is also shown that helmets certified to the most severe standard are overrepresented in this undamaged group (p < 0.001). Conclusions: It is clear that despite jockeys wearing a helmet, large proportions of concussion injuries still occur in the event of a jockey sustaining a fall. However, the data suggest it is likely that helmets reduce the severity of head injury as the occurrence of skull fracture is low. The proportion of undamaged helmets with an associated head injury suggests that many helmets may be too stiff relative to the surface they are impacting to reduce the risk of traumatic brain injury (TBI). It may be possible to improve helmet designs and certification tests to reduce the risk of head injury in low-severity impacts.	[Connor, Thomas A.; Clark, J. Michio; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland; [Connor, Thomas A.; Stewart, Matt; Burek, Roy] Charles Owen & Co, Wrexham, Wales; [Jayamohan, Jayaratnam] John Radcliffe Hosp, Dept Neurosurg, Oxford, England; [McGoldrick, Adrian] Irish Horseracing Regulatory Board, The Curragh, Kildare, Ireland; [Williams, Claire] British Equestrian Trade Assoc, Wetherby, England; [Seemungal, Barry M.; Smith, Rebecca] Imperial Coll London, Brain & Vestibular Grp, Charing Cross Hosp Campus, London, England		Gilchrist, MD (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland.	michael.gilchrist@ucd.ie		Seemungal, Barry/0000-0002-6578-0904; Stewart, Matt/0000-0001-8215-1184; Smith, Rebecca/0000-0003-2628-9861	European UnionEuropean Commission [642662]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/P006493/1] Funding Source: UKRI	This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 642662. The funding body had no role in the design of this study or in the collection, analysis or interpretation of the data.	Abu-Zidan FM, 2003, INJURY, V34, P897, DOI 10.1016/S0020-1383(03)00054-8; Adams J H, 1981, Acta Neuropathol Suppl, V7, P26; ASTM F1163-15, 2015, F116315 ASTM; Balendra G., 2007, BRIT J SPORT MED, V42, P22; Balendra G, 2007, BRIT J SPORT MED, V41, P162, DOI 10.1136/bjsm.2006.033894; Ball CG, 2007, AM J SURG, V193, P636, DOI 10.1016/j.amjsurg.2007.01.016; Bourdet N, 2014, INT J CRASHWORTHINES, V19, P222, DOI 10.1080/13588265.2013.805293; CAWLEY P, 1988, J SOUND VIB, V122, P299, DOI 10.1016/S0022-460X(88)80356-0; CAWLEY P, 1991, MECH SYST SIGNAL PR, V5, P1, DOI 10.1016/0888-3270(91)90011-S; Connor TA, 2016, REF ARES; DEBENEDETTE V, 1989, PHYSICIAN SPORTSMED, V17, P250, DOI 10.1080/00913847.1989.11709748; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; EN 1384:2017, 2017, 13842017 EN BRIT STA; European Committee for Standardization, 2015, 158WG11N185 CENTC EU; Gennarelli T A, 1981, Acta Neuropathol Suppl, V7, P23; Gilchrist MD, 2005, IUTAM S IMP BIOM FUN; Hodgson V, 1971, 710854 SAE, DOI [10.4271/710854, DOI 10.4271/710854]; Hodgson VR, 1973, DOTHS801002; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Kleiven S., 2002, THESIS; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; McCrory P, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2003.006338; McCrory P, 2006, BRIT J SPORT MED, V40, P614, DOI 10.1136/bjsm.2006.028449; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; PAS015:2011, 2011, PAS0152011 BRIT STAN; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Rueda MAF, 2010, INJURY, V41, P533, DOI 10.1016/j.injury.2009.05.009; The British Horse Society, 2012, EQ STAT; Turner M, 2002, BRIT J SPORT MED, V36, P403, DOI 10.1136/bjsm.36.6.403	31	12	12	2	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2199-1170	2198-9761		SPORTS MED-OPEN	Sports Med.-Open	MAY 24	2019	5	1							19	10.1186/s40798-019-0193-0			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	KO1OA	WOS:000515316800001	31127396	Green Published, gold			2022-02-06	
J	Miller, LE; Urban, JE; Kelley, ME; Powers, AK; Whitlow, CT; Maldjian, JA; Rowson, S; Stitzel, JD				Miller, Logan E.; Urban, Jillian E.; Kelley, Mireille E.; Powers, Alexander K.; Whitlow, Christopher T.; Maldjian, Joseph A.; Rowson, Steven; Stitzel, Joel D.			Evaluation of Brain Response during Head Impact in Youth Athletes Using an Anatomically Accurate Finite Element Model	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; FE model; HITS; strain; youth football	DIFFUSE AXONAL INJURY; 1ST EXPOSURE; FOOTBALL; STRAIN; AGE; ACCELERATIONS; MOTION; ATLAS	During normal participation in football, players are exposed to repetitive subconcussive head impacts, or impacts that do not result in signs and symptoms of concussion. To better understand the effects of repetitive subconcussive impacts, the biomechanics of on-field head impacts and resulting brain deformation need to be well characterized. The current study evaluates local brain response to typical youth football head impacts using the atlas-based brain model (ABM), an anatomically accurate brain finite element (FE) model. Head impact kinematic data were collected from three local youth football teams using the Head Impact Telemetry (HIT) System. The azimuth and elevation angles were used to identify impacts near six locations of interest, and low, moderate, and high acceleration magnitudes (5th, 50th, and 95th percentiles, respectively) were calculated from the grouped impacts for FE simulation. Strain response in the brain was evaluated by examining the range and peak maximum principal strain (MPS) values in each element. A total of 40,538 impacts from 119 individual athletes were analyzed. Impacts to the facemask resulted in 0.18 MPS for the high magnitude impact category. This was 1.5 times greater than the oblique impact location, which resulted in the lowest strain value of 0.12 for high magnitude impacts. Overall, higher strains resulted from a 95th percentile lateral impact (41.0g, 2556 rad/sec(2)) with two predominant axes of rotation than from a 95th percentile frontal impact (67.6g, 2641 rad/sec(2)) with a single predominant axis of rotation. These findings highlight the importance of accounting for directional dependence and relative contribution of axes of rotation when evaluating head impact response.	[Miller, Logan E.; Urban, Jillian E.; Kelley, Mireille E.; Powers, Alexander K.; Whitlow, Christopher T.; Stitzel, Joel D.] Wake Forest Sch Med, Dept Biomed Engn, 575 N Patterson Ave,Suite 120, Winston Salem, NC 27101 USA; [Maldjian, Joseph A.] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX USA; [Rowson, Steven] Virginia Polytech Inst & State Univ, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA		Miller, LE (corresponding author), Wake Forest Sch Med, Dept Biomed Engn, 575 N Patterson Ave,Suite 120, Winston Salem, NC 27101 USA.	logmille@wakehealth.edu	Lang, Steven/AAE-8102-2021; Rowson, Steven/B-1270-2012	Lang, Steven/0000-0003-1669-9146; Rowson, Steven/0000-0002-3227-0596	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS082453, R01 NS094410] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082453, R01NS094410] Funding Source: NIH RePORTER		Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Darling T, 2016, COMPUT METHOD BIOMEC, V19, P1432, DOI 10.1080/10255842.2016.1149574; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Eppinger R, 1999, DEV IMPROVED INJURY, P1; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Ji SB, 2015, ANN BIOMED ENG, V43, P1877, DOI 10.1007/s10439-014-1193-3; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Laituri K, 2015, SAE TECHNICAL PAPER; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Miller LE, 2017, COMPUT METHOD BIOMEC, V20, P1273, DOI 10.1080/10255842.2017.1340462; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Smith TA, 2015, SPORTS ENG, V18, P165, DOI 10.1007/s12283-015-0175-5; Sproule DW, 2017, P I MECH ENG P-J SPO, V231, P317, DOI 10.1177/1754337117703019; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Weaver AA, 2012, ANN BIOMED ENG, V40, P2005, DOI 10.1007/s10439-012-0553-0; Zanetti K, 2013, INT RES COUNC BIOMEC, P525; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	39	12	12	2	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2019	36	10					1561	1570		10.1089/neu.2018.6037			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HX7CZ	WOS:000467562900008	30489208	Green Published			2022-02-06	
J	Sagarkar, S; Balasubramanian, N; Mishra, S; Choudhary, AG; Kokare, DM; Sakharkar, AJ				Sagarkar, Sneha; Balasubramanian, Nagalakshmi; Mishra, Shruti; Choudhary, Amit G.; Kokare, Dadasaheb M.; Sakharkar, Amul J.			Repeated mild traumatic brain injury causes persistent changes in histone deacetylase function in hippocampus: Implications in learning and memory deficits in rats	BRAIN RESEARCH			English	Article						Cocaine- and amphetamine-regulated transcript peptide; HDAC inhibitors; Hippocampus; Learning and memory; Mild traumatic brain injury	OBJECT RECOGNITION TASK; SYNAPTIC PLASTICITY; SPATIAL MEMORY; MOUSE MODEL; COCAINE; CART; ACETYLATION; STRESS; HDAC3; METHYLATION	Impaired attention and memory represent some of the major long-term consequences of brain injuries. However, little is known about the underlying molecular mechanisms of brain trauma-induced cognitive decline. Histone deacetylases (HDACs) in the hippocampus are believed to impact learning and memory. Herein, we have induced repeated mild traumatic brain injury (rMTBI) in rats by using weight-drop paradigm, examined the recognition memory using novel object recognition task, and assessed the HDAC activities in the hippocampus post 48 h and 30 days of rMTBI. The recognition memory was significantly compromised in the rMTBI-exposed rats at both the time points. The rMTBI increased mRNA levels of different isoforms of HDACs (HDAC2-5 and HDAC11) at different time points coupled with rise in nuclear and cytosolic HDAC activities. However, a mild decrease in HDAC8 mRNA levels was observed at 30 days time point. As a corollary, rMTBI also caused persistent decrease in the levels of acetylated histone H3-Lys 9 (H3-K9ac) in promoter region of cocaine- and amphetamine-regulated transcript (CART) gene with concurrent decline in CART mRNA and peptide (CARTp) levels. Furthermore, the treatment with trichostatin A (TSA), a pan HDAC inhibitor, restored the rMTBI-induced deficits in recognition memory and HDAC activities with commensurate changes in the H3-K9ac and CART mRNA levels. Together, these results suggest that rMTBI may trigger persistent changes in HDAC-mediated histone acetylation at the CART gene promoter culminating into deficits in learning and memory. Further, the present study also identifies therapeutic potential of HDAC inhibitors in rescuing MTBI-induced cognitive deficits.	[Sagarkar, Sneha; Balasubramanian, Nagalakshmi; Mishra, Shruti; Sakharkar, Amul J.] Savitribai Phule Pune Univ, Dept Biotechnol, Pune 411007, Maharashtra, India; [Choudhary, Amit G.; Kokare, Dadasaheb M.] Rashtrasant Tukadoji Maharaj Nagpur Univ, Dept Pharmaceut Sci, Nagpur 440033, Maharashtra, India		Sakharkar, AJ (corresponding author), Savitribai Phule Pune Univ, Dept Biotechnol, Pune 411007, Maharashtra, India.	amul.sakharkar@unipune.ac.in			University Grants Commission (UGC), Government of India (GOI) [( F.4-5/151-FRP)/2014/BSR]; University Research Grant Scheme, Savitribai Phule Pune University (SPPU), Pune, India; Department Research and Development Program (DRDP) of the Department of Biotechnology, SPPU; DST-PURSE, SPPU; Science and Engineering Research Board (SERB), GOI, India [SB/SO/AS-12/2014]; UGC, GOIUniversity Grants Commission, India	This work was supported by the grants from the University Grants Commission (UGC), Government of India (GOI) (F.4-5/151-FRP)/2014/BSR) and University Research Grant Scheme, Savitribai Phule Pune University (SPPU), Pune, India to AJS. MS also acknowledge funds received through the Department Research and Development Program (DRDP) of the Department of Biotechnology, SPPU and DST-PURSE, SPPU. DMK acknowledges a grant from the Science and Engineering Research Board (SERB; SB/SO/AS-12/2014), GOI, India. NB thanks UGC, GOI for the award of junior research fellowship (UGC-JRF). The authors declare no conflicts of interest.	Abe T, 2008, CURR OPIN PHARMACOL, V8, P57, DOI 10.1016/j.coph.2007.12.002; Aggleton JP, 2010, BEHAV NEUROSCI, V124, P55, DOI 10.1037/a0018320; Agis-Balboa RC, 2013, J ALZHEIMERS DIS, V33, P35, DOI 10.3233/JAD-2012-121009; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Aubele T, 2008, HORM BEHAV, V54, P244, DOI 10.1016/j.yhbeh.2008.04.001; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bharne AP, 2016, HIPPOCAMPUS, V26, P1313, DOI 10.1002/hipo.22608; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Borkar CD, 2019, ADDICT BIOL, V24, P51, DOI 10.1111/adb.12579; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Burke SN, 2010, BEHAV NEUROSCI, V124, P559, DOI 10.1037/a0020893; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Dash PK, 2009, NEUROSCIENCE, V163, P1, DOI 10.1016/j.neuroscience.2009.06.028; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603; Fitzsimons HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083903; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Graff J, 2014, CELL, V156, P261, DOI 10.1016/j.cell.2013.12.020; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Guan JS, 2015, EXP NEUROL, V268, P30, DOI 10.1016/j.expneurol.2014.05.006; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hurd YL, 2000, J COMP NEUROL, V425, P583, DOI 10.1002/1096-9861(20001002)425:4<583::AID-CNE8>3.0.CO;2-#; Jin JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10224; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kim MS, 2012, J NEUROSCI, V32, P10879, DOI 10.1523/JNEUROSCI.2089-12.2012; Kosaka B., 2006, BRIT COLOMBIA MEDICA, V48, P447; Koylu EO, 1998, J COMP NEUROL, V391, P115; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Morrison BE, 2007, CELL MOL LIFE SCI, V64, P2258, DOI 10.1007/s00018-007-7035-9; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Oliveira AMM, 2010, LEARN MEMORY, V17, P155, DOI 10.1101/lm.1625310; Pandey SC, 2015, NEUROBIOL DIS, V82, P607, DOI 10.1016/j.nbd.2015.03.019; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Qiang M, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu072; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Sadakierska-Chudy A, 2017, NEUROTOX RES, V32, P141, DOI 10.1007/s12640-017-9728-7; Sagarkar S, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13074; Sagarkar S, 2017, NEUROBIOL DIS, V106, P101, DOI 10.1016/j.nbd.2017.06.016; Sailaja BS, 2012, P NATL ACAD SCI USA, V109, pE3687, DOI 10.1073/pnas.1209990110; Sakharkar AJ, 2016, BRAIN STRUCT FUNCT, V221, P4691, DOI 10.1007/s00429-016-1196-y; Sakharkar AJ, 2012, ALCOHOL CLIN EXP RES, V36, P61, DOI 10.1111/j.1530-0277.2011.01581.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schultz K, 2009, NEUROSCI LETT, V453, P104, DOI 10.1016/j.neulet.2009.02.008; Seress L, 2004, NEUROSCIENCE, V125, P13, DOI 10.1016/j.neuroscience.2003.12.035; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; Silvers JM, 2007, J NEUROSCI METH, V166, P99, DOI 10.1016/j.jneumeth.2007.06.032; Singh P, 2018, MOL NEUROBIOL, V55, P2432, DOI 10.1007/s12035-017-0490-x; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Tai YT, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/980657; Upadhya MA, 2011, LIFE SCI, V88, P322, DOI 10.1016/j.lfs.2010.12.008; Vargas-Lopez V, 2016, NEUROBIOL LEARN MEM, V134, P328, DOI 10.1016/j.nlm.2016.08.009; Vecera J, 2018, J CELL PHYSIOL, V233, P530, DOI 10.1002/jcp.25914; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wammes JD, 2017, BRAIN COGNITION, V111, P112, DOI 10.1016/j.bandc.2016.11.004; Wang WH, 2011, ANAT REC, V294, P1025, DOI 10.1002/ar.21389; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yan H, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6353845; Yermolaieva O, 2001, J NEUROSCI, V21, P7474, DOI 10.1523/JNEUROSCI.21-19-07474.2001; Zhu XL, 2017, AGING CELL, V16, P1073, DOI 10.1111/acel.12642; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, NEUROBIOL DIS, V41, P329, DOI 10.1016/j.nbd.2010.10.001	71	12	14	0	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 15	2019	1711						183	192		10.1016/j.brainres.2019.01.022			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HS7ZP	WOS:000464088100022	30664848				2022-02-06	
J	Selvaraj, P; Wen, J; Tanaka, M; Zhang, YM				Selvaraj, Prabhuanand; Wen, Jie; Tanaka, Mikiei; Zhang, Yumin			Therapeutic Effect of a Novel Fatty Acid Amide Hydrolase Inhibitor PF04457845 in the Repetitive Closed Head Injury Mouse Model	JOURNAL OF NEUROTRAUMA			English	Article						cannabinoid receptors; fatty acid amide hydrolase; neuroinflammation; PF04457845; repetitive closed head injury	TRAUMATIC BRAIN-INJURY; AMYLOID PRECURSOR PROTEIN; IMPROVES FUNCTIONAL RECOVERY; CANNABINOID RECEPTOR; MULTIPLE-SCLEROSIS; TAU; ACCUMULATION; NEUROINFLAMMATION; ENDOCANNABINOIDS; MEDIATORS	Concussive traumatic brain injury (TBI) is the predominant type of brain injury in young adults and is a risk factor for the development of chronic traumatic encephalopathy and other neurodegenerative diseases late in life. Using a repetitive closed head injury mouse model, we found that treatment with PF04457845, a novel fatty acid amide hydrolase (FAAH) inhibitor that selectively elevated the brain levels of anandamide, improved locomotor function, learning, and memory in TBI mice examined by beam walk, Y-maze, and Morris water maze tests. The accumulation of microglia and astrocytes and the expression of proinflammatory cytokines, including interleukin (IL)-1 beta, IL-6, and tumor necrosis factor alpha (TNF-alpha), in the ipsilateral TBI mouse cortex and hippocampus were significantly reduced by drug treatment. The increased expression of amyloid precursor protein (APP), phosphorylated Tau (p-Tau), phosphorylated glycogen synthase kinase 3 beta (pGSK3 beta) and p35/p25 subunits and the decreased expression of the pre-synaptic proteins, synaptophysin, synaptosome-associated protein of 25 kDa (SNAP25), and cysteine string protein alpha (alpha-CSP), in TBI mouse brain were also normalized by PF04458745 treatment. The improved locomotor function and working memory were partially mediated by activation of both cannabinoid (CB)1 and CB2 receptors, whereas the improvement on spatial learning and memory seemed to be CB1 receptor dependent. Interestingly, the blockage of PF04457845 on the reduced expression of synaptophysin, but not SNAP25 and alpha-CSP, was reversed by coadministration of the CB1 receptor antagonist. These results suggest that the therapeutic effect of PF04457845 is mediated by both cannabinoid receptor dependent and independent mechanisms, and selective inhibition of FAAH possesses a great potential for the treatment of TBI.	[Selvaraj, Prabhuanand; Wen, Jie; Tanaka, Mikiei; Zhang, Yumin] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Selvaraj, Prabhuanand; Zhang, Yumin] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Zhang, YM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	yumin.zhang@usuhs.edu					Acosta SA, 2017, J CELL PHYSIOL, V232, P665, DOI 10.1002/jcp.25629; Bennett DA, 2004, ARCH NEUROL-CHICAGO, V61, P378, DOI 10.1001/archneur.61.3.378; Bryan KJ, 2009, FRONT NEUROSCI, P1; Calvello R, 2012, PHARMACOL RES, V65, P137, DOI 10.1016/j.phrs.2011.09.009; Carlson SW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00532; Cartagena CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158576; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Chanda PK, 2010, MOL PHARMACOL, V78, P996, DOI 10.1124/mol.110.068304; Chauhan NB, 2010, J NEUROSCI METH, V190, P1, DOI 10.1016/j.jneumeth.2010.04.004; Chen HJC, 2018, INT J NEUROPSYCHOPH, V21, P786, DOI 10.1093/ijnp/pyy033; Chen Yuan-Hao, 2018, Oncotarget, V9, P11515, DOI 10.18632/oncotarget.23923; Chiurchiu V, 2018, PROG NEUROBIOL, V160, P82, DOI 10.1016/j.pneurobio.2017.10.007; Choi SH, 2008, FASEB J, V22, P1491, DOI 10.1096/fj.07-9411com; Choi SH, 2013, J NEUROCHEM, V124, P59, DOI 10.1111/jnc.12059; Choi SH, 2009, TRENDS PHARMACOL SCI, V30, P174, DOI 10.1016/j.tips.2009.01.002; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Faul M, 2010, TRAUMATIC BRAIN INJU; Fishbein-Kaminietsky M, 2014, J NEUROSCI RES, V92, P1669, DOI 10.1002/jnr.23452; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Giunta B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-51; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hunt D, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00007; Hwang J, 2010, LIFE SCI, V86, P615, DOI 10.1016/j.lfs.2009.06.003; Iannotti FA, 2016, PROG LIPID RES, V62, P107, DOI 10.1016/j.plipres.2016.02.002; Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003; Katz PS, 2015, J NEUROTRAUM, V32, P297, DOI 10.1089/neu.2014.3508; Kinsey SG, 2013, J PHARMACOL EXP THER, V345, P492, DOI 10.1124/jpet.112.201426; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Leishman E, 2016, PHARMACOL RES, V110, P159, DOI 10.1016/j.phrs.2016.04.020; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Linda Hans, 2011, Front Neurol, V2, P30, DOI 10.3389/fneur.2011.00030; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mayeux J, 2017, J NEUROTRAUM, V34, P436, DOI 10.1089/neu.2016.4452; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McPartland JM, 2015, BRIT J PHARMACOL, V172, P737, DOI 10.1111/bph.12944; Nisbet RM, 2015, ACTA NEUROPATHOL, V129, P207, DOI 10.1007/s00401-014-1371-2; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; O'Sullivan SE, 2010, IMMUNOBIOLOGY, V215, P611, DOI 10.1016/j.imbio.2009.09.007; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Oz M, 2006, PHARMACOL THERAPEUT, V111, P114, DOI 10.1016/j.pharmthera.2005.09.009; PATRICK G, 2005, NATURE, V402, P615; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Pertwee RG, 2014, P NUTR SOC, V73, P96, DOI 10.1017/S0029665113003649; Piro JR, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1166-9; Plummer S, 2016, AGING DIS, V7, P163, DOI 10.14336/AD.2015.0907; Pryce G, 2015, HANDB EXP PHARMACOL, V231, P213, DOI 10.1007/978-3-319-20825-1_7; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Schlosburg JE, 2014, J PHARMACOL EXP THER, V350, P196, DOI 10.1124/jpet.114.212753; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Schlosburg JE, 2009, AAPS J, V11, P39, DOI 10.1208/s12248-008-9075-y; Schmitt U, 2009, NEUROSCIENCE, V162, P234, DOI 10.1016/j.neuroscience.2009.04.046; Schurman LD, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00069; Schwab JM, 2000, ACTA NEUROPATHOL, V99, P609, DOI 10.1007/s004010051170; Schwab JM, 2002, J NEUROSURG, V96, P892, DOI 10.3171/jns.2002.96.5.0892; Schwab JM, 2001, J NEUROTRAUM, V18, P881, DOI 10.1089/089771501750451802; Shang JL, 2014, BRAZ J MED BIOL RES, V47, P1050, DOI 10.1590/1414-431X20143601; Shishido H, 2016, NEUROSCI LETT, V629, P62, DOI 10.1016/j.neulet.2016.06.066; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Tchantchou F, 2014, NEUROPHARMACOLOGY, V85, P427, DOI 10.1016/j.neuropharm.2014.06.006; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Thau-Zuchman O, 2012, J NEUROTRAUM, V29, P375, DOI 10.1089/neu.2010.1673; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Velosky AG, 2017, BEHAV BRAIN RES, V324, P115, DOI 10.1016/j.bbr.2017.02.017; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; Yu FS, 2012, J NEUROTRAUM, V29, P2342, DOI 10.1089/neu.2012.2449; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P443, DOI 10.1038/jcbfm.2014.216; Zhao ZA, 2017, BEHAV BRAIN RES, V323, P146, DOI 10.1016/j.bbr.2017.02.002; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	76	12	12	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2019	36	10					1655	1669		10.1089/neu.2018.6226			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HX7CZ	WOS:000467562900016	30526351				2022-02-06	
J	Baker, G; Matveychuk, D; MacKenzie, EM; Holt, A; Wang, YL; Kar, S				Baker, Glen; Matveychuk, Dmitriy; MacKenzie, Erin M.; Holt, Andrew; Wang, Yanlin; Kar, Satyabrata			Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine	CHEMICO-BIOLOGICAL INTERACTIONS			English	Article; Proceedings Paper	10th Meeting of the Canadian-Oxidative-Stress-Consortium (COSC)	MAY 30-JUN 01, 2018	Univ Alberta, Edmonton, CANADA	Canadian Oxidat Stress Consortium, Univ Alberta, Fac Pharm & Pharmaceut Sci, Univ Alberta, Off Vice President Res, MDPI, Antioxidants, Cedarlane, Bruker, Univ Alberta, Fac Med & Dent, Soc Redox Biol & Med	Univ Alberta	Phenelzine; Monoamine oxidase; GABA transaminase; Reactive aldehydes; Primary amine oxidase; Antidepressant	SENSITIVE AMINE OXIDASE; MILD COGNITIVE IMPAIRMENT; BRAIN MONOAMINE-OXIDASE; LIPID-PEROXIDATION PRODUCT; GAMMA-AMINOBUTYRIC-ACID; SPINAL-CORD-INJURY; ALZHEIMERS-DISEASE; DIABETES-MELLITUS; IN-VIVO; BETA-PHENYLETHYLIDENEHYDRAZINE	Phenelzine (beta-phenylethylhydrazine) is a monoamine oxidase (MAO)-inhibiting antidepressant with anxiolytic properties. It possesses a number of important pharmacological properties which may alter the effects of oxidative stress. After conducting a comprehensive literature search, the authors of this review paper aim to provide an overview and discussion of the mechanisms by which phenelzine may attenuate oxidative stress. It inhibits gamma-aminobutyric acid (GABA) transaminase, resulting in elevated brain GABA levels, inhibits both MAO and primary amine oxidase and, due to its hydrazine-containing structure, reacts chemically to sequester a number of reactive aldehydes (e.g. acrolein and 4-hydroxy-2-nonenal) proposed to be implicated in oxidative stress in a number of neurodegenerative disorders. Phenelzine is unusual in that it is both an inhibitor of and a substrate for MAO, the latter action producing at least one active metabolite, beta-phenylethylidenehydrazine (PEH). This metabolite inhibits GABA transaminase, is a very weak inhibitor of MAO but a strong inhibitor of primary amine oxidase, and sequesters aldehydes. Phenelzine may ameliorate the effects of oxidative stress by reducing formation of reactive metabolites (aldehydes, hydrogen peroxide, ammonia/ammonia derivatives) produced by the interaction of MAO with biogenic amines, by sequestering various other reactive aldehydes and by inhibiting primary amine oxidase. In PC12 cells treated with the neurotoxin MPP+, phenelzine has been reported to reduce several adverse effects of MPP+. It has also been reported to reduce lipid peroxidative damage induced in plasma and platelet proteins by peroxynitrite. In animal models, phenelzine has a neuroprotective effect in global ischemia and in cortical impact traumatic brain injury. Recent studies reported in the literature on the possible involvement of acrolein in spinal cord injury and multiple sclerosis indicate that phenelzine can attenuate adverse effects of acrolein in these models. Results from studies in our laboratories on effects of phenelzine and PEH on primary amine oxidase (which catalyzes formation of toxic aldehydes and is overexpressed in Alzheimer's disease), on sequestration of the toxic aldehyde acrolein, and on reduction of acrolein-induced toxicity in mouse cortical neurons are also reported.	[Baker, Glen; Matveychuk, Dmitriy; MacKenzie, Erin M.; Holt, Andrew; Wang, Yanlin; Kar, Satyabrata] Univ Alberta, Neurochem Res Unit, Dept Psychiat, Edmonton, AB, Canada; [Wang, Yanlin; Kar, Satyabrata] Univ Alberta, Dept Med Neurol, Edmonton, AB, Canada		Baker, G (corresponding author), Univ Alberta, Dept Psychiat NRU, 12-105B Clin Sci Bldg, Edmonton, AB T6G 2G3, Canada.	glen.baker@ualberta.ca; dmitriym@ualberta.ca; emm3@ualberta.ca; aholt@ualberta.ca; yanlin.wang8@gmail.com; skar@ualberta.ca			CIHRCanadian Institutes of Health Research (CIHR) [MOP-86712]; University of AlbertaUniversity of Alberta; CIHR Doctoral Research AwardCanadian Institutes of Health Research (CIHR)	The authors are grateful for funding from CIHR (MOP-86712, Phenylalkylhydrazine Drugs and Neuroprotection) and the University of Alberta. DM held a CIHR Doctoral Research Award. The expert administrative and technical help of Trudy Valliere, Tricia Kent and Dr. James Wong are gratefully acknowledged.	ADOLFSSON R, 1980, LIFE SCI, V27, P1029, DOI 10.1016/0024-3205(80)90025-9; Agostinelli E, 2010, AMINO ACIDS, V38, P353, DOI 10.1007/s00726-009-0431-8; Airas L, 2008, NEUROPATH APPL NEURO, V34, P394, DOI 10.1111/j.1365-2990.2007.00911.x; Al-Nuaimi SK, 2012, AM J THER, V19, P436, DOI 10.1097/MJT.0b013e31825b9eb5; Amritraj A, 2013, J BIOL CHEM, V288, P3136, DOI 10.1074/jbc.M112.412460; Baillet A, 2010, NEUROCHEM RES, V35, P1530, DOI 10.1007/s11064-010-0212-5; BAKER GB, 1991, J AFFECT DISORDERS, V21, P207, DOI 10.1016/0165-0327(91)90041-P; Baker GB, 2012, KLIN PSIKOFARMAKOL B, V22, P293, DOI 10.5455/bcp.20121030014051; BEACH TG, 1989, GLIA, V2, P420, DOI 10.1002/glia.440020605; Bender K. J., 2012, PSYCHIAT TIMES, V29, P1; Benson CA, 2013, BEHAV BRAIN RES, V252, P302, DOI 10.1016/j.bbr.2013.06.019; Binda C, 2008, BIOCHEMISTRY-US, V47, P5616, DOI 10.1021/bi8002814; Boomsma F, 1997, CARDIOVASC RES, V33, P387, DOI 10.1016/S0008-6363(96)00209-X; BOOMSMA F, 1995, CLIN SCI, V88, P675, DOI 10.1042/cs0880675; Boomsma F, 2000, EUR HEART J, V21, P1859, DOI 10.1053/euhj.2000.2176; BOOR PJ, 1992, TOXICOLOGY, V73, P251, DOI 10.1016/0300-483X(92)90067-O; Bradley MA, 2010, FREE RADICAL BIO MED, V48, P1570, DOI 10.1016/j.freeradbiomed.2010.02.016; BUIGUES J, 1987, J CLIN PSYCHIAT, V48, P55; Burke WJ, 2004, NEUROTOXICOLOGY, V25, P101, DOI 10.1016/S0161-813X(03)00090-1; Burke WJ, 2003, BRAIN RES, V989, P205, DOI 10.1016/S0006-8993(03)03354-7; Butler B, 2017, J NEUROL SCI, V379, P29, DOI 10.1016/j.jns.2017.05.039; Casado A, 2008, NEUROCHEM RES, V33, P450, DOI 10.1007/s11064-007-9453-3; Cassarino DS, 1999, BBA-MOL BASIS DIS, V1453, P49, DOI 10.1016/S0925-4439(98)00083-0; Cebak JE, 2017, J NEUROTRAUM, V34, P1302, DOI 10.1089/neu.2016.4624; Chen Che-Hong, 2016, Acta Neurol Taiwan, V25(4), P111; Chen CM, 2009, NEUROBIOL DIS, V33, P429, DOI 10.1016/j.nbd.2008.11.011; Chen K, 2006, J NEUROCHEM, V99, P1413, DOI 10.1111/j.1471-4159.2006.04181.x; Chen Z, 2016, J NEUROCHEM, V138, P328, DOI 10.1111/jnc.13639; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Clineschmidt B. V., 1996, BIOCHEM PHARMACOL, V18, P1011; Dalfo E, 2005, J NEUROPATH EXP NEUR, V64, P816, DOI 10.1097/01.jnen.0000179050.54522.5a; Dalfo E, 2008, NEUROBIOL AGING, V29, P408, DOI 10.1016/j.neurobiolaging.2006.10.022; Dang Thanh Nam, 2010, Curr Mol Pharmacol, V3, P66; DAVIDSON J, 1987, BRIT J PSYCHIAT, V150, P252, DOI 10.1192/bjp.150.2.252; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Due MR, 2014, J NEUROCHEM, V128, P776, DOI 10.1111/jnc.12500; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fernandes HB, 2009, FRONT NEUROSCI, P16; Ferrer I, 2002, NEUROSCI LETT, V321, P21, DOI 10.1016/S0304-3940(01)02465-X; Finberg JPM, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00340; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FOWLER CJ, 1980, J NEURAL TRANSM, V49, P1, DOI 10.1007/BF01249185; Fowler JS, 1997, NEUROBIOL AGING, V18, P431, DOI 10.1016/S0197-4580(97)00037-7; Fowler JS, 2002, METHODS, V27, P263, DOI 10.1016/S1046-2023(02)00083-X; GALVA MD, 1995, J NEURAL TRANSM-GEN, V101, P83, DOI 10.1007/BF01271547; Garpenstrand H, 1999, DIABETIC MED, V16, P514, DOI 10.1046/j.1464-5491.1999.00103.x; Gillman PK, 2011, J CLIN PSYCHOPHARM, V31, P66, DOI 10.1097/JCP.0b013e31820469ea; Gomez-Ramos A, 2003, J NEUROSCI RES, V71, P863, DOI 10.1002/jnr.10525; Green AR, 2000, NEUROPHARMACOLOGY, V39, P1483, DOI 10.1016/S0028-3908(99)00233-6; Greilberger J, 2008, FREE RADICAL RES, V42, P633, DOI 10.1080/10715760802255764; Gubisne-Haberle D, 2004, J PHARMACOL EXP THER, V310, P1125, DOI 10.1124/jpet.104.068601; Gustaw-Rothenberg K, 2010, GERIATR GERONTOL INT, V10, P161, DOI 10.1111/j.1447-0594.2009.00571.x; Hernandez MD, 2005, NEUROSCI LETT, V384, P183, DOI 10.1016/j.neulet.2005.04.074; Hernandez-Guillamon M, 2012, CEREBROVASC DIS, V33, P55, DOI 10.1159/000333370; Holt A, 2004, NEUROTOXICOLOGY, V25, P251, DOI 10.1016/S0161-813X(03)00104-9; HOUEN G, 1994, ACTA CHEM SCAND, V48, P52, DOI 10.3891/acta.chem.scand.48-0052; Huang YJ, 2013, TOXICOL LETT, V217, P184, DOI 10.1016/j.toxlet.2012.12.023; Ilic TV, 1999, FUNCT NEUROL, V14, P141; Jiang ZJ, 2008, NEUROPATH APPL NEURO, V34, P194, DOI 10.1111/j.1365-2990.2007.00886.x; JOHNSTON JP, 1968, BIOCHEM PHARMACOL, V17, P1285, DOI 10.1016/0006-2952(68)90066-X; JOSSAN SS, 1991, NEUROSCIENCE, V45, P1, DOI 10.1016/0306-4522(91)90098-9; Karadi I, 2002, CLIN CHIM ACTA, V323, P139, DOI 10.1016/S0009-8981(02)00189-4; Kuhla B, 2007, J BIOL CHEM, V282, P6984, DOI 10.1074/jbc.M609521200; Kulbe JR, 2018, J NEUROTRAUM, V35, P1280, DOI 10.1089/neu.2017.5353; Kumpula D. J., 2013, THESIS; Lee CS, 2003, NEUROCHEM RES, V28, P1833, DOI 10.1023/A:1026119708124; Leung G, 2011, NEUROSCIENCE, V173, P150, DOI 10.1016/j.neuroscience.2010.11.018; Li XH, 2012, NEUROMOL MED, V14, P338, DOI 10.1007/s12017-012-8191-0; LIEBOWITZ MR, 1988, J CLIN PSYCHIAT, V49, P252; Lin YZ, 2018, NEUROSCIENCE, V384, P120, DOI 10.1016/j.neuroscience.2018.05.029; Liu XY, 1996, DEMENTIA, V7, P128, DOI 10.1159/000106867; Liu-Snyder P, 2006, J NEUROSCI RES, V84, P219, DOI 10.1002/jnr.20862; Lizcano JM, 1996, BIOCHEM PHARMACOL, V52, P187, DOI 10.1016/0006-2952(96)00132-3; Lovell MA, 2001, NEUROBIOL AGING, V22, P187, DOI 10.1016/S0197-4580(00)00235-9; LYLES GA, 1992, BIOCHEM PHARMACOL, V43, P1409, DOI 10.1016/0006-2952(92)90196-P; Lyles GA, 1996, INT J BIOCHEM CELL B, V28, P259, DOI 10.1016/1357-2725(95)00130-1; LYLES GA, 1990, J PHARM PHARMACOL, V42, P322; MacKenzie E. M., 2009, THESIS; MacKenzie EM, 2008, BIOORGAN MED CHEM, V16, P8254, DOI 10.1016/j.bmc.2008.07.027; MacKenzie EM, 2010, KLIN PSIKOFARMAKOL B, V20, P179, DOI 10.1080/10177833.2010.11790656; Marchitti SA, 2007, PHARMACOL REV, V59, P125, DOI 10.1124/pr.59.2.1; Marcus DL, 1998, EXP NEUROL, V150, P40, DOI 10.1006/exnr.1997.6750; Martin-Aragon S, 2009, NEUROCHEM RES, V34, P373, DOI 10.1007/s11064-008-9789-3; Matveychuk D., 2015, THESIS; Matveychuk D, 2013, J NEURAL TRANSM, V120, P987, DOI 10.1007/s00702-013-0978-0; Matveychuk D, 2011, KLIN PSIKOFARMAKOL B, V21, P277, DOI 10.5455/bcp.19691231040000; MCGRATH PJ, 1986, J CLIN PSYCHIAT, V47, P420; MCMANUS DJ, 1992, BIOCHEM PHARMACOL, V43, P2486, DOI 10.1016/0006-2952(92)90331-C; Meszaros Z, 1999, METABOLISM, V48, P113, DOI 10.1016/S0026-0495(99)90019-7; Moghe A, 2015, TOXICOL SCI, V143, P242, DOI 10.1093/toxsci/kfu233; Musgrave T, 2011, BRAIN BEHAV IMMUN, V25, P1677, DOI 10.1016/j.bbi.2011.06.011; Mustafa AG, 2018, EXP THER MED, V16, P2132, DOI 10.3892/etm.2018.6419; Mustafa AG, 2018, ARCH PHYSIOL BIOCHEM, V124, P418, DOI 10.1080/13813455.2017.1415939; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; Niemann B, 2017, J AM COLL CARDIOL, V70, P230, DOI 10.1016/j.jacc.2017.05.043; O'Brien PJ, 2005, CRIT REV TOXICOL, V35, P609, DOI 10.1080/10408440591002183; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Ong WY, 2013, J ALZHEIMERS DIS, V35, P643, DOI 10.3233/JAD-121990; ORELAND L, 1986, PROG NEURO-PSYCHOPH, V10, P533, DOI 10.1016/0278-5846(86)90023-0; Ou JJ, 2002, EXP NEUROL, V175, P363, DOI 10.1006/exnr.2002.7923; Padurariu M, 2010, NEUROSCI LETT, V469, P6, DOI 10.1016/j.neulet.2009.11.033; Panneton WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015251; Park J, 2015, J NEUROCHEM, V135, P987, DOI 10.1111/jnc.13352; Paslawski T, 2001, DRUG DEVELOP RES, V54, P35, DOI 10.1002/ddr.1202; Paslawski TM, 1995, PROG BRAIN RES, V106, P181; PATEK DR, 1974, J BIOL CHEM, V249, P2373; Perluigi M, 2012, ANTIOXID REDOX SIGN, V17, P1590, DOI 10.1089/ars.2011.4406; POPOV N, 1969, J NEUROCHEM, V16, P899, DOI 10.1111/j.1471-4159.1969.tb08978.x; PRECIOUS E, 1988, J PHARM PHARMACOL, V40, P627, DOI 10.1111/j.2042-7158.1988.tb05322.x; Quartey MO, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00419; REINIKAINEN KJ, 1988, NEUROBIOL AGING, V9, P245, DOI 10.1016/S0197-4580(88)80061-7; Revett TJ, 2013, J PSYCHIATR NEUROSCI, V38, P6, DOI 10.1503/jpn.110190; Riederer P, 1987, Adv Neurol, V45, P111; Robinson D S, 1987, J Clin Psychopharmacol, V7, P61, DOI 10.1097/00004714-198702000-00034; Romano A, 2017, FREE RADICAL BIO MED, V111, P281, DOI 10.1016/j.freeradbiomed.2016.12.046; Ruiz P., 2009, KAPLAN SADOCKS COMPR, P3154; SAURA J, 1994, NEUROSCIENCE, V62, P15, DOI 10.1016/0306-4522(94)90311-5; Schwartz-Bloom RD, 2001, J NEUROCHEM, V77, P353, DOI 10.1046/j.1471-4159.2001.00274.x; Serra JA, 2009, NEUROCHEM RES, V34, P2122, DOI 10.1007/s11064-009-9997-5; Shamoto-Nagai M, 2007, J NEURAL TRANSM, V114, P1559, DOI 10.1007/s00702-007-0789-2; Shaw PJ, 1997, J NEUROL, V244, pS3, DOI 10.1007/BF03160574; SHEEHAN DV, 1980, ARCH GEN PSYCHIAT, V37, P51; Shemyakov SE, 2001, B EXP BIOL MED+, V131, P586, DOI 10.1023/A:1012371106766; SHERIF F, 1992, J NEURAL TRANSM-PARK, V4, P227, DOI 10.1007/BF02260906; Shi R, 2015, FREE RADICAL RES, V49, P888, DOI 10.3109/10715762.2015.1021696; Shi YZ, 2011, J NEUROCHEM, V117, P554, DOI 10.1111/j.1471-4159.2011.07226.x; Shih JC, 1999, ANNU REV NEUROSCI, V22, P197, DOI 10.1146/annurev.neuro.22.1.197; Shuaib A, 1997, HISTOL HISTOPATHOL, V12, P185; Sinem F, 2010, CURR ALZHEIMER RES, V7, P463, DOI 10.2174/156720510791383822; Singh IN, 2013, J CEREBR BLOOD F MET, V33, P593, DOI 10.1038/jcbfm.2012.211; Song MS, 2013, PROG NEURO-PSYCHOPH, V44, P118, DOI 10.1016/j.pnpbp.2013.02.001; Song MS, 2010, J NEUROCHEM, V114, P1405, DOI 10.1111/j.1471-4159.2010.06857.x; SPARKS DL, 1991, ARCH NEUROL-CHICAGO, V48, P718, DOI 10.1001/archneur.1991.00530190064017; Stewart JW, 2007, J CLIN PSYCHIAT, V68, P25, DOI 10.4088/JCP.0407e10; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; Sultana R, 2013, FREE RADICAL BIO MED, V62, P157, DOI 10.1016/j.freeradbiomed.2012.09.027; Tanay VA, 2002, P 23 C COLL INT NEUR; THASE ME, 1995, NEUROPSYCHOPHARMACOL, V12, P185, DOI 10.1016/0893-133X(94)00058-8; TIPTON KF, 1972, BIOCHEM PHARMACOL, V21, P268, DOI 10.1016/0006-2952(72)90278-X; TIPTON KF, 1972, BIOCHEM J, V128, P913, DOI 10.1042/bj1280913; TIPTON KF, 1971, BIOCHEM J, V121, pP33, DOI 10.1042/bj1210033P; Todd KG, 2008, J PHARM PHARM SCI, V11, P14, DOI 10.18433/J34S38; Todd KG, 1995, J AFFECT DISORDERS, V35, P125, DOI 10.1016/0165-0327(95)00056-9; Todd KG, 1999, J NEUROCHEM, V73, pS202; Tully M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00420; Uchida K, 1998, P NATL ACAD SCI USA, V95, P4882, DOI 10.1073/pnas.95.9.4882; Unzeta M, 2007, J NEURAL TRANSM, V114, P857, DOI 10.1007/s00702-007-0701-0; Volchegorskii IA, 2001, B EXP BIOL MED+, V132, P760, DOI 10.1023/A:1013081912452; Wang W, 2004, ACTA PHARMACOL SIN, V25, P630; Wei Z, 2008, NEUROPHARMACOLOGY, V54, P721, DOI 10.1016/j.neuropharm.2007.12.006; Williams TI, 2006, NEUROBIOL AGING, V27, P1094, DOI 10.1016/j.neurobiolaging.2005.06.004; WONG JTF, 1990, BRAIN RES BULL, V25, P179, DOI 10.1016/0361-9230(90)90272-2; Wood PL, 2006, J PSYCHIATR NEUROSCI, V31, P296; Wood PL, 2006, BRAIN RES, V1122, P184, DOI 10.1016/j.brainres.2006.09.003; Xiao MQ, 2017, FREE RADICAL BIO MED, V111, P316, DOI 10.1016/j.freeradbiomed.2017.04.363; Yang L, 2004, NEUROSCI LETT, V357, P73, DOI 10.1016/j.neulet.2003.12.032; Yang L, 2003, J NEUROCHEM, V87, P791, DOI 10.1046/j.1471-4159.2003.02069.x; Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883; YU PH, 1990, J PHARM PHARMACOL, V42, P882, DOI 10.1111/j.2042-7158.1990.tb07048.x; YU PH, 1989, BIOCHEM PHARMACOL, V38, P4245, DOI 10.1016/0006-2952(89)90522-4; Zhang W, 2007, EXPERT OPIN PHARMACO, V8, P1861, DOI 10.1517/14656566.8.12.1861	162	12	13	2	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0009-2797	1872-7786		CHEM-BIOL INTERACT	Chem.-Biol. Interact.	MAY 1	2019	304						139	147		10.1016/j.cbi.2019.03.003			9	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology	HU0BZ	WOS:000464937700015	30857888	hybrid			2022-02-06	
J	Ballard, DW; Kuppermann, N; Vinson, DR; Tham, E; Hoffman, JM; Swietlik, M; Davies, SJD; Alessandrini, EA; Tzimenatos, L; Bajaj, L; Mark, DG; Offerman, SR; Chettipally, UK; Paterno, MD; Schaeffer, MH; Richards, R; Casper, TC; Goldberg, HS; Grundmeier, RW; Dayan, PS				Ballard, Dustin W.; Kuppermann, Nathan; Vinson, David R.; Tham, Eric; Hoffman, Jeff M.; Swietlik, Marguerite; Davies, Sara J. Deakyne; Alessandrini, Evaline A.; Tzimenatos, Leah; Bajaj, Lalit; Mark, Dustin G.; Offerman, Steve R.; Chettipally, Uli K.; Paterno, Marilyn D.; Schaeffer, Molly H.; Richards, Rachel; Casper, T. Charles; Goldberg, Howard S.; Grundmeier, Robert W.; Dayan, Peter S.		PECARN; Clinical Res Emergency Serv	Implementation of a Clinical Decision Support System for Children With Minor Blunt Head Trauma Who Are at Nonnegligible Risk for Traumatic Brain Injuries	ANNALS OF EMERGENCY MEDICINE			English	Article							COMPUTED-TOMOGRAPHY USE; EMERGENCY-DEPARTMENT; CT; RULE; ASSOCIATION; PECARN; TRIAL; SCAN	Study objective: To determine the effect of providing risk estimates of clinically important traumatic brain injuries and management recommendations on emergency department (ED) outcomes for children with isolated intermediate Pediatric Emergency Care Applied Research Network clinically important traumatic brain injury risk factors. Methods: This was a secondary analysis of a nonrandomized clinical trial with concurrent controls, conducted at 5 pediatric and 8 general EDs betweenNovember 2011 and June 2014, enrolling patients younger than 18 yearswho hadminor blunt head trauma. After a baseline period, intervention sites received electronic clinical decision support providing patient-level clinically important traumatic brain injury risk estimates and management recommendations. The following primary outcomes in patients with one intermediate Pediatric Emergency Care Applied Research Network risk factor were compared before and after clinical decision support: proportion of ED computed tomography (CT) scans, adjusted for age, time trend, and site; and prevalence of clinically important traumatic brain injuries. Results: The risk of clinically important traumatic brain injuries was known for 3,859 children with isolated findings (1,711 at intervention sites before clinical decision support, 1,702 at intervention sites after clinical decision support, and 446 at control sites). In this group, pooled CT proportion decreased from 24.2% to 21.6% after clinical decision support (odds ratio 0.86; 95% confidence interval 0.73 to 1.01). Decreases in CT use were noted across intervention EDs, but not in controls. The pooled adjusted odds ratio for CT use after clinical decision support was 0.73 (95% confidence interval 0.60 to 0.88). Among the entire cohort, clinically important traumatic brain injury was diagnosed at the index ED visit for 37 of 37 (100%) patients before clinical decision support and 32 of 33 patients (97.0%) after clinical decision support. Conclusion: Providing specific risks of clinically important traumatic brain injury through electronic clinical decision support was associated with a modest and safe decrease in ED CT use for children at nonnegligible risk of clinically important traumatic brain injuries.	[Ballard, Dustin W.; Vinson, David R.; Mark, Dustin G.] Kaiser Permanente, Div Res, Oakland, CA 94612 USA; [Ballard, Dustin W.] Kaiser Permanente, San Rafael Med Ctr, San Rafael, CA 94903 USA; [Kuppermann, Nathan; Tzimenatos, Leah] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA; [Vinson, David R.] Kaiser Permanente, Med Ctr, Sacramento, CA USA; [Tham, Eric; Bajaj, Lalit] Univ Colorado, Sect Emergency Med, Dept Pediat, Aurora, CO USA; [Hoffman, Jeff M.] Childrens Hosp, 700 Childrens Dr, Columbus, OH 43205 USA; [Swietlik, Marguerite; Davies, Sara J. Deakyne] Childrens Hosp Colorado, Dept Res Informat, Aurora, CO USA; [Alessandrini, Evaline A.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Mark, Dustin G.] Kaiser Permanente, Oakland Med Ctr, Oakland, CA USA; [Offerman, Steve R.] Kaiser Permanente, South Sacramento Med Ctr, Sacramento, CA USA; [Chettipally, Uli K.] Kaiser Permanente, South San Francisco Med Ctr, San Francisco, CA USA; [Paterno, Marilyn D.; Goldberg, Howard S.] Brigham & Womens Hosp, Div Gen Internal Med, 75 Francis St, Boston, MA 02115 USA; [Paterno, Marilyn D.; Goldberg, Howard S.] Harvard Med Sch, Boston, MA 02115 USA; [Schaeffer, Molly H.; Goldberg, Howard S.] Partners HealthCare Syst, Informat Syst, Boston, MA USA; [Richards, Rachel; Casper, T. Charles] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Grundmeier, Robert W.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Grundmeier, Robert W.] Perelman Sch Med, Philadelphia, PA USA; [Dayan, Peter S.] Columbia Univ Coll Phys & Surg, Div Emergency Med, Dept Pediat, New York, NY USA		Ballard, DW (corresponding author), Kaiser Permanente, Div Res, Oakland, CA 94612 USA.; Ballard, DW (corresponding author), Kaiser Permanente, San Rafael Med Ctr, San Rafael, CA 94903 USA.	dustin.ballard@kp.org	Vinson, David R/AAK-3227-2020	Vinson, David R/0000-0001-6559-1858; Ballard, Dustin/0000-0002-5801-8794	American Recovery and Reinvestment Act-Office of the Secretary grant [S02MC19289-01-00]; Health Resources and Services Administration, Maternal and Child Health Bureau, Emergency Medical Services for Children Program [U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008, U03MC22684, U03MC22685]	By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org).The authors have stated that no such relationships exist. This study was supported by American Recovery and Reinvestment Act-Office of the Secretary grant S02MC19289-01-00. PECARN is supported by the Health Resources and Services Administration, Maternal and Child Health Bureau, Emergency Medical Services for Children Program through the following cooperative agreements: U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008, U03MC22684, and U03MC22685. Dr. Goldberg provides consultation to the following companies: Intelligent Medical Objects, Chicago, IL, and Practical Solutions in Medical Informatics, Pt Richmond, CA; and is on the Advisory Committee of Clearsense, Jacksonville, FL.	Atabaki SM, 2016, ACAD EMERG MED, V23, P566, DOI 10.1111/acem.12923; Babl FE, 2018, ANN EMERG MED, V71, P703, DOI 10.1016/j.annemergmed.2018.01.015; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Bennett P, 2017, J AM MED INFORM ASSN, V24, P655, DOI 10.1093/jamia/ocw151; Bressan S, 2012, ACAD EMERG MED, V19, P801, DOI 10.1111/j.1553-2712.2012.01384.x; Burstein B, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0814; Chen C, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040414; Curran JA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-25; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; Dayan PS, 2015, PEDIATRICS, V135, P504, DOI 10.1542/peds.2014-2695; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Dayan PS, 2014, ANN EMERG MED, V63, P657, DOI 10.1016/j.annemergmed.2014.01.009; Deakyne SJ, 2015, APPL CLIN INFORM, V6, P521, DOI 10.4338/ACI-2015-02-RA-0019; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Faul M, 2010, TRAUMATIC BRAIN INJU; Frush DP, 2008, PEDIAT RADIOL; Hamilton M, 2010, PEDIATRICS, V126, pE33, DOI 10.1542/peds.2009-0692; Hess EP, 2016, BMJ-BRIT MED J, V355, pi6165; Jennings RM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1349; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Larson DB, 2011, RADIOLOGY, V259, P793, DOI 10.1148/radiol.11101939; Lee LK, 2014, JAMA PEDIATR, V168, P837, DOI 10.1001/jamapediatrics.2014.361; Lee S, 2017, J AM COLL RADIOL, V14, P294, DOI 10.1016/j.jacr.2016.10.006; Lumba-Brown A, 2018, ANN EMERG MED, V72, P581, DOI 10.1016/j.annemergmed.2018.03.045; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Marin JR, 2014, ACAD EMERG MED, V21, P987, DOI 10.1111/acem.12458; Mooney JS, 2011, EMERG MED J, V28, P778, DOI 10.1136/emj.2009.083360; Mower WR, 2017, LANCET, V389, P2354, DOI 10.1016/S0140-6736(17)30932-7; Nigrovic LE, 2015, PEDIATRICS, V136, pE227, DOI 10.1542/peds.2014-3588; Nigrovic LE, 2013, PEDIATRICS, V132, pE689, DOI 10.1542/peds.2013-0909; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Nishijima DK, 2015, JAMA PEDIATR, V169, P1141, DOI 10.1001/jamapediatrics.2015.2743; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Schonfeld D, 2013, ANN EMERG MED, V62, P597, DOI 10.1016/j.annemergmed.2013.06.020; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; Sharp AL, 2018, ANN EMERG MED, V71, P54, DOI 10.1016/j.annemergmed.2017.06.022; Singh N, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.8732; Song H, 2015, MANAGE SCI, V61, P3032, DOI 10.1287/mnsc.2014.2118; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; 2018, APPL CLIN INFORM, V9, P693, DOI DOI 10.1055/S-0038-1669460	42	12	13	0	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.	MAY	2019	73	5					440	451		10.1016/j.annemergmed.2018.11.011			12	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HU8PN	WOS:000465551700010	30583957	Bronze			2022-02-06	
J	Ben Barnes, J; Presseau, C; Jordan, AH; Kline, NK; Young-McCaughan, S; Keane, TM; Peterson, AL; Litz, BT; Abdallah, CG; Averill, LA; Bryan, CJ; Cigrang, JA; Fox, PT; Fredman, SJ; Krystal, JH; McDevitt-Murphy, ME; McGeary, DD; Pruiksma, KE; Resick, PA; Roache, JD; Taylor, DJ				Ben Barnes, J.; Presseau, Candice; Jordan, Alexander H.; Kline, Nora K.; Young-McCaughan, Stacey; Keane, Terence M.; Peterson, Alan L.; Litz, Brett T.; Abdallah, Chadi G.; Averill, Lynnette A.; Bryan, Craig J.; Cigrang, Jeffrey A.; Fox, Peter T.; Fredman, Steffany J.; Krystal, John H.; McDevitt-Murphy, Meghan E.; McGeary, Donald D.; Pruiksma, Kristi E.; Resick, Patricia A.; Roache, John D.; Taylor, Daniel J.		Consortium Alleviate PTSD	Common Data Elements in the Assessment of Military-Related PTSD Research Applied in the Consortium to Alleviate PTSD	MILITARY MEDICINE			English	Article							DISORDERS IDENTIFICATION TEST; GENERALIZED ANXIETY DISORDER; TRAUMATIC BRAIN-INJURY; QUICK DRINKING SCREEN; PSYCHOMETRIC PROPERTIES; FAGERSTROM TEST; TIMELINE FOLLOWBACK; NICOTINE DEPENDENCE; INITIAL VALIDATION; SLEEP DISTURBANCE	Introduction: Driven by the need to share data, sufficiently power studies, and allow for cross-study comparisons of medical and psychiatric diseases, the President's National Research Action Plan issued in 2013 called for the use of state-of-the-art common data elements (CDEs) for research studies. CDEs are variables measured across independent studies that facilitate methodologically sound data aggregation and study replication. Researchers in the field of military-related post-traumatic stress disorder (PTSD) have suggested applicable CDEs; however, to date, these recommendations have been conceptual and not field-tested. The Consortium to Alleviate PTSD (CAP) -an interdisciplinary and multi-institutional, military-related PTSD research consortium funded by the Departments of Defense and Veterans Affairs -generated and applied CDEs that can be used to combine data from disparate studies to improve the methodological and statistical capabilities of study findings. We provide a description and rationale for the CAP CDEs and details about administration with two main goals: (1) to encourage military-related PTSD researchers to use these measures in future studies and (2) to facilitate comparison, replication, and data aggregation. Materials and Methods: The CAP compiled mandated (core) and optional CDEs based on the following criteria: (1) construct applicability to military-related PTSD; (2) precedence (use) in prior, related research; (3) published and strong psychometric evidence; (4) no cost (public domain); and (5) brevity, to limit participant burden. We provided descriptive statistics and internal consistency reliabilities for mandated measures from an initial cohort of around 400 participants enrolled in CAP studies. Results: Mandated CDEs in the CAP were found to have very good internal consistency reliability. Conclusion: Although further research is needed to determine the incremental validity of these CDEs, preliminary analyses indicated that each mandated measure has very good internal consistency reliability. Investigators designing militaryrelated PTSD research should consider using these field-tested CDEs to facilitate future data aggregation. Feedback based on empirical evidence or practical concerns to improve these CDEs is welcome.	[Ben Barnes, J.; Presseau, Candice; Jordan, Alexander H.; Kline, Nora K.; Litz, Brett T.] VA Boston Healthcare Syst, MAVERIC, Massachusetts Vet Epidemiol Res & Informat Ctr, 150 S Huntington Ave, Boston, MA 02130 USA; [Jordan, Alexander H.; Keane, Terence M.; Litz, Brett T.] Boston Univ, Dept Psychiat, Sch Med, 72 East Concord St, Boston, MA 02118 USA; [Young-McCaughan, Stacey; Peterson, Alan L.; McGeary, Donald D.; Pruiksma, Kristi E.; Roache, John D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Keane, Terence M.] VA Boston Healthcare Syst, Natl Ctr PTSD, Behav Sci Div, 7703 Floyd Curl Dr, Boston, MA 02130 USA; [Peterson, Alan L.] South Texas Vet Hlth Care Syst, Res & Dev Serv, 7400 Merton Minter, San Antonio, TX 78229 USA; [Peterson, Alan L.] Univ Texas San Antonio, Dept Psychol, One UTSA Circle, San Antonio, TX 78249 USA; [Litz, Brett T.] Boston Univ, Dept Psychol & Brain Sci, 64 Cummington Mall, Boston, MA 02215 USA; [Abdallah, Chadi G.; Averill, Lynnette A.; Krystal, John H.] VA Connecticut Healthcare Syst, Clin Neurosci Div, Natl Ctr PTSD, 950 Campbell Ave,151E, West Haven, CT 06516 USA; [Abdallah, Chadi G.; Averill, Lynnette A.; Krystal, John H.] Yale Univ, Sch Med, Dept Psychiat, 300 George St,Suite 901, New Haven, CT 06511 USA; [Bryan, Craig J.] Univ Utah, Natl Ctr Vet Studies, 260 S Cent Campus Dr,Suite 3525, Salt Lake City, UT 84112 USA; [Bryan, Craig J.] Univ Utah, Dept Psychol, 260 S Cent Campus Dr,Suite 3525, Salt Lake City, UT 84112 USA; [Cigrang, Jeffrey A.] Wright State Univ, Sch Profess Psychol, 9 N Edwin C Moses Blvd, Dayton, OH 45402 USA; [Fox, Peter T.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Fredman, Steffany J.] Penn State Univ, Dept Human Dev & Family Studies, 115 Hlth & Human Dev Bldg, University Pk, PA 16802 USA; [McDevitt-Murphy, Meghan E.] Univ Memphis, Dept Psychol, 400 Innovat Dr, Memphis, TN 38152 USA; [Resick, Patricia A.] Duke Univ, Dept Psychiat & Behav Sci, 1121 West Chapel Hill Rd,Suite 201, Durham, NC 27701 USA; [Taylor, Daniel J.] Univ North Texas, Dept Psychol, 1155 Union Circle 311280, Denton, TX 76203 USA		Ben Barnes, J (corresponding author), VA Boston Healthcare Syst, MAVERIC, Massachusetts Vet Epidemiol Res & Informat Ctr, 150 S Huntington Ave, Boston, MA 02130 USA.		Abdallah, Chadi/M-9969-2017; Keane, Terence/I-8253-2014	Abdallah, Chadi/0000-0001-5783-6181; Litz, Brett/0000-0002-0479-8887; Keane, Terence/0000-0002-0482-3149	Consortium to Alleviate PTSD award from the United States Department of Defense, Defense Health Program, Psychological Health and Traumatic Brain Injury Research Program (PH/TBI RP) [W81XWH-13-2-0065]; Consortium to Alleviate PTSD award from the United States Department of Veterans Affairs, Office of Research & Development, Clinical Science Research & Development Service [I01CX001136-01]	This research was supported by Consortium to Alleviate PTSD award numbers W81XWH-13-2-0065 from the United States Department of Defense, Defense Health Program, Psychological Health and Traumatic Brain Injury Research Program (PH/TBI RP), and I01CX001136-01 from the United States Department of Veterans Affairs, Office of Research & Development, Clinical Science Research & Development Service.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Babor TF, 2001, AUDIT ALCOHOL USE DI; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Batterham PJ, 2015, PSYCHOL ASSESSMENT, V27, P501, DOI 10.1037/pas0000053; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Buysse DJ, 2010, SLEEP, V33, P781, DOI 10.1093/sleep/33.6.781; Cameron IM, 2008, BRIT J GEN PRACT, V58, P32, DOI 10.3399/bjgp08X263794; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; de Meneses-Gaya IC, 2009, J BRAS PNEUMOL, V35, P73, DOI 10.1590/S1806-37132009000100011; Department of Defense and Department of Veterans Affairs, 2013, NAT RES ACT PLAN RES; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; Ebbert JO, 2006, ADDICT BEHAV, V31, P1716, DOI 10.1016/j.addbeh.2005.12.015; Erb SE, 2015, 31 ANN M INT SOC TRA; Foa EB, 1999, PSYCHOL ASSESSMENT, V11, P303, DOI 10.1037/1040-3590.11.3.303; Forbes D, 2004, J TRAUMA STRESS, V17, P249, DOI 10.1023/B:JOTS.0000029268.22161.bd; Forbes D, 2014, DEPRESS ANXIETY, V31, P166, DOI 10.1002/da.22148; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Johnson DC, 2011, MIL MED, V176, P161, DOI 10.7205/MILMED-D-10-00258; Kaloupek DG, 2010, ARCH PHYS MED REHAB, V91, P1684, DOI 10.1016/j.apmr.2010.06.032; Kazis LE, 2008, RAND VETERANS 12 ITE; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Kubany ES, 1996, PSYCHOL ASSESSMENT, V8, P428, DOI 10.1037/1040-3590.8.4.428; Lehrner A, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.23797; Litz BT, 2018, J TRAUMA STRESS, V31, P286, DOI 10.1002/jts.22276; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Marx B. P., 2013, DEV VALIDATION PTSD; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Metalsky GI, 1997, COGNITIVE THER RES, V21, P359, DOI 10.1023/A:1021882717784; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Nash WP, 2010, ARCH PHYS MED REHAB, V91, P1673, DOI 10.1016/j.apmr.2010.06.035; Nock MK, 2007, PSYCHOL ASSESSMENT, V19, P309, DOI 10.1037/1040-3590.19.3.309; Novaco RW, 2012, PSYCHOL ASSESSMENT, V24, P661, DOI 10.1037/a0026636; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Roy M, 2008, SUBST USE MISUSE, V43, P2116, DOI 10.1080/10826080802347586; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schwab KA, 2006, NEUROLOGY, V66, pA235; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sheehan J, 2016, CLIN TRIALS, V13, P671, DOI 10.1177/1740774516653238; Sobell LC, 2003, J STUD ALCOHOL, V64, P858, DOI 10.15288/jsa.2003.64.858; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stein NR, 2012, BEHAV MODIF, V36, P787, DOI 10.1177/0145445512446945; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Straus Murray A, 2004, Violence Vict, V19, P507; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Weathers F.W., 2013, PTSD CHECKLIST DSM 5; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Weathers FW., 2013, PTSD CHECKLIST DSM 5; Weinfurt KP, 2015, J SEX MED, V12, P1961, DOI 10.1111/jsm.12966; Yu L, 2012, BEHAV SLEEP MED, V10, P6, DOI 10.1080/15402002.2012.636266	52	12	12	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY-JUN	2019	184	5-6					E218	E226		10.1093/milmed/usy226			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HY5SU	WOS:000468188900015	30252077	hybrid			2022-02-06	
J	Jurick, SM; Crocker, LD; Keller, AV; Hoffman, SN; Bomyea, J; Jacobson, MW; Jak, AJ				Jurick, S. M.; Crocker, L. D.; Keller, A. V.; Hoffman, S. N.; Bomyea, J.; Jacobson, M. W.; Jak, A. J.			The Minnesota Multiphasic Personality Inventory-2-RF in Treatment-Seeking Veterans with History of Mild Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Symptom validity testing; Head injury; Traumatic brain injury; Assessment; Posttraumatic stress disorder; Depression	POSTTRAUMATIC-STRESS-DISORDER; PERFORMANCE VALIDITY TESTS; IRAQI FREEDOM VETERANS; RESPONSE BIAS SCALE; SYMPTOM VALIDITY; RESTRUCTURED FORM; NEUROPSYCHOLOGICAL ASSESSMENT; INADEQUATE EFFORT; MMPI-2 VALIDITY; UTILITY	Objective: This study examined the Minnesota Multiphasic Personality Inventory-Second Edition-Restructured Form (MMPI-2-RF) to better understand symptom presentation in a sample of treatment-seeking Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans with self-reported history of mild traumatic brain injury (mTBI). Method: Participants underwent a comprehensive clinical neuropsychological battery including performance and symptom validity measures and self-report measures of depressive, posttraumatic, and post-concussive symptomatology. Those with possible symptom exaggeration (SE+) on the MMPI-2-RF were compared with those without (SE-) with regard to injury, psychiatric, validity, and cognitive variables. Results: Between 50% and 87% of participants demonstrated possible symptom exaggeration on one or more MMPI-2-RF validity scales, and a large majority were elevated on content scales related to cognitive, somatic, and emotional complaints. The SE+ group reported higher depressive, posttraumatic, and post-concussive symptomatology, had higher scores on symptom validity measures, and performed more poorly on neuropsychological measures compared with the SE- group. There were no group differences with regard to injury variables or performance validity measures. Participants were more likely to exhibit possible symptom exaggeration on cognitive/somatic compared with traditional psychopathological validity scales. Conclusions: A sizable portion of treatment-seeking OEF/OIF Veterans demonstrated possible symptom exaggeration on MMPI-2-RF validity scales, which was associated with elevated scores on self-report measures and poorer cognitive performance, but not higher rates of performance validity failure, suggesting symptom and performance validity are distinct concepts. These findings have implications for the interpretation of clinical data in the context of possible symptom exaggeration and treatment in Veterans with persistent post-concussive symptoms.	[Jurick, S. M.] Univ Calif San Diego, San Diego State Univ, Joint Doctoral Program Clin Psychol, Dept Psychiat, San Diego, CA 92103 USA; [Jurick, S. M.] Vet Med Res Fdn, San Diego, CA USA; [Crocker, L. D.; Keller, A. V.; Hoffman, S. N.; Bomyea, J.; Jacobson, M. W.; Jak, A. J.] VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA USA; [Crocker, L. D.; Jak, A. J.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Jacobson, M. W.; Jak, A. J.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA		Jurick, SM (corresponding author), VA San Diego Healthcare Syst, 3350 La Jolla Village Dr MC 151B, San Diego, CA 92161 USA.	sjurick@ucsd.edu		Keller, Amber/0000-0002-2972-784X; Hoffman, Samantha/0000-0002-2792-8576	Department of DefenseUnited States Department of Defense [W81XWH-11-1-0641]; VA Office of Academic Affiliations Interprofessional Polytrauma and Traumatic Brain Injury Rehabilitation Fellowship	The authors have no conflicts of interest to report, and none have any financial interest with the subject matter discussed in the manuscript. The views expressed herein are those of the authors and do not necessarily reflect the views or the official policy of the Department of Veterans Affairs or U.S. Government. Authors were supported in part by Department of Defense award W81XWH-11-1-0641. Laura Crocker was supported by the VA Office of Academic Affiliations Interprofessional Polytrauma and Traumatic Brain Injury Rehabilitation Fellowship.	Anestis JC, 2015, ASSESSMENT, V22, P279, DOI 10.1177/1073191114541672; Arbisi PA, 2011, PSYCHOL ASSESSMENT, V23, P203, DOI 10.1037/a0021339; Armistead-Jehle P, 2016, APPL NEUROPSYCH-ADUL, V23, P264, DOI 10.1080/23279095.2015.1055564; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Axelrod BN, 2010, CLIN NEUROPSYCHOL, V24, P873, DOI 10.1080/13854040903527295; Bahraini NH, 2018, J HEAD TRAUMA REHAB, V33, pE7, DOI 10.1097/HTR.0000000000000307; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Burchett D, 2016, PSYCHOL ASSESSMENT, V28, P458, DOI 10.1037/pas0000205; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Butcher J, 1989, MANUAL ADM SCORING M; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2011, ARCH CLIN NEUROPSYCH, V26, P718, DOI 10.1093/arclin/acr070; Delis D.C., 1999, CALIFORNIA VERBAL LE, VSecond; Delis DC., 2001, DELIS KAPLAN EXECUTI; Denning J., 2012, M AM AC CLIN NEUR SE; Dretsch MN, 2017, APPL NEUROPSYCH-ADUL, V24, P376, DOI 10.1080/23279095.2016.1220947; Gass CS, 2012, J CLIN EXP NEUROPSYC, V34, P561, DOI 10.1080/13803395.2012.666228; Goodwin BE, 2013, PSYCHOL ASSESSMENT, V25, P671, DOI 10.1037/a0032214; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Grills CE, 2016, APPL NEUROPSYCH-ADUL, V23, P295, DOI 10.1080/23279095.2015.1079713; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heyanka DJ, 2015, ARCH CLIN NEUROPSYCH, V30, P369, DOI 10.1093/arclin/acv025; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Horner MD, 2014, CLIN NEUROPSYCHOL, V28, P703, DOI 10.1080/13854046.2014.925143; Ingram PB, 2016, CLIN NEUROPSYCHOL, V30, P473, DOI 10.1080/13854046.2016.1187769; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Jurick SM, 2016, J REHABIL RES DEV, V53, P571, DOI 10.1682/JRRD.2015.05.0094; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2014, ARCH CLIN NEUROPSYCH, V29, P236, DOI 10.1093/arclin/acu002; Locke DEC, 2010, EPILEPSY BEHAV, V17, P252, DOI 10.1016/j.yebeh.2009.12.004; Management of Concussion/ mTBI Working Group Department of Veterans Affairs Department of Defense, 2016, VA DOD CLIN PRACT GU; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Martin PK, 2015, ARCH CLIN NEUROPSYCH, V30, P377, DOI 10.1093/arclin/acv032; Mason LH, 2013, J PERS ASSESS, V95, P585, DOI 10.1080/00223891.2013.819512; McCabe DP, 2010, NEUROPSYCHOLOGY, V24, P222, DOI 10.1037/a0017619; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Nelson NW, 2011, CLIN NEUROPSYCHOL, V25, P716, DOI 10.1080/13854046.2011.579174; Peck CP, 2013, CLIN NEUROPSYCHOL, V27, P693, DOI 10.1080/13854046.2013.779032; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Roth R. S., 2013, J PALLIATIVE CARE ME, V1, P2; Russo AC, 2012, ARCH CLIN NEUROPSYCH, V27, P840, DOI 10.1093/arclin/acs090; Schroeder RW, 2016, CLIN NEUROPSYCHOL, V30, P515, DOI 10.1080/13854046.2016.1177118; Sellbom M, 2010, PSYCHOL ASSESSMENT, V22, P22, DOI 10.1037/a0018222; Sharf AJ, 2017, J PSYCHOPATHOL BEHAV, V39, P441, DOI 10.1007/s10862-017-9590-1; Silver JM, 2015, NEUROREHABILITATION, V36, P463, DOI 10.3233/NRE-151234; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Tellegen, 2008, MINNESOTA MULTIPHASI; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thomas ML, 2009, CLIN NEUROPSYCHOL, V23, P1067, DOI 10.1080/13854040902795000; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Webb JW, 2012, CLIN NEUROPSYCHOL, V26, P1377, DOI 10.1080/13854046.2012.728248; Wechsler D., 2008, WECHSLER ADULT INTEL; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Young JC, 2016, CLIN NEUROPSYCHOL, V30, P497, DOI 10.1080/13854046.2016.1159730; Young JC, 2011, ARCH CLIN NEUROPSYCH, V26, P194, DOI 10.1093/arclin/acr015; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	73	12	12	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2019	34	3					366	380		10.1093/arclin/acy048			15	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	HU2EU	WOS:000465084900009	29850866	hybrid			2022-02-06	
J	Song, Y; Li, T; Liu, ZG; Xu, ZK; Zhang, ZL; Chi, LY; Liu, YG				Song, Yan; Li, Tao; Liu, Zhiguo; Xu, Zhenkuan; Zhang, Zeli; Chi, Lingyi; Liu, Yuguang			Inhibition of Drp1 after traumatic brain injury provides brain protection and improves behavioral performance in rats	CHEMICO-BIOLOGICAL INTERACTIONS			English	Article						Traumatic brain injury; Drp1; Mdivi-1; Brain protection; Learning and memory; Anxiety	DEPENDENT PROTEIN-KINASE; MITOCHONDRIAL FISSION; DORSAL HIPPOCAMPUS; COGNITIVE DEFICITS; NEURONAL SURVIVAL; OXIDATIVE STRESS; PC12 CELLS; PHOSPHORYLATION; FUSION; MILD	The imbalance between mitochondrial fusion and fission has been implicated in cerebral ischemia and several neurodegenerative diseases. However, the role of mitochondrial fission in traumatic brain injury (TBI) remains poorly understood. Mitochondrial fission is mediated by dynamin-related protein 1 (Drp1), which is highly expressed in the nervous system. In the present study, we investigated the changes in Drp1 expression in the ipsilateral hippocampus of rats after TBI and the effects of Mdivi-1 (a selective inhibitor of Drp1) as a post-insult treatment for TBI. Our findings showed that the protein levels of Drp1 were increased at 6 h and peaked at 12 h post-TBI, but we did not observe Drp1 phosphorylation at Ser616, Ser637, Ser40 or Ser44 during this process. We examined the effect of Mdivi-1 on trauma-induced brain damage in both vitro and vivo. In cells, Mdivi-1 significantly attenuated H2O2-induced mitochondrial membrane potential (MMP) dissipation in PC-12 cells. Three days of Mdivi-1 treatment significantly reduced the cortical lesion volume, blood-brain barrier permeability, brain edema and oxidative stress. Mdivi-1 reduced activated caspase-3 release in the cortical border zone and hippocampal dentate gyrus three days after TBI. Furthermore, treatment with Mdivi-1 for 4 weeks rescued neurogenesis in DG and attenuated hippocampal atrophy. Regarding behavioral outcomes, Mdivi-1-treated TBI rats showed a significant improvement in water maze acquisition and retention compared with the saline-treated TBI rats. Moreover, Mdivi-1 treatment reduced anxiety-like behavior in an open-field test. Our results support the notion that Mdivi-1 provides brain protection and improves the behavioral performance in TBI rats.	[Song, Yan; Zhang, Zeli; Chi, Lingyi; Liu, Yuguang] Shandong Univ, Qilu Hosp, Dept Neurosurg, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China; [Song, Yan; Zhang, Zeli; Chi, Lingyi; Liu, Yuguang] Shandong Univ, Brain Sci Res Inst, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China; [Li, Tao] Forth Peoples Hosp Jinan, Dept Neurosurg, Jinan, Shandong, Peoples R China; [Liu, Zhiguo] Zhangqiu Peoples Hosp Shandong Prov, Dept Neurosurg, Jinan, Shandong, Peoples R China; [Xu, Zhenkuan] Shandong Univ, Hosp 2, Dept Neurosurg, Jinan, Shandong, Peoples R China		Chi, LY; Liu, YG (corresponding author), Shandong Univ, Qilu Hosp, Dept Neurosurg, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China.; Chi, LY; Liu, YG (corresponding author), Shandong Univ, Brain Sci Res Inst, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China.	chilingyi2000@126.com; yuguangliu3000@126.com			Promotive Research Fund for Young and Middle-Aged Scientists of Shandong Province [BS10YY026]; Independent Innovation Foundation of Shandong University, IIFSDU [2012TS144, 2015TS017]	The study was supported by the Promotive Research Fund for Young and Middle-Aged Scientists of Shandong Province (BS10YY026) and the Independent Innovation Foundation of Shandong University, IIFSDU (2012TS144, 2015TS017).	Agrawal M, 2013, ACS CHEM NEUROSCI, V4, P285, DOI 10.1021/cn300143m; Albrecht A, 2013, NEUROPSYCHOPHARMACOL, V38, P386, DOI 10.1038/npp.2012.192; Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Baloyannis SJ, 2006, J ALZHEIMERS DIS, V9, P119; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Cao Y, 2013, BRAIN RES, V1522, P59, DOI 10.1016/j.brainres.2013.05.033; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Costa V, 2010, EMBO MOL MED, V2, P490, DOI 10.1002/emmm.201000102; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Dobrachinski F, 2017, J NEUROTRAUM, V34, P1318, DOI 10.1089/neu.2016.4563; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Grohm J, 2012, CELL DEATH DIFFER, V19, P1446, DOI 10.1038/cdd.2012.18; Grohm J, 2010, BRAIN BEHAV IMMUN, V24, P831, DOI 10.1016/j.bbi.2009.11.015; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004; Hu P, 2016, HIPPOCAMPUS, V26, P911, DOI 10.1002/hipo.22574; Huang SB, 2015, DIABETES, V64, P1728, DOI 10.2337/db14-0758; Jahani-Asl A, 2011, J BIOL CHEM, V286, P4772, DOI 10.1074/jbc.M110.167155; Jezek P, 2009, INT J BIOCHEM CELL B, V41, P1790, DOI 10.1016/j.biocel.2009.02.014; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Knott AB, 2008, ANN NY ACAD SCI, V1147, P283, DOI 10.1196/annals.1427.030; Kong L, 2015, PHARMACOL RES, V99, P125, DOI 10.1016/j.phrs.2015.05.014; Lackner LL, 2009, BBA-MOL BASIS DIS, V1792, P1138, DOI 10.1016/j.bbadis.2008.11.011; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Lin YC, 2016, CELL MOL NEUROBIOL, V36, P27, DOI 10.1007/s10571-015-0217-3; Liu X, 2016, ACTA BIOCH BIOPH SIN, V48, P342, DOI 10.1093/abbs/gmw011; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; Manczak M, 2010, J ALZHEIMERS DIS, V20, pS609, DOI 10.3233/JAD-2010-100564; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Park SW, 2011, INVEST OPHTH VIS SCI, V52, P2837, DOI 10.1167/iovs.09-5010; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Qi X, 2013, J CELL SCI, V126, P789, DOI 10.1242/jcs.114439; Qiu X, 2013, NEUROSCIENCE, V245, P157, DOI 10.1016/j.neuroscience.2013.04.019; Reddy PH, 2011, BRAIN RES REV, V67, P103, DOI 10.1016/j.brainresrev.2010.11.004; Sannino S, 2012, LEARN MEMORY, V19, P211, DOI 10.1101/lm.025213.111; Scafidi S, 2009, J NEUROCHEM, V109, P189, DOI 10.1111/j.1471-4159.2009.05896.x; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Tang YP, 2010, EXP NEUROL, V223, P485, DOI 10.1016/j.expneurol.2010.01.015; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Trivedi MA, 2004, NEUROBIOL LEARN MEM, V81, P172, DOI 10.1016/j.nlm.2004.02.005; Volkening B, 2017, GLIA, V65, P817, DOI 10.1002/glia.23128; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Watson William D, 2013, Front Neuroenergetics, V5, P12, DOI 10.3389/fnene.2013.00012; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; White NM, 2006, LEARN MEMORY, V13, P119, DOI 10.1101/lm.138806; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wu Yan, 2007, Neurosci Bull, V23, P156, DOI 10.1007/s12264-007-0023-0; Yan J, 2015, NEUROBIOL AGING, V36, P211, DOI 10.1016/j.neurobiolaging.2014.08.005; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Yu FS, 2012, J NEUROTRAUM, V29, P362, DOI 10.1089/neu.2011.1942; Yu H, 2012, J NEUROSCI, V32, P4092, DOI 10.1523/JNEUROSCI.5048-11.2012; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang QS, 2016, EXP THER MED, V12, P4107, DOI 10.3892/etm.2016.3889; Zhao S, 2016, J NEUROTRAUM, V33, P2055, DOI 10.1089/neu.2015.4036; Zhao YX, 2014, CNS NEUROSCI THER, V20, P528, DOI 10.1111/cns.12266	78	12	13	0	11	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0009-2797	1872-7786		CHEM-BIOL INTERACT	Chem.-Biol. Interact.	MAY 1	2019	304						173	185		10.1016/j.cbi.2019.03.013			13	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology	HU0BZ	WOS:000464937700019	30894316				2022-02-06	
J	Theadom, A; McDonald, S; Starkey, N; Barker-Collo, S; Jones, KM; Ameratunga, S; Wilson, E; Feigin, VL				Theadom, Alice; McDonald, Skye; Starkey, Nicola; Barker-Collo, Suzanne; Jones, Kelly M.; Ameratunga, Shanthi; Wilson, Emily; Feigin, Valery L.		BIONIC4you Res Grp	Social Cognition Four Years After Mild-TBI: An Age-Matched Prospective Longitudinal Cohort Study	NEUROPSYCHOLOGY			English	Article						concussion; mild traumatic brain injury; adults; longitudinal; social cognition	TRAUMATIC BRAIN-INJURY; CONCUSSION SYMPTOMS QUESTIONNAIRE; EMOTION RECOGNITION; PRAGMATIC LANGUAGE; HOSPITAL ANXIETY; HEAD-INJURY; VALIDITY; SYMPTOMATOLOGY; IMPAIRMENTS; DEPRESSION	Objective: To assess longer-term social cognition after mild traumatic brain injury (mTBI) and to identify the sociodemographic and acute factors (mood, cognitive functioning, and symptoms) influencing social cognition. Method: Data were extracted for 121 adults who experienced a mTBI and completed the Emotion Evaluation and Social Inference Enriched tests of The Awareness of Social Inference Test (TASIT) 4 years postinjury. To identify early indicators of outcome, responses to the Hospital Anxiety and Depression Scale, Rivermead Post-Concussion Symptom Questionnaire, and CNS Vital Signs neurocognitive assessment conducted 1 month postinjury were also extracted. Social cognition scores were compared to age-matched TASIT norms (N = 121). Results: The mTBI group was significantly less able to interpret what people say and intend than norms, although the effect sizes were small (d = 0.43). There were 24.8% of people 4 years postmTBI and 9.9% of norms who experienced at least mild impairment in social inference. There were no significant differences between the mTBI group and norms for emotion evaluation. Poorer social inference 4 years after mTBI was significantly associated with lower cognitive flexibility and executive function (F = 2.57, df = 13,26, p = .02). Group differences remained after controlling for cognitive functioning (F = 104.59, df = 1,58, p = .001. Conclusions: These novel results suggest that adults postmTBI may experience social inference difficulties 4 years post-TBI that are not completely explained by cognitive difficulties. Further research is needed. General Scientific Summary A proportion of people who have experienced a mild brain injury may experience increased difficulties in understanding the meaning of conversations 4 years after their injury. These difficulties are not just due to cognitive deficits and may make it harder for people to participate in everyday life. Replication of these findings may suggest a new area for screening and intervention following a mild brain injury.	[Theadom, Alice; Jones, Kelly M.; Feigin, Valery L.] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, AR417 North Campus,90 Akoranga Dr, Auckland 1142, New Zealand; [McDonald, Skye; Wilson, Emily] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia; [Starkey, Nicola] Univ Waikato, Dept Psychol, Hamilton, New Zealand; [Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand		Theadom, A (corresponding author), Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, AR417 North Campus,90 Akoranga Dr, Auckland 1142, New Zealand.	alice.theadom@aut.ac.nz	Starkey, Nicola/AAJ-3795-2020; Feigin, Valery/AAF-2313-2019	Starkey, Nicola/0000-0002-4370-8186; Feigin, Valery L./0000-0002-6372-1740; Wilson, Emily/0000-0002-1949-7657	Health Research Council of New ZealandHealth Research Council of New Zealand [09/063A, 11/192, 13/408]	BIONIC4you Research Group members include Valery L. Feigin, Alice Theadom, Suzanne Barker-Collo, Kelly M. Jones, Kathryn McPherson, Amy Jones, Braden Te Ao, Paul Brown, Peggy Fairbairn-Dunlop (Auckland University of Technology), Rob Kydd, P. Alan Barber, Varsha Parag, Shanthi Ameratunga (University of Auckland), Nicola Starkey (University of Waikato), Tony Dowell (University of Otago), Michael Kahan, Grant Christey (Waikato Distract Health Board), and Natalie Hardaker (Accident Compensation Corporation). This work was funded by the Health Research Council of New Zealand (09/063A, 11/192, 13/408), although the research was conducted independently from the sponsor. We thank the research team for their dedication and performance, the staff at the coroner's office in Hamilton; the staff of the NZ Accident Compensation Corporation and Health Information Service; Waikato District Health Board; Waikato University staff; the many doctors, nurses and rehabilitation professionals and service providers such as ABI Management and administrative staff within and outside Hamilton; and the BIONIC participants and their families and friends. We thank CNS Vital Signs for supporting us in using this neuropsychological assessment.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cusi AM, 2011, PSYCHIAT RES, V188, P231, DOI 10.1016/j.psychres.2011.04.013; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Gualtieri C Thomas, 2008, Medscape J Med, V10, P90; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Honan, 2017, AWARENESS SOCIAL INF; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hopkins WG, 2002, SCALE MAGNITUDES EFF; Kelly M, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000269; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lahera G, 2013, J AFFECT DISORDERS, V146, P132, DOI 10.1016/j.jad.2012.06.032; Lennox BR, 2004, PSYCHOL MED, V34, P795, DOI 10.1017/S0033291704002557; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; McDonald S, 2016, APHASIOLOGY, V30, P801, DOI 10.1080/02687038.2015.1070948; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P528, DOI 10.1017/S1355617713000039; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McDonald S, 2012, AUST PSYCHOL, V47, P39, DOI 10.1111/j.1742-9544.2011.00054.x; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McLellan T, 2013, BRAIN INJURY, V27, P1032, DOI 10.3109/02699052.2013.794965; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Paul N, 2016, ARCH CLIN NEUROPSYCH, V31, P649, DOI 10.1093/arclin/acw043.173; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Ryan NP, 2016, INT J DEV NEUROSCI, V49, P23, DOI 10.1016/j.ijdevneu.2015.12.004; Schaafsma SM, 2015, TRENDS COGN SCI, V19, P65, DOI 10.1016/j.tics.2014.11.007; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Westerhof-Evers HJ, 2017, J HEAD TRAUMA REHAB, V32, P296, DOI 10.1097/HTR.0000000000000332; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wood RL, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00195; Ylvsaker M, 2001, BRAIN INJ SOURCE, V5; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	51	12	12	3	17	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAY	2019	33	4					560	567		10.1037/neu0000516			8	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	HV6RI	WOS:000466110100011	30920237				2022-02-06	
J	Lucca, LF; Lofaro, D; Pignolo, L; Leto, E; Ursino, M; Cortese, MD; Conforti, D; Tonin, P; Cerasa, A				Lucca, Lucia Francesca; Lofaro, Danilo; Pignolo, Loris; Leto, Elio; Ursino, Maria; Cortese, Maria Daniela; Conforti, Domenico; Tonin, Paolo; Cerasa, Antonio			Outcome prediction in disorders of consciousness: the role of coma recovery scale revised	BMC NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; UNRESPONSIVE WAKEFULNESS; PROLONGED DISORDERS; FOLLOW-UP; STATE; REHABILITATION; ADULTS; MODEL	BackgroundTo evaluate the utility of the revised coma remission scale (CRS-r), together with other clinical variables, in predicting emergence from disorders of consciousness (DoC) during intensive rehabilitation care.MethodsData were retrospectively extracted from the medical records of patients enrolled in a specialized intensive rehabilitation unit. 123 patients in a vegetative state (VS) and 57 in a minimally conscious state (MCS) were included and followed for a period of 8weeks. Demographical and clinical factors were used as outcome measures. Univariate and multivariate Cox regression models were employed for examining potential predictors for clinical outcome along the time.ResultsVS and MCS groups were matched for demographical and clinical variables (i.e., age, aetiology, tracheostomy and route of feeding). Within 2months after admission in intensive neurorehabilitation unit, 3.9% were dead, 35.5% had a full recovery of consciousness and 66.7% remained in VS or MCS. Multivariate analysis demonstrated that the best predictor of functional improvement was the CRS-r scores. In particular, patients with values greater than 12 at admission were those with a favourable likelihood of emergence from DoC.ConclusionsOur study highlights the role of the CRS-r scores for predicting a short-term favorable outcome.	[Lucca, Lucia Francesca; Pignolo, Loris; Leto, Elio; Ursino, Maria; Cortese, Maria Daniela; Tonin, Paolo; Cerasa, Antonio] S Anna Inst & Res Adv Neurorehabil RAN, I-88900 Crotone, Italy; [Lofaro, Danilo] UNICAL, DIMEG, Arcavacata Di Rende, Italy; [Lofaro, Danilo; Conforti, Domenico] Annunziata Hosp, Kidney & Transplantat Res Ctr, Cosenza, Italy; [Cerasa, Antonio] IBFM CNR, Neuroimaging Unit, I-88100 Catanzaro, Italy		Lucca, LF; Cerasa, A (corresponding author), S Anna Inst & Res Adv Neurorehabil RAN, I-88900 Crotone, Italy.	l.lucca@istitutosantanna.it; antonio.cerasa76@gmail.com	Tonin, Paolo/K-7483-2016; Cortese, Maria Daniela/AAB-9480-2022; Lofaro, Danilo/J-8687-2016; Lucca, Lucia Francesca/AAB-8558-2022; Lofaro, Danilo/ABD-7797-2020; cerasa, antonio/E-8614-2011; Riganello, Francesco/N-2615-2014	Tonin, Paolo/0000-0002-4867-1378; Cortese, Maria Daniela/0000-0002-8524-6581; Lofaro, Danilo/0000-0002-2081-463X; Lofaro, Danilo/0000-0002-2081-463X; cerasa, antonio/0000-0002-8022-4770; Riganello, Francesco/0000-0003-0678-9252; LUCCA, LUCIA FRANCESCA/0000-0002-7602-2711			ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bodien YG, 2016, ARCH PHYS MED REHAB, V97, P490, DOI 10.1016/j.apmr.2015.08.422; Bos S, 1997, ONLINE J KNOWL SYNTH, V26; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Cavinato M, 2009, BRAIN INJURY, V23, P973, DOI 10.3109/02699050903373493; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Dolce G, 2008, J NEUROTRAUM, DOI [10.1089/neu.2008.0536, DOI 10.1089/NEU.2008.0536, 10.1089/neu.2008.0536.]; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; Estraneo A, 2015, EUR J PHYS REHABIL M, V51; Estraneo A, 2018, ARCH PHYS MED REHAB, V99, P2523, DOI 10.1016/j.apmr.2018.04.024; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Estraneo Anna, 2017, COMA DISORDERS CONSC; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Klein AM, 2013, CLIN NEUROL NEUROSUR, V115, P2136, DOI 10.1016/j.clineuro.2013.08.004; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lofaro D, 2016, NEPHROL DIAL TRANSPL, V31; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Qin PM, 2015, ANN NEUROL, V78, P594, DOI 10.1002/ana.24479; Riganello F, 2016, J NEUROTRAUM, V33, P423, DOI 10.1089/neu.2015.3906; Riganello F, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-164; Schorr B, 2016, J NEUROL, V263, P937, DOI 10.1007/s00415-016-8084-5; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Steppacher I, 2014, ANN CLIN TRANSL NEUR, V1, P401, DOI 10.1002/acn3.63; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Verduijn M, 2011, NEPHROL DIAL TRANSPL, V26, P56, DOI 10.1093/ndt/gfq661; Voss A, 1993, SPECTRUM NEUROREHABI, P112; Whyte J, 2009, PROG BRAIN RES, V177, P63, DOI 10.1016/S0079-6123(09)17706-3; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1851, DOI 10.1016/j.apmr.2013.07.003; Zasler ND, 1997, ARCH PHYS MED REHAB, V78, pS12, DOI 10.1016/S0003-9993(97)90150-7	39	12	13	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	APR 18	2019	19								68	10.1186/s12883-019-1293-7			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HU2UH	WOS:000465126700001	30999877	Green Submitted, Green Published, gold			2022-02-06	
J	Bezyak, JL; Sabella, S; Hammel, J; McDonald, K; Jones, RA; Barton, D				Bezyak, Jill Louise; Sabella, Scott; Hammel, Joy; McDonald, Katherine; Jones, Robin Ann; Barton, Dana			Community participation and public transportation barriers experienced by people with disabilities	DISABILITY AND REHABILITATION			English	Article						Public transportation; disability; community participation; accessibility; barriers	TRAUMATIC BRAIN-INJURY; HEALTH-CARE; INDIVIDUALS; EMPLOYMENT; GENDER	Background: Barriers to public transportation quickly impact the ability of people with disabilities to fully experience their community. Objective: A national survey of people with disabilities was conducted to understand the barriers and supports to accessing public transportation and the impact on community participation. Method: A total of 1748 respondents responded to a web-based survey investigating the accessibility of public transportation. Results present frequency of barriers to public transportation and group differences using Pearson's chi-square technique and Mann-Whitney U tests. Results: A majority of respondents experienced difficulties accessing public transportation, and community activities that do not occur on a regular schedule are more affected by problems with public transportation. Individuals with blindness or low vision, psychiatric disabilities, chronic health conditions, or multiple disabilities experienced more problems using public transportation for community participation, along with participants who were female, Hispanic, Latino/Latina, or Spanish origin. Limitations: Survey distribution was convenience-based, which may have affected participation of certain disability groups, cultural groups, and/or those without computer access, and interpretations cannot be made regarding predictive or casual relationships. Conclusions: Significant challenges face individuals with disabilities as they use public transportation, and certain disability groups are more severely impacted by these problems.	[Bezyak, Jill Louise] Univ Northern Colorado, Rehabil Counseling & Sci, Gunter Hall,Room 1250,Campus Box 132, Greeley, CO 80639 USA; [Sabella, Scott] Univ Buffalo, Dept Counseling Sch & Educ Psychol, Buffalo, NY USA; [Hammel, Joy; Jones, Robin Ann] Univ Illinois, Dept Disabil & Human Dev, Chicago, IL USA; [McDonald, Katherine] Syracuse Univ, Falk Coll, Burton Blatt Inst, Syracuse, NY USA; [Barton, Dana] Meeting Challenge Inc, Colorado Springs, CO USA		Bezyak, JL (corresponding author), Univ Northern Colorado, Rehabil Counseling & Sci, Gunter Hall,Room 1250,Campus Box 132, Greeley, CO 80639 USA.	jill.bezyak@unco.edu		McDonald, Katherine/0000-0003-1195-7978	National Institute for Disability, Independent Living, and Rehabilitation Research	This work was supported by the National Institute for Disability, Independent Living, and Rehabilitation Research.	Alvarado CS, 2011, J HLTH DISPAR RES PR, V9, P184; Annual Disability Statistics Compendium, 2016, REH RES TRAIN CTR DI; [Anonymous], 2005, DISABILITY, pA15; [Anonymous], 2005, PROGRAM, pA15; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bezyak JL, 2017, J DISABIL POLICY STU, V28, P52, DOI 10.1177/1044207317702070; Chan F, 2005, CASE MANAGEMENT REHA, V1; Christensen K. M., 2014, REV DISABILITY STUDI, V5, P49; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Crudden A, 2005, J VISUAL IMPAIR BLIN, V99, P325; Dahan-Oliel N, 2016, DISABIL REHABIL, V38, P2102, DOI 10.3109/09638288.2015.1114033; del Rio C, 2015, DEMOGRAPHY, V52, P967, DOI 10.1007/s13524-015-0390-5; Denson C., 2015, J REHABIL, V66, P29; Gall MD, 2007, ED RES; Hall SA, 2017, J APPL RES INTELLECT, V30, P859, DOI 10.1111/jar.12276; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Harrison AL, 2017, DISABIL REHABIL, V39, P2071, DOI 10.1080/09638288.2016.1217081; Heinemann AW, 2015, ARCH PHYS MED REHAB, V96, P589, DOI 10.1016/j.apmr.2013.11.024; Iezzoni LI, 2006, HEALTH SERV RES, V41, P1258, DOI 10.1111/j.1475-6773.2006.00534.x; Jansuwan S, 2013, J URBAN PLAN D-ASCE, V139, P104, DOI 10.1061/(ASCE)UP.1943-5444.0000142; Kasl SV, 1998, ADVERSITY, STRESS AND PSYCHOPATHOLOGY, P111; Krahn GL, 2015, AM J PUBLIC HEALTH, V105, pS198, DOI 10.2105/AJPH.2014.302182; Lai JS, 2016, ARCH PHYS MED REHAB, V97, P2102, DOI 10.1016/j.apmr.2016.06.010; Marrocco A, 2017, J AM ASSOC NURSE PRA, V29, P282, DOI 10.1002/2327-6924.12449; McDonnall MC, 2011, J VISUAL IMPAIR BLIN, V105, P453, DOI 10.1177/0145482X1110500802; Milner P, 2009, DISABIL SOC, V24, P47, DOI 10.1080/09687590802535410; Namgung M, 2014, TRANSPORT RES REC, P136, DOI 10.3141/2415-15; PENFOLD C, 2008, TRAVEL BEHAV EXPERIE; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Preston V, 2016, ANN AM ASSOC GEOGR, V106, P300, DOI 10.1080/00045608.2015.1113118; Rogers D, 2002, BALANCING ACT STABIL; ROSENBLOOM S, 2007, FUTURE DISABILITY AM, P00519; Ryan Camille L., 2016, CURRENT POPULATION R; Shaikh A, 2014, PHYSICA A, V415, P54, DOI 10.1016/j.physa.2014.07.043; Skinner AC, 2007, J RURAL HEALTH, V23, P150, DOI 10.1111/j.1748-0361.2007.00082.x; Smith BJ, 2016, HEALTH PROMOT INT, V31, P572, DOI 10.1093/heapro/dav042; Syed ST, 2013, J COMMUN HEALTH, V38, P976, DOI 10.1007/s10900-013-9681-1; Taylor H, 2010, ADA 20 YEARS LATER K; The United States Department of Health and Human Services, 2017, 2017 POV GUID; U. S. Equal Employment Opportunity Commission, 2008, FACT SHEET EEOCS FIN; United States Census Bureau, 2017, DIS DAT AR COLL AM C; United States Department of Agriculture, 2016, RUR URB COMM AR COD; US Census Bureau, 2016, NEW CENS DAT SHOW DI; US Census Bureau, 2015, COMM CHAR SEX 2015 A; US Census Bureau, 2015, DIS CHAR 2015 AM COM; US Department of Health and Human Services, 2012, DISP HEALTHC QUAL RA; US Department of Labor, 2013, PERS DIS BARR EMPL T; US Department of Transportation: Bureau of Transportation Statistics, 2017, TRANSP DIFF KEEP HAL; Wallace R, 2005, TRANSPORT RES REC, P76, DOI 10.3141/1924-10; World Health Organization, 2007, INT CLASS FUNCT DIS	50	12	12	2	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	NOV 5	2020	42	23					3275	3283		10.1080/09638288.2019.1590469		APR 2019	9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	OH7IG	WOS:000465989100001	30991852				2022-02-06	
J	Meythaler, J; Fath, J; Fuerst, D; Zokary, H; Freese, K; Martin, HB; Reineke, J; Peduzzi-Nelson, J; Roskos, PT				Meythaler, Jay; Fath, John; Fuerst, Darren; Zokary, Hashem; Freese, Kristina; Martin, Heidi Baird; Reineke, Joshua; Peduzzi-Nelson, Jean; Roskos, P. Tyler			Safety and feasibility of minocycline in treatment of acute traumatic brain injury	BRAIN INJURY			English	Article						Brain injury; trauma; minocycline; rehabilitation	SPINAL-CORD-INJURY; MICROGLIAL ACTIVATION; MATRIX METALLOPROTEINASES; INTRAVENOUS MINOCYCLINE; RHEUMATOID-ARTHRITIS; CLINICAL-TRIALS; SERUM S-100B; ACUTE STROKE; DOUBLE-BLIND; MOUSE MODEL	Background: Minocycline is a pleomorphic neuroprotective agent well studied in animal models of traumatic brain injury (TBI) and brain ischemia. Methods: To test the hypothesis that administration of minocycline in moderate to severe TBI (Glasgow Coma Score 3-12). Fifteen patients were enrolled in a two-dose escalation study of minocycline to evaluate the safety of twice the recommended antibiotic dosage; tier 1 n = 7 at a loading dose of 800 mg followed by 200 mg twice a day (BID) for 7 days; tier 2 n = 8 at a loading dose of 800 mg followed by 400 mg BID for 7 days. Results: The mean initial GCS was 5.6 for Tier 1 patients and 5.4 for Tier 2. The Disability Rating Scale (DRS) had a trend towards improvement with the higher dose 12.5 SD +/- 7.7 (N = 5) for Tier 1 at 4 weeks and 8.5 SD +/- 9.9 at week 12 (N = 5), whereas for Tier 2 it was 9.7 +/- 6.9 (N = 6) for week 4 and 6.0 SD +/- 6.1 (N = 7) for week 12 (p = .251 repeated measures ANOVA). Liver function tests increased but resolved after the first week and there were no infections. Conclusions: Minocycline was safe for moderate to severe TBI at a dose twice that as recommended for treatment of infection. The higher dose did trend towards an improved outcome.	[Meythaler, Jay; Fuerst, Darren; Zokary, Hashem; Freese, Kristina; Martin, Heidi Baird; Peduzzi-Nelson, Jean; Roskos, P. Tyler] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil Oakwood, 10000 Telegraph Rd, Taylor, MI 48180 USA; [Fath, John] Oakwood Dearborn Hosp, Trauma Div, Dept Surg, Dearborn, MI USA; [Reineke, Joshua] South Dakota State Univ, Sch Pharm, Dearborn, MI USA		Meythaler, J (corresponding author), Wayne State Univ, Sch Med, Dept Phys Med & Rehabil Oakwood, 10000 Telegraph Rd, Taylor, MI 48180 USA.	jmeythal@med.wayne.edu			National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133A020509]; Oakwood Foundation	This study was funded by the National Institute on Disability, Independent Living, and Rehabilitation Research, Grant #: H133A020509 and the Oakwood Foundation. Performed under FDA IND #104298, ClinicalTrials.gov ID NCT01058395. The authors have no conflicts of interest in this study.	Arvin KL, 2002, ANN NEUROL, V52, P54, DOI 10.1002/ana.10242; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P471; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Casha S, 2012, BRAIN, V135, P1224, DOI 10.1093/brain/aws072; Centers for Disease Control and Prevention, 2014, TRAUM BRAIN INJ US F; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Delis D.C., 2000, CALIFORNIA VERBAL LE; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Fagan SC, 2010, STROKE, V41, P2283, DOI 10.1161/STROKEAHA.110.582601; Faul M, 2014, TRAUMATIC BRAIN INJU, P1; Fraser CL, 2012, ARCH NEUROL-CHICAGO, V69, P1067, DOI 10.1001/archneurol.2012.144; GOLUB LM, 1995, J CLIN PERIODONTOL, V22, P100; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; He Y, 2001, BRAIN RES, V909, P187, DOI 10.1016/S0006-8993(01)02681-6; Kikuchi K, 2014, CNS DRUGS, V28, P929, DOI 10.1007/s40263-014-0199-6; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Kohler E, 2013, STROKE, V44, P2493, DOI 10.1161/STROKEAHA.113.000780; Lampl Y, 2007, NEUROLOGY, V69, P1404, DOI 10.1212/01.wnl.0000277487.04281.db; Lee SM, 2004, J NEUROCHEM, V91, P568, DOI 10.1111/j.1471-4159.2004.02780.x; Lei J, 2013, J NEUROTRAUM, V30, P529, DOI 10.1089/neu.2012.2548; Lin SZ, 2001, NEUROSCI LETT, V315, P61, DOI 10.1016/S0304-3940(01)02324-2; Machado LS, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-56; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Meythaler JM, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1202; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Nagoshi N, 2015, EXPERT OPIN INV DRUG, V24, P645, DOI 10.1517/13543784.2015.1009629; National Insututes of Health National Cancer Institute, CANC THER NAT EV PRO; O'Dell JR, 2001, ARTHRITIS RHEUM-US, V44, P2235, DOI 10.1002/1529-0131(200110)44:10&lt;2235::AID-ART385&gt;3.0.CO;2-A; Orti V, 2000, J CHROMATOGR B, V738, P357, DOI 10.1016/S0378-4347(99)00547-2; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Raabe A, 2003, RESTOR NEUROL NEUROS, V21, P159; Rappaport M, 2005, NEUROPSYCHOL REHABIL, V15, P442, DOI 10.1080/09602010443000335; Rapport LJ, 1998, ARCH PHYS MED REHAB, V79, P629, DOI 10.1016/S0003-9993(98)90035-1; Sadowski T, 2001, INFLAMM RES, V50, P175, DOI 10.1007/s000110050742; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Smith A., 1982, SYMBOL DIGIT MODALIT; Srivastava MVP, 2012, NEUROL INDIA, V60, P23, DOI 10.4103/0028-3886.93584; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; Teng YD, 2004, P NATL ACAD SCI USA, V101, P3071, DOI 10.1073/pnas.0306239101; Tikka TM, 2001, J IMMUNOL, V166, P7527, DOI 10.4049/jimmunol.166.12.7527; TILLEY BC, 1995, ANN INTERN MED, V122, P81, DOI 10.7326/0003-4819-122-2-199501150-00001; Wang CX, 2003, BRAIN RES, V963, P327, DOI 10.1016/S0006-8993(02)04045-3; Ware J., 1998, SF 12 SCORE SF 12 PH, V2nd Ed; Wells JEA, 2003, BRAIN, V126, P1628, DOI 10.1093/brain/awg178; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Wolfson, 1993, HALSTEAD REITAN NEUR; Wood H, 2018, NAT REV NEUROL, V14, DOI 10.1038/nrneurol.2018.24; Wright J, 2000, DISABILITY RATING SC; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Xu L, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-7; Yablon SA, 1998, ARCH PHYS MED REHAB, V79, P594; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	59	12	13	1	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR 16	2019	33	5					679	689		10.1080/02699052.2019.1566968			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HR1NT	WOS:000462901200016	30744442				2022-02-06	
J	Carlozzi, NE; Kallen, MA; Hanks, R; Kratz, AL; Hahn, EA; Brickell, TA; Lange, RT; French, LM; Ianni, PA; Miner, JA; Sander, AM				Carlozzi, Noelle E.; Kallen, Michael A.; Hanks, Robin; Kratz, Anna L.; Hahn, Elizabeth A.; Brickell, Tracey A.; Lange, Rael T.; French, Louis M.; Ianni, Phillip A.; Miner, Jennifer A.; Sander, Angelle M.			The Development of a New Computer Adaptive Test to Evaluate Feelings of Being Trapped in Caregivers of Individuals With Traumatic Brain Injury: TBI-CareQOL Feeling Trapped Item Bank	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Caregiver; Health-related quality of life; Patient reported outcome measures; Psychometrics; Rehabilitation; Traumatic brain injury; Veterans	QUALITY-OF-LIFE; SOCIAL SUPPORT; TIME-COURSE; FOLLOW-UP; RECOVERY; FAMILY; HEALTH; OUTCOMES; REHABILITATION; MODEL	Objective: To develop a new patient-reported outcome measure that captures feelings of being trapped that are commonly experienced by caregivers of individuals with traumatic brain injury (TBI). Design: Cross-sectional. Setting: Three TBI Model Systems rehabilitation hospitals, an academic medical center, and a military medical treatment facility. Participants: Caregivers (N=560) of civilians with TBI (n=344) and caregivers of service members/veterans with TBI (n=216). Interventions: Not applicable. Outcome measures: Traumatic Brain Injury Caregiver Quality of Life (TBI-CareQOL) Feeling Trapped item bank. Results: From an initial item pool of 28 items, exploratory and confirmatory factor analyses supported the retention of 16 items. After graded response model (GRM) and differential item functioning analyses were conducted, 15 items were retained in the final measure. GRM calibration data, along with clinical expert input, were used to choose a 6-item, static short form (SF), and the calibration data were used for programming of the TBI-CareQOL Feeling Trapped computer adaptive test (CAT). CAT simulation analyses produced an r=0.99 correlation between CAT scores and the full item bank. Three-week short-form test-retest reliability was very good (r=0.84). Conclusions: The new TBI-CareQOL Feeling Trapped item bank was developed to provide a sensitive and efficient examination of the effect that feelings of being trapped, due to the caregiver role, have on health-related quality of life for caregivers of individuals with TBI. Both the CAT and corresponding 6-item SF demonstrate excellent psychometric properties. Future work is needed to establish the responsiveness of this measure to clinical interventions for these caregivers. (C) 2018 by the American Congress of Rehabilitation Medicine	[Carlozzi, Noelle E.; Kratz, Anna L.; Ianni, Phillip A.; Miner, Jennifer A.] Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Kallen, Michael A.; Hahn, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [Hanks, Robin] Rehabil Inst Michigan, Dept Psychol & Neuropsychol, Detroit, MI USA; [Hanks, Robin] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA; [Brickell, Tracey A.; Lange, Rael T.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Brickell, Tracey A.; Lange, Rael T.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada; [Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX 77030 USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA		Carlozzi, NE (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604; Hanks, Robin/0000-0002-3432-4789	National Institutes of Health-National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR); National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433, UL1TR002240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658] Funding Source: NIH RePORTER	Supported by the National Institutes of Health-National Institute of Nursing Research (grant no. R01NR013658), the National Center for Advancing Translational Sciences (grant no. UL1TR000433), and the Defense and Veterans Brain Injury Center.	Bailey EK, 2017, J HEAD TRAUMA REHAB, V32, P245, DOI 10.1097/HTR.0000000000000317; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Burns Anthony S, 2012, Handb Clin Neurol, V109, P47, DOI 10.1016/B978-0-444-52137-8.00003-6; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS85, DOI 10.1016/j.apmr.2018.05.034; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Cook KF, 2009, QUAL LIFE RES, V18, P447, DOI 10.1007/s11136-009-9464-4; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Crane PK, 2006, MED CARE, V44, pS115, DOI 10.1097/01.mlr.0000245183.28384.ed; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; DITUNNO JF, 1992, ARCH PHYS MED REHAB, V73, P431; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Fisher LB, 2016, BRAIN INJURY, V30, P1311, DOI 10.1080/02699052.2016.1195517; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hanauer DA, 2015, J BIOMED INFORM, V55, P290, DOI 10.1016/j.jbi.2015.05.003; Hart T, 2003, ARCH PHYS MED REHAB, V84, P221, DOI 10.1053/apmr.2003.50023; Hatcher L, 1994, STEP BY STEP APPROAC, P325; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P406, DOI 10.1016/S0003-9993(95)80568-0; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P399, DOI 10.1016/S0003-9993(95)80567-2; Jourdan C, 2017, J HEAD TRAUMA REHAB, V32, pE26, DOI 10.1097/HTR.0000000000000276; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Krauss Joachim K, 2015, Handb Clin Neurol, V128, P475, DOI 10.1016/B978-0-444-63521-1.00030-3; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Manskow US, 2017, NEUROREHABILITATION, V40, P211, DOI 10.3233/NRE-161406; Martin Y, 2006, AGING MENT HEALTH, V10, P101, DOI 10.1080/13607860500311953; McDonald R, 1999, TEST THEORY UNIFIED; McLaughlin Anne Marie, 1993, Brain Injury, V7, P45, DOI 10.3109/02699059309008155; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Pelletier PM, 2000, BRAIN COGNITION, V44, P45; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Reise SP, 2007, QUAL LIFE RES, V16, P19, DOI 10.1007/s11136-007-9183-7; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; Samejima F, 1996, HDB MODERN ITEM RESP, P85; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Seel RT, 2016, NEUROREHABILITATION, V39, P371, DOI 10.3233/NRE-161369; Smith A M, 1998, Rehabil Nurs, V23, P252; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Waters R L, 1998, J Spinal Cord Med, V21, P195; WATERS RL, 1993, ARCH PHYS MED REHAB, V74, P242; WATERS RL, 1992, ARCH PHYS MED REHAB, V73, P784; WATERS RL, 1994, ARCH PHYS MED REHAB, V75, P67; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Zaider TI, 2003, PSYCHOL MED, V33, P611, DOI 10.1017/S0033291703007414	62	12	12	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2019	100	4		1			S43	S51		10.1016/j.apmr.2018.06.025			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HR2FV	WOS:000462951900005	30075146	Green Accepted			2022-02-06	
J	Kosari-Nasab, M; Shokouhi, G; Ghorbanihaghjo, A; Mesgari-Abbasi, M; Salari, AA				Kosari-Nasab, Morteza; Shokouhi, Ghaffar; Ghorbanihaghjo, Amir; Mesgari-Abbasi, Mehran; Salari, Ali-Akbar			Quercetin mitigates anxiety-like behavior and normalizes hypothalamus-pituitary-adrenal axis function in a mouse model of mild traumatic brain injury	BEHAVIOURAL PHARMACOLOGY			English	Article						adrenocorticotropic hormone; anxiety; brain injury; depression; hypothalamus-pituitary-adrenal axis; mouse; quercetin	DEPRESSION-LIKE BEHAVIORS; ANXIOGENIC-LIKE BEHAVIOR; OXIDATIVE STRESS; HPA AXIS; MAJOR DEPRESSION; RAT MODEL; PROTECTS; DYSFUNCTION; MEMORY; ACETYLCHOLINESTERASE	Mild traumatic brain injury (mTBI) is a major public health risk for developing anxiety-related disorders and hypothalamus-pituitary-adrenal (HPA) axis dysregulation in humans. Extensive research has shown that dietary intake or supplementation of the natural flavonoid quercetin might be useful for treating anxiety-related symptoms. The objectives of this study were to determine whether quercetin treatment can attenuate anxiogenic-like behaviors and normalize HPA axis function in mice with mTBI. Animals subjected to mTBI were treated daily with quercetin (50mg/kg) or diazepam (positive control, 3mg/kg) for 14 days. Four behavioral tests (open field, plus maze, light-dark box, and zero maze) were used to assess anxiety-related behaviors in mice. To evaluate HPA axis function, adrenocorticotropic hormone and corticosterone were measured in the serum of mice after the anxiety tests. Quercetin treatment was found to significantly reduce anxiety-like behaviors in mTBI-induced mice. A strength of this study is the consistency of results among anxiety tests. The dysregulation of the HPA axis in mTBI-induced mice treated with quercetin was also attenuated, with decreased levels of adrenocorticotropic hormone and corticosterone. The effects of quercetin were comparable with those of diazepam treatment. Taken together, these results suggest that quercetin might be useful for treating anxiety-related symptoms and HPA axis hyperreactivity in patients with mTBI.	[Kosari-Nasab, Morteza; Shokouhi, Ghaffar; Ghorbanihaghjo, Amir; Mesgari-Abbasi, Mehran; Salari, Ali-Akbar] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran; [Shokouhi, Ghaffar] Tabriz Univ Med Sci, Dept Neurosurg, Tabriz, Iran; [Shokouhi, Ghaffar] Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz, Iran; [Ghorbanihaghjo, Amir] Tabriz Univ Med Sci, Biotechnol Res Ctr, Tabriz, Iran; [Salari, Ali-Akbar] SICBD, Alborz, Iran		Shokouhi, G (corresponding author), Tabriz Univ Med Sci, Drug Appl Res Ctr, Alborz, Iran.	shokouhigh@yahoo.com	Salari, Ali-Akbar/I-7843-2013	Salari, Ali-Akbar/0000-0002-4970-0337; Kosari-Nasab, Morteza/0000-0001-8454-5873	Drug Applied Research Center at Tabriz University of Medical Sciences [GN94/77]	This study was supported by the Drug Applied Research Center at Tabriz University of Medical Sciences (GN94/77).	Abdalla FH, 2014, PHYSIOL BEHAV, V135, P152, DOI 10.1016/j.physbeh.2014.06.008; Abelson JL, 2007, DEPRESS ANXIETY, V24, P66, DOI 10.1002/da.20220; Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Arciniegas DB, 2006, BEHAV NEUROL, V17, P25, DOI 10.1155/2006/460592; Ayatollahi AM, 2017, NEUROL RES, V39, P1056, DOI 10.1080/01616412.2017.1376789; Babri S, 2014, BRAIN BEHAV IMMUN, V37, P164, DOI 10.1016/j.bbi.2013.12.003; Bhutada P, 2010, PROG NEURO-PSYCHOPH, V34, P955, DOI 10.1016/j.pnpbp.2010.04.025; Chakraborty J, 2014, CNS NEUROSCI THER, V20, P10, DOI 10.1111/cns.12189; Davis JM, 2008, AM J PHYSIOL-REG I, V295, pR505, DOI 10.1152/ajpregu.90319.2008; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Du GL, 2018, MOL MED REP, V17, P7859, DOI 10.3892/mmr.2018.8801; Du GL, 2016, NEUROL RES, V38, P1012, DOI 10.1080/01616412.2016.1240393; Esmaeili MH, 2018, BRAIN RES BULL, V137, P265, DOI 10.1016/j.brainresbull.2018.01.001; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Gibellini L, 2011, EVID-BASED COMPL ALT, V2011, DOI DOI 10.1093/ECAM/NEQ053; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Haleagrahara N, 2009, EUR J PHARMACOL, V621, P46, DOI 10.1016/j.ejphar.2009.08.030; Jung CH, 2013, PHYTOTHER RES, V27, P139, DOI 10.1002/ptr.4687; Kawabata K, 2010, J NUTR BIOCHEM, V21, P374, DOI 10.1016/j.jnutbio.2009.01.008; Kim JH, 2011, NUTR RES PRACT, V5, P107, DOI 10.4162/nrp.2011.5.2.107; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kosari-Nasab M, 2018, BEHAV PHARM; Kosari-Nasab M, 2019, METAB BRAIN DIS; Kosari-Nasab M, 2018, LIFE SCI, V213, P198, DOI 10.1016/j.lfs.2018.10.040; Kosari-Nasab M, 2018, TOXICOL APPL PHARM, V338, P159, DOI 10.1016/j.taap.2017.11.012; Kosari-Nasab M, 2014, BEHAV PHARMACOL, V25, P325, DOI 10.1097/FBP.0000000000000051; Kumar A, 2008, J MED FOOD, V11, P469, DOI 10.1089/jmf.2006.0207; Maciel RM, 2016, BIOMED PHARMACOTHER, V84, P559, DOI 10.1016/j.biopha.2016.09.069; Sabogal-Guaqueta AM, 2015, NEUROPHARMACOLOGY, V93, P134, DOI 10.1016/j.neuropharm.2015.01.027; Marina M, 2010, J PHARM PHARM SCI, V13, P311, DOI 10.18433/J3VS3S; Mehta V, 2017, PHYSIOL BEHAV, V171, P69, DOI 10.1016/j.physbeh.2017.01.006; Merzoug S, 2014, N-S ARCH PHARMACOL, V387, P921, DOI 10.1007/s00210-014-1008-y; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Pei B, 2016, BIOCHEM BIOPH RES CO, V478, P199, DOI 10.1016/j.bbrc.2016.07.068; Ravindran LN, 2010, J CLIN PSYCHIAT, V71, P839, DOI 10.4088/JCP.10r06218blu; Reul JMHM, 2002, CURR OPIN PHARMACOL, V2, P23, DOI 10.1016/S1471-4892(01)00117-5; Rinwa P, 2013, NEUROSCIENCE, V255, P86, DOI 10.1016/j.neuroscience.2013.09.044; Rogerio AP, 2010, PHARMACOL RES, V61, P288, DOI 10.1016/j.phrs.2009.10.005; Sah SP, 2011, INDIAN J PHARMACOL, V43, P192, DOI 10.4103/0253-7613.77365; Salari AA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29595-0; Salari AA, 2017, INT J DEV NEUROSCI, V57, P62, DOI 10.1016/j.ijdevneu.2017.01.007; Samad N, 2018, PHYSIOL RES, V67, P795, DOI 10.33549/physiolres.933776; Selvakumar K, 2013, TOXICOL LETT, V222, P45, DOI 10.1016/j.toxlet.2013.06.237; Toumi ML, 2013, PHARMACOL BIOCHEM BE, V107, P1, DOI 10.1016/j.pbb.2013.03.009; Unsal C, 2015, TOXICOL IND HEALTH, V31, P1106, DOI 10.1177/0748233713486960; Yang T, 2014, CELL MOL NEUROBIOL, V34, P797, DOI 10.1007/s10571-014-0070-9; Youdim KA, 2004, FREE RADICAL BIO MED, V36, P592, DOI 10.1016/j.freeradbiomed.2003.11.023	51	12	13	2	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0955-8810	1473-5849		BEHAV PHARMACOL	Behav. Pharmacol.	APR	2019	30	2-3			SI		282	289		10.1097/FBP.0000000000000480			8	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	HR2SZ	WOS:000462988600017	30882424				2022-02-06	
J	Kosari-Nasab, M; Shokouhi, G; Azarfarin, M; Amirkhiz, MB; Abbasi, MM; Salari, AA				Kosari-Nasab, Morteza; Shokouhi, Ghaffar; Azarfarin, Maryam; Amirkhiz, Maryam Bannazadeh; Abbasi, Mehran Mesgari; Salari, Ali-Akbar			Serotonin 5-HT1A receptors modulate depression-related symptoms following mild traumatic brain injury in male adult mice	METABOLIC BRAIN DISEASE			English	Article						SSRIs; Brain injury; Serotonin; 5-HT1A; Depression; Mice	GABA-A RECEPTORS; MAJOR DEPRESSION; AGONIST 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; TRYPTOPHAN DEPLETION; 8-OH-DPAT; ANXIETY; MODEL; INCREASES; IMPACT; NEUROGENESIS	Traumatic brain injury is a complex phenomenon leading to neurological diseases and persistent disability that currently affects millions of people worldwide. Increasing evidence shows that a wide range of patients with mild traumatic brain injury (mTBI) suffer from depression during the initial stages of injury and the post-acute stages of recovery. However, the underlying mechanisms involved in depression following mTBI are still not fully understood. The aim of this study was to determine whether serotonin 5-hydroxytryptamine-1A (5-HT1A) receptor is involved in the regulation of depression-related behaviors following mild traumatic brain injury in mice. Mice with or without mTBI received intracerebroventricular injections of 5-HT1A receptor agonist (8-OH-DPAT) or antagonist (WAY-100635) for 5days, then animals were subjected to behavioral tests. Four behavioral tests including novelty-suppressed feeding test, forced swim test, sucrose preference test and tail suspension test were used to evaluate depression-related symptoms in animals. Our results indicated that mTBI induction increased depression-like symptoms through altering serotonin 5-HT1A receptor activity in the brain. Activation of 5-HT1A receptor by a subthreshold dose of 8-OH-DPAT led to a significant decrease in depression-like behaviors, whereas blockade of 5-HT1A receptor by a subthreshold dose of WAY-100635 resulted in a considerable increase in depression-like phenotypes in mTBI-induced mice. The major strength of the present study is that depression-related symptoms were assessed in four behavioral tests. The present study supports the idea that disturbances in the function of serotonergic system in the brain following mTBI can play an important role in the regulation of depression-related behaviors.	[Kosari-Nasab, Morteza; Shokouhi, Ghaffar; Amirkhiz, Maryam Bannazadeh; Abbasi, Mehran Mesgari; Salari, Ali-Akbar] Tabriz Univ Med Sci, Drug Appl Res Ctr, PO 51656-65811, Tabriz, Iran; [Shokouhi, Ghaffar] Tabriz Univ Med Sci, Dept Neurosurg, Tabriz, Iran; [Shokouhi, Ghaffar] Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz, Iran; [Azarfarin, Maryam] Higher Educ Inst Rab Rashid, Tabriz, Iran; [Salari, Ali-Akbar] SICBD, Alborz, Iran		Salari, AA (corresponding author), Tabriz Univ Med Sci, Drug Appl Res Ctr, PO 51656-65811, Tabriz, Iran.; Salari, AA (corresponding author), SICBD, Alborz, Iran.	aa.salari@yahoo.com	Salari, Ali-Akbar/I-7843-2013; Tabrizi, Ghaffar Shokouhi/L-6326-2017	Salari, Ali-Akbar/0000-0002-4970-0337; Tabrizi, Ghaffar Shokouhi/0000-0001-5081-9928; Kosari-Nasab, Morteza/0000-0001-8454-5873			Amani M, 2019, PSYCHOPHARMACOLOGY, V236, P1281, DOI 10.1007/s00213-018-5137-8; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Arango V, 2002, PROG BRAIN RES, V136, P443; Artigas F, 1996, TRENDS NEUROSCI, V19, P378, DOI 10.1016/S0166-2236(96)10037-0; Banasr M, 2004, NEUROPSYCHOPHARMACOL, V29, P450, DOI 10.1038/sj.npp.1300320; Bashiri H, 2018, NEUROL RES, V40, P938, DOI 10.1080/01616412.2018.1504158; Bhagwagar Z, 2004, MOL PSYCHIATR, V9, P386, DOI 10.1038/sj.mp.4001401; Blier P, 2003, BIOL PSYCHIAT, V53, P193, DOI 10.1016/S0006-3223(02)01643-8; Carr GV, 2010, HBK BEHAV NEUROSCI, V21, P493, DOI 10.1016/B978-0-12-374634-4.00030-7; Carr GV, 2011, PSYCHOPHARMACOLOGY, V213, P265, DOI [10.1007/s00213-010-1832-9, 10.1007/s00213-010-2097-z]; Cheng JP, 2008, BEHAV BRAIN RES, V194, P79, DOI 10.1016/j.bbr.2008.06.025; Cheng JP, 2016, BRAIN RES, V1640, P5, DOI 10.1016/j.brainres.2015.11.026; Cheng JP, 1640, BRAIN RES, P5; Deb S, 1999, AM J PSYCHIAT, V156, P374; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V119, P47, DOI 10.1007/BF02246053; DEVRY J, 1995, PSYCHOPHARMACOLOGY, V121, P1; Fann JR, 2017, J HEAD TRAUMA REHAB, V32, P332, DOI 10.1097/HTR.0000000000000322; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; FINKLESTEIN S, 1983, BRAIN RES, V271, P279, DOI 10.1016/0006-8993(83)90290-1; Gardner A, 2011, PROG NEURO-PSYCHOPH, V35, P730, DOI 10.1016/j.pnpbp.2010.07.030; Gould E, 1999, NEUROPSYCHOPHARMACOL, V21, pS46, DOI 10.1038/sj.npp.1395369; Hale MW, 2012, CELL MOL NEUROBIOL, V32, P695, DOI 10.1007/s10571-012-9827-1; Hirvonen J, 2008, INT J NEUROPSYCHOPH, V11, P465, DOI 10.1017/S1461145707008140; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jain NS, 2017, PSYCHOPHARMACOLOGY, V234, P447, DOI 10.1007/s00213-016-4478-4; Kanno T, 2015, MOL NEUROBIOL, V51, P523, DOI 10.1007/s12035-014-8718-5; Kaufman J, 2016, EUR NEUROPSYCHOPHARM, V26, P397, DOI 10.1016/j.euroneuro.2015.12.039; Kawa L, 2015, J NEUROTRAUM, V32, P1190, DOI 10.1089/neu.2014.3669; KENNETT GA, 1987, EUR J PHARMACOL, V134, P265, DOI 10.1016/0014-2999(87)90357-8; Kline AE, 2004, J NEUROTRAUM, V21, P175, DOI 10.1089/089771504322778631; Kline AE, 2002, NEUROSCI LETT, V333, P179, DOI 10.1016/S0304-3940(02)01101-1; Kline AE, 2001, NEUROSCIENCE, V106, P547, DOI 10.1016/S0306-4522(01)00300-1; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kosari-Nasab M, 2019, BEHAV PHARMACOL, V30, P220, DOI 10.1097/FBP.0000000000000450; Kosari-Nasab M, 2018, LIFE SCI, V213, P198, DOI 10.1016/j.lfs.2018.10.040; Kosari-Nasab M, 2018, TOXICOL APPL PHARM, V338, P159, DOI 10.1016/j.taap.2017.11.012; KOSTOWSKI W, 1992, PHARMACOL TOXICOL, V71, P24, DOI 10.1111/j.1600-0773.1992.tb00515.x; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; LUCKI I, 1991, J CLIN PSYCHIAT, V52, P24; LUCKI I, 1994, NEUROSCI BIOBEHAV R, V18, P85, DOI 10.1016/0149-7634(94)90039-6; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Moreno FA, 1999, BIOL PSYCHIAT, V46, P498, DOI 10.1016/S0006-3223(99)00095-5; Neumeister A, 2004, ARCH GEN PSYCHIAT, V61, P765, DOI 10.1001/archpsyc.61.8.765; PAPPIUS HM, 1987, J NEUROCHEM, V49, P321, DOI 10.1111/j.1471-4159.1987.tb03433.x; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; ROBINSON DS, 1990, J CLIN PSYCHOPHARM S, V10, P67; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Salari AA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29595-0; Salari AA, 2017, INT J DEV NEUROSCI, V57, P62, DOI 10.1016/j.ijdevneu.2017.01.007; Salari AA, 2015, EUR NEUROPSYCHOPHARM, V25, P1260, DOI 10.1016/j.euroneuro.2015.04.022; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; SINGH A, 1993, NEUROPHARMACOLOGY, V32, P331, DOI 10.1016/0028-3908(93)90153-T; Solati J, 2011, NEUROCHEM J+, V5, P194, DOI 10.1134/S1819712411030081; Stockmeier CA, 2003, J PSYCHIAT RES, V37, P357, DOI 10.1016/S0022-3956(03)00050-5; TSUIKI K, 1995, J NEUROCHEM, V64, P1319; Yue JK, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080093	59	12	12	0	9	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7490	1573-7365		METAB BRAIN DIS	Metab. Brain Dis.	APR	2019	34	2					575	582		10.1007/s11011-018-0366-4			8	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	HQ1KK	WOS:000462156500019	30607822				2022-02-06	
J	Walker, CL; Wu, XB; Liu, NK; Xu, XM				Walker, Chandler L.; Wu, Xiangbing; Liu, Nai-Kui; Xu, Xiao-Ming			Bisperoxovanadium Mediates Neuronal Protection through Inhibition of PTEN and Activation of PI3K/AKT-mTOR Signaling after Traumatic Spinal Injuries	JOURNAL OF NEUROTRAUMA			English	Article						bisperoxovanadium; bpV; mTOR spinal cord injury; neuroprotection; PTEN	CORD-INJURY; FUNCTIONAL RECOVERY; AXON REGENERATION; MOTOR FUNCTION; ADULT RATS; APOPTOSIS; AUTOPHAGY; BRAIN; PERSPECTIVE; INVOLVEMENT	Although mechanisms involved in progression of cell death in spinal cord injury (SCI) have been studied extensively, few are clear targets for translation to clinical application. One of the best-understood mechanisms of cell survival in SCI is phosphatidylinositol-3-kinase (PI3K)/Akt and associated downstream signaling. Clear therapeutic efficacy of a phosphatase and tensin homologue (PTEN) inhibitor called bisperoxovanadium (bpV) has been shown in SCI, traumatic brain injury, stroke, and other neurological disease models in both neuroprotection and functional recovery. The present study aimed to elucidate mechanistic influences of bpV activity in neuronal survival in in vitro and in vivo models of SCI. Treatment with 100 nM bpV(pic) reduced cell death in a primary spinal neuron injury model (p < 0.05) in vitro, and upregulated both Akt and ribosomal protein S6 (pS6) activity (p < 0.05) compared with non-treated injured neurons. Pre-treatment of spinal neurons with a PI3K inhibitor, LY294002 or mammalian target of rapamycin (mTOR) inhibitor, rapamycin blocked bpV activation of Akt and ribosomal protein S6 activity, respectively. Treatment with bpV increased extracellular signal-related kinase (Erk) activity after scratch injury in vitro, and rapamycin reduced influence by bpV on Erk phosphorylation. After a cervical hemicontusive SCI, Akt phosphorylation decreased in total tissue via Western blot analysis (p < 0.01) as well as in penumbral ventral horn motor neurons throughout the first week post-injury (p < 0.05). Conversely, PTEN activity appeared to increase over this period. As observed in vitro, bpV also increased Erk activity post-SCI (p < 0.05). Our results suggest that PI3K/Akt signaling is the likely primary mechanism of bpV action in mediating neuroprotection in injured spinal neurons.	[Walker, Chandler L.] Indiana Univ, Sch Dent, Dept Biomed & Appl Sci, Indianapolis, IN USA; [Walker, Chandler L.; Wu, Xiangbing; Liu, Nai-Kui; Xu, Xiao-Ming] Indiana Univ Sch Med, Dept Neurol Surg, Stark Neurosci Res Inst, Spinal Cord & Brain Injury Res Grp, Indianapolis, IN 46202 USA; [Walker, Chandler L.; Wu, Xiangbing; Liu, Nai-Kui; Xu, Xiao-Ming] Indiana Univ Sch Med, Goodman Campbell Brain & Spine, Indianapolis, IN 46202 USA		Xu, XM (corresponding author), Stark Neurosci Res Inst, Spinal Cord & Brain Injury Res Grp, 320 W 15th St,NS Bldg,Room 500E, Indianapolis, IN 46202 USA.	xu26@iupui.edu	Walker, Chandler L./D-2256-2014	Walker, Chandler L./0000-0002-8616-8263	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01 100531, 1R01 NS103481]; Merit Review Award from the U.S. Department of Veterans AffairsUS Department of Veterans Affairs [I01 BX002356, I01 BX003705]; Indiana Spinal Cord and Brain Injury Research Foundation [19919]; Mari Hulman George Endowment Funds; U.S. Department of Veterans AffairsUS Department of Veterans Affairs [IK2 RX002688]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS103481] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002356, I01BX003705, IK2RX002688] Funding Source: NIH RePORTER	This work was supported in part by NIH 1R01 100531, 1R01 NS103481, Merit Review Award I01 BX002356, I01 BX003705 from the U.S. Department of Veterans Affairs, Indiana Spinal Cord and Brain Injury Research Foundation No. 19919, Mari Hulman George Endowment Funds (XMX). This work was also partly supported by a Career Development Award from the U.S. Department of Veterans Affairs (IK2 RX002688) (CLW). A portion of this manuscript was prepared or derived from information presented in Dr. Walker's Doctoral Dissertation.	Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castedo M, 2002, CELL DEATH DIFFER, V9, P99, DOI 10.1038/sj.cdd.4400978; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; CRUZ C, 2002, CURR NEUROPHARMACOL, V5, P244; De Paula ML, 2014, GLIA, V62, P64, DOI 10.1002/glia.22584; Deng LX, 2011, EXP NEUROL, V229, P238, DOI 10.1016/j.expneurol.2011.02.001; Ding J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080429; Ek CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012021; Gao L, 2012, GROWTH FACTORS, V30, P167, DOI 10.3109/08977194.2012.678842; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Guo Y, 2018, NEUROCHEM RES, V43, P1111, DOI 10.1007/s11064-018-2525-8; Jiang XY, 2006, J NEUROSCI METH, V158, P13, DOI 10.1016/j.jneumeth.2006.05.014; Kanno H, 2011, SPINE, V36, pE1427, DOI 10.1097/BRS.0b013e3182028c3a; Kanno H, 2009, NEUROBIOL DIS, V33, P143, DOI 10.1016/j.nbd.2008.09.009; Kirshblum S. C., 2002, ARCH PHYS MED REHAB, V83, pS50; Kirshblum Steven C, 2002, J Spinal Cord Med, V25, P339; Lewandowski G, 2014, J NEUROSCI, V34, P9951, DOI 10.1523/JNEUROSCI.1996-14.2014; Li DY, 2009, J CEREBR BLOOD F MET, V29, P1903, DOI 10.1038/jcbfm.2009.102; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Liu NK, 2006, ANN NEUROL, V59, P606, DOI 10.1002/ana.20798; Liu R, 2018, NEUROCHEM RES, V43, P1424, DOI 10.1007/s11064-018-2558-z; Mao L, 2013, NEUROSCIENCE, V231, P272, DOI 10.1016/j.neuroscience.2012.11.050; Mao LL, 2015, NEUROSCI LETT, V602, P120, DOI 10.1016/j.neulet.2015.06.040; Nakashima S, 2008, J NEUROSCI, V28, P7293, DOI 10.1523/JNEUROSCI.1826-08.2008; Ohtake Y, 2014, BIOMATERIALS, V35, P4610, DOI 10.1016/j.biomaterials.2014.02.037; Park JH, 2011, ONCOGENE, V30, P4578, DOI 10.1038/onc.2011.174; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; Sekiguchi A, 2012, J NEUROTRAUM, V29, P946, DOI 10.1089/neu.2011.1919; Shi GD, 2011, BIOCHEM BIOPH RES CO, V404, P941, DOI 10.1016/j.bbrc.2010.12.085; Song WY, 2010, J NEUROSCI, V30, P15608, DOI 10.1523/JNEUROSCI.2581-10.2010; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Sury MD, 2011, NEUROBIOL DIS, V41, P201, DOI 10.1016/j.nbd.2010.09.007; Tewarie RDSN, 2010, NEUROREHABILITATION, V27, P129, DOI 10.3233/NRE-2010-0589; Varma AK, 2013, NEUROCHEM RES, V38, P895, DOI 10.1007/s11064-013-0991-6; Walker C.L., 2013, FRONT BIOL BEIJING, P8; Walker CL, 2015, EXP NEUROL, V264, P163, DOI 10.1016/j.expneurol.2014.12.002; Walker CL, 2014, NEUROSCI LETT, V573, P64, DOI 10.1016/j.neulet.2014.02.039; Walker CL, 2012, PLOS ONE, V7, P315, DOI 10.1371/journal.pone.0030012; Walker MJ, 2015, JOVE-J VIS EXP, DOI 10.3791/50149; Wang ZY, 2017, NEUROSCI LETT, V656, P158, DOI 10.1016/j.neulet.2017.07.036; Wu XB, 2017, MOL NEUROBIOL, V54, P6885, DOI 10.1007/s12035-016-0187-6; Yu CG, 2010, J NEUROCHEM, V113, P131, DOI 10.1111/j.1471-4159.2010.06579.x; Yu FS, 2005, NEUROBIOL DIS, V20, P491, DOI 10.1016/j.nbd.2005.04.004; Zhang HY, 2013, MOL NEUROBIOL, V48, P452, DOI 10.1007/s12035-013-8432-8; Zhang QG, 2007, FEBS LETT, V581, P495, DOI 10.1016/j.febslet.2006.12.055; Zhang ZF, 2017, BRIT J PHARMACOL, V174, P641, DOI 10.1111/bph.13727; Zhao J, 2013, NEUROSCIENCE, V238, P242, DOI 10.1016/j.neuroscience.2013.02.046; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004	51	12	12	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 15	2019	36	18					2676	2687		10.1089/neu.2018.6294		MAR 2019	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IV8QU	WOS:000462599200001	30672370	Green Published			2022-02-06	
J	Rubenstein, R; Sharma, DR; Chang, BG; Oumata, N; Came, M; Vaucelle, U; Lindberg, MF; Chiu, A; Wisniewski, T; Wang, KKW; Meijer, L				Rubenstein, Richard; Sharma, Deep R.; Chang, Binggong; Oumata, Nassima; Came, Morgane; Vaucelle, Use; Lindberg, Mattias F.; Chiu, Allen; Wisniewski, Thomas; Wang, Kevin K. W.; Meijer, Laurent			Novel Mouse Tauopathy Model for Repetitive Mild Traumatic Brain Injury: Evaluation of Long-Term Effects on Cognition and Biomarker Levels After Therapeutic Inhibition of Tau Phosphorylation	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; repetitive mild closed head injury; TghTau/PS1 transgenic mice; total tau and phosphorylated tau; cognition; brain and blood-based biomarkers; roscovitine; lithium chloride	FIBRILLARY ACIDIC PROTEIN; GLYCOGEN-SYNTHASE KINASE-3-BETA; CYCLIN-DEPENDENT KINASES; INTRACRANIAL LESIONS; SERUM-LEVELS; NEUROBEHAVIORAL CHANGES; COMPUTED-TOMOGRAPHY; ALZHEIMERS-DISEASE; DUAL-SPECIFICITY; PLASMA-LEVELS	Traumatic brain injury (TBI) is a risk factor for a group of neurodegenerative diseases termed tauopathies, which includes Alzheimer's disease and chronic traumatic encephalopathy (CTE). Although TBI is stratified by impact severity as either mild (m), moderate or severe, mTBI is the most common and the most difficult to diagnose. Tauopathies are pathologically related by the accumulation of hyperphosphorylated tau (P-tau) and increased total tau (T-tau). Here we describe: (i) a novel human tau-expressing transgenic mouse model, TghTau/PS1, to study repetitive mild closed head injury (rmCHI), (ii) quantitative comparison of T-tau and P-tau from brain and plasma in TghTau/PS1 mice over a 12 month period following rmCHI (and sham), (iii) the usefulness of P-tau as an early- and late-stage blood-based biochemical biomarker for rmCHI, (iii) the influence of kinase-targeted therapeutic intervention on rmCHI-associated cognitive deficits using a combination of lithium chloride (UCI) and R-roscovitine (ros), and (iv) correlation of behavioral and cognitive changes with concentrations of the brain and blood-based T-tau and P-tau. Compared to sham-treated mice, behavior changes and cognitive deficits of rrriCHI-treated TghTau/PS1 mice correlated with increases in both cortex and plasma T-tau and P-tau levels over 12 months. In addition, T-tau, but more predominantly P-tau, levels were significantly reduced in the cortex and plasma by LiCI + ros approaching the biomarker levels in sham and drug-treated sham mice (the drugs had only modest effects on the T-tau and P-tau levels in sham mice) throughout the 12 month study period. Furthermore, although we also observed a reversal of the abnormal behavior and cognitive deficits in the drug-treated rmCHI mice (compared to the untreated rmCHI mice) throughout the time course, these drug-treated effects were most pronounced up until 10 and 12 months where the abnormal behavior and cognition deficits began to gradually increase. These studies describe: (a) a translational relevant animal model for TBI-linked tauopathies, and (b) utilization of T-tau and P-tau as rmCHl biomarkers in plasma to monitor novel therapeutic strategies and treatment regimens for these neurodegenerative diseases.	[Rubenstein, Richard; Sharma, Deep R.; Chang, Binggong; Chiu, Allen] Suny Downstate Med Ctr, Lab Neurodegenerat Dis & CNS Biomarker Discovery, Dept Neurol, Brooklyn, NY 11203 USA; [Rubenstein, Richard; Sharma, Deep R.; Chang, Binggong; Chiu, Allen] Suny Downstate Med Ctr, Dept Physiol Pharmacol, Brooklyn, NY 11203 USA; [Oumata, Nassima; Came, Morgane; Vaucelle, Use; Lindberg, Mattias F.; Meijer, Laurent] ManRos Therapeut, Ctr Perharidy, Roscoff, France; [Wisniewski, Thomas] NYU, Sch Med, Ctr Cognit Neurol, New York, NY USA; [Wisniewski, Thomas] NYU, Sch Med, Dept Neurol, New York, NY USA; [Wisniewski, Thomas] NYU, Sch Med, Dept Pathol, New York, NY USA; [Wisniewski, Thomas] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Wang, Kevin K. W.] Univ Florida, Dept Emergency Med, Program Neurotrauma Neuroprote & Biomarker Res, Gainesville, FL USA; [Wang, Kevin K. W.] Univ Florida, Dept Psychiat, Program Neurotrauma Neuroprote & Biomarker Res, Gainesville, FL 32611 USA; [Wang, Kevin K. W.] Univ Florida, Dept Neurosci, Program Neurotrauma Neuroprote & Biomarker Res, Gainesville, FL 32610 USA		Rubenstein, R (corresponding author), Suny Downstate Med Ctr, Lab Neurodegenerat Dis & CNS Biomarker Discovery, Dept Neurol, Brooklyn, NY 11203 USA.; Rubenstein, R (corresponding author), Suny Downstate Med Ctr, Dept Physiol Pharmacol, Brooklyn, NY 11203 USA.	richard.rubenstein@downstate.edu	MEIJER, Laurent/ABE-7465-2021; Wisniewski, Thomas/Q-6525-2019	Wisniewski, Thomas/0000-0002-3379-8966; , laurent/0000-0003-3511-4916; Lindberg, Mattias/0000-0002-9734-8163	Office of the Assistant Secretary of Defense for Health Affairs through the Department of Defense (DOD) Broad Agency Announcement [W81XWH-14-2-0166]; Fonds Unique Interministeriel (FUI) TRIAD project; Fondation Jerome Lejeune; NIA grant [AG08051]; SUNY Downstate Medical Center; CIFRE/ManRos Therapeutics Ph.D. fellowshipFrench National Research Agency (ANR); NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG008051] Funding Source: NIH RePORTER	The authors would like to thank Dr. Peter Davies for the antitau antibodies. This study is supported in part by the Office of the Assistant Secretary of Defense for Health Affairs through the Department of Defense (DOD) Broad Agency Announcement under Award number W81XWH-14-2-0166 (RR). This study was also supported in part by the Fonds Unique Interministeriel (FUI) TRIAD project (LM), Fondation Jerome Lejeune (LM), NIA grant AG08051 (TW) and the SUNY Downstate Medical Center. MC is recipient of a CIFRE/ManRos Therapeutics Ph.D. fellowship. LV is a Master 2 student from the Universite Technologique de Compiegne (UTC).	Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; Begaz T, 2006, J NEUROTRAUM, V23, P1201, DOI 10.1089/neu.2006.23.1201; Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Bettayeb K, 2008, ONCOGENE, V27, P5797, DOI 10.1038/onc.2008.191; Bettayeb K, 2008, MOL CANCER THER, V7, P2713, DOI 10.1158/1535-7163.MCT-08-0080; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Boutajangout A, 2009, ALZHEIMERS DEMENT, V5, pP445; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; Carlson SW, 2018, J NEUROTRAUM, V35, P2827, DOI 10.1089/neu.2017.5509; Carlson SW, 2017, EXP NEUROL, V289, P55, DOI 10.1016/j.expneurol.2016.12.006; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Choe MC, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0573-9; Conradt L, 2011, NEOPLASIA, V13, P1026, DOI 10.1593/neo.111016; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Debdab M, 2011, J MED CHEM, V54, P4172, DOI 10.1021/jm200274d; Delehouze C, 2014, ONCOGENE, V33, P5675, DOI 10.1038/onc.2013.513; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Faul M., 2010, TRAUMATIC BRAIN INJU, DOI [10.15620/cdc.5571, DOI 10.15620/CDC.5571]; Geschwind DH, 2003, NEURON, V40, P457, DOI 10.1016/S0896-6273(03)00681-0; Grin'kina NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053775; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Hashiguchi M, 2002, J BIOL CHEM, V277, P44525, DOI 10.1074/jbc.M207426200; Hilton GD, 2008, J CEREBR BLOOD F MET, V28, P1845, DOI 10.1038/jcbfm.2008.75; Hladky SB, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0040-3; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kimura T, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00044; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Korfias S, 2006, BRAIN INJURY, V20, P867, DOI 10.1080/02699050600832395; Kubik S, 2005, J NEUROSCI, V25, P9205, DOI 10.1523/JNEUROSCI.1707-05.2005; Leclerc S, 2001, J BIOL CHEM, V276, P251, DOI 10.1074/jbc.M002466200; Lee JY, 2015, J KOREAN NEUROSURG S, V58, P93, DOI 10.3340/jkns.2015.58.2.93; Leeds PR, 2014, ACS CHEM NEUROSCI, V5, P422, DOI 10.1021/cn500040g; Li T, 2006, BIOCHEMISTRY-US, V45, P3125, DOI 10.1021/bi051634r; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Liu X, 2017, DISCOV MED, V23, P221; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; McAteer Kelly M, 2017, Concussion, V2, pCNC32, DOI 10.2217/cnc-2016-0031; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Meijer L, 2003, ACCOUNTS CHEM RES, V36, P417, DOI 10.1021/ar0201198; Menn B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012117; Misra RN, 2004, J MED CHEM, V47, P1719, DOI 10.1021/jm0305568; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Oumata N, 2008, J MED CHEM, V51, P5229, DOI 10.1021/jm800109e; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2015, ACAD EMERG MED, V22, P1274, DOI 10.1111/acem.12795; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Parry D, 2010, MOL CANCER THER, V9, P2344, DOI 10.1158/1535-7163.MCT-10-0324; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Peskind ER, 2015, JAMA NEUROL, V72, P1103, DOI 10.1001/jamaneurol.2015.1789; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Popowycz F, 2009, J MED CHEM, V52, P655, DOI 10.1021/jm801340z; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Rubenstein R, 2018, BEHAV BRAIN RES, V340, P29, DOI 10.1016/j.bbr.2016.04.041; Rubenstein R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0435-7; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Shahim P, 2016, J NEUROTRAUM, V33, P1995, DOI 10.1089/neu.2014.3741; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shim SS, 2016, J NEUROTRAUM, V33, P2065, DOI 10.1089/neu.2015.4177; Squires MS, 2010, MOL CANCER THER, V9, P920, DOI 10.1158/1535-7163.MCT-09-1071; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; Tahtouh T, 2012, J MED CHEM, V55, P9312, DOI 10.1021/jm301034u; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; Tang L, 2005, J BIOL CHEM, V280, P31220, DOI 10.1074/jbc.M500805200; Tanramluk D, 2009, CHEM BIOL DRUG DES, V74, P16, DOI 10.1111/j.1747-0285.2009.00832.x; Vita M, 2005, EUR J PHARM SCI, V25, P91, DOI 10.1016/j.ejps.2005.02.001; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Xi ZQ, 2011, MED HYPOTHESES, V76, P897, DOI 10.1016/j.mehy.2011.03.003; Yan XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048782; Yang WJ, 2017, ACTA NEUROL SCAND, V135, P622, DOI 10.1111/ane.12644; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Yu FS, 2013, J NEUROSURG, V119, P766, DOI 10.3171/2013.6.JNS13135; Yu FS, 2012, J NEUROTRAUM, V29, P362, DOI 10.1089/neu.2011.1942; Zetterberg H, 2015, MOL CELL NEUROSCI, V66, P99, DOI 10.1016/j.mcn.2015.02.003; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhao BQ, 2007, STROKE, V38, P748, DOI 10.1161/01.STR.0000253500.32979.d1; Zhu ZF, 2010, BRAIN RES BULL, V83, P272, DOI 10.1016/j.brainresbull.2010.07.008	116	12	13	1	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 11	2019	10								124	10.3389/fneur.2019.00124			21	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HO3GB	WOS:000460807000001	30915013	gold, Green Published			2022-02-06	
J	Sabin, KZ; Jiang, P; Gearhart, MD; Stewart, R; Echeverri, K				Sabin, Keith Z.; Jiang, Peng; Gearhart, Micah D.; Stewart, Ron; Echeverri, Karen			Ap-1(cFos/JunB)/miR-200a regulate the pro-regenerative glial cell response during axolotl spinal cord regeneration	COMMUNICATIONS BIOLOGY			English	Article							TRAUMATIC SCRATCH INJURY; FUNCTIONAL REGENERATION; C-JUN; DIRECTIONAL SPECIFICITY; EXTRACELLULAR-MATRIX; TRANSGENIC ANALYSIS; LOCOMOTOR RECOVERY; ADULT ZEBRAFISH; SCAR FORMATION; BRAIN-INJURY	Salamanders have the remarkable ability to functionally regenerate after spinal cord transection. In response to injury, GFAP+ glial cells in the axolotl spinal cord proliferate and migrate to replace the missing neural tube and create a permissive environment for axon regeneration. Molecular pathways that regulate the pro-regenerative axolotl glial cell response are poorly understood. Here we show axolotl glial cells up-regulate AP-1cFos/JunB after injury, which promotes a pro-regenerative glial cell response. Injury induced upregulation of miR-200a in glial cells supresses c-Jun expression in these cells. Inhibition of miR-200a during regeneration causes defects in axonal regrowth and transcriptomic analysis revealed that miR-200a inhibition leads to differential regulation of genes involved with reactive gliosis, the glial scar, extracellular matrix remodeling and axon guidance. This work identifies a unique role for miR-200a in inhibiting reactive gliosis in axolotl glial cells during spinal cord regeneration.	[Sabin, Keith Z.; Gearhart, Micah D.; Echeverri, Karen] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Jiang, Peng; Stewart, Ron] Morgridge Inst Res, Madison, WI 53715 USA; [Sabin, Keith Z.; Echeverri, Karen] Eugene Bell Ctr Regenerat Biol & Tissue Engn, Marine Biol Lab, Woods Hole, MA 02543 USA		Echeverri, K (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	kecheverri@mbl.edu		Sabin, Keith/0000-0001-6452-7299; Gearhart, Micah/0000-0002-9873-1930	Regenerative Medicine Minnesota Grant; NIH NCIDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 GM113846]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM113846] Funding Source: NIH RePORTER	This reseach was supported by a Regenerative Medicine Minnesota Grant and a NIH NCID R01 to KE. KZS has been supported by a NIH T32 GM113846 grant.	ABATE C, 1993, P NATL ACAD SCI USA, V90, P6766, DOI 10.1073/pnas.90.14.6766; Adams KL, 2018, NAT NEUROSCI, V21, P9, DOI 10.1038/s41593-017-0033-9; Aguirre A, 2014, CELL STEM CELL, V15, P589, DOI 10.1016/j.stem.2014.10.003; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Babcock AA, 2006, J NEUROSCI, V26, P12826, DOI 10.1523/JNEUROSCI.4937-05.2006; Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; BEATTIE MS, 1990, J NEUROBIOL, V21, P1108, DOI 10.1002/neu.480210714; Beauchemin M, 2015, DEVELOPMENT, V142, P4026, DOI 10.1242/dev.126649; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Becker T, 1998, J NEUROSCI, V18, P5789; BERNARDINI S, 1992, J HIRNFORSCH, V33, P241; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Boido M, 2011, J NEUROSURG-SPINE, V15, P97, DOI 10.3171/2011.1.SPINE10607; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; BUTLER EG, 1967, DEV BIOL, V15, P464, DOI 10.1016/0012-1606(67)90038-3; BUTLER EG, 1965, J EXP ZOOL, V160, P47, DOI 10.1002/jez.1401600106; Cao Z, 2015, CELL MOL NEUROBIOL, V35, P1073, DOI 10.1007/s10571-015-0215-5; Chen TL, 2016, RESTOR NEUROL NEUROS, V34, P325, DOI 10.3233/RNN-150602; Chernoff EAG, 2003, DEV DYNAM, V226, P295, DOI 10.1002/dvdy.10240; Chernoff EAG, 1996, INT J DEV BIOL, V40, P823; Chernoff EAG, 2002, SEMIN CELL DEV BIOL, V13, P361, DOI 10.1016/S1084952102000927; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CLARKE JDW, 1988, NEUROSCI LETT, V89, P1, DOI 10.1016/0304-3940(88)90471-5; COHEN AH, 1989, BRAIN RES, V496, P368, DOI 10.1016/0006-8993(89)91090-1; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; DAVIS GR, 1994, EXP NEUROL, V127, P94, DOI 10.1006/exnr.1994.1083; DAVIS GR, 1993, EXP BRAIN RES, V97, P83; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Diaz Quiroz JF, 2013, BIOCHEM J, V451, P353, DOI 10.1042/BJ20121807; Echeverri K, 2003, DEV DYNAM, V226, P418, DOI 10.1002/dvdy.10238; Echeverri K, 2002, SCIENCE, V298, P1993, DOI 10.1126/science.1077804; Edwards-Faret G, 2018, J COMP NEUROL, V526, P1712, DOI 10.1002/cne.24441; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; EGAR M, 1972, EXP NEUROL, V37, P422, DOI 10.1016/0014-4886(72)90085-4; Fei JF, 2014, STEM CELL REP, V3, P444, DOI 10.1016/j.stemcr.2014.06.018; Ferrara P, 2003, ONCOGENE, V22, P1461, DOI 10.1038/sj.onc.1206266; Fidler PS, 1999, J NEUROSCI, V19, P8778, DOI 10.1523/JNEUROSCI.19-20-08778.1999; Flevaris P, 2017, SEMIN THROMB HEMOST, V43, P169, DOI 10.1055/s-0036-1586228; Flowers GP, 2014, DEVELOPMENT, V141, P2165, DOI 10.1242/dev.105072; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Gaete M, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-13; Gao K, 2013, GLIA, V61, P2063, DOI 10.1002/glia.22577; Gibbs KM, 2006, BRAIN RES, V1088, P68, DOI 10.1016/j.brainres.2006.02.126; Gibbs KM, 2011, EUR J NEUROSCI, V33, P9, DOI 10.1111/j.1460-9568.2010.07477.x; Goldshmit Y, 2012, J NEUROSCI, V32, P7477, DOI 10.1523/JNEUROSCI.0758-12.2012; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Herman PE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18757-1; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hodgkinson CP, 2015, CIRC RES, V116, P1700, DOI 10.1161/CIRCRESAHA.116.304377; Hui SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084212; Hui SP, 2013, DEV DYNAM, V242, P847, DOI 10.1002/dvdy.23976; Hui SP, 2010, DEV DYNAM, V239, P2962, DOI 10.1002/dvdy.22438; Ji ZL, 2012, MOL CELL BIOL, V32, P385, DOI 10.1128/MCB.05504-11; Jiang P, 2017, DEV BIOL, V426, P143, DOI 10.1016/j.ydbio.2016.05.024; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee-Liu D, 2018, MOL CELL PROTEOMICS, V17, P592, DOI 10.1074/mcp.RA117.000215; Lee-Liu D, 2014, NEURAL DEV, V9, DOI 10.1186/1749-8104-9-12; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Li XQ, 2015, CANCER RES, V75, P3302, DOI 10.1158/0008-5472.CAN-15-0240; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lin G, 2008, DEV BIOL, V316, P323, DOI 10.1016/j.ydbio.2008.01.032; Lin GF, 2012, ANAT REC, V295, P1532, DOI 10.1002/ar.22437; Liu J, 2015, NAT CELL BIOL, V17, P856, DOI 10.1038/ncb3193; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; LURIE DI, 1991, J COMP NEUROL, V313, P669, DOI 10.1002/cne.903130410; Mabon PJ, 2000, EXP NEUROL, V166, P52, DOI 10.1006/exnr.2000.7488; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; MACKLER SA, 1986, J NEUROSCI, V6, P1814; Malnou CE, 2007, J BIOL CHEM, V282, P31046, DOI 10.1074/jbc.M702833200; Malnou CE, 2010, J BIOL CHEM, V285, P6552, DOI 10.1074/jbc.M109.032680; Mendez-Olivos EE, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00398; Munoz R, 2015, DEV BIOL, V408, P229, DOI 10.1016/j.ydbio.2015.03.009; OHARA CM, 1992, DEV DYNAM, V193, P103, DOI 10.1002/aja.1001930202; Piechaczyk M, 2008, BIOCHEM SOC T, V36, P864, DOI 10.1042/BST0360864; Quiroz JFD, 2014, DIS MODEL MECH, V7, P601, DOI 10.1242/dmm.014837; Raivich G, 2006, PROG NEUROBIOL, V78, P347, DOI 10.1016/j.pneurobio.2006.03.006; Renault-Mihara F, 2017, J CELL BIOL, V216, P2533, DOI 10.1083/jcb.201610102; Rodriguez-Martinez JA, 2017, ELIFE, V6, DOI 10.7554/elife.19272.001; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; ROVAINEN CM, 1976, J COMP NEUROL, V168, P545, DOI 10.1002/cne.901680407; Sabin K, 2015, DEV BIOL, V408, P14, DOI 10.1016/j.ydbio.2015.10.012; Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315; Schafer MKE, 2012, CELL TISSUE RES, V349, P39, DOI 10.1007/s00441-012-1345-4; Schinelli S, 2001, J NEUROSCI, V21, P8842, DOI 10.1523/JNEUROSCI.21-22-08842.2001; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; Sehm T, 2009, DEV BIOL, V334, P468, DOI 10.1016/j.ydbio.2009.08.008; SELZER ME, 1978, J PHYSIOL-LONDON, V277, P395, DOI 10.1113/jphysiol.1978.sp012280; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sirko S, 2015, GLIA, V63, P2340, DOI 10.1002/glia.22898; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Tapia VS, 2017, REGENERATION, V4, P21, DOI 10.1002/reg2.74; Tazaki A, 2017, DEV BIOL, V432, P63, DOI 10.1016/j.ydbio.2017.09.034; Thatcher EJ, 2008, P NATL ACAD SCI USA, V105, P18384, DOI 10.1073/pnas.0803713105; Trumbach D, 2015, CELL TISSUE RES, V359, P161, DOI 10.1007/s00441-014-1911-z; Vesely PW, 2009, MUTAT RES-REV MUTAT, V682, P7, DOI 10.1016/j.mrrev.2009.01.001; Wang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03137-6; Witman N, 2013, DEV BIOL, V383, P253, DOI 10.1016/j.ydbio.2013.09.011; Yeo S, 2013, GLIA, V61, P1488, DOI 10.1002/glia.22536; Yi MN, 2016, NEUROSCI LETT, V624, P62, DOI 10.1016/j.neulet.2016.05.004; YIN HS, 1984, SCIENCE, V224, P894, DOI 10.1126/science.6719120; Yoon J, 2013, INT J DEV BIOL, V57, P865, DOI 10.1387/ijdb.130163jk; Yu YM, 2011, NEUROSCIENCE, V183, P238, DOI 10.1016/j.neuroscience.2011.03.043; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zenz R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2338; Zukor KA, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-1	113	12	12	2	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA		2399-3642		COMMUN BIOL	Commun. Biol.	MAR 6	2019	2								91	10.1038/s42003-019-0335-4			13	Biology; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Science & Technology - Other Topics	HO7WC	WOS:000461159700001	30854483	Green Published, gold			2022-02-06	
J	Brunner, M; Palmer, S; Togher, L; Hemsley, B				Brunner, Melissa; Palmer, Stuart; Togher, Leanne; Hemsley, Bronwyn			'I kind of figured it out': the views and experiences of people with traumatic brain injury (TBI) in using social media-self-determination for participation and inclusion online	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article						traumatic brain injury; social media; rehabilitation	COMMUNICATION; ADULTS; REHABILITATION; RESILIENCE; TWITTER; EXCHANGE; MODEL	Background Social media can support people with communication disability to access information, social participation and support. However, little is known about the experiences of people with traumatic brain injury (TBI) who use social media to determine their needs in relation to social media use. Aims To determine the views and experiences of adults with TBI and cognitive-communication disability on using social media, specifically: (1) the nature of their social media experience; (2) barriers and facilitators to successful use; and (3) strategies that enabled their use of social media. Methods & Procedures Thirteen adults (seven men, six women) with TBI and cognitive-communication disability were interviewed about their social media experiences, and a content thematic analysis was conducted. Outcomes & Results Participants used several social media platforms including Facebook, Twitter, Instagram and virtual gaming worlds. All but one participant used social media several times each day and all used social media for social connection. Five major themes emerged from the data: (1) getting started in social media for participation and inclusion; (2) drivers to continued use of social media; (3) manner of using social media; (4) navigating social media; and (5) an evolving sense of social media mastery. In using platforms in a variety of ways, some participants developed an evolving sense of social media mastery. Participants applied caution in using social media, tended to learn through a process of trial and error, and lacked structured supports from family, friends or health professionals. They also reported several challenges that influenced their ability to use social media, but found support from peers in using the social media platforms. This information could be used to inform interventions supporting the use of social media for people with TBI and directions for future research. Conclusions & Implications: Social media offers adults with TBI several opportunities to communicate and for some to develop and strengthen social relationships. However, some adults with TBI also reported the need for more information about how to use social media. Their stories suggested a need to develop a sense of purpose in relation to using social media, and ultimately more routine and purposeful use to develop a sense of social media mastery. Further research is needed to examine the social media data and networks of people with TBI, to verify and expand upon the reported findings, and to inform roles that family, friends and health professionals may play in supporting rehabilitation goals for people with TBI.	[Brunner, Melissa; Hemsley, Bronwyn] UTS, Grad Sch Hlth, Speech Pathol, Ultimo, NSW, Australia; [Palmer, Stuart] Deakin Univ, Sch Engn, Geelong, Vic, Australia; [Togher, Leanne] Univ Sydney, Fac Hlth Sci, Speech Pathol, Sydney, NSW, Australia; [Togher, Leanne] UNSW, NHMRC Ctr Res Excellence Brain Recovery, Sydney, NSW, Australia		Brunner, M (corresponding author), UTS, Grad Sch Hlth, Speech Pathol, Ultimo, NSW, Australia.	melissa.brunner@uts.edu.au	Brunner, Melissa/AAS-5965-2020; Togher, Leanne/AAC-7083-2019; Hemsley, Bronwyn/A-7427-2010	Hemsley, Bronwyn/0000-0002-6255-3140; Togher, Leanne/0000-0002-4518-6748; Brunner, Melissa/0000-0001-6823-5189; Palmer, Stuart/0000-0002-2517-0597	University of Newcastle	The authors acknowledge and thank the research participants for contributing their time to be interviewed for this study; and the University of Newcastle for the administration of funding and support in the conduction of this study.	Australian Securities And Investments Commission (ASIC), 2015, 429 ASIC; Baker-Sparr C, 2018, J HEAD TRAUMA REHAB, V33, pE9, DOI 10.1097/HTR.0000000000000305; boyd D, 2014, ITS COMPLICATED SOCI; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Brunner M, 2018, BRAIN INJURY, V32, P49, DOI 10.1080/02699052.2017.1403047; Brunner M, 2017, BRAIN INJURY, V31, P1028, DOI 10.1080/02699052.2017.1292429; Brunner M, 2015, DISABIL REHABIL, V37, P1511, DOI 10.3109/09638288.2015.1045992; Ciccia AH, 2015, INT J LANG COMM DIS, V50, P436, DOI 10.1111/1460-6984.12153; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Coelho C, 2013, AM J SPEECH-LANG PAT, V22, pS438, DOI 10.1044/1058-0360(2013/12-0076); Creswell JW., 2014, RES DESIGN QUALITATI, V4; desLeeuw E. D., 2008, INT HDB SURVEY METHO; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Dumont C, 2004, J HEAD TRAUMA REHAB, V19, P431, DOI 10.1097/00001199-200411000-00002; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Hemsley B., 2017, 50 HAW INT C SYST SC, P41; Hemsley B, 2018, INT J SPEECH-LANG PA, V20, P50, DOI 10.1080/17549507.2017.1413137; Hemsley B, 2015, DISABIL REHABIL, V37, P1531, DOI 10.3109/09638288.2015.1045990; Hemsley B, 2014, DEV NEUROREHABIL, V17, P84, DOI 10.3109/17518423.2013.861529; Jenaro C, 2018, AGGRESS VIOLENT BEH, V38, P113, DOI 10.1016/j.avb.2017.12.003; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; Laukka E, 2019, HEALTH INFORM J, V25, P247, DOI 10.1177/1460458217704254; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Morgan G. A., 1990, EARLY EDUC DEV, V1, P318, DOI [DOI 10.1207/S15566935EED0105_1, DOI 10.1207/S15566935-ED0105_1]; Neils-Strunjas J, 2017, BRAIN INJURY, V31, P131, DOI 10.1080/02699052.2016.1229032; Oberst U, 2017, J ADOLESCENCE, V55, P51, DOI 10.1016/j.adolescence.2016.12.008; Paterson HL, 2017, AUGMENT ALTERN COMM, V33, P23, DOI 10.1080/07434618.2016.1275789; Patton M., 2015, QUALITATIVE RES EVAL, V4; Pew Research Center, 2017, ONL HAR 2017; Pew Research Center, 2016, SOC MED UPD 2016; Riessman K. C., 2008, NARRATIVE METHODS HU; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Sensis, 2017, SENS SOC MED REP 201; Sim P, 2013, BRAIN INJURY, V27, P717, DOI 10.3109/02699052.2013.775485; Suler J, 2004, CYBERPSYCHOL BEHAV, V7, P321, DOI 10.1089/1094931041291295; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Tatla SK, 2014, BRAIN INJURY, V28, P1022, DOI 10.3109/02699052.2014.890747; Tracy S.J., 2013, QUALITATIVE RES METH; Trevisan F, 2017, PUBLIC RELAT INQ, V6, P191, DOI 10.1177/2046147X17697785; Wakefield R, 2016, J STRATEGIC INF SYST, V25, P140, DOI 10.1016/j.jsis.2016.04.001	40	12	12	1	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-2822	1460-6984		INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	MAR-APR	2019	54	2			SI		221	233		10.1111/1460-6984.12405			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	HO1EP	WOS:000460648500006	29873159	Green Published, hybrid, Green Accepted			2022-02-06	
J	Cushman, DM; Borowski, L; Hansen, C; Hendrick, J; Bushman, T; Teramoto, M				Cushman, Daniel M.; Borowski, Lauren; Hansen, Colby; Hendrick, John; Bushman, Troy; Teramoto, Masaru			Gabapentin and Tricyclics in the Treatment of Post-Concussive Headache, a Retrospective Cohort Study	HEADACHE			English	Article						concussion; post-concussion syndrome; mild traumatic brain injury; amitriptyline; nortriptyline; post traumatic headache	TRAUMATIC BRAIN-INJURY; SYMPTOMS; EPIDEMIOLOGY; MANAGEMENT; ADOLESCENTS; DEPRESSION; IMPACT	Objective To examine the association of commonly prescribed post-concussive medications, namely gabapentin and tricyclic antidepressants (TCAs), with symptom reduction after concussion. Background Concussion is a common diagnosis in modern medicine. Many providers use medication to target the residual symptoms of a concussion, with little evidence supporting their efficacy. Design Retrospective study with longitudinal analysis using mixed-effects and piecewise regression analyses of 277 patients presenting to an academic sports medicine clinic, all of whom were clinically diagnosed with a concussion. Main outcomes were patient-reported headache score (quantitative variable; 0-6) and combined symptom score (quantitative variable; 0-132) from the Post-Concussion Symptom Scale (PCSS). Methods Patients self-reported their symptom scores on the PCSS at the time of each clinic visit. Gabapentin or TCAs were prescribed to some patients during their follow-ups for headache treatment, based on physician judgment. Patients were classified into 3 groups: (1) no medication; (2) gabapentin; or (3) TCAs. Follow-up data were evaluated over 1 year. A mixed-effects and piecewise regression analysis were performed to assess long- and short-term effects of medication status. Results The mixed-effects analysis showed a significant decrease in both headache and symptom scores over time in each medication group and in those not receiving medication (P <= .014 for all scenarios, B = -0.005 and -0.08, respectively). Although patients in the 2 medication groups showed significantly higher headache and symptom scores (P < .001), neither medication had a significant effect on longitudinal improvements in the outcome scores. The piecewise regression, however, showed short-term improvements with gabapentin (1.3 points, P = .004) and more sustained improvements with TCAs (3.5 points, P = .006). Conclusions Patients recover from a concussion with time, regardless of medication. Gabapentin and TCAs appear to have immediate effects on improving symptom burden, but long-term outcomes show similar improvement compared to those who are not prescribed medication. More rigorous prospective studies are required to better elucidate their efficacy.	[Cushman, Daniel M.; Hansen, Colby; Bushman, Troy; Teramoto, Masaru] Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT 84112 USA; [Borowski, Lauren] Univ Utah, Dept Family Med, Salt Lake City, UT USA; [Hendrick, John] Univ Utah, Dept Emergency Med, Salt Lake City, UT USA		Cushman, DM (corresponding author), Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT 84112 USA.	dan.cushman.work@gmail.com	Hansen, Colby/AAP-7680-2021	Hansen, Colby/0000-0002-8012-2483; Cushman, Daniel/0000-0002-4580-1173			Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Belman AL, 2001, ANN NEUROL, V50, pS109; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Brown AW, 2015, PM&R, V7, P3, DOI 10.1016/j.pmrj.2014.06.016; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x; Erickson J, 2012, NEUROLOGY S, V78; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; Group C in S, 2017, BRIT J SPORT MED, V51; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Halstead ME, 2016, SPORTS HEALTH, V8, P50, DOI 10.1177/1941738115622158; Hoffman J, 2016, REGRESSION MODELS CA; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; LABEL L S, 1991, Neurology, V41, P247; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lenaerts Marc E, 2004, Curr Treat Options Neurol, V6, P507, DOI 10.1007/s11940-004-0008-5; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Linde M, 2013, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD010609; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Mitchell M., 2015, STATA BEHAV SCI; Moore RA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007938.pub2; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Piland SG, 2003, J ATHL TRAINING, V38, P104; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P270, DOI 10.1016/j.pediatrneurol.2014.10.015; Pinto SM, 2017, PM&R, V9, P847, DOI 10.1016/j.pmrj.2016.12.009; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; SARAN A, 1988, INT J PSYCHIAT MED, V18, P75, DOI 10.2190/15AH-JB7Q-U94T-JEAF; Stache S, 2016, CLIN J SPORT MED, V26, P381, DOI 10.1097/JSM.0000000000000270; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Twisk J., 2003, APPL LONGITUDINAL DA; TYLER GS, 1980, HEADACHE, V20, P213, DOI 10.1111/j.1526-4610.1980.hed2004213.x; Vargas BB, 2012, CURR OPIN NEUROL, V25, P284, DOI 10.1097/WCO.0b013e3283535bf5; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468	38	12	12	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	MAR	2019	59	3					371	382		10.1111/head.13451			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HN4QI	WOS:000460168200006	30451286				2022-02-06	
J	Loftis, KL; Mazuchowski, EL; Clouser, MC; Gillich, PJ				Loftis, Kathryn L.; Mazuchowski, Edward L., II; Clouser, Mary C.; Gillich, Patrick J.			Prominent Injury Types in Vehicle Underbody Blast	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health Sciences System Research Symposium (MHSRS)	AUG 26-30, 2017	Kissimmee, FL			underbody blast; injury; combat; skeletal; visceral	ORTHOPEDIC INJURIES	Background To fully understand the injury mechanisms during an underbody blast (UBB) event with military vehicles and develop new testing standards specific to military vehicles, one must understand the injuries sustained by the occupants. Methods Injury data from Service Members (SM) involved in UBB theater events that occurred from 2010 to 2014 were analyzed. Analysis included the investigation of prominent skeletal and visceral torso injuries. Results were categorized by killed-in-action (n = 132 SM) and wounded-in-action (n = 1,887 SM). Results Over 90% (553/606 SM) of casualties in UBB events with Abbreviated Injury Scale (AIS) 2+ injury sustained at least one skeletal fracture, when excluding concussion. The most frequent skeletal injuries from UBB were foot fractures (13% of injuries) for wounded-in-action and tibia/fibula fractures (10% of injuries) for killed-in-action. Only 1% (11/1037 SM) of all casualties with AIS 2+ injuries had visceral torso injuries without also sustaining skeletal fractures. In these few casualties, the coded injuries were likely due to trauma from a loading path other than direct UBB loading. Conclusion Skeletal fractures are the most frequent AIS 2+ injury resulting from UBB events. Visceral torso injuries are infrequent in individuals that survive and they generally occur in conjunction with skeletal injuries.	[Loftis, Kathryn L.] Warfighter Survivabil Branch, Survivabil Lethal Anal Directorate, Res Dev & Engn Command, Bldg 4501,6509 Wayberry Rd, Aberdeen Proving Ground, MD 21005 USA; [Mazuchowski, Edward L., II] San Antonio Mil Med Syst, Forens Serv & Reg Armed Forces Med Examiner, Jbsa Ft Same Houston, TX 78234 USA; [Clouser, Mary C.] Leidos, 140 Sylvester, San Diego, CA 92129 USA; [Gillich, Patrick J.] Army Res Lab, Weap & Mat Res Directorate, Armor Mech Branch, Aberdeen Proving Ground, MD 21005 USA		Loftis, KL (corresponding author), Warfighter Survivabil Branch, Survivabil Lethal Anal Directorate, Res Dev & Engn Command, Bldg 4501,6509 Wayberry Rd, Aberdeen Proving Ground, MD 21005 USA.				Joint Trauma Analysis and Prevention of Injury in Combat program; Office of the Secretary of Defense for Health Affairs	This study was supported by the Joint Trauma Analysis and Prevention of Injury in Combat program. This supplement was sponsored by the Office of the Secretary of Defense for Health Affairs.	Alvarez J, 2011, EPIDEMIOLOGY BLAST I; Cross JD, 2011, J AM ACAD ORTHOP SUR, V19, pS1, DOI 10.5435/00124635-201102001-00002; Danelson Kerry A, 2015, Stapp Car Crash J, V59, P445; Gennarelli TA., 2008, ABBREVIATED INJURY S; Joint Theater Trauma System (JTTS), 2006, CLIN PRACT GUID DEF; Kilgo PD, 2003, J TRAUMA, V55, P599, DOI 10.1097/01.TA.0000085721.47738.BD; KILGO PD, 2003, J TRAUMA, V55, P606; Lin DL, 2004, MIL MED, V169, P807, DOI 10.7205/MILMED.169.10.807; Loftis KL, 2014, TRAUMA COMP CIVILIAN; Mertz Harold J, 2003, Stapp Car Crash J, V47, P155; Ramasamy A, 2011, PHILOS T R SOC B, V366, P160, DOI 10.1098/rstb.2010.0219; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Yoganandan Narayan, 2014, Stapp Car Crash J, V58, P123	13	12	12	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2019	184	3-4		S			261	264		10.1093/milmed/usy322			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	HQ9QA	WOS:000462761100038	30901412	hybrid			2022-02-06	
J	Wallace, DJ; Sayre, NL; Patterson, TT; Nicholson, SE; Hilton, D; Grandhi, R				Wallace, David J.; Sayre, Naomi L.; Patterson, T. Tyler; Nicholson, Susannah E.; Hilton, Donald; Grandhi, Ramesh			Spinal cord injury and the human microbiome: beyond the brain-gut axis	NEUROSURGICAL FOCUS			English	Article						microbiome; spinal cord injury; brain-gut axis	BARRIER FUNCTION; NERVOUS-SYSTEM; INTERVENTIONS; FAILURE	In addition to standard management for the treatment of the acute phase of spinal cord injury (SCI), implementation of novel neuroprotective interventions offers the potential for significant reductions in morbidity and long-term health costs. A better understanding of the systemic changes after SCI could provide insight into mechanisms that lead to secondary injury. An emerging area of research involves the complex interplay of the gut microbiome and the CNS, i.e., a brain-gut axis, or perhaps more appropriately, a CNS-gut axis. This review summarizes the relevant literature relating to the gut microbiome and SCI. Experimental models in stroke and traumatic brain injury demonstrate the bidirectional communication of the CNS to the gut with postinjury dysbiosis, gastrointestinal-associated lymphoid tissue-mediated neuroinflammatory responses, and bacterial-metabolite neurotransmission. Similar findings are being elucidated in SCI as well. Experimental interventions in these areas have shown promise in improving functional outcomes in animal models. This commensal relationship between the human body and its microbiome, particularly the gut microbiome, represents an exciting frontier in experimental medicine.	[Wallace, David J.; Sayre, Naomi L.; Hilton, Donald; Grandhi, Ramesh] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA; [Patterson, T. Tyler] Univ Texas Hlth Sci Ctr San Antonio, Long Sch Med, San Antonio, TX 78229 USA; [Nicholson, Susannah E.; Grandhi, Ramesh] Univ Texas Hlth Sci Ctr San Antonio, Div Trauma & Emergency Surg, Dept Surg, San Antonio, TX 78229 USA; [Sayre, Naomi L.] South Texas Vet Hlth Care Syst, Audie L Murphy Div, San Antonio, TX USA; [Grandhi, Ramesh] Univ Utah, Sch Med, Dept Neurosurg, Salt Lake City, UT USA		Wallace, DJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA.	wallaced2@uthscsa.edu	Nicholson, Susannah/AAI-2757-2021		BLRD VA [IK2 BX003240] Funding Source: Medline; Veterans AffairsUS Department of Veterans Affairs [IK2BX003240] Funding Source: NIH RePORTER		Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bansal V, 2010, J NEUROTRAUM, V27, P2255, DOI 10.1089/neu.2010.1372; Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Beynon AL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-40; Brenner LA, 2017, BRAIN BEHAV IMMUN, V65, P57, DOI 10.1016/j.bbi.2017.06.003; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Dickson RP, 2016, LANCET RESP MED, V4, P59, DOI 10.1016/S2213-2600(15)00427-0; Earley ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129996; El Aidy S, 2015, CLIN THER, V37, P954, DOI 10.1016/j.clinthera.2015.03.002; Finegold SM, 2008, MED HYPOTHESES, V70, P508, DOI 10.1016/j.mehy.2007.07.019; Furness JB, 2014, ADV EXP MED BIOL, V817, P39, DOI 10.1007/978-1-4939-0897-4_3; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Grice EA, 2012, ANNU REV GENOM HUM G, V13, P151, DOI 10.1146/annurev-genom-090711-163814; Hanage WP, 2014, NATURE, V512, P247, DOI 10.1038/512247a; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hayakawa M, 2011, DIGEST DIS SCI, V56, P2361, DOI 10.1007/s10620-011-1649-3; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Kabatas S, 2008, NEUROSCIENCE, V154, P1627, DOI 10.1016/j.neuroscience.2008.04.071; Katzenberger RJ, 2015, FLY, V9, P68, DOI 10.1080/19336934.2015.1085623; Kharrazian D, 2015, ALTERN THER HEALTH M, V21, P28; Kigerl KA, 2016, J EXP MED, V213, P2603, DOI 10.1084/jem.20151345; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Krezalek MA, 2016, SHOCK, V45, P475, DOI 10.1097/SHK.0000000000000534; Ma EL, 2017, BRAIN BEHAV IMMUN, V66, P56, DOI 10.1016/j.bbi.2017.06.018; MARSHALL JC, 1993, ANN SURG, V218, P111, DOI 10.1097/00000658-199308000-00001; Nicholson SE, 2018, SHOCK; O'Connor G, 2018, J NEUROTRAUM, V35, P2159, DOI 10.1089/neu.2017.5349; Patel JJ, 2016, CURR OPIN CRIT CARE, V22, P339, DOI 10.1097/MCC.0000000000000331; Pruitt DT, 2016, J NEUROTRAUM, V33, P871, DOI 10.1089/neu.2015.3972; Ringel Y, 2013, AM J PHYSIOL-GASTR L, V305, pG529, DOI 10.1152/ajpgi.00207.2012; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Saulnier DM, 2013, GUT MICROBES, V4, P17, DOI 10.4161/gmic.22973; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Sertaridou E, 2015, ANN GASTROENTEROL, V28, P309; Sherwin E, 2018, ANN NY ACAD SCI, V1420, P5, DOI 10.1111/nyas.13416; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Singh V, 2016, J NEUROSCI, V36, P7428, DOI 10.1523/JNEUROSCI.1114-16.2016; Stanley D, 2016, NAT MED, V22, P1277, DOI 10.1038/nm.4194; Sun J, 2016, NEUROSCI LETT, V613, P30, DOI 10.1016/j.neulet.2015.12.047; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Winek K, 2016, J CEREBR BLOOD F MET, V36, P891, DOI 10.1177/0271678X16636890; Winek K, 2016, STROKE, V47, P1354, DOI 10.1161/STROKEAHA.115.011800; Xu MQ, 2015, WORLD J GASTROENTERO, V21, P102, DOI 10.3748/wjg.v21.i1.102; Yamashiro K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171521; Yin J, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002699; Zaborin A, 2014, MBIO, V5, DOI 10.1128/mBio.01361-14	53	12	12	4	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	MAR	2019	46	3							E11	10.3171/2018.12.FOCUS18206			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HN4BW	WOS:000460130200011	30835680	gold			2022-02-06	
J	Williams, AM; Bhatti, UF; Dennahy, IS; Graham, NJ; Nikolian, VC; Chtraklin, K; Chang, PP; Zhou, J; Biesterveld, BE; Eliason, J; Alam, HB				Williams, Aaron M.; Bhatti, Umar F.; Dennahy, Isabel S.; Graham, Nathan J.; Nikolian, Vahagn C.; Chtraklin, Kiril; Chang, Panpan; Zhou, Jing; Biesterveld, Ben E.; Eliason, Jonathan; Alam, Hasan B.			Traumatic brain injury may worsen clinical outcomes after prolonged partial resuscitative endovascular balloon occlusion of the aorta in severe hemorrhagic shock model	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	77th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma (AAST) / Clinical Congress of Acute Care Surgery / 4th World Trauma Congress	SEP 26-29, 2018	San Diego, CA	Amer Assoc Surg Trauma		Traumatic brain injury; hemorrhagic shock; partial aortic occlusion; noncompressible torso hemorrhage; swine	EMERGENCY-DEPARTMENT THORACOTOMY; LARGE ANIMAL-MODEL; VALPROIC ACID; INTRACRANIAL HEMORRHAGE; INDUCED HYPOTHERMIA; HEAD-INJURY; REBOA; COMPLICATIONS; PROGRESSION; DEATHS	BACKGROUND The use of partial resuscitative endovascular balloon occlusion of the aorta (pREBOA) in combined hemorrhagic shock (HS) and traumatic brain injury (TBI) has not been well studied. We hypothesized that the use of pREBOA in the setting of TBI would be associated with worse clinical outcomes. METHODS Female Yorkshire swine were randomized to the following groups: HS-TBI, HS-TBI-pREBOA, and HS-pREBOA (n = 5/cohort). Animals in the HS-TBI group were left in shock for a total of 2 hours, whereas animals assigned to pREBOA groups were treated with supraceliac pREBOA deployment (60 minutes) 1 hour into the shock period. All animals were then resuscitated, and physiologic parameters were monitored for 6 hours. Further fluid resuscitation and vasopressors were administered as needed. At the end of the observation period, brain hemispheric swelling (%) and lesion size (mm(3)) were assessed. RESULTS Mortality was highest in the HS-TBI-pREBOA group (40% [2/5] vs. 0% [0/5] in the other groups, p = 0.1). Severity of shock was greatest in the HS-TBI-pREBOA group, as defined by peak lactate levels and pH nadir (p < 0.05). Fluid resuscitation and norepinephrine requirements were significantly higher in the HS-TBI-pREBOA group (p < 0.05). No significant differences were noted in brain hemispheric swelling and lesion size between the groups. CONCLUSION Prolonged application of pREBOA in the setting of TBI does not contribute to early worsening of brain lesion size and edema. However, the addition of TBI to HS-pREBOA may worsen the severity of shock. Providers should be aware of the potential physiologic sequelae induced by TBI. Copyright (c) 2018 Wolters Kluwer Health, Inc. All rights reserved.	[Williams, Aaron M.; Bhatti, Umar F.; Dennahy, Isabel S.; Graham, Nathan J.; Nikolian, Vahagn C.; Chtraklin, Kiril; Chang, Panpan; Zhou, Jing; Biesterveld, Ben E.; Eliason, Jonathan; Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA		Alam, HB (corresponding author), Univ Michigan, Univ Michigan Hosp, Dept Surg, 2920 Taubman Ctr 5331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu	Biesterveld, Ben/AAM-1087-2021		US Army Materiel and Research Command [W81XWH-09-1-0520]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [2 R01 GM084127]; Frederick A. Coller Surgical Society Research Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM084127] Funding Source: NIH RePORTER	A.M.W. and H.B.A. received grant funding. For all other authors, no conflicts are declared. This work was funded by the US Army Materiel and Research Command (contract W81XWH-09-1-0520), National Institutes of Health grant 2 R01 GM084127, and the Frederick A. Coller Surgical Society Research Grant.	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Alam HB, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002350; Biffl WL, 2015, J TRAUMA ACUTE CARE, V78, P1054, DOI 10.1097/TA.0000000000000609; Causey MW, 2013, J SURG RES, V184, P533, DOI 10.1016/j.jss.2013.03.087; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; DuBose JJ, 2017, J TRAUMA ACUTE CARE, V83, P197, DOI 10.1097/TA.0000000000001462; Eastridge BJ, 2006, J TRAUMA, V61, P1366, DOI 10.1097/01.ta.0000245894.78941.90; Fortuna G, 2016, J TRAUMA ACUTE CARE, V81, P63, DOI 10.1097/TA.0000000000000996; Freeman WD, 2012, NEUROL CLIN, V30, P211, DOI 10.1016/j.ncl.2011.09.002; Gentilello L, 2000, J TRAUMA, V48, P447; GUPTA BK, 1989, J TRAUMA, V29, P861, DOI 10.1097/00005373-198906000-00026; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Inoue J, 2016, J TRAUMA ACUTE CARE, V80, P559, DOI 10.1097/TA.0000000000000968; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Johnson MA, 2017, J TRAUMA ACUTE CARE, V83, P61, DOI [10.1097/TA.0000000000001372, 10.1097/TA.0000000000001518]; Johnson MA, 2016, J TRAUMA ACUTE CARE, V81, pS133, DOI 10.1097/TA.0000000000001146; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Kauvar DS, 2005, CRIT CARE, V9, P1, DOI 10.1186/cc3779; Krishnamoorthy V, 2016, CHEST, V149, P1325, DOI 10.1016/j.chest.2015.12.014; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; Madurska MJ, 2017, J TRAUMA ACUTE CARE, V83, P557, DOI 10.1097/TA.0000000000001574; Martin M, 2009, J TRAUMA, V66, pS51, DOI 10.1097/TA.0b013e31819d86ad; Matsumura Y, 2017, EMERG MED J, V34, P793, DOI 10.1136/emermed-2016-206383; Meislin H, 1997, J TRAUMA, V43, P433, DOI 10.1097/00005373-199709000-00008; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Napolitano LM, 2017, CRIT CARE CLIN, V33, P55, DOI 10.1016/j.ccc.2016.08.011; Nguyen H, 2009, CURR NEUROL NEUROSCI, V9, P486, DOI 10.1007/s11910-009-0071-0; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Norii T, 2015, J TRAUMA ACUTE CARE, V78, P721, DOI 10.1097/TA.0000000000000578; Rhee P, 2000, J TRAUMA, V48, P439, DOI 10.1097/00005373-200003000-00011; Russo RM, 2016, J AM COLL SURGEONS, V223, P359, DOI 10.1016/j.jamcollsurg.2016.04.037; Russo RM, 2016, J TRAUMA ACUTE CARE, V80, P372, DOI 10.1097/TA.0000000000000940; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Sellmann T, 2012, DTSCH ARZTEBL INT, V109, P849, DOI 10.3238/arztebl.2012.0849; Sokol KK, 2016, J TRAUMA ACUTE CARE, V80, P907, DOI 10.1097/TA.0000000000001051; Uchino H, 2016, AM J CASE REP, V17, P810, DOI 10.12659/AJCR.900267; Williams AM, 2019, J NEUROTRAUM, V36, P54, DOI 10.1089/neu.2018.5711; Williams TK, 2016, J TRAUMA ACUTE CARE, V81, P294, DOI 10.1097/TA.0000000000001075	42	12	13	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2019	86	3					415	423		10.1097/TA.0000000000002149			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	HN6WZ	WOS:000460329500005	30605139	Green Accepted			2022-02-06	
J	Bonow, RH; Quistberg, A; Rivara, FP; Vavilala, MS				Bonow, Robert H.; Quistberg, Alex; Rivara, Frederick P.; Vavilala, Monica S.			Intensive Care Unit Admission Patterns for Mild Traumatic Brain Injury in the USA	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Intensive care units; Health resources	GLASGOW COMA SCALE; SUBARACHNOID HEMORRHAGE; INTRACRANIAL HEMORRHAGE; LOW-RISK; OUTCOME PREDICTION; VALIDATION; GUIDELINES; WARFARIN; MODELS; STATES	BackgroundPatients with mild traumatic brain injury (TBI) are frequently admitted to an intensive care unit (ICU), but routine ICU use may be unnecessary. It is not clear to what extent this practice varies between hospitals.MethodsWe conducted a retrospective cohort study using the National Trauma Data Bank. Patients with at least one TBI ICD-9-CM diagnosis code, a head abbreviated injury score (AIS) 4, and Glasgow coma scale (GCS) 13 were included; individuals with only a concussion and those with a non-head AIS >2 were excluded. Primary outcomes were ICU admission and overtriage to the ICU, defined by: ICU stay 1day; hospital stay 2days; no intubation; no neurosurgery; and discharged to home. Mixed effects multivariable models were used to identify patient and facility characteristics associated with these outcomes.ResultsA total of 595,171 patients were included, 44.7% of whom were admitted to an ICU; 17.3% of these met the criteria for overtriage. Compared with adults, children <2years were more likely to be admitted to an ICU (RR 1.21, 95% CI 1.16-1.26) and to be overtriaged (RR 2.06, 95% CI 1.88-2.25). Similarly, patients with isolated subarachnoid hemorrhage were at greater risk of both ICU admission (RR 2.36, 95% CI 2.31-2.41) and overtriage (RR 1.22, 95% CI 1.17-1.28). The probabilities of ICU admission and overtriage varied as much as 16- and 11-fold across hospitals, respectively; median risk ratios were 1.67 and 1.53, respectively. The likelihood of these outcomes did not vary substantially with the characteristics of the treating facility.ConclusionsThere is considerable variability in ICU admission practices for mild TBI across the USA, and some of these patients may not require ICU-level care. Refined ICU use in mild TBI may allow for reduced resource utilization without jeopardizing patient outcomes.	[Bonow, Robert H.; Quistberg, Alex; Rivara, Frederick P.; Vavilala, Monica S.] Harborview Med Ctr, Harborview Injury Prevent Res Ctr, Seattle, WA 98104 USA; [Bonow, Robert H.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Quistberg, Alex] Drexel Univ, Dept Environm & Occupat Hlth, Philadelphia, PA 19104 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA		Bonow, RH (corresponding author), Harborview Med Ctr, Harborview Injury Prevent Res Ctr, Seattle, WA 98104 USA.	rbonow@uw.edu			Codman Neuro; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD057822] Funding Source: NIH RePORTER	RHB received partial, indirect salary support via an educational grant provided to the University of Washington Department of Neurological Surgery by Codman Neuro, who had no role in the design, conduct, or reporting of this research.	Ament JD, 2017, J NEUROSURG-PEDIATR, V19, P668, DOI 10.3171/2017.2.PEDS16419; Arabian SS, 2015, J TRAUMA ACUTE CARE, V79, P359, DOI 10.1097/TA.0000000000000788; Austin PC, 2018, STAT MED, V37, P572, DOI 10.1002/sim.7532; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Faul M, 2010, TRAUMATIC BRAIN INJU; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Greene NH, 2015, INJURY PREV, V21, P325, DOI 10.1136/injuryprev-2014-041524; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Hanak BW, 2014, WORLD NEUROSURG, V81, P165, DOI 10.1016/j.wneu.2012.11.068; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Larson DB, 2011, RADIOLOGY, V259, P793, DOI 10.1148/radiol.11101939; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Marr A., 2004, CENTRAL NERVOUS SYST; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Milbrandt EB, 2008, CRIT CARE MED, V36, P2504, DOI 10.1097/CCM.0b013e318183ef84; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; Myers SR, 2016, PEDIAT EMERG CARE; Nates JL, 2016, CRIT CARE MED, V44, P1553, DOI 10.1097/CCM.0000000000001856; Nishijima DK, 2014, ANN EMERG MED, V63, P448, DOI 10.1016/j.annemergmed.2013.11.003; Nishijima DK, 2013, ANN EMERG MED, V61, P509; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Phelan HA, 2014, J NEUROTRAUM, V31, P1733, DOI 10.1089/neu.2014.3377; Pruitt P, 2017, AM J EMERG MED, V35, P255, DOI 10.1016/j.ajem.2016.10.064; Quigley MR, 2013, J TRAUMA ACUTE CARE, V74, P581, DOI 10.1097/TA.0b013e31827d6088; Rabe-Kesketh S, 2012, MULTILEVEL LONGITUDI, V2; Ratcliff JJ, 2014, AM J EMERG MED, V32, P844, DOI 10.1016/j.ajem.2014.04.003; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Yun BJ, 2017, ACAD EMERG MED, V61, P113	36	12	12	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2019	30	1					157	170		10.1007/s12028-018-0590-0			14	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HJ8LA	WOS:000457449700019	30136076	Bronze			2022-02-06	
J	Coats, TJ; Fragoso-Iniguez, M; Roberts, I				Coats, Timothy J.; Fragoso-Iniguez, Marisol; Roberts, Ian			Implementation of tranexamic acid for bleeding trauma patients: a longitudinal and cross-sectional study	EMERGENCY MEDICINE JOURNAL			English	Article						trauma, major trauma management; haematology	CRASH-2	Objective To describe the use of tranexamic acid (TXA) in trauma care in England and Wales since the Clinical Randomization of an Antifibrinolytic in Significant Hemorrhage (CRASH-2) trial results were published in 2010. Methods A national longitudinal and cross-sectional study using data collected through the Trauma Audit and Research Network (TARN), the clinical audit of major trauma care for England and Wales. All patients in the TARN database injured in England and Wales were included apart from those with an isolated traumatic brain injury, with a primary outcome of the proportion of patients given TXA and the secondary outcome of time to treatment. Results Among 228 250 patients, the proportion of trauma patients treated with TXA increased from near zero in 2010 to 10% (4593) in 2016. In 2016, most patients (82%) who received TXA did so within 3 hours of injury, however, only 30% of patients received TXA within an hour of injury. Most (80%) of the patients who had an early blood transfusion were given TXA. Patients treated with TXA by an ambulance paramedic received treatment at a median of 49 min (IQR 33-72) compared with 111 min (IQR 77-162) for patients treated in hospital. Conclusions There is a low proportion of patients treated with TXA across the range of injury severity and the range of physiological indicators of severity of bleeding. Most patients receive treatment within the existing target of 3 hours from injury, however there remains the potential to further improve major trauma outcomes by the earlier treatment of a wider patient group.	[Coats, Timothy J.] Univ Leicester, Emergency Med, Leicester, Leics, England; [Fragoso-Iniguez, Marisol] Univ Manchester, Inst Populat Hlth, TARN, Manchester, Lancs, England; [Roberts, Ian] London Sch Hyg & Trop Med, Nutr & Publ Hlth Intervent Res Unit, London, England		Coats, TJ (corresponding author), Univ Leicester, Leicester LE1 7RH, Leics, England.	tc61@le.ac.uk	Coats, Timothy/AAW-1254-2021	Coats, Timothy/0000-0003-2736-2784	National Health Service of England and Wales; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/M009211/1] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/M009211/1] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [14/190/01, NF-SI-0611-10057, 11/01/04, 06/303/20] Funding Source: researchfish	The Trauma Audit and Research Network (TARN) data collection is funded by the National Health Service of England and Wales through subscriptions from participating hospitals.	[Anonymous], 1971, JAMA, V215, P277; Bouamra O, 2015, EMERG MED J, V32, P933, DOI 10.1136/emermed-2015-205176; Gayet-Ageron A, 2017, LANCET; Hunt BJ, 2015, BRIT J HAEMATOL, V170, P788, DOI 10.1111/bjh.13580; McCullough AL, 2014, BRIT J ANAESTH, V113, P202, DOI 10.1093/bja/aeu204; Napolitano LM, 2013, J TRAUMA ACUTE CARE, V74, P1575, DOI 10.1097/TA.0b013e318292cc54; Roberts I, 2017, TRIALS, V18, DOI 10.1186/s13063-016-1750-1; Roberts I, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5839; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685	11	12	12	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	FEB	2019	36	2					78	81	48	10.1136/emermed-2018-207693			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HM9NQ	WOS:000459812200006	30530744	Green Submitted			2022-02-06	
J	Kaimal, G; Jones, JP; Dieterich-Hartwell, R; Acharya, B; Wang, X				Kaimal, Girija; Jones, Jacqueline P.; Dieterich-Hartwell, Rebekka; Acharya, Binod; Wang, Xi			Evaluation of long- and short-term art therapy interventions in an integrative care setting for military service members with post-traumatic stress and traumatic brain injury	ARTS IN PSYCHOTHERAPY			English	Article						Program evaluation; Active duty military service members; Post traumatic stress; Traumatic brain injury; Art therapy	MENTAL-HEALTH; PROGRAM; VETERANS; DISORDER; PTSD; IRAQ; AFGHANISTAN; TBI	Background: Program evaluations can serve as a doorway to research in the creative arts therapies. This study provides findings from analyses of participant feedback on short- and long-term art therapy services for military service members with post-traumatic stress and traumatic brain injury (TBI). Methods: Data for the study included feedback surveys from 204 service members who received art therapy services as part of treatment at an integrative care setting. Results: The results indicate that long-term art therapy resulted in higher satisfaction with treatment. Art therapy helped most with developing a sense of self after injury, experiencing positive emotions, processing trauma, and reducing feelings of guilt, grief, and loss. There were no statistically significant differences in outcomes based on rank or severity of TBI, but art therapy services were found to be related to improved symptoms for service members with longer times in service. Implications: The feedback from evaluation helps identify potential areas for further research on how art therapy addresses issues of identity, time in service and experiences of emotions as a result of post-traumatic stress and TBI. Evaluation provides directions for further clinical treatment, and yields data on improving quality of care.	[Kaimal, Girija; Dieterich-Hartwell, Rebekka] Drexel Univ, Coll Nursing & Hlth Profess, Philadelphia, PA 19104 USA; [Acharya, Binod; Wang, Xi] Drexel Univ, Sch Publ Hlth, Philadelphia, PA 19104 USA; [Jones, Jacqueline P.] Ft Belvoir Community Hosp Intrepid Spirit One, Ft Belvoir, VA USA; [Jones, Jacqueline P.] Invisible Wounds Ctr, Eglin AFB, FL USA		Kaimal, G (corresponding author), Drexel Univ, Coll Nursing & Hlth Profess, Philadelphia, PA 19104 USA.	gk27@drexel.edu		Wang, Xi/0000-0003-2470-4187; Acharya, Binod/0000-0003-2153-1655	Creative Forces(R): NEA Military Healing Arts Network which is an initiative of the National Endowment for the Arts (NEA); U.S. Departments of Defense; Veterans AffairsUS Department of Veterans Affairs	The research was funded by Creative Forces (R): NEA Military Healing Arts Network which is an initiative of the National Endowment for the Arts (NEA) in partnership with the U.S. Departments of Defense and Veterans Affairs and the state and local arts agencies. This initiative serves the special needs of military patients and veterans who have been diagnosed with traumatic brain injury and psychological health conditions, as well as their families and caregivers. Administrative support for the initiative is provided by Americans for the Arts.	Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Baker DG, 2009, MIL MED, V174, P773; Barker V.L., 1991, MUSIC THERAPY PERSPE, V9, P26; Brady C, 2017, MED HUMANIT, V43, P30, DOI 10.1136/medhum-2016-011040; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Chambala A, 2008, ART THER, V25, P187, DOI 10.1080/07421656.2008.10129540; Coleman JA, 2016, J AGGRESS MALTREAT T, V25, P561, DOI 10.1080/10926771.2016.1157842; Collie K, 2006, ART THER, V23, P157, DOI 10.1080/07421656.2006.10129335; Cowell E., 2011, ARTS HLTH, V3, P173, DOI [10.1080/17533015.2011.561356, DOI 10.1080/17533015.2011.561356]; Defense and Veterans Brain Injury Center, 2017, DOD WORLDW NUMB TBI; DODD FG, 1975, AM J ART THER, V14, P83; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Feen-Calligan H, 2008, ART THER, V25, P177, DOI 10.1080/07421656.2008.10129544; Feldman MB, 2014, ART THER, V31, P102, DOI 10.1080/07421656.2014.935593; Fiet L., 2014, CARIBBEAN Q, V60, P58, DOI [10.1080/00086495.2014.11672526, DOI 10.1080/00086495.2014.11672526]; GOLUB D, 1985, ART PSYCHOTHER, V12, P285, DOI 10.1016/0197-4556(85)90041-3; Kaimal, 2018, INT J ART THERAPY, V23, P70, DOI [10.1080/17454832.2017.1388263, DOI 10.1080/17454832.2017.1388263]; Kaimal G, 2015, ART THER, V32, P89, DOI 10.1080/07421656.2015.1028310; Kline A, 2010, AM J PUBLIC HEALTH, V100, P276, DOI 10.2105/AJPH.2009.162925; Klorer PG, 2012, ART THER, V29, P180, DOI 10.1080/07421656.2012.730920; Kopytin A, 2013, ART THER, V30, P20, DOI 10.1080/07421656.2013.757758; Kroch R., 2009, THESIS; Lazarus -Leff B., 2013, ART THERAPY J AM ART, V15, P120, DOI [10.1080/07421656.1989.10758723, DOI 10.1080/07421656.1989.10758723]; Lobban J., 2014, INT J ART THER, V19, P3, DOI [https://doi.org/10.1080/17454832.2012.725547, DOI 10.1080/17454832.2012.725547]; Malchiodi C. A., 2014, CREATIVE ARTS PLAY T; Malchiodi CA, 2012, HDB ART THERAPY, P320; Nanda U, 2010, ENVIRON BEHAV, V42, P376, DOI 10.1177/0013916510361874; Pachalska M, 2013, ACTA NEUROPSYCHOL, V11, P435; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Reger MA, 2009, J CLIN PSYCHIAT, V70, P1266, DOI 10.4088/JCP.08m04361; Rowe C, 2017, HEALTH PROMOT PRACT, V18, P26, DOI 10.1177/1524839915626413; Sargent PD, 2013, PSYCHIAT ANN, V43, P181, DOI 10.3928/00485713-20130403-10; Summerall E. L., 2017, TRAUMATIC BRAIN INJU; Tanielian T., 2008, INVISIBLE WOUNDS MEN; U.S. Government Accountability Office, 2011, GAO1212; van der Kolk B.A., 2014, BODY KEEPS SCORE BRA; Van Lith T., 2017, INT J ADV COUNS, V39, P1; Walker M., 2017, ART THERAPY MILITARY, P111; Walker MS, 2017, INT J QUAL STUD HEAL, V12, DOI 10.1080/17482631.2016.1267317; Walker MS, 2016, ART PSYCHOTHER, V49, P10, DOI 10.1016/j.aip.2016.05.015; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	41	12	12	3	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-4556	1873-5878		ART PSYCHOTHER	Arts Psychother.	FEB	2019	62				SI		28	36		10.1016/j.aip.2018.10.003			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	IG5IR	WOS:000473837200007		hybrid			2022-02-06	
J	Veliz, P; Eckner, JT; Zdroik, J; Schulenberg, JE				Veliz, Philip; Eckner, James T.; Zdroik, Jennifer; Schulenberg, John E.			Lifetime Prevalence of Self-Reported Concussion Among Adolescents Involved in Competitive Sports: A National US Study	JOURNAL OF ADOLESCENT HEALTH			English	Article						Concussion; Sports; Adolescents	NONMEDICAL USE; HIGH-SCHOOL	Purpose: Examine lifetime prevalence of diagnosed concussion in US-national samples of 8th, 10th, and 12th graders involved in 16 different competitive sports; examine associations between concussion and individual sports, controlling for demographic characteristics and multiple sports involvement. Methods: Analysis of nationally representative Monitoring the Future data from 2 cohorts (2016-2017; n = 25,408). Results: Adolescents who participated in baseball, basketball, football, gymnastics, ice hockey, lacrosse, soccer, track, weightlifting, and ` other sports' had greater odds of reporting multiple diagnosed concussions compared with peers not participating in these sports. Adolescents who participated in tennis had lower odds of reporting any diagnosed concussion or multiple concussions. Females who participated in gymnastics, soccer, and swimming showed a stronger association in reporting a diagnosed concussion when compared with males who participated in these same types of sports. Conclusions: The study provides needed epidemiological information on prevalence of reported diagnosed concussion among teens participating in popular school and community sports. Certain high contact (e.g., football) and high volume (e.g., basketball) sports need increased efforts to manage adolescent athletes who already have a history of concussion or repeated concussions. (c) 2018 Society for Adolescent Health and Medicine. All rights reserved.	[Veliz, Philip] Univ Michigan, Sch Nursing, 400 North Ingalls, Ann Arbor, MI 48109 USA; [Eckner, James T.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI USA; [Zdroik, Jennifer] Mt St Marys Univ, Bolte Sch Business, Emmitsburg, MD USA; [Schulenberg, John E.] Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI USA; [Schulenberg, John E.] Univ Michigan, Dept Psychol, Ann Arbor, MI USA		Veliz, P (corresponding author), Univ Michigan, Sch Nursing, 400 North Ingalls, Ann Arbor, MI 48109 USA.	ptveliz@umich.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [L40DA042452, K23HD078502, R01DA001411]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD078502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA001411] Funding Source: NIH RePORTER	The development of this article was supported by research grants L40DA042452, K23HD078502, and R01DA001411 from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Centers for Disease Control and Prevention National Center for Health Statistics, NAT HLTH INT SURV 20; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Miech R. A., 2017, MONITORING FUTURE NA, VI; Raghunathan T.E., 2001, SURV METHODOL, V27, P85, DOI DOI 10.1002/SIM.1186; Veliz P, 2017, JAMA-J AM MED ASSOC, V318, P1180, DOI 10.1001/jama.2017.9087; Veliz P, 2017, J ADOLESCENT HEALTH, V60, P346, DOI 10.1016/j.jadohealth.2016.09.021; Veliz PT, 2013, AM J PUBLIC HEALTH, V103, pE28, DOI 10.2105/AJPH.2013.301242; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Westermann RW, 2015, SPORTS HEALTH, V7, P161, DOI 10.1177/1941738114559705; Wolf BR, 2009, AM J SPORT MED, V37, P2037, DOI 10.1177/0363546509339364; Zarrett N, 2018, TEEN SPORT AM WHY PA	15	12	12	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1054-139X	1879-1972		J ADOLESCENT HEALTH	J. Adolesc. Health	FEB	2019	64	2					272	275		10.1016/j.jadohealth.2018.08.023			4	Psychology, Developmental; Public, Environmental & Occupational Health; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Public, Environmental & Occupational Health; Pediatrics	HH6OA	WOS:000455849700021	30409755	Green Accepted			2022-02-06	
J	Bosch, M; McKenzie, JE; Ponsford, JL; Turner, S; Chau, M; Tavender, EJ; Knott, JC; Gruen, RL; Francis, JJ; Brennan, SE; Pearce, A; O'Connor, DA; Mortimer, D; Grimshaw, JM; Rosenfeld, JV; Meares, S; Smyth, T; Michie, S; Green, SE				Bosch, Marije; McKenzie, Joanne E.; Ponsford, Jennie L.; Turner, Simon; Chau, Marisa; Tavender, Emma J.; Knott, Jonathan C.; Gruen, Russell L.; Francis, Jill J.; Brennan, Sue E.; Pearce, Andrew; O'Connor, Denise A.; Mortimer, Duncan; Grimshaw, Jeremy M.; Rosenfeld, Jeffrey V.; Meares, Susanne; Smyth, Tracy; Michie, Susan; Green, Sally E.			Evaluation of a targeted, theory-informed implementation intervention designed to increase uptake of emergency management recommendations regarding adult patients with mild traumatic brain injury: results of the NET cluster randomised trial	IMPLEMENTATION SCIENCE			English	Article						Mild traumatic brain injury; Cluster trial; Effectiveness; Emergency department; Implementation science; Clinical practice guideline; Evidence-based practice	MINOR HEAD-INJURY; HOSPITAL ANXIETY; HEALTH; CONSENSUS; QUALITY; SCALE; CT; INNOVATIONS; DEPRESSION; GUIDELINES	BackgroundEvidence-based guidelines for management of mild traumatic brain injury (mTBI) in the emergency department (ED) are now widely available; however, clinical practice remains inconsistent with these guidelines. A targeted, theory-informed implementation intervention (Neurotrauma Evidence Translation (NET) intervention) was designed to increase the uptake of three clinical practice recommendations regarding the management of patients who present to Australian EDs with mild head injuries. The intervention involved local stakeholder meetings, identification and training of nursing and medical local opinion leaders, train-the-trainer workshops and standardised education materials and interactive workshops delivered by the opinion leaders to others within their EDs during a 3month period. This paper reports on the effects of this intervention.MethodsEDs (clusters) were allocated to receive either access to a clinical practice guideline (control) or the implementation intervention, using minimisation, a method that allocates clusters to groups using an algorithm to minimise differences in predefined factors between the groups. We measured clinical practice outcomes at the patient level using chart audit. The primary outcome was appropriate screening for post-traumatic amnesia (PTA) using a validated tool until a perfect score was achieved (indicating absence of acute cognitive impairment) before the patient was discharged home. Secondary outcomes included appropriate CT scanning and the provision of written patient information upon discharge. Patient health outcomes (anxiety, primary outcome: Hospital Anxiety and Depression Scale) were also assessed using follow-up telephone interviews. Outcomes were assessed by independent auditors and interviewers, blinded to group allocation.ResultsFourteen EDs were allocated to the intervention and 17 to the control condition; 1943 patients were included in the chart audit. At 2months follow-up, patients attending intervention EDs (n=893) compared with control EDs (n=1050) were more likely to have been appropriately assessed for PTA (adjusted odds ratio (OR) 20.1, 95%CI 6.8 to 59.3; adjusted absolute risk difference (ARD) 14%, 95%CI 8 to 19). The odds of compliance with recommendations for CT scanning and provision of written patient discharge information were small (OR 1.2, 95%CI 0.8 to 1.6; ARD 3.2, 95%CI -3.7 to 10 and OR 1.2, 95%CI 0.8 to 1.8; ARD 3.1, 95%CI -3.0 to 9.3 respectively).A total of 343 patients at ten interventions and 14 control sites participated in follow-up interviews at 4.3 to 10.7months post-ED presentation. The intervention had a small effect on anxiety levels (adjusted mean difference -0.52, 95%CI -1.34 to 0.30; scale 0-21, with higher scores indicating greater anxiety).ConclusionsOur intervention was effective in improving the uptake of the PTA recommendation; however, it did not appreciably increase the uptake of the other two practice recommendations. Improved screening for PTA may be clinically important as it leads to appropriate periods of observation prior to safe discharge. The estimated intervention effect on anxiety was of limited clinical significance. We were not able to compare characteristics of EDs who declined trial participation with those of participating sites, which may limit the generalizability of the results.Trial registrationAustralian New Zealand Clinical Trials Registry (ACTRN12612001286831), date registered 12 December 2012.	[Bosch, Marije; Chau, Marisa; Tavender, Emma J.; Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [Bosch, Marije; Chau, Marisa; Tavender, Emma J.; Gruen, Russell L.; Rosenfeld, Jeffrey V.] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Bosch, Marije; Chau, Marisa; Tavender, Emma J.; Gruen, Russell L.; Rosenfeld, Jeffrey V.] Monash Univ, Melbourne, Vic, Australia; [Bosch, Marije] Univ Groningen, Fac Econ & Business, Groningen, Netherlands; [McKenzie, Joanne E.; Turner, Simon; Brennan, Sue E.; O'Connor, Denise A.; Green, Sally E.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Ponsford, Jennie L.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Knott, Jonathan C.] Univ Melbourne, Melbourne Med Sch, Melbourne, Vic, Australia; [Knott, Jonathan C.] Royal Melbourne Hosp, Dept Emergency Med, Melbourne, Vic, Australia; [Gruen, Russell L.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Francis, Jill J.] City Univ London, Sch Hlth Sci, London, England; [Pearce, Andrew] MedSTAR Emergency Med Retrieval Serv, Adelaide, SA, Australia; [Pearce, Andrew] Royal Adelaide Hosp, Emergency Dept, Adelaide, SA, Australia; [Mortimer, Duncan] Monash Univ, Monash Business Sch, Ctr Hlth Econ, Melbourne, Vic, Australia; [Grimshaw, Jeremy M.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Grimshaw, Jeremy M.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic, Australia; [Meares, Susanne] Macquarie Univ, Dept Psychol, Sydney, NSW, Australia; [Smyth, Tracy] Westmead Hosp, Emergency Dept, Sydney, NSW, Australia; [Michie, Susan] UCL, Dept Clin Educ & Hlth Psychol, London, England		Bosch, M (corresponding author), Monash Univ, Dept Surg, Melbourne, Vic, Australia.; Green, SE (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.	marije.bosch@monash.edu; Sally.Green@monash.edu	O'Connor, Denise/ABC-6655-2020; Michie, Susan/A-1745-2010; McKenzie, Joanne/I-2925-2014	O'Connor, Denise/0000-0002-6836-122X; Michie, Susan/0000-0003-0063-6378; McKenzie, Joanne/0000-0003-3534-1641; Francis, Jill/0000-0001-5784-8895; Meares, Susanne/0000-0002-3859-9974; Turner, Simon/0000-0001-9163-4524; Brennan, Sue/0000-0003-1789-8809; Tavender, Emma/0000-0002-7230-712X; Mortimer, Duncan Stuart/0000-0002-7211-6454	Neurotrauma Evidence Translation (NET) Program - Victorian Transport Accident Commission (TAC), Australia; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Australian NHMRCNational Health and Medical Research Council of Australia [606726]; Australian Postgraduate Award, Australian National Health and Medical Research Council FellowshipNational Health and Medical Research Council of Australia; NHMRC AustralianNational Health and Medical Research Council of Australia [1072366]	This trial was part of a 5-year grant (the Neurotrauma Evidence Translation (NET) Program), funded by the Victorian Transport Accident Commission (TAC), Australia (https://www.tac.vic.gov.au/). RLG is supported by a Practitioner Fellowship from the Australian National Health and Medical Research Council. DAO is supported by an Australian NHMRC Public Health Fellowship (606726). JMG holds a Canada Research Chair in Health Knowledge and Transfer. EJT is supported by an Australian Postgraduate Award, Australian National Health and Medical Research Council Fellowship. JEM holds an NHMRC Australian Public Health Fellowship (1072366). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JEM, ST, SEG, MB and DM had full access to all the data in the study, and the corresponding authors had final responsibility for the decision to submit for publication.	[Anonymous], 2009, COCHRANE DATABASE SY; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P2, DOI 10.1016/j.jclinepi.2008.11.004; Baker R, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub3; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bosch M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148091; Bosch M, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-281; Bosch M, 2013, J EVAL CLIN PRACT, V19, P763, DOI 10.1111/j.1365-2753.2012.01835.x; Boudreaux ED, 2009, ACAD EMERG MED, V16, P1120, DOI 10.1111/j.1553-2712.2009.00543.x; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; Brazier JE, 2008, PRONEWSL, V40, P14; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Campbell A, 2005, CLIN GOVT INT J, V10, P2, DOI DOI 10.1108/14777270510579305; Cane J, 2015, BRIT J HEALTH PSYCH, V20, P130, DOI 10.1111/bjhp.12102; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chan V, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-102; Chen AY, 2011, EMERG THEMES EPIDEMI, V8, DOI 10.1186/1742-7622-8-4; Colquhoun H, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-51; Compton S, 2007, ACAD EMERG MED, V14, P991, DOI 10.1197/j.aem.2007.06.031; DeAngelis J, 2017, WEST J EMERG MED, V18, P821, DOI 10.5811/westjem.2017.6.33685; Donker-Cools BH, 2015, DISABIL REHABIL, P1; Eccles MP, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-61; Evans S, MINIM ALLOCATION MIN; Fitzmaurice G.M., 2004, APPL LONGITUDINAL AN, Ved; Foks KA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3527; Green SE, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-74; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Grimshaw JM, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-50; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Gulliford MC, 2005, J CLIN EPIDEMIOL, V58, P246, DOI 10.1016/j.jclinepi.2004.08.012; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hemming K, 2013, STATA J, V13, P114, DOI 10.1177/1536867X1301300109; Heskestad B, 2008, J TRAUMA, V65, P1309, DOI 10.1097/TA.0b013e31815e40cd; Hrisos S, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-37; Kerr J, 2007, EMERG MED J, V24, P330, DOI 10.1136/emj.2006.044230; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Leeman J, 2007, J ADV NURS, V58, P191, DOI 10.1111/j.1365-2648.2006.04207.x; Luo N, 2010, MED CARE, V48, P365, DOI 10.1097/MLR.0b013e3181c162a2; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mazza D, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-32; Meares S, 2011, BRAIN INJURY, V25, P1198, DOI 10.3109/02699052.2011.608213; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; Michie S, 2013, ANN BEHAV MED, V46, P81, DOI 10.1007/s12160-013-9486-6; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c869, 10.1016/j.ijsu.2011.10.001, 10.1016/j.jclinepi.2010.03.004]; Mortimer D, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0834-6; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; NSW Institute of Trauma and Injury Management, 2011, IN MAN CLOS HEAD INJ; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Powell BJ, 2012, MED CARE RES REV, V69, P123, DOI 10.1177/1077558711430690; Scott NW, 2002, CONTROL CLIN TRIALS, V23, P662, DOI 10.1016/S0197-2456(02)00242-8; Scott PA, 2013, LANCET NEUROL, V12, P139, DOI 10.1016/S1474-4422(12)70311-3; Squires JE, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0152-6; StataCorp, 2015, STAT STAT SOFTW REL; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Tan DW, 2018, SINGAP MED J, V59, P199, DOI 10.11622/smedj.2017046; Tavender EJ, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0264-7; Tavender EJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-8; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; The Cochrane Library, EPOC REV; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Tricco AC, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0370-1; Ukoumunne O.C., 1999, HEALTH TECHNOL ASSES, V3, P3, DOI DOI 10.3310/hta3050; Valente TW, 2007, HEALTH EDUC BEHAV, V34, P881, DOI 10.1177/1090198106297855; Walshe K, 2007, INT J QUAL HEALTH C, V19, P57, DOI 10.1093/intqhc/mzm004; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Zegers M, 2011, BMJ QUAL SAF, V20, P314, DOI 10.1136/bmjqs.2009.038976; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	75	12	12	1	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1748-5908			IMPLEMENT SCI	Implement. Sci.	JAN 17	2019	14								4	10.1186/s13012-018-0841-7			16	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	HH9BU	WOS:000456029700001	30654826	gold, Green Published, Green Accepted			2022-02-06	
J	Amara, JH; Stolzmann, KL; Iverson, KM; Pogoda, TK				Amara, Jomana H.; Stolzmann, Kelly L.; Iverson, Katherine M.; Pogoda, Terri K.			Predictors of Employment Status in Male and Female Post-9/11 Veterans Evaluated for Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						gender; depression; employment; neurobehavioral manifestations; posttraumatic stress disorder; substance use disorder; traumatic brain injury; unemployment; post-9/11 Veterans	PERSISTENT POSTCONCUSSIVE SYMPTOMS; PSYCHIATRIC DIAGNOSES; AFGHANISTAN; IRAQ; UNEMPLOYMENT; HISTORY; RISK; CARE	Objectives: The goal of this study was to investigate predictors of employment status in male and female post-9/11 Veterans evaluated for traumatic brain injury (TBI) in the Veterans Health Administration. Prior research suggests there are gender differences in psychosocial characteristics among this cohort. Methods: This was a cross-sectional analysis of post-9/11 Veterans who completed a TBI evaluation between July 2009 and September 2013. Results: Women had lower prevalence of deployment-related TBI (65.5%) compared with men (75.3%), but the percentages of those unemployed across the TBI diagnostic categories were similar for men (38%) and women (39%). Adjusted log-binomial regression found that unemployment was significantly associated with age, education, marital status, moderate/severe TBI, suspected posttraumatic stress disorder, depression, and drug abuse/dependence, and neurobehavioral symptom severity for men, whereas for women only more severe affective and cognitive symptoms were associated with unemployment. Conclusions: Although the unemployment rate was similar across gender, there was a clearer pattern of demographic and health factors, including TBI severity, that was significantly associated with employment status in men. There may be other factors contributing to the female Veteran unemployment rate, underscoring the need to investigate unique contributors to unemployment, as well as how treatment and employment services can be expanded and tailored for post-9/11 Veterans.	[Amara, Jomana H.] Naval Postgrad Sch, Def Resources Management Inst, Monterey, CA USA; [Stolzmann, Kelly L.; Pogoda, Terri K.] VA Boston Healthcare Syst, VA Hlth Serv Res & Dev Serv Ctr Healthcare Org &, Boston, MA USA; [Iverson, Katherine M.] VA Boston Healthcare Syst, Womens Hlth Sci Div, Natl Ctr PTSD, Boston, MA USA; [Iverson, Katherine M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02215 USA; [Pogoda, Terri K.] Boston Univ, Dept Hlth Law Policy & Management, Sch Publ Hlth, Boston, MA 02215 USA		Amara, JH (corresponding author), Naval Postgrad Sch, Def Resources Management Inst, Grad Sch Business & Publ Policy, 699 Dyer Rd,205A Halligan Hall, Monterey, CA 93943 USA.	jhamara@nps.edu	Pogoda, Terri/F-6243-2012	Pogoda, Terri/0000-0003-1397-8780	Department of Veterans Affairs (VA), Veterans Health Administration, Office of Research and Development Health Services Research and Development (HSR&D) service's Investigator Initiated Research Awards [11-078, 11-358]; HSR&D Career Development Award [10-029]; Presidential Early Career Award for Scientists and EngineersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [USA 14-275]; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [5R25MH08091607]; VA HSR&D Service, Quality Enhancement Research Initiative; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R25MH080916] Funding Source: NIH RePORTER	This material is based upon work supported in part by the Department of Veterans Affairs (VA), Veterans Health Administration, Office of Research and Development Health Services Research and Development (HSR&D) service's Investigator Initiated Research Awards #11-078 and #11-358 (Dr Pogoda). Dr Iverson's contribution was supported by her HSR&D Career Development Award (10-029) and a Presidential Early Career Award for Scientists and Engineers (USA 14-275). Dr Iverson is an investigator with the Implementation Research Institute (IRI) at the George Warren Brown School of Social Work, Washington University in St Louis, through an award from theNational Institute of Mental Health (5R25MH08091607) and VA HSR&D Service, Quality Enhancement Research Initiative. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs, the Department of Defense, or the US government.	Amara J, 2014, WOMEN HEALTH ISS, V24, P174; Amara J, 2014, WOMEN HEALTH ISS, V24, pE171, DOI 10.1016/j.whi.2013.12.004; Amoroso T, 2017, J NERV MENT DIS, V205, P318, DOI 10.1097/NMD.0000000000000621; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Brickell TA, 2017, J NEUROTRAUM, V34, P300, DOI 10.1089/neu.2016.4403; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carlson KF, 2018, ARCH PHYS MED REHAB, V99; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Defense and Veterans Brain Injury Center, DOD NUMB TRAUM BRAIN; Defense & Veterans Brain Injury Center, 2017, DOD WORLDW NUMB TBI; Department of Veterans Affairs & Department of Defense, 2016, VA DOD CLIN PRACT GU; Epidemiology Program Post-Deployment Health Group Office of Patient Care Services Veterans Health Administration Department of Veterans Affairs, 2017, ANAL VA HLTH CAR UT; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; IOM (Institute of Medicine), 2013, RET HOM IR AFGH ASS; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Kleylamp M, 2013, SOC SCI RES, V42, P836, DOI 10.1016/j.ssresearch.2012.12.017; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pogoda TK, 2018, ARCH PHYS MED REHAB, V99, pS14, DOI 10.1016/j.apmr.2017.06.029; Pogoda TK, 2017, BRAIN INJURY, V31, P1220, DOI 10.1080/02699052.2016.1274777; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Pogoda TK, 2014, J REHABIL RES DEV, V51, P363, DOI 10.1682/JRRD.2013.05.0115; ROSS CE, 1995, J HEALTH SOC BEHAV, V36, P230, DOI 10.2307/2137340; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; US Bureau of Labor Statistics, 2014, GOV MEAS UN, P1; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vogt D, 2017, SOC PSYCH PSYCH EPID, V52, P341, DOI 10.1007/s00127-016-1321-5; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f	35	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2019	34	1			SI		11	20		10.1097/HTR.0000000000000404			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HK0FH	WOS:000457573600005	29863619				2022-02-06	
J	Bittar, A; Bhatt, N; Hasan, TF; Montalbano, M; Puangmalai, N; McAllen, S; Ellsworth, A; Murillo, MC; Taglialatela, G; Lucke-Wold, B; Logsdon, A; Rosen, C; Turner, RC; Kayed, R				Bittar, Alice; Bhatt, Nemil; Hasan, Tasneem F.; Montalbano, Mauro; Puangmalai, Nicha; McAllen, Salome; Ellsworth, Anna; Murillo, Mariana Carretero; Taglialatela, Giulio; Lucke-Wold, Brandon; Logsdon, Aric; Rosen, Charles; Turner, Ryan C.; Kayed, Rakez			Neurotoxic tau oligomers after single versus repetitive mild traumatic brain injury	BRAIN COMMUNICATIONS			English	Article						traumatic brain injury; tau oligomers; tau polymorphisms; tau strains; neurodegeneration	PATHOLOGY; IMPAIRMENT; NEUROINFLAMMATION; NEURODEGENERATION; CONSCIOUSNESS; ACCUMULATION; OUTCOMES; STRAINS; DISEASE; BLAST	Mild traumatic brain injury accounts for the majority of head injuries and has been correlated with neurodegeneration and dementia. While repetitive mild traumatic brain injury is highly correlated to neurodegeneration, the correlation of a single mild traumatic brain injury with neurodegeneration is still unclear. Because tau aggregates are the main form of mild traumatic brain injury induced pathology, toxic forms of tau protein most likely play a role in the development of post-mild traumatic brain injury neurodegeneration. Therefore, it becomes crucial to characterize the properties of soluble tau aggregates in single versus repetitive mild traumatic brain injury. Herein, we isolated tau oligomers from wild-type mice exposed to single or repetitive mild traumatic brain injury and characterized the tau aggregates at functional, biochemical and biophysical levels. We demonstrated that single versus repetitive mild traumatic brain injuries frequencies lead to the formation of different tau oligomeric polymorphisms. These polymorphisms express different long-term potentiation impairment potencies, toxicity potentials, morphologies and strain indicating properties. To our knowledge, this is the first evidence that soluble tau oligomers derived from single versus repetitive mild traumatic brain injuries form distinct polymorphisms that possibly correlate with the risk of neurodegeneration after mild traumatic brain injury.	[Bittar, Alice; Bhatt, Nemil; Montalbano, Mauro; Puangmalai, Nicha; McAllen, Salome; Ellsworth, Anna; Taglialatela, Giulio; Kayed, Rakez] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Dept Neurol, 301 Univ Blvd,Route 0539,Med Res Bldg, Galveston, TX 77555 USA; [Hasan, Tasneem F.] Ochsner Louisiana State Univ, Dept Neurol, Hlth Sci Ctr, Shreveport, LA 71103 USA; [Murillo, Mariana Carretero] Baylor Coll Med, Houston, TX 77030 USA; [Lucke-Wold, Brandon] Univ Florida, Dept Neurosurg, Gainesville, FL 32608 USA; [Logsdon, Aric] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [Rosen, Charles] Cent Illinois Neural Hlth Sci, Bloomington, IL 61701 USA; [Turner, Ryan C.] West Virginia Univ, Hlth Sci Ctr, Dept Neurosurg, Sch Med, Morgantown, WV 26506 USA		Kayed, R (corresponding author), Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Dept Neurol, 301 Univ Blvd,Route 0539,Med Res Bldg, Galveston, TX 77555 USA.	rakayed@utmb.edu	Montalbano, Mauro/AAA-6833-2021; Puangmalai, Nicha/AAO-7521-2021; Lucke-Wold, Brandon/AAW-3525-2021; Lucke-Wold, Brandon/AAW-1881-2021	Montalbano, Mauro/0000-0002-0456-452X; Puangmalai, Nicha/0000-0002-1138-237X; Lucke-Wold, Brandon/0000-0001-6577-4080; Turner, Ryan/0000-0001-5523-0645	Gillson Longenbaugh foundation; Mitchel Center; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG054025, RFA1AG055771]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG052354] Funding Source: NIH RePORTER	This work was supported by the Gillson Longenbaugh foundation, the Mitchel Center, and the National Institutes of Health [Grant Nos. AG054025 and RFA1AG055771].	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bandyopadhyay A, 2018, SPR SER POLYM COMPOS, P135, DOI 10.1007/978-981-10-6514-9_5; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Bemiller SM, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0216-6; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Comerota MM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15357-x; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Fa M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19393; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Furman JL, 2015, JOVE-J VIS EXP, DOI 10.3791/53205; Gerson J, 2016, J NEUROTRAUM, V33, P2034, DOI 10.1089/neu.2015.4262; Ghag G, 2018, PROTEIN SCI, V27, P1901, DOI 10.1002/pro.3499; Guo JL, 2016, J EXP MED, V213, P2635, DOI 10.1084/jem.20160833; Hawkins BE, 2013, J BIOL CHEM, V288, P17042, DOI 10.1074/jbc.M113.472746; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kanaan NM, 2016, J NEUROPATH EXP NEUR, V75, P19, DOI 10.1093/jnen/nlv001; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Leyns CEG, 2017, P NATL ACAD SCI USA, V114, P11524, DOI 10.1073/pnas.1710311114; Little DM, 2014, ALZHEIMERS DEMENT, V10, pS188, DOI 10.1016/j.jalz.2014.04.002; Lo Cascio F, 2018, ACS CHEM NEUROSCI, V9, P1317, DOI 10.1021/acschemneuro.7b00501; LoBue C, 2016, J NEUROL NEUROSUR PS, V87, P817, DOI 10.1136/jnnp-2015-311438; Logsdon AF, 2017, ARCH NEUROSCI, V4, DOI 10.5812/archneurosci.44254; Luo YW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11458-9; Mayeux J, 2017, J NEUROTRAUM, V34, P436, DOI 10.1089/neu.2016.4452; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Narasimhan S, 2017, J NEUROSCI, V37, P11406, DOI 10.1523/JNEUROSCI.1230-17.2017; Narasimhan S, 2017, METHOD CELL BIOL, V141, P287, DOI 10.1016/bs.mcb.2017.06.009; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004; TEASDALE G, 1974, LANCET, V2, P81; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00222; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Yin YL, 2016, P NATL ACAD SCI USA, V113, pE3773, DOI 10.1073/pnas.1604519113	52	12	12	2	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND		2632-1297		BRAIN COMMUN	Brain Commun.		2019	1	1							04	10.1093/braincomms/fcz004			15	Clinical Neurology; Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	NW3RF	WOS:000574927100004	31608324	Green Published, gold			2022-02-06	
J	Boudreau, RM; Deshpande, KK; Day, GM; Hinckley, WR; Harger, N; Pritts, TA; Makley, AT; Goodman, MD				Boudreau, Ryan M.; Deshpande, Keshav K.; Day, Gregory M.; Hinckley, William R.; Harger, Nicole; Pritts, Timothy A.; Makley, Amy T.; Goodman, Michael D.			Prehospital Tranexamic Acid Administration During Aeromedical Transport After Injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Tranexamic acid; Trauma; Prehospital care; VTE	ACUTE COAGULOPATHY; TRAUMA; HYPERFIBRINOLYSIS; FIBRINOLYSIS; MORTALITY	Background: Tranexamic acid (TXA) has been shown to reduce mortality in the treatment of traumatic hemorrhage. This effect seems most profound when given early after injury. We hypothesized that extending a protocol for TXA administration into the prehospital aeromedical setting would improve outcomes while maintaining a similar safety profile to TXA dosed in the emergency department (ED). Materials and methods: We identified all trauma patients who received TXA during prehospital aeromedical transport or in the ED at our urban level I trauma center over an 18-mo period. These patients had been selected prospectively for TXA administration using a protocol that selected adult trauma patients with high-risk mechanism and concern for severe hemorrhage to receive TXA. Patient demographics, vital signs, lab values including thromboelastography, blood administration, mortality, and complications were reviewed retrospectively and analyzed. Results: One hundred sixteen patients were identified (62 prehospital versus 54 ED). Prehospital TXA patients were more likely to have sustained blunt injury (76% prehospital versus 46% ED, P = 0.002). There were no differences between groups in injury severity score or initial vital signs. There were no differences in complication rates or mortality. Patients receiving TXA had higher rates of venous thromboembolic events (8.1% in prehospital and 18.5% in ED) than the overall trauma population (2.1%, P < 0.001). Conclusions: Prehospital administration of TXA during aeromedical transport did not improve survival compared with ED administration. Treatment with TXA was associated with increased risk of venous thromboembolic events. Prehospital TXA protocols should be refined to identify patients with severe hemorrhagic shock or traumatic brain injury. (C) 2018 Elsevier Inc. All rights reserved.	[Boudreau, Ryan M.; Pritts, Timothy A.; Makley, Amy T.; Goodman, Michael D.] Univ Cincinnati, Dept Surg, Div Trauma, Sect Gen Surg, Cincinnati, OH 45267 USA; [Deshpande, Keshav K.] OhioHlth, Grant Med Ctr, Dept Surg, Columbus, OH USA; [Day, Gregory M.] UC Hlth, Mem Hosp, Dept Gen & Vasc Surg, Colorado Springs, CO USA; [Hinckley, William R.] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45267 USA; [Harger, Nicole] Univ Cincinnati, Med Ctr, UC Hlth, Dept Pharm, Cincinnati, OH 45267 USA		Goodman, MD (corresponding author), Univ Cincinnati, Dept Surg, Div Trauma Crit Care, 231 Albert Sabin Way,ML 0558, Cincinnati, OH 45267 USA.	goodmanmd@ucmail.uc.edu		Pritts, Timothy/0000-0003-2495-3255			Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brown JB, 2015, PREHOSP EMERG CARE, V19, P79, DOI 10.3109/10903127.2014.936635; Callcut RA, 2016, J TRAUMA ACUTE CARE, V80, P450, DOI 10.1097/TA.0000000000000914; Cotton BA, 2012, J TRAUMA ACUTE CARE, V73, P365, DOI 10.1097/TA.0b013e31825c1234; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Droege ME, 2014, J TRAUMA ACUTE CARE, V76, P450, DOI 10.1097/TA.0000000000000087; Godier A, 2017, J CLIN PATHOL, V70, P154, DOI 10.1136/jclinpath-2016-203854; Harvin JA, 2015, J TRAUMA ACUTE CARE, V78, P905, DOI 10.1097/TA.0000000000000612; Howard JT, 2017, J TRAUMA ACUTE CARE, V83, P579, DOI 10.1097/TA.0000000000001613; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; Makley AT, 2012, J SURG RES, V175, pE75, DOI 10.1016/j.jss.2011.11.1028; Mitra B, 2011, EUR J EMERG MED, V18, P137, DOI 10.1097/MEJ.0b013e328342310e; Moore EE, 2016, TRANSFUSION, V56, pS110, DOI 10.1111/trf.13486; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Napolitano LM, 2013, J TRAUMA ACUTE CARE, V74, P1575, DOI 10.1097/TA.0b013e318292cc54; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Theusinger OM, 2011, ANESTH ANALG, V113, P1003, DOI 10.1213/ANE.0b013e31822e183f; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20	21	12	13	2	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JAN	2019	233						132	138		10.1016/j.jss.2018.07.074			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	HB8JT	WOS:000451335500020	30502239				2022-02-06	
J	Ceci, M; Mariano, V; Romano, N				Ceci, Marcello; Mariano, Vittoria; Romano, Nicla			Zebrafish as a translational regeneration model to study the activation of neural stem cells and role of their environment	REVIEWS IN THE NEUROSCIENCES			English	Article						mammals; neurogenic niche; neuroinflammation; neuronal stem cells; reparative neurogenesis; zebrafish	ENDOTHELIAL GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; NEWLY GENERATED NEURONS; SPINAL-CORD REGENERATION; BLOOD-BRAIN-BARRIER; ERYTHROPOIETIN ENHANCES NEUROGENESIS; CHONDROITIN SULFATE PROTEOGLYCAN; CEREBRAL-ARTERY OCCLUSION; ADULT SUBVENTRICULAR ZONE; HORIZONTAL BASAL-CELLS	The review is an overview of the current knowledge of neuronal regeneration properties in mammals and fish. The ability to regenerate the damaged parts of the nervous tissue has been demonstrated in all vertebrates. Notably, fish and amphibians have the highest capacity for neurogenesis, whereas reptiles and birds are able to only regenerate specific regions of the brain, while mammals have reduced capacity for neurogenesis. Zebrafish (Danio rerio) is a promising model of study because lesions in the brain or complete cross-section of the spinal cord are followed by an effective neuro-regeneration that successfully restores the motor function. In the brain and the spinal cord of zebrafish, stem cell activity is always able to re-activate the molecular programs required for central nervous system regeneration. In mammals, traumatic brain injuries are followed by reduced neurogenesis and poor axonal regeneration, often insufficient to functionally restore the nervous tissue, while spinal injuries are not repaired at all. The environment that surrounds the stem cell niche constituted by connective tissue and stimulating factors, including pro-inflammation molecules, seems to be a determinant in triggering stem cell proliferation and/or the trans-differentiation of connective elements (mainly fibroblasts). Investigating and comparing the neuronal regeneration in zebrafish and mammals may lead to a better understanding of the mechanisms behind neurogenesis, and the failure of the regenerative response in mammals, first of all, the role of inflammation, considered the main inhibitor of the neuronal regeneration.	[Ceci, Marcello; Romano, Nicla] Univ Tuscia, Dept Ecol & Biol Sci, I-01100 Viterbo, Italy; [Mariano, Vittoria] Univ Lausanne, Dept Fundamental Neurosci, CH-1005 Lausanne, Switzerland		Romano, N (corresponding author), Univ Tuscia, Dept Ecol & Biol Sci, I-01100 Viterbo, Italy.	nromano@unitus.it		Romano, Nicla/0000-0002-0155-8271; Ceci, Marcello/0000-0002-5066-1590			Abdesselem H, 2009, J NEUROSCI, V29, P15489, DOI 10.1523/JNEUROSCI.3561-09.2009; Adolf B, 2006, DEV BIOL, V295, P278, DOI 10.1016/j.ydbio.2006.03.023; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; Arocho LC, 2011, CELL MOL NEUROBIOL, V31, P1057, DOI 10.1007/s10571-011-9705-2; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Bambakidis NC, 2003, J NEUROSURG, V99, P70, DOI 10.3171/spi.2003.99.1.0070; Bambakidis NC, 2012, J NEUROSURG, V116, P1114, DOI 10.3171/2012.1.JNS111285; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Barkho BZ, 2011, CURR STEM CELL RES T, V6, P327; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Barnea A, 2011, EUR J NEUROSCI, V34, P884, DOI 10.1111/j.1460-9568.2011.07851.x; Becker CG, 2004, J NEUROSCI, V24, P7837, DOI 10.1523/JNEUROSCI.2420-04.2004; Becker CG, 2002, J NEUROSCI, V22, P842, DOI 10.1523/JNEUROSCI.22-03-00842.2002; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Becker T, 1998, J NEUROSCI, V18, P5789; Becker T, 2001, J COMP NEUROL, V433, P131, DOI 10.1002/cne.1131; Becker T, 2000, GLIA, V29, P330, DOI 10.1002/(SICI)1098-1136(20000215)29:4<330::AID-GLIA4>3.0.CO;2-L; Bedard A, 2004, DEV BRAIN RES, V151, P159, DOI 10.1016/j.devbrainres.2004.03.021; Beites CL, 2005, EXP CELL RES, V306, P309, DOI 10.1016/j.yexcr.2005.03.027; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Bhalala OG, 2012, J NEUROSCI, V32, P17935, DOI 10.1523/JNEUROSCI.3860-12.2012; Boldrini M, 2018, CELL STEM CELL, V22, P589, DOI 10.1016/j.stem.2018.03.015; Boldrini M, 2012, BIOL PSYCHIAT, V72, P562, DOI 10.1016/j.biopsych.2012.04.024; Bollaerts I, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9478542; Bonfanti L, 2011, EUR J NEUROSCI, V34, P930, DOI 10.1111/j.1460-9568.2011.07832.x; Bonfanti L, 2011, THESCIENTIFICWORLDJO, V11, P1270, DOI 10.1100/tsw.2011.113; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Buckwalter MS, 2006, AM J PATHOL, V169, P154, DOI 10.2353/ajpath.2006.051272; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Carter LA, 2004, J NEUROSCI, V24, P5670, DOI 10.1523/JNEUROSCI.0330-04.2004; Chambers CB, 2001, DEVELOPMENT, V128, P689; Chapouton P, 2010, J NEUROSCI, V30, P7961, DOI 10.1523/JNEUROSCI.6170-09.2010; Chen XY, 2004, J COMP NEUROL, V469, P457, DOI 10.1002/cne.11031; Chou J, 2006, J NEUROL SCI, V240, P21, DOI 10.1016/j.jns.2005.08.015; Clint SC, 2001, DEV BRAIN RES, V130, P15, DOI 10.1016/S0165-3806(01)00193-6; Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001; Cullen D. Kacy, 2011, Critical Reviews in Biomedical Engineering, V39, P241; Curtis MA, 2012, DEV NEUROBIOL, V72, P990, DOI 10.1002/dneu.22028; De Winter F, 2002, EXP NEUROL, V175, P61, DOI 10.1006/exnr.2002.7884; Deierborg T, 2010, NEUROSCIENCE, V171, P1386, DOI 10.1016/j.neuroscience.2010.09.045; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Dias TB, 2012, J NEUROSCI, V32, P3245, DOI 10.1523/JNEUROSCI.6398-11.2012; Diekmann H, 2009, J NEUROSCI, V29, P1343, DOI 10.1523/JNEUROSCI.6039-08.2009; Doetsch F, 1997, J NEUROSCI, V17, P5046; Donovan MH, 2008, HIPPOCAMPUS, V18, P435, DOI 10.1002/hipo.20410; DOU CL, 1994, J NEUROSCI, V14, P7616; Duan HM, 2016, SCI CHINA LIFE SCI, V59, P1313, DOI 10.1007/s11427-016-0205-2; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Ekstrom P, 2001, J COMP NEUROL, V436, P92, DOI 10.1002/cne.1056; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Fabes J, 2006, EUR J NEUROSCI, V23, P1721, DOI 10.1111/j.1460-9568.2006.04704.x; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fernandez-Hernandez I, 2015, NEUROSCI BIOBEHAV R, V56, P62, DOI 10.1016/j.neubiorev.2015.06.021; Ferrer I, 2001, ACTA NEUROPATHOL, V101, P229; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; Fischer D, 2000, INVEST OPHTH VIS SCI, V41, P3943; Fischer D, 2012, PROG RETIN EYE RES, V31, P688, DOI 10.1016/j.preteyeres.2012.06.005; Fletcher RB, 2011, NEURON, V72, P748, DOI 10.1016/j.neuron.2011.09.009; Fournier A. E., 2003, METHOD ENZYMOL, V325, P473; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Fuentealba LC, 2012, CELL STEM CELL, V10, P698, DOI 10.1016/j.stem.2012.05.012; Fukuda S, 2003, J NEUROSCI, V23, P9357; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ganz J, 2010, GLIA, V58, P1345, DOI 10.1002/glia.21012; Gardner RT, 2013, J NEUROSCI, V33, P7175, DOI 10.1523/JNEUROSCI.5866-12.2013; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Gilbert S. F., 2005, DEV BIOL; Givogri MI, 2006, DEV NEUROSCI-BASEL, V28, P81, DOI 10.1159/000090755; Gokoffski KK, 2011, DEVELOPMENT, V138, P4131, DOI 10.1242/dev.065870; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Goldshmit Y, 2012, J NEUROSCI, V32, P7477, DOI 10.1523/JNEUROSCI.0758-12.2012; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Gong C, 2007, J NEUROSCI, V27, P1803, DOI 10.1523/JNEUROSCI.3111-06.2007; Gotts JE, 2005, EXP NEUROL, V194, P139, DOI 10.1016/j.expneurol.2005.02.001; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Grandel H, 2013, DEV GENES EVOL, V223, P131, DOI 10.1007/s00427-012-0425-5; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; Gris D, 2004, J NEUROSCI, V24, P4043, DOI 10.1523/JNEUROSCI.5343-03.2004; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Harvey BK, 2005, PHARMACOL THERAPEUT, V105, P113, DOI 10.1016/j.pharmthera.2004.09.003; Hauk TG, 2010, INVEST OPHTH VIS SCI, V51, P459, DOI 10.1167/iovs.09-4203; Holzschuh J, 2005, DEVELOPMENT, V132, P3731, DOI 10.1242/dev.01936; Hou SW, 2008, STROKE, V39, P2837, DOI 10.1161/STROKEAHA.107.510982; Hui SP, 2010, DEV DYNAM, V239, P2962, DOI 10.1002/dvdy.22438; Hynds DL, 1999, EXP NEUROL, V160, P244, DOI 10.1006/exnr.1999.7212; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Rehermann MI, 2011, CELL TISSUE RES, V344, P415, DOI 10.1007/s00441-011-1173-y; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Iosif RE, 2008, J CEREBR BLOOD F MET, V28, P1574, DOI 10.1038/jcbfm.2008.47; Iwai N, 2008, STEM CELLS, V26, P1298, DOI 10.1634/stemcells.2007-0891; Jaerve A, 2012, CELL TISSUE RES, V349, P229, DOI 10.1007/s00441-012-1427-3; Jin KL, 2006, J NEUROBIOL, V66, P236, DOI 10.1002/neu.20215; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kadota T, 2009, BRAIN RES, V1254, P120, DOI 10.1016/j.brainres.2008.11.094; Kalluri HSG, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E13; Kaslin J, 2008, PHILOS T R SOC B, V363, P101, DOI 10.1098/rstb.2006.2015; Kazanis I, 2012, NEUROSCIENTIST, V18, P15, DOI 10.1177/1073858410390379; KEIRSTEAD HS, 1995, J NEUROSCI, V15, P6963; Kim H, 2008, DEV DYNAM, V237, P2081, DOI 10.1002/dvdy.21620; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kitagawa H, 1998, STROKE, V29, P1417, DOI 10.1161/01.STR.29.7.1417; Kizil C, 2012, DEV CELL, V23, P1230, DOI 10.1016/j.devcel.2012.10.014; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kroehne V, 2011, DEVELOPMENT, V138, P4831, DOI 10.1242/dev.072587; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kyritsis N, 2014, TRENDS CELL BIOL, V24, P128, DOI 10.1016/j.tcb.2013.08.004; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Lanfranconi S, 2011, J CELL MOL MED, V15, P1645, DOI 10.1111/j.1582-4934.2009.00987.x; Larsson E, 2002, EXP NEUROL, V177, P1, DOI 10.1006/exnr.2002.7992; Lavine KJ, 2006, GENE DEV, V20, P1651, DOI 10.1101/gad.1411406; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lee SR, 2006, J NEUROSCI, V26, P3491, DOI 10.1523/JNEUROSCI.4085-05.2006; Lee-Liu D, 2013, GENESIS, V51, P529, DOI 10.1002/dvg.22406; LEIBINGER M, 2013, CELL DEATH DIS, V4; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Li Q, 2005, J NEUROSCI, V25, P1711, DOI 10.1523/JNEUROSCI.4393-04.2005; Liang D, 2001, MECH DEVELOP, V108, P29, DOI 10.1016/S0925-4773(01)00468-3; Liem K. F., 2002, FUNCTIONAL ANATOMY V; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Lin JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031686; Lin TN, 1997, MOL BRAIN RES, V49, P255, DOI 10.1016/S0169-328X(97)00152-6; Liu JL, 1998, J NEUROSCI, V18, P7768; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; Liu XF, 2001, J NEUROL SCI, V187, P91, DOI 10.1016/S0022-510X(01)00532-9; Liu XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023461; Lledo PM, 2005, TRENDS NEUROSCI, V28, P248, DOI 10.1016/j.tins.2005.03.005; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Londin ER, 2005, DEV BIOL, V279, P1, DOI 10.1016/j.ydbio.2004.11.016; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lucini C, 2008, HISTOL HISTOPATHOL, V23, P251, DOI 10.14670/HH-23.251; Luo YP, 2015, CELL, V161, P1175, DOI 10.1016/j.cell.2015.04.001; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Marz M, 2011, DEV DYNAM, V240, P2221, DOI 10.1002/dvdy.22710; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; Mann F, 2003, J NEUROBIOL, V57, P323, DOI 10.1002/neu.10303; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Martino G, 2011, PHYSIOL REV, V91, P1281, DOI 10.1152/physrev.00032.2010; Matsuzaki H, 2001, FASEB J, V15, P1218, DOI 10.1096/fj.00-0495fje; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Miyasaka N, 2007, DEVELOPMENT, V134, P2459, DOI 10.1242/dev.001958; Moriyama M, 2011, J NEUROSCI, V31, P3981, DOI 10.1523/JNEUROSCI.3617-10.2011; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nor JE, 1999, AM J PATHOL, V154, P375, DOI 10.1016/S0002-9440(10)65284-4; Oertle T, 2003, J NEUROSCI, V23, P5393; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Ohnishi Y, 2013, STEM CELL RES, V11, P1178, DOI 10.1016/j.scr.2013.08.005; Ortega-Perez I, 2007, J MOL HISTOL, V38, P555, DOI 10.1007/s10735-007-9114-5; Oya S, 2008, NEUROREPORT, V19, P805, DOI 10.1097/WNR.0b013e3282ff8641; Parent JM, 1997, J NEUROSCI, V17, P3727; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Park HC, 2003, DEVELOPMENT, V130, P3747, DOI 10.1242/dev.00576; Peng H, 2004, J NEUROSCI RES, V76, P35, DOI 10.1002/jnr.20045; Pirotte N, 2016, DEV BIOL, V409, P4, DOI 10.1016/j.ydbio.2015.09.025; Qian F, 2005, DEV DYNAM, V233, P1163, DOI 10.1002/dvdy.20444; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; Reimer MM, 2009, J NEUROSCI, V29, P15073, DOI 10.1523/JNEUROSCI.4748-09.2009; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Rothenaigner I, 2011, DEVELOPMENT, V138, P1459, DOI 10.1242/dev.058156; Russo A, 2017, HUM MOL GENET, V26, P1407, DOI 10.1093/hmg/ddx035; Sabo JK, 2009, NEUROSIGNALS, V17, P255, DOI 10.1159/000231892; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; Schlueter PJ, 2007, CELL DEATH DIFFER, V14, P1095, DOI 10.1038/sj.cdd.4402109; Schmidt R, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-3; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Schuster K, 2010, P NATL ACAD SCI USA, V107, P19531, DOI 10.1073/pnas.1002171107; Schwartz M, 2006, J NEUROTRAUM, V23, P360, DOI 10.1089/neu.2006.23.360; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Sieger D, 2013, GLIA, V61, P3, DOI 10.1002/glia.22385; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Song JH, 2005, J BIOL CHEM, V280, P12896, DOI 10.1074/jbc.M412139200; Sorrells SF, 2018, NATURE, V555, P377, DOI 10.1038/nature25975; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Svensson B, 2002, J CEREBR BLOOD F MET, V22, P1170, DOI 10.1097/01.wcb.0000037988.07114.98; Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Thundyil J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053528; Tonchev AB, 2011, ARCH ITAL BIOL, V149, P225, DOI 10.4449/aib.v149i2.1368; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Tureyen K, 2005, NEUROSURGERY, V57, P1254, DOI 10.1227/01.NEU.0000186040.96929.8A; Vajn K, 2013, NEUROSCI BULL, V29, P402, DOI 10.1007/s12264-013-1361-8; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; Vargas ME, 2015, J NEUROSCI, V35, P15026, DOI 10.1523/JNEUROSCI.2484-15.2015; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang L, 2009, NEUROSCIENCE, V158, P1356, DOI 10.1016/j.neuroscience.2008.10.064; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Wang XF, 2007, MOL CELL NEUROSCI, V36, P343, DOI 10.1016/j.mcn.2007.07.005; Wang Y, 1997, J NEUROSCI, V17, P4341; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Williams A, 2014, QJM-INT J MED, V107, P335, DOI 10.1093/qjmed/hct260; Willson CA, 2002, CELL TRANSPLANT, V11, P229; Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009; Xiao Mei-Juan, 2009, Int J Physiol Pathophysiol Pharmacol, V1, P192; Xin HQ, 2012, STEM CELLS, V30, P1556, DOI 10.1002/stem.1129; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Xu Y, 2005, EXP NEUROL, V192, P251, DOI 10.1016/j.expneurol.2004.12.021; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Yamamoto S, 2001, J NEUROSCI, V21, P9814, DOI 10.1523/JNEUROSCI.21-24-09814.2001; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yang P, 2012, EXP NEUROL, V236, P19, DOI 10.1016/j.expneurol.2012.03.019; Yin KJ, 2010, NEUROBIOL DIS, V38, P17, DOI 10.1016/j.nbd.2009.12.021; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yoneyama M, 2011, J PHARMACOL SCI, V115, P425, DOI 10.1254/jphs.11R02CP; Yu YM, 2011, NEUROSCIENCE, V183, P238, DOI 10.1016/j.neuroscience.2011.03.043; Yu YM, 2011, EUR J NEUROSCI, V33, P1587, DOI 10.1111/j.1460-9568.2011.07643.x; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zheng W, 2004, DEV NEUROSCI-BASEL, V26, P181, DOI 10.1159/000082136; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684; Zou SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007026; ZUPANC GKH, 1995, J COMP NEUROL, V353, P213, DOI 10.1002/cne.903530205; Zupanc GKH, 2001, BRAIN BEHAV EVOLUT, V58, P250, DOI 10.1159/000057569; Zupanc GKH, 2006, REGEN MED, V1, P207, DOI 10.2217/17460751.1.2.207	239	12	12	0	18	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	1607-8470		REV NEUROSCIENCE	Rev. Neurosci.	JAN	2019	30	1					45	66		10.1515/revneuro-2018-0020			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HF3HI	WOS:000454125700004	30067512				2022-02-06	
J	Chung, JY; Krapp, N; Wu, LM; Lule, S; McAllister, LM; Edmiston, WJ; Martin, S; Levy, E; Songtachalert, T; Sherwood, JS; Buckley, EM; Sanders, B; Izzy, S; Hickman, S; Guo, SZ; Lok, J; El Khoury, J; Lo, EH; Kaplan, D; Whalen, MJ				Chung, Joon Yong; Krapp, Nicolas; Wu, Limin; Lule, Sevda; McAllister, Lauren M.; Edmiston, William J.; Martin, Samantha; Levy, Emily; Songtachalert, Tanya; Sherwood, John S.; Buckley, Erin M.; Sanders, Bharat; Izzy, Saef; Hickman, Suzanne; Guo, Shuzhen; Lok, Josephine; El Khoury, Joseph; Lo, Eng H.; Kaplan, David; Whalen, Michael J.			Interleukin-1 Receptor 1 Deletion in Focal and Diffuse Experimental Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; interleukin-1; mice; traumatic brain injury	NECROSIS-FACTOR-ALPHA; INFLAMMATORY RESPONSE; ENDOTHELIAL-CELLS; MAMMALIAN TARGET; I RECEPTOR; MODEL; NEUTRALIZATION; CONCUSSION; AKT; ACTIVATION	Important differences in the biology of focal and diffuse traumatic brain injury (TBI) subtypes may result in unique pathophysiological responses to shared molecular mechanisms. Interleukin-1 (IL-1) signaling has been tested as a potential therapeutic target in preclinical models of cerebral contusion and diffuse TBI, and in a phase II clinical trial, but no published studies have examined IL-1 signaling in an impact/acceleration closed head injury (CHI) model. We hypothesized that genetic deletion of IL-1 receptor-1 (IL-1R1 KO) would be beneficial in focal (contusion) and CHI in mice. Wild type and IL-1R1 KO mice were subjected to controlled cortical impact (CCI), or to CHI. CCI produced brain leukocyte infiltration, HMGB1 translocation and release, edema, cell death, and cognitive deficits. CHI induced peak rotational acceleration of 9.7x10(5)+/- 8.1x10(4) rad/s(2), delayed time to righting reflex, and robust Morris water maze deficits without deficits in tests of anxiety, locomotion, sensorimotor function, or depression. CHI produced no discernable acute plasmalemma damage or cell death, blood-brain barrier permeability to IgG, or brain edema and only a modest increase in brain leukocyte infiltration at 72h. In both models, mature (17kDa) interleukin-1 beta (IL-1) was induced by 24h in CD31+ endothelial cells isolated from injured brain but was not induced in CD11b(+) cells in either model. High mobility group box protein-1 was released from injured brain cells in CCI but not CHI. Surprisingly, cognitive outcome in mice with global deletion of IL-1R1 was improved in CHI, but worse after CCI without affecting lesion size, edema, or infiltration of CD11b(+)/CD45(+) leukocytes in CCI. IL-1R1 may induce unique biological responses, beneficial or detrimental to cognitive outcome, after TBI depending on the pathoanatomical subtype. Brain endothelium is a hitherto unrecognized source of mature IL-1 in both models.	[Chung, Joon Yong; Krapp, Nicolas; Wu, Limin; Lule, Sevda; McAllister, Lauren M.; Edmiston, William J.; Martin, Samantha; Levy, Emily; Songtachalert, Tanya; Sherwood, John S.; Lok, Josephine; Whalen, Michael J.] Harvard Med Sch, Massachusetts Gen Hosp, Neurosci Ctr, 149 13th St,Room 6303, Charlestown, MA 02129 USA; [Chung, Joon Yong; Krapp, Nicolas; Wu, Limin; Lule, Sevda; McAllister, Lauren M.; Edmiston, William J.; Martin, Samantha; Levy, Emily; Songtachalert, Tanya; Sherwood, John S.; Lok, Josephine; Whalen, Michael J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02115 USA; [Krapp, Nicolas] Heidelberg Univ, Med Fak Mannheim, Mannheim, Germany; [Buckley, Erin M.; Sanders, Bharat] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Buckley, Erin M.; Sanders, Bharat] Emory Univ, Atlanta, GA 30322 USA; [Buckley, Erin M.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Izzy, Saef] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Hickman, Suzanne; El Khoury, Joseph] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Dept Med, Boston, MA 02115 USA; [Guo, Shuzhen; Lo, Eng H.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Guo, Shuzhen; Lo, Eng H.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Kaplan, David] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA		Whalen, MJ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Neurosci Ctr, 149 13th St,Room 6303, Charlestown, MA 02129 USA.	mwhalen@mgh.harvard.edu	; Lule, Sevda/N-8229-2017	Chung, Joon Yong/0000-0002-3980-2065; Lule, Sevda/0000-0001-7066-6471; Levy, Emily/0000-0002-3139-8838	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1RO1NS092847-01, 5RO1NSO91573, R21HD086385, NIA RF1AG051506]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD086385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091573, R01NS092847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1AG051506] Funding Source: NIH RePORTER	The work was funded by NIH/NINDS 1RO1NS092847-01 (to D.K.), 5RO1NSO91573 (to J.L.), R21HD086385 (to M.J.W.), and NIA RF1AG051506 (to J.E.K.).	ARAUJO DM, 1992, J NEUROSCI, V12, P1668; Badaut J, 2014, TRANSL STROKE RES, V5, P394, DOI 10.1007/s12975-013-0304-z; Basu A, 2002, J NEUROSCI, V22, P6071; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Cheng W, 2008, INFECT IMMUN, V76, P942, DOI 10.1128/IAI.01313-07; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Devan BD, 1996, NEUROBIOL LEARN MEM, V66, P305, DOI 10.1006/nlme.1996.0072; Ekmark-Lewen S, 2016, EUR J NEUROSCI, V43, P1016, DOI 10.1111/ejn.13190; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Faul M, 2010, TRAUMATIC BRAIN INJU; Giza CC, 2017, NEURON, V94, P1051, DOI 10.1016/j.neuron.2017.05.003; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Gonzalez-Perez O, 2012, NEUROSCIENCE, V226, P270, DOI 10.1016/j.neuroscience.2012.08.053; Gourin CG, 1997, J TRAUMA, V42, P1101, DOI 10.1097/00005373-199706000-00020; Grammas P, 2014, J ALZHEIMERS DIS, V40, P619, DOI 10.3233/JAD-2014-132057; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Holmin S, 2004, NEUROSCI LETT, V369, P108, DOI 10.1016/j.neulet.2004.07.044; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Kochanek PM, 2016, J NEUROTRAUM, V33, P606, DOI 10.1089/neu.2015.4133; Konsman JP, 2007, CLIN SCI, V112, P1, DOI 10.1042/CS20060043; Labow M, 1997, J IMMUNOL, V159, P2452; Lim YC, 2003, AM J PATHOL, V162, P1591, DOI 10.1016/S0002-9440(10)64293-9; Lin HW, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-15; Liu XY, 2015, J NEUROSCI, V35, P2860, DOI 10.1523/JNEUROSCI.3199-14.2015; Luheshi NM, 2009, BRIT J PHARMACOL, V157, P1318, DOI 10.1111/j.1476-5381.2009.00331.x; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Meyer-Hoffert U, 2009, FRONT BIOSCI-LANDMRK, V14, P3409, DOI 10.2741/3462; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Moriwaki K, 2016, CELL MOL LIFE SCI, V73, P2325, DOI 10.1007/s00018-016-2203-4; Ommaya AK, 1967, 11 STAPP CAR CRASH C, P73; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Parker LC, 2002, BRIT J PHARMACOL, V136, P312, DOI 10.1038/sj.bjp.0704715; Parker TM, 2017, BRAIN INJURY, V31, P2, DOI 10.1080/02699052.2016.1217045; Qian J, 2012, P NATL ACAD SCI USA, V109, P12189, DOI 10.1073/pnas.1205207109; Rodriguez-Grande B, 2014, J CEREBR BLOOD F MET, V34, P480, DOI 10.1038/jcbfm.2013.224; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salmeron K, 2016, J NEUROCHEM, V136, P573, DOI 10.1111/jnc.13422; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Semple BD, 2017, J NEUROSCI, V37, P7864, DOI 10.1523/JNEUROSCI.0982-17.2017; Smith DE, 2009, IMMUNITY, V30, P817, DOI 10.1016/j.immuni.2009.03.020; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113	53	12	12	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2019	36	2					370	379		10.1089/neu.2018.5659			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HM4LJ	WOS:000459444800019	29768967	Green Published			2022-02-06	
J	Cimino, AN; Yi, G; Patch, M; Alter, Y; Campbell, JC; Gundersen, KK; Tang, JT; Tsuyuki, K; Stockman, JK				Cimino, Andrea N.; Yi, Grace; Patch, Michelle; Alter, Yasmin; Campbell, Jacquelyn C.; Gundersen, Kristin K.; Tang, Judy T.; Tsuyuki, Kiyomi; Stockman, Jamila K.			The Effect of Intimate Partner Violence and Probable Traumatic Brain Injury on Mental Health Outcomes for Black Women	JOURNAL OF AGGRESSION MALTREATMENT & TRAUMA			English	Article						Intimate partner violence; domestic violence; physical abuse; sexual abuse; depression; posttraumatic stress disorder; strangulation; unconscious	POSTTRAUMATIC-STRESS-DISORDER; NONFATAL STRANGULATION; SYMPTOMS; DEPRESSION; RISK; CONSEQUENCES; SEVERITY; VICTIMS; NEED	Severe intimate partner violence (IPV) including loss of consciousness from head injuries and/or strangulation can result in traumatic brain injury (TBI), a brain pathology characterized by altered brain function, cognitive impairment, and mental health disorders, including depression and posttraumatic stress disorder (PTSD). This study examines the prevalence of probable TBI (defined as loss of consciousness from a blow to the head and/or strangulation) and its association with comorbid PTSD and depression among Black women, who experience both higher rates of IPV and greater mental health burden than White and Latina women. Data come from a retrospective cohort study of 95 Black women with abuse history including IPV, forced sex, and childhood maltreatment. About one-third of women (n = 32) had probable TBI. Among them, 38% (n = 12) were hit on the head, 38% (n = 12) were strangled to unconsciousness, and 25% (n = 8) were strangled and hit on the head. Women with IPV history and probable TBI had significantly greater odds of various physical injuries including those that required medical care compared to other abused women. Probable TBI significantly increased comorbid PTSD and depression by 8.93 points (SE = 3.40), after controlling for past violence (F-(4, (90)) = 3.67, p < .01). Findings from this study reinforce the need to screen women who lost consciousness due to IPV for TBI and facilitate referrals to IPV interventions and mental health treatment.	[Cimino, Andrea N.; Yi, Grace; Patch, Michelle; Campbell, Jacquelyn C.] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21205 USA; [Alter, Yasmin] Univ Maryland, Med Ctr, Shock Trauma, Baltimore, MD 21201 USA; [Gundersen, Kristin K.; Tang, Judy T.; Tsuyuki, Kiyomi; Stockman, Jamila K.] Univ Calif San Diego, Dept Med La Jolla, Div Infect Dis & Global Publ Hlth, San Diego, CA 92103 USA		Cimino, AN (corresponding author), Johns Hopkins Univ, Dept Community Publ Hlth, Sch Nursing, 525 N Wolfe St,SON House 110, Baltimore, MD 21205 USA.	andreacimino@mac.com	Stockman, Jamila/AAK-8960-2020	Patch, Michelle/0000-0003-3639-6003; Yi, Grace/0000-0001-9560-3805	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD077891]; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [L60MD011184, L60MD003701]; National Institute of Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K01AA025009]; Center for AIDS Research (CFAR) at Johns Hopkins University [P30AI094189]; NIH - NIAIDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID); NIH - NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH); NIH - NIDAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA); NIH - NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NIH - NHLBUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIH - NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); NIH - NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS); NIH - NIDDKUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of California, San DiegoUniversity of California System [2P30AI036214-24]; NIH - NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD077891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [P30AI094189, P30AI036214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K01AA025009] Funding Source: NIH RePORTER	This research was supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD077891-J.K. Stockman, J.C. Campbell, A.N. Cimino, K. Tsuyuki), the National Institute on Minority Health and Health Disparities (L60MD003701-J.K. Stockman; L60MD011184-K. Tsuyuki), and the National Institute of Alcohol Abuse and Alcoholism (K01AA025009-K. Tsuyuki). This research was also supported by the Center for AIDS Research (CFAR) at Johns Hopkins University (P30AI094189-A.N. Cimino) and University of California, San Diego (2P30AI036214.-24), an NIH-funded program which is supported by the following NIH Institutes and Centers: NIAID, NCI, NIMH, NIDA, NICHD, NHLB, NIA, NIGMS, and NIDDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the paper. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackerman RJ, 2003, WOMEN THER, V26, P343, DOI 10.1300/J015v26n03_11; Alston M, 2012, AUST SOC WORK, V65, P39, DOI 10.1080/0312407X.2011.594898; Anderson JC, 2015, J EMERG NURS, V41, P36, DOI 10.1016/j.jen.2014.01.015; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Black M C., 2011, NATL INTIMATE PARTNE; Breiding MJ., 2015, INTIMATE PARTNER VIO; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Campbell JC, 2009, J INTERPERS VIOLENCE, V24, P653, DOI 10.1177/0886260508317180; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; CDC, 2016, BAS INF TRAUM BRAIN; Centers for Diseas Control and Prevention (CDC), 2018, LEAD CAUS DEATH FEM; Centers for Disease Control and Prevention (CDC), 2015, REP C TRAUM BRAIN IN; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Chung P, 2013, J NEUROL NEUROPHYSIO, V5, P182; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Crowe LM, 2018, ARCH PHYS MED REHAB, V99, P1360, DOI 10.1016/j.apmr.2017.12.026; Drew LB, 2004, NEUROCRIT CARE, V1, P385, DOI 10.1385/NCC:1:3:385; Glass N, 2008, J EMERG MED, V35, P329, DOI 10.1016/j.jemermed.2007.02.065; Glover DA, 2010, J TRAUMA DISSOCIATIO, V11, P152, DOI 10.1080/15299730903502920; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Khan U., 2016, ONATI SOCIOLEGAL SER, V6, P1405; Kobeissy F., 2015, BRAIN NEUROTRAUMA MO; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; LeBeau R, 2014, PSYCHIAT RES, V218, P143, DOI 10.1016/j.psychres.2014.03.032; Leo P, 2016, TRANSLATIONAL RES TR; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Munivenkatappa Ashok, 2016, Int J Crit Illn Inj Sci, V6, P70, DOI 10.4103/2229-5151.183024; Murray CE, 2016, TRAUMA VIOLENCE ABUS, V17, P298, DOI 10.1177/1524838015584364; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; National Institute of Neurological Disorders and Stroke, 2018, CER HYP INF PAG; Panzer S, 2017, J FORENSIC LEG MED, V52, P62, DOI 10.1016/j.jflm.2017.08.007; Patch M, 2018, J EMERG NURS, V44, P384, DOI 10.1016/j.jen.2017.12.001; Pervez M, 2018, NEUROIMAG CLIN N AM, V28, P1, DOI 10.1016/j.nic.2017.09.010; Petrosky E, 2017, MMWR-MORBID MORTAL W, V66, P741, DOI 10.15585/mmwr.mm6628a1; Rehor JE, 2015, ARCH SEX BEHAV, V44, P825, DOI 10.1007/s10508-015-0524-2; RIMEL RW, 1979, JACEP-J AM COLL EMER, V8, P64, DOI 10.1016/S0361-1124(79)80039-8; Sabri B, 2016, SOC WORK PUBLIC HLTH, V31, P127, DOI 10.1080/19371918.2015.1087917; Sauvageau A, 2010, J FORENSIC SCI, V55, P1259, DOI 10.1111/j.1556-4029.2010.01459.x; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Smith DJ, 2001, J EMERG MED, V21, P323, DOI 10.1016/S0736-4679(01)00402-4; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stockman JK, 2015, J WOMENS HEALTH, V24, P256, DOI 10.1089/jwh.2014.4879.cxn; Strack G., 2018, ROLE EMERGENCY MED S; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Suliman S, 2009, COMPR PSYCHIAT, V50, P121, DOI 10.1016/j.comppsych.2008.06.006; TEASDALE G, 1974, LANCET, V2, P81; Training Institute on Strangulation Prevention, 2017, GWINN STRANG STEP SP; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Woods SJ, 2008, J MIDWIFERY WOM HEAL, V53, P538, DOI 10.1016/j.jmwh.2008.07.004; Zhang X., 2018, NATL INTIMATE PARTNE, P1; Zilkens RR, 2016, J FORENSIC LEG MED, V43, P1, DOI 10.1016/j.jflm.2016.06.005	61	12	12	1	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1092-6771	1545-083X		J AGGRESS MALTREAT T	J. Aggress. Maltreatment Trauma		2019	28	6			SI		714	731		10.1080/10926771.2019.1587657			18	Psychology, Clinical; Criminology & Penology; Family Studies; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Criminology & Penology; Family Studies; Psychiatry	IM2YW	WOS:000477859700005	31929719	Green Accepted			2022-02-06	
J	Cosgrave, M; Williams, S				Cosgrave, Matthew; Williams, Sean			The epidemiology of concussion in professional rugby union in Ireland	PHYSICAL THERAPY IN SPORT			English	Article						Concussion; Rugby union; Professional	WORLD CUP; INJURIES	Objectives: To determine incidence rates, severity and the nature of concussion in professional rugby union in Ireland. Design: Retrospective observational study of time-loss concussion. Setting: Professional rugby union in Ireland. Participants: 160 male professional rugby union players. Outcome measures: Incidence rates (concussion/1000 player-match-hours) and mean/median severity (days absence) of concussion. Results: This study observed 60 concussions in 47 players over the course of the 2016/17 season. The match concussion incidence rate was 18.4/1000 player-match-hours. Mean and median severity was 12 and 10 days respectively. Overall burden of match concussion was 5 days absence per team per match. Concussion severity (days absence) correlated positively with the number of symptoms (r(s) 0.32, p = 0.022) and symptom severity score (r(s) 0.28, p = 0.045) on HIA2/SCAT3 forms. A negative correlation was observed between symptom severity score and the number of days until subsequent injury (r(s) -0.28, p = 0.049). Tackling was the most common inciting event responsible for concussion. Conclusions: The burden of concussion in professional rugby union is high. Incidence rates appear to be increasing year on year while severity is unchanged. Return to play results in this study highlight the need for caution in concussion recovery and return to play protocols. (C) 2018 Elsevier Ltd. All rights reserved.	[Cosgrave, Matthew; Williams, Sean] Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England		Cosgrave, M (corresponding author), 14 Cranmore Gardens, Belfast BT9 6JL, Antrim, North Ireland.	matthewcosgrave@doctors.org.uk; S.Williams@bath.ac.uk	Williams, Sean/AAB-2790-2022; Williams, Sean/AAA-9361-2022	Williams, Sean/0000-0003-1460-0085; Williams, Sean/0000-0003-1460-0085			Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Brooks JHM, 2008, CLIN SPORT MED, V27, P51, DOI 10.1016/j.csm.2007.09.001; Cross MJ, 2019, BRIT J SPORT MED, V53, P1021, DOI 10.1136/bjsports-2017-097912; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Fuller CW, 2013, BRIT J SPORT MED, V47, P1184, DOI 10.1136/bjsports-2012-091155; Fuller CW, 2011, CLIN J SPORT MED, V21, P356, DOI 10.1097/JSM.0b013e31821f5085; GARRAWAY M, 1995, LANCET, V345, P1485; IRFU, 2013, PLAN IR WHIT PAP CRE; Kerr HA, 2008, BRIT J SPORT MED, V42, P595, DOI 10.1136/bjsm.2007.035881; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nicol A, 2011, J PUBLIC HEALTH-UK, V33, P256, DOI 10.1093/pubmed/fdq047; Palmer-Green DS, 2013, AM J SPORT MED, V41, P749, DOI 10.1177/0363546512473818; Rae K, 2007, CLIN J SPORT MED, V17, P201, DOI 10.1097/JSM.0b013e318059b536; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; West S, 2017, ENGL PROF RUGB INJ S; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1; World Rugby, 2017, WORLD RUGB CONC GUID; World Rugby, 2017, WORLD RUGB YEAR REV; Yeomans C, 2018, SPORTS MED, DOI [10.1007/540279-017-0838-4, DOI 10.1007/540279-017-0838-4]	22	12	12	1	12	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	JAN	2019	35						99	105		10.1016/j.ptsp.2018.11.010			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	HI7MB	WOS:000456639200016	30513491				2022-02-06	
J	Ellingson, BM; Yao, JW; Raymond, C; Chakhoyan, A; Khatibi, K; Salamon, N; Villablanca, JP; Wanner, I; Real, CR; Laiwalla, A; McArthur, DL; Monti, MM; Hovda, DA; Vespa, PM				Ellingson, Benjamin M.; Yao, Jingwen; Raymond, Catalina; Chakhoyan, Ararat; Khatibi, Kasra; Salamon, Noriko; Villablanca, J. Pablo; Wanner, Ina; Real, Courtney R.; Laiwalla, Azim; McArthur, David L.; Monti, Martin M.; Hovda, David A.; Vespa, Paul M.			pH-weighted molecular MRI in human traumatic brain injury (TBI) using amine proton chemical exchange saturation transfer echoplanar imaging (CEST EPI)	NEUROIMAGE-CLINICAL			English	Article						CEST; pH imaging; Traumatic brain injury; TBI	CEREBRAL PERFUSION-PRESSURE; METABOLITE RELAXATION-TIMES; GLASGOW-OUTCOME-SCALE; HEAD-INJURY; ACIDOSIS; GLUTAMATE; ACIDS; RAT; HYPERVENTILATION; MICRODIALYSIS	Cerebral acidosis is a consequence of secondary injury mechanisms following traumatic brain injury (FBI), including excitotoxicity and ischemia, with potentially significant clinical implications. However, there remains an unmet clinical need for technology for non-invasive, high resolution pH imaging of human TBI for studying metabolic changes following injury. The current study examined 17 patients with TBI and 20 healthy controls using amine chemical exchange saturation transfer echoplanar imaging (CEST EPI), a novel pH-weighted molecular MR imaging technique, on a clinical 3T MR scanner. Results showed significantly elevated pH-weighted image contrast (MTR asym at 3 ppm) in areas of T2 hyperintensity or edema (P < 0.0001), and a strong negative correlation with Glasgow Coma Scale (GCS) at the time of the MRI exam (R-2 = 0.4777, P = 0.0021), Glasgow Outcome Scale - Extended (GOSE) at 6 months from injury (R-2 = 0.5334, P = 0.0107), and a non-linear correlation with the time from injury to MRI exam (R-2 = 0.6317, P = 0.0004). This evidence suggests clinical feasibility and potential value of pH-weighted amine CEST EPI as a high-resolution imaging tool for identifying tissue most at risk for long-term damage due to cerebral acidosis.	[Ellingson, Benjamin M.; Yao, Jingwen; Raymond, Catalina; Chakhoyan, Ararat] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Ctr Comp Vis & Imaging Biomarkers, Los Angeles, CA 90024 USA; [Raymond, Catalina; Chakhoyan, Ararat; Salamon, Noriko; Villablanca, J. Pablo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90024 USA; [Yao, Jingwen] Univ Calif Los Angeles, Dept Bioengn, Henry Samueli Sch Engn & Appl Sci, Los Angeles, CA 90024 USA; [Ellingson, Benjamin M.; Monti, Martin M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Khatibi, Kasra; Wanner, Ina; Real, Courtney R.; Laiwalla, Azim; McArthur, David L.; Monti, Martin M.; Hovda, David A.; Vespa, Paul M.] Univ Calif Los Angeles, David Geffen Sch Med, UCLA Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA 90024 USA		Ellingson, BM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci & Psychiat, UCLA Brain Tumor Imaging Lab BTIL, 924 Westwood Blvd, Los Angeles, CA 90024 USA.	bellingson@mednet.ucla.edu	Yao, Jingwen/AAS-1724-2021	Yao, Jingwen/0000-0002-8828-1841; Monti, Martin M/0000-0001-5511-3780; Ellingson, Benjamin/0000-0002-2764-6640	American Cancer Society (ACS) Research Scholar GrantAmerican Cancer Society [RSG-15-003-01-CCE]; National Cancer Institute (NCI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [1P50CA211015-01A1, 1R21CA223757-01]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54NS100064]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54NS100064] Funding Source: NIH RePORTER	American Cancer Society (ACS) Research Scholar Grant (RSG-15-003-01-CCE) (Ellingson); National Cancer Institute (NCI) 1R21CA223757-01 (Ellingson); National Institute of Neurological Disorders and Stroke (NINDS) U54NS100064 (Vespa); National Cancer Institute (NCI) 1P50CA211015-01A1 (Ellingson).	Bryant RG, 1996, ANNU REV BIOPH BIOM, V25, P29, DOI 10.1146/annurev.bb.25.060196.000333; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Choi CH, 2006, MAGN RESON MED, V56, P971, DOI 10.1002/mrm.21055; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Folkersma H, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-67; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gupta AK, 2004, J NEUROTRAUM, V21, P678, DOI 10.1089/0897715041269722; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Harris RJ, 2018, MAGN RESON MED, V80, P1962, DOI 10.1002/mrm.27204; Harris RJ, 2016, NMR BIOMED, V29, P1563, DOI 10.1002/nbm.3611; Harris RJ, 2015, NEURO-ONCOLOGY, V17, P1514, DOI 10.1093/neuonc/nov106; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; Hurn P.D., 1996, J INTENSIVE CARE MED, V11, P205, DOI [10.1177/088506669601100403, DOI 10.1177/088506669601100403]; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Jin T, 2014, NMR BIOMED, V27, P1313, DOI 10.1002/nbm.3191; Jin T, 2012, NEUROIMAGE, V59, P1218, DOI 10.1016/j.neuroimage.2011.08.014; Jones CK, 2013, NEUROIMAGE, V77, P114, DOI 10.1016/j.neuroimage.2013.03.047; KALIMO H, 1981, J CEREBR BLOOD F MET, V1, P313, DOI 10.1038/jcbfm.1981.35; Kirkness CJ, 2005, ACTA NEUROCHIR SUPPL, V95, P13; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Li Y, 2008, J MAGN RESON IMAGING, V28, P342, DOI 10.1002/jmri.21453; Liepinsh E, 1996, MAGNET RESON MED, V35, P30, DOI 10.1002/mrm.1910350106; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; McDonald JW, 1998, J NEUROSCI, V18, P6290; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; MELLERGARD P, 1994, ACTA NEUROCHIR, P34; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; NAGY Z, 1985, ACTA NEUROPATHOL, V68, P160, DOI 10.1007/BF00688639; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PERRY TL, 1971, J NEUROCHEM, V18, P521, DOI 10.1111/j.1471-4159.1971.tb11980.x; Prabhakar Hemanshu, 2014, J Anaesthesiol Clin Pharmacol, V30, P318, DOI 10.4103/0970-9185.137260; Sengupta A, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1349-7; Shiogai T, 1999, ACT NEUR S, V75, P49; SIESJO BK, 1993, PROG BRAIN RES, V96, P23; Sun PZ, 2013, PHYS MED BIOL, V58, pN229, DOI 10.1088/0031-9155/58/17/N229; Swanson RA, 1996, DEV NEUROSCI-BASEL, V18, P515, DOI 10.1159/000111448; SWANSON RA, 1995, J CEREBR BLOOD F MET, V15, P417, DOI 10.1038/jcbfm.1995.52; Timofeev I, 2013, J CEREBR BLOOD F MET, V33, P422, DOI 10.1038/jcbfm.2012.186; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Traber F, 2004, J MAGN RESON IMAGING, V19, P537, DOI 10.1002/jmri.20053; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; Wang WZ, 2017, BRAIN BEHAV IMMUN, V64, P344, DOI 10.1016/j.bbi.2017.04.019; Willis C, 2004, COCHRANE DB SYST REV; Woessner DE, 2005, MAGN RESON MED, V53, P790, DOI 10.1002/mrm.20408; Woischneck D, 1998, ACT NEUR S, V71, P138; Wright PJ, 2008, MAGN RESON MATER PHY, V21, P121, DOI 10.1007/s10334-008-0104-8; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yao JW, 2018, TOMOGRAPHY, V4, P123, DOI 10.18383/j.tom.2018.00017; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Ying WH, 1999, J NEUROCHEM, V73, P1549, DOI 10.1046/j.1471-4159.1999.0731549.x; Yokota H, 2000, CRIT CARE MED, V28, P3275, DOI 10.1097/00003246-200009000-00025; Zauner A, 2002, J NEUROSURG, V97, P643, DOI 10.3171/jns.2002.97.3.0643	62	12	12	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2019	22								101736	10.1016/j.nicl.2019.101736			11	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IB2UA	WOS:000470123000084	30826686	Green Published, gold			2022-02-06	
J	He, H; Li, XF; He, YL				He, Hui; Li, Xiufang; He, Yuling			Hyperbaric oxygen therapy attenuates neuronal apoptosis induced by traumatic brain injury via Akt/GSK3 beta/beta-catenin pathway	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						hyperbaric oxygen; TBI; apoptosis; Akt; GSK3 beta; beta-catenin	ACTIVATION; EXPRESSION	Background: Given that the therapeutic effect of hyperbaric oxygen (HBO) therapy on traumatic brain injury (TBI) has been debated for a long time, it is necessary to clarify the mechanism underlying the effect of HBO on acute TBI. Methods: This study investigated the effect of HBO therapy on neuronal apoptosis induced by acute TBI using the mouse model of TBI. The number of apoptotic cells and expression of apoptosis-associated factors (including caspase 3, pAkt/Akt, pGSK3 beta/GSK3 beta, and beta-catenin) in pericontusional cortices of mice exposed to sham, TBI, and TBI + HBO treatment were measured and analyzed using TUNEL assay, quantitative reverse-transcription PCR, and Western blot. Results: Results showed that acute TBI increased the number of apoptotic neurons and mRNA expression and activated caspase 3 protein. With regard to proteins, acute TBI also resulted in decreased levels of pAkt/Akt, pGSK3 beta/GSK3 beta, and beta-catenin, which facilitates neuronal apoptosis. This study shows that HBO therapy reversed these changes of pAkt/Akt, pGSK3 beta/GSK3 beta, and beta-catenin induced by acute TBI and attenuated the apoptotic process in the pericontusional cortex. Conclusion: This study demonstrates the beneficial effect of HBO therapy on neuronal apoptosis caused by acute TBI. Furthermore, the mechanism underlying the therapeutic effect of HBO on acute TBI partly involves the Akt/GSK3 beta/beta-catenin pathway.	[He, Hui; He, Yuling] Zhuji Peoples Hosp Zhejiang Prov, Dept Emergency, 9 Jianmin Rd,Taozhu St, Zhuji 311800, Zhejiang, Peoples R China; [Li, Xiufang] Zhuji Peoples Hosp Zhejiang Prov, Dept Pathol, Zhuji, Zhejiang, Peoples R China		He, YL (corresponding author), Zhuji Peoples Hosp Zhejiang Prov, Dept Emergency, 9 Jianmin Rd,Taozhu St, Zhuji 311800, Zhejiang, Peoples R China.	heyuling198208@163.com					Baratz-Goldstein R, 2017, MOL CELL NEUROSCI, V83, P74, DOI 10.1016/j.mcn.2017.06.004; BENNETT MH, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD004609.PUB3; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Cho JH, 2009, AM J CHINESE MED, V37, P547, DOI 10.1142/S0192415X09007041; Cifu DX, 2014, J REHABIL RES DEV, V51, P1047, DOI 10.1682/JRRD.2014.01.0013; Coe J E, 1966, Am Surg, V32, P493; Dai PP, 2017, CELL PHYSIOL BIOCHEM, V41, P661, DOI 10.1159/000457945; Daly S, 2018, J NEUROTRAUM, V35, P623, DOI 10.1089/neu.2017.5225; Ding Z, 2013, INTERV NEUROL, V2, P201, DOI 10.1159/000362677; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Eve DJ, 2016, NEUROPSYCH DIS TREAT, V12, P2689, DOI 10.2147/NDT.S110126; Godman CA, 2010, ANN NY ACAD SCI, V1197, P178, DOI 10.1111/j.1749-6632.2009.05393.x; Hong Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096212; Hu Q, 2016, MED GAS RES, V6, P102, DOI 10.4103/2045-9912.184720; Liu H, 2016, CELL PHYSIOL BIOCHEM, V38, P2323, DOI 10.1159/000445586; Liu WW, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-13; Lorente L, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7110142; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Senapathi TGA, 2017, OPEN ACCESS EMERG M, V9, P69, DOI 10.2147/OAEM.S144722; Thom SR, 2009, J APPL PHYSIOL, V106, P988, DOI 10.1152/japplphysiol.91004.2008; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Wang F, 2016, NEUROL SCI, V37, P693, DOI 10.1007/s10072-015-2460-2; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Xiang PC, 2018, ACTA CIR BRAS, V33, P341, DOI 10.1590/s0102-865020180040000006; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Yu Z, 2015, CELL MOL NEUROBIOL, V35, P733, DOI 10.1007/s10571-015-0169-7; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025	32	12	12	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1178-2021		NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2019	15						369	374		10.2147/NDT.S183632			6	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	HI7SK	WOS:000456656100003	30774348	Green Published, gold, Green Submitted			2022-02-06	
J	Jang, I; Chun, IY; Brosch, JR; Bari, S; Zou, Y; Cummiskey, BR; Lee, TA; Lycke, RJ; Poole, VN; Shenk, TE; Svaldi, DO; Tamer, GG; Dydak, U; Leverenz, LJ; Nauman, EA; Talavage, TM				Jang, Ikbeom; Chun, Il Yong; Brosch, Jared R.; Bari, Sumra; Zou, Yukai; Cummiskey, Brian R.; Lee, Taylor A.; Lycke, Roy J.; Poole, Victoria N.; Shenk, Trey E.; Svaldi, Diana O.; Tamer, Gregory G., Jr.; Dydak, Ulrike; Leverenz, Larry J.; Nauman, Eric A.; Talavage, Thomas M.			Every hit matters: White matter diffusivity changes in high school football athletes are correlated with repetitive head acceleration event exposure	NEUROIMAGE-CLINICAL			English	Article						Subconcussive injury; Traumatic brain injury; Magnetic resonance imaging; Diffusion-weighted imaging; Diffusion tensor imaging	TRAUMATIC BRAIN-INJURY; DEFAULT MODE NETWORK; AXONAL INJURY; IMPACT EXPOSURE; FUNCTIONAL CONNECTIVITY; CHOLINE METABOLITES; COMPRESSION COLLAR; WATER DIFFUSION; SINGLE SEASON; SPORTS	Recent evidence of short-term alterations in brain physiology associated with repeated exposure to moderate intensity subconcussive head acceleration events (HAEs), prompts the question whether these alterations represent an underlying neural injury. A retrospective analysis combining counts of experienced HAEs and longitudinal diffusion-weighted imaging explored whether greater exposure to incident mechanical forces was associated with traditional diffusion-based measures of neural injury-reduced fractional anisotropy (FA) and increased mean diffusivity (MD). Brains of high school athletes (N = 61) participating in American football exhibited greater spatial extents (or volumes) experiencing substantial changes (increases and decreases) in both FA and MD than brains of peers who do not participate in collision-based sports (N = 15). Further, the spatial extents of the football athlete brain exhibiting traditional diffusion-based markers of neural injury were found to be significantly correlated with the cumulative exposure to HAEs having peak translational acceleration exceeding 20 g. This finding demonstrates that subconcussive HAEs induce low-level neurotrauma, with prolonged exposure producing greater accumulation of neural damage. The duration and extent of recovery associated with periods in which athletes do not experience subconcussive HAEs now represents a priority for future study, such that appropriate participation and training schedules may be developed to minimize the risk of long-term neurological dysfunction.	[Jang, Ikbeom; Chun, Il Yong; Bari, Sumra; Shenk, Trey E.; Talavage, Thomas M.] Purdue Univ, Sch Elect & Comp Engn, 465 Northwestern Ave, W Lafayette, IN 47907 USA; [Brosch, Jared R.] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN 46202 USA; [Zou, Yukai; Lycke, Roy J.; Poole, Victoria N.; Svaldi, Diana O.; Tamer, Gregory G., Jr.; Nauman, Eric A.; Talavage, Thomas M.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Zou, Yukai] Purdue Univ, Coll Vet Med, W Lafayette, IN 47907 USA; [Cummiskey, Brian R.; Lee, Taylor A.; Nauman, Eric A.] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Dydak, Ulrike] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA; [Leverenz, Larry J.] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA; [Nauman, Eric A.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA		Jang, I (corresponding author), Purdue Univ, Sch Elect & Comp Engn, 465 Northwestern Ave, W Lafayette, IN 47907 USA.	jibikbam@gmail.com	Zou, Yukai/AAX-4642-2021; Chun, Il Yong/AAL-2113-2021	Zou, Yukai/0000-0002-9924-5926; Chun, Il Yong/0000-0002-4226-3760; Poole, Victoria/0000-0003-0974-2564; Lee, Taylor/0000-0001-9218-9194; Talavage, Thomas/0000-0003-4977-6398	Purdue Research Foundation, United States; Indiana Clinical and Translational Sciences Institute Spinal Cord and Brain Injury Research Fund, United States, (SCBI) [207-5, 207-32]; Indiana Clinical and Translational Sciences Institute, United States; BrainScope Company, United States (GE-NFL Head Health Initiative); NVIDIA Corporation	The authors thank Dr. Evan L. Breedlove for his assistance in supervising some of the head acceleration event monitoring. This work was funded in part by grants from the Purdue Research Foundation, United States, the Indiana Clinical and Translational Sciences Institute Spinal Cord and Brain Injury Research Fund, United States, (SCBI #207-5 and #207-32), a Core Facilities Grant from the Indiana Clinical and Translational Sciences Institute, United States, and the BrainScope Company, United States (as part of a grant from the GE-NFL Head Health Initiative). The authors also gratefully acknowledge the support of NVIDIA Corporation with the donation of the Titan Xp GPU used for image processing in this research.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Andersson J.L.R., 2007, TECH REP; Andersson JLR, 2016, NEUROIMAGE, V141, P556, DOI 10.1016/j.neuroimage.2016.06.058; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Babb SM, 2004, PSYCHIAT RES-NEUROIM, V130, P1, DOI 10.1016/S0925-4927(03)00104-5; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bari S., 2018, BRAIN IMAGING BEHAV, P1; Barkovich AJ, 2000, AM J NEURORADIOL, V21, P1099; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2009, ARCH PHYS MED REHAB, V90, P145, DOI 10.1016/j.apmr.2008.06.025; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dechent P, 1999, AM J PHYSIOL-REG I, V277, pR698, DOI 10.1152/ajpregu.1999.277.3.R698; Gajawelli N, 2013, WORLD NEUROSURG, V80, P824, DOI 10.1016/j.wneu.2013.10.020; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Giza CC, 2017, NEURON, V94, P1051, DOI 10.1016/j.neuron.2017.05.003; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Glantz SA, 2012, PRIMER BIOSTATISTICS; Gong NJ, 2018, NEUROBIOL DIS, V119, P79, DOI 10.1016/j.nbd.2018.07.020; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kantarci K, 2017, NEUROBIOL AGING, V56, P172, DOI 10.1016/j.neurobiolaging.2017.04.024; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuzminski SJ, 2018, AM J NEURORADIOL, V39, P245, DOI 10.3174/ajnr.A5489; Lancaster JL, 2003, J MAGN RESON IMAGING, V17, P1, DOI 10.1002/jmri.10230; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Maddock RJ, 2011, NEUROIMAGE, V57, P1324, DOI 10.1016/j.neuroimage.2011.05.048; Magnoni S, 2015, BRAIN, V138, P2263, DOI 10.1093/brain/awv152; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mori S, 2005, MRI ATLAS HUMAN WHIT; Mori S., 2013, INTRO DIFFUSION TENS; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Myer G.D., 2018, BRIT J SPORT MED, P1; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Pan J, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15607; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Shenk TE, 2015, DEV NEUROPSYCHOL, V40, P63, DOI 10.1080/87565641.2015.1014088; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Simmonds DJ, 2014, NEUROIMAGE, V92, P356, DOI 10.1016/j.neuroimage.2013.12.044; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sotak CH, 2004, NEUROCHEM INT, V45, P569, DOI 10.1016/j.neuint.2003.11.010; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Sundman M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00334; Svaldi D.O., 2018, BRAIN IMAGING BEHAV, P1; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; Talavage TM, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00273; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tan J, 1998, MAGN RESON MED, V39, P1005, DOI 10.1002/mrm.1910390619; Wieshmann UC, 1999, MAGN RESON IMAGING, V17, P1269, DOI 10.1016/S0730-725X(99)00082-X; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yuan WH, 2018, HUM BRAIN MAPP, V39, P491, DOI 10.1002/hbm.23859	111	12	12	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2019	24								101930	10.1016/j.nicl.2019.101930			16	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY8MY	WOS:000504663800060	31630026	gold, Green Published			2022-02-06	
J	Kim, JH; Hwang, SY; Kwon, TH; Chong, K; Yoon, WK; Kim, JH				Kim, Jang Hun; Hwang, Soon-Young; Kwon, Taek-Hyun; Chong, Kyuha; Yoon, Won-Ki; Kim, Jong Hyun			Defining "early" cranioplasty to achieve lower complication rates of bone flap failure: resorption and infection	ACTA NEUROCHIRURGICA			English	Article						Bone flap resorption; Cranioplasty; Early cranioplasty; Surgical site infection; Optimal timing	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; RISK-FACTORS; SERIES	BackgroundAlthough cranioplasty (CP) is a frequently performed and simple procedure, complications are common, particularly bone flap resorption and infection. The timing of surgery is as an important contributory factor, but the optimal timing has not been clearly determined.ObjectiveWe retrospectively investigated bone flap resorption and surgical site infection after CP to determine the optimal timing of surgery for reduction of complications.MethodsThe study enrolled 126 patients who underwent decompressive craniectomy (DC) and subsequent CP. Patients with bone flap resorption or surgical site infection were analyzed as the complication group. Receiver operating characteristic curve analysis was performed and the Youden index was used to dichotomize early CP and late CP groups. Univariate and multivariate survival analyses were performed.ResultsThe complication group included 42 patients. The Youden index was used to identify a cutoff value for the DC-CP interval of >44days, and this was used to define early (<45days) and late (45days) CP. Late CP was a significant risk factor in univariate and multivariate Cox regression analyses.ConclusionThis study showed that early CP before 45days after DC is associated with a lower rate of bone flap resorption and surgical site infection than late CP.	[Kim, Jang Hun; Kwon, Taek-Hyun; Chong, Kyuha; Yoon, Won-Ki; Kim, Jong Hyun] Korea Univ, Coll Med, Guro Hosp, Dept Neurosurg, Seoul, South Korea; [Kim, Jang Hun] Korea Univ, Coll Med, Guro Hosp, Focused Training Ctr Trauma, Seoul, South Korea; [Hwang, Soon-Young] Korea Univ, Coll Med, Med Sci Res Ctr, Biostat Consulting Lab, Seoul, South Korea		Kim, JH (corresponding author), Korea Univ, Coll Med, Guro Hosp, Dept Neurosurg, Seoul, South Korea.	jhkimns@gmail.com		Kim, Jang Hun/0000-0001-8557-1627; Hwang, Soon Young/0000-0001-7474-1803; Chong, Kyuha/0000-0003-2501-0400	Korea University Grant	This was supported by Korea University Grant.	Artico M, 2003, SURG NEUROL, V60, P71, DOI 10.1016/S0090-3019(03)00031-4; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Brommeland T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0155-6; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Fan MC, 2018, WORLD NEUROSURG, V109, pE853, DOI 10.1016/j.wneu.2017.10.112; Halani SH, 2017, NEUROSURGERY, V81, P204, DOI 10.1093/neuros/nyx054; Hng D, 2015, CRANIOMAX TRAUM REC, V8, P190, DOI 10.1055/s-0034-1395383; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Kim Ji Sang, 2015, Korean J Neurotrauma, V11, P1, DOI 10.13004/kjnt.2015.11.1.1; Lu Y, 2012, BRIT J NEUROSURG, V26, P216, DOI 10.3109/02688697.2011.629699; Malcolm JG, 2016, J CLIN NEUROSCI, V33, P39, DOI 10.1016/j.jocn.2016.04.017; Marion DW, 2006, NEUROSURGERY, V58, P655; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Morton RP, 2018, J NEUROSURG, V128, P1648, DOI 10.3171/2016.11.JNS161917; Paredes I, 2015, NEUROCIRUGIA, V26, P115, DOI 10.1016/j.neucir.2014.10.001; Piedra Mark P, 2014, Surg Neurol Int, V5, P25, DOI 10.4103/2152-7806.127762; Piedra MP, 2012, J NEUROSURG-PEDIATR, V10, P268, DOI 10.3171/2012.6.PEDS1268; Quah BL, 2016, WORLD NEUROSURG, V94, P13, DOI 10.1016/j.wneu.2016.06.081; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Schoekler B, 2014, CLIN NEUROL NEUROSUR, V120, P64, DOI 10.1016/j.clineuro.2014.02.014; Schuss P, 2013, J NEUROTRAUM, V30, P91, DOI 10.1089/neu.2012.2542; Stieglitz LH, 2015, ACTA NEUROCHIR, V157, P275, DOI 10.1007/s00701-014-2310-7; Tsang ACO, 2015, J CLIN NEUROSCI, V22, P834, DOI 10.1016/j.jocn.2014.11.021; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; Yang NR, 2018, WORLD NEUROSURG, V110, pE160, DOI 10.1016/j.wneu.2017.10.117	26	12	13	1	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JAN	2019	161	1					25	31		10.1007/s00701-018-3749-8			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HH2SH	WOS:000455568300008	30511143				2022-02-06	
J	Lempke, L; Jaffri, A; Erdman, N				Lempke, Landon; Jaffri, Abbis; Erdman, Nicholas			The Effects of Early Physical Activity Compared to Early Physical Rest on Concussion Symptoms	JOURNAL OF SPORT REHABILITATION			English	Article						traumatic brain injury; rehabilitation; recovery; return to play; brain concussion	ASSOCIATION	Clinical Scenario: Currently, rest following concussion serves as the keystone of concussion treatment, but substantial evidence to support it is lacking. Recent literature suggests that early physical activity may be beneficial in reducing concussion symptoms which may influence clinical recovery time. Clinical Question: Does early physical activity decrease postconcussion symptoms compared to physical rest following concussion? Summary of Key Findings: A total of 5 articles were included that examined symptom duration changes at multiple time points. All 5 studies utilized follow-up time points compared to initial examination, but there was variance in the specific time points reported. Two studies employed control groups and compared strict or recommended rest to early activity or limited rest. Three studies were observational studies that directly compared baseline measurements to follow-up assessments. Clinical Bottom Line: Current evidence suggests that early physical activity in the acute phase following a concussion may decrease the time needed for symptom resolution compared to immediate rest. Strength of Recommendation: Using Centre for Evidence-Based Medicine 2011 level 3 evidence and higher, the results suggest that early physical activity during the acute phase of a concussion may decrease symptom duration; however, a lack of high-quality studies and inconsistent interventions are limitations to this recommendation.	[Lempke, Landon; Jaffri, Abbis; Erdman, Nicholas] Univ Virginia, Charlottesville, VA 22902 USA; [Lempke, Landon] Univ Georgia, Athens, GA 30602 USA		Lempke, L (corresponding author), Univ Virginia, Charlottesville, VA 22902 USA.; Lempke, L (corresponding author), Univ Georgia, Athens, GA 30602 USA.	lblempke@uga.edu	Lempke, Landon/C-4800-2018; Erdman, Nicholas/ABA-4554-2020	Lempke, Landon/0000-0003-0007-1362; Erdman, Nicholas/0000-0001-8109-7585			Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod TCV, 2017, J ATHL TRAINING, V52, P262, DOI 10.4085/1052-6050-51.6.06; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966	10	12	12	2	13	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	JAN	2019	28	1					99	105		10.1123/jsr.2017-0217			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	HI8SR	WOS:000456726700016	28952910	Bronze			2022-02-06	
J	Regasa, LE; Agimi, Y; Stout, KC				Regasa, Lemma Ebssa; Agimi, Yll; Stout, Katharine C.			Traumatic Brain Injury Following Military Deployment: Evaluation of Diagnosis and Cause of Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						blast; cause of injury; delayed diagnosis; deployment; motor vehicle; parachuting; record review; TBI; traumatic brain injury	US MILITARY; PREVALENCE	Objective: To evaluate the prevalence of delayed traumatic brain injury (TBI) diagnosis and cause of injury that resulted in a TBI diagnosis after military deployment. Design: Medical record notes were reviewed in 2016 from a random sample of 1150 US military service members who had their first-time deployment in 2011 and likely sustained a TBI. Location and cause of the injury were extracted from the progress note for analysis. Participants and Setting: Active-duty US military service members who received an International Classification of Diseases, Ninth Revision code for a TBI diagnosis in a military facility. Main Outcome Measures: Presence of TBI, location of injury, cause of injury, and time of diagnosis with respect to deployment. Results: The odds of being diagnosed with a deployment-related TBI were 8 times higher during the first 4 weeks upon return from deployment than the subsequent 32 weeks. The likelihood of diagnosing a deployment-sustained TBI during weeks 5 to 32 was 2 times higher than during 33 to 76 weeks following return from deployment. The proportion of deployment-related TBI diagnoses decreased with time following return from deployment but remained above 40% during weeks 33 to 76. Service branch, gender, race, occupation, and time between TBI diagnosis and return from deployment were significant predictors of deployment-related TBIs. Moving motor vehicle, sports, parachute, and being struck by objects were the top causes of injury in garrison (nondeployed setting), whereas blast produced the majority (66%) of all causes of injuries that resulted in a TBI in the deployed setting. Conclusion: The increased incidence rate of a TBI diagnosis following deployment can be attributed to delayed diagnosis of TBI sustained from injuries during deployment. TBIs sustained during deployment can be diagnosed beyond the initial 4 weeks after return from deployment and may continue up to 76 weeks following return from deployment.	[Regasa, Lemma Ebssa; Agimi, Yll; Stout, Katharine C.] DVBIC, 1335 East West Hwy,Ste 400, Silver Spring, MD 20910 USA; [Regasa, Lemma Ebssa] GDIT, Fairfax, VA USA; [Agimi, Yll] Informat Innovators Inc, Springfield, VA USA		Regasa, LE (corresponding author), DVBIC, 1335 East West Hwy,Ste 400, Silver Spring, MD 20910 USA.	lemma.regasa.ctr@mail.mil	AGIMI, YLL/AAL-9337-2021		Defense and Veterans Brain Injury Center (DVBIC)US Department of Veterans Affairs	This material was supported by Defense and Veterans Brain Injury Center (DVBIC). No outside sources contributed to the funding of this study. The authors gratefully acknowledge medical record review efforts provided by Dr Michael Thomas and teams of the Office of Surveillance at DVBIC. Comments provided by colleagues at DVBIC and participants during the DVBIC Journal Club presentation in improving the earlier version of this article are also acknowledged.	Amoroso PJ, 2000, AM J PREV MED, V18, P164, DOI 10.1016/S0749-3797(99)00176-2; [Anonymous], 2013, MSMR, V20, P9; Armed Forces Health Surveillance Branch, 2015, DEF DAT AN HLTH REP; Brundage John F, 2015, MSMR, V22, P2; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Faul M, 2010, TRAUMATIC BRAIN INJU; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Hyatt K, 2014, MIL MED, V179, P849, DOI 10.7205/MILMED-D-13-00526; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Regasa LE, 2016, J HEAD TRAUMA REHAB, V31, pE28, DOI 10.1097/HTR.0000000000000155; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; US Congress, 2006, J WARN NAT DEF AUTH; Viera AJ, 2005, FAM MED, V37, P360; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	16	12	14	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2019	34	1			SI		21	29		10.1097/HTR.0000000000000417			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HK0FH	WOS:000457573600007	30045222				2022-02-06	
J	Tan, XL; Sun, MJ; Brady, RD; Liu, SJ; Llanos, R; Cheung, S; Wright, DK; Casillas-Espinosa, PM; Sashindranath, M; O'Brien, TJ; McDonald, SJ; Turner, BJ; Shultz, SR				Tan, Xin Lin; Sun, Mujun; Brady, Rhys D.; Liu, Shijie; Llanos, Roxana; Cheung, Steve; Wright, David K.; Casillas-Espinosa, Pablo M.; Sashindranath, Maithili; O'Brien, Terence J.; McDonald, Stuart J.; Turner, Bradley J.; Shultz, Sandy R.			Transactive Response DNA-Binding Protein 43 Abnormalities after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						amyotrophic lateral sclerosis; chronic traumatic encephalopathy; concussion; fluid percussion injury; proteinopathy	FRONTOTEMPORAL LOBAR DEGENERATION; SODIUM SELENATE; HYPERPHOSPHORYLATED TAU; CYTOPLASMIC INCLUSIONS; OXIDATIVE STRESS; PHOSPHATASE 2A; MOUSE MODEL; TDP-43; PHOSPHORYLATION; NEUROINFLAMMATION	Initial studies have found some evidence for transactive response DNA-binding protein 43 (TDP-43) abnormalities after traumatic brain injury (TBI), and the presence of protein inclusions consisting of TDP-43 are a pathological hallmark of amyotrophic lateral sclerosis (ALS), a condition associated with TBI. However, no study has characterized changes in TDP-43 phosphorylation, mislocalization, and fragmentation (i.e., abnormalities linked to hallmark TDP-43 pathology) after TBI, and how these relate to functional outcomes. Further, how TBI affects an individual with a known predisposition to TDP-43 pathology is unknown. Therefore, this study examined the effects of TBI on TDP-43 post-translational processing, localization, and behavioral outcomes in wild-type (WT) mice and mutant TDP-43(A315T) mice (i.e., mice predisposed to TDP-43 pathology) at 24 h and 1 week after TBI. Post-mortem brain tissue from human patients with acute TBI was also examined. Western blots found that WT mice given TBI had increased TDP-43 phosphorylation, mislocalization, and fragmentation compared with sham-injured WT mice. The TDP-43(A315T) mice given a TBI had exacerbated TDP-43 abnormalities, worse cell death, and cognitive deficits compared with all other groups. In the human TBI patients, the only significant finding was increased nuclear accumulation of phosphorylated TDP-43 fragments. The discrepancy between the robust mouse findings and the largely non-significant human findings may be due to factors including heterogeneity in clinical TBI, the small group sizes, and temporal complexities with TDP-43 abnormalities. These findings indicate that TBI can induce a number of TDP-43 abnormalities that may contribute to the neurological consequences of TBI, though further research is still needed.	[Tan, Xin Lin; Sun, Mujun; Brady, Rhys D.; Casillas-Espinosa, Pablo M.; O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [Brady, Rhys D.; Liu, Shijie; Wright, David K.; Casillas-Espinosa, Pablo M.; O'Brien, Terence J.; Shultz, Sandy R.] Monash Univ, Dept Neurosci, Melbourne, Vic, Australia; [Sashindranath, Maithili] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic, Australia; [Llanos, Roxana; Cheung, Steve] Deakin Univ, Life & Environm Sci, Burwood, Vic, Australia; [McDonald, Stuart J.] La Trobe Univ, Physiol Anat & Microbiol, Bundoora, Vic, Australia; [Turner, Bradley J.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia		Shultz, SR (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic 3004, Australia.; Shultz, SR (corresponding author), Monash Univ, Cent Clin Sch, Dept Med, Melbourne, Vic 3004, Australia.	sandy.shultz@monash.edu	O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021; Sashindranath, Maithili/AAI-7408-2021	Sashindranath, Maithili/0000-0002-9712-4784; McDonald, Stuart/0000-0001-5190-3179			Arai T, 2010, NEUROPATHOLOGY, V30, P170, DOI 10.1111/j.1440-1789.2009.01089.x; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Buratti E, 2009, ADV GENET, V66, P1, DOI 10.1016/S0065-2660(09)66001-6; Che MX, 2011, FASEB J, V25, P2344, DOI 10.1096/fj.10-174482; De Marco G, 2011, ACTA NEUROPATHOL, V121, P611, DOI 10.1007/s00401-010-0786-7; Gregory JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031899; Guillemin I, 2005, PROTEOMICS, V5, P35, DOI 10.1002/pmic.200400892; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Iguchi Y, 2012, NEUROBIOL DIS, V45, P862, DOI 10.1016/j.nbd.2011.12.002; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Johnston M.V., 2005, METABOLISM, V7, P61; Johnstone MR, 2018, BRAIN INJURY, V32, P257, DOI 10.1080/02699052.2017.1394492; Kametani F, 2009, BIOCHEM BIOPH RES CO, V382, P405, DOI 10.1016/j.bbrc.2009.03.038; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kim HJ, 2014, NAT GENET, V46, P152, DOI 10.1038/ng.2853; Lee CN, 2012, HONG KONG MED J, V18, P48; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Li Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7183; Liu SJ, 2016, BRAIN, V139, P1919, DOI 10.1093/brain/aww116; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nonaka T, 2016, J BIOL CHEM, V291, P5473, DOI 10.1074/jbc.M115.695379; Perera ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090449; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rohn Troy T, 2009, Int J Physiol Pathophysiol Pharmacol, V1, P25; Rohn TT, 2009, HISTOL HISTOPATHOL, V24, P1081, DOI 10.14670/HH-24.1081; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099; Wang XJ, 2010, NEUROSCI LETT, V469, P112, DOI 10.1016/j.neulet.2009.11.055; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Yamashita T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2303; Yang ZH, 2014, J CEREBR BLOOD F MET, V34, P1444, DOI 10.1038/jcbfm.2014.105; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007	56	12	12	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2019	36	1					87	99		10.1089/neu.2017.5491			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HF0PB	WOS:000453863000008	29901412				2022-02-06	
J	Watson, CG; DeMaster, D; Ewing-Cobbs, L				Watson, Christopher G.; DeMaster, Dana; Ewing-Cobbs, Linda			Graph theory analysis of DTI tractography in children with traumatic injury	NEUROIMAGE-CLINICAL			English	Article						Pediatric; Traumatic injury; Diffusion tensor imaging; Tractography; Graph theory; Connectivity	POSTTRAUMATIC-STRESS-DISORDER; HUMAN CEREBRAL-CORTEX; SURFACE-BASED ANALYSIS; BRAIN-INJURY; WHITE-MATTER; STRUCTURAL CONNECTIVITY; CHILDHOOD MALTREATMENT; FALSE POSITIVES; DIFFUSION MRI; ADOLESCENTS	Objective: To evaluate brai structural connectivity in children with traumatic injury (TI) following a motor vehicle accident using graph theory analysis of DTI tractography data. Methods: DTI scans were acquired on a 3 T Philips scanner from children aged 8-15 years approximately 2 months post-injury. The TI group consisted of children with traumatic brain injury (TBI; n = 44) or extracranial injury (EI; n = 23). Healthy control children (n = 36) were included as an age-matched comparison group. A graph theory approach was applied to DTI tractography data to investigate injury-related differences in connectivity network characteristics. Group differences in structural connectivity evidenced by graph metrics including efficiency, strength, and modularity were assessed using the multi-threshold permutation correction (MTPC) and network-based statistic (NBS) methods. Results: At the global network level, global efficiency and mean network strength were lower, and modularity was higher, in the TBI than in the control group. Similarly, strength was lower and modularity higher when comparing the EI to the control group. At the vertex level, nodal efficiency, vertex strength, and average shortest path length were different between all pairwise comparisons of the three groups. Both nodal efficiency and vertex strength were higher in the control than in the EI group, which in turn were higher than in the TBI group. The opposite between-group relationships were seen with path length. These between-group differences were distributed throughout the brain, in both hemispheres. NBS analysis resulted in a cluster of 22 regions and 21 edges with significantly lower connectivity in the TBI group compared to controls. This cluster predominantly involves the frontal lobe and subcortical gray matter structures in both hemispheres. Conclusions: Graph theory analysis of DTI tractography showed diffuse differences in structural brain network connectivity in children 2 months post-TI. Network differences were consistent with lower network integration and higher segregation in the injured groups compared to healthy controls. Findings suggest that inclusion of trauma-exposed comparison groups in studies of TBI outcome is warranted to better characterize the indirect effect of stress on brain networks.	[Watson, Christopher G.; DeMaster, Dana; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Dept Pediat, Houston, TX 77030 USA		Watson, CG (corresponding author), Univ Texas Hlth Sci Ctr Houston, 6655 Travis St,Suite HMC 10-03, Houston, TX 77030 USA.	Christopher.G.Watson@uth.tmc.edu	Watson, Christopher G./P-5707-2018	Watson, Christopher G./0000-0002-7082-7631	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS046308]; Nicole and Evan Katz Pediatric Neurodevelopmental Fund	This work was funded by the National Institutes of Health grant R01-NS046308. The content is solely the responsibility of the authors and does not necessarily represent the official views of the granting institute. Support was also provided by the Nicole and Evan Katz Pediatric Neurodevelopmental Fund.	Andersson JLR, 2016, NEUROIMAGE, V141, P556, DOI 10.1016/j.neuroimage.2016.06.058; Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andersson JLR, 2015, NEUROIMAGE, V122, P166, DOI 10.1016/j.neuroimage.2015.07.067; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Baker STE, 2015, J NEUROSCI, V35, P9078, DOI 10.1523/JNEUROSCI.5043-14.2015; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baum GL, 2017, CURR BIOL, V27, P1561, DOI 10.1016/j.cub.2017.04.051; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Biederman J, 2002, AM J PSYCHIAT, V159, P36, DOI 10.1176/appi.ajp.159.1.36; Bonekamp D, 2007, NEUROIMAGE, V34, P733, DOI 10.1016/j.neuroimage.2006.09.020; Borse N, 2009, FAM COMMUNITY HEALTH, V32, P189, DOI 10.1097/01.FCH.0000347986.44810.59; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Cao M, 2014, DEV COGN NEUROS-NETH, V7, P76, DOI 10.1016/j.dcn.2013.11.004; Carrion VG, 2007, PEDIATRICS, V119, P509, DOI 10.1542/peds.2006-2028; Choi J, 2012, NEUROIMAGE, V59, P1071, DOI 10.1016/j.neuroimage.2011.09.033; Choi J, 2009, BIOL PSYCHIAT, V65, P227, DOI 10.1016/j.biopsych.2008.06.022; Csardi G., 2006, INTERJOURNAL COMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Reus MA, 2013, NEUROIMAGE, V70, P402, DOI 10.1016/j.neuroimage.2012.12.066; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; DeMaster D, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.832; Dennis EL, 2017, 2017 IEEE 14TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI 2017), P105, DOI 10.1109/ISBI.2017.7950479; Dennis EL, 2013, NEUROIMAGE, V64, P671, DOI 10.1016/j.neuroimage.2012.09.004; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Drakesmith M, 2015, NEUROIMAGE, V118, P313, DOI 10.1016/j.neuroimage.2015.05.011; Ewing-Cobbs L, 2017, PSYCHONEUROENDOCRINO, V84, P66, DOI 10.1016/j.psyneuen.2017.06.003; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Freedman D, 1983, J BUS ECON STAT, V1, P292, DOI DOI 10.2307/1391660; Genc S, 2017, J NEUROTRAUM, V34, P798, DOI 10.1089/neu.2016.4584; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Graham MS, 2016, NEUROIMAGE, V125, P1079, DOI 10.1016/j.neuroimage.2015.11.006; Graves JM, 2015, AM J PUBLIC HEALTH, V105, pE35, DOI 10.2105/AJPH.2015.302744; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hernandez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061892; Holbrook TL, 2005, J TRAUMA, V58, P764, DOI 10.1097/01.TA.0000159247.48547.7D; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Jackowski AP, 2008, PSYCHIAT RES-NEUROIM, V162, P256, DOI 10.1016/j.pscychresns.2007.08.006; Jackowski AP, 2009, PSYCHIAT CLIN NEUROS, V63, P1, DOI 10.1111/j.1440-1819.2008.01906.x; Jbabdi S, 2007, NEUROIMAGE, V37, P116, DOI 10.1016/j.neuroimage.2007.04.039; Jbabdi S, 2012, MAGN RESON MED, V68, P1846, DOI 10.1002/mrm.24204; Juranek J, 2012, BRAIN IMAGING BEHAV, V6, P36, DOI 10.1007/s11682-011-9140-5; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Kolaczyk E. D., 2014, STAT ANAL NETWORK DA, V65; Konigs M, 2017, HUM BRAIN MAPP, V38, P3603, DOI 10.1002/hbm.23614; Langeland W, 2008, NEUROSCI BIOBEHAV R, V32, P161, DOI 10.1016/j.neubiorev.2007.07.002; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Max JE, 1998, J NERV MENT DIS, V186, P589, DOI 10.1097/00005053-199810000-00001; Max JE, 2012, J AM ACAD CHILD PSY, V51, P1208, DOI 10.1016/j.jaac.2012.08.026; McEwen BS, 2016, NEUROPSYCHOPHARMACOL, V41, P3, DOI 10.1038/npp.2015.171; McEwen BS, 2015, NEUROBIOL STRESS, V1, P1, DOI 10.1016/j.ynstr.2014.09.001; Newman M, 2010, NETWORKS INTRO; NEWMAN MEJ, 2004, PHYS REV E 2, V69, DOI DOI 10.1103/PHYSREVE.69.026113; Nooner KB, 2013, J TRAUMA STRESS, V26, P784, DOI 10.1002/jts.21873; Ohashi K, 2017, NEUROIMAGE, V150, P50, DOI 10.1016/j.neuroimage.2017.02.037; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Puetz VB, 2017, HUM BRAIN MAPP, V38, P855, DOI 10.1002/hbm.23423; R Development Core Team, 2012, R LANG ENV STAT COMP; Ryan NP, 2018, PSYCHOL MED, V48, P679, DOI 10.1017/S0033291717002057; Shirtcliff EA, 2008, DEV PSYCHOBIOL, V50, P690, DOI 10.1002/dev.20336; Simmonds DJ, 2014, NEUROIMAGE, V92, P356, DOI 10.1016/j.neuroimage.2013.12.044; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Suo XL, 2017, RADIOLOGY, V282, P826, DOI 10.1148/radiol.2016160907; TEASDALE G, 1974, LANCET, V2, P81; Watson CG, 2018, BRAINGRAPH GRAPH THE; Wierenga LM, 2016, HUM BRAIN MAPP, V37, P717, DOI 10.1002/hbm.23062; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Yu QW, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00228; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zatzick DF, 2008, ARCH PEDIAT ADOL MED, V162, P642, DOI 10.1001/archpedi.162.7.642	85	12	12	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2019	21								101673	10.1016/j.nicl.2019.101673			11	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HN6ZP	WOS:000460337700086	30660661	gold, Green Published			2022-02-06	
J	Zhuang, ZR; Shen, ZW; Chen, YZ; Dai, ZZ; Zhang, XL; Mao, YF; Zhang, BN; Zeng, HY; Chen, PD; Wu, RH				Zhuang, Zerui; Shen, Zhiwei; Chen, Yanzi; Dai, Zhuozhi; Zhang, Xiaolei; Mao, Yifei; Zhang, Bingna; Zeng, Haiyan; Chen, Peidong; Wu, Renhua			Mapping the Changes of Glutamate Using Glutamate Chemical Exchange Saturation Transfer (GluCEST) Technique in a Traumatic Brain Injury Model: A Longitudinal Pilot Study	ACS CHEMICAL NEUROSCIENCE			English	Article						chemical exchange saturation transfer; MRI; glutamate; neuroinflammation; traumatic brain injury	CORTICAL IMPACT INJURY; MOUSE MODEL; NEUROINFLAMMATION; PATHOPHYSIOLOGY; COMPLEMENT; MECHANISMS; CYTOKINES; STRIATUM; NEURONS; PROFILE	Glutamate excitoxicity plays a crucial role in the pathophysiology of traumatic brain injury (TBI) through the initiation of secondary injuries. Glutamate chemical exchange saturation transfer (GluCEST) MRI is a newly developed technique to noninvasively image glutamate in vivo with high sensitivity and spatial resolution. The aim of the present study was to use a rat model of TBI to map changes in brain glutamate distribution and explore the capability of GluCEST imaging for detecting secondary injuries. Sequential GluCEST imaging scans were performed in adult male Sprague-Dawley rats before TBI and at 1, 3, 7, and 14 days after TBI. GluCEST% increased and peaked on day 1 after TBI in the core lesion of injured cortex and peaked on day 3 in the ipsilateral hippocampus, as compared to baseline and controls. GluCEST% gradually declined to baseline by day 14 after TBI. A negative correlation between the GluCEST% of the ipsilateral hippocampus on day 3 and the time in the correct quadrant was observed in injured rats. Immunolabeling for glial fibrillary acidic protein showed significant astrocyte activation in the ipsilateral hippocampus of TBI rats. IL-6 and TNF-alpha in the core lesion peaked on day 1 postinjury, while those in the ipsilateral hippocampus peaked on day 3. These subsequently gradually declined to sham levels by day 14. It was concluded that GluCEST imaging has potential to be a novel neuroimaging approach for predicting cognitive outcome and to better understand neuroinflammation following TBI.	[Zhuang, Zerui] Shantou Univ, Med Coll, Affiliated Hosp 2, Dept Neurosurg, Shantou 515041, Peoples R China; [Shen, Zhiwei; Chen, Yanzi; Dai, Zhuozhi; Zhang, Xiaolei; Mao, Yifei; Chen, Peidong; Wu, Renhua] Shantou Univ, Med Coll, Affiliated Hosp 2, Dept Radiol, 69 North Dongxia Rd, Shantou 515041, Peoples R China; [Zhang, Bingna] Shantou Univ, Med Coll, Affiliated Hosp 2, Translat Med, Shantou 515041, Peoples R China; [Zeng, Haiyan] Shantou Univ, Med Coll, Shantou 515041, Peoples R China		Wu, RH (corresponding author), Shantou Univ, Med Coll, Affiliated Hosp 2, Dept Radiol, 69 North Dongxia Rd, Shantou 515041, Peoples R China.	rhwu@stu.edu.cn	zeng, haiyan/AAQ-3650-2021	Zhang, Xiaolei/0000-0002-5909-5820	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471730]; Education Department Foundation of Guangdong Province [2017KQNCX071]; Science and Technology Planning Project of Shantou City [201718237]	This study was supported in part by grants from the National Natural Science Foundation of China (Grant No. 81471730) for R.W., Education Department Foundation of Guangdong Province (Grant No. 2017KQNCX071) for Z.Z, and Science and Technology Planning Project of Shantou City (Grant No. 201718237) for Z.Z.	Alawieh A, 2018, J NEUROSCI, V38, P2519, DOI 10.1523/JNEUROSCI.2197-17.2018; Amorini AM, 2017, J CELL MOL MED, V21, P530, DOI 10.1111/jcmm.12998; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bagga P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21035-3; Bagga P, 2016, J NEUROCHEM, V139, P432, DOI 10.1111/jnc.13771; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Cai KJ, 2012, NAT MED, V18, P302, DOI 10.1038/nm.2615; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Crescenzi R, 2017, HIPPOCAMPUS, V27, P285, DOI 10.1002/hipo.22693; Crescenzi R, 2014, NEUROIMAGE, V101, P185, DOI 10.1016/j.neuroimage.2014.06.067; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Davis KA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa7095; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; GEORGIEVA J, 1993, BRAIN RES BULL, V31, P463, DOI 10.1016/0361-9230(93)90110-W; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Haris M, 2013, NMR BIOMED, V26, P386, DOI 10.1002/nbm.2875; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Hinzman JM, 2012, J NEUROTRAUM, V29, P1197, DOI 10.1089/neu.2011.2261; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Jin T, 2018, J CEREBR BLOOD F MET, V38, P869, DOI 10.1177/0271678X17707419; Kogan Feliks, 2013, Curr Radiol Rep, V1, P102; Kosaki Y, 2014, HIPPOCAMPUS, V24, P1633, DOI 10.1002/hipo.22343; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marino S, 2011, NEUROCRIT CARE, V14, P127, DOI 10.1007/s12028-010-9406-6; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nandi P, 2009, ANAL CHIM ACTA, V651, P1, DOI 10.1016/j.aca.2009.07.064; Neumann H, 2002, J NEUROSCI, V22, P854, DOI 10.1523/JNEUROSCI.22-03-00854.2002; Pepin J, 2016, NEUROIMAGE, V139, P53, DOI 10.1016/j.neuroimage.2016.06.023; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Roalf DR, 2017, MOL PSYCHIATR, V22, P1298, DOI 10.1038/mp.2016.258; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Tang XY, 2017, ACS CHEM NEUROSCI, V8, P60, DOI 10.1021/acschemneuro.6b00173; Tu TW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19094-z; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang JY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0631-6; Wang WZ, 2017, BRAIN BEHAV IMMUN, V64, P344, DOI 10.1016/j.bbi.2017.04.019; Wu RH, 2012, CONTRAST MEDIA MOL I, V7, P384, DOI 10.1002/cmmi.505; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhang H, 2017, J CEREBR BLOOD F MET, V37, P3422, DOI 10.1177/0271678X17690165; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	59	12	12	1	8	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	JAN	2019	10	1					649	657		10.1021/acschemneuro.8b00482			17	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	HI3LM	WOS:000456351300066	30346712				2022-02-06	
J	Duncan, D; Barisano, G; Cabeen, R; Sepehrband, F; Garner, R; Braimah, A; Vespa, P; Pitkanen, A; Law, M; Toga, AW				Duncan, Dominique; Barisano, Giuseppe; Cabeen, Ryan; Sepehrband, Farshid; Garner, Rachaei; Braimah, Adebayo; Vespa, Paul; Pitkanen, Asia; Law, Meng; Toga, Arthur W.			Analytic Tools for Post-traumatic Epileptogenesis Biomarker Search in Multimodal Dataset of an Animal Model and Human Patients	FRONTIERS IN NEUROINFORMATICS			English	Article						MRI; EEG; epilepsy; epileptogenesis; informatics; neuroimaging; TBI; biomarker	TRAUMATIC BRAIN-INJURY; HIGH-FREQUENCY OSCILLATIONS; DIFFUSION-TENSOR; PERIVASCULAR SPACES; MRI; EEG; STATE; ABNORMALITIES; SEGMENTATION; CONNECTIVITY	Epilepsy is among the most common serious disabling disorders of the brain, and the global burden of epilepsy exerts a tremendous cost to society. Most people with epilepsy have acquired forms of the disorder, and the development of antiepileptogenic interventions could potentially prevent or cure epilepsy in many of them. However, the discovery of potential antiepileptogenic treatments and clinical validation would require a means to identify populations of patients at very high risk for epilepsy after a potential epileptogenic insult, to know when to treat and to document prevention or cure. A fundamental challenge in discovering biomarkers of epileptogenesis is that this process is likely multifactorial and crosses multiple modalities. Investigators must have access to a large number of high quality, well-curated data points and study subjects for biomarker signals to be detectable above the noise inherent in complex phenomena, such as epileptogenesis, traumatic brain injury (TBI), and conditions of data collection. Additionally, data generating and collecting sites are spread worldwide among different laboratories, clinical sites, heterogeneous data types, formats, and across multi-center preclinical trials. Before the data can even be analyzed, these data must be standardized. The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy (EpiBioS4Rx) is a multicenter project with the overarching goal that epileptogenesis after TBI can be prevented with specific treatments. The identification of relevant biomarkers and performance of rigorous preclinical trials will permit the future design and performance of economically feasible full-scale clinical trials of antiepileptogenic therapies. We have been analyzing human data collected from UCLA and rat data collected from the University of Eastern Finland, both centers collecting data for EpiBioS4Rx, to identify biomarkers of epileptogenesis. Big data techniques and rigorous analysis are brought to longitudinal data collected from humans and an animal model of TBI, epilepsy, and their interaction. The prolonged continuous data streams of intracranial, cortical surface, and scalp EEG from humans and an animal model of epilepsy span months. By applying our innovative mathematical tools via supervised and unsupervised learning methods, we are able to subject a robust dataset to recently pioneered data analysis tools and visualize multivariable interactions with novel graphical methods.	[Duncan, Dominique; Barisano, Giuseppe; Cabeen, Ryan; Sepehrband, Farshid; Garner, Rachaei; Braimah, Adebayo; Law, Meng; Toga, Arthur W.] Univ Southern Calif, Keck Sch Med USC, USC Stevens Neuroimaging & Informat Inst, Lab Neuro Imaging, Los Angeles, CA 90007 USA; [Vespa, Paul] Univ Calif Los Angeles, Dept Neurol, Sch Med, Div Neurosurg, Los Angeles, CA 90024 USA; [Pitkanen, Asia] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland		Duncan, D (corresponding author), Univ Southern Calif, Keck Sch Med USC, USC Stevens Neuroimaging & Informat Inst, Lab Neuro Imaging, Los Angeles, CA 90007 USA.	dduncan@loni.usc.edu	ARSLAN, Okan/AAA-3232-2020; Barisano, Giuseppe/AAE-3171-2019; Duncan, Dominique/AAP-9734-2020	Barisano, Giuseppe/0000-0001-5598-1369; Duncan, Dominique/0000-0002-6154-9262; Braimah, Adebayo/0000-0003-1135-9636	National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54NS100064, NIH P41-EB015922, NIH U54-EB020406]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U54EB020406, P41EB015922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U54NS100064] Funding Source: NIH RePORTER	This research was supported by the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) under Award Numbers U54NS100064 (EpiBioS4Rx), NIH P41-EB015922, and NIH U54-EB020406.	Abiega O, 2016, PLOS BIOL, V14, DOI [10.1371/journal.pbio.1002466, 10.1371/journal.pbio.1002508, 10.1371/journal.pbio.1002554]; Asgari M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38635; Bechmann I, 2001, EUR J NEUROSCI, V14, P1651, DOI 10.1046/j.0953-816x.2001.01793.x; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bragin A, 1999, HIPPOCAMPUS, V9, P137; Cabeen RP, 2018, P INT SOC MAGNETIC R, P8882; Cabeen RP, 2017, NEUROIMAGE, V146, P100, DOI 10.1016/j.neuroimage.2016.11.020; Cabeen RP, 2016, NEUROIMAGE, V127, P158, DOI 10.1016/j.neuroimage.2015.11.061; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Coifman RR, 2006, APPL COMPUT HARMON A, V21, P5, DOI 10.1016/j.acha.2006.04.006; Corraliza I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00262; DALESSANDRO R, 1982, J NEUROL NEUROSUR PS, V45, P1153, DOI 10.1136/jnnp.45.12.1153; DALESSANDRO R, 1988, ARCH NEUROL-CHICAGO, V45, P42, DOI 10.1001/archneur.1988.00520250048019; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Duncan D, 2019, NEUROBIOL DIS, V123, P127, DOI 10.1016/j.nbd.2018.05.026; Duncan D, 2018, DISCRETE CONT DYN-B, V23, P161, DOI 10.3934/dcdsb.2018010; Duncan D, 2016, MATH BIOSCI ENG, V13, P1119, DOI 10.3934/mbe.2016033; Duncan D, 2013, CLIN NEUROPHYSIOL, V124, P1943, DOI 10.1016/j.clinph.2013.03.028; Duncan D, 2013, MATH BIOSCI ENG, V10, P579, DOI 10.3934/mbe.2013.10.579; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Feldman RE, 2018, SEIZURE-EUR J EPILEP, V54, P11, DOI 10.1016/j.seizure.2017.11.004; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Guo D., 2018, P INT C IM PROC ICIP, P4427; Guo DZ, 2015, BMC MED IMAGING, V15, DOI 10.1186/s12880-015-0092-x; Gupta RK, 2005, EPILEPSIA, V46, P1465, DOI 10.1111/j.1528-1167.2005.01205.x; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Immonen R, 2013, J NEUROTRAUM, V30, P1305, DOI 10.1089/neu.2012.2815; Irimia A, 2014, J NEUROSURG SCI, V58, P129; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Jacobs J, 2012, PROG NEUROBIOL, V98, P302, DOI 10.1016/j.pneurobio.2012.03.001; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Labate A, 2008, NEUROLOGY, V71, P1094, DOI 10.1212/01.wnl.0000326898.05099.04; Labate A, 2015, EPILEPSIA, V56, P1109, DOI 10.1111/epi.13027; Liang SF, 2010, EURASIP J ADV SIG PR, DOI 10.1155/2010/853434; Mishra AM, 2011, NEUROSCI LETT, V497, P194, DOI 10.1016/j.neulet.2011.01.076; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Narayana Ponnada A, 2017, Concussion, V2, pCNC35, DOI 10.2217/cnc-2016-0028; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Perucca P, 2019, NEUROBIOL DIS, V123, P69, DOI 10.1016/j.nbd.2018.06.002; Pitkanen A, 2019, NEUROBIOL DIS, V123, P42, DOI 10.1016/j.nbd.2018.05.007; Pustina D, 2016, HUM BRAIN MAPP, V37, P1405, DOI 10.1002/hbm.23110; Ratib O, 2006, INT J COMPUT ASS RAD, V1, P187, DOI 10.1007/s11548-006-0056-2; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sierra-Marcos A, 2015, CLIN NEUROPHYSIOL, V126, P456, DOI 10.1016/j.clinph.2014.06.025; Staba RJ, 2014, NEUROTHERAPEUTICS, V11, P334, DOI 10.1007/s13311-014-0259-0; Talmon R, 2012, IEEE T SIGNAL PROCES, V60, P1159, DOI 10.1109/TSP.2011.2177973; Taoka T, 2017, JPN J RADIOL, V35, P172, DOI 10.1007/s11604-017-0617-z; Tubiv MA, 2019, NEUROBIOL DIS, V123, P115, DOI 10.1016/j.nbd.2018.05.014; van Vliet EA, 2017, EPILEPSIA, V58, P315, DOI 10.1111/epi.13621; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wetter NC, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.440; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Worrell GA, 2011, EPILEPSY CURR, V11, P118, DOI 10.5698/1535-7511-11.4.118; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004; Zhang SW, 2011, NEUROIMAGE, V54, P974, DOI 10.1016/j.neuroimage.2010.09.008; Zijlmans M, 2012, ANN NEUROL, V71, P169, DOI 10.1002/ana.22548	63	12	12	1	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5196			FRONT NEUROINFORM	Front. Neuroinformatics	DEC 20	2018	12								86	10.3389/fninf.2018.00086			13	Mathematical & Computational Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Neurosciences & Neurology	HF1IP	WOS:000453920300001	30618695	Green Published, gold			2022-02-06	
J	Volpi, PC; Robba, C; Rota, M; Vargiolu, A; Citerio, G				Volpi, Paola Cristina; Robba, Chiara; Rota, Matteo; Vargiolu, Alessia; Citerio, Giuseppe			Trajectories of early secondary insults correlate to outcomes of traumatic brain injury: results from a large, single centre, observational study	BMC EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Secondary injuries; Prehospital insults; Trajectory; Outcome	HEAD-INJURY; EPIDEMIOLOGY; MORTALITY; HYPOTENSION; INTUBATION; IMPACT; PREVENTION; GUIDELINES; MANAGEMENT; PROGNOSIS	Background: Secondary insults (SI), such as hypotension, hypoxia, and intracranial hypertension frequently occur after traumatic brain injury (TBI), and have a strong impact on patients' clinical outcomes. The aim of this study is to examine the trajectories of SI from the early phase of injury in the prehospital setting to hospital admission in a cohort of TBI patients. Methods: This is a retrospective, observational, single centre study on consecutive patients admitted from 1997 to 2016 to the Neuro Intensive Care Unit (NICU) at San Gerardo Hospital, in Monza, Italy. Trajectories of SI from the prehospital to hospital settings were defined as "sustained", "resolved", "new event", and "none". Univariate and multivariate logistic regression analyses were performed to correlate SI trajectories to a 6-months outcome. Results: Nine hundred sixty-seven patients were enrolled in the final analysis. About 20% had hypoxic or hypotensive events and 30.7% of patients had pupillary abnormalities. Hypotension and hypoxia were associated with an unfavourable outcome when "sustained" and "resolved", while pupillary abnormalities were associated with a poor outcome when "sustained" and as "new events". After adjusting for confounding factors, 6-month mortality strongly correlated with "sustained" hypotension (OR 11.25, 95% CI, 3.52-35.99), "sustained" pupillary abnormalities (OR 2.8, 95% CI, 1.51-5.2) and "new event" pupillary abnormalities (OR 2.8, 95% CI, 1.16-6.76). Conclusions: After TBI, sustained hypotension and pupillary abnormalities are important determinants for patients' outcomes. Early trajectories define the dynamics of SI and contribute to a better understanding of how early recognition and treatments in emergency settings could impact on 6-month outcomes and mortality.	[Volpi, Paola Cristina; Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Via Cadore 48, I-20900 Monza, MB, Italy; [Robba, Chiara] Univ Cambridge, Addenbrookes Hosp, Neurocrit Care Unit, Cambridge Univ Hosp Trust, Box 1,Hills Rd, Cambridge CB2 0QQ, England; [Robba, Chiara] Policlin San Martino IRCCS Oncol, Anaesthesia & Intens Care, I-16132 Genoa, GE, Italy; [Rota, Matteo] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Vargiolu, Alessia; Citerio, Giuseppe] San Gerardo Hosp, ASST Monza, Neurointens Care Unit, Via GB Pergolesi 33, I-20835 Monza, MB, Italy		Volpi, PC (corresponding author), Univ Milano Bicocca, Sch Med & Surg, Via Cadore 48, I-20900 Monza, MB, Italy.	paolac.volpi@gmail.com	Rota, Matteo/B-7488-2013; Citerio, Giuseppe/B-1839-2015; Robba, Chiara/AAS-7421-2020	Rota, Matteo/0000-0003-3928-5966; Citerio, Giuseppe/0000-0002-5374-3161; 			Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bossers SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141034; Bouras T, 2007, J NEUROTRAUM, V24, P1355, DOI 10.1089/neu.2005.370; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Citerio G, 2000, ACTA NEUROCHIR, V142, P769, DOI 10.1007/s007010070091; Denninghoff KR, 2017, PREHOSP EMERG CARE, V21, P539, DOI 10.1080/10903127.2017.1315201; Depreitere B, 2012, Acta Neurochir Suppl, V114, P289, DOI 10.1007/978-3-7091-0956-4_56; Fletcher AE, 2007, BRAIN INJURY, V21, P691, DOI 10.1080/02699050701426873; Harmsen AMK, 2015, INJURY, V46, P602, DOI 10.1016/j.injury.2015.01.008; JENNETT B, 1975, LANCET, V1, P480; Karamanos E, 2014, PREHOSP DISASTER MED, V29, P32, DOI 10.1017/S1049023X13008947; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Nolan J, 2015, ADULT ADV LIFE SUPPO; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; TEASDALE G, 1974, LANCET, V2, P81; Tramonti F, 2015, PSYCHOL HEALTH MED, V20, P933, DOI 10.1080/13548506.2015.1009380	30	12	12	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-227X			BMC EMERG MED	BMC Emerg. Med.	DEC 5	2018	18								52	10.1186/s12873-018-0197-y			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HF4CX	WOS:000454181900001	30518336	Green Published, gold			2022-02-06	
J	Asken, BM; Bauer, RM; DeKosky, ST; Houck, ZM; Moreno, CC; Jaffee, MS; Dubose, DN; Boone, JK; Weber, AG; Clugston, JR				Asken, Breton M.; Bauer, Russell M.; DeKosky, Steven T.; Houck, Zachary M.; Moreno, Charles C.; Jaffee, Michael S.; Dubose, Dewayne N.; Boone, Jonathan K.; Weber, Arthur G.; Clugston, James R.			Concussion BASICS II Baseline serum biomarkers, head impact exposure, and clinical measures	NEUROLOGY			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; INJURY; RELIABILITY; TAU	Objective To examine the effect of concussion history and cumulative exposure to collision sports on baseline serum biomarker concentrations, as well as associations between biomarker concentrations and clinical assessments. Methods In this observational cohort study, beta-amyloid peptide 42 (A beta(42)), total tau, S100 calcium binding protein B (S100B), ubiquitin carboxy-terminal hydrolyzing enzyme L1 (UCH-L1), glial fibrillary acidic protein, microtubule associated protein 2, and 29,39-cyclic-nucleotide 39phosphodiesterase serum concentrations were measured in 415 (61% male, 40% white, aged 19.0 +/- 1.2 years) nonconcussed collegiate athletes without recent exposure to head impacts. Regression analyses were used to evaluate the relationship between self-reported history of concussion(s), cumulative years playing collision sports, clinical assessments, and baseline biomarker concentrations. Football-specific analyses were performed using a modified Cumulative Head Impact Index. Clinical assessments included symptom, cognitive, balance, and oculomotor tests. Results Athletes with a greater number of concussions had a higher baseline A beta(42) concentration only (rho = 0.140, p = 0.005, small effect size). No biomarker concentrations correlated with cumulative exposure to collision sports. Race status fully mediated the correlations of S100B, UCHL1, and A beta(42) with cognitive scores. Football exposure, specifically, was not associated with serum biomarker concentrations or clinical assessment scores based on the modified Cumulative Head Impact Index. Conclusion Concussion-related serum biomarkers showed no consistent association with concussion history, cumulative exposure to collision sports, or clinical assessments in a sample of healthy collegiate athletes. Serum A beta(42) concentrations could increase following multiple previous concussions. Considering race status is essential when investigating links between biomarkers and cognition. The biomarkers studied may not detect residual effects of concussion or repetitive head impact exposure in otherwise asymptomatic collegiate athletes without recent exposure to head impacts. Much more research is needed for identifying reliable and valid blood biomarkers of brain trauma history.	[Asken, Breton M.; Bauer, Russell M.; Houck, Zachary M.; Moreno, Charles C.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA; [Bauer, Russell M.; DeKosky, Steven T.; Jaffee, Michael S.; Clugston, James R.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Clugston, James R.] Univ Florida, Dept Community Hlth & Family Med, Gainesville, FL USA; [Dubose, Dewayne N.; Boone, Jonathan K.; Clugston, James R.] Univ Florida, Univ Athlet Assoc, Gainesville, FL USA; [Weber, Arthur G.] Banyan Biomarkers Inc, Alachua, FL USA		Asken, BM (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA.	basken8@phhp.ufl.edu		DeKosky, Steven/0000-0003-3743-2758; Clugston, James/0000-0002-2103-1039; Asken, Breton/0000-0001-8419-142X	GE; NFL; Banyan Biomarkers, Inc.; U.S. Army Medical Research and Material Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-06-1-0517]; University of FloridaUniversity of Florida	This work was primarily supported by funds provided in a grant from the Head Health Initiative, a collaboration between GE and the NFL, Banyan Biomarkers, Inc., and the U.S. Army Medical Research and Material Command (USAMRMC) under contract W81XWH-06-1-0517. The University of Florida owns stock in Banyan Biomarkers, Inc., which is the sponsor of the study. In addition, the university has licensed technology to Banyan concerning blood biomarkers or proteins thereby allowing Banyan to use the technology. The company is interested in making a biomarker test for traumatic brain injury. If the biomarker test is sold commercially, then the University of Florida could benefit financially. Please feel free to ask any further questions you might have about this matter.	Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Asken BM, 2018, NEUROLOGY, V91, pE2109, DOI 10.1212/WNL.0000000000006613; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Asken BM, 2016, NEUROPSYCHOL REV, V26, P340, DOI 10.1007/s11065-016-9327-z; DeKosky ST, 2017, BRAIN INJURY, V31, P1177, DOI 10.1080/02699052.2017.1312528; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Houck Z, 2018, J INT NEUROPSYCH SOC, V24, P1, DOI 10.1017/S1355617717000716; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; O'Connor KL, MIL MED; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Papa L, 2017, J NEUROTRAUM, V34, P2187, DOI 10.1089/neu.2017.5030; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Zetterberg H, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.037143; Zetterberg H, 2009, BRAIN INJURY, V23, P723, DOI 10.1080/02699050903120399	23	12	12	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	DEC 4	2018	91	23					E2123	E2132		10.1212/WNL.0000000000006616			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK3XY	WOS:000457854000002	30404782	Green Published			2022-02-06	
J	Asken, BM; Bauer, RM; DeKosky, ST; Svingos, AM; Hromas, G; Boone, JK; DuBose, DN; Hayes, RL; Clugston, JR				Asken, Breton M.; Bauer, Russell M.; DeKosky, Steven T.; Svingos, Adrian M.; Hromas, Gabrielle; Boone, Jonathan K.; DuBose, Dewayne N.; Hayes, Ronald L.; Clugston, James R.			Concussion BASICS III Serum biomarker changes following sport-related concussion	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; BLOOD BIOMARKERS; S100B; MILD; RELIABILITY; ZURICH; TAU	Objective To evaluate changes in serum biomarker concentrations (beta-amyloid peptide 42 [A beta(42)], total tau, ubiquitin carboxy-terminal hydrolyzing enzyme L1, S100 calcium binding protein B [S100B], glial fibrillary acidic protein [GFAP], microtubule associated protein 2 [MAP2], and 2',3'-cyclic-nucleotide 3'-phosphodiesterase [CNPase]) after sport-related concussion (SRC) in a sample of collegiate athletes. Associations with clinical outcomes were also investigated. Methods Participants in this case-control study included 36 athletes (50% male, 61% white, aged 19.7 +/- 1.0 years) with SRC. Twenty-nine also had baseline blood drawn, allowing for within-patient analyses of concentration changes. Between-group analyses incorporated 86 demographically matched controls (51% male, 63% white, aged 19.6 +/- 1.1 years). Biomarker sensitivity/specificity for SRC vs controls and relative to standardized normative cutoffs was evaluated (receiver operating characteristics). We also analyzed associations between post-SRC clinical outcomes and both biomarker change from baseline and post-SRC concentrations. Results The majority of blood samples had concentrations of GFAP, MAP2, and CNPase below limits of quantification. Within-patient analyses indicated elevated S100B after SRC (p = 0.003, 67% of patients elevated), especially for blood samples collected <4 hours post-SRC (88% of patients). Significant between-group differences were limited to blood draws <4 hours post-SRC: A beta(42) (81% of SRC > control median, area under the curve [AUC] = 0.75 [95% confidence interval 0.59-0.91]), total tau (75% SRC > control, AUC = 0.74 [0.56-0.79]), and S100B (88% SRC > control; AUC [specific to white race] = 0.82 [0.72-0.93]). Using standardized normative cutoffs (z > 1.0), specificity ranged from 79.1% to 89.3% while sensitivity was <70%. Biomarkers were not associated with clinical outcomes. Conclusion For SRC, diagnostic accuracy of serum biomarkers appears best if blood is collected within a few hours. Accurate blood marker identification of SRC appears somewhat dependent on the "healthy" comparison. Additional research must evaluate whether physiologic changes in the absence of clinical changes, or vice versa, are relevant for concurrent or future neurologic health. Classification of evidence This study provides Class III evidence that certain serum biomarkers are elevated from baseline and higher than demographically matched controls after sport-related concussion.	[Asken, Breton M.; Bauer, Russell M.; Svingos, Adrian M.; Hromas, Gabrielle] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA; [Bauer, Russell M.; DeKosky, Steven T.; Clugston, James R.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Clugston, James R.] Univ Florida, Dept Community Hlth & Family Med, Gainesville, FL USA; [Boone, Jonathan K.; DuBose, Dewayne N.; Clugston, James R.] Univ Florida, Univ Athlet Assoc, Gainesville, FL USA; [Hayes, Ronald L.] Banyan Biomarkers Inc, Alachua, FL USA		Asken, BM (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA.	basken8@phhp.ufl.edu		Clugston, James/0000-0002-2103-1039; Asken, Breton/0000-0001-8419-142X; DeKosky, Steven/0000-0003-3743-2758	NFL; GE; Banyan Biomarkers, Inc.; U.S. Army Medical Research and Material Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-06-1-0517]; University of FloridaUniversity of Florida	This work was primarily supported by funds provided in a grant from the Head Health Initiative, a collaboration between GE and the NFL, Banyan Biomarkers, Inc., and the U.S. Army Medical Research and Material Command (USAMRMC) under contract W81XWH-06-1-0517. The University of Florida owns stock in Banyan Biomarkers, Inc., which is the sponsor of the study. In addition, the university has licensed technology to Banyan concerning blood biomarkers or proteins thereby allowing Banyan to use the technology. The company is interested in making a biomarker test for traumatic brain injury. If the biomarker test is sold commercially, then the University of Florida could benefit financially. Please feel free to ask any further questions you might have about this matter.	Asken BM, 2018, NEUROLOGY, V91, pE2109, DOI 10.1212/WNL.0000000000006613; Asken BM, 2018, NEUROLOGY, V91, pE2123, DOI 10.1212/WNL.0000000000006616; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Bouvier D, 2017, SPORTS MED, V47, P781, DOI 10.1007/s40279-016-0579-9; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2016, BRIT J SPORT MED, V2017, P838, DOI DOI 10.1136/BJSP0RTS-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2017, J NEUROTRAUM, V34, P3134, DOI 10.1089/neu.2017.5046; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Papa L., 2015, BRAIN NEUROTRAUMA MO; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Scaccianoce S, 2004, BRAIN RES, V1004, P208, DOI 10.1016/j.brainres.2004.01.028; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089	29	12	12	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	DEC 4	2018	91	23					E2133	E2143		10.1212/WNL.0000000000006617			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK3XY	WOS:000457854000003	30404786				2022-02-06	
J	Carlson, SW; Dixon, CE				Carlson, Shaun W.; Dixon, C. Edward			Lithium Improves Dopamine Neurotransmission and Increases Dopaminergic Protein Abundance in the Striatum after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						alpha synuclein; dopamine; neurotransmission; SNARE; striatum; traumatic brain injury	CONTROLLED CORTICAL IMPACT; GLYCOGEN-SYNTHASE KINASE-3-BETA; TYROSINE-HYDROXYLASE PHOSPHORYLATION; SYNAPTIC VESICLE DOCKING; CYSTEINE STRING PROTEIN; WATER MAZE PERFORMANCE; REDUCED EVOKED RELEASE; ALPHA-SYNUCLEIN; CSP-ALPHA; IN-VIVO	Experimental models of traumatic brain injury (TBI) recapitulate secondary injury sequela and cognitive dysfunction reported in patients afflicted with a TBI. Impairments in neurotransmission are reported in multiple brain regions in the weeks following experimental TBI and may contribute to behavioral dysfunction. Formation of the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex is an important mechanism for neurotransmitter exocytosis. We previously showed that lithium treatment attenuated hippocampal decreases in alpha-synuclein and VAMP2, enhanced SNARE complex formation, and improved cognitive performance after TBI. However, the effect of TBI on striatal SNARE complex formation is not known. We hypothesized lithium treatment would attenuate TBI-induced impairments in evoked dopamine release and increase the abundance of synaptic proteins associated with dopamine neurotransmission. The current study evaluated the effect of lithium (1 mmol/kg/day) administration on striatal evoked dopamine neurotransmission, SNARE complex formation, and proposed actions of lithium, including inhibition of GSK3 beta, assessment of synaptic marker protein abundance, and synaptic proteins important for dopamine synthesis and transport following controlled cortical impact (CCI). Sprague-Dawley rats were subjected to CCI or sham injury and treated daily with lithium chloride or vehicle for 7 days post-injury. We provide novel evidence that CCI reduces SNARE protein and SNARE complex abundance in the striatum at 1 week post-injury. Lithium administration improved evoked dopamine release and increased the abundance of alpha-synuclein, D2 receptor, and phosphorylated tyrosine hydroxylase in striatal synaptosomes post-injury. These findings show that lithium treatment attenuated dopamine neurotransmission deficits and increased the abundance of synaptic proteins important for dopamine signaling after TBI.	[Carlson, Shaun W.; Dixon, C. Edward] Univ Pittsburgh, Dept Neurol Surg, VA Pittsburgh Healthcare Syst, Safar Ctr Resuscitat Res, Pittsburgh, PA 15224 USA		Dixon, CE (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Safar Ctr Resuscitat Res, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	dixonec@upmc.edu		Carlson, Shaun/0000-0002-1413-5075	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32 NS090748] Funding Source: Medline		Bales JW, 2011, EXP NEUROL, V229, P300, DOI 10.1016/j.expneurol.2011.02.013; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; BAPTISTA T, 1993, J NEURAL TRANSM-GEN, V94, P75, DOI 10.1007/BF01245002; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Bobrovskaya L, 2007, J NEUROCHEM, V100, P479, DOI 10.1111/j.1471-4159.2006.04213.x; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bu W, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00449; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Butler B, 2017, J CHEM NEUROANAT, V83, P41, DOI 10.1016/j.jchemneu.2016.06.001; CAMPBELL DG, 1986, J BIOL CHEM, V261, P489; Can A, 2016, J NEUROCHEM, V139, P576, DOI 10.1111/jnc.13769; Carlson SW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00532; Carlson SW, 2017, EXP NEUROL, V289, P55, DOI 10.1016/j.expneurol.2016.12.006; Carlson SW, 2016, J NEUROTRAUM, V33, P113, DOI 10.1089/neu.2014.3839; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chen G, 1998, J NEUROCHEM, V70, P1768; Cordeiro ML, 2003, J NEUROSCI RES, V73, P865, DOI 10.1002/jnr.10707; Cordeiro ML, 2000, J NEUROCHEM, V74, P2365, DOI 10.1046/j.1471-4159.2000.0742365.x; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; EDELMAN AM, 1978, COMMUN PSYCHOPHARMAC, V2, P461; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Ferrie L, 2006, INT J NEUROPSYCHOPH, V9, P729, DOI 10.1017/S1461145705006243; Fortin SM, 2016, NEUROPSYCHOPHARMACOL, V41, P906, DOI 10.1038/npp.2015.220; FUNAKOSHI H, 1991, J BIOL CHEM, V266, P15614; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Harmon JL, 2017, J NEUROTRAUM, V34, P487, DOI 10.1089/neu.2015.4395; Hinzman JM, 2012, J NEUROTRAUM, V29, P1197, DOI 10.1089/neu.2011.2261; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Hornstein A, 1996, BRAIN INJURY, V10, P145, DOI 10.1080/026990596124647; Hu SX, 2009, NEUROBIOL DIS, V33, P193, DOI 10.1016/j.nbd.2008.10.007; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Koeda T, 1998, BRAIN DEV-JPN, V20, P124, DOI 10.1016/S0387-7604(98)00004-7; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; Liu M, 2017, J NEUROTRAUM, V34, P414, DOI 10.1089/neu.2015.4361; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; MOLINOFF PB, 1971, ANNU REV BIOCHEM, V40, P465, DOI 10.1146/annurev.bi.40.070171.002341; Mori S, 1998, NEUROPSYCHOPHARMACOL, V19, P233, DOI 10.1016/S0893-133X(98)00018-9; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Peng XMM, 2005, J CELL SCI, V118, P3523, DOI 10.1242/jcs.02481; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Sauerbeck A, 2012, EXP NEUROL, V234, P85, DOI 10.1016/j.expneurol.2011.12.012; Sawyer E, 2008, ANN PHARMACOTHER, V42, P247, DOI 10.1345/aph.1K284; Scarr Elizabeth, 2012, Clin Psychopharmacol Neurosci, V10, P25, DOI 10.9758/cpn.2012.10.1.25; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Shin SS, 2012, J NEUROTRAUM, V29, P843, DOI 10.1089/neu.2011.1966; Shin SS, 2011, NEUROSCI LETT, V496, P168, DOI 10.1016/j.neulet.2011.04.009; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sudhof TC, 2011, COLD SPRING HARB PER, P3; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Tsuji S, 2003, J NEURAL TRANSM, V110, P413, DOI 10.1007/s00702-002-0798-0; van Bregt DR, 2012, EXP NEUROL, V234, P8, DOI 10.1016/j.expneurol.2011.12.003; Vardar G, 2016, J NEUROSCI, V36, P7911, DOI 10.1523/JNEUROSCI.1314-16.2016; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Watcharasit P, 2002, P NATL ACAD SCI USA, V99, P7951, DOI 10.1073/pnas.122062299; Wiley CA, 2016, J NEUROTRAUM, V33, P1866, DOI 10.1089/neu.2015.4272; Yu FS, 2013, J NEUROSURG, V119, P766, DOI 10.3171/2013.6.JNS13135; Yu FS, 2012, J NEUROTRAUM, V29, P362, DOI 10.1089/neu.2011.1942; Yu IT, 2003, BIOCHEM BIOPH RES CO, V303, P1193, DOI 10.1016/S0006-291X(03)00494-7; Yu S, 2004, NEUROSCI LETT, V367, P34, DOI 10.1016/j.neulet.2004.05.118; Zhu ZF, 2010, BRAIN RES BULL, V83, P272, DOI 10.1016/j.brainresbull.2010.07.008; Zigova T, 1999, EXP NEUROL, V157, P251, DOI 10.1006/exnr.1999.7054	86	12	13	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2018	35	23					2827	2836		10.1089/neu.2017.5509			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HB1WO	WOS:000450819000009	29699444	Green Published			2022-02-06	
J	Du, Q; Weng, JF; Luo, LF; Cen, M; Yu, WH; Zheng, YK; Hu, W; Pan, JW; Dong, XQ				Du, Quan; Weng, Jian-Feng; Luo, Li-Feng; Cen, Meng; Yu, Wen-Hua; Zheng, Yong-Ke; Hu, Wei; Pan, Jian-Wei; Dong, Xiao-Qiao			Serum ST2 as a potential prognostic biomarker for traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; ST2; Prognosis; Severity; Inflammation	ANEURYSMAL SUBARACHNOID HEMORRHAGE; POSTTRAUMATIC CEREBRAL INFARCTION; NEURON-SPECIFIC ENOLASE; ACUTE LUNG INJURY; SOLUBLE ST2; INTERLEUKIN-1 RECEPTOR; CEREBROSPINAL-FLUID; PROTEIN-LEVELS; S100B PROTEIN; NF-H	Background: ST2, a receptor of interleukin-33, is involved in inflammation. We discerned the relationship between serum soluble ST2 (sST2) concentrations, inflammation, severity and prognosis following traumatic brain injury (TBI). Methods: We measured serum 5ST2, interleukin-6, tumor necrosis factor-alpha, C-reactive protein, myelin basic protein, glial fibrillary astrocyte protein, S100B, neuron-specific enolase, phosphorylated axonal neurofilament subunit H, Tau and ubiquitin carboxyl-terminal hydrolase L1 concentrations in 106 healthy controls and 106 severe TBI patients. We recorded long-term prognosis (i.e., 6-month mortality and functional outcome) and in hospital major adverse events, including in-hospital mortality, acute lung injury, acute traumatic coagulopathy, progressive hemorrhagic injury and posttraumatic cerebral infarction. Results: 5ST2 concentrations were significantly higher in patients than in controls and were significantly correlated with Glasgow coma scale (GCS) score and the preceding biomarkers concentrations. Serum sST2 was an independent prognostic predictor and its predictive ability significantly exceeded those of serum interleukin-6, tumor necrosis factor-alpha and C-reactive protein concentrations and was similar to those of GCS scores and serum concentrations of other remaining biomarkers. Moreover, 5ST2 concentrations significantly improved predictive ability of GCS score. Conclusion: Increased serum sST2 concentrations are significantly related to inflammation, severity and prognosis, substantialized ST2 as a potential prognostic biomarker for TBI.	[Du, Quan; Yu, Wen-Hua; Dong, Xiao-Qiao] Zhejiang Univ, Sch Med, Affiliated Hangzhou Peoples Hosp 1, Dept Neurosurg, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China; [Weng, Jian-Feng; Luo, Li-Feng; Cen, Meng] CHC Int Hosp, Dept Neurosurg, 599 Shiji Ave, Cixi 315315, Peoples R China; [Zheng, Yong-Ke; Hu, Wei] Zhejiang Univ, Sch Med, Affiliated Hangzhou Peoples Hosp 1, Dept Intens Care Unit, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China; [Pan, Jian-Wei] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China		Dong, XQ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hangzhou Peoples Hosp 1, Dept Neurosurg, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China.	dxqhyy@163.com		Pan, Jianwei/0000-0001-6353-1843	International Cooperation Project of Zhejiang Provincial Science and Technology Department [2015C34007]; Zhejiang Province Medical and Health Fund Project [2014KYA177, 2016RCB016]; Hangzhou Medical Research Fund Project [2014Z06, 2016Z10]; Ningbo Medical Research Fund Project [2016A12]; Hangzhou science and technology Fund project [20180533843]	The authors thank all staffs in Department of Neurosurgery, The CHC International Hospital (Cixi, China) for their technical support. This study was supported financially by the International Cooperation Project of Zhejiang Provincial Science and Technology Department (No.2015C34007), Zhejiang Province Medical and Health Fund Project (No. 2014KYA177, 2016RCB016), Hangzhou Medical Research Fund Project (No. 2014Z06, 2016Z10), Ningbo Medical Research Fund Project (No. 2016A12) and Hangzhou science and technology Fund project (No. 20180533843).	Adams H, 2016, NEUROSURG CLIN N AM, V27, P519, DOI 10.1016/j.nec.2016.05.007; Godoy DA, 2018, NEUROSURG CLIN N AM, V29, P195, DOI 10.1016/j.nec.2017.12.001; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Bahuleyan CG, 2018, INDIAN HEART J, V70, pS79, DOI 10.1016/j.ihj.2017.09.010; Belatar B, 2018, PAN AFR MED J, V29, DOI 10.11604/pamj.2018.29.36.10945; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Bowie A, 2000, J LEUKOCYTE BIOL, V67, P508, DOI 10.1002/jlb.67.4.508; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Capone-Neto A, 2009, CURR OPIN CRIT CARE, V15, P290, DOI 10.1097/MCC.0b013e32832e383e; Cohen MJ, 2014, THROMB RES, V133, pS25, DOI 10.1016/j.thromres.2014.03.013; Lopez ZRD, 2015, CLIN CHEM LAB MED, V53, pE179, DOI 10.1515/cclm-2014-1189; Dong XQ, 2010, CRIT CARE, V14, DOI 10.1186/cc9307; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Fremont RD, 2010, J TRAUMA, V68, P1121, DOI 10.1097/TA.0b013e3181c40728; Gao Y, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00095; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harris T, 2012, POSTGRAD MED J, V88, P595, DOI 10.1136/postgradmedj-2011-130285; Helbok R, 2015, J NEUROL NEUROSUR PS, V86, P79, DOI 10.1136/jnnp-2013-307326; Hemmila MR, 2017, CRIT CARE CLIN, V33, P193, DOI 10.1016/j.ccc.2016.08.010; Hirashima Y, 2001, NEUROL RES, V23, P715, DOI 10.1179/016164101101199225; Huang LT, 2015, CELL MOL NEUROBIOL, V35, P493, DOI 10.1007/s10571-014-0143-9; Kanda M, 2006, ACTA NEUROL SCAND, V113, P327, DOI 10.1111/j.1600-0404.2006.00587.x; Kellermann I, 2016, CLIN NEUROL NEUROSUR, V145, P79, DOI 10.1016/j.clineuro.2016.04.005; Kiiski H, 2016, J NEUROL SCI, V361, P144, DOI 10.1016/j.jns.2015.12.046; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Kuroiwa K, 2001, BIOCHEM BIOPH RES CO, V284, P1104, DOI 10.1006/bbrc.2001.5090; Lai PMR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151853; Laqqan M., 2018, PLOS ONE, V13, DOI DOI E0202406; Latronico N, 2009, J TRAUMA, V66, P1745, DOI 10.1097/TA.0b013e3181a56c8b; Lewis SB, 2008, J CEREBR BLOOD F MET, V28, P1261, DOI 10.1038/jcbfm.2008.12; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Lou MQ, 2013, CLIN NEUROL NEUROSUR, V115, P904, DOI 10.1016/j.clineuro.2012.09.001; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Luo QP, 2018, NEUROSCIENCE, V385, P75, DOI 10.1016/j.neuroscience.2018.05.047; Ma X, 2018, CLIN CHIM ACTA, V480, P138, DOI 10.1016/j.cca.2018.02.005; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; MIRVIS SE, 1990, AM J ROENTGENOL, V154, P1293, DOI 10.2214/ajr.154.6.2110744; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Ondruschka B, 2018, INT J LEGAL MED, V132, P531, DOI 10.1007/s00414-017-1768-2; Oshikawa K, 2001, AM J RESP CRIT CARE, V164, P277, DOI 10.1164/ajrccm.164.2.2008120; Ozyurt E, 2015, TURK NEUROSURG, V25, P877, DOI 10.5137/1019-5149.JTN.9181-13.0; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Perez-Martinez MT, 2018, J AM COLL CARDIOL, V72, P1429, DOI 10.1016/j.jacc.2018.06.062; Plesnila N, 2016, CURR OPIN PHARMACOL, V26, P110, DOI 10.1016/j.coph.2015.10.008; Rodney T, 2018, CYTOKINE, V110, P248, DOI 10.1016/j.cyto.2018.01.012; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; Shi LJ, 2018, CHINESE MED J-PEKING, V131, P316, DOI 10.4103/0366-6999.223847; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P12, DOI 10.1097/TA.0b013e3182aaa675; Sweet MJ, 2001, J IMMUNOL, V166, P6633, DOI 10.4049/jimmunol.166.11.6633; Tajima S, 2003, CHEST, V124, P1206, DOI 10.1378/chest.124.4.1206; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Tawk RG, 2016, NEUROSURGERY, V78, P487, DOI 10.1227/NEU.0000000000001140; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; TOMINAGA S, 1992, BIOCHIM BIOPHYS ACTA, V1171, P215, DOI 10.1016/0167-4781(92)90125-J; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; Weinberg EO, 2002, CIRCULATION, V106, P2961, DOI 10.1161/01.CIR.0000038705.69871.D9; WERENSKIOLD AK, 1989, MOL CELL BIOL, V9, P5207, DOI 10.1128/MCB.9.11.5207; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181; YANAGISAWA K, 1993, FEBS LETT, V318, P83, DOI 10.1016/0014-5793(93)81333-U; Yanagisawa K, 1997, J BIOCHEM-TOKYO, V121, P95; Yang DB, 2017, CLIN CHIM ACTA, V469, P99, DOI 10.1016/j.cca.2017.03.030; Yang YY, 2017, J NEUROSCI, V37, P4692, DOI 10.1523/JNEUROSCI.3233-16.2017	69	12	13	2	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	DEC	2018	487						145	152		10.1016/j.cca.2018.09.035			8	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	HC0MA	WOS:000451491300025	30266513				2022-02-06	
J	Liu, J; Zhou, GE; Kolls, BJ; Tan, YL; Fang, C; Wang, H; Laskowitz, DT				Liu, Ji; Zhou, Guanen; Kolls, Bradley J.; Tan, Yanli; Fang, Chuan; Wang, Haichen; Laskowitz, Daniel T.			Apolipoprotein E mimetic peptide CN-105 improves outcome in a murine model of SAH	STROKE AND VASCULAR NEUROLOGY			English	Article						apolipoprotein E; subarachnoid hemorrhage; vasospasm; microgliosis; inflammation	ANEURYSMAL SUBARACHNOID HEMORRHAGE; EARLY BRAIN-INJURY; MICROGLIAL ACTIVATION; ALZHEIMERS-DISEASE; CEREBRAL VASOSPASM; APOE GENOTYPE; DOUBLE-BLIND; MOUSE MODEL; INFLAMMATION; METAANALYSIS	Objective Subarachnoid haemorrhage (SAH) accounts for 3% of all strokes, and is associated with significant morbidity and mortality. There is growing evidence implicating apolipoprotein E (apoE) in mediating adaptive anti-inflammatory and neuroprotective responses following ischaemic and traumatic brain injury. In the current study, we test the efficacy of a small apoE mimetic peptide, CN-105 in a murine model of SAH. Methods Mice subjected to SAH received repeated intravenous injections of CN-105 every 12 hours for 3 days, with the first dose given 2 hours after injury. Daily functional outcomes were assessed by rotarod and neurological severity score. Haemorrhage grade and cerebral vascular diameters were measured at 5 days post-SAH. Cerebral microgliosis, neuronal degeneration and survival were analysed at 5 and 35 days post-SAH, respectively. Results CN-105 reduces histological evidence of inflammation, reduces vasospasm and neuronal injury and is associated with improved long-term behavioural outcomes in a murine model of SAH. Conclusions Given its favourable pharmacokinetic profile, central nervous system penetration and demonstration of clinical safety, CN-105 represents an attractive therapeutic candidate for treatment of brain injury associated with SAH.	[Liu, Ji; Zhou, Guanen] Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China; [Kolls, Bradley J.; Wang, Haichen; Laskowitz, Daniel T.] Duke Univ, Sch Med, Dept Neurol, Durham, NC 27708 USA; [Tan, Yanli] HeBei Univ, Dept Pathol, Basic Med Coll, Baoding, Peoples R China; [Fang, Chuan] HeBei Univ, Dept Neurosurg, Affiliated Hosp, Baoding, Peoples R China; [Wang, Haichen] Duke Univ, Dept Neurobiol, Sch Med, Durham, NC USA; [Laskowitz, Daniel T.] Duke Univ, Dept Anesthesiol, Sch Med, Durham, NC 27708 USA		Laskowitz, DT (corresponding author), Duke Univ, Sch Med, Dept Neurol, Durham, NC 27708 USA.; Laskowitz, DT (corresponding author), Duke Univ, Dept Anesthesiol, Sch Med, Durham, NC 27708 USA.	danl@neuro.duke.edu			DOD contract CDMRP [W81XWH-16-C-0142]	This work was partially supported by DOD contract CDMRP#W81XWH-16-C-0142.	ALLEN GS, 1983, NEW ENGL J MED, V308, P619, DOI 10.1056/NEJM198303173081103; Aono M, 2003, NEUROSCIENCE, V116, P437, DOI 10.1016/S0306-4522(02)00709-1; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Croy JE, 2004, BIOCHEMISTRY-US, V43, P7328, DOI 10.1021/bi036208p; Feng DY, 2016, MOL NEUROBIOL, V53, P5737, DOI 10.1007/s12035-015-9490-x; Galea JP, 2017, STROKE, V48, P2958, DOI 10.1161/STROKEAHA.117.017777; Gao J, 2006, NEUROCRIT CARE, V4, P25, DOI 10.1385/NCC:4:1:025; Gonias SL, 2014, AM J PATHOL, V184, P18, DOI 10.1016/j.ajpath.2013.08.029; Guptill JT, 2017, J CLIN PHARMACOL, V57, P770, DOI 10.1002/jcph.853; Guttman M, 2010, J MOL BIOL, V398, P306, DOI 10.1016/j.jmb.2010.03.022; Han SM, 2014, J CEREBR BLOOD F MET, V34, P108, DOI 10.1038/jcbfm.2013.170; Hoe HS, 2006, J BIOL CHEM, V281, P3425, DOI 10.1074/jbc.M509380200; Hoellig A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123398; Keene CD, 2011, CURR OPIN NEUROBIOL, V21, P920, DOI 10.1016/j.conb.2011.08.002; Kim J, 2014, MOL CELLS, V37, P767, DOI 10.14348/molcells.2014.0248; Kirkpatrick PJ, 2014, LANCET NEUROL, V13, P666, DOI 10.1016/S1474-4422(14)70084-5; Krajewski K, 2014, NEUROSURG REV, V37, P55, DOI 10.1007/s10143-013-0489-3; Lanterna LA, 2007, NEUROLOGY, V69, P766, DOI 10.1212/01.wnl.0000267640.03300.6b; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Laskowitz DT, 2017, SCI REP-UK, V7, DOI 10.1038/srep46461; Laskowitz DT, 2010, STROKE, V41, pS79, DOI 10.1161/STROKEAHA.110.595090; Laskowitz DT, 1997, J CEREBR BLOOD F MET, V17, P753; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Lei BL, 2016, SCI REP-UK, V6, DOI 10.1038/srep34834; Leijenaar JF, 2015, INT J STROKE, V12; Li FQ, 2006, J PHARMACOL EXP THER, V318, P956, DOI 10.1124/jpet.106.103671; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; Martin AM, 2008, J BIOL CHEM, V283, P12004, DOI 10.1074/jbc.M707607200; Mesis R.G., 2006, NEUROSURG FOCUS, V21, P1, DOI DOI 10.3171/FOC.2006.21.3.4; Misra UK, 2001, J LEUKOCYTE BIOL, V70, P677; Ophir G, 2005, NEUROBIOL DIS, V20, P709, DOI 10.1016/j.nbd.2005.05.002; Pang JW, 2017, TRANSL STROKE RES, V8, P257, DOI 10.1007/s12975-016-0507-1; Parra A, 2002, NEUROL RES, V24, P510, DOI 10.1179/016164102101200276; PICKARD JD, 1989, BRIT MED J, V298, P636, DOI 10.1136/bmj.298.6674.636; Pocivavsek A, 2009, J NEUROIMMUNOL, V214, P25, DOI 10.1016/j.jneuroim.2009.06.010; Pradilla G, 2010, NEUROSURG CLIN N AM, V21, P365, DOI 10.1016/j.nec.2009.10.008; Qiu Z, 2003, NEUROSCIENCE, V122, P291, DOI 10.1016/j.neuroscience.2003.08.017; Sheng ZY, 2008, NEUROPHARMACOLOGY, V55, P204, DOI 10.1016/j.neuropharm.2008.05.016; Tlaskowitz D, 2007, PHARMACOGENOMICS, V8, P959, DOI 10.2217/14E22416.8.8.959; Tu TM, 2017, ANN CLIN TRANSL NEUR, V4, P246, DOI 10.1002/acn3.399; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Wallmark S, 2016, ACTA NEUROCHIR, V158, P233, DOI 10.1007/s00701-015-2665-4; Wang HC, 2014, NEUROCRIT CARE, V20, P119, DOI 10.1007/s12028-013-9944-9; Weidauer S, 2008, NEURORADIOLOGY, V50, P1, DOI 10.1007/s00234-007-0294-1; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Wu Y, 2016, NEUROSCI LETT, V627, P92, DOI 10.1016/j.neulet.2016.05.058; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zoerle T, 2012, J CEREBR BLOOD F MET, V32, P1645, DOI 10.1038/jcbfm.2012.57	52	12	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2059-8688	2059-8696		STROKE VASC NEUROL	Stroke Vasc. Neurol.	DEC	2018	3	4					222	230	UNSP e000152	10.1136/svn-2018-000152			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JE5OZ	WOS:000490743100006	30637128	gold, Green Published			2022-02-06	
J	Maresca, G; Maggio, MG; Buda, A; La Rosa, G; Manuli, A; Bramanti, P; De Luca, R; Calabro, RS				Maresca, Giuseppa; Maggio, Maria Grazia; Buda, Antonio; La Rosa, Gianluca; Manuli, Alfredo; Bramanti, Placido; De Luca, Rosaria; Calabro, Rocco Salvatore			A novel use of virtual reality in the treatment of cognitive and motor deficit in spinal cord injury A case report	MEDICINE			English	Article						neurorehabilitation; spinal cord injury; virtual reality; VRRS	CLOSED HEAD-INJURY; BRAIN-INJURY; REHABILITATION; STROKE	Rationale: Aim of this study is to evaluate the cognitive and motor outcomes after a combined rehabilitative training using a standard cognitive approach and virtual reality (VR), in a patient with spinal cord injury (SCI). Patient's concerns: A 60-year-old right-handed man, affected by incomplete cervical SCI, came to our observation for a moderate tetraparesis, mainly involving the left side, after about 6-months from the acute event. The neurological examination showed imbalance with upper limb incoordination, besides the paresis mainly involving the left side. At a neuropsychological evaluation, he presented important impairment in cognitive and behavioural status, with temporal and spatial disorientation, a reduction of attention and memory process, deficit of executive function and a severe depression of mood, which was not detected during the previous recovery. Diagnosis: Motor and cognitive deficits in SCI. Interventions: The patient was 1st submitted to standard cognitive training and traditional physiotherapy, and then to a combined therapeutic approach, in which virtual reality training was provided by means of the virtual reality rehabilitation system (VRRS, Khymeia, Italy). Outcomes: After the combined therapeutic approach with the VRRS training, we observed a significant improvement in different cognitive domains, a notable reduction of anxiety and depressive symptoms, as well as motor performance, and balance improvement. Lessons: Virtual reality can be considered a promising tool for the rehabilitation of different neurological disorders, including patients with both motor and cognitive deficits following SCI.	[Maresca, Giuseppa; Maggio, Maria Grazia; Buda, Antonio; La Rosa, Gianluca; Manuli, Alfredo; Bramanti, Placido; De Luca, Rosaria; Calabro, Rocco Salvatore] IRCCS Ctr Neurolesi Bonino Pulejo, SS 113, I-98124 Messina, Italy		Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, SS 113, I-98124 Messina, Italy.	salbro77@tiscali.it	Bramanti, Placido/K-5117-2016; Manuli, Alfredo/ABF-3128-2020; Maggio, Maria Grazia/ABA-1852-2020; Maresca, Giusy/AAB-2242-2021; Calabro, Rocco S/K-7520-2016	Manuli, Alfredo/0000-0002-4030-1399; /0000-0003-0757-2389			Bauer S, 2004, J PERS ASSESS, V82, P60, DOI 10.1207/s15327752jpa8201_11; Carpinella I, 2016, GAIT POSTURE, V49, P23, DOI DOI 10.1016/j.gaitpost.2016.07.056; Cheung VCK, 2012, P NATL ACAD SCI USA, V109, P14652, DOI 10.1073/pnas.1212056109; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Craig A, 2017, SPINAL CORD, V55, P926, DOI 10.1038/sc.2017.41; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; De Luca R, 2016, NEUROPSYCHOL REHABIL; De Luca R, 2014, DISABIL HEALTH J, V7, P356, DOI 10.1016/j.dhjo.2014.04.003; Gavett BE, 2015, J INT NEUROPSYCH SOC, V21, P558, DOI 10.1017/S1355617715000582; Go Bette K., 1995, P21; Hartmann A, 2018, J NEUROL PHYS THER, V42, P102, DOI 10.1097/NPT.0000000000000218; Harvey Philip D, 2012, Dialogues Clin Neurosci, V14, P91; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; KREUTZER JS, 1988, ARCH PHYS MED REHAB, V69, P764; Larson EB, 2014, NEUROREHABILITATION, V34, P759, DOI 10.3233/NRE-141078; Laver K, 2015, EUR J PHYS REHAB MED, V51, P497; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4, 10.1002/14651858.CD008349.pub2]; Lin VW, 2002, SPINAL CORD MED PRIN; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P265, DOI 10.1080/13803395.2015.1004303; Pagliacci MC, 2003, SPINAL CORD, V41, P620, DOI 10.1038/sj.sc.3101521; Portaro S, 2017, DISABIL HLTH J; Rose FD, 2005, CYBER PSICHOL BEHAV, V8, P3, DOI DOI https://doi.org/10.1089/cpb.2005.8.241; Sabharwal S., 2014, ESSENTIALS PHYS MED; Shin H, 2015, J PHYS THER SCI, V27, P2999, DOI 10.1589/jpts.27.2999; Solana Sanchez J, 2013, INT C REC ADV NEUR, P182; Subramaniam S., 2017, INT C VIRT REH ICVR, P1; Turolla A, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-85	29	12	12	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	DEC	2018	97	50							e13559	10.1097/MD.0000000000013559			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HI3DH	WOS:000456326400056	30558016	gold, Green Published			2022-02-06	
J	Shibahashi, K; Sugiyama, K; Okura, Y; Tomio, J; Hoda, H; Hamabe, Y				Shibahashi, Keita; Sugiyama, Kazuhiro; Okura, Yoshihiro; Tomio, Jun; Hoda, Hidenori; Hamabe, Yuichi			Defining Hypotension in Patients with Severe Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Hypotension; Mortality; Risk factor; Threshold; Traumatic brain injury	BLOOD-PRESSURE; REDEFINING HYPOTENSION; PROGNOSTIC VALUE; MORTALITY; COHORT	BACKGROUND: Hypotension, a risk factor for increased mortality following traumatic brain injury (TBI), is traditionally defined as systolic blood pressure (SBP) <90 mm Hg. We aimed to redefine hypotension and determine its optimal threshold in patients with TBI. METHODS: We identified patients with severe TBI (Glasgow Coma Scale score <= 8 on admission) between 2004 and 2015 using data from the Japan Trauma Data Bank. Our endpoint was in-hospital mortality. Mixed effects logistic regression models were used to investigate the association between SBP on admission and in-hospital mortality, with hospitals considered as a random effects variable. We also conducted analyses stratified by age (<= 60 years and >60 years) to determine age-specific optimal levels of SBP. RESULTS: A total of 12,537 patients (5665 patients <= 60 years old and 6872 patients >60 years old) were eligible for the analyses. Overall, SBP of 110 mm Hg was the optimal threshold for hypotension, and adjusted odds ratio and C-statistic for mortality at SBP <110 mm Hg on admission were 1.58 (95% confidence interval, 1.42-1.76, P < 0.001) and 0.78 (95% confidence interval, 0.77-0.79), respectively. Stratified analyses showed that optimal thresholds for hypotension in patients <= 60 years old and >60 years old were 100 mm Hg and 120 mm Hg. CONCLUSIONS: The threshold for hypotension in patients with severe TBI should be redefined and modified by age, and patients <= 60 years old should be considered hypotensive hypotensive at SBP <100 mm Hg, whereas in older patients, SBP <120 mm Hy should be diagnosed as hypotension.	[Shibahashi, Keita; Sugiyama, Kazuhiro; Okura, Yoshihiro; Hoda, Hidenori; Hamabe, Yuichi] Tokyo Metropolitan Bokutoh Hosp, Tertiary Emergency Med Ctr, Tokyo, Japan; [Tomio, Jun] Univ Tokyo, Grad Sch Med, Dept Publ Hlth, Tokyo, Japan		Shibahashi, K (corresponding author), Tokyo Metropolitan Bokutoh Hosp, Tertiary Emergency Med Ctr, Tokyo, Japan.	kshibahashi@yahoo.co.jp		Sugiyama, Kazuhiro/0000-0003-4543-3064; Hoda, Hidenori/0000-0002-4283-4412			BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Eastridge BJ, 2007, J TRAUMA, V63, P291, DOI 10.1097/TA.0b013e31809ed924; Edwards M, 2010, AM SURGEON, V76, P1035; Franklin GA, 2007, J TRAUMA, V63, P297; Fuller G, 2014, INJURY, V45, P612, DOI 10.1016/j.injury.2013.09.008; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Qaseem A, 2017, ANN INTERN MED, V166, P430, DOI 10.7326/M16-1785; Shibahashi K, 2017, WORLD NEUROSURG, V107, P82, DOI [10.1016/J.WNEU.2017.07.117, 10.1016/j.wneu.2017.07.117]; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tietjen CS, 1996, CRIT CARE MED, V24, P311, DOI 10.1097/00003246-199602000-00022; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]	20	12	12	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2018	120						E667	E674		10.1016/j.wneu.2018.08.142			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HA9ZO	WOS:000450668300082	30189306				2022-02-06	
J	Vu, PA; Tucker, LB; Liu, J; McNamara, EH; Tran, T; Fu, AH; Kim, Y; McCabe, JT				Vu, Patricia A.; Tucker, Laura B.; Liu, Jiong; McNamara, Eileen H.; Thanhlong Tran; Fu, Amanda H.; Kim, Yeonho; McCabe, Joseph T.			Transient disruption of mouse home cage activities and assessment of orexin immunoreactivity following concussive- or blast-induced brain injury	BRAIN RESEARCH			English	Article						Traumatic brain injury; Concussion; Blast brain injury; Neurotrauma; Activity; Cognition; Orexin; Microglia; Mouse	SLEEP-WAKE DISTURBANCES; ANXIETY-LIKE BEHAVIOR; HEAD-INJURY; OPEN-FIELD; PHYSICAL-ACTIVITY; C57BL/6J MICE; MODEL; ACETAMINOPHEN; WAKEFULNESS; HYPOCRETIN	The employment of explosive weaponry in modern warfare exposes populations to shock wave-induced and impact-related brain injuries. Among the most common clinical complaints resulting from traumatic brain injury (TBI) are sleep-wake disturbances. The current study assessed the acute effects of mild concussive brain injury (CBI) and mild blast wave-induced brain injury (BTBI) on mouse behavior and orexin-A expression. Male C57BL/6J mice were exposed to CBI, BTBI, or sham procedures. Injured animals and their shams were further divided into the following subgroups: 24-h survival in standard group (SG) housing, 72-h survival in SG housing, and 72-h survival in Any-Maze cages (AMc). AMc enabled continuous monitoring of home cage activities. BTBI caused significant but transient decreases in wheel running and ingestive behaviors 24 h post-injury (PI), while CBI transiently decreased running and water intake. BTBI resulted in general hypoactivity in the open field (OF) at both PI time points for SG-housed animals. In contrast, CBI did not cause hypoactivity. Mice subjected to CBI traveled more in the center of the OF at both time points PI, suggesting that CBI caused reduced anxiety in mice. Increased activity in the center of the OF was also seen at 24 h PI after BTBI. CBI treatment caused increased CD11b immunostaining. However, neither injury was accompanied by an alteration in the number of orexin-A hypothalamic neurons. Taken together, shock wave exposure and concussive injury transiently reduced mouse activities, but some differences between the two injuries were seen.	[Vu, Patricia A.; Tucker, Laura B.; Liu, Jiong; McNamara, Eileen H.; Thanhlong Tran; Fu, Amanda H.; Kim, Yeonho; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Vu, Patricia A.; McNamara, Eileen H.; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Grad Program Neurosci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Tucker, Laura B.; Fu, Amanda H.; Kim, Yeonho; McCabe, Joseph T.] Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Ctr Neurosci & Regenerat Med, Preclin Studies Core, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		McCabe, JT (corresponding author), Uniformed Serv Univ Hlth Sci, FE Hebert Sch Med, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	Joseph.McCabe@usuhs.edu	McCabe, Joseph T/J-6293-2014	McCabe, Joseph T/0000-0002-1159-7442; Tucker, Laura/0000-0002-5984-6399; McNamara, Eileen/0000-0002-7238-212X	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [60855-300600-7.01]; Defense Health Agency [64682-307877-2.00]	The opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army, Department of Defense, the U.S. Government or the Uniformed Services University of the Health Sciences. The use of trade names does not constitute an official endorsement or approval of the use of such reagents or commercial hardware or software. This document may not be cited for purposes of advertisement. The investigators thank David Ritzel (Dyn-Fx Consulting) and Steve Parks (ORA, Inc) for their exceptional technical guidance and discussion in establishing the ABS at USUHS. This work was supported by The Center for Neuroscience and Regenerative Medicine [60855-300600-7.01] and The Defense Health Agency [64682-307877-2.00] to JTM.	Armed Forces Health Surveillance Center, 2015, MSMR, V22, P12; Baker W.E., 1973, EXPLOSIONS AIR; Barson JR, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/983964; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Broussard JI, 2018, BRAIN INJURY, V32, P113, DOI 10.1080/02699052.2017.1380228; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Elliott JE, 2018, SLEEP, V41, DOI 10.1093/sleep/zsx212; Fischer H, 2013, C RES SERV CRS REP C, P13; Gardani M, 2015, ARCH PHYS MED REHAB, V96, P1691, DOI 10.1016/j.apmr.2015.05.006; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Hamilton M, 2015, BRAIN INJURY, V29, P1572, DOI 10.3109/02699052.2015.1075145; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Heredia L, 2014, J PHARMACOL TOX MET, V69, P108, DOI 10.1016/j.vascn.2013.12.005; Hyatt K, 2014, MIL MED, V179, P849, DOI 10.7205/MILMED-D-13-00526; Jones K, 2001, SLEEP MED REV, V5, P463, DOI 10.1053/smrv.2001.0203; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Jones TM, 2016, PHYS THER, V96, P1982, DOI 10.2522/ptj.20160028; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kim YH, 2018, J NEUROSCI RES, V96, P501, DOI 10.1002/jnr.24099; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Logue OC, 2016, EXP NEUROL, V277, P227, DOI 10.1016/j.expneurol.2015.12.019; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; Noain D, 2018, J NEUROTRAUM, V35, P85, DOI 10.1089/neu.2017.5067; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Patel TP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00349; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Ritzel DV, 2018, SHOCK WAVES, V28, P101, DOI 10.1007/s00193-017-0768-y; Ritzel DV, 2011, RTO HUM FACT MED PAN; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Sawyer Q, 2016, J ATHL TRAINING, V51, P739, DOI 10.4085/1062-6050-51.12.01; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Sheng P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081802; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Sinclair KL, 2013, J CLIN EXP NEUROPSYC, V35, P210, DOI 10.1080/13803395.2012.762340; Skopin MD, 2015, J NEUROTRAUM, V32, P289, DOI 10.1089/neu.2014.3664; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stemper BD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00031; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; Thannickal TC, 2007, BRAIN, V130, P1586, DOI 10.1093/brain/awm097; Thomasy Hannah E., 2017, Neurobiology of Sleep and Circadian Rhythms, V2, P71, DOI 10.1016/j.nbscr.2016.03.001; Thompson T, 2015, PHARMACOL BIOCHEM BE, V133, P7, DOI 10.1016/j.pbb.2015.03.011; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Tzekov R, 2016, BRAIN INJURY, V30, P1428, DOI 10.1080/02699052.2016.1219062; Umathe SN, 2009, PROG NEURO-PSYCHOPH, V33, P1191, DOI 10.1016/j.pnpbp.2009.06.020; Vanderbeken I, 2017, NEUROREHABILITATION, V40, P33, DOI 10.3233/NRE-161388; VandeVord PJ, 2016, METHODS MOL BIOL, V1462, P101, DOI 10.1007/978-1-4939-3816-2_7; Velosky AG, 2017, BEHAV BRAIN RES, V324, P115, DOI 10.1016/j.bbr.2017.02.017; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; YEN JC, 1995, IEEE T IMAGE PROCESS, V4, P370, DOI 10.1109/83.366472; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Zaitone SA, 2012, BEHAV PHARMACOL, V23, P417, DOI 10.1097/FBP.0b013e3283566065	90	12	12	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 1	2018	1700						138	151		10.1016/j.brainres.2018.08.034			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HB8PU	WOS:000451353600015	30176241	hybrid			2022-02-06	
J	Wortman, RC; Meconi, A; Neale, KJ; Brady, RD; McDonald, SJ; Christie, BR; Wright, DK; Shultz, SR				Wortman, Ryan C.; Meconi, Alicia; Neale, Katie J.; Brady, Rhys D.; McDonald, Stuart J.; Christie, Brian R.; Wright, David K.; Shultz, Sandy R.			Diffusion MRI abnormalities in adolescent rats given repeated mild traumatic brain injury	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							TENSOR IMAGING DETECTS; AXONAL INJURY; COGNITIVE DYSFUNCTION; CORPUS-CALLOSUM; HEAD-INJURY; CONCUSSION; SPECTRUM; IMPAIRMENT; BIOMARKERS; MODEL	Objective Mild traumatic brain injury (mTBI) is a serious health concern in the adolescent population. Repeated mTBI may result in more pronounced deficits, and has been associated with long-term neurological consequences including neurodegeneration. As such, there is a critical need for the development of objective mTBI biomarkers to help guide medical management. Diffusion-weighted imaging (DWI) is an advanced magnetic resonance imaging (MRI) technique that may detect brain abnormalities after mTBI. Diffusion tensor imaging (DTI) is the most commonly applied DWI method, and initial studies have reported DTI changes in mTBI patients. Furthermore, new DWI methods (e.g., track-weighted imaging; TWI) are being developed that may also be sensitive to mTBIs, but remain to be comprehensively studied. Methods This study utilized the Awake Closed Head Injury (ACHI) model of mTBI to investigate changes in DTI and TWI following repeated mTBI in adolescent male and female rats. A total of four ACHI impacts, two/day over two consecutive days, were delivered beginning on postnatal day 25. At 1 day and 7 days postinjury, rats were euthanized and brains were collected for DWI analyses. Results Rats given repeated mTBI displayed changes in fractional anisotropy and radial diffusivity (i.e., DTI measures), as well as track density (i.e., TWI). Interpretation These findings are consistent with initial DTI findings in mTBI patients, suggest that TWI may complement DTI, support the utility of DWI measures as biomarkers in mTBI, and further validate the ACHI rat model of mTBI.	[Wortman, Ryan C.; Meconi, Alicia; Brady, Rhys D.; Wright, David K.; Shultz, Sandy R.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic 3004, Australia; [Wortman, Ryan C.; Neale, Katie J.; Christie, Brian R.; Shultz, Sandy R.] Univ Victoria, Div Med Sci, Victoria, BC V8P 5C2, Canada; [McDonald, Stuart J.] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic 3086, Australia; [Wright, David K.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Shultz, Sandy R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic 3010, Australia		Shultz, SR (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Alfred Ctr, 6th Floor,99 Commercial Rd, Melbourne, Vic 3004, Australia.	sandy.shultz@monash.edu	Christie, Brian Ross/AAF-3766-2019	Christie, Brian Ross/0000-0002-6830-0160; McDonald, Stuart/0000-0001-5190-3179	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); CFICanada Foundation for Innovation; Australian NHMRCNational Health and Medical Research Council of Australia; NSERCNatural Sciences and Engineering Research Council of Canada (NSERC)	RCW and AM were supported by Canadian Institutes of Health Research graduate fellowships. The studies were funded by grants from NSERC and CFI to BRC, and the Australian NHMRC to SRS.	Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Calamante F, 2012, NEUROIMAGE, V59, P2494, DOI 10.1016/j.neuroimage.2011.08.099; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Clough M, 2018, J NEUROTRAUM, V35, P730, DOI 10.1089/neu.2017.5204; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; KRAUS JF, 1990, NEUROSURGERY, V27, P334; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar A, 2014, INFLAMMOPHARMACOLOGY, V22, P155, DOI 10.1007/s10787-013-0187-3; LEBIHAN D, 1992, AM J ROENTGENOL, V159, P591, DOI 10.2214/ajr.159.3.1503032; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meconi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197187; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Pannek K, 2011, NEUROIMAGE, V55, P133, DOI 10.1016/j.neuroimage.2010.12.010; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Qin Y, 2018, BEHAV BRAIN RES, V340, P41, DOI 10.1016/j.bbr.2016.08.008; Raffelt D, 2011, NEUROIMAGE, V56, P1171, DOI 10.1016/j.neuroimage.2011.02.014; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wright DK, 2018, NEUROIMAGE-CLIN, V18, P315, DOI 10.1016/j.nicl.2018.01.033; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Wright DK, 2017, J NEUROTRAUM, V34, P2109, DOI 10.1089/neu.2016.4730; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	55	12	12	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	DEC	2018	5	12					1588	1598		10.1002/acn3.667			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HE1TS	WOS:000453056900011	30564624	Green Published, gold			2022-02-06	
J	Giacci, M; Fitzgerald, M				Giacci, Marcus; Fitzgerald, Melinda			Oligodendroglia Are Particularly Vulnerable to Oxidative Damage After Neurotrauma In Vivo	JOURNAL OF EXPERIMENTAL NEUROSCIENCE			English	Article						Neurotrauma; myelin; oligodendrocyte; oxidative damage	DEGENERATION; MACROPHAGES	In the paper "Oligodendroglia are particularly vulnerable to oxidative damage after neurotrauma in vivo,' we determined the extent of oxidative damage to specific cellular sub-populations and structures within regions vulnerable to secondary degeneration and assessed the effect this had on oligodendroglial function. Comparative assessment of oxidative damage demonstrated selective vulnerability of oligodendroglia, specifically oligodendrocyte progenitor cells (OPCs) to DNA oxidation in vivo. Immunohistochemical fate mapping along the oligodendroglial lineage showed a transient susceptibility of these cells to DNA oxidation, protein nitration, and lipid peroxidation, with mature oligodendrocytes derived immediately after injury more vulnerable to DNA oxidation than their counterparts existing at the time of injury or later derived. In situ hybridization demonstrated a reduction in myelin regulatory factor (MyRF) messenger RNA (mRNA) fluorescence in newly derived mature oligodendrocytes, suggesting a compromise in the production and maintenance of the myelin sheath in these cells. The data imply a deficit in the normal differentiation of OPCs to myelinating oligodendrocytes. associated with a transient increase in oxidative damage, which may contribute to the dysmyelinating phenotype seen at chronic time points after injury. Identifying and understanding the sources of this oxidative damage is integral for the development of therapeutic interventions for neurotrauma.	[Giacci, Marcus; Fitzgerald, Melinda] Univ Western Australia, Sch Biol Sci, Nedlands, WA, Australia; [Fitzgerald, Melinda] Curtin Univ, Curtin Hlth Innovat Res Inst, Belmont, MA USA; [Fitzgerald, Melinda] Perron Inst Neurol & Translat Sci, Sarich Neurosci Res Inst Bldg,8 Verdun St, Nedlands, WA 6009, Australia		Fitzgerald, M (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Belmont, MA USA.; Fitzgerald, M (corresponding author), Perron Inst Neurol & Translat Sci, Sarich Neurosci Res Inst Bldg,8 Verdun St, Nedlands, WA 6009, Australia.	lindy.fitzgerald@curtin.edu.au	Fitzgerald, Melinda/C-4235-2011	Fitzgerald, Melinda/0000-0002-4823-8179; Giacci, Marcus/0000-0002-8330-678X			BOISON D, 1995, J NEUROSCI, V15, P5502; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Doig RLO, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0380-1; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Emery B, 2009, CELL, V138, P172, DOI 10.1016/j.cell.2009.04.031; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Giacci MK, 2018, J NEUROSCI, V38, P6491, DOI 10.1523/JNEUROSCI.1898-17.2018; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Hamilton N, 2008, GLIA, V56, P734, DOI 10.1002/glia.20649; Ignarro LJ, 1999, BIOSCIENCE REP, V19, P51, DOI 10.1023/A:1020150124721; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez FO, 2014, F1000PRIME REP, V6, P13, DOI DOI 10.12703/P6-13; Matute C, 2001, TRENDS NEUROSCI, V24, P224, DOI 10.1016/S0166-2236(00)01746-X; Smith NM, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1227-0; Thorburne SK, 1996, J NEUROCHEM, V67, P1014	15	12	12	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1179-0695			J EXP NEUROSCI	J. Exp. Neurosci.	NOV 14	2018	12								1179069518810004	10.1177/1179069518810004			3	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	HH4DM	WOS:000455670900001	30479489	Green Published, gold			2022-02-06	
J	Makinde, HM; Just, TB; Cuda, CM; Bertolino, N; Procissi, D; Schwulst, SJ				Makinde, Hadijat M.; Just, Talia B.; Cuda, Carla M.; Bertolino, Nicola; Procissi, Daniele; Schwulst, Steven J.			Monocyte depletion attenuates the development of posttraumatic hydrocephalus and preserves white matter integrity after traumatic brain injury	PLOS ONE			English	Article							DIFFUSION TENSOR; MILD; REHABILITATION; DISORDERS; ABNORMALITIES; DISABILITY; SYMPTOMS; MRI	Monocytes are amongst the first cells recruited into the brain after traumatic brain injury (TBI). We have shown monocyte depletion 24 hours prior to TBI reduces brain edema, decreases neutrophil infiltration and improves behavioral outcomes. Additionally, both lesion and ventricle size correlate with poor neurologic outcome after TBI. Therefore, we aimed to determine the association between monocyte infiltration, lesion size, and ventricle volume. We hypothesized that monocyte depletion would attenuate lesion size, decrease ventricle enlargement, and preserve white matter in mice after TBI. C57BL/6 mice underwent pan monocyte depletion via intravenous injection of liposome-encapsulated clodronate. Control mice were injected with liposome-encapsulated PBS. TBI was induced via an open-head, controlled cortical impact. Mice were imaged using magnetic resonance imaging (MRI) at 1, 7, and 14 days post-injury to evaluate progression of lesion and to detect morphological changes associated with injury (3D T1-weighted MRI) including regional alterations in white matter patterns (multi-direction diffusion MRI). Lesion size and ventricle volume were measured using semi-automatic segmentation and active contour methods with the software program ITK-SNAP. Data was analyzed with the statistical software program PRISM. No significant effect of monocyte depletion on lesion size was detected using MRI following TBI (p = 0.4). However, progressive ventricle enlargement following TBI was observed to be attenuated in the monocyte-depleted cohort (5.3 +/- 0.9mm(3)) as compared to the sham-depleted cohort (13.2 +/- 3.1mm(3); p = 0.02). Global white matter integrity and regional patterns were evaluated and quantified for each mouse after extracting fractional anisotropy maps from the multi-direction diffusion-MRI data using Siemens Syngo DTI analysis package. Fractional anisotropy (FA) values were preserved in the monocyte-depleted cohort (123.0 +/- 4.4mm(3)) as compared to sham-depleted mice (94.9 +/- 4.6mm(3); p = 0.025) by 14 days post-TBI. All TBI mice exhibited FA values lower than those from a representative naive control group with intact white matter tracts and FA similar to 200 mm(3)). The MRI derived assessment of injury progression suggests that monocyte depletion at the time of injury may be a novel therapeutic strategy in the treatment of TBI. Furthermore, non-invasive longitudinal imaging allows for the evaluation of both TBI progression as well as therapeutic response over the course of injury.	[Makinde, Hadijat M.; Just, Talia B.; Schwulst, Steven J.] Northwestern Univ, Div Trauma & Crit Care, Dept Surg, Chicago, IL 60611 USA; [Cuda, Carla M.] Northwestern Univ, Dept Med, Div Rheumatol, Chicago, IL 60611 USA; [Bertolino, Nicola; Procissi, Daniele] Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA; [Procissi, Daniele] Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA		Schwulst, SJ (corresponding author), Northwestern Univ, Div Trauma & Crit Care, Dept Surg, Chicago, IL 60611 USA.	s-schwulst@northwestern.edu		Just, Talia/0000-0002-6372-7974; Procissi, Daniele/0000-0001-5350-0170; Schwulst, Steven/0000-0003-4248-8545; Cuda, Carla/0000-0002-2022-8171; Makinde, Hadijat-Kubura/0000-0001-8492-4187; Bertolino, Nicola/0000-0002-5924-0995	National Institutes of Health/National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [1K08GM117341-01]; American College of Surgeons/C. James Carrico Faculty Research Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K08GM117341] Funding Source: NIH RePORTER	This work was supported by 1) National Institutes of Health/National Institute of General Medical Sciences, Grant number: 1K08GM117341-01, Granted to SJS. 2) American College of Surgeons/C. James Carrico Faculty Research Award, No grant number, Granted to SJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea A, 2012, NEUROIMAGE, V63, P1633, DOI 10.1016/j.neuroimage.2012.07.021; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Dall'Ara E, 2016, MECH AGEING DEV, V160, P93, DOI 10.1016/j.mad.2016.08.001; Di G, 2018, WORLD NEUROSURG; Edlow BL, 2012, SEMIN NEUROL, V32, P374, DOI 10.1055/s-0032-1331810; Faul M, 2010, TRAUMATIC BRAIN INJU; Fotakopoulos G, 2016, J NEUROL SURG PART A, V77, P88, DOI 10.1055/s-0035-1558411; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hu QX, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00337; Jin X, 2012, J SOFTWARE, V7, P6, DOI DOI 10.1371/J0URNAL.P0NE.0041892; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Makinde HM, 2017, J IMMUNOL, V199, P3583, DOI 10.4049/jimmunol.1700896; Makinde HM, 2017, SHOCK, V48, P276, DOI 10.1097/SHK.0000000000000859; Martin LA, 2013, JAMA PSYCHIAT, V70, P1100, DOI 10.1001/jamapsychiatry.2013.1985; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Nasi D, 2018, WORLD NEUROSURG; Ozarslan E, 2005, MAGN RESON MED, V53, P866, DOI 10.1002/mrm.20411; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Scholz J, 2016, NEUROIMAGE, V142, P656, DOI 10.1016/j.neuroimage.2016.03.069; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Trahanas DM, 2015, SHOCK, V43, P255, DOI 10.1097/SHK.0000000000000291; Tu TW, 2017, J NEUROTRAUM, V34, P248, DOI 10.1089/neu.2015.4355; Vadivelu S, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.8.FOCUS16266; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; Weintraub AH, 2017, ARCH PHYS MED REHAB, V98, P312, DOI 10.1016/j.apmr.2016.08.478; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Wu YJL, 2017, BIRTH DEFECTS RES, V109, P758, DOI 10.1002/bdr2.1051; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	42	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0202722	10.1371/journal.pone.0202722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	WOS:000449027600006	30383765	Green Submitted, gold, Green Published			2022-02-06	
J	Mi, DJ; Dixit, S; Warner, TA; Kennard, JA; Scharf, DA; Kessler, ES; Moore, LM; Consoli, DC; Bown, CW; Eugene, AJ; Kang, JQ; Harrison, FE				Mi, Deborah J.; Dixit, Shilpy; Warner, Timothy A.; Kennard, John A.; Scharf, Daniel A.; Kessler, Eric S.; Moore, Lisa M.; Consoli, David C.; Bown, Corey W.; Eugene, Angeline J.; Kang, Jing-Qiong; Harrison, Fiona E.			Altered glutamate clearance in ascorbate deficient mice increases seizure susceptibility and contributes to cognitive impairment in APP/PSEN1 mice	NEUROBIOLOGY OF AGING			English	Article						Vitamin C; Ascorbate; GLT-1; Glutamate; Seizure; Behavior	GLT-1 TRANSPORTER ACTIVATOR; CUE-INDUCED REINSTATEMENT; TRAUMATIC BRAIN-INJURY; VITAMIN-C-DEFICIENCY; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; UP-REGULATION; HUNTINGTONS-DISEASE; MOUSE MODELS; AMYLOID DEPOSITION	Ascorbate (vitamin C) is critical as a first line of defense antioxidant within the brain, and specifically within the synapse. Ascorbate is released by astrocytes during glutamate clearance and disruption of this exchange mechanism may be critical in mediating glutamate toxicity within the synapse. This is likely even more critical in neurodegenerative disorders with associated excitotoxicity and seizures, in particular Alzheimer's disease, in which ascorbate levels are often low. Using Gulo(-/-) mice that are dependent on dietary ascorbate, we established that low brain ascorbate increased sensitivity to kainic acid as measured via behavioral observations, electroencephalography (EEG) measurements, and altered regulation of several glutamatergic system genes. Kainic acid-induced immobility was improved in wildtype mice following treatment with ceftriaxone, which upregulates glutamate transporter GLT-1. The same effect was not observed in ascorbate-deficient mice in which sufficient ascorbate is not available for release. A single, mild seizure event was sufficient to disrupt performance in the water maze in low-ascorbate mice and in APP(SWE)/PSEN1(dE9) mice. Together, the data support the critical role of brain ascorbate in maintaining protection during glutamatergic hyperexcitation events, including seizures. The study further supports a role for mild, subclinical seizures in cognitive decline in Alzheimer's disease. (C) 2018 Elsevier Inc. All rights reserved.	[Mi, Deborah J.; Dixit, Shilpy; Kennard, John A.; Harrison, Fiona E.] Vanderbilt Univ, Med Ctr, Dept Med, Div Diabet Endocrinol & Metab, 221 Kirkland Hall, Nashville, TN 37235 USA; [Warner, Timothy A.; Kang, Jing-Qiong] Vanderbilt Univ, Med Ctr, Dept Med, Div Neurol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Scharf, Daniel A.; Kessler, Eric S.; Moore, Lisa M.; Eugene, Angeline J.] Vanderbilt Univ, Undergrad Program Neurosci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Consoli, David C.; Bown, Corey W.] Vanderbilt Univ, Interdisciplinary Grad Program, 221 Kirkland Hall, Nashville, TN 37235 USA		Harrison, FE (corresponding author), Vanderbilt Univ, Med Ctr, Diabet Endocrinol & Metab, 7465 MRB4,2213 Garland Ave, Nashville, TN 37235 USA.	Fiona.harrison@vanderbilt.edu			NIA/NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG038739, T32-AG058524]; VAUS Department of Veterans Affairs [I01 CX001610-01]; EKS NICHD of the NIH [U54HD083211]; CURE; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 082635]; NCI/NIH Cancer CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [5P30 CA68485-19]; Vanderbilt Mouse Metabolic Phenotyping Center [2 U24 DK059637-16]; Dravet syndrome foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD083211] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [U24DK059637, U2CDK059637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH064913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG038739, T32AG058524] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001610] Funding Source: NIH RePORTER	Funding for these studies was provided by AG038739 from NIA/NIH to FEH and I01 CX001610-01 from the VA. Behavioral testing was performed in the Vanderbilt Mouse Neurobehavioral Laboratory, which is supported by the EKS NICHD of the NIH under Award #U54HD083211. The work was also supported by research grants from CURE, Dravet syndrome foundation, and NIH (NS 082635) to JQK. CWB received support from T32-AG058524 from NIA/NIH.; The authors acknowledge the Translational Pathology Shared Resource supported by NCI/NIH Cancer Center Support Grant 5P30 CA68485-19 and the Vanderbilt Mouse Metabolic Phenotyping Center Grant 2 U24 DK059637-16. The authors would like to acknowledge the assistance and technical support of Navila Sharif, Robert Zhang, and Meghan Montgomery. The authors would further like to thank Kylie Muccilli and Rafael Perez for assistance with creating figures and Dr Christine Konradi and Dr Julie Loundes-Taylor for assistance with statistical analyses.	Akman O, 2010, EPILEPSY RES, V89, P185, DOI 10.1016/j.eplepsyres.2009.12.005; Arain F, 2015, NEUROBIOL DIS, V82, P164, DOI 10.1016/j.nbd.2015.05.016; Arain FM, 2012, EPILEPSIA, V53, pE161, DOI 10.1111/j.1528-1167.2012.03596.x; Baker DA, 2002, J NEUROSCI, V22, P9134; Bezzina C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119910; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Chin J, 2013, EPILEPSY BEHAV, V26, P343, DOI 10.1016/j.yebeh.2012.11.040; Chung WK, 2009, NEUROBIOL DIS, V33, P499, DOI 10.1016/j.nbd.2008.12.004; Dixit S, 2015, ACS CHEM NEUROSCI, V6, P570, DOI 10.1021/cn500308h; Friedman D, 2012, CNS NEUROSCI THER, V18, P285, DOI 10.1111/j.1755-5949.2011.00251.x; Gale CR, 1996, BRIT MED J, V312, P608; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Glaso M, 2004, J Nutr Health Aging, V8, P407; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; GOODWIN JS, 1983, JAMA-J AM MED ASSOC, V249, P2917, DOI 10.1001/jama.249.21.2917; Harrison FE, 2010, FREE RADICAL BIO MED, V49, P821, DOI 10.1016/j.freeradbiomed.2010.06.008; Harrison FE, 2010, PHARMACOL BIOCHEM BE, V94, P543, DOI 10.1016/j.pbb.2009.11.009; Harrison FE, 2008, J NEUROCHEM, V106, P1198, DOI 10.1111/j.1471-4159.2008.05469.x; Harrison FE, 2012, J ALZHEIMERS DIS, V29, P711, DOI 10.3233/JAD-2012-111853; Harrison FE, 2010, BRAIN RES, V1348, P181, DOI 10.1016/j.brainres.2010.05.090; Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018; Hassel B, 2008, NEUROCHEM RES, V33, P232, DOI 10.1007/s11064-007-9463-1; Jackson HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125897; Jelenkovic AV, 2008, EXP BIOL MED, V233, P1389, DOI 10.3181/0803-RM-83; Karaman I, 2013, PHARMACOL BIOCHEM BE, V108, P61, DOI 10.1016/j.pbb.2013.04.013; Kim HJ, 2016, NEUROCHEM RES, V41, P1035, DOI 10.1007/s11064-015-1789-5; Kirvell SL, 2006, J NEUROCHEM, V98, P939, DOI 10.1111/j.1471-4159.2006.03935.x; Knackstedt LA, 2010, BIOL PSYCHIAT, V67, P81, DOI 10.1016/j.biopsych.2009.07.018; LaCrosse AL, 2017, J NEUROSCI, V37, P5809, DOI 10.1523/JNEUROSCI.3717-16.2017; Lam AD, 2017, NAT MED, V23, P678, DOI 10.1038/nm.4330; Larner AJ, 2011, EPILEPSY BEHAV, V21, P20, DOI 10.1016/j.yebeh.2011.03.022; MacGregor DG, 1996, BRAIN RES, V727, P133, DOI 10.1016/0006-8993(96)00362-9; Maeda N, 2000, P NATL ACAD SCI USA, V97, P841, DOI 10.1073/pnas.97.2.841; Masliah E, 1996, ANN NEUROL, V40, P759, DOI 10.1002/ana.410400512; Matos-Ocasio F, 2014, PHARMACOL BIOCHEM BE, V122, P118, DOI 10.1016/j.pbb.2014.03.011; Melendez RI, 2005, ALCOHOL CLIN EXP RES, V29, P326, DOI 10.1097/01.ALC.0000156086.65665.4D; Miller BR, 2008, NEUROSCIENCE, V153, P329, DOI 10.1016/j.neuroscience.2008.02.004; Miller BR, 2012, J NEUROCHEM, V121, P629, DOI 10.1111/j.1471-4159.2012.07691.x; Minkeviciene R, 2008, J NEUROCHEM, V105, P584, DOI 10.1111/j.1471-4159.2007.05147.x; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Noebels J, 2011, EPILEPSIA, V52, P39, DOI 10.1111/j.1528-1167.2010.02909.x; Oliveira MS, 2004, NEUROSCIENCE, V128, P721, DOI 10.1016/j.neuroscience.2004.07.012; Omrani A, 2009, J PHYSIOL-LONDON, V587, P4575, DOI 10.1113/jphysiol.2009.177881; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pandis D, 2012, EPILEPSY CURR, V12, P184, DOI 10.5698/1535-7511-12.5.184; Pauletti A, 2017, BRAIN, V140, P1885, DOI 10.1093/brain/awx117; Perrig WJ, 1997, J AM GERIATR SOC, V45, P718, DOI 10.1111/j.1532-5415.1997.tb01476.x; Polidori MC, 2002, J ALZHEIMERS DIS, V4, P517; Quinn J, 2003, J ALZHEIMERS DIS, V5, P309, DOI 10.3233/JAD-2003-5406; Rao PSS, 2015, PSYCHOPHARMACOLOGY, V232, P2333, DOI 10.1007/s00213-015-3868-3; Rebec GV, 2013, ANTIOXID REDOX SIGN, V19, P2115, DOI 10.1089/ars.2013.5387; Rinaldi P, 2003, NEUROBIOL AGING, V24, P915, DOI 10.1016/S0197-4580(03)00031-9; Ritter AC, 2016, EPILEPSIA, V57, P984, DOI 10.1111/epi.13397; Riviere S, 1998, INT J GERIATR PSYCH, V13, P749; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Sari Y, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-62; Sari Y, 2009, J NEUROSCI, V29, P9239, DOI 10.1523/JNEUROSCI.1746-09.2009; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Sierksma ASR, 2016, J ALZHEIMERS DIS, V51, P677, DOI 10.3233/JAD-151066; Sotiriou S, 2002, NAT MED, V8, P514, DOI 10.1038/nm0502-514; Steinbach JP, 1998, CELL DEATH DIFFER, V5, P858, DOI 10.1038/sj.cdd.4400391; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Trotti D, 1997, EUR J NEUROSCI, V9, P1236, DOI 10.1111/j.1460-9568.1997.tb01478.x; VOLICER L, 1995, DEMENTIA, V6, P258, DOI 10.1159/000106956; Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136; Ward MS, 2013, J NEUROCHEM, V124, P363, DOI 10.1111/jnc.12069; Warner TA, 2015, EPILEPSY RES, V110, P20, DOI 10.1016/j.eplepsyres.2014.11.017; Wilson JX, 1997, CAN J PHYSIOL PHARM, V75, P1149, DOI 10.1139/cjpp-75-10-11-1149; Wilson JX, 2000, BRAIN RES, V858, P61, DOI 10.1016/S0006-8993(99)02433-6; Zhang MY, 2014, NEUROBIOL AGING, V35, P2713, DOI 10.1016/j.neurobiolaging.2014.06.009; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007; Zumkehr J, 2015, NEUROBIOL AGING, V36, P2260, DOI 10.1016/j.neurobiolaging.2015.04.005	72	12	12	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	NOV	2018	71						241	254		10.1016/j.neurobiolaging.2018.08.002			14	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	GU7QY	WOS:000445521400023	30172223	Green Accepted, Bronze			2022-02-06	
J	Shetty, T; Nguyen, JT; Cogsil, T; Tsiouris, AJ; Niogi, SN; Kim, EU; Dalal, A; Halvorsen, K; Cummings, K; Zhang, TH; Masdeu, JC; Mukherjee, P; Marinelli, L				Shetty, Teena; Nguyen, Joseph T.; Cogsil, Taylor; Tsiouris, Apostolos John; Niogi, Sumit N.; Kim, Esther U.; Dalal, Aashka; Halvorsen, Kristin; Cummings, Kelianne; Zhang, Tianhao; Masdeu, Joseph C.; Mukherjee, Pratik; Marinelli, Luca			Clinical Findings in a Multicenter MRI Study of Mild TBI	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; age; gender; neuropsychological assessments; concussion; imaging; white matter hyperintensities; risk factors	TRAUMATIC-BRAIN-INJURY; SPORT-RELATED CONCUSSION; WHITE-MATTER HYPERINTENSITIES; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; ADOLESCENT BRAIN; RECOVERY; METAANALYSIS; POPULATION; MATURATION	Background: Uncertainty continues to surround mild traumatic brain injury (mTBI) diagnosis, symptoms, prognosis, and outcome due in part to a lack of objective biomarkers of injury and recovery. As mTBI gains recognition as a serious public health epidemic, there is need to identify risk factors, diagnostic tools, and imaging biomarkers to help guide diagnosis and management. Methods: One hundred and eleven patients (15-50 years old) were enrolled acutely after mTBI and followed with up to four standardized serial assessments over 3 months. Each encounter included a clinical exam, neuropsychological assessment, and magnetic resonance imaging (MRI). Chi-square and linear mixed models were used to assess changes over time and determine potential biomarkers of mTBI severity and outcome. Results: The symptoms most frequently endorsed after mTBI were headache (91%), not feeling right (89%), fatigue (86%), and feeling slowed down (84%). Of the 104 mTBI patients with a processed MRI scan, 28 (27%) subjects had white matter changes which were deemed unrelated to age, and 26 of these findings were deemed unrelated to acute trauma. Of the neuropsychological assessments tested, 5- and 6-Digit Backward Recall, the modified Balance Error Scoring System (BESS), and Immediate 5-Word Recall significantly improved longitudinally in mTBI subjects and differentiated between mTBI subjects and controls. Female sex was found to increase symptom severity scores (SSS) at every time point. Age >= 25 years was correlated with increased SSS. Subjects aged >= 25 also did not improve longitudinally on 5-Digit Backward Recall, Immediate 5-Word Recall, or Single-Leg Stance of the BESS, whereas subjects < 25 years improved significantly. Patients who reported personal history of depression, anxiety, or other psychiatric disorder had higher SSS at each time point. Conclusions: The results of this study show that 5- and 6-Digit Backward Recall, the modified BESS, and Immediate 5-Word Recall should be considered useful in demonstrating cognitive and vestibular improvement during the mTBI recovery process. Clinicians should take female sex, older age, and history of psychiatric disorder into account when managing mTBI patients. Further study is necessary to determine the true prevalence of white matter changes in people with mTBI.	[Shetty, Teena; Cogsil, Taylor; Kim, Esther U.; Halvorsen, Kristin] Hosp Special Surg, Dept Neurol, 535 E 70th St, New York, NY 10021 USA; [Nguyen, Joseph T.] Hosp Special Surg, Biostat Core, 535 E 70th St, New York, NY 10021 USA; [Tsiouris, Apostolos John; Niogi, Sumit N.] Weill Cornell Med, Dept Radiol, New York, NY USA; [Dalal, Aashka] New York Med Coll, Valhalla, NY 10595 USA; [Cummings, Kelianne] GE Global Res Healthcare, Waukesha, WI USA; [Zhang, Tianhao] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Masdeu, Joseph C.] Houston Methodist Hosp, Dept Neurol, Houston, TX USA; [Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Marinelli, Luca] GE Global Res Ctr, Niskayuna, NY USA		Shetty, T (corresponding author), Hosp Special Surg, Dept Neurol, 535 E 70th St, New York, NY 10021 USA.	shettyt@hss.edu	Marinelli, Luca/AAB-5933-2021; Nguyen, Joseph/ABC-1527-2021	Nguyen, Joseph/0000-0003-1686-3911; Cogsil, Taylor/0000-0002-5127-7566; Marinelli, Luca/0000-0001-7775-5952	General Electric - National Football League Head Health Initiative; HSS Department of Neurology; Houston Methodist Foundation	The funding for this study was provided by the General Electric - National Football League Head Health Initiative.; We would like to thank previous research coordinators and volunteers Dan Zuchelli, Lorena Loci, Megan Parmenter, and Zachary Gulergun, all of whom were integral in enrolling patients and documenting study visits. We would like to thank the entirety of the GE/NFL Medical Advisory Board for their continued direction as well as Dr. Victor Miranda, Ajit Shankaranarayanan, and Amy Gallenberg for their efforts. Within HSS, Tzipora Kuba's research management was necessary for the successful completion of this project. Dr. Hollis Potter and the HSS Radiology Department, specifically Joo Jung and Wendy Diesing, played an instrumental role in the guidance and execution of the imaging portion of this study. Lastly, we would like to thank the HSS Department of Neurology for providing the facility and support necessary for this investigation and specifically Virgen Gonzalez-Alakham for her efforts with enrollment. At Houston Methodist, Drs. Kenneth Podell and Howard Derman referred and studied patients, Jennifer Garrett coordinated the study, and Dr. Armen Kocharian provided MRI support. The Chao, Graham, Harrison and Natz Funds of the Houston Methodist Foundation contributed support.	Arain M, 2013, NEUROPSYCH DIS TREAT, V9, P449, DOI 10.2147/NDT.S39776; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bin Zahid A, 2018, APPL NEUROPSYCH-ADUL, V25, P110, DOI 10.1080/23279095.2016.1248765; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M, 2010, TRAUMATIC BRAIN INJU; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hofmann E, 1992, EUR RADIOL, V2, P154; Hopkins RO, 2006, J NEUROIMAGING, V16, P243, DOI 10.1111/j.1552-6569.2006.00047.x; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kostyun RO, 2015, SPORTS HEALTH, V7, P52, DOI 10.1177/1941738114555075; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lyoo IK, 2002, COMPR PSYCHIAT, V43, P361, DOI 10.1053/comp.2002.34636; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; National Research Council & Committee on sports- related concussions in youth, 2014, SPORTS RELATED CONCU; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; PUJOL J, 1993, ANN NEUROL, V34, P71, DOI 10.1002/ana.410340113; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Samson K., 2018, NEUROL TODAY, V18, P12, DOI 10.1097/01.NT.0000532091.01255.0b; Silverberg ND, 2014, BRAIN INJURY, V28, P1590, DOI 10.3109/02699052.2014.943287; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Vos P, 2015, TRAUMATIC BRAIN INJU; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	42	12	12	1	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 23	2018	9								836	10.3389/fneur.2018.00836			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GX7ST	WOS:000447977500001	30405511	gold, Green Published			2022-02-06	
J	Thomasy, HE; Opp, MR				Thomasy, Hannah E.; Opp, Mark R.			Hypocretin Mediates Sleep and Wake Disturbances in a Mouse Model of Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; controlled cortical impact; orexin; sleep; TBI; wake	EXCESSIVE DAYTIME SLEEPINESS; CONTROLLED CORTICAL IMPACT; SLOW-WAVE SLEEP; NOCTURNAL SLEEP; OREXIN KNOCKOUT; NIGHTTIME SLEEP; PROMOTES SLEEP; UNITED-STATES; WHITE-MATTER; MICE LACKING	Traumatic brain injury (TBI) is a major cause of disability worldwide. Post-TBI sleep and wake disturbances are extremely common and difficult for patients to manage. Sleep and wake disturbances contribute to poor functional and emotional outcomes from TBI, yet effective therapies remain elusive. A more comprehensive understanding of mechanisms underlying post-TBI sleep and wake disturbance will facilitate development of effective pharmacotherapies. Previous research in human patients and animal models indicates that altered hypocretinergic function may be a major contributor to sleep-wake disturbance after TBI. In this study, we further elucidate the role of hypocretin by determining the impact of TBI on sleep-wake behavior of hypocretin knockout (HCRT KO) mice. Adult male C57BL/6J and HCRT KO mice were implanted with electroencephalography recording electrodes, and pre-injury baseline recordings were obtained. Mice were then subjected to either moderate TBI or sham surgery. Additional recordings were obtained and sleep-wake behavior determined at 3, 7, 15, and 30 days after TBI or sham procedures. At baseline, HCRT KO mice had a significantly different sleep-wake phenotype than control C57BL/6J mice. Post-TBI sleep-wake behavior was altered in a genotype-dependent manner: sleep of HCRT KO mice was not altered by TBI, whereas C57BL/6J mice had more non-rapid eye movement sleep, less wakefulness, and more short wake bouts and fewer long wake bouts. Numbers of hypocretin-positive cells were reduced in C57BL/6J mice by TBI. Collectively, these data indicate that the hypocretinergic system is involved in the alterations in sleep-wake behavior that develop after TBI in this model, and suggest potential therapeutic interventions.	[Thomasy, Hannah E.; Opp, Mark R.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Opp, Mark R.] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA		Opp, MR (corresponding author), Univ Colorado, Dept Integrat Physiol, 2860 Wilderness Pl,Room 201K, Boulder, CO 80301 USA.	mark.opp@colorado.edu		Opp, Mark/0000-0002-9831-9866	Department of Anesthesiology and Pain Medicine of the University of Washington, Seattle, Washington; Graduate Program in Neuroscience of the University of Washington, Seattle, Washington; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AI115706]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R21AI115706] Funding Source: NIH RePORTER	We thank Dr. John Peever for providing the hypocretin knockout mice used in these experiments, and Dr. Maria Pavlova for overseeing their breeding. The technical assistance of Ms. Phoebe Domingo is greatly appreciated. This study was supported, in part, by the Department of Anesthesiology and Pain Medicine and the Graduate Program in Neuroscience of the University of Washington, Seattle, Washington, as well as the National Institutes of Health grant AI115706 (MRO).	Aitta-Aho T, 2016, NEUROBIOL LEARN MEM, V136, P183, DOI 10.1016/j.nlm.2016.10.005; Al-Adawi S, 2006, SLEEP MED, V7, P287, DOI 10.1016/j.sleep.2005.11.008; Anaclet C, 2009, J NEUROSCI, V29, P14423, DOI 10.1523/JNEUROSCI.2604-09.2009; Arbour C, 2015, SLEEP MED, V16, P534, DOI 10.1016/j.sleep.2014.12.002; Baracchi F, 2008, BRAIN BEHAV IMMUN, V22, P982, DOI 10.1016/j.bbi.2008.02.001; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2016, SLEEP MED CLIN, V11, P19, DOI 10.1016/j.jsmc.2015.10.004; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Benca RM, 2007, J CLIN PSYCHIAT, V68, P5; Betschart C, 2013, J MED CHEM, V56, P7590, DOI 10.1021/jm4007627; Blumberg MS, 2007, EUR J NEUROSCI, V25, P512, DOI 10.1111/j.1460-9568.2006.05292.x; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; BORBELY AA, 1981, ELECTROEN CLIN NEURO, V51, P483, DOI 10.1016/0013-4694(81)90225-X; Brisbare-Roch C, 2007, NAT MED, V13, P150, DOI 10.1038/nm1544; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Brundin L, 2007, EUR NEUROPSYCHOPHARM, V17, P573, DOI 10.1016/j.euroneuro.2007.01.005; Cajochen C, 2001, NEUROREPORT, V12, P2277, DOI 10.1097/00001756-200107200-00046; Cao M, 2011, CURR NEUROL NEUROSCI, V11, P227, DOI 10.1007/s11910-010-0172-9; Castriotta RJ, 2009, J CLIN SLEEP MED, V5, P137; Chan LG, 2015, J HEAD TRAUMA REHAB, V30, pE67, DOI 10.1097/HTR.0000000000000119; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chiu HY, 2013, J FORMOS MED ASSOC, V112, P545, DOI 10.1016/j.jfma.2013.06.007; De La Rue-Evans L, 2013, REHABIL NURS, V38, P2, DOI 10.1002/rnj.66; Deats SP, 2014, NEUROSCIENCE, V272, P252, DOI 10.1016/j.neuroscience.2014.04.069; Duclos C, 2015, AUST OCCUP THER J, V62, P2, DOI 10.1111/1440-1630.12164; Duffy CM, 2015, NEUROSCI LETT, V606, P140, DOI 10.1016/j.neulet.2015.08.033; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Goldbart A, 2014, SLEEP, V37, P1043, DOI 10.5665/sleep.3758; Gosselin N, 2010, J NEUROL NEUROSUR PS, V81, P1297, DOI 10.1136/jnnp.2010.222471; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Gotter AL, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-109; Grima NA, 2016, NEUROREHAB NEURAL RE, V30, P972, DOI 10.1177/1545968316650279; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hazra A, 2014, J NEUROSCI RES, V92, P1434, DOI 10.1002/jnr.23430; Huang T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/358125; Hunsley MS, 2006, GENES BRAIN BEHAV, V5, P451, DOI 10.1111/j.1601-183X.2005.00179.x; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Ingiosi AM, 2015, BRAIN BEHAV IMMUN, V48, P244, DOI 10.1016/j.bbi.2015.03.014; Ito N, 2008, NEUROSCIENCE, V157, P720, DOI 10.1016/j.neuroscience.2008.09.042; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Jimenez-Correa U, 2009, ARQ NEURO-PSIQUIAT, V67, P995, DOI 10.1590/S0004-282X2009000600006; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Kemp S, 2004, BRAIN INJURY, V18, P911, DOI 10.1080/02699050410001671892; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kishi T., 2015, PLOS ONE, P10; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Lequerica A, 2015, ARCH PHYS MED REHAB, V96, P1802, DOI 10.1016/j.apmr.2015.05.011; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Mang GM, 2012, SLEEP, V35, P1625, DOI 10.5665/sleep.2232; Mani Arash, 2015, Bull Emerg Trauma, V3, P93; Mantua J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00328; Menn SJ, 2014, J CLIN SLEEP MED, V10, P1181, DOI 10.5664/jcsm.4196; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Modarres Mo H., 2017, Neurobiology of Sleep and Circadian Rhythms, V2, P59, DOI 10.1016/j.nbscr.2016.06.001; Mollayeva T, 2017, SLEEP MED, V34, P179, DOI 10.1016/j.sleep.2017.02.021; Morairty SR, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00003; Mori T, 2016, PSYCHOPHARMACOLOGY, V233, P2343, DOI 10.1007/s00213-016-4282-1; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Nguyen S, 2017, ARCH PHYS MED REHAB, V98, P1508, DOI 10.1016/j.apmr.2017.02.031; Noain D, 2018, J NEUROTRAUM, V35, P85, DOI 10.1089/neu.2017.5067; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Pepeu G, 2017, BRAIN RES, V1670, P173, DOI 10.1016/j.brainres.2017.06.023; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Pizza F, 2015, SLEEP, V38, P1277, DOI 10.5665/sleep.4908; Plazzi G, 2014, SLEEP MED, V15, P1046, DOI 10.1016/j.sleep.2014.04.020; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Roth T, 2013, J CLIN SLEEP MED, V9, P955, DOI 10.5664/jcsm.3004; Rowe RK, 2014, BRAIN INJURY, V28, P504, DOI 10.3109/02699052.2014.888768; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Sabir M, 2015, BRAIN BEHAV IMMUN, V47, P118, DOI 10.1016/j.bbi.2014.12.023; Sandsmark DK, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx044; Sasaki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020360; Scammell T.E., 2004, SLEEP BIOL RHYTHMS, V2, pS13; Scammell TE, 2015, NEW ENGL J MED, V373, P2654, DOI 10.1056/NEJMra1500587; Schmidt AT, 2015, COGN BEHAV NEUROL, V28, P53, DOI 10.1097/WNN.0000000000000056; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Sheng P., 2013, PLOS ONE, P8; Sinclair KL, 2014, NEUROREHAB NEURAL RE, V28, P303, DOI 10.1177/1545968313508472; Sinclair KL, 2014, BEHAV SLEEP MED, V12, P13, DOI 10.1080/15402002.2012.726203; Skopin MD, 2015, J NEUROTRAUM, V32, P289, DOI 10.1089/neu.2014.3664; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; Sutton BC, 2014, SLEEP, V37, P505, DOI 10.5665/sleep.3486; Tannenbaum PL, 2016, SLEEP, V39, P603, DOI 10.5665/sleep.5536; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Thomasy Hannah E., 2017, Neurobiology of Sleep and Circadian Rhythms, V2, P71, DOI 10.1016/j.nbscr.2016.03.001; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Towns S.J., 2015, BRAIN INJURY, V7, P1; Tsunematsu T, 2013, BEHAV BRAIN RES, V255, P64, DOI 10.1016/j.bbr.2013.05.021; Tsunematsu T, 2011, J NEUROSCI, V31, P10529, DOI 10.1523/JNEUROSCI.0784-11.2011; Valko PO, 2016, SLEEP, V39, P1249, DOI 10.5665/sleep.5844; Valko PO, 2015, ANN NEUROL, V77, P177, DOI 10.1002/ana.24298; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; Wiseman-Hakes C, 2016, NEUROREHAB NEURAL RE, V30, P713, DOI 10.1177/1545968315619697; Wu HJ, 2014, SLEEP MED, V15, P607, DOI 10.1016/j.sleep.2013.12.012; Xu X, 2017, SLEEP MED, V33, P47, DOI 10.1016/j.sleep.2016.08.012; Yang LY, 2013, J NEUROSCI, V33, P5275, DOI 10.1523/JNEUROSCI.3200-12.2013; Yoshida Y, 2015, J MED CHEM, V58, P4648, DOI 10.1021/acs.jmedchem.5b00217	114	12	12	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2019	36	5					802	814		10.1089/neu.2018.5810		OCT 2018	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HR2BG	WOS:000446275800001	30136622	Green Published			2022-02-06	
J	Awad, H; Bratasz, A; Nuovo, G; Burry, R; Meng, XM; Kelani, H; Brown, M; Ramadan, ME; Williams, J; Bouhliqah, L; Popovich, PG; Guan, Z; Mcallister, C; Corcoran, SE; Kaspar, B; Basso, DM; Otero, JJ; Kirsch, C; Davis, IC; Croce, CM; Michaille, JJ; Tili, E				Awad, Hamdy; Bratasz, Anna; Nuovo, Gerard; Burry, Richard; Meng, Xiaomei; Kelani, Hesham; Brown, Melissa; Ramadan, Mohamed E.; Williams, Jim; Bouhliqah, Lamia; Popovich, Phillip G.; Guan, Zhen; Mcallister, Cynthia; Corcoran, Sarah E.; Kaspar, Brian; Basso, D. Michele; Otero, Jose J.; Kirsch, Claudia; Davis, Ian C.; Croce, Carlo Maria; Michaille, Jean-Jacques; Tili, Esmerina			MiR-155 deletion reduces ischemia-induced paralysis in an aortic aneurysm repair mouse model: Utility of immunohistochemistry and histopathology in understanding etiology of spinal cord paralysis	ANNALS OF DIAGNOSTIC PATHOLOGY			English	Article						Ischemia; Spinal cord; microRNA; Immunohistochemistry; Histopathology	BLOOD-BRAIN-BARRIER; REPERFUSION INJURY; ENDOTHELIAL-CELLS; MICRORNAS; INFLAMMATION; MFSD2A; MICE; TRANSPORTER; INHIBITION; DISEASE	Spinal cord paralysis is relatively common after surgical repair of thoraco-abdominal aortic aneurysm (TAAA) and its etiology is unknown. The present study was designed to examine the histopathology of the disease and investigate whether miR-155 ablation would reduce spinal cord ischemic damage and delayed hindlimb paralysis induced by aortic cross-clamping (ACC) in our mouse model. The loss of locomotor function in ACC-paralyzed mice correlated with the presence of extensive gray matter damage and central cord edema, with minimal white matter histopathology. qRTPCR and Western blotting showed that the spinal cords of wild-type ACC mice that escaped paralysis showed lower miR-155 expression and higher levels of transcripts encoding Mfsd2a, which is implicated in the maintenance of blood-brain barrier integrity. In situ based testing demonstrated that increased miR-155 detection in neurons was highly correlated with the gray matter damage and the loss of one of its targets, Mfsd2a, could serve as a good biomarker of the endothelial cell damage. In vitro, we demonstrated that miR-155 targeted Mfsd2a in endothelial cells and motoneurons and increased endothelial cell permeability. Finally, miR-155 ablation slowed the progression of central cord edema, and reduced the incidence of paralysis by 40%. In sum, the surgical pathology findings clearly indicated that the epicenter of the ischemic-induced paralysis was the gray matter and that endothelial cell damage correlated to Mfsd2a loss is a good biomarker of the disease. MiR-155 targeting therefore offers new therapeutic opportunity for edema caused by traumatic spinal cord injury and diagnostic pathologists, by using immunohistochemistry, can clarify if this mechanism also is important in other ischemic diseases of the CNS, including stroke.	[Awad, Hamdy; Kelani, Hesham; Brown, Melissa; Ramadan, Mohamed E.; Tili, Esmerina] Ohio State Univ, Wexner Med Ctr, Dept Anesthesiol, Columbus, OH 43210 USA; [Bratasz, Anna] OSU, Wexner Med Ctr, Small Anim Imaging Ctr Shared Resource, Columbus, OH 43210 USA; [Nuovo, Gerard; Williams, Jim] Phylogeny Inc, Powell, OH 43065 USA; [Burry, Richard; Popovich, Phillip G.; Guan, Zhen] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Meng, Xiaomei] Nationwide Childrens Hosp, Columbus, OH 43205 USA; [Bouhliqah, Lamia] OSU, Wexner Med Ctr, Dept ENT, Columbus, OH 43210 USA; [Mcallister, Cynthia; Corcoran, Sarah E.; Kaspar, Brian] Nationwide Childrens Hosp, Ctr Gene Therapy, Columbus, OH 43205 USA; [Basso, D. Michele] Ohio State Univ, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA; [Otero, Jose J.] OSU, Dept Pathol, Wexner Med Ctr, Columbus, OH 43210 USA; [Kirsch, Claudia] NSUH, Dept Radiol, 300 Community Dr, Manhasset, NY 11030 USA; [Davis, Ian C.] Coll Vet Med, Dept Vet Biosci, 1925 Coffey Rd, Columbus, OH 43210 USA; [Croce, Carlo Maria; Michaille, Jean-Jacques; Tili, Esmerina] Ohio State Univ, Dept Canc Biol & Genet, Wexner Med Ctr, Columbus, OH 43210 USA; [Croce, Carlo Maria; Michaille, Jean-Jacques; Tili, Esmerina] Ctr Comprehens Canc, Columbus, OH 43210 USA; [Michaille, Jean-Jacques] Univ Bourgogne Franche Comte, Fac Gabriel, BioPerox IL, UB INSERM IFR 100, 6 Bd Gabriel, F-21000 Dijon, France		Nuovo, G (corresponding author), Phylogeny Inc, Powell, OH 43065 USA.	Nuovo.1@osu.edu	Otero, Jose/AAI-4891-2020; Kirsch, Claudia Francoise Eve/H-7122-2019; Young, Richard A/F-6495-2012	Otero, Jose/0000-0003-0680-4520; Kirsch, Claudia Francoise Eve/0000-0002-4978-4198; Young, Richard A/0000-0001-8855-8647; Kelani, hesham/0000-0002-2816-2234	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO3NS102861]; OSU College of Medicine Office of Research Discovery Funding Program; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [UL1TR001070];  [IRG-67-003-50];  [P30-NS04758];  [P30CA16058]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS102861] Funding Source: NIH RePORTER	This work was supported by The National Institutes of Health (RO3NS102861 to E.T., H.A. and A.B.); IRG-67-003-50 to E.T.; OSU College of Medicine Office of Research Discovery Funding Program to E.T. and H.A.; P30-NS04758 to Center for Brain and SC Repair, P30CA16058 to Genomics Facility; and P30-MRI Pilot Project proposal/OSU/CCTS UL1TR001070 to H.A. by National Institute of Neurological Disorders and Stroke.	Acher C, 2012, ANN CARDIOTHORAC SUR, V1, P365, DOI 10.3978/j.issn.2225-319X.2012.08.06; Alakbarzade V, 2015, NAT GENET, V47, P814, DOI 10.1038/ng.3313; Andreoli Chiara, 2005, Radiol Med, V110, P636; Asatryan A, 2017, J BIOL CHEM, V292, P12390, DOI 10.1074/jbc.R117.783076; Awad H, 2017, CAN J ANESTH, V64, P1218, DOI 10.1007/s12630-017-0974-1; Awad H, 2010, ANESTHESIOLOGY, V113, P880, DOI 10.1097/ALN.0b013e3181ec61ee; Balconi G, 2000, ARTERIOSCL THROM VAS, V20, P1443, DOI 10.1161/01.ATV.20.6.1443; Bartanusz V, 2011, ANN NEUROL, V70, P194, DOI 10.1002/ana.22421; Bell MT, 2013, CIRCULATION, V128, pS152, DOI 10.1161/CIRCULATIONAHA.112.000024; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Bozzo A, 2011, J NEUROTRAUM, V28, P1401, DOI 10.1089/neu.2009.1236; Butovsky O, 2015, ANN NEUROL, V77, P75, DOI 10.1002/ana.24304; Caballero-Garrido E, 2015, J NEUROSCI, V35, P12446, DOI 10.1523/JNEUROSCI.1641-15.2015; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Ge SJ, 2006, J NEUROIMMUNOL, V177, P209, DOI 10.1016/j.jneuroim.2006.05.012; Hamilton JA, 2007, J MOL NEUROSCI, V33, P12, DOI 10.1007/s12031-007-0050-3; Kim EH, 2015, CNS NEUROSCI THER, V21, P385, DOI 10.1111/cns.12326; Kim M, 2013, KIDNEY INT, V84, P90, DOI 10.1038/ki.2013.43; Koval ED, 2013, HUM MOL GENET, V22, P4127, DOI 10.1093/hmg/ddt261; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lopez-Ramirez MA, 2014, FASEB J, V28, P2551, DOI 10.1096/fj.13-248880; McDonald RA, 2012, CARDIOVASC RES, V93, P594, DOI 10.1093/cvr/cvr299; Moore CS, 2013, ANN NEUROL, V74, P709, DOI 10.1002/ana.23967; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Nuovo GJ, 2009, BIOTECHNIQUES, V46, P115, DOI 10.2144/000113068; Pascal JM, 2015, DNA REPAIR, V32, P10, DOI 10.1016/j.dnarep.2015.04.008; SALAZARGRUESO EF, 1991, NEUROREPORT, V2, P505, DOI 10.1097/00001756-199109000-00002; Smith PD, 2012, CIRCULATION, V126, pS110, DOI 10.1161/CIRCULATIONAHA.111.080275; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tili E, 2017, CURR OPIN PHARMACOL, V37, P142, DOI 10.1016/j.coph.2017.10.010; Tili E, 2013, IMMUNOL REV, V253, P167, DOI 10.1111/imr.12050; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Ungaro F, 2017, GASTROENTEROLOGY, V153, P1363, DOI 10.1053/j.gastro.2017.07.048; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Wang XJ, 2010, NEUROPATHOLOGY, V30, P131, DOI 10.1111/j.1440-1789.2009.01061.x; Winkler EA, 2014, P NATL ACAD SCI USA, V111, pE1035, DOI 10.1073/pnas.1401595111	36	12	13	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1092-9134	1532-8198		ANN DIAGN PATHOL	Ann. Diagn. Pathol.	OCT	2018	36						12	20		10.1016/j.anndiagpath.2018.06.002			9	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	GW8OU	WOS:000447239200003	29966831	Green Accepted			2022-02-06	
J	Feldman, WB; Hey, SP; Kesselheim, AS				Feldman, William B.; Hey, Spencer Phillips; Kesselheim, Aaron S.			A Systematic Review Of The Food And Drug Administration's 'Exception From Informed Consent' Pathway	HEALTH AFFAIRS			English	Article							PUBLIC-ACCESS DEFIBRILLATION; TRAUMATIC BRAIN-INJURY; EMERGENCY RESEARCH; COMMUNITY CONSULTATION; HYPERTONIC RESUSCITATION; SURVIVAL; TRANSFUSION; BLOOD; TRIAL; SHOCK	In 1996 the Food and Drug Administration (FDA) created an "exception from informed consent" (EFIC) pathway for trials conducted on people incapacitated by life-threatening conditions with a therapeutic time window too narrow for reliable surrogate consent. The goals were to promote therapeutic innovation and encourage rigorous but ethical experimentation on this vulnerable population. To evaluate outcomes of this pathway, we reviewed the complete FDA docket of EFIC trials from the past two decades, encompassing forty-one trials. Among the 46,964 patients included in this review, ninety-six percent were enrolled without consent, and fewer than 1 percent withdrew before the primary endpoint. Two (8 percent) of the twenty-four superiority trials demonstrated a benefit from the experimental interventions. Many interventions were associated with adverse effects, including increased mortality, neurological deficits, and myocardial infarctions. Nearly one-third of US patients in EFIC trials were African American. While EFIC trials have yielded medical advances, investigators in future trials must pay better attention to managing withdrawals and ensuring fair demographic representation.	[Feldman, William B.] Harvard Med Sch, Boston, MA 02115 USA; [Feldman, William B.] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA; [Hey, Spencer Phillips] Harvard Ctr Bioeth, Boston, MA 02115 USA; [Hey, Spencer Phillips] Harvard Ctr Bioeth, Res Eth, Boston, MA 02115 USA; [Hey, Spencer Phillips; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law, 75 Francis St, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Harvard Med Sch, Med, Boston, MA 02115 USA		Feldman, WB (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Feldman, WB (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA.	wbfeldman@bwh.harvard.edu		Feldman, William/0000-0003-3467-5869	Laura and John Arnold Foundation; Engelberg Foundation; Harvard Program in Therapeutic Science	The authors thank Neal Dickert for his feedback on an earlier draft. The work of Spencer Hey and Aaron Kesselheim is funded by the Laura and John Arnold Foundation. Kesselheim also receives research support from the Engelberg Foundation and the Harvard Program in Therapeutic Science.	Aufderheide TP, 2011, LANCET, V377, P301, DOI 10.1016/S0140-6736(10)62103-4; BIROS MH, 1995, JAMA-J AM MED ASSOC, V273, P1283, DOI 10.1001/jama.273.16.1283; Brienza AM, 2016, ACAD EMERG MED, V23, P772, DOI 10.1111/acem.12969; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Fehr AE, 2015, ANN EMERG MED, V65, P162, DOI 10.1016/j.annemergmed.2014.06.023; Food and Drug Administration, 2011, GUID I REV BOARDS CL; Food and Drug Administration, 2013, CLIN TRIALS SHED LIG; Galea S, 2007, AM J EPIDEMIOL, V166, P534, DOI 10.1093/aje/kwm102; Haggins AN, 2018, CLIN TRIALS, V15, P29, DOI 10.1177/1740774517737318; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holsti M, 2015, CLIN TRIALS, V12, P67, DOI 10.1177/1740774514555586; Kerkhoff LA, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003582; Kim F, 2014, JAMA-J AM MED ASSOC, V311, P45, DOI 10.1001/jama.2013.282173; Klein L, 2018, ACAD EMERG MED, V25, P1169, DOI 10.1111/acem.13438; Largent EA, 2010, ARCH INTERN MED, V170, P668, DOI 10.1001/archinternmed.2010.80; Minei JP, 2013, J TRAUMA ACUTE CARE, V74, P165; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Moore EE, 2009, J AM COLL SURGEONS, V208, P1, DOI 10.1016/j.jamcollsurg.2008.09.023; Mosesso VN, 2004, RESUSCITATION, V61, P29, DOI 10.1016/j.resuscitation.2003.11.016; Nichol G, 2015, NEW ENGL J MED, V373, P2203, DOI 10.1056/NEJMoa1509139; Raymond TT, 2010, PEDIATRICS, V125, pE866, DOI 10.1542/peds.2009-2427; Rebers S, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0092-6; Reinier K, 2015, CIRCULATION, V132, P380, DOI 10.1161/CIRCULATIONAHA.115.015673; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Salzman JG, 2007, ANN EMERG MED, V50, P448, DOI 10.1016/j.annemergmed.2006.10.013; Scicluna Victoria M, 2017, AJOB Empir Bioeth, V8, P75, DOI 10.1080/23294515.2017.1308978; Selker HP, 2012, JAMA-J AM MED ASSOC, V307, P1925, DOI 10.1001/jama.2012.426; Silbergleit R, 2012, ACAD EMERG MED, V19, P448, DOI 10.1111/j.1553-2712.2012.01328.x; Sims CA, 2013, J TRAUMA ACUTE CARE, V74, P157, DOI 10.1097/TA.0b013e318278908a; Stiell IG, 2011, NEW ENGL J MED, V365, P787, DOI 10.1056/NEJMoa1010076; Sugarman J, 2009, RESUSCITATION, V80, P644, DOI 10.1016/j.resuscitation.2009.03.015; Twilley N, 2016, NEW YORKER; van Belle G, 2015, RESUSCITATION, V91, P76, DOI 10.1016/j.resuscitation.2014.11.029; Walden G, 2017, COMMUNICATION; Washington HA, 2006, MED APARTHEID DARK H; [No title captured]	40	12	12	0	1	PROJECT HOPE	BETHESDA	7500 OLD GEORGETOWN RD, STE 600, BETHESDA, MD 20814-6133 USA	0278-2715			HEALTH AFFAIR	Health Aff.	OCT	2018	37	10					1605	1614		10.1377/hlthaff.2018.0501			10	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	HS6ES	WOS:000463964200010	30273035				2022-02-06	
J	Glushakov, AO; Glushakova, OY; Korol, TY; Acosta, SA; Borlongan, CV; Valadka, AB; Hayes, RL; Glushakov, AV				Glushakov, Andriy O.; Glushakova, Olena Y.; Korol, Tetyana Y.; Acosta, Sandra A.; Borlongan, Cesar V.; Valadka, Alex B.; Hayes, Ronald L.; Glushakov, Alexander V.			Chronic Upregulation of Cleaved-Caspase-3 Associated with Chronic Myelin Pathology and Microvascular Reorganization in the Thalamus after Traumatic Brain Injury in Rats	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						chronic TBI; cleaved-caspase-3; thalamus; blood-brain barrier; microvascular reorganization; myelin pathology	CORTICAL PROJECTIONS; WHITE-MATTER; NEUROPLASTIC RESPONSES; THERAPEUTIC TARGETS; NEURONAL APOPTOSIS; ALZHEIMERS-DISEASE; PRECLINICAL MODEL; TEMPORAL PROFILE; SLEEP DISORDERS; HEAD-INJURY	Traumatic brain injury (TBI) is associated with long-term disabilities and devastating chronic neurological complications including problems with cognition, motor function, sensory processing, as well as behavioral deficits and mental health problems such as anxiety, depression, personality change and social unsuitability. Clinical data suggest that disruption of the thalamo-cortical system including anatomical and metabolic changes in the thalamus following TBI might be responsible for some chronic neurological deficits following brain trauma. Detailed mechanisms of these pathological processes are not completely understood. The goal of this study was to evaluate changes in the thalamus following TBI focusing on cleaved-caspase-3, a specific effector of caspase pathway activation and myelin and microvascular pathologies using immuno- and histochemistry at different time points from 24 h to 3 months after controlled cortical impact (CCI) in adult Sprague-Dawley rats. Significant increases in cleaved-caspase-3 immunoreactivity in the thalamus were observed starting one month and persisting for at least three months following experimental TBI. Further, the study demonstrated an association of cleaved-caspase-3 with the demyelination of neuronal processes and tissue degeneration in the gray matter in the thalamus, as reflected in alterations of myelinated fiber integrity (luxol fast blue) and decreases in myelin basic protein (MBP) immunoreactivity. The immunofluorescent counterstaining of cleaved-caspase-3 with endothelial barrier antigen (EBA), a marker of blood-brain barrier, revealed limited direct and indirect associations of cleaved caspase-3 with blood-brain barrier damage. These results demonstrate for the first time a significant chronic upregulation of cleaved-caspase-3 in selected thalamic regions associated with cortical regions directly affected by CCI injury. Further, our study is also the first to report that significant upregulation of cleaved-caspase-3 in selected ipsilateral thalamic regions is associated with microvascular reorganization reflected in the significant increases in the number of microvessels with blood-brain barrier alterations detected by EBA staining. These findings provide new insights into potential mechanisms of TBI cell death involving chronic activation of caspase-3 associated with disrupted cortico-thalamic and thalamo-cortical connectivity. Moreover, this study offers the initial evidence that this upregulation of activated caspase-3, delayed degeneration of myelinated nerve fibers and microvascular reorganization with impaired blood-brain barrier integrity in the thalamus might represent reciprocal pathological processes affecting neuronal networks and brain function at the chronic stages of TBI.	[Glushakov, Andriy O.; Acosta, Sandra A.; Borlongan, Cesar V.] Univ S Florida, Dept Neurosurg, Coll Med, Tampa, FL 33612 USA; [Glushakova, Olena Y.; Valadka, Alex B.; Hayes, Ronald L.] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA; [Korol, Tetyana Y.] Uppsala Univ, Dept Psychol, S-75142 Uppsala, Sweden; [Hayes, Ronald L.] Banyan Biomarkers Inc, Alachua, FL 32615 USA; [Glushakov, Alexander V.] Single Breath Inc, Midlothian, VA 23113 USA		Glushakova, OY (corresponding author), Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA.; Glushakov, AV (corresponding author), Single Breath Inc, Midlothian, VA 23113 USA.	aoglushakov@gmail.com; olenaglushakova@gmail.com; koroltanya@gmail.com; sacosta@health.usf.edu; cborlong@health.usf.edu; avaladka@gmail.com; rhayes@banyanbio.com; glushakov@single-breath.com	Glushakov, Alexander V/B-5452-2008; Glushakova, Olena/AAY-1130-2021	Glushakov, Alexander V/0000-0003-2872-8960; Glushakova, Olena/0000-0002-2109-3651	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002649] Funding Source: NIH RePORTER		Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Arai T, 1996, BRAIN RES, V743, P131, DOI 10.1016/S0006-8993(96)00854-2; Arida RM, 2003, PHYSIOL BEHAV, V79, P789, DOI 10.1016/S0031-9384(03)00204-X; Baratz-Goldstein R, 2017, MOL CELL NEUROSCI, V83, P74, DOI 10.1016/j.mcn.2017.06.004; Beer R, 2001, J NEUROCHEM, V78, P862, DOI 10.1046/j.1471-4159.2001.00460.x; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Carvey PM, 2009, J NEUROCHEM, V111, P291, DOI 10.1111/j.1471-4159.2009.06319.x; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2009, J CLIN SLEEP MED, V5, P137; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Conti AC, 1998, J NEUROSCI, V18, P5663; Costa LD, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00006; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dolenec P, 2015, J NEUROPATH EXP NEUR, V74, P512, DOI 10.1097/NEN.0000000000000194; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Garcia-Cabezas MA, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00107; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Glushakov AV, 2016, METHODS MOL BIOL, V1462, P481, DOI 10.1007/978-1-4939-3816-2_27; Glushakov AV, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00034; Glushakov AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113689; Glushakov AV, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-132; Glushakova Olena Y, 2017, Brain Circ, V3, P87, DOI 10.4103/bc.bc_27_16; Glushakova OY, 2018, J NEUROTRAUM, V35, P157, DOI 10.1089/neu.2017.4999; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Glushakova OY, 2012, TOXICOL SCI, V130, P158, DOI 10.1093/toxsci/kfs224; Gonzalez-Pardo H, 2012, NEUROSCIENCE, V202, P234, DOI 10.1016/j.neuroscience.2011.11.064; Guzzetta F, 2005, EPILEPSIA, V46, P889, DOI 10.1111/j.1528-1167.2005.64504.x; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Harrington ME, 1997, NEUROSCI BIOBEHAV R, V21, P705, DOI 10.1016/S0149-7634(96)00019-X; Hazra A, 2014, J NEUROSCI RES, V92, P1434, DOI 10.1002/jnr.23430; Hong YT, 2014, JAMA NEUROL, V71, P23, DOI 10.1001/jamaneurol.2013.4847; Ieraci A, 2006, PLOS MED, V3, P547, DOI 10.1371/journal.pmed.0030101; Jafarian M, 2015, NEUROSCIENCE, V298, P161, DOI 10.1016/j.neuroscience.2015.04.033; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002628; Ji W, 2017, CELL MOL NEUROBIOL, V37, P683, DOI 10.1007/s10571-016-0404-x; Johnson EA, 2005, EXP BRAIN RES, V167, P17, DOI 10.1007/s00221-005-2362-2; Kamishina H, 2008, BRAIN RES, V1204, P24, DOI 10.1016/j.brainres.2008.01.094; Kamishina H, 2009, BRAIN RES, V1264, P39, DOI 10.1016/j.brainres.2009.01.024; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Laouchedi M, 2015, J NEURORADIOLOGY, V42, P202, DOI 10.1016/j.neurad.2014.03.001; Laskowitz D., 2016, TRANSLATIONAL RES TR; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; LoBue C, 2017, CLIN NEUROPSYCHOL, V31, P85, DOI 10.1080/13854046.2016.1257069; Lorente L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0485-z; Losito E, 2015, EPILEPSY RES, V109, P90, DOI 10.1016/j.eplepsyres.2014.10.015; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Macolino CM, 2014, J NEUROSCI METH, V226, P139, DOI 10.1016/j.jneumeth.2014.01.008; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; McDonald CR, 2008, EPILEPSY RES, V79, P130, DOI 10.1016/j.eplepsyres.2008.01.006; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mendez MF, 2015, J ALZHEIMERS DIS, V47, P985, DOI 10.3233/JAD-143207; MOORE RY, 1989, BRAIN RES, V486, P190, DOI 10.1016/0006-8993(89)91294-8; Mustafa G, 2016, NEUROPHARMACOLOGY, V107, P27, DOI 10.1016/j.neuropharm.2016.03.016; Nakamura H, 2015, EUR J NEUROSCI, V41, P1294, DOI 10.1111/ejn.12882; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Nicholson DW, 1996, NAT BIOTECHNOL, V14, P297, DOI 10.1038/nbt0396-297; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; O'Neil M., 2014, VISUAL DYSFUNCTION P; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; PASQUIER DA, 1982, EXP BRAIN RES, V48, P409; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reep RL, 2009, NEUROBIOL LEARN MEM, V91, P104, DOI 10.1016/j.nlm.2008.08.010; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; SCHLAGETER K, 1993, BRAIN INJURY, V7, P439, DOI 10.3109/02699059309029687; Scorza FA, 1998, EPILEPSIA, V39, P1041, DOI 10.1111/j.1528-1157.1998.tb01288.x; Shibata H, 2000, NEUROSCI RES, V38, P303, DOI 10.1016/S0168-0102(00)00174-7; Shinkai M, 2005, ANAT EMBRYOL, V210, P317, DOI 10.1007/s00429-005-0047-z; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Siklos M, 2015, ACTA PHARM SIN B, V5, P506, DOI 10.1016/j.apsb.2015.08.001; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Taylor KM, 2016, PARKINSONISM RELAT D, V23, P57, DOI 10.1016/j.parkreldis.2015.12.005; Thompson SJ, 2012, NEUROSCI LETT, V520, P131, DOI 10.1016/j.neulet.2012.03.015; van Groen T, 2002, BEHAV BRAIN RES, V136, P329, DOI 10.1016/S0166-4328(02)00199-7; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; WARTON SS, 1988, EXP NEUROL, V100, P23, DOI 10.1016/0014-4886(88)90198-7; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	96	12	12	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	OCT	2018	19	10							3151	10.3390/ijms19103151			21	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	GY9HB	WOS:000448951000306	30322151	Green Published, gold, Green Submitted			2022-02-06	
J	Harch, PG; Fogarty, EE				Harch, Paul G.; Fogarty, Edward E.			Hyperbaric oxygen therapy for Alzheimer's dementia with positron emission tomography imaging: a case report	MEDICAL GAS RESEARCH			English	Article						Alzheimer's dementia; hyperbaric oxygen; textural analysis; positron emission tomography; imaging pharmacokinetics; pressure pharmacodynamics	POST-CONCUSSION SYNDROME; GENE-EXPRESSION; DOUBLE-BLIND; DISEASE; ANGIOGENESIS; RIVASTIGMINE; MODULATION; DONEPEZIL; PRESSURE; MODEL	A 58-year-old female was diagnosed with Alzheimer's dementia (AD) which was rapidly progressive in the 8 months prior to initiation of hyperbaric oxygen therapy (HBOT). (18)Fluorodeoxyglucose ((18)FDG) positron emission tomography (PET) brain imaging demonstrated global and typical metabolic deficits in AD (posterior temporal-parietal watershed and cingulate areas). An 8-week course of HBOT reversed the patient's symptomatic decline. Repeat PET imaging demonstrated a corresponding 6.5-38% regional and global increase in brain metabolism, including increased metabolism in the typical AD diagnostic areas of the brain. Continued HBOT in conjunction with standard pharmacotherapy maintained the patient's symptomatic level of function over an ensuing 22 months. This is the first reported case of simultaneous HBOT-induced symptomatic and (18)FDG PET documented improvement of brain metabolism in AD and suggests an effect on global pathology in AD.	[Harch, Paul G.] Louisiana State Univ, Sch Med, Dept Med, Sect Emergency & Hyperbar Med, New Orleans, LA 70112 USA; [Fogarty, Edward E.] Univ North Dakota, Sch Med & Hlth Sci, Dept Radiol, Bismarck, ND USA		Harch, PG (corresponding author), Louisiana State Univ, Sch Med, Dept Med, Sect Emergency & Hyperbar Med, New Orleans, LA 70112 USA.	paulharchmd@gmail.com					Alzheimer's Disease International, GLOB VOIC DEM; Barratt DM, 2002, NEUROLOGIST, V8, P186, DOI 10.1097/00127893-200205000-00005; Bilic I, 2005, UNDERSEA HYPERBAR M, V32, P1; Bis JC, 2020, MOL PSYCHIATR, V25, P1859, DOI 10.1038/s41380-018-0112-7; Centers for Disease Control and Prevention, ALZHEIMERS DIS; Chen Y, 2009, NEUROCHEM RES, V34, P1047, DOI 10.1007/s11064-008-9873-8; Dave KR, 2003, NEUROSCIENCE, V120, P113, DOI 10.1016/S0306-4522(03)00244-6; de la Torre J, 2018, J ALZHEIMERS DIS, V63, P35, DOI 10.3233/JAD-180004; DELATORRE JC, 1993, NEUROL RES, V15, P146; Frozza RL, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00037; Garibotto V, 2017, NEUROBIOL AGING, V52, P183, DOI 10.1016/j.neurobiolaging.2016.03.033; Godman CA, 2010, CELL STRESS CHAPERON, V15, P431, DOI 10.1007/s12192-009-0159-0; GUR RE, 1987, ARCH GEN PSYCHIAT, V44, P126; Gutsaeva DR, 2006, NEUROSCIENCE, V137, P493, DOI 10.1016/j.neuroscience.2005.07.061; Harch PG, 2007, BRAIN RES, V1174, P120, DOI 10.1016/j.brainres.2007.06.105; Harch PG, 2017, MED GAS RES, V7, P156, DOI 10.4103/2045-9912.215745; Harch PG, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0030-6; Harch PG, 2013, J NEUROTRAUM, V30, P1995, DOI 10.1089/neu.2012.2799; Harch PG, 1996, TXB HYPERBARIC MED, P480; Harch PG, 2018, TOWNSEND LETT    APR, V417, P30; HARCH PG, 1999, TXB HYPERBARIC MED, P319; Jain KK., 2017, TXB HYPERBARIC MED; Kendall AC, 2013, UNDERSEA HYPERBAR M, V40, P115; Khoury R, 2018, THER ADV DRUG SAF, V9, P171, DOI 10.1177/2042098617750555; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; MANSON PN, 1980, SURG FORUM, V31, P564; MARX RE, 1990, AM J SURG, V160, P519, DOI 10.1016/S0002-9610(05)81019-0; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mega MS, 2005, ARCH NEUROL-CHICAGO, V62, P721, DOI 10.1001/archneur.62.5.721; Nativio R, 2018, NAT NEUROSCI, V21, P497, DOI 10.1038/s41593-018-0101-9; Niu CC, 2013, J ORTHOP RES, V31, P204, DOI 10.1002/jor.22209; Onyango IG, 2018, NEURAL REGEN RES, V13, P19, DOI 10.4103/1673-5374.224362; Patel L, 2011, DRUG AGING, V28, P539, DOI 10.2165/11591860-000000000-00000; Potkin SG, 2001, INT J NEUROPSYCHOPH, V4, P223, DOI 10.1017/S1461145701002528; Promteangtrong Chetsadaporn, 2015, Dement. neuropsychol., V9, P330, DOI 10.1590/1980-57642015DN94000330; Rice L, 2017, EUR J RADIOL, V94, P16, DOI 10.1016/j.ejrad.2017.07.014; Rossignol DA, 2007, MED HYPOTHESES, V68, P1208, DOI 10.1016/j.mehy.2006.09.064; Rountree SD, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt7; Salinaro AT, 2018, IMMUN AGEING, V15, DOI 10.1186/s12979-017-0108-1; Schaefer SM, 2000, HUM BRAIN MAPP, V10, P1, DOI 10.1002/(SICI)1097-0193(200005)10:1<1::AID-HBM10>3.0.CO;2-O; Shapira R, 2018, NEUROBIOL AGING, V62, P105, DOI 10.1016/j.neurobiolaging.2017.10.007; Simsek K., 2015, OXID ANTIOXID MED SC, V4, P17, DOI [DOI 10.5455/OAMS.010415.RV.016, 10.5455/oams.010415.rv.016]; Smailagic N, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010632.pub2; Stefanova E, 2006, J NEURAL TRANSM, V113, P205, DOI 10.1007/s00702-005-0312-6; Sundar LKS, 2018, J CEREB BLOOD FLOW M; Suzuki J, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13349; Teipel SJ, 2006, PSYCHOPHARMACOLOGY, V187, P86, DOI 10.1007/s00213-006-0408-1; Trempe CL, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00205; Tune L, 2003, AM J GERIAT PSYCHIAT, V11, P169, DOI 10.1176/appi.ajgp.11.2.169; van der Flier WM, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.3; VANMETER KW, 1994, ANN EMERG MED, V24, P283, DOI 10.1016/S0196-0644(05)83748-5; Weaver LK, 2014, HYPERBARIC OXYGEN TH; Weinstein JD, 2018, NEURAL REGEN RES, V13, P190, DOI 10.4103/1673-5374.226381; World Health Organization, DEMENTIA	54	12	13	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2045-9912			MED GAS RES	Med. Gas Res.	OCT-DEC	2018	8	4					181	+		10.4103/2045-9912.248271			10	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	HH7LU	WOS:000455913100010	30713673	Green Published			2022-02-06	
J	Hecimoyich, M; King, D; Dempsey, AR; Murphy, M				Hecimoyich, Mark; King, Doug; Dempsey, Alasdair R.; Murphy, Myles			The King-Devick test is a valid and reliable tool for assessing sport-related concussion in Australian football: A prospective cohort study	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Diffuse axonal injury; Neuropsychological tests; Visual motor coordination; Brain injury	VISUAL SCREENING TOOL; JUNIOR RUGBY LEAGUE; EXPLORATORY ANALYSIS; EYE-MOVEMENTS; HEAD IMPACTS; RELIABILITY; TEAM	Objectives: Sport-related concussion (SRC) research has focused on impaired oculomotor function. The King-Devick (K-D) test measures oculomotor performance and is reported to identify suboptimal brain function. The use of the K-D test in Australian football (AF), a sport involving body contact and tackling, has not been documented. Therefore, the objective of this study was to determine the test-retest reliability and diagnostic accuracy of the K-D test on a sub-elite AF team. Design: Prospective cohort study Methods: In total, 22 male players (19.6 + 2.3 years) were tested and re-tested on the K-D test. Those suspected of having a SRC secondary to a significant head impact were tested. Randomly selected additional players without SRC were assessed for comparison. Results: There were observable learning effects between the first and second baseline testing (48 vs. 46 s). The ICC for the first and second baseline tests was 0.91. Post-match test times were longer than the baseline times for players with SRC (n = 7) (-1.9s; z = -5.08; p < 0.0001). Players tested with no signs of SRC (n = 13) had an improvement in time when compared with their baseline score (3.0 s; z = -4.38; p <0.0001). The overall sensitivity was 0.98, specificity 0.96, and a kappa of kappa = 0.94. The positive likelihood ratio was 11.6 and the positive predictive value was 89.0%. Conclusions: This study supports the use of the K-D test due to its test-retest reliability, high sensitivity and specificity, and fast and simple use that is ideal for sports medicine professionals to make quick judgement on management and playability. (C) 2018 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Hecimoyich, Mark] Univ Northern Iowa, Div Athlet Training, Cedar Falls, IA 50614 USA; [Hecimoyich, Mark; Dempsey, Alasdair R.] Murdoch Univ, Sch Psychol & Exercise Sci, Murdoch, WA, Australia; [King, Doug] Auckland Univ Technol, Fac Hlth & Environm Sci, SPRINZ, AUT Millennium, Auckland, New Zealand; [King, Doug] Univ New England, Sch Sci & Technol, Armidale, NSW, Australia; [Murphy, Myles] Univ Notre Dame Australia, Sch Physiotherapy, Fremantle, WA, Australia; [Murphy, Myles] Peel Thunder Football Club, Med Dept, Mandurah, WA, Australia		Hecimoyich, M (corresponding author), Univ Northern Iowa, Div Athlet Training, Cedar Falls, IA 50614 USA.; Hecimoyich, M (corresponding author), Murdoch Univ, Sch Psychol & Exercise Sci, Murdoch, WA, Australia.	mark.hecimovich@uni.edu	Dempsey, Alasdair/A-7098-2008; Murphy, Myles/Q-8313-2017	Dempsey, Alasdair/0000-0001-8219-6120; Murphy, Myles/0000-0001-6068-1096; Hecimovich, Mark/0000-0002-0373-8129	Australian Football League [RES-16656]	We would like to thank the Australian Football League for their funding of this research project (RES-16656: Quantifying Head Trauma in ARF 2016). We would like to thank exercise science student Mason Gittins for his work with the data collection process.	Australian Football League, CONC; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Davies EC, 2012, NEUROLOGY, V78, pE103, DOI 10.1212/WNL.0b013e318251833d; Dessy A, 2014, CLIN NEUROL NEUROSUR, V122, P59, DOI 10.1016/j.clineuro.2014.04.003; Dziemianowicz MS, 2012, CURR NEUROL NEUROSCI, V12, P547, DOI 10.1007/s11910-012-0299-y; Galetta Kristin M, 2016, Concussion, V1, pCNC8, DOI 10.2217/cnc.15.8; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Hajian-Tilaki K, 2014, J BIOMED INFORM, V48, P193, DOI 10.1016/j.jbi.2014.02.013; Harris S, 2015, 2015 SMA WA C; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hrysomallis C, 2007, INT J SPORTS MED, V28, P844, DOI 10.1055/s-2007-964897; King D, 2017, INT J SPORTS SCI COA, V12, P359, DOI 10.1177/1747954117710512; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King D, 2017, J NEUROSURG-PEDIATR, V19, P13, DOI 10.3171/2016.7.PEDS1684; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Krumholtz I, 2000, Optometry, V71, P426; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Marinides Z, 2015, NEUROL CLIN PRACT, V5, P25, DOI DOI 10.1212/CPJ.000000000; McCrory P, 2016, BRIT J SPORT MED, V2017, P838, DOI DOI 10.1136/BJSP0RTS-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; Oberlander TJ, 2017, J ATHL TRAINING, V52, P439, DOI 10.4085/1062-6050-52.2.12; Rist B., 2017, INT J EXERC SCI, V10, P619; Rizzo JR, 2016, ANN CLIN TRANSL NEUR, V3, P801, DOI 10.1002/acn3.345; Stepanek J, 2014, AVIAT SPACE ENVIR MD, V85, P700, DOI 10.3357/ASEM.3645.2014; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010	30	12	12	1	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	OCT	2018	21	10					1004	1007		10.1016/j.jsams.2018.03.011			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GX9CQ	WOS:000448096500006	29610049	Green Published			2022-02-06	
J	Lago, N; Pannunzio, B; Amo-Aparicio, J; Lopez-Vales, R; Peluffo, H				Lago, Natalia; Pannunzio, Bruno; Amo-Aparicio, Jesus; Lopez-Vales, Ruben; Peluffo, Hugo			CD200 modulates spinal cord injury neuroinflammation and outcome through CD200R1	BRAIN BEHAVIOR AND IMMUNITY			English	Article						CD200R1 blocking antibody; OX131; Microglia; Neuroinflammation; Immune receptor; Recombinant CD200; Therapeutic window; Neuroprotection; SCI	TRAUMATIC BRAIN-INJURY; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; RECEPTOR; MICROGLIA; MICE; REGENERATION; MACROPHAGES; ACTIVATION; EXPRESSION	The interaction between CD200 and its receptor CD200R1 is among the central regulators of microglia and macrophage phenotype. However, it remains to be established whether, in the context of a traumatic CNS injury, CD200R1 act as a negative regulator of these particular innate immune cells, and if the exogenous delivery of CD200 may ameliorate neurological deficits. In the present study, we first evaluated whether preventing the local interaction between the pair CD200-CD200R1, by using a selective blocking antibody against CD200R1, has a role on functional and inflammatory outcome after contusion-induced spinal cord injury (SCI) in mice. The injection of the alpha CD200R1, but not control IgG1, into the lesioned spinal cord immediately after the SCI worsened locomotor performance and exacerbated neuronal loss and demyelination. At the neuroimmunological level, we observed that microglial cells and macrophages showed increased levels of iNOS and Ly6C upon CD200R1 blockade, indicating that the disruption of CD200R1 drove these cells towards a more pro-inflammatory phenotype. Moreover, although CD200R1 blockade had no effect in the initial infiltration of neutrophils into the lesioned spinal cord, it significantly impaired their clearance, which is a key sign of excessive inflammation. Interestingly, intraparenchymal injection of recombinant CD200-His immediately after the injury induced neuroprotection and robust and long-lasting locomotor recovery. In conclusion, this study reveals that interaction of CD200-CD200R1 plays a crucial role in limiting inflammation and lesion progression after SCI, and that boosting the stimulation of this pathway may constitute a new therapeutic approach.	[Lago, Natalia; Pannunzio, Bruno; Peluffo, Hugo] Inst Pasteur Montevideo, Neuroinflammat & Gene Therapy Lab, Mataojo 2020, Montevideo 11400, Uruguay; [Pannunzio, Bruno; Peluffo, Hugo] UDELAR, Dept Histol & Embryol, Fac Med, Montevideo, Uruguay; [Amo-Aparicio, Jesus; Lopez-Vales, Ruben] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Inst Neurociencies, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Bellaterra 08193, Catalonia, Spain		Lago, N (corresponding author), Inst Pasteur Montevideo, Neuroinflammat & Gene Therapy Lab, Mataojo 2020, Montevideo 11400, Uruguay.	nlago@pasteur.edu.uy	Lopez-Vales, Ruben/E-2150-2011	Lopez-Vales, Ruben/0000-0001-7615-9550; Lago, Natalia/0000-0002-5631-8558; Peluffo, Hugo/0000-0001-6111-8668	Fundacio Marato TV3, Catalunya, Spain [110533]; Comision Sectorial de Investigacion Cientifica (CSIC-UDELAR), Uruguay; PEDECIBA, Uruguay; FOCEM (MERCOSUR Structural Convergence Fund) [COF 03/1111]; Banco de Seguros del Estado (BSE), Uruguay; Spanish Ministry of Economy and CompetitivenessSpanish Government [SAF2010-17851, SAF2013-48431-R]; TERCEL	This work has been supported by grants from Fundacio Marato TV3 (110533), Catalunya, Spain; Comision Sectorial de Investigacion Cientifica (CSIC-UDELAR), Uruguay; PEDECIBA, Uruguay; FOCEM (MERCOSUR Structural Convergence Fund), COF 03/1111; and Banco de Seguros del Estado (BSE), Uruguay to NL and HP, and grants from the Spanish Ministry of Economy and Competitiveness (SAF2010-17851; SAF2013-48431-R) and TERCEL to RLV. We thank all members of the transgenic animal unit (UATE) of the Institut Pasteur de Montevideo.	ACARIN L, 1994, J HISTOCHEM CYTOCHEM, V42, P1033, DOI 10.1177/42.8.8027523; Akkaya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063325; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Borrego F, 2013, BLOOD, V121, P1951, DOI 10.1182/blood-2012-09-435057; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Castranio EL, 2017, NEUROBIOL DIS, V105, P1, DOI 10.1016/j.nbd.2017.05.006; Chen ZQ, 2008, TRANSPLANTATION, V86, P1116, DOI 10.1097/TP.0b013e318186fec2; Cohen M, 2017, J NEUROSCI, V37, P972, DOI 10.1523/JNEUROSCI.2199-16.2016; Coll-Miro M, 2016, P NATL ACAD SCI USA, V113, P1411, DOI 10.1073/pnas.1523212113; Costello DA, 2011, J BIOL CHEM, V286, P34722, DOI 10.1074/jbc.M111.280826; David Samuel, 2012, Handb Clin Neurol, V109, P485, DOI 10.1016/B978-0-444-52137-8.00030-9; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Francos Quijorna I, 2017, J NEUROSCI OFFIC J S; Francos-Quijorna I, 2016, GLIA, V64, P2079, DOI 10.1002/glia.23041; Frank MG, 2007, BRAIN BEHAV IMMUN, V21, P47, DOI 10.1016/j.bbi.2006.03.005; Frank MG, 2006, NEUROBIOL AGING, V27, P717, DOI 10.1016/j.neurobiolaging.2005.03.013; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Klopstein A, 2012, J NEUROSCI, V32, P14478, DOI 10.1523/JNEUROSCI.0923-12.2012; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Liu YR, 2010, J NEUROSCI, V30, P2025, DOI 10.1523/JNEUROSCI.4272-09.2010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyons A, 2007, J NEUROSCI, V27, P8309, DOI 10.1523/JNEUROSCI.1781-07.2007; Lyons A, 2009, BRAIN BEHAV IMMUN, V23, P1020, DOI 10.1016/j.bbi.2009.05.060; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Mott RT, 2004, GLIA, V46, P369, DOI 10.1002/glia.20009; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Painter MM, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0040-9; Peluffo H, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0364-y; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Santos-Nogueira E, 2015, J NEUROSCI, V35, P10224, DOI 10.1523/JNEUROSCI.4703-14.2015; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Shrivastava K, 2012, J COMP NEUROL, V520, P2657, DOI 10.1002/cne.23062; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Sun FJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0546-2; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Valente T, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00129; Wang YX, 2016, BRAIN RES, V1648, P380, DOI 10.1016/j.brainres.2016.07.045; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6; Wright GJ, 2003, J IMMUNOL, V171, P3034, DOI 10.4049/jimmunol.171.6.3034	44	12	13	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	OCT	2018	73						416	426		10.1016/j.bbi.2018.06.002			11	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	GU6QO	WOS:000445440900042	29870752				2022-02-06	
J	Schaeffer, J; Tannahill, D; Cioni, JM; Rowlands, D; Keynes, R				Schaeffer, Julia; Tannahill, David; Cioni, Jean-Michel; Rowlands, Daire; Keynes, Roger			Identification of the extracellular matrix protein Fibulin-2 as a regulator of spinal nerve organization	DEVELOPMENTAL BIOLOGY			English	Article						RNA-sequencing; Chick; Sclerotome; Spinal nerve; Extracellular matrix; Fibulin-2	CREST CELL-MIGRATION; AXON GUIDANCE; CORD-INJURY; REACTIVE ASTROCYTES; SCAR FORMATION; GLIAL SCAR; SYSTEM; GROWTH; GENE; EXPRESSION	During amniote peripheral nervous system development, segmentation ensures the correct patterning of the spinal nerves relative to the vertebral column. Along the antero-posterior (rostro-caudal) axis, each somite-derived posterior half-sclerotome expresses repellent molecules to restrict axon growth and neural crest migration to the permissive anterior half-segment. To identify novel regulators of spinal nerve patterning, we investigated the differential gene expression of anterior and posterior half-sclerotomes in the chick embryo by RNA-sequencing. Several genes encoding extracellular matrix proteins were found to be enriched in either anterior (e.g. Tenascin-C, Laminin alpha 4) or posterior (e.g. Fibulin-2, Fibromodulin, Collagen VI alpha 2) half-sclerotomes. Among them, the extracellular matrix protein Fibulin-2 was found specifically restricted to the posterior half-sclerotome. By using in ovo ectopic expression in chick somites, we found that Fibulin-2 modulates spinal axon growth trajectories in vivo. While no intrinsic axon repellent activity of Fibulin-2 was found, we showed that it enhances the growth cone repulsive activity of Semaphorin 3A in vitro. Some molecules regulating axon growth during development are found to be upregulated in the adult central nervous system (CNS) following traumatic injury. Here, we found increased Fibulin-2 protein levels in reactive astrocytes at the lesion site of a mouse model of CNS injury. Together, these results suggest that the developing vertebral column and the adult CNS share molecular features that control axon growth and plasticity, which may open up the possibility for the identification of novel therapeutic targets for brain and spinal cord injury.	[Schaeffer, Julia; Cioni, Jean-Michel; Keynes, Roger] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Tannahill, David] Canc Res UK Cambridge Inst, Cambridge, England; [Rowlands, Daire] Cambridge John van Geest Ctr Brain Repair, Cambridge, England		Schaeffer, J (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.	julia.schaeffer13@gmail.com	Cioni, Jean-Michel/AAN-4921-2020	Keynes, Roger John/0000-0002-1557-7684; Schaeffer, Julia/0000-0002-1282-5793; Tannahill, David/0000-0002-3811-6864; Cioni, Jean-Michel/0000-0002-8651-5579	International Spinal Research Trust [RG71958]; Rosetrees TrustRosetrees Trust [M317]	This project was supported by the International Spinal Research Trust (registered charity) (Nathalie Rose Barr Studentship, ref. RG71958) and the Rosetrees Trust (ref. M317).	Aken BL, 2017, NUCLEIC ACIDS RES, V45, pD635, DOI 10.1093/nar/gkw1104; Alcendor DJ, 2011, AM J PATHOL, V179, P1443, DOI 10.1016/j.ajpath.2011.05.024; Bai G, 2011, CELL, V144, P106, DOI 10.1016/j.cell.2010.11.053; Bonanomi D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001735; Bourgeois A, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0088-3; BRONNERFRASER M, 1991, DEV BIOL, V143, P213, DOI 10.1016/0012-1606(91)90071-A; Charoy C, 2012, NEURON, V75, P1051, DOI 10.1016/j.neuron.2012.08.021; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; Clagett-Dame M, 2006, J NEUROBIOL, V66, P739, DOI 10.1002/neu.20241; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dick G, 2013, J BIOL CHEM, V288, P27384, DOI 10.1074/jbc.M111.310029; Didangelos A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21607; Eickholt BJ, 1999, DEVELOPMENT, V126, P2181; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fleming A, 2015, DEVELOPMENT, V142, P1733, DOI 10.1242/dev.118950; Fontanil T, 2014, ONCOTARGET, V5, P1253, DOI 10.18632/oncotarget.1690; Fredette BJ, 1996, DEVELOPMENT, V122, P3163; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Giger RJ, 2010, COLD SPRING HARB PER, V2; Goff L., 2013, R PACKAGE VERSION 2; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hara M, 2017, NAT MED, V23, P818, DOI 10.1038/nm.4354; Hilton BJ, 2017, DEVELOPMENT, V144, P3417, DOI 10.1242/dev.148312; Hopf M, 1999, EUR J BIOCHEM, V259, P917, DOI 10.1046/j.1432-1327.1999.00127.x; Hsu JYC, 2008, J NEUROSCI, V28, P13467, DOI 10.1523/JNEUROSCI.2287-08.2008; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; James ND, 2015, EXP NEUROL, V271, P131, DOI 10.1016/j.expneurol.2015.05.022; Jones E. V., 2014, NEURAL PLAST, V2014; Kapfhammer JP, 2007, NAT PROTOC, V2, P2005, DOI 10.1038/nprot.2007.295; Keynes R, 1997, NEURON, V18, P889, DOI 10.1016/S0896-6273(00)80329-3; KEYNES RJ, 1984, NATURE, V310, P786, DOI 10.1038/310786a0; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; Kuan CYK, 2004, MECH DEVELOP, V121, P1055, DOI 10.1016/j.mod.2004.05.001; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; Law EWL, 2012, ONCOGENE, V31, P728, DOI 10.1038/onc.2011.272; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Mansouri A, 1997, DEV DYNAM, V210, P53, DOI 10.1002/(SICI)1097-0177(199709)210:1<53::AID-AJA6>3.3.CO;2-4; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Modrell MS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1502; Moeendarbary E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14787; Moret F, 2007, DEVELOPMENT, V134, P4491, DOI 10.1242/dev.011452; Ohtake Y, 2015, BRAIN RES, V1619, P22, DOI 10.1016/j.brainres.2014.08.064; Olin AI, 2001, J BIOL CHEM, V276, P1253, DOI 10.1074/jbc.M006783200; Perissinotto D, 2000, DEVELOPMENT, V127, P2823; Piper M, 2005, NAT NEUROSCI, V8, P179, DOI 10.1038/nn1380; R Core Team, 2014, R LANG ENV STAT COMP; Roffers-Agarwal J, 2009, DEVELOPMENT, V136, P1879, DOI 10.1242/dev.032920; Romi E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5058; SASAKI T, 1995, J MOL BIOL, V254, P892, DOI 10.1006/jmbi.1995.0664; Scaal M, 2016, SEMIN CELL DEV BIOL, V49, P83, DOI 10.1016/j.semcdb.2015.11.003; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Tucker RP, 2001, DEV DYNAM, V222, P115, DOI 10.1002/dvdy.1171; Wang H, 2011, DEV DYNAM, V240, P1223, DOI 10.1002/dvdy.22498; Warrier S, 2017, DEV BIOL, V421, P245, DOI 10.1016/j.ydbio.2016.11.009; Yi CH, 2007, AM J PATHOL, V170, P1535, DOI 10.2353/ajpath.2007.060478	61	12	12	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606	1095-564X		DEV BIOL	Dev. Biol.	OCT 1	2018	442	1					101	114		10.1016/j.ydbio.2018.06.014			14	Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology	GV3DR	WOS:000445975000011	29944871	Green Published, hybrid			2022-02-06	
J	Benady, A; Freidin, D; Pick, CG; Rubovitch, V				Benady, Amit; Freidin, Dor; Pick, Chaim G.; Rubovitch, Vardit			GM1 ganglioside prevents axonal regeneration inhibition and cognitive deficits in a mouse model of traumatic brain injury	SCIENTIFIC REPORTS			English	Article							OUTGROWTH INHIBITION; BEHAVIORAL RECOVERY; ENTORHINAL CORTEX; NERVOUS-SYSTEM; CELL-DEATH; MICE; GROWTH; DIFFERENTIATION; RECOGNITION; SIALIDASE	Traumatic Brain Injury (TBI) is one of the most common causes of neurological damage in young populations. It has been previously suggested that one of the mechanisms that underlie brain injury is Axonal Outgrowth Inhibition (AOI) that is caused by altered composition of the gangliosides on the axon surface. In the present study, we have found a significant reduction of GM1 ganglioside levels in the cortex in a closed head traumatic brain injury model of a mouse, induced by a weight drop device. In addition, axonal regeneration in the brains of the injured mice was affected as seen by the expression of the axonal marker pNF-H and the growth cones (visualized by F-actin and beta-III-tubulin). NeuN immunostaining revealed mTBI-induced damage to neuronal survival. Finally, as expected, spatial and visual memories (measured by the Y-maze and the Novel Object Recognition tests, respectively) were also damaged 7 and 30 days post injury. A single low dose of GM1 shortly after the injury (2 mg/kg; IP) prevented all of the deficits mentioned above. These results reveal additional insights into the neuroprotective characteristics of GM1 in prevention of biochemical, cellular and cognitive changes caused by trauma, and may suggest a potential intervention for mTBI.	[Benady, Amit; Freidin, Dor; Pick, Chaim G.; Rubovitch, Vardit] Tel Aviv Univ, Dept Anat & Anthropol, Sackler Fac Med, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel		Rubovitch, V (corresponding author), Tel Aviv Univ, Dept Anat & Anthropol, Sackler Fac Med, Tel Aviv, Israel.	rubovitc@post.tau.ac.il			Ari and Regine Aprijaskis	This work was founded by "The Ari and Regine Aprijaskis for the support of the department of Anatomy and Anthropology, The sackler Faculty of Medicine". We thank Dr. Svetlana Trofimov for her contribution in performing the ELISA test and Dr's Yael Zilberstein, Miriam Shaharabani and Sasha Lichtenstein for their help in confocal microscopy and Imaris softwear analysis.	Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Chen Zhi-gang, 2003, Chin J Traumatol, V6, P23; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Di Pardo A, 2012, P NATL ACAD SCI USA, V109, P3528, DOI 10.1073/pnas.1114502109; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Forsayeth J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00045; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Gao Y, 2003, J NEUROSCI, V23, P11770; Gotow Takahiro, 2000, Medical Electron Microscopy, V33, P173, DOI 10.1007/s007950000019; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Heim LR, 2017, J NEUROTRAUM, V34, P2518, DOI 10.1089/neu.2016.4909; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Kenney K, 2018, JAMA NEUROL, V75, P1043, DOI 10.1001/jamaneurol.2018.0347; Kopitz J, 1997, EUR J CELL BIOL, V73, P1; Kornguth S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120164; Kulbe JR, 2017, PROG NEUROBIOL, V158, P15, DOI 10.1016/j.pneurobio.2017.08.003; Lee S, 2014, BIOL OPEN, V3, P974, DOI 10.1242/bio.20149779; Li L, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150898, 10.1371/journal.pone.0144219]; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Panni MK, 1998, BRAIN RES, V812, P76, DOI 10.1016/S0006-8993(98)00948-2; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029; Rubovitch V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41269; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; SABEL BA, 1984, SCIENCE, V225, P340, DOI 10.1126/science.6740316; Schnaar RL, 2016, J MOL BIOL, V428, P3325, DOI 10.1016/j.jmb.2016.05.020; Schnaar RL, 2010, FEBS LETT, V584, P1741, DOI 10.1016/j.febslet.2009.10.011; Schwab JM, 2005, BRAIN RES REV, V49, P295, DOI 10.1016/j.brainresrev.2004.10.007; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; Sorby-Adams AJ, 2018, AM J PHYSIOL-REG I, V315, pR165, DOI 10.1152/ajpregu.00163.2017; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200; von Reitzenstein C, 2001, EUR J BIOCHEM, V268, P326, DOI 10.1046/j.1432-1327.2001.01883.x; Vyas AA, 2005, J BIOL CHEM, V280, P16305, DOI 10.1074/jbc.M500250200; Vyas AA, 2002, P NATL ACAD SCI USA, V99, P8412, DOI 10.1073/pnas.072211699; Whitehead SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020808; Williams G, 2008, J BIOL CHEM, V283, P16641, DOI 10.1074/jbc.M802067200; Yuan AD, 2012, J CELL SCI, V125, P3257, DOI 10.1242/jcs.104729; Zhang Q, 2005, NEUROREPORT, V16, P1297, DOI 10.1097/01.wnr.0000174405.24763.bc; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	47	12	13	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 6	2018	8								13340	10.1038/s41598-018-31623-y			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GS6KA	WOS:000443802200001	30190579	Green Published, gold			2022-02-06	
J	Beidler, E; Bretzin, AC; Hanock, C; Covassin, T				Beidler, Erica; Bretzin, Abigail C.; Hanock, Colin; Covassin, Tracey			Sport-Related Concussion: Knowledge and Reporting Behaviors Among Collegiate Club-Sport Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						traumatic brain injuries; injury nondisclosure; university; physical activity	SCHOOL; OUTCOMES; PLAYERS	Context: Previous literature on sport-related concussion (SRC) knowledge and reporting behaviors has been limited to high school and National Collegiate Athletic Association collegiate athletes; however, knowledge regarding collegiate club-sport athletes is limited. Objective: To determine the level of SRC knowledge and reporting behaviors among collegiate club-sport athletes and to investigate differences between athletes in traditional and nontraditional sports. Design: Cross-sectional study. Setting: Survey. Patients or Other Participants: A total of 410 athletes (247 males, 163 females) involved in traditional (n = 244) or nontraditional (n = 165) collegiate club sports. Main Outcome Measure(s): The survey consisted of demographics, recognition of SRC signs and symptoms, general SRC knowledge, and reasons why athletes would not report SRCs. The independent variable was sport type. Sport-related concussion signs and symptoms and general knowledge were assessed by the frequency of correct answers to SRC signs and symptoms and general knowledge questions. Sport-related concussion-reporting behavior frequencies were evaluated by asking participants to indicate reasons why they did not or would not report an SRC. Results: The SRC signs and symptoms knowledge score was 23.01 +/- 3.19 and general SRC knowledge score was 36.49 +/- 4.16 (maximal score = 43). No differences were present for SRC signs and symptoms knowledge (F-1,F-408 =1.99, P= .16) or general SRC knowledge (F-1,F-408 = 3.28, P = .07) between athletes in traditional and nontraditional collegiate club sports. The most common reason for not reporting an SRC was not recognizing it as a serious injury (n = 165, 40.3%). Chi-square tests demonstrated significant relationships between sport type and 5 reasons for not reporting an SRC. Conclusions: The participants displayed moderate to high levels of knowledge of SRCs but indicated they had failed to or would fail to report SRCs for a variety of reasons. The lack of sports medicine coverage and disconnect between knowledge and injury recognition may make collegiate club-sport athletes more likely to participate while concussed.	[Beidler, Erica] Duquesne Univ, 118 Hlth Sci Bldg,600 Forbes Ave, Pittsburgh, PA 15282 USA; [Bretzin, Abigail C.; Hanock, Colin; Covassin, Tracey] Michigan State Univ, E Lansing, MI 48824 USA		Beidler, E (corresponding author), Duquesne Univ, 118 Hlth Sci Bldg,600 Forbes Ave, Pittsburgh, PA 15282 USA.	johnsone1@duq.edu		Bretzin, Abigail/0000-0003-3730-2849			[Anonymous], HIGH SCH SPORT PART; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Cohen J., 2013, STAT POWER ANAL BEHA; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Faure C, 2011, SPORT J, V14, P1; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Lifschutz L, 2012, RECREAT SPORTS J, V36, P104, DOI 10.1123/rsj.36.2.104; McAllister-Deitrick J, 2014, ATHL TRAIN SPORTS HL, V6, P280, DOI DOI 10.3928/01484834-20141112-03; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; National Collegiate Athletic Association, STUD ATHL PART 1981; Onate JA., 2009, ATHLETIC TRAINING SP, V1, DOI [DOI 10.3928/19425864-20090427-07, 10.3928/19425864-20090427-07]; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Roberts T., 2003, SPORTS CLUBS RESOURC; Schneider RC, 2008, RECREAT SPORTS J, V32, P62, DOI 10.1123/rsj.32.1.62; Shenouda C, 2012, PM&R, V4, P427, DOI 10.1016/j.pmrj.2012.02.016; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Wallace J, 2017, J ATHL TRAINING, V52, P228, DOI 10.4085/1062-6050-52.1.07	22	12	12	2	9	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP	2018	53	9					866	872		10.4085/1062-6050-266-17			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	GY4NU	WOS:000448540500006	30273011	Green Published, gold			2022-02-06	
J	Bernardo, ABI; Presbitero, A				Bernardo, Allan B., I; Presbitero, Alfred			Cognitive flexibility and cultural intelligence: Exploring the cognitive aspects of effective functioning in culturally diverse contexts	INTERNATIONAL JOURNAL OF INTERCULTURAL RELATIONS			English	Article						Cultural intelligence; Cognitive flexibility; Executive functions	TRAUMATIC BRAIN-INJURY; TOP MANAGEMENT TEAM; EXECUTIVE FUNCTION; DECISION-MAKING; PERSONALITY; PERFORMANCE; ADJUSTMENT; EXPERIENCE; LEADERSHIP; VALIDITY	Cultural intelligence or CQ is an important construct that is associated with effective functioning in culturally diverse contexts. More recently, research has attempted to identify factors that might relate to the strengthening or development of CQ. In this study, we examine cognitive flexibility as a possible psychological process that relates to CQ. In two studies, participants (total N = 694) completed different self-report measures of cognitive flexibility, need for cognitive closure, and a CQ scale. In study 1, CQ was associated with the subscale of cognitive flexibility which is related to tendency to consider multiple perspectives and generate multiple approaches to problem solving (R-2 = .24). In study 2, CQ was related to the executive function of shifting (R-2 = .04). The different effect sizes suggest that CQ might be more reflective of the cognitive preferences and tendencies that flexibly integrate various specific cognitive functions, instead of fundamental executive functions. The results add to the emerging literature on factors that might be associated with the development of CQ, and point to possible entry points for developing or training CQ in individuals.	[Bernardo, Allan B., I] Univ Macau, Macau, Peoples R China; [Presbitero, Alfred] Deakin Univ, Geelong, Vic, Australia		Bernardo, ABI (corresponding author), Univ Macau, Dept Psychol, E21-3060 Humanities & Social Sci Bldg,Ave Univ, Taipa, Macau, Peoples R China.	allanbibernardo@umac.mo	; Bernardo, Allan B. I./M-4613-2016	Presbitero, Alfred/0000-0002-3154-9026; Bernardo, Allan B. I./0000-0003-3938-266X	University of Macau Research and Development Administration Office [MYRG2014-00098-FSS]	This research was supported by a grant from the University of Macau Research and Development Administration Office (Grant No.: MYRG2014-00098-FSS) given to the first author. The authors thank Man Wai Lei, Yang Fuming, and Mao Sijie for their valuable assistance in various phases of the study.	Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Ang S, 2006, GROUP ORGAN MANAGE, V31, P100, DOI 10.1177/1059601105275267; Ang S., 2008, HDB CULTURAL INTELLI; Bernardo ABI, 2017, PERS INDIV DIFFER, V119, P307, DOI 10.1016/j.paid.2017.08.006; Bernardo ABI, 2016, CROSS-CULT RES, V50, P231, DOI 10.1177/1069397116641895; Chao MM, 2015, INT J INTERCULT REL, V47, P78, DOI 10.1016/j.ijintrel.2015.03.032; Chao MM, 2015, ASIAN J SOC PSYCHOL, V18, P91, DOI 10.1111/ajsp.12089; Chao MM, 2010, GROUP PROCESS INTERG, V13, P69, DOI 10.1177/1368430209343115; Chen ASY, 2014, INT J CROSS CULT MAN, V14, P270, DOI 10.1177/1470595814525064; Chen ASY, 2011, INT J INTERCULT REL, V35, P246, DOI 10.1016/j.ijintrel.2010.09.005; Chiu CY, 2009, J CROSS CULT PSYCHOL, V40, P282, DOI 10.1177/0022022108328912; Crowne KA, 2013, INT J CROSS CULT MAN, V13, P5, DOI 10.1177/1470595812452633; Deng L, 2009, CROSS CULT MANAG, V16, P347, DOI 10.1108/13527600911000339; Dennis JP, 2010, COGNITIVE THER RES, V34, P241, DOI 10.1007/s10608-009-9276-4; DeYoung CG, 2005, J PERS, V73, P825, DOI 10.1111/j.1467-6494.2005.00330.x; DeYoung CG, 2002, PERS INDIV DIFFER, V33, P533, DOI 10.1016/S0191-8869(01)00171-4; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.ps.41.020190.002221; Documentation and Information Centre of the Statistics and Census Service, 2017, 2016 POP BY CENS DET; Earley P. Christopher, 2003, CULTURAL INTELLIGENC; Eigsti IM, 2006, PSYCHOL SCI, V17, P478, DOI 10.1111/j.1467-9280.2006.01732.x; Fang F., 2018, INT J INTERCULTURAL, DOI [10.1016/j.ijintre1.2018.04.002, DOI 10.1016/J.IJINTRE1.2018.04.002]; Furr NR, 2012, STRATEG ENTREP J, V6, P236, DOI 10.1002/sej.1137; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Glass BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070350; Goclowska MA, 2013, GROUP PROCESS INTERG, V16, P217, DOI 10.1177/1368430212445076; Goldberg L.R., 1992, PSYCHOL ASSESS, V4, P26, DOI [DOI 10.1037/1040-3590.4.1.26, 10.1037/1040-3590.4.1.26]; Harrison N, 2012, INT J INTERCULT REL, V36, P224, DOI 10.1016/j.ijintrel.2011.03.007; Hodgkinson GP, 2002, ORGAN STUD, V23, P949, DOI 10.1177/0170840602236014; Huff KC, 2014, INT J INTERCULT REL, V38, P151, DOI 10.1016/j.ijintrel.2013.08.005; Ionescu T, 2012, NEW IDEAS PSYCHOL, V30, P190, DOI 10.1016/j.newideapsych.2011.11.001; Johnco C, 2014, PSYCHOL ASSESSMENT, V26, P1381, DOI 10.1037/a0038009; Kashima ES, 2006, INT J INTERCULT REL, V30, P471, DOI 10.1016/j.ijintrel.2005.12.003; Kong DT, 2017, CURR PSYCHOL, V36, P540, DOI 10.1007/s12144-016-9441-3; Korzilius H, 2017, INT J INTERCULT REL, V56, P13, DOI 10.1016/j.ijintrel.2016.11.001; Kruglanski A.W., 1990, PSYCHOL INQ, V1, P181, DOI [DOI 10.1207/S15327965PLI0103_1, 10.1207/s15327965pli0103_1]; Laureiro-Martinez D, 2018, STRATEGIC MANAGE J, V39, P1031, DOI 10.1002/smj.2774; Le H, 2018, SOC INDIC RES, V139, P237, DOI 10.1007/s11205-016-1393-3; Lee LY, 2014, ASIA PAC J HUM RESOU, V52, P215, DOI 10.1111/j.1744-7941.2013.00055.x; Lee LY, 2013, CAREER DEV INT, V18, P377, DOI 10.1108/CDI-06-2012-0062; Leung AKY, 2008, AM PSYCHOL, V63, P169, DOI 10.1037/0003-066X.63.3.169; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Li M, 2016, PERS INDIV DIFFER, V89, P105, DOI 10.1016/j.paid.2015.09.050; Lin YC, 2012, INT J INTERCULT REL, V36, P541, DOI 10.1016/j.ijintrel.2012.03.001; MacNab B, 2012, INT J HUM RESOUR MAN, V23, P1320, DOI 10.1080/09585192.2011.581636; MacNab BR, 2012, J MANAG EDUC, V36, P66, DOI 10.1177/1052562911412587; MacNab BR, 2012, INT J INTERCULT REL, V36, P62, DOI 10.1016/j.ijintrel.2010.12.001; MARTIN MM, 1995, PSYCHOL REP, V76, P623, DOI 10.2466/pr0.1995.76.2.623; McAuley T, 2010, J INT NEUROPSYCH SOC, V16, P495, DOI 10.1017/S1355617710000093; Moore A, 2009, CONSCIOUS COGN, V18, P176, DOI 10.1016/j.concog.2008.12.008; Panksepp, 1998, AFFECTIVE NEUROSCIEN; PAYNE JW, 1988, J EXP PSYCHOL LEARN, V14, P534, DOI 10.1037/0278-7393.14.3.534; Peretz C, 2011, NEUROEPIDEMIOLOGY, V36, P91, DOI 10.1159/000323950; Presbitero A, 2018, INT J HUM RESOUR MAN, V29, P2188, DOI 10.1080/09585192.2017.1322118; Presbitero A, 2017, INT J HUM RESOUR MAN, V28, P1547, DOI 10.1080/09585192.2015.1128464; Presbitero A, 2017, J VOCAT BEHAV, V98, P118, DOI 10.1016/j.jvb.2016.11.001; Presbitero A, 2016, INT J INTERCULT REL, V53, P28, DOI 10.1016/j.ijintrel.2016.05.004; Presbitero A, 2016, INT J INTERCULT REL, V50, P29, DOI 10.1016/j.ijintrel.2015.11.001; Raes AML, 2011, ACAD MANAGE REV, V36, P102, DOI 10.5465/amr.2009.0088; Reichard RJ, 2015, ACAD MANAG LEARN EDU, V14, P461, DOI 10.5465/amle.2013.0043; Rockstuhl T, 2011, J SOC ISSUES, V67, P825, DOI 10.1111/j.1540-4560.2011.01730.x; Roets A, 2011, PERS INDIV DIFFER, V50, P90, DOI 10.1016/j.paid.2010.09.004; Rosenblatt V., 2013, ACAD MANAG LEARN EDU, V12, P354, DOI DOI 10.5465/AM1E.2012.0199; Roth R.M., 2005, BRIEF BEHAV RATING I; Saucier G, 2003, J PERS SOC PSYCHOL, V85, P695, DOI 10.1037/0022-3514.85.4.695; Shaffer MA, 2012, J MANAGE, V38, P1282, DOI 10.1177/0149206312441834; Shu F, 2017, PERS INDIV DIFFER, V106, P21, DOI 10.1016/j.paid.2016.10.024; Slegers K, 2009, AGING CLIN EXP RES, V21, P43, DOI 10.1007/BF03324898; Sternberg R. J, 1985, IQ TRIARCHIC THEORY; Tadmor CT, 2013, PSYCHOL SCI, V24, P99, DOI 10.1177/0956797612452570; Tadmor CT, 2012, J PERS SOC PSYCHOL, V103, P750, DOI 10.1037/a0029719; Takeuchi R, 2005, ACAD MANAGE J, V48, P85; Tarique I., 2008, HDB CULTURAL INTELLI, P56; Templer KJ, 2006, GROUP ORGAN MANAGE, V31, P154, DOI 10.1177/1059601105275293; Van Dyne L., 2008, HDB CULTURAL INTELLI, P16; Vasiljevic M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057106; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Ward C, 2009, EDUC PSYCHOL MEAS, V69, P85, DOI 10.1177/0013164408322001; WEBSTER DM, 1994, J PERS SOC PSYCHOL, V67, P1049, DOI 10.1037/0022-3514.67.6.1049; Zaroff C. M., 2016, CHINESE TRANSLATION; Zillig LMP, 2002, PERS SOC PSYCHOL B, V28, P847, DOI 10.1177/0146167202289013	81	12	14	4	28	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0147-1767	1873-7552		INT J INTERCULT REL	Int. J. Intercult. Relat.	SEP	2018	66						12	21		10.1016/j.ijintrel.2018.06.001			10	Psychology, Social; Social Sciences, Interdisciplinary; Sociology	Social Science Citation Index (SSCI)	Psychology; Social Sciences - Other Topics; Sociology	GV3JZ	WOS:000445991500002					2022-02-06	
J	Bosco, FM; Gabbatore, I; Angeleri, R; Zettin, M; Parola, A				Bosco, F. M.; Gabbatore, I; Angeleri, R.; Zettin, M.; Parola, A.			Do executive function and theory of mind predict pragmatic abilities following traumatic brain injury? An analysis of sincere, deceitful and ironic communicative acts	JOURNAL OF COMMUNICATION DISORDERS			English	Article						Language; TBI; Theory of mind (ToM); Non-verbal Communication; Irony; Deceit; Communicative intention; Inferences; Cognitive pragmatics; Executive functions	PREFRONTAL LESIONS; SOCIAL COGNITION; MEMORY SPAN; ADULTS; IMPAIRMENT; COMPREHENSION; DEFICITS; DYSFUNCTION; CHILDREN; LANGUAGE	Quality of life and social integration are strongly influenced by the ability to communicate and previous research has shown that pragmatic ability can be specifically impaired in individuals with traumatic brain injury (TBI). In addition, TBI usually results in damage to the frontotemporal lobes with a consequent impairment of cognitive functions, i.e., attention, memory, executive function (EF) and theory of mind (ToM). The role of the underlying cognitive deficits in determining the communicative-pragmatic difficulties of an individual with TBI is not yet completely clear. This study examined the relationship between the ability to understand and produce various kinds of communicative acts, (i.e., sincere, deceitful and ironic) and the above-mentioned cognitive and ToM abilities following TBI. Thirty-five individuals with TBI and thirty-five healthy controls were given tasks assessing their ability to comprehend and produce sincere, deceitful and ironic communicative acts belonging to the linguistic and extralinguistic scales of the Assessment Battery for Communication (ABaCo), together with a series of EF and ToM tasks. The results showed that, when compared to healthy individuals, participants with TBI performed poorly overall in the comprehension and production of all the pragmatic phenomena investigated, (i.e., sincere, deceitful and ironic communicative acts), and they also exhibited impaired performance at the level of all the cognitive functions examined. Individuals with TBI also showed a decreasing trend in performance in dealing with sincere, deceitful and ironic communicative acts, on both the comprehension and production subscales of the linguistic and extralinguistic scales. Furthermore, a hierarchical regression analysis revealed that in patients with TBI but not in the controls EF had a significant effect on the comprehension of linguistic and extralinguistic irony only, while the percentage of explained variance increased with the inclusion of theory of mind. Indeed, ToM had a significant role in determining patients' performance in the extralinguistic production of sincere and deceitful communicative acts, linguistic and extralinguistic comprehension of deceit and the linguistic production of irony. However, with regard to the performance of patients with TBI in the various pragmatic tasks investigated, (i.e., sincere, deceitful and ironic communicative acts), EF was able to explain the pattern of patients' scores in the linguistic and extralinguistic comprehension but not in production ability. Furthermore, ToM seemed not to be able to explain the decreasing trend in the performance of patients in managing the various kinds of communicative acts investigated.	[Bosco, F. M.; Gabbatore, I; Parola, A.] Univ Turin, Dept Psychol, Via Po 14, I-10123 Turin, Italy; [Bosco, F. M.] Inst Neurosci Turin, Turin, Italy; [Zettin, M.] Ctr Puzzle, Turin, Italy; [Gabbatore, I] Univ Oulu, Child Language Res Ctr, Res Unit Logoped, Oulu, Finland; [Angeleri, R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA		Gabbatore, I (corresponding author), Univ Turin, Dept Psychol, Via Po 14, I-10123 Turin, Italy.	ilaria.gabbatore@unito.it	bosco, francesca marina/B-6746-2013; Gabbatore, Ilaria/AAC-1925-2019; Parola, alberto/AAK-3748-2020	bosco, francesca marina/0000-0001-6101-8587; Gabbatore, Ilaria/0000-0002-9724-8066; PAROLA, ALBERTO/0000-0002-6039-0907			AIRENTI G, 1993, COGNITIVE SCI, V17, P197, DOI 10.1207/s15516709cog1702_2; Altman D.G., 1990, PRACTICAL STAT MED R; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Angeleri R, 2016, MINERVA PSICH, V57, P93; Angeleri R, 2012, BEHAV RES METHODS, V44, P845, DOI 10.3758/s13428-011-0174-9; [Anonymous], 2014, MINERVA PSICHIATRICA; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Ashman TA, 2006, MT SINAI J MED, V73, P999; Bara B. G., 2010, LINGUISTIC PHILOS IN, V9, P182; Bara BG, 1997, BRAIN LANG, V59, P7, DOI 10.1006/brln.1997.1812; Bara BG, 2001, BRAIN LANG, V77, P72, DOI 10.1006/brln.2000.2430; Bara Bruno, 2010, COGNITIVE PRAGMATICS; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bosco F. M., 2018, ARCH CLIN NEUROPSYCH, DOI [10.1093/arclin/acy041acy041, DOI 10.1093/ARCLIN/ACY041ACY041]; Bosco F. M., 2017, APPL PSYCHOLINGUIST, P1; Bosco FM, 2008, J PRAGMATICS, V40, P583, DOI 10.1016/j.pragma.2007.05.004; Bosco FM, 2017, CORTEX, V94, P73, DOI 10.1016/j.cortex.2017.06.010; Bosco FM, 2017, BRAIN LANG, V168, P73, DOI 10.1016/j.bandl.2017.01.007; Bosco FM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00021; Bosco FM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00166; Bosco FM, 2015, INT J LANG COMM DIS, V50, P63, DOI 10.1111/1460-6984.12114; Bosco FM, 2014, CONSCIOUS COGN, V24, P84, DOI 10.1016/j.concog.2014.01.003; Bosco FM, 2013, J CHILD LANG, V40, P741, DOI 10.1017/S0305000913000081; Bosco FM, 2012, J COMMUN DISORD, V45, P181, DOI 10.1016/j.jcomdis.2012.01.005; Brizio A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01011; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Byom L, 2017, INT J LANG COMM DIS, V52, P501, DOI 10.1111/1460-6984.12289; Byom LJ, 2012, INT J LANG COMM DIS, V47, P310, DOI 10.1111/j.1460-6984.2011.00102.x; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Cole Morgan, 1975, SYNTAX SEMANTICS, V3, P59, DOI DOI 10.1017/CBO9780511609213.004; Colle L, 2013, J COMMUN DISORD, V46, P294, DOI 10.1016/j.jcomdis.2013.01.003; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Cummings L, 2017, PERSP PRAGMAT PHILO, V11, P587, DOI 10.1007/978-3-319-47489-2_22; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Della Sala S., 1984, ADV HEPATIC ENCEPHAL, P448; Dennis M, 2001, BRAIN LANG, V78, P1, DOI 10.1006/brln.2000.2431; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); ELITHORN A, 1964, BRIT J PSYCHOL, V55, P31, DOI 10.1111/j.2044-8295.1964.tb00895.x; ELITHORN A, 1955, J NEUROL NEUROSUR PS, V18, P287, DOI 10.1136/jnnp.18.4.287; Evans K, 2011, BRAIN INJURY, V25, P767, DOI 10.3109/02699052.2011.576307; Finch E, 2016, BRAIN INJURY, V30, P883, DOI 10.3109/02699052.2016.1146959; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Gabbatore I., 2017, NEURAL PLASTICITY 20; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Galetto V, 2013, J NEUROLINGUIST, V26, P649, DOI 10.1016/j.jneuroling.2013.05.004; Geraci A, 2010, BRAIN INJURY, V24, P978, DOI 10.3109/02699052.2010.487477; Grice H. P., 1975, SYNTAX SEMANTICS; Happe F, 2002, MIND LANG, V17, P24, DOI 10.1111/1468-0017.00187; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Honan CA, 2015, BRAIN LANG, V150, P69, DOI 10.1016/j.bandl.2015.08.007; Huber W., 1983, ITALIAN VERSION; Joanette Y, 2004, PROTOCOLE MONTREAL E; Johnco C, 2013, J ANXIETY DISORD, V27, P576, DOI 10.1016/j.janxdis.2012.10.004; Key-DeLyria SE, 2016, J SPEECH LANG HEAR R, V59, P759, DOI 10.1044/2016_JSLHR-L-15-0104; Key-DeLyria SE, 2016, AM J SPEECH-LANG PAT, V25, DOI 10.1044/2015_AJSLP-14-0111; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; Laiacona M., 1986, ARCH PSICOLOGIA NEUR; LeBlanc J, 2014, INT J SPEECH-LANG PA, V16, P582, DOI 10.3109/17549507.2013.871335; Marini A, 2017, J NEUROLINGUIST, V44, P91, DOI 10.1016/j.jneuroling.2017.03.005; Marini A, 2014, NEUROPSYCHOLOGIA, V64, P282, DOI 10.1016/j.neuropsychologia.2014.09.042; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; Martin I, 2005, APHASIOLOGY, V19, P712, DOI 10.1080/02687030500172203; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 1999, BRAIN LANG, V68, P486, DOI 10.1006/brln.1999.2124; McDonald S., 2015, J NEUROPSYCHOL, V11, P291; McDonald S, 2016, APHASIOLOGY, V30, P801, DOI 10.1080/02687038.2015.1070948; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Muller F., 2010, CORTEX, P1; Murphy A, 2015, APHASIOLOGY, V29, P151, DOI 10.1080/02687038.2014.959411; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; Parola A, 2018, PSYCHIAT RES, V260, P144, DOI 10.1016/j.psychres.2017.11.051; Parola A, 2016, J NEUROLINGUIST, V39, P10, DOI 10.1016/j.jneuroling.2015.12.003; PERNER J, 1989, CHILD DEV, V60, P689, DOI 10.2307/1130734; Peskin J, 1996, CHILD DEV, V67, P1735, DOI 10.2307/1131728; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rigon A, 2016, J INT NEUROPSYCH SOC, V22, P705, DOI 10.1017/S1355617716000539; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; Rowley DA, 2017, BRAIN INJURY, V31, P1564, DOI 10.1080/02699052.2017.1341645; Sacco K, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00048; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Spinnler H., 1987, ITALIAN J NEUROLO S8, V6; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Sullivan JR, 2009, APPL NEUROPSYCHOL, V16, P62, DOI 10.1080/09084280802644243; TEASDALE G, 1974, LANCET, V2, P81; Thomas E, 2014, NEUROPSYCHOL REV, V24, P514, DOI 10.1007/s11065-014-9272-7; Tirassa M, 2006, CONSCIOUS COGN, V15, P197, DOI 10.1016/j.concog.2005.06.005; Tirassa M, 2006, COGN SYST RES, V7, P128, DOI 10.1016/j.cogsys.2006.01.002; Turkstra LS, 2018, NEUROPSYCHOLOGIA, V111, P117, DOI 10.1016/j.neuropsychologia.2018.01.016; Turkstra LS, 2017, BRAIN IMPAIR, V18, P49, DOI 10.1017/BrImp.2016.29; Winner E, 1998, BRAIN LANG, V62, P89, DOI 10.1006/brln.1997.1889; WINNER E, 1991, BRIT J DEV PSYCHOL, V9, P257, DOI 10.1111/j.2044-835X.1991.tb00875.x; Yang FG, 2010, NEUROPSYCHOLOGIA, V48, P1923, DOI 10.1016/j.neuropsychologia.2010.03.011	110	12	12	5	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0021-9924	1873-7994		J COMMUN DISORD	J. Commun. Disord.	SEP-OCT	2018	75						102	117		10.1016/j.jcomdis.2018.05.002			16	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	GV7GV	WOS:000446290900008	29887277	Green Submitted, Green Accepted			2022-02-06	
J	Bruce, JM; Echemendia, RJ; Meeuwisse, W; Hutchison, MG; Aubry, M; Comper, P				Bruce, Jared M.; Echemendia, Ruben J.; Meeuwisse, Willem; Hutchison, Michael G.; Aubry, Mark; Comper, Paul			Development of a risk prediction model among professional hockey players with visible signs of concussion	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article						Concussion; Sports; Ice hockey	METABOLIC BRAIN VULNERABILITY; INTERNATIONAL-CONFERENCE; CONSENSUS STATEMENT; TEMPORAL WINDOW; VIDEO ANALYSIS; SPORT HELD; FOOTBALL; ZURICH; LEAGUE	Background Little research examines how to best identify concussed athletes. The purpose of the present study was to develop a preliminary risk decision model that uses visible signs (VS) and mechanisms of injury (MOI) to predict the likelihood of subsequent concussion diagnosis. Methods Coders viewed and documented VS and associated MOI for all NHL games over the course of the 2013-2014 and 2014-2015 regular seasons. After coding was completed, player concussions were identified from the NHL injury surveillance system and it was determined whether players exhibiting VS were subsequently diagnosed with concussions by club medical staff as a result of the coded event. Results Among athletes exhibiting VS, suspected loss of consciousness, motor incoordination or balance problems, being in a fight, having an initial hit from another player's shoulder and having a secondary hit on the ice were all associated with increased risk of subsequent concussion diagnosis. In contrast, having an initial hit with a stick was associated with decreased risk of subsequent concussion diagnosis. A risk prediction model using a combination of the above VS and MOI was superior to approaches that relied on individual VS and associated MOI (sensitivity=81%, specificity=72%, positive predictive value=26%). Conclusions Combined use of VS and MOI significantly improves a clinician's ability to identify players who need to be evaluated for possible concussion. A preliminary concussion prediction log has been developed from these data. Pending prospective validation, the use of these methods may improve early concussion detection and evaluation.	[Bruce, Jared M.; Echemendia, Ruben J.] Univ Missouri, Dept Psychol, 5030 Cherry Hall,Room 313, Kansas City, MO 64110 USA; [Echemendia, Ruben J.] Psychol & Neurobehav Associates, State Coll, PA USA; [Meeuwisse, Willem] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Hutchison, Michael G.; Comper, Paul] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Aubry, Mark] Ottawa Sport Med Ctr, Ottawa, ON, Canada		Bruce, JM (corresponding author), Univ Missouri, Dept Psychol, 5030 Cherry Hall,Room 313, Kansas City, MO 64110 USA.	brucejm@umkc.edu	Echemendia, Ruben/R-6939-2019				Alessi AG, 2013, NEUROLOGY, V80, P2178, DOI 10.1212/WNL.0b013e31828d9c13; Arnould A, 2016, ANN PHYS REHABIL MED, V59, P18, DOI 10.1016/j.rehab.2015.09.002; Echemendia RJ., 2017, BR J SPORTS MED; Fuller GW, 2017, J SCI MED SPORT, V20, P246, DOI 10.1016/j.jsams.2016.07.008; Gardner AJ, 2015, BRAIN INJURY, V29, P1182, DOI 10.3109/02699052.2015.1034179; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Group NCW, 2011, NHL CONC EV MAN PROT; Hutchison MG, 2014, BRIT J SPORT MED, V48, P125, DOI 10.1136/bjsports-2012-092059; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Makdissi G, 2016, J SCI MED SPORT, P1111; Makdissi M, 2016, J SCI MED SPORT, V19, P958, DOI 10.1016/j.jsams.2016.02.014; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Schwartz A, 2013, ANN NEUROL, V74, pA26, DOI 10.1002/ana.24031; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8	17	12	12	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	SEP	2018	52	17								10.1136/bjsports-2016-097091			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GS4GO	WOS:000443598200013	28377444				2022-02-06	
J	Caccioppola, A; Carbonara, M; Macri, M; Longhi, L; Magnoni, S; Ortolano, F; Triulzi, F; Zanier, ER; Zoerle, T; Stocchetti, N				Caccioppola, A.; Carbonara, M.; Macri, M.; Longhi, L.; Magnoni, S.; Ortolano, F.; Triulzi, F.; Zanier, E. R.; Zoerle, T.; Stocchetti, N.			Ultrasound-tagged near-infrared spectroscopy does not disclose absent cerebral circulation in brain-dead adults	BRITISH JOURNAL OF ANAESTHESIA			English	Article						brain death; brain monitoring; cerebral blood flow; near-infrared spectroscopy; ultrasound-tagged near-infrared spectroscopy	BLOOD-FLOW; TISSUE OXYGEN; SATURATION; OXIMETRY; TECHNOLOGY; PRESSURE; ISCHEMIA; DELIVERY; TENSION; INJURY	Background: Near-infrared spectroscopy, a non-invasive technique for monitoring cerebral oxygenation, is widely used, but its accuracy is questioned because of the possibility of extra-cranial contamination. Ultrasound-tagged near-infrared spectroscopy (UT-NIRS) has been proposed as an improvement over previous methods. We investigated UT-NIRS in healthy volunteers and in brain-dead patients. Methods: We studied 20 healthy volunteers and 20 brain-dead patients with two UT-NIRS devices, CerOx (TM) and c-FLOW (TM) (Ornim Medical, Kfar Saba, Israel), which measure cerebral flow index (CFI), a parameter related to changes in cerebral blood flow (CBF). Monitoring started after the patients had been declared brain dead for a median of 34 (range: 11-300) min. In 11 cases, we obtained further demonstration of absent CBF. Results: In healthy volunteers, CFI was markedly different in the two hemispheres in the same subject, with wide variability amongst subjects. In brain-dead patients (median age: 64 yr old, 45% female; 20% traumatic brain injury, 40% subarachnoid haemorrhage, and 40% intracranial haemorrhage), the median (inter-quartile range) CFI was 41 (36-47), significantly higher than in volunteers (33; 27-36). Conclusions: In brain-dead patients, where CBF is absent, the UT-NIRS findings can indicate an apparently perfused brain. This might reflect an insufficient separation of signals from extra-cranial structures from a genuine appraisal of cerebral perfusion. For non-invasive assessment of CBF-related parameters, the near-infrared spectroscopy still needs substantial improvement.	[Caccioppola, A.; Carbonara, M.; Macri, M.; Magnoni, S.; Ortolano, F.; Zoerle, T.; Stocchetti, N.] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Anesthesia & Crit Care, Neurosci Intens Care Unit, Milan, Italy; [Longhi, L.] Azienda Socio Sanit Terr Papa Giovanni XXIII, Dept Anesthesia & Crit Care Med, Neurosurg Intens Care Unit, Bergamo, Italy; [Triulzi, F.] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Neuroradiol, Milan, Italy; [Triulzi, F.; Stocchetti, N.] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Zanier, E. R.] IRCCS Ist Ric Farmacol Mario Negri, Lab Acute Brain Injury & Therapeut Strategies, Dept Neurosci, Milan, Italy		Stocchetti, N (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Anesthesia & Crit Care, Neurosci Intens Care Unit, Milan, Italy.; Stocchetti, N (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy.	nino.stocchetti@policlinico.mi.it	Carbonara, Marco/N-3793-2015; Longhi, Luca/AAF-9903-2021; Zanier, Elisa/AAA-8095-2020; Magnoni, Sandra/AAC-7479-2022; Caccioppola, Alessio/AAQ-2407-2020	Carbonara, Marco/0000-0002-1431-8322; Longhi, Luca/0000-0001-9894-8788; Zanier, Elisa/0000-0002-3011-8718; Magnoni, Sandra/0000-0002-1723-0844; Zoerle, Tommaso/0000-0001-8713-8085; Caccioppola, Alessio/0000-0003-1936-3111			BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BONNER R, 1981, APPL OPTICS, V20, P2097, DOI 10.1364/AO.20.002097; Brady K, 2010, STROKE, V41, P1951, DOI 10.1161/STROKEAHA.109.575159; Calderon-Arnulphi M, 2009, NEUROL RES, V31, P605, DOI 10.1179/174313209X383286; Casati A, 2005, ANESTH ANALG, V101, P740, DOI 10.1213/01.ane.0000166974.96219.cd; Davie SN, 2012, ANESTHESIOLOGY, V116, P834, DOI 10.1097/ALN.0b013e31824c00d7; Donati A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1500-5; Genbrugge C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1509-9; GERMON TJ, 1994, ANAESTHESIA, V49, P639; GERMON TJ, 1994, BRIT J ANAESTH, V73, P503, DOI 10.1093/bja/73.4.503; Ghosh A, 2012, ANESTH ANALG, V115, P1373, DOI 10.1213/ANE.0b013e31826dd6a6; Gomersall CD, 1997, CRIT CARE MED, V25, P1252, DOI 10.1097/00003246-199707000-00031; Greenberg S, 2016, CAN J ANESTH, V63, P24, DOI 10.1007/s12630-015-0451-7; Kerz T, 2016, J CLIN MONIT COMPUT, V30, P641, DOI 10.1007/s10877-015-9755-y; Kytta J, 1999, J NEUROSURG ANESTH, V11, P252, DOI 10.1097/00008506-199910000-00004; Maas AIR, 2010, INTENS CARE MED, V36, P1283, DOI 10.1007/s00134-010-1921-6; MCCORMICK PW, 1991, CRIT CARE MED, V19, P89, DOI 10.1097/00003246-199101000-00020; Muellner T, 1998, BRIT J NEUROSURG, V12, P136, DOI 10.1080/02688699845276; Murkin JM, 2015, J CARDIOTHOR VASC AN, V29, P1187, DOI 10.1053/j.jvca.2015.05.201; Naftalovich R, 2015, A A CASE REP, V5, P216, DOI 10.1213/XAA.0000000000000259; Nemoto EM, 2000, CRIT CARE MED, V28, P1052, DOI 10.1097/00003246-200004000-00023; Obrig H, 2014, NEUROIMAGE, V85, P535, DOI 10.1016/j.neuroimage.2013.03.045; Ornim Medical Ltd, 2016, ORN MED C FLOW US MA; Palmer S, 2005, NEUROCRIT CARE, V2, P17, DOI 10.1385/NCC:2:1:017; Purins K, 2012, NEUROCRIT CARE, V16, P462, DOI 10.1007/s12028-012-9675-3; Ron A, 2012, P SOC PHOTO-OPT INS, P8223; Rosenthal G, 2014, J NEUROSURG, V120, P901, DOI 10.3171/2013.12.JNS131089; Rossi S, 2000, ACTA NEUROCHIR SUPPL, V76, P199; Salazar F, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-58; Samra SK, 1999, J NEUROSURG ANESTH, V11, P1, DOI 10.1097/00008506-199901000-00001; Schytz HW, 2012, NEUROCRIT CARE, V17, P139, DOI 10.1007/s12028-012-9720-2; Smith ML, 2007, NEUROL RES, V29, P755, DOI 10.1179/016164107X208121; Tsalach A, 2015, BIOMED OPT EXPRESS, V6, P4871, DOI 10.1364/BOE.6.004871; Valencia L, 2015, ANAESTH CRIT CARE PA, V34, P345, DOI 10.1016/j.accpm.2015.06.008; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Weigl W, 2016, J CEREBR BLOOD F MET, V36, P1825, DOI 10.1177/0271678X16667953	36	12	12	1	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0007-0912	1471-6771		BRIT J ANAESTH	Br. J. Anaesth.	SEP	2018	121	3					588	594		10.1016/j.bja.2018.04.038			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	GT5CN	WOS:000444523600013	30115257	Bronze			2022-02-06	
J	Goyal, K; Hazarika, A; Khandelwal, A; Sokhal, N; Bindra, A; Kumar, N; Kedia, S; Rath, GP				Goyal, Keshav; Hazarika, Amarjyoti; Khandelwal, Ankur; Sokhal, Navdeep; Bindra, Ashish; Kumar, Niraj; Kedia, Shweta; Rath, Girjia P.			Non- Neurological Complications after Traumatic Brain Injury: A Prospective Observational Study	INDIAN JOURNAL OF CRITICAL CARE MEDICINE			English	Article						Complications; neurocritical care; nonneurological complications; outcome; systemic complications; traumatic brain injury	ACUTE LUNG INJURY; DISSEMINATED INTRAVASCULAR COAGULATION; VENTILATOR-ASSOCIATED PNEUMONIA; ACUTE KIDNEY INJURY; HEAD-INJURY; ORGAN DYSFUNCTION; COAGULOPATHY; IMPACT; HYPOTENSION; PREDICTORS	Introduction and Aims: Recognizing and treating nonneurological complications occurring in traumatic brain injury (TBI) patients during intensive care unit (ICU) stay are challenging. The aim is to estimate various nonneurological complications in TB! patients. The secondary aim is to see the effect of these complications on ICU stay, disability, and mortality. Materials and Methods: This was a prospective observational study at the neuro-ICU of a Level-I trauma center. A total of 154 TBI patients were enrolled. The period of the study was from admission to discharge from ICU or demise. Inclusion criteria were patients aged >16 years and patients with severe TBI (Glasgow coma score [GCS] <= 8). Nonneurological complications were frequent in TBI patients. Results: We observed respiratory complications to be the most common (61%). Other complications, in the decreasing order, included dyselectrolytemia (46.1%), cardiovascular (34.4%), coagulopathy (33.1%), sepsis (26%), abdominal complications (17.5%), and acute kidney injury (AKI, 3.9%). The presence of systemic complications except AKI was found to be significantly associated with increased ICU stay. Most of the patients of AKI died early in ICU. Respiratory dysfunction was found to be independently associated with 3.05 times higher risk of worsening clinical condition (disability) (P < 0.018). The presence of cardiovascular complications during ICU stay (4.2 times, P < 0.005), AKI (24.7 times, P < 0.02), coagulopathy (3.13 times, P < 0.047), and GCS <6 (4.2 times, P < 0.006) of TBI was independently associated with significantly increased risk of ICU mortality. Conclusion: TBI patients tend to have poor outcome due to concomitant nonneurological complications. These have significant bearing on ICU stay, disability, and mortality.	[Goyal, Keshav; Khandelwal, Ankur; Sokhal, Navdeep; Bindra, Ashish; Kumar, Niraj; Rath, Girjia P.] All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, Dept Neuroanaesthesiol & Crit Care, New Delhi 110029, India; [Kedia, Shweta] All India Inst Med Sci, Dept Neurosurg, New Delhi, India; [Hazarika, Amarjyoti] PGIMER, Dept Anaesthesiol & Intens Care, Chandigarh, India		Goyal, K (corresponding author), All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, Dept Neuroanaesthesiol & Crit Care, New Delhi 110029, India.	keshavgoyalster@gmail.com	Khandelwal, Ankur/AAW-1717-2020	Khandelwal, Ankur/0000-0002-7915-9158			Affonseca CA, 2007, J PEDIAT-BRAZIL, V83, P274, DOI 10.1590/S0021-75572007000400014; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Baitello André Luciano, 2013, Braz. J. Nephrol., V35, P127, DOI 10.5935/0101-2800.20130021; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dekker SE, 2016, J SURG RES, V205, P147, DOI 10.1016/j.jss.2016.06.023; Eddy VA, 2000, SURG CLIN N AM, V80, P845, DOI 10.1016/S0039-6109(05)70099-2; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Freeman WD, 2015, NEUROCRIT CARE, V22, P173, DOI 10.1007/s12028-015-0119-8; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Gururaj G, 2008, NATL MED J INDIA, V21, P14; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Iunovidov I M, 1977, Zh Nevropatol Psikhiatr Im S S Korsakova, V77, P1656; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; KEARNEY TJ, 1992, J TRAUMA, V32, P608, DOI 10.1097/00005373-199205000-00012; Kemp CD, 2008, AM SURGEON, V74, P866; Lee K, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/207247; Lim HB, 2007, ANAESTHESIA, V62, P474, DOI 10.1111/j.1365-2044.2007.04998.x; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Mascia L, 2007, CRIT CARE MED, V35, P1815, DOI 10.1097/01.CCM.0000275269.77467.DF; Meyer KS, 2012, CRIT CARE, V16, DOI 10.1186/cc11311; MINER ME, 1982, J PEDIATR-US, V100, P687, DOI 10.1016/S0022-3476(82)80565-9; Molitoris BA, 2007, J AM SOC NEPHROL, V18, P1992, DOI 10.1681/ASN.2007050567; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; MORRIS JA, 1991, J TRAUMA, V31, P1584, DOI 10.1097/00005373-199112000-00003; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Paiva WS, 2011, THER CLIN RISK MANAG, V7, P345, DOI 10.2147/TCRM.S17692; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; REGEL G, 1995, J TRAUMA, V38, P70, DOI 10.1097/00005373-199501000-00020; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Rincon-Ferrari MD, 2004, J TRAUMA, V57, P1234, DOI 10.1097/01.TA.0000119200.70853.23; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Selladurai BM, 1997, BRIT J NEUROSURG, V11, P398; SIEGEL JH, 1995, J NEUROTRAUM, V12, P579, DOI 10.1089/neu.1995.12.579; SIPKINS JH, 1981, NEPHRON, V28, P36, DOI 10.1159/000182092; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Tisdall M, 2006, J NEUROSURG ANESTH, V18, P57, DOI 10.1097/01.ana.0000191280.05170.0f; VALLADARES JB, 1980, NEUROSURGERY, V6, P138, DOI 10.1227/00006123-198002000-00004; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54; Zygun D, 2006, CRIT CARE, V10, DOI 10.1186/cc5007; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	48	12	12	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0972-5229	1998-359X		INDIAN J CRIT CARE M	Indian J. Crit. Care Med.	SEP	2018	22	9					632	638		10.4103/ijccm.IJCCM_156_18			7	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	HB1UU	WOS:000450813100002	30294128	Green Published, gold			2022-02-06	
J	Park, K; Ksiazek, T; Olson, B				Park, Kyoungyoun; Ksiazek, Thomas; Olson, Bernadette			Effectiveness of Vestibular Rehabilitation Therapy for Treatment of Concussed Adolescents With Persistent Symptoms of Dizziness and Imbalance	JOURNAL OF SPORT REHABILITATION			English	Article						brain concussion; vestibular therapy; postconcussion syndrome; balance; oculomotor	TRAUMATIC BRAIN-INJURY; CHILDREN; SPORT	Context: Adolescents who suffer sport concussion typically respond to a prescription of cognitive and physical rest in the acute phases of healing; however, some adolescents do not respond to rest alone. Dizziness, unsteadiness, and imbalance are impairments, which may linger longer than 30 days, leading to a diagnosis of postconcussion syndrome (PCS). Vestibular assessment and therapy may benefit adolescents suffering from these persistent symptoms. Clinical Question: Does vestibular rehabilitation therapy (VRT) rather than continued prescription of rest (cognitive and physical) reduce recovery time and persistent symptoms of dizziness, unsteadiness, and imbalance in adolescents (12-18 y) who suffer PCS following a sports-related concussion? Summary of Key Findings: All 4 studies selected included adolescents suffering from PCS, specifically continued dizziness, unsteadiness, and imbalance. VRT was an effective intervention for this population. Adolescents presenting with this cluster of symptoms may also demonstrate verbal and visual memory loss linked to changes in the vestibular system postconcussion. Improved screening tools can help better understand vestibular system changes, identify adolescents who may benefit from VRT sooner, and decrease long-term impairments. Clinical Bottom Line: Moderate evidence supports that adolescents who suffer from persistent symptoms of dizziness, unsteadiness, and imbalance following sport concussion should bee valuated more specifically and earlier for vestibular dysfunction and can benefit from participation in individualized VRT. Early evaluation and treatment may result in a reduction of time lost from sport as well as a return to their premorbid condition. For these adolescents, VRT may be more beneficial than continued physical and cognitive rest when an adolescent's symptoms last longer than 30 days. Strength of Recommendation: Grade B evidence exists to support that VRT is more effective than continued cognitive and physical rest in reducing persistent symptoms of dizziness, unsteadiness, and imbalance in adolescents who suffer PCS.	[Park, Kyoungyoun] Univ North Carolina Greensboro, Dept Kinesiol, Greensboro, NC USA; [Ksiazek, Thomas] Great Plains Hlth, Sports & Therapy Dept, North Platte, NE USA; [Olson, Bernadette] South Dakota State Univ, Dept Hlth & Nutr Sci, Brookings, SD 57007 USA		Olson, B (corresponding author), South Dakota State Univ, Dept Hlth & Nutr Sci, Brookings, SD 57007 USA.	Bernie.olson@sdstate.edu					Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Babcock L, 2016, JAMA-J AM MED ASSOC, V315, P987, DOI 10.1001/jama.2016.1276; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Howick J, 2011, OXFORD 2011 LEVELS E; Institute of Medicine and National Research Council, 2014, SPORTS RELATED CONCU, DOI [https://doi.org/10.17226/18377, DOI 10.17226/18377, 10.17226/18377]; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720	19	12	12	0	4	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	SEP	2018	27	5					485	490		10.1123/jsr.2016-0222			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	GT3PC	WOS:000444414600015	28530516				2022-02-06	
J	Teo, DB; Wong, HC; Yeo, AW; Lai, YW; Choo, EL; Merchant, RA				Teo, Desmond B.; Wong, Hung C.; Yeo, Ai W.; Lai, Yi W.; Choo, Ee L.; Merchant, Reshma A.			Characteristics of fall-related traumatic brain injury in older adults	INTERNAL MEDICINE JOURNAL			English	Article						frail elderly; accidental fall; brain injuries; traumatic; haematoma; subdural; head injuries; closed	EMERGENCY-DEPARTMENT VISITS; RISK-FACTORS; FUNCTIONAL DECLINE; SCREENING TOOL; PEOPLE; HOSPITALIZATION; IDENTIFICATION; VALIDATION; INCREASES; DISCHARGE	BackgroundOlder adults admitted for falls and its complications, including traumatic brain injury (TBI), is increasing. Recent studies have shown that those with falls who presented to the emergency department (ED) had an increased frequency of ED revisits, especially those with head trauma. AimTo determine the characteristics and predictors of fall-related traumatic brain injury (FRTBI) in older adults. MethodsRetrospective medical chart review of 339 patients aged 65 years and older admitted for TBI in 2014 due to a fall. Characteristics analysed include demographics, fall circumstances, prior ED visits, polypharmacy, readmission, functional status and specialist outpatient clinic utilisation before and after FRTBI. ResultsA total of 339 (37.4%) patients admitted due to FRTBI was 65 years old and older; 112 (33.0%) for subdural haemorrhage (SDH); 227 (67.0%) for head injury (HI), with a mean age of 80 years. A total of 46 (41.1%) patients with SDH and 107 (47.1%) with HI had a previous ED visit within the last year, while 22 (19.6%) of SDH and 49 (21.6%) of HI had hospitalisation 3 months prior to FRTBI. FRTBI was associated with significant decline in activities of daily living, polypharmacy and increased specialist outpatient clinic appointments (P < 0.001). Mortality was 11 (3.2%). Mild cognitive impairment or dementia was significantly associated with admissions for FRTBI, 3.31 (95% confidence interval 1.68-6.51, P = 0.001) using adjusted logistic regression. ConclusionFRTBI is associated with significant functional decline and increased resource utilisation with almost half of the patients having had prior ED visits or hospitalisation. Future studies should focus on falls risk assessment and interventions for high-risk older adults prior to discharge from ED and hospital, and its impact on readmissions due to FRTBI.	[Teo, Desmond B.] Natl Univ Healthcare Syst, Natl Univ Hosp, Univ Med Cluster, Div Adv Internal Med, 1E Kent Ridge Rd,NUHS Tower Block,Level 10, Singapore 119228, Singapore; [Merchant, Reshma A.] Natl Univ Healthcare Syst, Natl Univ Hosp, Univ Med Cluster, Div Geriatr Med, Singapore, Singapore; [Wong, Hung C.] Natl Univ Singapore, Yong Loo Lin Sch Med, Biostat Unit, Singapore, Singapore; [Lai, Yi W.] Natl Univ Singapore, Yong Loo Lin Sch Med, Deans Off, Singapore, Singapore; [Merchant, Reshma A.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Yeo, Ai W.] Natl Univ Healthcare Syst, Natl Univ Hosp, Dept Nursing, Singapore, Singapore; [Choo, Ee L.] Natl Univ Healthcare Syst, Natl Univ Hosp, Management Informat Corp Planning & Dev, Singapore, Singapore		Teo, DB (corresponding author), Natl Univ Healthcare Syst, Natl Univ Hosp, Univ Med Cluster, Div Adv Internal Med, 1E Kent Ridge Rd,NUHS Tower Block,Level 10, Singapore 119228, Singapore.	desmond_teo@nuhs.edu.sg	Teo, Desmond/X-5600-2019; Wong, Hung Chew/AAE-3594-2021; Merchant, Reshma/ABD-4044-2020; Merchant, Reshma Aziz/I-3033-2019	Teo, Desmond/0000-0002-0252-7426; Merchant, Reshma Aziz/0000-0002-9032-0184; Lai, yi wye/0000-0003-1511-971X			Blumenthal D, 2001, NEW ENGL J MED, V344, P766, DOI 10.1056/NEJM200103083441012; Callisaya ML, 2014, J AM GERIATR SOC, V62, P1527, DOI 10.1111/jgs.12925; Carpenter CR, 2009, ACAD EMERG MED, V16, P211, DOI 10.1111/j.1553-2712.2009.00351.x; Centers for Disease Control and Prevention, RAT TBI REL EM DEP V; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Choucair B, 2015, AM J PUBLIC HEALTH, V105, pS144, DOI 10.2105/AJPH.2015.302564; Close J, 1999, LANCET, V353, P93, DOI 10.1016/S0140-6736(98)06119-4; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Dendukuri N, 2004, J AM GERIATR SOC, V52, P290, DOI 10.1111/j.1532-5415.2004.52073.x; Department of Statistics Ministry of Trade and Industry Singapore, 2017, POP TRENDS 2017; Gribbin J, 2010, AGE AGEING, V39, P592, DOI 10.1093/ageing/afq092; Hanlon JT, 2017, J AM GERIATR SOC, V65, P1183, DOI 10.1111/jgs.14759; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Karam G, 2015, GERIATR GERONTOL INT, V15, P1107, DOI 10.1111/ggi.12538; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Korhonen N, 2013, JAMA-J AM MED ASSOC, V309, P1891, DOI 10.1001/jama.2013.3356; Lipsitz LA, 2015, HYPERTENSION, V66, P183, DOI 10.1161/HYPERTENSIONAHA.115.05513; Liu SW, 2015, AM J EMERG MED, V33, P1012, DOI 10.1016/j.ajem.2015.04.023; Luukinen H, 2005, EUR J NEUROL, V12, P86, DOI 10.1111/j.1468-1331.2004.00953.x; Marcum ZA, 2015, J GERONTOL A-BIOL, V70, P1562, DOI 10.1093/gerona/glv095; McCusker J, 1999, J AM GERIATR SOC, V47, P1229, DOI 10.1111/j.1532-5415.1999.tb05204.x; Meldon SW, 2003, ACAD EMERG MED, V10, P224, DOI 10.1197/aemj.10.3.224; Merchant RA, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2017.04.020; Meuleners LB, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0711-3; Muir SW, 2012, AGE AGEING, V41, P299, DOI 10.1093/ageing/afs012; Nagurney JM, 2017, ANN EMERG MED, V69, P426, DOI 10.1016/j.annemergmed.2016.09.018; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Salvi F, 2007, INTERN EMERG MED, V2, P292, DOI 10.1007/s11739-007-0081-3; Southerland LT, 2016, J AM GERIATR SOC, V64, P870, DOI 10.1111/jgs.14041; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Tiedemann A, 2013, EMERG MED J, V30, P918, DOI 10.1136/emermed-2012-201783; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Tirrell G, 2015, ACAD EMERG MED, V22, P461, DOI 10.1111/acem.12634; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357; Wu HY, 2006, ANN ACAD MED SINGAP, V35, P17	35	12	12	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-0903	1445-5994		INTERN MED J	Intern. Med. J.	SEP	2018	48	9					1048	1055		10.1111/imj.13794			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GS5GB	WOS:000443684400005	29573078				2022-02-06	
J	Uivarosan, D; Abdel-Daim, MM; Endres, L; Purza, L; Iovan, C; Bungau, S; Furau, CG; Tit, DM				Uivarosan, Diana; Abdel-Daim, Mohamed M.; Endres, Laura; Purza, Lavinia; Iovan, Ciprian; Bungau, Simona; Furau, Cristian Gheorghe; Tit, Delia Mirela			EFFECTS OF A PROTEIC SWINE EXTRACT ASSOCIATED TO RECOVERY TREATMENT ON FUNCTIONAL INDEPENDENCE AND QUALITY OF LIFE IN PATIENTS POST STROKE	FARMACIA			English	Article						proteic swine extract; cerebrovascular accident; stroke; medical recovery; quality of life	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; DOUBLE-BLIND; NEUROLOGICAL DISORDERS; NEUROTROPHIC TREATMENT; CEREBROLYSIN; TRIAL; REHABILITATION; EFFICACY	Stroke is one of the leading causes of mortality and morbidity worldwide. This study investigates the effect produced by associating a proteic swine extract (PSE) with classical recovery techniques on functional independence and quality of life of post-stroke patients. 139 patients that had suffered stroke were divided into 2 groups and were evaluated initially, at 6 and at 12 months. The FIM scale (Functional Independence Measure) and the SS-QoL scale (Stroke Specific Quality of Life Scale), were used to monitor the effects of therapy. There were no significant differences (p > 0.05) in the patients' evolution in terms of functional independence, but the effect size was more obvious in the group treated with PSE. The evolution of the quality of life was significantly better (p < 0.05) after six months for patients who had PSE associated treatment. The results of this study provide a favourable evidence for the use of associated therapy of PSE and classical recovery procedures in patients who had suffered a stroke.	[Uivarosan, Diana; Endres, Laura; Iovan, Ciprian] Univ Oradea, Fac Med & Pharm, Dept Preclin Sci, 10 P Ta 1 Decembrie St, Oradea, Romania; [Abdel-Daim, Mohamed M.] Suez Canal Univ, Fac Vet Med, Pharmacol Dept, Ismailia 41522, Egypt; [Abdel-Daim, Mohamed M.] Yokohama City Univ, Dept Ophthalmol & Microtechnol, Yokohama, Kanagawa, Japan; [Purza, Lavinia] Univ Oradea, Doctoral Sch, Dept Biomed Sci, 1 Univ St, Oradea, Romania; [Purza, Lavinia; Bungau, Simona; Tit, Delia Mirela] Univ Oradea, Fac Med & Pharm, Pharm Dept, 29 Nicolae Jiga St, Oradea, Romania; [Furau, Cristian Gheorghe] Vasile Goldis Western Univ Arad, Fac Med, Dept Life Sci, 86 L Rebreanu St, Arad, Romania		Iovan, C (corresponding author), Univ Oradea, Fac Med & Pharm, Dept Preclin Sci, 10 P Ta 1 Decembrie St, Oradea, Romania.	dr.iovan@biostandard.ro	Abdel-Daim, Mohamed M./B-2545-2013; Tit, Delia Mirela/AAT-5032-2020; Furau, Cristian/ABA-9686-2021; PURZA, LAVINIA/AAB-2547-2021; Uivarosan, Diana/AAT-6035-2020; Bungau, Simona Gabriela/C-1831-2015; Endres, Laura Maria/AAY-5100-2020	Abdel-Daim, Mohamed M./0000-0002-4341-2713; Tit, Delia Mirela/0000-0002-0296-6592; Furau, Cristian/0000-0001-7158-2579; Bungau, Simona Gabriela/0000-0003-3236-1292; Purza, Lavinia/0000-0002-2318-9235			Amiri-Nikpour MR, 2014, NEUROPSYCH DIS TREAT, V10, P2299, DOI 10.2147/NDT.S75304; Bornstein N, 2012, DRUG TODAY, V48, P43, DOI 10.1358/dot.2012.48(Suppl.A).1739723; Cavanagh S J, 2000, J Neurosci Nurs, V32, P17; Chen CC, 2013, BRIT J NEUROSURG, V27, P803, DOI 10.3109/02688697.2013.793287; Denti L, 2008, EUR J PHYS REHAB MED, V44, P3; Diserens K, 2006, CEREBROVASC DIS, V22, P183, DOI 10.1159/000093453; Elmaraezy A, 2017, CNS NEUROL DISORD-DR, V16, P789, DOI 10.2174/1871527315666161213110104; Fodor K, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4147320; Hartbauer M, 2001, J NEURAL TRANSM, V108, P459, DOI 10.1007/s007020170067; Hong Z, 2009, INT J STROKE, V4, P406, DOI 10.1111/j.1747-4949.2009.00340.x; Khalili H, 2017, CLIN NEUROL NEUROSUR, V152, P34, DOI 10.1016/j.clineuro.2016.11.011; Ladurner G, 2005, J NEURAL TRANSM, V112, P415, DOI 10.1007/s00702-004-0248-2; Legg L, 2004, LANCET, V363, P352; LOPEZ J, 2012, BMC HEALTH SERV RES, V12, DOI DOI 10.1186/1471-2407-12-48; Masliah E, 2012, DRUG TODAY, V48, P3, DOI 10.1358/dot.2012.48(Suppl.A).1739716; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Muresanu DF, 2016, STROKE, V47, P151, DOI 10.1161/STROKEAHA.115.009416; Muresanu DF, 2010, ACTA NEUROCHIR SUPPL, V106, P291, DOI 10.1007/978-3-211-98811-4_54; Onose G, 2017, FARMACIA, V65, P772; Uivarosan D, 2014, THESIS; Williams LS, 1999, NEUROLOGY, V53, P1839, DOI 10.1212/WNL.53.8.1839; Williams LS, 1999, STROKE, V30, P1362, DOI 10.1161/01.STR.30.7.1362	22	12	12	1	11	SOC STINTE FARMACEUTICE ROMANIA	BUCURESTI	BUCURESTI, STR TRAIAN VUIA 6, SECT 1, BUCURESTI, 020956, ROMANIA	0014-8237	2065-0019		FARMACIA	Farmacia	SEP-OCT	2018	66	5					826	830		10.31925/farmacia.2018.5.12			5	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	GW7VT	WOS:000447181100012		Bronze			2022-02-06	
J	Xu, B; Lian, S; Li, SZ; Guo, JR; Wang, JF; Wang, D; Zhang, LP; Yang, HM				Xu, Bin; Lian, Shuai; Li, Shi-Ze; Guo, Jing-Ru; Wang, Jian-Fa; Wang, Di; Zhang, Li-Ping; Yang, Huan-Min			GABAB receptor mediate hippocampal neuroinflammation in adolescent male and female mice after cold expose	BRAIN RESEARCH BULLETIN			English	Article						Adolescent mouse; Cold stress; Cognition; Neuroinflammation; Neuronal death	TRAUMATIC BRAIN-INJURY; OPEN-FIELD TEST; NF-KAPPA-B; OXIDATIVE STRESS; WORKING-MEMORY; TNF-ALPHA; MICROGLIAL ACTIVATION; NEURONAL APOPTOSIS; ALZHEIMERS-DISEASE; SIGNALING PATHWAY	Stress induces many non-specific inflammatory responses in the mouse brain, especially during adolescence. Although the impact of stress on the brain has long been reported, the effects of cold stress on hippocampal neuroinflammation in adolescent mice are not well understood; furthermore, whether these effects are gender specific are also not well established. Adolescent male and female C57BL/6 mice were exposed to 4 degrees C temperatures for 12 h, after which behavior was assessed using the open field test. Using western blotting and immunohistochemistry we also assessed glial cell numbers and microglial activation, as well as inflammatory cytokine levels and related protein expression levels. We found that in mice subjected to cold stress: 1) There were significant behavioral changes; 2) neuronal nuclei densities were smaller and total cell numbers were significantly decreased; 3) nuclear factor (NF)-KB and phosphorylated AKT were upregulated; 4) pro-inflammatory cytokines such as interleukin-6 and tumor necrosis factor-alpha were also upregulated; and 5) microglia were activated, while glial fibrillary acid protein and ionized calcium-binding adapter molecule 1 protein expression increased. Taken together, these results indicate that cold stress induces pro-inflammatory cytokine upregulation that leads to neuroinflammation and neuronal apoptosis in the hippocampi of adolescent mice. We believe that these effects are influenced by a GABAB/Rap1B/AKT/NF-kappa B pathway. Finally, male mice were more sensitive to the effects of cold stress than were female mice.	[Xu, Bin; Lian, Shuai; Li, Shi-Ze; Guo, Jing-Ru; Wang, Jian-Fa; Wang, Di; Yang, Huan-Min] Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, Daqing 163319, Peoples R China; [Zhang, Li-Ping] Heilongjiang Bayi Agr Univ, Coll Food Sci, Daqing 163319, Peoples R China		Yang, HM (corresponding author), Heilongjiang Bayi Agr Univ, Coll Anim Sci & Vet Med, Daqing 163319, Peoples R China.; Zhang, LP (corresponding author), Heilongjiang Bayi Agr Univ, Coll Food Sci, Daqing 163319, Peoples R China.	ZLP77@126.com; byndyhm@163.com	Lian, Shuai/AAF-9966-2019		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31672513, 31471586, 31772695]; National Key Research and Development Program [2016YFD0501210]	This work was supported by the National Natural Science Foundation of China (project no. 31672513, no. 31471586 and no. 31772695), National Key Research and Development Program (project no. 2016YFD0501210)	Al'Absi M, 2002, PSYCHOPHYSIOLOGY, V39, P95, DOI 10.1017/S0048577202001543; Alves ND, 2018, BRAIN STRUCT FUNCT, V223, P415, DOI 10.1007/s00429-017-1490-3; Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bollinger JL, 2016, BRAIN BEHAV IMMUN, V52, P88, DOI 10.1016/j.bbi.2015.10.003; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Chen J, 2010, J NEUROENDOCRINOL, V22, P1072, DOI 10.1111/j.1365-2826.2010.02054.x; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; Coimbra-Costa D, 2017, REDOX BIOL, V12, P216, DOI 10.1016/j.redox.2017.02.014; CRONAN JE, 1975, BACTERIOL REV, V39, P232, DOI 10.1128/MMBR.39.3.232-256.1975; De Simone V, 2015, ONCOGENE, V34, P3493, DOI 10.1038/onc.2014.286; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Dong HW, 2009, P NATL ACAD SCI USA, V106, P11794, DOI 10.1073/pnas.0812608106; Duchesne A, 2012, BIOL PSYCHOL, V89, P99, DOI 10.1016/j.biopsycho.2011.09.009; Elzinga BM, 2005, BEHAV NEUROSCI, V119, P98, DOI 10.1037/0735-7044.119.1.98; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Felix-Ortiz AC, 2014, J NEUROSCI, V34, P586, DOI 10.1523/JNEUROSCI.4257-13.2014; Ferre S, 2010, BBA-MOL BASIS DIS, V1802, P952, DOI 10.1016/j.bbadis.2010.06.016; Frank MG, 2007, BRAIN BEHAV IMMUN, V21, P47, DOI 10.1016/j.bbi.2006.03.005; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Guo WJ, 2018, CELL PHYSIOL BIOCHEM, V46, P2090, DOI 10.1159/000489449; Gur TL, 2017, BRAIN BEHAV IMMUN, V64, P50, DOI 10.1016/j.bbi.2016.12.021; He S, 2018, ENVIRON INT, V111, P295, DOI 10.1016/j.envint.2017.11.004; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Huang TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029102; Jenniches I, 2016, BIOL PSYCHIAT, V79, P858, DOI 10.1016/j.biopsych.2015.03.033; Kim HG, 2013, BIOL PHARM BULL, V36, P1556, DOI 10.1248/bpb.b13-00268; Kim J, 2016, POLYM J, V48, P829, DOI 10.1038/pj.2016.37; Kim SH, 2012, INT J PSYCHOPHYSIOL, V83, P348, DOI 10.1016/j.ijpsycho.2011.12.001; Kogler L, 2015, HUM BRAIN MAPP, V36, P1028, DOI 10.1002/hbm.22683; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kumar S, 2014, J EXP MED, V211, P1741, DOI 10.1084/jem.20131706; Lawrence T, 2010, INT J BIOCHEM CELL B, V42, P519, DOI 10.1016/j.biocel.2009.12.016; Lee W, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0324-6; Li JT, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00025; Li SJ, 2014, EUR REV MED PHARMACO, V18, P905; Lin CY, 2013, J CELL BIOCHEM, V114, P2061, DOI 10.1002/jcb.24553; Liu Y, 2017, BRAIN RES, V1670, P201, DOI 10.1016/j.brainres.2017.06.025; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Meehan C, 2017, BRAIN BEHAV IMMUN, V63, P8, DOI 10.1016/j.bbi.2016.07.144; Morgan CA, 2006, BIOL PSYCHIAT, V60, P722, DOI 10.1016/j.biopsych.2006.04.021; Morrissey MD, 2011, NEUROBIOL LEARN MEM, V95, P46, DOI 10.1016/j.nlm.2010.10.007; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Numakawa T, 2013, NEUROSCIENCE, V239, P157, DOI 10.1016/j.neuroscience.2012.09.073; Ostojic ZS, 2013, NEUROSCIENCE, V238, P39, DOI 10.1016/j.neuroscience.2013.01.072; Padgett CL, 2010, ADV PHARMACOL, V58, P123, DOI 10.1016/S1054-3589(10)58006-2; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; PREMKUMAR LS, 1994, J NEUROPHYSIOL, V71, P2570, DOI 10.1152/jn.1994.71.6.2570; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Raskin J, 2015, CURR ALZHEIMER RES, V12, P712, DOI 10.2174/1567205012666150701103107; Romeo RD, 2013, CURR DIR PSYCHOL SCI, V22, P140, DOI 10.1177/0963721413475445; Rosic NN, 2011, CELL STRESS CHAPERON, V16, P69, DOI 10.1007/s12192-010-0222-x; Saita E, 2016, BBA-MOL CELL BIOL L, V1861, P837, DOI 10.1016/j.bbalip.2016.01.003; Slavich GM, 2014, PSYCHOL BULL, V140, P774, DOI 10.1037/a0035302; Stone SSD, 2011, HIPPOCAMPUS, V21, P1348, DOI 10.1002/hipo.20845; Sugama S, 2007, NEUROSCIENCE, V146, P1388, DOI 10.1016/j.neuroscience.2007.02.043; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; White MG, 2003, J NEUROCHEM, V87, P958, DOI 10.1046/j.1471-4159.2003.02077.x; Xiao CF, 2007, DEV NEUROBIOL, V67, P438, DOI 10.1002/dneu.20344; Xu DL, 2017, J EXP BIOL, V220, P2187, DOI 10.1242/jeb.153601; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yeager MP, 2009, CRIT CARE MED, V37, P2727, DOI 10.1097/CCM.0b013e3181a592b3; Yilmaz U, 2015, RADIOLOGE, V55, P386, DOI 10.1007/s00117-014-2796-2; Yuruker V, 2015, METAB BRAIN DIS, V30, P223, DOI 10.1007/s11011-014-9623-3	68	12	13	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	SEP	2018	142						163	175		10.1016/j.brainresbull.2018.07.011			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY0PK	WOS:000448223400019	30031816				2022-02-06	
J	Mattugini, N; Merl-Pham, J; Petrozziello, E; Schindler, L; Bernhagen, J; Hauck, SM; Gotz, M				Mattugini, Nicola; Merl-Pham, Juliane; Petrozziello, Elisabetta; Schindler, Lisa; Bernhagen, Juergen; Hauck, Stefanie M.; Goetz, Magdalena			Influence of white matter injury on gray matter reactive gliosis upon stab wound in the adult murine cerebral cortex	GLIA			English	Article						astrocytes; brain injury; gray matter; microglia; NG2; proteomics; white matter	MIGRATION INHIBITORY FACTOR; SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; OLIGODENDROCYTE PRECURSOR CELLS; NEURAL STEM-CELLS; DATA-INDEPENDENT ACQUISITION; CENTRAL-NERVOUS-SYSTEM; IN-VITRO; CORPUS-CALLOSUM; GLIAL SCAR	Traumatic brain injury frequently affects the cerebral cortex, yet little is known about the differential effects that occur if only the gray matter (GM) is damaged or if the injury also involves the white matter (WM). To tackle this important question and directly compare similarities and differences in reactive gliosis, we performed stab wound injury affecting GM and WM (GM+) and one restricted to the GM (GM-) in the adult murine cerebral cortex. First, we examined glial reactivity in the regions affected (WM and GM) and determined the influence of WM injury on reactive gliosis in the GM comparing the same area in the two injury paradigms. In the GM+ injury microglia proliferation is increased in the WM compared with GM, while proliferating astrocytes are more abundant in the GM than in the WM. Interestingly, WM lesion exerted a strong influence on the proliferation of the GM glial cells that was most pronounced at early stages, 3 days post lesion. While astrocyte proliferation was increased, NG2 glia proliferation was decreased in the GM+ compared with GM- lesion condition. Importantly, these differences were not observed when a lesion of the same size affected only the GM. Unbiased proteomic analyses further corroborate our findings in support of a profound difference in GM reactivity when WM is also injured and revealed MIF as a key regulator of NG2 glia proliferation.	[Mattugini, Nicola; Goetz, Magdalena] Ludwig Maximilians Univ Munchen, Biomed Ctr BMC, Physiol Genom, Grosshaderner Str 9, D-82152 Planegg Martinsried, Germany; [Mattugini, Nicola; Goetz, Magdalena] Ludwig Maximilians Univ Munchen, Dept Physiol Genom, Helmholtz Ctr Munich, Inst Stem Cell Res,Biomed Ctr BMC, Grosshaderner Str 9, D-82152 Planegg Martinsried, Germany; [Mattugini, Nicola] Ludwig Maximilians Univ Munchen, Grad Sch Syst Neurosci, Grosshaderner Str 2, D-82152 Planegg Martinsried, Germany; [Merl-Pham, Juliane; Hauck, Stefanie M.] Helmholtz Ctr Munich, Res Unit Prot Sci, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Petrozziello, Elisabetta] Ludwig Maximilians Univ Munchen, Inst Immunol, Biomed Ctr BMC, Grosshadernerstr 9, D-82152 Planegg Martinsried, Germany; [Schindler, Lisa; Bernhagen, Juergen] Ludwig Maximilians Univ LMU Munich, Inst Stroke & Dementia Res ISD, Vasc Biol, D-81377 Munich, Germany; [Bernhagen, Juergen; Goetz, Magdalena] SyNergy Excellence Cluster, D-81377 Munich, Germany		Gotz, M (corresponding author), Ludwig Maximilians Univ Munchen, Biomed Ctr BMC, Physiol Genom, Grosshaderner Str 9, D-82152 Planegg Martinsried, Germany.	magdalena.goetz@helmholtz-muenchen.de	Merl-Pham, Juliane/N-7258-2014; Hauck, Stefanie/B-3300-2013	Merl-Pham, Juliane/0000-0002-3422-4083; Hauck, Stefanie/0000-0002-1630-6827; Mattugini, Nicola/0000-0003-4489-1661	German Research FoundationGerman Research Foundation (DFG) [SPP1757, SFB 870, EXC1010]	German Research Foundation, Grant/Award Numbers: SPP1757 and SFB 870; EXC1010 SyNergy	Adams KL, 2018, NAT NEUROSCI, V21, P9, DOI 10.1038/s41593-017-0033-9; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Arno B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6611; Ballabh P, 2004, PEDIATR RES, V56, P117, DOI 10.1203/01.PDR.0000130472.30874.FF; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Baumgart EV, 2012, GLIA, V60, P343, DOI 10.1002/glia.22269; Beliakoff J, 2008, MOL CELL BIOL, V28, P282, DOI 10.1128/MCB.00771-07; Ben Haim L, 2017, NAT REV NEUROSCI, V18, P31, DOI [10.1038/nrn.2016.159, 10.1038/nm.2016.159]; Ben Haim Lucile, 2015, Front Cell Neurosci, V9, P278, DOI 10.3389/fncel.2015.00278; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Boutte AM, 2012, ELECTROPHORESIS, V33, P3693, DOI 10.1002/elps.201200196; Bruderer R, 2016, PROTEOMICS, V16, P2246, DOI 10.1002/pmic.201500488; Bruderer R, 2015, MOL CELL PROTEOMICS, V14, P1400, DOI 10.1074/mcp.M114.044305; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Cavaglia M, 2001, BRAIN RES, V910, P81, DOI 10.1016/S0006-8993(01)02637-3; Conboy L, 2011, MOL PSYCHIATR, V16, P533, DOI 10.1038/mp.2010.15; Dai JX, 2014, GLIA, V62, P2096, DOI 10.1002/glia.22729; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Dewor M, 2007, FEBS LETT, V581, P4734, DOI 10.1016/j.febslet.2007.08.071; Dimou L, 2015, GLIA, V63, P1429, DOI 10.1002/glia.22859; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Dimou L, 2014, PHYSIOL REV, V94, P709, DOI 10.1152/physrev.00036.2013; Djudjaj S, 2017, J AM SOC NEPHROL, V28, P3590, DOI 10.1681/ASN.2017020190; Doi T, 2017, J NEUROSCI, V37, P10290, DOI 10.1523/JNEUROSCI.1109-17.2017; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Dumont CM, 2015, CELLS TISSUES ORGANS, V202, P52, DOI 10.1159/000446646; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Endo M, 2017, GLIA, V65, P182, DOI 10.1002/glia.23086; Fern RF, 2014, GLIA, V62, P1780, DOI 10.1002/glia.22722; Fernandez-Klett F, 2014, BRAIN PATHOL, V24, P404, DOI 10.1111/bpa.12162; Fewings NL, 2017, J AUTOIMMUN, V78, P57, DOI 10.1016/j.jaut.2016.12.006; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Gallo V, 2014, NEURON, V83, P283, DOI 10.1016/j.neuron.2014.06.010; Gaupp S, 2011, J NEUROPATH EXP NEUR, V70, P1138, DOI 10.1097/NEN.0b013e31823b188b; Geiger T, 2010, MOL CELL PROTEOMICS, V9, P2252, DOI 10.1074/mcp.M110.001537; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Goursaud S, 2009, J NEUROCHEM, V108, P1442, DOI 10.1111/j.1471-4159.2009.05889.x; Grosche A, 2016, MOL CELL PROTEOMICS, V15, P462, DOI 10.1074/mcp.M115.052183; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hammond TR, 2014, NEURON, V81, P588, DOI 10.1016/j.neuron.2013.11.015; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Han J, 2013, CELL DEATH DIFFER, V20, P1055, DOI 10.1038/cdd.2013.33; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; He DY, 2016, NAT NEUROSCI, V19, P678, DOI 10.1038/nn.4258; Heinemann U, 2012, GLIA, V60, P1251, DOI 10.1002/glia.22311; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Hsieh TH, 2017, CEREB CORTEX, V27, P5509, DOI 10.1093/cercor/bhw318; Hughes EG, 2013, NAT NEUROSCI, V16, P668, DOI 10.1038/nn.3390; Inacio AR, 2011, J CEREBR BLOOD F MET, V31, P1093, DOI 10.1038/jcbfm.2010.194; Jantzie LL, 2013, PEDIATR RES, V74, P658, DOI 10.1038/pr.2013.155; Jeong Hey-Kyeong, 2013, Exp Neurobiol, V22, P59, DOI 10.5607/en.2013.22.2.59; Jeong HK, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-28; Ji SP, 2011, J MOL CELL BIOL, V3, P351, DOI 10.1093/jmcb/mjr009; Joutel A, 2017, CLIN SCI, V131, P635, DOI 10.1042/CS20160380; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Li XM, 2006, J BIOL CHEM, V281, P23748, DOI 10.1074/jbc.M508365200; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lizhnyak PN, 2015, EXPERT REV PROTEOMIC, V12, P75, DOI 10.1586/14789450.2015.1000869; Luedike P, 2012, CIRCULATION, V125, P1880, DOI 10.1161/CIRCULATIONAHA.111.069104; Lundgaard I, 2014, NEUROSCIENCE, V276, P161, DOI 10.1016/j.neuroscience.2013.10.050; Martin-Lopez E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074039; McQueen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087227; Mehan ND, 2012, NEUROBIOL AGING, V33, P1857, DOI 10.1016/j.neurobiolaging.2011.09.029; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Moyon S, 2015, J NEUROSCI, V35, P4, DOI 10.1523/JNEUROSCI.0849-14.2015; Nemajerova A, 2007, CELL CYCLE, V6, P1030, DOI 10.4161/cc.6.9.4163; Nobs L, 2013, GLIA, V61, P1443, DOI 10.1002/glia.22533; Nyul-Toth A, 2016, AM J PHYSIOL-HEART C, V310, pH1702, DOI 10.1152/ajpheart.00774.2015; Ohta S, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0275-6; Pinnell N, 2015, IMMUNITY, V43, P870, DOI 10.1016/j.immuni.2015.10.007; Prins M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0098-6; Psachoulia K, 2009, NEURON GLIA BIOL, V5, P57, DOI 10.1017/S1740925X09990354; Rex S, 2014, MINI-REV MED CHEM, V14, P1116; Rodriguez JP, 2014, J NEUROSCI, V34, P10285, DOI 10.1523/JNEUROSCI.4915-13.2014; RODRIGUEZ MS, 2014, CELL DEATH DIS, V5; Rosenzweig S, 2013, STROKE, V44, P2579, DOI 10.1161/STROKEAHA.113.001796; Sabelstrom H, 2013, SCIENCE, V342, P637, DOI 10.1126/science.1242576; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Samanta J, 2015, NATURE, V526, P448, DOI 10.1038/nature14957; Schafer I, 2016, J CELL SCI, V129, P930, DOI 10.1242/jcs.172148; Schmidt F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040457; Sharma MJ, 2003, EMBO J, V22, P6101, DOI 10.1093/emboj/cdg585; Silver J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020602; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Simons D, 2011, J CELL MOL MED, V15, P668, DOI 10.1111/j.1582-4934.2010.01041.x; Sirko S, 2015, GLIA, V63, P2340, DOI 10.1002/glia.22898; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Sohn JH, 2015, J NEUROSCI, V35, P3756, DOI 10.1523/JNEUROSCI.3454-14.2015; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Tabata H, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00114; Tillmann S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00115; Trivedi A, 2006, CLIN NEUROSCI RES, V6, P283, DOI 10.1016/j.cnr.2006.09.007; TYSSELING VM, 2011, J NEUROINFLAMM, V8; Vigano F, 2013, NAT NEUROSCI, V16, P1370, DOI 10.1038/nn.3503; Wang YF, 2016, SCIENCE, V354, DOI 10.1126/science.aad6872; Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yang DB, 2017, CLIN CHIM ACTA, V469, P99, DOI 10.1016/j.cca.2017.03.030; Yang HJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10884; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhu Y, 2017, J NEUROSCI, V37, P2362, DOI 10.1523/JNEUROSCI.2751-16.2017	110	12	12	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	AUG	2018	66	8					1644	1662		10.1002/glia.23329			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GN1BV	WOS:000438719700008	29573353				2022-02-06	
J	Numa, A; Aneja, H; Awad, J; Ravindranathan, H; Singh, P; Swil, K; Williams, G				Numa, Andrew; Aneja, Himanshu; Awad, John; Ravindranathan, Hari; Singh, Puneet; Swil, Kevin; Williams, Gary			Admission Hyperoxia Is a Risk Factor for Mortality in Pediatric Intensive Care*	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						hyperoxia; hypoxia; mortality; outcome; pediatrics; risk-adjusted mortality	TRAUMATIC BRAIN-INJURY; CARDIAC-ARREST; ARTERIAL HYPEROXIA; OXYGEN-THERAPY; MYOCARDIAL-INFARCTION; MULTICENTER COHORT; OUTCOMES; ASSOCIATION; RESUSCITATION; TRIAL	Objectives: To determine whether the association between hyperoxia and increased risk-adjusted mortality in adult intensive care patients is also observed in a pediatric intensive care population. Design: Single-center retrospective analysis of admissions to ICU over a 5-year period commencing January 1, 2012, examining the relationship between Pao(2) measured within the first hour of admission and risk-adjusted mortality. Standardized mortality rates were calculated using the Pediatric Index of Mortality-3, and patients were grouped into 50mm Hg (6.67 kPa) Pao(2) bands to assess the relationship between initial Pao(2) and risk-adjusted mortality. Setting: Tertiary PICU with 17 beds and 1,100 annual admissions located in metropolitan Sydney, Australia. Patients: A total of 1,447 patients 0-18 years old with Pao(2) recorded at admission to the ICU. Interventions: None. Measurements and Main Results: There were 5,176 patients admitted to the ICU during the study period and 1,447 (28%) with Pao(2) recorded at admission. A U-shaped relationship between raw mortality and admission Pao(2) was observed, with lowest mortality (2.3% and 2.6%, respectively) observed in the 101-150 (13.5-20.0 kPa) and 151-200mm Hg (20.1-26.7 kPa) bands and the highest mortality observed in patients with Pao(2) less than 50mm Hg (6.67 kPa) with mortality of 5.3%, or greater than 350mm Hg (46.7 kPa) with mortality of 18.2%. Hyperoxia at admission was associated with an increase in risk-adjusted mortality, with polynomial regression indicating a strong correlation between Pao(2) band and risk-adjusted outcome (r(2) = 0.845). When included in a multivariate model that included the Pediatric Index of Mortality-3 variables, the odds ratio for hyperoxia (defined as Pao(2) > 250mm Hg [33.3 kPa]) predicting death was 2.66 (p = 0.047). Conclusions: In this single-center study, hyperoxia at admission to the PICU was highly correlated with increased risk-adjusted mortality. Further investigation of these observations in a large multicenter cohort is warranted.	[Numa, Andrew; Aneja, Himanshu; Awad, John; Ravindranathan, Hari; Singh, Puneet; Swil, Kevin; Williams, Gary] Sydney Childrens Hosp, Intens Care Unit, Randwick, NSW, Australia; [Numa, Andrew; Awad, John; Ravindranathan, Hari; Singh, Puneet; Swil, Kevin; Williams, Gary] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia		Numa, A (corresponding author), Sydney Childrens Hosp, Intens Care Unit, Randwick, NSW, Australia.; Numa, A (corresponding author), Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia.	a.numa@unsw.edu.au					Bellomo R, 2011, CRIT CARE, V15, DOI 10.1186/cc10090; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; de Jonge E, 2008, CRIT CARE, V12, DOI 10.1186/cc7150; Eastwood G, 2012, INTENS CARE MED, V38, P91, DOI 10.1007/s00134-011-2419-6; Elmer J, 2015, INTENS CARE MED, V41, P49, DOI 10.1007/s00134-014-3555-6; Ferguson LP, 2012, CIRCULATION, V126, P335, DOI 10.1161/CIRCULATIONAHA.111.085100; Girardis M, 2016, JAMA-J AM MED ASSOC, V316, P1583, DOI 10.1001/jama.2016.11993; Hafner C, 2017, SHOCK, V47, P436, DOI 10.1097/SHK.0000000000000740; Haldane JS, 1917, BRIT MED J, V1917, P181, DOI 10.1136/bmj.1.2928.181; Helmerhorst HJF, 2017, CRIT CARE MED, V45, P187, DOI 10.1097/CCM.0000000000002084; Helmerhorst HJF, 2016, CRIT CARE MED, V44, P554, DOI 10.1097/CCM.0000000000001461; Helmerhorst HJF, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1067-6; Hofmann R, 2017, NEW ENGL J MED, V377, P1240, DOI 10.1056/NEJMoa1706222; Janz DR, 2012, CRIT CARE MED, V40, P3135, DOI 10.1097/CCM.0b013e3182656976; Kilgannon JH, 2011, CIRCULATION, V123, P2717, DOI 10.1161/CIRCULATIONAHA.110.001016; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; NASH G, 1967, NEW ENGL J MED, V276, P368, DOI 10.1056/NEJM196702162760702; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Panwar R, 2016, AM J RESP CRIT CARE, V193, P43, DOI 10.1164/rccm.201505-1019OC; PATZ A, 1952, AM J OPHTHALMOL, V35, P1248, DOI 10.1016/0002-9394(52)91140-9; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Pollack MM, 2016, PEDIATR CRIT CARE ME, V17, P2, DOI 10.1097/PCC.0000000000000558; Priestly J, 1776, EXPT DIFFERENT KINDS; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Rincon F, 2014, CRIT CARE MED, V42, P387, DOI 10.1097/CCM.0b013e3182a27732; Rodriguez-Gonzalez R, 2014, SHOCK, V42, P148, DOI 10.1097/SHK.0000000000000189; Rosner B., 1990, FUNDAMENTALS BIOSTAT; Straney L, 2013, PEDIATR CRIT CARE ME, V14, P673, DOI 10.1097/PCC.0b013e31829760cf; Stub D, 2015, CIRCULATION, V131, P2143, DOI 10.1161/CIRCULATIONAHA.114.014494; Sznycer-Taub NR, 2016, PEDIATR CRIT CARE ME, V17, P350, DOI 10.1097/PCC.0000000000000655	32	12	12	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	AUG	2018	19	8					699	704		10.1097/PCC.0000000000001630			6	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	GP5WF	WOS:000440946300010	29927878				2022-02-06	
J	Webb, B; Humphreys, D; Heath, M				Webb, Brandon; Humphreys, Dave; Heath, Matthew			Oculomotor Executive Dysfunction during the Early and Later Stages of Sport-Related Concussion Recovery	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; behavioral assessments; cognitive function; human studies	TRAUMATIC BRAIN-INJURY; END-POINT BIAS; SUPERIOR COLLICULUS; ANTISACCADE TASK; EYE-MOVEMENT; SACCADES; PERFORMANCE; SYMPTOMS; DEFICITS; BALANCE	Executive dysfunction represents the most persistent sequela of mild traumatic brain injury. It is, however, largely unclear whether a sport -related concussion similarly contributes to a persistent executive dysfunction even when an athlete has been cleared medically for return to play. Here, individuals with a diagnosis of a sport -related concussion and their age and sex -matched controls completed an oculomotor assessment during the acute and later stages of injury recovery. Prosaccades (i.e., saccade to a target) and executive -related antisaccades (i.e., saccade mirror -symmetrical to a target) were completed: (1) 2-6 days after a concussive event (initial assessment), and (2) 14-20 days after the initial oculomotor assessment when individuals were cleared for return to play (follow-up assessment). At the initial assessment, the concussed group produced antisaccade reaction times (RT) that were 93 ms longer than the control group (p <0.001), whereas prosaccade RTs did not differ between groups (p = 0.25). At the follow-up assessment, concussed and control groups produced comparable pro- and antisaccade RTs (ps >0.31); however, the former group exhibited a continued increase in directional errors (p < 0.05). That initial assessment antisaccades but not prosaccades differed between groups indicates that the acute recovery of a concussion is associated with a selective executive -related oculomotor deficit, and the continued increase in directional errors at the follow-up assessment suggests that such a deficit persists even when an athlete has been cleared medically for return to play. The antisaccade task may therefore serve to assess subtle executive deficits and determine when an athlete may return to play safely.	[Webb, Brandon; Humphreys, Dave; Heath, Matthew] Univ Western Ontario, Sch Kinesiol, London, ON N6A 3K7, Canada; [Heath, Matthew] Univ Western Ontario, Grad Program Neurosci, London, ON N6A 3K7, Canada		Heath, M (corresponding author), Univ Western Ontario, Sch Kinesiol, London, ON N6A 3K7, Canada.; Heath, M (corresponding author), Univ Western Ontario, Grad Program Neurosci, London, ON N6A 3K7, Canada.	mheath2@uwo.ca					Barton JJS, 2008, EXP BRAIN RES, V186, P273, DOI 10.1007/s00221-007-1235-2; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; BRYDEN MP, 1977, NEUROPSYCHOLOGIA, V15, P617, DOI 10.1016/0028-3932(77)90067-7; Cantu R, 2006, Foundations of Sport-Related Brain Injuries, P87, DOI 10.1007/0-387-32565-4_5; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Dafoe JM, 2007, EXP BRAIN RES, V179, P563, DOI 10.1007/s00221-006-0817-8; DeSimone JC, 2014, VISION RES, V96, P17, DOI 10.1016/j.visres.2013.12.005; Everling S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0068; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; FISCHER B, 1992, EXP BRAIN RES, V89, P415; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gillen C, 2014, VISION RES, V105, P151, DOI 10.1016/j.visres.2014.10.010; Gillen C, 2014, EXP BRAIN RES, V232, P3201, DOI 10.1007/s00221-014-4010-1; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heath M, 2017, J ALZHEIMERS DIS, V56, P167, DOI 10.3233/JAD-160627; Heath M, 2016, J ALZHEIMERS DIS, V54, P923, DOI 10.3233/JAD-160288; Heath M, 2015, J VISION, V15, DOI 10.1167/15.4.4; Heath M, 2011, EXP BRAIN RES, V209, P117, DOI 10.1007/s00221-010-2525-7; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Juhola M, 2013, COMPUT BIOL MED, V43, P42, DOI 10.1016/j.compbiomed.2012.10.005; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Ledoux AA, 2017, BR J SPORTS MED; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Norman DA., 1986, CONSCIOUSNESS SELF R, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1]; Ozyurt J, 2006, NEUROREPORT, V17, P1005; PIERROTDESEILLIGNY C, 1991, BRAIN, V114, P1473, DOI 10.1093/brain/114.3.1473; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Silver JM, 2014, PSYCHIAT CLIN N AM, V37, P91, DOI 10.1016/j.psc.2013.11.001; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Teel EF, 2013, J SCI MED SPORT, V16, P190, DOI 10.1016/j.jsams.2012.09.007; Ting WKC, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00271; Wan L, 2017, INT J PSYCHOPHYSIOL, V114, P47, DOI 10.1016/j.ijpsycho.2017.02.003; WENBANSMITH MG, 1991, EXP BRAIN RES, V87, P218; WURTZ RH, 1980, ANNU REV NEUROSCI, V3, P189, DOI 10.1146/annurev.ne.03.030180.001201; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	44	12	12	3	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2018	35	16					1874	1881		10.1089/neu.2018.5673			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GQ2YY	WOS:000441527400005	30074868	Green Submitted			2022-02-06	
J	Chuckowree, JA; Zhu, ZD; Brizuela, M; Lee, KM; Blizzard, CA; Dickson, TC				Chuckowree, Jyoti A.; Zhu, Zhendan; Brizuela, Mariana; Lee, Ka M.; Blizzard, Catherine A.; Dickson, Tracey C.			The Microtubule-Modulating Drug Epothilone D Alters Dendritic Spine Morphology in a Mouse Model of Mild Traumatic Brain Injury	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						traumatic brain injury; fluid percussion injury; neuroplasticity; microtubule stabilization; epothilone D; dendritic spine; cortical projection neuron; mushroom spine	CONTROLLED CORTICAL IMPACT; FLUID PERCUSSION INJURY; AXON REGENERATION; POSTTRAUMATIC EPILEPSY; COGNITIVE IMPAIRMENT; PYRAMIDAL NEURONS; TRANSGENIC MOUSE; TAXOL; TRANSPORT; PATHOLOGY	Microtubule dynamics underpin a plethora of roles involved in the intricate development, structure, function, and maintenance of the central nervous system. Within the injured brain, microtubules are vulnerable to misalignment and dissolution in neurons and have been implicated in injury-induced glial responses and adaptive neuroplasticity in the aftermath of injury. Unfortunately, there is a current lack of therapeutic options for treating traumatic brain injury (TBI). Thus, using a clinically relevant model of mild TBI, lateral fluid percussion injury (FPI) in adult male Thy1-YFPH mice, we investigated the potential therapeutic effects of the brain-penetrant microtubule-stabilizing agent, epothilone D. At 7 days following a single mild lateral FPI the ipsilateral hemisphere was characterized by mild astroglial activation and a stereotypical and widespread pattern of axonal damage in the internal and external capsule white matter tracts. These alterations occurred in the absence of other overt signs of trauma: there were no alterations in cortical thickness or in the number of cortical projection neurons, axons or dendrites expressing YFP. Interestingly, a single low dose of epothilone D administered immediately following FPI (and sham-operation) caused significant alterations in the dendritic spines of layer 5 cortical projection neurons, while the astroglial response and axonal pathology were unaffected. Specifically, spine length was significantly decreased, whereas the density of mushroom spines was significantly increased following epothilone D treatment. Together, these findings have implications for the use of microtubule stabilizing agents in manipulating injury-induced synaptic plasticity and indicate that further study into the viability of microtubule stabilization as a therapeutic strategy in combating TBI is warranted.	[Chuckowree, Jyoti A.; Zhu, Zhendan; Brizuela, Mariana; Lee, Ka M.; Blizzard, Catherine A.; Dickson, Tracey C.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Brizuela, Mariana] Flinders Univ S Australia, Sch Med, Ctr Neurosci, Adelaide, SA, Australia; [Lee, Ka M.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia		Dickson, TC (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia.	Tracey.Dickson@utas.edu.au		Dickson, Tracey/0000-0002-9196-1661	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia; Select Foundation; Brain Foundation Australia; Motor Accident Insurance Board Tasmania; Flack Foundation; Internal Research Grant Scheme (University of Tasmania); Tasmanian Masonic Centenary Medical Research Foundation	This research was supported by the National Health and Medical Research Council of Australia, Select Foundation, Brain Foundation Australia, Motor Accident Insurance Board Tasmania, Flack Foundation, Internal Research Grant Scheme (University of Tasmania), and Tasmanian Masonic Centenary Medical Research Foundation.	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Altmann KH, 2000, BBA-REV CANCER, V1470, pM79, DOI 10.1016/S0304-419X(00)00009-3; Andrieux A, 2006, BIOL PSYCHIAT, V60, P1224, DOI 10.1016/j.biopsych.2006.03.048; Baas PW, 2013, BRAIN, V136, P2937, DOI 10.1093/brain/awt153; Barten DM, 2012, J NEUROSCI, V32, P7137, DOI 10.1523/JNEUROSCI.0188-12.2012; Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Blizzard CA, 2011, CEREB CORTEX, V21, P281, DOI 10.1093/cercor/bhq091; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Brizuela M, 2015, MOL CELL NEUROSCI, V66, P129, DOI 10.1016/j.mcn.2015.02.006; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Brunden KR, 2012, BIOCHEM SOC T, V40, P661, DOI 10.1042/BST20120010; Brunden KR, 2011, PHARMACOL RES, V63, P341, DOI 10.1016/j.phrs.2010.12.002; Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Cartelli D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01837; Chen JR, 2010, NEUROSCIENCE, V167, P414, DOI 10.1016/j.neuroscience.2010.02.028; Chen JR, 2003, J NEUROTRAUM, V20, P767, DOI 10.1089/089771503767869999; Chen QH, 2008, ORG BIOMOL CHEM, V6, P4542, DOI 10.1039/b814823f; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Clark JK, 2018, IEEE PHOTONICS J, V10, DOI 10.1109/JPHOT.2017.2784429; Cross DJ, 2015, BRAIN RES, V1618, P299, DOI 10.1016/j.brainres.2015.06.006; Koning ME, 2017, J NEUROTRAUM, V34, P257, DOI 10.1089/neu.2015.4377; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Deller T, 2006, ADV EXP MED BIOL, V557, P101; Dent EW, 2017, MOL BIOL CELL, V28, P1, DOI 10.1091/mbc.E15-11-0769; Dickson TC, 2007, NEUROREPORT, V18, P283, DOI 10.1097/WNR.0b013e3280143cdb; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 2002, NAT NEUROSCI, V5, P297, DOI 10.1038/nn830; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Goodin S, 2004, J CLIN ONCOL, V22, P2015, DOI 10.1200/JCO.2004.12.001; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Gu JP, 2008, J NEUROSCI, V28, P12120, DOI 10.1523/JNEUROSCI.2509-08.2008; Hanell A, 2015, ACTA NEUROPATHOL, V129, P317, DOI 10.1007/s00401-014-1376-x; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hur EM, 2014, INT NEUROUROL J, V18, P171, DOI 10.5213/inj.2014.18.4.171; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P313, DOI 10.1097/HTR.0b013e3181d6f9bd; Jagoda AS, 2009, J EMERG NURS, V35, pe5, DOI DOI 10.1016/J.JEN.2008.12.010; Jang EH, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5056418; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kapitein LC, 2010, METHOD CELL BIOL, V97, P111, DOI 10.1016/S0091-679X(10)97007-6; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Khrapunovich-Baine M, 2011, J BIOL CHEM, V286, P11765, DOI 10.1074/jbc.M110.162214; Lei WL, 2016, CURR OPIN NEUROBIOL, V39, P86, DOI 10.1016/j.conb.2016.04.010; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Michaud LB, 2009, ANN PHARMACOTHER, V43, P1294, DOI 10.1345/aph.1M005; Moscarello MA, 2002, MULT SCLER J, V8, P130, DOI 10.1191/1352458502ms776oa; Penazzi L, 2016, NEUROPHARMACOLOGY, V105, P84, DOI 10.1016/j.neuropharm.2016.01.002; Popovich PG, 2014, EXP NEUROL, V261, P97, DOI 10.1016/j.expneurol.2014.06.020; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Ruschel J, 2015, SCIENCE, V348, P347, DOI 10.1126/science.aaa2958; Salin P, 1995, J NEUROSCI, V15, P8234; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sengottuvel V, 2011, J NEUROSCI, V31, P2688, DOI 10.1523/JNEUROSCI.4885-10.2011; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Stone JR, 2004, EXP NEUROL, V190, P59, DOI 10.1016/j.expneurol.2004.05.022; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Wang HC, 2010, J CLIN NEUROSCI, V17, P157, DOI 10.1016/j.jocn.2009.07.099; Wang ML, 2016, J NEUROL SCI, V370, P244, DOI 10.1016/j.jns.2016.09.049; Wilde EA, 2016, J NEUROTRAUM, V33, P2000, DOI 10.1089/neu.2015.4212; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Zhang B, 2005, P NATL ACAD SCI USA, V102, P227, DOI 10.1073/pnas.0406361102; Zhao Y, 2009, EXPERT OPIN THER PAT, V19, P607, DOI 10.1517/13543770902775713	88	12	12	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	JUL 30	2018	12								223	10.3389/fncel.2018.00223			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO7DW	WOS:000440218000001	30104961	Green Published, gold, Green Accepted			2022-02-06	
J	Stovell, MG; Mada, MO; Helmy, A; Carpenter, TA; Thelin, EP; Yan, JL; Guilfoyle, MR; Jalloh, I; Howe, DJ; Grice, P; Mason, A; Giorgi-Coll, S; Gallagher, CN; Murphy, MP; Menon, DK; Hutchinson, PJ; Carpenter, KLH				Stovell, Matthew G.; Mada, Marius O.; Helmy, Adel; Carpenter, T. Adrian; Thelin, Eric P.; Yan, Jiun-Lin; Guilfoyle, Mathew R.; Jalloh, Ibrahim; Howe, Duncan J.; Grice, Peter; Mason, Andrew; Giorgi-Coll, Susan; Gallagher, Clare N.; Murphy, Michael P.; Menon, David K.; Hutchinson, Peter J.; Carpenter, Keri L. H.			The effect of succinate on brain NADH/NAD(+) redox state and high energy phosphate metabolism in acute traumatic brain injury	SCIENTIFIC REPORTS			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; MITOCHONDRIAL DYSFUNCTION; EMISSION-TOMOGRAPHY; CEREBRAL-ISCHEMIA; NMR-SPECTROSCOPY; SLC13 FAMILY; TRANSPORTERS; RAT; PH; MICRODIALYSIS	A key pathophysiological process and therapeutic target in the critical early post-injury period of traumatic brain injury (TBI) is cell mitochondrial dysfunction; characterised by elevation of brain lactate/pyruvate (L/P) ratio in the absence of hypoxia. We previously showed that succinate can improve brain extracellular chemistry in acute TBI, but it was not clear if this translates to a change in downstream energy metabolism. We studied the effect of microdialysis-delivered succinate on brain energy state (phosphocreatine/ATP ratio (PCr/ATP)) with P-31 MRS at 3T, and tissue NADH/NAD(+) redox state using microdialysis (L/P ratio) in eight patients with acute major TBI (mean 7 days). Succinate perfusion was associated with increased extracellular pyruvate (+26%, p < 0.0001) and decreased L/P ratio (-13%, p < 0.0001) in patients overall (baseline-vs-supplementation over time), but no clear-cut change in P-31 MRS PCr/ATP existed in our cohort (p > 0.4, supplemented-voxel-vs-contralateral voxel). However, the percentage decrease in L/P ratio for each patient following succinate perfusion correlated significantly with their percentage increase in PCr/ATP ratio (Spearman's rank correlation, r = -0.86, p = 0.024). Our findings support the interpretation that L/P ratio is linked to brain energy state, and that succinate may support brain energy metabolism in select TBI patients suffering from mitochondrial dysfunction.	[Stovell, Matthew G.; Helmy, Adel; Thelin, Eric P.; Yan, Jiun-Lin; Guilfoyle, Mathew R.; Jalloh, Ibrahim; Giorgi-Coll, Susan; Gallagher, Clare N.; Hutchinson, Peter J.; Carpenter, Keri L. H.] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Mada, Marius O.; Carpenter, T. Adrian; Hutchinson, Peter J.; Carpenter, Keri L. H.] Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge, England; [Thelin, Eric P.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Yan, Jiun-Lin] Chang Gung Univ, Keelung Chang Gung Mem Hosp, Coll Med, Dept Neurosurg, Taoyuan, Taiwan; [Howe, Duncan J.; Grice, Peter; Mason, Andrew] Univ Cambridge, Dept Chem, Cambridge, England; [Gallagher, Clare N.] Univ Calgary, Dept Clin Neurosci, Div Neurosurg, Calgary, AB, Canada; [Murphy, Michael P.] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England; [Menon, David K.] Univ Cambridge, Div Anaesthesia, Dept Med, Cambridge, England		Stovell, MG; Carpenter, KLH (corresponding author), Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge, England.; Carpenter, KLH (corresponding author), Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge, England.	mgs48@cam.ac.uk; klc1000@wbic.cam.ac.uk	Helmy, Adel/AAS-3084-2020; Thelin, Eric Peter/K-2144-2012; Murphy, Michael/C-2120-2009	Helmy, Adel/0000-0002-0531-0556; Thelin, Eric Peter/0000-0002-2338-4364; Murphy, Michael/0000-0003-1115-9618; Stovell, Matthew/0000-0002-4172-4617; Hutchinson, Peter/0000-0002-2796-1835	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986 ID79068, G1002277 ID98489]; National Institute for Health Research Biomedical Research Centre, CambridgeNational Institute for Health Research (NIHR); MGS - National Institute for Health Research Biomedical Research Centre, Cambridge; MOM - Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/N025792/1, SRAG/071, RG87629]; Swedish Society for Medical Research; IJ - Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1002277 ID 98489]; KLHC - National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme); CNG - the Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR); AH - Medical Research Council/Royal College of Surgeons of England Clinical Research Training FellowshipUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0802251]; Royal College of Surgeons of England, Pump Priming Grant; DKM - National Institute for Health Research Senior Investigator Awards; PJH - National Institute for Health Research Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; Wellcome Trust Investigator awardWellcome Trust [110159/Z/15/Z]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1002277, G0600986, MC_UU_00015/3, MC_U105663142, G0802251] Funding Source: UKRI	The authors thank Christopher Randell (PulseTeq Ltd) for custom-building the 31P head-coil and for advice on 31P MRS, Mr John Harwood (Manufacturing Unit, Department of Pharmacy, Ipswich Hospital NHS Trust) for supervising the formulation of the succinate, and Professor John D. Pickard for his advice and support setting up the study. We gratefully thank the patients and the healthy controls for participating in this study, and the patients' relatives for their assent. This work was supported by: Medical Research Council (Grant Nos. G0600986 ID79068 and G1002277 ID98489) and National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). Authors' support: MGS - National Institute for Health Research Biomedical Research Centre, Cambridge; MOM - Medical Research Council (Grant No. MR/N025792/1, Project code SRAG/071, ID RG87629); EPT - Postdoctoral scholarship funding from Swedish Society for Medical Research; IJ - Medical Research Council (Grant no. G1002277 ID 98489) and National Institute for Health Research Biomedical Research Centre, Cambridge; KLHC - National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme); CNG - the Canadian Institute of Health Research; AH - Medical Research Council/Royal College of Surgeons of England Clinical Research Training Fellowship (Grant no. G0802251), the National Institute for Health Research Biomedical Research Centre, Cambridge, and the Royal College of Surgeons of England, Pump Priming Grant; DKM - National Institute for Health Research Senior Investigator Awards; PJH - National Institute for Health Research Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship and the National Institute for Health Research Biomedical Research Centre, Cambridge. MPM Medical Research Council UK (MC_U105663142) and a Wellcome Trust Investigator award (110159/Z/15/Z).	Bergeron MJ, 2013, MOL ASPECTS MED, V34, P299, DOI 10.1016/j.mam.2012.12.001; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Carpenter KLH, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00026; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; de Graaf R. A, 2007, BASIC LIFE SCI, V55; ELEFF SM, 1990, ANN NEUROL, V27, P626, DOI 10.1002/ana.410270607; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; Gilissen J, 2016, PHARMACOL THERAPEUT, V159, P56, DOI 10.1016/j.pharmthera.2016.01.008; Giorgi-Coll S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01149-w; Hamel D, 2014, ARTERIOSCL THROM VAS, V34, P285, DOI 10.1161/ATVBAHA.113.302131; Hattingen E, 2009, BRAIN, V132, P3285, DOI 10.1093/brain/awp293; Jalloh I, 2017, J CEREBR BLOOD F MET, V37, P2626, DOI 10.1177/0271678X16672665; Kekuda R, 1999, J BIOL CHEM, V274, P3422, DOI 10.1074/jbc.274.6.3422; Lamp J, 2011, J BIOL CHEM, V286, P17777, DOI 10.1074/jbc.M111.232744; LEVINE SR, 1992, RADIOLOGY, V185, P537, DOI 10.1148/radiology.185.2.1410369; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; Menon DK, 2017, HAND CLINIC, V140, P239, DOI 10.1016/B978-0-444-63600-3.00014-3; Newcombe VFJ, 2008, J NEUROSURG, V109, P159, DOI 10.3171/JNS/2008/109/7/0159; Nordstrom CH, 2016, ACTA NEUROCHIR, V158, P1231, DOI 10.1007/s00701-016-2835-z; O'Connell MT, 2005, ACTA NEUROCHIR SUPPL, V95, P165; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Pajor AM, 1999, ANNU REV PHYSIOL, V61, P663, DOI 10.1146/annurev.physiol.61.1.663; Pajor AM, 2014, PFLUG ARCH EUR J PHY, V466, P119, DOI 10.1007/s00424-013-1369-y; Pan JW, 2008, EPILEPSIA, V49, P31, DOI 10.1111/j.1528-1167.2008.01508.x; PRICHARD JW, 1986, ANNU REV NEUROSCI, V9, P61; Protti A, 2006, CRIT CARE, V10, DOI 10.1186/cc5014; Schlessinger A, 2014, J BIOL CHEM, V289, P16998, DOI 10.1074/jbc.M114.554790; Smielewski P, 2005, ACT NEUR S, V95, P43; STOVELL MG, 2017, FRONT NEUROL, V8; STUBBS M, 1984, BIOCHEM J, V224, P241, DOI 10.1042/bj2240241; TAKAMI H, 1988, J BIOCHEM, V104, P35, DOI 10.1093/oxfordjournals.jbchem.a122417; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; Wallimann T, 2011, AMINO ACIDS, V40, P1271, DOI 10.1007/s00726-011-0877-3; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514	37	12	14	3	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 24	2018	8								11140	10.1038/s41598-018-29255-3			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN9TF	WOS:000439550200012	30042490	Green Published, gold			2022-02-06	
J	Assi, H; Moore, RD; Ellemberg, D; Hebert, S				Assi, Hussein; Moore, R. Davis; Ellemberg, Dave; Hebert, Sylvie			Sensitivity to sounds in sport-related concussed athletes: a new clinical presentation of hyperacusis	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; WILLIAMS-SYNDROME; NEURAL ACTIVITY; TINNITUS; LOUDNESS; DEPRESSION; CORTEX; QUESTIONNAIRE; MECHANISMS; PLASTICITY	Sensitivity to sounds is one frequent symptom of a sport-related concussion, but its assessment rarely goes beyond a single question. Here we examined sensitivity to sounds using psychoacoustic and psychometric outcomes in athletes beyond the acute phase of injury. Fifty-eight college athletes with normal hearing who either had incurred one or more sport-related concussions (N = 28) or who had never suffered head injury (N = 30) participated. Results indicated that the Concussed group scored higher on the Hyperacusis questionnaire and displayed greater sensitivity to sounds in psychoacoustic tasks compared to the Control group. However, further analyses that separated the Concussed group in subgroups with Sound sensitivity symptom (N = 14) and Without sound sensitivity symptom (N = 14) revealed that athletes with the sound complaint were the ones responsible for the effect: Concussed athletes with self-reported sound sensitivity had lower Loudness Discomfort Thresholds (LDLs), higher Depression and Hyperacusis scores, and shifted loudness growth functions compared to the other subgroup. A simple mediation model disclosed that LDLs exert their influence both directly on Hyperacusis scores as well as indirectly via depressive symptoms. We thus report a new clinical presentation of hyperacusis and discuss possible mechanisms by which it could arise from concussion.	[Assi, Hussein; Moore, R. Davis; Ellemberg, Dave] Univ Montreal, Dept Kinesiol, Montreal, PQ, Canada; [Hebert, Sylvie] Univ Montreal, Sch Speech Pathol & Audiol, Montreal, PQ, Canada; [Hebert, Sylvie] Int Lab Res Brain Mus & Sound BRAMS, Montreal, PQ, Canada		Hebert, S (corresponding author), Univ Montreal, Sch Speech Pathol & Audiol, Montreal, PQ, Canada.; Hebert, S (corresponding author), Int Lab Res Brain Mus & Sound BRAMS, Montreal, PQ, Canada.	Sylvie.hebert@umontreal.ca					Aazh H, 2017, AM J AUDIOL, V26, P562, DOI 10.1044/2017_AJA-17-0008; Attri D, 2010, J LARYNGOL OTOL, V124, P919, DOI 10.1017/S0022215109992258; Baguley DM, 2018, HNO, V66, P358, DOI 10.1007/s00106-017-0464-3; Basile CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082995; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, BDI 2 BECK DEPRESSIO; Blasing L, 2010, INT J AUDIOL, V49, P518, DOI 10.3109/14992021003724996; Boucher O, 2015, BRAIN RES, V1606, P102, DOI 10.1016/j.brainres.2015.02.030; de Magalhaes Sandra Lira Bastos, 2003, Int Tinnitus J, V9, P79; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; Fackrell K, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2723715; Falkenberg Eva-Signe, 2012, Int J Otolaryngol, V2012, P375460, DOI 10.1155/2012/375460; Filion P R, 1992, J Am Acad Audiol, V3, P193; Formby C, 2003, J ACOUST SOC AM, V114, P55, DOI 10.1121/1.1582860; Formby Craig, 2017, Seminars in Hearing, V38, P130, DOI 10.1055/s-0037-1598069; Fournier P, 2014, NEUROSCIENCE, V283, P64, DOI 10.1016/j.neuroscience.2014.08.007; Fukutake T, 1998, NEUROLOGY, V51, P1469, DOI 10.1212/WNL.51.5.1469; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gothelf D, 2006, NEUROLOGY, V66, P390, DOI 10.1212/01.wnl.0000196643.35395.5f; Guimaraes AC, 2014, BRAZ J OTORHINOLAR, V80, P24, DOI 10.5935/1808-8694.20140007; Hayes A. F., 2018, INTRO MEDIATION MODE; Hebert S, 2013, J NEUROSCI, V33, P2356, DOI 10.1523/JNEUROSCI.3461-12.2013; Jaramillo CA, 2016, HEADACHE, V56, P528, DOI 10.1111/head.12726; Khalfa S, 2002, ORL-J OTO-RHIN-LARYN, V64, P436, DOI 10.1159/000067570; Khalil S, 2002, J LARYNGOL OTOL, V116, P376; King D, 2014, J SCI MED SPORT, V17, P250, DOI 10.1016/j.jsams.2013.05.007; Knudson IM, 2016, JARO-J ASSOC RES OTO, V17, P223, DOI 10.1007/s10162-016-0555-y; Kolata SM, 2018, NEUROPSYCHOPHARMACOL, V43, P1445, DOI 10.1038/npp.2017.296; Landon J, 2012, NEUROPSYCHOL REHABIL, V22, P391, DOI 10.1080/09602011.2011.652496; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee E, 2008, NEUROLOGY, V70, P2413, DOI 10.1212/01.wnl.0000314691.26371.3a; Levitin DJ, 2005, J CHILD PSYCHOL PSYC, V46, P514, DOI 10.1111/j.1469-7610.2004.00376.x; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Nields JA, 1999, J NEUROPSYCH CLIN N, V11, P97, DOI 10.1176/jnp.11.1.97; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Pienkowski M, 2014, AM J AUDIOL, V23, P420, DOI 10.1044/2014_AJA-13-0037; Roberts LE, 2008, JARO-J ASSOC RES OTO, V9, P417, DOI 10.1007/s10162-008-0136-9; Rohl M, 2012, JARO-J ASSOC RES OTO, V13, P369, DOI 10.1007/s10162-012-0315-6; Rossi AF, 1999, J NEUROSCI, V19, P6145, DOI 10.1523/JNEUROSCI.19-14-06145.1999; Schecklmann M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086944; Steenerson K, 2017, NEUROL CLIN, V35, P403, DOI 10.1016/j.ncl.2017.03.011; Stein CJ, 2016, CLIN J SPORT MED, V26, P386, DOI 10.1097/JSM.0000000000000268; Szibor A, 2018, ACTA OTO-LARYNGOL, V138, P21, DOI 10.1080/00016489.2017.1367100; Tyler RS, 2014, AM J AUDIOL, V23, P402, DOI 10.1044/2014_AJA-14-0010; Weber H, 2002, MULT SCLER, V8, P505, DOI 10.1191/1352458502ms814oa; Westcott M, 2006, ACTA OTO-LARYNGOL, V126, P54, DOI 10.1080/03655230600895531; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Zhou T, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1061-9	50	12	12	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 2	2018	8								9921	10.1038/s41598-018-28312-1			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL2LX	WOS:000436953900030	29967340	Green Published, gold			2022-02-06	
J	Berginstrom, N; Nordstroem, P; Ekman, U; Eriksson, J; Andersson, M; Nyberg, L; Nordstrom, A				Berginstrom, Nils; Nordstroem, Peter; Ekman, Urban; Eriksson, Johan; Andersson, Micael; Nyberg, Lars; Nordstrom, Anna			Using Functional Magnetic Resonance Imaging to Detect Chronic Fatigue in Patients With Previous Traumatic Brain Injury: Changes Linked to Altered Striato-Thalamic-Cortical Functioning	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						fatigue; functional magnetic resonance imaging; mental; neuropsychology; traumatic brain injury	MULTIPLE-SCLEROSIS; HEAD-INJURY; COGNITIVE FATIGUE; BASAL GANGLIA; NEUROLOGICAL DISORDERS; PARKINSONS-DISEASE; POSTSTROKE FATIGUE; SCALE; QUESTIONNAIRE; MODERATE	Objective: To investigate whether functional magnetic resonance imaging (fMRI) can be used to detect fatigue after traumatic brain injury (TBI). Setting: Neurorehabilitation clinic. Participants: Patients with TBI (n = 57) and self-experienced fatigue more than 1 year postinjury, and age- and gender-matched healthy controls (n = 27). Main Measures: Self-assessment scales of fatigue, a neuropsychological test battery, and fMRI scanning during performance of a fatiguing 27-minute attention task. Results: During testing within the fMRI scanner, patients showed a higher increase in self-reported fatigue than controls from before to after completing the task (P < .001). The patients also showed lower activity in several regions, including bilateral caudate, thalamus, and anterior insula (all P < .05). Furthermore, the patients failed to display decreased activation over time in regions of interest: the bilateral caudate and anterior thalamus (all P < .01). Left caudate activity correctly identified 91% of patients and 81% of controls, resulting in a positive predictive value of 91%. Conclusion: The results suggest that chronic fatigue after TBI is associated with altered striato-thalamic-cortical functioning. It would be of interest to study whether fMRI can be used to support the diagnosis of chronic fatigue in future studies.	[Berginstrom, Nils] Umea Univ, Dept Community Med & Rehabil, Geriatr Med, S-90187 Umea, Sweden; [Ekman, Urban; Eriksson, Johan; Andersson, Micael; Nyberg, Lars] Umea Univ, Umea Ctr Funct Brain Imaging, Umea, Sweden; [Ekman, Urban; Eriksson, Johan; Andersson, Micael; Nyberg, Lars] Umea Univ, Dept Integrat Med Biol, Physiol Sect, Umea, Sweden; Umea Univ, Dept Publ Hlth & Clin Med Occupat & Environm Med, Umea, Sweden; [Nyberg, Lars] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Ekman, Urban] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden		Berginstrom, N (corresponding author), Umea Univ, Dept Community Med & Rehabil, Geriatr Med, S-90187 Umea, Sweden.	nils.berginstrom@umu.se	Nordstrom, Anna/F-2238-2010; Nyberg, Lars/M-5986-2019; Nordstrom, Anna/O-2504-2018	Nordstrom, Anna/0000-0003-3534-456X; Nyberg, Lars/0000-0002-3367-1746; Nordstrom, Anna/0000-0003-3534-456X; Ekman, Urban/0000-0003-3926-8656; Berginstrom, Nils/0000-0003-1192-4527	Umea University; Vasterbotten County Council; Torsten & Ragnar Soderberg's Foundation	Funding for this study was provided through regional agreement between Umea University and Vasterbotten County Council on cooperation in the field of Medicine, Odontology, and Health, and Torsten & Ragnar Soderberg's Foundation.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Bakshi R, 2003, MULT SCLER J, V9, P219, DOI 10.1191/1352458503ms904oa; Bandettini PA, 1997, HUM BRAIN MAPP, V5, P93; Berginstrom N, 2017, J HEAD TRAUMA REHAB, V32, pE46, DOI 10.1097/HTR.0000000000000236; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Chiou KS, 2016, J HEAD TRAUMA REHAB, V31, pE60, DOI 10.1097/HTR.0000000000000161; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Delis D.C., 2001, D KEFS DELIS KAPLAN; DeLuca J, 2008, J NEUROL SCI, V270, P28, DOI 10.1016/j.jns.2008.01.018; Dittner AJ, 2004, J PSYCHOSOM RES, V56, P157, DOI 10.1016/S0022-3999(03)00371-4; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Engstrom M, 2013, BRAIN BEHAV, V3, P715, DOI 10.1002/brb3.181; Filippi M, 2002, NEUROIMAGE, V15, P559, DOI 10.1006/nimg.2001.1011; Friedman JH, 2009, CURR TREAT OPTION NE, V11, P186, DOI 10.1007/s11940-009-0022-8; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Ingles JL, 1999, ARCH PHYS MED REHAB, V80, P173, DOI 10.1016/S0003-9993(99)90116-8; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Koch K, 2006, BRAIN RES, V1107, P140, DOI 10.1016/j.brainres.2006.06.003; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Miller AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098156; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Pavese N, 2010, BRAIN, V133, P3434, DOI 10.1093/brain/awq268; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rocca MA, 2016, MULT SCLER J, V22, P1144, DOI 10.1177/1352458515614407; Tang WK, 2013, J NEUROL SCI, V324, P131, DOI 10.1016/j.jns.2012.10.022; Tang WK, 2010, J NEUROL, V257, P178, DOI 10.1007/s00415-009-5284-2; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wang C, 2016, J NEUROSCI, V36, P3919, DOI 10.1523/JNEUROSCI.3652-15.2016; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Wei CJ, 2016, J NEUROL, V263, P269, DOI 10.1007/s00415-015-7958-2; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Ziino C, 2006, J INT NEUROPSYCH SOC, V12, P100, DOI 10.1017/S1355617706060139	45	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2018	33	4					266	274		10.1097/HTR.0000000000000340			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GR6GT	WOS:000442745900013	28926483				2022-02-06	
J	Kreutzer, JS; Marwitz, JH; Klyce, DW; Schaaf, KPW; Sima, AP; Welch, AM; Niemeier, JP				Kreutzer, Jeffrey S.; Marwitz, Jennifer H.; Klyce, Daniel W.; Schaaf, Kathryn P. Wilder; Sima, Adam P.; Welch, Abigail M.; Niemeier, Janet P.			Family Needs on an Inpatient Brain Injury Rehabilitation Unit: A Quantitative Assessment	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						caregiver; family needs; support systems	QUALITY-OF-LIFE; INTERVENTION IMPACT; CAREGIVER BURDEN; INDIVIDUALS; CARERS; HEALTH; SATISFACTION; REGRESSION; MEMBERS; STRESS	Objective: To examine the needs of family members in an inpatient setting and factors predicting extent to which needs are perceived as met. Setting: University health system inpatient rehabilitation unit. Participants: Adult survivors of traumatic brain injury and family members (n = 85). Design: Prospective, cross-sectional. Main Measure: Family Needs Questionnaire-Revised (FNQ-R). Results: Needs related to the Health Information subscale were most frequently rated as met, whereas needs related to the Instrumental Support and Emotional Support subscales were most frequently rated as unmet. Predictors related to the FNQ-R included family income, gender, and ethnicity. For 4 of 6 subscales, white family members were more likely to rate needs as unmet than minority members. For 3 subscales, females were more likely to rate needs as unmet than males. Greater household income was associated with fewer met needs for 2 subscales. Conclusions: The ranking of met and unmet needs in the present study was remarkably similar to previous studies within and outside the United States. Clinicians should not assume that families with relatively higher incomes will experience fewer unmet needs. Through structured assessment, clinicians can reveal perceived needs that might have otherwise been unrecognized and facilitate appropriate supports. Findings provide direction for inpatient program development.	[Kreutzer, Jeffrey S.; Marwitz, Jennifer H.; Klyce, Daniel W.; Schaaf, Kathryn P. Wilder; Welch, Abigail M.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, 1200 E Broad St,Rm 3-109,Box 980542, Richmond, VA 23298 USA; [Sima, Adam P.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA; [Schaaf, Kathryn P. Wilder] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Niemeier, Janet P.] Carolinas Med Ctr, Dept Phys Med & Rehabil, Charlotte, NC 28203 USA		Marwitz, JH (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, 1200 E Broad St,Rm 3-109,Box 980542, Richmond, VA 23298 USA.	jhmarwit@vcu.edu		Sima, Adam/0000-0001-8426-9987	National Institute on Disability and Rehabilitation Research (NIDRR) of the US Department of Education [H133A070036]; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0033]	The contents of this article were developed in part under a grant from the National Institute on Disability and Rehabilitation Research (NIDRR) of the US Department of Education (H133A070036) and a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant number 90DP0033). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS).	BENDEL RB, 1977, J AM STAT ASSOC, V72, P46, DOI 10.2307/2286904; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Cao J, 2014, JAMA-J AM MED ASSOC, V312, P543, DOI 10.1001/jama.2014.9440; Carifio J, 2008, MED EDUC, V42, P1150, DOI 10.1111/j.1365-2923.2008.03172.x; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; de Winter JCF, 2012, PRACT ASSESS RES EVA, V15; Doser K, 2014, BRAIN INJURY, V28, P1230, DOI 10.3109/02699052.2014.915985; Doyle ST, 2013, BRAIN INJURY, V27, P1441, DOI 10.3109/02699052.2013.826505; Ford JH, 2014, J REHABIL RES DEV, V51, P1311, DOI 10.1682/JRRD.2014.03.0066; Hastie T., 2008, RANDOM FORESTS, DOI DOI 10.1007/978-0-387-84858-7_15; Keenan Alanna, 2010, Can J Neurosci Nurs, V32, P25; Khalaila R, 2013, J ADV NURS, V69, P1172, DOI 10.1111/j.1365-2648.2012.06109.x; Kratz AL, 2017, NEUROPSYCHOL REHABIL, V27, P16, DOI 10.1080/09602011.2015.1051056; Kreutzer J. S., 1988, FAMILY NEEDS QUESTIO; Kreutzer JS, 2016, J FAM THEOR REV, V8, P386, DOI 10.1111/jftr.12150; Kreutzer JS, 2015, J HEAD TRAUMA REHAB, V30, P249, DOI 10.1097/HTR.0000000000000144; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; Kreutzer JS, 2002, J HEAD TRAUMA REHAB, V17, P349, DOI 10.1097/00001199-200208000-00008; Lefebvre Helene, 2012, J Trauma Nurs, V19, P197, DOI 10.1097/JTN.0b013e318275990d; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Moules S, 1999, BRAIN INJURY, V13, P983; Murray HM, 2006, BRAIN INJURY, V20, P575, DOI 10.1080/02699050600664590; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Norup A, 2015, NEUROREHABILITATION, V36, P203, DOI 10.3233/NRE-151208; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Schaaf KPW, 2013, REHABIL PSYCHOL, V58, P106, DOI 10.1037/a0031693; Schulz-Heik RJ, 2017, BRAIN INJURY, V31, P1287, DOI 10.1080/02699052.2017.1307449; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; Tverdov AH, 2016, BRAIN INJURY, V30, P324, DOI 10.3109/02699052.2015.1113566; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x	33	12	12	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2018	33	4					228	236		10.1097/HTR.0000000000000390			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GR6GT	WOS:000442745900009	29601345				2022-02-06	
J	Lennon, A; Hugentobler, JA; Sroka, MC; Nissen, KS; Kurowski, BG; Gagnon, I; Quatman-Yates, CC				Lennon, Anne; Hugentobler, Jason A.; Sroka, Mary Claire; Nissen, Katharine S.; Kurowski, Brad G.; Gagnon, Isabelle; Quatman-Yates, Catherine C.			An Exploration of the Impact of Initial Timing of Physical Therapy on Safety and Outcomes After Concussion in Adolescents	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						concussion; human movement system; physical therapy; rehabilitation; timing	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; POSTCONCUSSION SYNDROME; CERVICOVESTIBULAR REHABILITATION; VESTIBULAR REHABILITATION; ACTIVE REHABILITATION; SYMPTOMS; CHILDREN; REST	Background and Purpose: Physical therapy (PT) is a management strategy increasingly recognized to facilitate recovery after concussion. The purpose of this study was to investigate the safety and outcomes of multimodal impairment-based PT at varying time points after injury in youth diagnosed with concussion. Methods: Data were extracted retrospectively from medical records for patients who received PT for concussion-related impairments. Patient records were categorized into 3 cohorts on the basis of the timing of PT implementation: 0-20 days following injury (early intervention), 21 to 41 days following injury (middle intervention), and 42 or more days following injury (late intervention). The primary outcome measure was Post-Concussion Symptom Inventory score from the beginning to the end of the PT episode of care. Additional outcome measures included number of PT sessions, duration of PT episode of care (days), and occurrence of unplanned visits to a health care provider. Results: A total of 120 patient records (mean age of 14.77 years) were analyzed. Thirty-three, 39, and 48 individuals were categorized into the early, middle, and late intervention cohorts, respectively. There were no significant differences between intervention cohorts with regard to symptom change on the Post-Concussion Symptom Inventory from the beginning to the end of the PT episode of care, unplanned health care visits, number of PT sessions, or duration of PT episode of care. Discussion and Conclusions: Early initiation of PT may be safe and tolerable. Future prospective studies are needed to explore the efficacy of PT services administered early following injury to help characterize an optimal care plan for youth following concussion. Video Abstract available for more insights from the authors (see Supplemental Digital Content 1, available at: http://links.lww.com/JNPT/A210).	[Lennon, Anne; Hugentobler, Jason A.; Sroka, Mary Claire; Nissen, Katharine S.; Quatman-Yates, Catherine C.] Cincinnati Childrens Hosp Med Ctr, Div Occupat & Phys Therapy, Cincinnati, OH 45229 USA; [Hugentobler, Jason A.; Sroka, Mary Claire; Quatman-Yates, Catherine C.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, Cincinnati, OH 45229 USA; [Kurowski, Brad G.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Kurowski, Brad G.] Univ Cincinnati, Coll Med, Dept Pediat & Neurol & Rehabil Med, Cincinnati, OH USA; [Gagnon, Isabelle] McGill Univ, Hlth Ctr, Montreal Childrens Hosp, Montreal, PQ, Canada; [Quatman-Yates, Catherine C.] Ohio State Univ, Div Phys Therapy, 453 W 10th Ave,516 H Atwell Hall, Columbus, OH 43210 USA		Quatman-Yates, CC (corresponding author), Ohio State Univ, Div Phys Therapy, 453 W 10th Ave,516 H Atwell Hall, Columbus, OH 43210 USA.	catherine.quatman@osumc.edu	Quatman-Yates, Catherine/AAK-4507-2021; Quatman-Yates, Catherine/U-9580-2019	Gagnon, Isabelle/0000-0003-2043-1644	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [KL2 TR001426-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR001426] Funding Source: NIH RePORTER	Aspects of this work were funded in part by a National Institutes of Health KL2 TR001426-01.	Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Barlow KM, 2015, PEDIATR NEUROL, V53, P491, DOI 10.1016/j.pediatrneurol.2015.04.011; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Basso DM, 2017, J NEUROL PHYS THER, V41, pS24, DOI 10.1097/NPT.0000000000000165; Childs JD, 2008, J ORTHOP SPORT PHYS, V38, pA1, DOI 10.2519/jospt.2008.0303; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Dobney DM, 2018, J HEAD TRAUMA REHAB, V33, pE11, DOI 10.1097/HTR.0000000000000339; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Hugentobler JA, 2015, INT J SPORTS PHYS TH, V10, P676; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; McCarthy MT, 2015, ANN NY ACAD SCI, V1345, P89, DOI 10.1111/nyas.12736; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Page P, 2011, INT J SPORTS PHYS TH, V6, P254; Quatman-Yates C, 2016, PHYS THER, V96, P1753, DOI 10.2522/ptj.20150557; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schneider KJ, 2018, BRIT J SPORT MED, V52, P100, DOI 10.1136/bjsports-2017-098667; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; SCHNEIDER KJ, 2017, BRIT J SPORT MED, V51; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Stein CJ, 2016, CLIN J SPORT MED, V26, P386, DOI 10.1097/JSM.0000000000000268; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986	37	12	12	1	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	JUL	2018	42	3			SI		123	131		10.1097/NPT.0000000000000227			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GL1OM	WOS:000436873100002	29846269	Green Accepted			2022-02-06	
J	Vedantam, A; Robertson, CS; Gopinath, SP				Vedantam, Aditya; Robertson, Claudia S.; Gopinath, Shankar P.			Clinical characteristics and temporal profile of recovery in patients with favorable outcomes at 6 months after severe traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						severe traumatic brain injury; motor recovery; Glasgow Outcome Scale; withdrawal of life-sustaining treatment	SEVERE HEAD-INJURY; VEGETATIVE STATE; PREDICTION; WITHDRAWAL; VARIABLES; PROGNOSIS; COHORT	OBJECTIVE Early withdrawal of life-sustaining treatment due to expected poor prognosis is responsible for the majority of in-house deaths in severe traumatic brain injury (TBI). With increased focus on the decision and timing of withdrawal of care in patients with severe TBI, data on early neurological recovery in patients with a favorable outcome is needed to guide physicians and families. METHODS The authors reviewed prospectively collected data obtained in 1241 patients with head injury who were treated between 1986 and 2012. Patients with severe TBI, motor Glasgow Coma Scale (mGCS) score < 6 on admission, and those who had favorable outcomes (Glasgow Outcome Scale [GOS] score of 4 or 5, indicating moderate disability or good recovery) at 6 months were selected. Baseline demographic, clinical, and imaging data were analyzed. The time from injury to the first record of following commands (mGCS score of 6) after injury was recorded. The temporal profile of GOS scores from discharge to 6 months after the injury was also assessed. RESULTS The authors studied 218 patients (183 male and 35 female) with a mean age of 28.9 +/- 11.2 years. The majority of patients were able to follow commands (mGCS score of 6) within the 1st week after injury (71.4%), with the highest percentage of patients in this group recovering on Day 1 (28.6%). Recovery to the point of following commands beyond 2 weeks after the injury was seen in 14.8% of patients, who experienced significantly longer durations of intracranial pressure monitoring (p = 0.001) and neuromuscular blockade (p < 0.001). In comparison with patients with moderate disability, patients with good recovery had a higher initial GCS score (p = 0.01), lower incidence of anisocoria at admission (p = 0.048), and a shorter ICU stay (p < 0.001) and total hospital stay (p < 0.001). There was considerable improvement in GOS scores from discharge to follow-up at 6 months. CONCLUSIONS Up to 15% of patients with a favorable outcome after severe TBI may begin to follow commands beyond 2 weeks after the injury. These data caution against early withdrawal of life-sustaining treatment in patients with severe TBI.	[Vedantam, Aditya; Robertson, Claudia S.; Gopinath, Shankar P.] Baylor Coll Med, Dept Neurosurg, 7200 Cambridge,Ste 9A,MS BCM650, Houston, TX 77030 USA		Gopinath, SP (corresponding author), Baylor Coll Med, Dept Neurosurg, 7200 Cambridge,Ste 9A,MS BCM650, Houston, TX 77030 USA.	shankarg@bcm.edu					BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; JENNETT B, 1976, LANCET, V1, P1031; Lang EW, 1997, NEUROL RES, V19, P274, DOI 10.1080/01616412.1997.11740813; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Plaisier BR, 2002, AM SURGEON, V68, P159; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	18	12	12	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUL	2018	129	1					234	240		10.3171/2017.3.JNS162720			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GP2JB	WOS:000440655000029	28937323	Bronze			2022-02-06	
J	Corti, C; Poggi, G; Romaniello, R; Strazzer, S; Urgesi, C; Borgatti, R; Bardoni, A				Corti, Claudia; Poggi, Geraldine; Romaniello, Romina; Strazzer, Sandra; Urgesi, Cosimo; Borgatti, Renato; Bardoni, Alessandra			Feasibility of a home-based computerized cognitive training for pediatric patients with congenital or acquired brain damage: An explorative study	PLOS ONE			English	Article							WORKING-MEMORY; EXECUTIVE DYSFUNCTION; CONSORT STATEMENT; CHILDREN; REHABILITATION; PROGRAM; CANCER; INJURY; ADOLESCENTS; ATTENTION	Objectives Pediatric brain damage is associated with various cognitive deficits. Cognitive rehabilitation may prevent and reduce cognitive impairment. In recent years, home-based computerized cognitive training (CCT) has been introduced in clinical practice to increase treatment opportunities for patients (telerehabilitation). However, limited research has been conducted thus far on investigating the effects of remote CCT for the juvenile population in contexts other than English-speaking countries. The aim of the present study was to investigate the feasibility of a home-based CCT in a group of Italian adolescents with brain damage. A commercially available CCT (Lumosity) developed in the English language was used due to the lack of telerehabilitation programs in the Italian language that allow stimulation of multiple cognitive domains and, at the same time, remote automatic collection of data. Thus, this investigation provides information on the possibility of introducing CCT programs available in foreign languages in countries with limited investment in the telerehabilitation field. Methods 32 adolescents aged 11-16 with a diagnosis of congenital or acquired (either traumatic or non-traumatic) brain damage participated in the study. They received 40 training sessions (5 days/week for 8 weeks). Before starting the training program, they received face-to-face demonstration of training exercises and written instructions in their mother tongue. The feasibility of both training and study design and procedures was assessed through 9 criteria taken from extant literature. Results All 9 feasibility criteria were met. 31 out of the 32 participants demonstrated adherence to the training program. 94.2% of training sessions were completed in the recommended time frame. No significant technical issue was found. Conclusions Telerehabilitation seems to be a feasible practice for adolescents with brain damage. A training program developed in a foreign language can be used to counter the unavailability of programs in patients' mother tongue.	[Corti, Claudia; Poggi, Geraldine; Bardoni, Alessandra] Sci Inst IRCCS Eugenio Medea, Neurooncol & Neuropsychol Rehabil Unit, Bosisio Parini, Lecco, Italy; [Romaniello, Romina; Urgesi, Cosimo; Borgatti, Renato] Sci Inst IRCCS Eugenio Medea, Neuropsychiat & Neurorehabil Unit, Bosisio Parini, Lecco, Italy; [Strazzer, Sandra] Sci Inst IRCCS Eugenio Medea, Acquired Brain Injury Unit, Bosisio Parini, Lecco, Italy; [Urgesi, Cosimo] Univ Udine, Dept Languages & Literatures Commun Educ & Soc, Lab Cognit Neurosci, Udine, Italy		Corti, C (corresponding author), Sci Inst IRCCS Eugenio Medea, Neurooncol & Neuropsychol Rehabil Unit, Bosisio Parini, Lecco, Italy.	claudia.corti@bp.lnf.it	Corti, Claudia/AAH-7222-2019; Borgatti, Renato/AAA-4108-2022; Strazzer, Sandra/AAH-5712-2019; Romaniello, Romina/K-5160-2018; Poggi, Geraldina/K-4490-2016; BARDONI, ALESSANDRA/AAH-7233-2019; Urgesi, Cosimo/K-4688-2016	Corti, Claudia/0000-0003-1466-3182; Borgatti, Renato/0000-0001-8165-4994; Strazzer, Sandra/0000-0001-8414-6565; Romaniello, Romina/0000-0002-8709-6732; Poggi, Geraldina/0000-0003-0589-6347; BARDONI, ALESSANDRA/0000-0001-8404-3857; Urgesi, Cosimo/0000-0003-0572-1328	Italian Ministry of HealthMinistry of Health, Italy [NET - 2013-02356160]	This study was supported by the Italian Ministry of Health (Ricerca Corrente grants 2015-2017 to AB and Ricerca Finalizzata grant NET - 2013-02356160 to RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Bardoni A, 2013, BRAIN INJURY, V27, P1395, DOI 10.3109/02699052.2013.823652; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Bowen DJ, 2009, AM J PREV MED, V36, P452, DOI 10.1016/j.amepre.2009.02.002; Brennan DM, 2009, STUD HEALTH TECHNOL, V145, P231, DOI 10.3233/978-1-60750-018-6-231; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Chevignard M, 2016, ACTA PAEDIATR, V105, P574, DOI 10.1111/apa.13245; Conklin HM, 2015, J CLIN ONCOL, V33, P3894, DOI 10.1200/JCO.2015.61.6672; Santos Maria Tereza N. dos, 2014, Rev. paul. pediatr., V32, P136, DOI 10.1590/S0103-05822014000100020; Engvig A, 2010, NEUROIMAGE, V52, P1667, DOI 10.1016/j.neuroimage.2010.05.041; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gard G., 2001, PHYS THER REV, V6, P85; Goswami U, 2008, COGNITIVE DEV LEARNI; Hardy JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134467; Hardy KK, 2013, PSYCHO-ONCOLOGY, V22, P1856, DOI 10.1002/pon.3222; Hellgren L., 2015, OPEN J THERAPY REHAB, V3, P46, DOI [DOI 10.4236/OJTR.2015.32007, 10.4236/ojtr.2015.32007]; Hollingshead A. B, 1975, 4 FACTOR INDEX UNPUB; How TV, 2017, DISABIL REHABIL-ASSI, V12, P244, DOI 10.3109/17483107.2015.1129457; IRCCS Stella Maris University of Pisa University of Milan, TEL WORK MEM CHILDR; Kable JW, 2017, J NEUROSCI, V37, P7390, DOI 10.1523/JNEUROSCI.2832-16.2017; Kesler SR, 2011, BRAIN INJURY, V25, P101, DOI 10.3109/02699052.2010.536194; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Kueider AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040588; Kurowski BG, 2014, JAMA PEDIATR, V168, P523, DOI 10.1001/jamapediatrics.2013.5070; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Leon AC, 2011, J PSYCHIATR RES, V45, P626, DOI 10.1016/j.jpsychires.2010.10.008; Lohaugen GCC, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-269; Mulhern RK, 2003, CURR PROB CANCER, V27, P177, DOI 10.1016/S0147-0272(03)00026-6; Sadeghi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176429; Schmeler MR, 2008, INT J TELEREHABILITA, P12; Sjo NM, 2010, ACTA PAEDIATR, V99, P230, DOI 10.1111/j.1651-2227.2009.01587.x; Souza Ligia Maria Do N, 2007, Dev Neurorehabil, V10, P35, DOI 10.1080/13638490600822239; Spevack TV, 2007, PEDIATRIC NEUROPSYCHOLOGICAL INTERVENTION: A CRITICAL REVIEW OF SCIENCE AND PRACTICE, P6; Tam Sing-Fai, 2003, Occup Ther Int, V10, P20, DOI 10.1002/oti.175; Tavano A, 2007, BRAIN, V130, P2646, DOI 10.1093/brain/awm201; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; van't Hooft I, 2003, ACTA PAEDIATR, V92, P935, DOI 10.1080/08035250310004586; van 't Hooft I, 2007, NEUROREHABILITATION, V22, P109; Verhelst H, 2017, GAMES HEALTH J, V6, P28, DOI 10.1089/g4h.2016.0043; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wechsler D, 2012, WECHSLER INTELLIGENT; Zampolini M, 2008, ANN I SUPER SANITA, V44, P125; Zickefoose S, 2013, BRAIN INJURY, V27, P707, DOI 10.3109/02699052.2013.775484	47	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2018	13	6							e0199001	10.1371/journal.pone.0199001			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GJ8QS	WOS:000435655600040	29924823	Green Published, Green Submitted, gold			2022-02-06	
J	Raikes, AC; Bajaj, S; Dailey, NS; Smith, RS; Alkozei, A; Satterfield, BC; Killgore, WDS				Raikes, Adam C.; Bajaj, Sahil; Dailey, Natalie S.; Smith, Ryan S.; Alkozei, Anna; Satterfield, Brieann C.; Killgore, William D. S.			Diffusion Tensor Imaging (DTI) Correlates of Self-Reported Sleep Quality and Depression Following Mild Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						white matter integrity; Pittsburgh sleep quality index; beck depression inventory; fractional anisotropy; radial diffusivity; internal capsule; superior fronto-occipital fasciculus; corona radiata	POST-CONCUSSION SYMPTOMS; SPORT-RELATED CONCUSSION; CONTROLLED CORTICAL IMPACT; WHITE-MATTER CHANGES; AXONAL INJURY; MAJOR DEPRESSION; NEUROCOGNITIVE PERFORMANCE; POSTCONCUSSION SYMPTOMS; COGNITIVE IMPAIRMENT; PRIMARY INSOMNIA	Background: Mild traumatic brain injuries (mTBIs) are a significant social, sport, and military health issue. In spite of advances in the clinical management of these injuries, the underlying pathophysiology is not well-understood. There is a critical need to advance objective biomarkers, allowing the identification and tracking of the long-term evolution of changes resulting from mTBI. Diffusion-weighted imaging (DWI) allows for the assessment of white-matter properties in the brain and shows promise as a suitable biomarker of mTBI pathophysiology. Methods: 34 individuals within a year of an mTBI (age: 24.4 +/- 7.4) and 18 individuals with no history of mTBI (age: 23.2 +/- 3.4) participated in this study. Participants completed self-report measures related to functional outcomes, psychological health, post-injury symptoms, and sleep, and underwent a neuroimaging session that included DWI. Whole-brain white matter was skeletonized using tract-based spatial statistics (TBSS) and compared between groups as well as correlated within-group with the self-report measures. Results: There were no statistically significant anatomical differences between the two groups. After controlling for time since injury, fractional anisotropy (FA) demonstrated a negative correlation with sleep quality scores (higher FA was associated with better sleep quality) and increasing depressive symptoms in the mTBI participants. Conversely, mean (MD) and radial diffusivity (RD) demonstrated positive correlations with sleep quality scores (higher RD was associated with worse sleep quality) and increasing depressive symptoms. These correlations were observed bilaterally in the internal capsule (anterior and posterior limbs), corona radiata (anterior and superior), fornix, and superior fronto-occipital fasciculi. Conclusion: The results of this study indicate that the clinical presentation of mTBI, particularly with respect to depression and sleep, is associated with reduced white-matter integrity in multiple areas of the brain, even after controlling for time since injury. These areas are generally associated not only with sleep and emotion regulation but also cognition. Consequently, the onset of depression and sleep dysfunction as well as cognitive impairments following mTBI may be closely related to each other and to white-matter integrity throughout the brain.	[Raikes, Adam C.; Bajaj, Sahil; Dailey, Natalie S.; Smith, Ryan S.; Alkozei, Anna; Satterfield, Brieann C.; Killgore, William D. S.] Univ Arizona, Coll Med, Dept Psychiat, Social Cognit & Affect Neurosci Lab, Tucson, AZ 85721 USA		Raikes, AC (corresponding author), Univ Arizona, Coll Med, Dept Psychiat, Social Cognit & Affect Neurosci Lab, Tucson, AZ 85721 USA.	raikes.research@gmail.com	Raikes, Adam/M-2600-2019; Satterfield, Brieann/AAC-1475-2022; Bajaj, Sahil/C-6580-2016	Raikes, Adam/0000-0002-1609-6727; Bajaj, Sahil/0000-0003-0629-6036; Satterfield, Brieann C/0000-0002-8688-2416; Dailey, Natalie S./0000-0003-4800-4118; Smith, Ryan/0000-0002-4448-185X	Office of the Assistant Secretary of Defense for Health Affairs; Defense Health Agency J9, Research and Development Directorate, through the US Army Medical Research and Materiel Command (USAMRMC) [W81XWH-12-0386]	This work was supported by a grant to WK from the Office of the Assistant Secretary of Defense for Health Affairs and the Defense Health Agency J9, Research and Development Directorate, through the US Army Medical Research and Materiel Command (USAMRMC, Award #W81XWH-12-0386). The opinions, interpretations, conclusions and recommendations in this paper are solely those of the authors and are not necessarily endorsed by the Department of Defense or the U.S. Army Medical Research and Materiel Command.	Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Billiard M, 2013, SLEEP MED, V14, P462, DOI 10.1016/j.sleep.2013.01.009; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Datta SGS, 2009, NEUROL INDIA, V57, P594, DOI 10.4103/0028-3886.57810; de Guise E, 2016, APPL NEUROPSYCH-ADUL, V23, P213, DOI 10.1080/23279095.2015.1038747; Diedenhofen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121945; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dretsch Michael N, 2017, Open Neuroimag J, V11, P46, DOI 10.2174/1874440001711010046; Edden RA, 2011, J NEUROSCI METH, V201, P213, DOI 10.1016/j.jneumeth.2011.07.025; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Finkelstein E., 2006, INCIDENCE EC BURDEN; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jorge R, 2002, NEUROREHABILITATION, V17, P311; Kasper E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114543; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kirov II, 2013, J NEUROL, V260, P242, DOI 10.1007/s00415-012-6626-z; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larson-Prior LJ, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00165; Li SM, 2016, RADIOLOGY, V280, P520, DOI 10.1148/radiol.2016152038; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Longoni G, 2017, BRAIN, V140, P1300, DOI 10.1093/brain/awx041; Mani Arash, 2015, Bull Emerg Trauma, V3, P93; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Murphy ML, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-3; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Pandya D., 2009, FIBER PATHWAYS BRAIN; Pavot W., 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; R Core Team, 2016, R LANG ENV STAT COMP; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Riemann D, 2001, BIOL PSYCHOL, V57, P67, DOI 10.1016/S0301-0511(01)00090-4; Rock PL, 2014, PSYCHOL MED, V44, P2029, DOI 10.1017/S0033291713002535; Ryan NP, 2018, PSYCHOL MED, V48, P679, DOI 10.1017/S0033291717002057; Sexton CE, 2017, HUM BRAIN MAPP, V38, P5465, DOI 10.1002/hbm.23739; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Smith R, 2018, BRAIN BEHAV IMMUN, V67, P374, DOI 10.1016/j.bbi.2017.09.011; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Spiegelhalder K, 2014, HUM BRAIN MAPP, V35, P3431, DOI 10.1002/hbm.22412; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Storch EA, 2004, DEPRESS ANXIETY, V19, P187, DOI 10.1002/da.20002; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Sufrinko A, 2016, NEUROPSYCHOLOGY, V30, P484, DOI 10.1037/neu0000250; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Telzer EH, 2015, DEV COGN NEUROS-NETH, V14, P16, DOI 10.1016/j.dcn.2015.05.007; Theadom A, 2015, SLEEP MED, V16, P926, DOI 10.1016/j.sleep.2015.04.013; Thomas M, 2000, J SLEEP RES, V9, P335, DOI 10.1046/j.1365-2869.2000.00225.x; Ting WKC, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00271; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2016, J NEUROTRAUM, V33, P2000, DOI 10.1089/neu.2015.4212; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499	106	12	12	1	11	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 20	2018	9								468	10.3389/fneur.2018.00468			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GK0UP	WOS:000435827800001	29973910	Green Published, gold			2022-02-06	
J	Hammond, FM; Sherer, M; Malec, JF; Zafonte, RD; Dikmen, S; Bogner, J; Bell, KR; Barber, J; Temkin, N				Hammond, Flora M.; Sherer, Mark; Malec, James F.; Zafonte, Ross D.; Dikmen, Sureyya; Bogner, Jennifer; Bell, Kathleen R.; Barber, Jason; Temkin, Nancy			Amantadine Did Not Positively Impact Cognition in Chronic Traumatic Brain Injury: A Multi-Site, Randomized, Controlled Trial	JOURNAL OF NEUROTRAUMA			English	Article						amantadine; attention; brain injuries; cognition; executive function; memory	PSYCHOTROPIC MEDICATION USE; EFFICACY	Despite limited evidence to support the use of amantadine to enhance cognitive function after traumatic brain injury (TBI), the clinical use for this purpose is highly prevalent and is often based on inferred belief systems. The aim of this study was to assess effect of amantadine on cognition among individuals with a history of TBI and behavioral disturbance using a parallel-group, randomized, double-blind, placebo-controlled trial of amantadine 100mg twice-daily versus placebo for 60 days. Included in the study were 119 individuals with two or more neuropsychological measures greater than 1 standard deviation below normative means from a larger study of 168 individuals with chronic TBI (>6 months post-injury) and irritability. Cognitive function was measured at treatment days 0, 28, and 60 with a battery of neuropsychological tests. Composite indices were generated: General Cognitive Index (included all measures), a Learning Memory Index (learning/memory measures), and Attention/Processing Speed Index (attention and executive function measures). Repeated-measures analysis of variance revealed statistically significant between-group differences favoring the placebo group at day 28 for General Cognitive Index (p=0.002) and Learning Memory Index (p=0.001), but not Attention/Processing Speed Index (p=0.25), whereas no statistically significant between-group differences were found at day 60. There were no statistically significant between-group differences on adverse events. Cognitive function in individuals with chronic TBI is not improved by amantadine 100mg twice-daily. In the first 28 days of use, amantadine may impede cognitive processing. However, the effect size was small and mean scores for both groups were generally within expectations for persons with history of complicated mild-to-severe TBI, suggesting that changes observed across assessments may not have functional significance. The use of amantadine to enhance cognitive function is not supported by these findings.	[Hammond, Flora M.; Malec, James F.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Hammond, Flora M.; Malec, James F.] Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Hammond, Flora M.] Carolinas Rehabil, Dept Phys Med & Rehabil, Carolinas HealthCare Syst, Charlotte, NC USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Zafonte, Ross D.] Spaulding Rehabil Hosp, Boston, MA USA; [Dikmen, Sureyya; Bell, Kathleen R.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Bogner, Jennifer] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Bell, Kathleen R.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Barber, Jason; Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA		Hammond, FM (corresponding author), Rehabil Hosp Indiana, 4141 Shore Dr, Indianapolis, IN 46254 USA.	flora.Hammond@rhin.com		Bell, Kathleen/0000-0002-0928-2046	U.S. Department of Education, Office of Special Education and Rehabilitative Services, National Institute on Disability, Independent Living, and Rehabilitation Research [H133A080035]	The research reported in this article was supported by U.S. Department of Education, Office of Special Education and Rehabilitative Services, National Institute on Disability, Independent Living, and Rehabilitation Research grant H133A080035. This support included the funds to purchase amantadine. The study sponsor had no role in the design and conduct of this study; the collection, management, analysis, and interpretation of the data; or the preparation review, or approval of the manuscript.	Albrecht JS, 2017, AM J GERIAT PSYCHIAT, V25, P415, DOI 10.1016/j.jagp.2016.11.018; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Chow JJ, 2018, BEHAV BRAIN RES, V338, P40, DOI 10.1016/j.bbr.2017.10.013; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Distribution of IQ Scores, DISTR IQ SCOR; Francisco GE, 2007, BRAIN INJURY, V21, P1007, DOI 10.1080/02699050701559558; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Hammond FM, 2017, J HEAD TRAUMA REHAB, V32, P308, DOI 10.1097/HTR.0000000000000342; Hammond FM, 2015, J NEUROTRAUM, V32, P1230, DOI 10.1089/neu.2014.3803; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS256, DOI 10.1016/j.apmr.2015.01.025; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hamsher K., 1989, MULTILINGUAL APHASIA; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Leone H, 2005, J CLIN PHARM THER, V30, P101, DOI 10.1111/j.1365-2710.2005.00628.x; Mancini M, 2016, NEUROPHARMACOLOGY, V101, P341, DOI 10.1016/j.neuropharm.2015.10.015; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Polich G, 2018, J NEUROTRAUM, V35, P1205, DOI 10.1089/neu.2017.5506; Reddy CC, 2013, J HEAD TRAUMA REHAB, V28, P260, DOI 10.1097/HTR.0b013e318257fbc6; SAS, 2011, STAT AN SOFTW; Schneider WN, 1999, BRAIN INJURY, V13, P863; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wechsler D., 1939, MEASUREMENT ADULT IN; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D., 1994, ARMY INDIVIDUAL TEST; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016	27	12	12	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	19					2298	2305		10.1089/neu.2018.5767		JUN 2018	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GV3OA	WOS:000434866500001	29742960	Green Submitted, Green Published, Bronze			2022-02-06	
J	Meydan, C; Bekenstein, U; Soreq, H				Meydan, Chanan; Bekenstein, Uriya; Soreq, Hermona			Molecular Regulatory Pathways Link Sepsis With Metabolic Syndrome: Non-coding RNA Elements Underlying the Sepsis/Metabolic Cross-Talk	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						metabolic syndrome; miRs; ncRNAs; sepsis; SNPs	CARDIAC RESYNCHRONIZATION THERAPY; HEART-FAILURE PATIENTS; CIRCULATING MICRORNA-30D; CARDIOMYOCYTE APOPTOSIS; CARDIOVASCULAR-DISEASE; POSTTRAUMATIC-STRESS; ATRIAL-FIBRILLATION; INFLAMMATORY REFLEX; CATHETER ABLATION; ADIPOSE-TISSUE	Sepsis and metabolic syndrome (MetS) are both inflammation-related entities with high impact for human health and the consequences of concussions Both represent imbalanced parasympathetic/cholinergic response to insulting triggers and variably uncontrolled inflammation that indicates shared upstream regulators, including short microRNAs (miRs) and long non-coding RNAs (IncRNAs). These may cross talk across multiple systems, leading to complex molecular and clinical outcomes. Notably, biomedical and RNA-sequencing based analyses both highlight new links between the acquired and inherited pathogenic, cardiac and inflammatory traits of sepsis/MetS. Those include the HOTAIR and MIAT IncRNAs and their targets, such as miR-122, -150, -155, -182, -197, -375, -608 and HLA-DRA. Implicating non-coding RNA regulators in sepsis and MetS may delineate novel high-value biomarkers and targets for intervention.	[Meydan, Chanan] Mayanei Hayeshua Med Ctr, Dept Internal Med, Bnei Braq, Israel; [Bekenstein, Uriya; Soreq, Hermona] Hebrew Univ Jerusalem, Edmond & Lilly Safra Ctr Brain Sci, Alexander Silberman Inst Life Sci, Dept Biol Chem, Jerusalem, Israel		Soreq, H (corresponding author), Hebrew Univ Jerusalem, Edmond & Lilly Safra Ctr Brain Sci, Alexander Silberman Inst Life Sci, Dept Biol Chem, Jerusalem, Israel.	hermona.soreq@mail.huji.ac.il		Meydan, Chanan/0000-0002-8824-6309; Soreq, Hermona/0000-0002-0955-526X	European Research CouncilEuropean Research Council (ERC)European Commission [321501]; Israeli Ministry of Science, Technology and SpaceMinistry of Science, Technology and Space (MOST), Israel [53140]; Legacy Heritage Science Initiative (LHSI) of The Israel Science Foundation [817/13]; Austrian Research Promotion Agency (FFG Bridge1 project; Osterreichische Forschungsforderungsgesellschaft) [853294]; Edmond and Lily Safra Center for Brain Sciences (ELSC); Howard and Diana Wendy pre-doctoral fellowship; Israel I-Core Center of Excellence for Mass Trauma [817/13]	This research was supported by the European Research Council (Advanced Award 321501), The Israeli Ministry of Science, Technology and Space, Grant No. 53140, The Israel I-Core Center of Excellence for Mass Trauma and The Legacy Heritage Science Initiative (LHSI) of The Israel Science Foundation Grant No. 817/13, The Austrian Research Promotion Agency (FFG Bridge1 project; Osterreichische Forschungsforderungsgesellschaft, Grant number 853294) and the Edmond and Lily Safra Center for Brain Sciences (ELSC, to HS); UB was supported by the Howard and Diana Wendy pre-doctoral fellowship.	Abbasi J, 2017, JAMA-J AM MED ASSOC, V318, P506, DOI 10.1001/jama.2017.7997; Alvarez-Dominguez JR, 2015, CELL METAB, V21, P764, DOI 10.1016/j.cmet.2015.04.003; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMra1208623, 10.1056/NEJMc1312359]; Arner P, 2015, NAT REV ENDOCRINOL, V11, P276, DOI 10.1038/nrendo.2015.25; Aslan A, 2017, SHOCK, V48, P69, DOI 10.1097/SHK.0000000000000841; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barbash S, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.163; Barbash S, 2014, MOL BIOL EVOL, V31, P1237, DOI 10.1093/molbev/msu090; Barwari T, 2016, J AM COLL CARDIOL, V68, P2577, DOI 10.1016/j.jacc.2016.09.945; Bekenstein U, 2017, P NATL ACAD SCI USA, V114, pE4996, DOI 10.1073/pnas.1701201114; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bopp C, 2008, CRIT CARE, V12, DOI 10.1186/cc6164; Cajander S, 2013, CRIT CARE, V17, DOI 10.1186/cc13046; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Caserta S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28006; Chen Z, 2016, MOL METAB, V5, P164, DOI 10.1016/j.molmet.2015.12.003; Correia CN, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00118; Hert M, 2012, NAT REV ENDOCRINOL, V8, P114, DOI 10.1038/nrendo.2011.156; de Simone G, 2007, DIABETES CARE, V30, P1851, DOI 10.2337/dc06-2152; Divakaran V, 2008, CIRC RES, V103, P1072, DOI 10.1161/CIRCRESAHA.108.183087; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fedi M, 2008, J CLIN ENDOCR METAB, V93, P634, DOI 10.1210/jc.2007-1611; Galatzer-Levy IR, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.38; Gernapudi R, 2016, MOL CELL BIOL, V36, P30, DOI 10.1128/MCB.00702-15; Grassi G, 2007, HYPERTENSION, V49, P535, DOI 10.1161/01.HYP.0000255983.32896.b9; Greco S, 2012, DIABETES, V61, P1633, DOI 10.2337/db11-0952; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hanin G, 2018, GUT, V67, P1124, DOI 10.1136/gutjnl-2016-312869; Hanin G, 2014, HUM MOL GENET, V23, P4569, DOI 10.1093/hmg/ddu170; Hanisch UK, 2008, TRENDS NEUROSCI, V31, P176, DOI 10.1016/j.tins.2008.01.005; Hube F, 2011, NUCLEIC ACIDS RES, V39, P513, DOI 10.1093/nar/gkq833; Ingelsson E, 2006, HEART, V92, P1409, DOI 10.1136/hrt.2006.089011; Jackson JC, 2014, LANCET RESP MED, V2, P369, DOI 10.1016/S2213-2600(14)70051-7; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Karolina DS, 2012, J CLIN ENDOCR METAB, V97, pE2271, DOI 10.1210/jc.2012-1996; Karpe F, 2015, NAT REV ENDOCRINOL, V11, P90, DOI 10.1038/nrendo.2014.185; Korostowski L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002956; Krawczyk M, 2014, ELIFE, V3, DOI 10.7554/eLife.01776; Kumarswamy R, 2014, CIRC RES, V114, P1569, DOI 10.1161/CIRCRESAHA.114.303915; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lebow M, 2012, J NEUROSCI, V32, P6906, DOI 10.1523/JNEUROSCI.4012-11.2012; Lekkou A, 2004, CLIN DIAGN LAB IMMUN, V11, P161, DOI 10.1128/CDLI.11.1.161-167.2004; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Li MD, 2009, NAT REV GENET, V10, P225, DOI 10.1038/nrg2536; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111; Lin T, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.70; Lin XL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006308; Liu LT, 2016, CARDIOVASC RES, V111, P56, DOI 10.1093/cvr/cvw078; Liu RX, 2017, NAT MED, V23, P859, DOI 10.1038/nm.4358; Liu YC, 2014, ARTERIOSCL THROM VAS, V34, P902, DOI 10.1161/ATVBAHA.113.303123; Luna JM, 2015, CELL, V160, P1099, DOI 10.1016/j.cell.2015.02.025; Ma HF, 2017, J VIROL, V91, DOI 10.1128/JVI.01897-16; Marfella R, 2013, EUR J HEART FAIL, V15, P1277, DOI 10.1093/eurjhf/hft088; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Melman YF, 2015, CIRCULATION, V131, P2202, DOI 10.1161/CIRCULATIONAHA.114.013220; Meydan C, 2016, TRENDS MOL MED, V22, P798, DOI 10.1016/j.molmed.2016.07.001; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161; Moran I, 2012, CELL METAB, V16, P435, DOI 10.1016/j.cmet.2012.08.010; Morchikh M, 2017, MOL CELL, V67, P387, DOI 10.1016/j.molcel.2017.06.020; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Pan W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053950; Park SW, 2014, DIABETES, V63, P3057, DOI 10.2337/db13-1942; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rapicavoli NA, 2013, ELIFE, V2, DOI 10.7554/eLife.00762; Reddy MA, 2014, DIABETES, V63, P4249, DOI 10.2337/db14-0298; Reinhart K, 2017, NEW ENGL J MED, V377, P414, DOI 10.1056/NEJMp1707170; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Salta E, 2016, EMBO MOL MED, V8, P1005, DOI 10.15252/emmm.201606520; Santulli G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00015; Sardu C, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006558; Sardu C, 2016, CIRCULATION, V133, pE388, DOI 10.1161/CIRCULATIONAHA.115.018205; Sardu C, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/7292564; Sardu C, 2015, PHARMACOGENOMICS, V16, P1863, DOI 10.2217/pgs.15.117; Sardu C, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-176; Sardu C, 2014, PHARMACOGENOMICS, V15, P1159, DOI [10.2217/pgs.14.76, 10.2217/PGS.14.76]; Shahreyar M, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2017.12.26; Sonneville R, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-15; Sun J, 2016, SCI REP-UK, V6, DOI 10.1038/srep35421; Suzuki T, 2008, CIRC-HEART FAIL, V1, P242, DOI 10.1161/CIRCHEARTFAILURE.108.785485; Tang WF, 2016, J VIROL, V90, P1424, DOI 10.1128/JVI.02143-15; Tani H, 2012, GENOME RES, V22, P947, DOI 10.1101/gr.130559.111; Tracey KJ, 2010, NAT IMMUNOL, V11, P561, DOI 10.1038/ni0710-561; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2016, NAT REV GENET, V17, P601, DOI 10.1038/nrg.2016.85; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; Vasilescu C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007405; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Viereck J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1475; Wang JJ, 2010, ATHEROSCLEROSIS, V210, P237, DOI 10.1016/j.atherosclerosis.2009.10.042; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Wang ZQ, 2017, CELL MOL LIFE SCI, V74, P1117, DOI 10.1007/s00018-016-2398-4; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Wu HW, 2016, BIOCHEM BIOPH RES CO, V471, P240, DOI 10.1016/j.bbrc.2016.01.117; Xu GY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166235; Yan BA, 2015, CIRC RES, V116, P1143, DOI 10.1161/CIRCRESAHA.116.305510; Zaghloul N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01673; Zampetaki A, 2012, CIRC RES, V110, P508, DOI 10.1161/CIRCRESAHA.111.247445; Zgheib C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177453; Zhang AQ, 2015, ANN SURG, V261, P189, DOI 10.1097/SLA.0000000000000687; Zhang D, 2016, CELL REP, V16, P757, DOI 10.1016/j.celrep.2016.06.040; Zhao XY, 2015, TRENDS BIOCHEM SCI, V40, P586, DOI 10.1016/j.tibs.2015.08.002	115	12	13	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	JUN 5	2018	11								189	10.3389/fnmol.2018.00189			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GI2IU	WOS:000434194200001	29922126	gold, Green Published			2022-02-06	
J	Bailly, N; Laporte, JD; Afquir, S; Masson, C; Donnadieu, T; Delay, JB; Arnoux, PJ				Bailly, Nicolas; Laporte, Jean-Dominique; Afquir, Same; Masson, Catherine; Donnadieu, Thierry; Delay, Jean-Baptiste; Arnoux, Pierre-Jean			Effect of Helmet Use on Traumatic Brain Injuries and Other Head Injuries in Alpine Sport	WILDERNESS & ENVIRONMENTAL MEDICINE			English	Article						ski; snowboard; concussion	SNOW-PARKS; SNOWBOARDERS; SKIERS; RISK; SLOPES	Introduction-Sport helmet effectiveness in preventing traumatic brain injury (TBI) has been repeatedly questioned. This study assesses the effect of helmet use on risk of TBI and other types of head injury (OTHI) in alpine sports. Methods-From 2012 to 2014, data on the injured population were collected by physicians in on-mountain clinics in 30 French ski resorts, and interviews were conducted on the slope to sample a noninjured control population. Two sets of cases (1425 participants with TBI and 1386 with OTHI) were compared with 2 sets of controls (2145 participants without injury and 40,288 with an injury to a body part other than the head). The effect of helmet use on the risk of TBI and OTHI was evaluated with a multivariate logistic regression adjusted for age, sex, sport, skill level, crash type, and crash location, Results-Using participants without injury as control, we found that helmet wearers were less likely to sustain any head injury (odds ratio [OR](TBI) = 0.65; OROTHI = 0.42). When considering participants with an injury to another body part as control, the risk of OTHI was lower among helmet wearers (OROTHI: 0.61). However, no significant effect was found for the risk of TBI. Participants with low skill levels, those aged <26 and >50 years, snowboarders, and those involved in collision and in snowpark accidents were at higher risk of head injury. Conclusions-This study confirms the effectiveness of helmets in protecting users from head injuries but questions their effects on TBI, especially concussion.	[Bailly, Nicolas; Afquir, Same; Masson, Catherine; Arnoux, Pierre-Jean] Univ Mediterranee, Lab Biomecan Appl, Marseille, France; [Bailly, Nicolas; Donnadieu, Thierry] Salomon SAS, Annecy, France; [Laporte, Jean-Dominique; Delay, Jean-Baptiste] Med Montagne, Chambery, France		Bailly, N (corresponding author), Ctr Rech HSCM, Lab Rech Imagerie & Orthopedie, 5400,Boul Gouin Ouest,Local K-4075, Montreal, PQ H4J 1C5, Canada.	nicolas1.bailly@gmail.com	ARNOUX, Pierre Jean/AAK-6652-2021	ARNOUX, Pierre Jean/0000-0002-0311-560X			Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Association des Medecin de Montagne, 2013, DOSS PRESS ACC SPORT; Bailly N, 2017, SCAND J MED SCI SPOR, V27, P964, DOI 10.1111/sms.12699; Bailly N, 2017, MED SCI SPORT EXER, V49, P1, DOI 10.1249/MSS.0000000000001078; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Bouzat P, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0835-7; Demay A., 2006, THESIS; Dickson TJ, 2017, SCAND J MED SCI SPOR, V27, P236, DOI 10.1111/sms.12642; European Committee for Standardization, 2007, 1077 EN EUR COMM STA; Fukuda O, 2001, AM J SPORT MED, V29, P437, DOI 10.1177/03635465010290040901; Goulet C, 2007, CAN J PUBLIC HEALTH, V98, P402, DOI 10.1007/BF03405428; Goulet C, 2010, J SCI MED SPORT, V13, P39, DOI 10.1016/j.jsams.2008.10.002; Hagel BE, 2005, BRIT MED J, V330, P281, DOI 10.1136/bmj.38314.480035.7C; Koyama S, 2011, AM J SPORT MED, V39, P2656, DOI 10.1177/0363546511422331; Laporte J-D, 2008, J ASTM INT, V5, P1; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; Macnab AJ, 2002, INJURY PREV, V8, P324, DOI 10.1136/ip.8.4.324; Mcintosh A.S., 2014, CONCUSSIONS ATHLETIC, P167, DOI [DOI 10.1007/978-1-4939-0295-8_9, 10.1007/978-1-4939-0295-8_9]; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; Nakaguchi H, 2002, J NEUROSURG, V97, P542, DOI 10.3171/jns.2002.97.3.0542; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Ruedl G, 2015, SCAND J MED SCI SPOR, V25, P125, DOI 10.1111/sms.12139; Ruedl G, 2010, BRIT J SPORT MED, V44, P204, DOI 10.1136/bjsm.2009.066779; Ruedl G, 2013, ACCIDENT ANAL PREV, V50, P1221, DOI 10.1016/j.aap.2012.09.019; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Salomon S.A.S., RANGER 4D SKI HELMET; SATTIN RW, 1992, ANNU REV PUBL HEALTH, V13, P489, DOI 10.1146/annurev.pu.13.050192.002421; Scott MD, 2007, INJURY PREV, V13, P173, DOI 10.1136/ip.2006.014142; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Sulheim S, 2011, BRIT J SPORT MED, V45, P1303, DOI 10.1136/bjsports-2011-090407	30	12	12	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1080-6032	1545-1534		WILD ENVIRON MED	Wildern. Environ. Med.	JUN	2018	29	2					151	158		10.1016/j.wem.2017.11.007			8	Public, Environmental & Occupational Health; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Sport Sciences	GJ5NV	WOS:000435429100002	29397300	Bronze			2022-02-06	
J	Baracks, J; Casa, DJ; Covassin, T; Sacko, R; Scarneo, SE; Schnyer, D; Yeargin, SW; Neville, C				Baracks, Joshua; Casa, Douglas J.; Covassin, Tracey; Sacko, Ryan; Scarneo, Samantha E.; Schnyer, David; Yeargin, Susan W.; Neville, Christopher			Acute Sport-Related Concussion Screening for Collegiate Athletes Using an Instrumented Balance Assessment	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injuries; inertial sensor; Balance Error Scoring System	ERROR SCORING SYSTEM; MEASURING POSTURAL STABILITY; TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; SENSITIVITY; RELIABILITY; VALIDITY; EPIDEMIOLOGY; SPECIFICITY; MANAGEMENT	Context: Without a true criterion standard assessment, the sport-related concussion (SRC) diagnosis remains subjective. Inertial balance sensors have been proposed to improve acute SRC assessment, but few researchers have studied their clinical utility. Objective: To determine if group differences exist when using objective measures of balance in a sample of collegiate athletes with recent SRCs and participants serving as the control group and to calculate sensitivity and specificity to determine the diagnostic utility of the inertial balance sensor for acute SRC injuries. Design: Cross-sectional cohort study. Setting: Multicenter clinical trial. Patients or Other Participants: We enrolled 48 participants with SRC (age = 20.62+/-1.52 years, height = 179.76+/- 10.00 cm, mass = 83.92+/-23.22 kg) and 45 control participants (age = 20.85+/-1.42 years, height = 177.02+/-9.59 cm, mass = 74.61+/-14.92 kg) at 7 clinical sites in the United States. All were varsity or club collegiate athletes, and all participants with SRC were tested within 72 hours of SRC. Main Outcome Measure(s): Balance performance was assessed using an inertial balance sensor. Two measures (root mean square sway and 95% ellipse sway area) were analyzed to represent a range of general balance measures. Balance assessments were conducted in double-legged, single-legged, and tandem stances. Results: A main effect for group was associated with the root mean square sway measure (F1,91 = 11.75, P =.001), with the SRC group demonstrating balance deficits compared with the control group. We observed group differences in the 95% ellipse sway area measure for the double-legged (F1,91 = 11.59, P =.001), single-legged (F1,91 = 6.91, P =.01), and tandem (F1,91 = 7.54, P =.007) stances. Sensitivity was greatest using a cutoff value of 0.5 standard deviations (54% [ specificity = 71%]), whereas specificity was greatest using a cutoff value of 2 standard deviations (98% [ sensitivity = 33%]). Conclusions: Inertial balance sensors may be useful tools for objectively measuring balance during acute SRC evaluation. However, low sensitivity suggests that they may be best used in conjunction with other assessments to form a comprehensive screening that may improve sensitivity.	[Baracks, Joshua; Neville, Christopher] SUNY Upstate Med Univ, Upstate Concuss Ctr, Syracuse, NY 13210 USA; [Neville, Christopher] SUNY Upstate Med Univ, Dept Phys Therapy Educ Orthoped Surg &Physiol, Syracuse, NY 13210 USA; [Casa, Douglas J.; Scarneo, Samantha E.] Univ Connecticut, Korey Stringer Inst, Dept Kinesiol, Storrs, CT USA; [Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Sacko, Ryan; Yeargin, Susan W.] Univ South Carolina, Dept Phys Educ & Athlet Training, Columbia, SC USA; [Schnyer, David] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA		Neville, C (corresponding author), SUNY Upstate Med Univ, Dept Phys Therapy Educ Orthoped Surg &Physiol, Upstate Concuss Ctr, 3338 NAB,750 East Adams St, Syracuse, NY 13210 USA.	nevillec@upstate.edu	Schnyer, David/ABD-6372-2021	Schnyer, David/0000-0002-7472-2853; Sacko, Ryan/0000-0002-2104-6265; Neville, Christopher/0000-0002-8601-976X	BrainScope Company, Inc, from the US Navy (Naval Health Research Center, San Diego, CA) [W911QY-14-C-0098]	This study was funded in part through a contract with BrainScope Company, Inc, from the US Navy (Naval Health Research Center, San Diego, CA; contract W911QY-14-C-0098). We thank the BrainScope Company, Inc, team for organization and oversight of the clinical trial that made this study possible. We also thank the following individuals and sites for their assistance with data collection: Robert J. Elbin, PhD, at the University of Arkansas and Kenneth Podell, PhD, at Houston Methodist.	[Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; BrainScope Company Inc, 2015, OBJ BRAIN FUNCT ASS; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2017, J ATHL TRAINING, V52, P160, DOI 10.4085/1062-6050-51.9.05; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Burke MJ, 2015, BRAIN INJURY, V29, P300, DOI 10.3109/02699052.2014.974673; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dziemianowicz MS, 2012, CURR NEUROL NEUROSCI, V12, P547, DOI 10.1007/s11910-012-0299-y; Goldberg LD, 2006, SPORTS MED ARTHROSC, V14, P199, DOI 10.1097/01.jsa.0000212326.23560.09; Guskiewicz Kevin M, 2015, Handb Clin Neurol, V127, P157, DOI 10.1016/B978-0-444-52892-6.00010-6; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Han Seulki, 2016, J Phys Ther Sci, V28, P2515; Horak F, 2015, PHYS THER, V95, P461, DOI 10.2522/ptj.20140253; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Kerr ZY, 2015, J ATHL TRAINING, V50, P1174, DOI 10.4085/1062-6050-50.11.11; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Kutcher JS, 2013, BRIT J SPORT MED, V47, P299, DOI 10.1136/bjsports-2013-092257; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maassen GH, 2009, J CLIN EXP NEUROPSYC, V31, P339, DOI 10.1080/13803390802169059; Maassen GH, 2004, J INT NEUROPSYCH SOC, V10, P888, DOI 10.1017/S1355617704106097; MANCINI M, 2012, J NEUROENG REHABIL, V0009; Mancini M, 2011, PARKINSONISM RELAT D, V17, P557, DOI 10.1016/j.parkreldis.2011.05.010; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Merchant-Borna K, 2017, J ATHL TRAINING, V52, P245, DOI 10.4085/1062-6050-52.1.13; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Neville C, 2015, MED DEVICES-EVID RES, V8, P447, DOI 10.2147/MDER.S91719; Patterson JA, 2014, INT J SPORTS PHYS TH, V9, P135; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038	40	12	12	2	4	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUN	2018	53	6					597	605		10.4085/1062-6050-174-17			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GO1OQ	WOS:000439722900010	29897278	gold, Green Published			2022-02-06	
J	Fischer, JA; Olufs, ZPG; Katzenberger, RJ; Wassarman, DA; Perouansky, M				Fischer, Julie A.; Olufs, Zachariah P. G.; Katzenberger, Rebeccah J.; Wassarman, David A.; Perouansky, Misha			Anesthetics Influence Mortality in a Drosophila Model of Blunt Trauma With Traumatic Brain Injury	ANESTHESIA AND ANALGESIA			English	Article							VOLATILE ANESTHETICS; ISOFLURANE; AGENTS; INFLAMMATION; ACTIVATION	BACKGROUND: Exposure to anesthetics is common in the majority of early survivors of life-threatening injuries. Whether and to what degree general anesthetics influence outcomes from major trauma is unknown. Potential confounding effects of general anesthetics on outcome measures are usually disregarded. We hypothesized that exposure to isoflurane or sevoflurane modulates the outcome from blunt trauma with traumatic brain injury (bTBI). METHODS: We tested the hypothesis in a novel model of bTBI implemented in Drosophila melanogaster. Fruit flies of the standard laboratory strain w(1118) were cultured under standard conditions. We titrated the severity of bTBI to a mortality index at 24 hours (MI24) of approximately 20% under control conditions. We administered standard doses of isoflurane and sevoflurane before, before and during, or after bTBI and measured the resulting MI24. We report the MI24 as mean standard deviation. RESULTS: Isoflurane or sevoflurane administered for 2 hours before bTBI reduced the MI24 from 22.3 +/- 2.6 to 10.4 +/- 1.8 (P < 10(-9), n = 12) and from 19.3 +/- 0.9 to 8.9 +/- 1.1 (P < .0001, n = 8), respectively. In contrast, administration of isoflurane after bTBI increased the MI24 from 18.5% +/- 4.3% to 25.3% +/- 9.1% (P = .0026, n = 22), while sevoflurane had no effect (22.4 +/- 7.1 and 21.5 +/- 5.8, n = 22). CONCLUSIONS: In a whole animal model of bTBI, general anesthetics were not indifferent with respect to early mortality. Therefore, collateral effects of general anesthetics should be considered in the interpretation of results obtained in vertebrate trauma models. Invertebrate model organisms can serve as a productive platform to interrogate anesthetic targets that mediate collateral effects and to inform trauma research in higher organisms about the potential impact of anesthetics on outcomes.	[Fischer, Julie A.; Olufs, Zachariah P. G.; Perouansky, Misha] Univ Wisconsin, Sch Med & Publ Hlth, Dept Anesthesiol, 600 Highland Ave,B6-319 CSC, Madison, WI 53792 USA; [Fischer, Julie A.; Katzenberger, Rebeccah J.; Wassarman, David A.; Perouansky, Misha] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Genet, Madison, WI 53792 USA		Perouansky, M (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Anesthesiol, 600 Highland Ave,B6-319 CSC, Madison, WI 53792 USA.	mperouansky@wisc.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 NS091893, R01 NS083596] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS083596, R21NS091893] Funding Source: NIH RePORTER		Al Nimer F, 2013, BRAIN BEHAV IMMUN, V27, P109, DOI 10.1016/j.bbi.2012.10.002; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Cook RK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r21; Cornett PM, 2008, MOL PHARMACOL, V74, P1261, DOI 10.1124/mol.108.049684; Dawson AG, 2013, FLY, V7, P112, DOI 10.4161/fly.24142; De Maio A, 2005, SHOCK, V23, P11, DOI 10.1097/01.shk.0000144134.03598.c5; Duronio RJ, 2017, DIS MODEL MECH, V10, P1381, DOI 10.1242/dmm.031203; Harisseh R, 2017, J CARDIOVASC PHARM, V69, P326, DOI 10.1097/FJC.0000000000000479; Jevtovic-Todorovic V, 2013, BRIT J ANAESTH, V111, P143, DOI 10.1093/bja/aet177; Katzenberger RJ, 2016, G3-GENES GENOM GENET, V6, P4151, DOI 10.1534/g3.116.036194; Katzenberger RJ, 2015, JOVE-J VIS EXP, DOI 10.3791/52905; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Kichko TI, 2015, ANESTH ANALG, V120, P467, DOI 10.1213/ANE.0000000000000568; King EG, 2012, GENETICS, V191, P935, DOI 10.1534/genetics.112.138537; Kitano H, 2007, J CEREBR BLOOD F MET, V27, P1108, DOI 10.1038/sj.jcbfm.9600410; Kottler B, 2013, CURR BIOL, V23, P594, DOI 10.1016/j.cub.2013.02.021; Lee HT, 2004, ANESTHESIOLOGY, V101, P1313; Li JT, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/108928; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Matta JA, 2008, P NATL ACAD SCI USA, V105, P8784, DOI 10.1073/pnas.0711038105; McMurtrey RJ, 2010, BRAIN RES, V1358, P184, DOI 10.1016/j.brainres.2010.08.015; Olufs ZPG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20720-7; Redel A, 2009, EXP BIOL MED, V234, P1186, DOI 10.3181/0902-RM-58; Staib-Lasarzik I, 2014, J NEUROTRAUM, V31, P1664, DOI 10.1089/neu.2013.3243; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Stollings LM, 2016, ANESTHESIOLOGY, V125, P399, DOI 10.1097/ALN.0000000000001195; Tavare AN, 2012, INT J CANCER, V130, P1237, DOI 10.1002/ijc.26448; Tompkins RG, 2015, J TRAUMA ACUTE CARE, V78, P671, DOI 10.1097/TA.0000000000000568; Viera AJ, 2008, SOUTH MED J, V101, P730, DOI 10.1097/SMJ.0b013e31817a7ee4; Yuki K, 2008, FASEB J, V22, P4109, DOI 10.1096/fj.08-113324; Zhang YY, 2012, ANN NEUROL, V71, P687, DOI 10.1002/ana.23536	32	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	JUN	2018	126	6					1979	1986		10.1213/ANE.0000000000002906			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	GG3GS	WOS:000432580900030	29596093	Green Accepted, Bronze			2022-02-06	
J	Kim, C; Park, JM; Kong, T; Lee, S; Seo, KW; Choi, Y; Song, YS; Moon, J				Kim, Chul; Park, Ji-Min; Kong, TaeHo; Lee, Seungmin; Seo, Ki-Weon; Choi, Yuri; Song, Young Sook; Moon, Jisook			Double-Injected Human Stem Cells Enhance Rehabilitation in TBI Mice Via Modulation of Survival and Inflammation	MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; Human placenta-derived mesenchymal stem cells; Cell transplantation; Double injection; Functional recovery	TRAUMATIC BRAIN-INJURY; MESENCHYMAL STROMAL CELLS; NF-KAPPA-B; ALZHEIMERS-DISEASE; SIGNALING PATHWAY; OXIDATIVE STRESS; EXPRESSION; TRANSPLANTATION; ACTIVATION; BETA	Traumatic brain injury (TBI), a complicated form of brain damage, is a major cause of mortality in adults. Following mechanical and structural primary insults, a battery of secondary insults, including neurotransmitter-mediated cytotoxicity, dysregulation of calcium and macromolecule homeostasis, and increased oxidative stress, exacerbate brain injury and functional deficits. Although stem cell therapy is considered to be an alternative treatment for brain injuries, such as TBI and stroke, many obstacles remain. In particular, the time window for TBI treatment with either drugs or stem cells and their efficacy is still vague. Human placenta-derived mesenchymal stem cells (hpMSCs) have received extensive attention in stem cell therapy because they can be acquired in large numbers without ethical issues and because of their immune-modulating capacity and effectiveness in several diseases, such as Alzheimer's disease and stroke. Here, we tested the feasibility of hpMSCs for TBI treatment with an animal model and attempted to identify appropriate time points for cell treatments. Double injections at 4 and 24 h post-injury significantly reduced the infarct size and suppressed astrocyte and microglial activation around the injury. With reduced damage, double-injected mice showed enhanced anti-inflammatory- and TNF-alpha receptor 2 (TNFR2)-associated survival signals and suppressed pro-inflammatory and oxidative responses. In addition, double-treated TBI mice displayed restored sensory motor functions and reduced neurotoxic A beta(42) plaque formation around the damaged areas. In this study, we showed the extended therapeutic potentials of hpMSCs and concluded that treatment within an appropriate time window is critical for TBI recovery.	[Park, Ji-Min; Kong, TaeHo; Choi, Yuri; Moon, Jisook] CHA Univ, Dept Biotechnol, Coll Life Sci, Pangyo Ro 335 Beon Gil, Seoul, South Korea; [Kim, Chul; Park, Ji-Min; Kong, TaeHo; Lee, Seungmin; Seo, Ki-Weon; Song, Young Sook; Moon, Jisook] CHA Gen Hosp, Gen Res Inst, Seoul, South Korea; [Seo, Ki-Weon] SK Chem, Ecohub, 332 Pangyo Ro, Seongnam Si 13493, Gyeonggi Do, South Korea		Moon, J (corresponding author), CHA Univ, Dept Biotechnol, Coll Life Sci, Pangyo Ro 335 Beon Gil, Seoul, South Korea.; Moon, J (corresponding author), CHA Gen Hosp, Gen Res Inst, Seoul, South Korea.	jmoon@cha.ac.kr		Moon, Jisook/0000-0002-7044-4841	Bio & Medical Technology Development Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [NRF-2017M3A9B4025699, NRF-2017M3A9B4025709]	The authors really appreciate Yun-Hwa Jeong's in invaluable support for statistic analysis and Jae Hyun Park's kind assistance in histological analysis. This study was supported by Bio & Medical Technology Development Program through the National Research Foundation of Korea Funded by the Ministry of Science, ICT & Future Planning (NRF-2017M3A9B4025699 and NRF-2017M3A9B4025709).	Addington CP, 2015, BIOMARK INSIGHTS, V10, P43, DOI [10.4137/BMI.S20062, 10.4137/BMIMI.S20062]; Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Babini G, 2015, SCI REP-UK, V5, DOI 10.1038/srep09343; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Campos-Mora M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00405; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Fan CG, 1999, J MOL MED, V77, P577, DOI 10.1007/s001099900029; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Feurino LW, 2007, CANCER BIOL THER, V6, P1096, DOI 10.4161/cbt.6.7.4328; Graber DJ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0298-4; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kim KS, 2013, NEUROBIOL AGING, V34, P2408, DOI 10.1016/j.neurobiolaging.2013.03.029; Kranz A, 2010, BRAIN RES, V1315, P128, DOI 10.1016/j.brainres.2009.12.001; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Loov C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055983; Lotocki G, 2004, J NEUROSCI, V24, P11010, DOI 10.1523/JNEUROSCI.3823-04.2004; Lu J, 2013, P NATL ACAD SCI USA, V110, P10747, DOI 10.1073/pnas.1308950110; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; Marion DW, 2006, NEUROSURGERY, V58, P655; Miki T, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt66; Mishra SK, 2017, MOL CELL NEUROSCI, V78, P25, DOI 10.1016/j.mcn.2016.11.008; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Pan H, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/217580; Park KM, 2010, CELL SIGNAL, V22, P977, DOI 10.1016/j.cellsig.2010.01.010; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Peng WJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0034-0; Pischiutta F, 2014, NEUROPHARMACOLOGY, V79, P119, DOI 10.1016/j.neuropharm.2013.11.001; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Walker PA, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/369578; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wolbank S, 2010, ADV BIOCHEM ENG BIOT, V123, P1, DOI 10.1007/10_2010_71; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229; Yoo SW, 2013, NEUROBIOL DIS, V58, P249, DOI 10.1016/j.nbd.2013.06.001; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025; Zhou W, 2014, SEMIN CELL DEV BIOL, V35, P14, DOI 10.1016/j.semcdb.2014.07.013	54	12	13	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUN	2018	55	6					4870	4884		10.1007/s12035-017-0683-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GF5FI	WOS:000431991500026	28736792	Green Published			2022-02-06	
J	Kulbe, JR; Singh, IN; Wang, JA; Cebak, JE; Hall, ED				Kulbe, Jacqueline R.; Singh, Indrapal N.; Wang, Juan A.; Cebak, John E.; Hall, Edward D.			Continuous Infusion of Phenelzine, Cyclosporine A, or Their Combination: Evaluation of Mitochondrial Bioenergetics, Oxidative Damage, and Cytoskeletal Degradation following Severe Controlled Cortical Impact Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						aldehyde scavenging; cyclosporine A; lipid peroxidation; mitochondria; phenelzine	PERMEABILITY TRANSITION PORE; MONOAMINE-OXIDASE INHIBITORS; SPINAL-CORD-INJURY; LIPID-PEROXIDATION; CELL-DEATH; UNITED-STATES; ANTIOXIDANT THERAPIES; MOLECULAR-MECHANISMS; REACTIVE ALDEHYDES; ALZHEIMERS-DISEASE	To date, all monotherapy clinical traumatic brain injury (TBI) trials have failed, and there are currently no Food and Drug Administration (FDA)-approved pharmacotherapies for the acute treatment of severe TBI. Due to the complex secondary injury cascade following injury, there is a need to develop multi-mechanistic combinational neuroprotective approaches for the treatment of acute TBI. As central mediators of the TBI secondary injury cascade, both mitochondria and lipid peroxidation-derived aldehydes make promising therapeutic targets. Cyclosporine A (CsA), an FDA-approved immunosuppressant capable of inhibiting the mitochondrial permeability transition pore, and phenelzine (PZ), an FDA-approved monoamine oxidase inhibitor capable of scavenging neurotoxic lipid peroxidation-derived aldehydes, have both been shown to be partially neuroprotective following experimental TBI. Therefore, it follows that the combination of PZ and CsA may enhance neuroprotection over either agent alone through the combining of distinct but complementary mechanisms of action. Additionally, as the first 72 h represents a critical time period following injury, it follows that continuous drug infusion over the first 72 h following injury may also lead to optimal neuroprotective effects. This is the first study to examine the effects of a 72 h subcutaneous continuous infusion of PZ, CsA, and the combination of these two agents on mitochondrial respiration, mitochondrial bound 4-hydroxynonenal (4-HNE), and acrolein, and -spectrin degradation 72 h following a severe controlled cortical impact injury in rats. Our results indicate that individually, both CsA and PZ are able to attenuate mitochondrial 4-HNE and acrolein, PZ is able to maintain mitochondrial respiratory control ratio and cytoskeletal integrity but together, PZ and CsA are unable to maintain neuroprotective effects.	[Hall, Edward D.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, BBSRB Room 477,741 South Limestone St, Lexington, KY 40536 USA; Univ Kentucky, Coll Med, Dept Neurosci, Lexington, KY USA		Hall, ED (corresponding author), Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, BBSRB Room 477,741 South Limestone St, Lexington, KY 40536 USA.	edhall@uky.edu	Hall, Edward D/F-8930-2013	Kulbe, Jacqueline/0000-0002-7070-9264	NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R01 NS083405, 5R01 NS084857, NRSA NS096876]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS084857, T32NS077889, F30NS096876] Funding Source: NIH RePORTER	This work was supported by NIH-NINDS 5R01 NS083405 & 5R01 NS084857. Jacqueline R. Kulbe is currently supported by NIH-NINDS NRSA NS096876.	Aldini G, 2007, MED RES REV, V27, P817, DOI 10.1002/med.20073; Alessandri B, 2002, J NEUROTRAUM, V19, P829, DOI 10.1089/08977150260190429; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Bringold U, 2000, FREE RADICAL BIO MED, V29, P343, DOI 10.1016/S0891-5849(00)00318-X; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; Burcham PC, 2000, REDOX REP, V5, P47, DOI 10.1179/rer.2000.5.1.47; Burcham PC, 2004, MOL PHARMACOL, V65, P655, DOI 10.1124/mol.65.3.655; Burcham PC, 2006, MOL PHARMACOL, V69, P1056, DOI 10.1124/mol.105.018168; Burcham PC, 2002, TOXICOLOGY, V181, P229, DOI 10.1016/S0300-483X(02)00287-1; Cebak JE, 2017, J NEUROTRAUM, V34, P1302, DOI 10.1089/neu.2016.4624; Chen Z, 2016, J NEUROCHEM, V138, P328, DOI 10.1111/jnc.13639; Chinopoulos C, 2003, J BIOL CHEM, V278, P27382, DOI 10.1074/jbc.M303808200; Cohen G, 1999, J NEUROCHEM, V73, P2310, DOI 10.1046/j.1471-4159.1999.0732310.x; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Dixon CE, 2016, J NEUROTRAUM, V33, P553, DOI 10.1089/neu.2015.4122; Edmondson DE, 2009, BIOCHEMISTRY-US, V48, P4220, DOI 10.1021/bi900413g; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Fritz KS, 2013, FREE RADICAL BIO MED, V59, P85, DOI 10.1016/j.freeradbiomed.2012.06.025; Galvani S, 2008, FREE RADICAL BIO MED, V45, P1457, DOI 10.1016/j.freeradbiomed.2008.08.026; Garcia N, 2007, CELL BIOCHEM BIOPHYS, V49, P84, DOI 10.1007/s12013-007-0047-0; Gillman PK, 2011, J CLIN PSYCHOPHARM, V31, P66, DOI 10.1097/JCP.0b013e31820469ea; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Greco T, 2016, J CEREBR BLOOD F MET, V36, P1603, DOI 10.1177/0271678X15610584; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Hall E. D., 2015, J BIOENERG BIOMEMBR, V48, P169; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hamann K, 2008, J NEUROCHEM, V107, P712, DOI 10.1111/j.1471-4159.2008.05622.x; Hamann K, 2008, J NEUROCHEM, V104, P708, DOI 10.1111/j.1471-4159.2007.05002.x; Hansson MJ, 2008, FREE RADICAL BIO MED, V45, P284, DOI 10.1016/j.freeradbiomed.2008.04.021; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kobori N, 2011, NEUROSCIENCE, V172, P293, DOI 10.1016/j.neuroscience.2010.10.048; Kristal BS, 1996, J BIOL CHEM, V271, P6033, DOI 10.1074/jbc.271.11.6033; Kruman I, 1997, J NEUROSCI, V17, P5089; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LoPachin RM, 2008, TOXICOL SCI, V104, P235, DOI 10.1093/toxsci/kfm301; LoPachin RM, 2012, CHEM RES TOXICOL, V25, P239, DOI 10.1021/tx2003257; LoPachin RM, 2009, CHEM RES TOXICOL, V22, P1499, DOI 10.1021/tx900147g; Lovell MA, 2001, NEUROBIOL AGING, V22, P187, DOI 10.1016/S0197-4580(00)00235-9; Luo H, 2004, NEUROCHEM INT, V44, P475, DOI 10.1016/j.neuint.2003.09.006; Luo J, 2005, NEUROCHEM INT, V46, P243, DOI 10.1016/j.neuint.2004.09.001; Luo J, 2005, NEUROCHEM INT, V47, P449, DOI 10.1016/j.neuint.2005.07.002; Margulies S, 2016, J NEUROTRAUM, V33, P101, DOI 10.1089/neu.2014.3855; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Matveychuk D, 2014, PROG NEURO-PSYCHOPH, V53, P67, DOI 10.1016/j.pnpbp.2014.02.011; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; McEwen ML, 2007, J NEUROTRAUM, V24, P613, DOI 10.1089/neu.2006.9969; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Moghe A, 2015, TOXICOL SCI, V143, P242, DOI 10.1093/toxsci/kfu233; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Osier ND, 2016, BRAIN RES, V1640, P15, DOI 10.1016/j.brainres.2015.12.026; PACKER MA, 1995, EUR J BIOCHEM, V234, P231, DOI 10.1111/j.1432-1033.1995.231_c.x; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; PANTER SS, 1992, J NEUROTRAUM, V9, P47, DOI 10.1089/neu.1992.9.47; Park J, 2014, J NEUROCHEM, V129, P339, DOI 10.1111/jnc.12628; Pocernich CB, 2003, NEUROTOX RES, V5, P515, DOI 10.1007/BF03033161; Polasek TM, 2006, BRIT J CLIN PHARMACO, V61, P570, DOI 10.1111/j.1365-2125.2006.02627.x; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Radi R, 1998, CHEM RES TOXICOL, V11, P720, DOI 10.1021/tx980096z; Readnower RD, 2011, J NEUROTRAUM, V28, P1845, DOI 10.1089/neu.2011.1755; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shi RY, 2011, MOL NUTR FOOD RES, V55, P1320, DOI 10.1002/mnfr.201100217; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Singh IN, 2013, J CEREBR BLOOD F MET, V33, P593, DOI 10.1038/jcbfm.2012.211; Song MS, 2013, PROG NEURO-PSYCHOPH, V44, P118, DOI 10.1016/j.pnpbp.2013.02.001; Song MS, 2010, J NEUROCHEM, V114, P1405, DOI 10.1111/j.1471-4159.2010.06857.x; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TSUJI A, 1993, BIOCHEM PHARMACOL, V46, P1096, DOI 10.1016/0006-2952(93)90677-O; Vaishnav RA, 2010, J NEUROTRAUM, V27, P1311, DOI 10.1089/neu.2009.1172; Vanhove T, 2016, DRUG METAB REV, V48, P88, DOI 10.3109/03602532.2016.1151037; Wood PL, 2006, BRAIN RES, V1122, P184, DOI 10.1016/j.brainres.2006.09.003; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong YQ, 2009, FREE RADICAL RES, V43, P604, DOI 10.1080/10715760902977432	104	12	12	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2018	35	11					1280	1293		10.1089/neu.2017.5353			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GG7EW	WOS:000432862300009	29336204	Green Published			2022-02-06	
J	Letson, HL; Dobson, GP				Letson, Hayley L.; Dobson, Geoffrey P.			Adenosine, lidocaine, and Mg2+(ALM) resuscitation fluid protects against experimental traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; fluid percussion; inflammation; ALM; platelet	NEURON-SPECIFIC ENOLASE; 7.5-PERCENT NACL ADENOSINE; MG2+ ALM; RAT; COAGULOPATHY; MODEL; INTERLEUKIN-1; INFLAMMATION; BIOMARKERS; MILD	BACKGROUND Currently, no drug therapy prevents secondary injury progression after traumatic brain injury (TBI). Our aim was to investigate the effects of small-volume intravenous adenosine, lidocaine, and Mg2+ (ALM) resuscitation fluid after moderate TBI in a rat fluid-percussion injury model. METHODS Anesthetized, mechanically ventilated male Sprague-Dawley rats (449 5 g) were randomly assigned to one of four groups: (1) sham (craniotomy without TBI), (2) no-treatment, (3) saline-control, or (4) ALM therapy groups (all n = 16). A subdural probe was implanted in eight animals per group to measure cerebral blood flow. Fifteen minutes after moderate TBI was induced with lateral fluid percussion injury (2.57 atm), a single 3% NaCl ALM bolus (0.7 mL/kg) was injected intravenously, and after 60 minutes (Phase 1), 0.9% NaCl +/- ALM stabilization drip (0.5 mL/kg per hour) was administered for 3 hours (Phase 2). RESULTS Mortality (without subdural brain probe) was 25% (saline controls) and 0% (ALM). Sixty minutes after bolus, ALM significantly increased cardiac function, cortical blood flow (CBF; approximately threefold) and blunted systemic inflammation compared to saline controls. Three hours after infusion drip, ALM improved left ventricular function, supported higher CBF, decreased proinflammatory cytokines systemically (IL-1, tumor necrosis factor , and regulated on activation, normal T cell expressed and secreted [RANTES]), increased anti-inflammatory cytokines in brain tissue (IL-10, IL-4), lowered brain injury markers (neuron-specific enolase, Syndecan-1, HMGB-1), reduced coagulopathy, increased platelet aggregation, and maintained baseline fibrinogen levels. Saline-controls were proinflammatory (brain, heart, lung, and blood) and hypocoagulable with neurogenic enlargement of the right side of the heart. Survival time significantly correlated with plasma neuron-specific enolase (p = 0.001) and CBF at 180 minutes (p = 0.009), and CBF correlated with brain anti-inflammatory cytokines (p = 0.001-0.034). CONCLUSION After moderate TBI, ALM resuscitation fluid increased survival and protected against early secondary injury by reducing coagulopathy, inflammation, and platelet dysfunction.	[Letson, Hayley L.; Dobson, Geoffrey P.] James Cook Univ, Heart Trauma & Sepsis Res Lab, Coll Med & Dentistry, Townsville, Qld, Australia		Dobson, GP (corresponding author), James Cook Univ, Townsville, Qld, Australia.	geoffrey.dobson@jcu.edu.au	Letson, Hayley Louise/V-4659-2019	Letson, Hayley Louise/0000-0003-0135-134X	USSOCOM; IACUC [A2118]; USAMRMCU.S. Army Medical Research & Materiel Command (USAMRMC) [SO13004, W81XWH-15-1-0002]; US Department of DefenseUnited States Department of Defense	This work was supported by USSOCOM, IACUC protocol A2118, USAMRMC proposal SO13004 under Award No. W81XWH-15-1-0002. The opinions, interpretations, conclusions are those of the authors and are not necessarily endorsed by the US Department of Defense.; The authors thank the College of Medicine and Dentistry, James Cook University. The authors also particularly thank the US Department of Defense for continued support of our work. GPD is the inventor of the ALM concept for cardiac surgery, trauma, and sepsis. GPD and HLL declare no conflicts of interest.	Bahloul M, 2006, AM J CRIT CARE, V15, P462; Brough D, 2015, EXP PHYSIOL, V100, P1488, DOI 10.1113/EP085135; Brough D, 2011, TRENDS PHARMACOL SCI, V32, P617, DOI 10.1016/j.tips.2011.06.002; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; Dobson GP, 2016, J TRAUMA ACUTE CARE, V80, P135, DOI 10.1097/TA.0000000000000881; Dyson A, 2007, AM J PHYSIOL-HEART C, V293, pH526, DOI 10.1152/ajpheart.00052.2007; Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014; Granfeldt A, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0682-y; Granfeldt A, 2014, CRIT CARE MED, V42, pE329, DOI 10.1097/CCM.0000000000000225; Griffin MJ, 2016, CLIN VACCINE IMMUNOL, V23, P863, DOI 10.1128/CVI.00390-16; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kim BJ, 2014, J STROKE CEREBROVASC, V23, P2437, DOI 10.1016/j.jstrokecerebrovasdis.2014.05.020; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Kumar MA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0391-y; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Letson H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188144; Letson HL, 2017, J TRAUMA ACUTE CARE, V82, P1063, DOI 10.1097/TA.0000000000001454; Letson HL, 2015, J TRAUMA ACUTE CARE, V78, P773, DOI 10.1097/TA.0000000000000587; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Naganathar S, 2015, J TRAUMA ACUTE CARE, V79, P71, DOI 10.1097/TA.0000000000000694; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Qian R, 2015, AM J CARDIOVASC DIS, V5, P72; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Shear DA, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00073; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Streitberger KJ, 2017, CRIT CARE MED, V45, P1145, DOI 10.1097/CCM.0000000000002335; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Woertgen C, 2001, J NEUROTRAUM, V18, P569, DOI 10.1089/089771501300227378	40	12	12	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2018	84	6					908	916		10.1097/TA.0000000000001874			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	GJ4LE	WOS:000435351800010	29554045				2022-02-06	
J	Millet, A; Cuisinier, A; Bouzat, P; Batandier, C; Lemasson, B; Stupar, V; Pernet-Gallay, K; Crespy, T; Barbier, EL; Payen, JF				Millet, A.; Cuisinier, A.; Bouzat, P.; Batandier, C.; Lemasson, B.; Stupar, V.; Pernet-Gallay, K.; Crespy, T.; Barbier, E. L.; Payen, J. F.			Hypertonic sodium lactate reverses brain oxygenation and metabolism dysfunction after traumatic brain injury	BRITISH JOURNAL OF ANAESTHESIA			English	Article						brain injuries; traumatic; hypertonic solutions; mitochondria; sodium lactate	INTRACRANIAL HYPERTENSIVE EPISODES; POSITRON-EMISSION-TOMOGRAPHY; MAGNETIC-RESONANCE; COGNITIVE DEFICITS; TISSUE OXYGENATION; GLUCOSE; RAT; MICRODIALYSIS; MODEL; SUPPLEMENTATION	Background: The mechanisms by which hypertonic sodium lactate (HSL) solution act in injured brain are unclear. We investigated the effects of HSL on brain metabolism, oxygenation, and perfusion in a rodent model of diffuse traumatic brain injury (TBI). Methods: Thirty minutes after trauma, anaesthetised adult rats were randomly assigned to receive a 3 h infusion of either a saline solution (TBI-saline group) or HSL (TBI-HSL group). The sham-saline and sham-HSL groups received no insult. Three series of experiments were conducted up to 4 h after TBI (or equivalent) to investigate: 1) brain oedema using diffusion-weighted magnetic resonance imaging and brain metabolism using localized H-1-magnetic resonance spectroscopy (n = 10 rats per group). The respiratory control ratio was then determined using oxygraphic analysis of extracted mitochondria, 2) brain oxygenation and perfusion using quantitative blood-oxygenation-level-dependent magnetic resonance approach (n = 10 rats per group), and 3) mitochondrial ultrastructural changes (n = 1 rat per group). Results: Compared with the TBI-saline group, the TBI-HSL and the sham-operated groups had reduced brain oedema. Concomitantly, the TBI-HSL group had lower intracellular lactate/creatine ratio [0.049 (0.047-0.098) vs 0.097 (0.079-0.157); P < 0.05], higher mitochondrial respiratory control ratio, higher tissue oxygen saturation [77% (71-79) vs 66% (55-73); P < 0.05], and reduced mitochondrial cristae thickness in astrocytes [27.5 (22.5-38.4) nm vs 38.4 (31.0-47.5) nm; P < 0.01] compared with the TBI-saline group. Serum sodium and lactate concentrations and serum osmolality were higher in the TBI-HSL than in the TBI-saline group. Conclusions: These findings indicate that the hypertonic sodium lactate solution can reverse brain oxygenation and metabolism dysfunction after traumatic brain injury through vasodilatory, mitochondrial, and anti-oedema effects.	[Millet, A.; Cuisinier, A.; Bouzat, P.; Lemasson, B.; Stupar, V.; Pernet-Gallay, K.; Crespy, T.; Barbier, E. L.; Payen, J. F.] INSERM, Grenoble, France; [Millet, A.; Cuisinier, A.; Bouzat, P.; Lemasson, B.; Stupar, V.; Pernet-Gallay, K.; Crespy, T.; Barbier, E. L.; Payen, J. F.] Univ Grenoble Alpes, Grenoble Inst Neurosci, Grenoble, France; [Millet, A.] CHU Grenoble Alpes, Hop Michallon, Pole Couple Enfant, Grenoble, France; [Cuisinier, A.; Bouzat, P.; Crespy, T.; Payen, J. F.] CHU Grenoble Alpes, Hop Michallon, Pole Anesthesie Reanimat, Grenoble, France; [Batandier, C.] Univ Grenoble Alpes, INSERM, U1055, Lab Bioenerget Fondamentale & Appl, Grenoble, France		Payen, JF (corresponding author), INSERM, Grenoble, France.; Payen, JF (corresponding author), Univ Grenoble Alpes, Grenoble Inst Neurosci, Grenoble, France.; Payen, JF (corresponding author), CHU Grenoble Alpes, Hop Michallon, Pole Anesthesie Reanimat, Grenoble, France.	jean-francois.payen@univ-grenoble-alpes.fr	Barbier, Emmanuel/E-6302-2011; Bouzat, Pierre/L-6881-2014; Lemasson, Benjamin/L-1608-2014; Payen, Jean-Francois/L-6667-2014; Bouzat, Pierre/AAC-4105-2019; Lemasson, Benjamin/AAC-4092-2019	Barbier, Emmanuel/0000-0002-4952-1240; Lemasson, Benjamin/0000-0003-0446-3531; Bouzat, Pierre/0000-0003-4667-6738; Lemasson, Benjamin/0000-0003-0446-3531	Institut National de la Sante et de la Recherche MedicaleInstitut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche ScientifiqueCentre National de la Recherche Scientifique (CNRS); Ministere de l'Education, de la Recherche et de la Technologie; Fondation des Gueules Cassees; French programme, 'Investissement d'Avenir' from the French National Research Agency [ANR-11-INBS-0006]	Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; Ministere de l'Education, de la Recherche et de la Technologie; Fondation des Gueules Cassees; French programme, 'Investissement d'Avenir' from the French National Research Agency (ANR-11-INBS-0006, Infrastructure d'Avenir en Biologie Sante) to IRMaGe.	Alessandri B, 2012, J NEUROTRAUM, V29, P2181, DOI 10.1089/neu.2011.2067; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Berthet C, 2009, J CEREBR BLOOD F MET, V29, P1780, DOI 10.1038/jcbfm.2009.97; BOTTOMLEY PA, 1987, ANN NY ACAD SCI, V508, P333, DOI 10.1111/j.1749-6632.1987.tb32915.x; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P133, DOI 10.1097/MCC.0000000000000072; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Bouzat P, 2013, CRIT CARE MED, V41, P1316, DOI 10.1097/CCM.0b013e31827ca64e; Bouzier-Sore AK, 2003, J CEREBR BLOOD F MET, V23, P1298, DOI 10.1097/01.WCB.0000091761.61714.25; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Chen T, 2000, BRAIN RES, V861, P281, DOI 10.1016/S0006-8993(00)01992-2; Christen T, 2014, J CEREBR BLOOD F MET, V34, P1550, DOI 10.1038/jcbfm.2014.116; Christen T, 2011, NMR BIOMED, V24, P393, DOI 10.1002/nbm.1603; Dienel GA, 2016, J CEREBR BLOOD F MET, V36, P1844, DOI 10.1177/0271678X16666552; Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Ichai C, 2013, INTENS CARE MED, V39, P1413, DOI 10.1007/s00134-013-2978-9; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Lauritzen KH, 2014, CEREB CORTEX, V24, P2784, DOI 10.1093/cercor/bht136; Levasseur JE, 2006, NEUROSURGERY, V59, P1122, DOI 10.1227/01.NEU.0000245581.00908.AF; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; MARAN A, 1994, LANCET, V343, P16, DOI 10.1016/S0140-6736(94)90876-1; Meierhans R, 2012, MINERVA ANESTESIOL, V78, P185; Millet A, 2016, J NEUROTRAUM, V33, P1625, DOI 10.1089/neu.2015.4160; Payen JF, 1996, J CEREBR BLOOD F MET, V16, P1345, DOI 10.1097/00004647-199611000-00032; Prieto R, 2011, BRAIN RES, V1404, P39, DOI 10.1016/j.brainres.2011.06.006; Ratiney H, 2005, NMR BIOMED, V18, P1, DOI 10.1002/nbm.895; Rice AC, 2002, BRAIN RES, V928, P156, DOI 10.1016/S0006-8993(01)03299-1; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Schilte C, 2015, CRIT CARE MED, V43, P2212, DOI 10.1097/CCM.0000000000001137; Schurr A, 2007, NEUROSCIENCE, V147, P613, DOI 10.1016/j.neuroscience.2007.05.002; SCHURR A, 1988, SCIENCE, V240, P1326, DOI 10.1126/science.3375817; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Singh IN, 2013, J CEREBR BLOOD F MET, V33, P593, DOI 10.1038/jcbfm.2012.211; Smith D, 2003, J CEREBR BLOOD F MET, V23, P658, DOI 10.1097/01.WCB.0000063991.19746.11; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tropres I, 2001, MAGN RESON MED, V45, P397, DOI 10.1002/1522-2594(200103)45:3<397::AID-MRM1052>3.3.CO;2-V; Tropres I, 2015, MAGN RESON MED, V73, P325, DOI 10.1002/mrm.25396; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812	44	12	12	2	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0007-0912	1471-6771		BRIT J ANAESTH	Br. J. Anaesth.	JUN	2018	120	6					1295	1303		10.1016/j.bja.2018.01.025			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	GN4TA	WOS:000439024700020	29793596	Bronze			2022-02-06	
J	Ni, HB; Rui, Q; Xu, YT; Zhu, J; Gao, F; Dang, BQ; Li, D; Gao, R; Chen, G				Ni, Haibo; Rui, Qin; Xu, Yitian; Zhu, Jun; Gao, Fan; Dang, Baoqi; Li, Di; Gao, Rong; Chen, Gang			RACK1 upregulation induces neuroprotection by activating the IRE1-XBP1 signaling pathway following traumatic brain injury in rats	EXPERIMENTAL NEUROLOGY			English	Article						RACK1; IRE1; XBP1; Neuroprotection; Secondary brain injury; Traumatic brain injury	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; INDUCED APOPTOSIS; MESSENGER-RNA; NEURONS; HEMORRHAGE; EXPRESSION; RECEPTOR; IMPACT; MEMORY	Receptor for activated protein kinase C 1 (RACK1) is a multifaceted scaffolding protein known to be involved in the regulation of signaling events required for neuronal protection. In the present study, we investigated the role of RACK1 in secondary brain injury in a rat traumatic brain injury (TBI) model. A weight-drop TBI model was established in Sprague Dawley rats, and RACK1 in vivo knockdown and overexpression were performed 24 h before TBI insult. The IRE1 inhibitor 3,5-dibromosalicylaldehyde (DBSA) was administered by intracerebroventricular injection 1 h after TBI insult. Real-time PCR, Western blotting, immunofluorescence, neuronal apoptosis, brain water content, and neurological scores were evaluated. Our results revealed that TBI induced increased expression of endogenous RACK1, phosphorylated inositol-requiring enzyme 1 (p-IRE1), X-box binding protein-1 (XBP1) and glucose-regulated protein 78 (GRP78) in neurons. RACK1 overexpression significantly ameliorated neuronal apoptosis, blood-brain barrier disruption, brain edema and neurological deficits at 48 h after TBI, which was concomitant with upregulation of p-IRE1, XBP1 and GRP78 expression, while its knockdown induced the opposite effects. Furthermore, DBSA administration reversed the protective effects of RACK1 overexpression against brain injury and decreased the expression of p-IRE1, XBP1 and GRP78. In summary, the upregulation of RACK1 following brain contusion exerted neuroprotective effects against secondary brain injury, which were probably mediated by activation of the IRE1-XBP1 pathway.	[Ni, Haibo; Gao, Rong] First Peoples Hosp Zhangjiagang City, Dept Neurosurg, 68 Jiyang Western Rd, Suzhou 215006, Peoples R China; [Rui, Qin] First Peoples Hosp Zhangjiagang City, Dept Lab, Suzhou 215006, Peoples R China; [Xu, Yitian] Nanjing Med Univ, Dept Basic Med Sci, Nanjing 211166, Jiangsu, Peoples R China; [Zhu, Jun] Peoples Hosp Jingjicurg City, Dept Neurosurg, Taizhou 225300, Peoples R China; [Gao, Fan; Dang, Baoqi] Nanjing Univ Chinese Med, Dept Rehabil, Zhangjiagang Hosp Tradit Chinese Med, Suzhou 215006, Peoples R China; [Li, Di] First Peoples Hosp Zhangjiagang City, Dept Translat Med Ctr, Suzhou 215006, Peoples R China; [Chen, Gang] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou 215006, Peoples R China; [Chen, Gang] Soochow Univ, Affiliated Hosp 1, Brain & Nerve Res Lab, Suzhou 215006, Peoples R China		Li, D; Gao, R (corresponding author), First Peoples Hosp Zhangjiagang City, Dept Neurosurg, 68 Jiyang Western Rd, Suzhou 215006, Peoples R China.	lidi715@163.com; ronggao_zjg@163.com	Xu, Yitian/AAH-9794-2019				Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Casas-Tinto S, 2011, HUM MOL GENET, V20, P2144, DOI 10.1093/hmg/ddr100; Feng DY, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12395; Goldenberg-Cohen N, 2012, APOPTOSIS, V17, P278, DOI 10.1007/s10495-011-0678-x; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ito D, 2001, NEUROREPORT, V12, P4023, DOI 10.1097/00001756-200112210-00034; Jiang DD, 2015, SEMIN CANCER BIOL, V33, P48, DOI 10.1016/j.semcancer.2015.04.010; Koizumi N, 2001, PLANT PHYSIOL, V127, P949, DOI 10.1104/pp.010636; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li XY, 2015, J MOL NEUROSCI, V57, P63, DOI 10.1007/s12031-015-0577-7; Liu D, 2016, J MOL CELL BIOL, V8, P144, DOI 10.1093/jmcb/mjv066; Liu GL, 2011, BRAIN RES BULL, V84, P94, DOI 10.1016/j.brainresbull.2010.10.004; Liu LT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20183; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Ma J, 2014, BIOCHEM J, V462, P489, DOI 10.1042/BJ20140235; Neasta J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160948; Negoescu A, 1996, J HISTOCHEM CYTOCHEM, V44, P959, DOI 10.1177/44.9.8773561; Paschen W, 2003, J CEREBR BLOOD F MET, V23, P449, DOI 10.1097/01.WCB.0000054216.21675.AC; Peng RJ, 2013, ONCOL REP, V30, P2195, DOI 10.3892/or.2013.2723; Peyrl A, 2002, ELECTROPHORESIS, V23, P152, DOI 10.1002/1522-2683(200201)23:1<152::AID-ELPS152>3.0.CO;2-T; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; Shen HT, 2015, STROKE, V46, P2607, DOI 10.1161/STROKEAHA.115.009729; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Sun GZ, 2016, NEURAL REGEN RES, V11, P1260, DOI 10.4103/1673-5374.189190; Truettner JS, 2007, J NEUROTRAUM, V24, P599, DOI 10.1089/neu.2006.0186; Valdes P, 2014, P NATL ACAD SCI USA, V111, P6804, DOI 10.1073/pnas.1321845111; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang HY, 2001, BIOL PSYCHIAT, V50, P364, DOI 10.1016/S0006-3223(01)01147-7; Wu J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0790-0; Wu J, 2016, CELL PHYSIOL BIOCHEM, V38, P847, DOI 10.1159/000443039; Xu X, 2015, J NEUROCHEM, V133, P134, DOI 10.1111/jnc.13052; Zhou T, 2015, ONCOL REP, V33, P3006, DOI 10.3892/or.2015.3920; Zhu JJ, 2016, LIFE SCI, V151, P115, DOI 10.1016/j.lfs.2016.02.014	38	12	12	3	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUN	2018	304						102	113		10.1016/j.expneurol.2018.03.003			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GF3IF	WOS:000431838100010	29518365				2022-02-06	
J	Wu, ZY; Mazzola, CA; Catania, L; Owoeye, O; Yaramothu, C; Alvarez, T; Gao, Y; Li, XB				Wu, Ziyan; Mazzola, Catherine A.; Catania, Lori; Owoeye, Oyindamola; Yaramothu, Chang; Alvarez, Tara; Gao, Yu; Li, Xiaobo			Altered cortical activation and connectivity patterns for visual attention processing in young adults post-traumatic brain injury: A functional near infrared spectroscopy study	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						functional near-infrared spectroscopy (fNIRS); sports-related concussion (SRC); TBI induced inattention; traumatic brain injury (TBI); visual sustained attention	DEFICIT/HYPERACTIVITY DISORDER; SEX-DIFFERENCES; CONCUSSION SYMPTOMS; WORKING-MEMORY; NEUROPSYCHOLOGICAL FUNCTION; COGNITIVE CONTROL; CHILDREN; FNIRS; ADOLESCENTS; PREDICTORS	Aims: This study aimed at understanding the neurobiological mechanisms associated with inattention induced by traumatic brain injury (TBI). To eliminate the potential confounding caused by the heterogeneity of TBI, we focused on young adults postsports-related concussion (SRC). Methods: Functional near-infrared spectroscopy (fNIRS) data were collected from 27 young adults post-SRC and 27 group-matched normal controls (NCs), while performing a visual sustained attention task. Task responsive cortical activation maps and pairwise functional connectivity among six regions of interest were constructed for each subject. Correlations among the brain imaging measures and clinical measures of attention were calculated in each group. Results: Compared to the NCs, the SRC group showed significantly increased brain activation in left middle frontal gyrus (MFG) and increased functional connectivity between right inferior occipital cortex (IOC) bilateral calcarine gyri (CG). The left MFG activation magnitude was significantly negatively correlated with the hyperactive/impulsive symptom severity measure in the NCs, but not in the patients. The right hemisphere CG-IOC functional connectivity showed a significant positive correlation with the hyperactive/impulsive symptom severity measure in patients, but not in NCs. Conclusion: The current data suggest that abnormal left MFG activation and hyper-communications between right IOC and bilateral CG during visual attention processing may significantly contribute to behavioral manifestations of attention deficits in patients with TBI.	[Wu, Ziyan; Li, Xiaobo] New Jersey Inst Technol, Dept Elect & Comp Engn, Newark, NJ USA; [Mazzola, Catherine A.] New Jersey Pediat Neurosci Inst, Morristown, NJ USA; [Catania, Lori] North Jersey Neurodevelopmental Ctr, North Haledon, NJ USA; [Owoeye, Oyindamola; Yaramothu, Chang; Alvarez, Tara; Li, Xiaobo] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Gao, Yu] CUNY, Brooklyn Coll, Dept Psychol, Brooklyn, NY 11210 USA; [Gao, Yu] CUNY, Grad Ctr, Brooklyn, NY 11210 USA		Li, XB (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	xli.aecom@gmail.com		Yaramothu, Chang/0000-0003-4442-5409; Alvarez, Tara/0000-0002-8797-1613	New Jersey Commission on Brain Injury Research [CBIR17PIL012]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R03MH109791]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R03MH109791] Funding Source: NIH RePORTER	New Jersey Commission on Brain Injury Research, Grant/Award Number: CBIR17PIL012; National Institutes of Health, Grant/Award Number: R03MH109791	Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Chul J, 2009, NEUROIMAGE, V44, P428, DOI 10.1016/j.neuroimage.2008.08.036; Cocchi L, 2012, J NEUROSCI, V32, P17753, DOI 10.1523/JNEUROSCI.3272-12.2012; Cope M, 1988, Adv Exp Med Biol, V222, P183; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; De La Fuente A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00192; Dean PJ, 2015, BRAIN INJURY, P1; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Ghawami H, 2017, APPL NEUROPSYCH-ADUL, V24, P299, DOI 10.1080/23279095.2016.1157078; Hibino S, 2013, NEUROL MED-CHIR, V53, P299, DOI 10.2176/nmc.53.299; Irani F, 2007, CLIN NEUROPSYCHOL, V21, P9, DOI 10.1080/13854040600910018; Jang KE, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3127204; Kim BN, 2002, EUR ARCH PSY CLIN N, V252, P219, DOI 10.1007/s00406-002-0384-3; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Konigs M, 2017, BRAIN IMAGING BEHAV; Kontos AP, 2014, BRAIN IMAGING BEHAV, V8, P621, DOI 10.1007/s11682-014-9289-9; Krivitzky LS, 2011, J INT NEUROPSYCH SOC, V17, P1143, DOI 10.1017/S1355617711001226; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li XB, 2013, J AM ACAD CHILD PSY, V52, P756, DOI 10.1016/j.jaac.2013.04.016; Li XB, 2012, J AM ACAD CHILD PSY, V51, P1197, DOI 10.1016/j.jaac.2012.08.013; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Merzagora ACR, 2014, BRAIN IMAGING BEHAV, V8, P446, DOI 10.1007/s11682-013-9258-8; Munivenkatappa A, 2014, J NEUROSURG SCI; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pinto PS, 2012, J NEUROIMAGING, V22, pe18, DOI 10.1111/j.1552-6569.2011.00690.x; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Sanchez-Carrion R, 2008, J NEUROTRAUM, V25, P479, DOI 10.1089/neu.2007.0417; Scarapicchia V, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00419; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Schulz KP, 2017, CORTEX, V90, P1, DOI 10.1016/j.cortex.2017.01.019; Shin J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36203; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Siddiqui MF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01394-z; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Soeda A, 2005, NEURORADIOLOGY, V47, P501, DOI 10.1007/s00234-005-1372-x; Sozda CN, 2011, INT J PSYCHOPHYSIOL, V82, P97, DOI 10.1016/j.ijpsycho.2011.06.019; Sparrow E, 1999, CONNERS ADULT ADHD R; Tong YJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00313; Tong YJ, 2013, NEUROIMAGE, V76, P202, DOI 10.1016/j.neuroimage.2013.03.019; Tong YJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.106004; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Xia SG, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00162; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Zhan CY, 2017, BRAIN CONNECT, V7, P106, DOI 10.1089/brain.2016.0444; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Ziminermann P., 1994, TESTS EVALUATION ATT	59	12	12	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	JUN	2018	24	6					539	548		10.1111/cns.12811			10	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pharmacology & Pharmacy	GF5BT	WOS:000431980800008	29359534	Green Published, Bronze			2022-02-06	
J	McColl, TJ; Brady, RD; Shultz, SR; Lovick, L; Webster, KM; Sun, MJ; McDonald, SJ; O'Brien, TJ; Semple, BD				McColl, Thomas J.; Brady, Rhys D.; Shultz, Sandy R.; Lovick, Lauren; Webster, Kyria M.; Sun, Mujun; McDonald, Stuart J.; O'Brien, Terence J.; Semple, Bridgette D.			Mild Traumatic Brain Injury in Adolescent Mice Alters Skull Bone Properties to Influence a Subsequent Brain Impact at Adulthood: A Pilot Study	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; mouse model; inflammation; behavior; bone	COLLEGIATE FOOTBALL PLAYERS; LIFE COGNITIVE IMPAIRMENT; LATERAL FLUID PERCUSSION; SPORT-RELATED CONCUSSION; DEFAULT MODE NETWORK; STATES HIGH-SCHOOL; LONG-TERM; 1ST EXPOSURE; ANIMAL-MODEL; HIPPOCAMPAL-LESIONS	Mild traumatic brain injuries (mTBI) are common during adolescence, and limited clinical evidence suggests that a younger age at first exposure to a mTBI may lead to worse long-term outcomes. In this study, we hypothesized that a mTBI during adolescence would predispose toward poorer neurobehavioral and neuropathological outcomes after a subsequent injury at adulthood. Mice received a mild weight drop injury (mTBI) at adolescence (postnatal day 35; P35) and/or at adulthood (P70). Mice were randomized to 6 groups: 'sham' (sham-surgery at P35 only); 'P35' (mTBI at P35 only); 'P35 + sham' (mTBI at P35 + sham at P70); 'sham + P70' (sham at P35 + mTBI at P70); 'sham + sham' (sham at both P35 and P70); or 'P35 + P70' (mTBI at both P35 and P70). Acute apnea and an extended righting reflex time confirmed a mTBI injury at P35 and/or P70. Cognitive, psychosocial, and sensorimotor function was assessed over 1-week post-injury. Injured groups performed similarly to sham controls across all tasks. Immunofluorescence staining at 1 week detected an increase in glial activation markers in Sham + P70 brains only. Strikingly, 63% of Sham + P70 mice exhibited a skull fracture at impact, compared to 13% of P35 + P70 mice. Micro computed tomography of parietal skull bones found that a mTBI at P35 resulted in increased bone volume and strength, which may account for the difference in fracture incidence. In summary, a single mTBI to the adolescent mouse brain did not exacerbate the cerebral effects of a subsequent mTBI in adulthood. However, the head impact at P35 induced significant changes in skull bone structure and integrity. These novel findings support future investigation into the consequences of mTBI on skull bone.	[McColl, Thomas J.; Brady, Rhys D.; Shultz, Sandy R.; Lovick, Lauren; Webster, Kyria M.; Sun, Mujun; O'Brien, Terence J.; Semple, Bridgette D.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Brady, Rhys D.; McDonald, Stuart J.] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia; [Brady, Rhys D.; Shultz, Sandy R.; O'Brien, Terence J.; Semple, Bridgette D.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia		Semple, BD (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia.; Semple, BD (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia.	bridgette.semple@monash.edu	O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021	McDonald, Stuart/0000-0001-5190-3179; O'Brien, Terence/0000-0002-7198-8621; Sun, Mujun/0000-0002-9923-9913	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NINDS RFA-NS-16-012]; National Health and Medical Research Council of Australia (NHMRC)National Health and Medical Research Council of Australia; La Trobe University (Understanding Disease RFA); NHMRCNational Health and Medical Research Council of Australia	The authors acknowledge assistance from Narelle McGregor at the St Vincent's Institute of Medical Research mu CT facility in Melbourne. RB is supported by a grant from NINDS (NINDS RFA-NS-16-012) to TOB and SS. This work was supported by funding to BS and SS from the National Health and Medical Research Council of Australia (NHMRC), and to SM from La Trobe University (Understanding Disease RFA), as well as fellowships to SS and BS from NHMRC.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Allen GV, 2000, NEUROSCIENCE, V99, P93, DOI 10.1016/S0306-4522(00)00185-8; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; Brady RD, 2018, BONE, V109, P35, DOI 10.1016/j.bone.2017.05.015; Brady RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep34491; Brady RD, 2014, J ORTHOP RES, V32, P1277, DOI 10.1002/jor.22686; Broadbent NJ, 2006, LEARN MEMORY, V13, P187, DOI 10.1101/lm.134706; Broglio SP, 2017, J NEUROTRAUM, V34, P2675, DOI 10.1089/neu.2016.4767; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Clark RE, 2005, HIPPOCAMPUS, V15, P340, DOI 10.1002/hipo.20076; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Dwek JR, 2010, SKELETAL RADIOL, V39, P319, DOI 10.1007/s00256-009-0849-9; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Filley CM, 2015, NEUROLOGY, V84, P1068, DOI 10.1212/WNL.0000000000001357; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Juraska JM, 2004, ANN NY ACAD SCI, V1021, P431, DOI 10.1196/annals.1308.058; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Lillie EM, 2016, J BONE MINER RES, V31, P299, DOI 10.1002/jbmr.2613; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maroon JC, 2015, NEUROLOGY, V85, P1007, DOI 10.1212/WNL.0000000000001942; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mychasiuk R, 2014, BEHAV BRAIN RES, V259, P284, DOI 10.1016/j.bbr.2013.10.048; Mychasiuk R, 2015, NEUROBIOL DIS, V73, P1, DOI 10.1016/j.nbd.2014.09.003; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Osier N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070088; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Razi H, 2015, J BONE MINER RES, V30, P1864, DOI 10.1002/jbmr.2528; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Semple BD, 2017, BEHAV BRAIN RES, V319, P48, DOI 10.1016/j.bbr.2016.10.045; Semple BD, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00069; Semple BD, 2015, NEUROBIOL DIS, V74, P263, DOI 10.1016/j.nbd.2014.12.003; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Verna C, 2016, FRONT ORAL BIOL, V18, P28, DOI 10.1159/000351897; Wang Y, 2013, J CRANIOFAC SURG, V24, P1603, DOI 10.1097/SCS.0b013e3182a20ffb; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	79	12	13	0	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 25	2018	9								372	10.3389/fneur.2018.00372			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GH1FS	WOS:000433149000001	29887828	Green Published, gold			2022-02-06	
J	Goldshmit, Y; Jona, G; Schmukler, E; Solomon, S; Pinkas-Kramarski, R; Ruban, A				Goldshmit, Yona; Jona, Ghil; Schmukler, Eran; Solomon, Shira; Pinkas-Kramarski, Ronit; Ruban, Angela			Blood Glutamate Scavenger as a Novel Neuroprotective Treatment in Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						blood glutamate scavenger; cytotoxicity; glial scar; neuroprotection; spinal cord injury	EXCITATORY AMINO-ACIDS; OXALOACETATE TRANSAMINASE; CEREBROSPINAL-FLUID; CLINICAL-TRIALS; IMPACT INJURY; RAT MODEL; BRAIN; CELLS; REGENERATION; INHIBITION	Neurotrauma causes immediate elevation of extracellular glutamate (Glu) levels, which creates excitotoxicity and facilitates inflammation, glial scar formation, and consequently neuronal death. Finding factors that reduce the inflammatory response and glial scar formation, and increase neuronal survival and neurite outgrowth, are of major importance for improving the outcome after spinal cord injury (SCI). In the present study, we evaluated a new treatment aiming to remove central nervous system (CNS) Glu into the systemic blood circulation by intravenous (IV) administration of blood Glu scavengers (BGS) such as the enzyme recombinant glutamate-oxaloacetate transaminase 1 (rGOT1) and its co-substrate. In this study we induced in mice an SCI (hemisection), and 1h post-injury started administering BGS treatment for 5 consecutive days. The treatment reduced the expression levels of p-p38, which regulates apoptosis and increased the expression of p-Akt, which mediates cell survival. Moreover, this treatment decreased pro-inflammatory cytokine expression and microglia activation, reduced astrocytes' reactivity, and facilitated expression of radial glia markers such as Pax6 and nestin. BGS treatment increased the survival of neurons at lesion site and enabled axonal regeneration into the injury site. These effects were correlated with improved functional recovery of the left paretic hindlimb. Thus, early pharmacological intervention with BGS following SCI may be neuroprotective and create a pro-regenerative environment by modulating glia cell response. In light of our results, the availability of the method to remove excess Glu from CNS without the need to deliver drugs across the blood-brain barrier (BBB) and with minimal or no adverse effects may provide a major therapeutic asset.	[Goldshmit, Yona; Ruban, Angela] Tel Aviv Univ, Sackler Sch Med, Steyer Sch Hlth Profess, Tel Aviv, Israel; [Schmukler, Eran; Solomon, Shira; Pinkas-Kramarski, Ronit] Tel Aviv Univ, Dept Neurobiol, Tel Aviv, Israel; [Goldshmit, Yona] Monash Biotechnol, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Jona, Ghil] Weizmann Inst Sci, Dept Life Sci Core Facil, Rehovot, Israel		Goldshmit, Y; Ruban, A (corresponding author), Tel Aviv Univ, POB 39040, IL-6997801 Tel Aviv, Israel.	yona.goldshmit@monash.edu; angellruban@post.tau.ac.il		Ruban, Angela/0000-0003-1091-8854; Jona, Ghil/0000-0002-4526-6182; Pinkas-Kramarski, Ronit/0000-0002-1000-369X			Boyko M, 2012, NEUROCHEM RES, V37, P2198, DOI 10.1007/s11064-012-0843-9; Brea D, 2011, CLIN IMMUNOL, V139, P193, DOI 10.1016/j.clim.2011.02.001; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Clark IA, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0708-2; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Goldshmit Y, 2016, J NEUROCHEM, V138, P845, DOI 10.1111/jnc.13730; Goldshmit Y, 2014, BRAIN BEHAV, V4, P187, DOI 10.1002/brb3.172; Goldshmit Y, 2012, AM J PATHOL, V181, P978, DOI 10.1016/j.ajpath.2012.06.007; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Hackett AR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00199; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; LAJTHA A, 1959, J NEUROCHEM, V3, P322, DOI 10.1111/j.1471-4159.1959.tb12638.x; Landolt H, 1998, J CLIN NEUROSCI, V5, P193, DOI 10.1016/S0967-5868(98)90037-6; Li JS, 2006, J NEUROSURG-SPINE, V4, P165, DOI 10.3171/spi.2006.4.2.165; Li K, 2014, J NEUROSCI, V34, P7622, DOI 10.1523/JNEUROSCI.4690-13.2014; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; McAdoo DJ, 1999, EXP NEUROL, V159, P538, DOI 10.1006/exnr.1999.7166; Muir KW, 2006, CURR OPIN PHARMACOL, V6, P53, DOI 10.1016/j.coph.2005.12.002; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; O'Keefe SJ, 2007, J BIOL CHEM, V282, P34663, DOI 10.1074/jbc.M704236200; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; Perez-Mato M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.507; Pi RB, 2004, J NEUROCHEM, V91, P1219, DOI 10.1111/j.1471-4159.2004.02796.x; Risco A, 2012, P NATL ACAD SCI USA, V109, P11200, DOI 10.1073/pnas.1207290109; Ruban A, 2015, NEURODEGENER DIS, V15, P233, DOI 10.1159/000382034; Ruban A, 2015, INT J MOL SCI, V16, P3226, DOI 10.3390/ijms16023226; Ruban A, 2014, J CEREBR BLOOD F MET, V34, P221, DOI 10.1038/jcbfm.2013.186; Ruban A, 2012, INVEST NEW DRUG, V30, P2226, DOI [10.1007/s10637-012-9794-x, 10.1007/s10637-012-9799-5]; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Taves S, 2016, BRAIN BEHAV IMMUN, V55, P70, DOI 10.1016/j.bbi.2015.10.006; Teichberg VI, 2011, J CEREBR BLOOD F MET, V31, P1376, DOI 10.1038/jcbfm.2011.46; Tsai PJ, 2000, J NUTR, V130, p1002S, DOI 10.1093/jn/130.4.1002S; Umezawa H, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00072; Wang CY, 2015, GLIA, V63, P194, DOI 10.1002/glia.22743; Yang H, 2011, NEUROCHEM INT, V59, P1010, DOI 10.1016/j.neuint.2011.08.021; Zhang H, 2001, CLIN CHEM, V47, P1458; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021	44	12	13	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2018	35	21					2581	2590		10.1089/neu.2017.5524		MAY 2018	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GX0JY	WOS:000432335800001	29495919				2022-02-06	
J	Knollman-Porter, K; Brown, J; Flynn, M				Knollman-Porter, Kelly; Brown, Jessica; Flynn, Madelaine			A Preliminary Examination of Concussion Knowledge by Collegiate Athletes and Non-Athletes	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; VESTIBULAR REHABILITATION; SOCCER PLAYERS; MANAGEMENT; EDUCATION; SPORT; STATEMENT; SYMPTOMS; STRATEGIES	Purpose: Concussions affect various populations, including collegiate athletes and non-athletes. The purpose of this study was to compare collegiate varsity athletes, recreational athletes, and non-athletes' knowledge of concussion definition, symptoms, and support services available following injury. Preferred method of concussion education delivery was also examined. Method: We surveyed 306 current college students using an online survey system. The survey included free recall and forced-choice question formats. Quantitative analyses were used to analyze results and compare responses among groups. Results: Collegiate athletes and non-athletes demonstrate incomplete knowledge of concussion definition, related symptoms, and professionals involved in postinjury management. Varsity athletes rated self-knowledge of concussion parameters significantly higher than the other groups (p < .001), though few significant differences in actual knowledge levels were observed. Overall, respondents reported having the highest preference for concussion education delivered by medical professionals. Conclusion: Knowledge concerning concussion is incomplete in the collegiate population. Varsity athletes' exposure to formal education did not result in higher knowledge levels compared with other groups. Further examination of concussion educational delivery models' effect on change in concussion-related behavior in this population is warranted.	[Knollman-Porter, Kelly; Flynn, Madelaine] Miami Univ, Dept Speech Pathol & Audiol, Oxford, OH 45056 USA; [Brown, Jessica] Univ Arizona, Dept Speech Language & Hearing Sci, Tucson, AZ USA		Knollman-Porter, K (corresponding author), Miami Univ, Dept Speech Pathol & Audiol, Oxford, OH 45056 USA.	knollmkk@miamioh.edu					Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; [Anonymous], 2013, 2013 14 NCAA SPORTS; Babbie ER, 2011, BASICS SOCIAL RES; Baugh C.M., 2016, CONCUSSION, V1, P1, DOI [DOI 10.2217/CNC.15.6, 10.2217/cnc.15.6]; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Bertakis KD, 2009, PATIENT EDUC COUNS, V76, P356, DOI 10.1016/j.pec.2009.07.022; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Brown J., 2015, ANN CONV AM SPEECH L; Buchanan EA, 2009, J EMPIR RES HUM RES, V4, P37, DOI 10.1525/jer.2009.4.2.37; Caron JG, 2015, INJURY PREV, V21, P301, DOI 10.1136/injuryprev-2014-041479; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Coghlin Craig J, 2009, J Can Chiropr Assoc, V53, P233; Coulter A, 2007, BMJ-BRIT MED J, V335, P24, DOI 10.1136/bmj.39246.581169.80; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Dorman JM., 2002, HIST PRACTICE COLL H, P104; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Faul M, 2010, TRAUMATIC BRAIN INJU; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Granello DH, 2004, J COUNS DEV, V82, P387, DOI 10.1002/j.1556-6678.2004.tb00325.x; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hux K., 2016, ANN CONV AM SPEECH L; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; KICKBUSCH I., 2005, 8 EUR HLTH FOR BAD G; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Krause M, 2014, BRAIN INJURY, V28, P1301, DOI 10.3109/02699052.2014.916416; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; Linsenmeyer J. J., 2017, SPORTRISK, V11; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Musille A. M., 2016, THESIS; National Collegiate Athletic Association, STUD ATHL; Pennington B., 2008, NEW YORK TIMES; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Porter KK, 2014, AM J SPEECH-LANG PAT, V23, P507, DOI 10.1044/2014_AJSLP-13-0126; Powell JW, 2001, J ATHL TRAINING, V36, P307; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; SALAWAY G, 2008, ECAR STUDY UNDERGRAD; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Shenouda C, 2012, PM&R, V4, P427, DOI 10.1016/j.pmrj.2012.02.016; Sohlberg MM, 2016, AM J SPEECH-LANG PAT, V25, DOI 10.1044/2015_AJSLP-14-0128; The National Collegiate Athletic Association, 2014, 2014 2015 NCAA SPORT; Turner JC, 2015, J AM COLL HEALTH, V63, P530, DOI 10.1080/07448481.2015.1055567; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; World Health Organization, 2004, INT STAT CLASS DIS R, V1; Wright KB, 2005, J COMPUT-MEDIAT COMM, V10; Yousaf O, 2015, HEALTH PSYCHOL REV, V9, P264, DOI 10.1080/17437199.2013.840954; [No title captured]	61	12	12	1	5	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	MAY	2018	27	2					778	795		10.1044/2018_AJSLP-17-0108			18	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	GI1UE	WOS:000434155300019	29625433				2022-02-06	
J	Mayer, AR; Wertz, C; Ryman, SG; Storey, EP; Park, G; Phillips, J; Dodd, AB; Oglesbee, S; Campbell, R; Yeo, RA; Wasserott, B; Shaff, NA; Leddy, JJ; Mannix, R; Arbogast, KB; Meier, TB; Grady, MF; Master, CL				Mayer, Andrew R.; Wertz, Christopher; Ryman, Sephira G.; Storey, Eileen P.; Park, Grace; Phillips, John; Dodd, Andrew B.; Oglesbee, Scott; Campbell, Richard; Yeo, Ronald A.; Wasserott, Benjamin; Shaff, Nicholas A.; Leddy, John J.; Mannix, Rebekah; Arbogast, Kristy B.; Meier, Timothy B.; Grady, Matthew F.; Master, Christina L.			Neurosensory Deficits Vary as a Function of Point of Care in Pediatric Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						neurosensory; ocular motor; pmTBI; recovery; vestibular; vision	SPORT-RELATED CONCUSSION; KING-DEVICK; CONVERGENCE INSUFFICIENCY; PSYCHIATRIC-DISORDERS; EMERGENCY-DEPARTMENT; PROLONGED RECOVERY; CHILDREN; SYMPTOMS; ADOLESCENTS; SAMPLE	Neurosensory abnormalities are frequently observed following pediatric mild traumatic brain injury (pmTBI) and may underlie the expression of several common concussion symptoms and delay recovery. Importantly, active evaluation of neurosensory functioning more closely approximates real-world (e.g., physical and academic) environments that provoke symptom worsening. The current study determined whether symptom provocation (i.e., during neurosensory examination) improved classification accuracy relative to pre-examination symptom levels and whether symptoms varied as a function of point of care. Eighty-one pmTBI were recruited from the pediatric emergency department (PED; n = 40) or outpatient concussion clinic (n = 41), along with matched (age, sex, and education) healthy controls (HC; n = 40). All participants completed a brief (similar to 12min) standardized neurosensory examination and clinical questionnaires. The magnitude of symptom provocation upon neurosensory examination was significantly higher for concussion clinic than for PED patients. Symptom provocation significantly improved diagnostic classification accuracy relative to pre-examination symptom levels, although the magnitude of improvement was modest, and was greater in the concussion clinic. In contrast, PED patients exhibited worse performance on measures of balance, vision, and oculomotor functioning than the concussion clinic patients, with no differences observed between both samples and HC. Despite modest sample sizes, current findings suggest that point of care represents a critical but highly under-studied variable that may influence outcomes following pmTBI. Studies that rely on recruitment from a single point of care may not generalize to the entire pmTBI population in terms of how neurosensory deficits affect recovery.	[Mayer, Andrew R.; Wertz, Christopher; Ryman, Sephira G.; Phillips, John; Dodd, Andrew B.; Wasserott, Benjamin; Shaff, Nicholas A.] Lovelace Biomed & Environm Res Inst, Mind Res Network, Pete & Nancy Domenici Hall, Albuquerque, NM USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.; Campbell, Richard] Univ New Mexico, Sch Med, Dept Psychiat, Albuquerque, NM 87131 USA; [Mayer, Andrew R.; Phillips, John; Yeo, Ronald A.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Storey, Eileen P.; Grady, Matthew F.; Master, Christina L.] Childrens Hosp Philadelphia, Div Orthoped Surg, Philadelphia, PA 19104 USA; [Arbogast, Kristy B.; Grady, Matthew F.; Master, Christina L.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Philadelphia, PA 19104 USA; [Park, Grace; Oglesbee, Scott] Univ New Mexico Hosp, Emergency Med, Albuquerque, NM USA; [Leddy, John J.] SUNY Buffalo, Dept Orthopaed, Buffalo, NY USA; [Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA		Mayer, AR (corresponding author), Mind Res Network, Pete & Nancy Domenici Hall,1101 Yale Blvd NE, Albuquerque, NM 87106 USA.	amayer@mrn.org	Mannix, Rebekah/AAD-8702-2020	Master, Christina/0000-0002-6717-4270; Arbogast, Kristy/0000-0002-1694-4562	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1 R01 NS098494-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109089] Funding Source: NIH RePORTER	This study was funded by National Institutes of Health grant number 1 R01 NS098494-01A1 to A.R.M.	Aligene K, 2013, NEUROREHABILITATION, V32, P543, DOI 10.3233/NRE-130876; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Boutis K, 2015, J PEDIATR-US, V166, P1214, DOI 10.1016/j.jpeds.2015.02.013; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; DuPrey KM, 2017, AM J SPORT MED, V45, P2388, DOI 10.1177/0363546517705640; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1059, DOI 10.1682/JRRD.2010.09.0166; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hoffer ME, 2015, CURR OPIN NEUROL, V28, P74, DOI 10.1097/WCO.0000000000000164; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Lew HL, 2011, J HEAD TRAUMA REHAB, V26, P489, DOI 10.1097/HTR.0b013e318204e54b; Lew HL, 2010, NEUROREHABILITATION, V26, P213, DOI 10.3233/NRE-2010-0557; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Scheiman M, 2005, ARCH OPHTHALMOL-CHIC, V123, P14, DOI 10.1001/archopht.123.1.14; Silverberg ND, 2014, BRAIN INJURY, V28, P1590, DOI 10.3109/02699052.2014.943287; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Swanson MW, 2017, OPTOMETRY VISION SCI, V94, P60, DOI 10.1097/OPX.0000000000000977; Weise KK, 2017, OPTOMETRY VISION SCI, V94, P89, DOI 10.1097/OPX.0000000000000938; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	45	12	12	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2018	35	10					1178	1184		10.1089/neu.2017.5340			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GF8DL	WOS:000432198500009	29336197	Green Published			2022-02-06	
J	Rowland, JA; Stapleton-Kotloski, JR; Dobbins, DL; Rogers, E; Godwin, DW; Taber, KH				Rowland, Jared A.; Stapleton-Kotloski, Jennifer R.; Dobbins, Dorothy L.; Rogers, Emily; Godwin, Dwayne W.; Taber, Katherine H.			Increased Small-World Network Topology Following Deployment-Acquired Traumatic Brain Injury Associated with the Development of Post-Traumatic Stress Disorder	BRAIN CONNECTIVITY			English	Article						graph theory; magnetoencephalography; post-traumatic stress disorder; risk factor; traumatic brain injury	PERSISTENT POSTCONCUSSIVE SYMPTOMS; FUNCTIONAL CONNECTIVITY; AFGHANISTAN; RESILIENCE; VETERANS; RISK; IRAQ	Cross-sectional and longitudinal studies in active duty and veteran cohorts have both demonstrated that deployment-acquired traumatic brain injury (TBI) is an independent risk factor for developing post-traumatic stress disorder (PTSD), beyond confounds such as combat exposure, physical injury, predeployment TBI, and pre-deployment psychiatric symptoms. This study investigated how resting-state brain networks differ between individuals who developed PTSD and those who did not following deployment-acquired TBI. Participants included postdeployment veterans with deployment-acquired TBI history both with and without current PTSD diagnosis. Graph metrics, including small-worldness, clustering coefficient, and modularity, were calculated from individually constructed whole-brain networks based on 5-min eyes-open resting-state magnetoencephalography (MEG) recordings. Analyses were adjusted for age and premorbid IQ. Results demonstrated that participants with current PTSD displayed higher levels of small-worldness, F(1,12) = 5.364, p < 0.039, partial eta squared = 0.309, and Cohen's d = 0.972, and clustering coefficient, F(1, 12) = 12.204, p < 0.004, partial eta squared = 0.504, and Cohen's d = 0.905, than participants without current PTSD. There were no between-group differences in modularity or the number of modules present. These findings are consistent with a hyperconnectivity hypothesis of the effect of TBI history on functional networks rather than a disconnection hypothesis, demonstrating increased levels of clustering coefficient rather than a decrease as might be expected; however, these results do not account for potential changes in brain structure. These results demonstrate the potential pathological sequelae of changes in functional brain networks following deployment-acquired TBI and represent potential neurobiological changes associated with deployment-acquired TBI that may increase the risk of subsequently developing PTSD.	[Rowland, Jared A.; Stapleton-Kotloski, Jennifer R.; Taber, Katherine H.] WG Bill Hefner VA Med Ctr, Res & Acad Affairs Serv Line, Salisbury, NC USA; [Rowland, Jared A.; Taber, Katherine H.] Mid Atlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Rowland, Jared A.; Dobbins, Dorothy L.; Rogers, Emily; Godwin, Dwayne W.] Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC USA; [Rowland, Jared A.] Wake Forest Sch Med, Dept Psychiat & Behav Med, Winston Salem, NC USA; [Stapleton-Kotloski, Jennifer R.; Rogers, Emily] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC USA; [Taber, Katherine H.] Edward Via Coll Osteopath Med, Div Biomed Sci, Blacksburg, VA USA; [Taber, Katherine H.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA		Rowland, JA (corresponding author), WG Bill Hefner VAMC, Res & Acad Affairs Serv Line 11M, 1601 Brenner Ave, Salisbury, NC 28144 USA.	jared.rowland@va.gov	Taber, Katherine H/B-8260-2011; Stapleton-Kotloski, Jennifer/AAG-3967-2021; Rowland, Jared A./AAN-3030-2021	Taber, Katherine H/0000-0001-7382-6151; Rowland, Jared A./0000-0002-3655-3411; Dobbins, Dorothy/0000-0001-9903-5833	U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); U.S. Department of Veterans Affairs [Chronic Effects of Neurotrauma Consortium]US Department of Veterans Affairs [W81XWH-13-2-0095, 1 I01 RX002172-01, R01AA016852, AA026117]; W.G. "Bill" Hefner Veterans Affairs Medical Center; Mid-AtlanticMental Illness Research Education and Clinical Center (MIRECC); Wake Forest School of Medicine Department of Neurology; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA016852] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX002172] Funding Source: NIH RePORTER	This material is based upon work supported by the U.S. Army Medical Research and Material Command and from the U.S. Department of Veterans Affairs [Chronic Effects of Neurotrauma Consortium] under Award Nos. W81XWH-13-2-0095 and 1 I01 RX002172-01, R01AA016852 (to DWG), AA026117 (to DWG and JAR), as well as the resources of the W.G. "Bill" Hefner Veterans Affairs Medical Center, the Mid-AtlanticMental Illness Research Education and Clinical Center (MIRECC), and the Wake Forest School of Medicine Department of Neurology.	Alhourani A, 2016, J NEUROPHYSIOL, V116, P1840, DOI 10.1152/jn.00513.2016; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Davenport ND, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00085; First M.B., 1996, STRUCTURED CLIN INTE; Glenn DE, 2017, DEPRESS ANXIETY, V34, P723, DOI 10.1002/da.22642; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; James LM, 2013, JAMA PSYCHIAT, V70, P410, DOI 10.1001/jamapsychiatry.2013.878; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; PRICHARD D, 1994, PHYS REV LETT, V73, P951, DOI 10.1103/PhysRevLett.73.951; Robinson SE, 1998, BIOMAG 2000, P1; Rowland JA, 2017, BRAIN CONNECT, V7, P45, DOI 10.1089/brain.2015.0406; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; The Management of Concussion/mTBI Working Group, 2009, J REHABIL RES DEV, V46; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Vogt D., 2012, MANUAL DEPLOYMENT RI; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Wechsler D., 2009, ADV CLIN SOLUTIONS W; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	38	12	13	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2158-0014	2158-0022		BRAIN CONNECT	Brain Connect.	MAY	2018	8	4					205	211		10.1089/brain.2017.0556			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GP4VV	WOS:000440871400002	29634322	Green Published			2022-02-06	
J	Smith, ZZ; Benison, AM; Bercum, FM; Dudek, FE; Barth, DS				Smith, Zachariah Z.; Benison, Alexander M.; Bercum, Florencia M.; Dudek, F. Edward; Barth, Daniel S.			Progression of convulsive and nonconvulsive seizures during epileptogenesis after pilocarpine-induced status epilepticus	JOURNAL OF NEUROPHYSIOLOGY			English	Article						epilepsy; latent period; spike-wave discharge	TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; SPIKE-WAVE DISCHARGES; FLUID PERCUSSION INJURY; SPRAGUE-DAWLEY RATS; POSTTRAUMATIC EPILEPSY; INTERICTAL SPIKES; VIDEO-EEG; SUBCLINICAL SEIZURES; FUNCTIONAL-CHANGES	Although convulsive seizures occurring during pilocarpine-induced epileptogenesis have received considerable attention, nonconvulsive seizures have not been closely examined, even though they may reflect the earliest signs of epileptogenesis and potentially guide research on antiepileptogenic interventions. The definition of nonconvulsive seizures based on brain electrical activity alone has been controversial. Here we define and quantify electro-graphic properties of convulsive and nonconvulsive seizures in the context of the acquired epileptogenesis that occurs after pilocarpine-induced status epilepticus (SE). Lithium-pilocarpine was used to induce the prolonged repetitive seizures characteristic of SE; when SE was terminated with paraldehyde, seizures returned during the 2-day period after pilocarpine treatment. A distinct latent period ranging from several days to > 2 wk was then measured with continuous, long-term video-EEG. Nonconvulsive seizures dominated the onset of epileptogenesis and consistently preceded the first convulsive seizures but were still present later. Convulsive and nonconvulsive seizures had similar durations. Postictal depression (background suppression of the EEG) lasted for > 100 s after both convulsive and nonconvulsive seizures. Principal component analysis was used to quantify the spectral evolution of electrical activity that characterized both types of spontaneous recurrent seizures. These studies demonstrate that spontaneous nonconvulsive seizures have electrographic properties similar to convulsive seizures and confirm that nonconvulsive seizures link the latent period and the onset of convulsive seizures during post-SE epileptogenesis in an animal model. Nonconvulsive seizures may also reflect the earliest signs of epileptogenesis in human acquired epilepsy, when intervention could be most effective. NEW & NOTEWORTHY Nonconvulsive seizures usually represent the first bona fide seizure following a latent period, dominate the early stages of epileptogenesis, and change in severity in a manner consistent with the progressive nature of epileptogenesis. This analysis demonstrates that nonconvulsive and convulsive seizures have different behavioral outcomes but similar electrographic signatures. Alternatively. epileptiform spike-wave discharges fail to recapitulate several key seizure features and represent a category of electrical activity separate from nonconvulsive seizures in this model.	[Smith, Zachariah Z.; Benison, Alexander M.; Bercum, Florencia M.; Barth, Daniel S.] Univ Colorado, Dept Psychol & Neurosci, Campus Box 345, Boulder, CO 80309 USA; [Dudek, F. Edward] Univ Utah, Sch Med, Dept Neurosurg, Salt Lake City, UT USA		Barth, DS (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Campus Box 345, Boulder, CO 80309 USA.	daniel.barth@colorado.edu			U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [PR100040, EP150033]; Citizens United for Research in Epilepsy (CURE) [7153]	This work was supported by the U.S. Army Medical Research and Materiel Command (Grants PR100040 and EP150033) and by Citizens United for Research in Epilepsy (CURE) (Grant 7153).	Afra P, 2008, EPILEPSIA, V49, P677, DOI 10.1111/j.1528-1167.2007.01420.x; Alarcon G, 1996, SEIZURE-EUR J EPILEP, V5, P7, DOI 10.1016/S1059-1311(96)80014-8; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Avoli Massimo, 2006, Epilepsy Curr, V6, P203, DOI 10.1111/j.1535-7511.2006.00146.x; Avoli M, 2013, NEUROPHARMACOLOGY, V69, P37, DOI 10.1016/j.neuropharm.2012.06.044; BARTH DS, 1989, BRAIN RES, V484, P13, DOI 10.1016/0006-8993(89)90344-2; BERTRAM EH, 1994, BRAIN RES, V661, P157, DOI 10.1016/0006-8993(94)91192-4; Bower MR, 2017, EPILEPSIA, V58, P94, DOI 10.1111/epi.13614; Brandt C, 2015, NEUROBIOL DIS, V75, P78, DOI 10.1016/j.nbd.2014.12.015; Buckmaster PS, 1997, J COMP NEUROL, V385, P385; Chauviere L, 2012, ANN NEUROL, V71, P805, DOI 10.1002/ana.23549; Cook MJ, 2016, EPILEPSIA, V57, P359, DOI 10.1111/epi.13291; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 2010, EPILEPSY CURR, V10, P61, DOI 10.1111/j.1535-7511.2010.01358.x; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; DEVINSKY O, 1989, NEUROLOGY, V39, P527; Devinsky Orrin, 2008, Epilepsy Curr, V8, P31, DOI 10.1111/j.1535-7511.2008.00227.x; Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018; Dudek FE, 2010, EPILEPSY CURR, V10, P91, DOI 10.1111/j.1535-7511.2010.01368.x; Eastman CL, 2015, EXP NEUROL, V264, P150, DOI 10.1016/j.expneurol.2014.12.010; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Hamer HM, 2003, BRAIN, V126, P547, DOI 10.1093/brain/awg051; HEINEMANN U, 1992, EPILEPSY RES, P273; Huneau C, 2013, EPILEPSIA, V54, P2219, DOI 10.1111/epi.12406; Jenssen S, 2006, EPILEPSIA, V47, P1499, DOI 10.1111/j.1528-1167.2006.00622.x; Jin B, 2017, INT J NEUROSCI, V127, P651, DOI 10.1080/00207454.2016.1220946; Jung S, 2007, J NEUROSCI, V27, P13012, DOI 10.1523/JNEUROSCI.3605-07.2007; Kadam SD, 2010, J NEUROSCI, V30, P404, DOI 10.1523/JNEUROSCI.4093-09.2010; Karoly PJ, 2016, BRAIN, V139, P1066, DOI 10.1093/brain/aww019; Kelemen A, 2006, SEIZURE-EUR J EPILEP, V15, P49, DOI 10.1016/j.seizure.2005.10.007; Kelly KM, 2006, EXP NEUROL, V201, P495, DOI 10.1016/j.expneurol.2006.05.006; Kelly Kevin M, 2004, Epilepsy Curr, V4, P176, DOI 10.1111/j.1535-7597.2004.04503.x; Kelly KM, 2015, EPILEPSY RES, V117, P104, DOI 10.1016/j.eplepsyres.2015.09.009; Kharatishvili I, 2006, EPILEPSIA, V47, P81; Kim Daeyoung, 2011, J Epilepsy Res, V1, P57, DOI 10.14581/jer.11011; Kubova H, 2005, EPILEPSIA, V46, P38, DOI 10.1111/j.1528-1167.2005.01005.x; Levesque M, 2015, SEIZURE-EUR J EPILEP, V25, P18, DOI 10.1016/j.seizure.2014.11.008; Loscher W, 2015, EPILEPSY BEHAV, V52, P78, DOI 10.1016/j.yebeh.2015.08.037; LOTHMAN EW, 1992, EPILEPSY RES, P301; Mazzuferi M, 2012, EXP NEUROL, V238, P156, DOI 10.1016/j.expneurol.2012.08.022; MORRISETT RA, 1987, EXP NEUROL, V97, P193, DOI 10.1016/0014-4886(87)90293-7; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Pearce PS, 2014, EPILEPSY BEHAV, V32, P121, DOI 10.1016/j.yebeh.2014.01.004; Puttachary S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131705; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rakhade SN, 2011, EPILEPSIA, V52, P753, DOI 10.1111/j.1528-1167.2011.02992.x; Rodgers KM, 2015, J NEUROSCI, V35, P9194, DOI 10.1523/JNEUROSCI.0919-15.2015; Salami P, 2014, NEUROBIOL DIS, V67, P97, DOI 10.1016/j.nbd.2014.03.012; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Sloviter RS, 2013, NEUROPHARMACOLOGY, V69, P3, DOI 10.1016/j.neuropharm.2012.01.022; Staley KJ, 2011, NEUROSCI LETT, V497, P247, DOI 10.1016/j.neulet.2011.03.070; Taylor JA, 2017, J NEUROSCI, V37, P5861, DOI 10.1523/JNEUROSCI.3235-16.2017; THEODORE WH, 1994, NEUROLOGY, V44, P1403, DOI 10.1212/WNL.44.8.1403; THEODORE WH, 1983, NEUROLOGY, V33, P1115; Walker MC, 2002, BRAIN, V125, P1937, DOI 10.1093/brain/awf203; White A, 2010, EPILEPSIA, V51, P371, DOI 10.1111/j.1528-1167.2009.02339.x; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Williamson PD, 1998, EPILEPSIA, V39, P1182, DOI 10.1111/j.1528-1157.1998.tb01309.x; Zangaladze A, 2008, EPILEPSIA, V49, P2016, DOI 10.1111/j.1528-1167.2008.01672.x	61	12	12	0	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	MAY	2018	119	5					1818	1835		10.1152/jn.00721.2017			18	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	GP6HW	WOS:000440980300023	29442558	Bronze			2022-02-06	
J	Song, MJ; Nikoo, M; Choi, F; Schutz, CG; Jang, K; Krausz, RM				Song, Michael Jae; Nikoo, Mohammadali; Choi, Fiona; Schuetz, Christian G.; Jang, Kerry; Krausz, Reinhard Michael			Childhood Trauma and Lifetime Traumatic Brain Injury Among Individuals Who Are Homeless	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						childhood maltreatment; childhood trauma; cross-sectional study; homelessness; traumatic brain injury	ABUSE; PEOPLE; ADULTS; HEALTH; SYMPTOMS	Objectives: To study the association of childhood trauma and lifetime prevalence of traumatic brain injury (TBI) among individuals who are homeless. Design: Cross-sectional survey. Setting: Three cities in British Columbia, Canada. Participants: Five hundred individuals who are homeless and 19 years of age or older in 2009. Measurements: Traumatic brain injury was identified with National Survey of Homeless Assistance Providers and Clients (NSHAPC) and childhood trauma using the Childhood Trauma QuestionnaireShort Form (CTQ-SF). The relationship between childhood trauma and TBI was explored using multivariable logistic regression approach, adjusting for age, gender, any psychiatric diagnosis (anxiety disorder, mood disorder, psychosis), alcohol dependence, and substance dependence. The effect of number of childhood trauma types on TBI was also explored using multiple variables logistic regression approach adjusting for the same covariates. Results: The prevalence of TBI was 63.6% and childhood maltreatment was 87.7% among the sample population. During childhood of 487 participants included in the analysis, 57.7% experienced physical abuse, 62.8% physical neglect, 45.8% sexual abuse, 62.4% emotional abuse, and 55.2% emotional neglect. After adjustment, childhood trauma (adjusted odds ratio [aOR] = 2.26; 95% confidence interval [CI], 1.04-5.02), childhood physical abuse (aOR = 2.13; 95% CI, 1.19-3.87; n = 487), and childhood emotional abuse (aOR = 1.95; 95% CI, 1.09-3.51; n = 487) were significantly associated with history of TBI. After adjustment, having 4 different types of childhood trauma (aOR = 2.81; 95% CI, 1.11-7.31) was significantly associated with higher odds of reporting TBI history. Conclusions: Childhood trauma is significantly associated with lifetime prevalence of TBI in homeless populations in British Columbia, Canada, indicating an added level of vulnerability in this population. In addition, these findings suggest a potential role for childhood trauma prevention strategies and services mindful of the patients' history of trauma for this particularly vulnerable population.	[Song, Michael Jae; Krausz, Reinhard Michael] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Song, Michael Jae; Nikoo, Mohammadali; Choi, Fiona; Schuetz, Christian G.; Jang, Kerry; Krausz, Reinhard Michael] Univ British Columbia, Dept Psychiat, 430-5950 Univ Blvd,David Strangway Bldg, Vancouver, BC V6T 1Z3, Canada		Song, MJ (corresponding author), Univ British Columbia, Dept Psychiat, 430-5950 Univ Blvd,David Strangway Bldg, Vancouver, BC V6T 1Z3, Canada.	michaeljaesong@gmail.com			British Columbia Mental Health and Addiction Services (BCMHAS), a department within the Provincial Health Services Authority of British Columbia [20R 45028]	The British Columbia Health of the Homeless Survey (BCHOHS) was funded by the British Columbia Mental Health and Addiction Services (BCMHAS), a department within the Provincial Health Services Authority of British Columbia (grant number: 20R 45028). BCMHAS had no further role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Agorastos A, 2014, J PSYCHIATR RES, V58, P46, DOI 10.1016/j.jpsychires.2014.07.014; Andersen J, 2014, DISABIL REHABIL, V36, P2210, DOI 10.3109/09638288.2014.895870; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Billette J, 2011, STAT CANADA CAT, V82, P1; Burns E.E., 2010, J AGGRESSION MALTREA, V19, P801, DOI [10.1080/10926771.2010.522947, DOI 10.1080/10926771.2010.522947]; Burnstein DP, 1998, CHILDHOOD TRAUMA QUE; Burt M, 1999, HOMELESSNESS PROGRAM; Canadian Institute for Health Information, HEAD INJ CAN DEC CHA; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Hopper E., 2010, OPEN HLTH SERVICES P, V3, DOI [DOI 10.2174/1874924001003020080, 10.2174/1874924001003020080, DOI 10.2174/1874924001003010080]; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Krausz RM, 2013, SOC PSYCH PSYCH EPID, V48, P1235, DOI 10.1007/s00127-012-0649-8; Krausz RM, BRIT COLUMBIA HLTH H; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, P1986, DOI 10.2105/AJPH.2014.302087; MacMillan HL, 2001, AM J PSYCHIAT, V158, P1878, DOI 10.1176/appi.ajp.158.11.1878; Mar MY, 2014, VIOLENCE VICTIMS, V29, P999, DOI 10.1891/0886-6708.VV-D-13-00025; McKinlay A, 2017, DISABIL REHABIL, V39, P1296, DOI 10.1080/09638288.2016.1193905; McMillan TM, 2015, J NEUROTRAUM, V32, P116, DOI 10.1089/neu.2014.3387; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nikoo M, 2017, J HEAD TRAUMA REHAB, V32, pE19, DOI 10.1097/HTR.0000000000000262; Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x; Riggs S.A., 2010, J AGGRESS MALTREAT T, V19, P5, DOI [10.1080/10926770903475968, DOI 10.1080/10926770903475968]; Saddichha S, 2014, J CAN ACAD CHILD ADO, V23, P200; Sundin EC, 2015, SOC PSYCH PSYCH EPID, V50, P183, DOI 10.1007/s00127-014-0937-6; Thurman DJ, 2014, J CHILD NEUROL, V31, P1; To M, 2014, J HEAD TRAUMA REHAB, V30, P1; Topolovec-Vranic Jane, 2014, CMAJ Open, V2, pE69, DOI 10.9778/cmajo.20130046; Widom CS, 2008, CHILD ABUSE NEGLECT, V32, P785, DOI 10.1016/j.chiabu.2007.12.006	28	12	12	1	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2018	33	3					185	190		10.1097/HTR.0000000000000310			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ7HA	WOS:000435555500123	28520660				2022-02-06	
J	Sun, HT; Wang, HD; Diao, YF; Tu, Y; Li, XH; Zhao, WY; Ren, JB; Zhang, S				Sun, Hongtao; Wang, Hongda; Diao, Yunfeng; Tu, Yue; Li, Xiaohong; Zhao, Wanyong; Ren, Jibin; Zhang, Sai			Large retrospective study of artificial dura substitute in patients with traumatic brain injury undergo decompressive craniectomy	BRAIN AND BEHAVIOR			English	Article						artificial dura material; bovine-derived pericardium decompressive craniectomy; traumatic brain injury	MATER; PERICARDIUM; MULTICENTER; MANAGEMENT; SAFETY; RECONSTRUCTION; CRANIOPLASTY; INFLAMMATION; EFFICACY; DISEASES	Background: Decompressive craniectomy is widely used for treating patients with traumatic brain injury (TBI). Usually patients have dura mater defect due to surgery or injury itself. The defective area may left open or repaired by artificial dura substitutes. A variety of artificial dura substitutes have been used for this purpose. Objective: This study aimed to evaluate bovine-derived pericardium membrane as artificial dural material for patients with decompressive craniectomy. Methods: Totally 387 patients with severe TBI in our hospital were included in this study. Among them, 192 patients were treated with standard decompressive craniectomy without dura repair (control group). One hundred and ninety-five TBI patients were treated with dura repair by artificial dura materials (ADM). Nonlyophilized bovine pericardium membranes were used as artificial dura material. The postoperative complications were compared in both groups, including infection, seizure, and cerebrospinal fluid (CSF) leakage. Results: Patients in control group have higher complication rates than patients in ADM group, including subcutaneous hematoma (13.02% in control vs. 4.01% in ADM group, p=.004), infection (12.5% in control vs. 5.64% in ADM group, p=.021), CSF leakage (13.02% in control vs. 5.13% in ADM group, p=.012), and seizure (10.42% in control vs. 3.08% in ADM group, p=.007). Patients in ADM group are only associated with higher incidence of foreign body reaction (6 of 195 patients in ADM vs. none from control group). Conclusion: Bovine-derived pericardium membranes are successfully used as artificial dural substitutes for decompressive craniectomy. Patients with ADM have better clinical outcome than control group.	[Sun, Hongtao; Diao, Yunfeng; Zhao, Wanyong; Ren, Jibin] Logist Univ Peoples Armed Police Force, Affiliated Hosp, Brain Ctr, Dept Neurosurg 6, Tianjin, Peoples R China; [Wang, Hongda] Chongqing Med Univ, Div Clin Med, Chongqing, Peoples R China; [Tu, Yue; Li, Xiaohong; Zhang, Sai] Logist Univ Peoples Armed Police Force, Affiliated Hosp, Brain Ctr, Tianjin, Peoples R China		Zhang, S (corresponding author), Logist Univ Peoples Armed Police Force, Affiliated Hosp, Brain Ctr, Dept Neurosurg 6, Tianjin, Peoples R China.	zhangsai718@vip.126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [814712751004949]; Tianjin Science and Technology Plan Project [17YFZCSY00620]	National Natural Science Foundation of China, Grant/Award Number: 814712751004949; Tianjin Science and Technology Plan Project, Grant/Award Number: 17YFZCSY00620	Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Bai WS, 2013, J MATER SCI-MATER M, V24, P2247, DOI 10.1007/s10856-013-4964-8; Bejjani GK, 2007, J NEUROSURG, V106, P1028, DOI 10.3171/jns.2007.106.6.1028; Bonda DJ, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.5.FOCUS15126; Burkert W, 1988, Zentralbl Neurochir, V49, P318; Burkert W, 1989, Zentralbl Neurochir, V50, P106; Centonze Roberto, 2016, Asian J Neurosurg, V11, P201, DOI 10.4103/1793-5482.179645; Cho Yong Jun, 2017, Korean J Neurotrauma, V13, P9, DOI 10.13004/kjnt.2017.13.1.9; Citerio G, 2007, INTENS CARE MED, V33, P45, DOI 10.1007/s00134-006-0381-5; Compagnone C, 2005, NEUROSURGERY, V57, P1183; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2011, J NEUROTRAUM, V28, P2043, DOI 10.1089/neu.2011.1889; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; El Majdoub F, 2009, ACTA NEUROCHIR, V151, P833, DOI 10.1007/s00701-009-0207-7; Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014; Griessenauer CJ, 2015, WORLD NEUROSURG, V84, P2059, DOI 10.1016/j.wneu.2015.08.009; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hieu PD, 1996, CHILD NERV SYST, V12, P270; Ho KM, 2011, J TRAUMA, V71, P1637, DOI 10.1097/TA.0b013e31823a08f1; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Huang YH, 2011, J TRAUMA, V71, P533, DOI 10.1097/TA.0b013e318203208a; Jaeger M, 2003, J NEUROL NEUROSUR PS, V74, P513, DOI 10.1136/jnnp.74.4.513; Jito J, 2014, NEUROL MED-CHIR, V54, P634, DOI 10.2176/nmc.cr2013-0010; Kim DW, 2011, J NEUROSURG, V114, P485, DOI 10.3171/2010.9.JNS091764; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Matsumoto Y, 2013, NEUROL MED-CHIR, V53, P43, DOI 10.2176/nmc.53.43; Mtaweh H, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-015-0348-3; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Mundinger GS, 2016, J CRANIOFAC SURG, V27, P1971, DOI 10.1097/SCS.0000000000003043; Norrby E, 2011, J INTERN MED, V270, P1, DOI 10.1111/j.1365-2796.2011.02387.x; ONGKIKO CM, 1984, J NEUROSURG, V60, P1076, DOI 10.3171/jns.1984.60.5.1076; Osbun JW, 2012, WORLD NEUROSURG, V78, P498, DOI 10.1016/j.wneu.2011.12.011; Parizek J, 1996, J NEUROSURG, V84, P508, DOI 10.3171/jns.1996.84.3.0508; PARIZEK J, 1989, J NEUROSURG, V70, P905, DOI 10.3171/jns.1989.70.6.0905; Pettorini BL, 2010, BRIT J NEUROSURG, V24, P51, DOI 10.3109/02688690903386991; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shi ZD, 2009, BRIT J NEUROSURG, V23, P71, DOI 10.1080/02688690802582638; Sturiale CL, 2012, J NEUROTRAUM, V29, P2723, DOI 10.1089/neu.2012.2556; Suwanprateeb J, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-016-5736-z; Than KD, 2008, NEUROSURGERY, V63, P182, DOI 10.1227/01.NEU.0000313116.28200.67; Wang F, 2015, INDIAN J SURG, V77, pS1008, DOI 10.1007/s12262-014-1111-9; Wang H, 2013, CHINESE MED J-PEKING, V126, P3329, DOI 10.3760/cma.j.issn.0366-6999.20130618; Wang R, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001733; Yamada K, 2002, J NEUROSURG, V96, P731, DOI 10.3171/jns.2002.96.4.0731; Yamagata Sen, 1993, Neurologia Medico-Chirurgica, V33, P582, DOI 10.2176/nmc.33.582; Zhang DF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08959-y; Zhang GL, 2010, CHIN J TRAUMATOL, V13, P259, DOI 10.3760/cma.j.issn.1008-1275.2010.05.001	49	12	14	3	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	MAY	2018	8	5							e00907	10.1002/brb3.907			7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	GF4YN	WOS:000431970500001	29761002	Green Published, gold			2022-02-06	
J	Naidu, D; Borza, C; Kobitowich, T; Mrazik, M				Naidu, Dhiren; Borza, Carley; Kobitowich, Tara; Mrazik, Martin			Sideline Concussion Assessment: The King-Devick Test in Canadian Professional Football	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; eye movements; sideline assessment; sport concussion	SCREENING TOOL; ASSOCIATIONS; BALANCE; VISION	Sideline assessment tools are an important component of concussion evaluations. To date, there has been little data evaluating the clinical utility of these tests in professional football. The purpose of this study was to evaluate the clinical utility of the King-Devick (K-D) test in evaluating concussions in professional football players. Baseline data was collected over two consecutive seasons in the Canadian Football League as part of a comprehensive medical baseline evaluation. A pilot study with the K-D test began in 2015 with 306 participants and the next year (2016) there were 917 participants. In addition, a sample of 64 participants completed testing after physical exertion (practice or game). Participants with concussion demonstrated significantly higher (slower) results compared with baseline and the exercise group (F[2,211]=5.94; p=0.003). The data revealed a specificity of 84% and sensitivity of 62% for our sample. Reliability from season to season was good (intraclass correlation coefficient [ICC] 2,1=0.88; 95% confidence interval [CI]: 0.83, 0.91). On average, participants improved performances by a mean of 1.9sec (range, -26.6 to 23.8) in subsequent years. High reliability was attained in the exercise group. (ICC2,1=0.93; 95% CI: 0.89, 0.96). The K-D test presents as a reliable measure although sensitivity and specificity data from our sample indicate it should be used in conjunction with other measures for diagnosing concussion. Further research is required to identify stability of results over multiple usages.	[Naidu, Dhiren] Univ Alberta, Fac Dent & Med, Edmonton, AB, Canada; [Borza, Carley; Kobitowich, Tara; Mrazik, Martin] Univ Alberta, Dept Educ Psychol, 6-135 Educ North 11210-87 Ave, Edmonton, AB T6G 2G6, Canada		Mrazik, M (corresponding author), Univ Alberta, Dept Educ Psychol, 6-135 Educ North 11210-87 Ave, Edmonton, AB T6G 2G6, Canada.	mrazik@ualberta.ca			Football Operations; Canadian Football League; Pat Clayton Athletic Therapist Consultant; National Football League's Head, Neck, and Spine Committee; CFL Health and Safety Advisory Board	We would like to thank Kevin McDonald, Vice President of Football Operations, Canadian Football League, Pat Clayton Athletic Therapist Consultant, the National Football League's Head, Neck, and Spine Committee, and CFL Health and Safety Advisory Board for support and funding of this project.	Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Bruce JM, 2017, CLIN NEUROPSYCHOL, V31, P1329, DOI 10.1080/13854046.2017.1311375; Dhawan P., 2014, NEUROLOGY, V82, P11; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta K. M., 2015, CONCUSSION, V2; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Howitt Scott, 2016, J Can Chiropr Assoc, V60, P322; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; MacDonald JP, 2016, MED SCI SPORT EXER, V48, P627, DOI 10.1249/01.mss.0000486882.92607.c1; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Seidman DH, 2015, J NEUROL SCI, V356, P97, DOI 10.1016/j.jns.2015.06.021; Silverberg ND, 2014, BRAIN INJURY, V28, P1590, DOI 10.3109/02699052.2014.943287	17	12	12	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	19					2283	2286		10.1089/neu.2017.5490		APR 2018	4	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GV3OA	WOS:000431243300001	29421971				2022-02-06	
J	Posti, JP; Yli-Olli, M; Heiskanen, L; Aitasalo, KMJ; Rinne, J; Vuorinen, V; Serlo, W; Tenovuo, O; Vallittu, PK; Piitulainen, JM				Posti, Jussi P.; Yli-Olli, Matias; Heiskanen, Lauri; Aitasalo, Kalle M. J.; Rinne, Jaakko; Vuorinen, Ville; Serlo, Willy; Tenovuo, Olli; Vallittu, Pekka K.; Piitulainen, Jaakko M.			Cranioplasty After Severe Traumatic Brain Injury: Effects of Trauma and Patient Recovery on Cranioplasty Outcome	FRONTIERS IN NEUROLOGY			English	Article						cranioplasty; decompressive craniectomy; imaging; outcome; severe traumatic brain injury	REINFORCED COMPOSITE IMPLANT; DECOMPRESSIVE CRANIECTOMY; PROGNOSTIC VALUE; IMPACT; SCALE; RECONSTRUCTION; PERFUSION; COMA	Background: In patients with severe traumatic brain injury (sTBI) treated with decompressive craniectomy (DC), factors affecting the success of later cranioplasty are poorly known. Objective: We sought to investigate if injury- and treatment-related factors, and state of recovery could predict the risk of major complications in cranioplasty requiring implant removal, and how these complications affect the outcome. Methods: A retrospective cohort of 40 patients with DC following sTBI and subsequent cranioplasty was studied. Non-injury-related factors were compared with a reference population of 115 patients with DC due to other conditions. Results: Outcome assessed 1 day before cranioplasty did not predict major complications leading to implant removal. Successful cranioplasty was associated with better outcome, whereas a major complication attenuates patient recovery: in patients with favorable outcome assessed 1 year after cranioplasty, major complication rate was 7%, while in patients with unfavorable outcome the rate was 42% (p = 0.003). Of patients with traumatic subarachnoid hemorrhage (tSAH) on admission imaging 30% developed a major complication, while none of patients without tSAH had a major complication (p = 0.014). Other imaging findings, age, admission Glasgow Coma Scale, extracranial injuries, length of stay at intensive care unit, cranioplasty materials, and timing of cranioplasty were not associated with major complications. Conclusion: A successful cranioplasty after sTBI and DC predicts favorable outcome 1 year after cranioplasty, while stage of recovery before cranioplasty does not predict cranioplasty success or failure. tSAH on admission imaging is a major risk factor for a major complication leading to implant removal.	[Posti, Jussi P.; Yli-Olli, Matias; Heiskanen, Lauri; Rinne, Jaakko; Vuorinen, Ville] Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, Turku, Finland; [Posti, Jussi P.; Yli-Olli, Matias; Heiskanen, Lauri; Tenovuo, Olli] Turku Univ Hosp, Turku Brain Injury Ctr, Div Clin Neurosci, Turku, Finland; [Posti, Jussi P.; Yli-Olli, Matias; Heiskanen, Lauri; Rinne, Jaakko; Vuorinen, Ville; Tenovuo, Olli] Univ Turku, Dept Neurol, Turku, Finland; [Posti, Jussi P.; Yli-Olli, Matias; Aitasalo, Kalle M. J.; Vallittu, Pekka K.; Piitulainen, Jaakko M.] Univ Turku, Inst Dent, Dept Biomat Sci, Turku, Finland; [Posti, Jussi P.; Yli-Olli, Matias; Aitasalo, Kalle M. J.; Vallittu, Pekka K.; Piitulainen, Jaakko M.] Univ Turku, Inst Dent, TCBC, Turku, Finland; [Aitasalo, Kalle M. J.; Piitulainen, Jaakko M.] Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Div Surg & Canc Dis, Turku, Finland; [Serlo, Willy] Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland; [Serlo, Willy] Oulu Univ, PEDEGO Res Ctr, MRC Oulu, Oulu, Finland; [Vallittu, Pekka K.] City Turku Welf Div, Turku, Finland		Posti, JP (corresponding author), Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, Turku, Finland.; Posti, JP (corresponding author), Turku Univ Hosp, Turku Brain Injury Ctr, Div Clin Neurosci, Turku, Finland.; Posti, JP (corresponding author), Univ Turku, Dept Neurol, Turku, Finland.; Posti, JP (corresponding author), Univ Turku, Inst Dent, Dept Biomat Sci, Turku, Finland.; Posti, JP (corresponding author), Univ Turku, Inst Dent, TCBC, Turku, Finland.	jussi.posti@utu.fi	Posti, Jussi P./Y-2908-2019	Posti, Jussi P./0000-0002-5925-5193; Piitulainen, Jaakko/0000-0001-9788-8904	Government's Special Financial Transfer tied to academic research in Health Sciences (Finland); Emil Aaltonen Foundation; Finnish Brain Foundation	JPP is financially supported by Government's Special Financial Transfer tied to academic research in Health Sciences (Finland), Emil Aaltonen Foundation, and Finnish Brain Foundation.	Aitasalo KMJ, 2014, HEAD NECK-J SCI SPEC, V36, P722, DOI 10.1002/hed.23370; Ashayeri K, 2016, NEUROSURGERY, V79, P525, DOI 10.1227/NEU.0000000000001366; Bijlenga P, 2007, J NEUROL NEUROSUR PS, V78, P430, DOI 10.1136/jnnp.2006.099242; De Bonis P, 2012, J NEUROTRAUM, V29, P1071, DOI 10.1089/neu.2011.2116; Di Stefano C, 2016, BRAIN INJURY, V30, P164, DOI 10.3109/02699052.2015.1090013; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Picard NA, 2013, ACTA NEUROCHIR, V155, P2149, DOI 10.1007/s00701-013-1838-2; Piitulainen JM, 2015, WORLD NEUROSURG, V83, P708, DOI 10.1016/j.wneu.2015.01.014; Piitulainen JM, 2015, ACTA NEUROCHIR, V157, P681, DOI 10.1007/s00701-015-2363-2; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Schwarz F, 2016, J NEUROSURG, V124, P710, DOI 10.3171/2015.4.JNS159; Shahid AH, 2018, J NEUROSURG, V128, P229, DOI 10.3171/2016.10.JNS16678; Sorensen LT, 2003, ANN SURG, V238, P1, DOI 10.1097/01.SLA.0000074980.39700.31; Stiver SI, 2008, J NEUROSURG, V109, P245, DOI 10.3171/JNS/2008/109/8/0245; TEASDALE G, 1974, LANCET, V2, P81; Timofeev I, 1800, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zanaty Mario, 2014, ScientificWorldJournal, V2014, P356042, DOI 10.1155/2014/356042	23	12	12	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 9	2018	9								223	10.3389/fneur.2018.00223			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GC0NZ	WOS:000429475500001	29695995	Green Published, gold			2022-02-06	
J	Zeiler, FA; Smielewski, P; Donnelly, J; Czosnyka, M; Menon, DK; Ercole, A				Zeiler, Frederick A.; Smielewski, Peter; Donnelly, Joseph; Czosnyka, Marek; Menon, David K.; Ercole, Ari			Estimating Pressure Reactivity Using Noninvasive Doppler-Based Systolic Flow Index	JOURNAL OF NEUROTRAUMA			English	Article						autocorrelation; mixed effects modeling; PRx; pressure reactivity index	TRAUMATIC BRAIN-INJURY; CEREBROVASCULAR REACTIVITY; AUTOREGULATION	The study objective was to derive models that estimate the pressure reactivity index (PRx) using the noninvasive transcranial Doppler (TCD) based systolic flow index (Sx_a) and mean flow index (Mx_a), both based on mean arterial pressure, in traumatic brain injury (TBI). Using a retrospective database of 347 patients with TBI with intracranial pressure and TCD time series recordings, we derived PRx, Sx_a, and Mx_a. We first derived the autocorrelative structure of PRx based on: (A) autoregressive integrative moving average (ARIMA) modeling in representative patients, and (B) within sequential linear mixed effects (LME) models with various embedded ARIMA error structures for PRx for the entire population. Finally, we performed sequential LME models with embedded PRx ARIMA modeling to find the best model for estimating PRx using Sx_a and Mx_a. Model adequacy was assessed via normally distributed residual density. Model superiority was assessed via Akaike Information Criterion (AIC), Bayesian Information Criterion (BIC), log likelihood (LL), and analysis of variance testing between models. The most appropriate ARIMA structure for PRx in this population was (2,0,2). This was applied in sequential LME modeling. Two models were superior (employing random effects in the independent variables and intercept): (A) PRx approximate to Sx_a, and (B) PRx approximate to Sx_a + Mx_a. Correlation between observed and estimated PRx with these two models was: (A) 0.794 (p<0.0001, 95% confidence interval (CI)=0.788-0.799), and (B) 0.814 (p<0.0001, 95% CI=0.809-0.819), with acceptable agreement on Bland-Altman analysis. Through using linear mixed effects modeling and accounting for the ARIMA structure of PRx, one can estimate PRx using noninvasive TCD-based indices. We have described our first attempts at such modeling and PRx estimation, establishing the strong link between two aspects of cerebral autoregulation: measures of cerebral blood flow and those of pulsatile cerebral blood volume. Further work is required to validate.	[Zeiler, Frederick A.; Menon, David K.; Ercole, Ari] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada; [Smielewski, Peter; Donnelly, Joseph; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Brain Phys Lab, Cambridge, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada.	umzeiler@myumanitoba.ca	Donnelly, Joseph/E-9235-2018; Donnelly, Joseph/N-6803-2019; Ercole, Ari/B-6288-2009	Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; Ercole, Ari/0000-0001-8350-8093; czosnyka, marek/0000-0003-2446-8006; Zeiler, Frederick/0000-0003-1737-0510	Cambridge Commonwealth Trust Scholarship; Royal College of Surgeons of Canada - Harry S. Morton Travelling Fellowship in Surgery; University of Manitoba Clinician Investigator Program; R. Samuel McLaughlin Research and Education Award; Manitoba Medical Service Foundation; University of Manitoba Faculty of Medicine Dean's Fellowship Fund; National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre, an NIHR Senior Investigator Award; European Union (CENTER-TBI) [602150]; Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI17C1790]; Woolf Fisher Scholarship; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090] Funding Source: researchfish	This work was made possible through salary support through the Cambridge Commonwealth Trust Scholarship, the Royal College of Surgeons of Canada - Harry S. Morton Travelling Fellowship in Surgery, the University of Manitoba Clinician Investigator Program, R. Samuel McLaughlin Research and Education Award, the Manitoba Medical Service Foundation, and the University of Manitoba Faculty of Medicine Dean's Fellowship Fund.; These studies were supported by National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre, an NIHR Senior Investigator Award to DKM. Authors were also supported by a European Union Framework Program 7 grant (CENTER-TBI; Grant Agreement No. 602150); MC is supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number : HI17C1790).; JD is supported by a Woolf Fisher Scholarship (NZ).	Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Budohoski KP, 2012, NEUROCRIT CARE, V17, P211, DOI 10.1007/s12028-011-9572-1; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chatfield C., 2004, ANAL TIME SERIES; Crawley MJ, 2013, R BOOK, V2; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Donnelly J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1293-6; Douc R., 2017, NONLINEAR TIME SERIE; Le Roux P, 2014, NEUROCRIT CARE, V21, P1, DOI 10.1007/s12028-014-0041-5; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Zeiler F.A., 2017, NEUROCRIT CARE; Zeiler FA, 2018, J NEUROTRAUM, V35, P314, DOI 10.1089/neu.2017.5364; Zeiler FA, 2017, J NEUROTRAUM, V34, P3224, DOI 10.1089/neu.2017.5086; Zeiler FA, 2017, J NEUROTRAUM, V34, P3070, DOI 10.1089/neu.2017.5129; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388	18	12	12	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2018	35	14					1559	1568		10.1089/neu.2017.5596		APR 2018	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GK9FP	WOS:000429345200001	29397783	Green Submitted			2022-02-06	
J	Chang, R; Fox, EE; Greene, TJ; Swartz, MD; DeSantis, SM; Stein, DM; Bulger, EM; Melton, SM; Goodman, MD; Schreiber, MA; Zielinski, MD; O'Keeffe, T; Inaba, K; Tomasek, JS; Podbielski, JM; Appana, S; Yi, MS; Johansson, PI; Henriksen, HH; Stensballe, J; Steinmetz, J; Wade, CE; Holcomb, JB				Chang, Ronald; Fox, Erin E.; Greene, Thomas J.; Swartz, Michael D.; DeSantis, Stacia M.; Stein, Deborah M.; Bulger, Eileen M.; Melton, Sherry M.; Goodman, Michael D.; Schreiber, Martin A.; Zielinski, Martin D.; O'Keeffe, Terence; Inaba, Kenji; Tomasek, Jeffrey S.; Podbielski, Jeanette M.; Appana, Savitri; Yi, Misung; Johansson, Par I.; Henriksen, Hanne H.; Stensballe, Jakob; Steinmetz, Jacob; Wade, Charles E.; Holcomb, John B.		PROHS Study Grp	Abnormalities of laboratory coagulation tests versus clinically evident coagulopathic bleeding: results from the prehospital resuscitation on helicopters study (PROHS)	SURGERY			English	Article; Proceedings Paper	Association-for-Academic-Surgery/Society-of-University-Surgeons 12th Annual Meeting of the Academic-Surgical-Congress (ASC)	FEB 07-09, 2017	Las Vegas, NV	Acad Surg Congress, Assoc Acad Surg, Soc Univ Surg			TRAUMATIC BRAIN-INJURY; THROMBIN GENERATION; MASSIVE TRANSFUSION; HEMORRHAGIC-SHOCK; CLOT FORMATION; FIBRINOGEN; ADMISSION; PLASMA; MODEL; DYSFUNCTION	Background. Laboratory-based evidence of coagulopathy (LC) is observed in 25-35% of trauma patients, but clinically-evident coagulopathy (CC) is not well described. Methods. Prospective observational study of adult trauma patients transported by helicopter from the scene to nine Level 1 trauma centers in 2015. Patients meeting predefined highest-risk criteria were divided into CC+ (predefined as surgeon-confirmed bleeding from uninjured sites or injured sites not controllable by sutures) or CC-. We used a mixed-effects, Poisson regression with robust error variance to test the hypothesis that abnormalities on rapid thrombelastography (r-TEG) and international normalized ratio (INR) were independently associated with CC+. Results. Of 1,019 highest-risk patients, CC+ (n=41, 4%) were more severely injured (median 155 32 vs 17), had evidence of LC on r-TEG and INR, received more transfused blood products at 4 hours (37 vs 0 units), and had greater 30-day mortality (59% vs 12%) than CC- (n=978, 96%). The overall incidence of LC was 39%. 30-day mortality was 22% vs 9% in those with and without LC. In two separate models, r-TEG K-time >2.5 min (RR 13, 95% CI 1.1-1.7), r-TEG mA <55 mm (RR 2.5, 95% CI 2.0-3.2), platelet count <150 x 10(9)/L (RR 1.2, 95% CI 1.1-13), and INR >1.5 (RR 5.4, 95% CI 1.8-163) were independently associated with CC+. A combined regression model was not generated because too few patients underwent both r-TEG and INR. Conclusion. CC was rare compared to LC. CC was associated with poor outcomes and impairment of both clotting factor and platelet-mediated coagulation components. (C) 2017 Elsevier Inc. All rights reserved.	[Chang, Ronald; Fox, Erin E.; Swartz, Michael D.; Tomasek, Jeffrey S.; Podbielski, Jeanette M.; Johansson, Par I.; Henriksen, Hanne H.; Wade, Charles E.; Holcomb, John B.] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, Houston, TX 77030 USA; [Chang, Ronald; Wade, Charles E.; Holcomb, John B.] McGovern Med Sch, Dept Surg, Houston, TX USA; [Greene, Thomas J.; Swartz, Michael D.; DeSantis, Stacia M.; Appana, Savitri; Yi, Misung] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat, Houston, TX 77030 USA; [Stein, Deborah M.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Bulger, Eileen M.] Univ Washington, Sch Med, Dept Surg, Seattle, WA 98195 USA; [Melton, Sherry M.] New York Hlth & Hosp, Dept Surg, New York, NY USA; [Goodman, Michael D.] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH USA; [Schreiber, Martin A.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA; [Zielinski, Martin D.] Mayo Clin, Dept Surg, Rochester, MN USA; [O'Keeffe, Terence] Univ Arizona Hlth Sci, Dept Surg, Tucson, AZ USA; [Inaba, Kenji] Univ Southern Calif, Sch Med, Dept Surg, Los Angeles, CA USA; [Johansson, Par I.; Henriksen, Hanne H.; Stensballe, Jakob] Copenhagen Univ Hosp, Rigshosp, Capital Reg Blood Bank, Sect Transfus Med, Copenhagen, Denmark; [Stensballe, Jakob; Steinmetz, Jacob] Copenhagen Univ Hosp, Rigshosp, Ctr Head & Orthoped, Dept Anesthesia, Copenhagen, Denmark; [Steinmetz, Jacob] Helicopter Emergency Med Serv, Copenhagen, Denmark		Chang, R (corresponding author), 6410 Fannin St,Suite 1100, Houston, TX 77030 USA.	ronald.chang@uth.tmc.edu	Steinmetz, Jacob/AAY-6076-2020; Wong, Monica D/D-9016-2017; INABA, KENJI/AAC-8532-2020	Steinmetz, Jacob/0000-0001-9620-8911; Wong, Monica D/0000-0001-7041-9518; Greene, Thomas/0000-0002-5108-713X; McMullan, Jason/0000-0002-7656-7447; Johansson, Par Ingemar/0000-0001-9778-5964; Hee Henriksen, Hanne/0000-0003-1323-9718; Herrera, Anthony/0000-0001-5345-1241; Stein, Deborah/0000-0003-3683-3963; holcomb, john/0000-0001-8312-9157; chang, ronald/0000-0002-8947-0054; Swartz, Michael/0000-0003-3953-8775	U.S. National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL077863]; US Department of DefenseUnited States Department of Defense; T32 fellowship from the National Institute of General Medical Sciences [5T32GM008792]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL077863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008792] Funding Source: NIH RePORTER	The Prehospital Resuscitation on Helicopter Study (PROHS) was sponsored by the U.S. National Heart, Lung, and Blood Institute (U01HL077863) and the US Department of Defense. R.C. is supported by a T32 fellowship (grant no. 5T32GM008792) from the National Institute of General Medical Sciences (5T32GM008792). The opinions or conclusions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of any sponsor.	Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brown LM, 2011, J TRAUMA, V71, pS337, DOI 10.1097/TA.0b013e318227f67c; Cannon JW, 2017, J TRAUMA ACUTE CARE, V82, P605, DOI 10.1097/TA.0000000000001333; Cardenas JC, 2014, J TRAUMA ACUTE CARE, V77, P839, DOI 10.1097/TA.0000000000000348; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Chambers LA, 2011, AM J CLIN PATHOL, V136, P364, DOI 10.1309/AJCPH16YXJEFSHEO; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Chapman MP, 2016, J TRAUMA ACUTE CARE, V80, P16, DOI 10.1097/TA.0000000000000885; Cotton BA, 2012, J TRAUMA ACUTE CARE, V73, P365, DOI 10.1097/TA.0b013e31825c1234; Davenport R, 2013, CRIT CARE, V17, DOI 10.1186/cc13021; Galvagno SM, 2017, J TRAUMA ACUTE CARE, V83, P668, DOI 10.1097/TA.0000000000001584; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Jeger V, 2012, SCI WORLD J, DOI 10.1100/2012/821794; Johansson PI, 2014, BLOOD, V124, P3052, DOI 10.1182/blood-2014-05-575340; Johansson PI, 2012, CURR OPIN ANESTHESIO, V25, P235, DOI 10.1097/ACO.0b013e32834fab76; Kawasaki J, 2004, ANESTH ANALG, V99, P1440, DOI 10.1213/01.ANE.0000134805.30532.59; Kornblith LZ, 2014, J TRAUMA ACUTE CARE, V76, P255, DOI 10.1097/TA.0000000000000108; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Maegele M, 2015, J TRAUMA ACUTE CARE, V78, pS76, DOI 10.1097/TA.0000000000000632; Nascimento B, 2016, BRIT J ANAESTH, V117, P775, DOI 10.1093/bja/aew343; National Vital Statistics System National Center for Health Statistics Centers for Disease Control and Prevention, 2013, 10 LEAD CAUS DEATH A; Neal MD, 2015, J TRAUMA ACUTE CARE, V79, P490, DOI 10.1097/TA.0000000000000793; Niles SE, 2008, J TRAUMA, V64, P1459, DOI 10.1097/TA.0b013e318174e8bc; Ostrowski SR, 2012, J TRAUMA ACUTE CARE, V73, P60, DOI 10.1097/TA.0b013e31825b5c10; Rivard GE, 2005, J THROMB HAEMOST, V3, P2039, DOI 10.1111/j.1538-7836.2005.01513.x; SHEN L, 1983, J CLIN INVEST, V71, P1336, DOI 10.1172/JCI110885; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; SIMMONS RL, 1969, ANN SURG, V169, P455, DOI 10.1097/00000658-196904000-00001; Steinmetz J, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1439-5; Tian Y, 2015, BLOOD, V125, P2151, DOI 10.1182/blood-2014-09-598805; Wade CE, 2016, BURNS, V42, P1704, DOI 10.1016/j.burns.2016.05.001; Wolberg AS, 2008, TRANSFUS APHER SCI, V38, P15, DOI 10.1016/j.transci.2007.12.005; Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183	36	12	12	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	APR	2018	163	4					819	826		10.1016/j.surg.2017.10.050			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	GB3QE	WOS:000428971700029	29289392	Green Accepted, Green Submitted			2022-02-06	
J	Kajstura, TJ; Dougherty, SE; Linden, DJ				Kajstura, Tymoteusz J.; Dougherty, Sarah E.; Linden, David J.			Serotonin axons in the neocortex of the adult female mouse regrow after traumatic brain injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						serotonin; regeneration; traumatic brain injury; controlled cortical impact	SPINAL-CORD-INJURY; MICROGLIAL RESPONSE; CNS INJURY; REGENERATION; INHIBITION; DEPRESSION; PROMOTES; NEURONS; SYSTEM; ACTIVATION	It is widely held that injured neurons in the central nervous system do not undergo axonal regrowth. However, there is mounting evidence that serotonin axons are a notable exception. Serotonin axons undergo long-distance regrowth in the neocortex after amphetamine lesion, and, following a penetrating stab injury, they can regrow from cut ends to traverse the stab rift. Traumatic brain injury (TBI) is clinically prevalent and can lead to pathologies, such as depression, that are related to serotonergic dysfunction. Thus, whether serotonin axons can regrow after TBI is an important question. We used two models for TBI-a persistent open skull condition and controlled cortical impact-to evoke injury in adult female mouse neocortex, and assessed serotonin axon density 1 week, 1 month, and 3 months after injury by serotonin transporter immunohistochemistry. We found that after both forms of TBI, serotonin axon density is decreased posterior but not anterior to the injury site when measured in layer 1 at 1 week post surgery, and that serotonin axons are capable of regrowing into the distal zone to increase density by 1 month post surgery. This pattern is consistent with the anterior-to-posterior course of serotonin axons in the neocortex. TBI in these models is associated with significant reactive astrogliosis both anterior and posterior to the impact, but the degree of reactive astrogliosis is not correlated with serotonin axon density when measured 1 week after TBI. Microglial density remains constant following both types of injuries, but microglial condensation was detected 1 week after controlled cortical impact.	[Kajstura, Tymoteusz J.; Dougherty, Sarah E.; Linden, David J.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, 916 Hunterian Bldg,725 North Wolfe St, Baltimore, MD 21205 USA		Linden, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, 916 Hunterian Bldg,725 North Wolfe St, Baltimore, MD 21205 USA.	dlinden@jhmi.edu			Johns Hopkins University Brain Science Institute; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS050274, NS090822, NS81467]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS081467, F32NS090822, P30NS050274] Funding Source: NIH RePORTER	Funding was provided by the Johns Hopkins University Brain Science Institute, NIH NS81467 (D.J.L.), and NIH NS090822 (S.E.D.). The Johns Hopkins Neuroscience Imaging Core Facility, which aided this effort, is supported by NIH NS050274.	Abe K, 2016, NEUROL RES, V38, P358, DOI 10.1080/01616412.2015.1110402; Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; BOVOLENTA P, 1993, EUR J NEUROSCI, V5, P454, DOI 10.1111/j.1460-9568.1993.tb00512.x; Canty AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3038; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Cho BP, 2006, GLIA, V53, P92, DOI 10.1002/glia.20265; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Hagino S, 2003, GLIA, V42, P130, DOI 10.1002/glia.10207; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Hawthorne AL, 2011, J NEUROSCI, V31, P5605, DOI 10.1523/JNEUROSCI.6663-10.2011; He ZG, 2016, NEURON, V90, P437, DOI 10.1016/j.neuron.2016.04.022; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Jin YJ, 2016, NEURON, V91, P748, DOI 10.1016/j.neuron.2016.07.024; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kalmbach AS, 2012, J NEUROPHYSIOL, V108, P3138, DOI 10.1152/jn.00557.2012; Kanno H, 2014, J NEUROSCI, V34, P1838, DOI 10.1523/JNEUROSCI.2661-13.2014; Kohler S, 2016, J PSYCHOPHARMACOL, V30, P13, DOI 10.1177/0269881115609072; Lee JK, 2010, J NEUROSCI, V30, P10899, DOI 10.1523/JNEUROSCI.2269-10.2010; Lee YS, 2013, J NEUROSCI, V33, P10591, DOI 10.1523/JNEUROSCI.1116-12.2013; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; Mamounas LA, 2000, J NEUROSCI, V20, P771, DOI 10.1523/JNEUROSCI.20-02-00771.2000; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MOLLIVER ME, 1990, ANN NY ACAD SCI, V600, P640; Muller C.P., 2010, HDB BEHAV NEUROBIOLO; OHEARN E, 1988, J NEUROSCI, V8, P2788; Okaty BW, 2015, NEURON, V88, P774, DOI 10.1016/j.neuron.2015.10.007; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Sun F, 2010, CURR OPIN NEUROBIOL, V20, P510, DOI 10.1016/j.conb.2010.03.013; Szalay G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11499; TORK I, 1990, ANN NY ACAD SCI, V600, P9; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tuszynski MH, 2012, NEURON, V74, P777, DOI 10.1016/j.neuron.2012.05.006; WILSON MA, 1994, GLIA, V11, P18, DOI 10.1002/glia.440110105; Wood KM, 2013, ACS CHEM NEUROSCI, V4, P715, DOI 10.1021/cn4000378; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yoo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057415; Zou HY, 2009, J NEUROSCI, V29, P7116, DOI 10.1523/JNEUROSCI.5397-08.2009	46	12	13	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	APR	2018	96	4			SI		512	526		10.1002/jnr.24059			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV2DK	WOS:000424374300004	28485037	Green Accepted			2022-02-06	
J	Leeper, CM; Neal, MD; McKenna, C; Billiar, T; Gaines, BA				Leeper, Christine M.; Neal, Matthew D.; McKenna, Christine; Billiar, Timothy; Gaines, Barbara A.			Principal component analysis of coagulation assays in severely injured children	SURGERY			English	Article; Proceedings Paper	12th Annual Meeting of the Academic-Surgical-Congress (ASC)	FEB 07-09, 2017	Las Vegas, NV	Acad Surg Congress			ACUTE TRAUMATIC COAGULOPATHY; ADMISSION RAPID THROMBELASTOGRAPHY; FIBRINOLYSIS SHUTDOWN; PEDIATRIC TRAUMA; BRAIN-INJURY; HEAD TRAUMA; MORTALITY; DEFINITION; TIME; HYPERFIBRINOLYSIS	Background. Trauma-induced coagulopathy is common and associated with poor outcome in injured children. Our aim is to identify patterns of coagulation dysregulation after injury and associate these phenotypes with relevant clinical outcomes. Methods. We performed principal components analysis on prospectively collected data from children with the highest-level trauma activation June 2015-June 2016. Parameters included admission international normalized ratio, platelet count and thromboelastograms. Variables were reduced to principal components; principal component scores were generated for each subject and used in logistic regression with outcomes including mortality, disability, venous thromboembolism, and blood transfusion in the first 24 hours. Results. We included 133 subjects with median interquartile range age =10 (5-13 years), median interquartile range Injury Severity Score =17 (9-25), 73.5% boys, 70.8% blunt trauma. principal component analysis identified 3 significant principal components accounting for 75.0% of overall variance. Principal component 1 reflected clot strength; principal component 2 reflected abnormal fibrinolysis, both hyperfibrinolysis and fibrinolysis shutdown; principal component 3 reflected global clotting factor depletion. High principal component 1 score was associated with increased mortality (odds ratio =1.63) and blood transfusion (odds ratio 1.36). Principal component 2 score was correlated with Injury Severity Score (rho 0.4) and associated with venous thromboembolism (odds ratio 1.84), functional disability (odds ratio 1.66), mortality (odds ratio 2.07) and blood transfusion (odds ratio 2.79). PC3 score was associated with increased mortality (odds ratio 1.92) and blood transfusion (odds ratio 1.25). Conclusion. Principal component analysis detects 3 patterns of coagulation dysregulation using widely available laboratory parameters: (1) abnormalities in clot strength; (2) abnormalities in fibrinolysis, and (3) clotting factor depletion. While all were associated with mortality and transfusion, fibrinolytic dysregulation was associated with injury severity and portends particularly poor outcome including venous thromboembolism and disability. (C) 2017 Published by Elsevier Inc.	[Leeper, Christine M.; Neal, Matthew D.; Billiar, Timothy] Univ Pittsburgh, Med Ctr, Dept Surg, Div Gen Surg & Trauma, Pittsburgh, PA 15224 USA; [Leeper, Christine M.; McKenna, Christine; Gaines, Barbara A.] UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA		Gaines, BA (corresponding author), Univ Pittsburgh, Sch Med, UPMC, Childrens Hosp Pittsburgh, 7th Floor,Fac Pavil,One Childrens Hosp Dr, Pittsburgh, PA 15224 USA.	barbara.gaines@chp.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1-TR-001857]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001857] Funding Source: NIH RePORTER	Funding assistance for statistical analysis was supported by the National Institutes of Health Grant Number UL1-TR-001857.	Affonseca CA, 2007, J PEDIAT-BRAZIL, V83, P274, DOI 10.1590/S0021-75572007000400014; Albert M., 2014, INJURY RELATED EMERG; [Anonymous], 2015, CAUS CHILD MORT 2015; Attard C, 2013, J THROMB HAEMOST, V11, P1850, DOI 10.1111/jth.12372; Center for Disease Prevention and Control, 2014, 10 LEAD CAUS DEATH A; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Chin TL, 2014, SURGERY, V156, P570, DOI 10.1016/j.surg.2014.04.030; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; Hendrickson JE, 2012, J PEDIATR-US, V160, P204, DOI 10.1016/j.jpeds.2011.08.019; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; Kunitake RC, 2017, J TRAUMA ACUTE CARE, V82, P302, DOI 10.1097/TA.0000000000001313; Kutcher ME, 2015, J TRAUMA ACUTE CARE, V78, P516, DOI 10.1097/TA.0000000000000545; Kutcher ME, 2013, J TRAUMA ACUTE CARE, V74, P1223, DOI 10.1097/TA.0b013e31828b7fa1; Leeper CM, 2017, J TRAUMA ACUTE CARE, V82, P27, DOI 10.1097/TA.0000000000001308; Leeper CM, 2016, J TRAUMA ACUTE CARE, V81, P34, DOI 10.1097/TA.0000000000001002; Leeper CM, 2016, J TRAUMA ACUTE CARE, V80, P711, DOI 10.1097/TA.0000000000000954; Maegele M, 2014, SHOCK, V41, P21, DOI 10.1097/SHK.0000000000000088; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; Meizoso JP, 2017, J AM COLL SURGEONS, V224, P575, DOI 10.1016/j.jamcollsurg.2016.12.018; Moore HB, 2016, J AM COLL SURGEONS, V222, P347, DOI 10.1016/j.jamcollsurg.2016.01.006; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; Pape HC, 2014, J TRAUMA ACUTE CARE, V77, P780, DOI 10.1097/TA.0000000000000453; Patregnani JT, 2012, PEDIATR CRIT CARE ME, V13, P273, DOI 10.1097/PCC.0b013e31822f1727; Peltan ID, 2015, CRIT CARE MED, V43, P1429, DOI 10.1097/CCM.0000000000000981; Rizoli S, 2013, J TRAUMA ACUTE CARE, V74, P1229; Schochl H, 2009, J TRAUMA, V67, P125, DOI 10.1097/TA.0b013e31818b2483; Melo JRT, 2009, CHILD NERV SYST, V25, P1077, DOI 10.1007/s00381-009-0924-5; Vogel AM, 2013, J PEDIATR SURG, V48, P1371, DOI 10.1016/j.jpedsurg.2013.03.036; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb	33	12	14	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	APR	2018	163	4					827	831		10.1016/j.surg.2017.09.031			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	GB3QE	WOS:000428971700030	29248181				2022-02-06	
J	Osborne, NR; Anastakis, DJ; Davis, KD				Osborne, Natalie R.; Anastakis, Dimitri J.; Davis, Karen D.			Peripheral nerve injuries, pain, and neuroplasticity	JOURNAL OF HAND THERAPY			English	Article						Peripheral nerve injury; Neuroplasticity; Neuropathic pain; Rehabilitation	CARPAL-TUNNEL-SYNDROME; RANDOMIZED-CONTROLLED-TRIAL; SOMATOSENSORY CORTICAL PLASTICITY; GRADED MOTOR IMAGERY; NEUROPATHIC PAIN; BRAIN PLASTICITY; UPPER-EXTREMITY; FUNCTIONAL REORGANIZATION; TEMPORAL SUMMATION; SURGICAL-TREATMENT	Introduction: Peripheral nerve injuries (PNIs) cause both structural and functional brain changes that may be associated with significant sensorimotor abnormalities and pain. Purpose of the Study: The aim of this narrative review is to provide hand therapists an overview of PNI-induced neuroplasticity and to explain how the brain changes following PNI, repair, and during rehabilitation. Methods: Toward this goal, we review key aspects of neuroplasticity and neuroimaging and discuss sensory testing techniques used to study neuroplasticity in PNI patients. Results: We describe the specific brain changes that occur during the repair and recovery process of both traumatic (eg, transection) and nontraumatic (eg, compression) nerve injuries. We also explain how these changes contribute to common symptoms including hypoesthesia, hyperalgesia, cold sensitivity, and chronic neurogenic pain. In addition, we describe how maladaptive neuroplasticity as well as psychological and personality characteristics impacts treatment outcome. Discussion and Conclusion: Greater understanding of the brain's contribution to symptoms in recovering PNI patients could help guide rehabilitation strategies and inform the development of novel techniques to counteract these maladaptive brain changes and ultimately improve outcomes. (C) 2018 Hanley & Belfus, an imprint of Elsevier Inc. All rights reserved.	[Osborne, Natalie R.; Anastakis, Dimitri J.; Davis, Karen D.] Toronto Western Hosp, Krembil Res Inst, 399 Bathurst St,Room MP12-306, Toronto, ON M5T 2S8, Canada; [Osborne, Natalie R.; Anastakis, Dimitri J.; Davis, Karen D.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Anastakis, Dimitri J.; Davis, Karen D.] Univ Toronto, Dept Surg, Toronto, ON, Canada		Davis, KD (corresponding author), Toronto Western Hosp, Krembil Res Inst, 399 Bathurst St,Room MP12-306, Toronto, ON M5T 2S8, Canada.	karen.davis@uhnresearch.ca	Anastakis, Dimitri/Z-2322-2019; Anastakis, Dimitri/ABH-3466-2021	Anastakis, Dimitri/0000-0002-8716-1338	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Mayday Fund	The authors have no competing interests to report. KDD is funded by the Canadian Institutes of Health Research and the Mayday Fund.	Aboonq MS, 2015, NEUROSCIENCES, V20, P4; Anastakis DJ, 2008, HAND CLIN, V24, P425, DOI 10.1016/j.hcl.2008.04.005; Anastakis DJ, 2005, CLIN PLAST SURG, V32, P617, DOI 10.1016/j.cps.2005.05.008; ARENDTNIELSEN L, 1991, MUSCLE NERVE, V14, P508, DOI 10.1002/mus.880140604; Aroori Somaiah, 2008, Ulster Med J, V77, P6; Atroshi I, 1999, JAMA-J AM MED ASSOC, V282, P153, DOI 10.1001/jama.282.2.153; Avikainen S, 2002, NEUROIMAGE, V15, P640, DOI 10.1006/nimg.2001.1029; BACHYRITA P, 1990, NEUROPSYCHOLOGIA, V28, P547, DOI 10.1016/0028-3932(90)90033-K; Baron R, 2000, CLIN J PAIN, V16, pS12, DOI 10.1097/00002508-200006001-00004; Baron R, 2017, PAIN, V158, P261, DOI 10.1097/j.pain.0000000000000753; Bialosky JE, 2011, MANUAL THER, V16, P602, DOI 10.1016/j.math.2011.06.003; Bosma RL, 2017, PAIN, V158, P1192, DOI 10.1097/j.pain.0000000000000941; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Carlsson IK, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-89; Chen R, 2003, CLIN NEUROPHYSIOL, V114, P2434, DOI 10.1016/S1388-2457(03)00283-9; Clarke C, 2017, MUSCLE NERVE, V56, P814, DOI 10.1002/mus.25592; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Davis KD, 2013, J NEUROIMMUNE PHARM, V8, P518, DOI 10.1007/s11481-012-9386-8; Davis KD, 2011, NEUROSCIENTIST, V17, P407, DOI 10.1177/1073858410389185; DAVIS KD, 1993, J NEUROPHYSIOL, V69, P1071, DOI 10.1152/jn.1993.69.4.1071; de Tommaso M, 2009, CLIN NEUROPHYSIOL, V120, P353, DOI 10.1016/j.clinph.2008.11.017; Defrin R, 2001, PAIN, V89, P253, DOI 10.1016/S0304-3959(00)00369-9; DEVOR M, 1991, BRIT MED BULL, V47, P619, DOI 10.1093/oxfordjournals.bmb.a072496; Dhond RP, 2012, BRAIN, V135, P3062, DOI 10.1093/brain/aws233; Dias JJ, 2006, INJURY, V37, P1071, DOI 10.1016/j.injury.2006.07.023; Dilek B, 2018, J HAND THER, V31, P2, DOI 10.1016/j.jht.2017.09.004; Edwards RR, 2006, CLIN J PAIN, V22, P730, DOI 10.1097/01.ajp.0000210914.72794.bc; Edwards RR, 2005, J PAIN, V6, P338, DOI 10.1016/j.jpain.2005.02.013; Fernandez-de-las-Penas C, 2010, EXP BRAIN RES, V207, P85, DOI 10.1007/s00221-010-2436-7; Fernandez-Munoz JJ, 2016, CLIN J PAIN, V32, P122, DOI 10.1097/AJP.0000000000000241; Florence SL, 1995, J NEUROSCI, V15, P8083; GARRAGHTY PE, 1991, P NATL ACAD SCI USA, V88, P6976, DOI 10.1073/pnas.88.16.6976; Ghasemi-rad M, 2014, WORLD J RADIOL, V6, P284, DOI 10.4329/wjr.v6.i6.284; Gierthmuhlen J, 2012, PAIN, V153, P765, DOI 10.1016/j.pain.2011.11.009; Ginanneschi F, 2012, CLIN J PAIN, V28, P653, DOI 10.1097/AJP.0b013e3182430589; Goswami R, 2016, PAIN, V157, P729, DOI 10.1097/j.pain.0000000000000430; Graham B, 2016, J BONE JOINT SURG AM, V98, DOI 10.2106/JBJS.16.00719; Grinsell D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/698256; Gupta SK, 1997, CAN J NEUROL SCI, V24, P338, DOI 10.1017/S0317167100033023; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; Hansson T, 2003, J NEUROSURG, V99, P100, DOI 10.3171/jns.2003.99.1.0100; Hickmott PW, 2005, NAT NEUROSCI, V8, P140, DOI 10.1038/nn1384; de la Llave-Rincon AI, 2011, CLIN J PAIN, V27, P747, DOI 10.1097/AJP.0b013e31821c29d3; Iwatsuki K, 2016, CLIN NEUROPHYSIOL, V127, P2733, DOI 10.1016/j.clinph.2016.05.273; Jaquet JB, 2001, J TRAUMA, V51, P687, DOI 10.1097/00005373-200110000-00011; Jensen TS, 2014, LANCET NEUROL, V13, P924, DOI 10.1016/S1474-4422(14)70102-4; Jerosch-Herold C, 2016, J HAND SURG-EUR VOL, V41, P948, DOI 10.1177/1753193416657760; KAAS JH, 1983, ANNU REV NEUROSCI, V6, P325, DOI 10.1146/annurev.ne.06.030183.001545; Kennedy DL, 2016, PAIN, V157, P2410, DOI 10.1097/j.pain.0000000000000689; Killackey H P, 1989, J Cogn Neurosci, V1, P3, DOI 10.1162/jocn.1989.1.1.3; Knox A. D. C., 2015, NERVES NERVE INJURIE, P1055, DOI [10.1016/B978-0-12-802653-3.00113-5, DOI 10.1016/B978-0-12-802653-3.00113-5]; Landerholm AH, 2010, EUR J PAIN, V14, P847, DOI 10.1016/j.ejpain.2010.01.006; LANG E, 1995, MUSCLE NERVE, V18, P207, DOI 10.1002/mus.880180210; Lundborg G, 2007, ACTA PHYSIOL, V189, P207, DOI 10.1111/j.1748-1716.2006.01653.x; Lundborg G, 2000, J HAND SURG-BRIT EUR, V25B, P242, DOI 10.1054/jhsb.1999.0339; Maeda Y, 2017, BRAIN, V140, P914, DOI 10.1093/brain/awx015; Maeda Y, 2014, BRAIN, V137, P1741, DOI 10.1093/brain/awu096; Maeda Y, 2013, NEUROIMAGE-CLIN, V2, P313, DOI 10.1016/j.nicl.2013.02.001; Malessy MJA, 2003, J NEUROSURG, V98, P261, DOI 10.3171/jns.2003.98.2.0261; Malessy MJA, 1998, NEUROSURGERY, V42, P787, DOI 10.1097/00006123-199804000-00062; Malessy MJA, 1998, J NEUROSURG, V89, P568, DOI 10.3171/jns.1998.89.4.0568; McAllister RMR, 1996, J HAND SURG-BRIT EUR, V21B, P4, DOI 10.1016/S0266-7681(96)80004-0; Mendes RM, 2013, NEUROSCI LETT, V548, P33, DOI 10.1016/j.neulet.2013.04.019; Moseley GL, 2004, PAIN, V108, P192, DOI 10.1016/j.pain.2004.01.006; Napadow V, 2007, HUM BRAIN MAPP, V28, P159, DOI 10.1002/hbm.20261; Napadow V, 2006, NEUROIMAGE, V31, P520, DOI 10.1016/j.neuroimage.2005.12.017; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Nir RR, 2015, CURR OPIN SUPPORT PA, V9, P131, DOI 10.1097/SPC.0000000000000126; Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025; Novak Christine B, 2005, J Hand Ther, V18, P230, DOI 10.1197/j.jht.2005.02.002; Novak Christine B, 2016, Hand (N Y), V11, P173, DOI 10.1177/1558944715627633; Novak CB, 2010, PHYSIOTHER CAN, V62, P190, DOI 10.3138/physio.62.3.190; Novak CB, 2008, HAND CLIN, V24, P417, DOI 10.1016/j.hcl.2008.06.001; Nunez F, 2010, CLIN ORTHOP RELAT R, V468, P3328, DOI 10.1007/s11999-010-1551-x; Paula MH, 2016, BRAZ J PHYS THER, V20, P58, DOI 10.1590/bjpt-rbf.2014.0130; Pfau DB, 2012, CURR PAIN HEADACHE R, V16, P199, DOI 10.1007/s11916-012-0261-3; Polli A, 2017, EUR J PHYS REHAB MED, V53, P14, DOI 10.23736/S1973-9087.16.04215-5; PRICE DD, 1977, PAIN, V3, P57, DOI 10.1016/0304-3959(77)90035-5; Priganc VW, 2011, J HAND THER, V24, P164, DOI 10.1016/j.jht.2010.11.002; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; RAMACHANDRAN VS, 1995, NATURE, V377, P489, DOI 10.1038/377489a0; Robinson LR, 2000, MUSCLE NERVE, V23, P863, DOI 10.1002/(SICI)1097-4598(200006)23:6<863::AID-MUS4>3.0.CO;2-0; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Rosberg HE, 2005, SCAND J PLAST RECONS, V39, P360, DOI 10.1080/02844310500340046; Rosberg HE, 2005, J HAND SURG-BRIT EUR, V30B, P35, DOI 10.1016/j.jhsb.2004.09.003; Rosen B, 2007, J HAND SURG-BRIT EUR, V32E, P31, DOI 10.1016/j.jhsb.2006.08.019; Rosen B, 2006, J HAND SURG-BRIT EUR, V31B, P126, DOI 10.1016/j.jhsb.2005.10.017; Rosen B, 2005, SCAND J PLAST RECONS, V39, P104, DOI 10.1080/02844310510006187; Schmid AB, 2012, EUR J PAIN, V16, P217, DOI 10.1016/j.ejpain.2011.06.003; Schmid AB, 2014, BRAIN, V137, P3186, DOI 10.1093/brain/awu288; Schmid AB, 2013, J NEUROPATH EXP NEUR, V72, P662, DOI 10.1097/NEN.0b013e318298de5b; SELECKI BR, 1982, AUST NZ J SURG, V52, P111, DOI 10.1111/j.1445-2197.1982.tb06081.x; Severeijns R, 2001, CLIN J PAIN, V17, P165, DOI 10.1097/00002508-200106000-00009; Siao Peter, 2003, Phys Med Rehabil Clin N Am, V14, P261, DOI 10.1016/S1047-9651(02)00122-5; Soon B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183252; Staud R, 2007, PAIN, V129, P130, DOI 10.1016/j.pain.2006.10.010; Staud R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089086; Stevens JC, 1999, MUSCLE NERVE, V22, P1448, DOI 10.1002/(SICI)1097-4598(199910)22:10<1448::AID-MUS17>3.0.CO;2-Y; Tamburin S, 2011, J PAIN, V12, P205, DOI 10.1016/j.jpain.2010.06.010; Taub E, 2002, NAT REV NEUROSCI, V3, P228, DOI 10.1038/nrn754; Taylor CA, 2008, AM J PHYS MED REHAB, V87, P381, DOI 10.1097/PHM.0b013e31815e6370; Taylor KS, 2010, PAIN, V151, P582, DOI 10.1016/j.pain.2010.06.032; Taylor KS, 2009, BRAIN, V132, P3122, DOI 10.1093/brain/awp231; Tecchio F, 2002, HUM BRAIN MAPP, V17, P28, DOI 10.1002/hbm.10049; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Truini A, 2009, PAIN, V145, P105, DOI 10.1016/j.pain.2009.05.023; WALL JT, 1986, J NEUROSCI, V6, P218; WALL PD, 1977, PHILOS T R SOC B, V278, P361, DOI 10.1098/rstb.1977.0048; Werner RA, 2002, CLIN NEUROPHYSIOL, V113, P1373, DOI 10.1016/S1388-2457(02)00169-4; WOOLF CJ, 1992, NATURE, V355, P75, DOI 10.1038/355075a0; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Yang CP, 2011, J PAIN, V12, P272, DOI 10.1016/j.jpain.2010.09.001; Yang CP, 2009, CLIN J PAIN, V25, P327, DOI 10.1097/AJP.0b013e318190511c; Yarnitsky D, 1997, MUSCLE NERVE, V20, P198; Yarnitsky D, 2015, PAIN, V156, pS24, DOI 10.1097/01.j.pain.0000460343.46847.58; Zanette G, 2007, J PERIPHER NERV SYST, V12, P91, DOI 10.1111/j.1529-8027.2007.00127.x; Zanette G, 2006, PAIN, V122, P264, DOI 10.1016/j.pain.2006.01.034; Zanette G, 2010, PAIN, V148, P227, DOI 10.1016/j.pain.2009.10.025; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	122	12	15	5	14	HANLEY & BELFUS-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0894-1130	1545-004X		J HAND THER	J. Hand Ther.	APR-JUN	2018	31	2			SI		184	194		10.1016/j.jht.2018.01.011			11	Orthopedics; Rehabilitation; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation; Surgery	GF4MO	WOS:000431937200003	29706196				2022-02-06	
J	Peres, CMA; Caldas, JGMP; Puglia, P; de Andrade, AF; da Silva, IAF; Teixeira, MJ; Figueiredo, EG				Peres, Carlos Michel A.; Caldas, Jose Guilherme M. P.; Puglia, Paulo, Jr.; de Andrade, Almir F.; da Silva, Igor A. F.; Teixeira, Manoel J.; Figueiredo, Eberval G.			Endovascular management of acute epidural hematomas: clinical experience with 80 cases	JOURNAL OF NEUROSURGERY			English	Article						epidural hematoma; traumatic brain injury; middle meningeal artery; pseudoaneurysm; embolization; endovascular treatment; vascular disorders	MIDDLE MENINGEAL ARTERY; CHRONIC SUBDURAL-HEMATOMA; TRAUMATIC PSEUDOANEURYSM; CONSERVATIVE MANAGEMENT; NONOPERATIVE MANAGEMENT; EMBOLIZATION; HEMORRHAGE; SURGERY	OBJECTIVE Small acute epidural hematomas (EDHs) treated conservatively carry a nonmeasurable risk of late enlargement due to middle meningeal artery (MMA) lesions. Patients with EDHs need to stay hospitalized for several days, with neurological supervision and repeated CT scans. In this study, the authors analyzed the safety and efficacy of the embolization of the involved MMA and associated lesions. METHODS The study group consisted of 80 consecutive patients harboring small-to medium-sized EDHs treated by MMA embolization between January 2010 and December 2014. A literature review cohort was used as a control group. RESULTS The causes of head injury were falls, traffic-related accidents (including car, motorcycle, and pedestrian vs vehicle accidents), and assaults. The EDH topography was mainly temporal (lateral or pole). Active contrast leaking from the MMA was seen in 57.5%; arteriovenous fistulas between the MMA and diploic veins were seen in 10%; and MMA pseudoaneurysms were found in 13.6% of the cases. Embolizations were performed under local anesthesia in 80% of the cases, with N-butyl-2-cyanoacrylate, polyvinyl alcohol particles, or gelatin sponge (or a combination of these), obtaining MMA occlusion and complete resolution of the vascular lesions. All patients underwent follow-up CT scans between 1 and 7 days after the embolization. In the 80 cases in this series, no increase in size of the EDH was observed and the clinical evolution was uneventful, without Glasgow Coma Scale score modification after embolization and with no need for surgical evacuation. In contrast, the control cohort from the literature consisted of 471 patients, 82 (17.4%) of whom shifted from conservative treatment to surgical evacuation. CONCLUSIONS This study suggests that MMA embolization is a highly effective and safe method to achieve size stabilization in nonsurgically treated acute EDHs.	[Peres, Carlos Michel A.] Hosp Univ Francisca Mendes, 1085 Ave Via Lactea, BR-69060085 Manaus, AM, Brazil; [Caldas, Jose Guilherme M. P.; Puglia, Paulo, Jr.] Univ Sao Paulo, Sch Med, Div Neuroradiol, Sao Paulo, Brazil; [de Andrade, Almir F.; da Silva, Igor A. F.; Teixeira, Manoel J.; Figueiredo, Eberval G.] Univ Sao Paulo, Sch Med, Div Neurosurg, Sao Paulo, Brazil		Peres, CMA (corresponding author), Hosp Univ Francisca Mendes, 1085 Ave Via Lactea, BR-69060085 Manaus, AM, Brazil.	cmaperes@usp.br	Peres, Carlos Michel Albuquerque/N-1694-2019; Peres, Carlos Michel Albuquerque/E-4104-2017; Figueiredo, Eberval Gadelha/H-3488-2012; Caldas, Jose Guilherme M P/M-2554-2017	Peres, Carlos Michel Albuquerque/0000-0001-6606-3432; 			Balmer B, 2006, CHILD NERV SYST, V22, P363, DOI 10.1007/s00381-005-1254-x; Basamh M, 2016, CAN J NEUROL SCI, V43, P74, DOI 10.1017/cjn.2015.232; Bruneau M, 2002, SURG NEUROL, V57, P174, DOI 10.1016/S0090-3019(01)00668-1; Bullock M Ross, 2006, Neurosurgery, V58, pS7; CHEN TY, 1993, NEUROSURGERY, V32, P176, DOI 10.1227/00006123-199302000-00004; de Andrade AF, 2001, WORLD J SURG, V25, P1186; de Andrade AF, 2008, NEUROSURGERY, V62, P416, DOI 10.1227/01.neu.0000316008.11388.f2; Geibprasert S, 2009, AM J NEURORADIOL, V30, P1459, DOI 10.3174/ajnr.A1500; HAMILTON M, 1992, AM J NEURORADIOL, V13, P853; Hashimoto Takao, 2013, Surg Neurol Int, V4, P104, DOI 10.4103/2152-7806.116679; Jamous MA, 2009, PEDIATR NEUROSURG, V45, P181, DOI 10.1159/000218200; Khan MB, 2014, CHILD NERV SYST, V30, P1249, DOI 10.1007/s00381-014-2391-x; Kim Dong Ho, 2015, Korean J Neurotrauma, V11, P167, DOI 10.13004/kjnt.2015.11.2.167; KNUCKEY NW, 1989, J NEUROSURG, V70, P392, DOI 10.3171/jns.1989.70.3.0392; Lammy S, 2013, BRIT J NEUROSURG, V27, P383, DOI 10.3109/02688697.2012.717981; Mandai S, 2000, J NEUROSURG, V93, P686, DOI 10.3171/jns.2000.93.4.0686; Misaki K, 2008, NEUROL MED-CHIR, V48, P208, DOI 10.2176/nmc.48.208; Nayil K, 2012, TURK NEUROSURG, V22, P239, DOI 10.5137/1019-5149.JTN.3165-10.1; Offner PJ, 2006, AM J SURG, V192, P801, DOI 10.1016/j.amjsurg.2006.08.047; Ohshima T, 2012, NEUROL MED-CHIR, V52, P829, DOI 10.2176/nmc.52.829; Paiva WS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/413916; Paiva WS, 2010, CASE REP MED, V2010, DOI 10.1155/2010/219572; Protasoni M, 2011, J NEUROSURG, V114, P1723, DOI 10.3171/2010.12.JNS101732; Ross IB, 2009, J NEUROSURG, V110, P1247, DOI 10.3171/2008.7.JNS0883; SAKAI H, 1988, J NEUROSURG, V68, P566, DOI 10.3171/jns.1988.68.4.0566; Shah Q, 2005, AM J NEURORADIOL, V26, P2530; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; Suzuki S, 2004, AM J NEURORADIOL, V25, P1177; Takahashi K, 2002, NEUROL SURG TOKYO, V30, P535; Tsutsumi M, 2002, SURG NEUROL, V58, P325, DOI 10.1016/S0090-3019(02)00834-0; Wang CH, 2007, SURG NEUROL, V68, P676, DOI 10.1016/j.surneu.2006.11.048; Wu XH, 2014, J CRANIOFAC SURG, V25, pE111, DOI 10.1097/SCS.0000000000000450	32	12	15	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	APR	2018	128	4					1044	1050		10.3171/2016.11.JNS161398			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GB4QJ	WOS:000429045500243	28409733	Bronze			2022-02-06	
J	Raber, J; Torres, ERS; Akinyeke, T; Lee, J; Boutros, SJW; Turker, MS; Kronenberg, A				Raber, Jacob; Torres, Eileen Ruth S.; Akinyeke, Tunde; Lee, Joanne; Boutros, Sydney J. Weber; Turker, Mitchell S.; Kronenberg, Amy			Detrimental Effects of Helium Ion Irradiation on Cognitive Performance and Cortical Levels of MAP-2 in B6D2F1 Mice	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						object recognition; passive avoidance; fear conditioning; MAP-2; galactic cosmic radiation; helium ions	TRAUMATIC BRAIN-INJURY; OBJECT RECOGNITION; FE-56 IRRADIATION; FE-56-PARTICLE RADIATION; BEHAVIORAL TOXICITY; HIPPOCAMPAL-LESIONS; NEUROTROPHIC FACTOR; PARTICLE RADIATION; PASSIVE-AVOIDANCE; GENE-EXPRESSION	The space radiation environment includes helium (He-4) ions that may impact brain function. As little is known about the effects of exposures to He-4 ions on the brain, we assessed the behavioral and cognitive performance of C57BL/6J x DBA2/J F1 (B6D2F1) mice three months following irradiation with He-4 ions (250 MeV/n; linear energy transfer (LET) = 1.6 keV/rho m; 0, 21, 42 or 168 cGy). Sham-irradiated mice and mice irradiated with 21 or 168 cGy showed novel object recognition, but mice irradiated with 42 cGy did not. In the passive avoidance test, mice received a slight foot shock in a dark compartment, and latency to re-enter that compartment was assessed 24 h later. Sham-irradiated mice and mice irradiated with 21 or 42 cGy showed a higher latency on Day 2 than Day 1, but the latency to enter the dark compartment in mice irradiated with 168 cGy was comparable on both days. He-4 ion irradiation, at 42 and 168 cGy, reduced the levels of the dendritic marker microtubule-associated protein-2 (MAP-2) in the cortex. There was an effect of radiation on apolipoprotein E (apoE) levels in the hippocampus and cortex, with higher apoE levels in mice irradiated at 42 cGy than 168 cGy and a trend towards higher apoE levels in mice irradiated at 21 than 168 cGy. In addition, in the hippocampus, there was a trend towards a negative correlation between MAP-2 and apoE levels. While reduced levels of MAP-2 in the cortex might have contributed to the altered performance in the passive avoidance test, it does not seem sufficient to do so. The higher hippocampal and cortical apoE levels in mice irradiated at 42 than 168 cGy might have served as a compensatory protective response preserving their passive avoidance memory. Thus, there were no alterations in behavioral performance in the open filed or depressive-like behavior in the forced swim test, while cognitive impairments were seen in the object recognition and passive avoidance tests, but not in the contextual or cued fear conditioning tests. Taken together, the results indicate that some aspects of cognitive performance are altered in male mice exposed to 4He ions, but that the response is task-dependent. Furthermore, the sensitive doses can vary within each task in a non-linear fashion. This highlights the importance of assessing the cognitive and behavioral effects of charged particle exposure with a variety of assays and at multiple doses, given the possibility that lower doses may be more damaging due to the absence of induced compensatory mechanisms at higher doses.	[Raber, Jacob; Torres, Eileen Ruth S.; Akinyeke, Tunde; Lee, Joanne; Boutros, Sydney J. Weber] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Div Neurosci ONPRC, Dept Neurol, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Div Neurosci ONPRC, Dept Radiat Med, Portland, OR 97239 USA; [Turker, Mitchell S.] Oregon Hlth & Sci Univ, Oregon Inst Occupat Hlth Sci, Portland, OR 97239 USA; [Turker, Mitchell S.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Kronenberg, Amy] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA		Raber, J (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA.; Raber, J (corresponding author), Oregon Hlth & Sci Univ, Div Neurosci ONPRC, Dept Neurol, Portland, OR 97239 USA.; Raber, J (corresponding author), Oregon Hlth & Sci Univ, Div Neurosci ONPRC, Dept Radiat Med, Portland, OR 97239 USA.	raberj@ohsu.edu; torreei@ohsu.edu; akinyeke@ohsu.edu; joanneslee3@gmail.com; webesy@ohsu.edu; turkerm@ohsu.edu; a_kronenberg@lbl.gov		Boutros, Sydney/0000-0001-5832-150X; Torres, Eileen Ruth/0000-0002-5340-8734; Raber, Jacob/0000-0002-9861-9893	NASANational Aeronautics & Space Administration (NASA) [NNJ16HP23I]	None of the authors have competing financial interests or other conflicts of interest. The authors wish to thank Peter Guida, Adam Rusek, Chiara LaTessa, MaryAnn Petry and their staff members for their invaluable help at BNL and Dmytro Grygoryev and Stacey Gauny for assistance with the irradiations at the NSRL. This work was supported by NASA Grant NNJ16HP23I.	Acharya MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128316; Allen A., 2015, RADIAT RES, V184, P589; Allen AR, 2015, RADIAT RES, V184, P586, DOI 10.1667/RR14103.1; Allen AR, 2014, INT J RADIAT BIOL, V90, P214, DOI 10.3109/09553002.2014.859761; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Baarendse PJJ, 2008, HIPPOCAMPUS, V18, P11, DOI 10.1002/hipo.20356; Bellone J.A., 2014, J RADIAT RES, V55, pI95, DOI [10.1093/jrr/rrt154, DOI 10.1093/JRR/RRT154]; Benice TS, 2006, NEUROSCIENCE, V137, P413, DOI 10.1016/j.neuroscience.2005.08.029; Britten RA, 2012, RADIAT RES, V177, P146, DOI 10.1667/RR2637.1; Cohen SJ, 2015, BEHAV BRAIN RES, V285, P105, DOI 10.1016/j.bbr.2014.08.002; Cornwell BR, 2013, LEARN MEMORY, V20, P164, DOI 10.1101/lm.028902.112; Cucinotta FA, 2008, RADIAT RES, V170, P127, DOI 10.1667/RR1330.1; Cucinotta FA, 2015, HEALTH PHYS, V108, P131, DOI 10.1097/HP.0000000000000255; Denisova NA, 2002, RADIAT RES, V158, P725, DOI 10.1667/0033-7587(2002)158[0725:BSABRI]2.0.CO;2; DUNN TJ, 1988, J BIOL CHEM, V263, P10878; Engle SJ, 1996, HUM MOL GENET, V5, P1607, DOI 10.1093/hmg/5.10.1607; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Gaskin S, 2003, HIPPOCAMPUS, V13, P962, DOI 10.1002/hipo.10154; Gomes C, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-16; Haley GE, 2012, INT J RADIAT ONCOL, V84, P793, DOI 10.1016/j.ijrobp.2011.12.049; Haley GE, 2010, AGE, V32, P283, DOI 10.1007/s11357-010-9137-9; Harada A, 2002, J CELL BIOL, V158, P541, DOI 10.1083/jcb.200110134; Hassler DM, 2014, SCIENCE, V343, DOI 10.1126/science.1244797; Higuchi Y, 2002, J RADIAT RES, V43, pS219; Impey S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3110-7; Ji SJ, 2014, BRAIN RES, V1577, P77, DOI 10.1016/j.brainres.2014.06.035; KANDASAMY SB, 1994, RADIAT RES, V139, P352, DOI 10.2307/3578833; Kronenberg A, 2009, RADIAT RES, V172, P550, DOI 10.1667/RR1804.1; LINSTADT D, 1990, INT J RADIAT ONCOL, V19, P613, DOI 10.1016/0360-3016(90)90487-5; LO EH, 1991, INT J RADIAT ONCOL, V20, P689, DOI 10.1016/0360-3016(91)90010-2; Lorenzini CGA, 1997, BRAIN RES, V768, P242, DOI 10.1016/S0006-8993(97)00651-3; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McGinnis GJ, 2017, ONCOTARGET, V8, P9155, DOI 10.18632/oncotarget.13551; MINEKA S, 1979, PSYCHOL BULL, V86, P985, DOI 10.1037/0033-2909.86.5.985; Mizoguchi Y, 2014, J BIOL CHEM, V289, P18549, DOI 10.1074/jbc.M114.555334; NEUENJACOB E, 1993, CLIN NEUROPATHOL, V12, P315; Olsen RHJ, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00231; Parihar VK, 2016, SCI REP-UK, V6, DOI 10.1038/srep34774; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Peister A, 2006, EXP NEUROL, V201, P266, DOI 10.1016/j.expneurol.2006.03.023; PHILLIPS TL, 1977, INT J RADIAT ONCOL, V3, P109, DOI 10.1016/0360-3016(77)90236-X; Raber J, 2016, LIFE SCI SPACE RES, V9, P56, DOI 10.1016/j.lssr.2016.03.002; Raber Jacob, 2015, Life Sci Space Res (Amst), V7, P61, DOI 10.1016/j.lssr.2015.10.004; Raber J, 2015, RADIAT RES, V183, P708, DOI 10.1667/RR13951.1; Raber J, 2015, BEHAV BRAIN RES, V285, P53, DOI 10.1016/j.bbr.2015.01.046; Raber J, 2014, RADIAT RES, V181, P362, DOI 10.1667/RR13347.1; Raber J, 2013, BEHAV BRAIN RES, V246, P69, DOI 10.1016/j.bbr.2013.03.003; Raber J, 2013, BEHAV BRAIN RES, V246, P162, DOI 10.1016/j.bbr.2013.02.022; Rabin BM, 2007, ADV SPACE RES, V39, P981, DOI 10.1016/j.asr.2006.11.013; Rabin BM, 2015, RADIAT RES, V184, P266, DOI 10.1667/RR14001.1; RABIN BM, 1991, RADIAT RES, V128, P216, DOI 10.2307/3578141; RABIN BM, 1994, ADV SPACE RES, V14, P457, DOI 10.1016/0273-1177(94)90500-2; Rabin BM, 2002, J RADIAT RES, V43, pS225; RABIN BM, 2014, J BEHAV BRAIN SCI, V4, P297, DOI DOI 10.4236/JBBS.2014.47031; Slaba TC, 2016, LIFE SCI SPACE RES, V8, P52, DOI 10.1016/j.lssr.2016.01.001; Son Y, 2015, NEUROBIOL LEARN MEM, V121, P12, DOI 10.1016/j.nlm.2015.03.002; Stuster J., 2016, BEHAV ISSUES ASS LON; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Villasana L, 2010, RADIAT ENVIRON BIOPH, V49, P421, DOI 10.1007/s00411-010-0290-4; Villasana L, 2010, HIPPOCAMPUS, V20, P19, DOI 10.1002/hipo.20659; Villasana LE, 2011, INT J RADIAT ONCOL, V80, P567, DOI 10.1016/j.ijrobp.2010.12.034; Vlkolinsky R., 2012, P 23 ANN SPAC RAD IN; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Zeitlin C, 2013, SCIENCE, V340, P1080, DOI 10.1126/science.1235989; Zhang X, 2014, CELL PHYSIOL BIOCHEM, V34, P715, DOI 10.1159/000363036; Zhao Y, 2008, EUR J PHARMACOL, V581, P113, DOI 10.1016/j.ejphar.2007.12.005	66	12	12	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	APR	2018	19	4							1247	10.3390/ijms19041247			16	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	GJ0XU	WOS:000434978700326	29677125	gold, Green Published			2022-02-06	
J	Zavareh, MF; Hezaveh, AM; Nordfjaern, T				Zavareh, Mohsen Fallah; Hezaveh, Amin Mohamadi; Nordfjaern, Trond			Intention to use bicycle helmet as explained by the Health Belief Model, comparative optimism and risk perception in an Iranian sample	TRANSPORTATION RESEARCH PART F-TRAFFIC PSYCHOLOGY AND BEHAVIOUR			English	Article						Bicycle helmet; Intention; Health belief model; Risk perception; Comparative optimism	TRAUMATIC BRAIN-INJURY; SEAT-BELT USE; PLANNED BEHAVIOR; TRAFFIC SAFETY; UNREALISTIC OPTIMISM; DRIVING BEHAVIOR; HEAD-INJURIES; ATTITUDES; METAANALYSIS; DRIVERS	The present study was set out to identify variables which predict intention to use helmet among bicyclists. The theoretical framework was based on the Health Belief Model (HBM) integrated with risk perception and comparative optimism, as relevant constructs from the risk theories. The results were based on an internet survey carried out among bicyclists (n = 256). A second-order SEM revealed that while controlling for gender, age and cycling experience, risk perception (beta=.113, p < .05) fully mediated the effect of comparative optimism (beta = .201, p < .05) on intention to use a helmet. Perceived exemption from harm (beta = -.340, p < .05) and perceived barriers beta =.507, p < .001) were also found to be significant predictors of intention to use a bicycle helmet. The hypothesized model explained 55.8 percent of the variance within the intention to use a bicycle helmet. Theoretical implications of these findings are discussed. (C) 2018 Elsevier Ltd. All rights reserved.	[Zavareh, Mohsen Fallah] Kharazmi Univ, Fac Engn, Dept Civil Engn, Tehran, Iran; [Hezaveh, Amin Mohamadi] Univ Tennessee, Civil & Environm Engn, Knoxville, TN USA; [Nordfjaern, Trond] Norwegian Univ Sci & Technol NTNU, Dept Psychol, Trondheim, Norway		Zavareh, MF (corresponding author), Kharazmi Univ, Fac Engn, Dept Civil Engn, Tehran, Iran.	m.fallah@khu.ac.ir	Mohamadi, Amin/Q-3679-2019; Hezaveh, Amin Mohamadi/K-3698-2019; Nordfjaern, Trond/B-8391-2013	Hezaveh, Amin Mohamadi/0000-0003-2480-1956; Fallah Zavareh, Mohsen/0000-0001-6841-5876			Aghamolaei T, 2011, TRAFFIC INJ PREV, V12, P239, DOI 10.1080/15389588.2011.557757; Airaksinen N., 2010, ANN ADV AUTOMOTIVE M, V54, P267; Ajzen I., 2006, BEHAV INTERVENTIONS; Ali M, 2011, INJURY, V42, P864, DOI 10.1016/j.injury.2010.08.030; Ali M, 2011, TRAFFIC INJ PREV, V12, P104, DOI 10.1080/15389588.2010.535227; Ambak Kamarudin, 2010, AUSTR J BASIC APPL S, V4; Amoros E, 2012, INJURY PREV, V18, P27, DOI 10.1136/ip.2011.031815; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Bamberg S, 2006, ENVIRON BEHAV, V38, P820, DOI 10.1177/0013916505285091; Becker M H, 1977, Med Care, V15, P27, DOI 10.1097/00005650-197705001-00005; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Bostrom L, 2001, J TRAUMA, V50, P900, DOI 10.1097/00005373-200105000-00021; Braithwaite D, 2003, FAM PRACT, V20, P545, DOI 10.1093/fampra/cmg509; Brijs K, 2014, TRANSPORT RES F-TRAF, V26, P273, DOI 10.1016/j.trf.2014.08.002; Carpenter CJ, 2010, HEALTH COMMUN, V25, P661, DOI 10.1080/10410236.2010.521906; Clarke VA, 2000, J BEHAV MED, V23, P367, DOI 10.1023/A:1005500917875; Deery HA, 1999, J SAFETY RES, V30, P225, DOI 10.1016/S0022-4375(99)00018-3; DeJoy David M, 1990, P HUM FACT ERG SOC A, V34, P1032, DOI [DOI 10.1177/154193129003401416, 10.1177/154193129003401416]; DEJOY DM, 1992, ACCIDENT ANAL PREV, V24, P237, DOI 10.1016/0001-4575(92)90003-2; DEJOY DM, 1989, ACCIDENT ANAL PREV, V21, P333, DOI 10.1016/0001-4575(89)90024-9; DELHOMME P, 1991, ACCIDENT ANAL PREV, V23, P493, DOI 10.1016/0001-4575(91)90015-W; Elias W, 2012, TRANSPORT RES A-POL, V46, P1241, DOI 10.1016/j.tra.2012.05.013; ERSO, 2015, PED CYCL; Estabrooks P, 1998, J AGING HEALTH, V10, P441, DOI 10.1177/089826439801000403; Fahlstedt M, 2016, ACCIDENT ANAL PREV, V91, P135, DOI 10.1016/j.aap.2016.02.025; Floyd DL, 2000, J APPL SOC PSYCHOL, V30, P407, DOI 10.1111/j.1559-1816.2000.tb02323.x; Fyhri A, 2012, TRANSPORT RES F-TRAF, V15, P612, DOI 10.1016/j.trf.2012.06.003; Gliem J.A., 2003, P MIDW RES TO PRACT; Godin G, 2004, BRIT J HEALTH PSYCH, V9, P557, DOI 10.1348/1359107042304614; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Gunzler Douglas, 2013, Shanghai Arch Psychiatry, V25, P390, DOI 10.3969/j.issn.1002-0829.2013.06.009; Harre N, 2005, BRIT J PSYCHOL, V96, P215, DOI 10.1348/000712605X36019; HARRISON JA, 1992, HEALTH EDUC RES, V7, P107, DOI 10.1093/her/7.1.107; Hezaveh Amin Mohamadi, J TRANSPORT IN PRESS, DOI 10.1016/jjth.2017.11.003; Ho R., 2013, HDB UNIVARIATE MULTI; Hutcheson G. D., 1999, MULTIVARIATE SOCIAL; Iversen H, 2004, ERGONOMICS, V47, P555, DOI 10.1080/00140130410001658709; Joseph B, 2017, AM J SURG, V213, P413, DOI 10.1016/j.amjsurg.2016.05.021; JOSHI MS, 1994, ARCH DIS CHILD, V71, P536, DOI 10.1136/adc.71.6.536; Karkhaneh M, 2006, INJURY PREV, V12, P76, DOI 10.1136/ip.2005.010942; Karkhaneh M, 2013, ACCIDENT ANAL PREV, V59, P206, DOI 10.1016/j.aap.2013.05.027; Kaushik R, 2015, INJURY EPIDEMIOL, V2, P1; Kim KH, 2006, HANDBOOK OF COMPLEMENTARY METHODS IN EDUCATION RESEARCH, P161; Kline R. B., 2016, PRINCIPLES PRACTICE, VFourth; Lajunen T, 2004, J SAFETY RES, V35, P115, DOI 10.1016/j.jsr.2003.09.020; Lajunen T, 2001, J SAFETY RES, V32, P323, DOI 10.1016/S0022-4375(01)00056-1; LANGER EJ, 1975, J PERS SOC PSYCHOL, V32, P311, DOI 10.1037/0022-3514.32.2.311; Leijdesdorff HA, 2014, J NEUROTRAUM, V31, P459, DOI [10.1089/NEU.2013.3111, 10.1089/neu.2013.3111]; Little T. D., 2013, LONGITUDINAL STRUCTU; Lund IO, 2009, SAFETY SCI, V47, P547, DOI 10.1016/j.ssci.2008.07.008; Machin MA, 2008, ACCIDENT ANAL PREV, V40, P541, DOI 10.1016/j.aap.2007.08.010; Mallery P., 2003, SPSS WINDOWS STEP ST, V4th; Mark Conner, 2005, PREDICTING HLTH BEHA; Martha C, 2010, J RISK RES, V13, P429, DOI 10.1080/13669870903169275; McKenna FP, 2006, HEALTH PSYCHOL, V25, P163, DOI 10.1037/0278-6133.25.2.163; Morowatisharifabad MA, 2009, TRAFFIC INJ PREV, V10, P436, DOI 10.1080/15389580903081016; Moss Simon, 2017, FIT INDICES STRUCTUR; Munivenkatappa A, 2013, J NEUROSCI RURAL PRA, V4, P262, DOI 10.4103/0976-3147.118764; Munro S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-104; Netemeyer R.G., 2003, SCALING PROCEDURES I; NOAKES TD, 1995, SPORTS MED, V20, P348, DOI 10.2165/00007256-199520050-00006; Nordfjaern T, 2015, J RISK RES, V18, P566, DOI 10.1080/13669877.2014.910684; Nordfjaern T, 2014, SAFETY SCI, V66, P36, DOI 10.1016/j.ssci.2014.02.004; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; O'Callaghan FV, 2006, J SAFETY RES, V37, P425, DOI 10.1016/j.jsr.2006.08.001; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Ozkan T, 2012, ACCIDENT ANAL PREV, V49, P124, DOI 10.1016/j.aap.2011.03.009; Quine L, 2001, BRIT J HEALTH PSYCH, V6, P327, DOI 10.1348/135910701169241; Quine L, 1998, PSYCHOL HEALTH, V13, P251, DOI 10.1080/08870449808406750; Rocakova-Filemon Pavlina, 2008, OPINIONS STAKEHOLDER; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Ross TP, 2010, J AM COLL HEALTH, V59, P29, DOI 10.1080/07448481.2010.483702; Rousseau S., 2013, REV BUS EC LIT, V58, P158; Rutter DR, 1998, BRIT J PSYCHOL, V89, P681, DOI 10.1111/j.2044-8295.1998.tb02710.x; SafetyNet, 2009, SPEED; Schepers P, 2015, INJURY PREV, V21, pE138, DOI 10.1136/injuryprev-2013-040964; Secginli S, 2014, INT J INJ CONTROL SA, V21, P367, DOI 10.1080/17457300.2013.835323; Sethi M, 2015, INJURY, V46, P2483, DOI 10.1016/j.injury.2015.07.030; Sheeran P., 2002, EUROPEAN REV SOCIAL, V12, DOI [https://doi.org/10.1080/14792772143000003, DOI 10.1080/14792772143000003]; Shepperd JA, 2015, CURR DIR PSYCHOL SCI, V24, P232, DOI 10.1177/0963721414568341; Shih TH, 2008, FIELD METHOD, V20, P249, DOI 10.1177/1525822X08317085; Simsekoglu O, 2008, TRANSPORT RES F-TRAF, V11, P181, DOI 10.1016/j.trf.2007.10.001; Simsekoglu O, 2013, SAFETY SCI, V59, P187, DOI 10.1016/j.ssci.2013.05.014; Sjoberg L., 2004, EXPLAINING RISK PERC; Solmazer G, 2016, TRANSPORT RES F-TRAF, V38, P137, DOI 10.1016/j.trf.2016.01.001; STASSON M, 1990, J APPL SOC PSYCHOL, V20, P1541, DOI 10.1111/j.1559-1816.1990.tb01492.x; Stephens AN, 2014, PERS INDIV DIFFER, V68, P124, DOI 10.1016/j.paid.2014.04.016; Sullivan Gail M, 2013, J Grad Med Educ, V5, P541, DOI 10.4300/JGME-5-4-18; SWOV, 2011, SPEED CAM THEY WORK; Thompson Diane C, 1999, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001855/ABSTRACT; Ulleberg P, 2003, SAFETY SCI, V41, P427, DOI 10.1016/S0925-7535(01)00077-7; van der Pligt J, 1996, EUR PSYCHOL, V1, P34, DOI 10.1027/1016-9040.1.1.34; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; White MJ, 2011, ACCIDENT ANAL PREV, V43, P1309, DOI 10.1016/j.aap.2011.01.013; WITTE K, 1993, COMMUN RES, V20, P564, DOI 10.1177/009365093020004004; Wolfe SW, 2010, GREENS OPERATIVE HAN; World Health Organization, 2015, GLOB STAT REP ROAD S	99	12	12	1	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1369-8478	1873-5517		TRANSPORT RES F-TRAF	Transp. Res. Pt. F-Traffic Psychol. Behav.	APR	2018	54						248	263		10.1016/j.trf.2018.02.003			16	Psychology, Applied; Transportation	Social Science Citation Index (SSCI)	Psychology; Transportation	GC6HJ	WOS:000429890400020		Green Submitted			2022-02-06	
J	Cook, PA; Johnson, TM; Martin, SG; Gehrman, PR; Bhatnagar, S; Gee, JC				Cook, Philip A.; Johnson, Thomas M.; Martin, Suzanne G.; Gehrman, Philip R.; Bhatnagar, Seema; Gee, James C.			A Retrospective Study of Predictors of Return to Duty versus Medical Retirement in an Active Duty Military Population with Blast-Related Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blast; mTBI; RBANS; return to duty; white matter	NEUROPSYCHOLOGICAL STATUS RBANS; REPEATABLE BATTERY; HEADACHE IMPACT; CONCUSSION; SYMPTOMS; PTSD; VALIDITY; ANTS; TBI	Traumatic Brain Injury (TBI) has been described as the signature injury of the Global War on Terror. Explosive blast TBI has become a leading cause of injury as a result of the widespread use of improvised explosive devices in Iraq and Afghanistan. We present a retrospective cross-sectional study of patients with blast-related mild TBI (mTBI, N=303) seen at the Intrepid Spirit Concussion Recovery Center at Naval Medical Center Camp Lejeune. The objective was to predict outcomes of return to duty (RTD) vs. medical retirement via medical evaluation board (MEB), based on brain imaging, neuropsychological data, and history of mTBI. The motivation is to inform prognosis and target resources to improve outcomes for service members who are less likely to RTD through the standard treatment program. The RTD was defined operationally as individuals who completed treatment and were not recommended for medical retirement or separation for TBI or related sequelae. Higher scores on the Repeatable Battery for Neuropsychological Status (RBANS) test were associated positively with RTD (p=0.001). A history of three or more lifetime concussions was associated negatively with RTD, when compared with one concussion (p=0.04). Elevated apparent diffusion coefficient (ADC) in the anterior corona radiata was associated negatively with RTD (p=0.04). A logistic regression model was used to classify individuals with RBANS and imaging data (n=81) as RTD or MEB according to RBANS, ADC, and a history of multiple (3) concussions. The RBANS (p=0.003) and multiple concussions (p=0.03) were significant terms in the logistic model, but ADC was not (p=0.27). The area under the receiver operating characteristic curve was 0.77 (95% confidence interval 0.66-0.86). These results suggest cognitive testing and TBI history might be used to identify service members who are more likely to be retired medically from active duty.	[Cook, Philip A.; Gehrman, Philip R.; Bhatnagar, Seema; Gee, James C.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bhatnagar, Seema] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Johnson, Thomas M.; Martin, Suzanne G.] Naval Med Ctr Camp Lejeune, Camp Lejeune, NC USA; [Johnson, Thomas M.; Martin, Suzanne G.] Def & Vet Brain Injury Ctr, Camp Lejeune, NC USA; [Gehrman, Philip R.] Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA USA		Gee, JC (corresponding author), Univ Penn, Perelman Sch Med, Dept Radiol, 3700 Hamilton Walk, Philadelphia, PA 19104 USA.	gee@mail.med.upenn.edu	Bhatnagar, Seema/M-7110-2017	Bhatnagar, Seema/0000-0003-4371-0910	Defense Advanced Research Projects Agency (DARPA)United States Department of DefenseDefense Advanced Research Projects Agency (DARPA); US Army Research Office [W911NF1010093]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30-NS045839]	This work was supported by the Defense Advanced Research Projects Agency (DARPA) and the US Army Research Office under grant number W911NF1010093, and the National Institutes of Health under grant P30-NS045839.	Avants BB, 2011, NEUROINFORMATICS, V9, P381, DOI 10.1007/s12021-011-9109-y; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Bazarian JJ, 2006, ACAD EMERG MED, V13, P199, DOI 10.1197/j.aem.2005.07.031; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Coeytaux RR, 2006, J CLIN EPIDEMIOL, V59, P374, DOI 10.1016/j.jclinepi.2005.05.010; CONIGRAVE KM, 1995, ADDICTION, V90, P1349, DOI 10.1111/j.1360-0443.1995.tb03552.x; Defense and Veterans Brain Injury Center, 2014, INF NOT NEUR SYMPT I; Defense and Veterans Brain Injury Center Position Paper, 2006, ID TREATM COMB REL T; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Duff K, 2010, ARCH CLIN NEUROPSYCH, V25, P429, DOI 10.1093/arclin/acq045; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nelson N. W., 2015, BRAIN NEUROTRAUMA MO; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Radomski MV, 2013, MIL MED, V178, P246, DOI 10.7205/MILMED-D-12-00144; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Scott KL, 2016, CLIN NEUROPSYCHOL, V30, P66, DOI 10.1080/13854046.2015.1127427; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Stemper BD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00031; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tustison NJ, 2014, NEUROIMAGE, V99, P166, DOI 10.1016/j.neuroimage.2014.05.044; Vasterling JJ, 2012, PTSD MILD TRAUMATIC; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Zuckerman A, 2017, J NEUROTRAUM, V34, P145, DOI 10.1089/neu.2015.4310	44	12	12	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2018	35	8					991	1002		10.1089/neu.2017.5141		MAR 2018	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GC0DM	WOS:000426517400001	29239267	Green Published			2022-02-06	
J	Crichton, A; Oakley, E; Babl, FE; Greenham, M; Hearps, S; Delzoppo, C; Beauchamp, MH; Hutchison, JS; Guerguerian, AM; Boutis, K; Anderson, V				Crichton, Alison; Oakley, Ed; Babl, Franz E.; Greenham, Mardee; Hearps, Stephen; Delzoppo, Carmel; Beauchamp, Miriam H.; Hutchison, James S.; Guerguerian, Anne-Marie; Boutis, Kathy; Anderson, Vicki			Predicting Fatigue 12 Months after Child Traumatic Brain Injury: Child Factors and Postinjury Symptoms	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Mental fatigue; Muscle fatigue; Brain concussion; Adolescent; Children; Regression models; Longitudinal studies	QUALITY-OF-LIFE; GENERIC CORE SCALES; DIFFICULTIES QUESTIONNAIRE SDQ; PEDIATRIC MULTIPLE-SCLEROSIS; ACUTE LYMPHOBLASTIC-LEUKEMIA; SICKLE-CELL-DISEASE; PSYCHIATRIC-DISORDERS; POSTCONCUSSIVE SYMPTOMS; CEREBRAL-PALSY; SLEEP PROBLEMS	Objectives: Fatigue is a common and persisting symptom after childhood brain injury. This study examined whether child characteristics and symptomatology preinjury or 6 months postinjury (pain, sleep, and mood, inattention) predicted fatigue at 12months postinjury. Methods: Parents of 79 children (0-18 years) rated fatigue at 12 months after injury on a multidimensional scale (general, sleep/rest, and cognitive). Demographic and clinical data were collected at injury. Parents rated child sleep, pain, physical/motor function, mood, and inattention at injury (preinjury description), and 6 months postinjury. Children were divided into two traumatic brain injury severity groups: mild TBI (n = 57) and moderate/severe TBI (n = 27). Hierarchical regression models were used to examine (i) preinjury factors and (ii) symptoms 6 months postinjury predictive of fatigue (general, sleep/rest, and cognitive) at 12 months postinjury. Results: Sleep/rest fatigue was predicted by preinjury fatigue (7% of variance) and psychological symptoms preinjury (10% of variance). General fatigue was predicted by physical/motor symptoms (27%), sleep (10%) and mood symptoms (9%) 6 months postinjury. Sleep/rest fatigue was predicted by physical/motor symptoms (10%), sleep symptoms (13%) and mood symptoms (9%) 6 months postinjury. Cognitive fatigue was predicted by physical/motor symptoms (17%) 6 months postinjury. Conclusions: Preinjury fatigue and psychological functioning identified those at greatest risk of fatigue 12 months post-TBI. Predictors of specific fatigue domains at 12 months differed across each of the domains, although consistently included physical/motor function as well as sleep and mood symptoms postinjury.	[Crichton, Alison; Oakley, Ed; Babl, Franz E.; Greenham, Mardee; Hearps, Stephen; Delzoppo, Carmel; Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Crichton, Alison] Monash Childrens, Victorian Pediat Rehabil Serv, Melbourne, Vic, Australia; [Crichton, Alison; Greenham, Mardee; Anderson, Vicki] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Oakley, Ed; Babl, Franz E.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Oakley, Ed; Babl, Franz E.; Delzoppo, Carmel; Anderson, Vicki] Royal Childrens Hosp, Melbourne, Vic, Australia; [Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam H.] Ste Justine Hosp, Res Ctr, Montreal, PQ, Canada; [Hutchison, James S.; Guerguerian, Anne-Marie; Boutis, Kathy] Hosp Sick Children SickKids, Toronto, ON, Canada; [Hutchison, James S.] SickKids Res Inst, Neurosci & Mental Hlth Res Program, Toronto, ON, Canada; [Hutchison, James S.; Boutis, Kathy] Univ Toronto, Toronto, ON, Canada		Crichton, A (corresponding author), Murdoch Childrens Res Inst, 50 Flemington Rd, Parkville, Vic 3052, Australia.	ali.crichton@mcri.edu.au	Hearps, Stephen/L-6853-2016; Greenham, Mardee/AAR-1711-2020	Hearps, Stephen/0000-0003-2984-1172	Ontario Neurotrauma Foundation, Toronto, Canada; Victorian Neurotrauma Initiative, Melbourne, Australia; Victorian Government's Infrastructure Support Program, Melbourne, Australia; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1075048]; Moving Ahead; Neurosciences Victoria; Royal Children's Hospital Foundation	This work was supported by a jointly awarded grant from The Ontario Neurotrauma Foundation, Toronto, Canada and The Victorian Neurotrauma Initiative, Melbourne, Australia (V.A. & J.H.); the Victorian Government's Infrastructure Support Program, Melbourne, Australia (V.A., M.H.B, J.S.H); the National Health and Medical Research Council (A.C., Postgraduate Scholarship 1075048), (E.O. & F.E.B., Centre of Research Excellence Grant); Moving Ahead (A.C., seed grant); Neurosciences Victoria (A. C., Brain and Mind Scholarship); and the Royal Children's Hospital Foundation (F.E.B). We thank the parents and children for participating in this study. Thank you to Brenton Ward and Carmel Delzoppo (RCH) for assisting in recruitment of participants at RCH. We acknowledge the participants of the Pediatric Research Academic Initiative at SickKids Emergency (PRAISE) for identifying and participating in enrolment of study patients at the Toronto site. No conflicts exist. Members of the Biomarker and Quality of Life in Children with Traumatic Brain Injury group, by site: SickKids: Dr. Jamie Hutchison, Dr. Anne-Marie Guerguerian, Dr. Kathy Boutis, Dr. Martin Post, Sumaira Hussain, Judith Van Huyse, Amy Wilkinson, Helena Frndova. RCH: Dr. Vicki Anderson, Dr. Alison Crichton, Carmel Delzoppo, Mardee Greenham, Dr. Franz Babl, Dr. Warwick Butt. HSJ: Dr Miriam Beauchamp, Mariana Dumitrascu, Cindy Beaudoin, Dr. Catherine Farrell, Dr. Jocelyn Gravel, Charlotte Gagner.	Aaronson L S, 1999, Image J Nurs Sch, V31, P45; Alfano CA, 2009, CHILD YOUTH CARE FOR, V38, P327, DOI 10.1007/s10566-009-9081-y; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Berrin SJ, 2007, J PEDIATR PSYCHOL, V32, P330, DOI 10.1093/jpepsy/jsl017; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Briggs-Gowan M., 2006, BRIEF INFANT TODDLER; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2014, J HEAD TRAUMA REHAB, V29, P490, DOI 10.1097/HTR.0000000000000102; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Carskadon MA, 2004, ANN NY ACAD SCI, V1021, P276, DOI 10.1196/annals.1308.032; Carskadon MA, 2002, SLEEP, V25, P606, DOI 10.1093/sleep/25.6.606; CARTER BD, 1995, PEDIATRICS, V95, P179; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Chaudhuri A., 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Crichton A., 2016, J HEAD TRAUMA REHABI, V32, P107, DOI 10.1097/HTR.0000000000000248; Crichton A, 2015, PEDIATRICS, V135, pE1015, DOI 10.1542/peds.2014-2440; Crowley SJ, 2007, SLEEP MED, V8, P602, DOI 10.1016/j.sleep.2006.12.002; Dampier C, 2010, PEDIATR BLOOD CANCER, V55, P485, DOI 10.1002/pbc.22497; de Leon MB, 2009, ARCH PHYS MED REHAB, V90, P956, DOI 10.1016/j.apmr.2008.12.016; DENNIS M, 2007, COGNITIVE RESERVE TH, P53; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Eddy L, 2007, J SPEC PEDIATR NURS, V12, P105, DOI 10.1111/j.1744-6155.2007.00099.x; Elovic E., 2003, J HEAD TRAUMA REHABI, V18, P541, DOI 10.1097/00001199-200311000-00008; Elovic E., 2004, J HEAD TRAUMA REHABI, V19, P184, DOI 10.1097/00001199-200403000-00010; Elovic E., 2007, FATIGUE WINDOW BRAIN, P89; Elovic E, 2006, J HEAD TRAUMA REHAB, V21, P426, DOI 10.1097/00001199-200609000-00044; Ewing-Cobbs L, 2014, J PEDIATR PSYCHOL, V39, P653, DOI 10.1093/jpepsy/jsu018; Falk AC, 2013, SCAND J CARING SCI, V27, P51, DOI 10.1111/j.1471-6712.2012.00999.x; Finsterer J, 2014, AM J HOSP PALLIAT ME, V31, P562, DOI 10.1177/1049909113494748; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Garcia D, 2015, J PEDIATR PSYCHOL, V40, P391, DOI 10.1093/jpepsy/jsu093; Gedaly-Duff V, 2006, ONCOL NURS FORUM, V33, P641, DOI 10.1188/06.ONF.641-646; Gibson F, 2005, CANCER NURS, V28, P27, DOI 10.1097/00002820-200501000-00004; Gold JI, 2009, CLIN J PAIN, V25, P407, DOI 10.1097/AJP.0b013e318192bfb1; Goodman R, 2000, EUR CHILD ADOLES PSY, V9, P129, DOI 10.1007/s007870050008; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Gordijn MS, 2013, PEDIATR BLOOD CANCER, V60, P479, DOI 10.1002/pbc.24261; Gregory AM, 2016, J CHILD PSYCHOL PSYC, V57, P296, DOI 10.1111/jcpp.12469; Gregory AM, 2012, SLEEP MED REV, V16, P129, DOI 10.1016/j.smrv.2011.03.007; Grover SA, 2015, NEUROLOGY, V85, P1663, DOI 10.1212/WNL.0000000000001939; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hassett LM, 2009, J REHABIL MED, V41, P247, DOI 10.2340/16501977-0316; Hinds PS, 2013, PEDIATR BLOOD CANCER, V60, P402, DOI 10.1002/pbc.24233; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Ivanenko A, 2005, SLEEP MED REV, V9, P115, DOI 10.1016/j.smrv.2004.09.006; Karabekiroglu K, 2010, INFANT BEHAV DEV, V33, P503, DOI 10.1016/j.infbeh.2010.07.001; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Lofthouse N, 2009, CHILD ADOL PSYCH CL, V18, P893, DOI 10.1016/j.chc.2009.04.007; Looman WS, 2010, CLEFT PALATE-CRAN J, V47, P273, DOI [10.1597/09-009.1, 10.5555/09-009.1]; MacAllister WS, 2009, MULT SCLER J, V15, P1502, DOI 10.1177/1352458509345902; Marcus SB, 2009, CLIN GASTROENTEROL H, V7, P554, DOI 10.1016/j.cgh.2009.01.022; Mears C.J., 2004, J ADOLESCENT HEALTH, V35, DOI 10.1016/j.jadohealth.2004.02.012; Meeske K, 2004, CANCER, V101, P2116, DOI 10.1002/cncr.20609; Mindell JA, 1999, CHILD ADOL PSYCH CL, V8, P695; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Panepinto JA, 2014, PEDIATR BLOOD CANCER, V61, P171, DOI 10.1002/pbc.24776; Pattyn N, 2008, PHYSIOL BEHAV, V93, P369, DOI 10.1016/j.physbeh.2007.09.016; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ponsford JL, 2014, PSYCHIAT CLIN N AM, V37, P77, DOI 10.1016/j.psc.2013.10.001; Reed N, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008468; Ross KA, 2011, DEV MED CHILD NEUROL, V53, P692, DOI 10.1111/j.1469-8749.2011.03976.x; Schonberger M, 2014, J HEAD TRAUMA REHAB, V29, P427, DOI 10.1097/HTR.0b013e31829ddd08; Spencer-Smith M., 2011, HDB PEDIAT NEUROPSYC, P177; Stata Corp L, 2015, STAT STAT SOFTW REL, P14; Stone LL, 2010, CLIN CHILD FAM PSYCH, V13, P254, DOI 10.1007/s10567-010-0071-2; Sumpter R, 2011, BRAIN INJURY, V25, P1288, DOI 10.3109/02699052.2011.613090; Sundstrom A, 2007, BRAIN INJURY, V21, P1049, DOI 10.1080/02699050701630367; Taylor H.G., 2010, PEDIAT TRAUMATIC BRI, P145, DOI 10.1017/CBO9780511676383.009; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; TEASDALE G, 1974, LANCET, V2, P81; ter Wolbeek M, 2008, PEDIATRICS, V121, pE449, DOI 10.1542/peds.2007-1093; VANZOMEREN AH, 1984, CLOSED HEAD INJURY P; Varni JW, 2013, QUAL LIFE RES, V22, P2581, DOI 10.1007/s11136-013-0370-4; Varni JW, 2010, INT J PEDIATR OBES, V5, P34, DOI 10.3109/17477160903111706; Varni JW, 2009, PEDIATR DIABETES, V10, P321, DOI 10.1111/j.1399-5448.2008.00482.x; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 2006, DEV MED CHILD NEUROL, V48, P442, DOI 10.1017/S001216220600096X; Varni JW, 2004, J RHEUMATOL, V31, P2494; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Viner RM, 2008, ARCH PEDIAT ADOL MED, V162, P469, DOI 10.1001/archpedi.162.5.469; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	92	12	12	0	7	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2018	24	3					224	236		10.1017/S1355617717000893			13	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	FW9IX	WOS:000425650000002	28974281				2022-02-06	
J	Hobson, H; Hogeveen, J; Brewer, R; Catmur, C; Gordon, B; Krueger, F; Chau, A; Bird, G; Grafman, J				Hobson, Hannah; Hogeveen, Jeremy; Brewer, Rebecca; Catmur, Caroline; Gordon, Barry; Krueger, Frank; Chau, Aileen; Bird, Geoffrey; Grafman, Jordan			Language and alexithymia: Evidence for the role of the inferior frontal gyrus in acquired alexithymia	NEUROPSYCHOLOGIA			English	Article						Alexithymia; Language; Traumatic brain injury; Anterior insula; Inferior frontal gyrus	POSTTRAUMATIC-STRESS-DISORDER; AUTISTIC SPECTRUM DISORDER; EMOTION REGULATION; SOCIAL COGNITION; PERCEPTION; INTEROCEPTION; RECOGNITION; AWARENESS; CHILDREN; SPEECH	The clinical relevance of alexithymia, a condition associated with difficulties identifying and describing one's own emotion, is becoming ever more apparent. Increased rates of alexithymia are observed in multiple psychiatric conditions, and also in neurological conditions resulting from both organic and traumatic brain injury. The presence of alexithymia in these conditions predicts poorer regulation of one's emotions, decreased treatment response, and increased burden on carers. While clinically important, the aetiology of alexithymia is still a matter of debate, with several authors arguing for multiple 'routes' to impaired understanding of one's own emotions, which may or may not result in distinct subtypes of alexithymia. While previous studies support the role of impaired interoception (perceiving bodily states) in the development of alexithymia, the current study assessed whether acquired language impairment following traumatic brain injury, and damage to language regions, may also be associated with an increased risk of alexithymia. Within a sample of 129 participants with penetrating brain injury and 33 healthy controls, neuropsychological testing revealed that deficits in a non-emotional language task, object naming, were associated with alexithymia, specifically with difficulty identifying one's own emotions. Both region-of-interest and whole-brain lesion analyses revealed that damage to language regions in the inferior frontal gyrus was associated with the presence of both this language impairment and alexithymia. These results are consistent with a framework for acquired alexithymia that incorporates both interoceptive and language processes, and support the idea that brain injury may result in alexithymia via impairment in any one of a number of more basic processes.	[Hobson, Hannah] Univ Greenwich, Dept Psychol Social Work & Counselling, Avery Hill Rd, London SE9 2UG, England; [Hogeveen, Jeremy] Univ Calif Davis, MIND Inst, 2825 50th St, Sacramento, CA 95817 USA; [Brewer, Rebecca] Royal Holloway Univ London, Dept Psychol, Egham Hill, Egham TW20 0EX, Surrey, England; [Catmur, Caroline; Bird, Geoffrey] Kings Coll London, Inst Psychiat Psychol & Neurosci, MRC Social Genet & Dev Psychiat Ctr, 16 De Crespigny Pk, London SE5 8AF, England; [Gordon, Barry] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Gordon, Barry] Johns Hopkins Univ, Dept Cognit Sci, Baltimore, MD 21218 USA; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Chau, Aileen; Grafman, Jordan] Shirley Ryan Abil Lab, Cognit Neurosci Lab, Chicago, IL USA; [Bird, Geoffrey] Univ Oxford, Dept Expt Psychol, 5 Pk Rd, Oxford OX1 3PH, England; [Grafman, Jordan] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA		Hobson, H (corresponding author), Univ Greenwich, Dept Psychol Social Work & Counselling, Avery Hill Rd, London SE9 2UG, England.	h.hobson@greenwich.ac.uk	Bird, Geoff/AAA-3652-2020	Hobson, Hannah/0000-0002-7952-475X; Bird, Geoffrey/0000-0002-2310-0202; Catmur, Caroline/0000-0001-6996-4295	National Naval Medical Center; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Therapeutic Cognitive Neuroscience Fund	We thank our Vietnam veterans for their participation in the study. We are grateful to V. Raymont, S. Bonifant, B. Cheon, C. Ngo, A. Greathouse, K. Reding, and G. Tasick for testing and evaluating participants. The National Naval Medical Center and the National Institute of Neurological Disorders and Stroke provided their facilities and supported the research. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, the Department of Defense, or the U.S. Government. This research was supported by the Therapeutic Cognitive Neuroscience Fund (BG).	Amunts K, 2004, NEUROIMAGE, V22, P42, DOI 10.1016/j.neuroimage.2003.12.031; Amunts K, 2012, TRENDS COGN SCI, V16, P418, DOI 10.1016/j.tics.2012.06.005; Bagby RM, 2009, PERS INDIV DIFFER, V47, P413, DOI 10.1016/j.paid.2009.04.012; Barrett LF, 2006, PERS SOC PSYCHOL REV, V10, P20, DOI 10.1207/s15327957pspr1001_2; Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003; Becerra R, 2002, BRAIN INJURY, V16, P633, DOI 10.1080/02699050110119817; Bermond B., 1997, NONEXPRESSION EMOTIO, P115; Berthoz S, 2005, EUR PSYCHIAT, V20, P291, DOI 10.1016/j.eurpsy.2004.06.013; Berthoz S, 2013, PSYCHIAT RES, V208, P257, DOI 10.1016/j.psychres.2013.05.014; Bibby PA, 2011, PERS INDIV DIFFER, V51, P263, DOI 10.1016/j.paid.2010.05.001; Bird G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.61; Bird G, 2010, BRAIN, V133, P1515, DOI 10.1093/brain/awq060; Bogdanova Y, 2010, NEUROPSYCHOLOGIA, V48, P1295, DOI 10.1016/j.neuropsychologia.2009.12.033; Botting N, 2008, BRIT J DEV PSYCHOL, V26, P281, DOI 10.1348/026151007X235891; Brewer R, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150664; Brewer R, 2015, NEUROSCI BIOBEHAV R, V56, P348, DOI 10.1016/j.neubiorev.2015.07.006; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Buchsbaum BR, 2001, COGNITIVE SCI, V25, P663, DOI 10.1207/s15516709cog2505_2; Carlino E, 2010, PAIN, V151, P783, DOI 10.1016/j.pain.2010.09.013; Caruso D.R., 2002, MAYER SALOVEY CARUSO; Chahraoui K, 2008, REV NEUROL-FRANCE, V164, P242, DOI 10.1016/j.neurol.2007.09.006; Chen PY, 2016, CAMB CHINA LIBR, P1; Cook R, 2013, PSYCHOL SCI, V24, P723, DOI 10.1177/0956797612463582; Costa A, 2010, PSYCHOSOMATICS, V51, P22, DOI 10.1176/appi.psy.51.1.22; Eizaguirre AE, 2004, PERS INDIV DIFFER, V36, P321, DOI 10.1016/S0191-8869(03)00099-0; Ernst T, 2002, NEUROLOGY, V59, P1343, DOI 10.1212/01.WNL.0000031811.45569.B0; Ferguson E, 2009, J PERS, V77, P883, DOI 10.1111/j.1467-6494.2009.00568.x; Fiene L, 2015, AUTISM RES, V8, P709, DOI 10.1002/aur.1486; Ford JA, 2003, J SPEECH LANG HEAR R, V46, P21, DOI 10.1044/1092-4388(2003/002); Friederici AD, 2012, TRENDS COGN SCI, V16, P262, DOI 10.1016/j.tics.2012.04.001; Fujiki M, 2002, LANG SPEECH HEAR SER, V33, P102, DOI 10.1044/0161-1461(2002/008); Gaigg S.B., 2016, AUTISM, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CB09781107415324.004]; Garfinkel SN, 2016, BIOL PSYCHOL, V114, P117, DOI 10.1016/j.biopsycho.2015.12.003; GESCHWIN.N, 1970, SCIENCE, V170, P940, DOI 10.1126/science.170.3961.940; Glascher J, 2010, P NATL ACAD SCI USA, V107, P4705, DOI 10.1073/pnas.0910397107; Grynberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042429; Gu XS, 2013, J COMP NEUROL, V521, P3371, DOI 10.1002/cne.23368; Harry A, 2014, CLIN NEUROPSYCHOL, V28, P486, DOI 10.1080/13854046.2014.892155; Heaton P, 2012, PSYCHOL MED, V42, P2453, DOI 10.1017/S0033291712000621; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P62, DOI 10.1016/j.neuropsychologia.2005.04.011; Herbert BM, 2011, J PERS, V79, P1149, DOI 10.1111/j.1467-6494.2011.00717.x; Hill E, 2004, J AUTISM DEV DISORD, V34, P229, DOI 10.1023/B:JADD.0000022613.41399.14; Hogeveen J, 2016, NEUROPSYCHOLOGIA, V82, P142, DOI 10.1016/j.neuropsychologia.2016.01.021; Hsieh S, 2012, NEUROPSYCHOLOGY, V26, P624, DOI 10.1037/a0029326; Hsing CK, 2013, INT J PSYCHOL RES, V6, P56; JERNIGAN TL, 1993, ARCH NEUROL-CHICAGO, V50, P250, DOI 10.1001/archneur.1993.00540030016007; Kano M, 2011, PSYCHOSOM MED, V73, P588, DOI 10.1097/PSY.0b013e318223c7f8; Karukivi M, 2014, WORLD J PSYCHIATR, V4, P91, DOI 10.5498/wjp.v4.i4.91; Karukivi M, 2012, COMPR PSYCHIAT, V53, P54, DOI 10.1016/j.comppsych.2011.01.012; KEANE TM, 1988, J CONSULT CLIN PSYCH, V56, P85, DOI 10.1037/0022-006X.56.1.85; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; Kokkonen P, 2003, J PSYCHOSOM RES, V54, P491, DOI 10.1016/S0022-3999(02)00465-8; Kumfor F, 2012, NEUROPSYCHOL REV, V22, P280, DOI 10.1007/s11065-012-9201-6; LAMBERTY GJ, 1995, J NEUROPSYCH CLIN N, V7, P320; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; Lindell AK, 2006, NEUROPSYCHOL REV, V16, P131, DOI 10.1007/s11065-006-9011-9; Lindquist KA, 2006, EMOTION, V6, P125, DOI 10.1037/1528-3542.6.1.125; Lindquist KA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00444; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Lough S, 2001, NEUROCASE, V7, P123, DOI 10.1076/neur.7.2.123.16266; Lough S, 2002, J PSYCHOSOM RES, V53, P639, DOI 10.1016/S0022-3999(02)00433-6; LUDLOW CL, 1986, BRAIN, V109, P55, DOI 10.1093/brain/109.1.55; Lumley MA, 2007, J PERS ASSESS, V89, P230, DOI 10.1080/00223890701629698; Lupyan G, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00054; MALATESTA CZ, 1988, BRIT J SOC PSYCHOL, V27, P91, DOI 10.1111/j.2044-8309.1988.tb00807.x; McCallum M, 2003, PSYCHOL PSYCHOTHER-T, V76, P133, DOI 10.1348/147608303765951177; McDonald S, 2011, BRAIN IMPAIR, V12, P165; Merkenschlager A, 2012, FOLIA PHONIATR LOGO, V64, P73, DOI 10.1159/000335875; Messina A, 2014, J PSYCHOPATHOL, V20, P38; MILLER BL, 1995, DEMENTIA, V6, P195, DOI 10.1159/000106946; Miller LA, 2012, BEHAV NEUROL, V25, P53, DOI [10.1155/2012/683052, 10.3233/BEN-2012-0349]; Montebarocci O, 2011, PSYCHIAT QUART, V82, P245, DOI 10.1007/s11126-010-9166-7; Mori S, 2005, MRI ATLAS HUMAN WHIT; Murphy J., 2017, J EXP PSYCH IN PRESS; Murphy J, 2017, DEV COGN NEUROS-NETH, V23, P45, DOI 10.1016/j.dcn.2016.12.006; Nelson KE, 2011, FIRST LANG, V31, P164, DOI 10.1177/0142723710391887; Norman H, 2015, SCAND J PSYCHOL, V56, P405, DOI 10.1111/sjop.12217; Pandey R, 2011, EUR J PSYCHOL, V7, P604; PARKER JDA, 1993, EUR J PERSONALITY, V7, P221, DOI 10.1002/per.2410070403; Paulesu E, 1997, NEUROREPORT, V8, P2011, DOI 10.1097/00001756-199705260-00042; Pinard L, 1996, AM J ADDICTION, V5, P32; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Roberson D, 2000, MEM COGNITION, V28, P977, DOI 10.3758/BF03209345; Roberson D, 2010, EMOT REV, V2, P255, DOI 10.1177/1754073910361979; Schaefer M, 2014, BIOL PSYCHOL, V101, P69, DOI 10.1016/j.biopsycho.2014.05.012; Shah P, 2016, CORTEX, V81, P215, DOI 10.1016/j.cortex.2016.03.021; Silani G, 2008, SOC NEUROSCI-UK, V3, P97, DOI 10.1080/17470910701577020; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; TAYLOR GJ, 1991, PSYCHOSOMATICS, V32, P153, DOI 10.1016/S0033-3182(91)72086-0; Thompson LI, 1989, CLIN NEUROPSYCHOL, V3, P184, DOI [DOI 10.1080/13854048908403291, 10.1080/13854048908403291]; Thompson PM, 2005, P NATL ACAD SCI USA, V102, P15647, DOI 10.1073/pnas.0502548102; Thorberg FA, 2009, ADDICT BEHAV, V34, P237, DOI 10.1016/j.addbeh.2008.10.016; Tranel D, 2005, BRAIN, V128, P2872, DOI 10.1093/brain/awh643; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van 't Wout M, 2007, COMPR PSYCHIAT, V48, P27, DOI 10.1016/j.comppsych.2006.07.003; Wagner H, 2008, J RES PERS, V42, P83, DOI 10.1016/j.jrp.2007.04.001; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P471, DOI 10.1017/S1355617707070518; Woolley JD, 2007, NEUROLOGY, V69, P1424, DOI 10.1212/01.wnl.0000277461.06713.23	100	12	13	2	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	MAR	2018	111						229	240		10.1016/j.neuropsychologia.2017.12.037			12	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	GD6UQ	WOS:000430644300027	29360519	Green Accepted, Green Submitted			2022-02-06	
J	Karelina, K; Nicholson, S; Weil, ZM				Karelina, Kate; Nicholson, Samuel; Weil, Zachary M.			Minocycline blocks traumatic brain injury-induced alcohol consumption and nucleus accumbens inflammation in adolescent male mice	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Traumatic brain injury; Alcohol; Neuroinflammation; Microglia; Minocycline	VENTRAL TEGMENTAL AREA; MICROGLIAL ACTIVATION; ETHANOL-CONSUMPTION; SUBSTANCE-ABUSE; DRUG-USE; DRINKING; NEUROINFLAMMATION; INTERLEUKIN-1; DEGENERATION; MODULATION	Alcohol use is a well characterized risk factor for traumatic brain injury (TBI); however, emerging clinical and experimental research suggests that TBI may also be an independent risk factor for the development of alcohol use disorders. In particular, TBIs incurred early in life predict the development of problem alcohol use and increase vulnerability to neuroinflammation as a consequence of alcohol use. Critically, the neuroinflammatory response to alcohol, mediated in large part by microglia, may also function as a driver of further alcohol use. Here, we tested the hypothesis that TBI increases alcohol consumption through microglia-mediated neuroinflammation. Mice were injured as juveniles and alcohol consumption and preference were assessed in a free-choice voluntary drinking paradigm in adolescence. TBI increased alcohol consumption; however, treatment with minocycline, an inhibitor of microglial activation, reduced alcohol intake in TBI mice to sham levels. Moreover, a single injection of ethanol (2 g/kg) significantly increased microglial activation in the nucleus accumbens and microglial expression of the proinfiammatory cytokine IL-1 beta in TBI, but not sham or minocycline-treated, mice. Our data implicate TBI-induced microglial activation as a possible mechanism for the development of alcohol use disorders. (C) 2018 Elsevier Inc. All rights reserved.	[Karelina, Kate; Nicholson, Samuel; Weil, Zachary M.] Ohio State Univ, Wexner Med Ctr, Ctr Brain & Spinal Cord Repair, Grp Behav Neuroendocrinol,Dept Neurosci, Columbus, OH 43210 USA		Karelina, K (corresponding author), Ohio State Univ, Wexner Med Ctr, Ctr Brain & Spinal Cord Repair, Grp Behav Neuroendocrinol,Dept Neurosci, Columbus, OH 43210 USA.	ekaterina.karelina@osumc.edu; nicholson.208@buckeyemail.osu.edu; zachary.weil@osumc.edu	Weil, Zachary M/A-2439-2008	Weil, Zachary M/0000-0003-3758-1809	OSU Neurological Institute Pilot Award; Huron Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS NS045758]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS104177] Funding Source: NIH RePORTER	This work was supported by an OSU Neurological Institute Pilot Award, the Huron Foundation, and the National Institutes of Health (NINDS NS045758). The authors have no financial or personal conflicts of interest to declare. The funding sources had no involvement in the conduct of the research or preparation of the article.	Agrawal RG, 2011, BRAIN BEHAV IMMUN, V25, pS165, DOI 10.1016/j.bbi.2011.03.002; Albrechet-Souza L, 2015, ALCOHOL CLIN EXP RES, V39, P1609, DOI 10.1111/acer.12825; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Blednov YA, 2011, BRAIN BEHAV IMMUN, V25, pS92, DOI 10.1016/j.bbi.2011.01.008; Blednov YA, 2005, BEHAV BRAIN RES, V165, P110, DOI 10.1016/j.bbr.2005.06.026; Blednov YA, 2012, ADDICT BIOL, V17, P108, DOI 10.1111/j.1369-1600.2010.00284.x; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Chen H, 2009, NEUROSCI LETT, V452, P258, DOI 10.1016/j.neulet.2009.01.078; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Collins-Praino LE, 2018, BEHAV BRAIN RES, V336, P22, DOI 10.1016/j.bbr.2017.08.035; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Crews FT, 2011, BRAIN BEHAV IMMUN, V25, pS4, DOI 10.1016/j.bbi.2011.03.003; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Doremus TL, 2005, ALCOHOL CLIN EXP RES, V29, P1796, DOI 10.1097/01.alc.0000183007.65998.aa; Erny D, 2017, IMMUNOLOGY, V150, P7, DOI 10.1111/imm.12645; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Fernandez-Lizarbe S, 2009, J IMMUNOL, V183, P4733, DOI 10.4049/jimmunol.0803590; Fishbein D, 2016, INT J OFFENDER THER, V60, P575, DOI 10.1177/0306624X14554778; Frank MG, 2011, BRAIN BEHAV IMMUN, V25, pS21, DOI 10.1016/j.bbi.2011.01.005; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; GEORGE SR, 1995, J PHARMACOL EXP THER, V273, P373; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hutchinson MR, 2012, J NEUROSCI, V32, P11187, DOI 10.1523/JNEUROSCI.0684-12.2012; Hwa LS, 2016, PSYCHOPHARMACOLOGY, V233, P681, DOI 10.1007/s00213-015-4144-2; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Joldes GR, 2016, COMPUTATIONAL BIOMEC, P177; Jones NC, 2005, EUR J NEUROSCI, V22, P72, DOI 10.1111/j.1460-9568.2005.04221.x; Karelina K, 2017, EXP NEUROL, V297, P110, DOI 10.1016/j.expneurol.2017.08.003; Karelina K, 2017, BRAIN BEHAV IMMUN, V60, P304, DOI 10.1016/j.bbi.2016.11.009; Keitz M., 2003, Neural Plasticity, V10, P121, DOI 10.1155/NP.2003.121; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Kremlev SG, 2004, J NEUROIMMUNOL, V149, P1, DOI 10.1016/j.jneuroim.2003.11.012; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lacagnina MJ, 2017, NEUROPSYCHOPHARMACOL, V42, P2128, DOI 10.1038/npp.2017.82; Lim YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125130; Lippai D, 2013, J LEUKOCYTE BIOL, V94, P171, DOI 10.1189/jlb.1212659; llie G., 2015, HEAD TRAUMA REHABIL, V30, P293; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; Mayfield J, 2013, CURR OPIN NEUROBIOL, V23, P513, DOI 10.1016/j.conb.2013.01.024; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Melendez RI, 2011, ALCOHOL CLIN EXP RES, V35, P652, DOI 10.1111/j.1530-0277.2010.01383.x; Moller T, 2016, GLIA, V64, P1788, DOI 10.1002/glia.23007; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Pascual M, 2011, BRAIN BEHAV IMMUN, V25, pS80, DOI 10.1016/j.bbi.2011.02.012; Peterson VL, 2017, BEHAV BRAIN RES, V323, P172, DOI 10.1016/j.bbr.2017.01.049; Redin G S, 1966, Antimicrob Agents Chemother (Bethesda), V6, P371; Saiz PA, 2009, ALCOHOL CLIN EXP RES, V33, P2147, DOI 10.1111/j.1530-0277.2009.01058.x; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Shin SS, 2013, J NEUROTRAUM, V30, P259, DOI 10.1089/neu.2012.2462; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Stirling DP, 2005, NEUROSCIENTIST, V11, P308, DOI 10.1177/1073858405275175; Vaaramo K, 2014, EUR J NEUROL, V21, P293, DOI 10.1111/ene.12302; Vaughn AC, 2017, ACTA NEUROBIOL EXP, V77, P18; Vetter-O'Hagen C, 2009, ALCOHOL ALCOHOLISM, V44, P547, DOI 10.1093/alcalc/agp048; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Weil ZM, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00135; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Winqvist S, 2007, BRAIN INJURY, V21, P1079, DOI 10.1080/02699050701553221; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Yoneyama N, 2008, ALCOHOL, V42, P149, DOI 10.1016/j.alcohol.2007.12.006; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang L, 2006, PROG NEURO-PSYCHOPH, V30, P1381, DOI 10.1016/j.pnpbp.2006.05.015	80	12	13	1	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	MAR	2018	69						532	539		10.1016/j.bbi.2018.01.012			8	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	GG7VB	WOS:000432905200047	29395778	Green Accepted			2022-02-06	
J	Liao, YT; Yang, YH; Kuo, TY; Liang, HY; Huang, KY; Wang, TN; Lee, Y; McIntyre, RS; Chen, VCH				Liao, Yin-To; Yang, Yao-Hsu; Kuo, Ting-Yu; Liang, Hsin-Yi; Huang, Kuo-You; Wang, Tsu-Nai; Lee, Yena; McIntyre, Roger S.; Chen, Vincent Chin-Hung			Dosage of methylphenidate and traumatic brain injury in ADHD: a population-based study in Taiwan	EUROPEAN CHILD & ADOLESCENT PSYCHIATRY			English	Article						Attention-deficit/hyperactivity disorder; Traumatic brain injury; Methylphenidate	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; UNITED-STATES; CHILDREN; MEDICATION; RISK; ADOLESCENTS; DISCONTINUATION; PERSISTENCE; PREVALENCE	Preventive effect of stimulants on the risk of brain injuries had been reported. The aim of this study is to determine the extent to which methylphenidate (MPH) prescription moderates the risk of traumatic brain injuries (TBI) in individuals with attention-deficit/hyperactivity disorder (ADHD). Individuals with a recent diagnosis of ADHD between January 1997 and December 2013 (n = 163,618) were identified from Taiwan's National Health Insurance Research Database. A total of 124,438 adolescents and children with ADHD and without prior TBI diagnoses were included and evaluated for subsequent TBI. Methylphenidate prescription duration was subgrouped by the annual average cumulative defined daily dose (DDD): 0, > 0 to <= 28, > 28 to <= 84, and > 84. We identified 11,463 diagnoses of TBI among 124,438 adolescents and children with ADHD. A Cox regression model was used to investigate whether MPH prescription influenced the risk for TBI after adjusting for sex, age, level of urbanization, seizure, autism and sedative-anxiolytics use. A reduced TBI incidence was observed with MPH prescription DDDs > 84. The protective effect of MPH against TBI persisted after adjusting for confounding factors [hazard ratio (HR) = 0.49; 95% confidence interval (CI): 0.47-0.51]. There was also statistically significant difference in risk for TBI in subjects receiving > 0 to <= 28 or > 28 to <= 84 DDDs of MPH treatment (HR = 0.88, 95% CI = 0.83-0.92; HR = 0.76, 95% CI = 0.72-0.80, respectively) when compared with subjects not receiving treatment with MPH. Treatment with MPH for greater than 84 DDDs reduced the risk for TBI among children with ADHD.	[Liao, Yin-To] Chung Shan Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Liao, Yin-To] Chung Shan Med Univ, Sch Med, Dept Psychiat, Taichung, Taiwan; [Yang, Yao-Hsu] Chiayi Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan; [Yang, Yao-Hsu; Kuo, Ting-Yu] Chiayi Chang Gung Mem Hosp, Ctr Excellence Chang Gung Res Datalink, Chiayi, Taiwan; [Yang, Yao-Hsu] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan; [Liang, Hsin-Yi] Linkou Chang Gung Mem Hosp, Dept Child Psychiat, Taoyuan, Taiwan; [Liang, Hsin-Yi; Chen, Vincent Chin-Hung] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Huang, Kuo-You] Chung Shan Med Univ, Dept Speech Language Pathol & Audiol, Taichung, Taiwan; [Wang, Tsu-Nai] Kaohsiung Med Univ, Dept Publ Hlth, Coll Hlth Sci, Kaohsiung, Taiwan; [Lee, Yena; McIntyre, Roger S.] Univ Toronto, Univ Hlth Network, Mood Disorders Psychopharmacol Unit, Toronto, ON, Canada; [Lee, Yena; McIntyre, Roger S.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [McIntyre, Roger S.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [McIntyre, Roger S.] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada; [Chen, Vincent Chin-Hung] Chiayi Chang Gung Mem Hosp, Dept Psychiat, 6-8 West Sect,Jiapu Rd, Puzi 613, Chiayi, Taiwan		Chen, VCH (corresponding author), Chang Gung Univ, Sch Med, Taoyuan, Taiwan.; Chen, VCH (corresponding author), Chiayi Chang Gung Mem Hosp, Dept Psychiat, 6-8 West Sect,Jiapu Rd, Puzi 613, Chiayi, Taiwan.	hjcch@yahoo.com.tw	Students, MDPU/ABE-8402-2020; Lee, Yena/L-5505-2019; Lee, Yena/D-9016-2019; 楊, 曜旭/A-3450-2019; McIntyre, Roger/AAU-1000-2020	Lee, Yena/0000-0003-0629-9456; Lee, Yena/0000-0003-0629-9456; 楊, 曜旭/0000-0002-8080-0504; McIntyre, Roger/0000-0003-4733-2523; Wang, Tsu-Nai/0000-0002-0278-289X	Ministry of Science and Technology, R.O.C. [MOST 102-2314-B-040-004-MY3]; Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital [CMRPG6E0261]	The present study is supported in part by the Ministry of Science and Technology, R.O.C. (MOST 102-2314-B-040-004-MY3) and the Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital (CMRPG6E0261). All funding sources had no role in the study design, data collection, and analysis.	Aduen PA, 2015, J PSYCHIATR RES, V64, P59, DOI 10.1016/j.jpsychires.2015.03.009; Amiri A, 2013, PROG NEURO-PSYCHOPH, V47, P20, DOI 10.1016/j.pnpbp.2013.07.018; Bali Vishal, 2015, J Manag Care Spec Pharm, V21, P486; Barkley RA, 2006, J AM ACAD CHILD PSY, V45, P192, DOI 10.1097/01.chi.0000189134.97436.e2; Barkley RA, 2002, J ABNORM PSYCHOL, V111, P279, DOI 10.1037//0021-843X.111.2.279; Cairney J, 2014, DEV MED CHILD NEUROL, V56, P1040, DOI 10.1111/dmcn.12509; Chang Z, 2014, JAMA PSYCHIAT, V71, P319, DOI 10.1001/jamapsychiatry.2013.4174; Chen CY, 2011, J CHILD ADOL PSYCHOP, V21, P265, DOI 10.1089/cap.2010.0107; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Clancy TA, 2006, J CLIN CHILD ADOLESC, V35, P203, DOI 10.1207/s15374424jccp3502_4; Clemow DB, 2015, J PSYCHOPHARMACOL, V29, P1221, DOI 10.1177/0269881115602489; Dalsgaard S, 2015, LANCET PSYCHIAT, V2, P702, DOI 10.1016/S2215-0366(15)00271-0; Ertan C, 2012, EMERG MED J, V29, P911, DOI 10.1136/emermed-2011-200298; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fredriksen M, 2014, EUR NEUROPSYCHOPHARM, V24, P1873, DOI 10.1016/j.euroneuro.2014.09.013; Gajria K, 2014, NEUROPSYCH DIS TREAT, V10, P1543, DOI 10.2147/NDT.S65721; Gazer-Snitovsky M, 2019, J ATTEN DISORD, V23, P135, DOI 10.1177/1087054715580844; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Hong JH, 2013, PATIENT PREFER ADHER, V7, P987, DOI 10.2147/PPA.S50628; Hsu YC, 2013, SOC PSYCH PSYCH EPID, V48, P1889, DOI 10.1007/s00127-013-0702-2; Lee MJ, 2016, J AFFECT DISORDERS, V189, P110, DOI 10.1016/j.jad.2015.09.015; Lichtenstein P, 2012, NEW ENGL J MED, V367, P2006, DOI 10.1056/NEJMoa1203241; Man KKC, 2015, PEDIATRICS, V135, P40, DOI 10.1542/peds.2014-1738; Mikolajczyk R, 2015, JAMA PEDIATR, V169, P391, DOI 10.1001/jamapediatrics.2014.3275; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Raman SR, 2013, INJURY PREV, V19, P164, DOI 10.1136/injuryprev-2012-040483; Rowe R, 2004, J PEDIATR PSYCHOL, V29, P119, DOI 10.1093/jpepsy/jsh015; Schweren LJS, 2013, EUR NEUROPSYCHOPHARM, V23, P1151, DOI 10.1016/j.euroneuro.2012.10.014; Setyawan J, 2015, ADHD-ATTEND DEFICIT, V7, P75, DOI 10.1007/s12402-014-0143-0; Swanson JM, 2003, J CLIN PSYCHIAT, V64, P35; Tai YM, 2013, RES DEV DISABIL, V34, P1100, DOI 10.1016/j.ridd.2012.11.027; Tsai CJ, 2018, J ATTEN DISORD, V22, P229, DOI 10.1177/1087054715587094; Van Der Marel K, 2015, NEUROSCIENCE, V309, P243, DOI 10.1016/j.neuroscience.2015.04.044; Vaughan B, 2012, CHILD ADOL PSYCH CL, V21, P941, DOI 10.1016/j.chc.2012.07.005; Visser S. N., 2010, Morbidity and Mortality Weekly Report, V59, P1439; Wiguna T, 2012, CLIN NEUROPHARMACOL, V35, P81, DOI 10.1097/WNF.0b013e3182452572; Winston FK, 2013, JAMA PEDIATR, V167, P892, DOI 10.1001/jamapediatrics.2013.2315; YEOH C, 1993, BRIT MED J, V306, P972, DOI 10.1136/bmj.306.6883.972	39	12	12	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1018-8827	1435-165X		EUR CHILD ADOLES PSY	Eur. Child Adolesc. Psych.	MAR	2018	27	3					279	288		10.1007/s00787-017-1042-7			10	Psychology, Developmental; Pediatrics; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Pediatrics; Psychiatry	FZ4WL	WOS:000427592600004	28856464				2022-02-06	
J	Modi, AC; Vannest, J; Combs, A; Turnier, L; Wade, SL				Modi, Avani C.; Vannest, Jennifer; Combs, Angela; Turnier, Luke; Wade, Shari L.			Pattern of executive functioning in adolescents with epilepsy: A multimethod measurement approach	EPILEPSY & BEHAVIOR			English	Article						Seizure; Neuropsychological; Teenagers; Measurement; NIH toolbox; Working memory	TRAUMATIC BRAIN-INJURY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NEW-ONSET EPILEPSY; QUALITY-OF-LIFE; CHILDHOOD EPILEPSY; CORTICAL THICKNESS; PEDIATRIC EPILEPSY; ABSENCE EPILEPSY; WORKING-MEMORY; PARENT-REPORT	Youth with epilepsy demonstrate deficits in executive functioning (EF), the skills necessary for goal-directed behavior (e.g., problem-solving, initiating, monitoring, organization, planning, and working memory). Despite 30-50% of youth with epilepsy demonstrating EF deficits, no extant studies have utilized both performance and questionnaire-based measures to examine the pattern of EF deficits in adolescents with epilepsy. Study aims were to 1) identify the pattern of EF deficits in adolescents with epilepsy and 2) identity which assessment tools are most sensitive to EF deficits in this population (adolescents, ages 13-17, with epilepsy). An exploratory aim was to examine group differences on measures of EF by epilepsy type. Standard performance-based neuropsychological measures (Wechsler Intelligence Scale for Children - Version V or Wechsler Adult Intelligence Scale Working Memory Index-Version IV, Delis Kaplan Executive Functioning System, NIH Toolbox, Test of Everyday Attention for Children) and the Behavior Rating Inventory of Executive Functioning (BRIEF) comprised the multimethod assessment battery. Depending on the measure, 30% of adolescents with epilepsy had deficits in working memory, 17% in cognitive flexibility/problem solving, 6% in inhibition, and 18% in planning/organization. Attention was a significant problem for 15% of adolescents with epilepsy. Correlations among the various EF measures were quite poor. Across various EF domains, results indicated that adolescents with localization-related epilepsy demonstrated better EF skills compared to adolescents with unclassified epilepsy. Overall, our findings suggest that executive functioning deficits are selective and different from those observed in other neurological populations (e.g., attention deficit hyperactivity disorder (ADHD), traumatic brain injury) where problems with self regulation (i.e., inhibition, planning/organization) are more pronounced. These findings support utilizing multiple measures, including both performance-based neuropsychological tests and parent- and self-reports, to assess executive functioning difficulties in adolescents with epilepsy as they are uniquely sensitive to executive functioning domains. Adolescents with unclassified epilepsy also appear to be at higher risk for El' deficits and thus represent an important group to target for intervention. (C) 2018 Elsevier Inc. All rights reserved.	[Modi, Avani C.; Vannest, Jennifer; Combs, Angela; Turnier, Luke; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA		Modi, AC (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Promot Treatment Adherence & Self Management, 3333 Burnet Ave,MLC 7019, Cincinnati, OH 45229 USA.	avani.modi@cchmc.org		Modi, Avani/0000-0002-7580-3751	Research Innovation Pilot Program through Cincinnati Children's Hospital Medical Center	This work was supported by the Research Innovation Pilot Program through Cincinnati Children's Hospital Medical Center. The authors would like to thank the adolescents and their families who participated in this yearlong study. They would also like to thank the research staff involved in data collection.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Bagner DM, 2007, CHILD HEALTH CARE, V36, P169, DOI 10.1080/02739610701335001; Bailet LL, 2000, EPILEPSIA, V41, P426, DOI 10.1111/j.1528-1157.2000.tb00184.x; Campiglia M, 2014, EPILEPSY BEHAV, V39, P12, DOI 10.1016/j.yebeh.2014.07.023; Casaletto KB, 2015, J INT NEUROPSYCH SOC, V21, P378, DOI 10.1017/S1355617715000351; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Delis DC., 2001, DELIS KAPLAN EXECUTI; Ernst M, 2006, PSYCHOL MED, V36, P299, DOI 10.1017/S0033291705005891; Fastenau PS, 2004, EPILEPSIA, V45, P1261, DOI 10.1111/j.0013-9580.2004.15204.x; Gardner M, 2005, DEV PSYCHOL, V41, P625, DOI 10.1037/0012-1649.41.4.625; Gershon R., 2012, NIH TOOLBOX SCORING; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; Gioia G.A., 2000, BRIEF BEHAV RATING I; Guy SC, 2004, BRIEF SR BEHAV RATIN; Hermann B, 2006, BRAIN, V129, P2609, DOI 10.1093/brain/awl196; Hermann BP, 2008, EPILEPSIA, V49, P1847, DOI 10.1111/j.1528-1167.2008.01735.x; Hoie B, 2008, DEV MED CHILD NEUROL, V50, P530, DOI 10.1111/j.1469-8749.2008.03015.x; Hoie B, 2005, SEIZURE-EUR J EPILEP, V14, P223, DOI 10.1016/j.seizure.2004.10.006; Holbein CE, 2018, J PEDIAT PS IN PRESS; Isquith PK, 2014, APPL NEUROPSYCH-CHIL, V3, P197, DOI 10.1080/21622965.2013.870014; Jackson DC, 2013, J PEDIATR-US, V162, P1047, DOI 10.1016/j.jpeds.2012.10.046; Jones JE, 2010, EPILEPSY BEHAV, V18, P211, DOI 10.1016/j.yebeh.2010.03.015; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kernan CL, 2012, EPILEPSIA, V53, P2156, DOI 10.1111/j.1528-1167.2012.03706.x; Krivitzky LS, 2016, CHILD NEUROPSYCHOL, V22, P870, DOI 10.1080/09297049.2015.1054272; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; MacAllister WS, 2012, CHILD NEUROPSYCHOL, V18, P404, DOI 10.1080/09297049.2011.613812; Mahone EM, 2009, J INT NEUROPSYCH SOC, V15, P31, DOI 10.1017/S1355617708090164; Manly T., 1998, TEST EVERYDAY ATTENT; Masur D, 2013, NEUROLOGY, V81, P1572, DOI 10.1212/WNL.0b013e3182a9f3ca; McNally K, 2010, DIABETES CARE, V33, P1159, DOI 10.2337/dc09-2116; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Modi AC, 2017, EPILEPSY BEHAV, V72, P114, DOI 10.1016/j.yebeh.2017.04.009; Nakao K, 1992, 74 U CHIC NAT OP RES; Nassau JH, 1997, J PEDIATR PSYCHOL, V22, P771, DOI 10.1093/jpepsy/22.6.771; Parrish J, 2007, DEV MED CHILD NEUROL, V49, P412, DOI 10.1111/j.1469-8749.2007.00412.x; Pavone P, 2001, NEUROLOGY, V56, P1047, DOI 10.1212/WNL.56.8.1047; Piccinelli P, 2010, SEIZURE-EUR J EPILEP, V19, P540, DOI 10.1016/j.seizure.2010.07.014; Rapport MD, 2013, CLIN PSYCHOL REV, V33, P1237, DOI 10.1016/j.cpr.2013.08.005; Schraegle WA, 2016, EPILEPSY BEHAV, V62, P20, DOI 10.1016/j.yebeh.2016.06.006; Sherman EMS, 2006, EPILEPSIA, V47, P1936, DOI 10.1111/j.1528-1167.2006.00816.x; Slick DJ, 2006, CHILD NEUROPSYCHOL, V12, P181, DOI 10.1080/09297040600611320; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tranel D, 1994, DEV CONCEPT EXECUTIV; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Weschler D, 2008, WECHSLER ADULT INTEL; Weschler D., 2014, WECHLER INTELLIGENCE; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006	49	12	13	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	MAR	2018	80						5	10		10.1016/j.yebeh.2017.12.021			6	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	GA0PK	WOS:000428016400002	29396361				2022-02-06	
J	Paniccia, M; Verweel, L; Thomas, SG; Taha, T; Keightley, M; Wilson, KE; Reed, N				Paniccia, Melissa; Verweel, Lee; Thomas, Scott G.; Taha, Tim; Keightley, Michelle; Wilson, Katherine E.; Reed, Nick			Heart rate variability following youth concussion: how do autonomic regulation and concussion symptoms differ over time postinjury?	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; RECOVERY; PERFORMANCE; DYSFUNCTION; STATEMENT; IMPACT; SPORT; CHILD	Objectives Following youth concussion, objective physiological indicators are needed to corroborate changes in subjective clinical measures. The objectives of the current study were to: (1) explore the effect of concussion on heart rate variability (HRV) across days postinjury in youth athletes aged 13-18 years old, compared with healthy age-matched and sex-matched controls and (2) examine the relationship between postconcussion symptom domains (physical, cognitive, fatigue and emotional) and HRV. Methods Prospective, longitudinal, case-control study (N=44). This study comprised 29 concussed athletes between the ages of 13 and 18 years old (21 females, 8 males) and 15 age-matched and sex-matched controls). All participants completed baseline testing, which included demographic information (age, sex, concussion history), self-reported concussion symptoms (Post-Concussion Symptom Inventory [PCSI]) and a 24-hour heart rate recording via the Polar RS800CX system. The PCSI and HRV were collected weekly while the participant was symptomatic and then 1, 3 and 6 months following symptom resolution. HRV variables included time and frequency domain measures. Data visualisations and mixed effects modelling were used to derive parsimonious models. Results HRV increased across days postinjury. Concussion symptom domains (physical, cognitive, fatigue and emotional) all had a significant main effect on HRV; concussed participants who reported more symptoms had higher HRV compared with those who reported fewer symptoms. Visualisations of HRV depict the recovery trajectory as non-linear across time. No significant differences on HRV measures were found between concussed and control participants. Conclusion These preliminary findings provide the foundation to understand the varied trajectory and relationship between objective physiological measures and subjective symptom reporting.	[Paniccia, Melissa; Verweel, Lee; Wilson, Katherine E.; Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Concuss Ctr, Toronto, ON, Canada; [Thomas, Scott G.; Taha, Tim] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp Toronto, Bloorview Res Inst, Toronto, ON, Canada; [Keightley, Michelle; Reed, Nick] Univ Toronto, Rehabil Sci Inst, Fac Med, Toronto, ON, Canada; [Keightley, Michelle; Reed, Nick] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Paniccia, M (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Concuss Ctr, Toronto, ON, Canada.	melissa.paniccia@utoronto.ca	Thomas, Scott G/G-4522-2012	Thomas, Scott G/0000-0002-5564-4271	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [127048]; Ontario Neurotrauma Foundation; Ontario Brain Institute; Ontario government	This is work was funded by the Canadian Institutes of Health Research (#127048), the Ontario Neurotrauma Foundation and the Ontario Brain Institute. The Ontario Brain Institute is an independent non-profit corporation, funded partially by the Ontario government.	Aubert AE, 2003, SPORTS MED, V33, P889, DOI 10.2165/00007256-200333120-00003; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Berkoff D. J, 2008, CLIN J SPORT MED OFF, V18, P197; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Blake TA, 2016, BRAIN INJURY, V30, P132, DOI 10.3109/02699052.2015.1093659; Camm AJ, 1996, EUR HEART J, V17, P354; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; ECKBERG DL, 1980, AM J PHYSIOL, V239, pH581, DOI 10.1152/ajpheart.1980.239.5.H581; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Faulkner MS, 2003, HEART LUNG, V32, P10, DOI 10.1067/mhl.2003.6; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gioia G, 2006, ACUTE CONCUSSION EVA; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gutin B, 2005, MED SCI SPORT EXER, V37, P1856, DOI 10.1249/01.mss.0000175867.98628.27; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Hinds A, 2016, J NEUROL NEUROPHYSIO, V7, P388, DOI DOI 10.4172/2155-9562.1000388; Hutchison MG, 2016, J HEAD TRAUMA REHAB, P1; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Iverson GL, 2005, BRAIN INJURY, V19, P11, DOI 10.1080/02699050410001720068; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Kim Hun-Sung, 2014, J Diabetes Sci Technol, V8, P431; Kleiger RE, 2005, ANN NONINVAS ELECTRO, V10, P88, DOI 10.1111/j.1542-474X.2005.10101.x; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2016, BRIT J SPORT MED, P1; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Nunan D, 2010, PACE, V33, P1407, DOI 10.1111/j.1540-8159.2010.02841.x; Paniccia M, 2018, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00753; Paniccia M, 2017, AUTON NEUROSCI-BASIC, V208, P1, DOI 10.1016/j.autneu.2017.08.008; Reed N, 2014, HDB PARENTS KIDS INT; Reed N, 2014, JOVE-J VIS EXP, DOI 10.3791/51892; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sandercock GRH, 2006, SCAND J MED SCI SPOR, V16, P302, DOI 10.1111/j.1600-0838.2006.00556.x; Senthinathan A, 2017, CLIN J SPORT MED, V27, P288, DOI 10.1097/JSM.0000000000000337; Stancin T, 2001, J TRAUMA, V51, P69, DOI 10.1097/00005373-200107000-00011; Hunt AW, 2016, J ATHL TRAINING, V51, P749, DOI 10.4085/1062-6050-51.11.12	42	12	12	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.	MAR	2018	4	1							e000355	10.1136/bmjsem-2018-000355			9	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VJ4QA	WOS:000596798200064	30305921	gold, Green Published			2022-02-06	
J	Zogg, CK; Haring, RS; Xu, LK; Canner, JK; AlSulaim, HA; Hashmi, ZG; Salim, A; Engineer, LD; Haider, AH; Bell, JM; Schneider, EB				Zogg, Cheryl K.; Haring, R. Sterling; Xu, Likang; Canner, Joseph K.; AlSulaim, Hatim A.; Hashmi, Zain G.; Salim, Ali; Engineer, Lilly D.; Haider, Adil H.; Bell, Jeneita M.; Schneider, Eric B.			The Epidemiology of Pediatric Head Injury Treated Outside of Hospital Emergency Departments	EPIDEMIOLOGY			English	Article							TRAUMATIC-BRAIN-INJURY; INTERNATIONAL-CLASSIFICATION; CONCUSSION; SPORTS; TRENDS; TBI; SURVEILLANCE; CHILDREN; PROGRAM; VISITS	Background: Although head trauma-related deaths, hospitalizations, and emergency department visits are well characterized, few studies describe pediatric patients presenting outside of emergency departments. We compared the epidemiology and extent of healthcare-seeking pediatric (0-17 years) patients presenting in outpatient settings with those of patients seeking nonhospitalized emergency department care. Methods: We used MarketScan Medicaid and commercial claims, 2004-2013, to identify patients managed in two outpatient settings (physician's offices/clinics, urgent care) and the emergency department. We then examined differences in demographic and injury-specific factors, Centers for Disease Control and Prevention-defined head trauma diagnoses, the extent of and reasons for post-index visit ambulatory care use within 30/90/180 days, and annual and monthly variations in head trauma trends. Outpatient incidence rates in 2013 provided estimates of the nationwide US outpatient burden. Results: A total of 1,683,097 index visits were included, representing a nationwide burden in 2013 of 844,660 outpatient cases, a number that encompassed 51% of healthcare-seeking head trauma that year and that substantially increased in magnitude from 2004 to 2013. Two-thirds (68%) were managed in outpatient settings. While demographic distributions varied with index-visit location, injury-specific factors were comparable. Seasonal spikes appeared to coincide with school sports. Conclusions: There is an urgent need to better understand the natural history of head trauma in the >800,000 pediatric patients presenting each year for outpatient care. These outpatient injuries, which are more than double the number of head trauma cases recorded in the hospital-affiliated settings, illustrate the potential importance of expanding inclusion criteria in surveillance and prevention efforts designed to address this critical issue.	[Zogg, Cheryl K.] Yale Sch Med, 67 Cedar St,Room 316 ESH, New Haven, CT 06510 USA; [Zogg, Cheryl K.; Haring, R. Sterling; Hashmi, Zain G.; Salim, Ali; Haider, Adil H.; Schneider, Eric B.] Harvard TH Chan Sch Publ Hlth, Ctr Surg & Publ Hlth, Harvard Med Sch, Boston, MA USA; [Zogg, Cheryl K.; Haring, R. Sterling; Hashmi, Zain G.; Salim, Ali; Haider, Adil H.; Schneider, Eric B.] Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA; [Zogg, Cheryl K.; Haring, R. Sterling; Canner, Joseph K.; AlSulaim, Hatim A.; Hashmi, Zain G.; Engineer, Lilly D.; Schneider, Eric B.] Johns Hopkins Univ, Sch Med, Dept Surg, Johns Hopkins Surg Ctr Outcomes Res, Baltimore, MD 21205 USA; [Haring, R. Sterling] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Xu, Likang; Bell, Jeneita M.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Salim, Ali; Haider, Adil H.] Brigham & Womens Hosp, Div Trauma Burn & Surg Crit Care, 75 Francis St, Boston, MA 02115 USA; [Engineer, Lilly D.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Schneider, Eric B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA		Zogg, CK (corresponding author), Yale Sch Med, 67 Cedar St,Room 316 ESH, New Haven, CT 06510 USA.	czogg@jhmi.edu		Zogg, Cheryl/0000-0003-4461-746X	NIH Medical Scientist Training Program Training GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32GM007205]; Emergency Medical Foundation; American College of Emergency Physicians entitled, "Understanding Emergency Medicine Providers' Perceptions of the ACA in a Renewed Era of Healthcare Reform: National Survey and Qualitative Mixed-Methods Approach"; PCORI entitled "Patient-Centered Approaches to Collect Sexual Orientation/Gender Identity in the ED"Patient-Centered Outcomes Research Institute - PCORI [AD-1306-03980]; Harvard Surgery Affinity Research Collaborative (ARC) Program Grant entitled "Mitigating Disparities Through Enhancing Surgeons' Ability To Provide Culturally Relevant Care"; Henry M. Jackson Foundation for the Advancement of Military Medicine; Uniformed Services University of the Health Sciences entitled "The Comparative Effectiveness and Provider Induced Demand Collaboration"; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007205] Funding Source: NIH RePORTER	No funding specifically for this work was provided. C.K.Z. is supported by NIH Medical Scientist Training Program Training Grant T32GM007205. She is the Primary Investigator of a grant from the Emergency Medical Foundation and American College of Emergency Physicians entitled, "Understanding Emergency Medicine Providers' Perceptions of the ACA in a Renewed Era of Healthcare Reform: National Survey and Qualitative Mixed-Methods Approach." A.H.H. is the Primary Investigator of a contract (AD-1306-03980) with PCORI entitled "Patient-Centered Approaches to Collect Sexual Orientation/Gender Identity in the ED," a Harvard Surgery Affinity Research Collaborative (ARC) Program Grant entitled "Mitigating Disparities Through Enhancing Surgeons' Ability To Provide Culturally Relevant Care," and a collaborative research grant from the Henry M. Jackson Foundation for the Advancement of Military Medicine in conjunction with the Uniformed Services University of the Health Sciences entitled "The Comparative Effectiveness and Provider Induced Demand Collaboration." He is also a co-founder and equity-shareholder of the company Patient Doctor Technologies, Inc., which owns and operates the website www.doctella.com.	Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Boutis K, 2015, J PEDIATR-US, V166, P1214, DOI 10.1016/j.jpeds.2015.02.013; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Chan V, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0259-7; Chen C, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040414; Collins Christy L, 2014, Inj Epidemiol, V1, P13; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Dunn M, 2009, 200902 NAT CANC I DI; Faul M, 2010, TRAUMATIC BRAIN INJU; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hansen LG, 2011, HLTH RES DATA REAL W; Haring RS, 2015, BRAIN INJURY, V29, P989, DOI 10.3109/02699052.2015.1033014; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Institute of Medicine, 2013, SPORTS RELATED CONCU; Jung CS, 2011, ACTA NEUROCHIR, V153, P101, DOI 10.1007/s00701-010-0704-8; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kelleher E, 2014, J PEDIATR SURG, V49, P341, DOI 10.1016/j.jpedsurg.2013.10.016; Kirschen MP, 2014, NEUROLOGY, V83, P352, DOI 10.1212/WNL.0000000000000613; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Martinez-Beneito MA, 2011, ANN APPL STAT, V5, P2150, DOI 10.1214/11-AOAS471; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; National Center for Health Statistics Centers for Disease Control and Prevention, 2017, AMB CAR US PHYS OFF; National Center for Injury Prevention and Control, 2013, IMPL RET PLAY LEARN; National Center for Injury Prevention and Control Centers for Disease Control and Prevention, 2017, TRAUM BRAIN INJ CONC; National High School Sports Related Injury Surveillance System, 2016, HIGH SCH REP INJ ONL; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Rhee D, 2013, PEDIATRICS, V131, pE829, DOI 10.1542/peds.2012-2244; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Schappert Susan M, 2006, Vital Health Stat 13, P1; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Smith J., 2014, CURRENT POPULATION R, VP60-250; Statistical Research and Applications Branch National Cancer Institute, 2015, JOINPOINT TREND ANAL; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Stuart B, 2012, J EMERG NURS, V38, P435, DOI 10.1016/j.jen.2011.04.006; Tai-Seale M, 2007, HEALTH SERV RES, V42, P1871, DOI 10.1111/j.1475-6773.2006.00689.x; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Truven Health Analytics, 2017, MARKETSCAN RES DAT; Yu B, 2007, 200702 NAT CANC I DI	47	12	12	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1044-3983	1531-5487		EPIDEMIOLOGY	Epidemiology	MAR	2018	29	2					269	279		10.1097/EDE.0000000000000791			11	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	FW0BD	WOS:000424955200021	29240568	Green Accepted			2022-02-06	
J	Handy, JD; Avcu, P; Ko, N; Ortiz, A; Doria, MJ; Servatius, RJ				Handy, Justin D.; Avcu, Pelin; Ko, Nora; Ortiz, Alejandro; Doria, Michael J.; Servatius, Richard J.			Facilitated acquisition of the classically conditioned eyeblink response in active duty military expressing posttraumatic stress disorder symptoms	BEHAVIOURAL BRAIN RESEARCH			English	Article						PTSD; Eyeblink conditioning; Associative learning; Extinction; Personality	TRAUMATIC BRAIN-INJURY; BEHAVIORALLY INHIBITED TEMPERAMENT; ENVIRONMENTAL-INFLUENCES; FUNCTIONAL CONNECTIVITY; INDIVIDUAL-DIFFERENCES; PERSONALITY-TRAITS; AMYGDALAR RESPONSE; ANXIETY DISORDERS; FEAR INHIBITION; WAR VETERANS	Objective: Learning diathesis models underscore the role of hyper-conditioning in the development of PTSD following trauma exposure. Eyeblink classical conditioning is one method of examining associative learning biases independent of fear and threat produced by trauma. Facilitated learning is apparent in individuals self expressing PTSD symptoms, as well as behaviorally inhibited (BI) temperament, a vulnerability factor for PTSD. Here, we examine eyeblink conditioning in active duty military personnel and relate learning with PTSD symptomology. Method: Volunteers were 83 active duty United States Coast Guard personnel (18 females) recruited from small boat stations. Personnel were administered the PTSD Checklist (PCL) to assess current PTSD symptoms using DSM-IV criteria. BI temperament was assessed with the Adult Measure of Behavioural Inhibition (AMBI). Eyeblink conditioning was conducted using a partial reinforcement schedule, whereby paired trials (500-ms pure tone conditioned stimulus co-terminating with a 50-ms air-puff unconditional stimulus) were interpolated with 50% CS-alone trials. Results: Consistent with previous work, there was a high degree of concordance between BI and incidence of PTSD. Further, PTSD was associated with faster learning during the acquisition period, with conditioned responding sustained through the extinction period. Conclusions: These results reinforce the relationship between BI and PTSD in an active duty military sample, supporting previous observations in veteran and civilian samples. The conditioning data are consistent with predictions derived from a learning diathesis model of stress and anxiety, suggesting facilitated associative learning may represent an additional vulnerability for the development and maintenance of stress-related pathology.	[Handy, Justin D.; Ortiz, Alejandro; Servatius, Richard J.] Syracuse Vet Affairs Med Ctr, Dept Vet Affairs, Syracuse, NY USA; [Handy, Justin D.; Avcu, Pelin; Ko, Nora; Ortiz, Alejandro; Servatius, Richard J.] Rutgers State Univ, Dept Pharmacol Physiol & Neurosci, Rutgers Biomed Hlth Sci, Newark, NJ USA; [Avcu, Pelin; Ko, Nora] Rutgers State Univ, Grad Sch Biomed Sci, Newark, NJ USA; [Doria, Michael J.] USt Coast Guard, Washington, DC USA		Servatius, RJ (corresponding author), 800 Irving Ave, Syracuse, NY 13210 USA.	richard.servatius@va.gov		Servatius, Richard/0000-0002-7023-4895	Department of Veterans AffairsUS Department of Veterans Affairs; Stress & Motivated Behavior Institute; Medical Research funds	The research team is indebted for immeasurable support in conducting the research study to Admirals Dollymoore and Schwartz and CAPT Harnon as well as onsite access and support from: CWO Thomas Moore (CG Station Golden Gate), BMCS Eamon McCormak and BMC Jeremy Jarvis (Station St. Petersburg), LCDR William (Bill) Walsh and LT Leo Danaher (Station New York), BMCM Devin Spencer (Station San Francisco), LT Ben Crowell and LT Alexandria Richardson (Station Seattle), CWO Eric (Bee) Perry (Station Port Canaveral), CW04 Mark Helmers (Station, New Orleans), and LTJG Anthony Ippolito (Station Fort Lauderdale). Financial support was provided by Department of Veterans Affairs, Medical Research funds and the Stress & Motivated Behavior Institute.	Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Allen MT, 2016, BEHAV BRAIN RES, V304, P86, DOI 10.1016/j.bbr.2016.02.007; Allen MT, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00347; Avcu P, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00334; Beck K. D., 2011, BIOL PSYCHIAT, V35; Bell JD, 2007, BRAIN, V130, P2528, DOI 10.1093/brain/awm164; BIEDERMAN J, 1993, J AM ACAD CHILD PSY, V32, P814, DOI 10.1097/00004583-199307000-00016; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Blechert J, 2007, BEHAV RES THER, V45, P2019, DOI 10.1016/j.brat.2007.02.012; Blumenthal T. D., 1986, PSYCHOPHYSIOLOGY, V23; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Bonne O, 2003, BIOL PSYCHIAT, V54, P1077, DOI 10.1016/S0006-3223(03)00525-0; Bowman ML, 1999, CAN J PSYCHIAT, V44, P21, DOI 10.1177/070674379904400103; Breslau N, 2009, TRAUMA VIOLENCE ABUS, V10, P198, DOI 10.1177/1524838009334448; Caulfield MD, 2015, BEHAV BRAIN RES, V278, P476, DOI 10.1016/j.bbr.2014.10.027; Caulfield MD, 2016, BRAIN STRUCT FUNCT, V221, P3081, DOI 10.1007/s00429-015-1088-6; Caulfield MD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00348; Cheng DT, 2008, P NATL ACAD SCI USA, V105, P8108, DOI 10.1073/pnas.0800374105; Cheng DT, 2014, HUM BRAIN MAPP, V35, P1390, DOI 10.1002/hbm.22261; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; Clark R, 2013, J PSYCHIATR RES, V47, P1849, DOI 10.1016/j.jpsychires.2013.08.013; Degnan KA, 2007, DEV PSYCHOPATHOL, V19, P729, DOI 10.1017/S0954579407000363; Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49; Donald C. Mac, 2013, PLOS ONE, V8; EYSENCK HJ, 1979, BEHAV BRAIN SCI, V2, P155, DOI 10.1017/S0140525X00061653; Fauerbach JA, 2000, J NERV MENT DIS, V188, P510, DOI 10.1097/00005053-200008000-00006; Fernandez M, 2001, NEUROSCI LETT, V297, P101, DOI 10.1016/S0304-3940(00)01674-8; Fox NA, 2005, PSYCHOL SCI, V16, P921, DOI 10.1111/j.1467-9280.2005.01637.x; Freeman JH, 2015, BRAIN RES, V1621, P260, DOI 10.1016/j.brainres.2014.09.062; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; Gil S, 2006, PSYCHOSOM MED, V68, P904, DOI 10.1097/01.psy.0000242124.21796.f8; Ginsberg JP, 2008, J ANXIETY DISORD, V22, P809, DOI 10.1016/j.janxdis.2007.08.009; Ginsberg Jay P, 2008, Neuropsychiatr Dis Treat, V4, P635; Gladstone G, 2005, PSYCHIAT RES, V135, P133, DOI 10.1016/j.psychres.2005.03.005; Glatt SJ, 2013, AM J MED GENET B, V162B, P313, DOI 10.1002/ajmg.b.32167; Greer TL, 2005, J AFFECT DISORDERS, V86, P235, DOI 10.1016/j.jad.2005.02.006; Grillon C, 1999, J ABNORM PSYCHOL, V108, P134, DOI 10.1037/0021-843X.108.1.134; Hermann C, 2002, BIOL PSYCHIAT, V52, P328, DOI 10.1016/S0006-3223(02)01385-9; Hirshfeld D. R., 1992, J AM ACAD CHILD ADOL, V31; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holloway JL, 2014, BEHAV BRAIN RES, V261, P49, DOI 10.1016/j.bbr.2013.10.041; Holloway JL, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00076; Hunt EJF, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.23617; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; Jovanovic T, 2005, BIOL PSYCHIAT, V57, P1559, DOI 10.1016/j.biopsych.2005.02.025; Jovanovic T, 2009, PSYCHIAT RES, V167, P151, DOI 10.1016/j.psychres.2007.12.014; KAGAN J, 1987, CHILD DEV, V58, P1459, DOI 10.1111/j.1467-8624.1987.tb03858.x; Kashdan TB, 2009, J ANXIETY DISORD, V23, P185, DOI 10.1016/j.janxdis.2008.06.006; Ke J, 2016, ACTA RADIOL, V57, P1387, DOI 10.1177/0284185115585848; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Liberman LC, 2006, BEHAV RES THER, V44, P1491, DOI 10.1016/j.brat.2005.11.004; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; MASSARO DW, 1967, J EXP PSYCHOL, V75, P151, DOI 10.1037/h0024973; McLeod DS, 2001, J TRAUMA STRESS, V14, P259, DOI 10.1023/A:1011157800050; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Michael T, 2007, J ABNORM PSYCHOL, V116, P612, DOI 10.1037/0021-843X.116.3.612; Mommersteeg PMC, 2011, INT J BEHAV MED, V18, P131, DOI 10.1007/s12529-010-9096-7; Monaco J, 2014, EUR J NEUROSCI, V40, P3363, DOI 10.1111/ejn.12700; Morgan Barak E, 2006, Curr Psychiatry Rep, V8, P270, DOI 10.1007/s11920-006-0062-7; Myers CE, 2012, PSYCHIAT RES, V196, P271, DOI 10.1016/j.psychres.2011.11.015; Myers CE, 2012, STRESS, V15, P31, DOI 10.3109/10253890.2011.578184; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Norrholm SD, 2011, BIOL PSYCHIAT, V69, P556, DOI 10.1016/j.biopsych.2010.09.013; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Ordek G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00197; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; Paris J, 2000, HARVARD REV PSYCHIAT, V8, P175, DOI 10.1093/hrp/8.4.175; Park E, 2006, J NEUROPATH EXP NEUR, V65, P226, DOI 10.1097/01.jnen.0000202888.29705.93; Peri T, 2000, BIOL PSYCHIAT, V47, P512, DOI 10.1016/S0006-3223(99)00144-4; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; PITMAN RK, 1988, PSYCHIAT ANN, V18, P182, DOI 10.3928/0048-5713-19880301-11; PITMAN RK, 1986, J ABNORM PSYCHOL, V95, P208, DOI 10.1037/0021-843X.95.3.208; Rademaker AR, 2011, J ABNORM PSYCHOL, V120, P299, DOI 10.1037/a0021806; Robleto K, 2008, J NEUROSCI, V28, P2651, DOI 10.1523/JNEUROSCI.4781-07.2008; ROSENBAUM JF, 1993, HARVARD REV PSYCHIAT, V1, P2, DOI 10.3109/10673229309017052; Rubin DC, 2008, PSYCHOL REV, V115, P985, DOI 10.1037/a0013397; Schlund MW, 2010, NEUROIMAGE, V53, P769, DOI 10.1016/j.neuroimage.2010.06.058; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Schwartz CE, 2003, BIOL PSYCHIAT, V53, P854, DOI 10.1016/S0006-3223(02)01906-6; Schwartz CE, 2003, SCIENCE, V300, P1952, DOI 10.1126/science.1083703; Servatius RJ, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00015; Servatius RJ, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00168; SERVATIUS RJ, 1994, BEHAV NEUROSCI, V108, P1101, DOI 10.1037/0735-7044.108.6.1101; Servatius RJ, 2005, BIOL PSYCHIAT, V57, P865, DOI 10.1016/j.biopsych.2005.01.015; SPENCE KW, 1953, J EXP PSYCHOL, V45, P265, DOI 10.1037/h0056392; Spielberg JM, 2011, NEUROIMAGE, V54, P661, DOI 10.1016/j.neuroimage.2010.08.037; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; THOMPSON RF, 1991, NEUROPSYCHOLOGIA, V29, P571, DOI 10.1016/0028-3932(91)90011-V; Utz A, 2015, NEUROSCI LETT, V604, P173, DOI 10.1016/j.neulet.2015.07.026; VanElzakker MB, 2014, NEUROBIOL LEARN MEM, V113, P3, DOI 10.1016/j.nlm.2013.11.014; Vythilingam M, 2006, NEUROPSYCHOPHARMACOL, V31, P182, DOI 10.1038/sj.npp.1300843; Wang T., 2016, SCI REP, V6; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080	97	12	12	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	FEB 26	2018	339						106	113		10.1016/j.bbr.2017.11.014			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	FU9JX	WOS:000424173300012	29154809				2022-02-06	
J	Lin, HF; Chen, YD; Chen, SC				Lin, Heng-Fu; Chen, Ying-Da; Chen, Shyr-Chyr			Value of diagnostic and therapeutic laparoscopy for patients with blunt abdominal trauma: A 10-year medical center experience	PLOS ONE			English	Article							NONOPERATIVE MANAGEMENT; INJURIES; SURGERY; ASSOCIATION; GUIDELINES	Laparoscopy has been used for the diagnosis and treatment for hemodynamically stable patients with penetrating abdominal trauma. This study evaluated whether diagnostic and therapeutic laparoscopy can be used as effectively in select patients with blunt abdominal trauma. All hemodynamically stable patients undergoing operations for blunt abdominal trauma over a 10-year period (2006-2015) at a tertiary medical center were included. Patients undergoing laparotomy were categorized as group A. Patients who underwent laparoscopy were categorized as group B. The clinical outcomes of the 2 groups were compared. There were 139 patients in group A and 126 patients in group B. Group A patients were more severely injured (mean injury severity score of 23.3 vs. 18.9, P < .001) and had a higher frequency of traumatic brain injuries (25.2% vs. 14.3%, P = .039). The sensitivity and specificity of diagnostic laparoscopy for patients in group B was 99.1% and 100.0%, respectively. No non-therapeutic laparotomies were performed in group B, and the success rate of therapeutic laparoscopy was 92.0% (103/112) for patients with significant intra-abdominal injuries. Patients in the 2 groups had similar perioperative and postoperative outcomes in terms of operation times, blood loss, blood transfusion requirements, mortality, and complications (all, P > .05). Laparoscopy is a feasible and safe tool for the diagnosis and treatment of hemodynamically stable patients with blunt abdominal trauma who require surgery.	[Lin, Heng-Fu; Chen, Ying-Da] Far Eastern Mem Hosp, Dept Surg, New Taipei, Taiwan; [Lin, Heng-Fu; Chen, Shyr-Chyr] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Lin, Heng-Fu; Chen, Shyr-Chyr] Natl Taiwan Univ, Coll Med, Taipei, Taiwan		Chen, SC (corresponding author), Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan.; Chen, SC (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.	scchen@ntu.edu.tw		Lin, Heng Fu/0000-0002-5466-9231; CHEN, SHYR-CHYR/0000-0002-5858-3013			Ahmed N, 2005, J AM COLL SURGEONS, V201, P213, DOI 10.1016/j.jamcollsurg.2005.04.021; Carobbi A, 2010, SURG ENDOSC, V24, P1325, DOI 10.1007/s00464-009-0768-9; Chen RJ, 1998, J TRAUMA, V44, P691, DOI 10.1097/00005373-199804000-00024; Chestovich PJ, 2015, J TRAUMA ACUTE CARE, V78, P1076, DOI 10.1097/TA.0000000000000655; Choi YB, 2003, SURG ENDOSC, V17, P421, DOI 10.1007/s00464-002-8808-8; Como JJ, 2010, J TRAUMA, V68, P721, DOI 10.1097/TA.0b013e3181cf7d07; IVATURY RR, 1993, J TRAUMA, V34, P822, DOI 10.1097/00005373-199306000-00013; Johnson JJ, 2013, AM J SURG, V205, P317, DOI 10.1016/j.amjsurg.2012.10.021; JOSEPHS LG, 1994, J TRAUMA, V36, P815, DOI 10.1097/00005373-199406000-00011; Kawahara NT, 2009, J TRAUMA, V67, P589, DOI 10.1097/TA.0b013e3181a60593; Koto MZ, 2015, J LAPAROENDOSC ADV S, V25, P730, DOI 10.1089/lap.2015.0042; Lee PC, 2014, SURG INNOV, V21, P155, DOI 10.1177/1553350612474496; Lim KH, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0007-8; Lin HF, 2015, AM J SURG, V210, P326, DOI 10.1016/j.amjsurg.2014.11.009; Lin HF, 2014, SURG INNOV, V21, P355, DOI 10.1177/1553350613505717; Lin HF, 2010, WORLD J SURG, V34, P1653, DOI 10.1007/s00268-010-0485-5; Nicolau AE, 2011, CHIRURGIA-BUCHAREST, V106, P59; O'Malley E, 2013, WORLD J SURG, V37, P113, DOI 10.1007/s00268-012-1790-y; Peitzman AB, 2000, J TRAUMA, V49, P177, DOI 10.1097/00005373-200008000-00002; Sauerland S, 2006, SURG ENDOSC, V20, P14, DOI 10.1007/s00464-005-0564-0; Sitnikov V, 2009, SURG ENDOSC, V23, P125, DOI 10.1007/s00464-008-9910-3; SMITH RS, 1995, AM J SURG, V170, P632; Uranues S, 2015, WORLD J SURG, V39, P1381, DOI 10.1007/s00268-014-2904-5; Velmahos GC, 2003, ARCH SURG-CHICAGO, V138, P844, DOI 10.1001/archsurg.138.8.844; Zafar SN, 2015, AM J SURG, V209, P627, DOI 10.1016/j.amjsurg.2014.12.011	25	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2018	13	2							e0193379	10.1371/journal.pone.0193379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX1SB	WOS:000425831000051	29470527	Green Published, Green Submitted, gold			2022-02-06	
J	O'Phelan, KH; Otoshi, CK; Ernst, T; Chang, LD				O'Phelan, Kristine H.; Otoshi, Chad K.; Ernst, Thomas; Chang, Linda			Common Patterns of Regional Brain Injury Detectable by Diffusion Tensor Imaging in Otherwise Normal-Appearing White Matter in Patients with Early Moderate to Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain imaging; diffusion tensor imaging; head injury; MRI; traumatic brain injury	AXONAL INJURY; LESIONS; ABNORMALITIES; IMPAIRMENT; DISRUPTION; INTEGRITY; SUBACUTE; DAMAGE; TIME; MRI	Traumatic brain injury (TBI) alters the lives of millions of people every year. Although mortality rates have improved, attributed to better pre-hospital care and reduction of secondary injury in the critical care setting, improvements in functional outcomes post-TBI have been difficult to achieve. Diffusion-tensor imaging (DTI) allows detailed measurement of microstructural damage in regional brain tissue post-TBI, thus improving our understanding of the extent and severity of TBI. Twenty subjects were recruited from a neurological intensive care unit and compared to 18 healthy control subjects. Magnetic resonance imaging (MRI) scanning was performed on a 3.0-Tesla Siemens TIM Trio Scanner (Siemens Medical Solutions, Erlangen, Germany) including T1- and T2-weighted sequences and DTI. Images were processed using DTIStudio software. SAS (SAS Institute Inc., Cary, NC) was used for statistical analysis of group differences in 14 brain regions (25 regions of interests [ROIs]). Seventeen TBI subjects completed scanning. TBI and control subjects did not differ in age or sex. All TBI subjects had visible lesions on structural MRI. TBI subjects had seven brain regions (nine ROIs) that showed significant group differences on DTI metrics (fractional anisotropy, radial diffusion, or mean diffusion) compared to noninjured subjects, including the corpus callosum (genu and splenium), superior longitudinal fasciculus, internal capsule, right retrolenticular internal capsule, posterior corona radiata, and thalamus. However, 16 ROIs showed relatively normal DTI measures. Quantitative DTI demonstrates multiple areas of microstructual injury in specific normal-appearing white matter brain regions. DTI may be useful for assessing the extent of brain injury in patients with early moderate to severe TBI.	[O'Phelan, Kristine H.] Univ Miami, Miller Sch Med, Dept Neurol, 1120 NW 14th St,Don Soffer Clin Res Bldg 1356, Miami, FL 33136 USA; [Otoshi, Chad K.; Ernst, Thomas; Chang, Linda] Univ Hawaii Manoa, John A Burns Sch Med, Dept Med, Neurosci & MRI Res Program, Honolulu, HI 96822 USA; [Ernst, Thomas; Chang, Linda] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA		O'Phelan, KH (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol, 1120 NW 14th St,Don Soffer Clin Res Bldg 1356, Miami, FL 33136 USA.	kophelan@med.miami.edu			 [1R03DA024199];  [K24-DA16170]	This work was funded by 1R03DA024199 (KO) and K24-DA16170 (LC).	Adamson C, 2013, BRAIN INJURY, V27, P454, DOI 10.3109/02699052.2012.750756; Babcock L, 2015, J PEDIATR REHAB MED, V8, P285, DOI 10.3233/PRM-150347; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Ceritoglu C, 2009, NEUROIMAGE, V47, P618, DOI 10.1016/j.neuroimage.2009.04.057; Chiou KS, 2016, BRAIN IMAGING BEHAV, V10, P1274, DOI 10.1007/s11682-015-9497-y; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; D'souza Maria M, 2015, Indian J Radiol Imaging, V25, P404, DOI 10.4103/0971-3026.169445; de Groot M, 2016, RADIOLOGY, V279, P532, DOI 10.1148/radiol.2015150103; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Genc S., 2016, J NEUROTRAUM, V33, P1; Hashim E, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00097; Herrerra J.J., 2016, J NEUROTRAUM, V43, P291; HOLM S, 1979, SCAND J STAT, V6, P65; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Kasahara K, 2012, MAGN RESON IMAGING, V30, P496, DOI 10.1016/j.mri.2011.12.018; Kim J, 2014, J INT NEUROPSYCH SOC, V20, P887, DOI 10.1017/S1355617714000812; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Magnoni S, 2015, BRAIN, V138, P2263, DOI 10.1093/brain/awv152; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Moen KG, 2016, J NEUROSCI RES, V94, P623, DOI 10.1002/jnr.23728; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Sener S, 2016, NEUROSURGERY, V79, P786, DOI 10.1227/NEU.0000000000001325; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Spitz G., 2016, J NEUROTRAUM, V33, P1; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Toth A, 2018, BEHAV BRAIN RES, V340, P106, DOI 10.1016/j.bbr.2017.02.039; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F; Wilde EA, 2016, J NEUROTRAUM, V33, P2000, DOI 10.1089/neu.2015.4212; Wu HM, 2004, J NEUROTRAUM, V21, P149, DOI 10.1089/089771504322778613; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yang AC, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00143; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	52	12	14	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2018	35	5					739	749		10.1089/neu.2016.4944		FEB 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FX4ZY	WOS:000424829500001	29228858	Green Published			2022-02-06	
J	Servatius, RJ; Spiegler, KM; Handy, JD; Pang, KCH; Tsao, JW; Mazzola, CA				Servatius, Richard J.; Spiegler, Kevin M.; Handy, Justin D.; Pang, Kevin C. H.; Tsao, Jack W.; Mazzola, Catherine A.			Neurocognitive and Fine Motor Deficits in Asymptomatic Adolescents during the Subacute Period after Concussion	JOURNAL OF NEUROTRAUMA			English	Article						behavioral assessments; cognitive function; pediatric brain injury; traumatic brain injury	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; HEAD-TO-HEAD; HIGH-SCHOOL; POSTCONCUSSIVE SYMPTOMS; RECOVERY; PREDICTORS; NETWORKS; CHILDREN; OUTCOMES	Adolescents are at high risk for sustaining concussions. There is considerable controversy regarding the sensitivity of neurocognitive tests to detect and track dysfunction in the aftermath of concussion. Two neurocognitive test batteries were compared during the subacute phase of recovery from concussion to determine sensitivity to concussion. Adolescents (ages 11-17 years) with a concussion diagnosis (eight males, seven females, 9-69 days after injury) were recruited through a concussion clinic and compared with community nonconcussed volunteers (11 males, three females). Adolescents completed the online version of the Immediate Post-Concussion Assessment and Cognitive Test (ImPACT) on a desktop computer and the Defense Automated Neurobehavioral Assessment (DANA) on a handheld device, as well as the Grooved Pegboard Test, which assessed manual dexterity and motor speed. There were no differences in self-reported symptoms on the Post-Concussion Symptom Scale comparing concussed and nonconcussed adolescents. No significant between-groups differences were observed in ImPACT performance. Performance deficits were apparent for the DANA assessment, reflecting lower throughput scores for simple reaction time and response inhibition parameters in those with concussion. Concussed adolescents also had slower Grooved Pegboard Test performance when using the nondominant hand. Both the DANA test battery and the Grooved Pegboard Test appear to have promise as tools to detect persistent cognitive and motor dysfunction in the subacute period after concussion.	[Servatius, Richard J.; Handy, Justin D.; Pang, Kevin C. H.; Mazzola, Catherine A.] Rutgers State Univ, Rutgers Biomed Hlth Sci Pharmacol Physiol & Neuro, Newark, NJ USA; [Servatius, Richard J.; Spiegler, Kevin M.; Pang, Kevin C. H.] Rutgers State Univ, Grad Sch Biomed Sci, Newark, NJ USA; [Servatius, Richard J.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Handy, Justin D.] Cent New York Res Corp, Syracuse, NY USA; [Tsao, Jack W.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Tsao, Jack W.] Le Bonheur Childrens Hosp, Childrens Fdn, Res Inst, Memphis, TN USA; [Mazzola, Catherine A.] Morristown Med Ctr, Morristown, NJ USA		Servatius, RJ (corresponding author), Upstate Univ Hosp, Dept Psychiat, 750 East Adams St, Syracuse, NY 13210 USA.	servatir@upstate.edu		Spiegler, Kevin/0000-0002-9271-5825	Stress & Motivated Behavior Institute; Veterans AffairsUS Department of Veterans Affairs [I01BX000132] Funding Source: NIH RePORTER	The research team would like to acknowledge the efforts and contributions of Meghan Crippen and Sreeya Komaravolu in conducting this research study. Financial support was provided by the Stress & Motivated Behavior Institute.	Baker Robert J., 2000, Indian Journal of Pediatrics, V67, P317, DOI 10.1007/BF02820676; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Borich M, 2015, J NEUROTRAUM, V32, P265, DOI 10.1089/neu.2013.3269; BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO;2-C; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Fenton GW, 1996, CLIN ELECTROENCEPHAL, V27, P174; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995; Krivitzky LS, 2011, J INT NEUROPSYCH SOC, V17, P1143, DOI 10.1017/S1355617711001226; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lathan C, 2013, MIL MED, V178, P365, DOI 10.7205/MILMED-D-12-00438; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; Merritt VC, 2014, J CLIN EXP NEUROPSYC, V36, P1098, DOI 10.1080/13803395.2014.983463; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; Nelson LD, 2017, J INT NEUROPSYCH SOC, V23, P293, DOI 10.1017/S1355617717000157; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Newsome MR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00116; Pang KCH, 2015, J NEUROTRAUM, V32, P801, DOI 10.1089/neu.2014.3451; Randolph C, 2005, J ATHL TRAINING, V40, P139; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Schmidt JD, 2017, J NEUROTRAUM, V34, P1571, DOI 10.1089/neu.2016.4668; Sinopoli KJ, 2014, J NEUROTRAUM, V31, P1843, DOI 10.1089/neu.2014.3326; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Teel E, 2016, NEUROPSYCHOLOGY, V30, P474, DOI 10.1037/neu0000261; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Trites R. L., 1977, NEUROPSYCHOLOGICAL T; Urban KJ, 2017, J NEUROTRAUM, V34, P816, DOI 10.1089/neu.2016.4502; Virji-Babul N, 2014, J NEUROTRAUM, V31, P1914, DOI 10.1089/neu.2014.3450; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wright WG, 2017, DISABIL REHABIL, V39, P1564, DOI 10.1080/09638288.2016.1226432	39	12	12	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2018	35	8					1008	1014		10.1089/neu.2017.5314		FEB 2018	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GC0DM	WOS:000424831100001	29278998				2022-02-06	
J	Pinchi, E; Frati, A; Cipolloni, L; Aromatario, M; Gatto, V; La Russa, R; Pesce, A; Santurro, A; Fraschetti, F; Frati, P; Fineschi, V				Pinchi, Enrica; Frati, Alessandro; Cipolloni, Luigi; Aromatario, Mariarosaria; Gatto, Vittorio; La Russa, Raffaele; Pesce, Alessandro; Santurro, Alessandro; Fraschetti, Flavia; Frati, Paola; Fineschi, Vittorio			Clinical-pathological study on beta-APP, IL-1 beta, GFAP, NFL, Spectrin II, 8OHdG, TUNEL, miR-21, miR-16, miR-92 expressions to verify DAI-diagnosis, grade and prognosis	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; AXONAL INJURY; OXIDATIVE STRESS; INFLAMMATORY MEDIATORS; HEAD-INJURY; EPIDEMIOLOGY; DISABILITY; HIPPOCAMPUS; BIOMARKERS; MICRORNAS	Traumatic brain injury (TBI) is one of the most important death and disability cause, involving substantial costs, also in economic terms, when considering the young age of the involved subject. Aim of this paper is to report a series of patients treated at our institutions, to verify neurological results at six months or survival; in fatal cases we searched for beta APP, GFAP, IL-1 beta, NFL, Spectrin II, TUNEL and miR-21, miR-16, and miR-92 expressions in brain samples, to verify DAI diagnosis and grade as strong predictor of survival and inflammatory response. Concentrations of 8OHdG as measurement of oxidative stress was performed. Immunoreaction of beta-APP, IL-1 beta, GFAP, NFL, Spectrin II and 8OHdG were significantly increased in the TBI group with respect to control group subjects. Cell apoptosis, measured by TUNEL assay, were significantly higher in the study group than control cases. Results indicated that miR-21, miR-92 and miR-16 have a high predictive power in discriminating trauma brain cases from controls and could represent promising biomarkers as strong predictor of survival, and for the diagnosis of postmortem traumatic brain injury.	[Pinchi, Enrica; Cipolloni, Luigi; Aromatario, Mariarosaria; Gatto, Vittorio; La Russa, Raffaele; Santurro, Alessandro; Frati, Paola; Fineschi, Vittorio] Sapienza Univ Rome, Dept Anat Histol Forens & Orthopaed Sci SAIMLAL, Viale Regina Elena 336, I-00185 Rome, Italy; [Frati, Alessandro; Pesce, Alessandro; Fraschetti, Flavia] Sapienza Univ Rome, Dept Neurosci Mental Hlth & Sensory Organs NESMOS, Via Grottarossa 1035, I-00189 Rome, Italy; [Frati, Alessandro; La Russa, Raffaele; Frati, Paola; Fineschi, Vittorio] IRCCS Neuromed, Via Atinense 18, I-86077 Pozzilli, Italy		Fineschi, V (corresponding author), Sapienza Univ Rome, Dept Anat Histol Forens & Orthopaed Sci SAIMLAL, Viale Regina Elena 336, I-00185 Rome, Italy.; Fineschi, V (corresponding author), IRCCS Neuromed, Via Atinense 18, I-86077 Pozzilli, Italy.	vittorio.fineschi@uniroma1.it	Pesce, Alessandro/AAC-2223-2020; Frati, Alessandro/AAC-2204-2020; Cipolloni, Luigi/AAS-2680-2020; Fineschi, Vittorio/AAJ-4808-2020	Pesce, Alessandro/0000-0003-0250-4205; Fineschi, Vittorio/0000-0002-1686-3236; cipolloni, luigi/0000-0001-6464-3249; LA RUSSA, RAFFAELE/0000-0003-3433-7122; Santurro, Alessandro/0000-0001-5491-3719; FRATI, ALESSANDRO/0000-0001-8062-614X; Gatto, Vittorio/0000-0002-2378-9767			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; [Anonymous], 2015, C TRAUM BRAIN INJ US; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Barabas FM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16280-x; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bhalala OG, 2013, NAT REV NEUROL, V9, P328, DOI 10.1038/nrneurol.2013.67; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Blumbergs P.C., 2008, GREENFIELDS NEUROPAT, P733; Buller B, 2010, FEBS J, V277, P4299, DOI 10.1111/j.1742-4658.2010.07818.x; Chen RL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050957, 10.1371/journal.pone.0051246]; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Ge X., 2015, RNA DIS, V2, pe642; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Graham EM, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00196; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grosjean MB, 2007, HISTOL HISTOPATHOL, V22, P235, DOI 10.14670/HH-22.235; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Illerhaus G, 2011, BLOOD, V117, P2987, DOI 10.1182/blood-2011-01-330209; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Li DR, 2012, LEGAL MED-TOKYO, V14, P84, DOI 10.1016/j.legalmed.2011.12.007; Li Y, 2015, J NEUROL SCI, V359, P280, DOI 10.1016/j.jns.2015.08.035; Marr A., 2004, CENTRAL NERVOUS SYST; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; O'Connell KM, 2013, BIOL RES NURS, V15, P253, DOI 10.1177/1099800411431823; Oehmichen M, 1998, FORENSIC SCI INT, V95, P67, DOI 10.1016/S0379-0738(98)00075-9; Oehmichen M, 2003, J NEUROTRAUM, V20, P87, DOI 10.1089/08977150360517218; Ogata Mamoru, 2007, Legal Medicine, V9, P105, DOI 10.1016/j.legalmed.2006.11.013; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Povlishock J T, 1992, Hum Cell, V5, P345; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sakai K, 2014, AM J FOREN MED PATH, V35, P38, DOI 10.1097/PAF.0000000000000067; Sandhir R, 2014, NEUROCHEM INT, V78, P117, DOI 10.1016/j.neuint.2014.09.009; Schiavone S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09202-4; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Smith C., 2013, ESCOUROLLE POIRIERS, P59; SMITH DH, 1995, J NEUROTRAUM, V12, P573, DOI 10.1089/neu.1995.12.573; Stein DM, 2011, NEUROCRIT CARE, V14, P200, DOI 10.1007/s12028-010-9496-1; Stoicea N, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00011; Strickland IT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023423; Sun TY, 2014, J HUAZHONG U SCI-MED, V34, P548, DOI 10.1007/s11596-014-1313-1; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tao LY, 2006, FORENSIC SCI INT, V162, P174, DOI 10.1016/j.forsciint.2006.06.021; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; Wang WX, 2011, ACTA NEUROPATHOL, V121, P193, DOI 10.1007/s00401-010-0756-0; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zhang Y, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005567; Ziu MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014724	71	12	12	1	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	FEB 5	2018	8								2387	10.1038/s41598-018-20699-1			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU8FC	WOS:000424087700059	29402984	Green Published, gold			2022-02-06	
J	Farah, G; Siwek, D; Cummings, P				Farah, George; Siwek, Donald; Cummings, Peter			Tau accumulations in the brains of woodpeckers	PLOS ONE			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; DISEASE; NEUROPATHOLOGY; DIAGNOSIS; INJURY	Woodpeckers experience forces up to 1200-1400 g while pecking. It is assumed due to evolutionary adaptations, the woodpecker is immune to brain injury. This assumption has led to the use of the woodpecker as a model in the development of sports safety equipment such as football helmets. However, it is unknown at this time if the woodpecker brain develops neuro-trauma in relation to the high g-forces experienced during pecking. The brains of 10 ethanol preserved woodpeckers and 5 ethanol preserved red-winged black bird experimental controls were examined using Gallyas silver stain and anti-phospho-tau. The results demonstrated perivascular and white matter tract silver-positive deposits in eight out of the 10 woodpecker brains. The tau positive accumulations were seen in white matter tracts in 2 of the 3 woodpeckers examined. No staining was identified in control birds. The negative staining of controls birds contrasted with the diffuse positive staining woodpecker sections suggest the possibility that pecking may induce the accumulation of tau in the woodpecker brain. Further research is needed to better understand the relationship.	[Farah, George; Siwek, Donald; Cummings, Peter] Boston Univ, Dept Anat & Neurobiol, Sch Med, Boston, MA 02118 USA		Cummings, P (corresponding author), Boston Univ, Dept Anat & Neurobiol, Sch Med, Boston, MA 02118 USA.	pmc@bu.edu			Department of Anatomy and Neurobiology at the Boston University School of Medicine; Boston University School of Medicine's Department of Anatomy and Neurobiology Vesalius Grant	Boston University School of Medicine's Department of Anatomy and Neurobiology Vesalius Grant was the source of funding for this project (to George Farah). With this grant, we were able to purchase laboratory materials such as antibodies and various chemicals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the two museums who believed in our project and generously donated the preserved museum specimens to our project. A large debt of gratitude to the Field Museum of Chicago, IL and its Ornithology Department for donating specimens: 379007, 379008, 379005, 379006, 379009, 291433, 291434, 291435, and 238695. Secondly, to the Harvard Museum of Natural History at Harvard University in Cambridge, MA. We would like to thank Dr. Scott Edwards and Mr. Jeremiah Trimble from the Ornithology Department at the Harvard Museum of Comparative Zoology for their enthusiasm and generous specimen donation for this project. Without both museums' help, we would not have been able to complete this project. Another thanks to the Department of Anatomy and Neurobiology at the Boston University School of Medicine for funding this project. We would also like to thank Dr. Brian Le for his editorial contribution to the production of this manuscript. Finally, Mr. Farah and Dr. Cummings would like to dedicate this manuscript to Dr. Donald Siwek who suddenly passed away during the writing of this manuscript. His wealth of knowledge and mentorship was unbounded and will be dearly missed.	[Anonymous], 2017, TRAUM BRAIN INJ RES; [Anonymous], 2017, IHC STAIN PROT PAR F; Bailes JE, 2007, J ATHL TRAINING, V42, P126; BUEE L, 1994, ACTA NEUROPATHOL, V87, P469; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Kingsbury MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020720; MAY PRA, 1976, LANCET, V1, P454; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mehta P.S., 2016, SAE TECH PAP, DOI [10.4271/2016-01-0396, DOI 10.4271/2016-01-0396]; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Rubenstein R, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0435-7; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Uchihara T, 2007, ACTA NEUROPATHOL, V113, P483, DOI 10.1007/s00401-007-0200-2	15	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2018	13	2							e0191526	10.1371/journal.pone.0191526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7VI	WOS:000424060400013	29394252	gold, Green Published, Green Submitted			2022-02-06	
J	Anghinah, R; de Amorim, RLO; Paiva, WS; Schmidt, MT; Ianof, JN				Anghinah, Renato; Oliveira de Amorim, Robson Luis; Paiva, Wellingson Silva; Schmidt, Magali Taino; Ianof, Jessica Natuline			Traumatic brain injury pharmacological treatment: recommendations	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						guideline; therapeutics; brain injuries; traumatic	EXCESSIVE DAYTIME SLEEPINESS; RANDOMIZED-TRIAL; 1ST YEAR; PLACEBO; SERTRALINE; ATTENTION; RECOVERY; THERAPY; IMPACT; METHYLPHENIDATE	This article presents the recommendations on the pharmacological treatment employed in traumatic brain injury (TBI) at the outpatient clinic of the Cognitive Rehabilitation after TBI Service of the Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Brazil. A systematic assessment of the consensus reached in other countries, and of articles on TBI available in the PUBMED and LILACS medical databases, was carried out. We offer recommendations of pharmacological treatments in patients after TBI with different symptoms.	[Anghinah, Renato; Schmidt, Magali Taino; Ianof, Jessica Natuline] Univ Sao Paulo, Hosp Clin, Fac Med, Div Neurol,Serv Reabilitacao Cognitiva Pos TCE, Sao Paulo, SP, Brazil; [Oliveira de Amorim, Robson Luis; Paiva, Wellingson Silva] Univ Sao Paulo, Hosp Clin, Fac Med, Div Neurocirurgia,Serv Emergencia, Sao Paulo, SP, Brazil		Anghinah, R (corresponding author), FMUSP, Hosp Clin, Div Neurol, Rua Conselheiro Brotero 1505,9 Andar, BR-01232011 Sao Paulo, SP, Brazil.	anghinah@terra.com.br	Paiva, Wellingson S/G-5517-2013; Amorim, Robson/AAK-1368-2021	Paiva, Wellingson S/0000-0002-5165-7040; Amorim, Robson/0000-0003-2391-7519			ANDRADE AF, 1996, TEMAS ATUAIS NEUROCI, V2, P1; Banos JH, 2010, J HEAD TRAUMA REHAB, V25, P357, DOI 10.1097/HTR.0b013e3181d6c715; Davidson JRT, 2005, J CLIN PSYCHOPHARM, V25, P166, DOI 10.1097/01.jcp.0000155817.21467.6c; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; Jha A, 2008, J HEAD TRAUMA REHAB, V23, P52, DOI 10.1097/01.HTR.0000308721.77911.ea; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Khouzam HR, 1998, GEN HOSP PSYCHIAT, V20, P62, DOI 10.1016/S0163-8343(97)00097-2; Kim YW, 2009, CLIN NEUROPHARMACOL, V32, P63, DOI 10.1097/WNF.0b013e31816f1bc1; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Novack TA, 2009, J NEUROTRAUM, V26, P1921, DOI 10.1089/neu.2009.0895; O'Neill B, 2014, BRAIN INJURY, V28, P378, DOI 10.3109/02699052.2013.865264; Plantier D, 2016, ANN PHYS REHABIL MED, V59, P42, DOI 10.1016/j.rehab.2015.10.003; Rapoport MJ, 2010, J CLIN PSYCHIAT, V71, P1125, DOI 10.4088/JCP.09m05086blu; Sheng P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081802; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Whyte J, 2008, AM J PHYS MED REHAB, V87, P85, DOI 10.1097/PHM.0b013e3181619609; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Zhang L, 2004, ARCH PHYS MED REHAB, V85, P1050, DOI 10.1016/j.apmr.2003.10.014	24	12	12	0	4	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	FEB	2018	76	2					100	103		10.1590/0004-282X20170196			4	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	FX9TT	WOS:000426450500009	29489964	Green Published, gold			2022-02-06	
J	Cole, WR; Arrieux, JP; Ivins, BJ; Schwab, KA; Qashu, FM				Cole, Wesley R.; Arrieux, Jacques P.; Ivins, Brian J.; Schwab, Karen A.; Qashu, Felicia M.			A Comparison of Four Computerized Neurocognitive Assessment Tools to a Traditional Neuropsychological Test Battery in Service Members with and without Mild Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Computerized cognitive testing; Neurocognitive assessment tools; NCATs; Validity; Concussion; Mild traumatic brain injury; Service members	SPORT-RELATED CONCUSSION; COGSTATE BRIEF BATTERY; COGNITIVE IMPAIRMENT; BASE-LINE; VALIDITY TEST; RELIABILITY; IMPACT; SENSITIVITY; SAMPLE; ANAM	Objective: Computerized neurocognitive assessment tools (NCATS) are often used as a screening tool to identify cognitive deficits after mild traumatic brain injury (mTBI). However, differing methodology across studies renders it difficult to identify a consensus regarding the validity of NCATs. Thus, studies where multiple NCATs are administered in the same sample using the same methodology are warranted. Method: We investigated the validity of four NCATs: the ANAM4, CNS-VS, CogState, and ImPACT. Two NCATs were randomly assigned and a battery of traditional neuropsychological (NP) tests administered to healthy control active duty service members (n = 272) and to service members within 7 days of an mTBI (n = 231). Analyses included correlations between NCAT and the NP test scores to investigate convergent and discriminant validity, and regression analyses to identify the unique variance in NCAT and NP scores attributed to group status. Effect sizes (Cohen's f(2)) were calculated to guide interpretation of data. Results: Only 37 (0.6%) of the 5,655 correlations calculated between NCATs and NP tests are large (i. e. r >= 0.50). The majority of correlations are small (i. e. 0.30 > r >= 0.10), with no clear patterns suggestive of convergent or discriminant validity between the NCATs and NP tests. Though there are statistically significant group differences across most NCAT and NP test scores, the unique variance accounted for by group status is minimal (i. e. semipartial R-2 <= 0.033, 0.024, 0.062, and 0.011 for ANAM4, CNS-VS, CogState, and ImPACT, respectively), with effect sizes indicating small to no meaningful effect. Conclusion: Though the results are not overly promising for the validity of the four NCATs we investigated, traditional methods of investigating psychometric properties may not be appropriate for computerized tests. We offer several conceptual and methodological considerations for future studies regarding the validity of NCATs.	[Cole, Wesley R.; Arrieux, Jacques P.] Womack Army Med Ctr, Intrepid Spirit, Def & Vet Brain Injury Ctr, Ft Bragg, NC USA; [Ivins, Brian J.; Schwab, Karen A.; Qashu, Felicia M.] Def & Vet Brain Injury Ctr, Div Res, Silver Spring, MD USA; [Qashu, Felicia M.] NIH, Div Program Coordinat Planning & Strateg Initiat, Off Director, Bldg 10, Bethesda, MD 20892 USA		Cole, WR (corresponding author), Intrepid Spirit, Def & Vet Brain Injury Ctr, 3900 Longstreet,Bldg 3-4303, Ft Bragg, NC 28310 USA.	wesley.r.cole.ctr@mail.mil			Defense and Veterans Brain Injury Center through Henry M. Jackson Foundation for the Advancement of Military Medicine and General Dynamics Information Technology	This study was supported by the Defense and Veterans Brain Injury Center, through contract support from the Henry M. Jackson Foundation for the Advancement of Military Medicine and General Dynamics Information Technology.	Allen L. M., 2006, CARB COMPUTERIZED AS; Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Arrieux Jacques P, 2017, Concussion, V2, pCNC31, DOI 10.2217/cnc-2016-0021; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Cernich AN, 2007, ARCH CLIN NEUROPSYCH, V22, pS39, DOI 10.1016/j.acn.2006.10.004; Cohen J., 2013, STAT POWER ANAL BEHA; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Cole WR, 2017, J CLIN EXP NEUROPSYC, V39, P35, DOI 10.1080/13803395.2016.1198470; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Conners C. K., 2000, CONNERS CONTINUOUS P; Delis D.C., 2000, CVLT 2 CALIFORNIA VE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Gardner A, 2012, APPL NEUROPSYCH-ADUL, V19, P90, DOI 10.1080/09084282.2011.643945; Grills CE, 2016, APPL NEUROPSYCH-ADUL, V23, P295, DOI 10.1080/23279095.2015.1079713; Gualtieri C. T, 2015, FRONTIERS, V4, P11; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; Ivins BJ, 2015, ARCH CLIN NEUROPSYCH, V30, P26, DOI 10.1093/arclin/acu072; Jones WP, 2008, CLIN NEUROPSYCHOL, V22, P305, DOI 10.1080/13854040701281483; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Lim YY, 2013, ARCH CLIN NEUROPSYCH, V28, P320, DOI 10.1093/arclin/act021; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Meyers JE., 1995, REY COMPLEX FIGURE T; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493; Randolph C, 2005, J ATHL TRAINING, V40, P139; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Roebuck-Spencer TM, 2013, J ATHL TRAINING, V48, P499, DOI 10.4085/1062-6050-48.3.11; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Slick D. J, 2006, COMPENDIUM NEUROPSYC, P18; Wechsler D., 2008, WAIS 4 WECHSLER ADUL; Wechsler D., 2011, TEST PREMORBID FUNCT; Woodhouse J, 2013, CLIN NEUROPSYCHOL, V27, P376, DOI 10.1080/13854046.2012.762427	47	12	12	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2018	33	1					102	119		10.1093/arclin/acx036			18	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	FU8XL	WOS:000424139500009	28444123	Bronze			2022-02-06	
J	Dillahunt-Aspillaga, C; Powell-Cope, G				Dillahunt-Aspillaga, Christina; Powell-Cope, Gail			Community Reintegration, Participation, and Employment Issues in Veterans and Service Members With Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries, traumatic; Employment; Rehabilitation; Veterans	REHABILITATION; COMORBIDITIES; CHALLENGES; IRAQ	Traumatic brain injury (TBI) has been called the signature injury of the post-9/11 wars in Iraq, Afghanistan, and neighboring countries. Although similarities exist between veterans and service members with TBI, levels of severity and different constellations of coexisting comorbid conditions affect them differently. These conditions affect physical, cognitive, and emotional function, which in turn can complicate community reintegration (CR), or the ability to return to family, vocational, and community life. This special supplement of the Archives of Physical Medicine and Rehabilitation consists of articles written by accomplished teams from multiple disciplines, including anthropology, neuropsychology, nursing, occupational therapy, psychology, and rehabilitation sciences. Each article brings a different perspective to bear on what CR means for veterans and service members from examination of predictors and perceptions of veterans and service members and others to measurement studies. Collectively, this group of articles represents current thinking about CR and lays the groundwork for testing interventions to improve CR outcomes for veterans and service members (eg, employment, living situation, family life). Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Dillahunt-Aspillaga, Christina; Powell-Cope, Gail] James A Haley Vet Hosp, Hlth Serv Res & Dev Serv Ctr Innovat Disabil & Re, Tampa, FL USA; [Dillahunt-Aspillaga, Christina] Univ S Florida, Coll Behav & Community Sci, Dept Child & Family Studies, Rehab & Mental Hlth Counseling Program, Tampa, FL USA		Powell-Cope, G (corresponding author), Ctr Innovat Disabil & Rehabil Res, 8900 Grand Oak Circle 673-151R, Tampa, FL 33637 USA.	Gail.Powell-Cope@va.gov		Powell-Cope, Gail/0000-0002-4608-0128	Department of Veterans AffairsUS Department of Veterans Affairs; Department of EducationUS Department of Education; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services; Veterans Health Administrative Central Office; Veterans Affairs TBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center [W91YTZ-13-C-0015]; U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); U.S. Department of Veterans AffairsUS Department of Veterans Affairs [1 I50 HX001233-01, W81XWH-13-2-0095]; U.S. Department of Defense Congressionally Directed Medical Research Programs; American Congress of Rehabilitation Medicine	The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Education and the National Institute on Disability, Independent Living, and Rehabilitation Research. This research is sponsored by the Veterans Health Administrative Central Office, Veterans Affairs TBI Model System Program of Research and a subcontract from General Dynamics Health Solutions (no. W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center, U.S. Army Medical Research and Material Command, U.S. Department of Veterans Affairs (grant nos. 1 I50 HX001233-01 and W81XWH-13-2-0095), and U.S. Department of Defense Congressionally Directed Medical Research Programs.; Publication of this article was supported by the American Congress of Rehabilitation Medicine.	Besterman-Dahan K, 2018, ARCH PHYS MED REHAB, V99, pS72, DOI 10.1016/j.apmr.2017.06.035; Carlson KF, 2018, ARCH PHYS MED REHAB, V99, pS4, DOI 10.1016/j.apmr.2017.06.027; Cernich AN, 2012, J HEAD TRAUMA REHAB, V27, P253, DOI 10.1097/HTR.0b013e3182585cd5; Department of Veterans Affairs, 2014, BLUEPR EXC; Dillahunt-Aspillaga C, 2018, ARCH PHYS MED REHAB, V99, pS23, DOI 10.1016/j.apmr.2017.05.012; Elnitsky CA, 2018, ARCH PHYS MED REHAB, V99, pS58, DOI 10.1016/j.apmr.2017.10.008; Fanner CM, CHARACTERISTICS TREA; Gray M, 2018, ARCH PHYS MED REHAB, V99, pS33, DOI 10.1016/j.apmr.2017.08.465; Hawkins BL, 2018, ARCH PHYS MED REHAB, V99, pS65, DOI 10.1016/j.apmr.2017.07.018; Lew HL, 2007, J REHABIL RES DEV, V44, pVII; Manderscheid RW, 2007, ARCH PSYCHIAT NURS, V21, P122, DOI 10.1016/j.apnu.2006.12.006; Mortera MH, 2018, ARCH PHYS MED REHAB, V99, pS50, DOI 10.1016/j.apmr.2016.11.026; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Phillips KM, 2016, J REHABIL RES DEV, V53, P413, DOI 10.1682/JRRD.2014.05.0126; Pogoda TK, 2018, ARCH PHYS MED REHAB, V99, pS14, DOI 10.1016/j.apmr.2017.06.029; Pugh MJ, 2018, ARCH PHYS MED REHAB, V99, pS40, DOI 10.1016/j.apmr.2017.05.021; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Resnik L, 2012, J REHABIL RES DEV, V49, P87, DOI 10.1682/JRRD.2010.06.0107; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Sayer NA, 2014, SOC ISS POLICY REV, V8, P33, DOI 10.1111/sipr.12001; Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003; Scherer MR, 2018, ARCH PHYS MED REHAB, V99, pS79, DOI 10.1016/j.apmr.2017.04.012; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Trudel TM, 2007, J REHABIL RES DEV, V44, P1007, DOI 10.1682/JRRD.2006.12.0167; Wen PS, 2018, ARCH PHYS MED REHAB, V99, pS86, DOI 10.1016/j.apmr.2017.04.026	25	12	12	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2018	99	2		1			S1	S3		10.1016/j.apmr.2017.04.013			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FU7YY	WOS:000424069900001	29406019				2022-02-06	
J	Hendrickson, P; Pridgeon, J; Temkin, NR; Videtta, W; Petroni, G; Lujan, S; Guadagnoli, N; Urbina, Z; Pahnke, PB; Godoy, D; Pinero, G; Lora, FS; Aguilera, S; Rubiano, AM; Morejon, CS; Jibaja, M; Lopez, H; Romero, R; Dikmen, S; Chaddock, K; Chesnut, RM				Hendrickson, Peter; Pridgeon, James; Temkin, Nancy R.; Videtta, Walter; Petroni, Gustavo; Lujan, Silvia; Guadagnoli, Nahuel; Urbina, Zulma; Pahnke, Perla Blanca; Godoy, Daniel; Pinero, Gustavo; Lora, Freddy Sandi; Aguilera, Sergio; Rubiano, Andres M.; Morejon, Caridad Soler; Jibaja, Manuel; Lopez, Hubiel; Romero, Ricardo; Dikmen, Sureyya; Chaddock, Kelley; Chesnut, Randall M.			Development of a Severe Traumatic Brain Injury Consensus-Based Treatment Protocol Conference in Latin America	WORLD NEUROSURGERY			English	Article						Consensus treatment protocol; Global health; Intracranial hypertension; Intracranial pressure monitoring; Neurocritical care; Severe traumatic brain injury	EPIDEMIOLOGY; GUIDELINES; MANAGEMENT	BACKGROUND: Severe traumatic brain injury (sTBI) is a significant global health problem disproportionately affecting low-and middle-income countries (LMICs). Management of intracranial hypertension in sTBI is crucial to survival and optimal recovery. Practitioners in high-income countries routinely use intracranial pressure (ICP) monitors although their usefulness has been questioned. ICP monitors are usually unavailable in LMICs. No consensus-based/tested protocols or literature exists for sTBI treatment without ICP monitoring. METHODS: Investigators developed serial SurveyMonkey surveys for Latin American neurointensivists and neurosurgeons to determine current practice. These clinicians had extensive routine ongoing experience in sTBI without ICP monitoring. Surveys were administered and analyzed before/during/after a 2015 Buenos Aires consensus conference. Investigators identified areas of convergence blinded from colleagues' responses. A 47-clinician task force, representing 15 countries, who routinely manage patients with sTBI without monitors developed consensus-based treatment guidelines during a 3-day facilitated conference. RESULTS: Elements were added to the protocol at an 80% agreement threshold. Follow-on surveys resolved remaining elements to 97% agreement. The protocol addresses both tapering (on improvement) and neuroworsening. Staged treatment options were identified, plus unique clinical practice issues. This process introduced a research method to a large multidisciplinary group of LMIC clinicians. This report describes the process used to develop an LMIC-specific protocol that is transferable to other diseases/injuries. The protocol is being tested in 5 LMICs. - CONCLUSIONS: We derived consensus-based guidelines for sTBI treatment without ICP monitoring, and introduced a research method to a large multidisciplinary group of LMIC clinicians naive to such methods.	[Hendrickson, Peter; Pridgeon, James; Temkin, Nancy R.; Dikmen, Sureyya; Chaddock, Kelley; Chesnut, Randall M.] Univ Washington, Harborview Med Ctr, Seattle, WA 98195 USA; [Videtta, Walter] Hosp Nacl Prof Alejandro Posadas, Buenos Aires, DF, Argentina; [Petroni, Gustavo; Lujan, Silvia] Hosp Emergencia Dr Clemente Alvarez, Rosario, Argentina; [Guadagnoli, Nahuel] Hosp Privado Rosario, Hosp Emergencia, Rosario, Argentina; [Urbina, Zulma] Hosp Erasmo Meoz ICU 1, Cucuta, Colombia; [Pahnke, Perla Blanca] Hosp Municipal Urgencias, Cordoba, Argentina; [Urbina, Zulma] Sanatorio Pasteur, Catamarca, Argentina; [Pinero, Gustavo] Leonidas Lucero Hosp, Bahia Blanca, Buenos Aires, Argentina; [Lora, Freddy Sandi] Hosp Obrero 1 La Paz, La Paz, Bolivia; [Aguilera, Sergio] Hosp Reg, Inqu, Chile; [Rubiano, Andres M.] El Bosque Univ, Meditech Fdn, Neiva, Colombia; [Morejon, Caridad Soler] Ameijeiras Hosp, Havana, Cuba; [Jibaja, Manuel] Hosp Eugenio Espejo, Quito, Ecuador; [Lopez, Hubiel] Hosp Gen de la Plaza de la Salud, Santo Domingo, Dominican Rep; [Romero, Ricardo] Fdn Clin Campbell, Barranquilla, Colombia		Chesnut, RM (corresponding author), Univ Washington, Harborview Med Ctr, Seattle, WA 98195 USA.	chesnutr@uw.edu	RUBIANO, ANDRES M/K-6704-2012; Gallardo, Angel Jesus Lacerda/AAZ-9478-2020; Di Napoli, Mario/J-6418-2014	RUBIANO, ANDRES M/0000-0001-8931-3254; Gallardo, Angel Jesus Lacerda/0000-0001-9171-2000; Di Napoli, Mario/0000-0001-9609-4926; Chesnut, Randall/0000-0001-6377-3666; ROMERO FIGUEROA, RICARDO LUIS/0000-0002-3124-8717	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS080648] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS080648] Funding Source: NIH RePORTER		Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Murphy MK, 1998, HEALTH TECHNOL ASSES, V2, P1, DOI DOI 10.3310/hta2030; Murray CJL, 1996, GLOBAL HLTH STAT; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Puvanachandra P, 2008, SALUD PUBLICA MEXICO, V50, pS3; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sahjpaul R, 2000, CAN J NEUROL SCI, V27, P143; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Thangaratinam S, 2005, OBSTET GYNAECOL, V7, P120, DOI 10.1576/toag.7.2.120.27071; World Health Organization, 2020, WORLD HLTH REPORT 20	15	12	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2018	110						E952	E957		10.1016/j.wneu.2017.11.142			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FX1ZT	WOS:000425856900122	29203307	Green Accepted, Green Submitted			2022-02-06	
J	Langdon, R; Taraman, S				Langdon, Raquel; Taraman, Sharief			Posttraumatic Headache	PEDIATRIC ANNALS			English	Article							TRAUMATIC BRAIN-INJURY; COGNITIVE-BEHAVIORAL THERAPY; POSTCONCUSSION SYNDROME; PLUS AMITRIPTYLINE; ACUTE CONCUSSION; CHRONIC MIGRAINE; CHILDREN; ADOLESCENTS; MANAGEMENT	After sustaining a concussion or mild traumatic brain injury, headaches are one of the most common complaints. The pathophysiologic changes that occur in the setting of injury likely contribute to or cause posttraumatic headaches. Posttraumatic headaches often present as migraine or tension-type headaches. Unlike pain from other types of injuries, headaches following mild traumatic brain injury are more likely to persist. Preexisting conditions such as migraine and mood disorders may influence posttraumatic headache and complicate management. Patients are at high risk to overuse abortive medications and develop medication overuse headache. Headache hygiene and early education are essential for effective management. Abortive medications include nonsteroidal anti-inflammatory drugs and triptans. Preventive medications include tricyclic antidepressants and antiepileptics. Patients who fail outpatient therapies may benefit from referral for intravenous medications in the emergency department. Patients with persistent posttraumatic headache may benefit from multimodal treatments including physical rehabilitation and pain-focused cognitive-behavioral therapies.	[Langdon, Raquel] Childrens Natl Hlth Syst, Ctr Neurosci & Behav Hlth, Pediat Headache, Washington, DC USA; [Langdon, Raquel] George Washington Univ, Child Neurol, Washington, DC 20052 USA; [Taraman, Sharief] Childrens Hosp Orange Cty, Dept Pediat Neurol, 505 S Main St,Suite 1200, Orange, CA 92668 USA; [Taraman, Sharief] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA		Taraman, S (corresponding author), Childrens Hosp Orange Cty, Dept Pediat Neurol, 505 S Main St,Suite 1200, Orange, CA 92668 USA.	staraman@choc.org		Taraman, Sharief/0000-0003-2108-2490			Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bock S, 2015, CHILD NERV SYST, V31, P2111, DOI 10.1007/s00381-015-2846-8; Chan S, 2015, AM J EMERG MED, V33, P635, DOI 10.1016/j.ajem.2015.01.053; Colman I, 2004, NEUROLOGY, V62, P1695, DOI 10.1212/01.WNL.0000127304.91605.BA; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Giza Christopher C, 2014, Continuum (Minneap Minn), V20, P1545, DOI 10.1212/01.CON.0000458975.78766.11; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Hamalainen ML, 1997, NEUROLOGY, V48, P103, DOI 10.1212/WNL.48.1.103; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heyer GL, 2014, PEDIATR NEUROL, V50, P464, DOI 10.1016/j.pediatrneurol.2014.01.040; Kacperski J, 2016, HEADACHE, V56, P36, DOI 10.1111/head.12737; Kroner JW, 2016, HEADACHE, V56, P711, DOI 10.1111/head.12795; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Ng QX, 2017, HEADACHE, V57, P349, DOI 10.1111/head.13016; O'Brien HL, 2010, CURR TREAT OPTION NE, V12, P178, DOI 10.1007/s11940-010-0069-6; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P270, DOI 10.1016/j.pediatrneurol.2014.10.015; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P263, DOI 10.1016/j.pediatrneurol.2014.10.013; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Powers SW, 2013, JAMA-J AM MED ASSOC, V310, P2622, DOI 10.1001/jama.2013.282533; Seeger TA, 2015, J CHILD NEUROL, V30, P1142, DOI 10.1177/0883073814553973; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Wilson Maria-Carmen B, 2006, Curr Pain Headache Rep, V10, P387, DOI 10.1007/s11916-006-0065-4; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	33	12	12	0	2	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0090-4481	1938-2359		PEDIATR ANN	Pediatr. Ann.	FEB	2018	47	2					E61	E68		10.3928/19382359-20180131-01			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	FX2UX	WOS:000425919900006	29446796				2022-02-06	
J	Mortera, MH; Kinirons, SA; Simantov, J; Klingbeil, H				Mortera, Marianne H.; Kinirons, Stacy A.; Simantov, Jessie; Klingbeil, Heidi			Long-Term Neurobehavioral Symptoms and Return to Productivity in Operation Enduring Freedom/Operation Iraqi Freedom Veterans With and Without Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries, traumatic; Military personnel; Rehabilitation; Veterans	POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; TO-WORK INTERVENTIONS; WAR VETERANS; MILITARY; AFGHANISTAN; PREVALENCE; OUTCOMES; PAIN; TBI	Objective: To describe Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) veterans who underwent the Comprehensive Traumatic Brain Injury Evaluation (CTBIE), differences between the traumatic brain injury (TBI) and non-TBI subgroups, and factors associated with return to productivity (RTP). Design: Retrospective medical record review. Setting: Medical center. Participants: Medical records of OEF/OIF veterans (N=236) who underwent the CTBIE between 2009 and 2013. Interventions: Not applicable. Main Outcome Measures: Demographic characteristics, injury history, clinical presentation, and factors associated with RTP. Results: Veteran sample included 90.7% men, was 45.3% white and 34.7% black, with half of Hispanic origin, and had a mean age of 33 years. The mean time since injury was approximately 4 years. Reported symptoms were high, with >90% reporting anxiousness, irritability, sleep difficulty, forgetfulness, and headaches. TBI diagnosis was found in 163 veterans (69%). The TBI subgroup was younger (TBI: 32.5y vs non-TBI: 34.9y; P=.02), reported a greater number of injuries (P<.001), and had significantly higher rates of half of the reported symptoms. Greatest differences were noted with forgetfulness (TBI: 95.7% vs non-TBI: 79.5%; P<001), poor concentration (TBI: 90.2% vs non-TBI: 76.7%; P=.007), and headaches (TBI: 93.9% vs non-TBI: 83.6%; P=.014). RTP was 60.6% for the total veteran population. Factors associated with RTP were race (white) (odds ratio [OR], 2.00; 95% confidence interval [CI], 1.13-3.55; P=.018), sensitivity to light (OR, 2.58; 95% CI, 1.17-5.66; P=.018), and fatigue (OR, 3.68; 95% CI, 1.51-8.95; P=.004). Veterans that did RTP were 3 times less likely to report depression (OR,.32; 95% CI,.12.85; P=.022). Conclusions: Veterans reported a substantial number of lingering symptoms, with a higher prevalence in veterans with TBI. Veterans with reported depression were less likely to RTP. Future research should focus on the relation between depression and non-RTP and the effectiveness of Department of Veterans Affairs services. (C) 2017 by the American Congress of Rehabilitation Medicine	[Mortera, Marianne H.; Kinirons, Stacy A.; Simantov, Jessie; Klingbeil, Heidi] James J Peters Vet Affairs Med Ctr, Dept Rehabil Med, Bronx, NY USA; [Kinirons, Stacy A.] Columbia Univ, Med Ctr, Dept Rehabil & Regenerat Med, Program Phys Therapy, New York, NY 10032 USA		Kinirons, SA (corresponding author), Columbia Univ, Neurol Inst, CUMC, Rehabil & Regenerat Med, 8th Floor,710 West 168th St, New York, NY 10032 USA.	sak2113@cumc.columbia.edu			National Center for Advancing Translational Sciences, National Institutes for Health [UL1 TR000040]; American Congress of Rehabilitation Medicine	Supported with resources and the use of facilities at the Department of Rehabilitation Medicine, James J. Peters Veterans Affairs Medical Center, Bronx, NY; and by the National Center for Advancing Translational Sciences, National Institutes for Health (grant no. UL1 TR000040).; Publication of this article was supported by the American Congress of Rehabilitation Medicine.	Adler DA, 2011, PSYCHIAT SERV, V62, P39, DOI 10.1176/ps.62.1.pss6201_0039; Bailie JM, 2016, J HEAD TRAUMA REHAB, V31, P2, DOI 10.1097/HTR.0000000000000142; Bergman K, 2013, J NEUROSCI NURS, V45, P124, DOI 10.1097/JNN.0b013e31828a418b; Bisiker J, 2007, BRIT J OCCUPATIONAL, V70, P259; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Department of Veterans Affairs, VA DOD CLIN PRACT GU; Department of Veterans Affairs, 2010, SCREEN EV POSS TRAUM; Dillahunt-Aspillaga C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115873; Donker-Cools BHPM, 2016, BRAIN INJURY, V30, P113, DOI 10.3109/02699052.2015.1090014; Ettenhofer ML, 2012, MIL MED, V177, P1272, DOI 10.7205/MILMED-D-12-00095; Faul M, 2010, TRAUMATIC BRAIN INJU; Franche RL, 2005, J OCCUP REHABIL, V15, P607, DOI 10.1007/s10926-005-8038-8; Freeman M., 2014, J INT NEUROPSYCHOL S, V5, P1; Geurtsen GJ, 2011, ARCH PHYS MED REHAB, V92, P696, DOI 10.1016/j.apmr.2010.12.022; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Kim Y., 2009, SOLDIER STUDENT EASI; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Madaus JW, 2009, J POSTSECOND EDUC DI, V22, P10; Marchione M., 2012, ALMOST HALF NEW VETS; Ntsiea MV, 2015, CLIN REHABIL, V29, P663, DOI 10.1177/0269215514554241; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pape TLB, 2016, J HEAD TRAUMA REHAB, V31, pE10, DOI 10.1097/HTR.0000000000000220; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sayer NA, 2011, J HEAD TRAUMA REHAB, V26, P454, DOI 10.1097/HTR.0b013e3181ff393c; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; U.S. Department of Veterans Affairs & Department of Defense, 2016, VA DOD CLIN PRACT GU; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Winter L, 2016, BRAIN INJURY, V30, P373, DOI 10.3109/02699052.2016.1144080; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8	44	12	12	1	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2018	99	2		1			S50	S57		10.1016/j.apmr.2016.11.026			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FU7YY	WOS:000424069900007	28088381				2022-02-06	
J	Raji, CA; Henderson, TA				Raji, Cyrus A.; Henderson, Theodore A.			PET and Single-Photon Emission Computed Tomography in Brain Concussion	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article						Concussion; Mild traumatic brain injury; PET; SPECT; TBI; CTE	CHRONIC TRAUMATIC ENCEPHALOPATHY; CEREBRAL-BLOOD-FLOW; COGNITIVE REHABILITATION THERAPY; HEAD IMPACT EXPOSURE; FDG-PET; TECHNETIUM-99M-HMPAO SPECT; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; IONIZING-RADIATION; ALZHEIMERS-DISEASE	This article offers an overview of the application of PET and single-photon emission computed tomography brain imaging to concussion, a type of mild traumatic brain injury, and traumatic brain injury, in general. The article reviews the application of these neuronuclear imaging modalities in cross-sectional and longitudinal studies. In addition, this article frames the current literature with an overview of the basic physics and radiation exposure risks of each modality.	[Raji, Cyrus A.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, UCSF China Basin, 185 Berry St,Suite 350, San Francisco, CA 94158 USA; [Henderson, Theodore A.] Dr Theodore Henderson Inc, Neuroluminance Brain Hlth Ctr Inc, Neurolaser Fdn, Synapt Space Inc, 3979 East Arapahoe Rd,Suite 200, Centennial, CO 80122 USA		Henderson, TA (corresponding author), Dr Theodore Henderson Inc, Neuroluminance Brain Hlth Ctr Inc, Neurolaser Fdn, Synapt Space Inc, 3979 East Arapahoe Rd,Suite 200, Centennial, CO 80122 USA.	thesynapticspace7@gmail.com			Change Your Brain Change Your Life Foundation; Brainreader ApS	Dr C.A. Raji received consulting fees from the Change Your Brain Change Your Life Foundation and Brainreader ApS. T.A. Henderson is the president and principal owner of The Synaptic Space, a neuroimaging consulting firm. He is owner of Neuro-Luminance Corporation, a medical service company. He is also president and principal owner of Dr. Theodore Henderson, Inc, a medical service company. He is also Vice-President of the Neuro-Laser Foundation, a non-profit organization. Currently, he serves as president of the International Society of Applied Neuroimaging.	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Abu-Judeh H H, 2000, Nucl Med Rev Cent East Eur, V3, P5; Abu-Judeh HH, 1998, J NUCL MED, V39, P1357; Amen DA., 2011, MINERVA PSICHIAT, V52, P109; Amen DG, 2016, J ALZHEIMERS DIS, V53, P237, DOI 10.3233/JAD-160207; Amen DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129659; Amen DG, 2011, J PSYCHOACTIVE DRUGS, V43, P1, DOI 10.1080/02791072.2011.566489; American Cancer Society, 2010, CANC FACTS FIG 2015; American Nuclear Society Position Statement #41, HLTH EFF LOW LEV RAD; Assadi M, 2007, HELL J NUCL MED, V10, P183; Audenaert K., 2003, MED SCI MONITOR, V9, P112; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bergschneider M, 2003, J NEUROSURG, V86, P241; Bicik I, 1998, NEUROLOGY, V51, P345, DOI 10.1212/WNL.51.2.345; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; CARDIS E, 1995, RADIAT RES, V142, P117, DOI 10.2307/3579020; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; CHERRY SR, 2003, DIAGNOSTIC NUCL MED; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; COHEN BL, 2000, MED SENTINEL, V5, P128; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; CUSUMANO S, 1992, ELECTROEN CLIN NEURO, V84, P499, DOI 10.1016/0168-5597(92)90039-E; Darcourt J, 1999, ALASBIMN J, V2; Delbeke D, 2011, J NUCL MED, V52, p24S, DOI 10.2967/jnumed.110.085688; Desikan RS, 2013, AM J NEURORADIOL, V34, P2075, DOI 10.3174/ajnr.A3644; DEVOUS MD, 1995, J NEUROIMAGING, V5, pS2, DOI 10.1111/jon19955s1s2; Devous MD, 2010, FUNCTIONAL CEREBRAL, P3; Devous MD, BRAIN MAP METHODS; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Dubroff JG, 2008, SEMIN NEUROL, V28, P548, DOI 10.1055/s-0028-1083698; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Ernst M, 1998, J NUCL MED, V39, P689; Foster B, 2014, COMPUT BIOL MED, V50, P76, DOI 10.1016/j.compbiomed.2014.04.014; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Goethals I, 2004, J NEUROTRAUM, V21, P1059, DOI 10.1089/0897715041651051; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; Goshen E, 1996, NUCL MED COMMUN, V17, P418, DOI 10.1097/00006231-199605000-00011; GRAY BG, 1992, J NUCL MED, V33, P52; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Harkness LJ, 2009, IFMBE PROC, V25, P102, DOI 10.1007/978-3-642-03879-2_29; Hashimoto K, 2009, J REHABIL MED, V41, P661, DOI 10.2340/16501977-0388; Hattori N, 2009, J NUCL MED, V50, P1054, DOI 10.2967/jnumed.108.060368; Henderson Theodore A, 2015, Adv Mind Body Med, V29, P27; Hetherington H, 2015, Handb Clin Neurol, V127, P309, DOI 10.1016/B978-0-444-52892-6.00020-9; HILL TC, 1978, RADIOLOGY, V128, P803, DOI 10.1148/128.3.803; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Howe GR, 1996, RADIAT RES, V145, P694, DOI 10.2307/3579360; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; ICHISE M, 1994, J NUCL MED, V35, P217; ICRP, 2007, RAD RISK PERSP POS S, V103, P37; IMV Medical Information Division, 2013, IMV 2013 NUCL MED MA; Ito H, 2002, J CEREBR BLOOD F MET, V22, P997, DOI 10.1097/00004647-200208000-00011; Jacobs A, 1996, J NUCL MED, V37, P1605; Jian X, 2009, BRAIN INJURY, V23, P445, DOI 10.1080/02699050902838157; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Kinahan PE, 2010, SEMIN ULTRASOUND CT, V31, P496, DOI 10.1053/j.sult.2010.10.001; Kinuya K, 2004, NUCL MED COMMUN, V25, P333, DOI 10.1097/00006231-200404000-00004; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Laatsch L, 1999, BRAIN INJURY, V13, P555, DOI 10.1080/026990599121304; Laatsch L, 1997, BRAIN INJURY, V11, P851; Lee SW, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002137; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Liu CJ, 2015, ANN NUCL MED, V29, P342, DOI 10.1007/s12149-015-0952-z; Lupi A, 2007, CLIN NUCL MED, V32, P445, DOI 10.1097/RLU.0b013e3180537621; McGrath CL, 2013, JAMA PSYCHIAT, V70, P821, DOI 10.1001/jamapsychiatry.2013.143; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Menon PM, 2009, J ALZHEIMERS DIS, V18, P419, DOI 10.3233/JAD-2009-1166; Morries LD, 2015, NEUROPSYCH DIS TREAT, V11, P2159, DOI 10.2147/NDT.S65809; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; National Research Council (US), 1998, HLTH EFF EXP LOW LEV; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Owen JP, 2016, BRAIN CONNECT, V6, P548, DOI 10.1089/brain.2016.0431; Payne JK, 1996, J NUCL MED, V37, P1735; Pennington B., 2016, NY TIMES; Peschman J, 2011, J TRAUMA, V70, P1331, DOI 10.1097/TA.0b013e31821693e2; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Provenzano FA, 2010, NUCL MED COMMUN, V31, P952, DOI 10.1097/MNM.0b013e32833e37c4; Pryor James, 2016, J Lifestyle Med, V6, P7, DOI 10.15280/jlm.2016.6.1.7; Raji CA, 2015, BRAIN IMAGING BEHAV, V9, P527, DOI 10.1007/s11682-015-9385-5; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Richmond R, 2011, J TRAUMA, V71, pE8, DOI 10.1097/TA.0b013e3181fbaa46; Ringelstein A, 2014, J COMPUT ASSIST TOMO, V38, P25, DOI 10.1097/RCT.0b013e3182a3f9a0; ROBERTS MA, 1995, BRAIN INJURY, V9, P427, DOI 10.3109/02699059509008202; RON E, 1980, J NATL CANCER I, V65, P7; Ryan ME, 2014, J AM COLL RADIOL, V11, P939, DOI 10.1016/j.jacr.2014.07.017; SAENGER EL, 1968, J AMER MED ASSOC, V205, P855, DOI 10.1001/jama.205.12.855; SAKAS DE, 1995, J NEUROSURG, V83, P277, DOI 10.3171/jns.1995.83.2.0277; Sataloff RT, 1996, AM J OTOL, V17, P909; Shapey J, 2016, CURR GERIATR REP, V5, P71, DOI 10.1007/s13670-016-0166-9; Shetty VS, 2016, J AM COLL RADIOL, V13, P668, DOI 10.1016/j.jacr.2016.02.023; Shin SS, 2017, BRAIN IMAGING BEHAV, V11, P591, DOI 10.1007/s11682-017-9684-0; Shin YB, 2006, BRAIN INJURY, V20, P661, DOI 10.1080/02699050600677071; Stamatakis EA, 2002, J NUCL MED, V43, P476; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Sundman MH, 2014, J ALZHEIMERS PARKINS, V4, P137; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Takahashi H, 2014, AM J NEURORADIOL, V35, P906, DOI 10.3174/ajnr.A3780; Takahashi Y, 2013, ANN NUCL MED, V27, P11, DOI 10.1007/s12149-012-0653-9; Umile EM, 1998, BRAIN INJURY, V12, P577; United States Environmental Protection Agency, RAD PROT CALC YOUR R; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Veitch DP, MILITARY RISK FACTOR; Villemagne VL, 2016, CURR OPIN NEUROBIOL, V36, P43, DOI 10.1016/j.conb.2015.09.002; Wintermark M, 2015, AM J NEURORADIOL, V36, pE12, DOI 10.3174/ajnr.A4254; Wong GK, 2009, BRIT J NEUROSURG, V23, P601, DOI 10.3109/02688690902948184; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Zhang J, 2010, J NEUROTRAUM, V27, P35, DOI 10.1089/neu.2009.1049	123	12	12	0	23	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1052-5149	1557-9867		NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	FEB	2018	28	1					67	+		10.1016/j.nic.2017.09.003			17	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FR3UA	WOS:000418990900008	29157854				2022-02-06	
J	Schmidt, JD; Terry, DP; Ko, J; Newell, KM; Miller, LS				Schmidt, Julianne D.; Terry, Douglas P.; Ko, Jihyun; Newell, Karl M.; Miller, L. Stephen			Balance Regularity Among Former High School Football Players With or Without a History of Concussion	JOURNAL OF ATHLETIC TRAINING			English	Article						mild traumatic brain injuries; postural stability; retired athletes	TRAUMATIC BRAIN-INJURY; POSTURAL-CONTROL; MUSCULOSKELETAL INJURY; CEREBRAL CONCUSSION; APPROXIMATE ENTROPY; STABILITY; DYNAMICS; RECOVERY; DEFICITS; GAIT	Context: Subclinical postural-control changes may persist beyond the point when athletes are considered clinically recovered postconcussion. Objective: To compare postural-control performance between former high school football players with or without a history of concussion using linear and nonlinear metrics. Design: Case-control study. Setting: Clinical research laboratory. Patients or Other Participants: A total of 11 former high school football players (age range, 45-60 years) with 2 or more concussions and 11 age-and height-matched former high school football players without a history of concussion. No participant had college or professional football experience. Main Outcome Measure(s): Participants completed the Sensory Organization Test. We compared postural control (linear: equilibrium scores; nonlinear: sample and multiscale entropy) between groups using a 2 X 3 analysis of variance across conditions 4 to 6 (4: eyes open, sway-referenced platform; 5: eyes closed, sway-referenced platform; 6: eyes open, sway-referenced surround and platform). Results: We observed a group-by-condition interaction effect for medial-lateral sample entropy (F-2,F-40 = 3.26, P = .049, eta(2)(p) = 0.140). Participants with a history of concussion presented with more regular medial-lateral sample entropy values (0.90 +/- 0.41) for condition 5 than participants without a history of concussion (1.30 +/- 0.35; mean difference = -0.40; 95% confidence interval [CI] = -0.74, -0.06; t(20) = -2.48, P = .02), but conditions 4 (mean difference = -0.11; 95% CI: -0.37, 0.15; t(20) = -0.86, P = .40) and 6 (mean difference = -0.25; 95% CI: -0.55, 0.06; t(20) = -1.66, P = .11) did not differ between groups. Conclusions: Postconcussion deficits, detected using nonlinear metrics, may persist long after injury resolution. Subclinical concussion deficits may persist for years beyond clinical concussion recovery.	[Schmidt, Julianne D.; Terry, Douglas P.; Newell, Karl M.; Miller, L. Stephen] Univ Georgia, 330 River Rd, Athens, GA 30602 USA; [Ko, Jihyun] Seoul Natl Univ, Seoul, South Korea		Schmidt, JD (corresponding author), Univ Georgia, 330 River Rd, Athens, GA 30602 USA.	schmidtj@uga.edu			John and Mary Franklin Foundation; BioImaging Research Center at the University of Georgia; Department of Kinesiology at the University of Georgia	We thank Michael S. Ferrara, PhD, ATC, FNATA, and Martijn Verhoeven, PhD, for providing technical support. Funding for this study was provided by the John and Mary Franklin Foundation, the BioImaging Research Center at the University of Georgia, and the Department of Kinesiology at the University of Georgia (all via Drs Terry and Miller).	[Anonymous], 1991, EQ SYST DAT INT MAN; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Costa M, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/68008; Costa M, 2003, PHYSICA A, V330, P53, DOI 10.1016/j.physa.2003.08.022; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Gao JB, 2012, NONLINEAR DYNAM, V68, P431, DOI 10.1007/s11071-011-0281-2; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Greenhow A, 2015, NEUROETHICS-NETH, V8, P65, DOI 10.1007/s12152-014-9216-1; Groome LJ, 1999, J APPL PHYSIOL, V87, P530, DOI 10.1152/jappl.1999.87.2.530; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Harbourne RT, 2009, PHYS THER, V89, P284, DOI 10.2522/ptj.20080130.ar; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Nashner Lewis., 2016, BALANCE FUNCTION ASS, V2nd ed, P451; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Piirtola M, 2006, GERONTOLOGY, V52, P1, DOI 10.1159/000089820; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Terry DP, 2015, ARCH CLIN NEUROPSYCH, V30, P341, DOI 10.1093/arclin/acv020; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3	31	12	12	0	7	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	FEB	2018	53	2					109	114		10.4085/1062-6050-326-16			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	FY8CL	WOS:000427090400001	29332469	Green Published, gold			2022-02-06	
J	Terrell, TR; Abramson, R; Barth, JT; Bennett, E; Cantu, RC; Sloane, R; Laskowitz, DT; Erlanger, DM; McKeag, D; Nichols, G; Valentine, V; Galloway, L				Terrell, Thomas Roland; Abramson, Ruth; Barth, Jeffery T.; Bennett, Ellen; Cantu, Robert C.; Sloane, Richard; Laskowitz, Daniel T.; Erlanger, David M.; McKeag, Douglas; Nichols, Gregory; Valentine, Verle; Galloway, Leslie			Genetic polymorphisms associated with the risk of concussion in 1056 college athletes: a multicentre prospective cohort study	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN-E EPSILON-4; RECEPTOR IL-6R GENE; APOE PROMOTER; HEAD-INJURY; E GENOTYPE; INTERLEUKIN-6; ALLELE; TAU; BIOMARKERS	Background/aim To evaluate the association of genetic polymorphisms APOE, APOE G-219T promoter, microtubule associated protein(MAPT)/tau exon 6 Ser(53)Pro, MAPT/tau Hist(47)Tyr, IL-6572 G/C and IL-6R(Asp)358(Ala) with the risk of concussion in college athletes. Methods A 23-centre prospective cohort study of 1056 college athletes with genotyping was completed between August 2003 and December 2012. All athletes completed baseline medical and concussion questionnaires, and post-concussion data were collected for athletes with a documented concussion. Results The study cohort consisted of 1056 athletes of mean +/- SD age 19.7 +/- 1.5 years, 89.3% male, 59.4% Caucasian, 35.0% African-American, 5.6% other race. The athletes participated in American football, soccer, basketball, softball, men's wrestling and club rugby. A total of 133 (12.1% prevalence) concussions occurred during an average surveillance of 3 years per athlete. We observed a significant positive association between IL-6R CC (p=0.001) and a negative association between APOE4 (p=0.03) and the risk of concussion. Unadjusted and adjusted logistic regression analysis showed a significant association between IL-6R CC and concussion (OR 3.48; 95% CI 1.58 to 7.65; p=0.002) and between the APOE4 allele and concussion (OR 0.61; 95% CI 0.38 to 0.96; p=0.04), which persisted after adjustment for confounders. Conclusions IL-6R CC was associated with a three times greater concussion risk and APOE4 with a 40% lower risk.	[Terrell, Thomas Roland] Covenant Med Grp, Family Med & Sports Med Ctr, 110 Execut Pk Dr, Clinton, TN 37716 USA; [Terrell, Thomas Roland] Univ Tennessee, Grad Sch Med, Primary Care Sports Med, Dept Family Med, Knoxville, TN USA; [Abramson, Ruth] Univ South Carolina, Sch Med, Dept Neuropsychiat & Behav Sci, Columbia, SC USA; [Barth, Jeffery T.] Univ Virginia, Sch Med, Brain Injury & Sports Concuss Inst, Dept Psychiat & Neurobehav Sci, Charlottesville, VA 22908 USA; [Bennett, Ellen] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA; [Cantu, Robert C.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Cantu, Robert C.] Ctr Study Chron Traumat Encephalopathy, Boston, MA USA; [Sloane, Richard] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27710 USA; [Laskowitz, Daniel T.] Duke Univ Hosp, Neurobiol & Anesthesiol, Durham, NC USA; [Laskowitz, Daniel T.] Duke Univ, Med Ctr, Neurol & Anesthesiol, Durham, NC USA; [Erlanger, David M.] Rusk Inst Rehabil Med, New York, NY USA; [Erlanger, David M.] Univ Langone Med Ctr, New York, NY USA; [McKeag, Douglas] Univ Oregon, Hlth Sci Ctr, Dept Family Med, Portland, OR USA; [Nichols, Gregory] Oak Ridge Associated Univ, Oak Ridge, TN USA; [Valentine, Verle] Sanford Hlth Care, Sanford Orthopaed & Sports Med, Sioux Falls, SD USA; [Galloway, Leslie] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA; [Galloway, Leslie] Oak Ridge Natl Lab, Div Environm Sci, Toxicol & Risk Anal, POB 2008, Oak Ridge, TN 37831 USA		Terrell, TR (corresponding author), Covenant Med Grp, Family Med & Sports Med Ctr, 110 Execut Pk Dr, Clinton, TN 37716 USA.	tterrell20@gmail.com		Nichols, Gregory/0000-0002-1512-5602	National Operating Committee on Standards for Athletic Equipment (NOCSAE); American Medical Society of Sports Medicine (AMSSM); Physicians Medical Education and Research Foundation of the University of Tennessee Medical Center (PMERF)	Grant funding was provided by the National Operating Committee on Standards for Athletic Equipment (NOCSAE), American Medical Society of Sports Medicine (AMSSM), and Physicians Medical Education and Research Foundation of the University of Tennessee Medical Center (PMERF). The opinions expressed by the authors are not those of these organizations, but are rather our own.	Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Artiga MJ, 1998, FEBS LETT, V421, P105, DOI 10.1016/S0014-5793(97)01543-3; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Bennett E. R., 2016, TRANSLATIONAL RES TR, P1; Blackman JA, 2005, DEV MED CHILD NEUROL, V47, P64, DOI 10.1017/S0012162205000113; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Brody JR, 2004, BIOTECHNIQUES, V36, P214, DOI 10.2144/04362BM02; Bulstrode H, 2014, ANN NEUROL, V75, P186, DOI 10.1002/ana.24116; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Dalla Libera AL, 2011, BRAIN INJURY, V25, P365, DOI 10.3109/02699052.2011.556107; DARDIOTIS E, 2010, NEUROSURG FOCUS, V28; Dretsch MN, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.392; Erlanger DM, 2002, J HEAD TRAUMA REHAB, V17, P458, DOI 10.1097/00001199-200210000-00007; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Ferreira RC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003444; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Galicia JC, 2004, GENES IMMUN, V5, P513, DOI 10.1038/sj.gene.6364120; Garbers C, 2014, BBA-MOL BASIS DIS, V1842, P1485, DOI 10.1016/j.bbadis.2014.05.018; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Hercher LS, 2016, J GENET COUNS, V25, P1267, DOI 10.1007/s10897-016-9965-6; HIXSON JE, 1990, J LIPID RES, V31, P545; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Lambert JC, 1998, HUM MOL GENET, V7, P533, DOI 10.1093/hmg/7.3.533; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; Lawrence DW, 2015, BRAIN INJURY, V29, P1018, DOI 10.3109/02699052.2015.1005131; Lendon CL, 2003, NEUROLOGY, V61, P683, DOI 10.1212/01.WNL.0000078033.81925.80; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Lilius L, 1999, NEUROSCI LETT, V277, P29, DOI 10.1016/S0304-3940(99)00833-2; Lo TYM, 2009, CHILD NERV SYST, V25, P47, DOI 10.1007/s00381-008-0723-4; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Madura SA, 2016, BRAIN INJURY, V30, P908, DOI 10.3109/02699052.2016.1146958; McAllister Thomas W, 2015, Handb Clin Neurol, V128, P723, DOI 10.1016/B978-0-444-63521-1.00045-5; McCrea M., 2001, J ATHL TRAINING, V36, P73; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Myakishev MV, 2001, GENOME RES, V11, P163, DOI 10.1101/gr.157901; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; Nwachuku EL, 2016, CLIN NEUROL NEUROSUR, V149, P1, DOI 10.1016/j.clineuro.2016.06.009; Oh SA, 2014, BBA-GEN SUBJECTS, V1840, P637, DOI 10.1016/j.bbagen.2013.10.029; Panenka WJ, 2017, J NEUROTRAUM, V34, P2093, DOI 10.1089/neu.2016.4833; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Pittman AM, 2006, HUM MOL GENET, V15, pR188, DOI 10.1093/hmg/ddl190; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Qi HP, 2012, PLOS ONE, V7; Quinn TJ, 2004, NEUROPATH APPL NEURO, V30, P569, DOI 10.1111/j.1365-2990.2004.00581.x; Rafiq S, 2007, GENES IMMUN, V8, P552, DOI 10.1038/sj.gene.6364414; Reuter-Rice K, 2015, ANNU REV NURS RES-SE, V33, P185, DOI 10.1891/0739-6686.33.185; Rothaug M, 2016, BBA-MOL CELL RES, V1863, P1218, DOI 10.1016/j.bbamcr.2016.03.018; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Shahim P, 2016, J NEUROTRAUM, V33, P1995, DOI 10.1089/neu.2014.3741; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Terrell TR, 2017, J SPORT MED PHYS FIT, V57, P77, DOI 10.23736/S0022-4707.16.05092-1; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Tierney RT, 2010, CLIN J SPORT MED, V20, P464, DOI 10.1097/JSM.0b013e3181fc0a81; Wojtys EM, 1999, AM J SPORT MED, V27, P676, DOI 10.1177/03635465990270052401; Zeng S, 2014, GENET TEST MOL BIOMA, V18, P202, DOI 10.1089/gtmb.2013.0421; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	72	12	12	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	FEB	2018	52	3					192	+		10.1136/bjsports-2016-097419			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	FU5HT	WOS:000423884400013	28918391				2022-02-06	
J	Zhang, T; Chen, LY; Wang, Y; Zhang, MM; Wang, LL; Xu, XJ; Xiao, GR; Chen, J; Shen, YR; Zhou, N				Zhang, Ting; Chen, Lingyan; Wang, Yu; Zhang, Mengmeng; Wang, Lanlan; Xu, Xiangjun; Xiao, Gairong; Chen, Jing; Shen, Yeru; Zhou, Nong			Impaired theory of mind in Chinese children and adolescents with idiopathic generalized epilepsy: Association with behavioral manifestations of executive dysfunction	EPILEPSY & BEHAVIOR			English	Article						Idiopathic generalized epilepsy; Theory of mind; Executive function	TEMPORAL-LOBE EPILEPSY; DEFICIT HYPERACTIVITY DISORDER; AUTISM SPECTRUM DISORDER; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SOCIAL COGNITION; RATING INVENTORY; PRESCHOOL-CHILDREN; ROLANDIC EPILEPSY; 2ND-ORDER BELIEFS	Background: Epilepsy is a common neurological disorder with a core feature of cognitive impairments. Previous studies showed that patients with focal epilepsy have deficits in both theory of mind (ToM) and executive function (EF). However, there are few studies of ToM in patients with idiopathic generalized epilepsy (IGE), especially in populations with pediatric epilepsy. The aim of this study was to examine the characteristics of ToM and EF, including some of their subcomponents, and explore the relationship between them in Chinese children with IGE. Materials and methods: We recruited 54 children and adolescents with IGE as the experimental subjects and 37 typically developing children and adolescents as control subjects. Both groups completed ToM tests, namely, second-order false belief tasks (FBTs) and faux pas tasks (FPTs). Their caregivers completed the Behavior Rating Inventory of Executive Function (BRIEF) at the same time. Results: Children and adolescents with IGE displayed worse performance on some of the FBTs and FPTs than healthy controls (p < 0.01). They also exhibited widespread EF deficits, comprising eight subcomponents (p < 0.05). Pearson's correlation analysis revealed that several subcomponents of EF (inhibition, emotional control, initiation, working memory, and monitoring) were unequally correlated with FBT and FPT. Regression analysis showed that ToM had associations with inhibition, working memory, and duration of seizures. Analysis of variance (ANOVA) indicated that children with newly diagnosed epilepsy displayed significant deficits in FBT, FPT, and distinct subscales of EF. Conclusions: Our results revealed significant impairments in ToM and EF in children and adolescents with IGE compared with healthy controls. We found significant correlations between ToM and two subcomponents of EF (inhibition and working memory) in children with IGE. Additionally, the duration of seizures affected ToM in patients but was a less powerful predictor than the two subcomponents of EF. Even for children with new-onset seizures and without medication, the deficits in ToM and some distinct subscales of EF were apparent. This result has clinical implications for both nonpharmaceutical therapies and cognitive rehabilitation. (C) 2017 Elsevier Inc. All rights reserved.	[Zhang, Ting; Chen, Lingyan; Wang, Yu; Zhang, Mengmeng; Xiao, Gairong; Chen, Jing; Shen, Yeru; Zhou, Nong] Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, 210 Jixi Rd, Hefei, Anhui, Peoples R China; [Wang, Lanlan] Anhui Prov Hosp, Anhui Prov Stereotact Neurosurg Inst, Hefei, Anhui, Peoples R China; [Xu, Xiangjun] Wannan Med Coll, Affiliated Hosp 1, Dept Neurol, Wuhu, Anhui, Peoples R China		Zhou, N (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Neurol, 210 Jixi Rd, Hefei, Anhui, Peoples R China.	neurologyzhounong@163.com			National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271444, 81671290]; Anhui Provincial Natural Science Foundation in China [KJ2012A175]	This research was supported by Natural Science grants to Y Wang (Grant number: 81271444 and 81671290) from the National Science Foundation of China, Anhui Provincial Natural Science Foundation in China (KJ2012A175).	Alfstad KA, 2016, EPILEPSY BEHAV, V56, P88, DOI 10.1016/j.yebeh.2016.01.007; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Austin JK, 2011, EPILEPSY BEHAV, V21, P373, DOI 10.1016/j.yebeh.2011.05.028; Austin JK, 2001, PEDIATRICS, V107, P115, DOI 10.1542/peds.107.1.115; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bell B, 2011, NAT REV NEUROL, V7, P154, DOI 10.1038/nrneurol.2011.3; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bernhardt BC, 2009, NEUROIMAGE, V46, P373, DOI 10.1016/j.neuroimage.2009.01.055; Calarge C, 2003, AM J PSYCHIAT, V160, P1954, DOI 10.1176/appi.ajp.160.11.1954; Camfield PR, 2014, PEDIATR NEUROL, V51, P17, DOI 10.1016/j.pediatrneurol.2014.02.020; Caplan R, 2005, EPILEPSY BEHAV, V6, P218, DOI 10.1016/j.yebeh.2004.11.020; Carlson SM, 2001, CHILD DEV, V72, P1032, DOI 10.1111/1467-8624.00333; CAVE CB, 1992, HIPPOCAMPUS, V2, P151, DOI 10.1002/hipo.450020207; Chowdhury FA, 2014, EPILEPSIA, V55, P835, DOI 10.1111/epi.12604; Duh S, 2016, DEV PSYCHOL, V52, P582, DOI 10.1037/a0040068; Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x; Farrant A, 2005, EPILEPSY BEHAV, V7, P506, DOI 10.1016/j.yebeh.2005.07.018; Flavell JH, 1999, ANNU REV PSYCHOL, V50, P21, DOI 10.1146/annurev.psych.50.1.21; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gilotty L, 2002, CHILD NEUROPSYCHOL, V8, P241, DOI 10.1076/chin.8.4.241.13504; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Giovagnoli AR, 2014, EPILEPSY BEHAV, V39, P145, DOI 10.1016/j.yebeh.2014.05.021; Giovagnoli AR, 2011, EPILEPSIA, V52, P1995, DOI 10.1111/j.1528-1167.2011.03215.x; Hala S, 2003, J COGN DEV, V4, P275, DOI 10.1207/S15327647JCD0403_03; Hamilton K, 2016, J CHILD ADOLESC MENT, V28, P233, DOI 10.2989/17280583.2016.1268141; Harrington Leigh, 2005, Cogn Neuropsychiatry, V10, P87, DOI 10.1080/13546800344000327; Hermann BP, 2008, EPILEPSIA, V49, P1847, DOI 10.1111/j.1528-1167.2008.01735.x; Hu Y, 2016, EPILEPSY BEHAV, V57, P46, DOI 10.1016/j.yebeh.2016.01.027; Huizinga M, 2011, CHILD NEUROPSYCHOL, V17, P51, DOI 10.1080/09297049.2010.509715; Iarocci G, 2017, J AUTISM DEV DISORD, V47, P1818, DOI 10.1007/s10803-017-3103-7; Im-Bolter N, 2016, J EXP CHILD PSYCHOL, V149, P98, DOI 10.1016/j.jecp.2015.12.006; Jallon P, 2005, EPILEPSIA, V46, P10, DOI 10.1111/j.1528-1167.2005.00309.x; Jarratt KP, 2005, APPL NEUROPSYCHOL, V12, P83, DOI 10.1207/s15324826an1202_4; Jiang YB, 2014, EPILEPSY BEHAV, V37, P139, DOI 10.1016/j.yebeh.2014.06.005; Kavros PM, 2008, EPILEPSIA, V49, P1570, DOI 10.1111/j.1528-1167.2008.01610.x; Kim JB, 2014, EPILEPSIA, V55, P592, DOI 10.1111/epi.12580; Lew AR, 2015, DEV MED CHILD NEUROL, V57, P53, DOI 10.1111/dmcn.12613; Li YH, 2013, J INT NEUROPSYCH SOC, V19, P594, DOI 10.1017/S1355617713000143; Li ZH, 2004, NEUROIMAGE, V21, P181, DOI 10.1016/j.neuroimage.2003.08.043; Lin JJ, 2012, LANCET, V380, P1180, DOI 10.1016/S0140-6736(12)61455-X; Love CE, 2016, EPILEPSY BEHAV, V64, P37, DOI 10.1016/j.yebeh.2016.08.018; Maiman Moshe, 2018, Child Neuropsychol, V24, P975, DOI 10.1080/09297049.2017.1365829; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Monjauze C, 2005, BRAIN LANG, V92, P300, DOI 10.1016/j.bandl.2004.07.001; Neligan Aidan, 2012, Handb Clin Neurol, V107, P113, DOI 10.1016/B978-0-444-52898-8.00006-9; Noda Y, 2017, SCHIZOPHR B, V9, P1; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; PERNER J, 1985, J EXP CHILD PSYCHOL, V39, P437, DOI 10.1016/0022-0965(85)90051-7; Postle BR, 2006, NEUROSCIENCE, V139, P23, DOI 10.1016/j.neuroscience.2005.06.005; Pu S, 2013, PSYCHIAT RES-NEUROIM, V214, P73, DOI 10.1016/j.pscychresns.2013.05.011; Qian Ying, 2007, Beijing Da Xue Xue Bao Yi Xue Ban, V39, P277; Rantanen K, 2012, EPILEPSY BEHAV, V24, P295, DOI 10.1016/j.yebeh.2012.04.117; Raud T, 2015, EPILEPSY BEHAV, V52, P93, DOI 10.1016/j.yebeh.2015.08.028; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Riccio CA, 2015, APPL NEUROPSYCH-CHIL, V4, P277, DOI 10.1080/21622965.2014.923774; Rothmayr C, 2011, NEUROIMAGE, V56, P1705, DOI 10.1016/j.neuroimage.2010.12.052; Sabbagh MA, 2006, PSYCHOL SCI, V17, P74, DOI 10.1111/j.1467-9280.2005.01667.x; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Schacher M, 2006, EPILEPSIA, V47, P2141, DOI 10.1111/j.1528-1167.2006.00857.x; Shahaeian A, 2011, DEV PSYCHOL, V47, P1239, DOI 10.1037/a0023899; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; SIMON HA, 1975, COGNITIVE PSYCHOL, V7, P268, DOI 10.1016/0010-0285(75)90012-2; SULLIVAN K, 1994, DEV PSYCHOL, V30, P395, DOI 10.1037/0012-1649.30.3.395; Suurmeijer TPBM, 2001, EPILEPSIA, V42, P1160, DOI 10.1046/j.1528-1157.2001.37000.x; Ter-Stepanian M, 2017, J CAN ACAD CHILD ADO, V26, P21; Wang WH, 2015, EPILEPSIA, V56, P1117, DOI 10.1111/epi.13023; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Xu X J, 2016, Zhonghua Yi Xue Za Zhi, V96, P517, DOI 10.3760/cma.j.issn.0376-2491.2016.07.005; Zarrabipoor Hamid, 2016, Iran J Psychiatry, V11, P133	74	12	15	2	22	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	FEB	2018	79						205	212		10.1016/j.yebeh.2017.12.006			8	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	FX9PH	WOS:000426435800032	29309954				2022-02-06	
J	Bai, XF; Gao, YK				Bai, Xiao-Fei; Gao, Yong-Kai			Recombinant human erythropoietin for treating severe traumatic brain injury	MEDICINE			English	Article						efficacy; recombinant human erythropoietin; safety; traumatic brain injury	RANDOMIZED CONTROLLED-TRIAL; DOUBLE-BLIND; HEAD-INJURY; CLASSIFICATION; EPIDEMIOLOGY; OUTCOMES; MRI	Background: This study aimed to explore the efficacy and safety of recombinant human erythropoietin (RHE) for the treatment of severe traumatic brain injury (STBI). Methods: One hundred and twenty eligible patients with STBI were randomly divided into an intervention group or a control group equally. Patients in the intervention group received RHE. The participants in the control group received 0.9% saline. The outcome measurements included the Glasgow Outcome Scale (GOS) scores, mortality, and any adverse events. Results: At the end of 10-week follow-up after treatment, RHE neither showed greater efficacy in GOS scores (1-2, P = .43; 3-4, P = .25; 5-6, P = .58; 7-8, P = .23), nor the lower mortality in the intervention group than those in the control group (P = .47). In addition, both groups had similar safety profile. Conclusion: This study found that RHE did not improve the neurological outcomes in patients with STBI.	[Bai, Xiao-Fei; Gao, Yong-Kai] Peoples Hosp Yanan, Dept Neurosurg, Yanan 716000, Shaanxi, Peoples R China		Gao, YK (corresponding author), Peoples Hosp Yanan, Dept Neurosurg, Yanan 716000, Shaanxi, Peoples R China.	389545300@qq.com					Abou-Abbass H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005342; Han JS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002827; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; Jang SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004017; Juul S, 2012, J MATERN-FETAL NEO M, V25, P105, DOI 10.3109/14767058.2012.715025; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kumral A, 2011, BRAIN DEV-JPN, V33, P632, DOI 10.1016/j.braindev.2010.10.014; Li ZM, 2016, CLIN NEUROL NEUROSUR, V150, P80, DOI 10.1016/j.clineuro.2016.09.001; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Sashika H, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005968; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Wang L, 2015, TRANSL STROKE RES, V6, P50, DOI 10.1007/s12975-014-0362-x; Wang R, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001733; Wang Y, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006458	16	12	12	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	JAN	2018	97	1							e9532	10.1097/MD.0000000000009532			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8CQ	WOS:000424080300025	29505528	Green Published, gold			2022-02-06	
J	Bao, WX; He, FP; Yu, LH; Gao, J; Meng, FX; Ding, YH; Zou, H; Luo, BY				Bao, Wangxiao; He, Fangping; Yu, Lihua; Gao, Jian; Meng, Fanxia; Ding, Yahui; Zou, Hai; Luo, Benyan			Complement cascade on severe traumatic brain injury patients at the chronic unconscious stage: implication for pathogenesis	EXPERT REVIEW OF MOLECULAR DIAGNOSTICS			English	Article						Complement cascade; chronic disorders of consciousness; severe traumatic brain injury; iTRAQ; proteomics; plasma	PROTEOMICS; PATHOPHYSIOLOGY; RECOVERY; SYSTEM	Background: Patients who awake from severely traumatic brain injury (TBI) may remain unconscious for many years. Although behavioral assessment and functional imaging are currently used as diagnostic tools, the molecular basis underlying chronic condition has yet to be explored.Method: Plasma samples were obtained at 3 time points (1, 3 and 6months) from 18 patients with chronic disorders of consciousness who survived severe TBI, and 6 healthy volunteers. A coupled isobaric tag for relative and absolute quantitation (iTRAQ)-based proteomics approach was used to screen differentially expressed proteins (DEPs) between patients and controls. Potential molecular mechanisms were further discussed through bioinformatics analyses.Result: In total, 300 plasma proteins <1% false discovery rates were identified and 32 proteins were consistently altered between patients and controls. Biological pathway analysis revealed that the DEPs were predominantly involved in complement cascade.Conclusions: This study discussed potential mechanisms of complement cascade underlying chronic stage in severe TBI.	[Bao, Wangxiao; He, Fangping; Meng, Fanxia; Luo, Benyan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurol,Collaborat Innovat Ctr Brain Sci, Hangzhou, Zhejiang, Peoples R China; [Yu, Lihua] Zhejiang Prov Peoples Hosp, Dept Neurol, Hangzhou, Zhejiang, Peoples R China; [Gao, Jian] Hangzhou Hosp Zhejiang CAPR, Dept Rehabil, Hangzhou, Zhejiang, Peoples R China; [Ding, Yahui; Zou, Hai] Zhejiang Prov Peoples Hosp, Affiliated Hosp 1, Dept Neurol, Hangzhou, Zhejiang, Peoples R China; [Yu, Lihua; Ding, Yahui; Zou, Hai] Hangzhou Med Coll, Peoples Hosp, Hangzhou, Zhejiang, Peoples R China		Luo, BY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurol,Collaborat Innovat Ctr Brain Sci, Hangzhou, Zhejiang, Peoples R China.; Ding, YH; Zou, H (corresponding author), Zhejiang Prov Peoples Hosp, Dept Cardiol, Hangzhou, Zhejiang, Peoples R China.	dyh@zjheart.com; haire1993@163.com; luobenyan@zju.edu.cn			Science and Technology Plan of Zhejiang Province [2017C03011]	This work was supported by grants from the Science and Technology Plan of Zhejiang Province (2017C03011).	Anada RP, 2018, ELECTROPHORESIS, V39, P2308, DOI 10.1002/elps.201700407; Babikian T, 2018, J NEUROTRAUM, V35, P1637, DOI 10.1089/neu.2017.5366; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Bodien YG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00688; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brennan FH, 2016, SEMIN IMMUNOL, V28, P292, DOI 10.1016/j.smim.2016.03.015; Brennan FH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-137; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Gao WM, 2014, PEDIATR RES, V76, P280, DOI 10.1038/pr.2014.86; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x; Hardwick J, 2008, ISBT SCI SER, V3, P148, DOI 10.1111/j.1751-2824.2008.00195.x; Lizhnyak PN, 2015, EXPERT REV PROTEOMIC, V12, P75, DOI 10.1586/14789450.2015.1000869; Longhi L, 2014, CRIT CARE MED, V42, P1910, DOI 10.1097/CCM.0000000000000399; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Nguyen HX, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-26; Omenn GS, 2014, BBA-PROTEINS PROTEOM, V1844, P866, DOI 10.1016/j.bbapap.2013.10.016; Osthoff M, 2017, J NEUROTRAUM, V34, P2560, DOI 10.1089/neu.2016.4941; Pathan M, 2015, PROTEOMICS, V15, P2597, DOI 10.1002/pmic.201400515; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ruet A, 2018, J NEUROTRAUM, V35, P1552, DOI 10.1089/neu.2017.5242; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Thelin EP, 2018, BEHAV BRAIN RES, V340, P71, DOI 10.1016/j.bbr.2016.08.058; Wade DT, 1999, BMJ-BRIT MED J, V319, P841, DOI 10.1136/bmj.319.7213.841; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zhang P, 2016, J PROTEOMICS, V133, P93, DOI 10.1016/j.jprot.2015.12.014	30	12	13	1	6	TAYLOR & FRANCIS AS	OSLO	KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY	1473-7159	1744-8352		EXPERT REV MOL DIAGN	Expert Rev. Mol. Diagn.		2018	18	8					761	766		10.1080/14737159.2018.1471985			6	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	GP3FD	WOS:000440726700008	29718755				2022-02-06	
J	Boszczyk, A; Fudalej, M; Kwapisz, S; Klimek, U; Maksymowicz, M; Kordasiewicz, B; Rammelt, S				Boszczyk, Andrzej; Fudalej, Marcin; Kwapisz, Slawomir; Klimek, Urszula; Maksymowicz, Marta; Kordasiewicz, Bartlomiej; Rammelt, Stefan			Ankle fracture - Correlation of Lauge-Hansen classification and patient reported fracture mechanism	FORENSIC SCIENCE INTERNATIONAL			English	Article						Ankle fractures; Classification; Trauma; X-ray; Accidents	TRAUMATIC BRAIN-INJURY; MALLEOLAR FRACTURES; EVIDENTIAL VALUE; REPRODUCIBILITY; RECONSTRUCTION; LOCATION; SYSTEMS; BIAS; AO	Introduction: The genetic Lauge-Hansen classification is used for reconstruction of the mechanism of ankle injury. In this study, we addressed the question of agreement between the mechanism of the fracture as postulated by the Lauge-Hansen classification and mechanism reported by the patient in rotational ankle fractures. Material and methods: Radiographs of 78 patients with acute malleolar fractures were analyzed and compared with fracture mechanisms reported by these patients. Results: The patient reported mechanisms were in concordance with the mechanism deducted from the X-rays in 49% of cases. Only 17% of patients who recalled a pronation trauma actually had radiographs classified as pronation fractures while 76% of patients who recalled a supination trauma were also radiographically classified as having sustained supination type fractures. Conclusion: The Lauge-Hansen classification should be used with caution for determining the actual mechanism of injury as it was able to predict the patient reported fracture mechanism in less than 50% of cases. A substantial percentage of fractures appearing radiographically as supination type injuries may have been actually produced by a pronation fracture mechanism. (c) 2017 Elsevier B.V. All rights reserved.	[Boszczyk, Andrzej; Kwapisz, Slawomir; Klimek, Urszula; Maksymowicz, Marta; Kordasiewicz, Bartlomiej] Prof Adam Gruca Clin Hosp, Dept Traumatol & Orthopaed, Ctr Postgrad Med Educ, Konarskiego Str 13, PL-05400 Otwock, Poland; [Fudalej, Marcin] Med Univ Warsaw, Dept Forens Med, Wojciecha Oczki Str 1, PL-00001 Warsaw, Poland; [Rammelt, Stefan] Carl Gustav Carus TU Dresden, Univ Hosp, Univ Ctr Orthopaed & Traumatol, Fetscherstr 74, D-01307 Dresden, Germany		Boszczyk, A (corresponding author), Prof Adam Gruca Clin Hosp, Dept Traumatol & Orthopaed, Ctr Postgrad Med Educ, Konarskiego Str 13, PL-05400 Otwock, Poland.	ortopeda@boszczyk.pl; marcin_zms@wp.pl; skwapisz@gmail.com; urszula.u.klimek@gmail.com; maksymowicz.mm@gmail.com; bartekko@tlen.pl; Stefan.rammelt@uniklinikum-dresden.de	Rammelt, Stefan/AAE-5863-2019	Rammelt, Stefan/0000-0003-1141-6493; Boszczyk, Andrzej/0000-0003-3549-287X; Kordasiewicz, Bartlomiej/0000-0003-0748-9075			Bartonicek J, 2015, ARCH ORTHOP TRAUM SU, V135, P505, DOI 10.1007/s00402-015-2171-4; de Moraes VY, 2013, PATIENT SAF SURG, V7, DOI 10.1186/1754-9493-7-1; Fick R., 1904, HDB ANATOMIE MECHANK, VI; Gardner MJ, 2006, J ORTHOP TRAUMA, V20, P267, DOI 10.1097/00005131-200604000-00006; Haraguchi N, 2006, J BONE JOINT SURG AM, V88A, P1085, DOI 10.2106/JBJS.E.00856; Haraguchi N, 2009, J BONE JOINT SURG AM, V91A, P821, DOI 10.2106/JBJS.G.01288; Inman V. T., 1976, JOINTS ANKLE; Klammer G, 2013, FOOT ANKLE INT, V34, P189, DOI 10.1177/1071100712469334; Kwon JY, 2015, J BONE JOINT SURG AM, V97A, P604, DOI 10.2106/JBJS.N.00970; LAUGEHANSEN N, 1950, ARCH SURG-CHICAGO, V60, P957, DOI 10.1001/archsurg.1950.01250010980011; Madeley N J, 2004, Annu Proc Assoc Adv Automot Med, V48, P235; Marsh JL, 2007, J ORTHOP TRAUMA, V21, pS1, DOI 10.1097/00005131-200711101-00001; Michelson J, 1997, CLIN ORTHOP RELAT R, P198; NIELSEN JO, 1990, ACTA ORTHOP SCAND, V61, P385, DOI 10.3109/17453679008993545; Parenteau CS, 1996, ACCIDENT ANAL PREV, V28, P607, DOI 10.1016/0001-4575(96)00033-4; Rodriguez EK, 2013, FOOT ANKLE INT, V34, P1516, DOI 10.1177/1071100713491730; Schmidt S, 2016, INT J LEGAL MED, V130, P1593, DOI 10.1007/s00414-016-1437-x; Shariff SS, 2006, INJURY, V37, P888, DOI 10.1016/j.injury.2006.05.013; Silverberg ND, 2016, J HEAD TRAUMA REHAB, V31, P388, DOI 10.1097/HTR.0000000000000198; Teresinski G, 2002, FORENSIC SCI INT, V128, P127, DOI 10.1016/S0379-0738(02)00185-8; Teresinski G, 2001, FORENSIC SCI INT, V118, P65, DOI 10.1016/S0379-0738(00)00381-9; Verhage SM, 2015, SKELETAL RADIOL, V44, P1435, DOI 10.1007/s00256-015-2179-4; Warner SJ, 2015, J ORTHOP TRAUMA, V29, P574, DOI 10.1097/BOT.0000000000000393; Yang CC, 2014, J CLIN EXP NEUROPSYC, V36, P399, DOI 10.1080/13803395.2014.903899; Yin MC, 2015, ORTHOPEDICS, V38, pE626, DOI 10.3928/01477447-20150701-62	25	12	15	0	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	JAN	2018	282						94	100		10.1016/j.forsciint.2017.11.023			7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	FQ7ZX	WOS:000418583500014	29182957				2022-02-06	
J	Dong, C; Helton, ES; Zhou, P; Ouyang, X; de Tassigny, XD; Pascual, A; Lopez-Barneo, J; Ubogu, EE				Dong, Chaoling; Helton, E. Scott; Zhou, Ping; Ouyang, Xuan; d Anglemont de Tassigny, Xavier; Pascual, Alberto; Lopez-Barneo, Jose; Ubogu, Eroboghene E.			Glial-derived neurotrophic factor is essential for blood-nerve barrier functional recovery in an experimental murine model of traumatic peripheral neuropathy	TISSUE BARRIERS			English	Article						Animal model; blood-nerve barrier; conditional knockout; glial-derived neurotrophic factor; mouse; peripheral neuropathy; permeability; sciatic nerve crush injury; trauma	BRAIN-BARRIER; PHENOTYPIC HETEROGENEITY; VESICULAR TRANSPORT; TYROSINE KINASE; SCHWANN-CELLS; GDNFR-ALPHA; EXPRESSION; INJURY; PAIN; PERMEABILITY	There is emerging evidence that glial-derived neurotrophic factor (GDNF) is a potent inducer of restrictive barrier function in tight junction-forming microvascular endothelium and epithelium, including the human blood-nerve barrier (BNB) in vitro. We sought to determine the role of GDNF in restoring BNB function in vivo by evaluating sciatic nerve horseradish peroxidase (HRP) permeability in tamoxifen-inducible GDNF conditional knockout (CKO) adult mice following non-transecting crush injury via electron microscopy, with appropriate wildtype (WT) and heterozygous (HET) littermate controls. A total of 24 age-, genotype-and sex-matched mice >12 weeks of age were injected with 30 mg/kgHRP via tail vein injection 7 or 14 days following unilateral sciatic nerve crush, and both sciatic nerves were harvested 30 minutes later for morphometric assessment by light and electron microscopy. The number and percentage of HRP-permeable endoneurial microvessels were ascertained to determine the effect of GDNF in restoring barrier function in vivo. Following sciatic nerve crush, there was significant upregulation in GDNF protein expression in WT and HET mice that was abrogated in CKO mice. GDNF significantly restored sciatic nerve BNB HRP impermeability to near normal levels by day 7, with complete restoration seen by day 14 in WT and HET mice. A significant recovery lag was observed in CKO mice. This effect was independent on VE-Cadherin or claudin-5 expression on endoneurial microvessels. These results imply an important role of GDNF in restoring restrictive BNB function in vivo, suggesting a potential strategy to re-establish the restrictive endoneurial microenvironment following traumatic peripheral neuropathies.	[Dong, Chaoling; Helton, E. Scott; Zhou, Ping; Ouyang, Xuan; Ubogu, Eroboghene E.] Univ Alabama Birmingham, Dept Neurol, Div Neuromuscular Dis, Neuromuscular Immunopathol Res Lab, UAB Stn, Birmingham, AL 35294 USA; [d Anglemont de Tassigny, Xavier; Pascual, Alberto; Lopez-Barneo, Jose] Univ Seville, CSIC, Hosp Univ Virgen Rocio, Inst Biomed Sevilla IBiS, Seville, Spain		Ubogu, EE (corresponding author), Univ Alabama Birmingham, Dept Neurol, Div Neuromuscular Dis, 1720 7th Ave South,Sparks Ctr 200, Birmingham, AL 35294 USA.	eeubogu@uabmc.edu	Ubogu, Eroboghene/R-3894-2019; Pascual, Alberto P/E-9609-2015	Ubogu, Eroboghene/0000-0002-8307-9994; Pascual, Alberto P/0000-0001-5459-6207; ouyang, xuan/0000-0003-0356-4883	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS075212]; University of Alabama at Birmingham; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS075212] Funding Source: NIH RePORTER	This project was supported by National Institutes of Health (NIH) under Grant R01 NS075212 [2012-2017] and institutional funds from the University of Alabama at Birmingham. The funding sources had no involvement in the conduct of the research, manuscript preparation, data collection/analyses or decision to submit this work for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Argoff CE, 2006, MAYO CLIN PROC, V81, pS3, DOI 10.1016/S0025-6196(11)61474-2; Bar KJ, 1998, NEUROREPORT, V9, P43; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Bennett GJ, 1998, HOSP PRACT, V33, P95, DOI 10.3810/hp.1998.10.114; BRIDGE PM, 1994, EXP NEUROL, V127, P284, DOI 10.1006/exnr.1994.1104; Brun P, 2013, GASTROENTEROLOGY, V145, P1323, DOI 10.1053/j.gastro.2013.08.047; Callaghan BC, 2015, JAMA-J AM MED ASSOC, V314, P2172, DOI 10.1001/jama.2015.13611; Chen ZY, 2001, BRAIN RES, V902, P272, DOI 10.1016/S0006-8993(01)02395-2; Dong CL, 2017, EXP NEUROL, V292, P35, DOI 10.1016/j.expneurol.2017.02.012; Dong CL, 2016, ACTA NEUROPATHOL, V132, P739, DOI 10.1007/s00401-016-1599-0; Dworkin RH, 2002, CLIN J PAIN, V18, P343, DOI 10.1097/00002508-200211000-00001; Feldman EL, 2017, NEURON, V93, P1296, DOI 10.1016/j.neuron.2017.02.005; Frenzen PD, 2008, NEUROLOGY, V71, P21, DOI 10.1212/01.wnl.0000316393.54258.d1; Gordois A, 2003, DIABETES CARE, V26, P1790, DOI 10.2337/diacare.26.6.1790; Grinsell D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/698256; Hammarberg H, 1996, NEUROREPORT, V7, P857, DOI 10.1097/00001756-199603220-00004; Hashizume K, 2002, J NEUROPATH EXP NEUR, V61, P725, DOI 10.1093/jnen/61.8.725; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Hoke A, 2000, NEUROREPORT, V11, P1651; Hoke A, 2002, EXP NEUROL, V173, P77, DOI 10.1006/exnr.2001.7826; Ibanez CF, 2017, NEUROBIOL DIS, V97, P80, DOI 10.1016/j.nbd.2016.01.021; Ibanez CF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009134; Igarashi Y, 1999, BIOCHEM BIOPH RES CO, V261, P108, DOI 10.1006/bbrc.1999.0992; Igarashi Y, 2000, CELL STRUCT FUNCT, V25, P237, DOI 10.1247/csf.25.237; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; Jubran M, 2003, EXP NEUROL, V181, P204, DOI 10.1016/S0014-4886(03)00041-4; Kamimura Yasuhiro, 2002, Medical Electron Microscopy, V35, P139, DOI 10.1007/s007950200017; Kaya M, 2011, METHODS MOL BIOL, V763, P369, DOI 10.1007/978-1-61779-191-8_25; Ma NL, 1996, AM J PATHOL, V149, P1745; Magill CK, 2009, J RECONSTR MICROSURG, V25, P345, DOI 10.1055/s-0029-1215526; Marconi S, 2012, TISSUE ENG PT A, V18, P1264, DOI [10.1089/ten.tea.2011.0491, 10.1089/ten.TEA.2011.0491]; Martins T, 2013, NEUROPHARMACOLOGY, V65, P74, DOI 10.1016/j.neuropharm.2012.08.021; Meir M, 2016, AM J PHYSIOL-GASTR L, V310, pG1118, DOI 10.1152/ajpgi.00125.2016; Meir M, 2015, AM J PHYSIOL-GASTR L, V309, pG613, DOI 10.1152/ajpgi.00357.2014; Mizisin AP, 2011, ACTA NEUROPATHOL, V121, P291, DOI 10.1007/s00401-010-0783-x; Mukhamedshina YO, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/9857918; Natsume A, 2003, EXP NEUROL, V184, P878, DOI 10.1016/S0014-4886(03)00334-0; Naveilhan P, 1997, EUR J NEUROSCI, V9, P1450, DOI 10.1111/j.1460-9568.1997.tb01499.x; Nico B, 2003, GLIA, V42, P235, DOI 10.1002/glia.10216; Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025; Palispis WA, 2017, EXP NEUROL, V290, P106, DOI 10.1016/j.expneurol.2017.01.009; Palladino SP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17475-y; Pascual A, 2008, NAT NEUROSCI, V11, P755, DOI 10.1038/nn.2136; Peltonen S, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24956; Potente M, 2017, NAT REV MOL CELL BIO, V18, P477, DOI 10.1038/nrm.2017.36; Reddy CL, 2013, CELL MOL NEUROBIOL, V33, P789, DOI 10.1007/s10571-013-9946-3; Reina M A, 2003, Rev Esp Anestesiol Reanim, V50, P80; Reina M A, 2000, Rev Esp Anestesiol Reanim, V47, P464; Saadoun S, 2009, NEUROSCIENCE, V161, P764, DOI 10.1016/j.neuroscience.2009.03.069; Sadosky A, 2015, J DIABETES COMPLICAT, V29, P212, DOI 10.1016/j.jdiacomp.2014.10.013; Shimizu F, 2012, NEUROCHEM RES, V37, P401, DOI 10.1007/s11064-011-0626-8; Smith BH, 2012, CURR PAIN HEADACHE R, V16, P191, DOI 10.1007/s11916-012-0256-0; Smith CE, 2001, MICROSURG, V21, P290, DOI 10.1002/micr.1055; Steinkamp M, 2003, GASTROENTEROLOGY, V124, P1748, DOI 10.1016/S0016-5085(03)00404-9; Takahashi M, 2001, CYTOKINE GROWTH F R, V12, P361, DOI 10.1016/S1359-6101(01)00012-0; Tannemaat MR, 2008, EUR J NEUROSCI, V28, P1467, DOI 10.1111/j.1460-9568.2008.06452.x; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Ubogu EE, 2015, ACTA NEUROPATHOL, V130, P445, DOI 10.1007/s00401-015-1466-4; Ubogu EE, 2013, J VASC RES, V50, P289, DOI 10.1159/000353293; Ubogu EE, 2012, TRANSL NEUROSCI, V3, P373, DOI 10.2478/s13380-012-0039-4; Ubogu EE, 2012, J PERIPHER NERV SYST, V17, P53, DOI 10.1111/j.1529-8027.2012.00375.x; Ueno M, 2001, NEUROBIOL AGING, V22, P469, DOI 10.1016/S0197-4580(01)00213-5; Watson JC, 2015, MAYO CLIN PROC, V90, P940, DOI 10.1016/j.mayocp.2015.05.004; Xia RH, 2010, NEUROPATH APPL NEURO, V36, P388, DOI 10.1111/j.1365-2990.2010.01092.x; Xia RH, 2010, J NEUROIMMUNOL, V219, P54, DOI 10.1016/j.jneuroim.2009.11.019; Xu P, 2013, GLIA, V61, P1029, DOI 10.1002/glia.22491; Yano K, 2007, BLOOD, V109, P613, DOI 10.1182/blood-2006-05-026401; Yawn BP, 2009, PAIN MED, V10, P586, DOI 10.1111/j.1526-4637.2009.00588.x; Yosef N, 2012, MICROVASC RES, V83, P298, DOI 10.1016/j.mvr.2012.01.005; Yuan FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090463	76	12	12	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	2168-8370			TISSUE BARRIERS	Tissue Barriers		2018	6	2							e1479570	10.1080/21688370.2018.1479570			22	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	GW0GH	WOS:000446541000004	29913111	Green Published, Bronze			2022-02-06	
J	Emelifeonwu, JA; Reid, K; Rhodes, JKJ; Myles, L				Emelifeonwu, John A.; Reid, Kirsten; Rhodes, Jonathan K. J.; Myles, Lynn			Saved by the Pupillometer! - A role for pupillometry in the acute assessment of patients with traumatic brain injuries?	BRAIN INJURY			English	Article						Traumatic brain injury; TBI; acute subdural haematoma; neuroICU; pupillometer; NPi; uncal herniation	REACTIVITY	There is good evidence that pupil reactivity is useful for prognostication in acute head injuries. Despite this, most pupil assessments are subjective and are performed by physicians who may not be experts. They can therefore be unreliable. We present a case of a patient with seemingly irreversible demise from an acute traumatic subdural haematoma. This was determined by assessment of his pupils, which were non-reactive to light at the time of arrival to the neurosurgical theatre. He was transferred to the neurointensive care for brainstem death testing, where assessment by objective pupillometry determined that his pupils were in fact reactive. He made a good recovery following subsequent surgery to evacuate his subdural haematoma. We propose the widespread adoption of objective pupillometers in the assessment of acute head-injured patients and offer our case as an example of how an objective and accurate assessment can make a difference to patients' outcome.	[Emelifeonwu, John A.; Myles, Lynn] Western Gen Hosp, Dept Neurosurg, Crewe Rd South, Edinburgh EH4 2XU, Midlothian, Scotland; [Reid, Kirsten; Rhodes, Jonathan K. J.] Western Gen Hosp, Dept Neurointens Care, Edinburgh, Midlothian, Scotland		Emelifeonwu, JA (corresponding author), Western Gen Hosp, Dept Neurosurg, Crewe Rd South, Edinburgh EH4 2XU, Midlothian, Scotland.	johnemelifeonwu@gmail.com					ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Clusmann H, 2001, J NEUROL NEUROSUR PS, V71, P175, DOI 10.1136/jnnp.71.2.175; Faul M, 2010, TRAUMATIC BRAIN INJU; Kramer CL, 2014, NEUROCRIT CARE, V21, P309, DOI 10.1007/s12028-014-9988-5; Kuo JR, 2011, J FORMOS MED ASSOC, V110, P258, DOI 10.1016/S0929-6646(11)60038-7; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Litvan I, 2000, NEUROLOGY, V54, P530, DOI 10.1212/WNL.54.2.530; Meeker Michele, 2005, J Neurosci Nurs, V37, P34; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y	10	12	15	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	5					675	677		10.1080/02699052.2018.1429021			3	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WL	WOS:000427074200020	29388863				2022-02-06	
J	Ferris, CF; Morrison, TR; Iriah, S; Malmberg, S; Kulkarni, P; Hartner, JC; Trivedi, M				Ferris, Craig F.; Morrison, Thomas R.; Iriah, Sade; Malmberg, Samantha; Kulkarni, Praveen; Hartner, Jochen C.; Trivedi, Malav			Evidence of Neurobiological Changes in the Presymptomatic PINK1 Knockout Rat	JOURNAL OF PARKINSONS DISEASE			English	Article						PTEN-induced putative kinase 1; diffusion weighted imaging; biomarkers; Parkinson's disease; quantitative; anisotropy; substantia nigra	TRAUMATIC BRAIN-INJURY; IDIOPATHIC PARKINSONS-DISEASE; DORSAL COLUMN NUCLEI; MITOCHONDRIAL DYSFUNCTION; BASAL GANGLIA; ALPHA-SYNUCLEIN; OLFACTORY DYSFUNCTION; SELECTIVE HYPOSMIA; MOTOR DYSFUNCTION; MUTATION CARRIERS	Background: Genetic models of Parkinson's disease (PD) coupled with advanced imaging techniques can elucidate neurobiological disease progression, and can help identify early biomarkers before clinical signs emerge. PTEN-induced putative kinase 1 (PINK1) helps protect neurons from mitochondrial dysfunction, and a mutation in the associated gene is a risk factor for recessive familial PD. The PINK1 knockout (KO) rat is a novel model for familial PD that has not been neuroradiologically characterized for alterations in brain structure/function, alongside behavior, prior to 4 months of age. Objective: To identify biomarkers of presymptomatic PD in the PINK1 -/- rat at 3 months using magnetic resonance imaging techniques. Methods: At postnatal weeks 12-13; one month earlier than previously reported signs of motor and cognitive dysfunction, this study combined imaging modalities, including assessment of quantitative anisotropy across 171 individual brain areas using an annotated MRI rat brain atlas to identify sites of gray matter alteration between wild-type and PINK1 -/- rats. Results: The olfactory system, hypothalamus, thalamus, nucleus accumbens, and cerebellum showed differences in anisotropy between experimental groups. Molecular analyses revealed reduced levels of glutathione, ATP, and elevated oxidative stress in the substantia nigra, striatum and deep cerebellar nuclei. Mitochondrial genes encoding proteins in Complex IV, along with mRNA levels associated with mitochondrial function and genes involved in glutathione synthesis were reduced. Differences in brain structure did not align with any cognitive or motor impairment. Conclusions: These data reveal early markers, and highlight novel brain regions involved in the pathology of PD in the PINK1 -/- rat before behavioral dysfunction occurs.	[Ferris, Craig F.; Morrison, Thomas R.; Iriah, Sade; Malmberg, Samantha; Kulkarni, Praveen] Northeastern Univ, Ctr Translat NeuroImaging, Boston, MA 02115 USA; [Ferris, Craig F.] Northeastern Univ, Dept Psychol & Pharmaceut Sci, Boston, MA 02115 USA; [Trivedi, Malav] Nova Southeastern Univ, Ft Lauderdale, FL 33314 USA; [Hartner, Jochen C.] Horizon Discovery, Cambridge, England		Ferris, CF (corresponding author), Northeastern Univ, Ctr Translat NeuroImaging, Dept Psychol, Boston, MA 02115 USA.	c.ferris@neu.edu		Kulkarni, Praveen/0000-0002-8876-4544			ALLEN GI, 1974, PHYSIOL REV, V54, P957, DOI 10.1152/physrev.1974.54.4.957; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Aumann TD, 1996, J COMP NEUROL, V376, P420; Aumann TD, 1996, J COMP NEUROL, V368, P608, DOI 10.1002/(SICI)1096-9861(19960513)368:4<608::AID-CNE11>3.0.CO;2-D; Balan IS, 2013, J NEUROTRAUM, V30, P367, DOI 10.1089/neu.2012.2339; Baluchnejadmojarad T, 2017, EXP GERONTOL, V100, P70, DOI 10.1016/j.exger.2017.10.023; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Batlevi Y, 2011, NEUROBIOL DIS, V43, P46, DOI 10.1016/j.nbd.2010.09.009; Benito-Leon J, 2011, J NEUROL SCI, V310, P176, DOI 10.1016/j.jns.2011.06.054; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Bohnen NI, 2007, J NEUROL, V254, P84, DOI 10.1007/s00415-006-0284-y; Bohnen NI, 2008, NEUROSCI LETT, V447, P12, DOI 10.1016/j.neulet.2008.09.070; Bonifati Vincenzo, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS4, DOI 10.1016/S1353-8020(11)70004-9; Bostan AC, 2010, P NATL ACAD SCI USA, V107, P8452, DOI 10.1073/pnas.1000496107; Brevard ME, 2003, MAGN RESON IMAGING, V21, P995, DOI 10.1016/S0730-725X(03)00204-2; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cerasa A, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0687-9; Chen CH, 2014, NAT NEUROSCI, V17, P1767, DOI 10.1038/nn.3868; Chen YS, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00009; Dave KD, 2014, NEUROBIOL DIS, V70, P190, DOI 10.1016/j.nbd.2014.06.009; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; DOTY RL, 1988, NEUROLOGY, V38, P1237, DOI 10.1212/WNL.38.8.1237; Double KL, 2003, ARCH NEUROL-CHICAGO, V60, P545, DOI 10.1001/archneur.60.4.545; Eggers C, 2010, NEUROLOGY, V74, P1798, DOI 10.1212/WNL.0b013e3181e0f79c; Elkon H, 2002, J MOL NEUROSCI, V18, P229, DOI 10.1385/JMN:18:3:229; Ephraty L, 2007, MOVEMENT DISORD, V22, P566, DOI 10.1002/mds.21319; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Freichel C, 2007, NEUROBIOL AGING, V28, P1421, DOI 10.1016/j.neurobiolaging.2006.06.013; Gaenslen A, 2011, MOVEMENT DISORD, V26, P653, DOI 10.1002/mds.23499; Gan-Or Z, 2015, AUTOPHAGY, V11, P1443, DOI 10.1080/15548627.2015.1067364; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Gispert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005777; Glasl L, 2012, EXP NEUROL, V235, P214, DOI 10.1016/j.expneurol.2012.01.002; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Grant LM, 2015, J NEUROSCI RES, V93, P1713, DOI 10.1002/jnr.23625; Greenamyre JT, 1999, BIOCHEM SOC SYMP, V66, P85, DOI 10.1042/bss0660085; Greffard S, 2006, ARCH NEUROL-CHICAGO, V63, P584, DOI 10.1001/archneur.63.4.584; Haehner A, 2009, PARKINSONISM RELAT D, V15, P490, DOI 10.1016/j.parkreldis.2008.12.005; Haehner A, 2007, MOVEMENT DISORD, V22, P839, DOI 10.1002/mds.21413; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; HARTLEY A, 1994, J NEUROCHEM, V63, P1987; Hernandez DG, 2016, J NEUROCHEM, V139, P59, DOI 10.1111/jnc.13593; Hoshi E, 2005, NAT NEUROSCI, V8, P1491, DOI 10.1038/nn1544; Hu QS, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0060-6; Hummel T, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00125; Jost WH, 2003, J NEUROL, V250, P28, DOI 10.1007/s00415-003-1105-z; KALIL K, 1981, J COMP NEUROL, V195, P25, DOI 10.1002/cne.901950105; Kelm-Nelson CA, 2016, NEUROSCI LETT, V621, P75, DOI 10.1016/j.neulet.2016.04.003; King JA, 2005, J NEUROSCI METH, V148, P154, DOI 10.1016/j.jneumeth.2005.04.011; Kitada T, 2009, J NEUROCHEM, V111, P696, DOI 10.1111/j.1471-4159.2009.06350.x; Kranick SM, 2008, NEUROSIGNALS, V16, P35, DOI 10.1159/000109757; Kulkarni P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125748; Kulkarni P, 2012, BEHAV BRAIN RES, V230, P201, DOI 10.1016/j.bbr.2012.02.002; Li SJ, 2017, HUM BRAIN MAPP, V38, P4064, DOI 10.1002/hbm.23648; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071341; Madiha S, 2017, PAK J PHARM SCI, V30, P943; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; Mentis MJ, 2003, NEUROLOGY, V60, P612, DOI 10.1212/01.WNL.0000044154.92143.DC; Mirdamadi JL, 2016, J NEUROPHYSIOL, V116, P917, DOI 10.1152/jn.01132.2015; MOSELEY ME, 1991, MAGNET RESON MED, V19, P321, DOI 10.1002/mrm.1910190222; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nuber S, 2008, J NEUROSCI, V28, P2471, DOI 10.1523/JNEUROSCI.3040-07.2008; Onuki Y, 2015, CEREB CORTEX, V25, P313, DOI 10.1093/cercor/bht221; Palikaras Konstantinos, 2012, Frontiers in Genetics, V3, P297, DOI 10.3389/fgene.2012.00297; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Parrao T, 2012, NEURODEGENER DIS, V10, P179, DOI 10.1159/000335915; Peng J, 2005, J BIOL CHEM, V280, P29194, DOI 10.1074/jbc.M500984200; Pham TT, 2010, GENES BRAIN BEHAV, V9, P305, DOI 10.1111/j.1601-183X.2009.00559.x; Ponsen MM, 2004, ANN NEUROL, V56, P173, DOI 10.1002/ana.20160; Reetz K, 2008, BIOL PSYCHIAT, V64, P241, DOI 10.1016/j.biopsych.2007.12.010; Rial D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114216; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Siuda J, 2014, PARKINSONISM RELAT D, V20, P1274, DOI 10.1016/j.parkreldis.2014.08.019; Sommer U, 2004, MOVEMENT DISORD, V19, P1196, DOI 10.1002/mds.20141; Tanner CM, 2003, ADV NEUROL, V91, P133; Torsdottir G, 1999, PHARMACOL TOXICOL, V85, P239, DOI 10.1111/j.1600-0773.1999.tb02015.x; Trivedi M, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.52; Trivedi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02816-8; Trivedi M, 2014, MOL PHARMACOL, V85, P747, DOI 10.1124/mol.114.091728; Trivedi MS, 2014, J NUTR BIOCHEM, V25, P1011, DOI 10.1016/j.jnutbio.2014.05.004; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vila M, 1996, NEUROSCIENCE, V71, P903, DOI 10.1016/0306-4522(95)00549-8; Villeneuve LM, 2016, MOL NEUROBIOL, V53, P171, DOI 10.1007/s12035-014-8927-y; Walker MD, 2014, J PARKINSON DIS, V4, P483, DOI 10.3233/JPD-140344; Westermann B, 2008, J NEUROL NEUROSUR PS, V79, P19, DOI 10.1136/jnnp.2006.113860; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Witter L, 2015, CURR OPIN NEUROBIOL, V33, P150, DOI 10.1016/j.conb.2015.03.017; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Wu T, 2013, BRAIN, V136, P696, DOI 10.1093/brain/aws360; Yamaguchi H, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-10; Yang KM, 2018, BEHAV BRAIN RES, V339, P47, DOI 10.1016/j.bbr.2017.10.036; Yao Q, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00266; Zhang JQ, 2003, P 11 INT SOC MAG RES; Zheng Z, 2014, HUM BRAIN MAPP, V35, P1325, DOI 10.1002/hbm.22256; Zhou W, 2008, J BIOL CHEM, V283, P9863, DOI 10.1074/jbc.M710232200	104	12	12	1	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1877-7171	1877-718X		J PARKINSON DIS	J. Parkinsons Dis.		2018	8	2					281	301		10.3233/JPD-171273			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GJ6AR	WOS:000435465600010	29710734				2022-02-06	
J	Ganpule, S; Daphalapurkar, NP; Cetingul, MP; Ramesh, KT				Ganpule, S.; Daphalapurkar, N. P.; Cetingul, M. P.; Ramesh, K. T.			Effect of bulk modulus on deformation of the brain under rotational accelerations	SHOCK WAVES			English	Article						Brain bulk modulus; Computational head model; In vivo brain deformation; Comparison of strain fields; Prediction of injury	WHITE-MATTER INTEGRITY; INJURY; MODELS; VALIDATION; TISSUE; BIOMECHANICS; ANISOTROPY; IMPACTS; STRAIN; MOTION	Traumatic brain injury such as that developed as a consequence of blast is a complex injury with a broad range of symptoms and disabilities. Computational models of brain biomechanics hold promise for illuminating the mechanics of traumatic brain injury and for developing preventive devices. However, reliable material parameters are needed for models to be predictive. Unfortunately, the properties of human brain tissue are difficult to measure, and the bulk modulus of brain tissue in particular is not well characterized. Thus, a wide range of bulk modulus values are used in computational models of brain biomechanics, spanning up to three orders of magnitude in the differences between values. However, the sensitivity of these variations on computational predictions is not known. In this work, we study the sensitivity of a 3D computational human head model to various bulk modulus values. A subject-specific human head model was constructed from T1-weighted MRI images at 2- voxel resolution. Diffusion tensor imaging provided data on spatial distribution and orientation of axonal fiber bundles for modeling white matter anisotropy. Non-injurious, full-field brain deformations in a human volunteer were used to assess the simulated predictions. The comparison suggests that a bulk modulus value on the order of GPa gives the best agreement with experimentally measured in vivo deformations in the human brain. Further, simulations of injurious loading suggest that bulk modulus values on the order of GPa provide the closest match with the clinical findings in terms of predicated injured regions and extent of injury.	[Ganpule, S.] Indian Inst Technol Roorkee, Roorkee 247667, Uttar Pradesh, India; [Daphalapurkar, N. P.; Ramesh, K. T.] Johns Hopkins Univ, Hopkins Extreme Mat Inst, Baltimore, MD 21218 USA; [Cetingul, M. P.] Gen Elect Healthcare Maternal Infant Care, Laurel, MD 20723 USA		Ganpule, S (corresponding author), Indian Inst Technol Roorkee, Roorkee 247667, Uttar Pradesh, India.	shaileshfme@iitr.ac.in; nitin@jhu.edu; muge.pirtini@ge.com; ramesh@jhu.edu	Ramesh, KT/D-5451-2009; Daphalapurkar, Nitin/B-4397-2011	Ramesh, KT/0000-0003-2659-4698; Daphalapurkar, Nitin/0000-0001-5523-8874	National Institute of Neurological Disorders and Strokes, National Institutes of Health [R01NS055951]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055951] Funding Source: NIH RePORTER	The authors acknowledge funding from the National Institute of Neurological Disorders and Strokes, National Institutes of Health (Project #R01NS055951). The authors also thank Andy Knutsen and Dzung Pham from the Henry Jackson Foundation for sharing tagged MRI experimental data from Knutsen et al. J. Biomechanics [35]. The numerical technique to circumvent locking in Uintah MPM package (http://www.uintah.utah.edu) was implemented by James Guilkey of the University of Utah, and we express our appreciation for his help and that of Rebecca Brannon with Uintah.	Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bazin PL, 2008, MED IMAGE ANAL, V12, P616, DOI 10.1016/j.media.2008.06.008; Chandra N, 2017, MIL MED, V182, P105, DOI 10.7205/MILMED-D-16-00144; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; Cole RH., 1965, UNDERWATER EXPLOSION; Daphalapurkar NP, 2008, MECH ADV MATER STRUC, V15, P594, DOI 10.1080/15376490802470523; Doll S, 2000, J APPL MECH-T ASME, V67, P17, DOI 10.1115/1.321146; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; ETOH A, 1994, JPN J APPL PHYS 1, V33, P2874, DOI 10.1143/JJAP.33.2874; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Fung YC., 1993, BIOMECHANICS MECH PR, DOI [10.1007/978-1-4757-2257-4, DOI 10.1007/978-1-4757-2257-4]; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Ganpule S., 2014, P 17 US NAT C THEOR; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Herweh C, 2016, NEURORADIOLOGY, V58, P911, DOI 10.1007/s00234-016-1705-y; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Ivanov I, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00127; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Kamojjala K, 2015, ENG COMPUT-GERMANY, V31, P193, DOI 10.1007/s00366-013-0342-x; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Knutsen AK, 2014, J BIOMECH, V47, P3475, DOI 10.1016/j.jbiomech.2014.09.010; Lee SJ, 2014, J MECH BEHAV BIOMED, V29, P213, DOI 10.1016/j.jmbbm.2013.08.026; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mast CM, 2012, J COMPUT PHYS, V231, P5351, DOI 10.1016/j.jcp.2012.04.032; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; McElhaney JH, 1973, PERSPECTIVES BIOMEDI, P215, DOI DOI 10.1007/978-1-349-01604-4_34; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Osman NF, 2000, IEEE T MED IMAGING, V19, P186, DOI 10.1109/42.845177; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; Sadeghirad A, 2011, INT J NUMER METH ENG, V86, P1435, DOI 10.1002/nme.3110; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Sarvghad-Moghaddam H, 2015, COMPUT METHOD BIOMEC, V18, P1846, DOI 10.1080/10255842.2014.977878; Stalnaker R. L, 1969, THESIS; SULSKY D, 1995, COMPUT PHYS COMMUN, V87, P236, DOI 10.1016/0010-4655(94)00170-7; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Wismans, 1997, P 41 STAPP CAR CRASH, V41, P315, DOI DOI 10.4271/973338; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zoghi-Moghadam M, 2009, COMPUT METHOD BIOMEC, V12, P1, DOI [10.1080/10255840802020420, 10.1080/10255840903064897]	62	12	12	2	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-1287	1432-2153		SHOCK WAVES	Shock Waves	JAN	2018	28	1					127	139		10.1007/s00193-017-0791-z			13	Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Mechanics	FU0TF	WOS:000423562600010	29662272	Green Accepted			2022-02-06	
J	Garzon, F; Coimbra, D; Parcerisas, A; Rodriguez, Y; Garcia, JC; Soriano, E; Rama, R				Garzon, Fernando; Coimbra, Debora; Parcerisas, Antoni; Rodriguez, Yamila; Cesar Garcia, Julio; Soriano, Eduardo; Rama, Ramon			NeuroEPO Preserves Neurons from Glutamate-Induced Excitotoxicity	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Apoptosis; erythropoietin; excitotoxicity; neurodegenerative diseases; NeuroEPO; neuroprotection	MITOCHONDRIAL DYSFUNCTION; HUMAN-ERYTHROPOIETIN; APOPTOSIS; CALCIUM; MECHANISMS; PROTECTION; CA2+; NEUROPROTECTION; PATHOGENESIS; MODULATION	Many experimental studies show that erythropoietin (EPO) has a neuroprotective action in the brain. EPO in acute and chronic neurological disorders, particularly in stroke, traumatic brain injury, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis, has neuroprotective effects. We previously reported the neuroprotective effect of NeuroEPO, a low sialic form of EPO, against oxidative stress induced by glutamate excitotoxicity. In this paper, we analyze the effect of NeuroEPO against apoptosis induced by glutamate excitotoxicity in primary neuronal cultures obtained from the forebrains of Wistar rat embryos after 17 days of gestation. Excitotoxicity was induced after nine days of in vitro culture by treatment with a culture medium containing 100 mu M glutamate for 15 min. To withdraw glutamate, a new medium containing 100 ng NeuroEPO/mL was added. Apoptosis was analyzed after 24 h. Images obtained by phase contrast microscopy show that neurons treated with glutamate exhibit cell body shrinkage, loss of dendrites that do not make contact with neighboring cells, and that NeuroEPO was able to preserve the morphological characteristics of the control Immunocytochemistry images show that the culture is essentially pure in neurons; that glutamate causes cell mortality, and that this is partially avoided when the culture medium is supplemented with NeuroEPO. Activation of intrinsic apoptotic pathways was analyzed. The decreases in Bcl-2/Bax ratio, increase in the release of cytochrome c, and in the expression and activity of caspase-3 observed in cells treated with glutamate, were restored by NeuroEPO. The results from this study show that NeuroEPO protects cortical neurons from glutamate-induced apoptosis via upregulation of Bcl-2 and inhibit glutamate-induced activation of caspase-3.	[Garzon, Fernando; Coimbra, Debora; Parcerisas, Antoni; Soriano, Eduardo; Rama, Ramon] Univ Barcelona, Fac Biol, Dept Cell Biol Physiol & Immunol, Barcelona, Spain; [Garzon, Fernando] Univ Narino, Dept Anim Hlth, Pasto, Colombia; [Rodriguez, Yamila; Cesar Garcia, Julio] Univ Med Sci, Inst Preclin & Basic Sci, Dept Histol, Havana, Cuba; [Rodriguez, Yamila] Ctr Mol Immunol CIM, Havana, Cuba; [Cesar Garcia, Julio] Natl Ctr Anim Breeding, Cenpalab, Havana, Cuba; [Parcerisas, Antoni; Soriano, Eduardo] ISCIII, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Parcerisas, Antoni; Soriano, Eduardo] Vall dHebron Inst Res, Barcelona, Spain; [Soriano, Eduardo] ICREA, Barcelona, Spain		Rama, R (corresponding author), Univ Barcelona, Fac Biol, Dept Biol Cell Physiol & Immunol, Ave Diagonal 643, E-08028 Barcelona, Spain.	rrama@ub.edu	Soriano, Eduardo/AAB-3216-2019	Soriano, Eduardo/0000-0002-3204-9285; Garzon Gomez, Fernando/0000-0003-4481-9889	University of Barcelona; MINECOSpanish Government [SAF2016-7426-R]	We thank Drs. Daniel Amaro and Teresa Rodriguez (CIMAB (Habana, Cuba) for providing NeuroEPO and to Dr. E. Capilla for manuscript review and Dr. Pinto, T.C.C. Department of Neuropsychiatry and Behavioral Sciences, Federal University of Pernambuco (UFPE) Brasil for his help in the statistical analysis of the results. This work is a scientific collaboration between University of Barcelona and the University of Medical Sciences of Havana, Institute of Basic and Preclinical Sciences" Victoria de Giron". This work was funded by University of Barcelona (RR) and by grant SAF2016-7426-R (MINECO) (ES).	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Adam-Vizi V, 2010, J ALZHEIMERS DIS, V20, pS413, DOI 10.3233/JAD-2010-100465; Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; Berliocchi L, 2005, PHILOS T R SOC B, V360, P2255, DOI 10.1098/rstb.2005.1765; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Broxmeyer HE, 2013, J EXP MED, V210, P205, DOI 10.1084/jem.20122760; Castillo C, 2018, REDOX BIOL, V14, P285, DOI 10.1016/j.redox.2017.09.010; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V82, P1291, DOI 10.1016/j.bcp.2011.06.045; Chazotte B, 2011, COLD SPRING HARB PRO, V2011, P5556, DOI [10.1101/pdb.prot5556, DOI 10.1101/PDB.PROT5556]; Cheung NS, 1998, NEUROPHARMACOLOGY, V37, P1419, DOI 10.1016/S0028-3908(98)00123-3; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; D'Orsi B, 2017, NEUROCHEM INT, V109, P162, DOI 10.1016/j.neuint.2017.03.010; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; Feissner RF, 2009, FRONT BIOSCI-LANDMRK, V14, P1197, DOI 10.2741/3303; Galluzzi L, 2007, APOPTOSIS, V12, P803, DOI 10.1007/s10495-007-0720-1; Rodriguez JCG, 2009, THESCIENTIFICWORLDJO, V9, P970, DOI 10.1100/tsw.2009.103; Garzon F, 2018, BEHAV SCI, V8, P26; Gogvadze Vladimir, 2015, Methods Mol Biol, V1264, P385, DOI 10.1007/978-1-4939-2257-4_33; Greenwood SM, 2007, NEUROPHARMACOLOGY, V53, P891, DOI 10.1016/j.neuropharm.2007.10.003; HIGUCHI M, 1992, J BIOL CHEM, V267, P7703; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; Jiang J, 2014, ANAL BIOANAL CHEM, V406, P6265, DOI 10.1007/s00216-014-8037-8; Kroemer G, 2003, BIOCHEM BIOPH RES CO, V304, P433, DOI 10.1016/S0006-291X(03)00614-4; LAI PH, 1986, J BIOL CHEM, V261, P3116; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Li Mark Xiang, 2015, F1000Prime Rep, V7, P42, DOI 10.12703/P7-42; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Ludolph AC, 2000, J NEUROL, V247, P17; Maiese K, 2008, CURR NEUROVASC RES, V5, P125, DOI 10.2174/156720208784310231; Mallet RT, 2017, VITAM HORM, V105, P197, DOI 10.1016/bs.vh.2017.01.002; Maurice T, 2013, J PSYCHOPHARMACOL, V27, P1044, DOI 10.1177/0269881113494939; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Nguyen AQ, 2014, EXP BIOL MED, V239, P1461, DOI 10.1177/1535370214523703; Nguyen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.117; Nicholls DG, 2009, BBA-BIOENERGETICS, V1787, P1416, DOI 10.1016/j.bbabio.2009.03.010; Noguchi Constance Tom, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000860; Ong WY, 2013, J ALZHEIMERS DIS, V35, P643, DOI 10.3233/JAD-121990; Ponce Lucido L, 2013, Pathophysiology, V20, P31, DOI 10.1016/j.pathophys.2012.02.005; Prentice H, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/964518; Rabie T, 2008, PHYSIOLOGY, V23, P263, DOI 10.1152/physiol.00016.2008; Rego AC, 2003, NEUROCHEM RES, V28, P1563, DOI 10.1023/A:1025682611389; Rodriguez Cruz Y, 2017, J ALZHEIMERS DIS, V55, P231, DOI 10.3233/JAD-160500; Cruz YR, 2010, THESCIENTIFICWORLDJO, V10, P2288, DOI 10.1100/tsw.2010.215; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Sargin D, 2010, BEST PRACT RES-CLIN, V24, P573, DOI 10.1016/j.bpa.2010.10.005; SASAKI H, 1987, J BIOL CHEM, V262, P12059; Sasaki R, 2001, NEWS PHYSIOL SCI, V16, P110; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Siren AL, 2009, NEUROTHERAPEUTICS, V6, P108, DOI 10.1016/j.nurt.2008.10.041; Sonsalla PK, 1998, AMINO ACIDS, V14, P69, DOI 10.1007/BF01345245; Stanika RI, 2009, P NATL ACAD SCI USA, V106, P9854, DOI 10.1073/pnas.0903546106; Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013; Su KH, 2011, J CELL PHYSIOL, V226, P3330, DOI 10.1002/jcp.22678; Suhaili Siti Haji, 2017, Biophys Rev, V9, P443, DOI 10.1007/s12551-017-0308-0; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Wang Y, 2010, APOPTOSIS, V15, P1382, DOI 10.1007/s10495-010-0481-0; WEN DY, 1994, J BIOL CHEM, V269, P22839; White RJ, 1997, J PHYSIOL-LONDON, V498, P31, DOI 10.1113/jphysiol.1997.sp021839; Yuan RR, 2015, NEUROTHERAPEUTICS, V12, P850, DOI 10.1007/s13311-015-0379-1; Zhang YM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-13	72	12	12	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2018	65	4					1469	1483		10.3233/JAD-180668			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU7GH	WOS:000445487700033	30175978				2022-02-06	
J	Haid, T; Federolf, P				Haid, Thomas; Federolf, Peter			Human Postural Control: Assessment of Two Alternative Interpretations of Center of Pressure Sample Entropy through a Principal Component Factorization of Whole-Body Kinematics	ENTROPY			English	Article						neuromuscular control; motor control; center of pressure COP; principal component analysis PCA; degrees of freedom; complexity; balance; neuroscience	MULTISCALE ENTROPY; CEREBRAL CONCUSSION; APPROXIMATE ENTROPY; COMPLEXITY; VARIABILITY; BALANCE; RECOVERY; FEEDBACK; MOTION; STANCE	Sample entropy (SaEn), calculated for center of pressure (COP) trajectories, is often distinct for compromised postural control, e.g., in Parkinson, stroke, or concussion patients, but the interpretation of COP-SaEn remains subject to debate. The purpose of this paper is to test the hypotheses that COP-SaEn is related (Hypothesis 1; H1) to the complexity of the postural movement structures, i.e., to the utilization and coordination of the mechanical degrees of freedom; or (Hypothesis 2; H2) to the irregularity of the individual postural movement strategies, i.e., to the neuromuscular control of these movements. Twenty-one healthy volunteers (age 26.4 +/- 2.4; 10 females), equipped with 27 reflective markers, stood on a force plate and performed 2-min quiet stances. Principal movement strategies (PMs) were obtained from a principal component analysis (PCA) of the kinematic data. Then SaEn was calculated for the COP and PM time-series. H1 was tested by correlating COP-SaEn to the relative contribution of the PMs to the subject specific overall movement and H2 by correlating COP-SaEn and PM-SaEn. Both hypotheses were supported. This suggests that in a healthy population the COP-SaEn is linked to the complexity of the coordinative structure of postural movements, as well as to the irregularity of the neuromuscular control of specific movement components.	[Haid, Thomas; Federolf, Peter] Univ Innsbruck, Dept Sport Sci, A-6020 Innsbruck, Austria		Haid, T (corresponding author), Univ Innsbruck, Dept Sport Sci, A-6020 Innsbruck, Austria.	thomas.haid@uibk.ac.at; peter.federolf@uibk.ac.at	Federolf, Peter/H-4481-2019	Federolf, Peter/0000-0002-0266-6813			Bockemuhl T, 2010, HUM MOVEMENT SCI, V29, P73, DOI 10.1016/j.humov.2009.03.003; Browne J, 2000, PHYSIOL MEAS, V21, P515, DOI 10.1088/0967-3334/21/4/308; Busa M.A., 2016, J MULT SCLER, V3, P1, DOI [10. 4172/2376-0389. 1000177, DOI 10.4172/2376-0389.1000177]; Busa MA, 2016, J SPORT HEALTH SCI, V5, P44, DOI 10.1016/j.jshs.2016.01.018; Busa MA, 2016, GAIT POSTURE, V45, P7, DOI 10.1016/j.gaitpost.2015.12.007; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chen M.-S., RESISTANCE TRAININGI; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; de Carvalho M, 2012, CLIN NEUROPHYSIOL, V123, P2312, DOI 10.1016/j.clinph.2012.04.016; Dinkel D, 2017, GAIT POSTURE, V55, P167, DOI 10.1016/j.gaitpost.2017.04.017; Duchateau J, 2011, BRAIN RES, V1409, P42, DOI 10.1016/j.brainres.2011.06.011; Duclos Y, 2008, J NEUROSCI METH, V172, P231, DOI 10.1016/j.jneumeth.2008.05.001; Estrada L, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19090460; Federolf P, 2013, J BIOMECH, V46, P2626, DOI 10.1016/j.jbiomech.2013.08.008; Federolf P, 2012, J BIOMECH, V45, P1127, DOI 10.1016/j.jbiomech.2012.02.008; Federolf PA, 2016, J BIOMECH, V49, P364, DOI 10.1016/j.jbiomech.2015.12.030; Fournier KA, 2014, GAIT POSTURE, V39, P420, DOI 10.1016/j.gaitpost.2013.08.016; Gao JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024446; GlOersen O., 2017, J SPORTS SCI, P1, DOI [10.1080/02640414.2017.1298826, DOI 10.1080/02640414.2017.129882628287028, DOI 10.1080/02640414.2017.1298826]; GOLDIE PA, 1989, ARCH PHYS MED REHAB, V70, P510; Hansen C, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00206; Hodson-Tole EF, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00679; Hoffmann CP, 2017, GAIT POSTURE, V54, P236, DOI 10.1016/j.gaitpost.2017.03.015; Kanekar N, 2014, J NEUROSCI METH, V222, P91, DOI 10.1016/j.jneumeth.2013.10.020; Lakhani B, 2015, GAIT POSTURE, V41, P499, DOI 10.1016/j.gaitpost.2014.12.003; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Senthinathan A, 2017, CLIN J SPORT MED, V27, P288, DOI 10.1097/JSM.0000000000000337; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; Verrel J, 2009, PSYCHOL AGING, V24, P75, DOI 10.1037/a0014272; Yamagata M, 2017, CLIN INTERV AGING, V12, P499, DOI 10.2147/CIA.S132425; Yang Y, 2010, LECT NOTES COMPUT SC, V6298, P538, DOI 10.1007/978-3-642-15696-0_50	35	12	12	0	6	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1099-4300			ENTROPY-SWITZ	Entropy	JAN	2018	20	1							30	10.3390/e20010030			8	Physics, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Physics	FV8ZJ	WOS:000424876200030	33265120	gold, Green Published, Green Submitted			2022-02-06	
J	Houston, MN; Hoch, JM; Cameron, KL; Abt, JP; Peck, KY; Hoch, MC				Houston, Megan N.; Hoch, Johanna M.; Cameron, Kenneth L.; Abt, John P.; Peck, Karen Y.; Hoch, Matthew C.			Sex and number of concussions influence the association between concussion and musculoskeletal injury history in collegiate athletes	BRAIN INJURY			English	Article						Mild traumatic braining injury; musculoskeletal injury; sports medicine	SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; MULTIPLE CONCUSSIONS; RATES; RISK; EPIDEMIOLOGY; METAANALYSIS; PERFORMANCE; PREVENTION; INCREASES	Objectives: Examine the association between concussion and lower extremity injury in collegiate athletes and the influence of sex and the number of concussions on this relationship. Methods: A total of 468 collegiate student-athletes (200 Males, 268 Females) were recruited from collegiate athletic facilities of three universities to participate in this retrospective review. Participants provided injury history (concussions, ankle sprains, and knee injuries) information through a survey. Chi-square tests and odds ratios examined the relationship between concussion and ankle sprain or knee injury history within each sex and based on concussion history (0, 1, >1). Results: Females athletes with a concussion history had greater odds of reporting an ankle sprain or knee injury compared to females with no concussion history (OR = 1.88-2.54; p <= 0.020). Male athletes with a concussion history did not have greater odds of reporting an ankle sprain or knee injury. Athletes reporting multiple concussions had the greatest odds of ankle sprain or knee injury history compared to athletes with no previous concussions (OR = 2.43-2.56; p <= 0.004). No differences were identified between athletes with a single or multiple concussion history. Conclusion: Female athletes with a concussion history or participants with a multiple concussion history had the greatest odds of reporting an ankle or knee injury history compared to athletes with no concussion history.	[Houston, Megan N.; Cameron, Kenneth L.; Peck, Karen Y.] US Mil Acad, Keller Army Hosp, West Point, NY 10996 USA; [Hoch, Johanna M.; Abt, John P.; Hoch, Matthew C.] Univ Kentucky, Sports Med Res Inst, Lexington, KY 40506 USA		Hoch, MC (corresponding author), Univ Kentucky, Sports Med Res Inst, Lexington, KY 40506 USA.	Matt.hoch@uky.edu		Cameron, Kenneth/0000-0002-6276-4482; Hoch, Johanna/0000-0003-2906-9354			Agel J, 2016, CLIN J SPORT MED, V26, P518, DOI 10.1097/JSM.0000000000000290; Beidler E., 2017, BRIT J SPORT MED, V51, pA66.2, DOI [10.1136/bjsports-2016-097270.172, DOI 10.1136/BJSPORTS-2016-097270.172]; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Gabbe BJ, 2003, BRIT J SPORT MED, V37, P545, DOI 10.1136/bjsm.37.6.545; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hootman JM, 2012, J ATHL TRAINING, V47, P589, DOI 10.4085/1062-6050-47.5.06; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Houston MN, 2017, J SPORT REHABIL, V26, P365, DOI 10.1123/jsr.2016-0011; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Knowles SB, 2007, INJURY PREV, V13, P416, DOI 10.1136/ip.2006.014720; Lovalekar M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017434; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; National Collegiate Athletic Association, NCAA SPORTS SPONS PA; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Powell JW, 1999, J ATHL TRAINING, V34, P277; Resch JE, 2017, CLIN SPORT MED, V36, P717, DOI 10.1016/j.csm.2017.05.002; Roos KG, 2017, AM J SPORT MED, V45, P201, DOI 10.1177/0363546516660980; Sheu Yahtyng, 2016, Natl Health Stat Report, P1; SOBOROFF SH, 1984, CLIN ORTHOP RELAT R, P160; Toohey LA, 2017, BRIT J SPORT MED, V51, P1670, DOI 10.1136/bjsports-2017-097500; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	33	12	12	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	11					1353	1358		10.1080/02699052.2018.1512718			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GZ6GX	WOS:000449534000006	30136896				2022-02-06	
J	Johnstone, MR; Sun, MJ; Taylor, CJ; Brady, RD; Grills, BL; Church, JE; Shultz, SR; McDonald, SJ				Johnstone, Maddison R.; Sun, Mujun; Taylor, Caroline J.; Brady, Rhys D.; Grills, Brian L.; Church, Jarrod E.; Shultz, Sandy R.; McDonald, Stuart J.			Gambogic amide, a selective TrkA agonist, does not improve outcomes from traumatic brain injury in mice	BRAIN INJURY			English	Article						Nerve growth factor; neuroinflammation; neurite growth; synaptogenesis; apoptosis; behaviour	NERVE GROWTH-FACTOR; CONTROLLED CORTICAL IMPACT; APOPTOTIC CELL-DEATH; COGNITIVE DEFICITS; TRANSLATIONAL CHALLENGES; NEURONAL APOPTOSIS; CEREBRAL-CORTEX; ANIMAL-MODELS; SNAP 37889; RAT-BRAIN	Objectives: There is evidence that treatment with nerve growth factor (NGF) may reduce neuroinflammation and apoptosis after a traumatic brain injury (TBI). NGF is thought to exert its effects via binding to either TrkA or p75 neurotrophin receptors. This study aimed to investigate the effects of a selective TrkA agonist, gambogic amide (GA), on TBI pathology and outcomes in mice following lateral fluid percussion injury. Methods: Male C57BL/6 mice were given either a TBI or sham injury, and then received subcutaneous injections of either 2 mg/kg of GA or vehicle at 1, 24, and 48 h post-injury. Following behavioural studies, mice were euthanized at 72 h post-injury for analysis of neuroinflammatory, apoptotic, and neurite outgrowth markers. Results: Behavioural testing revealed that GA did not mitigate motor deficits after TBI. TBI caused an increase in cortical and hippocampal expression of several markers of neuroinflammation and apoptosis compared to sham groups. GA treatment did not attenuate these increases in expression, possibly contributed to by our finding of TrkA receptor down-regulation post-TBI. Conclusions: These findings suggest that GA treatment may not be suitable for attenuating TBI pathology and improving outcomes.	[Johnstone, Maddison R.; Taylor, Caroline J.; Brady, Rhys D.; Grills, Brian L.; Church, Jarrod E.; McDonald, Stuart J.] La Trobe Univ, Sch Life Sci, Dept Physiol Anat & Microbiol, Melbourne, Vic, Australia; [Sun, Mujun; Brady, Rhys D.; Shultz, Sandy R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Shultz, Sandy R.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic, Australia		McDonald, SJ (corresponding author), La Trobe Univ, Dept Physiol Anat & Microbiol, Hlth Sci 2 Bldg, Melbourne, Vic, Australia.	stuart.mcdonald@latrobe.edu.au		Church, Jarrod/0000-0001-8266-4043; McDonald, Stuart/0000-0001-5190-3179; Sun, Mujun/0000-0002-9923-9913	Understanding Disease RFA of La Trobe University; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	This work was supported by funding to SJM through the Understanding Disease RFA of La Trobe University and to SRS from the Australian National Health and Medical Research Council. No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the content of this article.	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; ANGELETTI RH, 1972, BRAIN RES, V46, P421, DOI 10.1016/0006-8993(72)90033-9; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bi FF, 2013, P NATL ACAD SCI USA, V110, P4069, DOI 10.1073/pnas.1218497110; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; BURGOS I, 1995, BRAIN RES, V692, P154, DOI 10.1016/0006-8993(95)00696-N; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Cekic M, 2012, RESTOR NEUROL NEUROS, V30, P115, DOI 10.3233/RNN-2011-0628; Chan CB, 2009, ONCOGENE, V28, P3825, DOI 10.1038/onc.2009.236; CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; Conte V, 2008, RESTOR NEUROL NEUROS, V26, P45; Conti AC, 1998, J NEUROSCI, V18, P5663; Dietrich WD, 1999, J NEUROTRAUM, V16, P567, DOI 10.1089/neu.1999.16.567; Ding JY, 2009, BRAIN RES, V1268, P125, DOI 10.1016/j.brainres.2009.02.060; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Falo MC, 2008, J NEUROTRAUM, V25, P769, DOI 10.1089/neu.2008.0511; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; FRIDEN PM, 1993, SCIENCE, V259, P373, DOI 10.1126/science.8420006; GAROFALO L, 1992, P NATL ACAD SCI USA, V89, P2639, DOI 10.1073/pnas.89.7.2639; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jang SW, 2007, P NATL ACAD SCI USA, V104, P16329, DOI 10.1073/pnas.0706662104; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Kao TH, 2015, EUR SPINE J, V24, P1959, DOI 10.1007/s00586-014-3675-2; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee S, 2015, CRIT REV IMMUNOL, V35, P77, DOI 10.1615/CritRevImmunol.2015012127; LEVIMONTALCINI R, 1956, P NATL ACAD SCI USA, V42, P695, DOI 10.1073/pnas.42.9.695; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; Li SH, 2006, NEUROSCI LETT, V409, P182, DOI 10.1016/j.neulet.2006.09.054; Lin HW, 2014, TRANSL STROKE RES, V5, P109, DOI 10.1007/s12975-013-0276-z; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Longhi L, 2004, J NEUROTRAUM, V21, P1723, DOI 10.1089/neu.2004.21.1723; Lv QS, 2014, J NEUROL SCI, V345, P48, DOI 10.1016/j.jns.2014.06.037; Lv QS, 2013, BRAIN RES, V1493, P80, DOI 10.1016/j.brainres.2012.11.028; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; Nudo RJ, 2003, J REHABIL MED, V35, P7, DOI 10.1080/16501960310010070; O'Dell DM, 2000, J NEUROSCI, V20, P4821; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; Rall JM, 2003, NEUROPATH APPL NEURO, V29, P118, DOI 10.1046/j.1365-2990.2003.00439.x; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; RINK A, 1995, AM J PATHOL, V147, P1575; Scheller KJ, 2017, NEUROPHARMACOLOGY, V118, P1, DOI 10.1016/j.neuropharm.2017.03.004; Scheller KJ, 2014, METHODSX, V1, P212, DOI 10.1016/j.mex.2014.09.003; Shah AG, 2009, HUM MOL GENET, V18, P4141, DOI 10.1093/hmg/ddp363; Shen JY, 2015, PHARMACOL REP, V67, P217, DOI 10.1016/j.pharep.2014.09.002; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Shultz SR, 2012, BEHAV BRAIN RES, V229, P145, DOI 10.1016/j.bbr.2011.12.015; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; SINSON G, 1995, J NEUROCHEM, V65, P2209; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Suk K, 2016, PROG NEUROBIOL, V144, P158, DOI 10.1016/j.pneurobio.2016.08.001; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Tian LL, 2012, BRAIN RES, V1440, P47, DOI 10.1016/j.brainres.2011.12.059; TRIA MA, 1994, EXP NEUROL, V127, P178, DOI 10.1006/exnr.1994.1093; TUSZYNSKI MH, 1991, ANN NEUROL, V30, P625, DOI 10.1002/ana.410300502; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Wu L, 2015, J NEUROCHEM, V132, P622, DOI 10.1111/jnc.13023; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yang YR, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0245-4; Yoon SO, 1998, J NEUROSCI, V18, P3273; Young J, 2015, BRAIN RES BULL, V115, P17, DOI 10.1016/j.brainresbull.2015.04.003	83	12	12	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	2					257	268		10.1080/02699052.2017.1394492			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WF	WOS:000427073600013	29227174				2022-02-06	
S	Karton, C; Hoshizaki, TB		Hainline, B; Stern, RA		Karton, Clara; Hoshizaki, T. Blaine			Concussive and subconcussive brain trauma: the complexity of impact biomechanics and injury risk in contact sport	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							SERUM NEUROFILAMENT LIGHT; DIFFUSE AXONAL INJURY; WHITE-MATTER; HEAD IMPACT; NEUROCHEMICAL AFTERMATH; CEREBRAL CONCUSSION; SINGLE SEASON; FOOTBALL; TOLERANCE; ELEMENT	Head impacts that transfer mechanical energy to the skull and create brain injuries have unique dynamic responses and brain tissue trauma characteristics. The magnitude of the impact energy and how it is transmitted creates three-dimensional linear and rotational accelerations of the head, resulting in unique strains on brain tissue. Biomechanical investigations of head injuries in contact sports have historically focused on attenuating energy transfer to the skull and brain. Typically, severe life-threatening events are caused by high-energy impact events that result in anatomic damage. Protective equipment attenuates energy transmission to neural tissues to decrease the risk of structural damage. In addition to reducing risk of skull fracture, helmets work by increasing impact compliance, to decrease the magnitude of the head's dynamic response and increase the duration of the event. This strategy helps prevent severe traumatic brain injuries and shifts the risk to concussion and repetitive head impact exposure. Metabolic, cellular, and physiologic responses characterize cumulative brain trauma that may manifest years later. Relying on the presence of symptoms to establish injury is subjective and limited in capturing the risks associated with neural tissue trauma. To more effectively capture brain injury risks in contact sports, we present the concept of brain trauma profiling, involving impact magnitude, frequency, interval, and duration of exposure. Brain trauma profiling captures and describes the cumulative and acute trauma-associated injury risks unique to each sport, level of play, and player position.	[Karton, Clara; Hoshizaki, T. Blaine] Univ Ottawa, Neurotrauma Impact Sci Lab, A106-200 Lees Ave, Ottawa, ON K1N 6N5, Canada		Hoshizaki, TB (corresponding author), Univ Ottawa, Neurotrauma Impact Sci Lab, A106-200 Lees Ave, Ottawa, ON K1N 6N5, Canada.	thoshiza@uottawa.ca					Adams J, 1987, P 31 STAPP CAR CRASH, V96, P1355, DOI DOI 10.4271/872197; Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Avalle M, 2001, INT J IMPACT ENG, V25, P455, DOI 10.1016/S0734-743X(00)00060-9; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Barth JT, 2001, J ATHL TRAINING, V36, P253; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Becker E.B., 1998, HELMET DEV STANDARDS; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Canadian Standards Association, 1996, CANCSAD113; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Dawson L, 2017, P INT SOC BIOMECHANI, P23; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Forero Rueda MA, 2010, COMPUT METHOD BIOMEC; Gadd C.W, 1966, USE WEIGHTED IMPULSE; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1972, P 16 STAPP CAR CRASH, P296; Giza CC, 2001, J ATHL TRAINING, V36, P228; GROSS A G, 1958, J Aviat Med, V29, P725; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; GURDJIAN ES, 1958, J NEUROSURG, V15, P125, DOI 10.3171/jns.1958.15.2.0125; Gurdjian ES, 1975, IMPACT HEAD INJURY M; Gurdjian ES, 1963, CONCUSSION MECH PATH, P370; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; HODGSON VR, 1967, AM J ANAT, V120, P113, DOI 10.1002/aja.1001200109; Hodgson VR, 1983, ROLE IMPACT LOCATION; Holbourn AHS, 1943, LANCET, V2, P438; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Karton C, 2016, FREQUENCY MAGNITUDE; Karton C, 2017, BIOMECHANICS HEAD IM; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kendall M, 2016, THESIS U OTTAWA CANA; Kendall M, 2012, COMP DYNAMIC IMPACT; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kuzminski SJ, 2018, AM J NEURORADIOL, V39, P245, DOI 10.3174/ajnr.A5489; Lehman EJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt188; Leslie, 2015, TRAFFIC INJ PREV, V16, P1; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; National Operating Committee on Safety for Athletic Equipment (NOCSAE), 2018, FOOTB HELM STAND OV; National Operating Committee on Standards for Athletic Equipment, 2007, STANDARD DROP TEST M; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; NEWMAN JA, 1993, ACCIDENTAL INJURY BI, P292; Newman JA, 2005, BIOMECHANICS HEAD TR; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ommaya AK, 1968, J BIOMECH; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Peng WG, 2016, NEUROBIOL DIS, V93, P215, DOI 10.1016/j.nbd.2016.05.015; Post A, 2013, THESIS U OTTAWA CANA; Post A, 2011, COMPUT METHOD BIOMEC, V17, p511 519; Post A, 2014, COMPUT METHOD BIOMEC, V17, P1785, DOI 10.1080/10255842.2013.766724; Post A, 2012, TRAUMA, V14, P327, DOI 10.1177/1460408612446573; Post A, 2012, P I MECH ENG P-J SPO, V226, P290, DOI 10.1177/1754337112436629; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Rousseau P., 2009, J ASTM INT, V6, P1; Rousseau P., 2014, THESIS U OTTAWA CANA; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Singh Anita, 2006, Stapp Car Crash J, V50, P601; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Snell Memorial Foundation, 2000, 1995 STAND PROT EQ 1; Snyder RG, 1970, 1970 INT AUT SAF C C; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Tagge CA., 2018, BRAIN, P1; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thibault L., 1971, P 15 STAPP CAR CRASH; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Unterharnscheidt FJ, 1971, TRANSLATIONAL VERSUS; VIANO DC, 1989, J BIOMECH, V22, P403, DOI 10.1016/0021-9290(89)90201-7; Walsh ES, 2011, SPORTS ENG, V13, P135, DOI 10.1007/s12283-011-0060-9; Ward CC., 1977, INTRACRANIAL PRESSUR; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; Williams B, 2006, ROUTL ADV INT RELAT, P1; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zanetti K., 2013, IDENTIFYING RISK PRO; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zhang L, 2003, NEW BIOMECHANICAL PR; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488	109	12	12	0	1	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						39	49		10.1016/B978-0-444-63954-7.00005-7			11	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100007	30482368				2022-02-06	
J	Mete, M; Aydemir, I; Unsal, UU; Collu, F; Vatandas, G; Gurcu, B; Duransoy, YK; Taneli, F; Tuglu, MI; Selcuki, M				Mete, Mesut; Aydemir, Isil; Unsal, Ulkun Unlu; Collu, Fatih; Vatandas, Gokhan; Gurcu, Beyhan; Duransoy, Yusuf Kurtulus; Taneli, Fatma; Tuglu, Mehmet Ibrahim; Selcuki, Mehmet			Neuroprotective Effects of Oleocanthal, a Compound in Virgin Olive Oil, in a Rat Model of Traumatic Brain Injury	TURKISH NEUROSURGERY			English	Article						Apoptosis; Neuroprotection; Oleocanthal; Rat; Traumatic brain injury	PATHOPHYSIOLOGY; INHIBITION	AIM: To evaluate the neuroprotective effects of deocanthal OC in a rat model of traumatic brain injury (TBI). MATERIAL and METHODS: Twenty-six adult male, Wistar albino rats were used. The rats were divided into 4 groups. Group 1 was the sham group (n=5). Group 2 was the trauma group (n=5) where rats were treated with 10 mg/kg saline intraperitoneally (IP) twice a day. Groups 3 and 4, rats were treated with 10 (group 3, n=8) or 30 (group 4, n=8) mg/kg OC IP twice a day. For each group, brain samples were collected 72 hours after injury. Brain samples and blood were evaluated with histopathological and biochemical methods. RESULTS: Histopathological evaluation revealed a significant difference between Group 2 and Group 4. Biochemical findings demonstrated that the oxidative stress index was highest in Group 2 and lowest in Group 4. CONCLUSION: OC has a protective effect on neural cells after TBI. This effect is achieved by reducing oxidative stress and apoptosis.	[Mete, Mesut; Vatandas, Gokhan; Duransoy, Yusuf Kurtulus; Selcuki, Mehmet] Celal Bayar Univ, Sch Med, Dept Neurosurg, Manisa, Turkey; [Aydemir, Isil] Omer Halisdemir Univ, Sch Med, Dept Histol & Embryol, Nigde, Turkey; [Unsal, Ulkun Unlu] Koc Univ, Sch Med, Dept Neurosurg, Istanbul, Turkey; [Collu, Fatih; Gurcu, Beyhan] Celal Bayar Univ, Fac Sci & Letters, Zool Sect, Dept Biol, Manisa, Turkey; [Taneli, Fatma] Celal Bayar Univ, Sch Med, Dept Biochem, Manisa, Turkey; [Tuglu, Mehmet Ibrahim] Celal Bayar Univ, Sch Med, Dept Histol & Embryol, Manisa, Turkey		Mete, M (corresponding author), Celal Bayar Univ, Sch Med, Dept Neurosurg, Manisa, Turkey.	dr.mmete@hotmail.com	Taneli, Fatma/AAG-4850-2019; COLLU, Fatih/AAG-5895-2019; Gurcu, Beyhan/AAI-1800-2019; Unsal, Ulkun Unlu/B-9861-2016	Taneli, Fatma/0000-0002-5194-0460; COLLU, Fatih/0000-0001-6978-8404; Unsal, Ulkun Unlu/0000-0001-5194-3138	Turkish Neurosurgical Society	Preparation for publication of this article was partly supported by the Turkish Neurosurgical Society.	Abuznait AH, 2013, ACS CHEM NEUROSCI, V4, P973, DOI 10.1021/cn400024q; Andrewes P, 2003, J AGR FOOD CHEM, V51, P1415, DOI 10.1021/jf026042j; Beauchamp GK, 2005, NATURE, V437, P45, DOI 10.1038/437045a; Centers for Disease Control and Prevention, TRAUM BRAIN INJ US R; Corona G, 2009, TOXICOL IND HEALTH, V25, P285, DOI 10.1177/0748233709102951; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Erel O, 2005, CLIN BIOCHEM, V38, P1103, DOI 10.1016/j.clinbiochem.2005.08.008; Ersoy B, 2009, WORLD J GASTROENTERO, V15, P5418, DOI 10.3748/wjg.15.5418; Gunther M, 2015, J CLIN NEUROSCI, V22, P1477, DOI 10.1016/j.jocn.2015.03.025; Iacono A, 2010, ARTHRITIS RHEUM-US, V62, P1675, DOI 10.1002/art.27437; Kosecik M, 2005, INT J CARDIOL, V100, P61, DOI 10.1016/j.ijcard.2004.05.069; Krohn M, 2015, J NEUROTRAUM, V32, P430, DOI 10.1089/neu.2014.3524; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; Mete M, 2015, BIOTECH HISTOCHEM, V90, P216, DOI 10.3109/10520295.2014.979439; Mete M, 2016, TURK J MED SCI, V46, P1900, DOI 10.3906/sag-1507-187; Numata M, 2013, INT J ONCOL, V42, P403, DOI 10.3892/ijo.2012.1723; Parkinson L, 2016, MOLECULES, V21, DOI 10.3390/molecules21121734; Parkinson L, 2014, INT J MOL SCI, V15, P12323, DOI 10.3390/ijms150712323; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Scotece M, 2015, DRUG DISCOV TODAY, V20, P406, DOI 10.1016/j.drudis.2014.10.017; Scotece M, 2012, LIFE SCI, V91, P1229, DOI 10.1016/j.lfs.2012.09.012; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018	26	12	12	1	4	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.		2018	28	6					858	865		10.5137/1019-5149.JTN.21417-17.2			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HA9UP	WOS:000450653000002	29204981	Bronze			2022-02-06	
J	Mouzon, B; Saltiel, N; Ferguson, S; Ojo, J; Lungmus, C; Lynch, C; Algamal, M; Morin, A; Carper, B; Bieler, G; Mufson, EJ; Stewart, W; Mullan, M; Crawford, F				Mouzon, Benoit; Saltiel, Nicole; Ferguson, Scott; Ojo, Joseph; Lungmus, Carlyn; Lynch, Cillian; Algamal, Moustafa; Morin, Alexander; Carper, Benjamin; Bieler, Gayle; Mufson, Elliott J.; Stewart, William; Mullan, Michael; Crawford, Fiona			Impact of age on acute post-TBI neuropathology in mice expressing humanized tau: a Chronic Effects of Neurotrauma Consortium Study	BRAIN INJURY			English	Article						Traumatic Brain Injury; neurodegeneration; tau; axonal injury; animal models; age; inflammation	TRAUMATIC BRAIN-INJURY; NEURONAL PLASTICITY; NATIONAL INSTITUTE; UNITED-STATES; MOUSE MODEL; PATHOPHYSIOLOGY; PHOSPHORYLATION; CONSEQUENCES; DISABILITY; MORTALITY	Objectives: We hypothesized that polypathology is more severe in older than younger mice during the acute phase following repetitive mild traumatic brain injury (r-mTBI).Methods: Young and aged male and female mice transgenic for human tau (hTau) were exposed to r-mTBI or a sham procedure. Twenty-four hours post-last injury, mouse brain tissue was immunostained for alterations in astrogliosis, microgliosis, tau pathology, and axonal injury.Results: Quantitative analysis revealed a greater percent distribution of glial fibrillary acid protein and Iba-1 reactivity in the brains of all mice exposed to r-mTBI compared to sham controls. With respect to axonal injury, the number of amyloid precursor protein-positive profiles was increased in young vs aged mice post r-mTBI. An increase in tau immunoreactivity was found in young and aged injured male hTau mice.Conclusions: We report the first evidence in our model that r-mTBI precipitates a complex sequelae of events in aged vs young hTau mice at an acute time point, typified by an increase in phosphorylated tau and astroglisosis, and a diminished microgliosis response and axonal injury in aged mice. These findings suggest differential age-dependent effects in TBI pathobiology.	[Mouzon, Benoit; Saltiel, Nicole; Ferguson, Scott; Ojo, Joseph; Lungmus, Carlyn; Lynch, Cillian; Algamal, Moustafa; Morin, Alexander; Mullan, Michael; Crawford, Fiona] Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA; [Mouzon, Benoit; Ferguson, Scott; Ojo, Joseph; Mullan, Michael; Crawford, Fiona] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Carper, Benjamin; Bieler, Gayle] RTI Res Triangle Pk, Durham, NC USA; [Mufson, Elliott J.] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Stewart, William] Queen Elizabeth Univ Hosp, Lab Med Bldg, Dept Neuropathol, Glasgow, Lanark, Scotland		Mouzon, B (corresponding author), Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA.	bmouzon@roskampinstitute.org	Carper, Benjamin A/L-3433-2017	Carper, Benjamin A/0000-0001-5882-2232; Algamal, Moustafa/0000-0002-6215-0122; Stewart, William/0000-0003-2199-2582	Department of DefenseUnited States Department of Defense; Chronic Effects of Neurotrauma Consortium (CENC) Award [W81XWH-13-2-0095]; Department of Veterans Affairs CENCUS Department of Veterans Affairs [I01 CX001135]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS038104, R01NS094]; NHS Research Scotland Career Researcher Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038104] Funding Source: NIH RePORTER	This work was supported by grant funding from Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award [W81XWH-13-2-0095] and Department of Veterans Affairs CENC [Award I01 CX001135]. Dr. Fiona Crawford is a VA Research Career Scientist. The authors report no conflicts of interest. The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Veterans Affairs or Department of Defense position, policy, or decision, unless so designated by other official documentation. Dr Stewart is supported by NIH grants [R01NS038104 and R01NS094], Department of Defense, and an NHS Research Scotland Career Researcher Fellowship.	Albayram O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01068-4; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Arendt T, 2003, J NEUROSCI, V23, P6972, DOI 10.1523/JNEUROSCI.23-18-06972.2003; Arendt T, 2013, AM J PHYSIOL-REG I, V305, pR478, DOI 10.1152/ajpregu.00117.2013; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cheng WH, 2018, EXP NEUROL, V301, P26, DOI 10.1016/j.expneurol.2017.12.007; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; de Vries R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190587; Elobeid A, 2012, ACTA NEUROPATHOL, V123, P97, DOI 10.1007/s00401-011-0906-z; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Ferguson SA, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00416; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Iqbal K, 2010, CURR ALZHEIMER RES, V7, P656, DOI 10.2174/156720510793611592; Johnson VE, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2014.241; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Li CY, 2018, ARCH PHYS MED REHAB, V99, P1279, DOI 10.1016/j.apmr.2017.12.006; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMillan TM, 2014, J NEUROL NEUROSUR PS, V85, P1214, DOI 10.1136/jnnp-2013-307279; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Raghupathi R, 2017, NEURAL REGEN RES, V12, P741, DOI 10.4103/1673-5374.206639; Rapoport MJ, 2001, BRAIN INJURY, V15, P857, DOI 10.1080/02699050110065303; Rowe RK, 2016, DEV NEUROSCI-BASEL, V38, P195, DOI 10.1159/000446773; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Zhang B, 2012, J NEUROSCI, V32, P3601, DOI 10.1523/JNEUROSCI.4922-11.2012	54	12	12	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	10			SI		1285	1294		10.1080/02699052.2018.1486457			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GS6YO	WOS:000443846200015	29927671	Green Accepted			2022-02-06	
S	Mucha, A; Fedor, S; Demarco, D		Hainline, B; Stern, RA		Mucha, Anne; Fedor, Sheri; Demarco, Danielle			Vestibular dysfunction and concussion	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							SPORTS-RELATED CONCUSSION; PAROXYSMAL POSITIONAL VERTIGO; TRAUMATIC BRAIN-INJURY; MOTOR SCREENING VOMS; HEAD IMPULSE TEST; BALANCE DISORDERS; MENIERES-DISEASE; POSTTRAUMATIC MIGRAINE; DIAGNOSTIC-CRITERIA; PHYSICAL-THERAPY	The assessment and treatment of sport-related concussion (SRC) often requires a multifaceted approach. Vestibular dysfunction represents an important profile of symptoms and pathology following SRC, with high prevalence and association with prolonged recovery. Signs and symptoms of vestibular dysfunction may include dizziness, vertigo, disequilibrium, nausea, and visual impairment. Identifying the central and peripheral vestibular mechanisms responsible for pathology can aid in management of SRC. The most common vestibular disturbances after SRC include benign paroxysmal positional vertigo, vestibulo-ocular reflex impairment, visual motion sensitivity, and balance impairment. A variety of evidence-based screening and assessment tools can help to identify the various types of vestibular pathology in SRC. When vestibular dysfunction is identified, there is emerging support for applying targeted vestibular rehabilitation to manage this condition.	[Mucha, Anne] UPMC Ctr Rehabil Serv, 3200 South Water St, Pittsburgh, PA 15203 USA; [Fedor, Sheri] Inova Phys Therapy Ctr, Fairfax, VA USA; [Demarco, Danielle] Baylor Inst Rehabil, Frisco, TX USA		Mucha, A (corresponding author), UPMC Ctr Rehabil Serv, 3200 South Water St, Pittsburgh, PA 15203 USA.	muchaa@upmc.edu					Adelsbeger R, 2015, IEEE T BIO-MED ENG, V62, P373, DOI 10.1109/TBME.2014.2354053; Akerman S, 2017, PHARMACOL THERAPEUT, V172, P151, DOI 10.1016/j.pharmthera.2016.12.005; Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Alshehri MM, 2016, J VESTIBUL RES-EQUIL, V26, P439, DOI 10.3233/VES-160598; Amoo-Achampong K, 2017, PHYSICIAN SPORTSMED, V45, P239, DOI 10.1080/00913847.2017.1327304; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Balaban CD, 2011, J VESTIBUL RES-EQUIL, V21, P315, DOI 10.3233/VES-2011-0428; Balaban CD, 2001, J ANXIETY DISORD, V15, P53, DOI 10.1016/S0887-6185(00)00042-6; Balatsouras DG, 2017, ANN OTO RHINOL LARYN, V126, P54, DOI 10.1177/0003489416674961; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bhattacharyya N, 2008, OTOLARYNG HEAD NECK, V139, pS47, DOI 10.1016/j.otohns.2008.08.022; Bhattacharyya N, 2017, OTOLARYNG HEAD NECK, V156, pS1, DOI 10.1177/0194599816689667; Blodow A, 2014, ACTA OTO-LARYNGOL, V134, P1239, DOI 10.3109/00016489.2014.939300; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Brandt T, 1996, Audiol Neurootol, V1, P187; Brandt T, 2017, NAT REV NEUROL, V13, P352, DOI 10.1038/nrneurol.2017.58; Bree D, 2018, CEPHALALGIA, V38, P246, DOI 10.1177/0333102416681571; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Bronstein AM, 2004, J NEUROL, V251, P381, DOI 10.1007/s00415-004-0410-7; Brown KE, 2006, ARCH PHYS MED REHAB, V87, P76, DOI 10.1016/j.apmr.2005.08.003; Carpenter MG, 1999, EXP BRAIN RES, V129, P93, DOI 10.1007/s002210050940; Choi Mi Suk, 2013, Korean J Audiol, V17, P13, DOI 10.7874/kja.2013.17.1.13; Chorney SR, 2017, LARYNGOSCOPE, V127, P2850, DOI 10.1002/lary.26564; Ciorba A, 2017, MED SCI MONITOR, V23, P6144, DOI 10.12659/MSM.905166; Colebatch JG, 2016, HAND CLINIC, V137, P133, DOI 10.1016/B978-0-444-63437-5.00010-8; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; Dieterich M, 2017, CURR OPIN NEUROL, V30, P107, DOI 10.1097/WCO.0000000000000417; Dobson JL, 2017, AM J PHYSIOL-REG I, V312, pR575, DOI 10.1152/ajpregu.00499.2016; DuPrey KM, 2017, AM J SPORT MED, V45, P2388, DOI 10.1177/0363546517705640; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; Esterov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080100; Fife TD, 2008, NEUROLOGY, V70, P2067, DOI 10.1212/01.wnl.0000313378.77444.ac; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Furman J. M., 2010, VESTIBULAR DISORDERS; Furman JM, 2005, J NEUROL NEUROSUR PS, V76, P1, DOI 10.1136/jnnp.2004.048926; Furman JM, 2013, LANCET NEUROL, V12, P706, DOI 10.1016/S1474-4422(13)70107-8; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Gordon CR, 2004, ARCH NEUROL-CHICAGO, V61, P1590, DOI 10.1001/archneur.61.10.1590; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; Gottshall Kim R, 2005, Int Tinnitus J, V11, P81; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Hain TC, 2011, NEUROREHABILITATION, V29, P127, DOI 10.3233/NRE-2011-0687; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Herdman SJ, 2014, VESTIBULAR REHABILIT; Hillier SL, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005397.pub3; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Jacob RG, 2009, J NEUROL NEUROSUR PS, V80, P74, DOI 10.1136/jnnp.2007.136432; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kang WS, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00166; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Keshner EA, 2004, J VESTIBUL RES-EQUIL, V14, P307; Kingma H, 2006, CURR OPIN NEUROL, V19, P21, DOI 10.1097/01.wco.0000199021.48538.d9; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; La Fountaine MF, 2011, J ATHL TRAINING, V46, P230; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Lee JD, 2017, INT J PEDIATR OTORHI, V94, P36, DOI 10.1016/j.ijporl.2017.01.012; Lee JD, 2011, EUR ARCH OTO-RHINO-L, V268, P1427, DOI 10.1007/s00405-010-1426-5; Lempert T, 2012, J VESTIBUL RES-EQUIL, V22, P167, DOI 10.3233/VES-2012-0453; Liu HJ, 2012, ACTA OTO-LARYNGOL, V132, P803, DOI 10.3109/00016489.2012.657359; Lopez-Escamez JA, 2015, J VESTIBUL RES-EQUIL, V25, P1, DOI 10.3233/VES-150549; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; MacDougall HG, 2009, NEUROLOGY, V73, P1134, DOI 10.1212/WNL.0b013e3181bacf85; Maitland C G, 2001, Curr Neurol Neurosci Rep, V1, P486, DOI 10.1007/s11910-001-0111-x; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P265, DOI 10.1080/13803395.2015.1004303; Bittar RSM, 2015, BRAZ J OTORHINOLAR, V81, P276, DOI 10.1016/j.bjorl.2014.08.012; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Naguib MB, 2012, J LARYNGOL OTOL, V126, P26, DOI 10.1017/S002221511100291X; NASHNER LM, 1982, J NEUROSCI, V2, P536; Neuhauser H, 2001, NEUROLOGY, V56, P436, DOI 10.1212/WNL.56.4.436; Useche JN, 2018, NEUROIMAG CLIN N AM, V28, P15, DOI 10.1016/j.nic.2017.09.006; ORCHIK DJ, 1993, AM J OTOL, V14, P290; Pavlou M, 2004, J NEUROL, V251, P983, DOI 10.1007/s00415-004-0476-2; Pearce KL, 2015, AM J SPORT MED, V43, P3055, DOI 10.1177/0363546515606430; Pellegrino ABW, 2017, CEPHALALGIA; Pisani V, 2015, INT J AUDIOL, V54, P329, DOI 10.3109/14992027.2014.989454; Polensek SH, 2010, AUDIOL NEURO-OTOL, V15, P241, DOI 10.1159/000255440; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Shepard NT, 2016, HAND CLINIC, V137, P119, DOI 10.1016/B978-0-444-63437-5.00009-1; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Sinopoli KJ, 2014, J NEUROTRAUM, V31, P1843, DOI 10.1089/neu.2014.3326; Staab JP, 2017, J VESTIBUL RES-EQUIL, V27, P191, DOI 10.3233/VES-170622; Staab JP, 2003, LARYNGOSCOPE, V113, P1714, DOI 10.1097/00005537-200310000-00010; Sufrinko A, 2018, J HEAD TRAUMA REHAB, V33, P7, DOI 10.1097/HTR.0000000000000315; Tuohimaa P, 1978, Acta Otolaryngol Suppl, V359, P3; Tyburski AL, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0726-1; Vass Z, 1998, NEUROSCIENCE, V84, P559, DOI 10.1016/S0306-4522(97)00503-4; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; von Brevern M, 2007, J NEUROL NEUROSUR PS, V78, P710, DOI 10.1136/jnnp.2006.100420; Whitney SL, 2000, LARYNGOSCOPE, V110, P1528, DOI 10.1097/00005537-200009000-00022; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720; Ziylan F, 2016, OTOL NEUROTOL, V37, P421, DOI 10.1097/MAO.0000000000001021	118	12	12	0	4	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						135	144		10.1016/B978-0-444-63954-7.00014-8			10	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100016	30482341				2022-02-06	
J	Ndode-Ekane, XE; Matthiesen, L; Banuelos-Cabrera, I; Palminha, CAP; Pitkanen, A				Ndode-Ekane, Xavier Ekolle; Matthiesen, Liz; Banuelos-Cabrera, Ivette; Palminha, Catia Alexandra Pegas; Pitkanen, Asla			T-cell infiltration into the perilesional cortex is long-lasting and associates with poor somatomotor recovery after experimental traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Fluid-percussion brain injury; functional impairment; inflammation; T-lymphocytes; traumatic brain injury	TEMPORAL-LOBE EPILEPSY; SPIKE-WAVE DISCHARGES; SPRAGUE-DAWLEY RATS; CLOSED-HEAD INJURY; IMMUNE-RESPONSE; POSTTRAUMATIC EPILEPSY; MUTANT MICE; MODEL; LYMPHOCYTES; MACROPHAGE	Background: T-lymphocyte (T-cell) invasion into the brain parenchyma is a major consequence of traumatic brain injury (TBI). However, the role of T-cells in the post-TBI functional outcome and secondary inflammatory processes is unknown. We explored the dynamics of T-cell infiltration into the cortex after TBI to establish whether the infiltration relates to post-injury functional impairment/recovery and progression of the secondary injury. Method: TBI was induced in rats by lateral fluid-percussion injury, and the acute functional impairment was assessed using the neuroscore Animals were killed between 1-90 d post-TBI for immunohistochemical analysis of T-cell infiltration (CD3), chronic macrophage/microglial reaction (CD68), blood-brain barrier (BBB) dysfunction (IgG), and endophenotype of the cortical injury. Furthermore, the occurrence of spontaneous seizures and spike-and-wave discharges were assessed using video-electroencephalography. Results: The number of T-cells peaked at 2-d post-TBI, and then dramatically decreased by 7-d post-TBI (5% of 2-d value). Unexpectedly, chronic T-cell infiltration at 1 or 3 months post-TBI did not correlate with the severity of chronic inflammation (p > 0.05) or BBB dysfunction (p > 0.05). Multiple regression analysis indicated that inflammation and BBB dysfunction is associated with 48% of the perilesional T-cell infiltration even at the chronic time-point (r = 0.695, F = 6.54, p < 0.05). The magnitude of T-cell infiltration did not predict the pathologic endophenotype of cortical injury, but the higher the number of T-cells in the cortex, the poorer the recovery index based on the neuroscore (r = -0.538, p < 0.05). T-cell infiltration was not associated with the number or duration of age-related spike-and-wave discharges (SWD). Nevertheless, the higher the number of SWD, the poorer the recovery index (r = -0.767, p < 0.5). Conclusions: These findings suggest that acute infiltration of T-cells into the brain parenchyma after TBI is a contributing factor to poor post-injury recovery.	[Ndode-Ekane, Xavier Ekolle; Matthiesen, Liz; Banuelos-Cabrera, Ivette; Palminha, Catia Alexandra Pegas; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland		Ndode-Ekane, XE (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland.	xavier.ekollendode-ekane@uef.fi		Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632	Academy of FinlandAcademy of FinlandEuropean Commission	This study was supported by the Academy of Finland.	Aloisi F, 2000, J IMMUNOL, V164, P1705, DOI 10.4049/jimmunol.164.4.1705; Arumugam TV, 2005, NEUROMOL MED, V7, P229, DOI 10.1385/NMM:7:3:229; Brait VH, 2012, J CEREBR BLOOD F MET, V32, P598, DOI 10.1038/jcbfm.2012.6; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Czigner A, 2007, ACTA NEUROCHIR, V149, P281, DOI 10.1007/s00701-006-1095-8; DRAPPA J, 1993, P NATL ACAD SCI USA, V90, P10340, DOI 10.1073/pnas.90.21.10340; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Jin WN, 2016, J CEREBR BLOOD F MET, V36, P1464, DOI 10.1177/0271678X15611137; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Kharlamov EA, 2003, EPILEPSY RES, V56, P185, DOI 10.1016/j.eplepsyres.2003.09.005; Kleinschnitz C, 2010, BLOOD, V115, P3835, DOI 10.1182/blood-2009-10-249078; Konoeda F, 2010, BIOCHEM BIOPH RES CO, V402, P500, DOI 10.1016/j.bbrc.2010.10.058; Li M, 2015, CHINESE MED J-PEKING, V128, P1072, DOI 10.4103/0366-6999.155094; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Ndode-Ekane XE, 2017, J NEUROTRAUM, V34, P459, DOI 10.1089/neu.2016.4404; Ndode-Ekane XE, 2013, MOL NEUROBIOL, V47, P914, DOI 10.1007/s12035-012-8386-2; Newell E, 2015, PEDIATR CRIT CARE ME, V16, P549, DOI 10.1097/PCC.0000000000000400; Niskanen JP, 2013, J NEUROTRAUM, V30, P546, DOI 10.1089/neu.2012.2416; Nissinen J, 2000, EPILEPSY RES, V38, P177, DOI 10.1016/S0920-1211(99)00088-1; Pankhurst MW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-172; Pearce PS, 2014, EPILEPSY BEHAV, V32, P121, DOI 10.1016/j.yebeh.2014.01.004; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Rodgers KM, 2015, J NEUROSCI, V35, P9194, DOI 10.1523/JNEUROSCI.0919-15.2015; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sallusto F, 2012, IMMUNOL REV, V248, P216, DOI 10.1111/j.1600-065X.2012.01140.x; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Walsh JT, 2015, J CLIN INVEST, V125, P699, DOI [10.1172/JCI176210, 10.1172/JCI76210]; Weckbach S, 2012, J NEUROTRAUM, V29, P1233, DOI 10.1089/neu.2011.2169; Wu QL, 2016, NEUROCHEM RES, V41, P2810, DOI 10.1007/s11064-016-1997-7; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056	43	12	12	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2018	36	4					485	501		10.3233/RNN-170811			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO0CI	WOS:000439587600004	29889085				2022-02-06	
J	Niemi-Nikkola, V; Saijets, N; Ylipoussu, H; Kinnunen, P; Pesala, J; Makela, P; Alen, M; Kallinen, M; Vainionpaa, A				Niemi-Nikkola, Ville; Saijets, Nelli; Ylipoussu, Henriikka; Kinnunen, Pietari; Pesala, Juha; Makela, Pirkka; Alen, Markku; Kallinen, Mauri; Vainionpaa, Aki			Traumatic Spinal Injuries in Northern Finland	SPINE			English	Article						associated injury; epidemiology; falls; incidence; road traffic; spinal cord injury; spinal fracture; spinal injury; transport; trauma; vertebral fracture	CORD-INJURY; CLINICAL ARTICLE; EPIDEMIOLOGY; FRACTURES; CARE; COMPLICATIONS; POPULATION; EXPERIENCE; DATABASE; CHINA	Study Design. A retrospective epidemiological study. Objective. To reveal incidence and epidemiological features of traumatic spinal injuries (TSI) in Northern Finland. Summary of Background Data. In Finland the annual incidence of traumatic spine fractures requiring inpatient care has been found to be 27/100,000, while international incidences have varied across the range of 16-64/100,000. More specific epidemiological data from Finland is not available. Internationally, the most common mechanisms of injury are road traffic as well as low and high falls. Associated injuries occur in 30% to 55% of cases. Methods. The study sample included patients with traumatic spinal injury admitted to Oulu University Hospital (OYS) with injury between the January 1, 2007 and December 31, 2011. Patient information was collected from the hospital care register, including all inpatient and outpatient visits and surgical procedures. Traumatic spinal column and spinal cord injuries were identified using International Classification of Diseases 10th revision or Nordic Classification of Surgical Procedures codes and all patient records were manually reviewed. Results. Nine hundred seventy-one patients met the criteria for TSI. The mean annual incidence of hospitalized traumatic spinal injuries was 26/100,000 in the whole of Northern Finland and 35/100,000 in the OYS main responsibility area. The most frequent etiology of TSI was low falls, which accounted for 35.8% of the injuries, followed by road traffic and high falls. Lumbar spine was the most common site of the fracture. Spinal surgery was performed in 376 (38.7%) cases. Three hundred eight patients (31.7%) suffered from associated injuries, 101 (10.4%) had a spinal cord injury, and 71 (7.3%) a brain injury. Conclusion. Low falls in elderly and road traffic injuries in younger age groups were the most common etiology of traumatic spinal injuries in Northern Finland and should be given more attention in primary prevention.	[Niemi-Nikkola, Ville; Saijets, Nelli; Ylipoussu, Henriikka; Alen, Markku; Kallinen, Mauri; Vainionpaa, Aki] Oulu Univ Hosp, Dept Med Rehabil, POB 21, FI-90029 Oulu, Finland; [Niemi-Nikkola, Ville; Saijets, Nelli; Ylipoussu, Henriikka; Kinnunen, Pietari] Univ Oulu, Fac Med, Oulu, Finland; [Pesala, Juha; Makela, Pirkka] Oulu Univ Hosp, Dept Surg, Div Orthopaed & Trauma Surg, Oulu, Finland; [Alen, Markku; Kallinen, Mauri; Vainionpaa, Aki] Univ Oulu, Ctr Life Course Epidemiol Res, Oulu, Finland		Niemi-Nikkola, V (corresponding author), Oulu Univ Hosp, Dept Med Rehabil, POB 21, FI-90029 Oulu, Finland.	ville.niemi-nikkola@student.oulu.fi	Vainionpaa, Aki/AAX-7762-2020	Vainionpaa, Aki/0000-0002-4837-156X	Northern Ostrobothnia Hospital District	The Northern Ostrobothnia Hospital District (State Research Funding; VTR) funds were received in support of this work.	Akmal M, 2003, SPINE, V28, P180, DOI 10.1097/00007632-200301150-00016; Bouyer B, 2015, ORTHOP TRAUMATOL-SUR, V101, P11, DOI 10.1016/j.otsr.2014.11.012; DeVivo M, 2006, SPINAL CORD, V44, P535, DOI 10.1038/sj.sc.3101958; Du Bois M, 2010, EUR SPINE J, V19, P74, DOI 10.1007/s00586-009-1115-5; FLETCHER DJ, 1995, SPINE, V20, P1136, DOI 10.1097/00007632-199505150-00005; Fredo HL, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-85; Grivna M, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0015-8; Hasler RM, 2011, EUR SPINE J, V20, P2174, DOI 10.1007/s00586-011-1866-7; Hu R, 1996, SPINE, V21, P492, DOI 10.1097/00007632-199602150-00016; Jansson KA, 2010, EUR J EPIDEMIOL, V25, P431, DOI 10.1007/s10654-010-9461-5; Kannus P, 2000, ARCH INTERN MED, V160, P2145, DOI 10.1001/archinte.160.14.2145; Kattail D, 2009, J TRAUMA, V67, P936, DOI 10.1097/TA.0b013e3181a8b431; Koskinen EA, 2014, SPINAL CORD, V52, P779, DOI 10.1038/sc.2014.131; Lenehan B, 2009, EUR SPINE J, V18, P938, DOI 10.1007/s00586-009-0923-y; Leucht P, 2009, INJURY, V40, P166, DOI 10.1016/j.injury.2008.06.040; Liu P, 2012, SPINE, V37, P1310, DOI 10.1097/BRS.0b013e3182474d8b; Moradi-Lakeh M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-789; Official Statistics of Finland (OSF), POPULATION STRUCTURE; Oliver M, 2012, INJURY, V43, P1296, DOI 10.1016/j.injury.2012.04.021; Pirouzmand F, 2010, J NEUROSURG-SPINE, V12, P131, DOI 10.3171/2009.9.SPINE0943; Roche SJ, 2008, INJURY, V39, P436, DOI 10.1016/j.injury.2007.12.012; SABOE LA, 1991, J TRAUMA, V31, P43, DOI 10.1097/00005373-199101000-00010; Somersalo A, 2014, ACTA ORTHOP, V85, P525, DOI 10.3109/17453674.2014.908340; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Wang HW, 2012, J NEUROSURG-SPINE, V17, P459, DOI 10.3171/2012.8.SPINE111003; Williams BJ, 2014, WORLD NEUROSURG, V81, P818, DOI 10.1016/j.wneu.2013.02.013; Yang NP, 2008, INJURY, V39, P443, DOI 10.1016/j.injury.2007.12.007	27	12	12	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	JAN 1	2018	43	1					E45	E51		10.1097/BRS.0000000000002214			7	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	GB0NI	WOS:000428742900008	28441317				2022-02-06	
J	Rabinowitz, AR; Arnett, PA				Rabinowitz, Amanda R.; Arnett, Peter A.			Positive psychology perspective on traumatic brain injury recovery and rehabilitation	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Neurorehabilitation; psychosocial factors; psychotherapy; traumatic brain Injury	QUALITY-OF-LIFE; SOCIAL SUPPORT; PSYCHOSOCIAL OUTCOMES; COGNITIVE DYSFUNCTION; MULTIPLE-SCLEROSIS; COPING STRATEGIES; UNITED-STATES; RESILIENCE; HOPE; HEALTH	Recovery from traumatic brain injury (TBI) is heterogeneous, with injury characteristics and neuropathological findings accounting for a relatively modest proportion of the variance in clinical outcome. Furthermore, premorbid personality traits and psychological characteristics may moderate psychosocial recovery. Constructs from the field of positive psychology have been examined in multiple illness populations and are increasingly gaining attention as factors that may influence recovery from TBI. Positive affect, hope, optimism, adaptive coping style, and resilience have all been examined in the context of TBI. These phenomena are of particular interest because they may inform treatment, either by reducing psychological distress and promoting better adjustment, or by augmenting existing therapies to improve engagement. In general, research suggests that higher levels of these factors predict better psychosocial functioning after injury. However, brain injury itself is associated with reduced levels of many of these positive traits, either relative to uninjured control samples or preinjury functioning. There have been proposals for targeting these positive traits in the context of TBI rehabilitation. Although more research is needed, the few controlled trials aimed at improving adaptive coping skills have shown promising results. Other positive psychological phenomena, such as grit, optimism, and positive affect are deserving of further study as potential intervention targets.	[Rabinowitz, Amanda R.] MossRehab, Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA; [Arnett, Peter A.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA		Rabinowitz, AR (corresponding author), MossRehab, Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	rabinowa@einstein.edu					Alarcon GM, 2013, PERS INDIV DIFFER, V54, P821, DOI 10.1016/j.paid.2012.12.004; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Arnett PA, 2002, CLIN NEUROPSYCHOL, V16, P341, DOI 10.1076/clin.16.3.341.13852; Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; Barnum DD, 1998, CHILD HEALTH CARE, V27, P15, DOI 10.1207/s15326888chc2701_2; Betz J, 2012, J NEUROTRAUM, V29, P1292, DOI 10.1089/neu.2011.2215; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Bryan FB, 2004, J SOC CLIN PSYCHOL, V23, P273, DOI 10.1521/jscp.23.2.273.31018; Carver CS, 2010, CLIN PSYCHOL REV, V30, P879, DOI 10.1016/j.cpr.2010.01.006; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Constantinescu G, 2017, AM J SPEECH-LANG PAT, V26, P1296, DOI 10.1044/2017_AJSLP-17-0040; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; Curry LA, 1997, J PERS SOC PSYCHOL, V73, P1257, DOI 10.1037/0022-3514.73.6.1257; D'Zurilla T.J., 1999, PROBLEM SOLVING THER, V2nd edn; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; Dawson DR, 2006, BRAIN COGNITION, V60, P214; Duckworth AL, 2007, J PERS SOC PSYCHOL, V92, P1087, DOI 10.1037/0022-3514.92.6.1087; Duckworth AL, 2005, ANNU REV CLIN PSYCHO, V1, P629, DOI 10.1146/annurev.clinpsy.1.102803.144154; Duckworth AL, 2011, SOC PSYCHOL PERS SCI, V2, P174, DOI 10.1177/1948550610385872; Evans JJ, 2011, BRAIN IMPAIR, V12, P117, DOI 10.1375/brim.12.2.117; Faul M, 2010, TRAUMATIC BRAIN INJU; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Fredrickson BL, 2003, AM SCI, V91, P330, DOI 10.1511/2003.4.330; Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238; Fredrickson BL, 2003, J PERS SOC PSYCHOL, V84, P365, DOI 10.1037/0022-3514.84.2.365; Fredrickson BL, 2002, PSYCHOL SCI, V13, P172, DOI 10.1111/1467-9280.00431; Fredrickson BL, 2000, MOTIV EMOTION, V24, P237, DOI 10.1023/A:1010796329158; Godwin EE, 2013, BRAIN INJURY, V27, P637, DOI 10.3109/02699052.2012.750745; Grace J, 2001, FRSBE FRONTAL SYSTEM; Gregorio GW, 2014, J HEAD TRAUMA REHAB, V29, pE43, DOI 10.1097/HTR.0b013e318292fb00; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Hanks RA, 2016, REHABIL PSYCHOL, V61, P269, DOI 10.1037/rep0000069; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Hochanadel A., 2015, J INT ED RES JIER, V11, P47, DOI [10.19030/jier.v11i1.9099, DOI 10.19030/JIER.V11I1.9099]; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Howell R.T., 2007, HEALTH PSYCHOL REV, V1, P83, DOI [10.1080/17437190701492486, DOI 10.1080/17437190701492486]; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Kwon P, 2002, J PERS, V70, P207; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Malec JF, 2004, REHABIL PSYCHOL, V49, P55, DOI 10.1037/0090-5550.49.1.55; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Peleg G, 2009, BRAIN INJURY, V23, P800, DOI 10.1080/02699050903196696; Pressman SD, 2005, PSYCHOL BULL, V131, P925, DOI 10.1037/0033-2909.131.6.925; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Rabinowitz AR, 2009, NEUROPSYCHOLOGY, V23, P581, DOI 10.1037/a0016064; Ramanathan DM, 2011, BRAIN INJURY, V25, P328, DOI 10.3109/02699052.2011.554336; Rasmussen HN, 2009, ANN BEHAV MED, V37, P239, DOI 10.1007/s12160-009-9111-x; Reed J, 2013, J HEALTH PSYCHOL, V18, P612, DOI 10.1177/1359105312451866; Richardson GE, 2002, J CLIN PSYCHOL, V58, P307, DOI 10.1002/jclp.10020; Robertson-Kraft C., 2014, TEACH COLL REC, V116, P35; ROTH S, 1986, AM PSYCHOL, V41, P813, DOI 10.1037/0003-066X.41.7.813; Rush BK, 2006, REHABIL PSYCHOL, V51, P257, DOI 10.1037/0090-5550.51.3.257; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Sharkey CM, 2018, J PEDIATR PSYCHOL, V43, P552, DOI 10.1093/jpepsy/jsx145; SNYDER CR, 1991, J PERS SOC PSYCHOL, V60, P570, DOI 10.1037/0022-3514.60.4.570; Snyder CR., 2007, J POSIT PSYCHOL, V2, P168, DOI [DOI 10.1080/17439760701409546, 10.1080/17439760701409546]; Sosin DM, 1996, BRAIN INJURY, V10, P47; Steptoe A, 2005, P NATL ACAD SCI USA, V102, P6508, DOI 10.1073/pnas.0409174102; Taylor SE, 2000, AM PSYCHOL, V55, P99, DOI 10.1037//0003-066X.55.1.99; Tellegen A., 1985, ANXIETY ANXIETY DISO, P681; Tennen H., 1999, COPING PSYCHOL WHAT, P279; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164	76	12	12	3	24	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2018	25	4			SI		295	303		10.1080/23279095.2018.1458514			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GG4SF	WOS:000432685800003	29781729				2022-02-06	
J	Ranson, C; George, J; Rafferty, J; Miles, J; Moore, I				Ranson, Craig; George, Jonathan; Rafferty, James; Miles, John; Moore, Isabel			Playing surface and UK professional rugby union injury risk	JOURNAL OF SPORTS SCIENCES			English	Article						Rugby union; injury; artificial turf; natural grass; playing surface	LOWER-EXTREMITY INJURIES; ARTIFICIAL TURF; CONSENSUS STATEMENT; AMERICAN FOOTBALL; RATES; SURVEILLANCE	Artificial rugby union playing surface installation is increasing. This prospective cohort study aimed to examine the effect of playing surface on match injury types within 157 players of two UK professional rugby union clubs playing 209 matches (96 on artificial surfaces and 113 on grass) over three seasons. There was no difference in overall injury risk between the two playing surfaces with injury incidence on artificial 80.2 (CI 69.9-91.7) and on grass 81.9 per 1000 match-hours (CI 72.2-92.5), with an incidence rate ratio (RR) of 0.98 (CI 0.82-1.17). There was a higher rate of concussion (RR 0.52, CI 0.34 - 0.78) and chest injuries on grass (RR 0.26 CI 0.07, 0.95), and a higher rate of thigh haematoma (RR 2.25, CI 1.05-4.82) foot injuries (RR 4.12, CI 1.10, 15.40) and injury to players being tackled (RR 1.46, CI 1.00, 2.15) on artificial. Whilst there was no higher injury risk for matches played on artificial versus natural grass surfaces, the higher incidence of concussion and chest injury on grass, and the higher rate of foot injuries on artificial surfaces may be related to tackle and footwear-to-surface interface factors.	[Ranson, Craig] English Inst Sport, Athlete Hlth, 299 Alan Turing Way, Manchester M11 3BS, Lancs, England; [George, Jonathan] Saracens Rugby Club, Med Dept, St Albans, England; [Rafferty, James] Swansea Univ, Sch Med, Swansea, W Glam, Wales; [Miles, John] Welsh Rugby Union, Med Dept, Cardiff, S Glam, Wales; [Moore, Isabel] Cardiff Metropolitan Univ, Cardiff Sch Sport & Hlth Sci, Cardiff, S Glam, Wales		Ranson, C (corresponding author), English Inst Sport, Athlete Hlth, 299 Alan Turing Way, Manchester M11 3BS, Lancs, England.	craigranson@me.com	Miles, John J/ABC-1105-2020; Ranson, Craig/AAQ-5452-2020	Miles, John J/0000-0001-5506-6304; Rafferty, James/0000-0002-1667-7265; Ranson, Craig/0000-0002-3783-0505			Andersson H, 2008, J SPORT SCI, V26, P113, DOI 10.1080/02640410701422076; Bittencourt NFN, 2016, BRIT J SPORT MED, V50, P1309, DOI 10.1136/bjsports-2015-095850; Cross MJ, 2019, BRIT J SPORT MED, V53, P1021, DOI 10.1136/bjsports-2017-097912; Dragoo JL, 2013, KNEE, V20, P191, DOI 10.1016/j.knee.2012.07.006; Efron B., 1994, INTRO BOOTSTRAP; Eirale C, 2015, CLIN J SPORT MED, V25, P73, DOI 10.1097/JSM.0000000000000066; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2010, J SPORT SCI, V28, P563, DOI 10.1080/02640411003629681; Gu K, 2008, BIOMETRICAL J, V50, P283, DOI 10.1002/bimj.200710403; Hagglund M, 2013, BRIT J SPORT MED, V47, P738, DOI 10.1136/bjsports-2013-092215; Hopkins W.G., 2010, SPORTSCIENCE, V14, P49; Iacovelli JN, 2013, BRIT J SPORT MED, V47, P789, DOI 10.1136/bjsports-2012-092113; Kordi R, 2011, BMC SPORTS SCI MED R, V3, DOI 10.1186/1758-2555-3-3; Kristenson K, 2013, BRIT J SPORT MED, V47, P775, DOI 10.1136/bjsports-2013-092266; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Moore IS, 2018, BRIT J SPORT MED, V52, P1137, DOI 10.1136/bjsports-2016-097040; Moore IS, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115596194; Orchard JW, 2016, BRIT J SPORT MED, V50, P1245, DOI 10.1136/bjsports-2016-096125; Rae K, 2007, CLIN J SPORT MED, V17, P201, DOI 10.1097/JSM.0b013e318059b536; Rennie DJ, 2016, J SCI MED SPORT, V19, P547, DOI 10.1016/j.jsams.2015.07.009; RFU, 2017, ENGL PROF RUGB INJ S; Taylor SA, 2012, PHYSICIAN SPORTSMED, V40, P66, DOI 10.3810/psm.2012.11.1989; Thomson A, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094478; van den Eijnde WAJ, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114533482; Williams S, 2016, SCAND J MED SCI SPOR, V26, P101, DOI 10.1111/sms.12402; Williams S, 2016, BRIT J SPORT MED, V50, P651, DOI 10.1136/bjsports-2015-094798; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1; World Rugby, 2014, MEMB UN; World Rugby, 2017, RUGB UN LAWS GAM REC	29	12	14	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.		2018	36	21					2393	2398		10.1080/02640414.2018.1458588			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GQ4QQ	WOS:000441658500001	29595083	Green Accepted			2022-02-06	
J	Rosas-Hernandez, H; Cuevas, E; Escudero-Lourdes, C; Lantz, SM; Gomez-Crisostomo, NP; Sturdivant, NM; Balachandran, K; Imam, SZ; Slikker, W; Paule, MG; Ali, SF				Rosas-Hernandez, Hector; Cuevas, Elvis; Escudero-Lourdes, Claudia; Lantz, Susan M.; Gomez-Crisostomo, Nancy P.; Sturdivant, Nasya M.; Balachandran, Kartik; Imam, Syed Z.; Slikker, William, Jr.; Paule, Merle G.; Ali, Syed F.			Characterization of Biaxial Stretch as an In Vitro Model of Traumatic Brain Injury to the Blood-Brain Barrier	MOLECULAR NEUROBIOLOGY			English	Article						Biaxial stretch; Blood-brain barrier; Traumatic brain injury; In vitro models	ENDOTHELIAL-CELLS; CYCLIC STRETCH; MILD; PERMEABILITY; DEFORMATION; VALIDATION; TBI	Traumatic brain injury (TBI) is one of the major causes of disability in the USA. It occurs when external mechanical forces induce brain damage that causes deformation of brain tissue. TBI is also associated with alterations of the blood-brain barrier (BBB). Using primary rat brain microvascular endothelial cells as an in vitro BBB model, the effects of biaxial stretch were characterized at 5, 10, 15, 25, and 50% deformation using a commercially available system. The results were compared to the effects of mild and moderate TBI in vivo, induced by the weight-drop method in mice. In vitro, live/dead cells, lactate dehydrogenase (LDH) release, caspase 3/7 staining, and tight junction (TJ) protein expression were evaluated 24 h after a single stretch episode. In vivo, Evans blue extravasation, serum levels of S100 beta, and TJ protein expression were evaluated. Stretch induced a deformation-dependent increase in LDH release, cell death, and activation of caspase 3/7, suggesting the induction of apoptosis. Interestingly, low magnitudes of deformation increased the expression of TJ proteins, likely in an attempt to compensate for stretch damage. High magnitudes of deformation decreased the expression of TJ proteins, suggesting that the damage was too severe to counteract. In vivo, mild TBI did not affect BBB permeability or the expression of TJ proteins. However, moderate TBI significantly increased BBB permeability and decreased the expression of these proteins, similar to the results obtained with a high magnitude deformation. These data support the use biaxial stretch as valuable tool in the study of TBI in vitro.	[Rosas-Hernandez, Hector; Cuevas, Elvis; Lantz, Susan M.; Imam, Syed Z.; Slikker, William, Jr.; Paule, Merle G.; Ali, Syed F.] US FDA, Neurochem Lab, Div Neurotoxicol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Escudero-Lourdes, Claudia] Univ Autonoma San Luis Potosi, Fac Ciencias Quim, Slp, San Luis Potosi, Mexico; [Gomez-Crisostomo, Nancy P.] Univ Autonoma Juarez Tabasco, Villahermosa, Tabasco, Mexico; [Sturdivant, Nasya M.; Balachandran, Kartik] Univ Arkansas, Dept Biomed Engn, Fayetteville, AR 72701 USA		Ali, SF (corresponding author), US FDA, Neurochem Lab, Div Neurotoxicol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	Syed.Ali@fda.hhs.gov	Rosas-Hernandez, Hector/AAU-1294-2020	Burks, Susan/0000-0002-4459-8126; Rosas-Hernandez, Hector/0000-0002-2736-8302			Andrews AM, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00043; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Birukova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL612, DOI 10.1152/ajplung.90236.2008; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Centers for Disease Control and Prevention, 2015, C TRAUM BRAIN INJ US; Chow BW, 2015, TRENDS NEUROSCI, V38, P598, DOI 10.1016/j.tins.2015.08.003; Collins NT, 2006, ARTERIOSCL THROM VAS, V26, P62, DOI 10.1161/01.ATV.0000194097.92824.b3; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Duckworth Josh L, 2013, Pathophysiology, V20, P23, DOI 10.1016/j.pathophys.2012.03.001; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Kabadi SV, 2015, J CEREBR BLOOD F MET, V35, P2010, DOI 10.1038/jcbfm.2015.165; Kang WH, 2015, BIOMECH MODEL MECHAN, V14, P561, DOI 10.1007/s10237-014-0622-4; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Knutsen AK, 2014, J BIOMECH, V47, P3475, DOI 10.1016/j.jbiomech.2014.09.010; Li HX, 2016, BRAIN RES, V1642, P70, DOI 10.1016/j.brainres.2016.03.031; Li W, 2016, BRAIN RES, V1646, P53, DOI 10.1016/j.brainres.2016.05.036; Liu MD, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fincel.2015.00168, 10.3389/fncel.2015.00168]; Liu XM, 2013, AM J PHYSIOL-HEART C, V304, pH1634, DOI 10.1152/ajpheart.00872.2012; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Rayamajhi Manira, 2013, Methods Mol Biol, V1040, P85, DOI 10.1007/978-1-62703-523-1_7; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Rosas-Hernandez H, 2016, NEUROSCI LETT, V629, P125, DOI 10.1016/j.neulet.2016.06.029; Salvador E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00323; Salvador E, 2013, JOVE-J VIS EXP, DOI 10.3791/50928; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Sherman SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep34097; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Sturdivant NM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33330; Suzuki N, 1997, BIOCHEM BIOPH RES CO, V239, P372, DOI 10.1006/bbrc.1997.7364; Wang ZX, 2016, MOL NEUROBIOL, V53, P1905, DOI 10.1007/s12035-015-9143-0; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Xu ZM, 2017, J NEUROTRAUM, V34, P925, DOI 10.1089/neu.2016.4491; Young LA, 2015, SEMIN NEUROL, V35, P5, DOI 10.1055/s-0035-1544242	35	12	12	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JAN	2018	55	1					258	266		10.1007/s12035-017-0738-5			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV6PC	WOS:000424702600026	28842857				2022-02-06	
J	Seagly, KS; O'Neil, RL; Hanks, RA				Seagly, Katharine S.; O'Neil, Rochelle L.; Hanks, Robin A.			Pre-injury psychosocial and demographic predictors of long-term functional outcomes post-TBI	BRAIN INJURY			English	Article						Brain injury; outcome assessment; predictors; functional independence; rehabilitation; multiple regression	TRAUMATIC BRAIN-INJURY; LIFE SATISFACTION; COMMUNITY INTEGRATION; SUBSTANCE-ABUSE; UNITED-STATES; SCALE; COMA; DISABILITY; VARIABLES; SEVERITY	Objective: To determine whether pre-injury psychosocial and demographic factors differentially influence long-term functional outcomes post-TBI. Setting: Urban rehabilitation hospital. Participants: 149 individuals, ages 16-75, who sustained a mild complicated, moderate or severe TBI, were enrolled in a TBI Model System (TBIMS), and had functional outcome data five-15 years post-injury. Design: Archival data were analysed with SPSS-18 using multiple regression to determine amount of variance accounted for in five functional domains. Predictors included age at injury, pre-injury education, Glasgow Coma Scale (GCS), pre-injury incarceration and psychiatric history. Measures: Craig Handicap Assessment and Reporting Technique (CHART), including Cognitive Independence, Physical Independence, Mobility, Occupation and Social Integration domains. Results: Models were significant for Cognitive and Physical Independence, Mobility, and Occupation. Incarceration and psychiatric history accounted for the most variance in Cognitive and Physical Independence, over and above GCS and age at injury. Psychiatric history was also the strongest predictor of Occupation. Mobility was the only domain in which GCS accounted for the most variance. Conclusion: Pre-injury psychosocial and demographic factors may be more important than injury severity for predicting some long-term functional outcomes post-TBI. It would likely be beneficial to assess these factors in the inpatient setting, with input from a multidisciplinary team, as an early understanding of prognostic indicators can help guide treatment for optimal functional outcomes.	[Seagly, Katharine S.] Univ Michigan, Dept Phys Med & Rehabil, Div Rehabil Psychol & Neuropsychol, Michigan Med, Ann Arbor, MI 48109 USA; [Hanks, Robin A.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI USA; [Hanks, Robin A.] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI USA; [Seagly, Katharine S.; O'Neil, Rochelle L.; Hanks, Robin A.] Rehabil Inst Michigan, Dept Psychol & Neuropsychol, Detroit, MI USA		Seagly, KS (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, Div Rehabil Psychol & Neuropsychol, Michigan Med, Ann Arbor, MI 48109 USA.	kseagly@med.umich.edu			National Institute on Disability and Rehabilitation Research [H133A080044]	This work was supported by the National Institute on Disability and Rehabilitation Research [H133A080044];	[Anonymous], 1979, SCALE AM J NURS, V79, P1551; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Centers for Disease Control and Prevention, 2016, INJ PREV CONTR; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; DAWSON DR, 1995, BRAIN INJURY, V9, P339, DOI 10.3109/02699059509005774; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Johnson DJ, 1998, ARCH CLIN NEUROPSYCH, V13, P116; Juarez V J, 1995, J Neurosci Nurs, V27, P283; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Kolakowsky-Hayner SA, 2001, BRAIN INJURY, V15, P53, DOI 10.1080/02699050150209138; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; Leezak MD, 2012, NEUROPSYCHOLOGICAL A; Mellick D, 2016, CENT OUTCOME MEAS BR; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Soo CA., 2005, BRAIN IMPAIR, V6, P75, DOI [DOI 10.1375/BRIM.2005.6.2.75, 10.1375/brim.2005.6.2.75]; Sugerman D., 2012, BRAIN INJURY MED, P45; TEASDALE G, 1974, LANCET, V2, P81; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; Walker N, 2003, AM J PHYS MED REHAB, V82, P936, DOI 10.1097/01.PHM.0000098041.42394.9A; Wertheimer JC, 2008, ARCH PHYS MED REHAB, V89, P1983, DOI 10.1016/j.apmr.2008.04.010; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; Williamson MLC, 2013, BRAIN INJURY, V27, P992, DOI 10.3109/02699052.2013.801512; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498	36	12	12	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	1					78	83		10.1080/02699052.2017.1374467			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7VS	WOS:000427072300008	29157000				2022-02-06	
J	Snell, DL; Martin, R; Macleod, AD; Surgenor, LJ; Siegert, RJ; Jean, E; Hay-Smith, C; Melzer, T; Hooper, GJ; Anderson, T				Snell, Deborah L.; Martin, Rachelle; Macleod, A. D.; Surgenor, Lois J.; Siegert, Richard J.; Jean, E.; Hay-Smith, C.; Melzer, Tracy; Hooper, Gary J.; Anderson, Tim			Untangling chronic pain and post-concussion symptoms: the significance of depression	BRAIN INJURY			English	Article						mTBI; chronic pain; psychological factors; depressive symptoms	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL STATUS RBANS; POSTCONCUSSION SYNDROME; REPEATABLE BATTERY; HOSPITAL ANXIETY; SEVERITY SCORE; NEW-ZEALAND; DSM-IV; QUESTIONNAIRE; SCALE	Objectives: Post-concussion-like symptoms (PCS) are common in patients without a history of brain injury, such as those with chronic pain (CP). This exploratory study examined neuro-cognitive and psychological functioning in patients with PCS following mild traumatic brain injury (mTBI) or CP, to assess unique and overlapping phenomenology.Methods: In this case-control study, participants (n=102) with chronic symptoms after mTBI (n=45) were matched with mTBI recovered (n=31) and CP groups (n=26), on age, gender, ethnicity and education. Psychological status, cognitive functioning, health symptoms, beliefs and behaviours were examined.Results: Participants who had not recovered from an mTBI and participants with CP did not differ in terms of PCS symptoms, quality of life, distress or illness behaviours, however, the CP group endorsed fewer subjective cognitive problems, more negative expectations about recovery and more distress (p<0.05). On cognitive testing participants who had not recovered from an mTBI demonstrated greater difficulties with attention (p<0.01) although differences disappeared when depression was controlled in the analyses.Conclusions: Unique patterns associated with each condition were evident though caution is required in attributing PCS and cognitive symptoms to a brain injury in people with mTBI presenting with chronic pain and/or depression. Psychological constructs such as illness and recovery beliefs appear to be important to consider in the development of treatment interventions.	[Snell, Deborah L.; Macleod, A. D.] Burwood Hosp, Concuss Clin, Christchurch, New Zealand; [Snell, Deborah L.; Hooper, Gary J.] Univ Otago Christchurch, Dept Orthopaed Surg & Musculoskeletal Med, Christchurch, New Zealand; [Surgenor, Lois J.] Univ Otago Christchurch, Dept Psychol Med, Christchurch, New Zealand; [Melzer, Tracy; Anderson, Tim] Univ Otago Christchurch, Dept Med, Christchurch, New Zealand; [Martin, Rachelle; Hay-Smith, C.] Univ Otago Wellington, Rehabil Teaching & Res Unit, Wellington, New Zealand; [Siegert, Richard J.] AUT Univ, Fac Hlth & Environm Studies, Auckland, New Zealand; [Melzer, Tracy; Anderson, Tim] New Zealand Brain Res Inst, Christchurch, New Zealand; [Melzer, Tracy; Anderson, Tim] Brain Res New Zealand, Ctr Res Excellence, Auckland, New Zealand		Snell, DL (corresponding author), Univ Otago Christchurch, Christchurch, New Zealand.	debbie.snell@otago.ac.nz	Siegert, Richard J./K-2030-2019; Martin, R/R-9971-2019	Martin, R/0000-0002-9533-3195; Siegert, Richard/0000-0002-3074-0929; Hooper, Gary/0000-0002-3424-5773	Health Research Council of New ZealandHealth Research Council of New Zealand [13/702]	This research has been supported by an Emerging Researcher First Grant from the Health Research Council of New Zealand (Grant no13/702).	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barker-Collo S, 2015, BRAIN INJURY, V29, P1604, DOI 10.3109/02699052.2015.1075143; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Beaupre M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/924692; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P343, DOI 10.1080/13854046.2013.774438; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Brunger H, 2014, BRAIN INJURY, V28, P71, DOI 10.3109/02699052.2013.857788; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Delis DC., 2001, DELIS KAPLAN EXECUTI; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; IASP, DEF CHRON PAIN SYNDR; IBM Corp, 2016, IBM SPSS STAT MAC VE; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Leventhal H, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P19; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; Mckay C, 2008, CLIN NEUROPSYCHOL, V22, P228, DOI 10.1080/13854040701260370; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V41, P611; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; NZGG, 2006, EV BAS BEST PRACT GU; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Randolph C., 1998, REPEATABLE BATTERY A; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Silver JM, 2014, PSYCHIAT CLIN N AM, V37, P91, DOI 10.1016/j.psc.2013.11.001; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Silverberg ND, 2017, J NEUROTRAUM, V34, P2141, DOI 10.1089/neu.2016.4719; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Snell DL, 2017, DISABIL REHABIL, V39, P1968, DOI 10.1080/09638288.2016.1213895; Snell DL, 2015, BRAIN INJURY, V29, P291, DOI 10.3109/02699052.2014.976594; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Snell DL, 2010, BRAIN INJURY, V24, P1595, DOI 10.3109/02699052.2010.523048; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Spence M, 2005, PSYCHOL MED, V35, P583, DOI 10.1017/S0033291704003484; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Suhr J, 2012, CLIN NEUROPSYCHOL, V26, P1128, DOI 10.1080/13854046.2012.713121; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; von Steinbuechel N, 2005, CURR OPIN NEUROL, V18, P681, DOI 10.1097/01.wco.0000194140.56429.75; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	73	12	12	1	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	5					583	592		10.1080/02699052.2018.1432894			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WL	WOS:000427074200009	29388838				2022-02-06	
J	Suskauer, SJ; Rane, S; Reesman, J; Slomine, BS				Suskauer, Stacy J.; Rane, Shruti; Reesman, Jennifer; Slomine, Beth S.			Caregiver-report of symptoms following traumatic brain injury in a small clinical sample of preschool-aged children	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Preschool child; traumatic brain injury; behavior	MILD HEAD-INJURY; EARLY-CHILDHOOD; YOUNG-CHILDREN; BEHAVIOR PROBLEMS; CONCUSSION; OUTCOMES; PERFORMANCE; PREVALENCE	PURPOSE: Preschool-aged children have a high rate of traumatic brain injuries (TBI). Anecdotally, caregivers of young children describe symptoms not typically associated with TBI. The objective of this study was to preliminarily describe symptoms reported following TBI in an outpatient sample of preschool-aged children. METHODS: Retrospective chart review was completed of the first specialty clinic visit by 28 children ages 3 through 5 years with TBI (32% mild, 50% moderate, 18% severe) to identify post-injury symptoms elicited by caregiver interview including querying of symptoms listed on the Acute Concussion Evaluation (ACE) plus an open-ended request to describe any other symptoms. RESULTS: Visits occurred on average 38 days post-injury. Caregivers endorsed typical post-concussive symptoms, with headache being most common. In addition, caregivers described other symptoms not captured by the ACE which were grouped into the following categories: Appetite Changes, Behavioral Dysregulation, Decreased Engagement, Disrupted Sleep, Enuresis, Increased Dependence, and Stomachaches. CONCLUSIONS: Caregivers of preschool-aged children with TBI endorse that young children experience many typical post-concussive symptoms but also a range of other symptoms which may not be typically associated with TBI. Additional work is needed to determine whether specialized evaluation tools and educational materials may be useful for this age group.	[Suskauer, Stacy J.; Rane, Shruti; Reesman, Jennifer; Slomine, Beth S.] Kennedy Krieger Inst, Baltimore, MD USA; [Suskauer, Stacy J.; Reesman, Jennifer; Slomine, Beth S.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA		Suskauer, SJ (corresponding author), Kennedy Krieger Inst, Pediat Rehabil, 707 North Broadway, Baltimore, MD 21205 USA.	suskauer@kennedykrieger.org			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23HD061611]	Data analysis and manuscript preparation were supported in part by NIH grant K23HD061611.	Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; Crowe LM, 2014, J HEAD TRAUMA REHAB, V29, P217, DOI 10.1097/HTR.0b013e31829babfd; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Kaldoja ML, 2012, BRAIN INJURY, V26, P1005, DOI 10.3109/02699052.2012.660516; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Lalonde G, 2016, J NEUROPSYCHOL; Lannsjo M, 2011, J REHABIL MED, V43, P997, DOI 10.2340/16501977-0875; Liu JH, 2013, BRAIN INJURY, V27, P1263, DOI 10.3109/02699052.2013.804205; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P233, DOI 10.1097/HTR.0b013e3182a2dd7f; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Shay N, 2014, J NEUROTRAUM, V31, P1305, DOI 10.1089/neu.2013.3275; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	26	12	12	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2018	11	1					7	14		10.3233/PRM-160424			8	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	GS5FA	WOS:000443681400002	29630559				2022-02-06	
J	Yulug, B; Kilic, E; Altunay, S; Ersavas, C; Orhan, C; Dalay, A; Tuzcu, M; Sahin, N; Juturu, V; Sahin, K				Yulug, Burak; Kilic, Ertugrul; Altunay, Serdar; Ersavas, Cenk; Orhan, Cemal; Dalay, Arman; Tuzcu, Mehmet; Sahin, Nurhan; Juturu, Vijaya; Sahin, Kazim			Cinnamon Polyphenol Extract Exerts Neuroprotective Activity in Traumatic Brain Injury in Male Mice	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Cinnamon; Traumatic brain injury; Glial fibrillary acidic protein; Interleukin 1-beta; Interleukin 6; Neural cell adhesion molecule; Nuclear factor-kappa B; Nuclear factor erythroid 2-related factor 2; Malondialdehyde; Superoxide dismutase; Catalase; Glutathione peroxidase	NF-KAPPA-B; TRANS-CINNAMALDEHYDE; OXIDATIVE STRESS; BETA-SECRETASE; ESSENTIAL OIL; AMYLOID-BETA; MOUSE MODEL; IN-VITRO; INHIBITION; PROTEINS	Introduction: Cinnamon polyphenol extract is a traditional spice commonly used in different areas of the world for the treatment of different disease conditions which are associated with inflammation and oxidative stress. Despite many preclinical studies showing the anti-oxidative and anti-inflammatory effects of cinnamon, the underlying mechanisms in signaling pathways via which cinnamon protects the brain after brain trauma remained largely unknown. However, there is still no preclinical study delineating the possible molecular mechanism of neuroprotective effects cinnamon polyphenol extract in Traumatic Brain Injury (TBI). The primary aim of the current study was to test the hypothesis that cinnamon polyphenol extract administration would improve the histopathological outcomes and exert neuroprotective activity through its antioxidative and anti-inflammatory properties following TBI. Methods: To investigate the effects of cinnamon, we induced brain injury using a cold trauma model in male mice that were treated with cinnamon polyphenol extract (10 mg/kg) or vehicle via intraperitoneal administration just after TBI. Mice were divided into two groups: TBI+vehicle group and TBI+ cinnamon polyphenol extract group. Brain samples were collected 24 h later for analysis. Results: We have shown that cinnamon polyphenol extract effectively reduced infarct and edema formation which were associated with significant alterations in inflammatory and oxidative parameters, including nuclear factor-KB, interleukin 1-beta, interleukin 6, nuclear factor erythroid 2-related factor 2, glial fibrillary acidic protein, neural cell adhesion molecule, malondialdehyde, superoxide dismutase, catalase and glutathione peroxidase. Conclusion: Our results identify an important neuroprotective role of cinnamon polyphenol extract in TBI which is mediated by its capability to suppress the inflammation and oxidative injury. Further, specially designed experimental studies to understand the molecular cross-talk between signaling pathways would provide valuable evidence for the therapeutic role of cinnamon in TBI and other TBI related conditions.	[Yulug, Burak] Alanya Alaaddin Keykubat Univ, Dept Neurol, Alanya Antalya, Turkey; [Yulug, Burak; Kilic, Ertugrul; Ersavas, Cenk] Istanbul Medipol Univ, Expt Neurol Lab, Regenerat & Restorat Med Res Ctr, Istanbul, Turkey; [Kilic, Ertugrul; Altunay, Serdar; Dalay, Arman] Univ Istanbul Medipol, Dept Physiol, Istanbul, Turkey; [Orhan, Cemal; Sahin, Nurhan; Sahin, Kazim] Firat Univ, Dept Anim Nutr, Elazig, Turkey; [Tuzcu, Mehmet] Firat Univ, Dept Biol, Elazig, Turkey; [Juturu, Vijaya] OmniAct Hlth Technol Inc, Sci & Clin Affairs, Res & Dev, Morristown, NJ USA		Yulug, B (corresponding author), Alanya Alaaddin Keykubat Univ, Dept Neurol, Alanya Antalya, Turkey.	burakyulug@gmail.com	TUZCU, MEHMET/H-2953-2018; Orhan, Cemal/Q-2086-2015; Sahin, Kazim/D-5625-2009; Yulug, Burak/O-8322-2016; Yulug, Burak/AAD-3930-2022; Sahin, Nurhan/D-5626-2009; sahin, nurhan/ABF-8007-2020; Kilic, Ertugrul/W-4563-2018	TUZCU, MEHMET/0000-0002-1329-3143; Orhan, Cemal/0000-0003-4138-7689; Sahin, Kazim/0000-0001-9542-5244; Yulug, Burak/0000-0002-9704-6173; sahin, nurhan/0000-0001-9487-1154; Kilic, Ertugrul/0000-0001-6494-8923			Amin KA, 2009, INT J CLIN EXP MED, V2, P254; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Bai Q, 2017, BEHAV BRAIN RES, V321, P79, DOI 10.1016/j.bbr.2016.12.037; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Bernardo MA, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/913651; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Brennemen M, 2017, FASEB J, V31; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Chen YF, 2016, NEUROMOL MED, V18, P322, DOI 10.1007/s12017-016-8395-9; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dugoua JJ, 2007, CAN J PHYSIOL PHARM, V85, P837, DOI 10.1139/Y07-080; Edwards G, 2017, BIOCHEM BIOPH RES CO, V483, P1137, DOI 10.1016/j.bbrc.2016.07.123; Esenwa CC, 2016, NAT REV NEUROL, V12, P594, DOI 10.1038/nrneurol.2016.125; Feng Y, 2016, MOL MED REP, V13, P5248, DOI 10.3892/mmr.2016.5201; Frydman-Marom A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016564; Guo JP, 2010, J ALZHEIMERS DIS, V19, P1359, DOI 10.3233/JAD-2010-1331; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hong JW, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-237; Jayaprakasha GK, 2011, CRIT REV FOOD SCI, V51, P547, DOI 10.1080/10408391003699550; JORGENSEN OS, 1995, NEUROCHEM RES, V20, P533, DOI 10.1007/BF01694535; Kang YJ, 2016, NUTR RES, V36, P1277, DOI [10.1016/j.nutres.2016.10.002, 1]; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; Kawai Y, 2011, J BIOL CHEM, V286, P7629, DOI 10.1074/jbc.M110.208173; Kelestemur T, 2016, NEUROSCI LETT, V612, P92, DOI 10.1016/j.neulet.2015.11.043; Khasnavis S, 2014, J NEUROIMMUNE PHARM, V9, P569, DOI 10.1007/s11481-014-9552-2; Kim DH, 2007, BIOGERONTOLOGY, V8, P545, DOI 10.1007/s10522-007-9098-2; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Malik Jai, 2015, Journal of Basic and Clinical Physiology and Pharmacology, V26, P275, DOI 10.1515/jbcpp-2014-0012; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; Martins I. J., 2016, Health, V8, P694, DOI 10.4236/health.2016.87073; Martins I.J., 2017, J DIABETES METAB DIS, V4; Martins IJ, 2017, J CLIN EPIGENET, V3, P3; Matsumura S, 2016, NAT PROD COMMUN, V11, P507; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; Medagama AB, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0098-9; Mingo AE, 2016, CELL DEATH DIS, V7, pe2464; Mirmosayyeb O, 2017, INT J PREVENTIVE MED, V8, DOI 10.4103/2008-7802.199640; Moselhy SS, 2009, BIOL RES, V42, P93, DOI [10.4067/S0716-97602009000100009, /S0716-97602009000100009]; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Pahan K, 2015, J MULT SCLER FOSTER, V2, DOI DOI 10.4172/2376-0389.1000149; Panickar KS, 2009, EXP NEUROL, V216, P420, DOI 10.1016/j.expneurol.2008.12.024; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Peterson DW, 2009, J ALZHEIMERS DIS, V17, P585, DOI 10.3233/JAD-2009-1083; Qin BL, 2014, LIFE SCI, V102, P72, DOI 10.1016/j.lfs.2014.02.038; Qin BL, 2014, NUTRITION, V30, P210, DOI 10.1016/j.nut.2013.07.001; Qin Bolin, 2010, J Diabetes Sci Technol, V4, P685; Rochfort KD, 2015, BIOCHEM SOC T, V43, P702, DOI 10.1042/BST20140319; Roussel AM, 2009, J AM COLL NUTR, V28, P16, DOI 10.1080/07315724.2009.10719756; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Salminen A, 2008, BIOESSAYS, V30, P939, DOI 10.1002/bies.20799; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Shahverdi AR, 2007, J FOOD SCI, V72, pS55, DOI 10.1111/j.1750-3841.2006.00204.x; Shalaby MA, 2014, J INTERCULT ETHNOPHA, V3, P144, DOI 10.5455/jice.20140818050741; Shaltiel-Karyo R, 2012, BBA-GEN SUBJECTS, V1820, P1628, DOI 10.1016/j.bbagen.2012.04.021; Tao XG, 2017, CHINESE MED J-PEKING, V130, P187, DOI 10.4103/0366-6999.198001; Tataranno ML, 2015, CLIN PERINATOL, V42, P529, DOI 10.1016/j.clp.2015.04.011; Tuzcu Z, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1583098; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yoon DS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.3; Zhang L, 2017, MOL NEUROBIOL; Zhang XS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.292; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004	66	12	12	0	9	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets		2018	17	6					439	447		10.2174/1871527317666180501110918			9	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	GQ1SB	WOS:000441417400005	29714150				2022-02-06	
J	Zhao, ML; Chen, SJ; Li, XH; Wang, LN; Chen, F; Zhong, SJ; Yang, C; Sun, SK; Li, JJ; Dong, HJ; Dong, YQ; Wang, Y; Chen, C				Zhao, Ming-Liang; Chen, Shi-Jin; Li, Xiao-Hong; Wang, Li-Na; Chen, Feng; Zhong, Shi-Jiang; Yang, Cheng; Sun, Sheng-Kai; Li, Jian-Jun; Dong, Hua-Jiang; Dong, Yue-Qing; Wang, Yi; Chen, Chong			Optical Depolarization of DCX-Expressing Cells Promoted Cognitive Recovery and Maturation of Newborn Neurons via the Wnt/beta-Catenin Pathway	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Adult neurogenesis; cognition; depolarization; optical; traumatic brain injury	TRAUMATIC BRAIN-INJURY; ADULT HIPPOCAMPAL NEUROGENESIS; OPTOGENETIC ACTIVATION; MILD HYPOTHERMIA; PROGENITOR CELLS; GRANULE CELLS; STEM-CELLS; DIFFERENTIATION; STIMULATION; EXCITATION	Electrical excitability by membrane depolarization is crucial for survival and maturation of newborn cells in the dentate gyrus of the hippocampus. However, traditional technology for membrane depolarization lacks temporal and spatial precision. Optogenetics can be used to activate channelrhodopsin-2 (ChR2), allowing cationic current to depolarize genetically targeted cells. In this study, we used ChR2-EGFP driven by doublecortin (DCX) to promote survival and maturation of newborn cells in the dentate gyrus after traumatic brain injury (TBI). C57BL/6 mice underwent lateral fluid percussion TBI. TBI mice were transfected with a lentivirus carrying the DCX-ChR2-EGFP gene. We observed that not only immature neurons but also type-2b intermediate progenitor (IPs) and neuroblasts expressed DCX-EGFP, indicating that DCX-expressing newborn cells could provide a long time window for electrical activity regulation. Quantitative results showed that the number of EGFP-expressing cells began to rise at 3 days after TBI and peaked at 9 days after TBI. By optical depolarization of DCX-EGFP- expressing cells between 3 and 12 days, we observed significantly improved cognitive deficits after TBI with enhanced survival and maturation of newborn cells in the dentate gyrus. We also investigated the role of optical depolarization in neural stem cells transfected with a lentivirus carrying the ChR2-DCX-EGFP gene in vitro. By administrating verapamil to block L-type calcium channels, we verified that the up-regulation of MAP2, NeuN, Neurog2, NeuroD1 and GluR2 in newborn cells was mediated by ChR2-elicted depolarization. By using beta-catenin inhibitor Dkk1, we demonstrated that optical depolarization of DCX-EGFP-expressing cells facilitated survival and maturation probably through the Wnt/beta-catenin signaling cascade.	[Zhao, Ming-Liang; Li, Xiao-Hong; Wang, Li-Na; Chen, Feng; Zhong, Shi-Jiang; Yang, Cheng; Sun, Sheng-Kai; Li, Jian-Jun; Dong, Hua-Jiang; Dong, Yue-Qing; Wang, Yi; Chen, Chong] Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp Brain Ctr, Tianjin Key Lab Neurotrauma Repair, Tianjin 300162, Peoples R China; [Chen, Shi-Jin] Yichang Second Peoples Hosp, Dept Cardiol, Yichang, Hubei, Peoples R China		Wang, Y; Chen, C (corresponding author), Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp Brain Ctr, Tianjin Key Lab Neurotrauma Repair, Tianjin 300162, Peoples R China.	wangyils2005@126.com; chongchen12@hotmail.com			National Nature Scientific Fund of China [81401067, 81471275, 81771352, 81671222, 81771350, 81772018]; Nature Scientific Fund of Tianjin [15JCQNJC11100, 15JCYBJC28100, 16JCYBJC27600]	This work was supported by the National Nature Scientific Fund of China (81401067, 81471275, 81771352, 81671222, 81771350, 81772018) and the Nature Scientific Fund of Tianjin (15JCQNJC11100, 15JCYBJC28100, 16JCYBJC27600).	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Bordia T, 2016, EXP NEUROL, V286, P32, DOI 10.1016/j.expneurol.2016.09.009; Bost A, 2017, NEUROSCIENCE, V346, P1, DOI 10.1016/j.neuroscience.2017.01.006; Chen C, 2016, NEUROSCIENCE, V335, P114, DOI 10.1016/j.neuroscience.2016.08.038; Cheng XW, 2011, CELL RES, V21, P338, DOI 10.1038/cr.2010.141; D'Ascenzo M, 2006, EUR J NEUROSCI, V23, P935, DOI 10.1111/j.1460-9568.2006.04628.x; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; El-Shamayleh Y, 2017, NEURON, V95, P51, DOI 10.1016/j.neuron.2017.06.002; Gao HL, 2016, J ALZHEIMERS DIS, V53, P1173, DOI 10.3233/JAD-160093; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; Han SY, 2015, P NATL ACAD SCI USA, V112, P13109, DOI 10.1073/pnas.1512243112; He XB, 2011, STEM CELLS, V29, P1861, DOI 10.1002/stem.739; Hodge RD, 2011, DEV NEUROBIOL, V71, P680, DOI 10.1002/dneu.20882; Hsieh J, 2013, SCIENCE, V339, P1534, DOI 10.1126/science.1237576; Hu J, 2015, MOL NEUROBIOL, V52, P1601, DOI 10.1007/s12035-014-8953-9; Janickova H, 2017, J NEUROCHEM, V142, P857, DOI 10.1111/jnc.14105; Karl C, 2005, J NEUROCHEM, V92, P264, DOI 10.1111/j.1471-4159.2004.02879.x; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kochanek PM, 2016, LANCET NEUROL, V15, P13, DOI 10.1016/S1474-4422(15)00339-7; Kondo T, 2011, STEM CELLS, V29, P836, DOI 10.1002/stem.624; Ladas TP, 2015, EXP NEUROL, V269, P120, DOI 10.1016/j.expneurol.2015.04.001; Liu D, 2015, CELL DEATH DIFFER, V22, P583, DOI 10.1038/cdd.2014.195; Melchior JR, 2015, J NEUROCHEM, V134, P833, DOI 10.1111/jnc.13177; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Nakanishi S, 2006, J PHYSIOL-LONDON, V575, P389, DOI 10.1113/jphysiol.2006.113340; Packer AM, 2013, NAT NEUROSCI, V16, P805, DOI 10.1038/nn.3427; Pina-Crespo JC, 2012, J NEUROSCI, V32, P15837, DOI 10.1523/JNEUROSCI.3735-12.2012; Ryu JR, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0224-4; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Stocchetti N, 2014, LANCET NEUROL, V13, P14, DOI 10.1016/S1474-4422(13)70280-1; Taylor NE, 2016, P NATL ACAD SCI USA, V113, P12826, DOI 10.1073/pnas.1614340113; Tonnesen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017560; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Tu Y, 2012, J NEUROTRAUM, V29, P2393, DOI 10.1089/neu.2012.2374; Urbach A, 2017, J CEREBR BLOOD F MET, V37, P1776, DOI 10.1177/0271678X16643736; Walker TL, 2008, J NEUROSCI, V28, P5240, DOI 10.1523/JNEUROSCI.0344-08.2008; Wang SM, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/876241; Wang X, 2014, NEUROPHARMACOLOGY, V76, P80, DOI 10.1016/j.neuropharm.2013.08.022; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhang JZ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-158; Zhao WY, 2017, BRAIN RES, V1669, P141, DOI 10.1016/j.brainres.2017.06.006	48	12	12	2	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2018	63	1					303	318		10.3233/JAD-180002			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GC8AU	WOS:000430016100028	29614674				2022-02-06	
J	Shams, Z; Khalatbary, AR; Ahmadvand, H; Zare, Z; Kian, K				Shams, Zahra; Khalatbary, Ali Reza; Ahmadvand, Hassan; Zare, Zohreh; Kian, Kosar			Neuroprotective effects of hyperbaric oxygen (HBO) therapy on neuronal death induced by sciatic nerve transection in rat	BMC NEUROLOGY			English	Article						Hyperbaric oxygen; Nerve transaction; Apoptosis; Inflammation	SPINAL-CORD-INJURY; ISCHEMIA-REPERFUSION INJURY; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE; MOTOR-NEURONS; GROWTH-FACTOR; IN-VITRO; APOPTOSIS; EXPRESSION; ACTIVATION	Background: Recent studies shows that hyperbaric oxygen (HBO) therapy exerts some protective effects against neural injuries. The purpose of this study was to determine the neuroprotective effects of HBO following sciatic nerve transection (SNT). Methods: Rats were randomly divided into five groups (n = 14 per group): Sham-operated (SH) group, SH + HBO group, SNT group, and SNT + pre-and SNT + post-HBO groups (100% oxygen at 2.0 atm absolute, 60 min/day for five consecutive days beginning on 1 day before and immediately after nerve transaction, respectively). Spinal cord segments of the sciatic nerve and related dorsal root ganglions (DRGs) were removed 4 weeks after nerve transection for biochemical assessment of malodialdehyde (MDA) levels in spinal cord, biochemical assessment of superoxide dismutase (SOD) and catalse (CAT) activities in spinal cord, immunohistochemistry of caspase-3, cyclooxigenase-2 (COX2), S100beta (S100 beta), and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) in spinal cord and DRG. Results: The results revealed that MDA levels were significantly decreased in the SNT + pre-HBO group, while SOD and CAT activities were significantly increased in SNT + pre-and SNT + post-HBO treated rats. Attenuated caspase-3 and COX-2 expression, and TUNEL reaction could be significantly detected in the HBO-treated rats after nerve transection. Also, HBO significantly increased S100 alpha expression. Conclusions: Based on these results, we can conclude that pre-and post-HBO therapy had neuroprotective effects against sciatic nerve transection-induced degeneration.	[Shams, Zahra; Khalatbary, Ali Reza; Zare, Zohreh; Kian, Kosar] Mazandaran Univ Med Sci, Dept Anat, Mol & Cell Biol Res Ctr, Fac Med, Sari, Iran; [Ahmadvand, Hassan] Lorestan Univ Med Sci, Dept Biochem, Fac Med, Khorramabad, Iran; [Ahmadvand, Hassan] Lorestan Univ Med Sci, Razi Herbal Res Ctr, Khorramabad, Iran		Khalatbary, AR (corresponding author), Mazandaran Univ Med Sci, Dept Anat, Mol & Cell Biol Res Ctr, Fac Med, Sari, Iran.	khalat90@yahoo.com	khalatbary, ali reza/A-4950-2014		Mazandaran University of Medical Sciences	This work was solely financed by Mazandaran University of Medical Sciences. No external funding was provided.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Broom DC, 2004, NEUROSCIENCE, V124, P891, DOI 10.1016/j.neuroscience.2004.01.003; Calvert JW, 2007, NEUROL RES, V29, P132, DOI 10.1179/016164107X174156; Chazalviel L, 2016, MED GAS RES, V6, P169, DOI 10.4103/2045-9912.191364; Chazalviel L, 2016, MED GAS RES, V6, P64, DOI 10.4103/2045-9912.184713; Chen J, 2016, BIOMED REP, V5, P136, DOI 10.3892/br.2016.673; Chen XY, 2016, NEUROCHEM RES, V41, P3032, DOI 10.1007/s11064-016-2022-x; Chen YS, 2008, BRAIN RES, V1197, P23, DOI 10.1016/j.brainres.2007.12.046; Cheng OM, 2011, STROKE, V42, P484, DOI 10.1161/STROKEAHA.110.604421; Chiarotto GB, 2014, BRAIN RES BULL, V106, P1, DOI 10.1016/j.brainresbull.2014.04.010; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; GILLARDON F, 1994, EUR J NEUROSCI, V6, P1641, DOI 10.1111/j.1460-9568.1994.tb00555.x; Groves MJ, 1997, J NEUROCYTOL, V26, P615, DOI 10.1023/A:1018541726460; Guedes RP, 2006, NEUROCHEM RES, V31, P603, DOI 10.1007/s11064-006-9058-2; Han G, 2013, PAIN RES MANAG, V18, P137, DOI 10.1155/2013/147043; Huang H, 2013, INT J CLIN EXP PATHO, V6, P1337; Huang YL, 1998, BRAIN RES, V785, P351, DOI 10.1016/S0006-8993(97)01425-X; Iwasaki Y, 1997, J NEUROL SCI, V151, P7, DOI 10.1016/S0022-510X(97)00073-7; Khalil Z, 2001, FREE RADICAL BIO MED, V31, P430, DOI 10.1016/S0891-5849(01)00597-4; KUTHAN H, 1986, BIOCHEM J, V237, P175, DOI 10.1042/bj2370175; Li HY, 2014, NEURAL REGEN RES, V9, P565, DOI 10.4103/1673-5374.130093; Li JS, 2009, NEUROSCIENCE, V159, P1309, DOI 10.1016/j.neuroscience.2009.01.011; Li JS, 2008, BRAIN RES, V1210, P223, DOI 10.1016/j.brainres.2008.03.007; Li QB, 2007, LIFE SCI, V80, P1087, DOI 10.1016/j.lfs.2006.11.043; Lin KC, 2012, J TRAUMA ACUTE CARE, V72, P650, DOI 10.1097/TA.0b013e31823c575f; Liu XH, 2015, SPINE, V40, pE1276, DOI 10.1097/BRS.0000000000001056; Liu ZP, 2001, J COMP NEUROL, V432, P35, DOI 10.1002/cne.1087; Long Y, 2014, INT J CLIN EXP MED, V7, P4073; Lou M, 2006, BRAIN RES BULL, V69, P109, DOI 10.1016/j.brainresbull.2005.11.009; Lu PG, 2013, J NEUROSURG SCI, V57, P253; Martin LJ, 1999, J NEUROBIOL, V40, P185, DOI 10.1002/(SICI)1097-4695(199908)40:2<185::AID-NEU5>3.3.CO;2-R; Nazario J, 2011, UNDERSEA HYPERBAR M, V38, P345; Oliveira ALR, 2002, J COMP NEUROL, V447, P381, DOI 10.1002/cne.10248; Oliveira ALR, 1997, NEUROREPORT, V8, P2837; Oroglu B, 2011, UNDERSEA HYPERBAR M, V38, P367; Ostrowski RP, 2008, NEUROBIOL DIS, V29, P1, DOI 10.1016/j.nbd.2007.07.020; Pan HC, 2009, NEUROCHEM RES, V34, P1304, DOI 10.1007/s11064-008-9910-7; Pan XR, 2015, NEUROSCI LETT, V600, P220, DOI 10.1016/j.neulet.2015.06.030; Parente L, 2003, BIOCHEM PHARMACOL, V65, P153, DOI 10.1016/S0006-2952(02)01422-3; Saito H, 2009, NEUROSCI LETT, V456, P30, DOI 10.1016/j.neulet.2009.03.075; Schafers M, 2003, J NEUROSCI, V23, P2517; Scheid T, 2013, NEUROCHEM RES, V38, P935, DOI 10.1007/s11064-013-1000-9; Sunami K, 2000, CRIT CARE MED, V28, P2831, DOI 10.1097/00003246-200008000-00025; Tandrup T, 2000, J COMP NEUROL, V422, P172, DOI 10.1002/(SICI)1096-9861(20000626)422:2<172::AID-CNE2>3.0.CO;2-H; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Vigneswara V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057861; Wee HY, 2015, J SURG RES, V197, P382, DOI 10.1016/j.jss.2015.04.052; Xu JJ, 2014, J NEUROTRAUM, V31, P1343, DOI 10.1089/neu.2013.3222; Yang LM, 2015, BRAIN RES, V1627, P21, DOI 10.1016/j.brainres.2015.08.011; Yang ZJ, 2010, EUR J APPL PHYSIOL, V108, P513, DOI 10.1007/s00421-009-1229-9; Zhang Xiang-Gen, 2012, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V28, P42; Zhao BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120122; Zhao BS, 2014, J MOL NEUROSCI, V53, P251, DOI 10.1007/s12031-013-0213-3; Zhou BC, 2016, NEURAL REGEN RES, V11, P1445, DOI 10.4103/1673-5374.191218; Zhou Y, 2013, CHINESE MED J-PEKING, V126, P3897, DOI 10.3760/cma.j.issn.0366-6999.20130571	57	12	12	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	DEC 16	2017	17								220	10.1186/s12883-017-1004-1			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FQ2FM	WOS:000418172300001	29246132	gold, Green Published			2022-02-06	
J	Clark, K; Sword, BA; Dupree, JL				Clark, Kareem; Sword, Brooke A.; Dupree, Jeffrey L.			Oxidative Stress Induces Disruption of the Axon Initial Segment	ASN NEURO			English	Article						axon initial segment; calcium; calpain; oxidative stress; reactive nitrogen species; reactive oxygen species	TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE; STRUCTURAL PLASTICITY; ACTIN DYNAMICS; ANIMAL-MODELS; CA2+ RELEASE; GUINEA-PIG; PEROXYNITRITE; DISEASE; CHANNEL	The axon initial segment (AIS), the domain responsible for action potential initiation and maintenance of neuronal polarity, is targeted for disruption in a variety of central nervous system pathological insults. Previous work in our laboratory implicates oxidative stress as a potential mediator of structural AIS alterations in two separate mouse models of central nervous system inflammation, as these effects were attenuated following reactive oxygen species scavenging and NADPH oxidase-2 ablation. While these studies suggest a role for oxidative stress in modulation of the AIS, the direct effects of reactive oxygen and nitrogen species (ROS/RNS) on the stability of this domain remain unclear. Here, we demonstrate that oxidative stress, as induced through treatment with 3-morpholinosydnonimine (SIN-1), a spontaneous ROS/RNS generator, drives a reversible loss of AIS protein clustering in primary cortical neurons invitro. Pharmacological inhibition of both voltage-dependent and intracellular calcium (Ca2+) channels suggests that this mechanism of AIS disruption involves Ca2+ entry specifically through L-type voltage-dependent Ca2+ channels and its release from IP3-gated intracellular stores. Furthermore, ROS/RNS-induced AIS disruption is dependent upon activation of calpain, a Ca2+-activated protease previously shown to drive AIS modulation. Overall, we demonstrate for the first time that oxidative stress, as induced through exogenously applied ROS/RNS, is capable of driving structural alterations in the AIS complex.	[Clark, Kareem; Dupree, Jeffrey L.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, POB 980709,1101 East Marshall St, Richmond, VA 23298 USA; [Clark, Kareem] Virginia Commonwealth Univ, Neurosci Curriculum, Richmond, VA USA; [Sword, Brooke A.; Dupree, Jeffrey L.] Hunter Holmes McGuire VA Med Ctr, Richmond, VA USA		Dupree, JL (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, POB 980709,1101 East Marshall St, Richmond, VA 23298 USA.	jeffrey.dupree@vcuhealth.org			Veterans Affairs Merit AwardUS Department of Veterans Affairs [5IO1BX002565]; NIH-NINDS Center core grant [5P30NS047463]; Veterans AffairsUS Department of Veterans Affairs [I01BX002565] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by a Veterans Affairs Merit Award (5IO1BX002565). Microscopy was performed at the Virginia Commonwealth University -Department of Anatomy and Neurobiology Microscopy Facility, supported, in part, with funding from NIH-NINDS Center core grant (5P30NS047463).	Almanza A, 2007, J NEUROPHYSIOL, V97, P1188, DOI 10.1152/jn.00849.2006; Baalman KL, 2013, J NEUROTRAUM, V30, P741, DOI 10.1089/neu.2012.2478; Benned-Jensen T, 2016, J NEUROSCI, V36, P2261, DOI 10.1523/JNEUROSCI.2631-15.2016; Benusa SD, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0889-3; Bhattacharjee A, 1997, ENDOCRINOLOGY, V138, P3735, DOI 10.1210/en.138.9.3735; Buffington SA, 2011, EUR J NEUROSCI, V34, P1609, DOI 10.1111/j.1460-9568.2011.07875.x; Carletti B, 2011, NEUROSCIENCE, V192, P285, DOI 10.1016/j.neuroscience.2011.05.060; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Clark KC, 2016, GLIA, V64, P1190, DOI 10.1002/glia.22991; De Simoni S, 2013, J NEUROCHEM, V125, P473, DOI 10.1111/jnc.12117; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; del Puerto A, 2015, CEREB CORTEX, V25, P2282, DOI 10.1093/cercor/bhu035; Donkor IO, 2015, EXPERT OPIN THER PAT, V25, P17, DOI 10.1517/13543776.2014.982534; Evans MD, 2013, J NEUROSCI, V33, P6950, DOI 10.1523/JNEUROSCI.0277-13.2013; Forte M, 2007, P NATL ACAD SCI USA, V104, P7558, DOI 10.1073/pnas.0702228104; Fusi F, 2017, BIOCHEM PHARMACOL, V140, P53, DOI 10.1016/j.bcp.2017.05.020; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Gutierrez-Martin Y, 2005, J NEUROCHEM, V92, P973, DOI 10.1111/j.1471-4159.2004.02964.x; Hamada MS, 2015, J NEUROSCI, V35, P7272, DOI 10.1523/JNEUROSCI.4747-14.2015; Harty RC, 2013, EPILEPSY RES, V105, P272, DOI 10.1016/j.eplepsyres.2013.03.004; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Hinman JD, 2013, STROKE, V44, P182, DOI 10.1161/STROKEAHA.112.668749; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Isaev NK, 2016, TOXICOL LETT, V250, P29, DOI 10.1016/j.toxlet.2016.04.002; Islam MT, 2017, NEUROL RES, V39, P73, DOI 10.1080/01616412.2016.1251711; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Johnstone VPA, 2014, INT J MOL SCI, V15, P19203, DOI 10.3390/ijms151019203; Kipp M, 2017, BRAIN PATHOL, V27, P123, DOI 10.1111/bpa.12454; Kuo CC, 2017, NEUROSURGERY, V80, P475, DOI 10.1093/neuros/nyw090; Leon-Espinosa G, 2012, J ALZHEIMERS DIS, V29, P841, DOI 10.3233/JAD-2012-112036; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Liu YY, 2014, J NEUROSCI, V34, P2813, DOI 10.1523/JNEUROSCI.3541-13.2014; Liu ZW, 2014, NEUROCHEM RES, V39, P361, DOI 10.1007/s11064-013-1233-7; Maggio DM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020245; Marin MA, 2016, EXP NEUROL, V281, P93, DOI 10.1016/j.expneurol.2016.04.018; Marks AR, 1997, AM J PHYSIOL-HEART C, V272, pH597, DOI 10.1152/ajpheart.1997.272.2.H597; Matsebatlela TM, 2015, CHEM-BIOL INTERACT, V233, P95, DOI 10.1016/j.cbi.2015.03.027; Mayhew CN, 2002, ANTIVIR RES, V56, P167, DOI 10.1016/S0166-3542(02)00108-0; Mendez-Armenta M, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/293689; Munnamalai V, 2014, J NEUROCHEM, V130, P526, DOI 10.1111/jnc.12734; Munnamalai V, 2009, J NEUROCHEM, V108, P644, DOI 10.1111/j.1471-4159.2008.05787.x; Munoz FM, 2017, TOXICOL SCI, V158, P444, DOI 10.1093/toxsci/kfx106; Nguemo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053407; Ohashi M, 2016, J PHYSIOL-LONDON, V594, P115, DOI 10.1113/JP271449; Ohkuma S, 2001, J NEUROCHEM, V76, P341, DOI 10.1046/j.1471-4159.2001.00045.x; Pan BX, 2004, FREE RADICAL BIO MED, V37, P823, DOI 10.1016/j.freeradbiomed.2004.06.014; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Qi XP, 2007, INVEST OPHTH VIS SCI, V48, P681, DOI 10.1167/iovs.06-0553; RAVENS U, 1990, N-S ARCH PHARMACOL, V341, P232; Redondo J, 2015, J NEUROSCI RES, V93, P882, DOI 10.1002/jnr.23556; Rocchitta G, 2005, BRAIN RES, V1047, P18, DOI 10.1016/j.brainres.2005.04.008; Rosenzweig S, 2013, STROKE, V44, P2579, DOI 10.1161/STROKEAHA.113.001796; Saeki M, 2000, NEUROCHEM RES, V25, P909, DOI 10.1023/A:1007540005737; Sakai J, 2012, IMMUNITY, V37, P1037, DOI 10.1016/j.immuni.2012.08.017; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Sepulveda-Diaz JE, 2015, BRAIN, V138, P1339, DOI 10.1093/brain/awv056; Shepherd MN, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.08.001; Singh RJ, 1999, ARCH BIOCHEM BIOPHYS, V361, P331, DOI 10.1006/abbi.1998.1007; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; Stoler O, 2016, ACTA PHARMACOL SIN, V37, P75, DOI 10.1038/aps.2015.107; Stroissnigg H, 2007, NAT CELL BIOL, V9, P1035, DOI 10.1038/ncb1625; Sun XQ, 2014, P NATL ACAD SCI USA, V111, P14271, DOI 10.1073/pnas.1411837111; Tang H, 2011, FREE RADICAL BIO MED, V51, P1501, DOI 10.1016/j.freeradbiomed.2011.07.005; Tiago T, 2011, CELL CALCIUM, V49, P174, DOI 10.1016/j.ceca.2011.01.009; Trackey JL, 2001, J NEUROCHEM, V79, P445, DOI 10.1046/j.1471-4159.2001.00584.x; Turchan J, 2003, NEUROLOGY, V60, P307, DOI 10.1212/01.WNL.0000042048.85204.3D; Vascak M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00157; Wimmer VC, 2010, J PHYSIOL-LONDON, V588, P1829, DOI 10.1113/jphysiol.2010.188417; Yamada R, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00250; Yamada T, 2015, ANN RHEUM DIS, V74, P1907, DOI 10.1136/annrheumdis-2013-205007; Zempel H, 2017, J BIOL CHEM, V292, P12192, DOI 10.1074/jbc.M117.784702	71	12	12	1	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1759-0914			ASN NEURO	ASN Neuro	DEC 11	2017	9	6							1759091417745426	10.1177/1759091417745426			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FP6QP	WOS:000417750900001	29228786	Green Published, gold			2022-02-06	
J	Abboud, T; Mende, KC; Jung, R; Czorlich, P; Vettorazzi, E; Priefler, M; Kluge, S; Westphal, M; Regelsberger, J				Abboud, Tammam; Mende, Klaus Christian; Jung, Roman; Czorlich, Patrick; Vettorazzi, Eik; Priefler, Marion; Kluge, Stefan; Westphal, Manfred; Regelsberger, Jan			Prognostic Value of Early S100 Calcium Binding Protein B and Neuron-Specific Enolase in Patients with Poor-Grade Aneurysmal Subarachnoid Hemorrhage: A Pilot Study	WORLD NEUROSURGERY			English	Article						Intracranial aneurysm; NSE; S100; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; LONG-TERM OUTCOMES; S-100 PROTEIN; CEREBROSPINAL-FLUID; ISCHEMIC-STROKE; SERUM; DAMAGE; PREDICTION; VASOSPASM; BIOMARKER	BACKGROUND: This prospective study was undertaken to investigate the value of early S100 calcium binding protein B (S100B) and neuron-specific enolase (NSE) in prognosticating outcome in patients with poorgrade aneurysmal subarachnoid hemorrhage and to develop a statistical model and cutoff values for clinical practice. METHODS: Between 2012 and 2014, patients with poor-grade subarachnoid hemorrhage (Hunt and Hess grade 3-5) who were admitted within 24 hours after hemorrhage were prospectively enrolled. Serum NSE and S100B levels were assayed once daily during the first 3 days after hemorrhage. Patient characteristics, Glasgow Coma Scale score, Hunt and Hess grade, and Fisher grade at admission were recorded. Glasgow Outcome Scale (GOS) score was obtained at 6 months and dichotomized as poor (score 1-3) or good (score 4-5). Logistic regression and receiver operating characteristic curve were used to assess the value of S100B and NSE in predicting outcome, and cutoff values were calculated using conditional interference trees. RESULTS: The study included 52 patients. Hunt and Hess grade was 3 in 23 patients, 4 in 15 patients, and 5 in 14 patients. S100B range was 0.07-5.62 mu g/L (mean 0.87 mu g/L +/- 1.06). NSE range was 5.7-94.2 mu g/L (mean 16.1 mu g/L +/- 10.5). At 6-month follow-up, 23 patients (44.2%) had a poor outcome, and 29 patients (55.8%) had a good outcome. Both S100B at day 1 (P = 0.004; cutoff 0.202 mu g/L) and NSE at day 1 (P = 0.047; cutoff 9.4 mu g/L) predicted good outcome with a specificity of 100%. The specificity of mean S100B in detecting patients with poor outcome reached 100% (P = 0.003) when combined with mean NSE levels. CONCLUSIONS: S100B and NSE measured during the first 3 days after hemorrhage showed, separately and combined, a significant predictive value in prognosticating clinical outcome in patients with poor-grade subarachnoid hemorrhage. A multicenter study with a large patient cohort is necessary to validate the above-mentioned cutoff values for clinical practice.	[Abboud, Tammam; Mende, Klaus Christian; Czorlich, Patrick; Westphal, Manfred; Regelsberger, Jan] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany; [Jung, Roman] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Hamburg, Germany; [Vettorazzi, Eik] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Priefler, Marion; Kluge, Stefan] Univ Med Ctr Hamburg Eppendorf, Dept Intens Care, Hamburg, Germany; [Abboud, Tammam] Univ Med Ctr Gottingen, Dept Neurosurg, Gottingen, Germany		Abboud, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany.; Abboud, T (corresponding author), Univ Med Ctr Gottingen, Dept Neurosurg, Gottingen, Germany.	tammamabboud@gmail.com	Czorlich, Patrick/H-8934-2019; Vettorazzi, Eik/B-8130-2019	Vettorazzi, Eik/0000-0002-3737-6402; Mende, Klaus Christian/0000-0003-4317-1718			Abboud T, 2015, ACTA NEUROCHIR, V157, P763, DOI 10.1007/s00701-015-2369-9; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Cunningham RT, 1996, EUR J CLIN INVEST, V26, P298, DOI 10.1046/j.1365-2362.1996.129282.x; Fujii M, 2013, TRANSL STROKE RES, V4, P432, DOI 10.1007/s12975-013-0257-2; Gelderblom M, 2013, NEUROBIOL DIS, V59, P177, DOI 10.1016/j.nbd.2013.07.017; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Guo ZD, 2011, ACTA NEUROCHIR SUPPL, V110, P63, DOI 10.1007/978-3-7091-0353-1_11; HARDEMARK HG, 1989, J NEUROSURG, V71, P727, DOI 10.3171/jns.1989.71.5.0727; HORN M, 1995, STROKE, V26, P290, DOI 10.1161/01.STR.26.2.290; JENNETT B, 1975, LANCET, V1, P480; Lai PMR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151853; Macdonald RL, 2007, NAT CLIN PRACT NEURO, V3, P256, DOI 10.1038/ncpneuro0490; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Moritz S, 2010, J NEUROSURG ANESTH, V22, P21, DOI 10.1097/ANA.0b013e3181bdf50d; Niyonkuru C, 2013, J NEUROTRAUM, V30, P938, DOI 10.1089/neu.2012.2578; Oertel M, 2006, J CLIN NEUROSCI, V13, P834, DOI 10.1016/j.jocn.2005.11.030; PERSSON L, 1988, ACTA NEUROCHIR, V93, P116, DOI 10.1007/BF01402892; Prohl J, 2007, CRIT CARE MED, V35, P1230, DOI 10.1097/01.CCM.0000261892.10559.85; Quintard H, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1200-1; Raheja A, 2016, J NEUROSURG, V125, P631, DOI 10.3171/2015.6.JNS15674; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Rivero-Arias Oliver, 2010, Cost Eff Resour Alloc, V8, P6, DOI 10.1186/1478-7547-8-6; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Sanchez-Pena P, 2008, CRIT CARE MED, V36, P2267, DOI 10.1097/CCM.0b013e3181809750; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Selakovic Vesna, 2003, Med Pregl, V56, P326, DOI 10.2298/MPNS0308326S; Shim JH, 2012, CEREBROVASC DIS, V34, P38, DOI 10.1159/000338786; THELIN EP, 2016, CRIT CARE, V20; Turck N, 2010, INTENS CARE MED, V36, P107, DOI 10.1007/s00134-009-1641-y; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181	34	12	13	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2017	108						669	675		10.1016/j.wneu.2017.09.074			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FN3CU	WOS:000415874900089	28943424				2022-02-06	
J	Ahl, R; Thelin, EP; Sjolin, G; Bellander, BM; Riddez, L; Talving, P; Mohseni, S				Ahl, R.; Thelin, E. P.; Sjolin, G.; Bellander, B. -M.; Riddez, L.; Talving, P.; Mohseni, S.			beta-Blocker after severe traumatic brain injury is associated with better long-term functional outcome: a matched case control study	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Beta-blocker; Traumatic brain injury; Functional outcome	SEVERE HEAD-INJURY; ORGAN DYSFUNCTION; PREDICTIVE-VALUE; IMPACT; CATECHOLAMINES; EPIDEMIOLOGY; PROPRANOLOL; SURVIVAL; TRIAL; SCALE	Purpose Severe traumatic brain injury (TBI) is the predominant cause of death and disability following trauma. Several studies have observed improved survival in TBI patients exposed to beta-blockers, however, the effect on functional outcome is poorly documented. Methods Adult patients with severe TBI (head AIS >= 3) were identified from a prospectively collected TBI database over a 5-year period. Patients with neurosurgical ICU length of stay < 48 h and those dying within 48 h of admission were excluded. Patients exposed to beta-blockers <= 48 h after admission and who continued with treatment until discharge constituted beta-blocked cases and were matched to non beta-blocked controls using propensity score matching. The outcome of interest was Glasgow Outcome Scores (GOS), as a measure of functional outcome up to 12 months after injury. GOS <= 3 was considered a poor outcome. Bivariate analysis was deployed to determine differences between groups. Odds ratio and 95% CI were used to assess the effect of beta-blockers on GOS. Results 362 patients met the inclusion criteria with 21% receiving beta-blockers during admission. After propensity matching, 76 matched pairs were available for analysis. There were no statistical differences in any variables included in the analysis. Mean hospital length of stay was shorter in the beta-blocked cases (18.0 vs. 26.8 days, p < 0.01). The risk of poor long-term functional outcome was more than doubled in non-beta-blocked controls (OR 2.44, 95% CI 1.01-6.03, p = 0.03). Conclusion Exposure to beta-blockers in patients with severe TBI appears to improve functional outcome. Further prospective randomized trials are warranted.	[Ahl, R.; Riddez, L.; Mohseni, S.] Karolinska Univ Hosp, Div Trauma & Emergency Surg, Dept Surg, S-17176 Stockholm, Sweden; [Sjolin, G.; Mohseni, S.] Orebro Univ Hosp, Div Trauma & Emergency Surg, Dept Surg, S-70185 Orebro, Sweden; [Ahl, R.; Mohseni, S.] Orebro Univ, Sch Med Sci, Orebro, Sweden; [Thelin, E. P.; Bellander, B. -M.] Karolinska Inst, Dept Clin Neurosci, S-17176 Solna, Sweden; [Talving, P.] Tartu Univ Hosp, Dept Surg, Puusepa 8, EE-50406 Tartu, Estonia		Mohseni, S (corresponding author), Karolinska Univ Hosp, Div Trauma & Emergency Surg, Dept Surg, S-17176 Stockholm, Sweden.; Mohseni, S (corresponding author), Orebro Univ Hosp, Div Trauma & Emergency Surg, Dept Surg, S-70185 Orebro, Sweden.; Mohseni, S (corresponding author), Orebro Univ, Sch Med Sci, Orebro, Sweden.	rebecka.ahl@karolinska.se; eric.thelin@ki.se; gabriel.sjolin@regionorebrolan.se; bo-michael.bellander@karolinska.se; louis.riddez@karolinska.se; peep.talving@ut.ee; mohsenishahin@yahoo.com	Thelin, Eric Peter/K-2144-2012; Ahl, Rebecka/AAG-4162-2020	Thelin, Eric Peter/0000-0002-2338-4364; Ahl, Rebecka/0000-0001-7930-3845; Mohseni, Shahin/0000-0001-7097-487X			Ahl R, 2017, INJURY, V48, P101, DOI 10.1016/j.injury.2016.10.041; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Bratton SL, 2008, J NEUROTRAUM, V25, P276; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kemp CD, 2008, AM SURGEON, V74, P866; Ko A, 2016, J TRAUMA ACUTE CARE, V80, P637, DOI 10.1097/TA.0000000000000959; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Mohseni S, 2015, WORLD J SURG, V39, P2076, DOI 10.1007/s00268-015-3039-z; Mohseni S, 2014, J TRAUMA ACUTE CARE, V76, P804, DOI 10.1097/TA.0000000000000139; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Munro PT, 2002, BRIT MED J, V325, P1001, DOI 10.1136/bmj.325.7371.1001; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	27	12	12	0	5	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	DEC	2017	43	6					783	789		10.1007/s00068-017-0779-5			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FO1PF	WOS:000416534600008	28275834	Green Published, hybrid			2022-02-06	
J	Kercood, S; Lineweaver, TT; Frank, CC; Fromm, ED				Kercood, Suneeta; Lineweaver, Tara T.; Frank, Colleen C.; Fromm, Erik D.			Cognitive Flexibility and Its Relationship to Academic Achievement and Career Choice of College Students With and Without Attention Deficit Hyperactivity Disorder	JOURNAL OF POSTSECONDARY EDUCATION AND DISABILITY			English	Article						Attention Deficit Hyperactivity Disorder; cognitive flexibility; academic achievement; career choice; career confidence	TRAUMATIC BRAIN-INJURY; OLDER-ADULTS; EXECUTIVE FUNCTION; SELF-REPORT; ADHD; CHILDREN; RECOVERY; MEMORY; METHYLPHENIDATE; ADOLESCENTS	The purpose of this study was to investigate the relationship between cognitive flexibility, academic skills, educational trajectories, and career goals of college students with and without Attention Deficit Hyperactivity Disorder (ADHD). Participants completed a demographic questionnaire, objective and subjective measures of cognitive flexibility, and tests of academic achievement. Cognitive Flexibility predicted academic achievement; reading skills increased as subjective cognitive flexibility increased and as the tendency to perseverate (i.e., to stick with an ineffective strategy) on the Wisconsin Card Sorting Test decreased. Objective cognitive flexibility also predicted mathematical and writing skills. Although students with different college majors did not vary significantly in their cognitive flexibility, the interaction between cognitive flexibility and ADHD shared a significant relationship with career confidence. Our results expand on the literature examining cognitive flexibility and have implications for both academic and career planning, particularly for students who may struggle with attention.	[Kercood, Suneeta; Lineweaver, Tara T.] Butler Univ, Indianapolis, IN 46208 USA; [Frank, Colleen C.] Univ Michigan, Ann Arbor, MI 48109 USA; [Fromm, Erik D.] Stryker Orthoped, Joint Reconstruct, Kalamazoo, MI USA		Kercood, S (corresponding author), Butler Univ, Indianapolis, IN 46208 USA.	skercood@butler.edu; tlinewea@butler.edu; ccfrank@umich.edu; erikdfromm4@gmail.com			Holcolm Faculty Research Grant from Butler University	This research was supported by a Holcolm Faculty Research Grant from Butler University.	Adams K., 2006, LEARN HLTH SOC CARE, V5, P55, DOI [DOI 10.1111/J.1473-6861.2006.00119.X, 10.1111/j.1473-6861.2006.00119.x]; Anderson C. M., 1998, COMMUN REP, V11, P1, DOI DOI 10.1080/08934219809367680; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Bakos Daniela Schneider, 2008, Psychol. Neurosci., V1, P183, DOI 10.1590/S1983-32882008000200011; Barkley RA, 2015, ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN ADULTS AND CHILDREN, P53; Bolton J. M., 2008, PSI CHI J UNDERGRADU, V13, P14; Britton JC, 2010, J AM ACAD CHILD PSY, V49, P944, DOI 10.1016/j.jaac.2010.05.006; Brooks BL, 2016, J INT NEUROPSYCH SOC, V22, P379, DOI 10.1017/S1355617715001368; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Clearfield MW, 2012, INFANT BEHAV DEV, V35, P29, DOI 10.1016/j.infbeh.2011.09.007; Conners C.K., 1999, CAARS ADULT ADHD RAT; Crumley JJ, 2014, PSYCHOL AGING, V29, P250, DOI 10.1037/a0035908; Cubillo A, 2010, J PSYCHIATR RES, V44, P629, DOI 10.1016/j.jpsychires.2009.11.016; de Vries M, 2012, J AUTISM DEV DISORD, V42, P2558, DOI 10.1007/s10803-012-1512-1; Deak GO, 2003, ADV CHILD DEV BEHAV, V31, P271; DELAHUNTY A, 1993, PSYCHOL MED, V23, P221, DOI 10.1017/S0033291700039015; Dellefield KS, 1996, NURS RES, V45, P284, DOI 10.1097/00006199-199609000-00006; Dreisbach G, 2004, J EXP PSYCHOL LEARN, V30, P343, DOI 10.1037/0278-7393.30.2.343; Dunleavy K. N., 2006, N AM J PSYCHOL, V8, P339; DuPaul GJ, 2013, J LEARN DISABIL-US, V46, P43, DOI 10.1177/0022219412464351; DuPaul GJ, 2001, J LEARN DISABIL-US, V34, P370, DOI 10.1177/002221940103400412; Eagan K., 2014, AM FRESHMAN NATL NOR; Eidsness M. A., 2009, COLL STUDENT J, V43, P822; Geurts HM, 2005, ARCH CLIN NEUROPSYCH, V20, P457, DOI 10.1016/j.acn.2004.11.001; Harpin VA, 2005, ARCH DIS CHILD, V90, pI2, DOI 10.1136/adc.2004.059006; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heiligenstein E, 1998, J AM COLL HEALTH, V46, P185, DOI 10.1080/07448489809595609; Heiligenstein E, 1999, J AM COLL HEALTH, V47, P181, DOI 10.1080/07448489909595644; Henderson, 1999, COLL FRESHMAN DISABI; Hostinar CE, 2012, P NATL ACAD SCI USA, V109, P17208, DOI 10.1073/pnas.1121246109; Ionescu T, 2012, NEW IDEAS PSYCHOL, V30, P190, DOI 10.1016/j.newideapsych.2011.11.001; JACQUES S, 2005, WHY LANGUAGE MATTERS; Johnco C, 2014, PSYCHOL ASSESSMENT, V26, P1381, DOI 10.1037/a0038009; Kaland N, 2008, J AUTISM DEV DISORD, V38, P1161, DOI 10.1007/s10803-007-0474-1; Kaminski PL, 2006, J COLL COUNS, V9, P60, DOI 10.1002/j.2161-1882.2006.tb00093.x; Kim Bryan S K, 2006, Cultur Divers Ethnic Minor Psychol, V12, P245, DOI 10.1037/1099-9809.12.2.245; Kuriyan AB, 2013, J ABNORM CHILD PSYCH, V41, P27, DOI 10.1007/s10802-012-9658-z; Lin WL, 2014, COGNITION EMOTION, V28, P834, DOI 10.1080/02699931.2013.854195; MARTIN MM, 1995, PSYCHOL REP, V76, P623, DOI 10.2466/pr0.1995.76.2.623; Marzocchi GM, 2008, J CHILD PSYCHOL PSYC, V49, P543, DOI 10.1111/j.1469-7610.2007.01859.x; Medina JA, 2010, ADHD-ATTEND DEFICIT, V2, P49, DOI 10.1007/s12402-009-0018-y; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; MOORE BA, 2013, HUMANIST PSYCHOL, V41, P319, DOI DOI 10.1080/08873267.2013.820954; Nadeau KG, 2005, J CLIN PSYCHOL, V61, P549, DOI 10.1002/jclp.20119; Norwalk K, 2009, J ATTEN DISORD, V13, P251, DOI 10.1177/1087054708320441; Painter CA, 2008, J EMPLOYMENT COUNS, V45, P178, DOI 10.1002/j.2161-1920.2008.tb00057.x; Palm KM, 2011, J PSYCHOPATHOL BEHAV, V33, P79, DOI 10.1007/s10862-010-9201-x; Pureza Janice R., 2011, Psychol. Neurosci., V4, P369, DOI 10.3922/j.psns.2011.3.010; Reiter-Palmon R., 2003, INDIVIDUAL DIFFERENC, V1, P124; Ritter SM, 2012, J EXP SOC PSYCHOL, V48, P961, DOI 10.1016/j.jesp.2012.02.009; Robin A. L., 1998, ADHD ADOLESCENTS DIA; Rubin R.B., 1994, COMMUNICATION RES RE, V11, P33, DOI [DOI 10.1080/08824099409359938, 10.1080/08824099409359938]; Sarrar L, 2011, PSYCHONEUROENDOCRINO, V36, P1396, DOI 10.1016/j.psyneuen.2011.03.014; SCOTT WA, 1962, SOCIOMETRY, V25, P405, DOI 10.2307/2785779; SHEKIM WO, 1990, COMPR PSYCHIAT, V31, P416, DOI 10.1016/0010-440X(90)90026-O; SMALL GW, 1995, AM J PSYCHIAT, V152, P1757; Spann MN, 2012, CHILD NEUROPSYCHOL, V18, P182, DOI 10.1080/09297049.2011.595400; TANNOCK R, 1995, J ABNORM CHILD PSYCH, V23, P235, DOI 10.1007/BF01447091; Tchanturia K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028331; Teubner-Rhodes SE, 2016, COGNITION, V150, P213, DOI 10.1016/j.cognition.2016.02.011; Timarova S, 2011, INTERPRETING, V13, P31, DOI 10.1075/intp.13.1.03tim; Tominey M. F., 1996, 407815 ERIC ED U TEX; VOGEL SA, 1992, J LEARN DISABIL, V25, P430, DOI 10.1177/002221949202500703; Wagner MM, 1996, FUTURE CHILD, V6, P103, DOI 10.2307/1602496; Weyandt L, 2013, J PSYCHOPATHOL BEHAV, V35, P421, DOI 10.1007/s10862-013-9351-8; WEYANDT LL, 1995, J PSYCHOPATHOL BEHAV, V17, P293, DOI 10.1007/BF02229304; Wilczenski F. L., 1993, COLL STUD J, V27, P184; Woodcock R. W., 2001, WOODCOCK JOHNSON TES, V3rd	69	12	14	3	13	ASSOC HIGHER EDUCATION & DISABILITY-AHEAD	COLUMBUS	ASSOC HIGHER EDUCATION & DISABILITY-AHEAD, COLUMBUS, OH 00000 USA	2379-7762	2328-3343		J POSTSECOND EDUC DI	J. Postsecond. Educ. Disabil.	WIN	2017	30	4					329	344					16	Education, Special	Emerging Sources Citation Index (ESCI)	Education & Educational Research	GL0RN	WOS:000436798000003					2022-02-06	
J	Kondziella, D; Fisher, PM; Larsen, VA; Hauerberg, J; Fabricius, M; Moller, K; Knudsen, GM				Kondziella, Daniel; Fisher, Patrick M.; Larsen, Vibeke Andree; Hauerberg, John; Fabricius, Martin; Moller, Kirsten; Knudsen, Gitte Moos			Functional MRI for Assessment of the Default Mode Network in Acute Brain Injury	NEUROCRITICAL CARE			English	Article						Critical care; Coma; Disorders of consciousness; Locked-in syndrome; Minimal conscious state; Neuroimaging; Traumatic brain injury; Unresponsive wakefulness syndrome; Vegetative state	CONNECTIVITY; CONSCIOUSNESS; DISORDERS	Assessment of the default mode network (DMN) using resting-state functional magnetic resonance imaging (fMRI) may improve assessment of the level of consciousness in chronic brain injury, and therefore, fMRI may also have prognostic value in acute brain injury. However, fMRI is much more challenging in critically ill patients because of cardiovascular vulnerability, intravenous sedation, and artificial ventilation. Using resting-state fMRI, we investigated the DMN in a convenience sample of patients with acute brain injury admitted to the intensive care unit. The DMN was classified dichotomously into "normal" and "grossly abnormal." Clinical outcome was assessed at 3 months. Seven patients with acute brain injury (4 females; median age 37 years [range 14-71 years]; 1 traumatic brain injury [TBI]; 6 non-TBI) were investigated by fMRI a median of 15 days after injury (range 5-25 days). Neurological presentation included 2 coma, 1 vegetative state/unresponsive wakefulness syndrome (VS/UWS), 3 minimal conscious state (MCS) minus, and 1 MCS plus. Clinical outcomes at 3 months included 1 death, 1 VS/UWS, 1 MCS plus, and 4 conscious states (CS; 1 modified Rankin Scale 0; 2 mRS 4; 1 mRS 5). Normal DMNs were seen in 4 out of 7 patients (1 MCS plus, 3 CS at follow-up). It is feasible to assess the DMN by resting-state fMRI in patients with acute brain injury already in the very early period of intensive care unit admission. Although preliminary data, all patients with a preserved DMN regained consciousness levels at follow-up compatible with MCS+ or better.	[Kondziella, Daniel] Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Fisher, Patrick M.] Copenhagen Univ Hosp, Neurobiol Res Unit, Copenhagen, Denmark; [Fisher, Patrick M.] Ctr Integrated Mol Brain Imaging, Copenhagen, Denmark; [Larsen, Vibeke Andree] Copenhagen Univ Hosp, Rigshosp, Dept Neuroradiol, Copenhagen, Denmark; [Hauerberg, John] Copenhagen Univ Hosp, Rigshosp, Dept Neurosurg, Copenhagen, Denmark; [Fabricius, Martin] Copenhagen Univ Hosp, Rigshosp, Dept Clin Neurophysiol, Copenhagen, Denmark; [Moller, Kirsten] Copenhagen Univ Hosp, Rigshosp, Dept Neuroanaesthesiol, Copenhagen, Denmark; [Knudsen, Gitte Moos] Univ Copenhagen, Rigshosp, Copenhagen, Denmark; [Knudsen, Gitte Moos] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark		Kondziella, D (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	daniel_kondziella@yahoo.com	Knudsen, Gitte Moos/C-1368-2013; Moller, Kirsten/A-4751-2009; Fisher, Patrick MacDonald/V-8158-2017	Knudsen, Gitte Moos/0000-0003-1508-6866; Moller, Kirsten/0000-0003-3058-1072; Fisher, Patrick MacDonald/0000-0002-8115-0611; Kondziella, Daniel/0000-0001-5562-9808			ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Demertzi A, 2015, BRAIN, V138, P2619, DOI 10.1093/brain/awv169; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Fisher PM, 2017, NEUROPSYCHOPHARMACOL, V42, P446, DOI 10.1038/npp.2016.208; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Guldenmund P, 2013, BRAIN CONNECT, V3, P273, DOI 10.1089/brain.2012.0117; Kirsch M, 2017, ANESTH ANALG, V124, P588, DOI 10.1213/ANE.0000000000001721; Koenig MA, 2014, NEUROCRIT CARE, V20, P348, DOI 10.1007/s12028-014-9953-3; Kondziella D, 2016, J NEUROL NEUROSUR PS, V87, P485, DOI 10.1136/jnnp-2015-310958; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Naci L, 2013, JAMA NEUROL, V70, P1235, DOI 10.1001/jamaneurol.2013.3686; Norton L, 2012, NEUROLOGY, V78, P175, DOI 10.1212/WNL.0b013e31823fcd61; Palanca BA, 2015, ANESTHESIOLOGY, V123, P346, DOI 10.1097/ALN.0000000000000731; Song XX, 2015, J ANESTH, V29, P279, DOI 10.1007/s00540-014-1889-4; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073	19	12	13	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2017	27	3					401	406		10.1007/s12028-017-0407-6			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FN7DT	WOS:000416179300013	28484929				2022-02-06	
J	Lv, Y; Zhang, L; Li, N; Mai, NK; Zhang, Y; Pan, SY				Lv, Yan; Zhang, Liang; Li, Na; Mai, Naiken; Zhang, Yu; Pan, Shuyi			Geraniol promotes functional recovery and attenuates neuropathic pain in rats with spinal cord injury	CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY			English	Article						geraniol; spinal cord injury; oxidative stress; N-methyl-D-aspartate receptor 1; inflammation	TRAUMATIC BRAIN-INJURY; ANTIOXIDANT THERAPIES; PARKINSONS-DISEASE; OXIDATIVE STRESS; HEME OXYGENASE-1; MICE MODEL; MONOTERPENE; DAMAGE; IMPAIRMENTS; DISRUPTION	Geraniol, a plant-derived monoterpene, has been extensively studied and showed a wide variety of beneficial effects. The aim of this study was to investigate the therapeutic effect of geraniol on functional recovery and neuropathic pain in rats with spinal cord injury (SCI). Rats received a clip-compression SCI and were treated with geraniol 6 h following SCI. Treatment of SCI rats with geraniol markedly improved locomotor function, and reduced sensitivity to the mechanical allodynia and thermal hyperalgesia. Treatment of SCI rats with geraniol increased NeuN-positive cells, suppressed expression of glial fibrillary acidic protein, and reduced activity of caspase-3 in the injured region. Treatment of SCI rats with geraniol reduced levels of malondialdehyde and 3-nitrotyrosine, upregulated protein expression of nuclear factor-erythroid 2-related factor 2 and heme oxygenase 1, and suppressed expression of inducible nitric oxide synthase in the injured region. In addition, treatment of SCI rats with geraniol downregulated protein expression of N-methyl-D-aspartate receptor 1 and reduced the number of CD68-positive cells and protein levels of TNF-alpha in the injured region. In conclusion, geraniol significantly promoted the recovery of neuronal function and attenuated neuropathic pain after SCI.	[Lv, Yan; Zhang, Liang; Li, Na; Mai, Naiken; Zhang, Yu; Pan, Shuyi] PLA Navy Gen Hosp, Dept Hyperbar Oxygen, Beijing 100048, Peoples R China		Pan, SY (corresponding author), PLA Navy Gen Hosp, Dept Hyperbar Oxygen, Beijing 100048, Peoples R China.	eleven3567@163.com					Alluin O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111072; Anwar MA, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00098; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Glitsch MD, 2008, NEUROSCIENCE, V151, P403, DOI 10.1016/j.neuroscience.2007.10.024; Gwak YS, 2013, PAIN, V154, P1699, DOI 10.1016/j.pain.2013.05.018; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hassler SN, 2014, J NEUROCHEM, V131, P413, DOI 10.1111/jnc.12830; Ibrahim SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117516; Isaksson J, 2005, SPINAL CORD, V43, P167, DOI 10.1038/sj.sc.3101672; Jayachandran M, 2015, MOL CELL BIOCHEM, V398, P39, DOI 10.1007/s11010-014-2203-3; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Lee BB, 2014, SPINAL CORD, V52, P110, DOI 10.1038/sc.2012.158; Li L, 2015, NEUROSCIENCE, V286, P27, DOI 10.1016/j.neuroscience.2014.11.037; Lin Y, 2007, J CEREBR BLOOD F MET, V27, P1010, DOI 10.1038/sj.jcbfm.9600412; Liu WM, 2011, J NEUROSCI RES, V89, P791, DOI 10.1002/jnr.22602; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Madankumar A, 2013, EUR J PHARMACOL, V705, P148, DOI 10.1016/j.ejphar.2013.02.048; Majdan M, 2016, EUR SPINE J, V25, P62, DOI 10.1007/s00586-015-3985-z; Mao L, 2012, J TRAUMA ACUTE CARE, V72, P189, DOI 10.1097/TA.0b013e31821bf541; Pearse DD, 2003, J NEUROPATH EXP NEUR, V62, P1096, DOI 10.1093/jnen/62.11.1096; Prasad SN, 2014, CHEM-BIOL INTERACT, V223, P27, DOI 10.1016/j.cbi.2014.08.016; Prasad SN, 2014, J NEUROSCI RES, V92, P1205, DOI 10.1002/jnr.23393; Rekha KR, 2014, CHEM-BIOL INTERACT, V217, P57, DOI 10.1016/j.cbi.2014.04.010; Rekha KR, 2013, BIOCHEM BIOPH RES CO, V440, P664, DOI 10.1016/j.bbrc.2013.09.122; Rekha KR, 2013, J MOL NEUROSCI, V51, P851, DOI 10.1007/s12031-013-0074-9; Sencer A, 2013, ULUS TRAVMA ACIL CER, V19, P313, DOI 10.5505/tjtes.2013.45804; Tiwari M, 2009, TOXICOL IN VITRO, V23, P295, DOI 10.1016/j.tiv.2008.12.014; Wang XL, 2012, J NEUROTRAUM, V29, P936, DOI 10.1089/neu.2011.1922; Yamauchi T, 2004, J NEUROTRAUM, V21, P1017, DOI 10.1089/0897715041651042; Zhang Q, 2014, EXP THER MED, V8, P1731, DOI 10.3892/etm.2014.2029; Zhang Yadong, 2002, Chin J Traumatol, V5, P40; ZIVIN JA, 1980, STROKE, V11, P200, DOI 10.1161/01.STR.11.2.200	36	12	12	0	9	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-4212	1205-7541		CAN J PHYSIOL PHARM	Can. J. Physiol. Pharmacol.	DEC	2017	95	12					1389	1395		10.1139/cjpp-2016-0528			7	Pharmacology & Pharmacy; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Physiology	FM3YT	WOS:000414948000001	28334550				2022-02-06	
J	Nakhjavan-Shahraki, B; Yousefifard, M; Hajighanbari, MJ; Oraii, A; Safari, S; Hosseini, M				Nakhjavan-Shahraki, B.; Yousefifard, M.; Hajighanbari, M. J.; Oraii, A.; Safari, S.; Hosseini, M.			Pediatric Emergency Care Applied Research Network (PECARN) prediction rules in identifying high risk children with mild traumatic brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Decision Support Systems, Clinical; Emergency Service, Hospital; Sensitivity and Specificity; Pediatrics	HEAD TRAUMA; COMPUTED-TOMOGRAPHY; LIMITATIONS; SYSTEMS	Pediatric Emergency Care Applied Research Network (PECARN) traumatic brain injury (TBI) prognostic rules is a scoring system for prediction of the need for computed tomography (CT) scanning in children with mild TBI. However, its validation has not been assessed in developing countries. Therefore, the present study was designed to assess the value of PECARN rule in identification of children with clinically important TBI (ciTBI). In this prospective cross-sectional study, 594 children (mean age: 7.9 +/- 5.3 years; 79.3% boys) with mild TBI brought to emergency ward of two healthcare centers in Tehran, Iran were assessed. PECARN checklist was filled for all patients and children were divided to three groups of low, intermediate and high risks. Patients were followed for 2 weeks by phone to assess their ciTBI status. At the end, discrimination power, calibration and overall performance of PECARN rule were assessed. PECARN had a sensitivity and specificity of 92.3 and 40.6%, respectively, in predicting ciTBI in children under 2 years and 100.0 and 57.8%, respectively, in individuals between the ages of 2 and 18. PECARN rule had a proper calibration in prediction of ciTBI and CT scan findings. Brier score (overall performance) of PECARN rule in predicting ciTBI in children under 2 and 2-18 years were 1.5 and 1.2, respectively. PECARN prediction rule has a proper validity in the prediction of ciTBI. Therefor it can be used for screening and identification of high risk children with mild TBI.	[Nakhjavan-Shahraki, B.] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Yousefifard, M.] Iran Univ Med Sci, Fac Med, Physiol Res Ctr, Tehran, Iran; [Yousefifard, M.] Iran Univ Med Sci, Fac Med, Dept Physiol, Tehran, Iran; [Hajighanbari, M. J.] Iran Univ Med Sci, Hafte Tir Hosp, Dept Emergency Med, Tehran, Iran; [Oraii, A.] Univ Tehran Med Sci, Sch Med, Dept Med, Tehran, Iran; [Safari, S.] Islamic Azad Univ, Amir Almomenin Hosp, Med Sci Branch, Clin Res Dev Ctr, Tehran, Iran; [Hosseini, M.] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Poursina Ave, Tehran, Iran		Hosseini, M (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Poursina Ave, Tehran, Iran.	mhossein110@yahoo.com	Safari, Saeed/J-4604-2017; Yousefifard, Mahmoud/P-1621-2018; Oraii, Alireza/AAX-6455-2021	Safari, Saeed/0000-0002-7407-1739; Yousefifard, Mahmoud/0000-0001-5181-4985; Oraii, Alireza/0000-0002-2422-2930; hosseini, mostafa/0000-0002-1334-246X			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alexiou George A, 2011, J Emerg Trauma Shock, V4, P403, DOI 10.4103/0974-2700.83872; Atabaki SM, 2016, ACAD EMERG MED, V23, P566, DOI 10.1111/acem.12923; Babl FE, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-148; Chabok SY, 2012, ARCH TRAUMA RES, V1, P19, DOI 10.5812/atr.5289; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Fred HL, 2004, TEX HEART I J, V31, P345; Hajian-Tilaki K, 2014, J BIOMED INFORM, V48, P193, DOI 10.1016/j.jbi.2014.02.013; Ide K, 2017, ACAD EMERG MED, V24, P308, DOI 10.1111/acem.13129; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Safari S, 2016, IRAN J KIDNEY DIS, V10, P101; Safari Saeed, 2016, J Clin Orthop Trauma, V7, P95, DOI 10.1016/j.jcot.2016.02.005; Schonfeld D, 2015, POSTGRAD MED J, V91, P634, DOI 10.1136/postgradmedj-2013-305004rep; Tham E, 2016, APPL CLIN INFORM, V7, P534, DOI 10.4338/ACI-2015-10-CR-0144; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Wildenschild D, 2002, J HYDROL, V267, P285, DOI 10.1016/S0022-1694(02)00157-9	17	12	12	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	DEC	2017	43	6					755	762		10.1007/s00068-017-0811-9			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FO1PF	WOS:000416534600005	28643031				2022-02-06	
J	Stettler, GR; Moore, EE; Moore, HB; Nunns, GR; Huebner, BR; Einersen, P; Ghasabyan, A; Silliman, CC; Banerjee, A; Sauaia, A				Stettler, Gregory R.; Moore, Ernest E.; Moore, Hunter B.; Nunns, Geoffrey R.; Huebner, Benjamin R.; Einersen, Peter; Ghasabyan, Arsen; Silliman, Christopher C.; Banerjee, Anirban; Sauaia, Angela			Platelet adenosine diphosphate receptor inhibition provides no advantage in predicting need for platelet transfusion or massive transfusion	SURGERY			English	Article							GOAL-DIRECTED-RESUSCITATION; TRAUMA-INDUCED COAGULOPATHY; RANDOMIZED-CLINICAL-TRIAL; BRAIN-INJURY; THROMBELASTOGRAPHY; DYSFUNCTION; THROMBOELASTOGRAPHY; MORTALITY; THERAPY; PATIENT	Background. Thrombelastography platelet mapping is a useful assay to assess antiplatelet therapy. Inhibited response to the adenosine diphosphate receptor on platelets occurs early after injury, but recent work suggests this alteration occurs even with minor trauma. However, the utility of thrombelastography platelet mapping, specifically the percent of adenosine diphosphate receptor inhibition, in predicting outcomes and guiding platelet transfusion in trauma-induced coagulopathy remains unknown We assessed the role of percent of adenosine diphosphate-inhibition in predicting survival, requirement for massive transfusion or platelet transfusion in patients at risk for trauma-induced coagulopathy. Methods. Thrombelastography platelet mapping was assessed in 303 trauma activation patients from 2014-2016 and in 89 healthy volunteers. Percent of adenosine diphosphate-inhibition is presented as median and interquartile range. We compared the area under the receiver operating characteristic curve of percent of adenosine diphosphate-inhibition, platelet count, and rapid thrombelastography maximum amplitude for in-hospital mortality, massive transfusion (>10 red blood cells or death/6 hours), and platelet transfusion (>0 platelet units or death/6 hour). Results. Overall, 35 (11.5%) patient died, 27 (8.9%) required massive transfusion and 46, platelet transfusions (15.2%). Median percent of adenosine diphosphate-inhibition was 42.5% (interquartile range: 22.4-69.1%), compared with 4.3% (interquartile range: 0-13.5%) in healthy volunteers (P<.0001). Patients that died, had a massive transfusion, or platelet transfusion had higher percent of adenosine diphosphate-inhibition than those that did not (P<.05 for all). However, percent of adenosine diphosphate-inhibition did not add significantly to the predictive performance of maximum amplitude or platelet count for any of the 3 outcomes, after adjustment for confounders. Subgroup analyses by severe traumatic brain injury, severe injury and requirement of red blood cells showed similar results. Conclusion. Adenosine diphosphate receptor inhibition did not add predictive value to predicting mortality, massive transfusion, or platelet transfusion. Thus, the role of thrombelastography platelet mapping as a solitary tool to guide platelet transfusions in trauma requires continued refinement.	[Stettler, Gregory R.; Moore, Ernest E.; Moore, Hunter B.; Nunns, Geoffrey R.; Huebner, Benjamin R.; Einersen, Peter; Silliman, Christopher C.; Banerjee, Anirban; Sauaia, Angela] Univ Colorado, Sch Med, Dept Surg, Denver, CO USA; [Moore, Ernest E.; Ghasabyan, Arsen] Univ Colorado, Sch Med, Denver Hlth Med Ctr, Denver, CO USA; [Silliman, Christopher C.] Univ Colorado, Dept Pediat, Sch Publ Hlth, Denver, CO 80202 USA; [Silliman, Christopher C.] Univ Colorado, Sch Publ Hlth, Bonfils Blood Ctr, Denver, CO 80202 USA; [Sauaia, Angela] Univ Colorado, Sch Publ Hlth, Dept Hlth Syst Management & Policy, Denver, CO 80202 USA		Moore, EE (corresponding author), Univ Colorado, Sch Med, Dept Surg, Denver Hlth Med Ctr, 655 Bannock St, Denver, CO 80203 USA.	ernest.moore@dhha.org		Einersen, Peter/0000-0001-9593-2801	National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32-GM008315, P50-GM49222]; National Heart Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [UM1-HL120877]; Department of Defense USAMRAAUnited States Department of Defense; Haemonetics;  [W81XWH-12-2-0028]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [UM1HL120877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50GM049222, T32GM008315] Funding Source: NIH RePORTER	Supported in part by the National Institute of General Medical Sciences grants: T32-GM008315 and P50-GM49222, the National Heart Lung and Blood Institute UM1-HL120877, in addition to the Department of Defense USAMRAA and W81XWH-12-2-0028. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the National Heart, Lung, and Blood institute, or the Department of Defense. Additional research support was provided by Haemonetics with shared intellectual property.	Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Bartels AN, 2016, SURGERY, V160, P954, DOI 10.1016/j.surg.2016.07.012; Brown LM, 2011, J TRAUMA, V71, pS337, DOI 10.1097/TA.0b013e318227f67c; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Clemetson KJ, 2012, THROMB RES, V129, P220, DOI 10.1016/j.thromres.2011.11.036; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Einersen PM, 2017, J TRAUMA ACUTE CARE, V82, P114, DOI 10.1097/TA.0000000000001270; Furie B, 2005, J CLIN INVEST, V115, P3355, DOI 10.1172/JCI26987; Gonzalez E, 2016, ANN SURG, V263, P1051, DOI 10.1097/SLA.0000000000001608; Gonzalez E, 2010, SEMIN THROMB HEMOST, V36, P723, DOI 10.1055/s-0030-1265289; Hobson AR, 2006, PLATELETS, V17, P509, DOI 10.1080/09537100600935259; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Ishikura H, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-016-0203-y; Kashuk JL, 2010, ANN SURG, V251, P604, DOI 10.1097/SLA.0b013e3181d3599c; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Li RZ, 2016, J TRAUMA ACUTE CARE, V80, P440, DOI 10.1097/TA.0000000000000915; Moore HB, 2015, J THROMB HAEMOST, V13, P1878, DOI 10.1111/jth.13067; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Sirajuddin S, 2016, J TRAUMA ACUTE CARE, V81, P328, DOI 10.1097/TA.0000000000001057; Vulliamy P, 2017, J TRAUMA ACUTE CARE, V83, P388, DOI 10.1097/TA.0000000000001520; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050	23	12	12	0	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	DEC	2017	162	6					1286	1294		10.1016/j.surg.2017.07.022			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FN8QU	WOS:000416291400012	28964508	Green Accepted			2022-02-06	
J	Zheng, YK; Dong, XQ; Du, Q; Wang, H; Yang, DB; Zhu, Q; Che, ZH; Shen, YF; Jiang, L; Hu, W; Wang, KY; Yu, WH				Zheng, Yong-Ke; Dong, Xiao-Qiao; Du, Quan; Wang, Hao; Yang, Ding-Bo; Zhu, Qiang; Che, Zhi-Hao; Shen, Yong-Feng; Jiang, Li; Hu, Wei; Wang, Ke-Yi; Yu, Wen-Hua			Comparison of plasma copeptin and multiple biomarkers for assessing prognosis of patients with aneurysmal subarachnoid hemorrhage	CLINICA CHIMICA ACTA			English	Article						Aneurysm; Subarachnoid hemorrhage; Copeptin; Cerebral vasospasm; Prognosis; Biomarkers	TRAUMATIC BRAIN-INJURY; NEURON-SPECIFIC ENOLASE; INTRACEREBRAL HEMORRHAGE; ISCHEMIC-STROKE; CEREBROSPINAL-FLUID; NF-H; SERUM; PREDICTION; VASOSPASM; MORTALITY	Background: Increased plasma copeptin concentrations are related to poor prognosis after aneurysmal subarachnoid hemorrhage (aSAH). The aim of this study was to assess prognostic significance of plasma copeptin detection compared with glial fibrillary astrocyte protein, myelin basic protein, S100B, phosphorylated axonal neurofilament subunit H, neuron-specific enolase, tau and ubiquitin carboxyl-terminal hydrolase L1 in aSAH. Methods: We detected plasma concentrations of the aforementioned biomarkers in 105 healthy controls using ELISA. Their predictive ability for symptomatic cerebral vasospasm and 6-month poor outcome (Glasgow Outcome Scale score of 1-3) were compared. Results: Plasma concentrations of the preceding biomarkers were highly correlated with World Federation of Neurological Surgeons subarachnoid hemorrhage scale (WFNS) scores as well as were significantly higher in patients with symptomatic cerebral vasospasm than in those without symptomatic cerebral vasospasm and in patients with poor outcome than in those with good outcome. In terms of area under receiver operating characteristic curve, their predictive value for symptomatic cerebral vasospasm and 6-month poor outcome was in the range of WFNS scores. Plasma copeptin concentration, but not plasma concentrations of other biomarkers, statistically significantly improved the predictive performance of WFNS scores. Conclusions: Copeptin in plasma might have the potential to be a useful prognostic biomarker for aSAH.	[Zheng, Yong-Ke; Hu, Wei] Nanjing Med Univ, Dept Intens Care Unit, Hangzhou Peoples Hosp 1, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China; [Dong, Xiao-Qiao; Du, Quan; Wang, Hao; Yang, Ding-Bo; Zhu, Qiang; Che, Zhi-Hao; Shen, Yong-Feng; Jiang, Li; Yu, Wen-Hua] Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Neurosurg, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China; [Wang, Ke-Yi] Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Cent Lab, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China		Yu, WH (corresponding author), Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Neurosurg, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China.	hzwenhuayu@163.com			Zhejiang Province Medical and Health Project; Hangzhou Medical Research Fund Project	The authors thank all staffs in Department of Neurosurgery, the Hangzhou First Peoples Hospital (Hangzhou, China) for their technical support. This study was supported financially by Zhejiang Province Medical and Health Project and Hangzhou Medical Research Fund Project.	Aksu F, 2016, CLIN LAB, V62, P2387, DOI 10.7754/Clin.Lab.2016.160532; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Cavus UY, 2014, EUR J TRAUMA EMERG S, V40, P373, DOI 10.1007/s00068-013-0357-4; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; Lopez ZRD, 2015, CLIN CHEM LAB MED, V53, pE179, DOI 10.1515/cclm-2014-1189; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; Dong XQ, 2011, PEPTIDES, V32, P253, DOI 10.1016/j.peptides.2010.11.021; DRAKE CG, 1988, J NEUROSURG, V68, P985; Etminan N, 2017, HAND CLINIC, V140, P195, DOI 10.1016/B978-0-444-63600-3.00012-X; Fenske W, 2012, J CLIN ENDOCR METAB, V97, P3426, DOI 10.1210/jc.2012-1981; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Freynhofer MK, 2012, WIEN MED WOCHENSCHR, V162, P489, DOI 10.1007/s10354-012-0148-2; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Fung C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053191; Grasso Giovanni, 2017, Surg Neurol Int, V8, P11, DOI 10.4103/2152-7806.198738; Grimm JW, 2015, J EMERG NURS, V41, P281, DOI 10.1016/j.jen.2014.12.018; Helbok R, 2015, J NEUROL NEUROSUR PS, V86, P79, DOI 10.1136/jnnp-2013-307326; Hirashima Y, 2001, NEUROL RES, V23, P715, DOI 10.1179/016164101101199225; Jaja BNR, 2015, J NEUROSURG, V122, P644, DOI 10.3171/2014.10.JNS132694; Kellermann I, 2016, CLIN NEUROL NEUROSUR, V145, P79, DOI 10.1016/j.clineuro.2016.04.005; Kiiski H, 2016, J NEUROL SCI, V361, P144, DOI 10.1016/j.jns.2015.12.046; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P221, DOI 10.1007/978-3-211-98811-4_41; Lai PMR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151853; Lewis SB, 2008, J CEREBR BLOOD F MET, V28, P1261, DOI 10.1038/jcbfm.2008.12; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Lin C, 2013, PEPTIDES, V42, P43, DOI 10.1016/j.peptides.2013.01.015; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; Russell JA, 2009, CRIT CARE MED, V37, P749, DOI 10.1097/CCM.0b013e318194d117; Serrone JC, 2015, EXPERT REV NEUROTHER, V15, P367, DOI 10.1586/14737175.2015.1018892; Shen YF, 2015, CLIN CHIM ACTA, V448, P155, DOI 10.1016/j.cca.2015.06.024; Staub D, 2009, CLIN CHIM ACTA, V399, P69, DOI 10.1016/j.cca.2008.09.016; Tamargo RJ, 2012, CRIT CARE, V16, DOI 10.1186/cc10594; Tawk RG, 2016, NEUROSURGERY, V78, P487, DOI 10.1227/NEU.0000000000001140; Tiebosch IACW, 2013, NEUROCRIT CARE, V18, P96, DOI 10.1007/s12028-012-9692-2; Tsakaldimis G, 2015, HELL J NUCL MED, V18, P103; Tu WJ, 2017, NEUROLOGY, V88, P1899, DOI 10.1212/WNL.0000000000003937; Wang CB, 2016, J DIABETES COMPLICAT, V30, P1532, DOI 10.1016/j.jdiacomp.2016.07.030; Wei ZJ, 2014, NEUROL SCI, V35, P1673, DOI 10.1007/s10072-014-1809-2; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181; Xu Q, 2017, HYPERTENS RES, V40, P465, DOI 10.1038/hr.2016.165; Yang DB, 2014, PEPTIDES, V58, P26, DOI 10.1016/j.peptides.2014.05.015; Yu GF, 2012, PEPTIDES, V33, P164, DOI 10.1016/j.peptides.2011.11.017; Yu WH, 2014, CLIN CHIM ACTA, V433, P174, DOI 10.1016/j.cca.2014.03.014; Zhang AM, 2013, EXP THER MED, V5, P467, DOI 10.3892/etm.2012.804; Zhang RY, 2017, MOL NEUROBIOL, V54, P169, DOI 10.1007/s12035-015-9626-z; Zhang X, 2012, PEPTIDES, V33, P336, DOI 10.1016/j.peptides.2012.01.011; Zhang ZY, 2014, PEPTIDES, V60, P13, DOI 10.1016/j.peptides.2014.07.016; Zhu XD, 2011, CRIT CARE, V15, DOI 10.1186/cc10575; Zweifel C, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-34	53	12	14	0	28	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	DEC	2017	475						64	69		10.1016/j.cca.2017.10.009			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	FP5NS	WOS:000417666800011	29037840				2022-02-06	
J	Bajaj, S; Vanuk, JR; Smith, R; Dailey, NS; Killgore, WDS				Bajaj, Sahil; Vanuk, John R.; Smith, Ryan; Dailey, Natalie S.; Killgore, William D. S.			Blue-light Therapy following Mild Traumatic Brain injury: effects on White Matter Water Diffusion in the Brain	FRONTIERS IN NEUROLOGY			English	Article						concussion; diffusion tensor imaging; fractional isotropy; isotropic diffusion; neuropsychological function; quantitative anisotropy; sleep; structural recovery	SLEEP LATENCY TEST; AXONAL INJURY; PREFRONTAL CORTEX; MEMORY; PERFORMANCE; INTEGRITY; DISTURBANCE; ACTIVATION; RESPONSES; COGNITION	Mild traumatic brain injury (mTBI) is a common and often inconspicuous wound that is frequently associated with chronic low-grade symptoms and cognitive dysfunction. Previous evidence suggests that daily blue wavelength light therapy may be effective at reducing fatigue and improving sleep in patients recovering from mTBI. However, the effects of light therapy on recovering brain structure remain unexplored. In this study, we analyzed white matter diffusion properties, including generalized fractional anisotropy, and the quantity of water diffusion in isotropic (i.e., isotropic diffusion) and anisotropic fashion (i.e., quantitative anisotropy, QA) for fibers crossing 11 brain areas known to be significantly affected following mTBI. Specifically, we investigated how 6 weeks of daily morning blue light exposure therapy (compared to an amber-light placebo condition) impacted changes in white matter diffusion in individuals with mTBI. We observed a significant impact of the blue light treatment (relative to the placebo) on the amount of water diffusion (QA) for multiple brain areas, including the corpus callosum, anterior corona radiata, and thalamus. Moreover, many of these changes were associated with improvements in sleep latency and delayed memory. These findings suggest that blue wavelength light exposure may serve as one of the potential non-pharmacological treatments for facilitating structural and functional recovery following mTBI; they also support the use of QA as a reliable neuro-biomarker for mTBI therapies.	[Bajaj, Sahil; Vanuk, John R.; Smith, Ryan; Dailey, Natalie S.; Killgore, William D. S.] Univ Arizona, Dept Psychiat, Coll Med, SCAN Lab, Tucson, AZ 85721 USA		Killgore, WDS (corresponding author), Univ Arizona, Dept Psychiat, Coll Med, SCAN Lab, Tucson, AZ 85721 USA.	killgore@psychiatry.arizona.edu	Bajaj, Sahil/C-6580-2016	Bajaj, Sahil/0000-0003-0629-6036; Smith, Ryan/0000-0002-4448-185X; Dailey, Natalie S./0000-0003-4800-4118	U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-11-1-0056]	This research was supported by a U.S. Army Medical Research and Materiel Command Grant (W81XWH-11-1-0056) to WK. Opinions, interpretations, conclusions, and recommendations in this study are those of the author and are not necessarily endorsed by the Department of Defense. We would also like to thank Dr. Fang-Cheng Yeh for answering our enquires on numerous occasions during data analysis.	Aggleton JP, 2010, EUR J NEUROSCI, V31, P2292, DOI 10.1111/j.1460-9568.2010.07251.x; Alkozei A, 2016, SLEEP, V39, P1671, DOI 10.5665/sleep.6090; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bekiesinska-Figatowska M, 2017, BRAIN DEV-JPN, V39, P203, DOI 10.1016/j.braindev.2016.10.003; Bellesi M, 2013, J NEUROSCI, V33, P14288, DOI 10.1523/JNEUROSCI.5102-12.2013; Benedetti F, 2017, J AFFECT DISORDERS, V218, P380, DOI 10.1016/j.jad.2017.05.008; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Carpenter J, 2016, BETTER PARTNER WORK, P1, DOI 10.1007/s11682-016-9650-2; CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; Chellappa SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016429; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; Cieslik EC, 2013, CEREB CORTEX, V23, P2677, DOI 10.1093/cercor/bhs256; Clarner T, 2012, GLIA, V60, P1468, DOI 10.1002/glia.22367; Correa A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164945; Dijk DJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000145; Duffy JF, 2009, SLEEP MED CLIN, V4, P165, DOI 10.1016/j.jsmc.2009.01.004; Elvsashagen T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127351; Feldman HM, 2010, J DEV BEHAV PEDIATR, V31, P346, DOI 10.1097/DBP.0b013e3181dcaa8b; FlorinLechner SM, 1996, BRAIN RES, V742, P89, DOI 10.1016/S0006-8993(96)00967-5; Fong SYY, 2005, J PSYCHOSOM RES, V58, P55, DOI 10.1016/j.jpsychores.2004.05.004; FOOTE SL, 1991, PROG BRAIN RES, V88, P521; Fritzsche KH, 2010, NEUROIMAGE, V51, P242, DOI 10.1016/j.neuroimage.2010.02.007; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Huang XQ, 2015, INT J CLIN EXP MED, V8, P21991; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jiang CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109984; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2012, J NEUROSCI RES, V90, P2043, DOI 10.1002/jnr.23083; Kurowski BG, 2016, J HEAD TRAUMA REHAB, V31, P369, DOI 10.1097/HTR.0000000000000180; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Littner MR, 2005, SLEEP, V28, P113, DOI 10.1093/sleep/28.1.113; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Menzler K, 2012, SLEEP MED, V13, P736, DOI 10.1016/j.sleep.2012.02.013; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Miller KE, 2008, EXP CELL RES, V314, P1981, DOI 10.1016/j.yexcr.2008.03.004; Mori S, 2005, MRI ATLAS HUMAN WHIT; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Paniak C, 2000, BRAIN INJURY, V14, P219; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Phipps-Nelson J, 2009, CHRONOBIOL INT, V26, P891, DOI 10.1080/07420520903044364; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Sinclair KL, 2014, NEUROREHAB NEURAL RE, V28, P303, DOI 10.1177/1545968313508472; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Sullivan KA, 2015, J NEUROTRAUM, V32, P474, DOI 10.1089/neu.2013.3284; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Viola AU, 2008, SCAND J WORK ENV HEA, V34, P297, DOI 10.5271/sjweh.1268; WINOCUR G, 1985, BEHAV BRAIN RES, V16, P135, DOI 10.1016/0166-4328(85)90088-9; Wright HR, 2004, J PINEAL RES, V36, P140, DOI 10.1046/j.1600-079X.2003.00108.x; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030; Yeh FC, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005203; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Yeh FC, 2011, NEUROIMAGE, V58, P91, DOI 10.1016/j.neuroimage.2011.06.021	70	12	12	2	10	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 22	2017	8								616	10.3389/fneur.2017.00616			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FN3SH	WOS:000415918700001	29213254	Green Published, gold			2022-02-06	
J	Friedman, SD; Poliakov, AV; Budech, C; Shaw, DWW; Breiger, D; Jinguji, T; Krabak, B; Coppel, D; Lewis, TM; Browd, S; Ojemann, JG				Friedman, Seth D.; Poliakov, Andrew V.; Budech, Christopher; Shaw, Dennis W. W.; Breiger, David; Jinguji, Thomas; Krabak, Brian; Coppel, David; Lewis, Tressa Mattioli; Browd, Samuel; Ojemann, Jeffrey G.			GABA alterations in pediatric sport concussion	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; HEAD IMPACT EXPOSURE; YOUTH FOOTBALL; INHIBITION; DIFFUSION; STATEMENT; SPECTRA; MEMORY	Objective: To evaluate whether frontal-lobe magnetic resonance spectroscopy measures of g-aminobutyric acid (GABA) would be altered in a sample of adolescents scanned after sport concussion because mild traumatic brain injury is often associated with working memory problems. Methods: Eleven adolescents (age 14-17 years) who had sustained a first-time sport concussion were studied with MRI/magnetic resonance spectroscopy within 23 to 44 days after injury (mean 30.4 +/- 6.1 days). Age-and sex-matched healthy controls, being seen for sports-related injuries not involving the head and with no history of concussion, were also examined. GABA/creatine 1 phosphocreatine (Cre) was measured in left-sided frontal lobe and central posterior cingulate regions. The frontal voxel was positioned to overlap with patient-specific activation on a 1-back working memory task. Results: Increased GABA/Cre was shown in the frontal lobe for the concussed group. A decreased relationship was observed in the parietal region. High correlations between GABA/Cre and task activation were observed for the control group in the frontal lobe, a relationship not shown in the concussed participants. Conclusions: GABA/Cre appears increased in a region colocalized with working memory task activation after sport concussion. Further work extending these results in larger samples and at time points across the injury episode will aid in refining the clinical significance of these observations.	[Friedman, Seth D.; Poliakov, Andrew V.; Budech, Christopher; Shaw, Dennis W. W.; Breiger, David; Jinguji, Thomas; Krabak, Brian; Coppel, David; Lewis, Tressa Mattioli; Browd, Samuel; Ojemann, Jeffrey G.] Seattle Childrens Hosp, Seattle, WA 98105 USA; [Friedman, Seth D.; Poliakov, Andrew V.; Budech, Christopher; Shaw, Dennis W. W.; Breiger, David; Jinguji, Thomas; Krabak, Brian; Coppel, David; Lewis, Tressa Mattioli; Browd, Samuel; Ojemann, Jeffrey G.] Seattle Res Inst, Seattle, WA 98105 USA; [Shaw, Dennis W. W.; Breiger, David; Jinguji, Thomas; Krabak, Brian; Coppel, David; Browd, Samuel; Ojemann, Jeffrey G.] Univ Washington, Seattle, WA 98195 USA		Ojemann, JG (corresponding author), Seattle Childrens Hosp, Seattle, WA 98105 USA.; Ojemann, JG (corresponding author), Seattle Res Inst, Seattle, WA 98105 USA.; Ojemann, JG (corresponding author), Univ Washington, Seattle, WA 98195 USA.	jeff.ojemann@seattlechildrens.org			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R03NS08650-02]	This work was conducted with a grant from the NIH (5R03NS08650-02) and work-in-progress MEGA-PRESS software package from Siemens Medical Systems.	Aguila MER, 2015, NMR BIOMED, V28, P890, DOI 10.1002/nbm.3321; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Balz J, 2016, NEUROIMAGE, V125, P724, DOI 10.1016/j.neuroimage.2015.10.087; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Boy F, 2010, CURR BIOL, V20, P1779, DOI 10.1016/j.cub.2010.09.003; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Croall Iain, 1800, Top Magn Reson Imaging, V24, P267, DOI 10.1097/RMR.0000000000000063; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; Dunning DL, 2016, NEUROPSYCHOLOGY, V30, P811, DOI 10.1037/neu0000285; Dzhala V, 2012, J NEUROSCI, V32, P4017, DOI 10.1523/JNEUROSCI.5139-11.2012; Edden RAE, 2014, J MAGN RESON IMAGING, V40, P1445, DOI 10.1002/jmri.24478; Edden RAE, 2009, J NEUROSCI, V29, P15721, DOI 10.1523/JNEUROSCI.4426-09.2009; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hannawi Y, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0642-9; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harris AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117531; Imbrosci B, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/614329; Ishak GE, 2012, AM J NEURORADIOL, V33, P1726, DOI 10.3174/ajnr.A3045; Maccotta L, 2007, CEREB CORTEX, V17, P443, DOI 10.1093/cercor/bhj161; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Muthukumaraswamy SD, 2012, HUM BRAIN MAPP, V33, P455, DOI 10.1002/hbm.21223; Pangilinan PH, 2010, PM&R, V2, P1127, DOI 10.1016/j.pmrj.2010.07.007; Poliachik SL, 2016, PEDIATR NEUROL, V54, P43, DOI 10.1016/j.pediatrneurol.2015.09.012; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Puts NAJ, 2011, J NEUROSCI, V31, P16556, DOI 10.1523/JNEUROSCI.4489-11.2011; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Sumner P, 2010, NAT NEUROSCI, V13, P825, DOI 10.1038/nn.2559; Wang GY, 2017, NEUROIMAGE, V147, P164, DOI 10.1016/j.neuroimage.2016.12.013	33	12	12	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	NOV 21	2017	89	21					2151	2156		10.1212/WNL.0000000000004666			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FP5RF	WOS:000417677500008	29030453	Green Published			2022-02-06	
J	Nelson, LD; Furger, RE; Ranson, J; Tarima, S; Hammeke, TA; Randolph, C; Barr, WB; Guskiewicz, K; Olsen, CM; Lerner, EB; McCrea, MA				Nelson, Lindsay D.; Furger, Robyn E.; Ranson, Jana; Tarima, Sergey; Hammeke, Thomas A.; Randolph, Christopher; Barr, William B.; Guskiewicz, Kevin; Olsen, Christopher M.; Lerner, E. Brooke; McCrea, Michael A.			Acute Clinical Predictors of Symptom Recovery in Emergency Department Patients with Uncomplicated Mild Traumatic Brain Injury or Non-Traumatic Brain Injuries	JOURNAL OF NEUROTRAUMA			English	Article						computerized testing; concussion; reaction time; recovery; somatic symptoms	POST-CONCUSSION SYMPTOMS; POSTCONCUSSION-LIKE SYMPTOMS; MINOR HEAD-INJURY; OUTCOME PREDICTION; HIGH-SCHOOL; PROLONGED RECOVERY; HEALTH-STATUS; FOLLOW-UP; TO-HEAD; DEPRESSION	There is a subset of patients with mild traumatic brain injury (mTBI) who report persistent symptoms that impair their functioning and quality of life. Being able to predict which patients will experience prolonged symptom recovery would help clinicians target resources for clinical follow-up to those most in need, and would facilitate research to develop precision medicine treatments for mTBI. The purpose of this study was to investigate the predictors of symptom recovery in a prospective sample of emergency department trauma patients with either mTBI or non-mTBI injuries. Subjects were examined at several time points from within 72 h to 45 days post-injury. We quantified and compared the value of a variety of demographic, injury, and clinical assessment (symptom, neurocognitive) variables for predicting self-reported symptom duration in both mTBI (n = 89) and trauma control (n = 73) patients. Several injury-related and neuropsychological variables assessed acutely (< 72 h) post-injury predicted symptom duration, particularly loss of consciousness (mTBI group), acute somatic symptom burden (both groups), and acute reaction time (both groups), with reasonably good model fit when including all of these variables (area under the receiver operating characteristic curve [AUC] = 0.76). Incorporating self-reported litigation involvement modestly increased prediction further (AUC = 0.80). The results highlight the multifactorial nature of mTBI recovery, and injury recovery more generally, and the need to incorporate a variety of variables to achieve adequate prediction. Further research to improve this model and validate it in new and more diverse trauma samples will be useful to build a neurobiopsychosocial model of recovery that informs treatment development.	[Nelson, Lindsay D.; Furger, Robyn E.; Ranson, Jana; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.; Furger, Robyn E.; Ranson, Jana; Olsen, Christopher M.; McCrea, Michael A.] Med Coll Wisconsin, Neurosci Res Ctr, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Tarima, Sergey] Med Coll Wisconsin, Div Biostat, Milwaukee, WI 53226 USA; [Hammeke, Thomas A.] Med Coll Wisconsin, Dept Psychiat, Milwaukee, WI 53226 USA; [Olsen, Christopher M.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Lerner, E. Brooke] Med Coll Wisconsin, Dept Emergency Med, Milwaukee, WI 53226 USA; [Randolph, Christopher] Loyola Univ Med Ctr, Dept Neurol, Maywood, IL 60153 USA; [Barr, William B.] NYU, Dept Neurol, Sch Med, New York, NY 10016 USA; [Guskiewicz, Kevin] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Guskiewicz, Kevin] Univ North Carolina Chapel Hill, Dept Orthoped, Chapel Hill, NC USA		Nelson, LD (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.; Nelson, LD (corresponding author), Med Coll Wisconsin, Neurosci Res Ctr, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.; Nelson, LD (corresponding author), Med Coll Wisconsin, Neurosci Res Ctr, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.; Nelson, LD (corresponding author), Med Coll Wisconsin, Neurosci Res Ctr, Dept Neurol, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.	linelson@mcw.edu	Ranson, Jana/H-9899-2019; Lerner, E. Brooke/AAM-9590-2020	Lerner, E. Brooke/0000-0003-0043-3757; Barr, William/0000-0001-7711-7758	United States Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-12-1-0004]; Clinical and Translational Science Institute [1UL1-RR031973 (-01)]; National Center for Advancing Translational Sciences, National Institutes of Health (NIH) [8UL1TR000055]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R21DA039276] Funding Source: NIH RePORTER	We thank David Gray, Adam Pfaller, and Ashley LaRoche for their contributions to data collection and Jennifer Hill for her role in project management. This work was supported by the United States Army Medical Research and Materiel Command under award number W81XWH-12-1-0004. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the United States Army. The REDCap electronic database service used for the study was supported by Clinical and Translational Science Institute grant 1UL1-RR031973 (-01) and by the National Center for Advancing Translational Sciences, National Institutes of Health (NIH) grant 8UL1TR000055. The manuscript's contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Angst MS, 2006, ANESTHESIOLOGY, V104, P570, DOI 10.1097/00000542-200603000-00025; [Anonymous], 2003, GREENS MED SYMPT VAL; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Chan LG, 2015, J HEAD TRAUMA REHAB, V30, pE67, DOI 10.1097/HTR.0000000000000119; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Chapman BP, 2014, DEV PSYCHOL, V50, P1426, DOI 10.1037/a0034135; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; DeLeo JA, 2004, NEUROSCIENTIST, V10, P40, DOI 10.1177/1073858403259950; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Faul M, 2010, TRAUMATIC BRAIN INJU; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Furger R. E, 2016, CONCUSSION, V1, P1; Goodwin RD, 2006, J HEALTH PSYCHOL, V11, P643, DOI 10.1177/1359105306066610; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Grace PM, 2016, P NATL ACAD SCI USA, V113, pE3441, DOI 10.1073/pnas.1602070113; Grace PM, 2015, HEADACHE, V55, P475, DOI 10.1111/head.12552; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Grubenhoff JA, 2016, J PEDIATR-US, V174, P27, DOI 10.1016/j.jpeds.2016.03.027; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Helmick K, 2006, DEFENSE VETERANS BRA, P1; Hook MA, 2007, BEHAV BRAIN RES, V179, P281, DOI 10.1016/j.bbr.2007.02.035; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hutchinson MR, 2008, BRAIN BEHAV IMMUN, V22, P1178, DOI 10.1016/j.bbi.2008.05.004; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Jacobsen JHW, 2014, INT REV NEUROBIOL, V118, P129, DOI 10.1016/B978-0-12-801284-0.00006-3; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Krueger KR, 2006, AGE AGEING, V35, P428, DOI 10.1093/ageing/afl028; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Larrabee, 1997, Semin Clin Neuropsychiatry, V2, P196; Lee M, 2011, PAIN PHYSICIAN, V14, P145; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; McCarthy L, 2001, DRUG ALCOHOL DEPEN, V62, P111, DOI 10.1016/S0376-8716(00)00181-2; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nelson LD, 2017, J INT NEUROPSYCH SOC, V23, P293, DOI 10.1017/S1355617717000157; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Putnam S. H., 1994, ADV MED PSYCHOTHERAP, V7, P1; Root JM, 2016, J PEDIATR-US, V174, P39, DOI 10.1016/j.jpeds.2016.03.020; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Salengros JC, 2010, J CARDIOTHOR VASC AN, V24, P608, DOI 10.1053/j.jvca.2009.10.006; Savola O, 2003, EUR J NEUROL, V10, P175, DOI 10.1046/j.1468-1331.2003.00552.x; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Sutin AR, 2010, BIOL PSYCHOL, V84, P186, DOI 10.1016/j.biopsycho.2010.01.012; Taylor AB, 2006, EDUC PSYCHOL MEAS, V66, P228, DOI 10.1177/0013164405278580; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van Gulik L, 2012, BRIT J ANAESTH, V109, P616, DOI 10.1093/bja/aes247; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Watkins LR, 2009, TRENDS PHARMACOL SCI, V30, P581, DOI 10.1016/j.tips.2009.08.002; WechslerD, 2001, WECHSLER TEST ADULT; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Xie XJ, 2017, MOL PAIN, V13, DOI 10.1177/1744806917706582; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	90	12	13	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2018	35	2					249	259		10.1089/neu.2017.4988		NOV 2017	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FT1TA	WOS:000417095500001	29017409	Green Published			2022-02-06	
J	Sen, AK; Gurdziel, K; Liu, J; Qu, W; Nuga, OO; Burl, RB; Huttemann, M; Pique-Regi, R; Ruden, DM				Sen, Arko; Gurdziel, Katherine; Liu, Jenney; Qu, Wen; Nuga, Oluwademi O.; Burl, Rayanne B.; Huttemann, Maik; Pique-Regi, Roger; Ruden, Douglas. M.			Smooth, an hnRNP-L Homolog, Might Decrease Mitochondrial Metabolism by Post-Transcriptional Regulation of Isocitrate Dehydrogenase (Idh) and Other Metabolic Genes in the Sub-Acute Phase of Traumatic Brain Injury	FRONTIERS IN GENETICS			English	Article						traumatic brain injury; alternative splicing; intron retention; histone modification; smooth; hnRNP-L	CYTOCHROME-C-OXIDASE; MESSENGER-RNA; TYROSINE PHOSPHORYLATION; SUBUNIT-I; DROSOPHILA; DEMETHYLASE; NEURODEGENERATION; PLURIPOTENCY; PROTEIN; ROLES	Traumatic brain injury (TBI) can cause persistent pathological alteration of neurons. This may lead to cognitive dysfunction, depression and increased susceptibility to life threatening diseases, such as epilepsy and Alzheimer's disease. To investigate the underlying genetic and molecular basis of TBI, we subjected W-1118 Drosophila melanogaster to mild closed head trauma and found that mitochondrial activity is reduced in the brains of these flies 24h after inflicting trauma. To determine the transcriptomic changes after mild TBI, we collected fly heads 24 h after inflicting trauma, and performed RNA-seq analyses. Classification of alternative splicing changes showed selective retention (RI) of long introns (>81 bps), with a mean size of similar to 3,000 nucleotides. Some of the genes containing RI showed a significant reduction in transcript abundance and are involved in mitochondrial metabolism such as Isocitrate dehydrogenase (Idh), which makes alpha-KG, a co-factor needed for both DNA and histone demethylase enzymes. The long introns are enriched in CA-rich motifs known to bind to Smooth (Sm), a heterogeneous nuclear ribonucleoprotein L (hnRNP-L) class of splicing factor, which has been shown to interact with the H3K36 histone methyltransferase, SFT2, and to be involved in intron retention in human cells. H3K36me3 is a histone mark that demarcates exons in genes by interacting with the mRNA splicing machinery. Mutating sm (sm(4)/Df) resulted in loss of both basal and induced levels of RI in many of the same long-intron containing genes. Reducing the levels of Kdm4A, the H3K36me3 histone demethylase, also resulted in loss of basal levels of RI in many of the same long-intron containing genes. Chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) for H3K36me3 revealed increased levels of this histone modification in retained introns post-trauma at CA-rich motifs. Based on these results, we propose a model in which TBI temporarily decreases mitochondrial activity in the brain 24 h after inflicting trauma, which decreases alpha-KG levels, and increases H3K36me3 levels and intron retention of long introns by decreasing Kdm4A activity. The consequent reduction in mature mRNA levels in metabolism genes, such as Idh, further reduces alpha-KG levels in a negative feedback loop. We further propose that decreasing metabolism after TBI in such a manner is a protective mechanism that gives the brain time to repair cellular damage induced by TBI.	[Sen, Arko; Ruden, Douglas. M.] Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48202 USA; [Sen, Arko; Qu, Wen; Nuga, Oluwademi O.] Wayne State Univ, Dept Pharmacol, Detroit, MI 48201 USA; [Gurdziel, Katherine; Burl, Rayanne B.; Ruden, Douglas. M.] Wayne State Univ, Dept Obstet & Gynecol, CS Mott Ctr Human Growth & Dev, Detroit, MI 48202 USA; [Liu, Jenney; Burl, Rayanne B.; Huttemann, Maik; Pique-Regi, Roger] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA; [Pique-Regi, Roger; Ruden, Douglas. M.] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48202 USA		Ruden, DM (corresponding author), Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI 48202 USA.; Ruden, DM (corresponding author), Wayne State Univ, Dept Obstet & Gynecol, CS Mott Ctr Human Growth & Dev, Detroit, MI 48202 USA.; Ruden, DM (corresponding author), Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48202 USA.	douglasr@wayne.edu	Ruden, Douglas/ABE-1418-2021	Sen, Arko/0000-0001-9876-281X; Huttemann, Maik/0000-0001-6310-7081	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01ES012933, 5P30ES020957, 1UG3OD023285, 5R01GM109215]; pilot finds from the Wayne State University Office of the Vice President for Research; NIH Center grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 CA022453]; Perinatology Research Branch of the National Institutes of Child Health and Development at Wayne State University; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA022453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES012933, P30ES020957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM058905, R01GM109215] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UH3OD023285, UG3OD023285] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health (NIH) [grant number 5R01ES012933 (DR), 5P30ES020957 (DR), 1UG3OD023285 (DR), 5R01GM109215 (RP-R)] and pilot finds from the Wayne State University Office of the Vice President for Research (DR). Funding was also provided by the NIH Center grant P30 CA022453 to the Karmanos Cancer Institute at Wayne State University and the Perinatology Research Branch of the National Institutes of Child Health and Development at Wayne State University.	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Andrews S., 2010, BABRAHAM BIOINFORMAT; Arnold S, 1999, FEBS LETT, V443, P105, DOI 10.1016/S0014-5793(98)01694-9; Arnold S, 1997, EUR J BIOCHEM, V249, P350, DOI 10.1111/j.1432-1033.1997.t01-1-00350.x; Arnold S, 2012, ADV EXP MED BIOL, V748, P305, DOI 10.1007/978-1-4614-3573-0_13; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Barekat A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25252; Barrand S, 2010, BIOCHEM BIOPH RES CO, V401, P611, DOI 10.1016/j.bbrc.2010.09.116; Bischof J, 2014, NAT PROTOC, V9, P1607, DOI 10.1038/nprot.2014.105; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chapin A, 2014, G3-GENES GENOM GENET, V4, P485, DOI 10.1534/g3.113.009357; Chia N, 2011, EPIGENETICS-US, V6, P853, DOI 10.4161/epi.6.7.16461; Copur O, 2013, DEVELOPMENT, V140, P3478, DOI 10.1242/dev.097204; Crona F, 2013, DEV BIOL, V373, P453, DOI 10.1016/j.ydbio.2012.11.011; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Draper I, 2009, FLY, V3, P235, DOI 10.4161/fly.9517; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Herz HM, 2014, SCIENCE, V345, P1065, DOI 10.1126/science.1255104; Huang XD, 2011, MOL CELL BIOL, V31, P3682, DOI 10.1128/MCB.06001-11; Hung LH, 2008, RNA, V14, P284, DOI 10.1261/rna.725208; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kadenbach B, 2004, BBA-BIOENERGETICS, V1655, P400, DOI 10.1016/j.bbabio.2003.06.005; KARPEN GH, 1992, GENETICS, V132, P737; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim S, 2011, P NATL ACAD SCI USA, V108, P13564, DOI 10.1073/pnas.1109475108; Layalle S, 2005, GENES CELLS, V10, P119, DOI 10.1111/j.1365-2443.2005.00822.x; Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200; Lee I, 2009, METHOD ENZYMOL, V457, P193, DOI 10.1016/S0076-6879(09)05011-3; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039758; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Lorbeck MT, 2010, GENE, V450, P8, DOI 10.1016/j.gene.2009.09.007; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Pelosi M, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0689-7; Pradeepa MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002717; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Samavati L, 2008, J BIOL CHEM, V283, P21134, DOI 10.1074/jbc.M801954200; Smith ER, 2008, MOL CELL BIOL, V28, P1041, DOI 10.1128/MCB.01504-07; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsurumi A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02894; Unterharnscheidt F, 1995, Rev Neurol, V23, P661; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200; Zhang DZ, 2005, MOL CELL BIOL, V25, P6404, DOI 10.1128/MCB.25.15.6404-6414.2005; Zhao JX, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317697546; Zhou HL, 2014, NUCLEIC ACIDS RES, V42, P701, DOI 10.1093/nar/gkt875	51	12	12	0	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1664-8021		FRONT GENET	Front. Genet.	NOV 15	2017	8								175	10.3389/fgene.2017.00175			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FM6OP	WOS:000415173800001	29187863	Green Published, gold			2022-02-06	
J	Beauchamp, MH				Beauchamp, Miriam H.			Neuropsychology's Social Landscape: Common Ground With Social Neuroscience	NEUROPSYCHOLOGY			English	Article						neuropsychology; social neuroscience; social cognition; behavior; assessment	TRAUMATIC BRAIN-INJURY; AUTISM SPECTRUM DISORDERS; CEREBRAL BLOOD-FLOW; VIRTUAL-REALITY; COGNITIVE NEUROSCIENCE; CLINICAL-NEUROPSYCHOLOGY; NEURAL BASIS; COMMUNICATION DIFFICULTIES; BEHAVIORAL-VARIANT; EXECUTIVE FUNCTION	Looking back 25 years into neuropsychology's past coincides almost perfectly with the birth of social neuroscience as a discipline. Social neuroscience aims to identify the biological bases of social behavior through multilevel analyses of neural, cognitive, and social processes. Neuropsychology, on the other hand, aspires to understand brain-behavior relationships more generally. Given that much of human behavior comprises social interactions, the goals, theories, methods, and findings derived from social neuroscience are likely to have bearing on the issues and interests of neuropsychologists. This review summarizes some of the main developments that have emerged from social neuroscience and their relevance to neuropsychology. Applications of social neuroscience principles are presented in the context of brain insult, assessment, and intervention. Recommendations are made for improving neuropsychological approaches to the evaluation of social cognition and competence. In closing, a discussion of the challenges and possible future directions for the 2 disciplines is offered. General Scientific Summary Neuropsychology and social neuroscience share some common goals and methods. In this review, the contributions of social neuroscience to neuropsychological research and practice are considered and applications of social neuroscience findings to the study of brain disorders, assessment, and intervention are discussed, alongside recommendations for the joint evolution of the 2 disciplines.	[Beauchamp, Miriam H.] Univ Montreal, Montreal, PQ, Canada; [Beauchamp, Miriam H.] Ste Justine Hosp Res Ctr, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada		Beauchamp, MH (corresponding author), Ste Justine Hosp Res Ctr, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.; Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca			Fonds de la recherche en sante du Quebec career fellowship	This work was supported by a Fonds de la recherche en sante du Quebec career fellowship to Miriam II. Beauchamp. The author is grateful for the constructive comments provided by Keith Yeates and Lyn Turkstra on a preliminary version of the manuscript. Thank you to Cindy Beaudoin, Anne Seni and Catherine Landry-Roy for their assistance with the content and preparation of the boxes and figures.	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 2003, ANN NY ACAD SCI, V985, P326; Adolphs R, 2013, CURR OPIN NEUROBIOL, V23, P291, DOI 10.1016/j.conb.2013.04.011; Adolphs R, 2010, NEURON, V65, P752, DOI 10.1016/j.neuron.2010.03.006; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Ahmed SP, 2015, DEV COGN NEUROS-NETH, V15, P11, DOI 10.1016/j.dcn.2015.07.006; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Annaz D, 2012, J AUTISM DEV DISORD, V42, P401, DOI 10.1007/s10803-011-1256-3; Apperly IA, 2005, TRENDS COGN SCI, V9, P572, DOI 10.1016/j.tics.2005.10.004; Arsenio WF, 2004, CHILD DEV, V75, P987, DOI 10.1111/j.1467-8624.2004.00720.x; Avram M, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-39; Baez S., 2016, CURRENT TOPICS BEHAV, V30, P379; Barlow J, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003680.pub3; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Barrett LF, 2013, CURR OPIN NEUROBIOL, V23, P361, DOI 10.1016/j.conb.2012.12.012; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Beauchamp C, 2013, EDUC PSYCHOL REV, V25, P47, DOI 10.1007/s10648-012-9207-x; Beauchamp MH, 2013, BRAIN INJURY, V27, P896, DOI 10.3109/02699052.2013.775486; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Beaumont J. G., 2008, INTRO NEUROPSYCHOLOG, V2nd; Beblo T, 2011, NEUROPSYCHOL REV, V21, P337, DOI 10.1007/s11065-011-9171-0; Bedford R, 2012, J AUTISM DEV DISORD, V42, P2208, DOI 10.1007/s10803-012-1450-y; Bellerose J.S., 2011, BRAIN MAPPING NEURAL, P181; Bierman K. L., 2004, PEER REJECTION DEV P; Bilder RM, 2011, J INT NEUROPSYCH SOC, V17, P7, DOI 10.1017/S1355617710001396; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2012, J ROY SOC MED, V105, P111, DOI 10.1258/jrsm.2011.110221; Blakemore SJ, 2010, HUM BRAIN MAPP, V31, P926, DOI 10.1002/hbm.21052; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Blakemore SJ, 2004, TRENDS COGN SCI, V8, P216, DOI 10.1016/j.tics.2004.03.012; Blumstein DT, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00034; Bohil CJ, 2011, NAT REV NEUROSCI, V12, P752, DOI 10.1038/nrn3122; Bonfils KA, 2017, PSYCHIAT RES, V249, P293, DOI 10.1016/j.psychres.2016.12.033; Bonfils KA, 2016, SCHIZOPHR RES, V175, P109, DOI 10.1016/j.schres.2016.03.037; Bonini L., 2016, NEUROSCIENTIST, V23; Bonini L, 2011, ANN NY ACAD SCI, V1225, P166, DOI 10.1111/j.1749-6632.2011.06002.x; Bora E, 2016, PSYCHOL MED, V46, P699, DOI 10.1017/S0033291715002573; Bora E, 2016, EPILEPSY BEHAV, V60, P50, DOI 10.1016/j.yebeh.2016.04.024; Bora E, 2013, SCHIZOPHR RES, V144, P31, DOI 10.1016/j.schres.2012.12.013; Borod J., 2000, NEUROPSYCHOLOGY EMOT; Bouchard S, 2011, EXPERT REV NEUROTHER, V11, P207, DOI 10.1586/ERN.10.196; BROTHERS L, 1990, BEHAV BRAIN RES, V41, P199, DOI 10.1016/0166-4328(90)90108-Q; Bufalari I, 2007, CEREB CORTEX, V17, P2553, DOI 10.1093/cercor/bhl161; Byrne Richard W., 1996, Evolutionary Anthropology, V5, P172, DOI 10.1002/(SICI)1520-6505(1996)5:5<172::AID-EVAN6>3.0.CO;2-H; Cacioppo JT, 2014, WORLD PSYCHIATRY, V13, P131, DOI 10.1002/wps.20118; Cacioppo JT, 2013, PERSPECT PSYCHOL SCI, V8, P667, DOI 10.1177/1745691613507456; Cacioppo JT, 2010, SOC COGNITION, V28, P675, DOI 10.1521/soco.2010.28.6.675; Cacioppo JT, 2002, AM PSYCHOL, V57, P819, DOI 10.1037/0003-066X.57.11.819; CACIOPPO JT, 1992, AM PSYCHOL, V47, P1019, DOI 10.1037/0003-066X.47.8.1019; Cacioppo S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02027; Cage E, 2013, AUTISM RES, V6, P433, DOI 10.1002/aur.1313; Carrigan B, 2016, BRAIN COGNITION, V108, P88, DOI 10.1016/j.bandc.2016.07.007; Casebeer WD, 2003, NAT REV NEUROSCI, V4, P840, DOI 10.1038/nrn1223; Casey BJ, 2005, CURR OPIN NEUROBIOL, V15, P239, DOI 10.1016/j.conb.2005.03.012; Cassel A., 2016, NEUROPSYCHOLOGICAL R; Chang YC, 2016, RES AUTISM SPECT DIS, V27, P1, DOI 10.1016/j.rasd.2016.03.010; Cheng Y, 2008, NEUROIMAGE, V40, P1833, DOI 10.1016/j.neuroimage.2008.01.064; Chiasson V, 2017, BRAIN IMPAIR, V18, P102, DOI 10.1017/BrImp.2016.33; Chiasson V, 2017, CLIN NEUROPSYCHOL, V31, P515, DOI 10.1080/13854046.2016.1268650; Chisholm JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092696; Chita-Tegmark M, 2016, RES DEV DISABIL, V48, P79, DOI 10.1016/j.ridd.2015.10.011; Cooper RP, 2010, TOP COGN SCI, V2, P398, DOI 10.1111/j.1756-8765.2010.01090.x; Corrigan PW, 1997, PSYCHIATRY, V60, P309, DOI 10.1080/00332747.1997.11024809; COSTA L, 1983, J CLIN NEUROPSYCHOL, V5, P1, DOI 10.1080/01688638308401147; Cotter J, 2016, NEUROLOGY, V87, P1727, DOI 10.1212/WNL.0000000000003236; Couper E., 2002, BRAIN IMPAIR, V3, P105, DOI [DOI 10.1375/BRIM.3.2.105, 10.1375/brim.3.2.105]; Cowell JM, 2015, P NATL ACAD SCI USA, V112, P12657, DOI 10.1073/pnas.1508832112; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Crone EA, 2015, WIRES COGN SCI, V6, P53, DOI 10.1002/wcs.1327; Crowe LM, 2011, CLIN PSYCHOL REV, V31, P767, DOI 10.1016/j.cpr.2011.03.008; Das P, 2012, SCHIZOPHR RES, V134, P158, DOI 10.1016/j.schres.2011.08.019; DAVIDSON RJ, 1995, CURR OPIN NEUROBIOL, V5, P217, DOI 10.1016/0959-4388(95)80029-8; de Borst AW, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00576; de Castro BO, 2002, CHILD DEV, V73, P916, DOI 10.1111/1467-8624.00447; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2010, PERSPECT PSYCHOL SCI, V5, P767, DOI 10.1177/1745691610388780; Dickerson Bradford C, 2015, Continuum (Minneap Minn), V21, P660, DOI 10.1212/01.CON.0000466659.05156.1d; Dinstein I, 2008, CURR BIOL, V18, pR956, DOI 10.1016/j.cub.2008.09.007; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dunbar RIM, 2009, ANN HUM BIOL, V36, P562, DOI 10.1080/03014460902960289; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.3.CO;2-P; Eddy CM, 2016, LANCET PSYCHIAT, V3, P1079, DOI 10.1016/S2215-0366(16)30144-4; Eddy CM, 2013, BEHAV NEUROL, V27, P15, DOI [10.3233/BEN-120298, 10.1155/2013/417516]; Elsabbagh M, 2016, BIOL PSYCHIAT, V80, P94, DOI 10.1016/j.biopsych.2016.02.019; Erdley CA, 2010, ABCT CLIN ASSESS SER, P21, DOI 10.1007/978-1-4419-0609-0_2; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fehr T, 2014, BRAIN RES, V1583, P141, DOI 10.1016/j.brainres.2014.04.041; Fett AKJ, 2011, NEUROSCI BIOBEHAV R, V35, P573, DOI 10.1016/j.neubiorev.2010.07.001; Fiske S.T., 2013, SOCIAL COGNITION BRA; Fletcher-Watson S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008785.pub2; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109, DOI 10.1152/jn.1984.51.5.1109; Frith CD, 2008, NEURON, V60, P503, DOI 10.1016/j.neuron.2008.10.032; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Funamoto A, 2015, INFANT MENT HEALTH J, V36, P3, DOI 10.1002/imhj.21481; Furlong Mairead, 1800, Evid Based Child Health, V8, P318, DOI 10.1002/ebch.1905; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gangitano M, 2004, EUR J NEUROSCI, V20, P2193, DOI 10.1111/j.1460-9568.2004.03655.x; Gibson J, 2011, RES DEV DISABIL, V32, P2458, DOI 10.1016/j.ridd.2011.07.014; Giedd JN, 2008, J ADOLESCENT HEALTH, V42, P335, DOI 10.1016/j.jadohealth.2008.01.007; Gill KE, 2016, EARLY INTERV PSYCHIA, V10, P77, DOI 10.1111/eip.12182; Gomes A, 2014, DEV NEUROPSYCHOL, V39, P9, DOI 10.1080/87565641.2013.827197; Gonzalez-Liencres C, 2013, NEUROSCI BIOBEHAV R, V37, P1537, DOI 10.1016/j.neubiorev.2013.05.001; Green MF, 2016, J CLIN PSYCHIAT, V77, P8, DOI 10.4088/JCP.14074su1c.02; Green MF, 2015, NAT REV NEUROSCI, V16, P620, DOI 10.1038/nrn4005; Green MF, 2013, SCHIZOPHRENIA BULL, V39, P1192, DOI 10.1093/schbul/sbt131; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Gur RC, 2016, AM J MED GENET B, V171, P132, DOI 10.1002/ajmg.b.32394; Guyer AE, 2016, NEUROSCI BIOBEHAV R, V70, P74, DOI 10.1016/j.neubiorev.2016.07.037; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; Happe F, 2017, ANNU REV PSYCHOL, V68, P243, DOI 10.1146/annurev-psych-010416-044046; Happe F, 2014, J CHILD PSYCHOL PSYC, V55, P553, DOI 10.1111/jcpp.12162; Healey KM, 2016, CLIN PSYCHOL REV, V50, P108, DOI 10.1016/j.cpr.2016.10.001; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Henry JD, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.229; Henry JD, 2014, NEUROPSYCHOLOGIA, V56, P53, DOI 10.1016/j.neuropsychologia.2013.12.024; Heyes C, 2010, NEUROIMAGE, V51, P789, DOI 10.1016/j.neuroimage.2010.02.034; Hickok G, 2009, J COGNITIVE NEUROSCI, V21, P1229, DOI 10.1162/jocn.2009.21189; Hillis AE, 2014, BRAIN, V137, P981, DOI 10.1093/brain/awt317; Camargo SPH, 2014, J AUTISM DEV DISORD, V44, P2096, DOI 10.1007/s10803-014-2060-7; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Ibanez A, 2012, NEUROLOGY, V78, P1354, DOI 10.1212/WNL.0b013e3182518375; Jackson PL, 2006, NEUROIMAGE, V31, P429, DOI 10.1016/j.neuroimage.2005.11.026; Jeste SS, 2015, CURR OPIN NEUROL, V28, P110, DOI 10.1097/WCO.0000000000000181; Jordan K, 2013, INT J REHABIL RES, V36, P221, DOI 10.1097/MRR.0b013e32835d0b43; Kahane G, 2015, SOC NEUROSCI-UK, V10, P551, DOI 10.1080/17470919.2015.1023400; Kaplan JT, 2006, SOC NEUROSCI-UK, V1, P175, DOI 10.1080/17470910600985605; Keane J, 2002, NEUROPSYCHOLOGIA, V40, P655, DOI 10.1016/S0028-3932(01)00156-7; Kennedy DP, 2012, TRENDS COGN SCI, V16, P559, DOI 10.1016/j.tics.2012.09.006; Kensinger EA, 2017, J GERONTOL B-PSYCHOL, V72, P61, DOI 10.1093/geronb/gbw056; Keysers C, 2009, CURR OPIN NEUROBIOL, V19, P666, DOI 10.1016/j.conb.2009.10.006; Kilford EJ, 2016, NEUROSCI BIOBEHAV R, V70, P106, DOI 10.1016/j.neubiorev.2016.08.016; Kim ES, 2013, J AUTISM DEV DISORD, V43, P1038, DOI 10.1007/s10803-012-1645-2; Kim K, 2007, CYBERPSYCHOL BEHAV, V10, P215, DOI 10.1089/cpb.2006.9966; KLING A S, 1992, P353; Koscik TR, 2012, J INT NEUROPSYCH SOC, V18, P394, DOI 10.1017/S1355617712000264; Ku J, 2007, CYBERPSYCHOL BEHAV, V10, P567, DOI 10.1089/cpb.2007.9989; Kumfor F, 2012, NEUROPSYCHOL REV, V22, P280, DOI 10.1007/s11065-012-9201-6; Kurtz MM, 2016, CLIN PSYCHOL REV, V43, P80, DOI 10.1016/j.cpr.2015.09.003; Lalonde G, 2013, J NEUROSCI METH, V219, P76, DOI 10.1016/j.jneumeth.2013.07.005; Lamm C, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0083; Leekam S, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0082; Lemerise EA, 2000, CHILD DEV, V71, P107, DOI 10.1111/1467-8624.00124; Levallois C, 2012, NAT REV NEUROSCI, V13, P789, DOI 10.1038/nrn3354; Levenson RW, 2014, ANNU REV CLIN PSYCHO, V10, P581, DOI 10.1146/annurev-clinpsy-032813-153653; Lieberman MD, 2012, NEUROIMAGE, V61, P432, DOI 10.1016/j.neuroimage.2011.12.089; Lindinger NM, 2016, ALCOHOL CLIN EXP RES, V40, P367, DOI 10.1111/acer.12961; Lozier LM, 2014, DEV PSYCHOPATHOL, V26, P933, DOI 10.1017/S0954579414000479; Marsh LE, 2011, NEUROIMAGE, V56, P1511, DOI 10.1016/j.neuroimage.2011.02.003; Marshall PJ, 2011, DEV COGN NEUROS-NETH, V1, P110, DOI 10.1016/j.dcn.2010.09.001; Martin AK, 2016, NEUROPSYCHOLOGIA, V93, P158, DOI 10.1016/j.neuropsychologia.2016.10.013; Matto HC, 2010, SOC WORK, V55, P147, DOI 10.1093/sw/55.2.147; Matusall S., 2011, OXFORD HDB SOCIAL NE, P9; Mazza M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00791; McConachie H, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19410; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Miller BL, 2003, ANN NEUROL, V54, pS7, DOI 10.1002/ana.10568; Mills KL, 2014, SOC COGN AFFECT NEUR, V9, P123, DOI 10.1093/scan/nss113; Mitchell P, 2007, J AUTISM DEV DISORD, V37, P589, DOI 10.1007/s10803-006-0189-8; Moll J, 2003, NEUROREPORT, V14, P299, DOI 10.1097/01.wnr.0000057866.05120.28; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Mortensen JA, 2014, INFANT MENT HEALTH J, V35, P336, DOI 10.1002/imhj.21451; Mueser KT, 2013, ANNU REV CLIN PSYCHO, V9, P465, DOI 10.1146/annurev-clinpsy-050212-185620; Murphy SM, 2014, RES DEV DISABIL, V35, P2821, DOI 10.1016/j.ridd.2014.07.026; Murza KA, 2016, INT J LANG COMM DIS, V51, P236, DOI 10.1111/1460-6984.12212; National Collaborating Centre for Mental Health, 2013, ANT BEH COND DIS CHI; Nikolaides A, 2016, EUR ARCH PSY CLIN N, V266, P649, DOI 10.1007/s00406-016-0705-6; Northoff G, 2010, NEURON, V65, P748, DOI 10.1016/j.neuron.2010.02.024; Ochsner KN, 2008, BIOL PSYCHIAT, V64, P48, DOI 10.1016/j.biopsych.2008.04.024; Ochsner KN, 2004, CURR OPIN NEUROBIOL, V14, P254, DOI 10.1016/j.conb.2004.03.011; Ochsner KN, 2001, AM PSYCHOL, V56, P717, DOI 10.1037//0003-066X.56.9.717; Okruszek L, 2017, SCHIZOPHR RES, V190, P3, DOI 10.1016/j.schres.2017.03.013; Otero TL, 2015, CHILD ADOL PSYCH CL, V24, P99, DOI 10.1016/j.chc.2014.09.002; Park KM, 2009, HUM PSYCHOPHARM CLIN, V24, P619, DOI 10.1002/hup.1071; Parsons S, 2005, AUTISM, V9, P95, DOI 10.1177/1362361305049032; Parsons S, 2004, J AUTISM DEV DISORD, V34, P449, DOI 10.1023/B:JADD.0000037421.98517.8d; Parsons TD, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7040042; Parsons TD, 2009, DEV NEUROREHABIL, V12, P224, DOI 10.1080/17518420902991719; Pavone EF, 2016, J NEUROSCI, V36, P268, DOI 10.1523/JNEUROSCI.0494-15.2016; Payne JM, 2016, NEUROPSYCHOLOGY, V30, P439, DOI 10.1037/neu0000262; Pelphrey K, 2004, MENT RETARD DEV D R, V10, P259, DOI 10.1002/mrdd.20040; Penn DL, 2007, PSYCHIAT SERV, V58, P449; Penn PR, 2009, DEV NEUROREHABIL, V12, P32, DOI 10.1080/17518420902739365; Pfeifer JH, 2012, SOC COGN AFFECT NEUR, V7, P1, DOI 10.1093/scan/nsr099; Pinkham AE, 2008, SCHIZOPHR RES, V99, P164, DOI 10.1016/j.schres.2007.10.024; Pinkham AE, 2014, SCHIZOPHRENIA BULL, V40, P813, DOI 10.1093/schbul/sbt081; Port RG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00414; Puente A. E., 1989, HDB CLIN CHILD NEURO, P3; RALEIGH MJ, 1981, EXP NEUROL, V73, P378, DOI 10.1016/0014-4886(81)90273-9; Ramsey R, 2013, J COGNITIVE NEUROSCI, V25, P670, DOI 10.1162/jocn_a_00345; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2008, CURR OPIN NEUROBIOL, V18, P179, DOI 10.1016/j.conb.2008.08.001; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Robillard G, 2010, STUD HEALTH TECHNOL, V154, P57, DOI 10.3233/978-1-60750-561-7-57; ROLAND PE, 1982, J NEUROPHYSIOL, V48, P467, DOI 10.1152/jn.1982.48.2.467; Romine CB, 2005, APPL NEUROPSYCHOL, V12, P190, DOI 10.1207/s15324826an1204_2; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Rosen HJ, 2004, DEMENT GERIATR COGN, V17, P277, DOI 10.1159/000077154; Ruff RM, 2003, ARCH CLIN NEUROPSYCH, V18, P847, DOI 10.1016/j.acn.2003.07.002; Samuels BM, 2009, MIND BRAIN EDUC, V3, P45, DOI 10.1111/j.1751-228X.2008.01052.x; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Schaafsma SM, 2015, TRENDS COGN SCI, V19, P65, DOI 10.1016/j.tics.2014.11.007; Scourfield J, 1999, BRIT J PSYCHIAT, V175, P559, DOI 10.1192/bjp.175.6.559; Sevinc G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087427; Shany-Ur T, 2011, CURR OPIN NEUROL, V24, P550, DOI 10.1097/WCO.0b013e32834cd42a; Shaw DJ, 2013, DEV NEUROPSYCHOL, V38, P256, DOI 10.1080/87565641.2013.783832; Singer T, 2012, NEUROIMAGE, V61, P437, DOI 10.1016/j.neuroimage.2012.01.109; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Suchy Y., 2011, CLIN NEUROPSYCHOLOGY; Tan B. L., 2016, ASIAN J PSYCHIAT; Tarr MJ, 2002, NAT NEUROSCI, V5, P1089, DOI 10.1038/nn948; Telford EJ, 2016, J CHILD PSYCHOL PSYC, V57, P861, DOI 10.1111/jcpp.12546; Todorov A, 2006, BRAIN RES, V1079, P76, DOI 10.1016/j.brainres.2005.12.114; Tousignant B, 2017, INFANT BEHAV DEV, V48, P5, DOI 10.1016/j.infbeh.2015.11.006; Turkstra LS, 2014, AJIDD-AM J INTELLECT, V119, P319, DOI 10.1352/1944-7558-119.4.319; Vakil E, 2012, J CLIN EXP NEUROPSYC, V34, P135, DOI 10.1080/13803395.2011.623121; Verweij M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00332; Vivanti G, 2014, J ABNORM CHILD PSYCH, V42, P1395, DOI 10.1007/s10802-014-9874-9; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; Vrijhof CI, 2016, J ADOLESCENCE, V52, P27, DOI 10.1016/j.adolescence.2016.07.005; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Will GJ, 2016, DEV COGN NEUROS-NETH, V19, P288, DOI 10.1016/j.dcn.2016.05.004; Wittenberg D, 2008, NEUROPSYCHOL REV, V18, P91, DOI 10.1007/s11065-008-9056-z; Woodward AL, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0181; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Zaki J, 2009, ANN NY ACAD SCI, V1167, P16, DOI 10.1111/j.1749-6632.2009.04601.x; Zelazo PD, 2010, SOC NEUROSCI-UK, V5, P417, DOI 10.1080/17470919.2010.510002; Zwaigenbaum L, 2013, BEHAV BRAIN RES, V251, P133, DOI 10.1016/j.bbr.2013.04.004	240	12	12	1	18	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	NOV	2017	31	8			SI		981	1002		10.1037/neu0000395			22	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	FT6JH	WOS:000423259900010	29376673				2022-02-06	
J	Coppieters, I; De Pauw, R; Caeyenberghs, K; Danneels, L; Kregel, J; Pattyn, A; Meeus, M; Cagnie, B				Coppieters, Iris; De Pauw, Robby; Caeyenberghs, Karen; Danneels, Lieven; Kregel, Jeroen; Pattyn, Astrid; Meeus, Mira; Cagnie, Barbara			Decreased Regional Grey Matter Volume in Women with Chronic Whiplash-Associated Disorders: Relationships with Cognitive Deficits and Disturbed Pain Processing	PAIN PHYSICIAN			English	Article						Whiplash injuries; neck pain; magnetic resonance imaging; grey matter; cognitive dysfunction; pain catastrophizing; central sensitization	NECK-DISABILITY-INDEX; CENTRAL SENSITIVITY SYNDROMES; ANTERIOR CINGULATE CORTEX; TRAUMATIC BRAIN-INJURY; HUMAN CEREBRAL-CORTEX; CHRONIC PELVIC PAIN; QUALITY-OF-LIFE; LOW-BACK-PAIN; GRAY-MATTER; CENTRAL SENSITIZATION	Background: Patients with chronic whiplash-associated disorders (CWAD) are characterized by pain of traumatic origin, cognitive deficits, and central sensitization (CS). Previous neuroimaging studies revealed altered grey matter volume (GMV) in mild traumatic brain injury patients and chronic pain conditions also characterized by CS. It can therefore be hypothesized that GMV alterations also play a role in the persistent complaints of CWAD. However, brain alterations remain poorly investigated in these patients. Objectives: This study examined regional GMV alterations in patients with CWAD compared to patients with non-traumatic chronic idiopathic neck pain (CINP), who normally do not show CS at a group level, and healthy controls. Additionally, in both patient groups, relationships between regional GMV and measures of cognition as well as pain processing were assessed. Study Design: A cross-sectional case-control study. Setting: This study was performed at the Department of Rehabilitation Sciences and Physiotherapy of Ghent University in cooperation with the Ghent Institute for Functional and Metabolic Imaging. Methods: Ninety-three women (28 healthy controls, 34 CINP patients, and 31 CWAD patients) were enrolled. First, T1-weighted magnetic resonance images (MRIs) were acquired to examine GMV alterations in the brain regions involved in processing cognition and pain. Next, cognitive performance, pain cognitions, and CS symptoms were assessed. Finally, hyperalgesia and conditioned pain modulation efficacy were examined. Results: Regional GMV of the right lateral orbitofrontal cortex, left supramarginal cortex, and left posterior cingulate cortex was decreased in CWAD patients compared to healthy controls (P = 0.023; P = 0.012; P = 0.047, respectively). Additionally, GMV of the right superior parietal cortex and left posterior cingulate cortex was decreased in CWAD patients compared to CINP patients (P = 0.008; P = 0.035, respectively). Decreased regional GMV correlated with worse cognitive performance, higher maladapted pain cognitions, CS symptoms, and hyperalgesia in CWAD patients (r(s) = -0.515 to -0.657; P < 0.01). In CINP patients, decreased regional GMV correlated only with worse cognitive performance (r(s) = -0.499 to -0.619; P < 0.01), and no GMV differences compared with the controls could be revealed. Limitations: No conclusions about the causality of the observed relationships can be drawn. Conclusions: These results provide the first evidence for reduced GMV in cortical regions involved in processing cognition and pain in patients with CWAD. Accordingly, it is recommended that therapy approaches for CWAD patients should address the brain and take into account neuroplasticity of the central nervous system (CNS).	[Coppieters, Iris; De Pauw, Robby; Danneels, Lieven; Kregel, Jeroen; Pattyn, Astrid; Meeus, Mira; Cagnie, Barbara] Univ Ghent, Dept Rehabil Sci & Physiotherapy, Ghent, Belgium; [Coppieters, Iris; Kregel, Jeroen; Meeus, Mira] Www Paininmot Be, Pain Mot Int Res Grp, Brussels, Belgium; [Caeyenberghs, Karen] Australian Catholic Univ, Sch Psychol, Sydney, NSW, Australia; [Kregel, Jeroen] Free Univ Brussels, Dept Physiotherapy Human Physiol & Anat KIMA, Brussels, Belgium; [Meeus, Mira] Univ Antwerp, Dept Rehabil Sci & Physiotherapy, Antwerp, Belgium		Coppieters, I (corresponding author), Univ Ghent, Rehabil Sci & Physiotherapy, Pintelaan 185, B-9000 Ghent, Belgium.	Iris.coppieters@ugent.be	Coppieters, Iris/AAI-3812-2021; Coppieters, Iris/M-8749-2014; De Pauw, Robby/ABF-6976-2020; Meeus, Mira/B-3332-2011; cagnie, barbara/D-9830-2017; Danneels, Lieven/F-9883-2017	Coppieters, Iris/0000-0003-1598-632X; De Pauw, Robby/0000-0002-4242-9062; Meeus, Mira/0000-0002-2022-5114; cagnie, barbara/0000-0003-4342-4519; Danneels, Lieven/0000-0002-3030-2697	Special Research Fund of Ghent University (BOF-Ghent); Agency for Innovation by Science and Technology (IWT)Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)	The authors gratefully acknowledge the patients of this study, without whom this study could have never been completed successfully. For its financial support, the authors' gratitude goes out to the Special Research Fund of Ghent University (BOF-Ghent) and the Agency for Innovation by Science and Technology (IWT), who made this experimental research possible. Finally, we acknowledge Stephanie Bogaert for her radiological assistance with the T2*-weighted MRI analyses, and we acknowledge the neuroradiological expertise of Dr. Karel Deblaere and Dr. Eva Genbrugge to visually inspect all the T2*-weighted brain images. Mira Meeus and Barbara Cagnie contributed equally as last authors.	Ailliet L, 2015, EUR SPINE J, V24, P88, DOI 10.1007/s00586-014-3359-y; Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; As-Sanie S, 2012, PAIN, V153, P1006, DOI 10.1016/j.pain.2012.01.032; Baliki MN, 2015, NEURON, V87, P474, DOI 10.1016/j.neuron.2015.06.005; Baliki MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026010; Barad MJ, 2014, J PAIN, V15, P197, DOI 10.1016/j.jpain.2013.10.011; BARNSLEY L, 1994, PAIN, V58, P283, DOI 10.1016/0304-3959(94)90123-6; Bay E, 2012, BRAIN INJURY, V26, P941, DOI 10.3109/02699052.2012.666365; Blankstein U, 2010, GASTROENTEROLOGY, V138, P1783, DOI 10.1053/j.gastro.2009.12.043; Borghouts JAJ, 1998, PAIN, V77, P1, DOI 10.1016/S0304-3959(98)00058-X; Borsbo B, 2008, J REHABIL MED, V40, P562, DOI 10.2340/16501977-0207; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Bruel-Jungerman E, 2007, NEUROSCIENTIST, V13, P492, DOI 10.1177/1073858407302725; Bulls HW, 2015, J PAIN RES, V8, P311, DOI 10.2147/JPR.S84607; Cagnie B, 2014, SEMIN ARTHRITIS RHEU, V44, P68, DOI 10.1016/j.semarthrit.2014.01.001; Cathcart Stuart, 2006, J Headache Pain, V7, P21, DOI 10.1007/s10194-006-0265-7; Cauda F, 2014, NEUROIMAGE-CLIN, V4, P676, DOI 10.1016/j.nicl.2014.04.007; Chien A, 2010, MANUAL THER, V15, P48, DOI 10.1016/j.math.2009.05.012; Coppieters I, 2017, PHYS THER, V97, P338, DOI 10.2522/ptj.20160259; Coppieters I, 2016, J PAIN, V17, P949, DOI 10.1016/j.jpain.2016.04.005; Coppieters I, 2015, PAIN PHYSICIAN, V18, pE389; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Davis CG, 2013, J FORENSIC LEG MED, V20, P74, DOI 10.1016/j.jflm.2012.05.004; Davis KD, 2013, J NEUROIMMUNE PHARM, V8, P518, DOI 10.1007/s11481-012-9386-8; de Lange FP, 2008, BRAIN, V131, P2172, DOI 10.1093/brain/awn140; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Diaz-Piedra C, 2016, BRAIN IMAGING BEHAV, V10, P1184, DOI 10.1007/s11682-015-9485-2; Dimitriadis Z, 2015, J BACK MUSCULOSKELET, V28, P797, DOI 10.3233/BMR-150587; Elliott JM, 2009, J ORTHOP SPORT PHYS, V39, P312, DOI 10.2519/jospt.2009.2826; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Fejer R, 2006, EUR SPINE J, V15, P834, DOI 10.1007/s00586-004-0864-4; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Gwilym SE, 2010, ARTHRITIS RHEUM-US, V62, P2930, DOI 10.1002/art.27585; Hubbard CS, 2014, ENEURO, V1, DOI 10.1523/ENEURO.0006-14.2014; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; Jorritsma W, 2012, EUR SPINE J, V21, P93, DOI 10.1007/s00586-011-1920-5; Jorritsma W, 2010, EUR SPINE J, V19, P1695, DOI 10.1007/s00586-010-1406-x; Killgore WDS, 2016, NEUROSCI LETT, V612, P238, DOI 10.1016/j.neulet.2015.12.033; Kosek E, 1999, SCAND J REHABIL MED, V31, P89; Kregel J, 2016, CLIN J PAIN, V32, P624, DOI 10.1097/AJP.0000000000000306; Kregel J, 2015, SEMIN ARTHRITIS RHEU, V45, P229, DOI 10.1016/j.semarthrit.2015.05.002; Lame IE, 2008, J HEALTH PSYCHOL, V13, P820, DOI 10.1177/1359105308093866; Lee DH, 2015, J PAIN, V16, P580, DOI 10.1016/j.jpain.2015.03.006; Lewis GN, 2012, PAIN RES MANAG, V17, P98, DOI 10.1155/2012/610561; Li Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070921; Luerding R, 2008, BRAIN, V131, P3222, DOI 10.1093/brain/awn229; Maleki N, 2012, BRAIN, V135, P2546, DOI 10.1093/brain/aws175; Malfliet A, 2015, PAIN PHYSICIAN, V18, P223; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; Mayer TG, 2012, PAIN PRACT, V12, P276, DOI 10.1111/j.1533-2500.2011.00493.x; McAllister SJ, 2016, CLIN EXP RHEUMATOL, V34, pS48; Meeus M, 2010, J REHABIL MED, V42, P884, DOI [10.2340/16501977-0595, 10.2340/16501977.0595]; Moayedi M, 2011, NEUROIMAGE, V55, P277, DOI 10.1016/j.neuroimage.2010.12.013; Mordasini L, 2012, J UROLOGY, V188, P2233, DOI 10.1016/j.juro.2012.08.043; Moshourab RA, 2015, BRAIN NEUROTRAUMA MO; Mukaka MM, 2012, MALAWI MED J, V24, P69; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Neblett R, 2013, J PAIN, V14, P438, DOI 10.1016/j.jpain.2012.11.012; Ng TS, 2014, CLIN J PAIN, V30, P436, DOI 10.1097/AJP.0b013e3182a03940; Niddam DM, 2017, EUR J PAIN, V21, P148, DOI 10.1002/ejp.911; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; Ogino Y, 2005, ANESTHESIOLOGY, V103, P821, DOI 10.1097/00000542-200510000-00021; Osman A, 1997, J BEHAV MED, V20, P589, DOI 10.1023/A:1025570508954; PERELLE IB, 1994, BEHAV GENET, V24, P217, DOI 10.1007/BF01067189; Piche M, 2013, J PAIN, V14, P1217, DOI 10.1016/j.jpain.2013.05.009; Popescu A, 2010, PAIN, V150, P309, DOI 10.1016/j.pain.2010.05.013; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Rehberg B, 2012, INT J NEUROSCI, V122, P298, DOI 10.3109/00207454.2011.649868; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Roelofs J, 2003, PAIN, V101, P299, DOI 10.1016/S0304-3959(02)00338-X; Roelofs J, 2002, BEHAV RES THER, V40, P1081, DOI 10.1016/S0005-7967(02)00008-6; Ruigrok ANV, 2014, NEUROSCI BIOBEHAV R, V39, P34, DOI 10.1016/j.neubiorev.2013.12.004; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Schierz O, 2012, COMMUNITY DENT ORAL, V40, P507, DOI 10.1111/j.1600-0528.2012.00692.x; Schmidt-Wicke T, 2015, BRAIN ADAPTING PAIN, P247; Schmidt-Wilcke T, 2015, BEST PRACT RES CL RH, V29, P29, DOI 10.1016/j.berh.2015.04.030; Scott D, 2005, CLIN J PAIN, V21, P175, DOI 10.1097/00002508-200503000-00009; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Seminowicz DA, 2013, J PAIN, V14, P1573, DOI 10.1016/j.jpain.2013.07.020; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smallwood RF, 2013, J PAIN, V14, P663, DOI 10.1016/j.jpain.2013.03.001; SPITZER WO, 1995, SPINE S8, V20, P1, DOI DOI 10.1097/00007632-199504151-00001; Sterling M, 2004, MANUAL THER, V9, P60, DOI 10.1016/j.math.2004.01.006; Takasaki H, 2012, ARCH PHYS MED REHAB, V93, P1774, DOI 10.1016/j.apmr.2012.05.013; Tamburin S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01350; Tousignant-Laflamme Y, 2008, BRAIN RES, V1230, P73, DOI 10.1016/j.brainres.2008.06.120; Tracey I, 2005, CURR OPIN NEUROBIOL, V15, P478, DOI 10.1016/j.conb.2005.06.010; Van Damme S, 2002, PAIN, V96, P319, DOI 10.1016/S0304-3959(01)00463-8; van Damme S., 2000, GEDRAGSTHERAPIE, V33, P209; Van Oosterwijck J, 2013, EUR J PAIN, V17, P299, DOI 10.1002/j.1532-2149.2012.00193.x; Verhagen AP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003338.pub3; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Vernon H, 2008, J MANIP PHYSIOL THER, V31, P491, DOI 10.1016/j.jmpt.2008.08.006; Walitt B, 2016, CURR RHEUMATOL REV, V12, P55, DOI 10.2174/1573397112666151231111104; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Whiteside A, 2004, PAIN, V109, P497, DOI 10.1016/j.pain.2004.02.029; Yarnitsky D, 2010, CURR OPIN ANESTHESIO, V23, P611, DOI 10.1097/ACO.0b013e32833c348b; Ylinen J, 2007, MANUAL THER, V12, P192, DOI 10.1016/j.math.2006.06.010; Younger JW, 2010, PAIN, V149, P222, DOI 10.1016/j.pain.2010.01.006; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zusman M, 2002, MANUAL THER, V7, P80, DOI 10.1054/math.2002.0442	112	12	12	0	14	AM SOC INTERVENTIONAL PAIN PHYSICIANS	PADUCAH	81 LAKEVIEW DR, PADUCAH, KY 42001 USA	1533-3159			PAIN PHYSICIAN	Pain Physician	NOV-DEC	2017	20	7					E1025	E1051					27	Anesthesiology; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology	FT1EM	WOS:000422877600003	29149149				2022-02-06	
J	Cordaro, M; Casili, G; Paterniti, I; Cuzzocrea, S; Esposito, E				Cordaro, Marika; Casili, Giovanna; Paterniti, Irene; Cuzzocrea, Salvatore; Esposito, Emanuela			Fumaric Acid Esters Attenuate Secondary Degeneration after Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						fumaric acid esters; neuroinflammation; neuroprotection; spinal cord injury	PLACEBO-CONTROLLED PHASE-3; NRF2 ANTIOXIDANT PATHWAY; NF-KAPPA-B; DIMETHYL FUMARATE; MULTIPLE-SCLEROSIS; INFLAMMATORY RESPONSE; SIGNALING PATHWAY; OXIDATIVE STRESS; ORAL BG-12; CELLS	Spinal cord injury (SCI) causes permanent changes in motor, sensory, and autonomic functions. Unfortunately, there are no stable cures and current treatments include surgical decompression, methylprednisolone, and hemodynamic control that lead to modest function recovery. Fumaric acid esters (FAEs) were firstly used in the management of an immunological skin disorder, such as psoriasis. Because of their potent anti-inflammatory effects, they have been introduced in multiple sclerosis (MS). Investigation has shown not only an anti-inflammatory, but also supposed neuroprotective mechanism of action. The goal of the present work was to evaluate the potential beneficial effects of dimethyl fumarate (DMF) and monomethyl fumarate (MMF) in a mouse model of traumatic SCI. SCI was produced by extradural compression for 1 min of the spinal cord at the T6-7 level using an aneurysm clip, and DMF and MMF (both at 30 mg/kg) were administered by oral gavage to the mice 1 and 6 h after SCI. For locomotor activity, study mice were treated with FAEs once daily for 10 days. We observed that mice treated with DMF exhibited a significant and sustained recovery of motor function. FAEs significantly reduced the severity of inflammation by a modulation of pro-inflammatory cytokines and apoptosis factors, and increased neutrophic factors such as anti-brain-derived neurotrophic factor (BDNF), anti-glial cell-derived neurotrophic factor (GDNF), and neurotrophin-3 (NT3). Our results showed important protective effects of DMF in an animal model of SCI, considerably improving recovery of motor function, possibly by reducing the secondary inflammation and tissue injury that characterize this model. DMF may constitute a promising target for future SCI therapies.	[Cordaro, Marika; Casili, Giovanna; Paterniti, Irene; Cuzzocrea, Salvatore; Esposito, Emanuela] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Viale Ferdinando Stagno DAlcontres 31, I-98166 Messina, Italy; [Cuzzocrea, Salvatore] St Louis Univ, Sch Med, Pharmacol & Physiol Sci, St Louis, MO USA		Esposito, E (corresponding author), Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Viale Ferdinando Stagno DAlcontres 31, I-98166 Messina, Italy.	eesposito@unime.it	Casili, Giovanna/AAC-3740-2022; Cordaro, Marika/K-7329-2016	Casili, Giovanna/0000-0002-0552-1396; Cordaro, Marika/0000-0002-3980-0043; Cuzzocrea, Salvatore/0000-0001-6131-3690			Albrecht P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-163; Ashrafian H, 2012, CELL METAB, V15, P361, DOI 10.1016/j.cmet.2012.01.017; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Bhatnagar T, 2016, COMPUT METHOD BIOMEC, V19, P386, DOI 10.1080/10255842.2015.1032944; Bomprezzi R, 2015, THER ADV NEUROL DISO, V8, P20, DOI 10.1177/1756285614564152; Bracken MB, 1998, J NEUROSURG, V89, P699, DOI 10.3171/jns.1998.89.5.0699; Chen H, 2014, J CLIN INVEST, V124, P2188, DOI 10.1172/JCI72151; Cho H, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0452-z; Dibbert S, 2013, ARCH DERMATOL RES, V305, P447, DOI 10.1007/s00403-013-1332-y; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P669, DOI 10.1161/ATVBAHA.111.241836; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; Genovese T, 2009, PHARMACOL RES, V59, P338, DOI 10.1016/j.phrs.2009.01.018; Ghoreschi K, 2011, J EXP MED, V208, P2291, DOI 10.1084/jem.20100977; Gillard GO, 2015, J NEUROIMMUNOL, V283, P74, DOI 10.1016/j.jneuroim.2015.04.006; Gold R, 2012, CLIN IMMUNOL, V142, P44, DOI 10.1016/j.clim.2011.02.017; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Gomes-Leal W, 2004, EXP NEUROL, V190, P456, DOI 10.1016/j.expneurol.2004.06.028; Haarmann A, 2015, INT J MOL SCI, V16, P19086, DOI 10.3390/ijms160819086; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Howden R, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/104308; Jensen MP, 2007, ARCH PHYS MED REHAB, V88, P638, DOI 10.1016/j.apmr.2007.02.002; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Labruyere R, 2010, SPINE, V35, pS259, DOI 10.1097/BRS.0b013e3181f1a979; Lang-Lazdunski L, 2003, J VASC SURG, V38, P564, DOI 10.1016/S0741-5214(03)00473-7; Lastres-Becker I, 2016, ANTIOXID REDOX SIGN, V25, P61, DOI 10.1089/ars.2015.6549; Lin-Holderer J, 2016, NEUROPHARMACOLOGY, V105, P228, DOI 10.1016/j.neuropharm.2016.01.023; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Litjens NHR, 2004, BRIT J CLIN PHARMACO, V58, P429, DOI 10.1111/j.1365-2125.2004.02145.x; MULLANE KM, 1985, J PHARMACOL METHOD, V14, P157, DOI 10.1016/0160-5402(85)90029-4; Nakamura M, 2001, EXP NEUROL, V169, P407, DOI 10.1006/exnr.2001.7670; Naseem Mehar, 2014, ScientificWorldJournal, V2014, P586270, DOI 10.1155/2014/586270; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Paterniti I, 2014, J NEUROINFLAMM, V11, DOI [10.1186/1742-2094-11-6, 10.1186/s12974-014-0136-0]; Paterniti I, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-91; Paterniti I, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-20; Paterniti I, 2010, J NEUROCHEM, V112, P611, DOI 10.1111/j.1471-4159.2009.06471.x; Peng HY, 2012, J BIOL CHEM, V287, P28017, DOI 10.1074/jbc.M112.383380; Promsote W, 2014, INVEST OPHTH VIS SCI, V55, P5382, DOI 10.1167/iovs.14-14179; Rahman M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4944; Reick C, 2014, EXP NEUROL, V257, P50, DOI 10.1016/j.expneurol.2014.04.003; RIVLIN AS, 1978, SURG NEUROL, V10, P39; Scannevin RH, 2012, J PHARMACOL EXP THER, V341, P274, DOI 10.1124/jpet.111.190132; Schilling S, 2006, CLIN EXP IMMUNOL, V145, P101, DOI 10.1111/j.1365-2249.2006.03094.x; Schmidt MM, 2010, NEUROCHEM INT, V57, P460, DOI 10.1016/j.neuint.2010.01.006; Schmidt TJ, 2007, BIOORGAN MED CHEM, V15, P333, DOI 10.1016/j.bmc.2006.09.053; SHEA TB, 1994, BIOTECHNIQUES, V16, P1126; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Treumer F, 2003, J INVEST DERMATOL, V121, P1383, DOI 10.1111/j.1523-1747.2003.12605.x; Wang Q, 2015, INT J MOL SCI, V16, P13885, DOI 10.3390/ijms160613885; Werdenberg D, 2003, BIOPHARM DRUG DISPOS, V24, P259, DOI 10.1002/bdd.364; Wilms H, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-30; Wilson JR, 2012, SPINAL CORD, V50, P840, DOI 10.1038/sc.2012.59; Yazdi MR, 2008, CLIN DERMATOL, V26, P522, DOI 10.1016/j.clindermatol.2008.07.001	57	12	13	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 1	2017	34	21					3027	3040		10.1089/neu.2016.4678			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FK6VJ	WOS:000413643000009	27889959				2022-02-06	
J	Kearney, PE; See, J				Kearney, Philip E.; See, James			Misunderstandings of concussion within a youth rugby population	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Head injuries; Adolescent; Sports safety; Return to sport; England	SCHOOL FOOTBALL PLAYERS; UNION PLAYERS; SPORTS CONCUSSION; KNOWLEDGE; ATTITUDES; EDUCATION; PREVENTION; MANAGEMENT; STUDENTS; BEHAVIOR	Objectives: The recognition and management of concussion has become a major health concern within rugby union. Identifying misconceptions and attitudes regarding concussion is valuable for informing player education. Therefore, the purpose of this study was to explore the knowledge of, and attitudes towards, concussion in subgroups of youth rugby players. Design: Cross-sectional survey. Methods: Information sheets and consent forms were distributed at training sessions for multiple teams at each of three schools and three clubs. Players who returned consent forms completed a custom-designed survey at a subsequent session. Results: Two hundred and fifty-five English players, aged 11-17 years, completed the anonymous survey. Sixty-one participants reported a total of 77 concussions. Self-reported return to play ranged from 0 to 365 days; only seven players (11%) reported a return to play after the Rugby Football Union's recommendation of 23 days. Although the majority of findings relating to players' knowledge of concussion were positive, a number of important misunderstandings were revealed. While the majority of players reported positive attitudes towards concussion, a substantial minority (up to 30%) reported inappropriate attitudes in response to specific questions. Participants who played at multiple venues did report superior knowledge and attitudes relative to their peers who played at a single venue. Conclusion: Despite generally positive results, youth rugby players were found to hold a number of misconceptions regarding concussion which should be the focus for education initiatives. Considering general subgroups of players by concussion history, age, or playing position appears unlikely to enhance the design of concussion education programmes. (C) 2017 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Kearney, Philip E.; See, James] Univ Chichester, Inst Sport, Chichester, England		Kearney, PE (corresponding author), Univ Chichester, Inst Sport, Chichester, England.	p.kearney@chi.ac.uk		Kearney, Philip/0000-0003-3425-663X			Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Bay R. C., 2010, ATHLETIC TRAINING SP, V2, P208, DOI DOI 10.3928/19425864-20100524-03; CARIFIO J, 1994, J ALCOHOL DRUG EDUC, V39, P74; Cote J., 2016, HDB YOUTH SPORT; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Delahunty SE, 2015, J SCHOOL HEALTH, V85, P17, DOI 10.1111/josh.12219; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Edens JF, 2001, LAW HUMAN BEHAV, V25, P235, DOI 10.1023/A:1010793810896; Finch C, 2002, INJ PREV, V8, P151, DOI 10.1136/ip.8.2.151; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hendricks S, 2012, SAFETY SCI, V50, P266, DOI 10.1016/j.ssci.2011.08.061; Hollis SJ, 2012, BRIT J SPORT MED, V46, P735, DOI 10.1136/bjsm.2011.085332; HOLM S, 1979, SCAND J STAT, V6, P65; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Kirkwood G, 2015, BRIT J SPORT MED, V49, P506, DOI 10.1136/bjsports-2014-093774; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Miyashita TL, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114554549; Mrazik M, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094848; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Quarrie KL, 2013, J SCI MED SPORT, V16, P353, DOI 10.1016/j.jsams.2012.08.005; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Tator CH, 2012, J CLIN SPORT PSYCHOL, V6, P293, DOI 10.1123/jcsp.6.3.293; White P, 2014, JSCI MED SPORT, V18, pe102	30	12	12	0	18	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	NOV	2017	20	11					981	985		10.1016/j.jsams.2017.04.019			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	FL4YS	WOS:000414238100006	28476439	Green Submitted, Green Accepted			2022-02-06	
J	Landry-Roy, C; Bernier, A; Gravel, J; Beauchamp, MH				Landry-Roy, Catherine; Bernier, Annie; Gravel, Jocelyn; Beauchamp, Miriam H.			Predictors of Sleep Outcomes Following Mild Traumatic Brain Injury in Preschoolers: Subjective and Objective Assessment of Outcome	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						actigraphy; concussion; pediatric; sleep; traumatic brain injury	MINOR HEAD-INJURY; YOUNG-CHILDREN; POSTCONCUSSIVE SYMPTOMS; BEHAVIORAL OUTCOMES; ADOLESCENTS; DISTURBANCES; PATTERNS; PREVALENCE; ACTIGRAPHY; CONSCIOUSNESS	Objectives: To investigate sleep and its predictors in preschoolers with mild traumatic brain injury (mTBI). Participants and procedure: The sample included 225 children, aged 18 to 60 months, divided into 3 groups: children with accidental mTBI (n = 85), children with orthopedic injury (n = 58), and typically developing children (n = 82). Retrospective reports of preinjury sleep and family functioning were obtained as part of a baseline assessment at the time of recruitment. Parental ratings of sleep problems were collected 6 months postinjury on the full sample, and actigraphy data were collected on a subset of children. Demographic, preinjury, and periinjury factors were examined as potential predictors of sleep outcomes. Results: No group differences were found in ratings of sleep problems or for nighttime sleep duration and sleep efficiency, as measured by actigraphy. Besides, preexisting sleep disturbances and brain injury resulting in alteration of consciousness were identified as predictors of poorer sleep in the mTBI group. Conclusion: Although mTBI did not result in group-level sleep disturbances 6 months postinjury, the findings suggest that premorbid and injury-related factors place some children at risk for poorer sleep after mTBI. These factors should be documented so clinicians can intervene early.	[Landry-Roy, Catherine; Bernier, Annie; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Landry-Roy, Catherine; Gravel, Jocelyn; Beauchamp, Miriam H.] CHU St Justine Res Ctr, Montreal, PQ, Canada		Landry-Roy, C (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP11036]	Preparation of this article was supported by the Canadian Institutes of Health Research (MOP11036 to M.H.B).	Abidin, 1995, PARENTING STRESS IND; Acebo C, 2005, SLEEP, V28, P1568, DOI 10.1093/sleep/28.12.1568; Acebo C, 1999, SLEEP, V22, P95, DOI 10.1093/sleep/22.1.95; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Astill RG, 2012, PSYCHOL BULL, V138, P1109, DOI 10.1037/a0028204; ATKINSON E, 1995, CHILD CARE HLTH DEV, V21, P233, DOI 10.1111/j.1365-2214.1995.tb00754.x; Beauchamp MH, 2013, HAND CLINIC, V112, P913, DOI 10.1016/B978-0-444-52910-7.00013-1; Beebe DW, 2007, J PEDIATR PSYCHOL, V32, P845, DOI 10.1093/jpepsy/jsm003; Beebe DW, 2011, PEDIATR CLIN N AM, V58, P649, DOI 10.1016/j.pcl.2011.03.002; Belanger ME, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00158; Belanger ME, 2013, J CLIN SLEEP MED, V9, P701, DOI 10.5664/jcsm.2844; Biggs SN, 2013, SLEEP MED, V14, P1304, DOI 10.1016/j.sleep.2013.06.014; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Byars KC, 2011, SLEEP MED, V12, P898, DOI 10.1016/j.sleep.2011.05.002; Cassidy JD, 2004, J REHABIL MED, pS28; Catroppa C, 2015, NEW FRONTIERS PEDIAT; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Dahl RE, 2007, J FAM PSYCHOL, V21, P1, DOI 10.1037/0893-3200.21.1.1; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; El-Sheikh M., 2011, SLEEP AND DEVELOPMEN; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Evans BM, 2002, J ROY SOC MED, V95, P591, DOI 10.1258/jrsm.95.12.591; Faul M, 2010, TRAUMATIC BRAIN INJU; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Garcia D, 2015, J PEDIATR PSYCHOL, V40, P391, DOI 10.1093/jpepsy/jsu093; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hobson JA, 2002, NAT REV NEUROSCI, V3, P679, DOI 10.1038/nrn915; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Jenni OG, 2007, PEDIATRICS, V120, pe769, DOI 10.1542/peds.2006-3300; Kaufman Y, 2001, PEDIATR NEUROL, V24, P129, DOI 10.1016/S0887-8994(00)00254-X; Korinthenberg R, 2004, BRAIN DEV-JPN, V26, P113, DOI 10.1016/S0387-7604(03)00110-4; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Meltzer LJ, 2012, SLEEP, V35, P159, DOI 10.5665/sleep.1608; Milroy G, 2008, J PEDIATR PSYCHOL, V33, P242, DOI 10.1093/jpepsy/jsm099; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Myers R. H., 1990, CLASSICAL MODERN REG; National Sleep Foundation, 2004, CHILDR SLEEP SLEEP A; Owens Judith A, 2005, Behav Sleep Med, V3, P18, DOI 10.1207/s15402010bsm0301_4; OwensStively J, 1997, J DEV BEHAV PEDIATR, V18, P314, DOI 10.1097/00004703-199710000-00005; Pillar G, 2003, PEDIATR NEUROL, V29, P131, DOI 10.1016/S0887-8994(03)00149-8; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Sadeh A, 2015, MONOGR SOC RES CHILD, V80, P33, DOI 10.1111/mono.12143; Sadeh A, 2007, SLEEP MED CLIN, V2, P513, DOI 10.1016/j.jsmc.2007.05.012; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Shay N, 2014, J NEUROTRAUM, V31, P1305, DOI 10.1089/neu.2013.3275; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Thurber S., 2012, ARCH ASSESSMENT PSYC, V2, P73; Werner H, 2008, ARCH PEDIAT ADOL MED, V162, P350, DOI 10.1001/archpedi.162.4.350; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	57	12	12	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2017	32	6					E13	E23		10.1097/HTR.0000000000000303			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FQ8BO	WOS:000418588100002	28422896				2022-02-06	
J	Prabhakaran, K; Petrone, P; Lombardo, G; Stoller, C; Policastro, A; Marini, CP				Prabhakaran, Kartik; Petrone, Patrizio; Lombardo, Gary; Stoller, Christy; Policastro, Anthony; Marini, Corrado P.			Mortality rates of severe traumatic brain injury patients: impact of direct versus nondirect transfers	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Transfer; Mortality	HEAD-INJURY; MANAGEMENT	Background: Direct transport of patients with severe traumatic brain injury (sTBI) to trauma centers (TCs) that can provide definitive care results in lower mortality rates. This study investigated the impact of direct versus nondirect transfers on the mortality rates of patients with sTBI. Methods: Data on patients with TBI admitted between January 1, 2012, and December 31, 2013, to our Level I TC were obtained from the trauma registry. Data included patient age, sex, mechanism, and type of injury, comorbidities, Glasgow Coma Scale, Injury Severity scores, prehospital time, time to request and to transfer, time to initiation of multimodality monitoring and goal-directed therapy protocol, dwell time in the emergency department (EDT), and mortality. Data, reported in means +/- standard deviation, were analyzed with the Student t-test and chi-square. Statistical significance was accepted at a P value < 0.05. Results: sTBI direct transfer to TC versus transfer from non-TCs (NTC): Of the 1187 patients with TBI admitted to our TC, 768 (64.7%) were admitted directly from the scene, whereas 419 (35.3%) were admitted after secondary transfer. One hundred seventy-one (22.2%) of the direct transfers had Glasgow Coma Scale < 8 (sTBI) and 92 (21.9%) of the secondary transfers had sTBI. The transfer time: Time from scene to arrival to the EDT was significantly shorter for TC versus NTCs 43 +/- 14 versus 77 +/- 26 min, respectively (P < 0.05). EDT dwell time before transfer and time from injury to arrival to TC were 4.2 +/- 2.1 and 6.2 +/- 8.3 h, respectively. Mortality: There was a statistically significant lower mortality for patients with sTBI transferred directly from the scene to TCs as opposed to patients secondarily transferred, 33/171 (19.3%) versus 33/92 (35.8%), respectively (P < 0.05). Conclusions: To decrease TBI-related mortality, patients with suspected sTBI should be taken directly to a Level I or II TC unless they require life-saving stabilization at NTCs. (C) 2017 Elsevier Inc. All rights reserved.	[Prabhakaran, Kartik; Lombardo, Gary; Stoller, Christy; Policastro, Anthony] New York Med Coll, Div Trauma Surg Surg Crit Care & Emergency Gen Su, Dept Surg, Westchester Med Ctr,Univ Hosp, E150 Taylor Pavil,100 Woods Rd, Valhalla, NY 10595 USA; [Petrone, Patrizio; Marini, Corrado P.] Winthrop Univ Hosp, Div Trauma Surg Surg Crit Care & Emergency Gen Su, Mineola, NY 11501 USA		Prabhakaran, K (corresponding author), New York Med Coll, Div Trauma Surg Surg Crit Care & Emergency Gen Su, Dept Surg, Westchester Med Ctr,Univ Hosp, E150 Taylor Pavil,100 Woods Rd, Valhalla, NY 10595 USA.	Kartik.Prabhakaran@wmchealth.org	Petrone, Patrizio/AAQ-7986-2020	Petrone, Patrizio/0000-0002-7629-1663			Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Clark RSB, 1997, NEUROSURGERY, V41, P1284, DOI 10.1097/00006123-199712000-00010; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2010, TRAUMATIC BRAIN INJU; Faul M, 2016, PREHOSP EMERG CARE, V20, P594, DOI 10.3109/10903127.2016.1149651; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Sharma S, 2014, J AM COLL SURGEONS, V218, P510, DOI 10.1016/j.jamcollsurg.2014.01.002; Sharma S, 2014, J AM COLL SURGEONS, V218, P51, DOI 10.1016/j.jamcollsurg.2013.10.005; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675	21	12	13	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	NOV	2017	219						66	71		10.1016/j.jss.2017.05.103			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FK8RF	WOS:000413775200011	29078912				2022-02-06	
J	Sahyouni, R; Mahmoodi, A; Mahmoodi, A; Rajaii, RR; Hasjim, BJ; Bustillo, D; Huang, M; Tran, DK; Chen, JW				Sahyouni, Ronald; Mahmoodi, Amin; Mahmoodi, Amir; Rajaii, Ramin R.; Hasjim, Bima J.; Bustillo, David; Huang, Melissa; Diem Kieu Tran; Chen, Jefferson W.			Interactive iBook-Based Patient Education in a NeuroTrauma Clinic	NEUROSURGERY			English	Article						Concussion; Education; Ibook; Neurological surgery; TBI	TRAUMATIC BRAIN-INJURY; RECURRENT CONCUSSION; POPULATION; ATTENTION; RISK; INTELLIGENCE; SECONDARY; DEFICITS; IMPACT; AUTHOR	BACKGROUND: Traumatic brain injury (TBI) is a leading cause of death and disability in the United States. Educational interventions may alleviate the burden of TBI for patients and their families. Interactive modalities that involve engagement with the educational material may enhance patient knowledge acquisition when compared to static text-based educational material. OBJECTIVE: To determine the effects of educational interventions in the outpatient setting on self-reported patient knowledge, with a focus on iPad-based (Apple, Cupertino, California) interactive modules. METHODS: Patients and family members presenting to a NeuroTrauma clinic at a tertiary care academic medical center completed a presurvey assessing baseline knowledge of TBI or concussion, depending on the diagnosis. Subjects then received either an interactive iBook (Apple) on TBI or concussion, or an informative pamphlet with identical information in text format. Subjects then completed a postsurvey prior to seeing the neurosurgeon. RESULTS: All subjects (n = 152) significantly improved on self-reported knowledge measures following administration of either an iBook (Apple) or pamphlet (P < .01, 95% confidence interval [CI]). Subjects receiving the iBook (n = 122) performed significantly better on the postsurvey (P < .01, 95% CI), despite equivalent presurvey scores, when compared to those receiving pamphlets (n = 30). Lastly, patients preferred the iBook to pamphlets (P < .01, 95% CI). CONCLUSION: Educational interventions in the outpatient NeuroTrauma setting led to significant improvement in self-reported measures of patient and family knowledge. This improved understanding may increase compliance with the neurosurgeon's recommendations and may help reduce the potential anxiety and complications that arise following a TBI.	[Sahyouni, Ronald; Rajaii, Ramin R.; Hasjim, Bima J.] UC Irvine Sch Med, Irvine, CA USA; [Mahmoodi, Amin] UC Irvine Dept Biomed Engn, Irvine, CA USA; [Mahmoodi, Amir; Bustillo, David; Huang, Melissa; Diem Kieu Tran; Chen, Jefferson W.] UC Irvine Dept Neurol Surg, Irvine, CA USA		Chen, JW (corresponding author), UC Irvine Med Ctr, 101 City Dr South, Orange, CA 92868 USA.	jeffewc1@uci.edu	chen, jeff/AAR-7375-2020	chen, jeff/0000-0003-0624-6864; Hasjim, Bima/0000-0003-4301-9011; Mahmoodi, Amin/0000-0003-0012-9245; Sahyouni, Ronald/0000-0002-2124-0535	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 GM008620-17]	Ronald Sahyouni was funded, in part, by NIH grant number - T32 GM008620-17. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Agarwal N, 2013, J CLIN NEUROSCI, V20, P1357, DOI 10.1016/j.jocn.2012.10.047; Bloomfield ILM, 2010, J INT NEUROPSYCH SOC, V16, P17, DOI 10.1017/S1355617709990798; Bonwell CC, 1991, 1 ASHEERIC; Briggs M, 2014, J VIS COMMUN MED, V37, P59, DOI 10.3109/17453054.2014.974516; Brito J, 2012, INT MECH ENG C EXP H; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Centers for Disease Control and Prevention (USA), 2012, INJ PREV CONTR TRAUM; Chen JW, 2015, CONCUSSION; Chen JW, 2015, TRAUMATIC BRAIN INJU; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Cusea J., 1992, COOPERATIVE LEARNING, V2, P2; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Ferguson WJ, 2002, FAM MED, V34, P353; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Fox MP, 2009, PATIENT EDUC COUNS, V77, P6, DOI 10.1016/j.pec.2009.02.011; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Ginstfeldt T, 2010, BRAIN INJURY, V24, P1123, DOI 10.3109/02699052.2010.506853; Gliem J.A., 2003, MIDW RES PRACT C AD; Graham Suzanne, 2008, Perm J, V12, P67; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hendrickson S G, 1998, Inj Prev, V4, P126; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Konigs M, 2016, EUR J NEUROL, V23, P21, DOI 10.1111/ene.12719; Konigs M, 2012, J NEUROL NEUROSUR PS, V83, P1048, DOI 10.1136/jnnp-2012-302635; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Levinson W, 2000, JAMA-J AM MED ASSOC, V284, P1021, DOI 10.1001/jama.284.8.1021; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mello MJ, 2009, ACAD EMERG MED, V16, P243, DOI 10.1111/j.1553-2712.2009.00357.x; Millis BJ, 1997, SERIES HIGHER ED; Mitchell SE, 2012, J HEALTH COMMUN, V17, P325, DOI 10.1080/10810730.2012.715233; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Norman G, 2010, ADV HEALTH SCI EDUC, V15, P625, DOI 10.1007/s10459-010-9222-y; PARKIN PC, 1993, PEDIATRICS, V91, P772; Payne KFB, 2012, J VIS COMMUN MED, V35, P162, DOI 10.3109/17453054.2012.747173; Pellman EJ, 2006, NEUROSURG FOCUS, V21, P1; Prince M, 2004, J ENG EDUC, V93, P223, DOI 10.1002/j.2168-9830.2004.tb00809.x; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sarmiento K, 2008, J HEAD TRAUMA REHAB, V23, P164, DOI 10.1097/01.HTR.0000319933.22709.61; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Stewart S, 2015, ANAT SCI EDUC, V8, P429, DOI 10.1002/ase.1501; Stierwalt Julie A. G., 2002, Seminars in Speech and Language, V23, P129, DOI 10.1055/s-2002-24989; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Thomas N, P WORLDCOMP, P16; US Department of Health and Human Services at Center for Disease Control and Prevention (USA), 2010, TRAUMATIC BRAIN INJU; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	56	12	12	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	NOV	2017	81	5					787	794		10.1093/neuros/nyx095			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	FL6RQ	WOS:000414374300031	28368534				2022-02-06	
J	Sinha, S; Raheja, A; Samson, N; Goyal, K; Bhoi, S; Selvi, A; Sharma, P; Sharma, BS				Sinha, Sumit; Raheja, Amol; Samson, Neha; Goyal, Keshav; Bhoi, Sanjeev; Selvi, Arul; Sharma, Pushpa; Sharma, Bhawani Shankar			A randomized placebo-controlled trial of progesterone with or without hypothermia in patients with acute severe traumatic brain injury	NEUROLOGY INDIA			English	Article						Factorial design; hypothermia; progesterone; randomized clinical trial; severe head injury	SEVERE HEAD-INJURY; CLINICAL-TRIAL	Objective: Among newer neuroprotectant modalities, hypothermia and progesterone have shown a beneficial role in preliminary studies enrolling patients with severe traumatic brain injury (sTBI). The primary objective of this study was to evaluate the efficacy of progesterone with or without prophylactic hypothermia in acute sTBI patients. Materials and Methods: This is a prospective, outcome assessor, statistician blinded, randomized, and placebo-controlled phase II trial of progesterone with or without hypothermia (factorial design). All adult patients (18-65 years) with acute sTBI (Glasgow coma score of 4-8) and presenting to trauma center within 8 h after injury were included in the trial. Computer-generated randomization was done after exclusion; sequentially numbered, opaque, sealed envelope technique was used for allocation concealment. The enrollment duration was from January 2012 to October 2014. The primary endpoint was dichotomized Glasgow outcome score (GOS) [poor recovery = GOS 1-3; good recovery = GOS 4-5], and secondary endpoints were functional independence measure (FIM) score and mortality rate at 6 and 12 months follow-up after recruitment. Results: A total of 107 patients were randomized into four groups (placebo [n = 27], progesterone [n = 26], hypothermia alone [n = 27], and progesterone + hypothermia [n = 27]). The study groups were comparable in baseline parameters except for a higher incidence of decompressive craniectomy in the placebo group (P = 0.001). The analysis of GOS at 6 months revealed statistically significant better outcome in the hypothermia group (82%; P = 0.01) and a weaker evidence for progesterone group (74%; P = 0.07) as compared with the placebo group (44%). However, the outcome benefit was marginal at 1-year follow-up for the hypothermia group (82% vs. 58%, P = 0.17). The adjusted odds ratio of poor recovery at 6 months in the hypothermia group was 0.21 (confidence interval = 0.05-0.84, P = 0.03), as compared with the placebo group. Although mean FIM scores at 6 and 12 months respectively were marginally higher in the hypothermia and progesterone groups compared with the placebo group (P = 0.06 and 0.27), the proportion of functionally independent individuals were similar in all the groups (P = 0.79 and 0.51). The mortality rates were similar in all the groups at 6 and 12 months (P = 0.78 and 0.52 respectively). Conclusions: A strong evidence for prophylactic hypothermia and a weak evidence for progesterone therapy was observed for a better primary outcome at 6 months as compared to the placebo. A similar trend was observed at a 1-year follow-up. Contrary to our hypothesis, prophylactic hypothermia therapy suppressed the beneficial effects of progesterone therapy in sTBI patients. The complex cascades of factors responsible for such interactions are still unknown and need to be further determined.	[Sinha, Sumit; Raheja, Amol; Samson, Neha; Sharma, Bhawani Shankar] All India Inst Med Sci, Dept Neurosurg, New Delhi 110029, India; [Goyal, Keshav] All India Inst Med Sci, Dept Neuroanaesthesia, New Delhi, India; [Bhoi, Sanjeev] All India Inst Med Sci, Dept Emergency Med, New Delhi, India; [Selvi, Arul] All India Inst Med Sci, Lab Med, New Delhi, India; [Sharma, Pushpa] Uniformed Serv Univ Hlth Sci, Dept Anesthesiol, Bethesda, MD 20814 USA		Sinha, S (corresponding author), All India Inst Med Sci, Dept Neurosurg, New Delhi 110029, India.	sumitneuro@gmail.com	Sharma, Pushpa/AAY-8756-2020		Department of Biotechnology, Ministry of Science and Technology, India	The National Trial Registry Number CTRI/2009/091/000893; Funded by Department of Biotechnology, Ministry of Science and Technology, India.	Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, THER HYPOTHERMIA TEM, V1, DOI 10.1089/ther.2011.0009; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; Sinha S, 2014, INDIAN J NEUROSURG, V3, P138, DOI 10.4103/2277-9167.146827; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	14	12	13	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	NOV-DEC	2017	65	6					1304	1311		10.4103/0028-3886.217973			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM7IL	WOS:000415249200028	29133706				2022-02-06	
J	Zuraik, C; Sampalis, J				Zuraik, Christopher; Sampalis, John			Epidemiology of Traumatic Injuries at an Urban Hospital in Port-au-Prince, Haiti	WORLD JOURNAL OF SURGERY			English	Article							CAPACITY; PATTERNS; CARE	Traumatic injuries represent a major burden of disease worldwide. Haiti lacks statistics on the epidemiology of traumatic injuries, as there is no formal injury surveillance program. This study will assess the burden of traumatic injuries in an urban trauma center in the capital city of Port-au-Prince, Haiti. A retrospective, cross-sectional chart review study at an urban trauma hospital was carried out for the period December 1, 2015, to January 31, 2016. Data were obtained through the hospital's main patient logbook, medical charts, and trauma registry forms. Data on medical documentation, demographics, and injury characteristics were collected and analyzed using descriptive statistics. A total of 410 patients were evaluated for treatment of traumatic injuries during the 2-month study. The mean age in years was 30, with 66.3% male and 78.4% less than 41 years of age. There were 6.6 injuries per day and no correlation between frequency of injury and day of the week. Road traffic accidents accounted for 43.0% of trauma modes. The mean and median length of stay were 6.6 and 3.0 days. 9.0% of patients suffered severe trauma (ISS ae<yen> 16). 21.0% of patients with traumatic brain injury suffered severe head injuries. Extremity trauma was the most frequently injured anatomical region (50.0%). 22.7% of patients were admitted, and 15.1% patients underwent at least one surgical procedure. Road traffic accidents are the primary reason for injury; thus, prevention initiatives and improved trauma care may provide substantial public health benefits.	[Zuraik, Christopher; Sampalis, John] McGill Univ, Dept Expt Surg, Fac Med, Montreal, PQ, Canada; [Zuraik, Christopher; Sampalis, John] JSS Med Res Inc, Sci Affairs, 9400 Henri Bourassa Blvd West, St Laurent, PQ H4S 1N8, Canada		Sampalis, J (corresponding author), McGill Univ, Dept Expt Surg, Fac Med, Montreal, PQ, Canada.; Sampalis, J (corresponding author), JSS Med Res Inc, Sci Affairs, 9400 Henri Bourassa Blvd West, St Laurent, PQ H4S 1N8, Canada.	jsampalis@jssresearch.com					Adeyekun AA, 2013, NIGER J CLIN PRACT, V16, P19, DOI 10.4103/1119-3077.106717; Aluisio AR, 2015, PREHOSP DISASTER MED, V30, P599, DOI 10.1017/S1049023X15005361; Aluisio AR, 2014, PREHOSP DISASTER MED, V29, P230, DOI 10.1017/S1049023X14000430; Association for the Advancement of Automotive Medicine, 2016, ABBR INJ SCAL AIS; Brasure M., 2012, AGENCY HEALTHCARE RE, V72, pES1; DeGennaro V, 2015, J CRANIOFAC SURG, V26, P1042, DOI 10.1097/SCS.0000000000001678; Dewberry L, 2014, J SURG RES, V192, P34, DOI 10.1016/j.jss.2014.06.009; Emejulu J. K. C., 2008, East and Central African Journal of Surgery, V13, P86; Furey Andrew, 2015, J Orthop Trauma, V29 Suppl 10, pS14, DOI 10.1097/BOT.0000000000000407; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Kobusingye OC, 2002, INJ PREV, V8, P133, DOI 10.1136/ip.8.2.133; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marsh RH, 2015, LANCET GLOBAL HLTH S, V2, pV3; McCullough C, 2016, J SURG RES, V201, P126, DOI 10.1016/j.jss.2015.10.018; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; Mock CN, 1998, J TRAUMA, V44, P804, DOI 10.1097/00005373-199805000-00011; MOCK CN, 1993, J TRAUMA, V35, P518, DOI 10.1097/00005373-199310000-00004; Mock CN, 2003, ACCIDENT ANAL PREV, V35, P81, DOI 10.1016/S0001-4575(01)00092-6; Mutasingwa D R, 2001, Cent Afr J Med, V47, P203; Organization W.H, 2008, GLOBAL BURDEN DIS 20; Peden M, 2003, INJURY LEADING CAUSE; Siddiqui Arshad A, 2004, J Coll Physicians Surg Pak, V14, P173; The Haiti Case Study, 2012, WORK PAP COLL NATO H; Wamai R.G., 2011, JAPAN MED ASS J, V54, P56; World Health Organization, 2010, INJ VIOL FACTS; Zafarghandi MR, 2003, J TRAUMA, V55, P459, DOI 10.1097/01.TA.0000027132.39340.FE; Zagaran E, 2013, AM COLL SURG, V218, P41; Zavalaa Diego E, 2008, Med Confl Surviv, V24, P260, DOI 10.1080/13623690802373884	29	12	12	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	NOV	2017	41	11					2674	2680		10.1007/s00268-017-4088-2			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FJ9QN	WOS:000413114900004	28681141				2022-02-06	
J	Annoni, F; Fontana, V; Brimioulle, S; Creteur, J; Vincent, JL; Taccone, FS				Annoni, Filippo; Fontana, Vito; Brimioulle, Serge; Creteur, Jacques; Vincent, Jean-Louis; Taccone, Fabio S.			Early Effects of Enteral Urea on Intracranial Pressure in Patients With Acute Brain Injury and Hyponatremia	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						urea; intracranial pressure; brain injury; osmotic therapy	ANEURYSMAL SUBARACHNOID HEMORRHAGE; REBOUND PHENOMENON; CONIVAPTAN; CARE; MANAGEMENT; DIAGNOSIS; AGENT	Background: Hyponatremia occurs commonly after acute brain injury and is often due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Urea administration is 1 therapeutic option. Methods: In our Department, enteral urea is routinely administered to patients with acute brain injury who develop hyponatremia consistent with SIADH and do not respond to an initial sodium load. We reviewed the records of all patients over a 2-year period, who had acute brain injury, received enteral urea because of hyponatremia, and had intracranial pressure (ICP) monitoring using an intraventricular catheter. We recorded demographic, biological, and clinical data; mean ICP values during the 6 hours before and after the first dose of urea were also recorded. Results: We included 40 patients (23 subarachnoid hemorrhage, 8 traumatic brain injury, 6 intracranial hemorrhage, 2 postbrain tumor surgery, and 1 ischemic stroke); median age was 54 years (IQRs, 44 to 63 y) and median admission APACHE II score was 19 (13 to 19); 6-month survival was 63%. Median baseline sodium was 133 mEq/L (131 to 135 mEq/L). No patients received additional therapy to decrease ICP during the 6 hours following urea initiation. After the first urea dose (15 g), ICP decreased from 14 (13 to 18 mm Hg) to 11 mm Hg (8 to 13 mm Hg) (P < 0.001). Changes in ICP were not correlated to changes in sodium (r(2) = 0.02). The reduction in ICP was larger in patients with ICP >= 15 mm Hg (n = 22) than in the others (-8 mm Hg [-14 to -3 mm Hg] vs. -2 mm Hg [-3 to 0 mm Hg], P = 0.001). Conclusions: Enteral urea administration in patients with acute brain injury and hyponatremia is associated with a significant reduction in ICP independent of changes in sodium levels.	[Annoni, Filippo; Fontana, Vito; Brimioulle, Serge; Creteur, Jacques; Vincent, Jean-Louis; Taccone, Fabio S.] Univ Libre Bruxelles, Erasme Univ Hosp, Dept Intens Care, Route Lennik 808, B-1070 Brussels, Belgium		Taccone, FS (corresponding author), Univ Libre Bruxelles, Erasme Univ Hosp, Dept Intens Care, Route Lennik 808, B-1070 Brussels, Belgium.	ftaccone@ulb.ac.be		annoni, filippo/0000-0002-1271-9034; Vincent, Jean-Louis/0000-0001-6011-6951			[Anonymous], 2011, 57136 EPA; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Brimioulle S, 2008, INTENS CARE MED, V34, P125, DOI 10.1007/s00134-007-0905-7; Cerda-Esteve M, 2008, EUR J INTERN MED, V19, P249, DOI 10.1016/j.ejim.2007.06.019; CLARK K, 1962, ARCH NEUROL-CHICAGO, V6, P414, DOI 10.1001/archneur.1962.00450230076009; Coussement J, 2012, AM J NEPHROL, V35, P265, DOI 10.1159/000336716; Curtis NJ, 2002, AGE AGEING, V31, P151, DOI 10.1093/ageing/31.2.151-a; Decaux G, 2000, ACTA CLIN BELG, V55, P68, DOI 10.1080/17843286.2000.11754274; Decaux G, 2010, CRIT CARE, V14, DOI 10.1186/cc9292; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; HASAN D, 1990, ANN NEUROL, V27, P106, DOI 10.1002/ana.410270118; JAVID M, 1958, SURG CLIN N AM, V38, P907; JAVID M, 1964, J NEUROSURG, V21, P1059, DOI 10.3171/jns.1964.21.12.1059; Katayama Y, 2007, STROKE, V38, P2373, DOI 10.1161/STROKEAHA.106.480038; Kloppenburg WD, 1997, CLIN SCI, V93, P73, DOI 10.1042/cs0930073; McClelland S, 2008, NEUROSURGERY, V62, P965, DOI 10.1227/01.neu.0000318183.25783.77; Murphy T, 2009, NEUROCRIT CARE, V11, P14, DOI 10.1007/s12028-008-9179-3; Otvos B, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.1.FOCUS13558; Pierrakos C, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-13; Rabinstein AA, 2011, NEUROCRIT CARE, V15, P354, DOI 10.1007/s12028-011-9585-9; Rajan S, 2015, INDIAN J ANAESTH, V59, P416, DOI 10.4103/0019-5049.160943; Soupart A, 2007, NEPHROL DIAL TRANSPL, V22, P1856, DOI 10.1093/ndt/gfm138; Spasovski G, 2014, EUR J ENDOCRINOL, V170, pG1, DOI 10.1530/EJE-13-1020; Stelfox HT, 2008, CRIT CARE, V12, DOI 10.1186/cc7162; Udelson JE, 2001, CIRCULATION, V104, P2417, DOI 10.1161/hc4501.099313; Wright WL, 2009, NEUROCRIT CARE, V11, P6, DOI 10.1007/s12028-008-9152-1	26	12	12	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	2017	29	4					400	405		10.1097/ANA.0000000000000340			6	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	FJ9QX	WOS:000413116200005	27438797				2022-02-06	
J	Clark, AL; Delano-Wood, L; Sorg, SF; Werhane, ML; Hanson, KL; Schiehser, DM				Clark, Alexandra L.; Delano-Wood, Lisa; Sorg, Scott F.; Werhane, Madeleine L.; Hanson, Karen L.; Schiehser, Dawn M.			Cognitive fatigue is associated with reduced anterior internal capsule integrity in veterans with history of mild to moderate traumatic brain injury	BRAIN IMAGING AND BEHAVIOR			English	Article						Fatigue; Cognitive fatigue; White matter microstructure; TBI	QUALITY-OF-LIFE; WHITE-MATTER; MULTIPLE-SCLEROSIS; DIFFUSION; STRATEGIES; TRACKING; FIBERS; IMPACT; MRI	No known studies have directly examined white matter microstructural correlates of cognitive fatigue post-TBI in a Veteran sample. We therefore investigated the relationship between cognitive fatigue and white matter integrity in Veterans with history of mild to moderate TBI (mmTBI). 59 Veterans (TBI = 34, Veteran Controls [VCs] = 25]) with and without history of mmTBI underwent structural 3T DTI scans and completed questionnaires related to cognitive fatigue and psychiatric symptoms. Tractography was employed on six regions of interest, including the anterior and posterior limbs of the internal capsule; genu; body and splenium of the corpus callosum; and cingulum bundle. Group analyses revealed that those with history of mmTBI displayed significantly greater levels of cognitive fatigue relative to those with no history of head injury (p = .02). Within the mmTBI group, independent of psychiatric symptoms, decreased white matter microstructural integrity of the left anterior internal capsule was associated with greater levels of cognitive fatigue (p = .01). Results show that the subjective experience of cognitive fatigue following neurotrauma may be linked to the disruption of striato-thalamo-cortical tracts that are important in mediating arousal and higher-order cognitive processes. These findings build upon those from existing functional neuroimaging studies in those with history of TBI, providing further evidence for the neural basis of cognitive fatigue in head injured adults.	[Clark, Alexandra L.; Werhane, Madeleine L.] SDSU UCSD, Joint Doctoral Program Clin Psychol, San Diego, CA USA; [Clark, Alexandra L.; Delano-Wood, Lisa; Sorg, Scott F.; Werhane, Madeleine L.; Hanson, Karen L.; Schiehser, Dawn M.] VASDHS, 3350 La Jolla Village Dr, San Diego, CA 92161 USA; [Delano-Wood, Lisa; Schiehser, Dawn M.] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Delano-Wood, Lisa; Sorg, Scott F.; Hanson, Karen L.; Schiehser, Dawn M.] Univ Calif San Diego, Sch Med, Dept Psychiat, 9500 Gillman Dr, La Jolla, CA 92093 USA		Schiehser, DM (corresponding author), VASDHS, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.; Schiehser, DM (corresponding author), VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA.; Schiehser, DM (corresponding author), Univ Calif San Diego, Sch Med, Dept Psychiat, 9500 Gillman Dr, La Jolla, CA 92093 USA.	dschiehser@ucsd.edu			Veterans Affairs: a Career Development Award [2-065-10S]; Veterans Affairs: Merit AwardUS Department of Veterans Affairs [829-MR-NB-25,860]; Department of Defense Investigator-Initiated Research Grant [W81XWH-10-2-0169]	This work was supported by grants awarded by the Veterans Affairs: a Career Development Award to D.S. (2-065-10S) and Merit Award to L.D.-W (829-MR-NB-25,860). This work was further supported by a Department of Defense Investigator-Initiated Research Grant to L.D.-W. (W81XWH-10-2-0169). Dr. Delano-Wood also received resources from the VA Center of Excellence for Stress and Mental Health.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Bester M, 2013, J NEUROL SCI, V330, P61, DOI 10.1016/j.jns.2013.04.005; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; DeLuca J, 2005, ISS CLIN COGN NEUROP, P1; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Dobryakova E, 2013, J INT NEUROPSYCH SOC, V19, P849, DOI 10.1017/S1355617713000684; Edlow BL, 2012, SEMIN NEUROL, V32, P374, DOI 10.1055/s-0032-1331810; Genova HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078811; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hanken K, 2015, MULT SCLER RELAT DIS, V4, P39, DOI 10.1016/j.msard.2014.11.006; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; Liu XX, 2010, METHODS, V50, P205, DOI 10.1016/j.ymeth.2009.06.008; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Schiehser DM, 2017, NEUROPSYCHOL REHABIL, V27, P1031, DOI 10.1080/09602011.2016.1215999; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, P116, DOI 10.1097/HTR.0000000000000019; Siegert RJ, 2009, J INT NEUROPSYCH SOC, V15, P142, DOI 10.1017/S1355617708090048; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Vos S. B., 2011, P INT SOC MAG RESON, V19, P145; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wang R., 2007, P INT SOC MAG RESON, V15, P3720; Weathers F.W., 1993, ANN CONV INT SOC TRA	40	12	12	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	OCT	2017	11	5					1548	1554		10.1007/s11682-016-9594-6			7	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FK6HU	WOS:000413604900020	27738990				2022-02-06	
J	Free, KE; Greene, AM; Bondi, CO; Lajud, N; de la Tremblaye, PB; Kline, AE				Free, Kristin E.; Greene, Anna M.; Bondi, Corina O.; Lajud, Naima; de la Tremblaye, Patricia B.; Kline, Anthony E.			Comparable impediment of cognitive function in female and male rats subsequent to daily administration of haloperidol after traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Antipsychotic drug; Beam-walking; Behavior; Controlled cortical impact (CCI); Functional recovery; Haloperidol; Hippocampus; Learning and memory; Morris water maze; Sex; Traumatic brain injury	CONTROLLED CORTICAL IMPACT; LYMPHOBLASTOID CELL-LINES; ENVIRONMENTAL ENRICHMENT; DOPAMINE TRANSPORTER; HISTOLOGICAL BENEFITS; GENDER-DIFFERENCES; TREATMENT REGIMEN; MOTOR RECOVERY; WORKING-MEMORY; CORTEX INJURY	Antipsychotic drugs, such as haloperidol (HAL), are prescribed in the clinic to manage traumatic brain injury (TBI)-induced agitation. While preclinical studies have consistently shown that once-daily administration of HAL hinders functional recovery after TBI in male rats, its effects in females are unknown. Hence, the objective of this study was to directly compare neurobehavioral and histological outcomes in both sexes to determine whether the reported deleterious effects of HAL extend to females. Anesthetized adult female and male rats received either a controlled cortical impact (CCI) or sham injury and then were randomly assigned to a dosing regimen of HAL (0.5 mg/kg, i.p.) or vehicle (VEH; 1 mL/kg, i.p.) that was initiated 24 h after injury and continued once daily for 19 consecutive days. Motor function was tested using established beam-balance/walk protocols on post-operative days 1-5 and acquisition of spatial learning was assessed with a well-validated Morris water maze task on days 14-19. Cortical lesion volume was quantified at 21 days. No statistical differences were revealed between the HAL and VEH-treated sham groups and thus they were pooled for each sex. HAL only impaired motor recovery in males (p < 0.05), but significantly diminished spatial learning in both sexes (p < 0.05). Females, regardless of treatment, exhibited smaller cortical lesions vs VEH-treated males (p < 0.05). Taken together, the data show that daily HAL does not prohibit motor recovery in females, but does negatively impact cognition. These task-dependent differential effects of HAL in female vs male rats may have clinical significance as they can direct therapy. (C) 2017 Elsevier Inc. All rights reserved.	[Free, Kristin E.; Greene, Anna M.; Bondi, Corina O.; Lajud, Naima; de la Tremblaye, Patricia B.; Kline, Anthony E.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA 15224 USA; [Free, Kristin E.; Greene, Anna M.; Bondi, Corina O.; Lajud, Naima; de la Tremblaye, Patricia B.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15224 USA; [Bondi, Corina O.] Univ Pittsburgh, Neurobiol, Pittsburgh, PA 15224 USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15224 USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15224 USA; [Lajud, Naima] Inst Mexicano Seguro Social Morelia, Ctr Invest Biomed Michoacan, Div Neurociencias, Morelia, Michoacan, Mexico; [Kline, Anthony E.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA 15224 USA; [Kline, Anthony E.] Univ Pittsburgh, Psychol, Pittsburgh, PA 15224 USA		Kline, AE (corresponding author), Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh,Safar Ctr Resuscitat Re, John G Rangos Res Ctr,Phys Med & Rehabil,Crit Car, Room 6126,4401 Penn Ave, Pittsburgh, PA 15224 USA.	klineae@upmc.edu	Lajud, Naima/B-4605-2018	Lajud, Naima/0000-0003-3905-798X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS060005, HD069620, HD069620-S1, NS084967, NS094950, NS099683]; University of Pittsburgh Physicians/UPMC Academic Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS084967, T32NS086749, R03NS094950, R01NS060005, R21NS099683] Funding Source: NIH RePORTER	This work was supported, in part, by the National Institutes of Health grants NS060005, HD069620, HD069620-S1, NS084967 (AEK), NS094950, NS099683 (COB), and the University of Pittsburgh Physicians/UPMC Academic Foundation (COB).	Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Cheng JP, 2008, BEHAV BRAIN RES, V194, P79, DOI 10.1016/j.bbr.2008.06.025; Cheng JP, 2016, BRAIN RES, V1640, P5, DOI 10.1016/j.brainres.2015.11.026; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; de la Tremblaye PB, 2017, J NEUROTRAUM, V34, P1610, DOI 10.1089/neu.2016.4790; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Folweiler KA, 2017, J NEUROTRAUM, V34, P451, DOI 10.1089/neu.2016.4417; Galani R, 2001, RESTOR NEUROL NEUROS, V18, P161; Goldstein LB, 2002, NEUROREHAB NEURAL RE, V16, P321, DOI 10.1177/154596830201600402; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; HOVDA DA, 1985, P W PHARMACOL SOC, V28, P209; Kadyan V, 2004, AM J PHYS MED REHAB, V83, P747, DOI 10.1097/01.PHM.0000140790.30468.F4; KAPETANOVIC IM, 1982, J PHARMACOL EXP THER, V221, P434; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Lavalaye J, 2000, EUR J NUCL MED, V27, P867, DOI 10.1007/s002590000279; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Magnotti LJ, 2008, J AM COLL SURGEONS, V206, P984, DOI 10.1016/j.jamcollsurg.2007.12.038; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Monaco CM, 2014, J NEUROTRAUM, V31, P1934, DOI 10.1089/neu.2014.3541; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Morag A, 2013, J MOL NEUROSCI, V49, P554, DOI 10.1007/s12031-012-9852-z; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Olsen AS, 2012, J NEUROTRAUM, V29, P1898, DOI 10.1089/neu.2012.2358; Phelps TI, 2017, NEUROREHAB NEURAL RE, V31, P25, DOI 10.1177/1545968316650281; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Radabaugh HL, 2016, EXP NEUROL, V286, P61, DOI 10.1016/j.expneurol.2016.09.015; RIVEST R, 1995, BRAIN RES, V692, P269, DOI 10.1016/0006-8993(95)00611-S; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rosengarten H, 2002, PROG NEURO-PSYCHOPH, V26, P1047, DOI 10.1016/S0278-5846(02)00221-X; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Stark AL, 2010, PHARMACOGENOMICS J, V10, P505, DOI 10.1038/tpj.2010.3; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Weeks J. J., 2016, BEHAV BRAIN RES; Wheeler HE, 2012, PHARMACOGENOMICS, V13, P55, DOI [10.2217/PGS.11.121, 10.2217/pgs.11.121]; Wilson MS, 2003, AM J PHYS MED REHAB, V82, P871, DOI 10.1097/01.PHM.0000091982.33232.CB	54	12	12	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	OCT	2017	296						62	68		10.1016/j.expneurol.2017.07.004			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FE6CC	WOS:000408296600007	28698031	Green Accepted			2022-02-06	
J	Holzmacher, JL; Townsend, K; Seavey, C; Gannon, S; Schroeder, M; Gondek, S; Collins, L; Amdur, RL; Sarani, B				Holzmacher, Jeremy L.; Townsend, Kerry; Seavey, Caleb; Gannon, Stephanie; Schroeder, Mary; Gondek, Stephen; Collins, Lois; Amdur, Richard L.; Sarani, Babak			Association of Expanded Medicaid Coverage With Hospital Length of Stay After Injury	JAMA SURGERY			English	Article							AFFORDABLE CARE ACT; TRAUMATIC BRAIN-INJURY; INSURANCE STATUS; PATIENT PROTECTION; MORTALITY; OUTCOMES; IMPACT; RACE; REHABILITATION; DISPARITIES	IMPORTANCE The expansion of Medicaid eligibility under the Affordable Care Act is a state-level decision that affects how patients with traumatic injury (trauma patients) interact with locoregional health care systems. Washington, DC; Maryland; and Virginia represent 3 unique payer systems with liberal, moderate, and no Medicaid expansion, respectively, under the Affordable Care Act. Characterizing the association of Medicaid expansion with hospitalization after injury is vital in the disposition planning for these patients. OBJECTIVE To determine the association between expanded Medicaid eligibility under the Affordable Care Act and duration of hospitalization after injury. DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort study included patients admitted from Virginia, Maryland, andWashington, DC, to a single level I trauma center. Data were collected from January 1, 2013, through March 6, 2016, in Virginia andWashington, DC, and from May 1, 2013, through March 6, 2016, in Maryland. All patients with Medicare or Medicaid coverage and all uninsured patients were included. Patients with private insurance, patients with severe head or pelvic injuries, and those who died during hospitalization were excluded. MAIN OUTCOMES AND MEASURES Hospital length of stay (LOS) and whether its association with patient insurance status varied by state of residence. RESULTS A total of 2314 patients (1541 men [66.6%] and 773 women [33.4%]; mean [SD] age, 52.9 [22.8] years) were enrolled in the study. The uninsured rate in theWashington, DC, cohort (190 of 1699 [11.2%]) was significantly lower compared with rates in the Virginia (141 of 296 [47.6%]) or the Maryland (106 of 319 [33.2%]) cohort (P <.001). On multivariate regression controlling for injury severity and demographic variables, the difference in LOS for Medicaid vs non-Medicaid recipients varied significantly by state. For Medicaid recipients, mean LOS inWashington, DC, was significantly shorter (2.57 days; 95% CI, 2.36-2.79 days) than in Maryland (3.51 days; 95% CI, 2.81-4.38 days; P =.02) or Virginia (3.9 days; 95% CI, 2.79-5.45 days; P =.05). CONCLUSIONS AND RELEVANCE Expanded Medicaid eligibility is associated with shorter hospital LOS in mildly injured Medicaid recipients.	[Holzmacher, Jeremy L.; Townsend, Kerry; Seavey, Caleb; Schroeder, Mary; Gondek, Stephen; Amdur, Richard L.; Sarani, Babak] George Washington Univ, Dept Surg, Ctr Trauma & Crit Care, 2150 Penn Ave NW,Ste 6B, Washington, DC 20037 USA; [Gannon, Stephanie] George Washington Univ Hosp, Dept Social Work, Washington, DC USA; [Collins, Lois] George Washington Univ Hosp, Dept Nursing, Washington, DC USA		Sarani, B (corresponding author), George Washington Univ, Dept Surg, Ctr Trauma & Crit Care, 2150 Penn Ave NW,Ste 6B, Washington, DC 20037 USA.		Amdur, Richard L/AAE-5345-2019	Seavey, Caleb/0000-0002-0334-2976			Alghnam S, 2016, QUAL LIFE RES, V25, P987, DOI 10.1007/s11136-015-1126-0; [Anonymous], 2016, MEDICAID ELIGIBILITY; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Benitez JA, 2016, HEALTH AFFAIR, V35, P528, DOI 10.1377/hlthaff.2015.1294; Blavin F, 2016, JAMA-J AM MED ASSOC, V316, P1475, DOI 10.1001/jama.2016.14765; Boninger JW, 2012, ARCH PHYS MED REHAB, V93, P929, DOI 10.1016/j.apmr.2012.03.014; Cheslik TG, 2016, J TRAUMA ACUTE CARE, V80, P1010, DOI 10.1097/TA.0000000000001052; Chikani V, 2015, WEST J EMERG MED, V16, P408, DOI 10.5811/westjem.2015.1.23560; Ciesla DJ, 2012, J TRAUMA ACUTE CARE, V73, P618, DOI 10.1097/TA.0b013e3182509132; Crandall M, 2013, AM J PUBLIC HEALTH, V103, P1103, DOI 10.2105/AJPH.2013.301223; Department of Health and Human Services, 2016, ANN UPD HHS POV GUID; Duron VP, 2012, J TRAUMA ACUTE CARE, V73, P1093, DOI 10.1097/TA.0b013e31826fc844; Englum BR, 2016, AM SURGEON, V82, P281; Gallup, 2014, US UN RAT SINKS 13 4; Gerry JM, 2016, INJURY, V47, P197, DOI 10.1016/j.injury.2015.09.003; HAAS JS, 1994, AM J PUBLIC HEALTH, V84, P1605, DOI 10.2105/AJPH.84.10.1605; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; HealthCare.gov, WHAT MARK HLTH INS P; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Joseph B, 2016, J TRAUMA ACUTE CARE, V81, P427, DOI 10.1097/TA.0000000000001082; Mashaw JL, 2013, J HEALTH POLIT POLIC, V38, P255, DOI 10.1215/03616878-1966243; Metcalfe D, 2016, J SURG RES, V203, P140, DOI 10.1016/j.jss.2016.02.036; Obama B, 2016, JAMA-J AM MED ASSOC, V316, P525, DOI 10.1001/jama.2016.9797; Perkins J, 2013, J LAW MED ETHICS, V41, P77, DOI 10.1111/jlme.12045; Sawhney JS, 2016, SURG INFECT, V17, P541, DOI 10.1089/sur.2015.210; Social Security Administration, 2020, MED INF; Taghavi S, 2012, SURGERY, V152, P227, DOI 10.1016/j.surg.2012.05.039; The White House, CONS DEC NOT EXP MED; Toussaint RJ, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.00740; Tsai TC, 2015, JAMA SURG, V150, P59, DOI 10.1001/jamasurg.2014.2071; Ward B. W., 2015, EARLY RELEASE SELECT; Zogg CK, 2016, JAMA SURG, V151, DOI 10.1001/jamasurg.2016.3609	32	12	12	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6254	2168-6262		JAMA SURG	JAMA Surg.	OCT	2017	152	10					960	966		10.1001/jamasurg.2017.1720			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	FK1MR	WOS:000413246500016	28658482	Green Published			2022-02-06	
J	Guimaraes, JAM; Rocha, LR; Rocha, THN; Bonfim, DC; da Costa, RS; Cavalcanti, AD; Roesler, CR; Machado, JAP; Aguiar, DP; Duarte, MEL				Matheus Guimaraes, Joao Antonio; Rocha, Leonardo Rosa; Noronha Rocha, Tito Henrique; Bonfim, Danielle Cabral; da Costa, Rafaela Sartore; Cavalcanti, Amanda dos Santos; Roesler, Carlos Rodrigo; Perini Machado, Jamila Alessandra; Aguiar, Diego Pinheiro; Leite Duarte, Maria Eugenia			Vertical femoral neck fractures in young adults: a closed fixation strategy using a transverse cancellous lag screw	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Vertical femoral neck fracture; Transverse cancellous screw; Closed internal fixation; High shear angle; Vertical femoral neck fracture	INTERNAL-FIXATION; INTRACAPSULAR FRACTURES; SUBCAPITAL FRACTURES; LOCKING PLATE; REDUCTION; FAILURE; FEMUR; SHAFT; HIP	Vertical femoral neck fractures (Pauwels type Ill classification) in young adults generally occur as a consequence of high-energy trauma and are frequently seen in association with multiple injuries. Considering the controversies regarding the optimal fixation for this fracture, our aim was to evaluate the clinical outcome of a closed fixation strategy for vertical femoral neck fractures in young adults using two parallel and one transverse cancellous lag screws. This was a single-surgeon, prospective study including 20 young adults with average age of 38.75 years (range 18-59 years) with a high-energy Pauwels III femoral neck fracture. Closed reduction and internal fixation with three cancellous lag screws were performed. The first screw was inserted crosswise to avoid further shear forces. Second and third parallel screws were placed above the lesser trochanter and centrally on the greater trochanter, respectively. Clinical outcomes were assessed by comparing postoperative and final follow-up radiographs 24 months post-injury. Eleven patients had an isolated vertical femoral neck fracture. Of these, five had further femoral neck comminution. Nine patients had an associated ipsilateral femoral shaft fracture. All fractures were displaced at the time of the first radiological evaluation. Closed reduction quality was considered excellent or good in 15 patients. After 24 months, bone union was achieved in 16 cases. Osteonecrosis of the femoral head developed in association with two fractures, and a nonunion developed in association with two fractures. We conclude that vertical high-energy femoral neck fractures can be treated successfully with internal fixation with two parallel cancellous lag screws positioned above the lesser trochanter and a third screw inserted centrally on the greater trochanter at an angle perpendicular to the fracture line. (C) 2017 Elsevier Ltd. All rights reserved.	[Matheus Guimaraes, Joao Antonio; Rocha, Leonardo Rosa; Noronha Rocha, Tito Henrique] Natl Inst Traumatol & Orthoped, Trauma Ctr, Rio De Janeiro, Brazil; [Bonfim, Danielle Cabral; da Costa, Rafaela Sartore; Cavalcanti, Amanda dos Santos; Perini Machado, Jamila Alessandra; Aguiar, Diego Pinheiro; Leite Duarte, Maria Eugenia] Natl Inst Traumatol & Orthoped, Res Div, Rio De Janeiro, Brazil; [Roesler, Carlos Rodrigo] Univ Fed Santa Catarina, Biomech Engn Lab, Mech Engn Dept, Univ Hosp, Florianopolis, SC, Brazil		Guimaraes, JAM (corresponding author), Natl Inst Traumatol & Orthoped, Trauma Ctr, Rio De Janeiro, Brazil.	jmatheusguimaraes@gmail.com	de Mello Roesler, Carlos Rodrigo/AAK-3298-2020; Rocha, Leonardo/AAR-9667-2020; Bonfim, Danielle Cabral/Q-8321-2018; Sartore, Rafaela/AAV-5609-2021	de Mello Roesler, Carlos Rodrigo/0000-0002-9430-7059; Rocha, Leonardo/0000-0002-7680-9522; Bonfim, Danielle Cabral/0000-0002-0104-4780; Sartore, Rafaela/0000-0002-1801-8650; Cavalcanti, Amanda/0000-0002-8792-7524			ALHO A, 1992, ACTA ORTHOP SCAND, V63, P639; Alves T, 2010, ORTHOPEDICS, V33; Aminian A, 2007, J ORTHOP TRAUMA, V21, P544, DOI 10.1097/BOT.0b013e31814b822e; [Anonymous], 1996, J ORTHOP TRAUMA, V10, pV; Barei DP, 2003, J TRAUMA, V55, P80, DOI 10.1097/01.TA.0000046259.43886.25; BARNES R, 1976, J BONE JOINT SURG BR, V58, P2, DOI 10.1302/0301-620X.58B1.1270491; Bartonicek J, 2001, J ORTHOP TRAUMA, V15, P358, DOI 10.1097/00005131-200106000-00009; Bedi A, 2009, J ORTHOP TRAUMA, V23, P249, DOI 10.1097/BOT.0b013e3181a03675; Berkes MB, 2012, J ORTHOP TRAUMA, V26, pE170, DOI 10.1097/BOT.0b013e31823b4cd1; Bonnaire FA, 2002, INJURY, V33, pS24; Collinge CA, 2014, J ORTHOP TRAUMA, V28, P270, DOI 10.1097/BOT.0000000000000014; Enocson A, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-171; GARDEN RS, 1964, J BONE JOINT SURG BR, V46, P630, DOI 10.1302/0301-620X.46B4.630; Glassner PJ, 2011, J ORTHOP TRAUMA, V25, P76, DOI 10.1097/BOT.0b013e3181e31ccc; Haidukewych GJ, 2004, J BONE JOINT SURG AM, V86A, P1711, DOI 10.2106/00004623-200408000-00015; HOLMBERG S, 1987, CLIN ORTHOP RELAT R, P42; Liporace F, 2008, J BONE JOINT SURG AM, V90A, P1654, DOI 10.2106/JBJS.G.01353; Nowotarski PJ, 2012, INJURY, V43, P802, DOI 10.1016/j.injury.2011.09.012; PARKER MJ, 1991, J BONE JOINT SURG BR, V73, P826, DOI 10.1302/0301-620X.73B5.1894675; Probe Robert, 2006, J Am Acad Orthop Surg, V14, P565; PROTZMAN RR, 1976, J BONE JOINT SURG AM, V58, P689, DOI 10.2106/00004623-197658050-00020; SCHECK M, 1959, J BONE JOINT SURG AM, V41, P1187, DOI 10.2106/00004623-195941070-00003; Selvan VT, 2004, INJURY, V35, P136, DOI 10.1016/S0020-1383(03)00059-7; Sirkin M, 1999, J ORTHOP TRAUMA, V13, P78, DOI 10.1097/00005131-199902000-00002; Szita J, 2002, INJURY, V33, pS41; Upadhyay A, 2004, J BONE JOINT SURG BR, V86B, P1035, DOI 10.1302/0301-620X.86B7.15047; Zlowodzki M, 2008, J BONE JOINT SURG BR, V90B, P1487, DOI 10.1302/0301-620X.90B11.20582; Zlowodzki M, 2008, J TRAUMA, V64, P163, DOI 10.1097/01.ta.0000241143.71274.63	28	12	18	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	OCT	2017	48			4			S10	S16		10.1016/S0020-1383(17)30769-6			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	FN3XM	WOS:000415935600004	29145961				2022-02-06	
J	Moon-Massat, P; Mullah, SHER; Abutarboush, R; Saha, BK; Pappas, G; Haque, A; Auker, C; McCarron, RM; Arnaud, F; Scultetus, A				Moon-Massat, Paula; Mullah, Saad Habib-E-Rasul; Abutarboush, Rania; Saha, Biswajit K.; Pappas, Georgina; Haque, Ashraful; Auker, Charles; McCarron, Richard M.; Arnaud, Francoise; Scultetus, Anke			Cerebral Vasoactivity and Oxygenation with Oxygen Carrier M101 in Rats	JOURNAL OF NEUROTRAUMA			English	Article						brain; hemoglobin-based oxygen carrier; oxygen therapeutic; trauma; vascular reactivity	TRAUMATIC BRAIN-INJURY; SMALL-VOLUME RESUSCITATION; BLOOD SUBSTITUTES; MOUSE-BRAIN; HEMOGLOBIN; HBOC-201; SWINE; SULFHEMOGLOBIN; ARTERIOLES; HEMORRHAGE	The severity of traumatic brain injury (TBI) may be reduced if oxygen can be rapidly provided to the injured brain. This study evaluated if the oxygen-carrier M101 causes vasoconstricton of pial vasculature in healthy rats (Experiment 1) and if M101 improves brain tissue oxygen (PbtO(2)) in rats with controlled cortical impact (CCI)-TBI (Experiment 2). M101 (12.5 mL/kg intravenous [IV] over 2 h) caused a mild (9mm Hg) increase in the mean arterial blood pressure (MAP) of healthy rats without constriction of cerebral pial arterioles. M101 (12 mL/kg IV over 1 h) caused a modest (27mm Hg) increase in MAP (peak, 123 +/- 5mm Hg [mean +/- standard error of the mean]) of CCI-TBI rats and restored PbtO(2) to near pre-injury levels. In both M101 and untreated control (NON) groups, PbtO(2) was similar to 30 +/- 2mm Hg pre-injury and decreased (p <= 0.05) to similar to 16 +/- 2mm Hg 15 min after CCI. In NON, PbtO(2) remained similar to 50% of baseline but M101 administration resulted in a sustained increase in PbtO(2) (peak, 25 +/- 5mm Hg), which was not significantly different from pre-injury until the end of the study, when it decreased again below pre-injury (but was still higher than NON). Histopathology showed no differences between groups. In conclusion, M101 increased systemic blood pressures without concurrent cerebral pial vasoconstriction (in healthy rats) and restored PbtO(2) to 86% of pre-injury for at least 80 min when given soon after CCITBI. M101 should be evaluated in a clinically-relevant large animal model for pre-hospital treatment of TBI.	[Moon-Massat, Paula; Mullah, Saad Habib-E-Rasul; Abutarboush, Rania; Saha, Biswajit K.; Pappas, Georgina; Haque, Ashraful; Auker, Charles; McCarron, Richard M.; Arnaud, Francoise; Scultetus, Anke] Operat & Undersea Med Directorate, Naval Med Res Ctr, Dept Neurotrauma, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [McCarron, Richard M.; Arnaud, Francoise; Scultetus, Anke] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA		Moon-Massat, P (corresponding author), Operat & Undersea Med Directorate, Naval Med Res Ctr, Dept Neurotrauma, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	paula.moon-massat.ctr@mail.mil			Defense Health Program [603115HP.3730.001.A1247]	The work was supported by Defense Health Program work unit # 603115HP.3730.001.A1247.	Abutarboush Rania, 2013, Curr Drug Discov Technol, V10, P315; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; De Figueiredo LFP, 1998, MEDICINA-BUENOS AIRE, V58, P403; Defazio R, 2015, TOXICOL PATHOL, V43, P249, DOI 10.1177/0192623314538345; Drabkin DL, 1935, J BIOL CHEM, V112, P51; Esipova TV, 2011, ANAL CHEM, V83, P8756, DOI 10.1021/ac2022234; Evelyn KA, 1938, J BIOL CHEM, V126, P655; Faul M, 2010, TRAUMATIC BRAIN INJU; Hare GMT, 2004, ANESTH ANALG, V99, P528, DOI 10.1213/01.ANE.0000136769.65960.D1; Imbrosci B, 2015, BRAIN STRUCT FUNCT, V220, P1649, DOI 10.1007/s00429-014-0750-8; Le Gall T, 2014, J BIOTECHNOL, V187, P1, DOI 10.1016/j.jbiotec.2014.07.008; Lee SK, 2002, ACAD EMERG MED, V9, P969; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Mallet V, 2014, ARTIF ORGANS, V38, P691, DOI 10.1111/aor.12307; Manley GT, 2003, ADV EXP MED BIOL, V530, P311; Mozzarelli A, 2010, BLOOD TRANSFUS-ITALY, V8, pS59, DOI 10.2450/2010.010S; Natanson C, 2008, JAMA-J AM MED ASSOC, V299, P2304, DOI 10.1001/jama.299.19.jrv80007; Ohata H, 2001, ANESTH ANALG, V93, P697, DOI 10.1097/00000539-200109000-00032; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Patel MB, 2006, J TRAUMA, V61, P46, DOI 10.1097/01.ta.0000219730.71206.3a; Rebel A, 2006, AM J PHYSIOL-HEART C, V290, pH1027, DOI 10.1152/ajpheart.00500.2005; ROSENBLUM WI, 1976, STROKE, V7, P283, DOI 10.1161/01.STR.7.3.283; ROSENBLUM WI, 1963, ARCH NEUROL-CHICAGO, V9, P414, DOI 10.1001/archneur.1963.00460100102012; Rosenthal G, 2008, J NEUROSURG, V108, P575, DOI 10.3171/JNS/2008/108/3/0575; Rousselot Morgane, 2006, Biotechnology Journal, V1, P333, DOI 10.1002/biot.200500049; Silverman TA, 2009, ANESTHESIOLOGY, V111, P946, DOI 10.1097/ALN.0b013e3181ba3c2c; Thuillier R, 2011, AM J TRANSPLANT, V11, P1845, DOI 10.1111/j.1600-6143.2011.03614.x; Tsai AG, 2007, ANTIOXID REDOX SIGN, V9, P979, DOI 10.1089/ars.2007.1633; Tsai Amy G, 2012, Curr Drug Discov Technol, V9, P166; Vandegriff KD, 2008, BRIT J PHARMACOL, V154, P1649, DOI 10.1038/bjp.2008.219; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	35	12	12	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2017	34	19					2812	2822		10.1089/neu.2015.3908			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FI1DZ	WOS:000411672700015	26161914				2022-02-06	
J	Yang, L; Liu, ZJ; Ren, HL; Zhang, L; Gao, SM; Ren, L; Chai, Z; Meza-Romero, R; Benedek, G; Vandenbark, AA; Offner, H; Li, MS				Yang, Liu; Liu, Zhijia; Ren, Honglei; Zhang, Lei; Gao, Siman; Ren, Li; Chai, Zhi; Meza-Romero, Roberto; Benedek, Gil; Vandenbark, Arthur A.; Offner, Halina; Li, Minshu			DR alpha 1-MOG-35-55 treatment reduces lesion volumes and improves neurological deficits after traumatic brain injury	METABOLIC BRAIN DISEASE			English	Article						Traumatic brain injury; DRa1-MOG-alpha 35-55 therapy; Neurological deficits; CD74; Infiltrating macrophages/microglia	EXPERIMENTAL STROKE; CD74 EXPRESSION; ISCHEMIC-STROKE; CELL; INFLAMMATION; CONSTRUCTS; ACTIVATION	Traumatic brain injury (TBI) results in severe neurological impairments without effective treatments. Inflammation appears to be an important contributor to key pathogenic events such as secondary brain injury following TBI and therefore serves as a promising target for novel therapies. We have recently demonstrated the ability of a molecular construct comprised of the human leukocyte antigen (HLA)-DR alpha 1 domain linked covalently to mouse (m)MOG-35-55 peptide (DR alpha 1-MOG-35-55 construct) to reduce CNS inflammation and tissue injury in animal models of multiple sclerosis and ischemic stroke. The aim of the current study was to determine if DR alpha 1-MOG-35-55 treatment of a fluid percussion injury (FPI) mouse model of TBI could reduce the lesion size and improve disease outcome measures. Neurodeficits, lesion size, and immune responses were determined to evaluate the therapeutic potential and mechanisms of neuroprotection induced by DR alpha 1-MOG-35-55 treatment. The results demonstrated that daily injections of DR alpha 1-MOG-35-55 given after FPI significantly reduced numbers of infiltrating CD74(+) and CD86(+) macrophages and increased numbers of CD206(+) microglia in the brain concomitant with smaller lesion sizes and improvement in neurodeficits. Conversely, DR alpha 1-MOG-35-55 treatment of TBI increased numbers of circulating CD11b(+) monocytes and their expression of CD74 but had no detectable effect on cell numbers or marker expression in the spleen. These results demonstrate that DR alpha 1-MOG-35-55 therapy can reduce CNS inflammation and significantly improve histological and clinical outcomes after TBI. Future studies will further examine the potential of DR alpha 1-MOG-35-55 for treatment of TBI.	[Yang, Liu; Liu, Zhijia; Ren, Honglei; Zhang, Lei; Gao, Siman; Ren, Li; Li, Minshu] Tianjin Med Univ, Tianjin Neurol Inst, Dept Neurol, Gen Hosp, Tianjin 300052, Peoples R China; [Yang, Liu; Li, Minshu] St Josephs Hosp, Phoenix, AZ 85013 USA; [Chai, Zhi] Shanxi Univ Tradit Chinese Med, Collaborat Innovat Ctr 2011, Neurobiol Res Ctr, Taiyuan 030619, Shanxi, Peoples R China; [Meza-Romero, Roberto; Benedek, Gil; Vandenbark, Arthur A.; Offner, Halina] VA Portland Hlth Care Syst, Neuroimmunol Res, Portland, OR 97239 USA; [Meza-Romero, Roberto; Benedek, Gil; Vandenbark, Arthur A.; Offner, Halina] Oregon Hlth & Sci Univ, Dept Neurol UHS 46, Tykeson MS Res Lab, Portland, OR 97201 USA; [Benedek, Gil; Vandenbark, Arthur A.; Offner, Halina] Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Vandenbark, Arthur A.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Offner, Halina] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA		Li, MS (corresponding author), Tianjin Med Univ, Tianjin Neurol Inst, Dept Neurol, Gen Hosp, Tianjin 300052, Peoples R China.; Li, MS (corresponding author), St Josephs Hosp, Phoenix, AZ 85013 USA.; Offner, H (corresponding author), VA Portland Hlth Care Syst, Neuroimmunol Res, Portland, OR 97239 USA.; Offner, H (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol UHS 46, Tykeson MS Res Lab, Portland, OR 97201 USA.; Offner, H (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.; Offner, H (corresponding author), Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA.	offnerva@ohsu.edu; minshuli2012@163.com			National Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81,471,535]; US National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS092713, AI 122574]; Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R41AI122574, R42AI122574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092713, R01NS076013, R01NS075887] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX000226] Funding Source: NIH RePORTER	This study was supported in part by the National Science Foundation of China grant 81,471,535 (to ML); US National Institutes of Health grants R01NS092713 (to HO) and AI 122574 (to AAV); Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. The contents do not represent the views of the Department of Veterans Affairs or the United States Government.	Basrai HS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153418; Benedek G, 2017, NEUROCHEM INT, V107, P138, DOI 10.1016/j.neuint.2016.10.007; Benedek G, 2014, METAB BRAIN DIS, V29, P37, DOI 10.1007/s11011-013-9440-0; Burrows GG, 2001, J IMMUNOL, V167, P4386, DOI 10.4049/jimmunol.167.8.4386; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dziennis S, 2011, METAB BRAIN DIS, V26, P123, DOI 10.1007/s11011-011-9241-2; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Meng YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106238; Meza-Romero R, 2016, METAB BRAIN DIS, V31, P249, DOI 10.1007/s11011-016-9798-x; Meza-Romero R, 2014, J IMMUNOL, V192, P4164, DOI 10.4049/jimmunol.1303118; Pan J, 2014, TRANSL STROKE RES, V5, P577, DOI 10.1007/s12975-014-0345-y; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Subramanian S, 2009, STROKE, V40, P2539, DOI 10.1161/STROKEAHA.108.543991; Tobin RP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0143-5; Tsukano H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22315; Vandenbark AA, 2013, J AUTOIMMUN, V40, P96, DOI 10.1016/j.jaut.2012.08.004; Wang CH, 2003, J IMMUNOL, V171, P1934, DOI 10.4049/jimmunol.171.4.1934; Wang JY, 2017, TRANSL STROKE RES, V8, P284, DOI 10.1007/s12975-016-0514-2; Zhu WB, 2015, TRANSL STROKE RES, V6, P60, DOI 10.1007/s12975-014-0373-7; Zhu WB, 2014, TRANSL STROKE RES, V5, P612, DOI 10.1007/s12975-014-0348-8	23	12	12	0	5	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7490	1573-7365		METAB BRAIN DIS	Metab. Brain Dis.	OCT	2017	32	5					1395	1402		10.1007/s11011-017-9991-6			8	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	FG9BD	WOS:000410732300006	28303450	Green Accepted			2022-02-06	
J	Brizuela, M; Blizzard, CA; Chuckowree, JA; Pitman, KA; Young, KM; Dickson, T				Brizuela, Mariana; Blizzard, Catherine A.; Chuckowree, Jyoti A.; Pitman, Kimberley A.; Young, Kaylene M.; Dickson, Tracey			Mild Traumatic Brain Injury Leads to Decreased Inhibition and a Differential Response of Calretinin Positive Interneurons in the Injured Cortex	JOURNAL OF NEUROTRAUMA			English	Article						calretinin; cortex; GAD67; interneuron; mild traumatic brain injury; mouse	POSTTRAUMATIC-STRESS-DISORDER; SYNAPTIC-TRANSMISSION; GRANULE CELLS; PLASTICITY; NEURONS; REORGANIZATION; MODEL; PROLIFERATION; EPIDEMIOLOGY; NEUROGENESIS	It is clear that even mild forms of traumatic brain injury (TBI) can have lasting cognitive effects; however, the specific cellular changes responsible for the functional deficits remain poorly understood. Previous studies suggest that not all neurons respond in the same way and that changes to neuronal architecture may be subtype specific. The current study aimed to characterize the response of interneurons to TBI. To model TBI in vitro, the neurites of primary cortical neurons were transected at 15 days in vitro. In response, calretinin(+) interneurons underwent significant neurite remodeling around the injury site. By examining the response of pyramidal neurons, GAD67-GFP(+) interneurons, and calretinin(+) interneurons to the injury, we found that this response was specific to the calretinin(+) cells. To determine whether calretinin(+) interneurons respond in this way to a clinically relevant in vivo model of mild diffuse and focal injury, we subjected mice to the lateral fluid percussion injury model. We found that calretinin(+) interneuron density was unaltered by this mild injury, but consistent with our in vitro data, these neurons underwent morphological alterations in their dendrites. These alterations evolved over a 28-day period, and calretinin(+) interneurons in the injured mice had a reduction in mean dendrite length and reduced number of secondary dendrites than those in the sham-injured controls by 7 days post-injury. Further, these structural alterations were accompanied by a reduction in the frequency of miniature inhibitory post-synaptic currents in layer V pyramidal neurons. These data suggest that even a mild TBI can lead to an overall change in the excitatory/inhibitory balance of the cortex that may play an important role in the longer-term behavioral pathology associated with mild TBI.	[Brizuela, Mariana; Blizzard, Catherine A.; Chuckowree, Jyoti A.; Pitman, Kimberley A.; Young, Kaylene M.; Dickson, Tracey] Univ Tasmania, Menzies Inst Med Res, Private Bag 23, Hobart, Tas 7000, Australia		Dickson, T (corresponding author), Univ Tasmania, Menzies Inst Med Res, Private Bag 23, Hobart, Tas 7000, Australia.	Tracey.Dickson@utas.edu.au	; Pitman, Kimberley/O-4843-2017	Dickson, Tracey/0000-0002-9196-1661; Young, Kaylene/0000-0002-1686-3463; Blizzard, Catherine/0000-0002-8683-2937; Pitman, Kimberley/0000-0003-3198-9336	National Health and Medical Research Foundation; Tasmanian Masonic Medical Research Foundation; Rebecca L. Cooper Medical Research Foundation; Clive and Vera Ramaciotti Foundation	GAD67-GFP mice were developed by Prof. Nobuaki Tamamaki (Kyoto University) and were provided by Prof. John Bekkers (Australian National University). This work was support by the National Health and Medical Research Foundation, the Tasmanian Masonic Medical Research Foundation, the Rebecca L. Cooper Medical Research Foundation and the Clive and Vera Ramaciotti Foundation.	Albrecht MA, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00105; Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Banerjee A, 2013, INT J NEUROPSYCHOPH, V16, P1309, DOI 10.1017/S1461145712001216; Barinka F, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00108; Baroncelli L, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/286073; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Blizzard CA, 2013, J NEUROTRAUM, V30, P1908, DOI 10.1089/neu.2013.2850; Blizzard CA, 2011, CEREB CORTEX, V21, P281, DOI 10.1093/cercor/bhq091; Cafferty WBJ, 2008, TRENDS NEUROSCI, V31, P215, DOI 10.1016/j.tins.2008.02.004; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Canty AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3038; Caputi A, 2009, CEREB CORTEX, V19, P1345, DOI 10.1093/cercor/bhn175; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Chen JL, 2013, NEUROSCIENTIST, V19, P384, DOI 10.1177/1073858413479824; Chen JL, 2011, J NEUROSCI, V31, P12437, DOI 10.1523/JNEUROSCI.0420-11.2011; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Chuckowree JA, 2004, NEUROSCIENTIST, V10, P280, DOI 10.1177/1073858404263511; Clarke LE, 2012, J NEUROSCI, V32, P8173, DOI 10.1523/JNEUROSCI.0928-12.2012; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Cope EC, 2016, EXP NEUROL, V279, P96, DOI 10.1016/j.expneurol.2016.02.017; Dancause N, 2011, PROG BRAIN RES, V192, P273, DOI 10.1016/B978-0-444-53355-5.00015-4; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Di Cristo G, 2007, NAT NEUROSCI, V10, P1569, DOI 10.1038/nn2008; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dzaja D, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00103; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Hayes R L, 1987, Brain Inj, V1, P93, DOI 10.3109/02699058709034449; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hollrigel GS, 1997, J NEUROSCI, V17, P5119; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Keck T, 2011, NEURON, V71, P869, DOI 10.1016/j.neuron.2011.06.034; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Keyvani K, 2002, J NEUROPATH EXP NEUR, V61, P831, DOI 10.1093/jnen/61.10.831; King AE, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-59; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lee WCA, 2008, P NATL ACAD SCI USA, V105, P19968, DOI 10.1073/pnas.0810149105; Li W, 2016, J NEUROL, V263, P1280, DOI 10.1007/s00415-016-8093-4; Macias M, 2008, ACTA NEUROBIOL EXP, V68, P334; Marik SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000395; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Mtchedlishvili Z, 2010, NEUROBIOL DIS, V38, P464, DOI 10.1016/j.nbd.2010.03.012; Ostergard T, 2016, J NEUROSCI METH, V272, P50, DOI 10.1016/j.jneumeth.2016.03.023; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Peredeny JV, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00017; Peterson TC, 2015, BEHAV BRAIN RES, V294, P254, DOI 10.1016/j.bbr.2015.08.007; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Sullivan K. A., 2016, NEUROPSYCHOL REV; Suzuki N, 2010, CEREB CORTEX, V20, P2971, DOI 10.1093/cercor/bhq046; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Toth K, 2014, FRONT NEUROANAT, V8, DOI [10.3389/fnana.2014.00100, 10.3389/thana.2014.00100]; Toth K, 2010, BRAIN, V133, P2763, DOI 10.1093/brain/awq149; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Young NA, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00027	74	12	13	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34	17					2504	2517		10.1089/neu.2017.4977			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FE6HI	WOS:000408310200003	28463587	Green Accepted			2022-02-06	
J	Dang, DK; Shin, EJ; Tran, HQ; Kim, DJ; Jeong, JH; Jang, CG; Nah, SY; Sato, H; Nabeshima, T; Yoneda, Y; Kim, HC				Dang, Duy-Khanh; Shin, Eun-Joo; Tran, Hai-Quyen; Kim, Dae-Joong; Jeong, Ji Hoon; Jang, Choon-Gon; Nah, Seung-Yeol; Sato, Hideyo; Nabeshima, Toshitaka; Yoneda, Yukio; Kim, Hyoung-Chun			The role of system Xc(-) in methamphetamine-induced dopaminergic neurotoxicity in mice	NEUROCHEMISTRY INTERNATIONAL			English	Article						Methamphetamine neurotoxicity; System Xc(-); xCT knockout mice; Glutamate-related toxicity; Oxidative damage; Striatum	GLUTAMATE-RECEPTOR ANTAGONIST; TRAUMATIC BRAIN-INJURY; KINASE C-DELTA; OXIDATIVE STRESS; IN-VIVO; CYSTINE/GLUTAMATE ANTIPORTER; EXTRACELLULAR GLUTAMATE; PROTECTIVE AUTOIMMUNITY; MOLECULAR PHARMACOLOGY; MICROGLIAL ACTIVATION	The cystine/glutamate antiporter (system Xc(-), Sxc) transports cystine into cell in exchange for glutamate. Since xCT is a specific subunit of Sxc, we employed xCT knockout mice and investigated whether this antiporter affected methamphetamine (MA)-induced dopaminergic neurotoxicity. MA treatment significantly increased striatal oxidative burdens in wild type mice. xCT inhibitor [i.e., S-4-carboxyphenylglycine (CPG), sulfasalazine] or an xCT knockout significantly protected against these oxidative burdens. MA -induced increases in lba-1 expression and lba-1-labeled microglial immunoreactivity (Iba1-IR) were significantly attenuated by CPG or sulfasalazine administration or xCT knockout. CPG or sulfasalazine significantly attenuated MA -induced TUNEL-positive cell populations in the striatum of Taconic ICR mice. The decrease in excitatory amino acid transporter-2 (or glutamate transporter-1) expression and increase in glutamate release were attenuated by CPG, sulfasalazine or xCT knockout. In addition, CPG, sulfasalazine or xCT knockout significantly protected against dopaminergic loss (i.e., decreases in tyrosine hydroxylase expression and immunoreactivity, and an increase in dopamine turnover rate) induced by MA. However, CPG, sulfasalazine or xCT knockout did not significantly affect the impaired glutathione system [i.e., decrease in reduced glutathione (GSH) and increase in oxidized glutathione (GSSG)] induced by MA. Our results suggest that Sxc mediates MA -induced neurotoxicity via facilitating oxidative stress, microgliosis, proapoptosis, and glutamate-related toxicity. (C) 2017 Elsevier Ltd. All rights reserved.	[Dang, Duy-Khanh; Kim, Hyoung-Chun] Kangwon Natl Univ, Coll Pharm, Neuropsychopharmacol & Toxicol Program, Chunchon 24341, South Korea; [Tran, Hai-Quyen; Kim, Dae-Joong; Jeong, Ji Hoon] Kangwon Natl Univ, Sch Med, Dept Anat & Cell Biol, Chunchon 24341, South Korea; [Kim, Dae-Joong; Jeong, Ji Hoon; Jang, Choon-Gon] Chung Ang Univ, Dept Pharmacol, Coll Med, Seoul 06974, South Korea; [Tran, Hai-Quyen; Kim, Dae-Joong; Jeong, Ji Hoon] Sungkyunkwan Univ, Sch Pharm, Dept Pharmacol, Suwon 16419, South Korea; [Shin, Eun-Joo; Kim, Dae-Joong; Jang, Choon-Gon] Konkuk Univ, Coll Vet Med & Bio Mol Informat Ctr, Ginsentol Res Lab & Dept Physiol, Seoul 05029, South Korea; [Tran, Hai-Quyen; Jang, Choon-Gon; Nah, Seung-Yeol] Niigata Univ, Dept Med Technol, Lab Biochem & Mol Biol, Niigata, Niigata 9502181, Japan; [Tran, Hai-Quyen; Jang, Choon-Gon; Nah, Seung-Yeol] Fujita Hlth Univ Grad Sch Hlth Sci, Adv Diagnost Syst, Res Lab, Toyoake, Aichi 4701192, Japan; [Tran, Hai-Quyen; Nah, Seung-Yeol] Kanazawa Univ Venture Business Lab, Sect Prophylact Pharmacol, Kanazawa, Ishikawa 9201192, Japan		Kim, HC (corresponding author), Kangwon Natl Univ, Coll Pharm, Neuropsychopharmacol & Toxicol Program, Chunchon 24341, South Korea.	kimhc@kangwon.ac.kr	Yoneda, Yukio/ABI-1864-2020	Yoneda, Yukio/0000-0002-4624-177X	Korea Food and Drug Administration, Republic of Korea [14182MFDS979]; BK21 PLUS program, National Research Foundation of Korea, Republic of Korea; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [17K07158] Funding Source: KAKEN	This study was supported by a grant (14182MFDS979) from the Korea Food and Drug Administration, Republic of Korea. Duy-Khanh Dang and Hai-Quyen Tran were supported by the BK21 PLUS program, National Research Foundation of Korea, Republic of Korea. Equipment at the Institute of New Drug Development Research (Kangwon National University) was used for this study. The English in this document has been checked by at least two professional editors, both native speakers of English (e-World Editing, Inc. Eugene, OR 97401, USA).	Ares-Santos S, 2014, NEUROPSYCHOPHARMACOL, V39, P1066, DOI 10.1038/npp.2013.307; Baker DA, 2002, J NEUROSCI, V22, P9134; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Bentea E, 2015, NEUROSCI LETT, V593, P1, DOI 10.1016/j.neulet.2015.03.013; Bjornsen LP, 2014, J NEUROCHEM, V128, P641, DOI 10.1111/jnc.12509; Bridges RJ, 2012, BRIT J PHARMACOL, V165, P20, DOI 10.1111/j.1476-5381.2011.01480.x; Cadet JL, 2009, INT REV NEUROBIOL, V88, P101, DOI 10.1016/S0074-7742(09)88005-7; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Chung WJ, 2009, J NEUROCHEM, V110, P182, DOI 10.1111/j.1471-4159.2009.06129.x; Chung WJ, 2005, J NEUROSCI, V25, P7101, DOI 10.1523/JNEUROSCI.5258-04.2005; Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dang D.D., 2016, P 20 PAC AS C INF SY, P1; Dang DK, 2017, FREE RADICAL BIO MED, V108, P204, DOI 10.1016/j.freeradbiomed.2017.03.033; Dang DK, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0478-x; David HN, 2001, EUR J NEUROSCI, V13, P2157, DOI 10.1046/j.0953-816x.2001.01584.x; De Bundel D, 2011, J NEUROSCI, V31, P5792, DOI 10.1523/JNEUROSCI.5465-10.2011; Domercq M, 2007, J IMMUNOL, V178, P6549, DOI 10.4049/jimmunol.178.10.6549; Escartin C, 2006, J NEUROSCI, V26, P5978, DOI 10.1523/JNEUROSCI.0302-06.2006; Evonuk KS, 2015, J IMMUNOL, V195, P450, DOI 10.4049/jimmunol.1401108; Freeman HJ, 2012, CLIN MED INSIGHTS-GA, V5, P77, DOI 10.4137/CGast.S8673; Garzon-Muvdi T, 2013, NEUROSURGERY, V73, P719, DOI 10.1227/NEU.0000000000000080; Gerlach M, 1996, J NEURAL TRANSM, V103, P987, DOI 10.1007/BF01291788; Gras G, 2006, J LEUKOCYTE BIOL, V80, P1067, DOI 10.1189/jlb.0306153; Grewer C, 2005, J MEMBRANE BIOL, V203, P1, DOI 10.1007/s00232-004-0731-6; Grewer C, 2014, PFLUG ARCH EUR J PHY, V466, P3, DOI 10.1007/s00424-013-1397-7; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; Tran HYP, 2012, FREE RADICAL BIO MED, V52, P1159, DOI 10.1016/j.freeradbiomed.2011.12.008; Holmseth S, 2012, J NEUROSCI, V32, P6000, DOI 10.1523/JNEUROSCI.5347-11.2012; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Jones DP, 2004, FASEB J, V18, P1246, DOI 10.1096/fj.03-0971fje; Jung BD, 2010, NEUROCHEM INT, V56, P229, DOI 10.1016/j.neuint.2009.10.005; Kim HC, 2000, BRAIN RES, V874, P15, DOI 10.1016/S0006-8993(00)02560-9; Kim HC, 2000, BRAIN RES, V862, P247, DOI 10.1016/S0006-8993(00)02085-0; Lewerenz J, 2006, J NEUROCHEM, V98, P916, DOI 10.1111/j.1471-4159.2006.03921.x; Lewerenz J, 2009, J NEUROCHEM, V111, P332, DOI 10.1111/j.1471-4159.2009.06347.x; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Maragakis NJ, 2004, NEUROBIOL DIS, V15, P461, DOI 10.1016/j.nbd.2003.12.007; Marpegan L, 2005, J NEUROIMMUNOL, V160, P102, DOI 10.1016/j.jneuroim.2004.11.003; Massie A, 2015, J NEUROCHEM, V135, P1062, DOI 10.1111/jnc.13348; Massie A, 2011, FASEB J, V25, P1359, DOI 10.1096/fj.10-177212; Matute C, 2006, GLIA, V53, P212, DOI 10.1002/glia.20275; Maximova OA, 2006, J HISTOCHEM CYTOCHEM, V54, P97, DOI 10.1369/jhc.5A6758.2005; Melzer N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003149; Miranda AS, 2010, BRAZ J MED BIOL RES, V43, P1173, DOI 10.1590/S0100-879X2010007500130; Moretto MB, 2005, EXP NEUROL, V195, P400, DOI 10.1016/j.expneurol.2005.06.005; Nakajima K, 2001, NEUROSCI LETT, V307, P171, DOI 10.1016/S0304-3940(01)01943-7; National Research Council of the National Academies, 2011, GUIDE CARE USE LAB A; NICHOLLS DG, 1987, J NEUROCHEM, V49, P50, DOI 10.1111/j.1471-4159.1987.tb03393.x; NICHOLLS DG, 1986, NATURE, V321, P772, DOI 10.1038/321772a0; OLIVER CN, 1987, J BIOL CHEM, V262, P5488; Pellegrino D, 2007, J NUCL MED, V48, P1147, DOI 10.2967/jnumed.106.037796; PEPPERCORN MA, 1973, GASTROENTEROLOGY, V64, P240; Persson M, 2005, GLIA, V51, P111, DOI 10.1002/glia.20191; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; Rao VLR, 1998, J NEUROCHEM, V70, P2020; REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9; Rimaniol AC, 2000, J IMMUNOL, V164, P5430, DOI 10.4049/jimmunol.164.10.5430; Robinson MB, 2016, NEUROCHEM INT, V98, P56, DOI 10.1016/j.neuint.2016.03.014; Rodriguez-Moreno A, 2013, FEBS LETT, V587, P788, DOI 10.1016/j.febslet.2013.01.071; ROMANOSILVA MA, 1993, BIOCHEM J, V296, P313, DOI 10.1042/bj2960313; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; SCHRODER H, 1972, CLIN PHARMACOL THER, V13, P539; Schwartz M, 2003, TRENDS NEUROSCI, V26, P297, DOI 10.1016/S0166-2236(03)00126-7; Shaked I, 2005, J NEUROCHEM, V92, P997, DOI 10.1111/j.1471-4159.2004.02954.x; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shin EJ, 2005, NEUROSCIENCE, V133, P715, DOI 10.1016/j.neuroscience.2005.02.030; Shin EJ, 2014, MOL NEUROBIOL, V49, P1400, DOI 10.1007/s12035-013-8617-1; Shin EJ, 2012, BEHAV BRAIN RES, V232, P98, DOI 10.1016/j.bbr.2012.04.001; Silva CD, 2014, NEUROTOX RES, V25, P295, DOI 10.1007/s12640-013-9423-2; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Trotti D, 1996, J BIOL CHEM, V271, P5976, DOI 10.1074/jbc.271.11.5976; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Vandenberg RJ, 2013, PHYSIOL REV, V93, P1621, DOI 10.1152/physrev.00007.2013; Vermeiren C, 2005, J NEUROCHEM, V94, P405, DOI 10.1111/j.1471-4159.2005.03216.x; VOLTERRA A, 1994, J NEUROSCI, V14, P2924; Wang QS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-124; Nguyen XKT, 2015, J PINEAL RES, V58, P86, DOI 10.1111/jpi.12195; Zhang W, 2006, FASEB J, V20, P2496, DOI 10.1096/fj.06-6006com; Zhu JPQ, 2006, NEUROSCIENCE, V140, P607, DOI 10.1016/j.neuroscience.2006.02.055; Zhu JPQ, 2006, NEUROTOXICOLOGY, V27, P131, DOI 10.1016/j.neuro.2005.05.014	84	12	12	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	SEP	2017	108						254	265		10.1016/j.neuint.2017.04.013			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FC1AL	WOS:000406569700028	28457879				2022-02-06	
J	Foran, I; Upasani, VV; Wallace, CD; Britt, E; Bastrom, TP; Bomar, JD; Pennock, AT				Foran, Ian; Upasani, Vidyadhar V.; Wallace, Charles D.; Britt, Elise; Bastrom, Tracey P.; Bomar, James D.; Pennock, Andrew T.			Acute Pediatric Monteggia Fractures: A Conservative Approach to Stabilization	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						Monteggia fracture; radial head dislocation; radial head subluxation; ulna fracture; Bado classification	OPEN REDUCTION; EQUIVALENT LESIONS; CHILDREN; DISLOCATIONS; RECONSTRUCTION; CHILDHOOD; INJURIES	Background: In 2015, a multicenter study group proposed a treatment algorithm for pediatric Monteggia fractures based upon the ulnar fracture pattern. This strategy recommends surgical stabilization for all complete ulna fractures. The purpose of this study was to evaluate whether an initial non-operative approach to pediatric Monteggia fractures resulted in poorer outcomes and a higher rate of complications. Methods: This institutional review board approved retrospective study evaluated all Monteggia fractures presenting to a level 1 pediatric trauma center between 2008 and 2014. Chart and radiographic reviews were performed on 94 patients who met inclusion criteria. The mean age was 5.5 years (range, 1 to 13 y). The mean clinical follow-up was 18 weeks. Major complications were defined as those requiring an unplanned second procedure (other than implant removal) or that may result in long-term disability (residual radial head subluxation/dislocation). Univariate (P < 0.05) and Multivariate Classification and Regression Tree (CART) (P < 0.05) analyses were used to identify variables associated with the need for surgical stabilization. Results: At final follow-up, there were no cases of residual radiocapitellar joint subluxation or dislocation and all fractures had healed. The majority (83%) of patients were successfully managed with a cast. Univariate analysis found Bado type and maximum ulna angulation as significant predictors (P < 0.05), whereas the CART analysis found ulna angulation > 36.5 degrees as the only primary predictor of requiring surgical stabilization. Overall, good outcomes were achieved in all patients with few major complications. Conclusions: Although treatment algorithms are intended to minimize complications and maximize good outcomes, we believe that an unintentional consequence of the recently proposed pediatric Monteggia fracture treatment guideline may be the overtreatment of these injuries. In our cohort, the majority of patients were able to avoid the operating room and surgical implants without compromising outcomes or complications. This more conservative approach, however, requires close monitoring of patients in the first 3 weeks during which most reductions were lost.	[Foran, Ian; Upasani, Vidyadhar V.; Wallace, Charles D.; Britt, Elise; Pennock, Andrew T.] Univ Calif San Diego, Dept Orthopaed Surg, San Diego, CA 92103 USA; [Upasani, Vidyadhar V.; Wallace, Charles D.; Bastrom, Tracey P.; Bomar, James D.; Pennock, Andrew T.] Rady Childrens Hosp & Hlth Ctr, Dept Orthoped, San Diego, CA USA		Pennock, AT (corresponding author), 3030 Childrens Way,Suite 410, San Diego, CA 92123 USA.	apennock@rchsd.org	Foran, Ian/AAR-3768-2020; Upasani, Vidyadhar/AAY-6332-2020	Foran, Ian/0000-0002-6805-2275; Upasani, Vidyadhar/0000-0003-2635-9823			Bado J L, 1967, Clin Orthop Relat Res, V50, P71; Bae DS, 2005, OPER TECH ORTHOP, V15, P308, DOI 10.1053/j.oto.2005.08.001; Beutel BG, 2012, ORTHOPEDICS, V35, P138, DOI 10.3928/01477447-20120123-32; David-West KS, 2005, INJURY, V36, P1206, DOI 10.1016/j.injury.2004.12.033; Degreff I, 2004, J ORTHOP TRAUMA, V18, P375, DOI 10.1097/00005131-200407000-00008; Deshpande S, 2001, J ORTHOP TRAUMA, V15, P373, DOI 10.1097/00005131-200106000-00014; DORMANS JP, 1990, ORTHOP CLIN N AM, V21, P251; Guven M, 2008, ACTA ORTHOP TRAUMATO, V42, P90; Hui JHP, 2005, J PEDIATR ORTHOPED, V25, P501, DOI 10.1097/01.bpo.0000158812.37225.b3; Leonidou A, 2012, J PEDIATR ORTHOPED, V32, P352, DOI 10.1097/BPO.0b013e31825611fc; LETTS M, 1985, J BONE JOINT SURG BR, V67, P724, DOI 10.1302/0301-620X.67B5.4055869; Monteggia GB, 1814, INSTITUZIONI CHIRURG, V5, P131; Nakamura K, 2009, J BONE JOINT SURG AM, V91A, P1394, DOI 10.2106/JBJS.H.00644; OLNEY BW, 1989, J PEDIATR ORTHOPED, V9, P219; PEIRO A, 1977, J BONE JOINT SURG AM, V59, P92, DOI 10.2106/00004623-197759010-00017; Perrin J., 1909, THESIS; R Core Team, 2009, R LANG ENV STAT COMP; Ramski DE, 2015, J PEDIATR ORTHOPED, V35, P115, DOI 10.1097/BPO.0000000000000213; Rehim SA, 2014, J HAND SURG-AM, V39, P1384, DOI 10.1016/j.jhsa.2014.02.024; Ring D, 1996, J BONE JOINT SURG BR, V78B, P734, DOI 10.1302/0301-620X.78B5.0780734; Ring D, 1998, J Am Acad Orthop Surg, V6, P215; Ring D, 2013, ORTHOP CLIN N AM, V44, P59, DOI 10.1016/j.ocl.2012.08.007; Rodgers WB, 1996, J BONE JOINT SURG AM, V78A, P1322, DOI 10.2106/00004623-199609000-00005; VINZ H, 1991, ZBL CHIR, V116, P143; WILEY JJ, 1985, J BONE JOINT SURG BR, V67, P728, DOI 10.1302/0301-620X.67B5.4055870	25	12	12	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-6798	1539-2570		J PEDIATR ORTHOPED	J. Pediatr. Orthop.	SEP	2017	37	6					E335	E341		10.1097/BPO.0000000000001001			7	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	FD4FJ	WOS:000407486700001	28520680				2022-02-06	
J	Greer, K; Chen, J; Brickler, T; Gourdie, R; Theus, MH				Greer, Kisha; Chen, Jiang; Brickler, Thomas; Gourdie, Robert; Theus, Michelle H.			Modulation of gap junction-associated Cx43 in neural stem/progenitor cells following traumatic brain injury	BRAIN RESEARCH BULLETIN			English	Article						Cx43; Traumatic brain injury; Neural stem progenitor cell; Gap junction; Apoptosis	ENHANCED HIPPOCAMPAL NEUROGENESIS; COGNITIVE IMPAIRMENT; CONNEXIN EXPRESSION; SUBVENTRICULAR ZONE; ADULT NEUROGENESIS; PROGENITOR CELLS; RADIAL GLIA; PHOSPHORYLATION; HEMICHANNELS; ACTIVATION	Restoration of learning and memory deficits following traumatic brain injury (TBI) is attributed, in part, to enhanced neural stem/progenitor cell (NSPCs) function. Recent findings suggest gap junction (GJ)-associated connexin 43 (Cx43) plays a key role in the cell cycle regulation and function of NSPCs and is modulated following TBI. Here, we demonstrate that Cx43 is up-regulated in the dentate gyrus following TBI and is expressed on vimentin-positive cells in the subgranular zone. To test the role of Cx43 on NSPCs, we exposed primary cultures to the alpha-connexin Carboxyl Terminal (alpha CT1) peptide which selectively modulates GJ-associated Cx43. Treatment with alpha CT1 substantially reduced proliferation and increased caspase 3/7 expression on NSPCs in a dose-dependent manner. alpha CT1 exposure also reduced overall expression of Cx43 and phospho (p)-Serine368. These findings demonstrate that Cx43 positively regulates adult NPSCs; the modulation of which may influence changes in the dentate gyrus following TBI.	[Greer, Kisha; Chen, Jiang; Brickler, Thomas; Theus, Michelle H.] Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, 215 Duck Pond Dr, Blacksburg, VA 24061 USA; [Gourdie, Robert] Virgnia Tech Carillion Res Inst, Coll Med, 2 Riverside Circle, Roanoke, VA 24016 USA		Theus, MH (corresponding author), Virginia Tech, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Duck Pond Dr 0442, Blacksburg, VA 24061 USA.	mtheus@vt.edu			VT's Institute of Critical Technology and Science; Virginia Maryland College of Veterinary Medicine;  [R01 NS096281];  [NS096281];  [R15 NS081623]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL056728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS096281, R15NS081623] Funding Source: NIH RePORTER	The authors would like to thank VT-IMSD Programs for student support (K.M.G.). This work was supported by R01 NS096281 (MHT), diversity supplement NS096281 (MHT, KG), R15 NS081623 (MHT) and VT's Institute of Critical Technology and Science. We recognize the Virginia Maryland College of Veterinary Medicine for student and financial support. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or any other funding agency.	Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Baumann G, 2013, EXP BIOL MED, V238, P830, DOI 10.1177/1535370213494558; Bittman K, 1997, J NEUROSCI, V17, P7037; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Brickler T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6373506; Cameron SJ, 2003, J BIOL CHEM, V278, P18682, DOI 10.1074/jbc.M213283200; Cheng AW, 2004, DEV BIOL, V272, P203, DOI 10.1016/j.ydbio.2004.04.031; Cina C, 2009, J NEUROSCI, V29, P2009, DOI 10.1523/JNEUROSCI.5025-08.2009; Contreras JE, 2004, BRAIN RES REV, V47, P290, DOI 10.1016/j.brainresrev.2004.08.002; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P31, DOI 10.3322/caac.21320; Dixon KJ, 2015, J NEUROTRAUM, V32, P753, DOI 10.1089/neu.2014.3390; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Eungdamrong NJ, 2004, BIOL CELL, V96, P355, DOI 10.1016/j.biolcel.2004.03.004; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Freitas AS, 2012, DEV NEUROBIOL, V72, P1482, DOI 10.1002/dneu.22005; Ghatnekar GS, 2009, REGEN MED, V4, P205, DOI 10.2217/17460751.4.2.205; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Grek CL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1229-6; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Han XD, 2011, J NEUROTRAUM, V28, P995, DOI 10.1089/neu.2010.1563; Hoang QV, 2010, MOL VIS, V16, P1343; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Kennedy KL, 2003, MOL REPROD DEV, V64, P61, DOI 10.1002/mrd.10219; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kunze A, 2009, P NATL ACAD SCI USA, V106, P11336, DOI 10.1073/pnas.0813160106; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Lemcke H, 2013, CELL SIGNAL, V25, P2676, DOI 10.1016/j.cellsig.2013.08.030; Leuner B, 2010, ANNU REV PSYCHOL, V61, P111, DOI 10.1146/annurev.psych.093008.100359; Li Shang-Xun, 2011, Fa Yi Xue Za Zhi, V27, P286; Liebmann M, 2013, NEUROSCI LETT, V545, P40, DOI 10.1016/j.neulet.2013.04.013; MALDONADO PE, 1988, J MEMBRANE BIOL, V106, P203, DOI 10.1007/BF01872158; Naus CC, 2016, SEMIN CELL DEV BIOL, V50, P59, DOI 10.1016/j.semcdb.2015.12.008; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; Plotkin LI, 2002, J BIOL CHEM, V277, P8648, DOI 10.1074/jbc.M108625200; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Saez JC, 2005, BBA-BIOMEMBRANES, V1711, P215, DOI 10.1016/j.bbamem.2005.01.014; Santopietro John, 2015, N C Med J, V76, P96; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Smyth JW, 2013, CELL REP, V5, P611, DOI 10.1016/j.celrep.2013.10.009; Soder BL, 2009, PLAST RECONSTR SURG, V123, P1440, DOI 10.1097/PRS.0b013e3181a0741d; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Sun D, 2014, NEURAL REGEN RES, V9, P688, DOI 10.4103/1673-5374.131567; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Sun LQ, 2015, BEHAV BRAIN RES, V291, P315, DOI 10.1016/j.bbr.2015.05.049; Sun LQ, 2014, NEUROL SCI, V35, P677, DOI 10.1007/s10072-013-1575-6; Sun Y, 2012, INT J ONCOL, V41, P941, DOI 10.3892/ijo.2012.1524; Sutor B, 2005, BBA-BIOMEMBRANES, V1719, P59, DOI 10.1016/j.bbamem.2005.09.005; Sutor Bernd, 2002, Results Probl Cell Differ, V39, P53; Swanson T.M., 2017, PUBLIC HLTH REP; Theus MH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.165; Theus M. H., 2012, CURR PROTOC STEM CEL, V2; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Ueki T, 2001, NEUROSCI LETT, V313, P53, DOI 10.1016/S0304-3940(01)02249-2; Vikhamar G, 1998, CELL ADHES COMMUN, V5, P451, DOI 10.3109/15419069809005603; Whiting M.D., 2006, ANIMAL MODELCOGNIT; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579; Zhou JZ, 2014, FEBS LETT, V588, P1186, DOI 10.1016/j.febslet.2014.01.001	71	12	14	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	SEP	2017	134						38	46		10.1016/j.brainresbull.2017.06.016			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FI3HA	WOS:000411847400006	28648814	Green Accepted, Green Published, hybrid			2022-02-06	
J	Landes, M; Venugopal, R; Berman, S; Heffernan, S; Maskalyk, J; Azazh, A				Landes, Megan; Venugopal, Raghu; Berman, Sara; Heffernan, Spencer; Maskalyk, James; Azazh, Aklilu			Epidemiology, clinical characteristics and outcomes of head injured patients in an Ethiopian emergency centre	AFRICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Head injury; Emergency medicine; Low resource setting; Epidemiology; Outcomes	TRAUMATIC BRAIN-INJURY; COUNTRIES; CARE	Introduction: Head injury is a leading cause of mortality in Africa. We characterise the epidemiology and outcomes of head injury at an Ethiopian emergency centre. Methods: We conducted a prospective cohort study of all head injured patients presenting to the Emergency Centre of Tikur Anbessa Specialised Hospital, Addis Ababa. Data was collected via a standardised form from the patient's chart, radiology reports and operative reports. Patients were followed until discharge, facility transfer, death, or 7 days in hospital. Consent was obtained from the patient or substitute decision maker. Results: Among 204 head injured patients enrolled, the majority were < 30 years old (51.0%) and male (86.8%). Forty-one percent of injuries occurred from road traffic accidents (RTAs). A significant number of patients had at least one indicator of severe injury on presentation: 51 (25.0%) had a GCS < 9, 53 (26.0%) had multi-system trauma, 95 (46.6%) had >= 1 abnormal vital sign and of the 133 patients with data available, 37 (27.8%) had a Revised Trauma Score (RTS) < 6. Patients injured by RTA were more likely to have indicators of severe injury than other mechanisms, including multi-system trauma (OR 3.2, 95% CI 1.7-6.2, p = 0.00), GCS < 9 (OR 3.7, 95% CI 1.8-7.4, p = 0.00), >= 1 abnormal vital sign (OR 2.5, 95% CI 1.4-4.6, p = 0.00) or an RTS score < 6 (OR 3.6, 95% CI 1.6-8.1, p = 0.00). Overall, 149 (73.0%) patients were discharged from hospital, 34 (16.7%) were transferred to another hospital, and 21 patients died (10.3%). In multivariable analysis, death was significantly associated with age over 60 years (aOR 68.8, 95% CI 2.0-2329.0, p = 0.02), GCS < 9 (aOR 14.8, 95% CI 2.2-99.5, p = 0.01), fixed bilateral pupils (aOR 39.1, 95% CI 4.2-362.8, p < 0.01) and hypoxia (oxygen saturation < 90%; aOR 14.2%, 95% CI 2.6-123.9, p = 0.01). Conclusion: Head injury represents a significant risk for morbidity and mortality in Ethiopia, of which RTA's increase injury severity. Targeted approaches to improving care of the injured may improve outcomes. (C) 2017 Publishing services provided by Elsevier B.V. on behalf of African Federation for Emergency Medicine.	[Landes, Megan; Venugopal, Raghu; Berman, Sara; Maskalyk, James] Univ Toronto, Global Hlth Emergency Med, Toronto, ON, Canada; [Landes, Megan] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Landes, Megan; Venugopal, Raghu; Berman, Sara] Univ Hlth Network, Toronto, ON, Canada; [Venugopal, Raghu; Maskalyk, James] Univ Toronto, Dept Med, Toronto, ON, Canada; [Heffernan, Spencer] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Maskalyk, James] St Michaels Hosp, Toronto, ON, Canada; [Azazh, Aklilu] Addis Ababa Univ, Sch Med, Dept Emergency Med, Addis Ababa, Ethiopia		Landes, M (corresponding author), Univ Toronto, Global Hlth Emergency Med, Toronto, ON, Canada.; Landes, M (corresponding author), Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada.; Landes, M (corresponding author), Univ Hlth Network, Toronto, ON, Canada.	mclandes@gmail.com			University Health Network Emergency Department Research Committee	The authors would like to thank University Health Network Emergency Department Research Committee who provided generous support for this project.	Adeleye AO, 2009, NEUROEPIDEMIOLOGY, V32, P136, DOI 10.1159/000182821; Azazh Aklilu, 2014, Ethiop Med J, VSuppl 2, P1; Biluts Hagos, 2009, Ethiop Med J, V47, P135; Cadotte DW, 2010, WORLD NEUROSURG, V73, P270, DOI 10.1016/j.wneu.2010.02.017; Chalya Phillipo L, 2011, Tanzan J Health Res, V13, P74; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Charles Mock CJ, 2010, STRENGTHENING CARE I; Chesnut RM, 2000, EARLY INDICATORS PRO; Chowdhury T, 2014, SAUDI J ANAESTH, V8, P114, DOI 10.4103/1658-354X.125971; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; El-Gindi S., 2001, REV ESPANOLA NEUROPS, V3, P3; Emejulu J K C, 2008, Afr J Med Med Sci, V37, P383; Emejulu JKC, 2010, E CENT AFR J SURG, V15, P28; Georgoff P, 2010, WORLD NEUROSURG, V74, P331, DOI 10.1016/j.wneu.2010.03.025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hunchak C, 2015, ETHIOP BMC RES NOTES, V8, P605, DOI DOI 10.1186/s13104-015-1592-z; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Minardi J, 2009, MT SINAI J MED, V76, P138, DOI 10.1002/msj.20105; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Mwang'ombe N J, 2001, East Afr Med J, V78, P238; Persson A., 2008, ADV TRANSPORTATION S, V15, P5; Qureshi JS, 2013, INT J SURG, V11, P265, DOI 10.1016/j.ijsu.2013.01.011; Razzak JA, 2002, B WORLD HEALTH ORGAN, V80, P900; Saidi Hassan, 2014, J Trauma Manag Outcomes, V8, P4, DOI 10.1186/1752-2897-8-4; United Nations, 2016, REP SECR GEN PROGR S; World Health Organization, 2013, GLOB STAT REP ROAD S	27	12	13	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2211-419X	2211-4203		AFR J EMERG MED	Afr. J. Emerg. Med.	SEP	2017	7	3					130	134		10.1016/j.afjem.2017.04.001			5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	FN2RT	WOS:000415841900008	30456124	Green Published, gold			2022-02-06	
